Citrus Sinensis ID: 004702

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-----
Protein Sequence
MGCRCSTSRTSTAAAAHAQAKPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTDGYDSVQQLELMAFDYER
Secondary Structure (PSIPRED)
cccccccHHHHccccccccccccccccccccccccccccccccccccccEEEEcccccccccccccccEEEEEEEEccEEEEEEEcccccccccccccccccccccccccEEEccccEEEEEccccEEEEccccccccccccEEccccccccccccccccccccEEEcccccccEEEEEEEcccccccccccccEEEEEEEcccEEEEccccccccccccccEEEEEEEcccccHHHHHHcccccEEccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccEEEEccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHHHccccccccEEEEcHHHHHHHHcccccccccccccEEEEEEcccccEEEEEEcccccHHHHHHHHHHHHHHHHccccccccEEcEEcccccEEEEEEEcccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEEEEEcccccccHHHHcccccccccccccccEEEEEHHccccccccccccccccHHHHHHHHHHcccccccccHHHHccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccEEcccccccc
Secondary Structure Prediction (SSPRO)
cccccHHHHHHHccccccccccccccccccEEEcccccccccccccccEEEEEcccccccccEEccccEEEEEEEcccEEEEEEcccccccccccccccccccccccccEEEEccccEEEEEEcccEEEEEcccccccEEEEEEEEcccccccccccccccccEEcccccccccEEEEEEEcccccccccccccEEEEEEEcccEEccccccccccccccccEEEEEEEEccccHHHHcccccccEEEcccccccccccEEEEccccccccccccccccccHHcccccccccccEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHcccccccEEEEEcHHHHHHHHHcccHEEccccccEEEEEEEccccEEEEEEcEEEcHHHHHHHHHHHHHHHHHHHHHHHHHHcccccEEccEEEEEEcccccHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcHHHcEEEcccccEEccccccEEccccccccHHHccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHccHHHHHcHHHHccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccccccccccccHHcccccccccccccccccccccccccccccccccccEEEEEccccc
Coil and Loop (DISEMBL)
mgcrcstsrtSTAAAAHaqakprcpnrcgdveipypfgtkrgcflnkdflitcndtlnppkpflrkssiEVVNISIDGHLNVMQYTAKVcydakgysvdsnlpyitlskftfsrtgnKFVVIGCDSYAYVLGFlgedryksgctstcdsldyvtngscvgtgccqieipgglKELEVEAFSfknhtkvssfnpctyafvvdqsqfhftsnylalggirdefpmvldweIITDKTCeeakicglnascdtpkdntstssgyrckcnkgyegnpylsdgcrdvnecedpsrnncthicdnipgsytcrcrkgfhgdgrkdgggctpnqYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSklhgqssekakiFTEEEIKTVTNNyadvigcggsgnvykgflpdrtpvavkkskfvdqAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYlhsetnvpiihrdvksanilldenctpkvsdfgasklvpidaiqnctvvqgtlgyldpeylqtckltdksdvySFGVVLVELLTGkmallsdkpeEERSLAMNFLSSLKQNRLLEIldnrivndgNKQQLKEVAKLAARCISvrgeerptmKEVSLELQGRLslmsngqyylrdnvesngvqeteYFTSTFYecrngigshttptdgydsVQQLELMAFDYER
Flexible Loop (DISEMBL)
mgcrcstsrtstaaaahaqakprcpnrcgDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKIcglnascdtpkdntstssgyrckcNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGdgrkdgggcTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHkkgnlswerRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCIsvrgeerptmkeVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGshttptdgydsVQQLELMAFDYER
Low Complexity Region (SEG)
MGcrcstsrtstaaaahaqakprcPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCrkgfhgdgrkdgggCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTDGYDSVQQLELMAFDYER
Disordered region (IsUnstruct)
*************************NRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKICGLNASCD**********GYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNG**I*****************IFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL***********MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVR*************LQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTDGY***************
Disordered Region (DISOPRED)
*****************************DVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDG**********QYTVIKVALGVGISFVVAIMSISWLHFLWT***********************************KIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL****EEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG********************************************************M****E*
Disordered Region (DISEMBL)
***********************CPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKICGLNASCDT**********YRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSK********AKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTDGYDSVQQLELMAFDYER
Disordered Region (DISPRO)
**********************RCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM*****************************************GYDSVQQLELMAFD***
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGCRCSTSRTSTAAAAHAQAKPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTDGYDSVQQLELMAFDYER
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	735	2.2.26 [Sep-21-2011]
Q9LMP1	732	Wall-associated receptor	yes	no	0.940	0.943	0.445	1e-169
Q9LMN7	733	Wall-associated receptor	no	no	0.934	0.937	0.427	1e-157
Q9LMN8	741	Wall-associated receptor	no	no	0.927	0.920	0.422	1e-156
Q9LMN6	738	Wall-associated receptor	no	no	0.941	0.937	0.413	1e-155
Q39191	735	Wall-associated receptor	no	no	0.923	0.923	0.413	1e-154
Q7X8C5	748	Wall-associated receptor	no	no	0.847	0.832	0.381	1e-117
Q9SA25	720	Wall-associated receptor	no	no	0.863	0.881	0.379	1e-115
Q9LN59	788	Putative wall-associated	no	no	0.836	0.780	0.390	1e-114
Q8RY17	751	Wall-associated receptor	no	no	0.868	0.849	0.388	1e-114
Q9LMT9	764	Putative wall-associated	no	no	0.838	0.806	0.371	1e-112

>sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1

 Score =  595 bits (1535), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 328/737 (44%), Positives = 465/737 (63%), Gaps = 46/737 (6%)

Query: 18  AQAKPRCPNRCGDVEIPYPFGTKRGCFLNKD--FLITCNDTLNPPKPFLRKSSIEVVNIS 75
            Q +  C  RCG+V + YPFGT  GC+   D  F +TCN+     K F    ++ V+N+S
Sbjct: 23  GQPRKECQTRCGNVAVEYPFGTSPGCYYPGDESFNLTCNEQ---EKLFF--GNMPVINMS 77

Query: 76  IDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLG 135
           + G L V    ++VCYD++G   D      TL  FT S   N+F V+GC+SYA+ L   G
Sbjct: 78  LSGQLRVRLVRSRVCYDSQGKQTDYIAQRTTLGNFTLSEL-NRFTVVGCNSYAF-LRTSG 135

Query: 136 EDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCT 195
            ++Y +GC S CDS     NGSC G GCCQI +P G   + V+  SF NH  V  FNPCT
Sbjct: 136 VEKYSTGCISICDSAT-TKNGSCSGEGCCQIPVPRGYSFVRVKPHSFHNHPTVHLFNPCT 194

Query: 196 YAFVVDQSQFHFTSNYLALGGIRD--EFPMVLDWEIITDKTCEEAK---ICGLNASCDTP 250
           YAF+V+   F F +    L  +R+   FP+VLDW I  DKTC++ +   +CG N++C   
Sbjct: 195 YAFLVEDGMFDFHA-LEDLNNLRNVTTFPVVLDWSI-GDKTCKQVEYRGVCGGNSTCF-- 250

Query: 251 KDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTH--ICDNIPGSYTCRCR 308
             +++  +GY CKC +G+EGNPYL +GC+D+NEC   SR+NC+    C+N  GS+ C C 
Sbjct: 251 --DSTGGTGYNCKCLEGFEGNPYLPNGCQDINECIS-SRHNCSEHSTCENTKGSFNCNCP 307

Query: 309 KGFHGDGRKDG-GGCT----PNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLK 363
            G+    RKD    CT    P  +   ++ LG  I F V ++ IS L      R++ +L+
Sbjct: 308 SGY----RKDSLNSCTRKVRPEYFRWTQIFLGTTIGFSVIMLGISCLQQKIKHRKNTELR 363

Query: 364 EKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGF 421
           +KFFEQNGG +L Q +S   G S+   KIFTE+ +K  TN Y +  ++G GG G VYKG 
Sbjct: 364 QKFFEQNGGGMLIQRVSGA-GPSNVDVKIFTEKGMKEATNGYHESRILGQGGQGTVYKGI 422

Query: 422 LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN 481
           LPD + VA+KK++  +++++++FINE++V+ QIN RNVV++LGCCLET+VPLLVYEF+ +
Sbjct: 423 LPDNSIVAIKKARLGNRSQVEQFINEVLVLSQINHRNVVKVLGCCLETEVPLLVYEFINS 482

Query: 482 GTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT 538
           GTLF+H+H      +L+WE RLRI  E AG L+YLHS  ++PIIHRD+K+ANILLD+N T
Sbjct: 483 GTLFDHLHGSLYDSSLTWEHRLRIATEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLT 542

Query: 539 PKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            KV+DFGAS+L+P+D  Q  T+VQGTLGYLDPEY  T  L +KSDVYSFGVVL+ELL+G+
Sbjct: 543 AKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQ 602

Query: 599 MALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGE 658
            AL  ++P   ++L   F S+ K NR  EI+D +++N+ N+++++E A++AA C  + GE
Sbjct: 603 KALCFERPHCPKNLVSCFASATKNNRFHEIIDGQVMNEDNQREIQEAARIAAECTRLMGE 662

Query: 659 ERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTD 718
           ERP MKEV+ EL+     +   +Y   D     G  E E+          G    T+ + 
Sbjct: 663 ERPRMKEVAAELEAL--RVKTTKYKWSDQYRETG--EIEHLLGVQILSAQG---ETSSSI 715

Query: 719 GYDSVQQLELMAFDYER 735
           GYDS++ +  +  +  R
Sbjct: 716 GYDSIRNVTTLDIEAGR 732

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1

 Score =  557 bits (1435), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 317/742 (42%), Positives = 454/742 (61%), Gaps = 55/742 (7%)

Query: 18  AQAKPRCPNRCGDVEIPYPFGTKRGCFLNKD--FLITCNDTLNPPKPFLRKSSIEVVNIS 75
           AQ +  C  RCGDV I YPFG   GC+   D  F ITC +     KP +  S+IEV+N +
Sbjct: 23  AQPRDDCQTRCGDVPIDYPFGISTGCYYPGDDSFNITCEED----KPNVL-SNIEVLNFN 77

Query: 76  IDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLG 135
             G L  +   + VCYD +  + D    +  L   +FS   NKF ++GC+++A +L   G
Sbjct: 78  HSGQLRGLIPRSTVCYDQQTNN-DFESLWFRLDNLSFS-PNNKFTLVGCNAWA-LLSTFG 134

Query: 136 EDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIE--IPGGLKELEVEAFSFKNHTKVSSFNP 193
              Y +GC S CD+     N  C G GCC+ E  IP     +E +   F+N T V  FNP
Sbjct: 135 IQNYSTGCMSLCDTPP-PPNSKCNGVGCCRTEVSIPLDSHRIETQPSRFENMTSVEHFNP 193

Query: 194 CTYAFVVDQSQFHFTSNYLALGGIRD-----EFPMVLDWEIITDKTCEEA---KICGLNA 245
           C+YAF V+   F+F+S    L  ++D      FP++LDW I  ++TCE+     ICG N+
Sbjct: 194 CSYAFFVEDGMFNFSS----LEDLKDLRNVTRFPVLLDWSI-GNQTCEQVVGRNICGGNS 248

Query: 246 SCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRN-NCTHICDNIPGSYT 304
           +C     +++   GY CKC +G++GNPYLSDGC+D+NEC     N + T  C+N  GS+ 
Sbjct: 249 TCF----DSTRGKGYNCKCLQGFDGNPYLSDGCQDINECTTRIHNCSDTSTCENTLGSFH 304

Query: 305 CRCRKGFHGDGRKDGGGCT------PNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRR 358
           C+C  G   D       C       P       V LG  I F++ +++IS++      R+
Sbjct: 305 CQCPSG--SDLNTTTMSCIDTPKEEPKYLGWTTVLLGTTIGFLIILLTISYIQQKMRHRK 362

Query: 359 HMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGN 416
           + +L+++FFEQNGG +L Q LS   G S+   KIFTEE +K  T+ Y +  ++G GG G 
Sbjct: 363 NTELRQQFFEQNGGGMLIQRLSGA-GPSNVDVKIFTEEGMKEATDGYNESRILGQGGQGT 421

Query: 417 VYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY 476
           VYKG L D + VA+KK++  D++++++FINE++V+ QIN RNVV+LLGCCLET+VPLLVY
Sbjct: 422 VYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVY 481

Query: 477 EFVGNGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           EF+ +GTLF+H+H      +L+WE RLRI  E AG L+YLHS  ++PIIHRDVK+ANILL
Sbjct: 482 EFISSGTLFDHLHGSMFDSSLTWEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANILL 541

Query: 534 DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVE 593
           DEN T KV+DFGAS+L+P+D  Q  T+VQGTLGYLDPEY  T  L +KSDVYSFGVVL+E
Sbjct: 542 DENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLME 601

Query: 594 LLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCI 653
           LL+G+ AL  ++P+  + L   F+S++K+NRL EI+D +++N+ N+++++E A++A  C 
Sbjct: 602 LLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEIIDGQVMNEYNQREIQESARIAVECT 661

Query: 654 SVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSH 713
            + GEERP+MKEV+ EL+      +  Q+           +E E+          G    
Sbjct: 662 RIMGEERPSMKEVAAELEALRVKTTKHQW------SDQYPKEVEHLLGVQILSTQG---- 711

Query: 714 TTPTDGYDSVQQLELMAFDYER 735
            T + GYDS+Q +  +  +  R
Sbjct: 712 DTSSIGYDSIQNVTRLDIETGR 733

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2

 Score =  553 bits (1425), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 319/755 (42%), Positives = 464/755 (61%), Gaps = 73/755 (9%)

Query: 18  AQAKPR--CPNRCGDVEIPYPFGTKRGCFLNKD--FLITCNDTLNPPKPFLRKSSIEVVN 73
            Q +PR  C  +CG+V I YPFG   GC+   D  F +TC       +  L    I+V N
Sbjct: 23  GQHQPREDCKLKCGNVTIEYPFGISTGCYYPGDDNFNLTCV----VEEKLLLFGIIQVTN 78

Query: 74  ISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGF 133
           IS  GH++V+      CY+ K  +  + L Y   S F+ S + NKF ++GC++ + +L  
Sbjct: 79  ISHSGHVSVLFERFSECYEQKNETNGTALGYQLGSSFSLS-SNNKFTLVGCNALS-LLST 136

Query: 134 LGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIE---IPGGLKELEVEAFSFKNH----- 185
            G+  Y +GC S C+S     NG C G GCC  E   +P      +  +   +N      
Sbjct: 137 FGKQNYSTGCLSLCNSQPEA-NGRCNGVGCCTTEDFSVPFDSDTFQFGSVRLRNQVNNSL 195

Query: 186 ----TKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRD--EFPMVLDWEIITDKTCEEA- 238
               T V  FNPCTYAF+V+  +F+F S+   L  +R+   FP+ LDW I  ++TCE+A 
Sbjct: 196 DLFNTSVYQFNPCTYAFLVEDGKFNFDSSK-DLKNLRNVTRFPVALDWSI-GNQTCEQAG 253

Query: 239 --KICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCT--H 294
             +ICG N+SC     N++T +GY CKCN+GY+GNPY S+GC+D++EC   + +NC+   
Sbjct: 254 STRICGKNSSCY----NSTTRNGYICKCNEGYDGNPYRSEGCKDIDECISDT-HNCSDPK 308

Query: 295 ICDNIPGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLW 354
            C N  G + C+C  G+  +       CT  +Y   ++ L + I  +V +++   +    
Sbjct: 309 TCRNRDGGFDCKCPSGYDLNSSMS---CTRPEYKRTRIFLVIIIGVLVLLLAAICIQHAT 365

Query: 355 TRRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCG 412
            +R++ KL+ +FFEQNGG +L Q LS   G S+   KIFTEE +K  TN Y +  ++G G
Sbjct: 366 KQRKYTKLRRQFFEQNGGGMLIQRLSGA-GLSNIDFKIFTEEGMKEATNGYDESRILGQG 424

Query: 413 GSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP 472
           G G VYKG LPD T VA+KK++  D  ++D+FI+E++V+ QIN RNVV++LGCCLET+VP
Sbjct: 425 GQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQINHRNVVKILGCCLETEVP 484

Query: 473 LLVYEFVGNGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           LLVYEF+ NGTLF+H+H      +L+WE RLRI  E AG L+YLHS  ++PIIHRD+K+A
Sbjct: 485 LLVYEFITNGTLFDHLHGSIFDSSLTWEHRLRIAIEVAGTLAYLHSSASIPIIHRDIKTA 544

Query: 530 NILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGV 589
           NILLDEN T KV+DFGASKL+P+D  Q  T+VQGTLGYLDPEY  T  L +KSDVYSFGV
Sbjct: 545 NILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTTGLLNEKSDVYSFGV 604

Query: 590 VLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLA 649
           VL+ELL+G+ AL  ++P+  + L   F+S+ ++NRL EI+D++++N+ N ++++E A++A
Sbjct: 605 VLMELLSGQKALCFERPQASKHLVSYFVSATEENRLHEIIDDQVLNEDNLKEIQEAARIA 664

Query: 650 ARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFY--ECR 707
           A C  + GEERP MKEV+ +L+            LR       V++T++  S  Y  E  
Sbjct: 665 AECTRLMGEERPRMKEVAAKLEA-----------LR-------VEKTKHKWSDQYPEENE 706

Query: 708 NGIGSH-------TTPTDGYDSVQQLELMAFDYER 735
           + IG H       T+ + GYDS++ + ++  +  R
Sbjct: 707 HLIGGHILSAQGETSSSIGYDSIKNVAILDIETGR 741

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1

 Score =  548 bits (1411), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 307/743 (41%), Positives = 449/743 (60%), Gaps = 51/743 (6%)

Query: 18  AQAKPRCPNRCGDVEIPYPFGTKRGCFLNKD--FLITC-NDTLNPPKPFLRKSSIEVVNI 74
            Q  PRCP +CG+V + YPFG   GC+  +D  F ++C N+ L     F +   +EVV I
Sbjct: 22  GQTLPRCPEKCGNVTLEYPFGFSPGCWRAEDPSFNLSCVNENL-----FYK--GLEVVEI 74

Query: 75  SIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFL 134
           S    L V+   + +CY++KG        +  L   T S   N    +GC+SYA+V    
Sbjct: 75  SHSSQLRVLYPASYICYNSKGKFAKGTYYWSNLGNLTLSGN-NTITALGCNSYAFVSSN- 132

Query: 135 GEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVS--SFN 192
           G  R   GC S CD+L +  NG C G GCCQ  +P G   L V ++ F N T V   S  
Sbjct: 133 GTRRNSVGCISACDALSHEANGECNGEGCCQNPVPAGNNWLIVRSYRFDNDTSVQPISEG 192

Query: 193 PCTYAFVVDQSQFHFTSN--YLALGGIRDEFPMVLDWEIITDKTCEEA--KICGLNASCD 248
            C YAF+V+  +F + ++  Y  L      FP+VLDW I   +TC +   K CG+N  C 
Sbjct: 193 QCIYAFLVENGKFKYNASDKYSYLQNRNVGFPVVLDWSI-RGETCGQVGEKKCGVNGICS 251

Query: 249 TPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPS---RNNCT--HICDNIPGSY 303
               N+++  GY CKC  G++GNPYL +GC+D+NEC   +   ++NC+    C+N  G +
Sbjct: 252 ----NSASGIGYTCKCKGGFQGNPYLQNGCQDINECTTANPIHKHNCSGDSTCENKLGHF 307

Query: 304 TCRCRKGFHGDGRKDGGGCTPN------QYTVIKVALGVGISFVVAIMSISWLHFLWTRR 357
            C CR  +  +   +   C P       ++T I   LG  I F+V +++IS +       
Sbjct: 308 RCNCRSRYELNTTTNT--CKPKGNPEYVEWTTI--VLGTTIGFLVILLAISCIEHKMKNT 363

Query: 358 RHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSG 415
           +  +L+++FFEQNGG +L Q LS   G S+   KIFTEE +K  T+ Y +  ++G GG G
Sbjct: 364 KDTELRQQFFEQNGGGMLMQRLSGA-GPSNVDVKIFTEEGMKEATDGYDENRILGQGGQG 422

Query: 416 NVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV 475
            VYKG LPD + VA+KK++  D +++++FINE++V+ QIN RNVV+LLGCCLET+VPLLV
Sbjct: 423 TVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLV 482

Query: 476 YEFVGNGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANIL 532
           YEF+ +GTLF+H+H      +L+WE RLR+  E AG L+YLHS  ++PIIHRD+K+ANIL
Sbjct: 483 YEFISSGTLFDHLHGSMFDSSLTWEHRLRMAVEIAGTLAYLHSSASIPIIHRDIKTANIL 542

Query: 533 LDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLV 592
           LDEN T KV+DFGAS+L+P+D     T+VQGTLGYLDPEY  T  L +KSDVYSFGVVL+
Sbjct: 543 LDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLM 602

Query: 593 ELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARC 652
           ELL+G+ AL  ++P+  + +   F S+ K+NRL EI+D +++N+ N++++++ A++A  C
Sbjct: 603 ELLSGQKALCFERPQTSKHIVSYFASATKENRLHEIIDGQVMNENNQREIQKAARIAVEC 662

Query: 653 ISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGS 712
             + GEERP MKEV+ EL+  L +      +  +  E    ++TE+          G   
Sbjct: 663 TRLTGEERPGMKEVAAELEA-LRVTKTKHKWSDEYPEQ---EDTEHLVGVQKLSAQG--- 715

Query: 713 HTTPTDGYDSVQQLELMAFDYER 735
            T+ + GYDS++ + ++  +  R
Sbjct: 716 ETSSSIGYDSIRNVAILDIEAGR 738

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2

 Score =  546 bits (1406), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 309/747 (41%), Positives = 453/747 (60%), Gaps = 68/747 (9%)

Query: 19  QAKPRCPNRCGDVEIPYPFGTKRGCFL--NKDFLITCNDTLNPPKPFLRKSSIEVVNISI 76
           Q    C N+CG++ I YPFG   GC+   N+ F ITC +     +P +  S IEV N + 
Sbjct: 27  QPGENCQNKCGNITIEYPFGISSGCYYPGNESFSITCKE----DRPHVL-SDIEVANFNH 81

Query: 77  DGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGE 136
            G L V+   +  CYD +G   + +  + TL   + S   NK   +GC++ + +L   G 
Sbjct: 82  SGQLQVLLNRSSTCYDEQGKKTEEDSSF-TLENLSLS-ANNKLTAVGCNALS-LLDTFGM 138

Query: 137 DRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFS--FKNHTKVSSFNPC 194
             Y + C S CDS     +G C G GCC++++   L     E  S   K+ T    F+PC
Sbjct: 139 QNYSTACLSLCDSPPEA-DGECNGRGCCRVDVSAPLDSYTFETTSGRIKHMTSFHDFSPC 197

Query: 195 TYAFVVDQSQFHFTS--NYLALGGIRDEFPMVLDWEIITDKTCEEA---KICGLNASC-- 247
           TYAF+V+  +F+F+S  + L L  +   FP++LDW +  ++TCE+     ICG N++C  
Sbjct: 198 TYAFLVEDDKFNFSSTEDLLNLRNVM-RFPVLLDWSV-GNQTCEQVGSTSICGGNSTCLD 255

Query: 248 DTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPS---RNNCT--HICDNIPGS 302
            TP++      GY C+CN+G++GNPYLS GC+DVNEC   S   R+NC+    C N  G 
Sbjct: 256 STPRN------GYICRCNEGFDGNPYLSAGCQDVNECTTSSTIHRHNCSDPKTCRNKVGG 309

Query: 303 YTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKL 362
           + C+C+ G+  D       C   ++    + L   I F+V ++ ++ +       +  KL
Sbjct: 310 FYCKCQSGYRLDTTT--MSCKRKEFAWTTILLVTTIGFLVILLGVACIQQRMKHLKDTKL 367

Query: 363 KEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKG 420
           +E+FFEQNGG +L Q LS   G S+   KIFTE+ +K  TN YA+  ++G GG G VYKG
Sbjct: 368 REQFFEQNGGGMLTQRLSGA-GPSNVDVKIFTEDGMKKATNGYAESRILGQGGQGTVYKG 426

Query: 421 FLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG 480
            LPD + VA+KK++  D +++++FINE++V+ QIN RNVV+LLGCCLET+VPLLVYEF+ 
Sbjct: 427 ILPDNSIVAIKKARLGDSSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFIT 486

Query: 481 NGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC 537
           NGTLF+H+H      +L+WE RL+I  E AG L+YLHS  ++PIIHRD+K+ANILLD N 
Sbjct: 487 NGTLFDHLHGSMIDSSLTWEHRLKIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDVNL 546

Query: 538 TPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           T KV+DFGAS+L+P+D  +  T+VQGTLGYLDPEY  T  L +KSDVYSFGVVL+ELL+G
Sbjct: 547 TAKVADFGASRLIPMDKEELETMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSG 606

Query: 598 KMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRG 657
           + AL   +P+  + L   F ++ K+NRL EI+   ++N+ N ++++E A++AA C  + G
Sbjct: 607 QKALCFKRPQSSKHLVSYFATATKENRLDEIIGGEVMNEDNLKEIQEAARIAAECTRLMG 666

Query: 658 EERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFY--ECRNGIGSH-- 713
           EERP MKEV+ +L+            LR       V++T++  S  Y  E  + IG H  
Sbjct: 667 EERPRMKEVAAKLEA-----------LR-------VEKTKHKWSDQYPEENEHLIGGHIL 708

Query: 714 -----TTPTDGYDSVQQLELMAFDYER 735
                T+ + GYDS++ + ++  +  R
Sbjct: 709 SAQGETSSSIGYDSIKNVAILDIETGR 735

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1

 Score =  423 bits (1088), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 267/700 (38%), Positives = 385/700 (55%), Gaps = 77/700 (11%)

Query: 13  AAAAHAQAKPRCPNRCGDVEIPYPFGTK-RGCFLNKDFLITCNDTLNPPKPFLRKSSIEV 71
             ++  Q   RC   CG++ IP+PFG   + C+LN  + + CN T +   PFL + + E+
Sbjct: 24  GVSSARQPPDRCNRVCGEISIPFPFGIGGKDCYLNPWYEVVCNSTNS--VPFLSRINREL 81

Query: 72  VNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTG--------NKFVVIG 123
           VNIS++G +++     K    + G S  ++ P +T      +  G        N  V +G
Sbjct: 82  VNISLNGVVHI-----KAPVTSSGCSTGTSQP-LTPPPLNVAGQGSPYFLTDKNLLVAVG 135

Query: 124 CDSYAYVLGFLGEDRYKSGCTSTCDSLDYVT----NGSCVGTGCCQIEIPGGLKELEVEA 179
           C   A + G   +    + C S+C+  +  +    N  C G  CCQ  IP G  ++    
Sbjct: 136 CKFKAVMAGITSQ---ITSCESSCNERNSSSQEGRNKICNGYKCCQTRIPEGQPQVISVD 192

Query: 180 FSFKNHTKVSSFNPCTYAF----------VVDQSQFHFTSNYLALGGIRDEFPMVLDWEI 229
                    +    C  AF          V +  +FH    Y A+          L W  
Sbjct: 193 IEIPQGNNTTGEGGCRVAFLTSDKYSSLNVTEPEKFH-GHGYAAVE---------LGWFF 242

Query: 230 ITDKTCEEAKICGLNASCDTPKDNT---STSSGY-------RCKCNK-GYEGNPYLSDGC 278
            T  + +   I   NAS  TP  +    S S GY        C CN  GY+GNP+L  GC
Sbjct: 243 DTSDSRDTQPISCKNASDTTPYTSDTRCSCSYGYFSGFSYRDCYCNSPGYKGNPFLPGGC 302

Query: 279 RDVNECE-DPSRNNCT-HICDNIPGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGV 336
            DV+EC+ D  RN C    C N+PG + C+ +K              P Q   +   + +
Sbjct: 303 VDVDECKLDIGRNQCKDQSCVNLPGWFDCQPKK--------------PEQLKRVIQGVLI 348

Query: 337 GISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEE 396
           G + ++    I  L+    +RR +    KFF +NGG +L+Q+L++  G + E ++IF+  
Sbjct: 349 GSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEG-NVEMSRIFSSH 407

Query: 397 EIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           E++  T+N+    V+G GG G VYKG L D   VAVK+SK VD+ +++EFINE+VV+ QI
Sbjct: 408 ELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQI 467

Query: 455 NRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLS 511
           N RN+V+LLGCCLET+VP+LVYEFV NG L + +H + +   ++WE RL I  E AG LS
Sbjct: 468 NHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALS 527

Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           YLHS  + PI HRD+K+ NILLDE    KVSDFG S+ V ID     T V GT GY+DPE
Sbjct: 528 YLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPE 587

Query: 572 YLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN 631
           Y Q+ K T+KSDVYSFGVVLVELLTG+      + EE R LA +F+ ++K+NR+L+I+D+
Sbjct: 588 YFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDD 647

Query: 632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
           RI ++ N  Q+  VA LA RC++ +G++RP M+EVS+EL+
Sbjct: 648 RIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELE 687

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1

 Score =  417 bits (1071), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 270/712 (37%), Positives = 385/712 (54%), Gaps = 77/712 (10%)

Query: 12  TAAAAHAQAKPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNP-PKPFLRKSSIE 70
            AA+    A   C + CG+V +PYPFG  +GC+ NK F I C  + +  P   L +    
Sbjct: 21  AAASTFPLALRNCSDHCGNVSVPYPFGIGKGCYKNKWFEIVCKSSSDQQPILLLPRIRRA 80

Query: 71  VVNISIDGHLNVMQYTA---------KVCYDAKGYSVDS-NL---PYITLSKFTFSRTGN 117
           V + ++    ++  Y             C +  GYS  S NL   P+       F    N
Sbjct: 81  VTSFNLGDPFSISVYNKFYIQSPLKHSGCPNRDGYSSSSLNLKGSPF-------FISENN 133

Query: 118 KFVVIGCDSYAY--VLGFLGEDRYKSGCTSTC--DSLDYV-TNGSCVGTGCCQIEIPGGL 172
           KF  +GC++ A+  V G         GC +TC  +   Y   N SCVG  CCQ+ IP   
Sbjct: 134 KFTAVGCNNKAFMNVTGL-----QIVGCETTCGNEIRSYKGANTSCVGYKCCQMTIP--- 185

Query: 173 KELEVEAFSFKNHTKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRD--EFPMV-LDWEI 229
             L+++ F         +   C  AF+   +QF  + +      + +  E+  + L+W +
Sbjct: 186 PLLQLQVFDATVEKLEPNKQGCQVAFL---TQFTLSGSLFTPPELMEYSEYTTIELEWRL 242

Query: 230 ITDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSR 289
                  +  +C         K NT     Y+C C+ GYEGNPY+  GC+D++EC DP  
Sbjct: 243 DLSYMTSKRVLC---------KGNTFFEDSYQCSCHNGYEGNPYIPGGCQDIDECRDPHL 293

Query: 290 NNC-THICDNIPGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSIS 348
           N C    C N+ GSY  RC K                  T   +  G   S ++ ++   
Sbjct: 294 NKCGKRKCVNVLGSY--RCEK------------------TWPAILSGTLSSGLLLLIFGM 333

Query: 349 WLHFLWTRRRHM-KLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTN--NY 405
           WL     R+R + K K KFF++NGG +L+Q+ S LHG S  + K+F+  +++  T+  N 
Sbjct: 334 WLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHG-SVNRTKVFSSNDLENATDRFNA 392

Query: 406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           + ++G GG G VYKG L D   VAVKKSK + +  ++EFINE++++ QIN RNVV++LGC
Sbjct: 393 SRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGC 452

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPII 522
           CLET+VP+LVYEF+ N  LF+H+H       +SWE RL I  E A  LSYLHS  ++PI 
Sbjct: 453 CLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIY 512

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRDVKS NILLDE    KVSDFG S+ V ID     T+VQGT+GY+DPEYLQ+   T KS
Sbjct: 513 HRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKS 572

Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DVYSFGV+L+ELLTG+  +   + +E R L   FL +++ +RL EILD RI  + +++++
Sbjct: 573 DVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEV 632

Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQ 694
             VAKLA RC+S+  E RPTM++V +EL    S     Q   ++  E   +Q
Sbjct: 633 LAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQAQNGEEHAHIQ 684

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2

 Score =  414 bits (1065), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 282/723 (39%), Positives = 393/723 (54%), Gaps = 108/723 (14%)

Query: 28  CGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISI---DGHLNVMQ 84
           CG++ IPYPFG ++GC+LN+ + I C    N   PFL K  + VVNIS+   DG+ N + 
Sbjct: 38  CGNINIPYPFGIEKGCYLNEWYKIECK---NATYPFLFKMGMAVVNISLPGDDGYNNPVS 94

Query: 85  YTA---KVCYDAKGYSVDS----NLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGED 137
           Y +   K+   + G S D     ++   T S F F   GN  V +GC+S A +      +
Sbjct: 95  YGSIRVKIPITSIGCSRDGKESGSVLNFTDSPFYFG-IGNSLVAVGCNSKASLTNI---N 150

Query: 138 RYKSGCTSTC----------------------DSLDYVT------NG----SCVGTGCCQ 165
             K GC   C                      + L Y +      NG    SC G GCC 
Sbjct: 151 PSKVGCELNCTASKETLPSKSIPFFDKTGCSNNKLPYYSSLCTKNNGEDERSCDGNGCC- 209

Query: 166 IEIPGGLKE-------LEVEAFSFKNHTKVSSFNPCTYAFVVDQ-SQFHFTSNYLALGGI 217
             I G L         + +E+F   N TK+     C  AF+ D  S F   S    L   
Sbjct: 210 --IAGLLDSEAPQVIGINIESFDHGNSTKLE----CRVAFLTDDVSPFSNASEPKRLFAK 263

Query: 218 RDEFPMVLDWEIITDK-------TCEEAKI-------CGLNASCDTPKDNTSTSSGYRCK 263
           R    + L W I T         +C+  K          L  SC       S +    C 
Sbjct: 264 R-YATVSLGWVIQTKNLSFVNSLSCKNTKEYDNSTYNIKLVTSCICNNVTISGTDYANCG 322

Query: 264 CNKGYEGNPYLSDGCRDVNECEDPS---RNNC--THICDNIPGSYTCRCRKGFHGDGRKD 318
           C++GYEGNPYL  GC+D+NEC   S   R NC  +  C N+PG++ C             
Sbjct: 323 CSQGYEGNPYLPGGCKDINECLRNSYGQRQNCRESDTCVNLPGTFNC------------- 369

Query: 319 GGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILRQE 378
                 N+  V  + +G     +V ++ I WL     +RR  K K KFF++NGG +L+Q+
Sbjct: 370 ----IGNKTRVTMIGVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQ 425

Query: 379 LSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKFV 436
           L+   G + EK +IF+  E++  T+N+++  ++G GG G VYKG L D   VAVKKSK V
Sbjct: 426 LNTNKG-NVEKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVV 484

Query: 437 DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN--- 493
           D+ K++EFINE+V++ QIN R+VV+LLGCCLET+VP LVYEF+ NG LF+HIH++ +   
Sbjct: 485 DEDKLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYT 544

Query: 494 LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID 553
            +W  RLRI  + AG LSYLHS  + PI HRD+KS NILLDE    KVSDFG S+ V ID
Sbjct: 545 KTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTID 604

Query: 554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLS-DKPEEERSL 612
                TV+ GT+GY+DPEY  + + TDKSDVYSFGVVLVEL+TG+  +++    +E R L
Sbjct: 605 HTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGL 664

Query: 613 AMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG 672
           A +F  ++K+NR  EI+D RI +    +Q+  VA LA RC++ +G++RP M++V  +L+ 
Sbjct: 665 ADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEK 724

Query: 673 RLS 675
            L+
Sbjct: 725 ILA 727

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1

 Score =  411 bits (1057), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 268/690 (38%), Positives = 383/690 (55%), Gaps = 52/690 (7%)

Query: 12  TAAAAHAQAKPRCPNRCGDVEIPYPFGT-KRGCFLNKDFLITCNDTLNPPK--PFLRKSS 68
           T A +   +   C   CG +EIP+PFG  +R CFLN  + + CN T +     PFL K +
Sbjct: 25  TTAQSPPSSSTSCNRICGGIEIPFPFGIGRRDCFLNDWYEVVCNSTTSGKSLAPFLYKIN 84

Query: 69  IEVVNI----SIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFT--FSRTGNKFVVI 122
            E+V+I    SID    V+   + V            LP     K +  F    N+ V +
Sbjct: 85  RELVSITLRSSIDSSYGVVHIKSPVTSSGCSQRPVKPLPLNLTGKGSPFFITDSNRLVSV 144

Query: 123 GCDSYAYVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKE-LEVEAFS 181
           GCD+ A +      +   +GC S+CD      +  C G  CCQ +IP    + + V+  S
Sbjct: 145 GCDNRALITDI---ESQITGCESSCDGDKSRLDKICGGYTCCQAKIPADRPQVIGVDLES 201

Query: 182 FKNHT------KVSSFNPCTY--AFVVDQSQFHFTS-NYLALGGIRDEFPMVLDWEIITD 232
              +T      KV+     TY  A V +  QF+      + LG   D      D  +   
Sbjct: 202 SGGNTTQGGNCKVAFLTNETYSPANVTEPEQFYTNGFTVIELGWYFD----TSDSRLTNP 257

Query: 233 KTC---EEAKICGLNASCDTPKDNTSTSSGYRCKCNK-GYEGNPYLSDGCRDVNECED-P 287
             C    E  I     SC     N S      C CN+ GY GNPYL  GC D++ECE+  
Sbjct: 258 VGCVNLTETGIYTSAPSCVCEYGNFSGFGYSNCYCNQIGYRGNPYLPGGCIDIDECEEGK 317

Query: 288 SRNNCTHI-CDNIPGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMS 346
             ++C  + C N+PGS+ C      +G G+             +   L +G   +  ++ 
Sbjct: 318 GLSSCGELTCVNVPGSWRCE----LNGVGK----------IKPLFPGLVLGFPLLFLVLG 363

Query: 347 ISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYA 406
           I  L     +RR +  K  FF++NGG +L+Q+L+   G + + +KIF+ +E++  T+N+ 
Sbjct: 364 IWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTT-RGGNVQSSKIFSSKELEKATDNFN 422

Query: 407 --DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
              V+G GG G VYKG L D   VAVK+SK +D+ K++EFINE+ V+ QIN RN+V+L+G
Sbjct: 423 MNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMG 482

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPI 521
           CCLET+VP+LVYE + NG LF+ +H   +   ++W+ RLRI+ E AG L+YLHS  + P+
Sbjct: 483 CCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPV 542

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
            HRDVK+ NILLDE    KVSDFG S+ + +D     T+V GT GYLDPEY QT + TDK
Sbjct: 543 YHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDK 602

Query: 582 SDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ 641
           SDVYSFGVVLVEL+TG+      +PEE R L  +F  ++KQNR+L+I+D+RI      +Q
Sbjct: 603 SDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQ 662

Query: 642 LKEVAKLAARCISVRGEERPTMKEVSLELQ 671
           +  VAKLA RC+S++G++RP M+EVS+EL+
Sbjct: 663 VLAVAKLARRCLSLKGKKRPNMREVSVELE 692

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1

 Score =  406 bits (1043), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 272/733 (37%), Positives = 387/733 (52%), Gaps = 117/733 (15%)

Query: 24  CPNRCGDVEIPYPFGTKR-GCFLNKDFLITCNDTLNPPK--PFLRKSSIEVVNISIDGHL 80
           C ++CGD++IP+PFG    GC+L++ + + C  +    K  PFL K ++EVVNIS+ G  
Sbjct: 26  CTHKCGDIQIPFPFGIGEIGCYLDEWYQVECRPSATSGKVFPFLPKINMEVVNISLPGTN 85

Query: 81  NVMQYT--------AKVCYDAKGYSVDSNLPYITLSKFT----FSRTGNKFVVIGCDSYA 128
           + + YT         K    + G S D N   +TL+ FT    F    N  V +GC++ A
Sbjct: 86  DDIFYTYPSFSSIRVKSPVASMGCSTDGNDSGLTLN-FTETPFFFGDQNNLVAVGCNNKA 144

Query: 129 YVLGFLGEDRYKSGCTSTCD------------------SLDYVTNG-------------- 156
            +      +    GC STC                   S+D VT                
Sbjct: 145 SLTNV---EPTMVGCESTCTTSNNSRSIPFFNKVGCSGSVDSVTRDLLPKNYIPVCSTTK 201

Query: 157 ------SCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVVDQ-------- 202
                  C G GCCQ + P G ++L     +   +  ++    C  AF+ D+        
Sbjct: 202 IQDDTLICNGEGCCQAKAPVGSQQLIGVTITNSTNGNLTKGGGCKVAFLTDEVYTLSNAT 261

Query: 203 --SQFHFTSNYLALGGI----RDEFPMVLDWEII--TDKTCEEAKICGLNASCDTPKDNT 254
              QF      ++LG         F   LD +     DK  +  + C    +CD   ++ 
Sbjct: 262 DPEQFFSKGVTVSLGWFIQTKNHSFLQSLDCQNRGELDKGKKRTRQC----TCD---NHI 314

Query: 255 STSSGY-RCKCNKGYEGNPYLSDGCRDVNECEDPSRNNC-------THICDNIPGSYTCR 306
           ++  GY  C C  GY+GNPY+SD C+D+NEC +  +N C        + C N  G + C 
Sbjct: 315 ASGMGYASCACASGYKGNPYVSDDCQDINECTE-YKNPCGDTRILYRNTCINTSGGHRCI 373

Query: 307 CRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMS--ISWLHFLWTRRRHMKLKE 364
                               Y + +V LG+G  F V I+   I W   L  +RR    K 
Sbjct: 374 -------------------DYHIPEVMLGLGAGFFVLIVGGGIWWWRKLLRKRRMTNRKR 414

Query: 365 KFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFL 422
           KFF++NGG +L+Q+L+   G+  EK K+F+  E++  T+N+ D  VIG GG G VYKG L
Sbjct: 415 KFFKRNGGLLLQQQLNTTQGRV-EKTKLFSSRELEKATDNFNDNRVIGQGGQGTVYKGML 473

Query: 423 PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG 482
            D   VAVKKS  VD+ K+ EFINE++++ QIN R+VV+LLGCCLET+VP+LVYEF+ NG
Sbjct: 474 VDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETEVPILVYEFIPNG 533

Query: 483 TLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP 539
            LF+H+H++ +     W  R+RI  + +G  SYLH+    PI HRD+KS NILLDE    
Sbjct: 534 NLFQHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDIKSTNILLDEKYRA 593

Query: 540 KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           KVSDFG S+ V ID     TV+ GT+GY+DPEY  +   T+KSDVYSFGVVLVEL+TG+ 
Sbjct: 594 KVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYSFGVVLVELITGEK 653

Query: 600 ALLS-DKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGE 658
            +++  + +E   LA  F  ++++NRL EI+D RI ND   +Q+  VA LA RC+   G+
Sbjct: 654 PVITLSETQEITGLADYFRLAMRENRLFEIIDARIRNDCKLEQVIAVANLALRCLKKTGK 713

Query: 659 ERPTMKEVSLELQ 671
            RP M+EVS  L+
Sbjct: 714 TRPDMREVSTALE 726

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	735
255558508	1433	ATP binding protein, putative [Ricinus c	0.876	0.449	0.579	0.0
359492355	745	PREDICTED: wall-associated receptor kina	0.921	0.908	0.555	0.0
225459705	742	PREDICTED: wall-associated receptor kina	0.878	0.870	0.563	0.0
359492353	820	PREDICTED: wall-associated receptor kina	0.937	0.840	0.512	0.0
225456209	736	PREDICTED: wall-associated receptor kina	0.957	0.956	0.508	0.0
359492347	722	PREDICTED: wall-associated receptor kina	0.884	0.900	0.526	0.0
224092689	743	predicted protein [Populus trichocarpa]	0.921	0.911	0.511	0.0
449453095	1706	PREDICTED: uncharacterized protein LOC10	0.908	0.391	0.492	0.0
224092683	724	predicted protein [Populus trichocarpa]	0.892	0.906	0.493	0.0
449453099	876	PREDICTED: wall-associated receptor kina	0.897	0.753	0.501	0.0

>gi|255558508|ref|XP_002520279.1| ATP binding protein, putative [Ricinus communis] gi|223540498|gb|EEF42065.1| ATP binding protein, putative [Ricinus communis]

 Score =  770 bits (1988), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 389/671 (57%), Positives = 499/671 (74%), Gaps = 27/671 (4%)

Query: 11   STAAAAHAQAKPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTL---NPPKPFLRKS 67
            ST+A  H      CP+RCG+V IPYPFG + GC+L+ +FLITCND+L   + P P+LRKS
Sbjct: 733  STSAGFH------CPDRCGNVSIPYPFGIE-GCYLSPEFLITCNDSLTANSTPVPYLRKS 785

Query: 68   SIEVVNISIDGHLNVMQYTAKVCYDAKGYSVDS-NLPYITLSKFTFSRTGNKFVVIGCDS 126
            +I+V NIS+DG L ++Q  A+ CY+  G         ++TLSKFT S++ NKF VIGCDS
Sbjct: 786  NIKVTNISLDGRLEIVQVAARDCYNKSGIRQPGFRRRFLTLSKFTISKSHNKFTVIGCDS 845

Query: 127  YAYVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHT 186
            YAY+ GF     Y+SGC S C   D V   SC G+GCCQIEIP GL      A+SFKNHT
Sbjct: 846  YAYLDGFRYGKFYRSGCMSLCADPDLVDGKSCSGSGCCQIEIPDGLYHANATAYSFKNHT 905

Query: 187  KVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKICGLNAS 246
             +SSFNPCTYAF+V+ S+F+F+  YL       EFPMVLDW +  + T + A  C  +A+
Sbjct: 906  NISSFNPCTYAFIVEDSRFNFSFEYLENIPTDKEFPMVLDWAV--NNTLKHA--CKDHAN 961

Query: 247  CDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCR 306
               P +N    SGY CKC +GY+GNPYL  GC DVNEC++ ++N CT  C N+ GSYTC 
Sbjct: 962  SYQPDNN----SGYLCKCQEGYQGNPYL--GCEDVNECKNENQNKCTDRCTNLDGSYTCS 1015

Query: 307  CRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKF 366
            C KG+HGDGRKDG GC P+Q ++IK+ LGVGI F+V I+  SW++ +  +R+ +KLKEKF
Sbjct: 1016 CPKGYHGDGRKDGQGCIPDQLSLIKIILGVGIGFIVFIVVSSWIYLVLRKRKLIKLKEKF 1075

Query: 367  FEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNY--ADVIGCGGSGNVYKGFLPD 424
            +++NGG+IL+Q+LS+  G +++ AK+FT EE+K  TNNY  +++IG GG G VYKG + D
Sbjct: 1076 YQKNGGAILQQKLSRRDG-NTDAAKVFTAEELKKATNNYDESNIIGKGGFGTVYKGIVTD 1134

Query: 425  RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
               VA+KKS+ VDQA++++FINE++V+ QIN RNVVRLLGCCLET+VPLLVYEF+ NGTL
Sbjct: 1135 NRVVAIKKSRTVDQAQVEQFINEVIVLSQINHRNVVRLLGCCLETEVPLLVYEFITNGTL 1194

Query: 485  FEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV 541
            F++IH + N   LSWE RLRI AETAG LSYLHS   +PIIHRDVKS NILLD N   KV
Sbjct: 1195 FDYIHCESNASALSWETRLRIAAETAGALSYLHSAATIPIIHRDVKSTNILLDANHAAKV 1254

Query: 542  SDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL 601
            SDFGAS+LVP+D  Q  T+VQGT GYLDPEYL T +LTDKSDVYSFGVVLVELLT   AL
Sbjct: 1255 SDFGASRLVPVDENQLSTMVQGTWGYLDPEYLHTNQLTDKSDVYSFGVVLVELLTSMKAL 1314

Query: 602  LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
              D+PEE+RSLAM FLSS+++  L  ILD+RIV+  NK+Q++EVAK+A  C++++GEERP
Sbjct: 1315 CFDRPEEDRSLAMYFLSSVRKGDLFGILDSRIVDQRNKEQIEEVAKVAEGCLTLKGEERP 1374

Query: 662  TMKEVSLELQG 672
            TMKEV++EL+G
Sbjct: 1375 TMKEVAVELEG 1385

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359492355|ref|XP_002284688.2| PREDICTED: wall-associated receptor kinase 2-like [Vitis vinifera]

 Score =  752 bits (1942), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/711 (55%), Positives = 496/711 (69%), Gaps = 34/711 (4%)

Query: 21  KPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSS--IEVVNISIDG 78
           KP C   CGDV IPYPFGT+ GC+LN DFLI CN +L+PPKP L  SS  ++V+NISI+ 
Sbjct: 28  KPDCEATCGDVSIPYPFGTREGCYLNDDFLIACNHSLSPPKPLLWNSSFNLQVLNISIED 87

Query: 79  H-LNVMQYTAKVCYDAKGYSVDS-NLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGE 136
           H L +  +  + CYD  G   D   L Y  L +F FS  GN+F  IGCD+ A   G  G 
Sbjct: 88  HRLRIYTFVGRDCYDKMGKQYDQPTLAYANLPRFPFSDKGNRFTAIGCDTIAVFNGLNGA 147

Query: 137 DRYKSGCTSTCDSLDYVTNGSCVGTGCCQIE-IPGGLKELEVEAFSFKNHTKVSSFNPCT 195
           D + +GC S C+S+  VTNGSC G GCCQ   IP GL        SF NHTKV SFNPC+
Sbjct: 148 DDFTTGCLSLCNSIRSVTNGSCSGIGCCQTSNIPKGLFSYYASVGSFYNHTKVWSFNPCS 207

Query: 196 YAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAK------ICGLNASCDT 249
           YAF+ ++  F+F+S  L     R  FP +LDW +  +KTCEEAK       C  N+ C  
Sbjct: 208 YAFLAEEESFNFSSADLKDLQNRTVFPTLLDWAV-GNKTCEEAKKNLTSYACKDNSYCY- 265

Query: 250 PKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRK 309
              N+    GYRC C+ G++GNPYL +GC+D++EC DP RN CT +C N PGSYTC C K
Sbjct: 266 ---NSDNGPGYRCNCSSGFQGNPYLPNGCQDIDECADPKRNECTKVCINTPGSYTCSCPK 322

Query: 310 GFHGDGRKD--GGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFF 367
           G+HG+GR+D  G GCTP    + ++ +G+ I  +  +++ SWL++   +R+ +KLKEKFF
Sbjct: 323 GYHGNGRRDENGDGCTP----LFELNVGIFIGLIALLITSSWLYWGLKKRKFIKLKEKFF 378

Query: 368 EQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDR 425
           +QNGG +L+Q+L    G SSE  KIFT EE++  TN Y +  +IG GG G VYKG L D 
Sbjct: 379 QQNGGLMLQQQLHGREG-SSESVKIFTAEELEKATNKYDEDTIIGRGGYGTVYKGILADG 437

Query: 426 TPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
             VA+KKSK VDQ +I++FINE+VV+ QIN RNVV+LLGCCLET+VPLLVYEF+ NGTLF
Sbjct: 438 RVVAIKKSKLVDQTQIEQFINEVVVLSQINHRNVVKLLGCCLETEVPLLVYEFITNGTLF 497

Query: 486 EHIHKKG---NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVS 542
           ++IH K    ++SWE RLRI AETAGVLSYLHS  ++PIIHRDVKS NILLD+N T KVS
Sbjct: 498 DYIHNKSKASSISWETRLRIAAETAGVLSYLHSSASIPIIHRDVKSTNILLDDNYTAKVS 557

Query: 543 DFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           DFGAS+LVP+D  Q  T+VQGTLGYLDPEYL T +LT+KSDVYSFGVVLVELLTGK AL 
Sbjct: 558 DFGASRLVPLDQTQLSTMVQGTLGYLDPEYLHTSQLTEKSDVYSFGVVLVELLTGKKALS 617

Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDNRIV-NDGNKQQLKEVAKLAARCISVRGEERP 661
            D+PEEERSLAM+FLSSLK +RL +IL++ IV ND N +QLK+VAKLA RC+ V+GEERP
Sbjct: 618 FDRPEEERSLAMHFLSSLKNDRLFQILEDYIVPNDENMEQLKDVAKLAKRCLEVKGEERP 677

Query: 662 TMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGS 712
           TMKEV+ EL G + +M+   +    N+E N  +ETE       +  N  GS
Sbjct: 678 TMKEVARELDG-MRMMTKHPWV---NIELNP-EETECLLGEHSDAHNNGGS 723

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225459705|ref|XP_002284700.1| PREDICTED: wall-associated receptor kinase 1-like [Vitis vinifera]

 Score =  720 bits (1859), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/667 (56%), Positives = 482/667 (72%), Gaps = 21/667 (3%)

Query: 19  QAKPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISIDG 78
           Q+KP CP+RCG+V IPYPFGT+ GC+LN++FLITC+++ +PPK FL  S+I V NI+ DG
Sbjct: 28  QSKPGCPDRCGNVSIPYPFGTREGCYLNEEFLITCDNSTSPPKAFLTNSNINVTNINFDG 87

Query: 79  HLNVMQYTAKVCYDAKGY-SVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGED 137
            L+V+   A+ CY   G    +S     +LS F+ S T NKF  +GCD+YA + G+ G D
Sbjct: 88  ELHVLSLMARNCYYPNGTEQPNSTTASFSLSIFSISDTLNKFFAVGCDTYALLQGYQGGD 147

Query: 138 RYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYA 197
            Y +GC S C S   V +GSC G GCCQ+  P GL +  +   S+ NHTKV  FNPC+YA
Sbjct: 148 LYTTGCMSICSSEKQVQDGSCSGAGCCQVSFPEGLDDTTLTLSSYFNHTKVHDFNPCSYA 207

Query: 198 FVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKI------CGLNASCDTPK 251
           F+ ++S F+F+S  L      ++ P V+DW I  ++TC+ AK       C  N++C  P 
Sbjct: 208 FIAEESAFNFSSKNLTNLQDMEKLPRVVDWSI-GNETCQVAKTNPSSYACKENSTCSEP- 265

Query: 252 DNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHI--CDNIPGSYTCRCRK 309
              S  SGY CKC  GY GNPYL DGC+D++ECE+ S N C     C NIPG+YTC CRK
Sbjct: 266 ---SGRSGYLCKCFDGYHGNPYL-DGCQDIDECENSSLNKCVEKARCKNIPGNYTCSCRK 321

Query: 310 GFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQ 369
           G+HGDGR+DG GC PN   VI++ALGV I  +  +M  SWL++   +R+ +KLK+KFFEQ
Sbjct: 322 GYHGDGREDGDGCNPNMLQVIQIALGVSIGLISLLMGSSWLYWGLKKRKFIKLKKKFFEQ 381

Query: 370 NGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTP 427
           NGG +LRQ+LS   G S+E  KIF+ EE++  T+ YA+  +IG GG G VYKG L +   
Sbjct: 382 NGGLMLRQQLSSQEG-SNETVKIFSAEELEKATDKYAENKIIGQGGYGTVYKGTLTNGRI 440

Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VA+KKSK VD+++I++FINE++V+ QIN RNVV+LLGCCLET+VPLLVYEF+ NGTLF++
Sbjct: 441 VAIKKSKMVDKSQIEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDY 500

Query: 488 IHKKGNLS---WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           IHK   +S   WE RLRI  ETA VLSYLHS  + PIIHRDVKS NILLD+N T KVSDF
Sbjct: 501 IHKGKKISTSSWEVRLRIATETAEVLSYLHSAASTPIIHRDVKSTNILLDDNYTAKVSDF 560

Query: 545 GASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSD 604
           GAS+LVP+D  Q  T+VQGTLGYLDPEYL T +LT+KSDVYSFGVVLVELLT K AL  D
Sbjct: 561 GASRLVPLDQTQLSTMVQGTLGYLDPEYLLTSQLTEKSDVYSFGVVLVELLTAKKALSFD 620

Query: 605 KPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMK 664
           KPEEERSLAM FLSSLK +RL ++LD RIVN+ N +QLKE A LA +C+ ++G+ERPTMK
Sbjct: 621 KPEEERSLAMYFLSSLKDDRLFQVLDERIVNEENIEQLKETANLAKKCLKLKGDERPTMK 680

Query: 665 EVSLELQ 671
           EV+++L+
Sbjct: 681 EVAMKLE 687

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359492353|ref|XP_002284691.2| PREDICTED: wall-associated receptor kinase 3-like [Vitis vinifera]

 Score =  712 bits (1839), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 384/750 (51%), Positives = 511/750 (68%), Gaps = 61/750 (8%)

Query: 21  KPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISIDGHL 80
           KP CP+ CGDV IPYPFGT+  C+LN++FLITC+++ + PK FL + +I V NIS+DG L
Sbjct: 75  KPGCPDSCGDVSIPYPFGTREDCYLNEEFLITCDNSTSLPKAFLTEGNINVTNISLDGEL 134

Query: 81  NVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYK 140
           +++   A  CY+  G   D+  PY  LS F+ S T NKFV +GCD+YA + G+ GED Y+
Sbjct: 135 HLLSLIAHNCYNRNGTLQDNLEPYFRLSIFSISGTLNKFVAVGCDTYALLSGYQGEDLYR 194

Query: 141 SGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVV 200
           +GC S C S   V +GSC G GCCQI  P GLK   +   S+ NHT+V  FNPC+YAF+V
Sbjct: 195 TGCMSICSSKKQVQDGSCSGAGCCQISFPEGLKNTTLILSSYFNHTEVHDFNPCSYAFIV 254

Query: 201 DQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKICGLNASCDTPKDNTS----- 255
           +++ F+F+S  L+     ++ PMV+DW I  ++TC+ AK    + +C   K+N++     
Sbjct: 255 EEAAFNFSSKNLSNLQDIEKLPMVVDWSI-GNETCQVAKTNQTSYAC---KENSTCYESN 310

Query: 256 TSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHI--CDNIPGSYTCRCRKGFHG 313
           +  GY CKC  GY GNPYL DGC+D++EC++ S N C     C N PG+YTC C KG+HG
Sbjct: 311 SRPGYLCKCFDGYHGNPYL-DGCQDIDECKNSSLNKCVKKARCKNTPGNYTCSCSKGYHG 369

Query: 314 DGRKDGGGCTPNQYTVIKVALG-------------------------------VGISFVV 342
           DGR DG GC PN+  +I+V+LG                               VGI  + 
Sbjct: 370 DGRDDGDGCNPNELQLIQVSLGMIFFFALSILLKRKFNYDIFHLLVLICSNVGVGIGLIS 429

Query: 343 AIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVT 402
            ++  SWL++   +R+ +KLKE+FF+QNGG +L+++LSK  G S+E  KIFT  E++  T
Sbjct: 430 LLIGSSWLYWGLKKRKFIKLKEEFFQQNGGLMLQKQLSKREG-STETIKIFTGAELEKAT 488

Query: 403 NNY--ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVV 460
           N Y  + +IG GG G VYKG L D   VA+KKSK VD+++I++FINE++V+ QIN RNVV
Sbjct: 489 NKYNESKIIGHGGYGTVYKGTLTDGRIVAIKKSKMVDKSQIEQFINEVLVLSQINHRNVV 548

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS---WERRLRITAETAGVLSYLHSET 517
           +LLGCCLET+VPLLVYEF+ NGTLF+HIH K N S   WE RLRI  ETAGVLSYLHS  
Sbjct: 549 KLLGCCLETKVPLLVYEFITNGTLFDHIHNKSNTSIIPWEIRLRIATETAGVLSYLHSAA 608

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
           ++PIIHRDVKS NILLD+N T KVSDFGAS+LVP+D  Q  T+VQGTLGYLDPEYL T +
Sbjct: 609 SIPIIHRDVKSTNILLDDNYTAKVSDFGASRLVPLDQTQLSTMVQGTLGYLDPEYLLTSQ 668

Query: 578 LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG 637
           LT+KSDVYSFGVVLVELLTG+ AL  D+PE++RSLAM FL SL+ +RL ++LD  IVN+ 
Sbjct: 669 LTEKSDVYSFGVVLVELLTGEKALSFDRPEDKRSLAMYFLFSLRDDRLFQVLDEHIVNEE 728

Query: 638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETE 697
           N +QLKE AKLA RC+ ++G+ERPTMKEV +EL+G L +M    +     ++S   QE E
Sbjct: 729 NIEQLKEAAKLAKRCLRLKGDERPTMKEVVMELEG-LRIMKTHPW-----IDS---QENE 779

Query: 698 YFTSTF---YECRNGIGSHTTPTDGYDSVQ 724
           +  S F   Y+  +G  +  T +  Y+S++
Sbjct: 780 HLFSDFTHTYDDGDGNSNGVTISAIYESLR 809

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456209|ref|XP_002282887.1| PREDICTED: wall-associated receptor kinase 2-like isoform 3 [Vitis vinifera]

 Score =  701 bits (1810), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/734 (50%), Positives = 501/734 (68%), Gaps = 30/734 (4%)

Query: 15  AAHAQAKPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNI 74
            A   A P C + CG++ IPYPFGT   C+LN+DF I CN T    + FL  S+I+V++I
Sbjct: 20  VAAELALPGCASHCGNISIPYPFGTTPECYLNQDFFINCNST---HQAFLTDSNIDVLSI 76

Query: 75  SIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFL 134
           S+ G L V+ Y A+ CY+  G  V +N P++TL+KF  S T NKF+ +GCD+YA++ G  
Sbjct: 77  SVSGQLRVLSYVARDCYNKSGQRVANNDPWMTLAKFPISHTRNKFMTVGCDTYAFIKGSS 136

Query: 135 GEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPC 194
           G+ +YK+GC S C+S D V NGSC G GCCQ  IP  +  +++   S+ ++T V  FNPC
Sbjct: 137 GK-KYKTGCLSLCESKDSVINGSCSGIGCCQTTIPVNVTSIDISVDSYDSYTGVWEFNPC 195

Query: 195 TYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKICGLNASCDTPKDNT 254
            +AFV +   F+F+S  L     + + P VLDW  I D+ C++AK  G + +C   KDN+
Sbjct: 196 GFAFVAEDGYFNFSSADLLDLQNKTKVPTVLDW-TIGDEKCDQAKENGTSYAC---KDNS 251

Query: 255 -----STSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRK 309
                    GYRC C++GYEGNPYL +GC+D++ECE  +  N TH C N+PGS++C C  
Sbjct: 252 YCYDPDNGPGYRCNCSEGYEGNPYLLNGCKDIDECEVDNPCNVTHTCRNLPGSFSCFCPA 311

Query: 310 GFHGDGRKDGGGCTPN---QYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKF 366
           G+ GDG K G GC      Q+  I  A G+ IS +V ++  SWL++ + +R+ +KLKEKF
Sbjct: 312 GYEGDGFKIGTGCNHVLMLQFYFILFA-GISISLLVLLLVSSWLYWGFRKRKLIKLKEKF 370

Query: 367 FEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPD 424
           FEQNGG +L+Q LSK H   +E  KIFT E++K  TNNY +  V+G GG G VYKG L D
Sbjct: 371 FEQNGGIMLQQLLSK-HEGFAEATKIFTTEDLKKATNNYDERRVLGRGGQGTVYKGILAD 429

Query: 425 RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
              VAVKKSK +DQ+++++FINE++++ Q+N RNVV+LLGCCLET+VPLLVYEFV NGTL
Sbjct: 430 NRVVAVKKSKIMDQSQVEQFINEVIILSQVNHRNVVKLLGCCLETEVPLLVYEFVINGTL 489

Query: 485 FEHIHKKG---NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV 541
           ++H+H +    ++SWE RLRI  ETAG L YLHS  + PIIHRDVKS NILLD N T KV
Sbjct: 490 YDHLHNQDQTYSISWETRLRIATETAGALWYLHSAASTPIIHRDVKSTNILLDNNYTAKV 549

Query: 542 SDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL 601
           SDFGAS+L+P+D  Q  T+VQGTLGYLDPEY  + +LT+KSDVYSFGVVLVELLTGK AL
Sbjct: 550 SDFGASRLIPLDQAQLTTLVQGTLGYLDPEYFHSSQLTEKSDVYSFGVVLVELLTGKKAL 609

Query: 602 LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
             D+ EEER+LAM F+SS+K +RL EILD+R++N+GN + LKEVA LA RC+ V+GEERP
Sbjct: 610 SFDRLEEERNLAMFFVSSMKDDRLFEILDDRVLNEGNTKHLKEVAILAKRCLMVKGEERP 669

Query: 662 TMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTDGYD 721
           TMKEV++EL+G   L ++       N E     ETEY      +     G +++   GYD
Sbjct: 670 TMKEVAMELEGLRILETHPWVNNNSNPE-----ETEYLIGQSQDAYK--GDNSSNIIGYD 722

Query: 722 SVQQLELMAFDYER 735
           S++   ++ F+  R
Sbjct: 723 SIRDQVMVDFNGGR 736

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359492347|ref|XP_003634400.1| PREDICTED: wall-associated receptor kinase 2-like [Vitis vinifera]

 Score =  697 bits (1799), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/686 (52%), Positives = 473/686 (68%), Gaps = 36/686 (5%)

Query: 10  TSTAAAAHAQAKPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSI 69
            S A AA AQAKP CP+RCG+V IPYPFGTK+ C  ++ FL+ CND++ PPK  L   ++
Sbjct: 19  ASMAEAAVAQAKPGCPDRCGNVSIPYPFGTKKDCNHSQHFLLHCNDSVMPPKLTL-GMNL 77

Query: 70  EVVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITL-SKFTFSRTGNKFVVIGCDSYA 128
            VV+IS+ G L ++ +  + CY++ G  V  N P++ L S +T S   NKF+ +GCD+YA
Sbjct: 78  HVVSISL-GELKILNFLGRDCYNSYGGLVYENDPWLRLGSGYTISGKRNKFIAVGCDTYA 136

Query: 129 YVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKV 188
            V  + GE+RY +GC S CDS+  V +GSC G GCC+  IP G     V+  S+ NH  V
Sbjct: 137 IVRAYKGEERYTTGCMSVCDSITNVKSGSCSGIGCCETSIPEGTTNFTVKLSSYNNHRSV 196

Query: 189 SSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAK-----ICGL 243
            +FNPC+YAFVV+++ F F+SN        +  P+VLDW I  ++ C+ A+      C  
Sbjct: 197 WAFNPCSYAFVVEETHFKFSSNQFRDLNNTENLPVVLDWRIGKER-CKAARKTETYACKG 255

Query: 244 NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHI--CDNIPG 301
            + C  P D     SGY CKC  GY GNPYL DGC+D+NEC+DPS N C     C N PG
Sbjct: 256 KSECYEPDD----WSGYLCKCLDGYHGNPYLPDGCQDINECDDPSLNKCVKKGRCKNTPG 311

Query: 302 SYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMK 361
           +YTC C KG              +   +I   +G GI F++ ++SISWL++   +R+ ++
Sbjct: 312 NYTCSCPKG--------------SLTILICSNVGAGIGFMILLLSISWLYWGLKKRKFIR 357

Query: 362 LKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNY--ADVIGCGGSGNVYK 419
           LKEKFF+QNGG +L+Q+LS+  G S E  KIFT  E++  TN Y  ++++G GG G VYK
Sbjct: 358 LKEKFFQQNGGLMLQQQLSRQEG-SDETIKIFTAGELEKATNKYDESNIVGRGGYGTVYK 416

Query: 420 GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV 479
           G L +   VAVKKSK +D+++I++FINE++V+ QIN RNVV+LLGCCLET+VPLLVYEF+
Sbjct: 417 GTLTNGRIVAVKKSKMIDKSQIEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFI 476

Query: 480 GNGTLFEHIH---KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN 536
            NGTLF +IH   K   +SWE RLRI  ETAGVLSYLHS T+ PIIHRDVKS NILLD+N
Sbjct: 477 TNGTLFNYIHGERKASTISWEVRLRIATETAGVLSYLHSATSTPIIHRDVKSTNILLDDN 536

Query: 537 CTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
            T KVSDFGAS+LVP+D  Q  T+VQGTLGYLDPEYL T +LT+KSDVYSFGVV VELLT
Sbjct: 537 YTAKVSDFGASRLVPLDQAQLSTLVQGTLGYLDPEYLLTSQLTEKSDVYSFGVVFVELLT 596

Query: 597 GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVR 656
           G+ AL  D+ EEERSLAM FLSS K + L ++LD  IVN+GN +QL+E A LA RC+ ++
Sbjct: 597 GEKALSFDRSEEERSLAMYFLSSWKDDNLFQVLDKHIVNEGNIEQLREAANLAKRCLRLK 656

Query: 657 GEERPTMKEVSLELQGRLSLMSNGQY 682
           G+ERPTMKEVS+EL+ R+ +M    +
Sbjct: 657 GDERPTMKEVSMELE-RIKMMEKQAW 681

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224092689|ref|XP_002309699.1| predicted protein [Populus trichocarpa] gi|222855675|gb|EEE93222.1| predicted protein [Populus trichocarpa]

 Score =  693 bits (1789), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/706 (51%), Positives = 481/706 (68%), Gaps = 29/706 (4%)

Query: 12  TAAAAHAQAKPRC-PNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIE 70
           TAA     AKP C  +RCG+V IPYPFGT   C+ +  FLITCN T NPPK FL   ++ 
Sbjct: 16  TAATELPIAKPGCQEDRCGNVSIPYPFGTGEDCYYDPQFLITCNHTFNPPKAFLGNGNLS 75

Query: 71  VVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITL---SKFTFSRTGNKFVVIGCDSY 127
           V  I++DG L +MQY AK CY+  G     N+P+I L     + FS T N FV IGCD+Y
Sbjct: 76  VTEITLDGKLRLMQYIAKDCYNRAGARTTRNIPWINLPVQGPYVFSDTDNMFVAIGCDTY 135

Query: 128 AYVLGFLGE--DRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNH 185
           A +LG   +  D Y  GC S C +   V N +C G GCCQ  I  G+K  EV   S  NH
Sbjct: 136 AGLLGIREDTNDTYLVGCISECSNKTVVPN-TCSGVGCCQTSIAKGMKYFEVRLSSETNH 194

Query: 186 TKVSSFNPCTYAFVVDQSQFHF-TSNYLALGGIRDEFPMVLDWEIITDK--TCEEAKI-- 240
           T +  FNPC++AF++++ QF F  SN   L  +R + P+++DW I  +K  T E+ K+  
Sbjct: 195 TGIWEFNPCSFAFMIEKKQFSFFPSNLSDLEQVR-KVPIIVDWSIGRNKCETLEKNKMSN 253

Query: 241 -CGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPS-RNNCTHICDN 298
            C   + C  P++     SGY CKC  GY+GNPYL +GC+++NEC DP    NC+H C +
Sbjct: 254 ACQGQSKCHDPEN----GSGYICKCLDGYQGNPYLPNGCQNINECSDPKVARNCSHNCID 309

Query: 299 IPGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRR 358
             G+YTC C KG+HGDGR DG  C  N+ +VI+VA+G+G      +M I+WL++ +++ +
Sbjct: 310 TEGNYTCSCPKGYHGDGRIDGERCIRNRSSVIQVAVGIGAGLTSLLMGITWLYWGYSKWK 369

Query: 359 HMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGN 416
            MKLKEKFF QNGG +L Q+LS+  G  +E AKIF+  E++  T+ Y +  ++G GG G 
Sbjct: 370 LMKLKEKFFRQNGGLMLEQQLSRREGPVTETAKIFSAAELEKATDKYHESRILGRGGFGT 429

Query: 417 VYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY 476
           VYKG L D   VA+KKSK +D ++I++FINE+VV+ QIN RNVV+LLGCCLET+VPLLVY
Sbjct: 430 VYKGTLTDGRTVAIKKSKTIDHSQIEQFINEVVVLYQINHRNVVKLLGCCLETEVPLLVY 489

Query: 477 EFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           E+V NGTL++HIH K     L+WE RL+I +ETAGVLSYLHS  +VPIIHRDVKS NILL
Sbjct: 490 EYVANGTLYDHIHDKSKVSALTWEIRLKIASETAGVLSYLHSAASVPIIHRDVKSTNILL 549

Query: 534 DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVE 593
           D + T KVSDFG S+L+P+D ++  T+VQGTLGYLDPEYL T +LTDKSDVYSFGVVLVE
Sbjct: 550 DNSYTAKVSDFGTSRLIPLDQVELSTMVQGTLGYLDPEYLHTSQLTDKSDVYSFGVVLVE 609

Query: 594 LLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCI 653
           LLTG  A+   KPE ER+L+  FL +LK++RL+ IL + +VN  N +QLK VA +A +C+
Sbjct: 610 LLTGMKAISFHKPEGERNLSSYFLCALKEDRLVHILQDCMVNQDNIRQLKGVANIAKKCL 669

Query: 654 SVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYF 699
            V+GEERP MK V++EL+G   L ++ ++   +  + + V+ETEY 
Sbjct: 670 RVKGEERPYMKNVAMELEG---LRTSAKHPWTN--DKSDVEETEYL 710

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449453095|ref|XP_004144294.1| PREDICTED: uncharacterized protein LOC101209380 [Cucumis sativus]

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/698 (49%), Positives = 478/698 (68%), Gaps = 30/698 (4%)

Query: 10  TSTAAAAHAQAKPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSI 69
           ++    A +QA P C   CGDV+IPYPFG K+GC+LN+ F ITCN T++PPK FL  ++I
Sbjct: 17  STAIVVASSQALPDCDEWCGDVQIPYPFGVKQGCYLNQTFSITCNKTVSPPKAFLMNTNI 76

Query: 70  EVVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYIT----LSKFTFSRTGNKFVVIGCD 125
            V NIS++G L+++Q   + CY+ +G  + S++P +T     + F  +   NKF+ IGCD
Sbjct: 77  SVTNISLNGELHILQPIVRDCYE-QGIVIGSSVPTVTDLLVPAMFPIADGKNKFIAIGCD 135

Query: 126 SYAYVLGFLGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNH 185
           ++  + G L    Y SGC S C +   + N +C+G GCC++EIP  L  L++   SF NH
Sbjct: 136 TFGLIGGELNGSGYVSGCISMCLNESMIGNDTCLGNGCCELEIPNELMNLKLLVGSFFNH 195

Query: 186 TKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRD-EFPMVLDWEIITDKTCEEAKICGLN 244
           + V  FNPC YAFVV    F F S Y+     +D E  +V+ W I          +CGLN
Sbjct: 196 SSVKDFNPCGYAFVVGNEGFEFDSKYIR--SFQDVEVEVVVGWAIGNGSN----YVCGLN 249

Query: 245 ASCDTPKDNTSTSSG---YRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTH--ICDNI 299
           +     K N S S+    +RC+C +G++GNPYL  GC+D++EC+D + N C +   C N 
Sbjct: 250 S-----KRNYSFSNDGHEFRCQCLEGFQGNPYLPQGCQDIDECKDETLNQCKYNSKCVNT 304

Query: 300 PGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRH 359
            G+YTC+C K F GDGR +G GCT +  T I + +GVG+ F V ++  +W+   + + + 
Sbjct: 305 IGNYTCKCPKNFKGDGRNEGVGCTRDSKTFIPIIIGVGVGFTVFVIGSTWIFLGYKKWKF 364

Query: 360 MKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNY--ADVIGCGGSGNV 417
           +K KEKFFE+NGG +L+++LS+     +E  ++FT+EE++  T +Y  + ++G GG G V
Sbjct: 365 IKRKEKFFEENGGFVLQRQLSQWQ-SPNEMVRVFTQEELEKATKHYDNSTIVGKGGYGTV 423

Query: 418 YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE 477
           YKG L D   VA+KKSKF+DQ++ D+FINE++V+ QIN RNVVRLLGCCLETQVPLLVYE
Sbjct: 424 YKGVLEDGLTVAIKKSKFIDQSQTDQFINEVIVLSQINHRNVVRLLGCCLETQVPLLVYE 483

Query: 478 FVGNGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD 534
           F+ NGTLFEHIH K    +LSWE R +I  ETAGVLSYLHS  + PIIHRD+K+ NILLD
Sbjct: 484 FITNGTLFEHIHDKTKYSSLSWEARFKIALETAGVLSYLHSSASTPIIHRDIKTTNILLD 543

Query: 535 ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVEL 594
           EN T KVSDFG SKLVP+D  Q  T+VQGTLGYLDPEYL T +LT+KSDVYSFG+VL+EL
Sbjct: 544 ENYTAKVSDFGTSKLVPMDQTQLSTMVQGTLGYLDPEYLLTSELTEKSDVYSFGIVLLEL 603

Query: 595 LTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI-VNDGNKQQLKEVAKLAARCI 653
           +TGK A+  D PEEER+LAM  L ++K++RL E+++ RI V + N +++K+VAK+A +C+
Sbjct: 604 ITGKKAVSFDGPEEERNLAMYVLCAMKEDRLEEVVEKRIMVKEANFEEIKQVAKVAKKCL 663

Query: 654 SVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESN 691
            ++GEERP MKEV++EL+G + LM     ++ +N  SN
Sbjct: 664 RIKGEERPNMKEVAIELEG-VRLMQVEHSWVNNNNLSN 700

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224092683|ref|XP_002309698.1| predicted protein [Populus trichocarpa] gi|222855674|gb|EEE93221.1| predicted protein [Populus trichocarpa]

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/703 (49%), Positives = 469/703 (66%), Gaps = 47/703 (6%)

Query: 12  TAAAAHAQAKPRC-PNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIE 70
           TAA     AKP C  +RCG+V IPYPFGT   C+ +  FLITCN T NPPK F+  +++ 
Sbjct: 21  TAATQLPIAKPGCQEDRCGNVSIPYPFGTGEDCYYDPQFLITCNHTFNPPKAFIGNTNLS 80

Query: 71  VVNISIDGHLNVMQYTAKVCYDAKGYSVDSNLPYITL---SKFTFSRTGNKFVVIGCDSY 127
           V  I++DG L +MQY AK CY+  G     N P+I L     + FS T N FV IGCD+ 
Sbjct: 81  VTEITLDGKLRLMQYIAKDCYNRAGARTRRNRPWINLPVQGPYVFSDTDNVFVAIGCDTL 140

Query: 128 AYVLGFLGE--DRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNH 185
           A +LG   +  D Y  GC S C +  YV N +C G GCCQ  +  G+K  +V   S+ NH
Sbjct: 141 AAMLGRREDKNDTYLVGCLSKCSNKKYVPN-TCSGIGCCQTSLAKGIKYFDVSLSSYNNH 199

Query: 186 TKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKI---CG 242
           T +  FNPC++AF++++ +    +                       +T E+ K+   C 
Sbjct: 200 TGIWEFNPCSFAFMIEEKRIGRNNC----------------------ETLEKNKMSNACQ 237

Query: 243 LNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPS-RNNCTHICDNIPG 301
             + C  P++     SGY CKC  GY+GNPYL +GC+++NEC DP   +NC+H C +  G
Sbjct: 238 GQSKCHDPEN----GSGYICKCLDGYQGNPYLPNGCQNINECSDPKVAHNCSHTCIDTEG 293

Query: 302 SYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMK 361
           +YTC C KG+HGDGR DG  C  N+ +VI+VA+G G+  +  +M I+WL++ + + + MK
Sbjct: 294 NYTCSCPKGYHGDGRIDGERCIRNRSSVIQVAVGTGVGLISLLMGITWLYWGYNKWKLMK 353

Query: 362 LKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYK 419
           LKEKFF QNGG +L Q+LS+  G  +E AKIF+ EE++  T+ Y +  ++G GG G VYK
Sbjct: 354 LKEKFFRQNGGLMLEQQLSRREGPVTETAKIFSAEELEKATDKYHESRILGRGGFGTVYK 413

Query: 420 GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV 479
           G L D   VA+KKSK +D ++I++FINE+VV+ QIN RNVV+LLGCCLET+VPLLVYE+V
Sbjct: 414 GTLTDGRTVAIKKSKTIDHSQIEQFINEVVVLYQINHRNVVKLLGCCLETEVPLLVYEYV 473

Query: 480 GNGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN 536
            NGTL++HIH K     L+WE RL+I +ETAGVLSYLHS  +VPIIHRDVKS NILLD +
Sbjct: 474 ANGTLYDHIHDKCKVSALTWEIRLKIASETAGVLSYLHSAASVPIIHRDVKSTNILLDNS 533

Query: 537 CTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
            T KVSDFG S+ +P+D ++  T+VQGTLGYLDPEYL T +LTDKSDVYSFGVVLVELLT
Sbjct: 534 YTAKVSDFGTSRFIPLDQVELSTMVQGTLGYLDPEYLHTSQLTDKSDVYSFGVVLVELLT 593

Query: 597 GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVR 656
           G  A+   KPE ER+L+  FL +LK++RL+ IL + +VN  N +QLKEVA +A +C+ V+
Sbjct: 594 GMKAISFHKPEGERNLSSYFLCALKEDRLVHILQDCMVNQDNIRQLKEVANIAKKCLRVK 653

Query: 657 GEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYF 699
           GEERP MK V++EL+G   L ++ ++   +  + + V+ETEY 
Sbjct: 654 GEERPNMKNVAMELEG---LRTSAKHPWTN--DKSDVKETEYL 691

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449453099|ref|XP_004144296.1| PREDICTED: wall-associated receptor kinase 5-like [Cucumis sativus]

 Score =  668 bits (1723), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/684 (50%), Positives = 460/684 (67%), Gaps = 24/684 (3%)

Query: 7   TSRTSTAAAAHAQAKPRCPNRCGDVEIPYPFGTKRGCFLNKD-FLITCNDTLNPP---KP 62
           ++ T+      +QA P C   CGDV+IPYPFG K GC+LN + FL+ C+ T + P   KP
Sbjct: 28  SATTNATVTVASQALPGCDEWCGDVQIPYPFGMKEGCYLNNETFLLRCSPTADNPNVSKP 87

Query: 63  FLRKSSIEVV-NISI-DGHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFV 120
           FL     E+V +ISI  G + V    A+ C+       D     I +  +T S T NKF+
Sbjct: 88  FLSPQRPEMVTDISIISGEIKVWTLVAQECHSPDTALNDFTNFGIDVPTYTISHTKNKFI 147

Query: 121 VIGCDSYAYVLGF-LGEDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEA 179
           V+GCD+ A   G  +    +K+ C + CD+++ V +G+C G GCCQ+++P GL  +E   
Sbjct: 148 VMGCDTIALFSGKGVKVQLFKTACVAFCDNIESVKDGACSGNGCCQLDLPSGLDSIEFSV 207

Query: 180 FSFKNHTKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAK 239
            S  NHT VSSFNPC YAFV +Q  F F+S Y+      +  P+VLDW I  D TC  AK
Sbjct: 208 GSLSNHTNVSSFNPCGYAFVTEQDSFDFSSKYIR-NFPTETIPLVLDWAISND-TCVTAK 265

Query: 240 -----ICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTH 294
                +CG N+      D     S YRC+C  G+EGNPYL DGC+D++ECED S N+C  
Sbjct: 266 DKTNCVCGKNS---FKVDLLDDPSRYRCRCLHGFEGNPYLPDGCQDIDECEDESLNDCRF 322

Query: 295 ICDNIPGSYTCRCRKGFHGDGRKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLW 354
            C N  G+YTC C K   GDGR  G GCT N  + +++ +GV + F V ++  +WL+  +
Sbjct: 323 ECVNTIGNYTCNCPKDSKGDGRLQGDGCTRNSKSFVQIIVGVTVGFTVLVIGSAWLYLGY 382

Query: 355 TRRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCG 412
            + + +KLKEKFF++NGG +L+Q LS+    S +  +IFT+EE+   TN Y D  V+G G
Sbjct: 383 KKWKFLKLKEKFFQKNGGLMLQQHLSQWQA-SPDLVRIFTQEELDKATNKYDDSAVVGKG 441

Query: 413 GSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP 472
           G G VYKG L D + +A+KKSK VDQ++ D+FINE++V+ QIN RNVV+LLGCCLET+VP
Sbjct: 442 GFGTVYKGVLDDGSVLAIKKSKLVDQSQTDQFINEVIVLSQINHRNVVKLLGCCLETEVP 501

Query: 473 LLVYEFVGNGTLFEHIHKKGN----LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKS 528
           LLVYEF+ NGTL+E++H K N    LSWE RLRI AETAGV+SYLHS  + PIIHRD+K+
Sbjct: 502 LLVYEFISNGTLYEYVHDKTNGRNFLSWEARLRIAAETAGVISYLHSSASTPIIHRDIKT 561

Query: 529 ANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
            NILLD N T KVSDFGASKLVP+D  Q  T+VQGTLGYLDPEYL T +LTDKSDVYSFG
Sbjct: 562 TNILLDHNYTAKVSDFGASKLVPMDQTQLSTMVQGTLGYLDPEYLLTSELTDKSDVYSFG 621

Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           +VL+EL+TGK A+  + PE ER+LAM  + ++K++RL E+++  +  + N QQ+KE AKL
Sbjct: 622 IVLLELITGKKAVSFEGPEAERNLAMYVMCAMKEDRLEEVVEKGMATNANIQQIKEAAKL 681

Query: 649 AARCISVRGEERPTMKEVSLELQG 672
           A  C+ ++GEERP+MKEV++EL+G
Sbjct: 682 ATTCLRIKGEERPSMKEVAMELEG 705

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	735
TAIR|locus:2014912	732	WAK2 "wall-associated kinase 2	0.933	0.937	0.447	9.6e-160
TAIR|locus:2014962	733	WAK5 "wall associated kinase 5	0.915	0.918	0.438	8.8e-150
TAIR|locus:2014897	741	WAK3 "wall associated kinase 3	0.927	0.920	0.419	8.1e-147
TAIR|locus:2014952	738	WAK4 "wall associated kinase 4	0.934	0.930	0.411	5.7e-146
TAIR|locus:2014902	735	WAK1 "cell wall-associated kin	0.929	0.929	0.410	2.5e-145
TAIR|locus:2032875	720	AT1G16260 [Arabidopsis thalian	0.575	0.587	0.450	1.9e-127
TAIR|locus:2016377	788	AT1G19390 [Arabidopsis thalian	0.689	0.643	0.417	9.8e-116
TAIR|locus:2126316	786	AT4G31100 [Arabidopsis thalian	0.731	0.684	0.400	1.1e-114
TAIR|locus:2019893	751	RFO1 "RESISTANCE TO FUSARIUM O	0.876	0.857	0.390	9.7e-112
TAIR|locus:2200562	748	WAKL2 "wall associated kinase-	0.885	0.870	0.387	2.6e-111

TAIR|locus:2014912 WAK2 "wall-associated kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1556 (552.8 bits), Expect = 9.6e-160, P = 9.6e-160
 Identities = 324/724 (44%), Positives = 458/724 (63%)

Query:    27 RCGDVEIPYPFGTKRGCFLNKD--FLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVMQ 84
             RCG+V + YPFGT  GC+   D  F +TCN+     K F    ++ V+N+S+ G L V  
Sbjct:    32 RCGNVAVEYPFGTSPGCYYPGDESFNLTCNEQ---EKLFF--GNMPVINMSLSGQLRVRL 86

Query:    85 YTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGCT 144
               ++VCYD++G   D      TL  FT S   N+F V+GC+SYA+ L   G ++Y +GC 
Sbjct:    87 VRSRVCYDSQGKQTDYIAQRTTLGNFTLSEL-NRFTVVGCNSYAF-LRTSGVEKYSTGCI 144

Query:   145 STCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVVDQSQ 204
             S CDS     NGSC G GCCQI +P G   + V+  SF NH  V  FNPCTYAF+V+   
Sbjct:   145 SICDSAT-TKNGSCSGEGCCQIPVPRGYSFVRVKPHSFHNHPTVHLFNPCTYAFLVEDGM 203

Query:   205 FHFTSNYLALGGIRD--EFPMVLDWEIITDKTCEEAK---ICGLNASCDTPKDNTSTSSG 259
             F F +    L  +R+   FP+VLDW I  DKTC++ +   +CG N++C    D+T   +G
Sbjct:   204 FDFHA-LEDLNNLRNVTTFPVVLDWSI-GDKTCKQVEYRGVCGGNSTCF---DSTG-GTG 257

Query:   260 YRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCT-H-ICDNIPGSYTCRCXXXXXXXXXX 317
             Y CKC +G+EGNPYL +GC+D+NEC   SR+NC+ H  C+N  GS+ C C          
Sbjct:   258 YNCKCLEGFEGNPYLPNGCQDINECIS-SRHNCSEHSTCENTKGSFNCNCPSGYRKDSLN 316

Query:   318 X-XXXCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILR 376
                    P  +   ++ LG  I F V ++ IS L      R++ +L++KFFEQNGG +L 
Sbjct:   317 SCTRKVRPEYFRWTQIFLGTTIGFSVIMLGISCLQQKIKHRKNTELRQKFFEQNGGGMLI 376

Query:   377 QELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSK 434
             Q +S   G S+   KIFTE+ +K  TN Y +  ++G GG G VYKG LPD + VA+KK++
Sbjct:   377 QRVSGA-GPSNVDVKIFTEKGMKEATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKAR 435

Query:   435 FVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK--- 491
               +++++++FINE++V+ QIN RNVV++LGCCLET+VPLLVYEF+ +GTLF+H+H     
Sbjct:   436 LGNRSQVEQFINEVLVLSQINHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLYD 495

Query:   492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
              +L+WE RLRI  E AG L+YLHS  ++PIIHRD+K+ANILLD+N T KV+DFGAS+L+P
Sbjct:   496 SSLTWEHRLRIATEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIP 555

Query:   552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS 611
             +D  Q  T+VQGTLGYLDPEY  T  L +KSDVYSFGVVL+ELL+G+ AL  ++P   ++
Sbjct:   556 MDKEQLTTIVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPHCPKN 615

Query:   612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
             L   F S+ K NR  EI+D +++N+ N+++++E A++AA C  + GEERP MKEV+ EL+
Sbjct:   616 LVSCFASATKNNRFHEIIDGQVMNEDNQREIQEAARIAAECTRLMGEERPRMKEVAAELE 675

Query:   672 GRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTDGYDSVQQLELMAF 731
               L + +  +Y   D     G  E E+          G    T+ + GYDS++ +  +  
Sbjct:   676 A-LRVKTT-KYKWSDQYRETG--EIEHLLGVQILSAQG---ETSSSIGYDSIRNVTTLDI 728

Query:   732 DYER 735
             +  R
Sbjct:   729 EAGR 732

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009751 "response to salicylic acid stimulus" evidence=IDA

GO:0009311 "oligosaccharide metabolic process" evidence=IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0009992 "cellular water homeostasis" evidence=IMP;IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA

GO:0010027 "thylakoid membrane organization" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0016226 "iron-sulfur cluster assembly" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1462 (519.7 bits), Expect = 8.8e-150, P = 8.8e-150
 Identities = 316/720 (43%), Positives = 450/720 (62%)

Query:    27 RCGDVEIPYPFGTKRGCFLNKD--FLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVMQ 84
             RCGDV I YPFG   GC+   D  F ITC +     KP +  S+IEV+N +  G L  + 
Sbjct:    32 RCGDVPIDYPFGISTGCYYPGDDSFNITCEED----KPNVL-SNIEVLNFNHSGQLRGLI 86

Query:    85 YTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGCT 144
               + VCYD +  +   +L +  L   +FS   NKF ++GC+++A +L   G   Y +GC 
Sbjct:    87 PRSTVCYDQQTNNDFESL-WFRLDNLSFS-PNNKFTLVGCNAWA-LLSTFGIQNYSTGCM 143

Query:   145 STCDSLDYVTNGSCVGTGCCQIE--IPGGLKELEVEAFSFKNHTKVSSFNPCTYAFVVDQ 202
             S CD+     N  C G GCC+ E  IP     +E +   F+N T V  FNPC+YAF V+ 
Sbjct:   144 SLCDTPP-PPNSKCNGVGCCRTEVSIPLDSHRIETQPSRFENMTSVEHFNPCSYAFFVED 202

Query:   203 SQFHFTSNYLALGGIRD--EFPMVLDWEIITDKTCEEA---KICGLNASCDTPKDNTSTS 257
               F+F+S    L  +R+   FP++LDW I  ++TCE+     ICG N++C    D+T   
Sbjct:   203 GMFNFSS-LEDLKDLRNVTRFPVLLDWSI-GNQTCEQVVGRNICGGNSTCF---DSTR-G 256

Query:   258 SGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNC--THICDNIPGSYTCRCXXXXXXXX 315
              GY CKC +G++GNPYLSDGC+D+NEC     +NC  T  C+N  GS+ C+C        
Sbjct:   257 KGYNCKCLQGFDGNPYLSDGCQDINECTTRI-HNCSDTSTCENTLGSFHCQCPSGSDLNT 315

Query:   316 XXXXXXCTPNQ---YTV-IKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNG 371
                    TP +   Y     V LG  I F++ +++IS++      R++ +L+++FFEQNG
Sbjct:   316 TTMSCIDTPKEEPKYLGWTTVLLGTTIGFLIILLTISYIQQKMRHRKNTELRQQFFEQNG 375

Query:   372 GSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVA 429
             G +L Q LS   G S+   KIFTEE +K  T+ Y +  ++G GG G VYKG L D + VA
Sbjct:   376 GGMLIQRLSGA-GPSNVDVKIFTEEGMKEATDGYNESRILGQGGQGTVYKGILQDNSIVA 434

Query:   430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
             +KK++  D++++++FINE++V+ QIN RNVV+LLGCCLET+VPLLVYEF+ +GTLF+H+H
Sbjct:   435 IKKARLGDRSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLH 494

Query:   490 KK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA 546
                   +L+WE RLRI  E AG L+YLHS  ++PIIHRDVK+ANILLDEN T KV+DFGA
Sbjct:   495 GSMFDSSLTWEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGA 554

Query:   547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             S+L+P+D  Q  T+VQGTLGYLDPEY  T  L +KSDVYSFGVVL+ELL+G+ AL  ++P
Sbjct:   555 SRLIPMDQEQLTTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERP 614

Query:   607 EEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
             +  + L   F+S++K+NRL EI+D +++N+ N+++++E A++A  C  + GEERP+MKEV
Sbjct:   615 QSSKHLVSYFVSAMKENRLHEIIDGQVMNEYNQREIQESARIAVECTRIMGEERPSMKEV 674

Query:   667 SLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTDGYDSVQQL 726
             + EL+      +  Q+   D       +E E+          G     T + GYDS+Q +
Sbjct:   675 AAELEALRVKTTKHQW--SDQYP----KEVEHLLGVQILSTQG----DTSSIGYDSIQNV 724

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1434 (509.9 bits), Expect = 8.1e-147, P = 8.1e-147
 Identities = 308/735 (41%), Positives = 451/735 (61%)

Query:    27 RCGDVEIPYPFGTKRGCFLNKD--FLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVMQ 84
             +CG+V I YPFG   GC+   D  F +TC       +  L    I+V NIS  GH++V+ 
Sbjct:    34 KCGNVTIEYPFGISTGCYYPGDDNFNLTCV----VEEKLLLFGIIQVTNISHSGHVSVLF 89

Query:    85 YTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGCT 144
                  CY+ K  +  + L Y   S F+ S + NKF ++GC++ + +L   G+  Y +GC 
Sbjct:    90 ERFSECYEQKNETNGTALGYQLGSSFSLS-SNNKFTLVGCNALS-LLSTFGKQNYSTGCL 147

Query:   145 STCDSLDYVTNGSCVGTGCCQIE---IPGGLKELEVEAFSFKN---------HTKVSSFN 192
             S C+S     NG C G GCC  E   +P      +  +   +N         +T V  FN
Sbjct:   148 SLCNSQPEA-NGRCNGVGCCTTEDFSVPFDSDTFQFGSVRLRNQVNNSLDLFNTSVYQFN 206

Query:   193 PCTYAFVVDQSQFHFTSNYLALGGIRD--EFPMVLDWEIITDKTCEEA---KICGLNASC 247
             PCTYAF+V+  +F+F S+   L  +R+   FP+ LDW I  ++TCE+A   +ICG N+SC
Sbjct:   207 PCTYAFLVEDGKFNFDSSK-DLKNLRNVTRFPVALDWSI-GNQTCEQAGSTRICGKNSSC 264

Query:   248 DTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTH--ICDNIPGSYTC 305
                  N++T +GY CKCN+GY+GNPY S+GC+D++EC   + +NC+    C N  G + C
Sbjct:   265 Y----NSTTRNGYICKCNEGYDGNPYRSEGCKDIDECISDT-HNCSDPKTCRNRDGGFDC 319

Query:   306 RCXXXXXXXXXXXXXXCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEK 365
             +C              CT  +Y   ++ L + I  +V +++   +     +R++ KL+ +
Sbjct:   320 KCPSGYDLNSSMS---CTRPEYKRTRIFLVIIIGVLVLLLAAICIQHATKQRKYTKLRRQ 376

Query:   366 FFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLP 423
             FFEQNGG +L Q LS   G S+   KIFTEE +K  TN Y +  ++G GG G VYKG LP
Sbjct:   377 FFEQNGGGMLIQRLSGA-GLSNIDFKIFTEEGMKEATNGYDESRILGQGGQGTVYKGILP 435

Query:   424 DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT 483
             D T VA+KK++  D  ++D+FI+E++V+ QIN RNVV++LGCCLET+VPLLVYEF+ NGT
Sbjct:   436 DNTIVAIKKARLADSRQVDQFIHEVLVLSQINHRNVVKILGCCLETEVPLLVYEFITNGT 495

Query:   484 LFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPK 540
             LF+H+H      +L+WE RLRI  E AG L+YLHS  ++PIIHRD+K+ANILLDEN T K
Sbjct:   496 LFDHLHGSIFDSSLTWEHRLRIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDENLTAK 555

Query:   541 VSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMA 600
             V+DFGASKL+P+D  Q  T+VQGTLGYLDPEY  T  L +KSDVYSFGVVL+ELL+G+ A
Sbjct:   556 VADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTTGLLNEKSDVYSFGVVLMELLSGQKA 615

Query:   601 LLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEER 660
             L  ++P+  + L   F+S+ ++NRL EI+D++++N+ N ++++E A++AA C  + GEER
Sbjct:   616 LCFERPQASKHLVSYFVSATEENRLHEIIDDQVLNEDNLKEIQEAARIAAECTRLMGEER 675

Query:   661 PTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTDGY 720
             P MKEV+ +L+     +   ++   D       +E E+          G    T+ + GY
Sbjct:   676 PRMKEVAAKLEALR--VEKTKHKWSDQYP----EENEHLIGGHILSAQG---ETSSSIGY 726

Query:   721 DSVQQLELMAFDYER 735
             DS++ + ++  +  R
Sbjct:   727 DSIKNVAILDIETGR 741

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1426 (507.0 bits), Expect = 5.7e-146, P = 5.7e-146
 Identities = 302/734 (41%), Positives = 441/734 (60%)

Query:    25 PNRCGDVEIPYPFGTKRGCFLNKD--FLITC-NDTLNPPKPFLRKSSIEVVNISIDGHLN 81
             P +CG+V + YPFG   GC+  +D  F ++C N+ L     F +   +EVV IS    L 
Sbjct:    29 PEKCGNVTLEYPFGFSPGCWRAEDPSFNLSCVNENL-----FYK--GLEVVEISHSSQLR 81

Query:    82 VMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKS 141
             V+   + +CY++KG        +  L   T S   N    +GC+SYA+V    G  R   
Sbjct:    82 VLYPASYICYNSKGKFAKGTYYWSNLGNLTLSGN-NTITALGCNSYAFVSSN-GTRRNSV 139

Query:   142 GCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVS--SFNPCTYAFV 199
             GC S CD+L +  NG C G GCCQ  +P G   L V ++ F N T V   S   C YAF+
Sbjct:   140 GCISACDALSHEANGECNGEGCCQNPVPAGNNWLIVRSYRFDNDTSVQPISEGQCIYAFL 199

Query:   200 VDQSQFHFTSN--YLALGGIRDEFPMVLDWEIITDKTCEEA--KICGLNASCDTPKDNTS 255
             V+  +F + ++  Y  L      FP+VLDW I   +TC +   K CG+N  C     N++
Sbjct:   200 VENGKFKYNASDKYSYLQNRNVGFPVVLDWSI-RGETCGQVGEKKCGVNGICS----NSA 254

Query:   256 TSSGYRCKCNKGYEGNPYLSDGCRDVNECE--DP-SRNNCT--HICDNIPGSYTCRCXXX 310
             +  GY CKC  G++GNPYL +GC+D+NEC   +P  ++NC+    C+N  G + C C   
Sbjct:   255 SGIGYTCKCKGGFQGNPYLQNGCQDINECTTANPIHKHNCSGDSTCENKLGHFRCNCRSR 314

Query:   311 XXXXXXXXXXXCTPN---QYTV-IKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKF 366
                        C P    +Y     + LG  I F+V +++IS +       +  +L+++F
Sbjct:   315 YELNTTTNT--CKPKGNPEYVEWTTIVLGTTIGFLVILLAISCIEHKMKNTKDTELRQQF 372

Query:   367 FEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPD 424
             FEQNGG +L Q LS   G S+   KIFTEE +K  T+ Y +  ++G GG G VYKG LPD
Sbjct:   373 FEQNGGGMLMQRLSGA-GPSNVDVKIFTEEGMKEATDGYDENRILGQGGQGTVYKGILPD 431

Query:   425 RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
              + VA+KK++  D +++++FINE++V+ QIN RNVV+LLGCCLET+VPLLVYEF+ +GTL
Sbjct:   432 NSIVAIKKARLGDNSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTL 491

Query:   485 FEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV 541
             F+H+H      +L+WE RLR+  E AG L+YLHS  ++PIIHRD+K+ANILLDEN T KV
Sbjct:   492 FDHLHGSMFDSSLTWEHRLRMAVEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKV 551

Query:   542 SDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL 601
             +DFGAS+L+P+D     T+VQGTLGYLDPEY  T  L +KSDVYSFGVVL+ELL+G+ AL
Sbjct:   552 ADFGASRLIPMDKEDLATMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKAL 611

Query:   602 LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
               ++P+  + +   F S+ K+NRL EI+D +++N+ N++++++ A++A  C  + GEERP
Sbjct:   612 CFERPQTSKHIVSYFASATKENRLHEIIDGQVMNENNQREIQKAARIAVECTRLTGEERP 671

Query:   662 TMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTDGYD 721
              MKEV+ EL+  L +      +  +  E    ++TE+          G    T+ + GYD
Sbjct:   672 GMKEVAAELEA-LRVTKTKHKWSDEYPEQ---EDTEHLVGVQKLSAQG---ETSSSIGYD 724

Query:   722 SVQQLELMAFDYER 735
             S++ + ++  +  R
Sbjct:   725 SIRNVAILDIEAGR 738

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0048527 "lateral root development" evidence=RCA;IMP

GO:0048589 "developmental growth" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1420 (504.9 bits), Expect = 2.5e-145, P = 2.5e-145
 Identities = 299/729 (41%), Positives = 441/729 (60%)

Query:    26 NRCGDVEIPYPFGTKRGCFL--NKDFLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVM 83
             N+CG++ I YPFG   GC+   N+ F ITC +     +P +  S IEV N +  G L V+
Sbjct:    34 NKCGNITIEYPFGISSGCYYPGNESFSITCKED----RPHVL-SDIEVANFNHSGQLQVL 88

Query:    84 QYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDSYAYVLGFLGEDRYKSGC 143
                +  CYD +G   + +  + TL   + S   NK   +GC++ + +L   G   Y + C
Sbjct:    89 LNRSSTCYDEQGKKTEEDSSF-TLENLSLS-ANNKLTAVGCNALS-LLDTFGMQNYSTAC 145

Query:   144 TSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFS--FKNHTKVSSFNPCTYAFVVD 201
              S CDS     +G C G GCC++++   L     E  S   K+ T    F+PCTYAF+V+
Sbjct:   146 LSLCDSPPEA-DGECNGRGCCRVDVSAPLDSYTFETTSGRIKHMTSFHDFSPCTYAFLVE 204

Query:   202 QSQFHFTS--NYLALGGIRDEFPMVLDWEIITDKTCEEA---KICGLNASCDTPKDNTST 256
               +F+F+S  + L L  +   FP++LDW +  ++TCE+     ICG N++C    D+T  
Sbjct:   205 DDKFNFSSTEDLLNLRNVM-RFPVLLDWSV-GNQTCEQVGSTSICGGNSTC---LDSTPR 259

Query:   257 SSGYRCKCNKGYEGNPYLSDGCRDVNECEDPS---RNNCTH--ICDNIPGSYTCRCXXXX 311
             + GY C+CN+G++GNPYLS GC+DVNEC   S   R+NC+    C N  G + C+C    
Sbjct:   260 N-GYICRCNEGFDGNPYLSAGCQDVNECTTSSTIHRHNCSDPKTCRNKVGGFYCKCQSGY 318

Query:   312 XXXXXXXXXXCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNG 371
                       C   ++    + L   I F+V ++ ++ +       +  KL+E+FFEQNG
Sbjct:   319 RLDTTTMS--CKRKEFAWTTILLVTTIGFLVILLGVACIQQRMKHLKDTKLREQFFEQNG 376

Query:   372 GSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVA 429
             G +L Q LS   G S+   KIFTE+ +K  TN YA+  ++G GG G VYKG LPD + VA
Sbjct:   377 GGMLTQRLSGA-GPSNVDVKIFTEDGMKKATNGYAESRILGQGGQGTVYKGILPDNSIVA 435

Query:   430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
             +KK++  D +++++FINE++V+ QIN RNVV+LLGCCLET+VPLLVYEF+ NGTLF+H+H
Sbjct:   436 IKKARLGDSSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLH 495

Query:   490 KK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA 546
                   +L+WE RL+I  E AG L+YLHS  ++PIIHRD+K+ANILLD N T KV+DFGA
Sbjct:   496 GSMIDSSLTWEHRLKIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDVNLTAKVADFGA 555

Query:   547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             S+L+P+D  +  T+VQGTLGYLDPEY  T  L +KSDVYSFGVVL+ELL+G+ AL   +P
Sbjct:   556 SRLIPMDKEELETMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFKRP 615

Query:   607 EEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
             +  + L   F ++ K+NRL EI+   ++N+ N ++++E A++AA C  + GEERP MKEV
Sbjct:   616 QSSKHLVSYFATATKENRLDEIIGGEVMNEDNLKEIQEAARIAAECTRLMGEERPRMKEV 675

Query:   667 SLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTFYECRNGIGSHTTPTDGYDSVQQL 726
             + +L+     +   ++   D       +E E+          G    T+ + GYDS++ +
Sbjct:   676 AAKLEALR--VEKTKHKWSDQYP----EENEHLIGGHILSAQG---ETSSSIGYDSIKNV 726

Query:   727 ELMAFDYER 735
              ++  +  R
Sbjct:   727 AILDIETGR 735

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0007166 "cell surface receptor signaling pathway" evidence=IPI

GO:0005773 "vacuole" evidence=IDA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0009615 "response to virus" evidence=IEP

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0009505 "plant-type cell wall" evidence=IDA

TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)]

 Score = 955 (341.2 bits), Expect = 1.9e-127, Sum P(2) = 1.9e-127
 Identities = 203/451 (45%), Positives = 279/451 (61%)

Query:   251 KDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNC-THICDNIPGSYTCRCXX 309
             K NT     Y+C C+ GYEGNPY+  GC+D++EC DP  N C    C N+ GSY C    
Sbjct:   255 KGNTFFEDSYQCSCHNGYEGNPYIPGGCQDIDECRDPHLNKCGKRKCVNVLGSYRCE--- 311

Query:   310 XXXXXXXXXXXXCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHM-KLKEKFFE 368
                           P    ++   L  G+  ++  M   WL     R+R + K K KFF+
Sbjct:   312 -----------KTWP---AILSGTLSSGLLLLIFGM---WLLCKANRKRKVAKQKRKFFQ 354

Query:   369 QNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTN--NYADVIGCGGSGNVYKGFLPDRT 426
             +NGG +L+Q+ S LHG S  + K+F+  +++  T+  N + ++G GG G VYKG L D  
Sbjct:   355 RNGGLLLQQQTSFLHG-SVNRTKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGM 413

Query:   427 PVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE 486
              VAVKKSK + +  ++EFINE++++ QIN RNVV++LGCCLET+VP+LVYEF+ N  LF+
Sbjct:   414 IVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFD 473

Query:   487 HIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
             H+H       +SWE RL I  E A  LSYLHS  ++PI HRDVKS NILLDE    KVSD
Sbjct:   474 HLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSD 533

Query:   544 FGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLS 603
             FG S+ V ID     T+VQGT+GY+DPEYLQ+   T KSDVYSFGV+L+ELLTG+  +  
Sbjct:   534 FGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSL 593

Query:   604 DKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTM 663
              + +E R L   FL +++ +RL EILD RI  + +++++  VAKLA RC+S+  E RPTM
Sbjct:   594 LRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTM 653

Query:   664 KEVSLELQGRLSLMSNGQYYLRDNVESNGVQ 694
             ++V +EL    S     Q   ++  E   +Q
Sbjct:   654 RDVFIELDRMQSKRKGTQSQAQNGEEHAHIQ 684

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)]

 Score = 990 (353.6 bits), Expect = 9.8e-116, Sum P(2) = 9.8e-116
 Identities = 239/572 (41%), Positives = 330/572 (57%)

Query:   140 KSGCTST----CDSLDYVTNG----SCVGTGCC-----QIEIPGGLKELEVEAFSFKNHT 186
             K+GC++       SL    NG    SC G GCC       E P  +  + +E+F   N T
Sbjct:   177 KTGCSNNKLPYYSSLCTKNNGEDERSCDGNGCCIAGLLDSEAPQVIG-INIESFDHGNST 235

Query:   187 KVSSFNPCTYAFVVDQ-SQFHFTSNYLALGGIRDEFPMVLDWEIITDK-------TCEEA 238
             K+     C  AF+ D  S F   S    L   R    + L W I T         +C+  
Sbjct:   236 KLE----CRVAFLTDDVSPFSNASEPKRLFAKRYA-TVSLGWVIQTKNLSFVNSLSCKNT 290

Query:   239 KICG-------LNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPS--- 288
             K          L  SC       S +    C C++GYEGNPYL  GC+D+NEC   S   
Sbjct:   291 KEYDNSTYNIKLVTSCICNNVTISGTDYANCGCSQGYEGNPYLPGGCKDINECLRNSYGQ 350

Query:   289 RNNC--THICDNIPGSYTCRCXXXXXXXXXXXXXXCTPNQYTVIKVALGVGISFVVAIMS 346
             R NC  +  C N+PG++ C                   N+  V  + +G     +V ++ 
Sbjct:   351 RQNCRESDTCVNLPGTFNC-----------------IGNKTRVTMIGVGSAFGILVLVVG 393

Query:   347 ISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYA 406
             I WL     +RR  K K KFF++NGG +L+Q+L+   G + EK +IF+  E++  T+N++
Sbjct:   394 IWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKG-NVEKTRIFSSRELEKATDNFS 452

Query:   407 D--VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
             +  ++G GG G VYKG L D   VAVKKSK VD+ K++EFINE+V++ QIN R+VV+LLG
Sbjct:   453 ESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLG 512

Query:   465 CCLETQVPLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPI 521
             CCLET+VP LVYEF+ NG LF+HIH++ +    +W  RLRI  + AG LSYLHS  + PI
Sbjct:   513 CCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPI 572

Query:   522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
              HRD+KS NILLDE    KVSDFG S+ V ID     TV+ GT+GY+DPEY  + + TDK
Sbjct:   573 YHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDK 632

Query:   582 SDVYSFGVVLVELLTGKMALLS-DKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK- 639
             SDVYSFGVVLVEL+TG+  +++    +E R LA +F  ++K+NR  EI+D RI  DG K 
Sbjct:   633 SDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARI-RDGCKP 691

Query:   640 QQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
             +Q+  VA LA RC++ +G++RP M++V  +L+
Sbjct:   692 EQVMAVANLARRCLNSKGKKRPCMRKVFTDLE 723

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)]

 Score = 1006 (359.2 bits), Expect = 1.1e-114, Sum P(2) = 1.1e-114
 Identities = 236/589 (40%), Positives = 329/589 (55%)

Query:   140 KSGCTSTCDSLDYVTNGS-----CVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPC 194
             K+GC+ +       T        C G GCCQ  +P   +++ +      N  K ++   C
Sbjct:   177 KTGCSFSYTFAQVCTGNKPEDMGCDGRGCCQASLPREPQQV-IGIRIESNDGKSTTSGDC 235

Query:   195 TYAFVVDQ----------SQFHFTSNY--LALGGIRD----EFPMVLDWEIITDKTCEEA 238
               AF+ D+           Q H    Y  L+LG I       F   L  +I  D     +
Sbjct:   236 RVAFLTDEFFSLSKLTKPEQLH-AKRYATLSLGWIMQTRNTSFVNSLACKIRKDTDTAYS 294

Query:   239 KICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNEC-EDPSRNNCTHICD 297
                 +   CD      S      C+CN GY+GNPY SDGCRD++EC E+P     T  C 
Sbjct:   295 NDQSIKCICDYTMSIISDIRYANCECNLGYKGNPYDSDGCRDIDECKENPKYCKETDTCV 354

Query:   298 NIPGSYTCRCXXXXXXXXXXXXXXCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRR 357
             N  G Y C                   ++   I +  G G   +V +  + WL     +R
Sbjct:   355 NFEGGYRC-----------------VGDKTKAIMIGAGTGFGVLVLVGGVWWLRKFLVKR 397

Query:   358 RHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSG 415
             R  K K+KFF++NGG +L+QEL+   G   EKA+IFT +E++  T N+++  V+G GG G
Sbjct:   398 RMAKRKKKFFKRNGGLLLQQELNTRQGVV-EKARIFTSKELEKATENFSENRVLGHGGQG 456

Query:   416 NVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV 475
              VYKG L D   VAVKKSK +D+ K+ EFINE+V++ QIN R+VV+LLGCCLET+VP+LV
Sbjct:   457 TVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILV 516

Query:   476 YEFVGNGTLFEHIHKKG----NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANI 531
             YEF+ NG LF+HIH++      + W  RLRI  + AG LSYLHS  + PI HRD+KS NI
Sbjct:   517 YEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNI 576

Query:   532 LLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVL 591
             LLDE    KV+DFG S+ V ID     TV+ GT+GY+DPEY ++ + T+KSDVYSFGV+L
Sbjct:   577 LLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVIL 636

Query:   592 VELLTG-KMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAA 650
              EL+TG K  ++    +E  +LA +F  ++K+ RL +I+D RI +D   +Q+  VA LA 
Sbjct:   637 AELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVMAVANLAM 696

Query:   651 RCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLR--DNVESNGVQETE 697
             +C+S RG  RP M+EV  EL+   +   + Q   R  +  E +GV+E E
Sbjct:   697 KCLSSRGRNRPNMREVFTELERICTSPEDSQVQNRIDEEEEEDGVEEEE 745

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
 Identities = 275/705 (39%), Positives = 396/705 (56%)

Query:    26 NR-CGDVEIPYPFGT-KRGCFLNKDFLITCNDTLNPPK--PFLRKSSIEVVNI----SID 77
             NR CG +EIP+PFG  +R CFLN  + + CN T +     PFL K + E+V+I    SID
Sbjct:    38 NRICGGIEIPFPFGIGRRDCFLNDWYEVVCNSTTSGKSLAPFLYKINRELVSITLRSSID 97

Query:    78 GHLNVMQYTAKVCYDAKGYSVDSNLPYITLSKFT--FSRTGNKFVVIGCDSYAYVLGFLG 135
                 V+   + V            LP     K +  F    N+ V +GCD+ A +     
Sbjct:    98 SSYGVVHIKSPVTSSGCSQRPVKPLPLNLTGKGSPFFITDSNRLVSVGCDNRALITDI-- 155

Query:   136 EDRYKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKE-LEVEAFSFKNHT------KV 188
             E +  +GC S+CD      +  C G  CCQ +IP    + + V+  S   +T      KV
Sbjct:   156 ESQI-TGCESSCDGDKSRLDKICGGYTCCQAKIPADRPQVIGVDLESSGGNTTQGGNCKV 214

Query:   189 SSFNPCTY--AFVVDQSQFHFTSNY--LALGGIRDEFPMVLDWEIITDKTCEEAKICGLN 244
             +     TY  A V +  QF +T+ +  + LG   D      D  +     C      G+ 
Sbjct:   215 AFLTNETYSPANVTEPEQF-YTNGFTVIELGWYFD----TSDSRLTNPVGCVNLTETGIY 269

Query:   245 AS---CDTPKDNTSTSSGY-RCKCNK-GYEGNPYLSDGCRDVNECED-PSRNNCTHI-CD 297
              S   C     N S   GY  C CN+ GY GNPYL  GC D++ECE+    ++C  + C 
Sbjct:   270 TSAPSCVCEYGNFS-GFGYSNCYCNQIGYRGNPYLPGGCIDIDECEEGKGLSSCGELTCV 328

Query:   298 NIPGSYTCRCXXXXXXXXXXXXXXCTPNQYTVIKVALGVGISFVVAIMSISW--LHFLWT 355
             N+PGS+ C                  P       + LG  + F+V  + I W  + F+  
Sbjct:   329 NVPGSWRCELNGVGKIKPLF------PG------LVLGFPLLFLV--LGI-WGLIKFVKK 373

Query:   356 RRRHMKLKEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGG 413
             RR+ ++ K  FF++NGG +L+Q+L+   G + + +KIF+ +E++  T+N+    V+G GG
Sbjct:   374 RRKIIR-KRMFFKRNGGLLLKQQLTT-RGGNVQSSKIFSSKELEKATDNFNMNRVLGQGG 431

Query:   414 SGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL 473
              G VYKG L D   VAVK+SK +D+ K++EFINE+ V+ QIN RN+V+L+GCCLET+VP+
Sbjct:   432 QGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPI 491

Query:   474 LVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
             LVYE + NG LF+ +H   +   ++W+ RLRI+ E AG L+YLHS  + P+ HRDVK+ N
Sbjct:   492 LVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTN 551

Query:   531 ILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVV 590
             ILLDE    KVSDFG S+ + +D     T+V GT GYLDPEY QT + TDKSDVYSFGVV
Sbjct:   552 ILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVV 611

Query:   591 LVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAA 650
             LVEL+TG+      +PEE R L  +F  ++KQNR+L+I+D+RI      +Q+  VAKLA 
Sbjct:   612 LVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLAR 671

Query:   651 RCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQE 695
             RC+S++G++RP M+EVS+EL+   S   + + ++ +  E     E
Sbjct:   672 RCLSLKGKKRPNMREVSVELERIRSSPEDLELHIEEEDEEECAME 716

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009620 "response to fungus" evidence=IMP

TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
 Identities = 272/702 (38%), Positives = 392/702 (55%)

Query:    26 NR-CGDVEIPYPFGTK-RGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISIDGHLNVM 83
             NR CG++ IP+PFG   + C+LN  + + CN T + P  FL + + E+VNIS++G +++ 
Sbjct:    36 NRVCGEISIPFPFGIGGKDCYLNPWYEVVCNSTNSVP--FLSRINRELVNISLNGVVHIK 93

Query:    84 Q-YTAKVCYDAKGYSVDSNLPYITLS---KFTFSRTGNKFVVIGCDSYAYVLGFLGE-DR 138
                T+  C  + G S     P + ++      F    N  V +GC   A + G   +   
Sbjct:    94 APVTSSGC--STGTSQPLTPPPLNVAGQGSPYFLTDKNLLVAVGCKFKAVMAGITSQITS 151

Query:   139 YKSGCTSTCDSLDYVTNGSCVGTGCCQIEIPGGLKELEVEAFSFKNHTKVSSFNPCTYAF 198
              +S C     S     N  C G  CCQ  IP G  ++             +    C  AF
Sbjct:   152 CESSCNERNSSSQEGRNKICNGYKCCQTRIPEGQPQVISVDIEIPQGNNTTGEGGCRVAF 211

Query:   199 VVDQ--SQFHFTSNYLALGGIRDEFPMVLDWEIITDKTCEEAKICGLNASCDTP-KDNTS 255
             +     S  + T      G       + L W   T  + +   I   NAS  TP   +T 
Sbjct:   212 LTSDKYSSLNVTEPEKFHG--HGYAAVELGWFFDTSDSRDTQPISCKNASDTTPYTSDTR 269

Query:   256 TS------SG--YR-CKCNK-GYEGNPYLSDGCRDVNECE-DPSRNNCT-HICDNIPGSY 303
              S      SG  YR C CN  GY+GNP+L  GC DV+EC+ D  RN C    C N+PG +
Sbjct:   270 CSCSYGYFSGFSYRDCYCNSPGYKGNPFLPGGCVDVDECKLDIGRNQCKDQSCVNLPGWF 329

Query:   304 TCRCXXXXXXXXXXXXXXCTPNQYTVIKVALGVGISFVVAIMSISWLH-FLWTRRRHMKL 362
              C+                 P Q   +   + +G + ++    I  L+ F+  RR+ +++
Sbjct:   330 DCQPKK--------------PEQLKRVIQGVLIGSALLLFAFGIFGLYKFVQKRRKLIRM 375

Query:   363 KEKFFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKG 420
             + KFF +NGG +L+Q+L++  G + E ++IF+  E++  T+N+    V+G GG G VYKG
Sbjct:   376 R-KFFRRNGGMLLKQQLARKEG-NVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKG 433

Query:   421 FLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG 480
              L D   VAVK+SK VD+ +++EFINE+VV+ QIN RN+V+LLGCCLET+VP+LVYEFV 
Sbjct:   434 MLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVP 493

Query:   481 NGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC 537
             NG L + +H + +   ++WE RL I  E AG LSYLHS  + PI HRD+K+ NILLDE  
Sbjct:   494 NGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERN 553

Query:   538 TPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
               KVSDFG S+ V ID     T V GT GY+DPEY Q+ K T+KSDVYSFGVVLVELLTG
Sbjct:   554 RAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTG 613

Query:   598 KMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRG 657
             +      + EE R LA +F+ ++K+NR+L+I+D+RI ++ N  Q+  VA LA RC++ +G
Sbjct:   614 EKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKG 673

Query:   658 EERPTMKEVSLELQG-RLSLMSNGQYYLRDNVESNGVQETEY 698
             ++RP M+EVS+EL+  R S   +G +   D+ E +   E  +
Sbjct:   674 KKRPNMREVSIELEMIRSSHYDSGIHIEDDDEEDDQAMELNF 715

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LMP1	WAK2_ARATH	2, ., 7, ., 1, 1, ., -	0.4450	0.9401	0.9439	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00015471001 SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (743 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	735
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-42
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-42
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-38
pfam13947	106	pfam13947, GUB_WAK_bind, Wall-associated receptor	3e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-25
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-19
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-19
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-19
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-17
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-15
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-15
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-14
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-14
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-06
cd00054	38	cd00054, EGF_CA, Calcium-binding EGF-like domain,	3e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-06
smart00179	39	smart00179, EGF_CA, Calcium-binding EGF-like domai	6e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-05
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-05
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-04
pfam12947	36	pfam12947, EGF_3, EGF domain	3e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-04
pfam07645	42	pfam07645, EGF_CA, Calcium-binding EGF domain	4e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-04
cd00053	36	cd00053, EGF, Epidermal growth factor domain, foun	4e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-04
smart00181	35	smart00181, EGF, Epidermal growth factor-like doma	7e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.002
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  162 bits (413), Expect = 2e-45
 Identities = 85/264 (32%), Positives = 123/264 (46%), Gaps = 20/264 (7%)

Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQ--AKIDEFINELVVVLQINRRNVVRLLG 464
            +G G  G VYK         VAVK  K   +   K      E+ ++ +++  N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
              +     LV E+   G LF+++ + G LS +   +I  +    L YLHS     IIHR
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHR 122

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL-TDKSD 583
           D+K  NILLDEN   K++DFG +K +   +  + T   GT  Y+ PE L        K D
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181

Query: 584 VYSFGVVLVELLTGKMALLSDKP-EEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           V+S GV+L ELLTGK       P   E  L    L        LE  D    + G+    
Sbjct: 182 VWSLGVILYELLTGKP------PFSGENILDQLQLIRRILGPPLEF-DEPKWSSGS---- 230

Query: 643 KEVAKLAARCISVRGEERPTMKEV 666
           +E   L  +C++    +RPT +E+
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  160 bits (407), Expect = 4e-45
 Identities = 67/191 (35%), Positives = 100/191 (52%), Gaps = 9/191 (4%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKI-DEFINELVVVLQINRRNVVRLLGCC 466
           +G GG G VY          VA+K  K  D + + +E + E+ ++ ++N  N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 467 LETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            +     LV E+   G+L + + +  G LS +  LRI  +    L YLHS     IIHRD
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117

Query: 526 VKSANILLDENC-TPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC-KLTDKSD 583
           +K  NILLD +    K++DFG SKL+          + GT  Y+ PE L      ++KSD
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT-SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 584 VYSFGVVLVEL 594
           ++S GV+L EL
Sbjct: 177 IWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  157 bits (399), Expect = 1e-43
 Identities = 65/194 (33%), Positives = 96/194 (49%), Gaps = 7/194 (3%)

Query: 407 DVIGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLLG 464
           + +G G  G VY          VA+K  K     K  E  + E+ ++ ++   N+VRL  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
              +     LV E+   G LF+ + K+G LS +       +    L YLHS+    I+HR
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVHR 121

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+K  NILLDE+   K++DFG ++   +D  +  T   GT  Y+ PE L         D+
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 585 YSFGVVLVELLTGK 598
           +S GV+L ELLTGK
Sbjct: 180 WSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  156 bits (397), Expect = 3e-43
 Identities = 84/275 (30%), Positives = 131/275 (47%), Gaps = 34/275 (12%)

Query: 408 VIGCGGSGNVYKGFL-----PDRTPVAVKKSK-FVDQAKIDEFINELVVVLQINRRNVVR 461
            +G G  G VYKG L        T VAVK  K    + + +EF+ E  ++ +++  N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVP 520
           LLG C + +   +V E++  G L + + K G  L+ +  L++  + A  + YL S     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---KN 122

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD-----PEYLQT 575
            +HRD+ + N L+ EN   K+SDFG S+ +  D        +   G L      PE L+ 
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGGKLPIKWMAPESLKD 178

Query: 576 CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
            K T KSDV+SFGV+L E+ T     L ++P    S     L  L+    L   +N    
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT-----LGEQPYPGMSNE-EVLELLEDGYRLPRPEN---- 228

Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL 670
                   E+ +L  +C +   E+RPT  E+  +L
Sbjct: 229 -----CPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  153 bits (389), Expect = 4e-42
 Identities = 86/274 (31%), Positives = 127/274 (46%), Gaps = 31/274 (11%)

Query: 407 DVIGCGGSGNVYKGFL-----PDRTPVAVKKSKFVDQAK-IDEFINELVVVLQINRRNVV 460
             +G G  G VYKG L       +  VAVK  K     + I+EF+ E  ++ +++  NVV
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNV 519
           +LLG C E +   +V E++  G L  ++ K +  LS    L    + A  + YL S+   
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK--- 121

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG---YLDPEYLQTC 576
             IHRD+ + N L+ EN   K+SDFG S+ +  D        +G      ++ PE L+  
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKLPIRWMAPESLKEG 178

Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
           K T KSDV+SFGV+L E+ T     L ++P    S     L  LK    L    N     
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT-----LGEQPYPGMSNE-EVLEYLKNGYRLPQPPN----- 227

Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL 670
                  E+  L  +C +   E+RPT  E+   L
Sbjct: 228 ----CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  153 bits (389), Expect = 5e-42
 Identities = 86/272 (31%), Positives = 131/272 (48%), Gaps = 26/272 (9%)

Query: 407 DVIGCGGSGNVYKGFL-----PDRTPVAVKKSK-FVDQAKIDEFINELVVVLQINRRNVV 460
             +G G  G VYKG L          VAVK  K    + +I+EF+ E  ++ +++  N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETN 518
           +LLG C E +  ++V E++  G L +++ K     LS    L    + A  + YL S+  
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK-- 122

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
              IHRD+ + N L+ EN   K+SDFG S+ +  D        +  + ++ PE L+  K 
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 579 TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
           T KSDV+SFGV+L E+ T     L ++P    S A   L  LK+   L    N       
Sbjct: 182 TSKSDVWSFGVLLWEIFT-----LGEEPYPGMSNA-EVLEYLKKGYRLPKPPN------- 228

Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEVSLEL 670
                E+ KL  +C +   E+RPT  E+   L
Sbjct: 229 --CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  143 bits (362), Expect = 2e-38
 Identities = 87/284 (30%), Positives = 128/284 (45%), Gaps = 41/284 (14%)

Query: 407 DVIGCGGSGNVYKGFLPDR----TPVAVKKSK-FVDQAKIDEFINELVVVLQINRRNVVR 461
             +G G  G VYKG L  +    T VAVK  K    + +  +F+ E  V+ ++   NVVR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK---------KGNLSWERRLRITAETAGVLSY 512
           LLG C E +   LV E++  G L +++ K         K  LS +  L    + A  + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 513 LHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG-----Y 567
           L S      +HRD+ + N L+ E+   K+SDFG S+ V  D        + T G     +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY----RKKTGGKLPIRW 173

Query: 568 LDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE 627
           + PE L+    T KSDV+SFGV+L E+ T     L   P    S     L  L++   L 
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT-----LGATPYPGLS-NEEVLEYLRKGYRLP 227

Query: 628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
             +     D       E+ +L   C  +  E+RPT  E+   L+
Sbjct: 228 KPEY--CPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding

 Score =  128 bits (324), Expect = 3e-35
 Identities = 43/107 (40%), Positives = 66/107 (61%), Gaps = 2/107 (1%)

Query: 21  KPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISI-DGH 79
            P CP+RCG+V IPYPFG   GC  +  F +TCN+T +PP+  L   + EV++IS+ +G 
Sbjct: 1   LPGCPDRCGNVSIPYPFGIGPGCARDPGFELTCNNTTSPPRLLLGNGNYEVLSISLANGT 60

Query: 80  LNVMQYTAKVCYDAKGYSVDSNLPYITLSKFTFSRTGNKFVVIGCDS 126
           + V+   +  CY++ G   D+    +    F FS + NKFVV+GC++
Sbjct: 61  VRVLDPISSNCYNSSGKRTDNGSLSLGGP-FFFSSSRNKFVVVGCNT 106

This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (333), Expect = 2e-34
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 13/199 (6%)

Query: 408 VIGCGGSGNVYKGFLPDRTP--VAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLL 463
           ++G G  G+VY     D T   +AVK  +     + +++    E+ ++  +   N+VR  
Sbjct: 7   LLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 464 GCCL-ETQVPLLVY-EFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVP 520
           G    E +  L ++ E+V  G+L   + K G L  E  +R  T +    L+YLHS     
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EPVIRKYTRQILEGLAYLHSNG--- 121

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV-VQGTLGYLDPEYLQTCKLT 579
           I+HRD+K ANIL+D +   K++DFG +K +        T  V+GT  ++ PE ++  +  
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181

Query: 580 DKSDVYSFGVVLVELLTGK 598
             +D++S G  ++E+ TGK
Sbjct: 182 RAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  122 bits (307), Expect = 4e-30
 Identities = 80/277 (28%), Positives = 120/277 (43%), Gaps = 25/277 (9%)

Query: 408 VIGCGGSGNVYKGFLPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQIN-RRNVVRLL 463
            +G G  G VY     DR  VA+K   K       +++ F+ E+ ++  +N   N+V+L 
Sbjct: 7   KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHK---KGNLSWERRLRITAETAGVLSYLHSETNVP 520
               +     LV E+V  G+L + + K   KG LS    L I A+    L YLHS+    
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---G 121

Query: 521 IIHRDVKSANILLDEN-CTPKVSDFGASKLVPIDAI-----QNCTVVQGTLGYLDPEYLQ 574
           IIHRD+K  NILLD +    K+ DFG +KL+P            +   GT GY+ PE L 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 575 TCKL---TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN 631
              L   +  SD++S G+ L ELLTG      +K     S  +  +  L    L   L  
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL 668
                 +    K  + L  + ++   + R +      
Sbjct: 242 SNPELIS----KAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  118 bits (298), Expect = 7e-30
 Identities = 63/194 (32%), Positives = 96/194 (49%), Gaps = 7/194 (3%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           + IG GG G VYK         VA+K  K   + K ++ INE+ ++ +    N+V+  G 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR-ITAETAGVLSYLHSETNVPIIHR 524
            L+     +V EF   G+L + +        E ++  +  E    L YLHS     IIHR
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHR 122

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+K+ANILL  +   K+ DFG S  +  D     T+V GT  ++ PE +       K+D+
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMV-GTPYWMAPEVINGKPYDYKADI 180

Query: 585 YSFGVVLVELLTGK 598
           +S G+  +EL  GK
Sbjct: 181 WSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 8e-28
 Identities = 57/190 (30%), Positives = 97/190 (51%), Gaps = 11/190 (5%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             IG G  G+V  G    +  VAVK  K  D      F+ E  V+  +   N+V+LLG  
Sbjct: 12  ATIGKGEFGDVMLGDYRGQK-VAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHR 524
           L+     +V E++  G+L +++  +G   ++  ++L    +    + YL  +     +HR
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHR 126

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+ + N+L+ E+   KVSDFG +K    +A Q     +  + +  PE L+  K + KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182

Query: 585 YSFGVVLVEL 594
           +SFG++L E+
Sbjct: 183 WSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 9e-27
 Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 9/196 (4%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLL 463
           D+IG G  G VYKG  L     VA+K+     + +  +   + E+ ++  +   N+V+ +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G    +    ++ E+  NG+L + I K G            +    L+YLH +    +IH
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIH 122

Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+K+ANIL  ++   K++DFG A+KL   D  ++   V GT  ++ PE ++    +  S
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEMSGASTAS 180

Query: 583 DVYSFGVVLVELLTGK 598
           D++S G  ++ELLTG 
Sbjct: 181 DIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  109 bits (274), Expect = 1e-26
 Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 7/195 (3%)

Query: 407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFI-NELVVVLQINRRNVVRLLG 464
            V+G G SG VYK    P     A+KK       +  + +  EL  +       VV+  G
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNVPIIH 523
              +     +V E++  G+L + + K G +  E  L  I  +    L YLH++ +  IIH
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLLKKVGKIP-EPVLAYIARQILKGLDYLHTKRH--IIH 123

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+K +N+L++     K++DFG SK++  + +  C    GT+ Y+ PE +Q    +  +D
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLE-NTLDQCNTFVGTVTYMSPERIQGESYSYAAD 182

Query: 584 VYSFGVVLVELLTGK 598
           ++S G+ L+E   GK
Sbjct: 183 IWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  109 bits (275), Expect = 1e-26
 Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 39/222 (17%)

Query: 407 DVIGCGGSGNVYKGFL-PDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINR-RNVVR 461
            +IG G    V            A+K   K + + + K+     E  V+ ++N    +++
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 462 LLGC-----CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR-ITAETAGVLSYLHS 515
           L         L       V E+  NG L ++I K G+L  E+  R   AE    L YLHS
Sbjct: 67  LYYTFQDEENL-----YFVLEYAPNGELLQYIRKYGSLD-EKCTRFYAAEILLALEYLHS 120

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID--AIQNCTVVQ----------- 562
                IIHRD+K  NILLD++   K++DFG +K++  +     N                
Sbjct: 121 ---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 563 ------GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
                 GT  Y+ PE L        SD+++ G ++ ++LTGK
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (270), Expect = 5e-26
 Identities = 74/272 (27%), Positives = 114/272 (41%), Gaps = 37/272 (13%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKS--KFVDQAKIDEFINELVVVLQINRRNVVRLL 463
             IG G  G VY      D     +K+     + + + ++ +NE+ ++ ++N  N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGN----LSWERRLRITAETAGVLSYLHSETNV 519
               E     +V E+   G L + I K+         E+ L    +    L YLHS    
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
            I+HRD+K  NI L  N   K+ DFG SK++        TVV GT  YL PE  Q     
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181

Query: 580 DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK 639
            KSD++S G VL EL T K       P E  +L                L  +I+  G  
Sbjct: 182 YKSDIWSLGCVLYELCTLK------HPFEGENLLE--------------LALKILK-GQY 220

Query: 640 QQL-----KEVAKLAARCISVRGEERPTMKEV 666
             +      E+  L +  +    EERP++ ++
Sbjct: 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 3e-25
 Identities = 66/197 (33%), Positives = 104/197 (52%), Gaps = 16/197 (8%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           IG G  G+VYKG L   T VAVK  +S      K  +F+ E  ++ Q +  N+V+L+G C
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGVC 61

Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
           ++ Q   +V E V  G+L   + KK N L+ ++ L+++ + A  + YL S+     IHRD
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG-----YLDPEYLQTCKLTD 580
           + + N L+ EN   K+SDFG S+    +       V   L      +  PE L   + T 
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 581 KSDVYSFGVVLVELLTG 597
           +SDV+S+G++L E  + 
Sbjct: 175 ESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  104 bits (261), Expect = 4e-25
 Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 22/267 (8%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +++G G  G V+KG L D+TPVAVK  K     + KI +F++E  ++ Q +  N+V+L+G
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIG 59

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIH 523
            C + Q   +V E V  G     + KK + L  ++ ++   + A  ++YL S+     IH
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIH 116

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+ + N L+ EN   K+SDFG S+        +  + Q  + +  PE L   + + +SD
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 584 VYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           V+S+G++L E                 SL +     +   +  E ++        ++   
Sbjct: 177 VWSYGILLWETF---------------SLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPD 221

Query: 644 EVAKLAARCISVRGEERPTMKEVSLEL 670
           +V K+  RC   + E RP   E+  EL
Sbjct: 222 DVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 5e-25
 Identities = 61/169 (36%), Positives = 87/169 (51%), Gaps = 6/169 (3%)

Query: 431 KKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIH 489
           KK K + + +++  + E  ++ +IN   +V+L     +T+  L LV E+   G LF H+ 
Sbjct: 27  KKKKIIKRKEVEHTLTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLS 85

Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K+G  S ER     AE    L YLHS     II+RD+K  NILLD +   K++DFG +K 
Sbjct: 86  KEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKE 142

Query: 550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           +            GT  YL PE L         D +S GV+L E+LTGK
Sbjct: 143 L-SSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (259), Expect = 8e-25
 Identities = 78/274 (28%), Positives = 133/274 (48%), Gaps = 42/274 (15%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           IG G  G V+ G+  ++  VA+K  +   + +   ++FI E  V+++++   +V+L G C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 467 LETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            E     LV+EF+ +G L +++  ++G  S E  L +  +    ++YL S     +IHRD
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           + + N L+ EN   KVSDFG ++ V  D   + T  +  + +  PE     K + KSDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 586 SFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN------ 638
           SFGV++ E+ + GK       P E RS                  ++ +V   N      
Sbjct: 186 SFGVLMWEVFSEGKT------PYENRS------------------NSEVVETINAGFRLY 221

Query: 639 KQQL--KEVAKLAARCISVRGEERPTMKEVSLEL 670
           K +L  + V +L   C   R E+RP+   +  +L
Sbjct: 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 99.5 bits (248), Expect = 3e-23
 Identities = 68/199 (34%), Positives = 110/199 (55%), Gaps = 13/199 (6%)

Query: 408 VIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           VIG G  G VY G L D    +   AVK  ++  D  ++++F+ E +++   +  NV+ L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 463 LGCCLETQ-VPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVP 520
           LG CL ++  PL+V  ++ +G L   I     N + +  +    + A  + YL S+  V 
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV- 120

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYLQTCK 577
             HRD+ + N +LDE+ T KV+DFG ++ +      ++ N T  +  + ++  E LQT K
Sbjct: 121 --HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178

Query: 578 LTDKSDVYSFGVVLVELLT 596
            T KSDV+SFGV+L EL+T
Sbjct: 179 FTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 8e-23
 Identities = 64/217 (29%), Positives = 114/217 (52%), Gaps = 21/217 (9%)

Query: 390 AKIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKK-SKFVDQAKIDE 443
            +I  E E++ +      V+G G  G VYKG ++P+    + PVA+K   +        E
Sbjct: 1   LRILKETELEKIK-----VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE 55

Query: 444 FINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRI 502
            ++E  V+  ++  +VVRLLG CL +QV  L+ + +  G L +++   K N+  +  L  
Sbjct: 56  ILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNW 114

Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
             + A  +SYL  +    ++HRD+ + N+L+      K++DFG +KL+ +D  +     +
Sbjct: 115 CVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD--EKEYHAE 169

Query: 563 G---TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           G    + ++  E +     T KSDV+S+GV + EL+T
Sbjct: 170 GGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 54/194 (27%), Positives = 102/194 (52%), Gaps = 7/194 (3%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V++G   + TPVAVK  K        +F+ E  ++ ++    +++L   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 469 TQVPLLVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
            +   +V E +  G+L E++       L   + + + A+ A  ++YL ++     IHRD+
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129

Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N+L+ EN   KV+DFG ++++  D  +     +  + +  PE     + + KSDV+S
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWS 189

Query: 587 FGVVLVELLT-GKM 599
           FG++L E++T G+M
Sbjct: 190 FGILLTEIVTYGRM 203

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 57/199 (28%), Positives = 107/199 (53%), Gaps = 16/199 (8%)

Query: 408 VIGCGGSGNVYKGFL--PDRT--PVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           VIG G  G V +G L  P +    VA+K  K+   D+ ++D F+ E  ++ Q +  N++R
Sbjct: 11  VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIR 69

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           L G   +++  +++ E++ NG+L + +    G  +  + + +    A  + YL   + + 
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG---TLGYLDPEYLQTCK 577
            +HRD+ + NIL++ N   KVSDFG S+   ++  +     +G    + +  PE +   K
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 578 LTDKSDVYSFGVVLVELLT 596
            T  SDV+SFG+V+ E+++
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 9/195 (4%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKS---KFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           IG G  G V+K        V   K      +++ + +E I+E  V+ +++   ++R    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
            L+     +V E+  NG L + +       L  ++  R   +    L++LHS+    I+H
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILH 124

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+KS N+ LD     K+ D G +KL+  +     T+V GT  YL PE  +     +KSD
Sbjct: 125 RDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYNEKSD 183

Query: 584 VYSFGVVLVELLTGK 598
           V++ GVVL E  TGK
Sbjct: 184 VWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 12/199 (6%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGC 465
           IG G  G VY    L     +AVK+ +  D     I E  +E+ V+  +   N+V+  G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            +  +   +  E+   GTL E +     L        T +    L+YLHS     I+HRD
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRD 124

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG---YLDPEYLQTCKLTDK- 581
           +K ANI LD N   K+ DFG +  +  +       VQ   G   Y+ PE +   K     
Sbjct: 125 IKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHG 184

Query: 582 --SDVYSFGVVLVELLTGK 598
             +D++S G V++E+ TGK
Sbjct: 185 RAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.4 bits (232), Expect = 4e-21
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 24/267 (8%)

Query: 409 IGCGGSGNVYKGFLP--DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           +G G  G VY+G       T VAVK  K  D  +++EF+ E  V+ +I   N+V+LLG C
Sbjct: 14  LGGGQYGEVYEGVWKKYSLT-VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 467 LETQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
                  ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHR
Sbjct: 72  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 128

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+ + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188

Query: 585 YSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE 644
           ++FGV+L E+ T  M   S  P  + S            ++ E+L+     +  +    +
Sbjct: 189 WAFGVLLWEIATYGM---SPYPGIDLS------------QVYELLEKGYRMERPEGCPPK 233

Query: 645 VAKLAARCISVRGEERPTMKEVSLELQ 671
           V +L   C      +RP+  E+    +
Sbjct: 234 VYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 92.9 bits (231), Expect = 5e-21
 Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 30/228 (13%)

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI-HKKGNLSWERR-LRI 502
           +NE+V++  +   N++      ++    L+  E+   GTL++ I  +KG L  E   L  
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106

Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
             +    +SY+H      I+HRD+K+ NI L +    K+ DFG SK++  +     TVV 
Sbjct: 107 LFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV- 162

Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
           GT  Y+ PE  Q  K   KSD+++ G VL ELLT K    +  P                
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-------------- 208

Query: 623 NRLLEILDNRIVN----DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                 L  +IV             E+  L    +    E+RPT  EV
Sbjct: 209 ------LVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 93.6 bits (233), Expect = 6e-21
 Identities = 74/283 (26%), Positives = 130/283 (45%), Gaps = 35/283 (12%)

Query: 409 IGCGGSGNVYKG---FLPDRT--PVAVKKSKFVDQ--AKIDEFINELVVVLQINRRNVVR 461
           +G G  G V       L D T   VAVK             +F  E+ ++  ++  N+V+
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 462 LLGCCLET--QVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETN 518
             G C +   +   L+ E++ +G+L +++ + +  ++ +R L  +++    + YL S+  
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR- 129

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV----QGTLGYLDPEYLQ 574
              IHRD+ + NIL++     K+SDFG +K++P D  ++   V    +  + +  PE L+
Sbjct: 130 --YIHRDLAARNILVESEDLVKISDFGLAKVLPED--KDYYYVKEPGESPIFWYAPECLR 185

Query: 575 TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV 634
           T K +  SDV+SFGV L EL T      S   E  R +       +   RLLE+L     
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLELLK---- 240

Query: 635 NDGNKQQLK-------EVAKLAARCISVRGEERPTMKEVSLEL 670
                ++L        EV  L   C     ++RP+  ++ L +
Sbjct: 241 ---EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 7e-21
 Identities = 76/264 (28%), Positives = 127/264 (48%), Gaps = 28/264 (10%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G    +  VA+K  +    ++ D+FI E  V+++++  N+V+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 469 TQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            +   +V E++ NG L  ++  +KG L  E  L + ++    + YL S      IHRD+ 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLA 127

Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT---LGYLDPEYLQTCKLTDKSDV 584
           + N L+ E+   KVSDFG ++ V  D     T  QGT   + +  PE     + + KSDV
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 585 YSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           +SFGV++ E+ + GKM      P E  S           + ++E +         K    
Sbjct: 185 WSFGVLMWEVFSEGKM------PYERFS----------NSEVVESVSAGYRLYRPKLAPT 228

Query: 644 EVAKLAARCISVRGEERPTMKEVS 667
           EV  +   C   + E+RP  K++ 
Sbjct: 229 EVYTIMYSCWHEKPEDRPAFKKLL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 76/301 (25%)

Query: 409 IGCGGSGNVYKGFLPD------RTPVAVKKSKFVDQAKID---EFINELVVVLQINRRNV 459
           +G G  G VY+G           T VA+K     + A +    EF+NE  V+ + N  +V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKT--VNENASMRERIEFLNEASVMKEFNCHHV 71

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTL----------FEHIHKKGNLSWERRLRITAETAGV 509
           VRLLG     Q  L+V E +  G L           E+    G  + ++ +++ AE A  
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV--------------PIDAI 555
           ++YL ++     +HRD+ + N ++ E+ T K+ DFG ++ +              P+   
Sbjct: 132 MAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186

Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP-----EEER 610
                      ++ PE L+    T KSDV+SFGVVL E     MA L+++P      EE 
Sbjct: 187 -----------WMAPESLKDGVFTTKSDVWSFGVVLWE-----MATLAEQPYQGLSNEE- 229

Query: 611 SLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL 670
              + F+       L E   ++            + +L   C     + RPT  E+   L
Sbjct: 230 --VLKFVIDGGHLDLPENCPDK------------LLELMRMCWQYNPKMRPTFLEIVSSL 275

Query: 671 Q 671
           +
Sbjct: 276 K 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 92.1 bits (228), Expect = 3e-20
 Identities = 76/288 (26%), Positives = 137/288 (47%), Gaps = 32/288 (11%)

Query: 391 KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFVDQAKID-EF 444
           +I  E E+K V      V+G G  G VYKG ++P+    + PVA+K        K + EF
Sbjct: 2   RILKETELKRVK-----VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEF 56

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           ++E +++  ++  ++VRLLG CL   + L V + + +G L +++H+ K N+  +  L   
Sbjct: 57  MDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWC 115

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQ 562
            + A  + YL       ++HRD+ + N+L+      K++DFG ++L+  D  + N    +
Sbjct: 116 VQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 172

Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++  E +   K T +SDV+S+GV + EL+T         P  E    +     L Q
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ 232

Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL 670
             +  I               +V  +  +C  +  + RP  KE++ E 
Sbjct: 233 PPICTI---------------DVYMVMVKCWMIDADSRPKFKELAAEF 265

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 89.6 bits (222), Expect = 9e-20
 Identities = 60/198 (30%), Positives = 108/198 (54%), Gaps = 13/198 (6%)

Query: 408 VIGCGGSGNVYKGFL--PDR--TPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           VIG G  G V++G L  P R    VA+K  K  + ++ + D F++E  ++ Q +  N++R
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQFSHHNIIR 70

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVP 520
           L G   + +  +++ E++ NG L +++    G  S  + + +    A  + YL   +++ 
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKL 578
            +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K 
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187

Query: 579 TDKSDVYSFGVVLVELLT 596
           T  SDV+SFG+V+ E+++
Sbjct: 188 TSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 24/268 (8%)

Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKI-DEFINELVVVLQINRRNVVRLLGCC 466
           IG G  G V+ G L  D TPVAVK  +      +  +F+ E  ++ Q +  N+VRL+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            + Q   +V E V  G     +  +G  L  +  +++    A  + YL S+     IHRD
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCT--VVQGTLGYLDPEYLQTCKLTDKSD 583
           + + N L+ E    K+SDFG S+    D +   T  + Q  + +  PE L   + + +SD
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178

Query: 584 VYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           V+SFG++L E                 SL     ++L   +  E ++  +     +    
Sbjct: 179 VWSFGILLWEAF---------------SLGAVPYANLSNQQTREAIEQGVRLPCPELCPD 223

Query: 644 EVAKLAARCISVRGEERPTMKEVSLELQ 671
            V +L  RC      +RP+   V  ELQ
Sbjct: 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 20/205 (9%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVD----QAKIDEFINELVVVLQINRRNVVR 461
           +VIG G +  VY    LP+   VA+K+   +D    Q  +DE   E+  + Q N  NVV+
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKR---IDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFE---HIHKKGNLSWERRLRITAETAGVLSYLHSETN 518
                +      LV  ++  G+L +     + +G L       +  E    L YLHS   
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC----TVVQGTLGYLDPEYL- 573
              IHRD+K+ NILL E+ + K++DFG S  +     +      T V GT  ++ PE + 
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEVME 179

Query: 574 QTCKLTDKSDVYSFGVVLVELLTGK 598
           Q      K+D++SFG+  +EL TG 
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 76/282 (26%), Positives = 133/282 (47%), Gaps = 32/282 (11%)

Query: 391 KIFTEEEIKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELV 449
            I +E + + +  N  + IG G SG VYK         VA+KK +   Q   +  INE++
Sbjct: 10  DIVSEGDPRELYKNL-EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEIL 67

Query: 450 VVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAG 508
           ++      N+V      L      +V E++  G+L + I      ++  +   +  E   
Sbjct: 68  IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ 127

Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGY 567
            L YLHS+    +IHRD+KS NILL ++ + K++DFG A++L    + +N +VV GT  +
Sbjct: 128 GLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN-SVV-GTPYW 182

Query: 568 LDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE 627
           + PE ++      K D++S G++ +E+  G+   L + P      A+ FL          
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----AL-FL---------- 227

Query: 628 ILDNRI--VNDGNK--QQLKEVAKLAARCISVRGEERPTMKE 665
           I    I  + +  K   + K+      +C+    E+RP+ +E
Sbjct: 228 ITTKGIPPLKNPEKWSPEFKDFLN---KCLVKDPEKRPSAEE 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 74/272 (27%), Positives = 126/272 (46%), Gaps = 30/272 (11%)

Query: 409 IGCGGSGNVYKGFLPDRT---PVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G V KG    +     VAVK  K+   D A  DE + E  V+ Q++   +VR++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G C E +  +LV E    G L + + K  +++ +    +  + +  + YL  ETN   +H
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE-ETN--FVH 118

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT----LGYLDPEYLQTCKLT 579
           RD+ + N+LL      K+SDFG SK +  D  +N    +      + +  PE +   K +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGAD--ENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 580 DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK 639
            KSDV+SFGV++ E  +        KP             +K N + +++++    +  +
Sbjct: 177 SKSDVWSFGVLMWEAFS-----YGQKP----------YKGMKGNEVTQMIESGERMECPQ 221

Query: 640 QQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
           +   E+  L   C +   +ERP    V L L+
Sbjct: 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAK-----IDEFINELVVVLQINRRNVVRL 462
           +G G  G+VY+G  L D    AVK+    D  +     + +   E+ ++ ++   N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 463 LGCCLETQVPLLVY-EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           LG   E    L ++ E V  G+L + + K G+         T +    L YLH       
Sbjct: 68  LGTEREED-NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---T 123

Query: 522 IHRDVKSANILLDENCTPKVSDFGASK-LVPIDAIQNCTVVQGTLGYLDPEYL-QTCKLT 579
           +HRD+K ANIL+D N   K++DFG +K +V     ++    +G+  ++ PE + Q     
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEVIAQQGGYG 180

Query: 580 DKSDVYSFGVVLVELLTGK 598
             +D++S G  ++E+ TGK
Sbjct: 181 LAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 87.2 bits (216), Expect = 5e-19
 Identities = 60/193 (31%), Positives = 102/193 (52%), Gaps = 6/193 (3%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V  G    +  VA+K  K    ++ DEFI E  V+++++   +V+L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            +   +V E++ NG L  ++ + G      + L +  +    ++YL S+     IHRD+ 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLA 127

Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           + N L+D+    KVSDFG S+ V  D   +    +  + +  PE L   K + KSDV++F
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAF 187

Query: 588 GVVLVELLT-GKM 599
           GV++ E+ + GKM
Sbjct: 188 GVLMWEVYSLGKM 200

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 63/195 (32%), Positives = 89/195 (45%), Gaps = 9/195 (4%)

Query: 408 VIGCGGSGNVYKGFLPD-RTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           VIG G  G V      D +   A+K   K K V++  +   +NE  ++ ++N   +V L 
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
               + +   LV + +  G L  H+ +K   S E+      E    L YLHS+    IIH
Sbjct: 67  YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIH 123

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+K  NILLDE     ++DF  +  V  D     T   GT GY+ PE L     +   D
Sbjct: 124 RDIKPDNILLDEQGHVHITDFNIATKVTPD--TLTTSTSGTPGYMAPEVLCRQGYSVAVD 181

Query: 584 VYSFGVVLVELLTGK 598
            +S GV   E L GK
Sbjct: 182 WWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 12/199 (6%)

Query: 405 YADVIGCGGSGNVYKG-FLPDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRL 462
           Y   +G G SG V K    P    +AVK  +  +++A   + + EL ++ + N   +V  
Sbjct: 5   YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64

Query: 463 LGCCL-ETQVPLLVYEFVGNGTLFEHIHKKGNLSW-ERRL-RITAETAGVLSYLHSETNV 519
            G       + + + E++  G+L + I K+      ER L +I       L+YLH +   
Sbjct: 65  YGAFYNNGDISICM-EYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK- 121

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
            IIHRDVK +NIL++     K+ DFG S  + ++++    V  GT  Y+ PE +Q    +
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFV--GTSSYMAPERIQGNDYS 177

Query: 580 DKSDVYSFGVVLVELLTGK 598
            KSD++S G+ L+EL TG+
Sbjct: 178 VKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 86.6 bits (214), Expect = 7e-19
 Identities = 59/193 (30%), Positives = 102/193 (52%), Gaps = 15/193 (7%)

Query: 407 DVIGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           ++IG G  G V +G +   +  V   K     QA    F+ E  V+ +++ +N+VRLLG 
Sbjct: 12  EIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGV 67

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIH 523
            L   +  +V E +  G L   +  +G   +S  + L+ + + A  + YL S+    ++H
Sbjct: 68  ILHNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+ + NIL+ E+   KVSDFG +++  +    +   V+ T     PE L+  K + KSD
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSSKSD 179

Query: 584 VYSFGVVLVELLT 596
           V+S+GV+L E+ +
Sbjct: 180 VWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 58/195 (29%), Positives = 103/195 (52%), Gaps = 10/195 (5%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI--DEFINELVVVLQINRRNVVRLLGCC 466
           +G G  G V+ G    +  VA+K    +++  +  ++FI E  V+++++   +V+L G C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 467 LETQVPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            + +   +V EF+ NG L  ++  ++G LS +  L +  +    + YL   +    IHRD
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           + + N L+      KVSDFG ++ V  D   + +  +  + +  PE     K + KSDV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185

Query: 586 SFGVVLVELLT-GKM 599
           SFGV++ E+ T GKM
Sbjct: 186 SFGVLMWEVFTEGKM 200

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 60/194 (30%), Positives = 102/194 (52%), Gaps = 21/194 (10%)

Query: 408 VIGCGGSGNV----YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
            IG G  G+V    Y+G       VAVK  K  + A    F+ E  V+ Q+   N+V+LL
Sbjct: 13  TIGKGEFGDVMLGDYRG-----NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLL 65

Query: 464 GCCLETQVPL-LVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVP 520
           G  +E +  L +V E++  G+L +++  +G   L  +  L+ + +    + YL +     
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--- 122

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
            +HRD+ + N+L+ E+   KVSDFG +K     + Q+   +   + +  PE L+  K + 
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFST 178

Query: 581 KSDVYSFGVVLVEL 594
           KSDV+SFG++L E+
Sbjct: 179 KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 75/248 (30%), Positives = 117/248 (47%), Gaps = 42/248 (16%)

Query: 388 EKAKIFTEEEIKTVTNNYADV--IGCGGSGNVYKGFLPD---RTPVAVKKSKFV---DQA 439
           E A++F++++ + +   + D+  IG G  G VY  F  D      VA+KK  +       
Sbjct: 3   EIAELFSKDDPEKL---FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNE 57

Query: 440 KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF-VGNGTLFEHIHKKGNLSWER 498
           K  + I E+  + Q+   N +   GC L      LV E+ +G+ +    +HKK      +
Sbjct: 58  KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP----LQ 113

Query: 499 RLRITAETAGVL---SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
            + I A   G L   +YLHS      IHRD+K+ NILL E  T K++DFG++ LV   + 
Sbjct: 114 EVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV---SP 167

Query: 556 QNCTVVQGTLGYLDPEY---LQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSL 612
            N  V  GT  ++ PE    +   +   K DV+S G+  +EL   K  L +         
Sbjct: 168 ANSFV--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------- 216

Query: 613 AMNFLSSL 620
            MN +S+L
Sbjct: 217 -MNAMSAL 223

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 32/272 (11%)

Query: 409 IGCGGSGNVYKGFL----PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G+V KG           VAVK  K + +   K  EF+ E  V+ Q++   +VRL
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRL 61

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           +G C    + +LV E    G L +++ K+  +       +  + A  ++YL S+  V   
Sbjct: 62  IGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV--- 117

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDA--IQNCTVVQGTLGYLDPEYLQTCKLTD 580
           HRD+ + N+LL      K+SDFG S+ +   +   +  T  +  L +  PE +   K + 
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177

Query: 581 KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVNDGN 638
           KSDV+S+GV L E  +        KP  E          +K   ++ +L++  R+     
Sbjct: 178 KSDVWSYGVTLWEAFS-----YGAKPYGE----------MKGAEVIAMLESGERLPRPEE 222

Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEVSLEL 670
             Q  E+  +   C   R E+RPT  E+    
Sbjct: 223 CPQ--EIYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 10/195 (5%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           + +G G  G+VYK         VA+K      +  + E I E+ ++ Q +   +V+  G 
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
             +     +V E+ G G++ + +      L+ E    I  +T   L YLHS      IHR
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHR 123

Query: 525 DVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           D+K+ NILL+E    K++DFG S +L    A +N TV+ GT  ++ PE +Q     +K+D
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN-TVI-GTPFWMAPEVIQEIGYNNKAD 181

Query: 584 VYSFGVVLVELLTGK 598
           ++S G+  +E+  GK
Sbjct: 182 IWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 19/200 (9%)

Query: 409 IGCGGSGNVYKG----FLPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V +G          PVAVK  KS  +    +D+F+ E  ++  ++  N++RL
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVP 520
            G  L T   ++V E    G+L + + K   G+           + A  + YL S+    
Sbjct: 62  YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL----GYLDPEYLQTC 576
            IHRD+ + NILL  +   K+ DFG  + +P +  ++  V++  L     +  PE L+T 
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQN--EDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 577 KLTDKSDVYSFGVVLVELLT 596
             +  SDV+ FGV L E+ T
Sbjct: 176 TFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 76/290 (26%), Positives = 137/290 (47%), Gaps = 36/290 (12%)

Query: 391 KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFVDQAKID-EF 444
           +I  E E+K V      V+G G  G VYKG ++PD    + PVA+K  +     K + E 
Sbjct: 2   RILKETELKKVK-----VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEI 56

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           ++E  V+  +    V RLLG CL + V L V + +  G L +++ + K  +  +  L   
Sbjct: 57  LDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWC 115

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQ 562
            + A  +SYL     V ++HRD+ + N+L+      K++DFG ++L+ ID  + +    +
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172

Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++  E +   + T +SDV+S+GV + EL+T        KP +           +  
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGA-----KPYD----------GIPA 217

Query: 623 NRLLEILD--NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL 670
             + ++L+   R+          +V  +  +C  +  E RP  +E+  E 
Sbjct: 218 REIPDLLEKGERLPQPPICT--IDVYMIMVKCWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 55/192 (28%), Positives = 95/192 (49%), Gaps = 10/192 (5%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKID--EFINELVVVLQINRRNVVRLLGCC 466
           +G G  G V+ G     T VAVK  K      +    F+ E  ++ ++    +V+L   C
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
            E +   +V E++  G+L + +       L   + + + A+ A  ++YL S      IHR
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHR 127

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+ + NIL+ EN   K++DFG ++L+  D        +  + +  PE     + T KSDV
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187

Query: 585 YSFGVVLVELLT 596
           +SFG++L E++T
Sbjct: 188 WSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 18/206 (8%)

Query: 408 VIGCGGSGNVYKGFLPD----------RTPVAVKKSKFVDQAKIDEFINELVVVLQINRR 457
           +IG G  G+VY G                P     SK   ++ +D    E+ ++ ++   
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           N+V+ LG  L+     +  E+V  G++   ++  G            +    L+YLH+  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT-----VVQGTLGYLDPEY 572
              IIHRD+K ANIL+D     K+SDFG SK +  +++   T      +QG++ ++ PE 
Sbjct: 127 ---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 573 LQTCKLTDKSDVYSFGVVLVELLTGK 598
           ++    T K+D++S G ++VE+LTGK
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 89.5 bits (222), Expect = 3e-18
 Identities = 91/367 (24%), Positives = 155/367 (42%), Gaps = 32/367 (8%)

Query: 323 TPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSKL 382
           TP+ +  I   LG    F+V  +      F+   R    L+ K  E   G+   Q     
Sbjct: 625 TPSWWFYITCTLGA---FLVLALVAFGFVFI---RGRNNLELKRVENEDGTWELQFFD-- 676

Query: 383 HGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQAKI 441
               S+ +K  T  +I +      +VI  G  G  YKG  + +     VK+   V+    
Sbjct: 677 ----SKVSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP- 730

Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
              I ++    ++   N+V+L+G C   +   L++E++    L E +    NLSWERR +
Sbjct: 731 SSEIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRK 784

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
           I    A  L +LH   +  ++  ++    I++D    P +       L+  D     T  
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKC 838

Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK 621
             +  Y+ PE  +T  +T+KSD+Y FG++L+ELLTGK    +D         + +     
Sbjct: 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP--ADAEFGVHGSIVEWARYCY 896

Query: 622 QNRLLEI-LDNRIVNDG--NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS 678
            +  L++ +D  I  D   N+ ++ EV  LA  C +     RP   +V   L+      S
Sbjct: 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956

Query: 679 NGQYYLR 685
           +    L+
Sbjct: 957 SCVTGLK 963

Length = 968

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.5 bits (210), Expect = 6e-18
 Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 19/199 (9%)

Query: 407 DVIGCGGSGNVYKGFL----PDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNV 459
             +G G  G V    L          A+K   K+K V   +++  +NE  ++  I    +
Sbjct: 7   KTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNV 519
           V L G   +     LV E+V  G LF H+ K G           A+    L YLHS    
Sbjct: 64  VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD-- 121

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
            I++RD+K  N+LLD +   K++DFG +K V       C    GT  YL PE +   K  
Sbjct: 122 -IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIIL-SKGY 175

Query: 580 DKS-DVYSFGVVLVELLTG 597
            K+ D ++ G+++ E+L G
Sbjct: 176 GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 84.3 bits (208), Expect = 7e-18
 Identities = 61/196 (31%), Positives = 97/196 (49%), Gaps = 11/196 (5%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD----QAKIDEFINELVVVLQINRRNVVRL 462
           + IG G  G VYKG   D     V   K +D    + +I++   E+ V+ Q +   + R 
Sbjct: 10  ERIGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G  L+     ++ E++G G+  + + K G L       I  E    L YLHSE     I
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK---I 123

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+K+AN+LL E    K++DFG +  +    I+  T V GT  ++ PE ++      K+
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKA 182

Query: 583 DVYSFGVVLVELLTGK 598
           D++S G+  +EL  G+
Sbjct: 183 DIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 50/194 (25%), Positives = 97/194 (50%), Gaps = 7/194 (3%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V++G   +R  VA+K  K  D  K  +F  E+  + ++  ++++ L   C  
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 469 TQVPLLVYEFVGNGTLFEHIH--KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
            +   ++ E +  G+L   +   +   L     + +  + A  ++YL  +     IHRD+
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDL 130

Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + NIL+ E+   KV+DFG ++L+  + +   +  +    +  PE       + KSDV+S
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWS 189

Query: 587 FGVVLVELLT-GKM 599
           FG++L E+ T G++
Sbjct: 190 FGILLYEMFTYGQV 203

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 83.9 bits (207), Expect = 8e-18
 Identities = 53/215 (24%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 390 AKIFTEEEIKTVTNNYADVIGCGGSGNVYKGF-LPD----RTPVAVKK-SKFVDQAKIDE 443
           A+I  E E++ +      ++G G  G V+KG  +P+    + PVA+K       +    E
Sbjct: 1   ARILKETELRKLK-----LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQE 55

Query: 444 FINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRI 502
             + ++ +  ++   +VRLLG C    + L V +    G+L +H+ + + +L  +R L  
Sbjct: 56  ITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW 114

Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC-TVV 561
             + A  + YL       ++HR++ + NILL  +   +++DFG + L+  D  +   +  
Sbjct: 115 CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171

Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           +  + ++  E +   + T +SDV+S+GV + E+++
Sbjct: 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.5 bits (206), Expect = 8e-18
 Identities = 67/270 (24%), Positives = 131/270 (48%), Gaps = 28/270 (10%)

Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN 455
           E IK V       +G G  G V+ G+  + T VAVK  K      +  F+ E  ++  + 
Sbjct: 6   ESIKLVKK-----LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQ 59

Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYL 513
              +VRL     + +   ++ E++  G+L + +     G +   + +  +A+ A  ++Y+
Sbjct: 60  HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119

Query: 514 HSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL 573
             +     IHRD+++AN+L+ E+   K++DFG ++++  +        +  + +  PE +
Sbjct: 120 ERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176

Query: 574 QTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR 632
                T KSDV+SFG++L E++T GK+      P    S + + +S+L++   +  ++N 
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKI------PYPGMSNS-DVMSALQRGYRMPRMEN- 228

Query: 633 IVNDGNKQQLKEVAKLAARCISVRGEERPT 662
                   +L ++ K    C   + EERPT
Sbjct: 229 -----CPDELYDIMKT---CWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 83.7 bits (207), Expect = 8e-18
 Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 43/286 (15%)

Query: 408 VIGCGGSGNVYKGFL--PDRTP--VAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVR 461
           ++G G  G+V +G L   D +   VAVK  K      ++I+EF++E   +   +  NV++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 462 LLGCCLETQ------VPLLVYEFVGNGTLFEHI------HKKGNLSWERRLRITAETAGV 509
           L+G C E         P+++  F+ +G L   +           L  +  L+   + A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYL 568
           + YL +      IHRD+ + N +L E+ T  V+DFG SK +   D  +   + +  + ++
Sbjct: 126 MEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI 628
             E L     T KSDV++FGV + E+ T      +  P  E     ++L     NRL   
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQ---TPYPGVENHEIYDYL--RHGNRL--- 234

Query: 629 LDNRIVNDGNKQQ---LKEVAKLAARCISVRGEERPTMKEVSLELQ 671
                     KQ    L E+  L   C     ++RPT  ++   L+
Sbjct: 235 ----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 84.2 bits (208), Expect = 8e-18
 Identities = 69/242 (28%), Positives = 112/242 (46%), Gaps = 10/242 (4%)

Query: 428 VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTL 484
           VAVK  K     +    +  E+ ++  +   N+V+  GCC E   +   L+ E+V  G+L
Sbjct: 36  VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95

Query: 485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
            +++  K  L+  + L    +    ++YLHS+     IHRD+ + N+LLD +   K+ DF
Sbjct: 96  RDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDF 151

Query: 545 GASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K VP           G   + +   E L+  K +  SDV+SFGV L ELLT   +  
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211

Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPT 662
           S   + E  +       +   RL+E+L+  +     K   +EV  L   C     + RPT
Sbjct: 212 SPPKKFEEMIGPK-QGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPT 270

Query: 663 MK 664
            +
Sbjct: 271 FR 272

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 36/219 (16%)

Query: 408 VIGCGGSGNVYKGFL------PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
            +G G  G V+ G         D+  VAVK  K    + A+ D F  E  ++      N+
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAELLTNFQHENI 70

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIH--------------KKGNLSWERRLRITAE 505
           V+  G C E   P++V+E++ +G L + +                 G L+  + L+I  +
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGT 564
            A  + YL S+  V   HRD+ + N L+  +   K+ DFG S+ V   D  +    V G 
Sbjct: 131 IASGMVYLASQHFV---HRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR----VGGH 183

Query: 565 ----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GK 598
               + ++ PE +   K T +SDV+SFGVVL E+ T GK
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 74/263 (28%), Positives = 120/263 (45%), Gaps = 29/263 (11%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD----QAKIDEFINELVVVLQINRRNVVRLLG 464
           IG G  G V+KG   D     V   K +D    + +I++   E+ V+ Q +   V +  G
Sbjct: 12  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
             L+     ++ E++G G+  + + + G L   +   I  E    L YLHSE     IHR
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK---IHR 125

Query: 525 DVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           D+K+AN+LL E+   K++DFG A +L      +N  V  GT  ++ PE ++      K+D
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIKQSAYDSKAD 183

Query: 584 VYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           ++S G+  +EL  G       +P       M  L  + +N       N    +GN    K
Sbjct: 184 IWSLGITAIELAKG-------EPPHSELHPMKVLFLIPKN-------NPPTLEGNYS--K 227

Query: 644 EVAKLAARCISVRGEERPTMKEV 666
            + +    C++     RPT KE+
Sbjct: 228 PLKEFVEACLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 83.1 bits (205), Expect = 3e-17
 Identities = 73/288 (25%), Positives = 135/288 (46%), Gaps = 32/288 (11%)

Query: 391 KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFVDQAKID-EF 444
           +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +     K + E 
Sbjct: 2   RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 56

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           ++E  V+  ++  +V RLLG CL + V L + + +  G L +++ + K N+  +  L   
Sbjct: 57  LDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWC 115

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQ 562
            + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  D  + +    +
Sbjct: 116 VQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172

Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++  E +     T +SDV+S+GV + EL+T         P  E S  +     L Q
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 232

Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL 670
             +  I               +V  +  +C  +  + RP  +E+ +E 
Sbjct: 233 PPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEF 265

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 11/219 (5%)

Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVKK     Q + +   NE+V++      N+V +    L      +V EF+  G L + 
Sbjct: 47  VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD- 105

Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I     ++ E+   +       LS+LH++    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 106 IVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFC 162

Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPE 607
             V  +  +  ++V GT  ++ PE +       + D++S G++++E++ G+    ++ P 
Sbjct: 163 AQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL 221

Query: 608 EE----RSLAMNFLSSLKQ--NRLLEILDNRIVNDGNKQ 640
           +     R      L +L +   RL   LD  +V D  ++
Sbjct: 222 QAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 76/296 (25%), Positives = 123/296 (41%), Gaps = 40/296 (13%)

Query: 392 IFTEEEIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKK-SKFVDQAKIDEF 444
            F    ++ +T      +G G  G V+             T V VK   K  D+    EF
Sbjct: 1   AFPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEF 55

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL--FEHIHKKG-------NLS 495
             EL +  +++ +NVVRLLG C E +   ++ E+   G L  F    K          LS
Sbjct: 56  RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115

Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
            ++++ +  + A  + +L   +N   +HRD+ + N L+      KVS    SK V     
Sbjct: 116 TKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172

Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
                    L +L PE +Q    + KSDV+SFGV++ E+ T          +EE      
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------ 226

Query: 616 FLSSLKQNRL-LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL 670
            L+ L+  +L L + +              + KL  RC +V  ++RP+  E+   L
Sbjct: 227 VLNRLQAGKLELPVPEG---------CPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 73/283 (25%), Positives = 120/283 (42%), Gaps = 38/283 (13%)

Query: 404 NYA--DVIGCGGSGNVYK--------GFLPDR----TPVAVKKSKFVDQAKIDEFINELV 449
            YA  + +G G  G VYK          L  +       A  K K      I + ++E+ 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 450 VVL-QINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI----HKKGNLSWERRLRITA 504
           ++  Q+   N+VR     LE     +V + +    L EH      KK   + ER   I  
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 505 ETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT 564
           +    L YLH E    I+HRD+   NI+L E+    ++DFG +K    ++    T V GT
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGT 176

Query: 565 LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR 624
           + Y  PE ++     +K+DV++FG +L ++ T +    S       SLA   +       
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN---MLSLATKIV-----EA 228

Query: 625 LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
           + E L   + ++       +V  +   C++   E RP + +VS
Sbjct: 229 VYEPLPEGMYSE-------DVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.5 bits (202), Expect = 5e-17
 Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 13/196 (6%)

Query: 408 VIGCGGSGNVYKGFLPDRT---PVAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVRL 462
            IG G  G VYK    D+     VA+K    +++A+  I++   E+  + Q     + + 
Sbjct: 8   CIGKGSFGEVYKAI--DKRTNQVVAIKVID-LEEAEDEIEDIQQEIQFLSQCRSPYITKY 64

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G  L+     ++ E+ G G+  + + K G L       I  E    L YLH E     I
Sbjct: 65  YGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK---I 120

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+K+ANILL E    K++DFG S  +     +  T V GT  ++ PE ++     +K+
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKA 179

Query: 583 DVYSFGVVLVELLTGK 598
           D++S G+  +EL  G+
Sbjct: 180 DIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 81.3 bits (200), Expect = 7e-17
 Identities = 59/195 (30%), Positives = 101/195 (51%), Gaps = 9/195 (4%)

Query: 407 DVIGCGGSGNVYKGFLPDRTP--VAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLL 463
           + IG G  G V+KG + +RT   VA+K     + + +I++   E+ V+ Q +   V +  
Sbjct: 10  ERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G  L+     ++ E++G G+  + + + G     +   +  E    L YLHSE     IH
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK---IH 124

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+K+AN+LL E    K++DFG +  +    I+  T V GT  ++ PE +Q      K+D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKAD 183

Query: 584 VYSFGVVLVELLTGK 598
           ++S G+  +EL  G+
Sbjct: 184 IWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 19/203 (9%)

Query: 407 DVIGCGGSGNVYKGFL--PDR--TPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVV 460
           +VIG G  G V +G L  P +    VA+K  KS + ++ + D F++E  ++ Q +  N++
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNII 68

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNV 519
            L G   +++  +++ EF+ NG L   + +  G  +  + + +    A  + YL SE N 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL-SEMNY 127

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG------YLDPEYL 573
             +HRD+ + NIL++ N   KVSDFG S+ +  D          +LG      +  PE +
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD--PTYTSSLGGKIPIRWTAPEAI 183

Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
              K T  SDV+S+G+V+ E+++
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 10/194 (5%)

Query: 408 VIGCGGSGNVYKGFL----PDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRL 462
            IG G  G+VY+G       ++  VAVK  K     +  ++F+ E  ++ Q +  ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           +G   E  V  +V E    G L  ++   K +L     +  + + +  L+YL S+  V  
Sbjct: 73  IGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV-- 129

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
            HRD+ + N+L+      K+ DFG S+ +  ++    +  +  + ++ PE +   + T  
Sbjct: 130 -HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188

Query: 582 SDVYSFGVVLVELL 595
           SDV+ FGV + E+L
Sbjct: 189 SDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 67/264 (25%), Positives = 116/264 (43%), Gaps = 41/264 (15%)

Query: 417 VYKGFLPDRTPVAV---KKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL 473
           +YKG   +   V +   KK     +  ID   NE+  + +I+  N++++ G  ++    L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 474 ----LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
               L+ E+   G L E + K+ +LS++ +L +  +    L  L+  TN P  ++++ S 
Sbjct: 95  PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSV 152

Query: 530 NILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC--KLTDKSDVYSF 587
           + L+ EN   K+   G  K++     +N       + Y   + L     + T K D+YS 
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVN----FMVYFSYKMLNDIFSEYTIKDDIYSL 208

Query: 588 GVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL----- 642
           GVVL E+ TGK+      P E  +               EI D  I+N  N  +L     
Sbjct: 209 GVVLWEIFTGKI------PFENLTTK-------------EIYDL-IINKNNSLKLPLDCP 248

Query: 643 KEVAKLAARCISVRGEERPTMKEV 666
            E+  +   C S    +RP +KE+
Sbjct: 249 LEIKCIVEACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 80.7 bits (199), Expect = 8e-17
 Identities = 67/260 (25%), Positives = 125/260 (48%), Gaps = 30/260 (11%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G+    T VA+K  K       + F+ E  ++ Q+    +VRL      
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-- 70

Query: 469 TQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
           TQ P+ ++ E++ NG+L + +       L+  + + + A+ A  ++++  +     IHRD
Sbjct: 71  TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRD 127

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           +++ANIL+ E    K++DFG ++L+  +        +  + +  PE +     T KSDV+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187

Query: 586 SFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEILDNRIVN-DGNKQQL 642
           SFG++L E++T G++       PE  ++L   +               R+   D   ++L
Sbjct: 188 SFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---------------RMPRPDNCPEEL 232

Query: 643 KEVAKLAARCISVRGEERPT 662
            E+ +    C   + EERPT
Sbjct: 233 YELMR---LCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 56/179 (31%), Positives = 88/179 (49%), Gaps = 16/179 (8%)

Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEH 487
            +KK+  + + ++D+ + E  ++ Q     VV+L     + +  L LV E++  G L   
Sbjct: 25  VIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASL 83

Query: 488 IHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA 546
           +   G+L  E   RI  AE    L YLH   +  IIHRD+K  NIL+D N   K++DFG 
Sbjct: 84  LENVGSLD-EDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGL 139

Query: 547 SKL--------VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           SK+        +  D  ++  +V GT  Y+ PE +     +   D +S G +L E L G
Sbjct: 140 SKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 72/267 (26%), Positives = 121/267 (45%), Gaps = 25/267 (9%)

Query: 409 IGCGGSGNVYK-GFLPDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGC 465
           +G G  G+V K   +P  T +A KK   +    +   + + EL ++ +     +V   G 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
            L      +  EF+  G+L + I+KK G +  E   +I       L+YL++     I+HR
Sbjct: 72  FLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHR 128

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+K +NIL++     K+ DFG S  + I++I +  V  GT  Y+ PE +Q  K T KSDV
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFV--GTSTYMSPERIQGGKYTVKSDV 185

Query: 585 YSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN----KQ 640
           +S G+ ++EL  GK          +               +L++L  +IV +        
Sbjct: 186 WSLGISIIELALGKFPF--AFSNIDDD------GQDDPMGILDLL-QQIVQEPPPRLPSS 236

Query: 641 QLKEVAK-LAARCISVRGEERPTMKEV 666
              E  +     C+     ERPT +++
Sbjct: 237 DFPEDLRDFVDACLLKDPTERPTPQQL 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 58/300 (19%)

Query: 408 VIGCGGSGNVYKGF------LPDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVV 460
            +G G  G V K            T VAVK   +    +++ + ++E  ++ Q+N  +V+
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 461 RLLGCCLETQVPLLVYEFVGNGTL--FEHIHKK-----------GNLSWERRLRITAETA 507
           +L G C +    LL+ E+   G+L  F    +K            N S+       A T 
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 508 GVL-----------SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ 556
           G L            YL     + ++HRD+ + N+L+ E    K+SDFG S+    D  +
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR----DVYE 179

Query: 557 NCTVVQGTLG-----YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS 611
             + V+ + G     ++  E L     T +SDV+SFGV+L E++T               
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------------- 224

Query: 612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
           L  N    +   RL  +L      +  +   +E+  L   C     ++RPT  ++S EL+
Sbjct: 225 LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 59/198 (29%), Positives = 108/198 (54%), Gaps = 13/198 (6%)

Query: 408 VIGCGGSGNVYKGFL--PDR--TPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           VIG G  G V  G L  P +   PVA+K  K+ + ++ + D F++E  ++ Q +  N++ 
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNIIH 69

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVP 520
           L G   +++  ++V E++ NG+L   + K  G  +  + + +    A  + YL   +++ 
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMG 126

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKL 578
            +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K 
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 579 TDKSDVYSFGVVLVELLT 596
           T  SDV+S+G+V+ E+++
Sbjct: 187 TSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 73/271 (26%), Positives = 117/271 (43%), Gaps = 37/271 (13%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR----NVVRLLG 464
           +G G  G+V K  L +   +   K+   D     +   +++  L+IN+      +V+  G
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 465 CCLETQVPLL--VYEFVGNGTL---FEHIHKKGNLSWERRLRITAETAGVL---SYLHSE 516
             L+     +    E+   G+L   ++ + K+G    E+ L   AE   VL   SYLHS 
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAE--SVLKGLSYLHSR 124

Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYLDPEYLQT 575
               IIHRD+K +NILL      K+ DFG S +LV   A        GT  Y+ PE +Q 
Sbjct: 125 K---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQG 177

Query: 576 CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA----MNFLSSLKQNRLLEILDN 631
              +  SDV+S G+ L+E+   +       PE E  L     ++++ ++    L +   N
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPF---PPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234

Query: 632 RIVNDGNKQQLKEVAKLAARCISVRGEERPT 662
            I         +E      +C+      RPT
Sbjct: 235 GIKWS------EEFKDFIKQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 78.4 bits (194), Expect = 5e-16
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 12/203 (5%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLL 463
           + IG G  G V K     D   +  K+  +  + + +  + ++E+ ++ ++   N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 464 GCCL--ETQVPLLVYEFVGNGTLFEHIHK--KGNLSWERR--LRITAETAGVLSYLH--S 515
              +    Q   +V E+   G L + I K  K     E     RI  +    L   H  S
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT 575
           +    ++HRD+K ANI LD N   K+ DFG +K++  D+    T V GT  Y+ PE L  
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNH 184

Query: 576 CKLTDKSDVYSFGVVLVELLTGK 598
               +KSD++S G ++ EL    
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 79.0 bits (194), Expect = 5e-16
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 14/203 (6%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G SG VY    +     VA+K+     Q K +  INE++V+ +    N+V  L   L
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 468 ETQVPLLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
                 +V E++  G+L + + +    +G ++      +  E    L +LHS     +IH
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALDFLHSNQ---VIH 138

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+KS NILL  + + K++DFG    +  +  +  T+V GT  ++ PE +       K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197

Query: 584 VYSFGVVLVELLTGKMALLSDKP 606
           ++S G++ +E++ G+   L++ P
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 11/197 (5%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           ++IG G  G VY+G  +P    VA+K     +   D + I   +  L  + Q    N+ +
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
             G  L+     ++ E+   G++   + K G ++ +    I  E    L Y+H    V +
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHK---VGV 122

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD- 580
           IHRD+K+ANIL+      K+ DFG + L+  ++ +  T V GT  ++ PE +   K  D 
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYDT 181

Query: 581 KSDVYSFGVVLVELLTG 597
           K+D++S G+ + E+ TG
Sbjct: 182 KADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.0 bits (192), Expect = 6e-16
 Identities = 72/255 (28%), Positives = 120/255 (47%), Gaps = 33/255 (12%)

Query: 408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDE---FINELVVVLQINRRNVVRLLG 464
           V+G G  G V+         + + K   V+Q   DE     NE  V+  ++  N++    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPII 522
             LE +  ++V E+   GTL E+I K+ N  L  +  L    +    L ++H++    I+
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---IL 123

Query: 523 HRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           HRD+K+ NILLD++    K+ DFG SK++   + +  TVV GT  Y+ PE  +      K
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYTVV-GTPCYISPELCEGKPYNQK 181

Query: 582 SDVYSFGVVLVELLT-------------------GKMALLSDKPEEE-RSLAMNFLS--S 619
           SD+++ G VL EL +                   G  A +SD+   + R L ++ L+   
Sbjct: 182 SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDP 241

Query: 620 LKQNRLLEILDNRIV 634
            K+ +L +I+   I 
Sbjct: 242 SKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 19/200 (9%)

Query: 408 VIGCGGSGNVYKGFLPDRTP--VAVKKSKFVDQAKIDEFI--NELVVVLQINRRNVVRLL 463
           V+G G  G V K      T   VA+KK K  +  +  +     E+ V+ Q+   N+V L 
Sbjct: 8   VVGEGAYGVVLKCRNKA-TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPII 522
                     LV+E+V   TL E +    G L  +       +    ++Y HS     II
Sbjct: 67  EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---II 122

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+K  NIL+ E+   K+ DFG ++ +        T    T  Y  PE L    + D +
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL----VGDTN 178

Query: 583 -----DVYSFGVVLVELLTG 597
                DV++ G ++ ELL G
Sbjct: 179 YGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.4 bits (193), Expect = 8e-16
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 14/205 (6%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           + IG G SG VY    +     VA+K+     Q K +  INE++V+ +    N+V  L  
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 466 CLETQVPLLVYEFVGNGTLF----EHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
            L      +V E++  G+L     E    +G ++      +  E    L +LHS     +
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQ---V 136

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           IHRD+KS NILL  + + K++DFG    +  +  +  T+V GT  ++ PE +       K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195

Query: 582 SDVYSFGVVLVELLTGKMALLSDKP 606
            D++S G++ +E++ G+   L++ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 27/267 (10%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSK---FVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           IG G    VYK   L D   VA+KK +    +D     + + E+ ++ Q++  NV++ L 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 465 CCLETQVPLLVYEFVGNGTL---FEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNVP 520
             +E     +V E    G L    +H  K+  L  ER + +   +    L ++HS+    
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--- 126

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
           I+HRD+K AN+ +      K+ D G  +          ++V GT  Y+ PE +       
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185

Query: 581 KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV-NDGNK 639
           KSD++S G +L E+   +     DK        MN L SL +   +E  D   +  D   
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDK--------MN-LYSLCKK--IEKCDYPPLPADHYS 234

Query: 640 QQLKEVAKLAARCISVRGEERPTMKEV 666
           ++L++   L +RCI+   E+RP +  V
Sbjct: 235 EELRD---LVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 68/220 (30%), Positives = 103/220 (46%), Gaps = 31/220 (14%)

Query: 407 DVIGCGGSGNVYK-GFLPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVR-- 461
             +G G  G+VYK   L D    A+K+     + Q + ++ +NE+ ++  +N  N++   
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 462 ---LLGCCLETQVPLLVYEFVGNGTLFEHIHK---KGNLSWERRL-RITAETAGVLSYLH 514
              L G  L      +V E+   G L + I K   K  L  E+ + RI  +    L  LH
Sbjct: 66  EAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 515 SETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ-GTLGYLDPEYL 573
            +    I+HRD+KSANILL  N   K+ D G SK+      +N    Q GT  Y+ PE  
Sbjct: 121 EQK---ILHRDLKSANILLVANDLVKIGDLGISKV----LKKNMAKTQIGTPHYMAPEVW 173

Query: 574 QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
           +    + KSD++S G +L E+ T         P E RS+ 
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAP------PFEARSMQ 207

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 78.0 bits (192), Expect = 9e-16
 Identities = 66/253 (26%), Positives = 118/253 (46%), Gaps = 29/253 (11%)

Query: 426 TPVAVKKSKFV-----DQAKI-DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV 479
           T +AVK+  +V     +Q ++ +    E+ ++ ++N  +++R+LG   E     L  E++
Sbjct: 26  TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85

Query: 480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP 539
             G++   + K G       +  T +    LSYLH      IIHRDVK AN+L+D     
Sbjct: 86  AGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQR 142

Query: 540 -KVSDFGA-----SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVE 593
            +++DFGA     +K       Q   +  GT+ ++ PE L+  +     DV+S G V++E
Sbjct: 143 LRIADFGAAARLAAKGTGAGEFQGQLL--GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE 200

Query: 594 LLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCI 653
           + T K    ++K     +L     S+     + E L            L++V     RC+
Sbjct: 201 MATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL---------SPGLRDV---TLRCL 248

Query: 654 SVRGEERPTMKEV 666
            ++ E+RP  +E+
Sbjct: 249 ELQPEDRPPSREL 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 9/173 (5%)

Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRN-VVRLLGCCLETQVPL-LVYEFVGNGTLFEH 487
           +KK+  V +AK  E       VL+  RR   +  L    +T   L L+ ++V  G LF H
Sbjct: 36  LKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTH 95

Query: 488 IHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA 546
           ++++ + + E  +R+  AE    L +LH    + II+RD+K  NILLD      ++DFG 
Sbjct: 96  LYQREHFT-ESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGL 151

Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL--TDKSDVYSFGVVLVELLTG 597
           SK    +  +      GT+ Y+ PE ++          D +S GV+  ELLTG
Sbjct: 152 SKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 5/171 (2%)

Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEH 487
            +KK   +    ++  + E  V+    +   +  L  C +T+  L  V E+V  G L  H
Sbjct: 27  VLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFH 86

Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I + G     R     AE    L +LH      II+RD+K  N+LLD     K++DFG  
Sbjct: 87  IQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMC 143

Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           K   +  +   T   GT  Y+ PE L         D ++ GV+L E+L G+
Sbjct: 144 KEGILGGVTTSTFC-GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 26/203 (12%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEF----INELVVVLQINRRNVVRLL 463
           +G G  G VYK         VA+KK +  D  + +      + E+ ++ ++   N+V+LL
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRL-DNEE-EGIPSTALREISLLKELKHPNIVKLL 64

Query: 464 G-CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR------ITAETAGVLSYLHSE 516
                E ++  LV+E+     L +++ K+        ++      +       L+Y HS 
Sbjct: 65  DVIHTERKL-YLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRG-----LAYCHS- 116

Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               I+HRD+K  NIL++ +   K++DFG ++   I        V  TL Y  PE L   
Sbjct: 117 --HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGS 173

Query: 577 KLTDKS-DVYSFGVVLVELLTGK 598
           K    + D++S G +  E++TGK
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 28/180 (15%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L+YL  +    I+HRDVK +NIL++     K+ DFG S  + ID++ N  V  GT  Y+ 
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMS 166

Query: 570 PEYLQTCKLTDKSDVYSFGVVLVELLTGK----------MALLSDKPEEE-------RSL 612
           PE LQ    T +SD++S G+ LVE+  G+          +  +  +P  E       R +
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226

Query: 613 AMNFLSSLKQNRLLEILDNRIVNDG-----NKQQLKEVAKLAARCISVRGEERPTMKEVS 667
           + +   S +   + E+LD  IVN+      +     E      +C+    +ER  +KE++
Sbjct: 227 SGHPPDSPRPMAIFELLDY-IVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 25/210 (11%)

Query: 409 IGCGGSGNVY----KGFLP--DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+       LP  D+  VAVK  K   ++   +F  E  ++  +  +++VR 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 463 LGCCLETQVPLLVYEFVGNGTL--FEHIHKK-------------GNLSWERRLRITAETA 507
            G C E +  L+V+E++ +G L  F   H               G L+  + L I ++ A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 508 GVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK-LVPIDAIQNCTVVQGTLG 566
             + YL S   +  +HRD+ + N L+ +    K+ DFG S+ +   D  +        + 
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           ++ PE +   K T +SD++SFGVVL E+ T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 55/169 (32%), Positives = 80/169 (47%), Gaps = 4/169 (2%)

Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI 488
            ++K+  V ++++   + E  V+ Q+N   +V L       +   LV  F+  G LF H+
Sbjct: 25  TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHL 84

Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            ++G     R    TAE    L  LH      +I+RD+K  NILLD      + DFG  K
Sbjct: 85  QREGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCK 141

Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           L   D  +  T   GT  YL PE L     T   D ++ GV+L E+LTG
Sbjct: 142 LNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 11/198 (5%)

Query: 409 IGCGGSGNVYKGFLPDR-TPVAVKKSKFVDQAK-----IDEFINELVVVLQINRRNVVRL 462
           +G G  G VY  +  D    +AVK+  F   +      ++    E+ ++  +    +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            GC  + +   +  E++  G++ + +   G L+     + T +    + YLHS     I+
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IV 126

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV--VQGTLGYLDPEYLQTCKLTD 580
           HRD+K ANIL D     K+ DFGASK +         +  V GT  ++ PE +       
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGR 186

Query: 581 KSDVYSFGVVLVELLTGK 598
           K+DV+S G  +VE+LT K
Sbjct: 187 KADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 34/220 (15%)

Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK-----KGNL-----SWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++       + N      S ++ +++  E A  ++
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186

Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 76.9 bits (189), Expect = 4e-15
 Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 18/233 (7%)

Query: 381 KLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNV----YKGFLPDRTPVAVK---KS 433
           K    S+++ K   + ++K    N+   +G G  G V    YK    D  PVA+K   KS
Sbjct: 12  KKDSDSTKEPK--RKNKMKYEDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEKS 67

Query: 434 KFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN 493
           K + Q ++D   +E  ++  IN    V L G   +     LV EFV  G  F  + +   
Sbjct: 68  KIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR 127

Query: 494 LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID 553
              +      A+   +  YL S   + I++RD+K  N+LLD++   K++DFG +K+V   
Sbjct: 128 FPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184

Query: 554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
               C    GT  Y+ PE L        +D ++ G+ + E+L G     +++P
Sbjct: 185 TYTLC----GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 75.5 bits (185), Expect = 5e-15
 Identities = 59/195 (30%), Positives = 100/195 (51%), Gaps = 17/195 (8%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ ++    +V+L     E
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRL----RITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G+L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 73  EPI-YIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT---LGYLDPEYLQTCKLTDK 581
           D+++ANIL+ EN   KV+DFG ++L+  +     T  QG    + +  PE     + T K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFG++L EL T
Sbjct: 184 SDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 75.9 bits (186), Expect = 5e-15
 Identities = 69/265 (26%), Positives = 124/265 (46%), Gaps = 32/265 (12%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G SG VY    +     VA+++     Q K +  INE++V+ +    N+V  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 468 ETQVPLLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
                 +V E++  G+L + + +    +G ++      +  E    L +LHS     +IH
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQ---VIH 139

Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+KS NILL  + + K++DFG  +++ P  + ++  V  GT  ++ PE +       K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVTRKAYGPKV 197

Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSL-AMNFLSSLKQNRLLEILDNRIVNDGNKQQ 641
           D++S G++ +E++ G+   L++ P     L A N    L+    L  +    +N      
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN------ 251

Query: 642 LKEVAKLAARCISVRGEERPTMKEV 666
                    RC+ +  E+R + KE+
Sbjct: 252 ---------RCLDMDVEKRGSAKEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.5 bits (185), Expect = 5e-15
 Identities = 75/281 (26%), Positives = 136/281 (48%), Gaps = 36/281 (12%)

Query: 409 IGCGGSGNVYKGFLPDRT---PVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G+V +G L        VAVK  K     ++++++F++E V + + +  NV+RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 464 GCCLETQ------VPLLVYEFVGNGTLFEHI--HKKGN----LSWERRLRITAETAGVLS 511
           G CL+T        P+++  F+ +G L   +   + G+    L  +  ++   + A  + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYLDP 570
           YL S++    IHRD+ + N +L+EN    V+DFG S K+   D  +   + +  + ++  
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 571 EYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD 630
           E L     T KSDV+SFGV + E+ T      +  P  E S   ++L   + NRL +  D
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQ---TPYPGVENSEIYDYLR--QGNRLKQPPD 238

Query: 631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
                      L  +  L + C  +  ++RP+ + +  EL+
Sbjct: 239 C----------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 76.1 bits (187), Expect = 6e-15
 Identities = 53/147 (36%), Positives = 73/147 (49%), Gaps = 5/147 (3%)

Query: 463 LGCCLETQVPLL-VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L C  +T+  L  V EF+  G L  HI  KG     R     AE    L +LHS+    I
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---I 117

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           I+RD+K  N++LD +   K++DFG  K   +      +   GT  Y+ PE LQ  K T  
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCK-ENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176

Query: 582 SDVYSFGVVLVELLTGKMALLSDKPEE 608
            D +SFGV+L E+L G+     D  +E
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGDDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 75.5 bits (185), Expect = 7e-15
 Identities = 66/260 (25%), Positives = 124/260 (47%), Gaps = 22/260 (8%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G SG V+    +     VA+K+     Q K +  INE++V+ ++   N+V  L   L
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 468 ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
                 +V E++  G+L + + +   +   +   +  E    L +LH+     +IHRD+K
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHANQ---VIHRDIK 142

Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           S N+LL  + + K++DFG    +  +  +  T+V GT  ++ PE +       K D++S 
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSL 201

Query: 588 GVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAK 647
           G++ +E++ G+   L++ P   R+L +             I  N      N ++L  + +
Sbjct: 202 GIMAIEMVEGEPPYLNENP--LRALYL-------------IATNGTPELQNPEKLSPIFR 246

Query: 648 -LAARCISVRGEERPTMKEV 666
               RC+ +  E+R + KE+
Sbjct: 247 DFLNRCLEMDVEKRGSAKEL 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 75.2 bits (185), Expect = 8e-15
 Identities = 69/263 (26%), Positives = 121/263 (46%), Gaps = 36/263 (13%)

Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP--LLVYEFVGNGTLF 485
           VAVKK +      + +F  E+ ++  +   N+V+  G C         LV E++  G+L 
Sbjct: 36  VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95

Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K +  L   + L   ++    + YL S+     +HRD+ + NIL++     K+ DF
Sbjct: 96  DYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF 152

Query: 545 GASKLVPIDAIQNCTVV----QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMA 600
           G +K++P D  +    V    +  + +  PE L   K +  SDV+SFGVVL EL T    
Sbjct: 153 GLTKVLPQD--KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---- 206

Query: 601 LLSDKPEEERSLAMNFLSSLKQN-----RLLEILDNRIVNDGNKQQL-------KEVAKL 648
             SDK     +  M  + + KQ       L+E+L        N  +L        E+  +
Sbjct: 207 -YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK-------NNGRLPAPPGCPAEIYAI 258

Query: 649 AARCISVRGEERPTMKEVSLELQ 671
              C +    +RP+  E++L+++
Sbjct: 259 MKECWNNDPSQRPSFSELALQVE 281

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 9e-15
 Identities = 59/192 (30%), Positives = 89/192 (46%), Gaps = 11/192 (5%)

Query: 409 IGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G  G+VYK   +     VA+K  K       +    E+ ++ +    N+V   G  L
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 468 ETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                 +V E+ G G+L +     +G LS  +   +  ET   L+YLH ET    IHRD+
Sbjct: 71  RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH-ETGK--IHRDI 127

Query: 527 KSANILLDENCTPKVSDFGASKLVPIDA-IQNCTVVQGTLGYLDPEYLQTCKLTD---KS 582
           K ANILL E+   K++DFG S    + A I       GT  ++ PE     +      K 
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKC 185

Query: 583 DVYSFGVVLVEL 594
           D+++ G+  +EL
Sbjct: 186 DIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 75.5 bits (185), Expect = 9e-15
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 5/179 (2%)

Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVK      Q + +   NE+V++     +NVV +    L  +   ++ EF+  G L + 
Sbjct: 49  VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD- 107

Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I  +  L+ E+   +       L YLHS+    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 108 IVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFC 164

Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             +  D  +  ++V GT  ++ PE +       + D++S G++++E++ G+    SD P
Sbjct: 165 AQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 54/178 (30%), Positives = 85/178 (47%), Gaps = 9/178 (5%)

Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           +KK + +   ++     E  ++++++   +V ++    +      + EFV  G LF H+ 
Sbjct: 51  LKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110

Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G    +      AE      YLHS+    II+RD+K  N+LLD     KV+DFG +K 
Sbjct: 111 KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKK 167

Query: 550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGKMALLSDKP 606
           VP      C    GT  YL PE +Q+ K   K+ D ++ GV+L E + G      D P
Sbjct: 168 VPDRTFTLC----GTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220

Length = 329

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 35/214 (16%)

Query: 409 IGCGGSGNVYKG--FLPDR----TPVAVKKSKFVDQAKI-DEFINELVVVLQINRRNVVR 461
           +G G  G VYKG    P+     T VA+K  K   + K+  EF  E  ++  +   N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHI----------------HKKGNLSWERRLRITAE 505
           LLG C + Q   +++E++ +G L E +                  K +L     L I  +
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGT 564
            A  + YL S      +HRD+ + N L+ E  T K+SDFG S+ +   D  +    VQ  
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR----VQSK 185

Query: 565 ----LGYLDPEYLQTCKLTDKSDVYSFGVVLVEL 594
               + ++ PE +   K T +SD++SFGVVL E+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 77/284 (27%), Positives = 136/284 (47%), Gaps = 39/284 (13%)

Query: 408 VIGCGGSGNVYKGFLPDR----TPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           ++G G  G+V +  L         VAVK  K+     + I+EF+ E   + + +  NV++
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 462 LLGCCLETQ------VPLLVYEFVGNGTL--FEHIHKKG----NLSWERRLRITAETAGV 509
           L+G  L ++      +P+++  F+ +G L  F  + + G     L  +  +R   + A  
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYL 568
           + YL S+     IHRD+ + N +L+EN T  V+DFG S K+   D  +     +  + +L
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLE 627
             E L     T  SDV++FGV + E++T G+    +     E S   N+L  +K NRL +
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQ----TPYAGVENSEIYNYL--IKGNRLKQ 236

Query: 628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
             D           L++V +L  +C S   + RP+ + +  +L+
Sbjct: 237 PPDC----------LEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 15/194 (7%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VAVK  K    +  + F+ E  ++ ++    +V+L     E
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 469 TQVPLLVYEFVGNGTLFEHIHKKG---NLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
             +  +V E++  G+L + + K G    L     + + A+ A  ++Y+     +  IHRD
Sbjct: 73  EPI-YIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT---LGYLDPEYLQTCKLTDKS 582
           ++SANIL+ +    K++DFG ++L+  +     T  QG    + +  PE     + T KS
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 583 DVYSFGVVLVELLT 596
           DV+SFG++L EL+T
Sbjct: 185 DVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 71/267 (26%), Positives = 118/267 (44%), Gaps = 27/267 (10%)

Query: 409 IGCGGSGNVYKG-FLPDRTPVAVKKSKFVD----QAKIDEFINELVVVLQINRRNVVRLL 463
           IG G    VY+   L D  PVA+KK +  D    +A+ D  I E+ ++ Q+N  NV++  
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHPNVIKYY 68

Query: 464 GCCLETQVPLLVYEFVGNGTL---FEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNV 519
              +E     +V E    G L    +H  K+  L  E+ + +   +    L ++HS    
Sbjct: 69  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR-- 126

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
            ++HRD+K AN+ +      K+ D G  +          ++V GT  Y+ PE +      
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 184

Query: 580 DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK 639
            KSD++S G +L E+   +     DK        MN  S  K+   +E  D   +   + 
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDK--------MNLYSLCKK---IEQCDYPPLPSDHY 233

Query: 640 QQLKEVAKLAARCISVRGEERPTMKEV 666
            +  E+ +L   CI+   E+RP +  V
Sbjct: 234 SE--ELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 68/209 (32%), Positives = 97/209 (46%), Gaps = 32/209 (15%)

Query: 409 IGCGGSGNVYKG-FLPDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINR-RNVVRLLG- 464
           IG G  G V K    P  T +AVK+    VD+ +    + +L VV++ +    +V+  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 465 ------C--CLE---TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL 513
                 C  C+E     +    Y++V       +   K  +  E   +I   T   L+YL
Sbjct: 72  LFREGDCWICMELMDISLDKF-YKYV-------YEVLKSVIPEEILGKIAVATVKALNYL 123

Query: 514 HSETNVPIIHRDVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYLDPEY 572
             E    IIHRDVK +NILLD N   K+ DFG S +LV  D+I   T   G   Y+ PE 
Sbjct: 124 KEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV--DSIAK-TRDAGCRPYMAPER 178

Query: 573 LQTCKLTD---KSDVYSFGVVLVELLTGK 598
           +          +SDV+S G+ L E+ TGK
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 14/211 (6%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKK------SKFVDQAKIDEFINELVVVLQINRRNVV 460
           +V+G G  G VY G       +AVK+      +    + + ++   E+ ++  +   N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           + LG CL+     +  EFV  G++   +++ G L      + T +    ++YLH    V 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH-NNCV- 123

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC-----TVVQGTLGYLDPEYLQT 575
            +HRD+K  N++L  N   K+ DFG ++ +    +          + GT  ++ PE +  
Sbjct: 124 -VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182

Query: 576 CKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                KSD++S G  + E+ TGK  L S   
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.4 bits (182), Expect = 2e-14
 Identities = 75/253 (29%), Positives = 120/253 (47%), Gaps = 37/253 (14%)

Query: 385 QSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPD-RTP--VAVKKSKFVDQA-- 439
           +  E A++F +E+ + +  +  + IG G  G VY  F  D RT   VA+KK  +  +   
Sbjct: 10  KDPEIAELFFKEDPEKLFTDLRE-IGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSN 66

Query: 440 -KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF-VGNGTLFEHIHKKGNLSWE 497
            K  + I E+  + +I   N +   GC L      LV E+ +G+ +    +HKK      
Sbjct: 67  EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP----L 122

Query: 498 RRLRITAETAGVL---SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV-PID 553
           + + I A T G L   +YLHS     +IHRD+K+ NILL E    K++DFG++ +  P +
Sbjct: 123 QEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179

Query: 554 AIQNCTVVQGTLGYLDPEY---LQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER 610
           +        GT  ++ PE    +   +   K DV+S G+  +EL   K  L +       
Sbjct: 180 SF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----- 228

Query: 611 SLAMNFLSSLKQN 623
             AM+ L  + QN
Sbjct: 229 --AMSALYHIAQN 239

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 48/126 (38%), Positives = 70/126 (55%), Gaps = 4/126 (3%)

Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           L+ +F+  G LF  + K+   + E      AE A  L +LHS   + II+RD+K  NILL
Sbjct: 75  LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILL 131

Query: 534 DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVE 593
           DE    K++DFG SK   ID  +      GT+ Y+ PE +     T  +D +SFGV++ E
Sbjct: 132 DEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 190

Query: 594 LLTGKM 599
           +LTG +
Sbjct: 191 MLTGSL 196

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 66/218 (30%), Positives = 98/218 (44%), Gaps = 25/218 (11%)

Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQ 453
           E E +   N    V+G G  G VY    L  +  +A+K+    D   +     E+ +   
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 454 INRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRI--TAETAGVL 510
           +  RN+V+ LG   E     +  E V  G+L   +  K G L    +  I  T +    L
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121

Query: 511 SYLHSETNVPIIHRDVKSANILLDE-NCTPKVSDFGASKLVPIDAIQNCT-VVQGTLGYL 568
            YLH      I+HRD+K  N+L++  +   K+SDFG SK +    I  CT    GTL Y+
Sbjct: 122 KYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQYM 176

Query: 569 DPEYLQTCKLTDK--------SDVYSFGVVLVELLTGK 598
            PE      + DK        +D++S G  +VE+ TGK
Sbjct: 177 APE------VIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 53/232 (22%)

Query: 405 YADVIGCGGSGNVYK----GFLPDR--TPVAVKKSKFVDQAKID---EFINELVVVLQIN 455
           Y   IG G  G V++    G LP    T VAVK  K  ++A  D   +F  E  ++ + +
Sbjct: 9   YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALMAEFD 66

Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK----------------------KGN 493
             N+V+LLG C   +   L++E++  G L E +                           
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 494 LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS------ 547
           LS   +L I  + A  ++YL SE     +HRD+ + N L+ EN   K++DFG S      
Sbjct: 127 LSCTEQLCIAKQVAAGMAYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 548 ---KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
              K    DAI         + ++ PE +   + T +SDV+++GVVL E+ +
Sbjct: 184 DYYKASENDAI--------PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 14/197 (7%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFIN--ELVVVLQINRRNVVRLLGC 465
           IG G  G VYK         VA+KK K   +++        E+ ++ ++N  N+++LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 466 CLETQVPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
                   LV+EF+ +  L++ I  ++  L          +    L++ HS     I+HR
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHR 122

Query: 525 DVKSANILLDENCTPKVSDFGASKLV--PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           D+K  N+L++     K++DFG ++    P+    +  V   T  Y  PE L   K     
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV---TRWYRAPELLLGDKGYSTP 179

Query: 583 -DVYSFGVVLVELLTGK 598
            D++S G +  ELL+ +
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 36/218 (16%)

Query: 405 YADVIGCGGSGNVYKGFLPD---RTPVAVKKSK-FVDQAKIDEFINELVVVLQIN-RRNV 459
           + DVIG G  G V K  +     R   A+K+ K +  +    +F  EL V+ ++    N+
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRIT 503
           + LLG C       L  E+  +G L + + K                   LS ++ L   
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
           A+ A  + YL  +     IHRD+ + NIL+ EN   K++DFG S+   +        V+ 
Sbjct: 131 ADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKK 180

Query: 564 TLG-----YLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           T+G     ++  E L     T  SDV+S+GV+L E+++
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 72/229 (31%), Positives = 106/229 (46%), Gaps = 36/229 (15%)

Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKFVDQA---KIDEFINELVVVLQINRRNVVRL 462
           IG G  G VY  F  +      VAVKK  +  +    K  + I E+  + Q+   N +  
Sbjct: 29  IGHGSFGAVY--FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 463 LGCCLETQVPLLVYEF-VGNGTLFEHIHKKGNLSWERRLRITAETAGVL---SYLHSETN 518
            GC L+     LV E+ +G+ +    +HKK      + + I A T G L   +YLHS   
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSHN- 141

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEY---LQ 574
             +IHRD+K+ NILL E    K++DFG ASK  P ++        GT  ++ PE    + 
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF------VGTPYWMAPEVILAMD 193

Query: 575 TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN 623
             +   K DV+S G+  +EL   K  L +         AM+ L  + QN
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQN 235

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 52/296 (17%)

Query: 405 YADVIGCGGSGNVYKGFLP---DRTPVAVKKSK-FVDQAKIDEFINELVVVLQINRR-NV 459
           + DVIG G  G V +  +     +   A+K  K F  +    +F  EL V+ ++    N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRIT 503
           + LLG C       +  E+   G L + + K                   L+ ++ L+  
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
           ++ A  + YL  +     IHRD+ + N+L+ EN   K++DFG S+   +        V+ 
Sbjct: 126 SDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEV-------YVKK 175

Query: 564 TLG-----YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
           T+G     ++  E L     T KSDV+SFGV+L E++               SL      
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV---------------SLGGTPYC 220

Query: 619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL 674
            +    L E L      +  +    EV +L  +C   R  ERP   ++S++L  R+
Sbjct: 221 GMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL-SRM 275

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.8 bits (178), Expect = 4e-14
 Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 15/194 (7%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K       + F+ E  ++ ++    +V L     E
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
             +  +V EF+G G+L + + K+G+   L   + + + A+ A  ++Y+     +  IHRD
Sbjct: 73  EPI-YIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT---LGYLDPEYLQTCKLTDKS 582
           +++ANIL+ +N   K++DFG ++L+  +     T  QG    + +  PE     + T KS
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 583 DVYSFGVVLVELLT 596
           DV+SFG++L EL+T
Sbjct: 185 DVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 51/172 (29%), Positives = 90/172 (52%), Gaps = 18/172 (10%)

Query: 458 NVVRLLGCCLETQVPLLVY-EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
           N+V+ LG    T+  L ++ E+V  G++   +   G    +     T +    L+YLHS+
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127

Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP--IDAIQNCTVVQGTLGYLDPEYLQ 574
               I+HRD+K+ N+L+D +   K+SDFG SK      D  QN + +QG++ ++ PE + 
Sbjct: 128 G---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQGSVFWMAPEVIH 183

Query: 575 TCK--LTDKSDVYSFGVVLVELLTGKMALLSDKP--EEERSLAMNFLSSLKQ 622
           +     + K D++S G V++E+  G+      +P  +EE   AM  L + + 
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIAAMFKLGNKRS 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 78/294 (26%), Positives = 124/294 (42%), Gaps = 52/294 (17%)

Query: 407 DVIGCGGSGNVYKGFLPD---RTPVAVKKSK-FVDQAKIDEFINELVVVLQINRR-NVVR 461
           DVIG G  G V K  +     R   A+K+ K +  +    +F  EL V+ ++    N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAE 505
           LLG C       L  E+  +G L + + K                   LS ++ L   A+
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL 565
            A  + YL  +     IHRD+ + NIL+ EN   K++DFG S+   +        V+ T+
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTM 170

Query: 566 G-----YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
           G     ++  E L     T  SDV+S+GV+L E+++     L   P    + A      L
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----LGGTPYCGMTCA-ELYEKL 224

Query: 621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL 674
            Q   LE       +D       EV  L  +C   +  ERP+  ++ + L  R+
Sbjct: 225 PQGYRLE--KPLNCDD-------EVYDLMRQCWREKPYERPSFAQILVSL-NRM 268

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 73.0 bits (180), Expect = 5e-14
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 29/209 (13%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEF----INELVVVLQINRRNVVRLL 463
           IG G  G VYK         VA+KK + ++  K + F    I E+ ++ ++   N+VRL 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR-MENEK-EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 464 GCCLETQVP--LLVYEFVGNGTLFEH-----IHKKGNLSWERRLR-ITAETAGVLSYLHS 515
                       +V+E+       +H     +        E +++    +    L YLHS
Sbjct: 65  EIVTSKGKGSIYMVFEY------MDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT--VVQGTLGYLDPEYL 573
                I+HRD+K +NIL++ +   K++DFG ++        + T  V+  TL Y  PE L
Sbjct: 119 NG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELL 173

Query: 574 QTCKLTD-KSDVYSFGVVLVELLTGKMAL 601
                   + D++S G +L EL  GK   
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 48/140 (34%), Positives = 71/140 (50%), Gaps = 11/140 (7%)

Query: 463 LGCCLETQVPLL-VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L C  +T+  L  V E++  G L  HI   G     R     AE    L +LH +    I
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---I 117

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKL-VPIDAIQN--CTVVQGTLGYLDPEYLQTCKL 578
           I+RD+K  N+LLD++   K++DFG  K  +  +   +  C    GT  Y+ PE L+  K 
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC----GTPDYIAPEILKGQKY 173

Query: 579 TDKSDVYSFGVVLVELLTGK 598
            +  D +SFGV+L E+L G+
Sbjct: 174 NESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.8 bits (178), Expect = 7e-14
 Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 5/179 (2%)

Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVKK     Q + +   NE+V++   +  NVV +    L      +V EF+  G L + 
Sbjct: 50  VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD- 108

Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I     ++ E+   +       LSYLH++    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 109 IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFC 165

Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             V  +  +  ++V GT  ++ PE +       + D++S G++++E++ G+    ++ P
Sbjct: 166 AQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.8 bits (179), Expect = 7e-14
 Identities = 74/268 (27%), Positives = 126/268 (47%), Gaps = 45/268 (16%)

Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT--- 483
           VAVK  +        ++F+ E+ ++ +++  N+ RLLG C       ++ E++ NG    
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 484 -LFEHIHKKGN-------LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE 535
            L +H+ +          LS+   L +  + A  + YL    N   +HRD+ + N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGK 165

Query: 536 NCTPKVSDFGASK-LVPIDAIQNCTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVV 590
           N T K++DFG S+ L   D  +    VQG     + ++  E +   K T KSDV++FGV 
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYR----VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221

Query: 591 LVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL-------K 643
           L E+LT    L  ++P E           L   +++E   +   +DG +  L       K
Sbjct: 222 LWEILT----LCREQPYEH----------LTDQQVIENAGHFFRDDGRQIYLPRPPNCPK 267

Query: 644 EVAKLAARCISVRGEERPTMKEVSLELQ 671
           ++ +L   C     E+RPT +E+ L LQ
Sbjct: 268 DIYELMLECWRRDEEDRPTFREIHLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 70/262 (26%), Positives = 121/262 (46%), Gaps = 42/262 (16%)

Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL-- 484
           VAVK  +  V +   ++F+ E+ ++ ++   N++RLLG C+      ++ E++ NG L  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 485 ----------FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD 534
                     F H +   ++S    L +  + A  + YL S   +  +HRD+ + N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVG 163

Query: 535 ENCTPKVSDFGASK-LVPID--AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVL 591
            + T K++DFG S+ L   D   IQ   V+   + ++  E +   K T  SDV++FGV L
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVL--PIRWMAWESILLGKFTTASDVWAFGVTL 221

Query: 592 VELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE------- 644
            E+ T    L  ++P           S L   +++E       N G +  L +       
Sbjct: 222 WEMFT----LCKEQP----------YSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSP 267

Query: 645 VAKLAARCISVRGEERPTMKEV 666
           V KL  RC S   ++RPT  ++
Sbjct: 268 VFKLMMRCWSRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 72/277 (25%), Positives = 124/277 (44%), Gaps = 38/277 (13%)

Query: 423 PDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV 479
           P+R T VAVK  K    +  + + I+E+ ++  I + +N++ LLG C +     ++ E+ 
Sbjct: 47  PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106

Query: 480 GNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             G L E++  +                  LS++  +    + A  + YL S+     IH
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIH 163

Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+ + N+L+ E+   K++DFG A  +  ID  +  T  +  + ++ PE L     T +S
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 223

Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+SFGV+L E+ T   +     P EE               L ++L      D      
Sbjct: 224 DVWSFGVLLWEIFTLGGSPYPGVPVEE---------------LFKLLKEGHRMDKPSNCT 268

Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSN 679
            E+  +   C      +RPT K++  +L   L+L SN
Sbjct: 269 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 49/136 (36%), Positives = 63/136 (46%), Gaps = 5/136 (3%)

Query: 463 LGCCLETQVPLL-VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L CC +T   L  V EFV  G L  HI K       R     AE    L +LH +    I
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---I 117

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           I+RD+K  N+LLD     K++DFG  K    +     T   GT  Y+ PE LQ       
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGPS 176

Query: 582 SDVYSFGVVLVELLTG 597
            D ++ GV+L E+L G
Sbjct: 177 VDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 5/179 (2%)

Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVKK     Q + +   NE+V++      NVV +    L      +V EF+  G L + 
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD- 106

Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I     ++ E+   +       LS LH++    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 107 IVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC 163

Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             V  +  +  ++V GT  ++ PE +       + D++S G++++E++ G+    ++ P
Sbjct: 164 AQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 17/187 (9%)

Query: 424 DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT 483
           D+  VAVK  K        +F  E  ++  +   ++V+  G C+E    ++V+E++ +G 
Sbjct: 34  DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 93

Query: 484 LFEHIHKKG-------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L + +   G              L+  + L I  + A  + YL S+     +HRD+ + N
Sbjct: 94  LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRN 150

Query: 531 ILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGV 589
            L+ EN   K+ DFG S+ V   D  +        + ++ PE +   K T +SDV+S GV
Sbjct: 151 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210

Query: 590 VLVELLT 596
           VL E+ T
Sbjct: 211 VLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.5 bits (183), Expect = 1e-13
 Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 17/170 (10%)

Query: 444 FINELVVVLQINRRNVVRLL--GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           F  E  +  ++   N+V LL  G      +   V+E+V   TL E +   G L      R
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAADGALPAGETGR 83

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASKLVP----ID 553
           +  +    L+  H   N  I+HRD+K  NI++          KV DFG   L+P     D
Sbjct: 84  LMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHA-KVLDFGIGTLLPGVRDAD 139

Query: 554 AIQ--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL 601
                  T V GT  Y  PE L+   +T  SD+Y++G++ +E LTG+  +
Sbjct: 140 VATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 74/251 (29%), Positives = 120/251 (47%), Gaps = 39/251 (15%)

Query: 388 EKAKIFTEEEIKTVTNNYADV--IGCGGSGNVYKGFLPD---RTPVAVKKSKFVDQA--- 439
           + A++F +++ + +   ++D+  IG G  G VY  F  D      VA+KK  +  +    
Sbjct: 3   DVAELFFKDDPEKL---FSDLREIGHGSFGAVY--FARDVRNSEVVAIKKMSYSGKQSNE 57

Query: 440 KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF-VGNGTLFEHIHKKGNLSWER 498
           K  + I E+  + ++   N ++  GC L      LV E+ +G+ +    +HKK      +
Sbjct: 58  KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQ 113

Query: 499 RLRITAETAGVL---SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
            + I A T G L   +YLHS     +IHRDVK+ NILL E    K+ DFG++ ++   A 
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM---AP 167

Query: 556 QNCTVVQGTLGYLDPEY---LQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSL 612
            N  V  GT  ++ PE    +   +   K DV+S G+  +EL   K  L +         
Sbjct: 168 ANXFV--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------- 218

Query: 613 AMNFLSSLKQN 623
           AM+ L  + QN
Sbjct: 219 AMSALYHIAQN 229

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 72.0 bits (176), Expect = 2e-13
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 10/162 (6%)

Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ +R   +  L    +T   L  V E+   G LF H+ ++   S +R     AE    
Sbjct: 48  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 107

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHSE NV  ++RD+K  N++LD++   K++DFG  K    + I++   ++   GT  
Sbjct: 108 LDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFCGTPE 161

Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           YL PE L+        D +  GVV+ E++ G++   +   E+
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 13/201 (6%)

Query: 408 VIGCGGSGNVYKGFLPDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQI--NRRN--VVR 461
           ++G G  G VY  +  D    +AVK+  F  D  +  + +N L   +Q+  N R+  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 462 LLGCCLE-TQVPLLVY-EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNV 519
             GC  +  +  L ++ E++  G++ + +   G L+     R T +    +SYLHS    
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM-- 126

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV--VQGTLGYLDPEYLQTCK 577
            I+HRD+K ANIL D     K+ DFGASK +    +    +  V GT  ++ PE +    
Sbjct: 127 -IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185

Query: 578 LTDKSDVYSFGVVLVELLTGK 598
              K+DV+S    +VE+LT K
Sbjct: 186 YGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 68/261 (26%), Positives = 113/261 (43%), Gaps = 37/261 (14%)

Query: 424 DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT 483
           D+  VAVK  K    A   +F  E  ++  +   ++V+  G C +    ++V+E++ +G 
Sbjct: 34  DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 93

Query: 484 L--FEHIH--------------KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
           L  F   H               KG L   + L I ++ A  + YL S+     +HRD+ 
Sbjct: 94  LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLA 150

Query: 528 SANILLDENCTPKVSDFGASK-LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           + N L+  N   K+ DFG S+ +   D  +        + ++ PE +   K T +SDV+S
Sbjct: 151 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 210

Query: 587 FGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV 645
           FGV+L E+ T GK         E        +  + Q R+LE    R+         KEV
Sbjct: 211 FGVILWEIFTYGKQPWFQLSNTE-------VIECITQGRVLE--RPRVCP-------KEV 254

Query: 646 AKLAARCISVRGEERPTMKEV 666
             +   C     ++R  +KE+
Sbjct: 255 YDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 18/221 (8%)

Query: 409 IGCGGSGNVYK------GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+K      G +  R  + ++    +  A  ++ I EL V+ + N   +V  
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGF 68

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G         +  E +  G+L + + K G +  +   +++      L+YL  +    I+
Sbjct: 69  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 126

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRDVK +NIL++     K+ DFG S  + ID++ N  V  GT  Y+ PE LQ    + +S
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQGTHYSVQS 183

Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN 623
           D++S G+ LVE+  G+  +    P + + L + F   ++ +
Sbjct: 184 DIWSMGLSLVEMAIGRYPI---PPPDAKELELMFGCPVEGD 221

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 11/172 (6%)

Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
            V E+V  G LF H+ ++   S +R     AE    L YLHS     I++RD+K  N++L
Sbjct: 72  FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLML 128

Query: 534 DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVE 593
           D++   K++DFG  K    DA    T   GT  YL PE L+        D +  GVV+ E
Sbjct: 129 DKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 187

Query: 594 LLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL-----EILDNRIVNDGNKQ 640
           ++ G++   +   + E+   +  +  +K  R L      +L   ++ D NK+
Sbjct: 188 MMCGRLPFYNQ--DHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 7/186 (3%)

Query: 430 VKKSKFVDQAKIDEFI-NELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEH 487
           +KK+  V +AK  E    E  V+  I +   +  L    +T   L L+ +++  G LF H
Sbjct: 36  LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTH 95

Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           + ++     +     + E    L +LH    + II+RD+K  NILLD N    ++DFG S
Sbjct: 96  LSQRERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 152

Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT-DKS-DVYSFGVVLVELLTGKMALLSDK 605
           K    D ++      GT+ Y+ P+ ++      DK+ D +S GV++ ELLTG      D 
Sbjct: 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212

Query: 606 PEEERS 611
            +  ++
Sbjct: 213 EKNSQA 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 408 VIGCGGSGNVYKGFLPDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQINR----RNVVR 461
           ++G G  G VY  +  D    +AVK+ +F  +  +  + +N L   +Q+ +      +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 462 LLGCCLETQVPLL--VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNV 519
             GC  +     L    E +  G++ + +   G L+     + T +    +SYLHS    
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM-- 126

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV--VQGTLGYLDPEYLQTCK 577
            I+HRD+K ANIL D     K+ DFGASK +    +    +  V GT  ++ PE +    
Sbjct: 127 -IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185

Query: 578 LTDKSDVYSFGVVLVELLTGK 598
              K+D++S G  +VE+LT K
Sbjct: 186 YGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 18/179 (10%)

Query: 428 VAVKKSKFVDQAKIDE---FINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGNGT 483
           VAVK  K    A   E    ++EL ++  + N  N+V LLG C      L++ E+   G 
Sbjct: 68  VAVKMLK--PTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125

Query: 484 LFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV 541
           L   + +K    L+ E  L  + + A  +++L S+     IHRD+ + N+LL      K+
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182

Query: 542 SDFGASKLVPIDAIQNCTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
            DFG ++ +  D   +  VV+G     + ++ PE +  C  T +SDV+S+G++L E+ +
Sbjct: 183 CDFGLARDIMND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 23/224 (10%)

Query: 447 ELVVVLQINRRNVVRLLGCCLE-TQVPLLVY-EFVGNGTLFEHIHKKGNLSWERRLRITA 504
           E+ ++  +    +V+  GC  +  +  L ++ E++  G++ + +   G L+     + T 
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113

Query: 505 ETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV--VQ 562
           +    +SYLHS     I+HRD+K ANIL D     K+ DFGASK +    +    +  V 
Sbjct: 114 QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170

Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
           GT  ++ PE +       K+DV+S G  +VE+LT       +KP      AM  +  +  
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-------EKPPWAEYEAMAAIFKIA- 222

Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                    +  N      + E A+    CI V    RP+ +E+
Sbjct: 223 --------TQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 19/201 (9%)

Query: 409 IGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQAKIDEFI-NELVVVLQINR-RNVVRLLGC 465
           IG G  G VYK  F      +AVK+ +     + ++ I  +L VVL+ +    +V+  G 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 466 CL-ETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRL-RITAETAGVLSYLHSETNVPII 522
            + ++ V  +  E +   T  + + K+      E  L ++T      L YL  +  V  I
Sbjct: 83  FITDSDV-FICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV--I 137

Query: 523 HRDVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           HRDVK +NILLD +   K+ DFG S +LV  D+    T   G   Y+ PE +       K
Sbjct: 138 HRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAK-TRSAGCAAYMAPERIDPPDPNPK 194

Query: 582 ----SDVYSFGVVLVELLTGK 598
               +DV+S G+ LVEL TG+
Sbjct: 195 YDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 38/222 (17%)

Query: 409 IGCGGSGNVYKGFLPD------RTPVAVKKSKFVDQAKIDE---FINELVVVLQINRRNV 459
           +G G  G VY+G   D       T VAVK     + A + E   F+NE  V+      +V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 71

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHI--------HKKGNL--SWERRLRITAETAGV 509
           VRLLG   + Q  L+V E + +G L  ++        +  G    + +  +++ AE A  
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--- 566
           ++YL+++     +HRD+ + N ++  + T K+ DFG ++    D  +     +G  G   
Sbjct: 132 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184

Query: 567 --YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             ++ PE L+    T  SD++SFGVVL E+ +     L+++P
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-----LAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 7/163 (4%)

Query: 446 NELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAE 505
           NE  V+ +++   ++RL     + +   ++ E+V  G LF ++   G  S    L   +E
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL 565
               L YLHS+    I++RD+K  NILLD+    K++DFG +K +       C    GT 
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTP 162

Query: 566 GYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            YL PE +Q+       D ++ G+++ E+L G      D P  
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 64/261 (24%), Positives = 123/261 (47%), Gaps = 28/261 (10%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+       T VAVK  K      ++ F+ E  V+  +    +V+L      
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 70

Query: 469 TQVPL-LVYEFVGNGTLFEHIH-KKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
           T+ P+ ++ EF+  G+L + +   +G+     + +  +A+ A  ++++        IHRD
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 127

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           +++ANIL+  +   K++DFG ++++  +        +  + +  PE +     T KSDV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187

Query: 586 SFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           SFG++L+E++T G++       PE  R+L   +    +  R           +   ++L 
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGY----RMPR----------PENCPEELY 233

Query: 644 EVAKLAARCISVRGEERPTMK 664
            +     RC   R EERPT +
Sbjct: 234 NI---MMRCWKNRPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 20/218 (9%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSK---FVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           IG G    VY+   L DR PVA+KK +    +D     + + E+ ++ Q+N  NV++ L 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 465 CCLETQVPLLVYEFVGNGTL---FEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNVP 520
             +E     +V E    G L    ++  K+  L  ER + +   +    + ++HS     
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--- 126

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
           ++HRD+K AN+ +      K+ D G  +          ++V GT  Y+ PE +       
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185

Query: 581 KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
           KSD++S G +L E+   +     DK        MN  S
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDK--------MNLFS 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 6e-13
 Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 17/185 (9%)

Query: 429 AVKKSKFVDQAKIDEFINELVVVL-QINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
            +KKS  + + ++     E  +++ Q     V +L           LV E++  G     
Sbjct: 28  VLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASL 87

Query: 488 IHKKGNLS--WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG 545
           I   G L   W ++    AE    +  LH      IIHRD+K  N+L+D+    K++DFG
Sbjct: 88  IKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFG 142

Query: 546 ASK--LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLS 603
            S+  L     +       GT  YL PE +        SD +S G V+ E L G     +
Sbjct: 143 LSRNGLENKKFV-------GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195

Query: 604 DKPEE 608
           + P+ 
Sbjct: 196 ETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 11/195 (5%)

Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKFVDQAKI-DEFINELVVVLQINRRNVVRLLG 464
           +G G  G V KG    R     VA+K  K  ++  + DE + E  ++ Q++   +VR++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
            C E +  +LV E    G L + +  KK  ++    + +  + +  + YL  +     +H
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVH 118

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDA--IQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D    +  +  +  L +  PE +   K + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178

Query: 582 SDVYSFGVVLVELLT 596
           SDV+S+G+ + E  +
Sbjct: 179 SDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 20/196 (10%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G  G+VYK   +      A+K  K            E++++      N+V   G  L
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 468 ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
                 +  EF G G+L +  H  G LS  +   ++ ET   L YLHS+     +HRD+K
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRDIK 133

Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE---------YLQTCKL 578
            ANILL +N   K++DFG S  +     +  + + GT  ++ PE         Y Q C  
Sbjct: 134 GANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQLC-- 190

Query: 579 TDKSDVYSFGVVLVEL 594
               D+++ G+  +EL
Sbjct: 191 ----DIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 71/252 (28%), Positives = 111/252 (44%), Gaps = 26/252 (10%)

Query: 400 TVTNNYADV--IGCGGSGNVYKGFLPDRT---PVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y  +  IG G  G V   F  D      VAVKK    F +Q        ELV++ 
Sbjct: 18  TVLKRYQQLKPIGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 75

Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + IH    L  ER   +  + 
Sbjct: 76  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHM--ELDHERMSYLLYQM 132

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++    + +    VV  T  
Sbjct: 133 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRY 187

Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL---SSLKQN 623
           Y  PE +      +  D++S G ++ EL+ G +        ++ +  +  L   S+   N
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247

Query: 624 RLLEILDNRIVN 635
           RL   + N + N
Sbjct: 248 RLQPTVRNYVEN 259

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 17/198 (8%)

Query: 409 IGCGGSGNVYKGFL-PDRTPVAVK--KSKFVDQAKIDEFI-NELVVVLQINRRNVVRLLG 464
           +G GG G V    +       A+K  K + + +    E I +E  ++ + N   +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
              + +   ++ E+   G L+  +  +G           A       YLH+     II+R
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYR 117

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNC----TVVQGTLGYLDPEYLQTCKLTD 580
           D+K  N+LLD N   K+ DFG +K      +++     T   GT  Y+ PE +       
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAK-----KLKSGQKTWTFC-GTPEYVAPEIILNKGYDF 171

Query: 581 KSDVYSFGVVLVELLTGK 598
             D +S G++L ELLTG+
Sbjct: 172 SVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 51/147 (34%), Positives = 70/147 (47%), Gaps = 5/147 (3%)

Query: 463 LGCCLETQVPLL-VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L C  +T+  L  V E++  G L  HI         R     AE    L +LHS+    I
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---I 117

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           ++RD+K  NILLD +   K++DFG  K   +   + CT   GT  Y+ PE L   K    
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNTS 176

Query: 582 SDVYSFGVVLVELLTGKMALLSDKPEE 608
            D +SFGV+L E+L G+        EE
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 37/271 (13%)

Query: 428 VAVKKSK-FVDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109

Query: 486 EHIHKKGNLSWERRLRI----------------TAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +     E    I                T + A  + YL S+     IHRD+ + 
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166

Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ V  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226

Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 227 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 271

Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSN 679
              C       RPT K++  +L   L+L +N
Sbjct: 272 MRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 408 VIGCGGSGNVY---KGFLPDRTPV----AVKKSKFVDQAKIDEFINELVVVLQINRRN-V 459
           V+G G  G V+   K    D   +     ++K+  V +AK  E       VL+  R++  
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 460 VRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSET 517
           +  L    +T+  L L+ ++V  G +F H++++ N S E  +R  + E    L +LH   
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS-EDEVRFYSGEIILALEHLH--- 122

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
            + I++RD+K  NILLD      ++DFG SK    +  +      GT+ Y+ PE ++   
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG 182

Query: 578 LTDKS-DVYSFGVVLVELLTG 597
              K+ D +S G+++ ELLTG
Sbjct: 183 GHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 31/218 (14%)

Query: 405 YADVIGCGGSGNVYKG--FLPDRTP---VAVKKSKFVDQAK-IDEFINELVVVLQINRRN 458
           + + +G    G +YKG  +LP       VA+K  K ++  +   EF  E  ++ +++  N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 459 VVRLLGCCLETQVPLLVYEFVGNGTLFEHI-----HK------------KGNLSWERRLR 501
           +V LLG   + Q   +++E++  G L E +     H             K +L     L 
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNC 558
           I  + A  + YL S      +H+D+ + NIL+ E    K+SD G S+ +       +Q  
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           +++   + ++ PE +   K +  SD++SFGVVL E+ +
Sbjct: 186 SLL--PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 5/150 (3%)

Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ  R   +  L    +T   L  V E+   G LF H+ ++   S +R     AE    
Sbjct: 48  VLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 107

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L YLHS     +++RD+K  N++LD++   K++DFG  K    D     T   GT  YL 
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLA 163

Query: 570 PEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           PE L+        D +  GVV+ E++ G++
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 11/161 (6%)

Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ  R   +  L    +T   L  V E+   G LF H+ ++   + ER     AE    
Sbjct: 48  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 107

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHS     +++RD+K  N++LD++   K++DFG  K    + I +   ++   GT  
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPE 160

Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPE 607
           YL PE L+        D +  GVV+ E++ G++   +   E
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 42/127 (33%), Positives = 68/127 (53%), Gaps = 6/127 (4%)

Query: 474 LVYEFVGNGTLFEHIH-KKGNLSWERR-LRITAETAGVLSYLHSETNVPIIHRDVKSANI 531
           +V E+   G L + I  ++G L  E   L+   +    + ++H +    ++HRD+KS NI
Sbjct: 75  IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNI 131

Query: 532 LLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVL 591
            L +N   K+ DFG+++L+       CT V GT  Y+ PE  +     +KSD++S G +L
Sbjct: 132 FLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCIL 190

Query: 592 VELLTGK 598
            EL T K
Sbjct: 191 YELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 56/183 (30%), Positives = 87/183 (47%), Gaps = 11/183 (6%)

Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHI 488
           VKK    D   ID    E  V  Q +    +  L  C +T   L LV E+V  G L  H+
Sbjct: 28  VKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM 87

Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            ++  L  E      AE    L++LH      II+RD+K  N+LLD +   K++D+G  K
Sbjct: 88  QRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK 144

Query: 549 --LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK--MALLSD 604
             L P D     +   GT  Y+ PE L+  +     D ++ GV++ E++ G+    +++D
Sbjct: 145 EGLGPGDTT---STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITD 201

Query: 605 KPE 607
            P+
Sbjct: 202 NPD 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.8 bits (165), Expect = 4e-12
 Identities = 57/186 (30%), Positives = 86/186 (46%), Gaps = 13/186 (6%)

Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL-VYEFVGNGTLFEHI 488
           VKK    D   ID    E  V  Q +    +  L  C +T+  L  V E+V  G L  H+
Sbjct: 28  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 87

Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            ++  L  E     +AE +  L+YLH      II+RD+K  N+LLD     K++D+G  K
Sbjct: 88  QRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144

Query: 549 --LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL----L 602
             L P D     +   GT  Y+ PE L+        D ++ GV++ E++ G+        
Sbjct: 145 EGLRPGDTT---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 201

Query: 603 SDKPEE 608
           SD P++
Sbjct: 202 SDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 54/169 (31%), Positives = 85/169 (50%), Gaps = 9/169 (5%)

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWE--RRLR 501
           +NE  ++ ++N R VV L     ET+  L LV   +  G L  HI+  G   +E  R + 
Sbjct: 48  LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF 106

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
             AE    L  LH E    I++RD+K  NILLD++   ++SD G +  VP        V 
Sbjct: 107 YAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV- 162

Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER 610
            GT+GY+ PE ++  + T   D ++ G +L E++ G+      K + +R
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 66.7 bits (162), Expect = 5e-12
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 18/214 (8%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR-RNVVRLLGC 465
           +++G G  G VYKG       +A  K   V   + +E   E+ ++ + +  RN+    G 
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 466 CLETQVP------LLVYEFVGNGTLFEHI-HKKGN-LSWERRLRITAETAGVLSYLHSET 517
            ++   P       LV EF G G++ + I + KGN L  E    I  E    LS+LH   
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 131

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
              +IHRD+K  N+LL EN   K+ DFG S  +     +  T + GT  ++ PE +   +
Sbjct: 132 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 187

Query: 578 LTD-----KSDVYSFGVVLVELLTGKMALLSDKP 606
             D     KSD++S G+  +E+  G   L    P
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 30/212 (14%)

Query: 409 IGCGGSGNVYKGFLPD-------RTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
           +G G  G VY+G   D          VAVK  +    DQ K  EF+ E  ++   N  N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHPNI 61

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK-------GNLSWERRLRITAETAGVLSY 512
           V+LLG CL  +   ++ E +  G L  ++            L+ +  L I  + A    Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 513 LHSETNVPIIHRDVKSANILLDENC-----TPKVSDFG-ASKLVPIDAIQNCTVVQGTLG 566
           L     +  IHRD+ + N L+ E         K+ DFG A  +   D  +     +G L 
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG--EGLLP 176

Query: 567 --YLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
             ++ PE L   K T +SDV+SFGV++ E+LT
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 43/120 (35%), Positives = 67/120 (55%), Gaps = 9/120 (7%)

Query: 484 LFEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVS 542
            ++ ++ KG    E  L +I       L YLHS+ +V  IHRDVK +N+L++ N   K+ 
Sbjct: 89  FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLC 146

Query: 543 DFGASKLVPIDAIQNCTVVQGTLGYLDPEYL---QTCKLTD-KSDVYSFGVVLVELLTGK 598
           DFG S  + +D++   T+  G   Y+ PE +      K  D KSDV+S G+ ++EL TG+
Sbjct: 147 DFGISGYL-VDSVAK-TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 6e-12
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 21/200 (10%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKF-VDQAKIDEF-INELVVVLQINRR---NVVRL 462
           IG G  G VYK   L     VA+KK +  + +  I    + E+ ++ Q+      N+VRL
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 463 LGCC----LETQVPL-LVYEFVGN--GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHS 515
           L  C     + ++ L LV+E V     T      K G L  E    +  +    + +LHS
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDFLHS 125

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID-AIQNCTVVQGTLGYLDPEYLQ 574
                I+HRD+K  NIL+  +   K++DFG +++   + A+ +  V   TL Y  PE L 
Sbjct: 126 HR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV---TLWYRAPEVLL 179

Query: 575 TCKLTDKSDVYSFGVVLVEL 594
                   D++S G +  EL
Sbjct: 180 QSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 30/214 (14%)

Query: 409 IGCGGSGNVYKGFL------PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINR-RNV 459
           +G G  G V K          + + VAVK  K    ++   D  ++E+ ++  I + +N+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHKNI 78

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRIT 503
           + LLG C +     +V E+  +G L + +  +                  L+ +  +   
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQ 562
            + A  + +L S+     IHRD+ + N+L+ E+   K++DFG ++ +  ID  +  T  +
Sbjct: 139 YQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
             + ++ PE L     T +SDV+SFGV+L E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 66.1 bits (162), Expect = 7e-12
 Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 32/214 (14%)

Query: 407 DVIGCGGSGNVYKGFLPDRTP-VAVKKSKFVDQAKIDEFINELVVVLQ--INRRNVVRLL 463
           +VIG G  G VYK         VA+K    +     +E I E   +L+   N  N+    
Sbjct: 12  EVIGEGTYGKVYKARHKKTGQLVAIKIMDII--EDEEEEIKEEYNILRKYSNHPNIATFY 69

Query: 464 GCCLETQVPL-------LVYEFVGNGTLFEHIHKKGNLSWERRLR------ITAETAGVL 510
           G  ++ + P        LV E  G G++ + +  KG     +RL+      I  ET   L
Sbjct: 70  GAFIK-KNPPGNDDQLWLVMELCGGGSVTDLV--KGLRKKGKRLKEEWIAYILRETLRGL 126

Query: 511 SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDP 570
           +YLH      +IHRD+K  NILL +N   K+ DFG S  +     +  T + GT  ++ P
Sbjct: 127 AYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAP 182

Query: 571 EYLQTCKLTD------KSDVYSFGVVLVELLTGK 598
           E +  C          +SDV+S G+  +EL  GK
Sbjct: 183 EVI-ACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.0 bits (163), Expect = 8e-12
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 7/192 (3%)

Query: 409 IGCGGSGNVYK-GFLPDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           +G G  G V K    P    +A K     +  A  ++ I EL V+ + N   +V   G  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                  +  E +  G+L + + +   +  E   +++      L+YL  +    I+HRDV
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDV 130

Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           K +NIL++     K+ DFG S  + ID++ N  V  GT  Y+ PE LQ    + +SD++S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQGTHYSVQSDIWS 187

Query: 587 FGVVLVELLTGK 598
            G+ LVEL  G+
Sbjct: 188 MGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 44/124 (35%), Positives = 60/124 (48%), Gaps = 4/124 (3%)

Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
            V +FV  G LF H+ ++ +    R     AE A  L YLHS   + I++RD+K  NILL
Sbjct: 73  FVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILL 129

Query: 534 DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVE 593
           D      ++DFG  K   I      T   GT  YL PE ++     +  D +  G VL E
Sbjct: 130 DSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYE 188

Query: 594 LLTG 597
           +L G
Sbjct: 189 MLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 9/169 (5%)

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWE--RRLR 501
           +NE  ++ ++N + VV L     ET+  L LV   +  G L  HI+  GN  +E  R L 
Sbjct: 48  LNEKQILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF 106

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
             AE    L  LH E     ++RD+K  NILLD+    ++SD G +  +P        V 
Sbjct: 107 YAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV- 162

Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER 610
            GT+GY+ PE L   + T   D +  G ++ E++ G+      K + +R
Sbjct: 163 -GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 46/137 (33%), Positives = 65/137 (47%), Gaps = 5/137 (3%)

Query: 463 LGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L  C +T   L  V E+V  G L  HI + G       +   AE A  L +LHS+    I
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---I 122

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           I+RD+K  N++LD     K++DFG  K          T   GT  Y+ PE +        
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQPYGKS 181

Query: 582 SDVYSFGVVLVELLTGK 598
            D ++FGV+L E+L G+
Sbjct: 182 VDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 22/197 (11%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           +G G  G+VYK   L      AVK  K            E+ +V +    N+V   G  L
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 468 ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
             +   +  E+ G G+L +  H  G LS  +   +  ET   L+YLHS+     +HRD+K
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRDIK 133

Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPE---------YLQTCK 577
            ANILL +N   K++DFG A+K+    A +   +  GT  ++ PE         Y Q C 
Sbjct: 134 GANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVEKNGGYNQLC- 190

Query: 578 LTDKSDVYSFGVVLVEL 594
                D+++ G+  +EL
Sbjct: 191 -----DIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 20/205 (9%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLG 464
           D +G G  G+VYK    P    +A+K+ +  +D++K ++ I EL ++ +     +V   G
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSW---ERRL-RITAETAGVLSYLHSETNVP 520
                    +  E++  G+L + ++  G  +    E  L RIT      L +L  E N  
Sbjct: 67  AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123

Query: 521 IIHRDVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
           IIHRDVK  N+L++ N   K+ DFG S  LV   A  N     G   Y+ PE +++    
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPN 179

Query: 580 D------KSDVYSFGVVLVELLTGK 598
                  +SDV+S G+ ++E+  G+
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 2e-11
 Identities = 64/251 (25%), Positives = 100/251 (39%), Gaps = 43/251 (17%)

Query: 407 DVIGCGGSGNVYKGFLPD-RTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
            VIG G  G V+     D     A+K   KS  + + +I     E  ++   +   +V+L
Sbjct: 7   KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66

Query: 463 LGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNL--SWERRLRITAETAGVLSYLHSETNV 519
                + +  L LV E++  G L   + +K        R     AE    L  +H    +
Sbjct: 67  Y-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY--IAELVLALDSVHK---L 120

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASK------------------------LVPIDAI 555
             IHRD+K  NIL+D +   K++DFG  K                        LV     
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 556 QN-----CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER 610
           +       + V GT  Y+ PE L+      + D +S GV+L E+L G     SD  +E  
Sbjct: 181 KQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239

Query: 611 SLAMNFLSSLK 621
           +  +N+  SL+
Sbjct: 240 NKIINWKESLR 250

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 47/147 (31%), Positives = 69/147 (46%), Gaps = 5/147 (3%)

Query: 463 LGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L  C +T   L  V E+V  G L   I + G       +   AE A  L +LHS+    I
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---I 122

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           I+RD+K  N++LD     K++DFG  K    D +   T   GT  Y+ PE +        
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEIIAYQPYGKS 181

Query: 582 SDVYSFGVVLVELLTGKMALLSDKPEE 608
            D ++FGV+L E+L G+     +  +E
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFEGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 65.2 bits (160), Expect = 2e-11
 Identities = 46/138 (33%), Positives = 64/138 (46%), Gaps = 30/138 (21%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAI-QNCT--VVQGTL 565
           L YLHS     +IHRD+K +NIL++ NC  K+ DFG A  + P +      T  VV  T 
Sbjct: 116 LKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV--TR 170

Query: 566 GYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK---------------MALLSDKPEEE 609
            Y  PE L +     K+ D++S G +  ELLT K               + +L    EE+
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230

Query: 610 RSL-----AMNFLSSLKQ 622
                   A N+L SL +
Sbjct: 231 LKFITSEKARNYLKSLPK 248

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 61/252 (24%), Positives = 114/252 (45%), Gaps = 42/252 (16%)

Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK----------- 490
           ++F+ E+ ++ ++   N++RLL  C+ +    ++ E++ NG L + + +           
Sbjct: 64  NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123

Query: 491 KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK-L 549
              +S+   + +  + A  + YL S   +  +HRD+ + N L+ +N T K++DFG S+ L
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 550 VPID--AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPE 607
              D   IQ   V+   + ++  E +   K T  SDV++FGV L E+LT    L  ++P 
Sbjct: 181 YSGDYYRIQGRAVL--PIRWMSWESILLGKFTTASDVWAFGVTLWEILT----LCKEQP- 233

Query: 608 EERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL--------KEVAKLAARCISVRGEE 659
                     S L   +++E        D  +Q            + KL   C     +E
Sbjct: 234 ---------YSQLSDEQVIEN-TGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKE 283

Query: 660 RPTMKEVSLELQ 671
           RP+ +E+   L 
Sbjct: 284 RPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 45/124 (36%), Positives = 65/124 (52%), Gaps = 6/124 (4%)

Query: 475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD 534
           V ++V  G LF H+ ++ +    R     AE A  L YLHS   + II+RD+K  NILLD
Sbjct: 74  VLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLD 130

Query: 535 ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVE 593
                 ++DFG  K   I+  +  +   GT  YL PE L+  +  D++ D +  G VL E
Sbjct: 131 SQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYE 188

Query: 594 LLTG 597
           +L G
Sbjct: 189 MLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 9/195 (4%)

Query: 408 VIGCGGSGNVYKGFL--PDRT--PVAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRL 462
           ++G G  G + +G L  P +   PVA+   +     K    F+ E + + Q +  N+VRL
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPI 521
            G        ++V E++ NG L   + K +G L   + + +    A  + YL   + +  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGY 128

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           +H+ + +  +L++ +   K+S F   +    +AI      +  + +  PE +Q    +  
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188

Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFG+V+ E+++
Sbjct: 189 SDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 11/176 (6%)

Query: 428 VAVKKSK-FVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTL 484
           VAVK  K       I +   E+ ++  +   N+V+  G C E       L+ EF+ +G+L
Sbjct: 36  VAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95

Query: 485 FEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
            E++ + K  ++ +++L+   +    + YL S   V   HRD+ + N+L++     K+ D
Sbjct: 96  KEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGD 152

Query: 544 FGASKLVPIDAIQNCTV---VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           FG +K +  D  +  TV   +   + +  PE L   K    SDV+SFGV L ELLT
Sbjct: 153 FGLTKAIETDK-EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 18/214 (8%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR-RNVVRLLGC 465
           +V+G G  G VYKG       +A  K   V + + +E   E+ ++ + +  RN+    G 
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 466 CLETQVP------LLVYEFVGNGTLFEHIHK-KGNLSWERRLR-ITAETAGVLSYLHSET 517
            ++   P       LV EF G G++ + +   KGN   E  +  I  E    L++LH+  
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK 141

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
              +IHRD+K  N+LL EN   K+ DFG S  +     +  T + GT  ++ PE +   +
Sbjct: 142 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 197

Query: 578 LTD-----KSDVYSFGVVLVELLTGKMALLSDKP 606
             D     +SD++S G+  +E+  G   L    P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 15/195 (7%)

Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           +G G  G VYK     +      A K  +   + ++++F+ E+ ++ +    N+V L   
Sbjct: 13  LGDGAFGKVYKA--QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR-ITAETAGVLSYLHSETNVPIIHR 524
                   ++ EF   G L   + +      E ++R +  +    L++LHS     +IHR
Sbjct: 71  YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHR 127

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD---- 580
           D+K+ NILL  +   K++DFG S       +Q      GT  ++ PE +      D    
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNK-STLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186

Query: 581 -KSDVYSFGVVLVEL 594
            K+D++S G+ L+EL
Sbjct: 187 YKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 60/246 (24%), Positives = 110/246 (44%), Gaps = 26/246 (10%)

Query: 405 YADV--IGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           Y D+  +GCG +G V+     D    VAVKK    D   +   + E+ ++ +++  N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 462 L--------------LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETA 507
           +              +G   E     +V E++   T   ++ ++G LS E       +  
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME--TDLANVLEQGPLSEEHARLFMYQLL 124

Query: 508 GVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
             L Y+HS  NV  +HRD+K AN+ ++ E+   K+ DFG +++V         + +G + 
Sbjct: 125 RGLKYIHS-ANV--LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 567 --YLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN 623
             Y  P   L     T   D+++ G +  E+LTGK         E+  L +  +  +++ 
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241

Query: 624 RLLEIL 629
              E+L
Sbjct: 242 DRNELL 247

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 15/187 (8%)

Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHI 488
           +KK    D   ID    E  V    +    +  L  C +T+  L  V EFV  G L  H+
Sbjct: 28  IKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM 87

Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            ++  L  E     +AE +  L++LH      II+RD+K  N+LLD     K++D+G  K
Sbjct: 88  QRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144

Query: 549 --LVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK----MAL 601
             + P D     C    GT  Y+ PE L+        D ++ GV++ E++ G+    +  
Sbjct: 145 EGIRPGDTTSTFC----GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200

Query: 602 LSDKPEE 608
           +SD P++
Sbjct: 201 MSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 4e-11
 Identities = 43/123 (34%), Positives = 59/123 (47%), Gaps = 4/123 (3%)

Query: 484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
           LF ++ + G L  E+ + I       L+YLH      IIHRDVK+ NI LDE     + D
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGD 228

Query: 544 FGAS-KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           FGA+ KL        C    GTL    PE L       K+D++S G+VL E+    + L 
Sbjct: 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288

Query: 603 SDK 605
             +
Sbjct: 289 GKQ 291

Length = 392

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 64.1 bits (157), Expect = 4e-11
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 29/206 (14%)

Query: 409 IGCGGSGNVYKGFLPDR---TPVAVKKSKFVDQAKIDEFIN-----ELVVVLQINRRNVV 460
           +G G    VYK    D+     VA+KK K  ++ +  + IN     E+ ++ ++   N++
Sbjct: 8   LGEGTYAVVYKAR--DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR------ITAETAGVLSYLH 514
            LL          LV+EF+   T  E + K  ++     L           T   L YLH
Sbjct: 66  GLLDVFGHKSNINLVFEFME--TDLEKVIKDKSI----VLTPADIKSYMLMTLRGLEYLH 119

Query: 515 SETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYL 573
           S     I+HRD+K  N+L+  +   K++DFG A      +      VV  T  Y  PE L
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPELL 174

Query: 574 QTCKL-TDKSDVYSFGVVLVELLTGK 598
              +      D++S G +  ELL   
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 27/196 (13%)

Query: 423 PDRT-PVAVKKSKFVDQAK---IDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYE 477
           PD+T  VAVK  K  D A    + + I+E+ ++  I + +N++ LLG C +     ++ E
Sbjct: 41  PDQTVTVAVKMLK--DNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVE 98

Query: 478 FVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPI 521
           +   G L E +  +                  LS++  +    + A  + YL S      
Sbjct: 99  YAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---C 155

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
           IHRD+ + N+L+ E+   K++DFG ++ V  ID  +  +  +  + ++ PE L     T 
Sbjct: 156 IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH 215

Query: 581 KSDVYSFGVVLVELLT 596
           +SDV+SFG+++ E+ T
Sbjct: 216 QSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 66/223 (29%), Positives = 92/223 (41%), Gaps = 43/223 (19%)

Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKFVDQAKIDEF----INELVVVLQINRRNVVR 461
           IG G  G VY+    D T    VA+KK +  D  + D      + E+ ++L +   N+V 
Sbjct: 15  IGEGTYGIVYRA--RDTTSGEIVALKKVRM-DNER-DGIPISSLREITLLLNLRHPNIVE 70

Query: 462 LL----GCCLETQVPLLVYEFV---------GNGTLFEHIHKKGNLSWERRLRITAETAG 508
           L     G  L++    LV E+             T F     K          +  +   
Sbjct: 71  LKEVVVGKHLDSI--FLVMEYCEQDLASLLDNMPTPFSESQVKC---------LMLQLLR 119

Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGY 567
            L YLH      IIHRD+K +N+LL +    K++DFG A             VV  TL Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWY 174

Query: 568 LDPEYLQTCKLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEE 609
             PE L  C     + D+++ G +L ELL  K  LL  K E E
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK-PLLPGKSEIE 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 50/176 (28%), Positives = 90/176 (51%), Gaps = 27/176 (15%)

Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI------HKKGN-- 493
           ++F+ E+ ++ ++   N++RLLG C++     ++ E++ NG L + +       K+ N  
Sbjct: 64  NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123

Query: 494 -----------LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVS 542
                      +S+   L +  + A  + YL S   +  +HRD+ + N L+ EN T K++
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIA 180

Query: 543 DFGASK-LVPID--AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELL 595
           DFG S+ L   D   IQ   V+   + ++  E +   K T  SDV++FGV L E+L
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVL--PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 9/157 (5%)

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWE--RRLR 501
           +NE  ++ ++N R VV L     ET+  L LV   +  G L  HI+  GN  ++  R + 
Sbjct: 48  LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF 106

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
             AE    L  LH E    I++RD+K  NILLD+    ++SD G +  +P        V 
Sbjct: 107 YAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV- 162

Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            GT+GY+ PE ++  + T   D +  G ++ E++ GK
Sbjct: 163 -GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 67/277 (24%), Positives = 123/277 (44%), Gaps = 39/277 (14%)

Query: 426 TPVAVK--KSKFVDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNG 482
             VAVK  K    D+  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G
Sbjct: 45  VTVAVKMLKDDATDK-DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG 103

Query: 483 TLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
            L E++  +                  L+++  +    + A  + YL S+     IHRD+
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDL 160

Query: 527 KSANILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
            + N+L+ E+   K++DFG ++ V  ID  +  T  +  + ++ PE L     T +SDV+
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220

Query: 586 SFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV 645
           SFGV+L E+ T   +     P EE               L ++L      D       E+
Sbjct: 221 SFGVLLWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTHEL 265

Query: 646 AKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQY 682
             +   C      +RPT K++  +L   L++ S  +Y
Sbjct: 266 YMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEY 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 62.5 bits (152), Expect = 8e-11
 Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 10/164 (6%)

Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERR- 499
           +E   E+ V+  +   N+V+      E     +V ++   G L++ I+  +G L  E + 
Sbjct: 44  EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI 103

Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV--PIDAIQN 557
           L    +    L ++H      I+HRD+KS NI L ++ T K+ DFG ++++   ++  + 
Sbjct: 104 LDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160

Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL 601
           C    GT  YL PE  +     +KSD+++ G VL E+ T K A 
Sbjct: 161 CI---GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 62.9 bits (153), Expect = 9e-11
 Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 9/157 (5%)

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGN--LSWERRLR 501
           +NE  ++ +++ R +V L     ET+  L LV   +  G L  HI+  G       R + 
Sbjct: 41  LNEKKILEKVSSRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF 99

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
             A+    L +LH      I++RD+K  N+LLD++   ++SD G +  V +   +     
Sbjct: 100 YAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR 154

Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            GT GY+ PE LQ        D ++ G  L E++ G+
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 11/150 (7%)

Query: 463 LGCCLETQVPLL-VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L CC +T+  L  V E+V  G L   I +       R     AE    L +LH      +
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---V 117

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN---CTVVQGTLGYLDPEYLQTCKL 578
           I+RD+K  NILLD     K++DFG  K    + I N    T   GT  Y+ PE LQ  + 
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCK----EGILNGVTTTTFCGTPDYIAPEILQELEY 173

Query: 579 TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
               D ++ GV++ E++ G+    +D  ++
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDD 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 1e-10
 Identities = 40/95 (42%), Positives = 54/95 (56%), Gaps = 9/95 (9%)

Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL----VPIDAIQN-CTVVQG 563
           VL  +H   +  +IHRD+KSANILL  N   K+ DFG SK+    V  D  +  C    G
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC----G 207

Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           T  Y+ PE  +    + K+D++S GV+L ELLT K
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242

Length = 496

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 82/291 (28%), Positives = 116/291 (39%), Gaps = 51/291 (17%)

Query: 407 DVIGCGGSGNVYKG---FLPDRTPVAVKKSKFVDQAKIDE---FINELVVVLQINRRNVV 460
           D IG G  G V  G       +  V VK+ +    A  DE   F+ E+    ++N  NV+
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELR--ASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 461 RLLGCCLETQVPLLVYEFVGNGTL-----FEHIHKKGNLSWERRLRITAETAGVLSYLHS 515
           + LG C+E+   LLV EF   G L                 +   R+  E A  L +LH 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAI--QNCTVVQGTLGYLDPEY 572
                 IH D+   N  L  + + K+ D+G A +  P D    ++C  V   L +L PE 
Sbjct: 119 AD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV--PLRWLAPEL 173

Query: 573 -------LQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL 625
                  L     T KS+++S GV + EL T      +D+P  + S        LKQ   
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLS----DEQVLKQV-- 222

Query: 626 LEILDNRIVNDGNKQQLKEVAKLAARCISV------RGEERPTMKEVSLEL 670
             + +  I     K QL    K + R   V        E RPT +EV   L
Sbjct: 223 --VREQDIKLP--KPQLDL--KYSDRWYEVMQFCWLDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 9/157 (5%)

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSW--ERRLR 501
           +NE  ++ ++N R VV L     ET+  L LV   +  G L  HI+  GN  +  +R + 
Sbjct: 48  LNEKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF 106

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
             AE    L  L  E    I++RD+K  NILLD+    ++SD G +  +P        V 
Sbjct: 107 YAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV- 162

Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            GT+GY+ PE +   K T   D +  G ++ E++ G+
Sbjct: 163 -GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 41/127 (32%), Positives = 65/127 (51%), Gaps = 10/127 (7%)

Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           L+ E++  G LF H+ ++G    +      +E +  L +LH +    II+RD+K  NILL
Sbjct: 77  LILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILL 133

Query: 534 DENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLGYLDPEYLQTCKLTDKSDVYSFGVV 590
           D     K++DFG  K    ++I   TV     GT+ Y+ PE L         D +S G +
Sbjct: 134 DAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGAL 189

Query: 591 LVELLTG 597
           + ++LTG
Sbjct: 190 MYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 7/156 (4%)

Query: 446 NELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNL--SWERRLRIT 503
            E++++ ++   N+V       E     +V E+   G L + I+++  +  S ++ L   
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDEN-CTPKVSDFGASKLVPIDAIQNCTVVQ 562
            + +  L ++H      I+HRD+KS NI L +N    K+ DFG ++ +  D+++      
Sbjct: 108 VQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCV 163

Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           GT  YL PE  Q     +K+D++S G VL EL T K
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 45/126 (35%), Positives = 62/126 (49%), Gaps = 7/126 (5%)

Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           LV +++  G LF H+ K+G  S +R     AE    L +LH      I++RD+K  NILL
Sbjct: 73  LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILL 129

Query: 534 DENCTPKVSDFGASKL-VPIDAIQNCTVVQGTLGYLDPEYLQTCK-LTDKSDVYSFGVVL 591
           D      + DFG SK  +  +   N     GT  YL PE L   K  T   D +S GV++
Sbjct: 130 DATGHIALCDFGLSKANLTDNKTTNTFC--GTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187

Query: 592 VELLTG 597
            E+  G
Sbjct: 188 FEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 41/210 (19%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFV-----DQAKIDEFINELVVVLQINRRNVVRL 462
           IG G  G VYK    P     A+K    V     +     +   E+ ++  +N  NVV+ 
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALK----VIYGNHEDTVRRQICREIEILRDVNHPNVVK- 136

Query: 463 LGCCL-------ETQVPLLVYEFVGNGTL-FEHIHKKGNLSWERRLRITAETAGVLSYLH 514
              C        E QV L   EF+  G+L   HI  +  L+   R  ++      ++YLH
Sbjct: 137 ---CHDMFDHNGEIQVLL---EFMDGGSLEGTHIADEQFLADVARQILSG-----IAYLH 185

Query: 515 SETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ 574
                 I+HRD+K +N+L++     K++DFG S+++    +  C    GT+ Y+ PE + 
Sbjct: 186 RRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA-QTMDPCNSSVGTIAYMSPERIN 241

Query: 575 TCKLTD------KSDVYSFGVVLVELLTGK 598
           T  L          D++S GV ++E   G+
Sbjct: 242 T-DLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 4/109 (3%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L YLHS     I+HRD+K  N+L++ NC  K+ DFG +++   D  ++ T    T  Y  
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 570 PEYLQTCK-LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL 617
           PE L   +  T   D++S G +  ELL  ++   +  P ++  L  + L
Sbjct: 173 PEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLL 221

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 31/205 (15%)

Query: 409 IGCGGSGNVYKGFLPDRT---PVAVKKSKFVDQAKIDEFINELVV----VLQ-INRRNVV 460
           IG G  G V+K    DR     VA+KK   V   +++  I    +     LQ      VV
Sbjct: 8   IGEGAHGIVFKAK--DRETGETVALKK---VALRRLEGGIPNQALREIKALQACQHPYVV 62

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV-------LSYL 513
           +LL         +LV E++    L E +        E R    A+           ++Y+
Sbjct: 63  KLLDVFPHGSGFVLVMEYMP-SDLSEVLRD------EERPLPEAQVKSYMRMLLKGVAYM 115

Query: 514 HSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL 573
           H+     I+HRD+K AN+L+  +   K++DFG ++L   +  +  +    T  Y  PE L
Sbjct: 116 HANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 574 QTCKLTDKS-DVYSFGVVLVELLTG 597
              +  D   D+++ G +  ELL G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 51/222 (22%)

Query: 408 VIGCGGSGNVYKGFL------PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVV 460
            +G G  G VY+G             VAVK       +    +F+ E +++ + N +N+V
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN-------LSWERRLRITAETAGVLSYL 513
           RL+G   E     ++ E +  G L   + +          L+ +  L    + A    YL
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 514 HSETNVPIIHRDVKSANILLDENCT-----PKVSDFGASK--------------LVPIDA 554
             E N   IHRD+ + N LL   C       K++DFG ++              ++PI  
Sbjct: 133 --EEN-HFIHRDIAARNCLL--TCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK- 186

Query: 555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                       ++ PE       T K+DV+SFGV+L E+ +
Sbjct: 187 ------------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 44/137 (32%), Positives = 67/137 (48%), Gaps = 5/137 (3%)

Query: 463 LGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L  C +T   L  V E+V  G L  HI + G     + +   AE +  L +LH      I
Sbjct: 66  LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---I 122

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           I+RD+K  N++LD     K++DFG  K   +D +   T   GT  Y+ PE +        
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEIIAYQPYGKS 181

Query: 582 SDVYSFGVVLVELLTGK 598
            D +++GV+L E+L G+
Sbjct: 182 VDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 51/166 (30%), Positives = 73/166 (43%), Gaps = 32/166 (19%)

Query: 465 CCLETQVPL-LVYEFVGNG---TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           C  ET+  L +V E+V  G   TL ++I   G L  +      AET   L YLH   N  
Sbjct: 68  CSFETKRHLCMVMEYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLH---NYG 121

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV------------------VQ 562
           I+HRD+K  N+L+      K++DFG SK+     + + T                   V 
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDTREFLDKQVC 177

Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  Y+ PE +         D ++ G++L E L G +    D PEE
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 42/124 (33%), Positives = 59/124 (47%), Gaps = 4/124 (3%)

Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
            V ++V  G LF H+ ++      R     AE A  + YLHS     II+RD+K  NILL
Sbjct: 73  FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILL 129

Query: 534 DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVE 593
           D      ++DFG  K   ++  +  +   GT  YL PE L+        D +  G VL E
Sbjct: 130 DSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYE 188

Query: 594 LLTG 597
           +L G
Sbjct: 189 MLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)

Query: 405 YADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKID-EFINELVVVLQINRRNVVRL 462
           Y +++G G  G VYK + L  R  +AVK        ++  + ++EL ++ + +   ++  
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNVPI 521
            G         +  EF+  G+L   +++K     E  L RI       L+YL S   + I
Sbjct: 65  YGAFFVENRISICTEFMDGGSL--DVYRKIP---EHVLGRIAVAVVKGLTYLWS---LKI 116

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           +HRDVK +N+L++     K+ DFG S  + +++I    V  GT  Y+ PE +   +    
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYV--GTNAYMAPERISGEQYGIH 173

Query: 582 SDVYSFGVVLVELLTGK 598
           SDV+S G+  +EL  G+
Sbjct: 174 SDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 61.3 bits (149), Expect = 6e-10
 Identities = 40/123 (32%), Positives = 59/123 (47%), Gaps = 7/123 (5%)

Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
           TAE    L  +HS   +  IHRDVK  N+LLD++   K++DFG    +  + +  C    
Sbjct: 148 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204

Query: 563 GTLGYLDPEYLQTCKLTD----KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
           GT  Y+ PE L++         + D +S GV L E+L G     +D      S  M+  +
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN 264

Query: 619 SLK 621
           SL 
Sbjct: 265 SLT 267

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 48/150 (32%), Positives = 65/150 (43%), Gaps = 4/150 (2%)

Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
            V +++  G LF H+ ++      R     AE A  L YLHS   + I++RD+K  NILL
Sbjct: 73  FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILL 129

Query: 534 DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVE 593
           D      ++DFG  K   I+     +   GT  YL PE L         D +  G VL E
Sbjct: 130 DSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 188

Query: 594 LLTGKMALLSDKPEEERSLAMNFLSSLKQN 623
           +L G     S    E     +N    LK N
Sbjct: 189 MLYGLPPFYSRNTAEMYDNILNKPLQLKPN 218

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 60.9 bits (148), Expect = 8e-10
 Identities = 53/187 (28%), Positives = 78/187 (41%), Gaps = 16/187 (8%)

Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRN---VVRLLGCCLETQVPLLVYEFVGNGTLF 485
           A+KK   + + +++  + E  +    N      +V L  C         V E+   G L 
Sbjct: 31  ALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLM 90

Query: 486 EHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
            HIH   ++  E R     A     L YLH      I++RD+K  N+LLD     K++DF
Sbjct: 91  MHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADF 145

Query: 545 GASK--LVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL 601
           G  K  +   D     C    GT  +L PE L     T   D +  GV++ E+L G+   
Sbjct: 146 GLCKEGMGFGDRTSTFC----GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201

Query: 602 LSDKPEE 608
             D  EE
Sbjct: 202 PGDDEEE 208

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 25/200 (12%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGC 465
           +G G  G VYK    ++   A+  +K ++   + ++++++ E+ ++   N   +V+LLG 
Sbjct: 20  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR------ITAETAGVLSYLHSETNV 519
                   ++ EF   G +   +     L  +R L       I  +    L YLHS    
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIM-----LELDRGLTEPQIQVICRQMLEALQYLHSMK-- 130

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
            IIHRD+K+ N+LL  +   K++DFG S    +  +Q      GT  ++ PE +    + 
Sbjct: 131 -IIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 580 D-----KSDVYSFGVVLVEL 594
           D     K+D++S G+ L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.0 bits (145), Expect = 8e-10
 Identities = 82/272 (30%), Positives = 120/272 (44%), Gaps = 53/272 (19%)

Query: 408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL--GC 465
           +IG GG G VY     D   +   K   +D+ +I     E    L +N R ++ L+  G 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGE---TLALNERIMLSLVSTGD 55

Query: 466 C---------LETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLH 514
           C           T   L  + + +  G L  H+ + G  S E+ +R    E    L ++H
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-EKEMRFYATEIILGLEHMH 114

Query: 515 SETNVPIIHRDVKSANILLDENCTPKVSDFGA----SKLVPIDAIQNCTVVQGTLGYLDP 570
              N  +++RD+K ANILLDE+   ++SD G     SK  P  ++       GT GY+ P
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-------GTHGYMAP 164

Query: 571 EYLQTCKLTDKS-DVYSFGVVLVELLTG----KMALLSDKPEEER-SLAMN------FLS 618
           E LQ     D S D +S G +L +LL G    +     DK E +R +L +N      F  
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSP 224

Query: 619 SLKQNRLLEILDNRIVND------GNKQQLKE 644
            LK   LLE L  R V+          Q++KE
Sbjct: 225 ELKS--LLEGLLQRDVSKRLGCLGRGAQEVKE 254

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 40/229 (17%)

Query: 407 DVIGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQA---KIDEFINELVVVLQINRRN 458
           D++  G  G ++ G L D  P     V VK  K  D A   ++   + E  ++  ++ +N
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK--DHASEIQVTLLLQESCLLYGLSHQN 69

Query: 459 VVRLLGCCLE-TQVPLLVYEF--VGNGTLFEHIHKKGNLSWERRLR------ITAETAGV 509
           ++ +L  C+E  + P ++Y +   GN  LF    + G  +  + L       +  + A  
Sbjct: 70  ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK-LVPIDAIQNCTVVQGTLG-- 566
           +SYLH      +IH+D+ + N ++DE    K++D   S+ L P+D   +C      LG  
Sbjct: 130 MSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMD--YHC------LGDN 178

Query: 567 ------YLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEE 608
                 ++  E L   + +  SDV+SFGV+L EL+T G+   +   P E
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 21/201 (10%)

Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVRLL 463
           IG G  G VYK    ++     VA+KK +   + +      I E+ ++ ++N  N+V+LL
Sbjct: 8   IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65

Query: 464 GCCLETQVPL-LVYEFVGNGTL--FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
              + T+  L LV+EF+ +  L  F        +          +    L++ HS     
Sbjct: 66  DV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--- 120

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L  CK 
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEILLGCKY 177

Query: 579 -TDKSDVYSFGVVLVELLTGK 598
            +   D++S G +  E++T +
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 21/212 (9%)

Query: 400 TVTNNYADV--IGCGGSGNVYKGF--LPDRTPVAVKK--SKFVDQAKIDEFINELVVVLQ 453
           TV   Y ++  IG G  G V   +  + DR  VA+KK    F +Q        ELV++  
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRAYRELVLMKC 72

Query: 454 INRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETA 507
           +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  +  
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQML 129

Query: 508 GVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGY 567
             + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  Y
Sbjct: 130 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYY 184

Query: 568 LDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
             PE +      +  D++S G ++ E++  K+
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 34/97 (35%), Positives = 52/97 (53%), Gaps = 5/97 (5%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L YLH++    IIHRDVK+ NI +++     + D GA++  P+ A      + GT+    
Sbjct: 170 LRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVA-PAFLGLAGTVETNA 224

Query: 570 PEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           PE L   K   K+D++S G+VL E+L     +  D P
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261

Length = 357

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 78/269 (28%), Positives = 114/269 (42%), Gaps = 47/269 (17%)

Query: 408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLG--- 464
           +IG GG G VY     D   +   K   +D+ +I     E    L +N R ++ L+    
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGE---TLALNERIMLSLVSTGD 55

Query: 465 ----CCLET--QVP---LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHS 515
                C+      P     + + +  G L  H+ + G  S        AE    L ++H 
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH- 114

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGA----SKLVPIDAIQNCTVVQGTLGYLDPE 571
             N  +++RD+K ANILLDE+   ++SD G     SK  P  ++       GT GY+ PE
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-------GTHGYMAPE 165

Query: 572 YLQTCKLTDKS-DVYSFGVVLVELLTG----KMALLSDKPEEER-SLAMNFL----SSLK 621
            LQ     D S D +S G +L +LL G    +     DK E +R +L M        S +
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 225

Query: 622 QNRLLEILDNRIVND------GNKQQLKE 644
              LLE L  R VN          Q++KE
Sbjct: 226 LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 13/205 (6%)

Query: 409 IGCGGSGNVYKGFLPDRTPVA----VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +G GG G V+     D   +     +KKS      ++   + E  ++       +V+LL 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIH 523
              + +   L  E+V  G     ++  G LS E   R   AE    +  LH    +  IH
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS-EDHARFYMAEMFEAVDALH---ELGYIH 124

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+K  N L+D +   K++DFG SK      +     V G+  Y+ PE L+        D
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYDFTVD 180

Query: 584 VYSFGVVLVELLTGKMALLSDKPEE 608
            +S G +L E L G        P E
Sbjct: 181 YWSLGCMLYEFLCGFPPFSGSTPNE 205

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 72/244 (29%), Positives = 106/244 (43%), Gaps = 25/244 (10%)

Query: 382 LHGQSSEKAKIFTEEEIKTVTNNY--ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQA 439
           L+G     + +   E +   T+ +   + IG G  G VYK  + ++   ++   K +D  
Sbjct: 1   LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYK--VTNKKDGSLAAVKILDPI 58

Query: 440 K-IDEFINELVVVLQI--NRRNVVRLLGC------CLETQVPLLVYEFVGNGTLFEHIHK 490
             +DE I     +LQ   N  NVV+  G        +  Q+  LV E    G++ E +  
Sbjct: 59  SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELV-- 115

Query: 491 KGNLSWERRLR---ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           KG L   +RL    I+    G L  L    N  IIHRDVK  NILL      K+ DFG S
Sbjct: 116 KGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175

Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS-----DVYSFGVVLVELLTGKMALL 602
             +    ++  T V GT  ++ PE +   +  D S     DV+S G+  +EL  G   L 
Sbjct: 176 AQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234

Query: 603 SDKP 606
              P
Sbjct: 235 DMHP 238

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 60.9 bits (147), Expect = 2e-09
 Identities = 66/249 (26%), Positives = 111/249 (44%), Gaps = 47/249 (18%)

Query: 443 EFINELVVVLQINRRNVVRLLGCCLE--TQVPLLVYEFVGNGTLFEHIHKK----GNLSW 496
           + + E+ V+ ++  +N+VR +   L    Q   ++ EF   G L  +I K     G +  
Sbjct: 58  QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117

Query: 497 ERRLRITAETAGVLSYLHSETNVP----IIHRDVKSANILLDE---------------NC 537
              + IT +    L+Y H+  + P    ++HRD+K  NI L                 N 
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 538 TP--KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL--QTCKLTDKSDVYSFGVVLVE 593
            P  K+ DFG SK + I+++ +  V  GT  Y  PE L  +T    DKSD+++ G ++ E
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235

Query: 594 LLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCI 653
           L +GK       P  + +     +S LK+   L I          K + KE+  L    +
Sbjct: 236 LCSGK------TPFHKANNFSQLISELKRGPDLPI----------KGKSKELNILIKNLL 279

Query: 654 SVRGEERPT 662
           ++  +ERP+
Sbjct: 280 NLSAKERPS 288

Length = 1021

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 65/284 (22%), Positives = 124/284 (43%), Gaps = 59/284 (20%)

Query: 409 IGCGGSGNVYKGFLPD--------RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVV 460
           +G G    ++KG   +        +T V +K      +   + F     ++ Q++ +++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNL---SWERRLRITAETAGVLSYLHSET 517
              G C+     ++V E+V  G+L  ++ K  NL   SW  +L +  + A  L +L  + 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 518 NVPIIHRDVKSANILL-----DENCTP---KVSDFGASKLV-PIDAIQNCTVVQGTLGYL 568
              + H +V + N+LL      +   P   K+SD G S  V P +      ++   + ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIPWV 171

Query: 569 DPEYLQTCK-LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE 627
            PE ++  + L+  +D +SFG  L E+ +G      DKP          LS+L   + L+
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKP----------LSALDSQKKLQ 216

Query: 628 ILDNRIVNDGNKQQL-----KEVAKLAARCISVRGEERPTMKEV 666
             ++R        QL      E+A L  +C+    + RP+ + +
Sbjct: 217 FYEDR-------HQLPAPKWTELANLINQCMDYEPDFRPSFRAI 253

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 12/92 (13%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTVVQGTLGY 567
           L Y+HS     ++HRD+K +NIL++ENC  K+ DFG ++      IQ+   T    T  Y
Sbjct: 121 LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR------IQDPQMTGYVSTRYY 171

Query: 568 LDPEYLQTCKLTD-KSDVYSFGVVLVELLTGK 598
             PE + T +  D + D++S G +  E+L GK
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 38/225 (16%)

Query: 453 QINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLS 511
           Q++ +++V L G C+     ++V EFV  G L   +H+K + L+   + ++  + A  LS
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS 119

Query: 512 YLHSETNVPIIHRDVKSANILL-----DENCTP--KVSDFGASKLVPIDAIQNCTVVQGT 564
           YL  +    ++H +V + NILL     D  C P  K+SD G    +PI  +     V+  
Sbjct: 120 YLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG----IPITVLSRQECVE-R 171

Query: 565 LGYLDPEYLQTCK-LTDKSDVYSFGVVLVELLTGKMALLSDKP--EEERSLAMNFLSSLK 621
           + ++ PE ++  K L+  +D +SFG  L E+       L DK   E+ER      +    
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLV-- 229

Query: 622 QNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                                KE+A L   C++    +RP  + +
Sbjct: 230 -----------------TPSCKELADLMTHCMNYDPNQRPFFRAI 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 22/195 (11%)

Query: 474 LVYEFVGNGTLFEHI-HKKGNLSWERR-LRITAETAGVLSYLHSETNVPIIHRDVKSANI 531
           +V  F   G L+  +  +KG L  E + +    + A  L YLH +    I+HRD+K+ N+
Sbjct: 77  IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNV 133

Query: 532 LLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVL 591
            L      KV D G ++++        T++ GT  Y+ PE         KSDV++ G  +
Sbjct: 134 FLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYNYKSDVWALGCCV 192

Query: 592 VELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAAR 651
            E+ T K A          +  MN L       +  I++ ++     K    E+ +L A 
Sbjct: 193 YEMATLKHAF--------NAKDMNSL-------VYRIIEGKL-PPMPKDYSPELGELIAT 236

Query: 652 CISVRGEERPTMKEV 666
            +S R E+RP++K +
Sbjct: 237 MLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 21/212 (9%)

Query: 400 TVTNNYADV--IGCGGSGNVYKGF--LPDRTPVAVKK--SKFVDQAKIDEFINELVVVLQ 453
           TV   Y ++  IG G  G V   +  + +R  VA+KK    F +Q        ELV++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKC 79

Query: 454 INRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETA 507
           +N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  +  
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQML 136

Query: 508 GVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGY 567
             + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  Y
Sbjct: 137 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYY 191

Query: 568 LDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
             PE +      +  D++S G ++ E++ G +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 6/115 (5%)

Query: 513 LHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
           +HS   +  +HRD+K  N+L+D     K++DFG++  +  + + N  +  GT  Y+ PE 
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Query: 573 LQTCKLTDKS------DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK 621
           L T     K       D +S GV+  E++ G+         +  +  MNF   LK
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK 229

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 5e-09
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 6/92 (6%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGY 567
           L Y+HS  NV  +HRD+K +N+LL+ NC  K+ DFG +++   +      + +   T  Y
Sbjct: 119 LKYIHS-ANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175

Query: 568 LDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
             PE +   K   K+ D++S G +L E+L+ +
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 41/122 (33%), Positives = 59/122 (48%), Gaps = 7/122 (5%)

Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
           TAE    L  +HS   +  IHRDVK  N+LLD++   K++DFG    +  + +  C    
Sbjct: 148 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204

Query: 563 GTLGYLDPEYLQT----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
           GT  Y+ PE L++         + D +S GV L E+L G     +D      S  MN  +
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 264

Query: 619 SL 620
           SL
Sbjct: 265 SL 266

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.9 bits (142), Expect = 5e-09
 Identities = 46/137 (33%), Positives = 67/137 (48%), Gaps = 24/137 (17%)

Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSY--------LHSETNVPIIHR 524
           LL+ E+   G L + I ++     +  L       G+L Y        +HS     ++HR
Sbjct: 141 LLIMEYGSGGDLNKQIKQR----LKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHR 193

Query: 525 DVKSANILLDENCTPKVSDFGASKL----VPIDAIQN-CTVVQGTLGYLDPEYLQTCKLT 579
           D+KSANI L      K+ DFG SK     V +D   + C    GT  YL PE  +  + +
Sbjct: 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC----GTPYYLAPELWERKRYS 249

Query: 580 DKSDVYSFGVVLVELLT 596
            K+D++S GV+L ELLT
Sbjct: 250 KKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 7e-09
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 23/202 (11%)

Query: 409 IGCGGSGNVYKG--FLPDRTPVAVKKSKFVDQAKIDE-----FINELVVVLQINRRNVVR 461
           IG G  G VYK    L     VA+KK +   +   DE      I E+ ++ ++N  N+VR
Sbjct: 7   IGEGTYGVVYKARDKLTGEI-VALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVR 62

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRL--RITAETAGVLSYLHSETNV 519
           LL          LV+EF+ +  L +++        +  L      +    ++Y HS    
Sbjct: 63  LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
            ++HRD+K  N+L+D     K++DFG ++   VP+    +  V   TL Y  PE L   +
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEILLGSR 175

Query: 578 LTDKS-DVYSFGVVLVELLTGK 598
                 D++S G +  E++  +
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 57.8 bits (140), Expect = 7e-09
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 23/212 (10%)

Query: 400 TVTNNYAD--VIGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y +   IG G  G V   Y         VA+KK    F +         ELV++ 
Sbjct: 13  TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQN--VAIKKLSRPFQNVTHAKRAYRELVLMK 70

Query: 453 QINRRNVVRLLGC-----CLET-QVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL        LE  Q   LV E + +  L + I    +L  ER   +  + 
Sbjct: 71  LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM--DLDHERMSYLLYQM 127

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 128 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 182

Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           Y  PE +      +  D++S G ++ E++ G 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 15/195 (7%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGC 465
           +G G  G VYK    ++    +  +K +D   + ++++++ E+ ++   +  N+V+LL  
Sbjct: 13  LGDGAFGKVYKA--QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITA-ETAGVLSYLHSETNVPIIHR 524
                   ++ EF   G +   + +      E ++R+   +T   L+YLH      IIHR
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHR 127

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD---- 580
           D+K+ NIL   +   K++DFG S       IQ      GT  ++ PE +      D    
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186

Query: 581 -KSDVYSFGVVLVEL 594
            K+DV+S G+ L+E+
Sbjct: 187 YKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 57.6 bits (140), Expect = 8e-09
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 8/94 (8%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQ---GTL 565
           L Y+HS     +IHRD+K +NILL+ +C  K++DFG A  L  ++      V+     T 
Sbjct: 120 LKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 566 GYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
            Y  PE L       K  D++S G +L E+L GK
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 57.7 bits (140), Expect = 9e-09
 Identities = 35/96 (36%), Positives = 48/96 (50%), Gaps = 20/96 (20%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +NI ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 131 LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRA 183

Query: 570 PE-------YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE       Y QT       D++S G ++ ELLTGK
Sbjct: 184 PEIMLNWMHYNQTV------DIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.4 bits (139), Expect = 9e-09
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 5/90 (5%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     ++HRD+K +N+LL+ NC  K+ DFG ++    +     T    T  Y  
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRA 176

Query: 570 PEYLQTC-KLTDKSDVYSFGVVLVELLTGK 598
           PE L  C + T   DV+S G +  ELL  K
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 56.8 bits (138), Expect = 1e-08
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 36/208 (17%)

Query: 409 IGCGGSGNVYKGFLPDRTP---VAVK--KSKFVDQAKIDEFIN--ELVVVLQINR-RNVV 460
           +G G  G+VY     ++     VA+K  K KF      +E +N  E+  + ++N   N+V
Sbjct: 7   LGDGTFGSVYLA--RNKETGELVAIKKMKKKF---YSWEECMNLREVKSLRKLNEHPNIV 61

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHI-HKKGNLSWERRLR-ITAETAGVLSYLHSETN 518
           +L     E      V+E++  G L++ +  +KG    E  +R I  +    L+++H    
Sbjct: 62  KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG- 119

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC---TVVQGTLGYLDPEYLQT 575
               HRD+K  N+L+      K++DFG ++      I++    T    T  Y  PE L  
Sbjct: 120 --FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVSTRWYRAPEIL-- 170

Query: 576 CKLTDKS-----DVYSFGVVLVELLTGK 598
             L   S     D+++ G ++ EL T +
Sbjct: 171 --LRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 15/177 (8%)

Query: 428 VAVKKSKFVDQAKIDEF----INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT 483
           VA+KK  F++           + E+ ++ Q+   N+V L+      +   LV+EFV +  
Sbjct: 29  VAIKK--FLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86

Query: 484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
           L +       L   R  +   +    + + HS     IIHRD+K  NIL+ ++   K+ D
Sbjct: 87  LDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCD 143

Query: 544 FGASKLV--PIDAIQNCTVVQGTLGYLDPEYL-QTCKLTDKSDVYSFGVVLVELLTG 597
           FG ++ +  P +     T    T  Y  PE L    K     D+++ G ++ E+LTG
Sbjct: 144 FGFARTLAAPGEV---YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 31/226 (13%)

Query: 397 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTP------VAVKKSKFVDQAKI---DEFINE 447
           EI   T  + + +G    G VYKG L    P      VA+K  K  D+A+    +EF +E
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK--DKAEGPLREEFKHE 58

Query: 448 LVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI-----HK-----------K 491
            ++  ++   N+V LLG   + Q   +++ +  +  L E +     H            K
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV- 550
             L     + I  + A  + +L S     ++H+D+ + N+L+ +    K+SD G  + V 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
             D  +        + ++ PE +   K +  SD++S+GVVL E+ +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 46/153 (30%), Positives = 65/153 (42%), Gaps = 16/153 (10%)

Query: 458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           N+V L    +      LV +    G L+ HI K  N+  E   R  AE    L  LH E 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI----DAIQNCTVVQGTLGYLDPEYL 573
              I+ RD+   NILLD+    +++ F     V      +A++N         Y  PE  
Sbjct: 106 ---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM--------YCAPEVG 154

Query: 574 QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
              + T+  D +S G +L ELLTG   L+   P
Sbjct: 155 GISEETEACDWWSLGAILFELLTG-KTLVECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 37/225 (16%)

Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K+  +++ ++     E  ++++ +   VV++     + +   L+ EF+  G +   + 
Sbjct: 34  LRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM 93

Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           KK  LS E      AET   +  +H    +  IHRD+K  N+LLD     K+SDFG    
Sbjct: 94  KKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150

Query: 550 V----------------PID-AIQNCTVVQ-----------------GTLGYLDPEYLQT 575
           +                P D + QN    +                 GT  Y+ PE    
Sbjct: 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ 210

Query: 576 CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
                  D +S GV++ E+L G     S+ P+E     MN+  +L
Sbjct: 211 TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETL 255

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 37/225 (16%)

Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K+  +++ ++     E  ++++ +   VV++     +     L+ EF+  G +   + 
Sbjct: 34  LRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM 93

Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG---- 545
           KK  L+ E      AET   +  +H    +  IHRD+K  N+LLD     K+SDFG    
Sbjct: 94  KKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150

Query: 546 ------------ASKLVPID-AIQNCTVVQ-----------------GTLGYLDPEYLQT 575
                        +  +P D   QN    +                 GT  Y+ PE    
Sbjct: 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ 210

Query: 576 CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
                  D +S GV++ E+L G     S+ P+E     MN+  +L
Sbjct: 211 TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETL 255

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 40/122 (32%), Positives = 59/122 (48%), Gaps = 7/122 (5%)

Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
           TAE    L  +HS   + +IHRDVK  N+LLD++   K++DFG    +    +  C    
Sbjct: 148 TAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204

Query: 563 GTLGYLDPEYLQT----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
           GT  Y+ PE L++         + D +S GV L E+L G     +D      S  M+  +
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN 264

Query: 619 SL 620
           SL
Sbjct: 265 SL 266

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 28/223 (12%)

Query: 393 FTEEEIKT---VTNNYADV--IGCGGSGNVYKGFLPDRT--PVAVKK--SKFVDQAKIDE 443
           + +E  KT   V + Y D+  +G G  G V    L  RT   VA+KK    F  +     
Sbjct: 2   YRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKR 60

Query: 444 FINELVVVLQINRRNVVRLLGCCLETQVPL-------LVYEFVGNGTLFEHIHKKGNLSW 496
              EL ++  +   NV+ LL       + L       LV  F+G  T    + K   LS 
Sbjct: 61  AYRELRLLKHMKHENVIGLLDV-FTPDLSLDRFHDFYLVMPFMG--TDLGKLMKHEKLSE 117

Query: 497 ERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ 556
           +R   +  +    L Y+H+     IIHRD+K  N+ ++E+C  K+ DFG ++    D+  
Sbjct: 118 DRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQT--DSEM 172

Query: 557 NCTVVQGTLGYLDPEY-LQTCKLTDKSDVYSFGVVLVELLTGK 598
              VV  T  Y  PE  L     T   D++S G ++ E+LTGK
Sbjct: 173 TGYVV--TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 7/90 (7%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L Y+HS     +IHRD+K +N+L++E+C  ++ DFG ++ +     ++   +     T  
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 567 YLDPEYLQTC-KLTDKSDVYSFGVVLVELL 595
           Y  PE L +  + T   D++S G +  E+L
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 5/108 (4%)

Query: 513 LHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
           +HS   +  +HRD+K  N+LLD N   +++DFG+   +  D     +V  GT  Y+ PE 
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174

Query: 573 LQTC-----KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
           LQ       K   + D +S GV + E+L G+    ++   E     MN
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 18/164 (10%)

Query: 438 QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGN--L 494
           + +I E +N   +V           L    E++  L LV   +  G L  HI+  G   L
Sbjct: 43  EKEILEKVNSPFIVN----------LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL 92

Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             ER +  +A+    + +LHS   + I++RD+K  N+LLD+    ++SD G +  V +  
Sbjct: 93  EMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKD 147

Query: 555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            +  T   GT GY+ PE L+    +   D ++ G  + E++ G+
Sbjct: 148 GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 33/214 (15%)

Query: 407 DVIGCGGSGNVYKGFLPDRTP-VAVKKSKFVDQAKIDEF----INELVVVLQINRRNVVR 461
             IG G  G VYK    D    VA+KK + +D  K + F    I E+ ++ Q+N RN+V 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVR-LDNEK-EGFPITAIREIKILRQLNHRNIVN 70

Query: 462 LLGCCLETQVPL----------LVYEFVGNGT--LFE----HIHKKGNLSWERRLRITAE 505
           L     + Q  L          LV+E++ +    L E    H  +    S+ ++L     
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL----- 125

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL 565
             G L+Y H +     +HRD+K +NILL+     K++DFG ++L   +  +  T    TL
Sbjct: 126 LEG-LNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181

Query: 566 GYLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
            Y  PE  L   +     DV+S G +L EL T K
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 12/155 (7%)

Query: 450 VVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIH----KKGNLSWERRLRITA 504
           ++ +++ R +V L     +T+  L LV   +  G L  HI+    +       R    TA
Sbjct: 46  ILAKVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTA 104

Query: 505 ETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV-VQG 563
           +    L +LH      II+RD+K  N+LLD +   ++SD G +  V +   Q+ T    G
Sbjct: 105 QIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAG 159

Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           T G++ PE LQ  +     D ++ GV L E++  +
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.8 bits (129), Expect = 9e-08
 Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 5/85 (5%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           + Y+H      I+HRD+K+ NI L  N   K+ DFG S+L+ + +    T   GT  Y+ 
Sbjct: 119 VHYMHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATTFTGTPYYMS 173

Query: 570 PEYLQTCKLTDKSDVYSFGVVLVEL 594
           PE L+      KSD++S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 24/202 (11%)

Query: 409 IGCGGSGNVYKGFLPDRT--PVAVKKSKFVDQAKI--DEFINELVVVLQINRRNVVRLLG 464
           +G G  G+V    +  RT   VA+KK     Q++I       EL ++  +   NV+ LL 
Sbjct: 23  VGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL- 80

Query: 465 CCLETQVPLLVYEFVGNGTL-----FEHIHK--KGNLSWERRLRITAETAGVLSYLHSET 517
              +     +  +   +  L        + K     LS ++   +  +    L Y+HS  
Sbjct: 81  ---DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG 137

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY-LQTC 576
              IIHRD+K  N+ ++E+C  K+ DFG ++    DA     VV  T  Y  PE  L   
Sbjct: 138 ---IIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVV--TRWYRAPEVILNWM 190

Query: 577 KLTDKSDVYSFGVVLVELLTGK 598
                 D++S G ++ E+LTGK
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG---TLG 566
           L Y+HS  NV  +HRD+K  N+L++ +C  K+ DFG ++    +  +N   +     T  
Sbjct: 118 LKYIHS-ANV--LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 567 YLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
           Y  PE + + +   K+ DV+S G +L ELL  K
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 6/159 (3%)

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITA 504
             E  ++  IN  ++++L G     +   L+        L+ ++  K N++    L I  
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAICDILAIER 189

Query: 505 ETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV-VQG 563
                + YLH      IIHRD+K+ NI ++      + DFGA+   P+D   N      G
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWAG 245

Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           T+    PE L         D++S G+VL E+ T   +L 
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284

Length = 391

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 32/207 (15%)

Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLL 463
           IG G  G VYKG   ++     VA+KK +    ++      I E+ ++ ++   N+V L 
Sbjct: 8   IGEGTYGVVYKG--RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH--KKGNLSWERRLRITAETAGVLSYLHSETNV-- 519
              ++     L++EF+ +  L +++    KG            +   V SYL+       
Sbjct: 66  DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQ---------YMDAELVKSYLYQILQGIL 115

Query: 520 -----PIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEY 572
                 ++HRD+K  N+L+D     K++DFG ++   +P+    +  V   TL Y  PE 
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV---TLWYRAPEV 172

Query: 573 L-QTCKLTDKSDVYSFGVVLVELLTGK 598
           L  + + +   D++S G +  E+ T K
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 20/201 (9%)

Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLL 463
           IG G  G VYK    DR     +A+KK +    D+      I E+ ++ ++   N+VRL 
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITA--ETAGVLSYLHSETNVPI 521
                 +   LV+E++ +  L +H+    + +   RL  T   +    ++Y HS     +
Sbjct: 68  DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---V 123

Query: 522 IHRDVKSANILLDE-NCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPE-YLQTCK 577
           +HRD+K  N+L+D      K++DFG ++   +P+    +  V   TL Y  PE  L +  
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---TLWYRAPEILLGSRH 180

Query: 578 LTDKSDVYSFGVVLVELLTGK 598
            +   D++S G +  E++  K
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 69/293 (23%), Positives = 126/293 (43%), Gaps = 48/293 (16%)

Query: 400 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKS---------KFVDQAKID---EFINE 447
           T TN Y   +   G G   +  + D  P+    +         K +D +  D    F   
Sbjct: 7   TRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFET 66

Query: 448 LVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAET 506
             ++ Q++  ++  + G C+     ++V EFV +G L   + K KG +    ++ +  + 
Sbjct: 67  ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQL 126

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILL-----DENCTP--KVSDFGASKLVPIDAIQNCT 559
           A  LSYL  +    ++H +V + NILL      E  +P  K+SD G    V   A+    
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPG----VSFTALSREE 179

Query: 560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVEL-LTGKMALLSDKPEEERSLAMNFL 617
            V+  + ++ PE +     L+  +D +SFG  L+E+   G++ L    P E+        
Sbjct: 180 RVE-RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE--- 235

Query: 618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL 670
              K++RL E               KE+A L ++C++    +RP+ + +  +L
Sbjct: 236 ---KKHRLPE------------PSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 37/221 (16%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFV--------DQAKIDE------FINELVVVLQ 453
           +G G  G V K +       VA+KK K +        D+  +         + EL ++ +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 454 INRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL 513
           I   N++ L+   +E     LV + +    L + + +K  L+  +   I  +    L+ L
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135

Query: 514 HSETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCT------------- 559
           H       +HRD+  ANI ++     K++DFG A +          +             
Sbjct: 136 H---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192

Query: 560 -VVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVLVELLTGK 598
            VV  TL Y  PE L    K     D++S G +  ELLTGK
Sbjct: 193 KVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 57/204 (27%), Positives = 85/204 (41%), Gaps = 21/204 (10%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINEL--VVVL----QINRRNVVRL 462
           IG G  G VYK   P        KS  V   +    ++ +  V +L      +  N+VRL
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 463 LGCCL------ETQVPLLVYEFVGNG--TLFEHIHKKGNLSWERRLRITAETAGVLSYLH 514
           +  C       ET+V L V+E V     T  + +   G L  E    +  +    L +LH
Sbjct: 68  MDVCATSRTDRETKVTL-VFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDFLH 125

Query: 515 SETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ 574
           +     I+HRD+K  NIL+      K++DFG +++          VV  TL Y  PE L 
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVLL 180

Query: 575 TCKLTDKSDVYSFGVVLVELLTGK 598
                   D++S G +  E+   K
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 5/99 (5%)

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC----- 576
           +HRD+K  NIL+D N   +++DFG+   +  D     +V  GT  Y+ PE LQ       
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
           K   + D +S GV + E+L G+    ++   E     MN
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 38/213 (17%)

Query: 409 IGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFI-----NELVVVLQINRRNVVRL 462
           IG G  G V+K    +    VA+K+ +  D    DE +      E+ ++ ++  +N+VRL
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRL 64

Query: 463 LGCCLETQVPLLVYEFVG----------NGTLFEHIHKKGNLSWERRLRITAETAGVLSY 512
                  +   LV+E+            NG +   I K       + L           +
Sbjct: 65  YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA----------F 114

Query: 513 LHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDP 570
            HS     ++HRD+K  N+L+++N   K++DFG ++   +P+       V   TL Y  P
Sbjct: 115 CHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV---TLWYRPP 168

Query: 571 EYLQTCKLTDKS-DVYSFGVVLVELLTGKMALL 602
           + L   KL   S D++S G +  EL      L 
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 51.2 bits (123), Expect = 8e-07
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 14/100 (14%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG----------ASKLVPIDAIQNCT 559
           ++YLH      I+HRD+K+ANIL+D     K++DFG            K       +  T
Sbjct: 128 INYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 560 VVQGTLGYLDPEY-LQTCKLTDKSDVYSFGVVLVELLTGK 598
            +  T  Y  PE  L   + T   D++  G V  E+ T +
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 1e-06
 Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 51/225 (22%)

Query: 407 DVIGCGGSGN---VYKGFL---PDRTPVAVKKSKFVDQAKIDEF----INELVVVLQINR 456
           ++ GC G G    VYK       D    A+KK K  D+ +          E+ ++ ++  
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACREIALLRELKH 61

Query: 457 RNVVRLLGCCLE--TQVPLLVYEFVGNGTLFEH-----IHKKGNLSWERRLRITAETAGV 509
            NVV L+   LE   +   L++++       EH     I       + R+ +  +    +
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYA------EHDLWQIIK------FHRQAKRVSIPPSM 109

Query: 510 -----------LSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASKLV--PI 552
                      + YLHS     ++HRD+K ANIL+     E    K+ D G ++L   P+
Sbjct: 110 VKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166

Query: 553 DAIQNCTVVQGTLGYLDPEYLQTCK-LTDKSDVYSFGVVLVELLT 596
             + +   V  T+ Y  PE L   +  T   D+++ G +  ELLT
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 18/165 (10%)

Query: 445 INELVVVLQIN---RRNVVRLLGCCL------ETQVPLLVYEFVGNG--TLFEHIHKKGN 493
           I E+ V+  +      NVVRL   C       ET++ L V+E V     T  + + + G 
Sbjct: 49  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL-VFEHVDQDLTTYLDKVPEPG- 106

Query: 494 LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID 553
           +  E    +  +    L +LHS     ++HRD+K  NIL+  +   K++DFG +++    
Sbjct: 107 VPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 163

Query: 554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
                 VV  TL Y  PE L         D++S G +  E+   K
Sbjct: 164 MALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 133 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 185

Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 33/93 (35%), Positives = 47/93 (50%), Gaps = 7/93 (7%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC--TVVQGTLGY 567
           L Y+H+  NV   HRD+K  NIL + +C  K+ DFG +++   D       T    T  Y
Sbjct: 116 LKYIHT-ANV--FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172

Query: 568 LDPEYLQT--CKLTDKSDVYSFGVVLVELLTGK 598
             PE   +   K T   D++S G +  E+LTGK
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 5/99 (5%)

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ-----TC 576
           +HRD+K  N+LLD+N   +++DFG+   +  D      V  GT  Y+ PE LQ       
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
           +   + D +S GV + E+L G+    ++   E     MN
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 50.3 bits (121), Expect = 2e-06
 Identities = 55/193 (28%), Positives = 98/193 (50%), Gaps = 26/193 (13%)

Query: 428 VAVKKSKFVDQAKIDEF----INELVVVLQINRRNVVRL----LGCCLETQVPLLVYEFV 479
           VA+KK K   + + + F    + E+ ++L++   N+V +    +G  L+ ++  +V E+V
Sbjct: 33  VALKKLKM--EKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD-KI-YMVMEYV 88

Query: 480 GNG--TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC 537
            +   +L E + +    S E +  +    +GV ++LH      I+HRD+K++N+LL+   
Sbjct: 89  EHDLKSLMETMKQPFLQS-EVKCLMLQLLSGV-AHLHDNW---ILHRDLKTSNLLLNNRG 143

Query: 538 TPKVSDFGASKLVPIDAIQNCT--VVQGTLGYLDPE-YLQTCKLTDKSDVYSFGVVLVEL 594
             K+ DFG ++      ++  T  VV  TL Y  PE  L   + +   D++S G +  EL
Sbjct: 144 ILKICDFGLAREYG-SPLKPYTQLVV--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200

Query: 595 LTGKMALLSDKPE 607
           LT K  L   K E
Sbjct: 201 LTKK-PLFPGKSE 212

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 11/179 (6%)

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRI-T 503
           I E+ ++  +   N+V L       +   LV+E++ +  L +++   GNL     ++I  
Sbjct: 51  IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM 109

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG--ASKLVPIDAIQNCTVV 561
            +    LSY H      I+HRD+K  N+L++E    K++DFG   +K VP     N  V 
Sbjct: 110 FQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV- 165

Query: 562 QGTLGYLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS 619
             TL Y  P+  L + + +   D++  G +L E+ TG+        +EE  L    L +
Sbjct: 166 --TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGT 222

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.5 bits (119), Expect = 2e-06
 Identities = 42/138 (30%), Positives = 65/138 (47%), Gaps = 31/138 (22%)

Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERRLR-ITAETAGVLSYLHSETNVPIIHRDVKSANI 531
           +L+ +++ +G LF+ + K+G LS E  ++ I  +    L+ LH      IIH D+K  N+
Sbjct: 85  VLIMDYIKDGDLFDLLKKEGKLS-EAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENV 140

Query: 532 LLDEN------CTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           L D        C     D+G  K++   +  +     GTL Y  PE     K+   +   
Sbjct: 141 LYDRAKDRIYLC-----DYGLCKIIGTPSCYD-----GTLDYFSPE-----KIKGHNYDV 185

Query: 586 SF-----GVVLVELLTGK 598
           SF     GV+  ELLTGK
Sbjct: 186 SFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 44/212 (20%)

Query: 412 GGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFI---NELVVVLQINRRNVVRLLGCCLE 468
               ++ K   P  T VAVKK   +D    ++      E++   Q+   N++  +   + 
Sbjct: 13  LMIVHLAK-HKPTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70

Query: 469 TQVPLLVYEFVGNGT---LFEHIHKKGNLSWERRLRITAETA------GVLS---YLHSE 516
                +V   +  G+   L +    +G            E A       VL+   Y+HS+
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEG----------LPELAIAFILKDVLNALDYIHSK 120

Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDF---------GASKLVPIDAIQNCTVVQGTLGY 567
                IHR VK+++ILL  +    +S           G  + V  D  ++       L +
Sbjct: 121 G---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN---LPW 174

Query: 568 LDPEYLQTCKL--TDKSDVYSFGVVLVELLTG 597
           L PE LQ       +KSD+YS G+   EL  G
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins

 Score = 44.2 bits (105), Expect = 3e-06
 Identities = 15/37 (40%), Positives = 18/37 (48%), Gaps = 4/37 (10%)

Query: 280 DVNECEDPSRNNC--THICDNIPGSYTCRCRKGFHGD 314
           D++EC   S N C     C N  GSY C C  G+ G 
Sbjct: 1   DIDECA--SGNPCQNGGTCVNTVGSYRCSCPPGYTGR 35

Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements. Length = 38

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  ++ DFG ++     A    T    T  Y  
Sbjct: 131 LKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRA 183

Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELL GK
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 47/187 (25%), Positives = 71/187 (37%), Gaps = 44/187 (23%)

Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           L+ E++  G +   + KK   + E      AET   +  +H    +  IHRD+K  N+LL
Sbjct: 78  LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLL 134

Query: 534 DENCTPKVSDFG-------------------ASKLVPIDAIQN----------------- 557
           D     K+SDFG                   A     +D I                   
Sbjct: 135 DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRA 194

Query: 558 ---CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM 614
               TV  GT  Y+ PE         + D +S GV++ E+L G     SD P+E     +
Sbjct: 195 LAYSTV--GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII 252

Query: 615 NFLSSLK 621
           N+  +L+
Sbjct: 253 NWKETLQ 259

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 32/162 (19%)

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT----LGYLDPEYLQTCK 577
           IHRD+ + NILL EN   K+ DFG ++ +  D      V +G+    L ++ PE +    
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKGSARLPLKWMAPESIFDKV 252

Query: 578 LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG 637
            T +SDV+SFGV+L E+ +     L   P     +   F   LK              DG
Sbjct: 253 YTTQSDVWSFGVLLWEIFS-----LGASPYPGVQINEEFCQRLK--------------DG 293

Query: 638 NKQQLKEVAKLAAR-----CISVRGEERPTMKEVSLELQGRL 674
            + +  E A          C     +ERPT   + +E+ G L
Sbjct: 294 TRMRAPENATPEIYRIMLACWQGDPKERPTFSAL-VEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 10/107 (9%)

Query: 494 LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID 553
           L  E  L  + + A  +S+L S+     IHRD+ + NILL      K+ DFG ++ +  D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 554 AIQNCTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           +     VV+G     + ++ PE +  C  T +SDV+S+G++L E+ +
Sbjct: 268 S---NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.1 bits (117), Expect = 5e-06
 Identities = 32/101 (31%), Positives = 58/101 (57%), Gaps = 10/101 (9%)

Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT 559
           LR +++ A  + +L S+     IHRDV + N+LL +    K+ DFG ++ +  D+     
Sbjct: 215 LRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS---NY 268

Query: 560 VVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           VV+G     + ++ PE +  C  T +SDV+S+G++L E+ +
Sbjct: 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 48.9 bits (117), Expect = 5e-06
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 42/215 (19%)

Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKFVDQAKIDEF----INELVVVLQINRRNVVR 461
           IG G  G V+K     +     VA+KK   ++  K + F    + E+ ++  +   NVV 
Sbjct: 20  IGQGTFGEVFKA--RHKKTKQIVALKKV-LMENEK-EGFPITALREIKILQLLKHENVVN 75

Query: 462 LLGCCLETQVP--------LLVYEFVGN--GTLFEHIHKKGNLSWERRLRITAETAGVLS 511
           L+  C     P         LV+EF  +    L  + + K  LS  +++         L 
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNG--LY 133

Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK--LVPIDAIQNC---TVVQGTLG 566
           Y+H      I+HRD+K+ANIL+ ++   K++DFG ++   +  ++  N     VV  TL 
Sbjct: 134 YIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV--TLW 188

Query: 567 YLDPEYLQTCKLTDKS-----DVYSFGVVLVELLT 596
           Y  PE L    L ++      D++  G ++ E+ T
Sbjct: 189 YRPPELL----LGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|214542 smart00179, EGF_CA, Calcium-binding EGF-like domain

 Score = 43.4 bits (103), Expect = 6e-06
 Identities = 17/46 (36%), Positives = 21/46 (45%), Gaps = 9/46 (19%)

Query: 280 DVNECEDPSRNNCTH--ICDNIPGSYTCRCRKGFHGDGRKDGGGCT 323
           D++EC   S N C +   C N  GSY C C  G+      DG  C 
Sbjct: 1   DIDECA--SGNPCQNGGTCVNTVGSYRCECPPGYT-----DGRNCE 39

Length = 39

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 6e-06
 Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 20/114 (17%)

Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK--------LVP 551
           L I  +    + Y+HS+    ++HRD+K  NILL       + D+GA+         L+ 
Sbjct: 116 LSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 552 IDAIQ------NCTV---VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           ID  +      + T+   + GT  Y+ PE L     ++ +D+Y+ GV+L ++LT
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 41/159 (25%), Positives = 64/159 (40%), Gaps = 45/159 (28%)

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG------------------ 545
           AE    +  +H    +  IHRD+K  NIL+D +   K++DFG                  
Sbjct: 108 AELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164

Query: 546 -----------------ASKLVPIDAI-----QNCTV--VQGTLGYLDPEYLQTCKLTDK 581
                              +L P++       Q C    + GT  Y+ PE L     T  
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224

Query: 582 SDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
            D +S GV+L E+L G+   L+D P E +   +N+ ++L
Sbjct: 225 CDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 48.0 bits (115), Expect = 8e-06
 Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 31/184 (16%)

Query: 428 VAVK--KSKFVDQAKIDEFINELVVVLQINRR-----NVVRLLGCCLE--TQVPLLVYEF 478
            A+K  K  F    +++    E+    Q  RR     N++RL+    +  T    LV+E 
Sbjct: 27  YAIKCMKKHFKSLEQVNNL-REI----QALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81

Query: 479 VGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC 537
           + +  L+E I  +K  L  +R      +    L ++H      I HRD+K  NIL+ ++ 
Sbjct: 82  M-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKDDI 137

Query: 538 TPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD-----KSDVYSFGVVLV 592
             K++DFG+ +   I +    T    T  Y  PE    C LTD     K D+++ G V  
Sbjct: 138 L-KLADFGSCR--GIYSKPPYTEYISTRWYRAPE----CLLTDGYYGPKMDIWAVGCVFF 190

Query: 593 ELLT 596
           E+L+
Sbjct: 191 EILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 9e-06
 Identities = 29/80 (36%), Positives = 45/80 (56%), Gaps = 9/80 (11%)

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG-----TLGYLDPEYLQTC 576
           IHRD+ + NILL EN   K+ DFG ++    D  ++   V+       L ++ PE +   
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLAR----DIYKDPDYVRKGDARLPLKWMAPESIFDK 250

Query: 577 KLTDKSDVYSFGVVLVELLT 596
             T +SDV+SFGV+L E+ +
Sbjct: 251 VYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 15/232 (6%)

Query: 407 DVIGCGGSGNVYKGF--LPDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLL 463
           D +G G    VYKG   L D   VA+K+ +   ++      I E+ ++  +   N+V L 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPII 522
                 +   LV+E++ +  L +++   GN      +++   +    L+Y H      ++
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VL 126

Query: 523 HRDVKSANILLDENCTPKVSDFG--ASKLVPIDAIQNCTVVQGTLGYLDPE-YLQTCKLT 579
           HRD+K  N+L++E    K++DFG   +K +P     N  V   TL Y  P+  L +   +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV---TLWYRPPDILLGSTDYS 183

Query: 580 DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN 631
            + D++  G +  E+ TG+        EE+       L +  +     IL N
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 22/200 (11%)

Query: 409 IGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQA------KIDEFINELVVVLQINRRNVVR 461
           IG G  G V+K    +    VA+KK  FV+        KI   + E+ ++ Q+   N+V 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKK--FVESEDDPVIKKIA--LREIRMLKQLKHPNLVN 64

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFE-HIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           L+      +   LV+E+  +  L E   + +G +      +I  +T   +++ H      
Sbjct: 65  LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHKHN--- 120

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLV--PIDAIQNCTVVQGTLGYLDPEYL-QTCK 577
            IHRDVK  NIL+ +    K+ DFG ++++  P D   +      T  Y  PE L    +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV---ATRWYRAPELLVGDTQ 177

Query: 578 LTDKSDVYSFGVVLVELLTG 597
                DV++ G V  ELLTG
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 62/219 (28%), Positives = 92/219 (42%), Gaps = 27/219 (12%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQA-KIDEFINELVVVLQI--NRRNVVRLL 463
           + IG G  G V+K  + ++   +    K +D    IDE I     +L+   +  NVV+  
Sbjct: 24  ETIGKGTYGKVFK--VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFY 81

Query: 464 GCCLETQVP-----LLVYEFVGNGTLFEHIHKKGNLSWERRLR------ITAETAGVLSY 512
           G   +  V       LV E    G++ + +  KG L    R+       I  E    L +
Sbjct: 82  GMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEALMGLQH 139

Query: 513 LHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
           LH       IHRDVK  NILL      K+ DFG S  +    ++  T V GT  ++ PE 
Sbjct: 140 LHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEV 195

Query: 573 LQTCKLTDKS-----DVYSFGVVLVELLTGKMALLSDKP 606
           +   +  D +     DV+S G+  +EL  G   L    P
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 25/81 (30%), Positives = 48/81 (59%), Gaps = 6/81 (7%)

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           ++HRD+K  N+L+++    K++DFG ++   +P++   N  V   TL Y  P+ L   + 
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPDVLLGSRT 177

Query: 579 TDKS-DVYSFGVVLVELLTGK 598
              S D++S G ++ E++TG+
Sbjct: 178 YSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 44/183 (24%), Positives = 85/183 (46%), Gaps = 11/183 (6%)

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRI-T 503
           I E+ ++  +   N+V L       +   LV+E++ +  L +++   GN+     ++I  
Sbjct: 52  IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFL 110

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG--ASKLVPIDAIQNCTVV 561
            +    L+Y H      ++HRD+K  N+L++E    K++DFG   +K VP     N  V 
Sbjct: 111 YQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV- 166

Query: 562 QGTLGYLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
             TL Y  P+  L + + + + D++  G +  E+ +G+        E+E  L    L + 
Sbjct: 167 --TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224

Query: 621 KQN 623
            + 
Sbjct: 225 TEE 227

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 30/79 (37%), Positives = 45/79 (56%), Gaps = 7/79 (8%)

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT----LGYLDPEYLQTCK 577
           IHRD+ + NILL EN   K+ DFG ++ +  D      V +G     L ++ PE +    
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRV 257

Query: 578 LTDKSDVYSFGVVLVELLT 596
            T +SDV+SFGV+L E+ +
Sbjct: 258 YTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 36/121 (29%), Positives = 56/121 (46%), Gaps = 17/121 (14%)

Query: 499 RLRITAETAGVLS---YLHSETNVPIIHRDVKSANILLDENCTPK---VSDFGASKLVPI 552
             ++TA    +LS   Y+H E    IIHRD+K+ N+L++    P+   + DFGA+     
Sbjct: 259 LAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVN---GPEDICLGDFGAACFA-- 310

Query: 553 DAIQNCTVVQGTLGYLD---PEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE 609
               +     G  G +D   PE L     T   D++S G+V+ E      +L S    +E
Sbjct: 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370

Query: 610 R 610
           R
Sbjct: 371 R 371

Length = 461

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 27/76 (35%), Positives = 40/76 (52%), Gaps = 3/76 (3%)

Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           LV E++  G +   +H  G    E  ++  +E A  L YLH      IIHRD+K  N+L+
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLI 137

Query: 534 DENCTPKVSDFGASKL 549
                 K++DFG SK+
Sbjct: 138 SNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 15/106 (14%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG--ASKLVPIDAIQNCTVVQGTLGY 567
           L+Y+H +    I+HRD+K  N+L+      K++DFG   +K +P     +  V   TL Y
Sbjct: 116 LAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV---TLWY 169

Query: 568 LDPEYLQTCKLTDKS---DVYSFGVVLVELLTGKMAL--LSDKPEE 608
             P+ L     TD S   D++  G + +E+L G+ A   +SD  E+
Sbjct: 170 RPPDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 34/132 (25%), Positives = 56/132 (42%), Gaps = 22/132 (16%)

Query: 484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD--------- 534
           L + I K G  S     +I  +T   L Y H+E +  ++H D+K  NIL++         
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPV 275

Query: 535 -------ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
                  + C  ++ D G       D   + T +  T  Y  PE +        +D++S 
Sbjct: 276 TNRALPPDPCRVRICDLGGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331

Query: 588 GVVLVELLTGKM 599
           G ++ EL TGK+
Sbjct: 332 GCIIYELYTGKL 343

Length = 467

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 64/256 (25%), Positives = 118/256 (46%), Gaps = 41/256 (16%)

Query: 367 FEQNGGSILRQELSKLH--GQSSEKAKIFTEEEIKTVTNNY--ADVIGCGGSGNVYKGFL 422
           FE N   +  +E S  +  G+  ++ K+   +  ++   +Y   ++IG G  G VY+   
Sbjct: 28  FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87

Query: 423 PDRTP-VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL-----LGCCLETQVPL--- 473
            D +  VA+KK     Q K      EL+++  +N  N++ L       C  + +  +   
Sbjct: 88  IDTSEKVAIKKVLQDPQYKN----RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143

Query: 474 LVYEFVGNGTLFEHI--HKKGNLSWERRL--RITAETAGVLSYLHSETNVPIIHRDVKSA 529
           +V EF+   T+ +++  + + N +    L    + +    L+Y+HS+    I HRD+K  
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQ 199

Query: 530 NILLDENC-TPKVSDFGASKLVPIDAIQNCTVVQGTLGYL------DPE-YLQTCKLTDK 581
           N+L+D N  T K+ DFG++K        N    Q ++ Y+       PE  L     T  
Sbjct: 200 NLLIDPNTHTLKLCDFGSAK--------NLLAGQRSVSYICSRFYRAPELMLGATNYTTH 251

Query: 582 SDVYSFGVVLVELLTG 597
            D++S G ++ E++ G
Sbjct: 252 IDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 47/175 (26%), Positives = 79/175 (45%), Gaps = 9/175 (5%)

Query: 428 VAVKKSKFVDQAKIDEF----INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT 483
           VA+KK  F D  + +E     + EL ++  + + N+V L           LV+E+V    
Sbjct: 29  VAIKK--FKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86

Query: 484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
           L E + +  N     ++R  +    ++  +H      I+HRD+K  N+L+  N   K+ D
Sbjct: 87  L-ELLEEMPNGVPPEKVR--SYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCD 143

Query: 544 FGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           FG ++ +   +  N T    T  Y  PE L         D++S G +L EL  G+
Sbjct: 144 FGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 38/145 (26%), Positives = 57/145 (39%), Gaps = 46/145 (31%)

Query: 522 IHRDVKSANILLDENCTPKVSDFG------------------------------------ 545
           IHRD+K  NIL+D +   K++DFG                                    
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 546 ---ASKLVPID-----AIQNCTV--VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELL 595
                +L P++       Q C    + GT  Y+ PE L     T   D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 596 TGKMALLSDKPEEERSLAMNFLSSL 620
            G+   L+  P E +   +N+ +SL
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSL 267

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 9/95 (9%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG--ASKLVPIDAIQNCTVVQGTLGY 567
           LSY+H      I+HRD+K  N+L+ +    K++DFG   +K VP     N  V   TL Y
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV---TLWY 169

Query: 568 LDPE-YLQTCKLTDKSDVYSFGVVLVELLTGKMAL 601
             P+  L + + +   D++  G + VE++ G  A 
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 10/96 (10%)

Query: 510 LSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASKLV--PIDAIQNCTVVQG 563
           + YLH+     ++HRD+K ANIL+     E    K++D G ++L   P+  + +   V  
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 564 TLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
           T  Y  PE L   +   K+ D+++ G +  ELLT +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 45/185 (24%), Positives = 85/185 (45%), Gaps = 25/185 (13%)

Query: 494 LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID 553
           LS+   +  + + A  + +L S+  V   HRD+ + N+L+ E    K+ DFG ++ +  D
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKLVKICDFGLARDIMRD 292

Query: 554 AIQNCTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE 609
           +     + +G+    L ++ PE +     T  SDV+SFG++L E+ T     L   P  E
Sbjct: 293 S---NYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT-----LGGTPYPE 344

Query: 610 RSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE 669
             +   F +++K+         R+    +     E+ ++  +C   + E RP   ++   
Sbjct: 345 LPMNEQFYNAIKRGY-------RMAKPAHASD--EIYEIMQKCWEEKFEIRPDFSQLVH- 394

Query: 670 LQGRL 674
           L G L
Sbjct: 395 LVGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 10/96 (10%)

Query: 510 LSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASKLV--PIDAIQNCTVVQG 563
           + YLH+     ++HRD+K ANIL+     E    K++D G ++L   P+  + +   V  
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 564 TLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
           T  Y  PE L   +   K+ D+++ G +  ELLT +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 39/146 (26%), Positives = 58/146 (39%), Gaps = 46/146 (31%)

Query: 522 IHRDVKSANILLDENCTPKVSDFG---------------------ASKLVPIDA---IQN 557
           IHRD+K  NIL+D +   K++DFG                        + P D    + N
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 558 C-------TVVQ---------------GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELL 595
           C       T+ Q               GT  Y+ PE L     T   D +S GV+L E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 596 TGKMALLSDKPEEERSLAMNFLSSLK 621
            G+   L+  P E +   +N+ ++L 
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLH 268

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|205157 pfam12947, EGF_3, EGF domain

 Score = 38.3 bits (90), Expect = 3e-04
 Identities = 11/22 (50%), Positives = 14/22 (63%)

Query: 295 ICDNIPGSYTCRCRKGFHGDGR 316
            C N  GS+TC C+ G+ GDG 
Sbjct: 13  TCTNTGGSFTCTCKSGYTGDGV 34

This family includes a variety of EGF-like domain homologues. This family includes the C-terminal domain of the malaria parasite MSP1 protein. Length = 36

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 21/153 (13%)

Query: 458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERR-------LRITAETAGVL 510
           N+++ LG C+E    LLV+E+   G L  ++ ++    W RR        R+  E A  +
Sbjct: 56  NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE---QWHRRNSQLLLLQRMACEIAAGV 112

Query: 511 SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLD 569
           +++H       +H D+   N  L  + T KV D+G        D I+        L +L 
Sbjct: 113 THMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLA 169

Query: 570 PEY-------LQTCKLTDKSDVYSFGVVLVELL 595
           PE        L T + T  S+V++ GV L EL 
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 11/92 (11%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG--ASKLVPIDAIQNCTVVQGTLGY 567
           L+Y H      ++HRD+K  N+L+ E    K++DFG   +K VP     N  V   TL Y
Sbjct: 116 LAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV---TLWY 169

Query: 568 LDPEYL--QTCKLTDKSDVYSFGVVLVELLTG 597
             P+ L   T   T   D++  G +  E+ TG
Sbjct: 170 RPPDVLLGSTEYST-SLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|219496 pfam07645, EGF_CA, Calcium-binding EGF domain

 Score = 38.5 bits (90), Expect = 4e-04
 Identities = 14/34 (41%), Positives = 19/34 (55%), Gaps = 3/34 (8%)

Query: 280 DVNECEDPSRNNC--THICDNIPGSYTCRCRKGF 311
           DV+EC D   +NC    +C N  GS+ C C  G+
Sbjct: 1   DVDECADG-THNCPANTVCVNTIGSFECVCPDGY 33

Length = 42

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.5 bits (102), Expect = 4e-04
 Identities = 30/117 (25%), Positives = 54/117 (46%), Gaps = 8/117 (6%)

Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K   L  + R  I  +    + Y+H +    +IHRD+K  NI L+ +    + DFG +  
Sbjct: 261 KDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMP 316

Query: 550 V--PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSD 604
                +A     V  GT+    PE L      + +D++S G++L+++L+     + D
Sbjct: 317 FEKEREAFDYGWV--GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371

Length = 501

>gnl|CDD|238010 cd00053, EGF, Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium

 Score = 37.8 bits (88), Expect = 4e-04
 Identities = 15/36 (41%), Positives = 16/36 (44%), Gaps = 4/36 (11%)

Query: 283 ECEDPSRNNC--THICDNIPGSYTCRCRKGFHGDGR 316
           EC     N C     C N PGSY C C  G+ GD  
Sbjct: 1   ECAAS--NPCSNGGTCVNTPGSYRCVCPPGYTGDRS 34

Length = 36

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 42.2 bits (99), Expect = 5e-04
 Identities = 59/212 (27%), Positives = 83/212 (39%), Gaps = 36/212 (16%)

Query: 409 IGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQAKIDE---FINELVVVLQINRRNVVRLLG 464
           IG G  G V  G      TP  V   +    A + E   F+ E      +   N+++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIH---KKGNLSWERRL--RITAETAGVLSYLHSETNV 519
            C E    LLV EF   G L  ++    K   ++ +     R+  E A  L +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKL--------------VPIDAIQNCTV--VQG 563
             IH D+   N LL  + T K+ D+G S                VP+  I    V  V G
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELL 595
            L  +D         T +S+V+S GV + EL 
Sbjct: 180 NLLVVDQ--------TKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|214544 smart00181, EGF, Epidermal growth factor-like domain

 Score = 37.5 bits (87), Expect = 7e-04
 Identities = 17/35 (48%), Positives = 20/35 (57%), Gaps = 3/35 (8%)

Query: 283 ECEDPSRNNCTH-ICDNIPGSYTCRCRKGFHGDGR 316
           EC   S   C++  C N PGSYTC C  G+ GD R
Sbjct: 1   ECA--SGGPCSNGTCINTPGSYTCSCPPGYTGDKR 33

Length = 35

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 41/172 (23%), Positives = 78/172 (45%), Gaps = 24/172 (13%)

Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT 559
           L  T + A  + +L S+  V   HRD+ + N+LL +    K+ DFG ++ +  D   +  
Sbjct: 240 LSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQGKIVKICDFGLARDIMHD---SNY 293

Query: 560 VVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
           V +G+    + ++ PE +     T  SDV+S+G++L E+ +     L   P     +   
Sbjct: 294 VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS-----LGGTPYPGMIVDST 348

Query: 616 FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
           F + +K    +   D+           +EV  +  +C +   E+RP+   +S
Sbjct: 349 FYNKIKSGYRMAKPDH---------ATQEVYDIMVKCWNSEPEKRPSFLHLS 391

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 34/144 (23%), Positives = 63/144 (43%), Gaps = 29/144 (20%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDE--NCTPKVSDFGASK--LVPIDAIQNCTVVQGTL 565
           +++ H      ++HRD+K  N+L+D+      K++D G  +   +P+ +  +  V   TL
Sbjct: 123 VAHCHKHG---VMHRDLKPQNLLVDKQKGLL-KIADLGLGRAFSIPVKSYTHEIV---TL 175

Query: 566 GYLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR 624
            Y  PE  L +   +   D++S G +  E+   +     D             S L+Q  
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD-------------SELQQ-- 220

Query: 625 LLEILDNRIVNDGNKQQLKEVAKL 648
           LL I   +++    +Q    V+KL
Sbjct: 221 LLHIF--KLLGTPTEQVWPGVSKL 242

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.2 bits (89), Expect = 0.004
 Identities = 28/143 (19%), Positives = 56/143 (39%), Gaps = 20/143 (13%)

Query: 409 IGCGGSGNVYKGFLPDRT-PVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           +  G +  VY   L  +     +K      + K  +   E+ ++  + R+ +        
Sbjct: 6   LKGGLTNRVYL--LGTKDEDYVLKI--NPSREKGADREREVAILQLLARKGL-------- 53

Query: 468 ETQVPLLVYEFVGNGT---LFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPII 522
              VP ++     +G    L E I  +    +S E +  I  + A +L+ LH    + + 
Sbjct: 54  --PVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 523 HRDVKSANILLDENCTPKVSDFG 545
           H D+   NIL+D+     + D+ 
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	735
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
PF13947	106	GUB_WAK_bind: Wall-associated receptor kinase gala	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
PRK10345	210	hypothetical protein; Provisional	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
smart00090	237	RIO RIO-like kinase.	99.7
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.68
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
PF08488	103	WAK: Wall-associated kinase; InterPro: IPR013695 T	99.58
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.57
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.24
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.19
KOG1243	690	consensus Protein kinase [General function predict	99.16
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.14
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.11
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.1
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.01
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.97
KOG3087	229	consensus Serine/threonine protein kinase [General	98.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.87
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.81
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.79
KOG1219	4289	consensus Uncharacterized conserved protein, conta	98.77
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.64
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.57
PRK09902	216	hypothetical protein; Provisional	98.51
COG4248	637	Uncharacterized protein with protein kinase and he	98.5
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.48
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.29
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.18
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.16
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.1
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.08
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.07
KOG1214	1289	consensus Nidogen and related basement membrane pr	98.06
PF01636	239	APH: Phosphotransferase enzyme family This family	98.05
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.0
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.97
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.85
PLN02876	822	acyl-CoA dehydrogenase	97.84
PF12662	24	cEGF: Complement Clr-like EGF-like	97.78
PRK10593	297	hypothetical protein; Provisional	97.75
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.66
KOG1219	4289	consensus Uncharacterized conserved protein, conta	97.6
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.55
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.5
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.49
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.48
PF07645	42	EGF_CA: Calcium-binding EGF domain; InterPro: IPR0	97.36
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.28
KOG4260	350	consensus Uncharacterized conserved protein [Funct	97.27
KOG4260	350	consensus Uncharacterized conserved protein [Funct	97.2
PF07645	42	EGF_CA: Calcium-binding EGF domain; InterPro: IPR0	97.19
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.16
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.06
PF12947	36	EGF_3: EGF domain; InterPro: IPR024731 This entry	96.93
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.84
PRK05231	319	homoserine kinase; Provisional	96.82
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.71
KOG2270	520	consensus Serine/threonine protein kinase involved	96.44
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.43
KOG4289	2531	consensus Cadherin EGF LAG seven-pass G-type recep	96.38
KOG1214	1289	consensus Nidogen and related basement membrane pr	96.31
PLN02236	344	choline kinase	96.3
smart00179	39	EGF_CA Calcium-binding EGF-like domain.	96.3
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.26
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.26
KOG4289	2531	consensus Cadherin EGF LAG seven-pass G-type recep	96.22
PF00008	32	EGF: EGF-like domain This is a sub-family of the P	96.2
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.2
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.12

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-54  Score=462.39  Aligned_cols=286  Identities=47%  Similarity=0.736  Sum_probs=253.1

Q ss_pred             cccccCHHHHHhhhccccc--cccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEE
Q 004702          389 KAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC  466 (735)
Q Consensus       389 ~~~~~~~~ei~~~~~~~~~--~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~  466 (735)
                      ..+.|+..||+.+|.+|.+  +||+|+||.||+|.+.++..||||++.........+|.+|+.+|.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            6788999999999999994  99999999999999999999999988764443145599999999999999999999999


Q ss_pred             eecC-ceeEEEEecCCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEee
Q 004702          467 LETQ-VPLLVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD  543 (735)
Q Consensus       467 ~~~~-~~~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D  543 (735)
                      .+.+ .++||||||++|+|.++|+...  +++|.+|++||.++|+||+|||....++||||||||+|||||+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9999 4999999999999999999864  899999999999999999999999988999999999999999999999999


Q ss_pred             ccCCcccCC-CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc
Q 004702          544 FGASKLVPI-DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ  622 (735)
Q Consensus       544 FGls~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  622 (735)
                      ||+++..+. ....... ..||.+|+|||++..+..+.|+|||||||+|+||+||+++.....+.....+..+....+..
T Consensus       221 FGLa~~~~~~~~~~~~~-~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVSTT-VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCccccceeee-cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            999987654 2222111 16999999999999999999999999999999999999988766555555677777888888


Q ss_pred             cchhhHhhhccc-CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          623 NRLLEILDNRIV-NDGNK-QQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       623 ~~~~~~~d~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      .++.+++|+++. .+... +....+..++.+|++.+|.+||+|.||+++|+.+..
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            899999999987 55453 688889999999999999999999999999966543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=404.40  Aligned_cols=257  Identities=35%  Similarity=0.505  Sum_probs=217.3

Q ss_pred             cccccccccCcEEEEEEEcCCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecC-ceeEEEEecC
Q 004702          404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-VPLLVYEFVG  480 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~E~~~  480 (735)
                      .+.+.||+|+||+||+|.+++...||||++...+  ....++|.+|+.+|.+++|||||+++|+|.+.. ...+|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            4455799999999999999877779999987533  233679999999999999999999999999987 7899999999


Q ss_pred             CCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEeeccCCcccCCCcccc
Q 004702          481 NGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-TPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       481 ~gsL~~~l~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGls~~~~~~~~~~  557 (735)
                      +|+|.++++.  +..+++..+++|+.|||+||.|||+++.  ||||||||+||||+.+. ++||+|||+++...... ..
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~  200 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS  200 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence            9999999988  5789999999999999999999999874  99999999999999997 99999999998765322 23


Q ss_pred             eeeeccccCccCccccc--CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          558 CTVVQGTLGYLDPEYLQ--TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~--~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      .+...||+.|||||.+.  ...|+.|+|||||||+||||+||+.||....... ..              ..++......
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-~~--------------~~v~~~~~Rp  265 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-VA--------------SAVVVGGLRP  265 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-HH--------------HHHHhcCCCC
Confidence            34467999999999999  5689999999999999999999999998776522 11              1111222223


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ..+....+.+..|+.+||+.||..||++.|++..|+.+.....
T Consensus       266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            3344467889999999999999999999999999999887654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=406.46  Aligned_cols=263  Identities=30%  Similarity=0.431  Sum_probs=230.3

Q ss_pred             CHHHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          394 TEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       394 ~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      ..++++.....+.+.||+|-||+||.|.++....||+|.++... ...++|++|+++|++|+|+|||+++|+|..++..+
T Consensus       199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            34556666667788999999999999999998899999988643 33578999999999999999999999999999999


Q ss_pred             EEEEecCCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          474 LVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      ||||||+.|+|.++|+.  ...+...+.+.++.|||+|++||++++   +|||||.++||||+++..+||+||||++...
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999987  467999999999999999999999999   9999999999999999999999999999766


Q ss_pred             CCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       552 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      .+.........-++.|.|||.+....++.|||||||||+||||+| |+.|+......+                +.+.++
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~~~le  418 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VLELLE  418 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HHHHHh
Confidence            666655555556889999999999999999999999999999999 888876554433                334455


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      ....-+.+..++.++.+||..||+.+|++|||++.+...|+.+...
T Consensus       419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            5566666778899999999999999999999999999999887653

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.4e-46  Score=414.17  Aligned_cols=263  Identities=29%  Similarity=0.406  Sum_probs=224.9

Q ss_pred             HHHHHhhhccccccccccCcEEEEEEEcC------CCcEEEEEEeeccChh-HHHHHHHHHHHHHhcCCCceEEEceEEe
Q 004702          395 EEEIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFVDQA-KIDEFINELVVVLQINRRNVVRLLGCCL  467 (735)
Q Consensus       395 ~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~  467 (735)
                      ..+++.....+.+.||+|+||+||+|...      +...||||.++..... ...+|.+|+++|..|+|||||+|+|+|.
T Consensus       480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            44566666678889999999999999843      3567999999976655 7899999999999999999999999999


Q ss_pred             ecCceeEEEEecCCCchhHHhhhc----------C----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 004702          468 ETQVPLLVYEFVGNGTLFEHIHKK----------G----NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL  533 (735)
Q Consensus       468 ~~~~~~lV~E~~~~gsL~~~l~~~----------~----~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl  533 (735)
                      +++..++|+|||..|+|.+||...          .    +|+..+.+.||.|||.|+.||.++.   +|||||..+|+||
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV  636 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV  636 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence            999999999999999999999743          2    3889999999999999999999999   9999999999999


Q ss_pred             cCCCCeEEeeccCCcccCCCcccc-eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHH
Q 004702          534 DENCTPKVSDFGASKLVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERS  611 (735)
Q Consensus       534 ~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~  611 (735)
                      .++..|||+||||++.+...+.+. .....-.++||+||.+..++||.+||||||||||||+++ |+.|++.....+...
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe  716 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE  716 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence            999999999999999765433333 223346789999999999999999999999999999999 999998776655332


Q ss_pred             HHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                             .++.+++         .+.+..++.+++.||..||+.+|.+||+++||-..|+.....
T Consensus       717 -------~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  717 -------CIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -------HHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                   2233333         344667889999999999999999999999999999976543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=365.58  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=208.0

Q ss_pred             cccccccCcEEEEEEEcC-CCcEEEEEEee-ccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc-eeEEEEecCCC
Q 004702          406 ADVIGCGGSGNVYKGFLP-DRTPVAVKKSK-FVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV-PLLVYEFVGNG  482 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV~E~~~~g  482 (735)
                      ...||+|..|+|||++++ ++..+|+|.+. ..+....+++.+|+++++..+|||||.++|.|..... ..|+||||.+|
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG  163 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG  163 (364)
T ss_pred             hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence            457999999999999865 57889999985 4567778899999999999999999999999999985 99999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|+++++..+.+++...-+|+.++++||.|||. .+   ||||||||+||||+..|.+||+|||.++.+...   .....
T Consensus       164 SLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tf  237 (364)
T KOG0581|consen  164 SLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTF  237 (364)
T ss_pred             CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcccc
Confidence            999999988899999999999999999999996 56   999999999999999999999999999977544   33456


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH-H
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK-Q  640 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~-~  640 (735)
                      .||..|||||.+.+..|+.++||||||++++|+.+|+.|+....+....  +..        -+..|++..- ...+. .
T Consensus       238 vGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~--~~~--------Ll~~Iv~~pp-P~lP~~~  306 (364)
T KOG0581|consen  238 VGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD--IFE--------LLCAIVDEPP-PRLPEGE  306 (364)
T ss_pred             cccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC--HHH--------HHHHHhcCCC-CCCCccc
Confidence            6999999999999999999999999999999999999998654111000  000        1122333211 11222 4


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+++++.++..||++||.+||++.|++..
T Consensus       307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  307 FSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            77899999999999999999999998864

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=361.53  Aligned_cols=200  Identities=30%  Similarity=0.503  Sum_probs=180.1

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.||+|+|++||+|+++ ++..||||.+...  ..+..+....|+.+|+.++|||||+|++++...+..+||||||.+
T Consensus        14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g   93 (429)
T KOG0595|consen   14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG   93 (429)
T ss_pred             ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence            4556999999999999954 5789999998765  667778888999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC------CCeEEeeccCCcccCCCcc
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN------CTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~------~~~kl~DFGls~~~~~~~~  555 (735)
                      |+|.++|+..+.+++.....++.|||.||++||+++   ||||||||.||||+.+      -.+||+|||+|+.+.....
T Consensus        94 GDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~  170 (429)
T KOG0595|consen   94 GDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM  170 (429)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH
Confidence            999999999999999999999999999999999999   9999999999999764      4689999999998864322


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHH
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE  609 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~  609 (735)
                        .....|++.|||||++..++|+.|+|+||+|++||++++|+.||......+-
T Consensus       171 --a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL  222 (429)
T KOG0595|consen  171 --AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL  222 (429)
T ss_pred             --HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence              2345699999999999999999999999999999999999999987665553

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6e-45  Score=394.39  Aligned_cols=263  Identities=24%  Similarity=0.382  Sum_probs=228.8

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcCC----CcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ  470 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  470 (735)
                      .||...-..+.++||.|.||+|++|+++-    ...||||.++. ..+.+..+|+.|+.||.++.||||++|.|+.....
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            35555555667899999999999999753    45799999986 45667889999999999999999999999999999


Q ss_pred             ceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      ..+||.|||+||+|+.||+++ +.+++.++..++..||.|++||.+.+   +|||||.++||||+.+..+||+||||++.
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence            999999999999999999876 67999999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCcccceeee--ccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          550 VPIDAIQNCTVV--QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       550 ~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                      +.++.....+..  .-+++|.|||.+...+++.+||||||||||||.++ |.+||......+                +.
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------VI  844 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VI  844 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------------HH
Confidence            866553333322  23679999999999999999999999999999998 999998765433                23


Q ss_pred             hHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       627 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ..++..+..+.+.+++..|.+||..||++|-.+||++.||+..|+++++.-
T Consensus       845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            344556666778899999999999999999999999999999999988653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-43  Score=375.48  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=214.6

Q ss_pred             hhccccccccccCcEEEEEEEc-CCCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .++...++||+|||+.||+++. ..|..||+|++..   ......+...+|+++.++|+|||||++++++++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            3455677999999999999996 8899999998764   45566788899999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      |++++++|.++++.++++++..+..++.||+.||.|||+++   |||||||..|+||+++.++||+|||||..+..+...
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er  174 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER  174 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence            99999999999998899999999999999999999999999   999999999999999999999999999988755444


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      . ....||+.|+|||++.....+-.+||||+|||||.||.|++||....-.+.-.       .++.        ..+  .
T Consensus       175 k-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~-------~Ik~--------~~Y--~  236 (592)
T KOG0575|consen  175 K-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN-------KIKL--------NEY--S  236 (592)
T ss_pred             c-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH-------HHHh--------cCc--c
Confidence            3 34579999999999999999999999999999999999999997654333221       1111        111  1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+...+.+..+||.++|+.+|.+|||+.+|+..
T Consensus       237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            233556788999999999999999999999853

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-44  Score=346.54  Aligned_cols=253  Identities=26%  Similarity=0.372  Sum_probs=209.6

Q ss_pred             ccccccccccCcEEEEEEE-cCCCcEEEEEEee--ccChhHHHHHHHHHHHHHhcCCCceEEEce-EEeecC-ceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSK--FVDQAKIDEFINELVVVLQINRRNVVRLLG-CCLETQ-VPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~-~~~lV~E  477 (735)
                      +.+.++||+|.||+|||+. +.++..||.|+++  ..+.+..++...|+.+|++|+|||||++++ -+.++. ..+||||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            3445689999999999997 7789999999887  467778889999999999999999999998 444444 4889999


Q ss_pred             ecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          478 FVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETN-VPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       478 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~-~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++..|+|...++.    ++.+++..+++++.|++.||..+|++-. ..|+||||||.||+|+.+|.+||+||||++.+..
T Consensus       101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s  180 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS  180 (375)
T ss_pred             hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence            9999999999974    3679999999999999999999999321 2399999999999999999999999999998876


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      ..... ....|||.||+||.+....|+.||||||+|+++|||..-+.||....-.+       ....+.+...       
T Consensus       181 ~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~-------  245 (375)
T KOG0591|consen  181 KTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDY-------  245 (375)
T ss_pred             hhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCC-------
Confidence            54433 44569999999999999999999999999999999999999998763222       2222333222       


Q ss_pred             ccCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          633 IVNDGN-KQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       633 ~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                        .+.+ ..++.+|.+||..|+..||+.||+...++..+..
T Consensus       246 --~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  246 --PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             --CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence              1123 5678899999999999999999997666655554

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=403.68  Aligned_cols=268  Identities=27%  Similarity=0.423  Sum_probs=224.0

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcCC--Cc----EEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEee
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLPD--RT----PVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE  468 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~--~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~  468 (735)
                      .+++.....+.+.||+|.||.||+|.+.+  +.    .||||.++. .+.++..+|++|..+|+.++|||||+++|+|.+
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            34455666678899999999999998543  32    489998875 567888999999999999999999999999999


Q ss_pred             cCceeEEEEecCCCchhHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 004702          469 TQVPLLVYEFVGNGTLFEHIHKK-------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV  541 (735)
Q Consensus       469 ~~~~~lV~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl  541 (735)
                      ...++|++|||++|+|..+|++.       ..|+...++.++.|||+|+.||++++   +|||||.++|+||++...+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEE
Confidence            99999999999999999999875       46999999999999999999999999   999999999999999999999


Q ss_pred             eeccCCcccCCCcccc-eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHH
Q 004702          542 SDFGASKLVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSS  619 (735)
Q Consensus       542 ~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  619 (735)
                      +|||+|+.+....... .....-..+|||||.+.++.++.|+|||||||+|||++| |..||......+.....      
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------  917 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------  917 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------
Confidence            9999999554333322 222235679999999999999999999999999999999 88888766554422211      


Q ss_pred             hcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhccCCcc
Q 004702          620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQY  682 (735)
Q Consensus       620 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~~~~~  682 (735)
                      +..+          +.+.+..++..+++||..||+.+|++||++..|++.+..+.+......+
T Consensus       918 ~~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~  970 (1025)
T KOG1095|consen  918 LEGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY  970 (1025)
T ss_pred             HhCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence            1122          2334567788999999999999999999999999999998887664443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-43  Score=354.78  Aligned_cols=251  Identities=26%  Similarity=0.362  Sum_probs=204.8

Q ss_pred             hccccccccccCcEEEEEEE-cCCCcEEEEEEeeccCh-------hHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          402 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQ-------AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      .+-+.+.||+|+||.|-+|. .+++..||||+++....       .......+|+++|++|+|||||++++++...+..|
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y  252 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY  252 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence            44567899999999999998 56789999998864211       12233569999999999999999999999999999


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CCeEEeeccCCccc
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN---CTPKVSDFGASKLV  550 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFGls~~~  550 (735)
                      |||||++||.|.+++-.++.+.+..-..++.|++.|+.|||+.|   |+||||||+|||+..+   ..+||+|||+|+..
T Consensus       253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            99999999999999999989999999999999999999999999   9999999999999765   77999999999987


Q ss_pred             CCCcccceeeeccccCccCcccccCCC---CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCK---LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      .  ....+....||+.|.|||++.+..   +..|.|+||+|||||-+|+|.+||.......  .+.    +.+..++.. 
T Consensus       330 g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~----eQI~~G~y~-  400 (475)
T KOG0615|consen  330 G--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK----EQILKGRYA-  400 (475)
T ss_pred             c--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH----HHHhcCccc-
Confidence            5  334455677999999999997654   3347899999999999999999996543322  111    111111111 


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                           .......+.+++..+||.+||..||++|||+.|++..
T Consensus       401 -----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  401 -----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             -----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                 1123355677899999999999999999999998753

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-42  Score=368.11  Aligned_cols=266  Identities=30%  Similarity=0.403  Sum_probs=222.3

Q ss_pred             HHHHHhhhccccccccccCcEEEEEEEcCC--C--cE-EEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEE
Q 004702          395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPD--R--TP-VAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCC  466 (735)
Q Consensus       395 ~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~  466 (735)
                      .++|......+.++||+|+||+||+|.+..  +  .. ||||..+.   .....+.+|++|+++|++++|||||+++|++
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            456666666777999999999999998643  2  23 89998874   5578889999999999999999999999999


Q ss_pred             eecCceeEEEEecCCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          467 LETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       467 ~~~~~~~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                      .....+++|||++.||+|.++|++.+ .++..++++++.+.|.||+|||+++   +|||||.++|+|++.++.+||+|||
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence            99999999999999999999999876 5999999999999999999999999   9999999999999999999999999


Q ss_pred             CCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccc
Q 004702          546 ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNR  624 (735)
Q Consensus       546 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  624 (735)
                      |++.-..... ......-+.+|+|||.+....|+.++|||||||++||+++ |..||......+....+           
T Consensus       308 Ls~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI-----------  375 (474)
T KOG0194|consen  308 LSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI-----------  375 (474)
T ss_pred             cccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH-----------
Confidence            9886531111 1112235789999999999999999999999999999999 88898776655432221           


Q ss_pred             hhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhccC
Q 004702          625 LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSN  679 (735)
Q Consensus       625 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~~  679 (735)
                          +-.......+...+.++..++.+||..+|++||||.++.+.|+.+.....+
T Consensus       376 ----~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  376 ----VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ----HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                112222233345667889999999999999999999999999998877653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-41  Score=339.68  Aligned_cols=238  Identities=27%  Similarity=0.352  Sum_probs=202.0

Q ss_pred             ccccccccCcEEEEEEEc-CCCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          405 YADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.++||+|+||+||.++. +.++.+|+|.+++   ....+.+....|..+|.+++||.||++...+++.+.+|||+||+.
T Consensus        29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~  108 (357)
T KOG0598|consen   29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN  108 (357)
T ss_pred             eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence            457999999999999984 4578899998764   445567888999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ||.|..+|.+.+.+++..+.-++.+|+.||.|||+++   ||||||||+|||||++|.++|+||||++..-.+... ...
T Consensus       109 GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~-t~t  184 (357)
T KOG0598|consen  109 GGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA-TRT  184 (357)
T ss_pred             CccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCCc-ccc
Confidence            9999999999999999999999999999999999999   999999999999999999999999999965433222 233


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..||+.|||||++.+..|+..+|.||||+++|||++|.+||......+..       ..+...+         ....+.-
T Consensus       185 fcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~-------~~I~~~k---------~~~~p~~  248 (357)
T KOG0598|consen  185 FCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY-------DKILKGK---------LPLPPGY  248 (357)
T ss_pred             ccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH-------HHHhcCc---------CCCCCcc
Confidence            67999999999999999999999999999999999999999866543321       2222222         1111222


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC
Q 004702          641 QLKEVAKLAARCISVRGEERPT  662 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt  662 (735)
                      ...+.++++.+.|+.+|++|.-
T Consensus       249 ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  249 LSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             CCHHHHHHHHHHhccCHHHhcC
Confidence            4578899999999999999963

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=345.72  Aligned_cols=252  Identities=28%  Similarity=0.386  Sum_probs=204.5

Q ss_pred             hccccccccccCcEEEEEEEcCC-CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC--ceeEEEEe
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ--VPLLVYEF  478 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~E~  478 (735)
                      .+...+.||+|+||.||++...+ +...|||.+...+....+.+.+|+.+|++++|||||+.+|.....+  ...+.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            34457799999999999999654 8899999987654444777889999999999999999999855444  58899999


Q ss_pred             cCCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEeeccCCcccCC--Cc
Q 004702          479 VGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NCTPKVSDFGASKLVPI--DA  554 (735)
Q Consensus       479 ~~~gsL~~~l~~~~-~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGls~~~~~--~~  554 (735)
                      +++|+|.+++...+ .|++..+.++..||++||+|||+++   ||||||||+||||+. ++.+||+|||+++....  ..
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999999876 7999999999999999999999999   999999999999999 79999999999987653  22


Q ss_pred             ccceeeeccccCccCcccccCCC-CCccccchhHHHHHHHHHhCCccCCCC-ChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCK-LTDKSDVYSFGVVLVELLTGKMALLSD-KPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVyS~Gvvl~elltG~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .......+||+.|||||++..+. ...++||||||+++.||+||+.||... ...+      ..         ..+....
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~------~~---------~~ig~~~  239 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE------AL---------LLIGRED  239 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH------HH---------HHHhccC
Confidence            22334567999999999999633 335999999999999999999998653 1111      11         1111111


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      ...+.+...+.+..+++.+|++.+|++|||+.|++...-
T Consensus       240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            122334456678999999999999999999999987654

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=353.58  Aligned_cols=267  Identities=24%  Similarity=0.329  Sum_probs=220.2

Q ss_pred             CHHHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhH-HHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          394 TEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAK-IDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       394 ~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      ...|+......|.++||+|-||+|.+........||||+++...... ..+|.+|+++|.+++||||++|+|+|..++..
T Consensus       531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            34566666777889999999999999999888999999999755544 58999999999999999999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          473 LLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      .+|+|||++|+|.++|...  ..+.-..-++|+.||+.||+||.+.+   +|||||.++|+|++.++++||+|||+++.+
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence            9999999999999999876  33456677889999999999999999   999999999999999999999999999966


Q ss_pred             CCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh--CCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          551 PIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT--GKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       551 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ...... ......-+++|||||.+..++++.+||||+||++|||+++  ...||.....++.......+.   ..     
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~---~~-----  759 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFF---RD-----  759 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhc---CC-----
Confidence            544333 3333446789999999999999999999999999999877  677886554433322221111   11     


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                       --.......+.-++.++++||.+||+.+-++||+++++...|++
T Consensus       760 -~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  760 -QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             -CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence             11122334455677889999999999999999999999998875

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=361.29  Aligned_cols=263  Identities=27%  Similarity=0.425  Sum_probs=220.2

Q ss_pred             cccccCHHHHHhhhccccccccccCcEEEEEEEc-CCC----cEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEE
Q 004702          389 KAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFL-PDR----TPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRL  462 (735)
Q Consensus       389 ~~~~~~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~-~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l  462 (735)
                      ..+++++.|+++     .++||+|+||+||||.+ ..+    -+||||.+.. ...+...++++|+.+|..++|||+++|
T Consensus       689 ~lrI~kEtelkk-----~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RL  763 (1177)
T KOG1025|consen  689 LLRILKETELKK-----DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRL  763 (1177)
T ss_pred             heeechhhhhhh-----hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHH
Confidence            445666656554     46899999999999984 333    4688888764 455667899999999999999999999


Q ss_pred             ceEEeecCceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 004702          463 LGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV  541 (735)
Q Consensus       463 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl  541 (735)
                      +|+|.... +.||++||+.|+|.++++.. ..+..+..+.|..|||+||.|||.+.   +|||||.++||||..-..+||
T Consensus       764 Lgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvki  839 (1177)
T KOG1025|consen  764 LGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKI  839 (1177)
T ss_pred             hhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEE
Confidence            99998776 78999999999999999864 68999999999999999999999998   999999999999999999999


Q ss_pred             eeccCCcccCCCccccee-eeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHH
Q 004702          542 SDFGASKLVPIDAIQNCT-VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSS  619 (735)
Q Consensus       542 ~DFGls~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  619 (735)
                      .|||+++++..+...... ...-.+.|||-|.+....++.++|||||||++|||+| |..|+......+..         
T Consensus       840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~---------  910 (1177)
T KOG1025|consen  840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP---------  910 (1177)
T ss_pred             EecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh---------
Confidence            999999998765544332 2335779999999999999999999999999999999 99998776554422         


Q ss_pred             hcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       620 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                             +++....+.+.+..+..+++.++.+||..|+..||+++++..++.++.+.
T Consensus       911 -------dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  911 -------DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             -------HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence                   22222333444666778999999999999999999999999999887664

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=354.43  Aligned_cols=244  Identities=27%  Similarity=0.440  Sum_probs=210.7

Q ss_pred             ccccccCcEEEEEEE-cCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchh
Q 004702          407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLF  485 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  485 (735)
                      ++||+|+.|.||.+. ...+..||||++....+...+-+++|+.+|+..+|+|||+++..+...+.+|+|||||++|+|.
T Consensus       279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT  358 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT  358 (550)
T ss_pred             hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence            479999999999997 5568889999999888888888999999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeecccc
Q 004702          486 EHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL  565 (735)
Q Consensus       486 ~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~  565 (735)
                      +.+... .+++.++..|..++++||+|||.++   |+|||||.+|||++.++.+||+|||++..+....... ....||+
T Consensus       359 DvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR-~TmVGTP  433 (550)
T KOG0578|consen  359 DVVTKT-RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR-STMVGTP  433 (550)
T ss_pred             hhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCcc-ccccCCC
Confidence            999765 5999999999999999999999999   9999999999999999999999999999887665544 3456999


Q ss_pred             CccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHH
Q 004702          566 GYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV  645 (735)
Q Consensus       566 ~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  645 (735)
                      .|||||+.....|.+|.||||||++++||+-|.+||....+....-+    +   ..+       .......+...+.++
T Consensus       434 YWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL----I---a~n-------g~P~lk~~~klS~~~  499 (550)
T KOG0578|consen  434 YWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----I---ATN-------GTPKLKNPEKLSPEL  499 (550)
T ss_pred             CccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH----H---hhc-------CCCCcCCccccCHHH
Confidence            99999999999999999999999999999999999987544332111    1   111       111112234566889


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHH
Q 004702          646 AKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       646 ~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+++.+||+.|+++||++.|+++.
T Consensus       500 kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  500 KDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HHHHHHHhhcchhcCCCHHHHhcC
Confidence            999999999999999999999864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-40  Score=346.39  Aligned_cols=259  Identities=24%  Similarity=0.313  Sum_probs=210.9

Q ss_pred             cccccccCcEEEEEEE-cCCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeEEEEecC
Q 004702          406 ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVG  480 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~E~~~  480 (735)
                      .++||+|.||.||+++ +.+|..||+|+++...  +....-..+||.||++|+||||++|.+...+.  ...|||+|||+
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd  201 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD  201 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence            3579999999999998 6779999999988644  44456678999999999999999999999877  68899999997


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      + +|.-++... -.+++.++..++.||+.||+|+|+++   |+|||||.+|||||.+|.+||+|||||+++........+
T Consensus       202 h-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T  277 (560)
T KOG0600|consen  202 H-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYT  277 (560)
T ss_pred             c-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcccc
Confidence            7 888888764 47999999999999999999999999   999999999999999999999999999988877777777


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh--hHhhhcc---
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL--EILDNRI---  633 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~d~~~---  633 (735)
                      ..+-|+.|.|||++.+ ..|+.+.|+||.|+||.||++|++.|....+.+....+....-...+..+.  ++.....   
T Consensus       278 ~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp  357 (560)
T KOG0600|consen  278 SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKP  357 (560)
T ss_pred             cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCC
Confidence            7788999999999887 469999999999999999999999998877666555544332222222221  1110000   


Q ss_pred             -------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          634 -------VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       634 -------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                             ..+.....+....+|+..+|..||.+|.|+.++++
T Consensus       358 ~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  358 QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                   01112223456788999999999999999998874

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=353.88  Aligned_cols=239  Identities=27%  Similarity=0.461  Sum_probs=203.6

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchhH
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE  486 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  486 (735)
                      +-||.|+.|.||+|++.+ +.||||+++...+       .+|+-|++|+|+||+.+.|+|....-++|||||++.|-|.+
T Consensus       130 eWlGSGaQGAVF~Grl~n-etVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~  201 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLHN-ETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE  201 (904)
T ss_pred             hhhccCcccceeeeeccC-ceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence            359999999999999964 5699999764333       46677999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccC
Q 004702          487 HIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG  566 (735)
Q Consensus       487 ~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~  566 (735)
                      .|+...++.......|..+||.|+.|||.+.   |||||||+-||||..+..+||+|||-++.....  ...-.+.||..
T Consensus       202 VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVa  276 (904)
T KOG4721|consen  202 VLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVA  276 (904)
T ss_pred             HHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHh
Confidence            9999999999999999999999999999999   999999999999999999999999999876533  22334569999


Q ss_pred             ccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHH
Q 004702          567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVA  646 (735)
Q Consensus       567 y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~  646 (735)
                      |||||++.+...++|.|||||||||||||||..||.......       ++-.+.        ...+..+.+..+++-+.
T Consensus       277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-------IIwGVG--------sNsL~LpvPstcP~Gfk  341 (904)
T KOG4721|consen  277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-------IIWGVG--------SNSLHLPVPSTCPDGFK  341 (904)
T ss_pred             hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-------eEEecc--------CCcccccCcccCchHHH
Confidence            999999999999999999999999999999999986543211       011111        12223344566778899


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          647 KLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       647 ~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      -|+++||+..|.+||++++++..|+-.
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            999999999999999999999999853

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.5e-40  Score=355.05  Aligned_cols=259  Identities=28%  Similarity=0.386  Sum_probs=204.6

Q ss_pred             HhhhccccccccccCcEEEEEEEc------CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecC
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQ  470 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~  470 (735)
                      ....+.+.++||+|+||.||+|..      ..+..||||+++.. .....+.+.+|+.+|.++ +||||+++++++...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            344566788999999999999973      23467999998743 334456789999999999 8999999999887644


Q ss_pred             -ceeEEEEecCCCchhHHhhhc----------------------------------------------------------
Q 004702          471 -VPLLVYEFVGNGTLFEHIHKK----------------------------------------------------------  491 (735)
Q Consensus       471 -~~~lV~E~~~~gsL~~~l~~~----------------------------------------------------------  491 (735)
                       ..++||||+++|+|.+++...                                                          
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             578999999999999998742                                                          


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-ceeeeccccC
Q 004702          492 ----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLG  566 (735)
Q Consensus       492 ----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~  566 (735)
                          ..+++..+++++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++....+... ......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                24788899999999999999999998   999999999999999999999999999865432221 1122346788


Q ss_pred             ccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHH
Q 004702          567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV  645 (735)
Q Consensus       567 y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  645 (735)
                      |+|||.+.+..++.++||||||++||||++ |..||......+.      +...+..+..         ...+...+.++
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTR---------MRAPENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCC---------CCCCCCCCHHH
Confidence            999999999899999999999999999997 9999865433221      1111111110         11122345678


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          646 AKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       646 ~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      .+|+.+||+.+|.+|||+.||++.|+.++.
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-39  Score=341.35  Aligned_cols=259  Identities=22%  Similarity=0.312  Sum_probs=207.3

Q ss_pred             ccccCHHHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhH---HHHHHHHHHHHHhcCCCceEEEceEE
Q 004702          390 AKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAK---IDEFINELVVVLQINRRNVVRLLGCC  466 (735)
Q Consensus       390 ~~~~~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~  466 (735)
                      .+.++.++|+..+   ...||+|+++.||+|.+ ++..||||+++......   .+.|.+|+.+|++++||||++++|++
T Consensus        12 ~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~   87 (283)
T PHA02988         12 IKCIESDDIDKYT---SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI   87 (283)
T ss_pred             ceecCHHHcCCCC---CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence            3444555553221   23799999999999998 57889999987543322   57788999999999999999999998


Q ss_pred             ee----cCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEE
Q 004702          467 LE----TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKV  541 (735)
Q Consensus       467 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl  541 (735)
                      .+    ....++||||+++|+|.+++.+...+++...++++.|++.||+|||+. +   ++||||||+|||+++++.+||
T Consensus        88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl  164 (283)
T PHA02988         88 IDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKI  164 (283)
T ss_pred             EecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEE
Confidence            77    346789999999999999999888899999999999999999999985 6   889999999999999999999


Q ss_pred             eeccCCcccCCCcccceeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHH
Q 004702          542 SDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS  619 (735)
Q Consensus       542 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  619 (735)
                      +|||+++......    ....|+..|+|||.+.+  ..++.++||||||+++|||++|+.||......+...   .    
T Consensus       165 ~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~---~----  233 (283)
T PHA02988        165 ICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD---L----  233 (283)
T ss_pred             cccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH---H----
Confidence            9999998654322    12347899999999976  689999999999999999999999997654322111   1    


Q ss_pred             hcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       620 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                      +        +........+...+.++.+|+.+||+.||++|||+.||++.|+.+.
T Consensus       234 i--------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        234 I--------INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             H--------HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            1        0000111112235678999999999999999999999999998764

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=350.26  Aligned_cols=265  Identities=27%  Similarity=0.408  Sum_probs=232.0

Q ss_pred             ccCHHHHHhhhccccccccccCcEEEEEEEcCC-CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC
Q 004702          392 IFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ  470 (735)
Q Consensus       392 ~~~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  470 (735)
                      ....+|+++.......+||-|-||.||.|.|+. ...||||.++. +.-.+++|+.|..+|+.++|||+|+|+|+|..+.
T Consensus       258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            447788888888888999999999999999875 56799999874 4456899999999999999999999999999999


Q ss_pred             ceeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK  548 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~  548 (735)
                      ..|||.|||.+|+|.++|++-  ..++.-.++.++.||+.|++||..++   +|||||.++|.||.++..+||+||||++
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence            999999999999999999863  45777888999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       549 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ++..+.........-.+.|.|||.+....++.|+|||+|||+|||+.| |-.||....-                ..+..
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------------SqVY~  477 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYG  477 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------------HHHHH
Confidence            998766554444456789999999999999999999999999999999 7778754322                22345


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      +++..+.-+.+..+++.+++||+.||+.+|.+||+++|+.+.++.++..
T Consensus       478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            5666666677778899999999999999999999999999999977653

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=333.91  Aligned_cols=257  Identities=27%  Similarity=0.386  Sum_probs=208.2

Q ss_pred             hccccccccccCcEEEEEEE-cCCCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          402 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .|.+.++||.|..++||+|+ .+.+..||||++.... ..+.+.+.+|+..|+.++||||++++-.|..+..+|+||.||
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM  106 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM  106 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence            35567899999999999998 6678999999987532 334688899999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-  556 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-  556 (735)
                      .+|++.++++..  ..+++..+..|+.++++||.|||.++   .||||||+.||||+.+|.+||+|||.+..+...... 
T Consensus       107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence            999999999874  45999999999999999999999999   999999999999999999999999988766432221 


Q ss_pred             --ceeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          557 --NCTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       557 --~~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                        ......||+.|||||++..  ..|+.|+||||||++..||.+|..||....+...  +.    ..+. +......-..
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll----~tLq-n~pp~~~t~~  256 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LL----LTLQ-NDPPTLLTSG  256 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HH----HHhc-CCCCCccccc
Confidence              1134579999999999543  5699999999999999999999999976655332  11    1111 1111111112


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +..+..+.....+.+++..||+.||.+|||++++++
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            222334455678999999999999999999999875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-40  Score=344.38  Aligned_cols=246  Identities=23%  Similarity=0.339  Sum_probs=208.0

Q ss_pred             cccccccccCcEEEEEEE-cCCCcEEEEEEeec---cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEe
Q 004702          404 NYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKF---VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .|+++||.|+|++|++++ ...+..+|||++.+   ..+...+-...|-.+|.+| +||.|++|+-.+.++..+|+|+||
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~  155 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY  155 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence            478899999999999998 45688999998753   3444455566788899999 899999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc--
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ--  556 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~--  556 (735)
                      +++|+|.++|++.+.+++.....++.||+.||+|||+.+   ||||||||+|||||+|+++||+|||.++.+......  
T Consensus       156 A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~  232 (604)
T KOG0592|consen  156 APNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE  232 (604)
T ss_pred             cCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence            999999999999999999999999999999999999999   999999999999999999999999999987532211  


Q ss_pred             --------c--eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          557 --------N--CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       557 --------~--~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                              .  ...++||..|.+||++.....+..+|+|+|||+||+|+.|++||....+......              
T Consensus       233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk--------------  298 (604)
T KOG0592|consen  233 NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK--------------  298 (604)
T ss_pred             CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH--------------
Confidence                    1  1447799999999999999999999999999999999999999976654332211              


Q ss_pred             hHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       627 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                       |++  +..+++...++.+.+|+.+.|..||.+|+|..||-+.
T Consensus       299 -I~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  299 -IQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -HHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence             111  1123344455788999999999999999999877654

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=352.04  Aligned_cols=266  Identities=27%  Similarity=0.462  Sum_probs=213.2

Q ss_pred             cCHHHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC
Q 004702          393 FTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ  470 (735)
Q Consensus       393 ~~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  470 (735)
                      ..++||......+.+.||+|.||+||+|.+.+  .||||+++.  ...+..+.|++|+.++++-+|.||+-++|+|....
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            35566766666778899999999999999854  499999875  45567899999999999999999999999999887


Q ss_pred             ceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      . .||.-++++.+|+.+|+.. ..+...+.+.||.|||+|+.|||.++   |||||||+.||+|.++++|||+||||+..
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence            7 8999999999999999964 56899999999999999999999999   99999999999999999999999999864


Q ss_pred             cCCC-cccceeeeccccCccCcccccC---CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          550 VPID-AIQNCTVVQGTLGYLDPEYLQT---CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       550 ~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                      ...- .........|...|||||++..   .+|+..|||||||+|+|||++|..||. ....+..      +-.+..+.+
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqI------ifmVGrG~l  610 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQI------IFMVGRGYL  610 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhhe------EEEeccccc
Confidence            3221 1111222347889999999864   468999999999999999999999997 3332211      001111100


Q ss_pred             hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       626 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .  .|  . ........+++.+|+..||..++++||.+.+|+..|+.++..
T Consensus       611 ~--pd--~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  611 M--PD--L-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             C--cc--c-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            0  00  0 001224557899999999999999999999999999988775

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=334.41  Aligned_cols=266  Identities=26%  Similarity=0.357  Sum_probs=200.0

Q ss_pred             cccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHh--cCCCceEEEceEEeecC----ceeEEEE
Q 004702          404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQ--INRRNVVRLLGCCLETQ----VPLLVYE  477 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lV~E  477 (735)
                      .+.++||+|.||.||||.+.+ +.||||++.   ..+.+.|.+|-.|.+.  +.|+||+++++.-....    .++||+|
T Consensus       213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             hhHHHhhcCccceeehhhccC-ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            456789999999999999865 789999976   4556778888887765  57999999999876555    7899999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET------NVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~------~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      |.+.|+|.++|+.+ .++|....+|+..+++||+|||+..      +++|+|||||++||||.+|++.-|+|||||..+.
T Consensus       289 fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  289 FHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             eccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            99999999999875 7999999999999999999999863      5789999999999999999999999999999876


Q ss_pred             CCccc-ceeeeccccCccCcccccCC-CCC-----ccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc-
Q 004702          552 IDAIQ-NCTVVQGTLGYLDPEYLQTC-KLT-----DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN-  623 (735)
Q Consensus       552 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~-----~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-  623 (735)
                      ..... ......||.+|||||++.+. .+.     .+.||||+|.|||||+++-..+......+   +..-|...+... 
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~---Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE---YQLPFEAEVGNHP  444 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc---ccCchhHHhcCCC
Confidence            44332 22335699999999999763 233     37899999999999999655432111111   011111111111 


Q ss_pred             ---chhhH-hhhcccCCCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          624 ---RLLEI-LDNRIVNDGNK-----QQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       624 ---~~~~~-~d~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                         .+.+. +..+.+...+.     ..+.-|.+.+..||..||+.|.|+.=|.+++..+....
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence               11111 11111111111     23467899999999999999999999999998766543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.3e-40  Score=321.65  Aligned_cols=257  Identities=23%  Similarity=0.274  Sum_probs=201.6

Q ss_pred             cccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          408 VIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      ++|+|+||+|||.+.+ .|+.||||++....  +.-.+-.++|+++|++|+|+|+|.|+.+|.....++||+||++.--|
T Consensus         9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL   88 (396)
T KOG0593|consen    9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVL   88 (396)
T ss_pred             ccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHH
Confidence            7999999999999965 58999999986532  33345568999999999999999999999999999999999977444


Q ss_pred             hHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccc
Q 004702          485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT  564 (735)
Q Consensus       485 ~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt  564 (735)
                      +++-+....++.+.+.+++.|+++|+.|+|+++   +|||||||+||||+.++.+||+|||+|+.+.. .....+....|
T Consensus        89 ~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVAT  164 (396)
T KOG0593|consen   89 HELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVAT  164 (396)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhhhhhh
Confidence            444334467999999999999999999999999   99999999999999999999999999998763 22334556689


Q ss_pred             cCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc--------cc------hhhHh
Q 004702          565 LGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ--------NR------LLEIL  629 (735)
Q Consensus       565 ~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~~------~~~~~  629 (735)
                      ..|.|||.+.+ .+|....|||++|+++.||++|.+-|....+.+..-.+...+..+..        +.      +.+.-
T Consensus       165 RWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~  244 (396)
T KOG0593|consen  165 RWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPE  244 (396)
T ss_pred             hhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCC
Confidence            99999999887 78999999999999999999999988776665544333322211111        11      11111


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ++.-.+......+.-+.+++..||+.||.+|++-+|++.
T Consensus       245 ~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  245 HPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111111122234457899999999999999999999874

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.7e-39  Score=336.77  Aligned_cols=256  Identities=20%  Similarity=0.340  Sum_probs=207.5

Q ss_pred             HhhhccccccccccCcEEEEEEEcC----CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      ....+.+.++||+|+||.||+|.+.    .+..||+|.++.. .......|.+|+.++.+++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3445667889999999999999753    3568999998754 3344567899999999999999999999999999999


Q ss_pred             EEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          474 LVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      +||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||.+.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999764 57899999999999999999999998   99999999999999999999999998765432


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      ..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ...+...        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~-------~~~~~~~--------  224 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-------IKAVEDG--------  224 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHHCC--------
Confidence            22222222235678999999999999999999999999999875 9999976543321       1111111        


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                       ...+.+...+..+.+++.+||+.+|.+||++.||.+.|+++
T Consensus       225 -~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 -FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence             11112234557899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=342.76  Aligned_cols=244  Identities=26%  Similarity=0.397  Sum_probs=209.9

Q ss_pred             cccccccCcEEEEEEEc-CCCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          406 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .+.||+|+||.||+|.. ..++.||+|.+.. ....+++++.+|+.+|.+++++||.+++|.+..+..++++|||+.+|+
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs   97 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS   97 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence            47899999999999985 4578899999874 455567889999999999999999999999999999999999999999


Q ss_pred             hhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeecc
Q 004702          484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG  563 (735)
Q Consensus       484 L~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~g  563 (735)
                      +.+.|+....+.+..+.-|+.+++.||.|||+++   .+|||||+.||||..++.+||+|||.+..+....... ....|
T Consensus        98 v~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfvG  173 (467)
T KOG0201|consen   98 VLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFVG  173 (467)
T ss_pred             hhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc-ccccc
Confidence            9999998877789999999999999999999999   9999999999999999999999999998887665555 45679


Q ss_pred             ccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHH
Q 004702          564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK  643 (735)
Q Consensus       564 t~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  643 (735)
                      |+.|||||++....|+.|+||||||++.+||++|.+|+....+..                +.-++-...........++
T Consensus       174 TPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP~L~~~~S~  237 (467)
T KOG0201|consen  174 TPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPPRLDGDFSP  237 (467)
T ss_pred             cccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCCccccccCH
Confidence            999999999998899999999999999999999999997665522                1111111111112225667


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          644 EVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       644 ~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+.+++..||+.+|+.||++.++++.
T Consensus       238 ~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  238 PFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            89999999999999999999998853

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-40  Score=345.27  Aligned_cols=260  Identities=25%  Similarity=0.406  Sum_probs=224.0

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcCC---C--cEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLPD---R--TPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ  470 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  470 (735)
                      +|.+....+.++||.|-||.||+|++.+   |  -.||||.-+. ....+.+.|+.|..+|++++||||++|+|+|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            3444444566799999999999998532   2  3588998775 666778999999999999999999999999976 4


Q ss_pred             ceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      ..|||||.++-|.|..+|+.+ ..|+......++.||..||+|||+..   +|||||..+||||...--+||+|||+++.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence            669999999999999999876 57999999999999999999999999   99999999999999999999999999999


Q ss_pred             cCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhH
Q 004702          550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEI  628 (735)
Q Consensus       550 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (735)
                      +..+.....+...-++.|||||.+.-.+++.+||||.|||.+||++. |.+||......+.                .-.
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------------I~~  604 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------------IGH  604 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------EEE
Confidence            98887777666667889999999999999999999999999999998 9999987654331                112


Q ss_pred             hhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       629 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      ++..-..+.+..+++.|+.|+.+||+.+|.+||++.|+...|..++..
T Consensus       605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence            233334455677889999999999999999999999999999998873

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.2e-39  Score=350.14  Aligned_cols=259  Identities=25%  Similarity=0.377  Sum_probs=205.0

Q ss_pred             HHHhhhccccccccccCcEEEEEEEc------CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEee
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLE  468 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~  468 (735)
                      ++....+.+.+.||+|+||.||+++.      ..+..||||+++.. .....+.+.+|+.+|..+ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            34444567788999999999999963      23568999998743 334456789999999999 89999999999999


Q ss_pred             cCceeEEEEecCCCchhHHhhhc---------------------------------------------------------
Q 004702          469 TQVPLLVYEFVGNGTLFEHIHKK---------------------------------------------------------  491 (735)
Q Consensus       469 ~~~~~lV~E~~~~gsL~~~l~~~---------------------------------------------------------  491 (735)
                      .+..++||||+++|+|.++++..                                                         
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            99999999999999999998642                                                         


Q ss_pred             ------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          492 ------------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       492 ------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                                        ..+++..+++++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                              14788899999999999999999998   999999999999999999999999999866433


Q ss_pred             cccc-eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          554 AIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       554 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++ |..||........      +...+..+        
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~~~~~--------  333 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKMIKEG--------  333 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHHHHhC--------
Confidence            2211 112235678999999999999999999999999999998 8888865432211      11111111        


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                       .....+...+.++.+|+.+||+.+|++|||+.||++.|++.
T Consensus       334 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         334 -YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             11111112346799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.1e-39  Score=336.21  Aligned_cols=247  Identities=38%  Similarity=0.559  Sum_probs=196.5

Q ss_pred             ccccccccCcEEEEEEEcC-----CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          405 YADVIGCGGSGNVYKGFLP-----DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.. .....++|.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999976     2567999999753 445588999999999999999999999999988889999999


Q ss_pred             cCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC-cc
Q 004702          479 VGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID-AI  555 (735)
Q Consensus       479 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~-~~  555 (735)
                      +++|+|.++|+..  ..+++..++.|+.|+++||+|||+++   ++|+||+++||||++++.+||+|||++...... ..
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            9999999999986  78999999999999999999999998   999999999999999999999999999876322 12


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+......+       +...+.....         
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~~---------  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQR---------  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTEE---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccccc---------
Confidence            22222347789999999999889999999999999999999 678876553322       1111111111         


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      ...+...+..+.+++.+||+.+|++|||+.+++++|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            112223456789999999999999999999999887

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.6e-39  Score=309.76  Aligned_cols=259  Identities=22%  Similarity=0.244  Sum_probs=207.2

Q ss_pred             cccccccCcEEEEEEE-cCCCcEEEEEEeeccChh--HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          406 ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQA--KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      .++||+|.||.||+|+ ...++.||||+++..+..  -....++|++.|+.++|+||+.|++++...+...||+|||+. 
T Consensus         7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-   85 (318)
T KOG0659|consen    7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-   85 (318)
T ss_pred             hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence            4689999999999998 567899999998854332  234578999999999999999999999999999999999965 


Q ss_pred             chhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|+..++.+ ..++..++..++.++++||+|+|++.   |+||||||.|+|++.++.+||+|||+++.+.......... 
T Consensus        86 dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~-  161 (318)
T KOG0659|consen   86 DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ-  161 (318)
T ss_pred             cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc-
Confidence            899999876 57899999999999999999999999   9999999999999999999999999999887544333222 


Q ss_pred             ccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH------hhhccc
Q 004702          562 QGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI------LDNRIV  634 (735)
Q Consensus       562 ~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~d~~~~  634 (735)
                      .-|..|.|||.+.+ ..|+...|+||.|+++.||+-|.+-|....+.+....+...+-.-.++.+.++      ++-+..
T Consensus       162 V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~  241 (318)
T KOG0659|consen  162 VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQF  241 (318)
T ss_pred             eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcC
Confidence            57899999998876 56999999999999999999988777776666655554433322222222221      111111


Q ss_pred             C-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          635 N-----DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       635 ~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .     ........++.+|+..+|..||.+|+|+.|++++
T Consensus       242 P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  242 PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1     1122344677999999999999999999998853

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.6e-38  Score=337.61  Aligned_cols=259  Identities=24%  Similarity=0.334  Sum_probs=201.5

Q ss_pred             hhccccccccccCcEEEEEEEcCC-----------------CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPD-----------------RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRL  462 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l  462 (735)
                      -.+.+.++||+|+||.||++.+++                 +..||+|.++.. ......+|.+|+.+|.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            345667899999999999997532                 336999988753 34456789999999999999999999


Q ss_pred             ceEEeecCceeEEEEecCCCchhHHhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 004702          463 LGCCLETQVPLLVYEFVGNGTLFEHIHKK-------------------GNLSWERRLRITAETAGVLSYLHSETNVPIIH  523 (735)
Q Consensus       463 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH  523 (735)
                      ++++.+.+..++||||+++++|.+++...                   ..+++..+++++.|++.||+|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            99999999999999999999999998643                   24688899999999999999999998   999


Q ss_pred             cCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh--CCcc
Q 004702          524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT--GKMA  600 (735)
Q Consensus       524 ~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt--G~~p  600 (735)
                      |||||+|||+++++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999865432221 1122235789999999988899999999999999999987  5567


Q ss_pred             CCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          601 LLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      |......+.........   ....      .......+...+..+.+|+.+||+.+|++|||+.||.+.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQVIENAGEFF---RDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHHHHHHHHHHh---hhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            76544332221111111   1000      00001112234567899999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=337.48  Aligned_cols=261  Identities=22%  Similarity=0.271  Sum_probs=207.8

Q ss_pred             hccccccccccCcEEEEEEE-cCCCcEEEEEEeeccChhHHHH--HHHHHHHHHhcC-CCceEEEceEEeecC-ceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDE--FINELVVVLQIN-RRNVVRLLGCCLETQ-VPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~lV~  476 (735)
                      +|...++||.|.||.||+|+ ...+..||||+++..-.. +++  -++|++.|++|+ ||||++|..++.+.+ .+++||
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            44556789999999999998 567889999998753332 333  358999999999 999999999999988 899999


Q ss_pred             EecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||+. +|+++++.+ ..+++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+||.+..  .
T Consensus        90 E~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S--k  163 (538)
T KOG0661|consen   90 EFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS--K  163 (538)
T ss_pred             Hhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc--C
Confidence            99954 999999876 67999999999999999999999999   99999999999999888999999999997653  3


Q ss_pred             cceeeeccccCccCccccc-CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh------H
Q 004702          556 QNCTVVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE------I  628 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  628 (735)
                      ...+...-|..|+|||++. ..-|+.+.|+|++|+|++||.+-++-|.+..+.++...+-..+..-.+..+.+      .
T Consensus       164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence            4456677899999999875 56799999999999999999999988877766555444333322222222111      1


Q ss_pred             hhhcc---cC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          629 LDNRI---VN----DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       629 ~d~~~---~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +.-++   ..    ..-...+.+..+|+.+|++.||.+|||+.|.++.
T Consensus       244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11111   10    0112255789999999999999999999998865

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-38  Score=328.14  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=208.8

Q ss_pred             HHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      +......+.+.||+|++|.||+|...++..||+|.++... ...+++.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            3445567788999999999999998778889999987543 235678999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          478 FVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999997653  6899999999999999999999998   99999999999999999999999999987653322


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      ........+..|+|||++.+..++.++||||||+++|||++ |+.||..........       .+..         ...
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~---------~~~  222 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-------QVDQ---------GYR  222 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-------HHHc---------CCC
Confidence            22222223468999999999899999999999999999999 888886543322111       1111         111


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      .......+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            111223457899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2e-38  Score=346.35  Aligned_cols=259  Identities=25%  Similarity=0.409  Sum_probs=205.0

Q ss_pred             HHhhhccccccccccCcEEEEEEEc------CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeec
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLET  469 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  469 (735)
                      +....+.+.+.||+|+||.||+++.      .++..||||+++.. .....+.+.+|+.+++.+ +|+||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            3444566788999999999999873      22357999998743 344467788999999999 899999999999999


Q ss_pred             CceeEEEEecCCCchhHHhhhc----------------------------------------------------------
Q 004702          470 QVPLLVYEFVGNGTLFEHIHKK----------------------------------------------------------  491 (735)
Q Consensus       470 ~~~~lV~E~~~~gsL~~~l~~~----------------------------------------------------------  491 (735)
                      +..++||||+++|+|.++++..                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999998642                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc-e
Q 004702          492 ------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-C  558 (735)
Q Consensus       492 ------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~-~  558 (735)
                                  .++++.++++|+.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++......... .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                        24788899999999999999999998   9999999999999999999999999998654332211 1


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....++..|||||++....++.++||||||+++|||++ |+.||........      +.....         .......
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~---------~~~~~~~  336 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVK---------RGYQMSR  336 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHH---------cccCccC
Confidence            12235678999999998899999999999999999997 9999865432211      011111         1111111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                      +...+.++.+++.+||+.+|.+|||+.+|++.|++++
T Consensus       337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            1123468999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=338.69  Aligned_cols=245  Identities=25%  Similarity=0.348  Sum_probs=202.8

Q ss_pred             hccccccccccCcEEEEEEE-cCCCcEEEEEEeecc----Ch-hHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFV----DQ-AKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.+.||+|+||+|+.|. ...+..||+|.+...    .. ...+.+.+|+.++++++ ||||++++.+.......++
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i   97 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI   97 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence            45567899999999999997 456799999965542    11 23445567999999999 9999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEeeccCCcccCCC
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-CTPKVSDFGASKLVPID  553 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGls~~~~~~  553 (735)
                      ||||+.+|+|.+++.+.+++.+..+.+++.|++.|++|+|+.+   |+||||||+|||++.+ +++||+|||++.... .
T Consensus        98 vmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~  173 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP-G  173 (370)
T ss_pred             EEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC-C
Confidence            9999999999999999889999999999999999999999999   9999999999999999 999999999999874 1


Q ss_pred             cccceeeeccccCccCcccccCCC-CC-ccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCK-LT-DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      .........|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||........       ...+..+        
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-------~~ki~~~--------  238 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-------YRKIRKG--------  238 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-------HHHHhcC--------
Confidence            222334556999999999999977 76 689999999999999999999976332211       1111111        


Q ss_pred             cccCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHH
Q 004702          632 RIVNDGNKQQ-LKEVAKLAARCISVRGEERPTMKEVS  667 (735)
Q Consensus       632 ~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~ev~  667 (735)
                      .+.-  +... +.++..|+.+||..+|.+|+|+.+|+
T Consensus       239 ~~~~--p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 EFKI--PSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             CccC--CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            1111  1112 67899999999999999999999998

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.8e-38  Score=326.91  Aligned_cols=252  Identities=24%  Similarity=0.414  Sum_probs=206.8

Q ss_pred             hhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      ..+.+.++||+|+||.||+|...++..||+|++.... ...+.+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            3445678999999999999998888889999876433 346789999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          481 NGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       481 ~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|.++++..  ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++..........
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR  161 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence            99999999753  56899999999999999999999988   99999999999999999999999999987654332222


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....++..|+|||++....++.++||||||+++|||++ |+.||......+...       .+....         ..+.
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-------~~~~~~---------~~~~  225 (261)
T cd05072         162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS-------ALQRGY---------RMPR  225 (261)
T ss_pred             CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHH-------HHHcCC---------CCCC
Confidence            23346778999999998889999999999999999998 899986543322111       111110         0111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      ....+.++.+++.+||+.+|++||++.++++.|++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            12244678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.3e-38  Score=338.19  Aligned_cols=241  Identities=24%  Similarity=0.290  Sum_probs=199.9

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ++||+|+||.||++.. .++..||||+++..   .......+++|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999985 46889999988742   3344567889999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      +|.+++.....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...... .......
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~  156 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC  156 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccccee
Confidence            99999988888999999999999999999999998   9999999999999999999999999987532221 1223345


Q ss_pred             cccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHH
Q 004702          563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL  642 (735)
Q Consensus       563 gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  642 (735)
                      ||+.|+|||.+.+..++.++||||||+++|||++|+.||...........       +....          ...+....
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~-------~~~~~----------~~~p~~~~  219 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL-------ILMEE----------IRFPRTLS  219 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH-------HHcCC----------CCCCCCCC
Confidence            99999999999999999999999999999999999999976443221111       10000          01122345


Q ss_pred             HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          643 KEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       643 ~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      .++.+|+.+||+.||++||     ++.++++
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            7789999999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.2e-38  Score=326.42  Aligned_cols=253  Identities=26%  Similarity=0.387  Sum_probs=206.6

Q ss_pred             hhccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      ....+.+.||+|+||.||+|... .+..||+|.++.. .....++.+|+.++++++|+||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            34556778999999999999854 4788999987643 334678999999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      ++++|.+++...  ..+++..++.++.|+++||+|||+.+   ++||||||+|||+++++.+||+|||++..........
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            999999999754  46899999999999999999999998   9999999999999999999999999998765432222


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+..       ..+.         .....+
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~---------~~~~~~  225 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLE---------KGYRME  225 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHH---------CCCCCC
Confidence            222234678999999998899999999999999999998 88888654332211       1111         111112


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      .+...+.++.+++.+||+.+|++|||+.+++++|+.+
T Consensus       226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            2233457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.1e-38  Score=324.47  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=202.6

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ..+.+.||+|+||.||++.++++..+|+|.++... ...++|.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   84 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG   84 (256)
T ss_pred             cEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence            34567899999999999998888889999876432 23467899999999999999999999999999999999999999


Q ss_pred             chhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|.++++.. ..+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.............
T Consensus        85 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05114          85 CLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA  161 (256)
T ss_pred             cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence            999999754 56899999999999999999999998   99999999999999999999999999986543332222233


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      .++..|+|||.+....++.++||||||+++|||++ |+.||......+...       .+.....         ...+..
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~-------~i~~~~~---------~~~~~~  225 (256)
T cd05114         162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE-------MISRGFR---------LYRPKL  225 (256)
T ss_pred             CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHCCCC---------CCCCCC
Confidence            35678999999998889999999999999999999 888986554322111       1111110         011112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      .+.++.+|+.+||+.+|++||++.|+++.|
T Consensus       226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.8e-38  Score=329.59  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=205.0

Q ss_pred             ccccccccccCcEEEEEEEcCC------CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      ..+.+.||+|+||.||+|....      ...||+|.++.. ......+|.+|+.++.+++||||+++++++...+..+++
T Consensus         7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   86 (283)
T cd05048           7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML   86 (283)
T ss_pred             cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence            4567789999999999998543      257999988643 344456789999999999999999999999998899999


Q ss_pred             EEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCe
Q 004702          476 YEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP  539 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~  539 (735)
                      |||+++++|.+++...                ..+++..++.++.|+++||+|||+.+   ++|+||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05048          87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTV  163 (283)
T ss_pred             EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcE
Confidence            9999999999999754                45888999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHH
Q 004702          540 KVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFL  617 (735)
Q Consensus       540 kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  617 (735)
                      ||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+..       
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~-------  236 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI-------  236 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------
Confidence            9999999986533221 11222346788999999998899999999999999999998 99998765443211       


Q ss_pred             HHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       618 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      ..+...         .....+...+.++.+|+.+||+.+|.+||++.||++.|+.
T Consensus       237 ~~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EMIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            111111         1112234556889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.3e-38  Score=329.45  Aligned_cols=247  Identities=24%  Similarity=0.282  Sum_probs=198.7

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      ...+.||+|+||+||++.. .++..||+|.+....   ......+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05631           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence            3457899999999999985 568899999876432   223456789999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      ++|+|.+++...  ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++........  
T Consensus        83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  157 (285)
T cd05631          83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--  157 (285)
T ss_pred             CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--
Confidence            999999888643  46899999999999999999999998   99999999999999999999999999987543222  


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....|+..|+|||++.+..++.++||||||++||||++|+.||............   ...+..          .....
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~----------~~~~~  224 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKE----------DQEEY  224 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhc----------ccccC
Confidence            22345899999999999999999999999999999999999999765432211111   111110          00112


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPT-----MKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  668 (735)
                      +...+.++.+|+.+||+.+|.+||+     +.++++
T Consensus       225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            2334568899999999999999997     566554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.5e-38  Score=330.50  Aligned_cols=263  Identities=20%  Similarity=0.218  Sum_probs=203.3

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||+||+++.. ++..||+|+++..  .....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV   82 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence            455678999999999999865 5788999988743  2334567889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      +++.|..+......+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...........
T Consensus        83 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          83 EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            98877766555567999999999999999999999998   999999999999999999999999999876543333333


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch---------hhHhh
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL---------LEILD  630 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~d  630 (735)
                      ...|++.|+|||++.+..++.++||||||+++|||++|+.||......+...........+....+         .....
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            445899999999999888999999999999999999999999765443322221111111000000         00000


Q ss_pred             hcccC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 NRIVN------DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 ~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +....      ......+.++.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000      001123467999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=380.90  Aligned_cols=259  Identities=27%  Similarity=0.399  Sum_probs=205.5

Q ss_pred             ccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          405 YADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      ..++||+|+||.||+|.. .++..||||+++......    ..|++.+++++|||||+++|++.+.+..++||||+++|+
T Consensus       694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~  769 (968)
T PLN00113        694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN  769 (968)
T ss_pred             cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence            456899999999999985 578899999986543221    346888999999999999999999999999999999999


Q ss_pred             hhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeecc
Q 004702          484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG  563 (735)
Q Consensus       484 L~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~g  563 (735)
                      |.++++.   ++|..+.+|+.|+++||+|||+...++|+||||||+||+++.++.+++. |+.......+     ....+
T Consensus       770 L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~  840 (968)
T PLN00113        770 LSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFI  840 (968)
T ss_pred             HHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccc
Confidence            9999963   8999999999999999999997655569999999999999999888875 6665543221     12247


Q ss_pred             ccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC--CCCHHH
Q 004702          564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN--DGNKQQ  641 (735)
Q Consensus       564 t~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~  641 (735)
                      +..|||||++.+..++.|+||||||+++|||+||+.||...... ......+............++|+.+..  ....+.
T Consensus       841 t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  919 (968)
T PLN00113        841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE  919 (968)
T ss_pred             cccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHHH
Confidence            89999999999999999999999999999999999998533221 112222222222333344455555433  234566


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ..++.+++.+||+.+|++||||.||+++|+.+.+..
T Consensus       920 ~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        920 IVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            778999999999999999999999999999876643

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=334.17  Aligned_cols=242  Identities=27%  Similarity=0.310  Sum_probs=199.0

Q ss_pred             ccccCcEEEEEEEcC-CCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          409 IGCGGSGNVYKGFLP-DRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       409 lG~G~~g~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      ||+|+||.||++... ++..||+|+++.   ........+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999854 578899998864   2344567788999999999999999999999999999999999999999


Q ss_pred             hHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccc
Q 004702          485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT  564 (735)
Q Consensus       485 ~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt  564 (735)
                      .+++.....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... .......||
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt  156 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT  156 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence            999988888999999999999999999999998   9999999999999999999999999998643222 122334589


Q ss_pred             cCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHH
Q 004702          565 LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE  644 (735)
Q Consensus       565 ~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  644 (735)
                      +.|+|||.+.+..++.++||||||+++|||++|+.||......+..       ..+...        .  ...+.....+
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-------~~~~~~--------~--~~~~~~~~~~  219 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-------RKILQE--------P--LRFPDGFDRD  219 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH-------HHHHcC--------C--CCCCCcCCHH
Confidence            9999999999999999999999999999999999999764432211       111110        0  1112234567


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          645 VAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       645 l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      +.+++.+||+.+|.+||++..+.+.|.
T Consensus       220 ~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         220 AKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            899999999999999997655555444

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-37  Score=335.33  Aligned_cols=263  Identities=23%  Similarity=0.297  Sum_probs=204.6

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+...+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+++|++++||||+++++++...+..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   85 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence            3445678999999999999854 5788999987753 3445677999999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      ++++|.+++.....+++..+..++.|++.||+|||+.+  .|+||||||+|||++.++.+||+|||++.......   ..
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~  160 (331)
T cd06649          86 DGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN  160 (331)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc---cc
Confidence            99999999988888999999999999999999999863  29999999999999999999999999987653321   12


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHH--------------------
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS--------------------  619 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--------------------  619 (735)
                      ...|+..|+|||.+.+..++.++||||||+++|||++|+.||......+...........                    
T Consensus       161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd06649         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV  240 (331)
T ss_pred             cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence            345899999999999989999999999999999999999999654432211110000000                    


Q ss_pred             -------hcccchhhHhhh----cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          620 -------LKQNRLLEILDN----RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       620 -------~~~~~~~~~~d~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                             .......+..+.    ............++.+|+.+||+.||++|||+.||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                   000000011110    00000112345789999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.2e-37  Score=328.31  Aligned_cols=258  Identities=28%  Similarity=0.397  Sum_probs=209.6

Q ss_pred             hhhccccccccccCcEEEEEEEc------CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      ...+.+.+.||+|+||+||++..      .++..+|+|.+........+.+.+|+.++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            34455678999999999999974      234568999988766677788999999999999999999999999999999


Q ss_pred             EEEEecCCCchhHHhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 004702          474 LVYEFVGNGTLFEHIHKKG-------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPK  540 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k  540 (735)
                      +||||+++++|.+++....             .+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999997532             4899999999999999999999998   99999999999999999999


Q ss_pred             EeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHH
Q 004702          541 VSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLS  618 (735)
Q Consensus       541 l~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  618 (735)
                      |+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |+.||......+.       ..
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-------~~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------IE  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HH
Confidence            999999986543221 11122335778999999998899999999999999999999 8888865543221       11


Q ss_pred             HhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       619 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .+..+...         ..+...+.++.+|+.+||+.+|.+|||+.||+..|+.+.+.
T Consensus       234 ~i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         234 CITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            11111111         11122346799999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.2e-38  Score=323.69  Aligned_cols=249  Identities=27%  Similarity=0.403  Sum_probs=203.0

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      +.+.+.||+|+||+||++...++..+|+|.++... ...++|.+|+.++++++||||+++++++.+.+..++||||+.++
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG   84 (256)
T ss_pred             eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence            45677899999999999998777789999877433 23467899999999999999999999999888899999999999


Q ss_pred             chhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|.+++... ..+++..+++++.|++.||+|||+.+   ++|+||||+|||+++++.+||+|||+++.............
T Consensus        85 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05113          85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS  161 (256)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence            999999764 46899999999999999999999998   99999999999999999999999999886643322222223


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      .++..|++||.+....++.++||||||+++|||++ |+.||......+...       .+.....         ......
T Consensus       162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~-------~~~~~~~---------~~~~~~  225 (256)
T cd05113         162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE-------KVSQGLR---------LYRPHL  225 (256)
T ss_pred             ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-------HHhcCCC---------CCCCCC
Confidence            35678999999998889999999999999999999 999986544322111       1111100         011112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      .+..+.+++.+||+.+|.+|||+.+|+..|+
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            3478899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-38  Score=337.89  Aligned_cols=251  Identities=23%  Similarity=0.293  Sum_probs=205.6

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||.||+|... ++..||||+++..   .......+.+|+.++.+++||||+++++++...+..++||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            345678999999999999865 5789999998743   233456788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++++|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....    ..
T Consensus        83 ~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~  155 (333)
T cd05600          83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA  155 (333)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence            999999999988888999999999999999999999998   99999999999999999999999999986543    22


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....|++.|+|||++.+..++.++||||||++||||++|+.||......+.......+...+         .........
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------~~~~~~~~~  226 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---------QRPVYDDPR  226 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc---------cCCCCCccc
Confidence            33458999999999999899999999999999999999999997655433222211111000         000000001


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ...+.++.+|+.+||+.+|.+||++.|+++.
T Consensus       227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            2345788999999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.3e-37  Score=341.63  Aligned_cols=262  Identities=24%  Similarity=0.344  Sum_probs=207.4

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcCC------CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcC-CCceEEEceEEe
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKFV-DQAKIDEFINELVVVLQIN-RRNVVRLLGCCL  467 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~  467 (735)
                      .++....+.+.++||+|+||.||+|+...      ...||||+++.. .....+.+++|+.+|++++ ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            34445556677899999999999998421      346999998743 3444578999999999996 999999999999


Q ss_pred             ecCceeEEEEecCCCchhHHhhhc--------------------------------------------------------
Q 004702          468 ETQVPLLVYEFVGNGTLFEHIHKK--------------------------------------------------------  491 (735)
Q Consensus       468 ~~~~~~lV~E~~~~gsL~~~l~~~--------------------------------------------------------  491 (735)
                      +.+..+|||||+++|+|.++|+..                                                        
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999999999988642                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 004702          492 ----------------------------------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANI  531 (735)
Q Consensus       492 ----------------------------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NI  531 (735)
                                                              ..+++..+++++.|+++||+|||+.+   |+||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence                                                    13778889999999999999999998   99999999999


Q ss_pred             EEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHH
Q 004702          532 LLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEE  609 (735)
Q Consensus       532 Ll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~  609 (735)
                      |+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++||||++ |..||........
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            9999999999999999865432221 1122346788999999998899999999999999999997 8888865432211


Q ss_pred             HHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          610 RSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                            +...+...         .....+...+.++.+++.+||+.+|++|||+.+|++.|+.++.
T Consensus       349 ------~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 ------FYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ------HHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                  11111111         1111223445789999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.6e-38  Score=331.77  Aligned_cols=244  Identities=24%  Similarity=0.370  Sum_probs=208.3

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +...+.||+|+||.||||+.+ +...||+|.+.+  ..+++.+...+|+++++.++||||+.++.++....+.++|.||+
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a   83 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA   83 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence            344678999999999999854 567899998764  34556778999999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      .+ +|..+|...+.++++.+..|+.+++.||.|||+.+   |+|||+||.|||++.++.+|++|||+++.+.. .....+
T Consensus        84 ~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vlt  158 (808)
T KOG0597|consen   84 VG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVLT  158 (808)
T ss_pred             hh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-Cceeee
Confidence            76 99999999999999999999999999999999999   99999999999999999999999999998765 334556


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      .+.||+.|||||...++.|+..+|.||+|++|||+++|++||+...-.       +..+.+..+.        .  ..+.
T Consensus       159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-------~Lv~~I~~d~--------v--~~p~  221 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-------QLVKSILKDP--------V--KPPS  221 (808)
T ss_pred             eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-------HHHHHHhcCC--------C--CCcc
Confidence            678999999999999999999999999999999999999999643221       1122221111        1  1133


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+..+..++...|..||.+|.|-.+++.
T Consensus       222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            56678999999999999999999888764

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.6e-38  Score=324.13  Aligned_cols=253  Identities=24%  Similarity=0.398  Sum_probs=210.8

Q ss_pred             hhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      ..+.+.++||.|+||.||+|...++..+++|.+........+++.+|+.+++.++|+||+++++++...+..++||||++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME   85 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence            34556789999999999999988889999999887666667789999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          481 NGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       481 ~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|.++++..  ..+++.++++++.|++.||+|||+.+   |+|+||||+||||++++.+||+|||++.....+.... 
T Consensus        86 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~-  161 (261)
T cd05148          86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS-  161 (261)
T ss_pred             cCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccccc-
Confidence            99999999863  46899999999999999999999998   9999999999999999999999999998764332221 


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....++..|++||.+....++.++||||||+++++|++ |+.||......+...   .    +.         .......
T Consensus       162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~---~----~~---------~~~~~~~  225 (261)
T cd05148         162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD---Q----IT---------AGYRMPC  225 (261)
T ss_pred             cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH---H----HH---------hCCcCCC
Confidence            23346778999999998899999999999999999998 888886544322111   1    11         1111122


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      +...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            334457889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.8e-37  Score=327.56  Aligned_cols=256  Identities=27%  Similarity=0.382  Sum_probs=209.6

Q ss_pred             hccccccccccCcEEEEEEEcC------CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .+.+.+.||+|+||.||++...      ++..+++|.++.......+.+.+|+.++++++|+||+++++++...+..++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV   85 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence            3445678999999999999742      3456899998776666677899999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCe
Q 004702          476 YEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP  539 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~  539 (735)
                      |||+++++|.+++...                ..+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence            9999999999999753                23899999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHH
Q 004702          540 KVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFL  617 (735)
Q Consensus       540 kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  617 (735)
                      ||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..       
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-------  235 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-------  235 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------
Confidence            9999999976543221 11223346788999999999899999999999999999999 99998665443311       


Q ss_pred             HHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       618 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      ..+......         ......+..+.+++.+||+.+|.+|||+.+|+++|+.+.+.
T Consensus       236 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 ECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            111111111         11223456799999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.3e-38  Score=334.69  Aligned_cols=241  Identities=24%  Similarity=0.305  Sum_probs=199.0

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ++||+|+||.||++.. .++..||+|.++..   .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999985 46889999998742   3345567889999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      +|..++.....+++..+..++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++...... .......
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~  156 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFC  156 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccccc
Confidence            99999988888999999999999999999999998   9999999999999999999999999987532221 1222345


Q ss_pred             cccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHH
Q 004702          563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL  642 (735)
Q Consensus       563 gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  642 (735)
                      |++.|+|||.+.+..++.++||||||+++|||++|+.||......+....       +...        ..  ..+...+
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~-------~~~~--------~~--~~p~~~~  219 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-------ILME--------EI--RFPRTLS  219 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-------HhcC--------CC--CCCCCCC
Confidence            89999999999998999999999999999999999999976543321111       0000        00  1122345


Q ss_pred             HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          643 KEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       643 ~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      .++.+|+.+||+.+|++||     ++.++++
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            7889999999999999998     7777764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-37  Score=322.12  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=205.1

Q ss_pred             ccccccccccCcEEEEEEEcCC----CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      +.+.+.||+|+||.||+|.+..    ...||||.++.. ......+|.+|+.++++++||||+++++++...+..++|||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   85 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE   85 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence            4567899999999999998642    457999987643 34456789999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc-c
Q 004702          478 FVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA-I  555 (735)
Q Consensus       478 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~-~  555 (735)
                      |+++++|.+++... ..+++..+++++.|++.||+|||+.+   |+|+||||+|||+++++.+||+|||+++...... .
T Consensus        86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence            99999999999764 47899999999999999999999988   9999999999999999999999999998775211 1


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+..       ..+...         ..
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-------~~~~~~---------~~  226 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-------KAVEDG---------YR  226 (266)
T ss_pred             eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-------HHHHcC---------CC
Confidence            11122235678999999998899999999999999999998 99998654332211       111111         01


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      .+.+...+..+.+|+.+||+.+|++||++.||++.|+.+
T Consensus       227 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.3e-37  Score=326.32  Aligned_cols=252  Identities=28%  Similarity=0.417  Sum_probs=205.3

Q ss_pred             hhccccccccccCcEEEEEEEcCC------CcEEEEEEeeccChh-HHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKFVDQA-KIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      .++.+.+.||+|+||.||+|...+      +..||||.++..... ..+.+.+|+++|+.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            445667899999999999998533      478999998754433 5678999999999999999999999999999999


Q ss_pred             EEEEecCCCchhHHhhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCe
Q 004702          474 LVYEFVGNGTLFEHIHKK--------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP  539 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~  539 (735)
                      +||||+++++|.+++...              ..+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            999999999999999754              24789999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHH
Q 004702          540 KVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFL  617 (735)
Q Consensus       540 kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  617 (735)
                      ||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+...      
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~------  235 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE------  235 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH------
Confidence            9999999976532221 11222335788999999999999999999999999999999 999987654433211      


Q ss_pred             HHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       618 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                       .+..+..         ...+...+..+.+++.+||+.+|++|||+.||++.|+
T Consensus       236 -~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 -CITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             1111111         1112234578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-37  Score=334.26  Aligned_cols=242  Identities=24%  Similarity=0.290  Sum_probs=200.1

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ++||+|+||.||++.. .++..||+|+++..   .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999985 46889999998742   3445677889999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      +|.+++.....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...... .......
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~  156 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFC  156 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccccc
Confidence            99999988888999999999999999999999998   9999999999999999999999999987543221 1223345


Q ss_pred             cccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHH
Q 004702          563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL  642 (735)
Q Consensus       563 gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  642 (735)
                      ||+.|+|||.+.+..++.++||||||++||||++|+.||......+...       .+....          ...+....
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~-------~~~~~~----------~~~p~~~~  219 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------LILMED----------IKFPRTLS  219 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH-------HhccCC----------ccCCCCCC
Confidence            8999999999999899999999999999999999999997654322111       110000          01122345


Q ss_pred             HHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 004702          643 KEVAKLAARCISVRGEERP-----TMKEVSLE  669 (735)
Q Consensus       643 ~~l~~li~~cl~~~p~~RP-----t~~ev~~~  669 (735)
                      .++.+|+.+||+.+|.+||     ++.|+++.
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            6789999999999999997     78887754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-37  Score=332.15  Aligned_cols=257  Identities=25%  Similarity=0.377  Sum_probs=204.2

Q ss_pred             hhccccccccccCcEEEEEEEcC-CCc----EEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP-DRT----PVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      ..+...+.||+|+||+||+|++. ++.    .||+|.++.. .....+++.+|+.+++.++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            34455678999999999999853 333    3899998753 345567899999999999999999999999765 5679


Q ss_pred             EEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          475 VYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      |+||+++|+|.+++... ..+++..+++++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999875 46899999999999999999999998   999999999999999999999999999876543


Q ss_pred             cccce-eeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          554 AIQNC-TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       554 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      ..... ....++..|+|||.+....++.++||||||+++|||++ |+.||......+..       ..+.         .
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-------~~~~---------~  226 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILE---------K  226 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHh---------C
Confidence            32211 12224678999999999999999999999999999998 99998654332211       1111         1


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ......+.....++.+++.+||+.+|.+||++.+++..|..+.+..
T Consensus       227 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         227 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            1111112223457899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=347.32  Aligned_cols=259  Identities=21%  Similarity=0.304  Sum_probs=216.6

Q ss_pred             hhhccccccccccCcEEEEEEEcCCC-cEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceE-Eee---c---C
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLPDR-TPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGC-CLE---T---Q  470 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~-~~~---~---~  470 (735)
                      .....+.++|.+|||+.||.+....+ ..+|+|++-..++...+...+|+.+|++|. |||||.+++. ...   .   -
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34455678999999999999997665 999999998889999999999999999997 9999999993 221   1   2


Q ss_pred             ceeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK  548 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~  548 (735)
                      +.+|+||||.+|.|-+++..+  ..|++.++++|+.|+++|+++||... +||||||||-+||||+.++..||||||.+.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            468999999999999999864  46999999999999999999999986 899999999999999999999999999986


Q ss_pred             ccCCCcc--cce------eeeccccCccCcccc---cCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH
Q 004702          549 LVPIDAI--QNC------TVVQGTLGYLDPEYL---QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL  617 (735)
Q Consensus       549 ~~~~~~~--~~~------~~~~gt~~y~aPE~~---~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~  617 (735)
                      -.-....  ...      -...-|+.|+|||++   .+..+++|+|||+|||+||-|.....||.....           
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------  263 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------  263 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence            4322111  000      011268999999976   567899999999999999999999999964422           


Q ss_pred             HHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       618 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                              ..|++..+..+....++..|.+||..||+.+|.+||++.||+..+-.++....
T Consensus       264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                    34566666666667899999999999999999999999999999998876543

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-37  Score=321.38  Aligned_cols=248  Identities=28%  Similarity=0.435  Sum_probs=202.2

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ..+.+.||+|+||.||++..+++..+|+|.+..... ..++|.+|+.++++++||||+++++++...+..++||||++++
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG   84 (256)
T ss_pred             cchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence            456789999999999999987777899998764322 3457889999999999999999999999999999999999999


Q ss_pred             chhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.............
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~  161 (256)
T cd05059          85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT  161 (256)
T ss_pred             CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence            999999764 46899999999999999999999998   99999999999999999999999999986543322222222


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      .++..|+|||.+....++.++||||||+++|||++ |+.||......+...       .+...         .....+..
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~~~---------~~~~~~~~  225 (256)
T cd05059         162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE-------SVSAG---------YRLYRPKL  225 (256)
T ss_pred             CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH-------HHHcC---------CcCCCCCC
Confidence            24568999999998899999999999999999999 788886544332111       11111         11111223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      .+.++.+|+.+||+.+|++|||+.||++.|
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            457899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-38  Score=305.85  Aligned_cols=231  Identities=28%  Similarity=0.367  Sum_probs=200.6

Q ss_pred             cccccccCcEEEEEEEcC-CCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          406 ADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.||.|+||.|.+++.+ ++..+|+|.++.   ....+.+...+|..+|+.+.||.+++|.+.+.+.+..+|||||+++
T Consensus        49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G  128 (355)
T KOG0616|consen   49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG  128 (355)
T ss_pred             eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence            457999999999999854 578899998864   4556677888999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |.|..+|++.+++++..+.-+|.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+++.....    .-..
T Consensus       129 GElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~Tl  201 (355)
T KOG0616|consen  129 GELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TWTL  201 (355)
T ss_pred             ccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc----EEEe
Confidence            999999999999999999999999999999999999   999999999999999999999999999976533    3456


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||.++...+..++|-|||||++|||+.|..||....+...       ..        .|+...+  .++.-.
T Consensus       202 CGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-------Y~--------KI~~~~v--~fP~~f  264 (355)
T KOG0616|consen  202 CGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-------YE--------KILEGKV--KFPSYF  264 (355)
T ss_pred             cCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-------HH--------HHHhCcc--cCCccc
Confidence            799999999999999999999999999999999999999988766321       11        1222222  123345


Q ss_pred             HHHHHHHHHHcccCCCCCC
Q 004702          642 LKEVAKLAARCISVRGEER  660 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~R  660 (735)
                      ..++.+|+...|+.|-.+|
T Consensus       265 s~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  265 SSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CHHHHHHHHHHHhhhhHhh
Confidence            5788999999999998887

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-38  Score=329.67  Aligned_cols=241  Identities=24%  Similarity=0.314  Sum_probs=199.8

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||.||++... ++..||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            345678999999999999864 6889999998642   223456788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++++|.+++.....+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......    
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----  155 (291)
T cd05612          83 VPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----  155 (291)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc----
Confidence            999999999998888999999999999999999999998   9999999999999999999999999998654321    


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+...       .+...+        .  ..+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~-------~i~~~~--------~--~~~  218 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE-------KILAGK--------L--EFP  218 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhCC--------c--CCC
Confidence            22458999999999999899999999999999999999999997654322111       111111        0  112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPT-----MKEVS  667 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~  667 (735)
                      ......+.+|+.+||+.||.+||+     +.|++
T Consensus       219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l  252 (291)
T cd05612         219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK  252 (291)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence            223567899999999999999995     66555

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.3e-38  Score=330.43  Aligned_cols=239  Identities=25%  Similarity=0.328  Sum_probs=203.7

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      .+||+|+||.||+++. ..|..+|+|++++   ....+++..+.|-.+|...++|+||+|+..+.+.+.+||||||++||
T Consensus       147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG  226 (550)
T KOG0605|consen  147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG  226 (550)
T ss_pred             eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence            4899999999999984 4689999999875   34556777889999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC----------
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI----------  552 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~----------  552 (735)
                      ++..+|...+.|++..+..++.+++.|+..||..|   +|||||||+|+|||..|.+||+||||+.-+..          
T Consensus       227 D~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~  303 (550)
T KOG0605|consen  227 DMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLD  303 (550)
T ss_pred             cHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcch
Confidence            99999999999999999999999999999999999   99999999999999999999999999853210          


Q ss_pred             -------------Cccc----c-------------------eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh
Q 004702          553 -------------DAIQ----N-------------------CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT  596 (735)
Q Consensus       553 -------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt  596 (735)
                                   +...    .                   .....|||.|||||++.+..|+..+|.||||+|+||||.
T Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLv  383 (550)
T KOG0605|consen  304 EQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLV  383 (550)
T ss_pred             hhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHh
Confidence                         0000    0                   011349999999999999999999999999999999999


Q ss_pred             CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 004702          597 GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPT  662 (735)
Q Consensus       597 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  662 (735)
                      |.+||....+.+.-..+.+|...+....             ......+..+||.+++. ||++|.-
T Consensus       384 GyPPF~s~tp~~T~rkI~nwr~~l~fP~-------------~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  384 GYPPFCSETPQETYRKIVNWRETLKFPE-------------EVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhhhccCCC-------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999888776665555544443211             22334788999999999 9999987

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-37  Score=334.24  Aligned_cols=236  Identities=25%  Similarity=0.341  Sum_probs=197.6

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||.||++... +++.||+|.++..   .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   99 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF   99 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence            456779999999999999864 5788999988642   233456788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +.+|+|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++......    
T Consensus       100 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----  172 (329)
T PTZ00263        100 VVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT----  172 (329)
T ss_pred             CCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----
Confidence            999999999998888999999999999999999999998   9999999999999999999999999998664322    


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+..       ..+...+        .  ..+
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~i~~~~--------~--~~p  235 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-------EKILAGR--------L--KFP  235 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-------HHHhcCC--------c--CCC
Confidence            2345899999999999999999999999999999999999999765432211       1111111        1  111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC
Q 004702          639 KQQLKEVAKLAARCISVRGEERPT  662 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt  662 (735)
                      .....++.+|+.+||+.||.+||+
T Consensus       236 ~~~~~~~~~li~~~L~~dP~~R~~  259 (329)
T PTZ00263        236 NWFDGRARDLVKGLLQTDHTKRLG  259 (329)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCC
Confidence            123457889999999999999997

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.8e-37  Score=318.75  Aligned_cols=246  Identities=28%  Similarity=0.390  Sum_probs=200.0

Q ss_pred             cccccCcEEEEEEEc---CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          408 VIGCGGSGNVYKGFL---PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      .||+|+||.||+|.+   .++..+|+|+++..  +....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964   35788999987643  3445678999999999999999999999875 45678999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc--eee
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTV  560 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~--~~~  560 (735)
                      +|.+++.....+++..+++++.|++.||+|||+.+   |+||||||.|||+++++.+||+|||+++.........  ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            99999988778999999999999999999999998   9999999999999999999999999998765433211  112


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      ..++..|+|||.+....++.++||||||+++|||++ |+.||......+.       ...+...         ...+.+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~i~~~---------~~~~~~~  221 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-------TQMIESG---------ERMECPQ  221 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCC---------CCCCCCC
Confidence            234578999999988889999999999999999998 9999865433221       1111111         1111222


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ..+.++.+|+.+||+.+|++||++.+|.+.|++.
T Consensus       222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            3557899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.5e-37  Score=319.50  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=202.8

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.+.+.||+|+||.||++...++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. ....++||||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK   84 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence            4556789999999999999988888899999875333 3467899999999999999999999875 4567899999999


Q ss_pred             CchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          482 GTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       482 gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      ++|.++++..  ..+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++..+.........
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence            9999999763  45899999999999999999999998   999999999999999999999999999876443222222


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ...++..|+|||.+....++.++||||||+++|||++ |+.||......+..       ..+.         .....+.+
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-------~~~~---------~~~~~~~~  225 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL-------EQVE---------RGYRMPCP  225 (260)
T ss_pred             CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHH---------cCCCCCCC
Confidence            2335678999999988889999999999999999999 88888654332211       1111         11111122


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      ...+..+.+|+.+||+.+|++|||+.++++.|++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            3445689999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.1e-37  Score=319.61  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=205.1

Q ss_pred             hhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      ...+.+.++||+|+||.||+|...+...||+|+++.... ..++|.+|+.++++++|+||+++++.+. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            345677889999999999999987777899999875332 3467899999999999999999999874 45679999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      ++++|.+++...  ..+++..++.++.|+++||+|||+.+   |+|+||||+||++++++.+||+|||+++.+.......
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            999999999763  45899999999999999999999998   9999999999999999999999999998765433222


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      .....++..|+|||...+..++.++||||||+++|||++ |+.||......+...       .+..         .....
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~-------~~~~---------~~~~~  223 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------QVER---------GYRMP  223 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH-------HHhc---------CCCCC
Confidence            223346778999999998899999999999999999999 777876543322110       1100         01111


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                      ...+.+..+.+|+.+||+.+|++||++.++++.|+..+
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            12345678899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=303.72  Aligned_cols=260  Identities=25%  Similarity=0.357  Sum_probs=214.7

Q ss_pred             hhhccccccccccCcEEEEEEE-cCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC-----cee
Q 004702          400 TVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-----VPL  473 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~  473 (735)
                      ..++.+.+.||+|||+-||.+. +.++..+|+|++.....++.+..++|++..++++||||++++.+...+.     ..|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4467788999999999999998 6778899999999888888999999999999999999999998876544     489


Q ss_pred             EEEEecCCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          474 LVYEFVGNGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      |+++|...|+|.+.+...    ..+++.+.+.|+.++.+||++||+.. +|+.||||||.|||+.+.+.++|.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence            999999999999999753    46999999999999999999999987 6899999999999999999999999999886


Q ss_pred             cCCCcccc--------eeeeccccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHH
Q 004702          550 VPIDAIQN--------CTVVQGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS  618 (735)
Q Consensus       550 ~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~  618 (735)
                      ........        ......|..|.|||.+.   +...++++||||||++||+|+.|.-||.....            
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------------  246 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------------  246 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------------
Confidence            64322111        11234789999999885   45688999999999999999999999853211            


Q ss_pred             Hhcccch-hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          619 SLKQNRL-LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       619 ~~~~~~~-~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                        +.+.+ ..+...++..+.....++.+.+|+.+|++.||.+||++.+++..++.++
T Consensus       247 --~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 --QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence              11111 2233334444444457889999999999999999999999999998764

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.8e-37  Score=323.49  Aligned_cols=252  Identities=24%  Similarity=0.392  Sum_probs=202.5

Q ss_pred             hccccccccccCcEEEEEEEc-----CCCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      ...+.+.||+|+||+||+|..     .++..|++|.++. .......++.+|+.++++++||||+++++++......++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            345678999999999999974     2457899999874 3344557889999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC
Q 004702          476 YEFVGNGTLFEHIHKK-----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT  538 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~  538 (735)
                      |||+++++|.+++...                 ..+++.+++.++.|++.||+|||+++   |+||||||+|||+++++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~  162 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCc
Confidence            9999999999998532                 24788999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHH
Q 004702          539 PKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNF  616 (735)
Q Consensus       539 ~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~  616 (735)
                      +||+|||+++....... .......++..|+|||++.+..++.++||||||++||||++ |..||......+...     
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~-----  237 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE-----  237 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----
Confidence            99999999986543221 11222335678999999988889999999999999999999 888886544322111     


Q ss_pred             HHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          617 LSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       617 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                        .+....         ....+...+.++.+++.+||+.+|.+||++.+|+++|..
T Consensus       238 --~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 --MVRKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              111111         111122345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.4e-37  Score=318.79  Aligned_cols=255  Identities=25%  Similarity=0.402  Sum_probs=207.5

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      +|...++.+.++||+|+||.||++..+++..||+|.+..... ..+++.+|+.++++++|+||++++++.. .+..++||
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            345567778899999999999999988889999998874333 3567899999999999999999999864 45689999


Q ss_pred             EecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          477 EFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       477 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||+.+++|.+++...  ..+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999998753  46899999999999999999999988   9999999999999999999999999998765332


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      ........++..|+|||++....++.++||||||++++||++ |+.||......+..       ..+..         ..
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~---------~~  220 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-------QNLER---------GY  220 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-------HHHHc---------CC
Confidence            222223346778999999998889999999999999999999 99998654432211       11111         11


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      ..+.+...+.++.+++.+||+.+|++|||+++++..|+.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            111122344679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.8e-37  Score=332.71  Aligned_cols=259  Identities=27%  Similarity=0.367  Sum_probs=204.6

Q ss_pred             HhhhccccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeec-
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLET-  469 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-  469 (735)
                      ....+.+.++||+|+||.||+|...      .++.||+|+++.. .....+.+.+|+.++.++ +|+||+++++++... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3345667889999999999999642      2468999998743 234456788999999999 899999999988754 


Q ss_pred             CceeEEEEecCCCchhHHhhhc----------------------------------------------------------
Q 004702          470 QVPLLVYEFVGNGTLFEHIHKK----------------------------------------------------------  491 (735)
Q Consensus       470 ~~~~lV~E~~~~gsL~~~l~~~----------------------------------------------------------  491 (735)
                      ...+++|||+++++|.+++...                                                          
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            4678999999999999998642                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCc
Q 004702          492 ---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGY  567 (735)
Q Consensus       492 ---~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y  567 (735)
                         ..+++..+.+++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...... ......++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               25799999999999999999999998   999999999999999999999999999876433221 12223467789


Q ss_pred             cCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHH
Q 004702          568 LDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVA  646 (735)
Q Consensus       568 ~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~  646 (735)
                      +|||++.+..++.++||||||++||||++ |..||......+.      +...+...         .....+.....++.
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~~~  306 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEG---------TRMRAPEYATPEIY  306 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhcc---------CCCCCCccCCHHHH
Confidence            99999999999999999999999999998 9999865433221      11111111         11111223456789


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          647 KLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       647 ~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      +++.+||+.+|++||++.||++.|+.++.
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-37  Score=324.42  Aligned_cols=268  Identities=25%  Similarity=0.367  Sum_probs=203.8

Q ss_pred             ccccccccccCcEEEEEEEc-----CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV  475 (735)
                      +.+.+.||+|+||.||++..     .++..||+|+++.......+.+.+|++++++++||||+++++++...  ...++|
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   85 (284)
T cd05081           6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV   85 (284)
T ss_pred             ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence            44567899999999999974     24778999998877777778899999999999999999999987543  467899


Q ss_pred             EEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          476 YEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |||+++++|.+++... ..+++..++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          86 MEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             EEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            9999999999999764 46899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             ccc--eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          555 IQN--CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       555 ~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      ...  .....++..|+|||.+.+..++.++||||||+++|||++|..++.......................+.+.+...
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN  242 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence            211  111223456999999998889999999999999999999877653321110000000000000000111122222


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ...+.....+.++.+|+.+||+.+|++|||+.||++.|+.+
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11122233456899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.5e-37  Score=330.79  Aligned_cols=264  Identities=23%  Similarity=0.321  Sum_probs=203.9

Q ss_pred             HhhhccccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ....+.+.+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            3445566789999999999999865 5778899987643 4445677999999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+++++|.+++.....+++..+..++.|+++||.|||+. +   |+||||||+|||+++++.+||+|||++....... 
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            9999999999998888899999999999999999999985 5   9999999999999999999999999987653221 


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHH----------------
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS----------------  619 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~----------------  619 (735)
                        .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+...........                
T Consensus       159 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             --cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence              12345899999999999889999999999999999999999998654332211100000000                


Q ss_pred             ----hcc-----cchhhHhhhcccC---CC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          620 ----LKQ-----NRLLEILDNRIVN---DG-NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       620 ----~~~-----~~~~~~~d~~~~~---~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                          ...     .....+.+.....   .. ......++.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                000     0000111110000   00 0113467899999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-37  Score=333.97  Aligned_cols=243  Identities=25%  Similarity=0.337  Sum_probs=200.6

Q ss_pred             hccccccccccCcEEEEEEEcCC--CcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPD--RTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.+.||+|+||.||+|...+  +..||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            35567899999999999998543  368999987642   3344567889999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      ||+++|+|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus       111 Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---  184 (340)
T PTZ00426        111 EFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---  184 (340)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC---
Confidence            99999999999998888999999999999999999999998   999999999999999999999999999865432   


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                       .....||+.|+|||++.+..++.++||||||+++|||++|+.||....+.....   .    +..        ...  .
T Consensus       185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~---~----i~~--------~~~--~  246 (340)
T PTZ00426        185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ---K----ILE--------GII--Y  246 (340)
T ss_pred             -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH---H----Hhc--------CCC--C
Confidence             123458999999999999889999999999999999999999997654322111   1    111        100  1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      .+......+.+++.+||+.+|.+|+     ++.|+++
T Consensus       247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            1222345788999999999999995     6777654

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-37  Score=333.20  Aligned_cols=263  Identities=23%  Similarity=0.328  Sum_probs=198.3

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC-----ceeE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-----VPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l  474 (735)
                      +.+.++||+|+||.||+|+. .++..||||+++..  .......+.+|+.++++++||||+++++++....     ..++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            45577999999999999985 46889999988642  2334567889999999999999999999886433     4799


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||||+. ++|.+++.....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          82 VFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence            999995 689999988888999999999999999999999998   9999999999999999999999999998653222


Q ss_pred             c--cceeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHH--------HHHhcc
Q 004702          555 I--QNCTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF--------LSSLKQ  622 (735)
Q Consensus       555 ~--~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~  622 (735)
                      .  .......|+..|+|||++.+  ..++.++||||||+++|||++|+.||...............        ...+..
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            1  11233458999999999875  67899999999999999999999999765432221111110        001111


Q ss_pred             cchhhHhh---hcccCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          623 NRLLEILD---NRIVND---GNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       623 ~~~~~~~d---~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ....+.+.   ......   ........+.+++.+||+.+|++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            11111110   000000   001123567899999999999999999998853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3e-37  Score=325.27  Aligned_cols=261  Identities=20%  Similarity=0.259  Sum_probs=198.8

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.++||+|+||.||+|... ++..||+|.++... ......+.+|+.++++++||||+++++++...+..++||||+.
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            445678999999999999854 67899999886432 2234567899999999999999999999999889999999997


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      + +|.+++... ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++....... ...
T Consensus        87 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~~  161 (288)
T cd07871          87 S-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TYS  161 (288)
T ss_pred             c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-ccc
Confidence            4 899988764 45799999999999999999999998   99999999999999999999999999976532221 122


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh---------Hh
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE---------IL  629 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~  629 (735)
                      ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+................+..         ..
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            3457899999998865 5689999999999999999999999976655443322221111000000100         01


Q ss_pred             hhcccCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          630 DNRIVNDG----NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       630 d~~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+......    ......++.+|+.+||+.||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            11100000    0112357889999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.4e-37  Score=324.83  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=204.6

Q ss_pred             ccccccccccCcEEEEEEEcCC-C--cEEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLPD-R--TPVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~-~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      +.+.++||+|+||.||+|...+ +  ..+++|.++. ......+.|.+|+.++.++ +||||+++++++...+..++|||
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e   83 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE   83 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence            4567799999999999998654 3  3478888774 3445567899999999999 79999999999999999999999


Q ss_pred             ecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 004702          478 FVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV  541 (735)
Q Consensus       478 ~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl  541 (735)
                      |+++++|.++++..                ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEE
Confidence            99999999999753                24889999999999999999999988   999999999999999999999


Q ss_pred             eeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHh
Q 004702          542 SDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSL  620 (735)
Q Consensus       542 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  620 (735)
                      +|||++.......  .......+..|+|||++....++.++||||||+++|||++ |..||......+...       .+
T Consensus       161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~-------~~  231 (297)
T cd05089         161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE-------KL  231 (297)
T ss_pred             CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HH
Confidence            9999987432111  1111223567999999998889999999999999999998 999987654332111       11


Q ss_pred             cccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       621 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      .         .......+...+..+.+|+.+||+.+|.+|||+.++++.|+.++...+
T Consensus       232 ~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         232 P---------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             h---------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            1         111111222345678999999999999999999999999998887664

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.3e-37  Score=314.60  Aligned_cols=246  Identities=30%  Similarity=0.469  Sum_probs=201.7

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchh
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLF  485 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  485 (735)
                      ++||+|+||.||+|...++..+|+|.++... ......+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4799999999999998888999999876543 344557899999999999999999999999999999999999999999


Q ss_pred             HHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccc
Q 004702          486 EHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT  564 (735)
Q Consensus       486 ~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt  564 (735)
                      +++... ..+++..++.++.|++.+|.|||+.+   ++|+||||+||++++++.+||+|||++...............++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            998754 46899999999999999999999998   99999999999999999999999999876543322222222356


Q ss_pred             cCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHH
Q 004702          565 LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK  643 (735)
Q Consensus       565 ~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  643 (735)
                      ..|+|||++....++.++||||||+++|||++ |..||...........       +...         .....+...+.
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-------~~~~---------~~~~~~~~~~~  221 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-------VEKG---------YRMSCPQKCPD  221 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-------HHcC---------CCCCCCCCCCH
Confidence            78999999998899999999999999999999 8889865543321111       1111         01111223457


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          644 EVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       644 ~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      .+.+++.+||+.+|++||++.|++++|.
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            8999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.7e-37  Score=329.28  Aligned_cols=241  Identities=23%  Similarity=0.314  Sum_probs=197.2

Q ss_pred             ccccccCcEEEEEEEc----CCCcEEEEEEeecc----ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          407 DVIGCGGSGNVYKGFL----PDRTPVAVKKSKFV----DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      ++||+|+||.||++..    ..+..||||.++..    .......+.+|+.+|+.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999974    35788999998742    223345678899999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++++|.+++.....+.+..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++....... ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  157 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT  157 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence            999999999988888999999999999999999999998   99999999999999999999999999875432221 12


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....|++.|+|||++.+..++.++||||||++||||++|+.||.........       ..+...        ..  ..+
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~-------~~~~~~--------~~--~~~  220 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI-------DKILKG--------KL--NLP  220 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcC--------CC--CCC
Confidence            2345899999999999988999999999999999999999999765432211       111111        10  112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      .....++.+++.+||+.+|++||     ++.+++.
T Consensus       221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            23346789999999999999999     6777665

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.1e-37  Score=315.17  Aligned_cols=246  Identities=28%  Similarity=0.448  Sum_probs=199.0

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      +.||+|+||.||+|+.. ++..||+|.... ........+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999864 688899998764 3344567799999999999999999999999999999999999999999


Q ss_pred             hHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc-eeeec
Q 004702          485 FEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQ  562 (735)
Q Consensus       485 ~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~-~~~~~  562 (735)
                      .+++... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......... .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999764 46899999999999999999999998   9999999999999999999999999987653221111 11112


Q ss_pred             cccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       563 gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .+..|+|||.+.+..++.++||||||+++|||++ |..||..........                .+........+...
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~----------------~~~~~~~~~~~~~~  221 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE----------------AIEQGVRLPCPELC  221 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH----------------HHHcCCCCCCcccC
Confidence            3467999999999899999999999999999998 888875443322111                11111111222334


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      +..+.+|+.+||+.+|++|||+.||+++|+
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.4e-37  Score=325.37  Aligned_cols=263  Identities=27%  Similarity=0.359  Sum_probs=209.6

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcC--------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEE
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCC  466 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~  466 (735)
                      ++....+.+.+.||+|+||.||++...        +...+|+|.++.. ......++.+|+.+++.+ +||||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            444456678889999999999999742        2346999988743 344567788999999999 799999999999


Q ss_pred             eecCceeEEEEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 004702          467 LETQVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN  530 (735)
Q Consensus       467 ~~~~~~~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~N  530 (735)
                      ...+..++||||+++|+|.+++...                ..+++.++++++.|++.||+|||+.+   ++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence            9999999999999999999999753                24889999999999999999999988   9999999999


Q ss_pred             EEEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHH
Q 004702          531 ILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEE  608 (735)
Q Consensus       531 ILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~  608 (735)
                      ||+++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            99999999999999998765432111 1122234578999999998889999999999999999998 788875543322


Q ss_pred             HHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          609 ERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ..       ..+...         ...+.+...+.++.+|+.+||+.+|.+|||+.+|++.|+.++....
T Consensus       251 ~~-------~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         251 LF-------KLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             HH-------HHHHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence            11       111111         1112223345788999999999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.2e-36  Score=325.02  Aligned_cols=238  Identities=25%  Similarity=0.320  Sum_probs=192.8

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHh-cCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQ-INRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||+||++... ++..||||.++..   .....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999854 5778999988742   23344556667777765 4899999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~  156 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF  156 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccccc
Confidence            999999988888999999999999999999999998   9999999999999999999999999998643222 222334


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...       .+...          ....+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~-------~i~~~----------~~~~~~~~  219 (316)
T cd05592         157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD-------SILND----------RPHFPRWI  219 (316)
T ss_pred             cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHcC----------CCCCCCCC
Confidence            58999999999999899999999999999999999999997654322111       11100          01112234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKE  665 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~e  665 (735)
                      ..++.+|+.+||+.+|.+||++.+
T Consensus       220 ~~~~~~ll~~~l~~~P~~R~~~~~  243 (316)
T cd05592         220 SKEAKDCLSKLFERDPTKRLGVDG  243 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChH
Confidence            467889999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.6e-37  Score=320.26  Aligned_cols=252  Identities=24%  Similarity=0.394  Sum_probs=199.4

Q ss_pred             cccccccccCcEEEEEEEcC-CCc----EEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRT----PVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.||+|+||+||+|.+. ++.    .+++|++... ......++..|+.++++++||||+++++++.. ...++++|
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e   88 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ   88 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence            34578999999999999853 343    4777876543 23345678889999999999999999998754 45689999


Q ss_pred             ecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc-
Q 004702          478 FVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI-  555 (735)
Q Consensus       478 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~-  555 (735)
                      |+++|+|.+++... ..+++..++.|+.|++.||+|||+.+   ++||||||+|||+++++.+||+|||+++....... 
T Consensus        89 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T cd05111          89 LSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK  165 (279)
T ss_pred             eCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence            99999999999764 57999999999999999999999998   99999999999999999999999999986643322 


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      .......++..|++||.+....++.++||||||+++|||++ |+.||...........       +..+.         .
T Consensus       166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~---------~  229 (279)
T cd05111         166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKGE---------R  229 (279)
T ss_pred             cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCC---------c
Confidence            22233447789999999998899999999999999999998 9999876543321111       11111         0


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ...+......+.+++.+||..+|.+|||+.|+++.|..+.+
T Consensus       230 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            01111233567889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.2e-37  Score=321.46  Aligned_cols=251  Identities=26%  Similarity=0.359  Sum_probs=200.2

Q ss_pred             hccccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.+.||+|+||.||+|...      .+..||||+++.. ......+|.+|+.+++.++||||+++++++.+....++
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   86 (277)
T cd05062           7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV   86 (277)
T ss_pred             HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence            4556789999999999998743      2467999987643 33455678999999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeec
Q 004702          475 VYEFVGNGTLFEHIHKK----------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF  544 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF  544 (735)
                      ||||+++++|.+++...          ..+++..++.++.|+++||+|||+.+   ++|+||||+|||+++++.+||+||
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~df  163 (277)
T cd05062          87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCC
Confidence            99999999999999753          23678899999999999999999988   999999999999999999999999


Q ss_pred             cCCcccCCCcccc-eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcc
Q 004702          545 GASKLVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQ  622 (735)
Q Consensus       545 Gls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  622 (735)
                      |+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+..       .....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~-------~~~~~  236 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL-------RFVME  236 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHc
Confidence            9987654322211 112235778999999998899999999999999999999 67887654332211       11111


Q ss_pred             cchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       623 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      ...         ...+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       237 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         237 GGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             CCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            111         1112234467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.5e-37  Score=331.79  Aligned_cols=242  Identities=24%  Similarity=0.286  Sum_probs=198.7

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ++||+|+||.||++.. .++..||+|.++..   .......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999984 46889999998742   3344567789999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|.+++.....+++..+..++.||+.||+|||+ .+   |+||||||+||||++++.+||+|||+++....... .....
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~  156 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF  156 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence            999999888889999999999999999999997 67   99999999999999999999999999875432211 12234


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||.+.+..++.++||||||++||||++|+.||......+.....       ...        .  ...+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-------~~~--------~--~~~p~~~  219 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LME--------E--IRFPRTL  219 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-------hcC--------C--CCCCCCC
Confidence            5899999999999989999999999999999999999999765432211111       000        0  0112234


Q ss_pred             HHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERP-----TMKEVSLE  669 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RP-----t~~ev~~~  669 (735)
                      ..++.+|+.+||+.||++|+     ++.++++.
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            56789999999999999997     88888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.3e-37  Score=317.76  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=204.1

Q ss_pred             ccccccccccCcEEEEEEEcCC-C---cEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLPD-R---TPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      +...++||+|+||.||+|+... +   ..+|+|+++.. .....+++.+|++++++++|+||+++++++...+..++|||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (268)
T cd05063           7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE   86 (268)
T ss_pred             ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence            3456799999999999998642 2   36999988643 34556789999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          478 FVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      |+++++|.+++... ..+++.+++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.........
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          87 YMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence            99999999999764 57899999999999999999999998   999999999999999999999999999866432222


Q ss_pred             cee--eeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          557 NCT--VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       557 ~~~--~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      ...  ....+..|+|||++....++.++||||||+++|||++ |+.||......+.       ...+...         .
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~-------~~~i~~~---------~  227 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-------MKAINDG---------F  227 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-------HHHHhcC---------C
Confidence            111  1123457999999998889999999999999999998 9999865443221       1111111         1


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ..+.....+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus       228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-36  Score=318.11  Aligned_cols=251  Identities=27%  Similarity=0.444  Sum_probs=198.8

Q ss_pred             cccccccccCcEEEEEEEcCCCc---EEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeec------Cce
Q 004702          404 NYADVIGCGGSGNVYKGFLPDRT---PVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLET------QVP  472 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~~~---~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~  472 (735)
                      .+.++||+|+||.||+|.+.+..   .+|+|.++.  ......+.+.+|+.+++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            35678999999999999865432   589998764  3455678899999999999999999999987532      246


Q ss_pred             eEEEEecCCCchhHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccC
Q 004702          473 LLVYEFVGNGTLFEHIHK------KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA  546 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl  546 (735)
                      ++||||+++|+|.+++..      ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999988742      235899999999999999999999988   99999999999999999999999999


Q ss_pred             CcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccc
Q 004702          547 SKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNR  624 (735)
Q Consensus       547 s~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  624 (735)
                      ++.+...... ......+++.|++||.+....++.++||||||+++|||++ |+.||......+.       ...+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI-------YDYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHcCC
Confidence            9876433221 1122235678999999999999999999999999999999 7888865433221       11111111


Q ss_pred             hhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          625 LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       625 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      .         .......+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       232 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 R---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             C---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1         011223446789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=319.51  Aligned_cols=251  Identities=25%  Similarity=0.322  Sum_probs=199.7

Q ss_pred             ccccccccccCcEEEEEEE-cCCCcEEEEEEeeccCh--------------hHHHHHHHHHHHHHhcCCCceEEEceEEe
Q 004702          403 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQ--------------AKIDEFINELVVVLQINRRNVVRLLGCCL  467 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~  467 (735)
                      +.+.+.||+|.||.|-++. ..++..||||++.....              ...+...+|+.+|++++|||||+|+.+..
T Consensus        99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD  178 (576)
T KOG0585|consen   99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD  178 (576)
T ss_pred             eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence            4456789999999999998 45688999998753211              12457889999999999999999999987


Q ss_pred             e--cCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          468 E--TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       468 ~--~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                      +  .+..|||+||+..|.+...-.....+++.++.+++.++..||+|||.++   ||||||||+|+||++++++||+|||
T Consensus       179 DP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFG  255 (576)
T KOG0585|consen  179 DPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFG  255 (576)
T ss_pred             CcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccc
Confidence            5  4578999999998877554433344999999999999999999999999   9999999999999999999999999


Q ss_pred             CCcccCCCccc----ceeeeccccCccCcccccCCC----CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH
Q 004702          546 ASKLVPIDAIQ----NCTVVQGTLGYLDPEYLQTCK----LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL  617 (735)
Q Consensus       546 ls~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~  617 (735)
                      .+...+.....    ......||+.|||||...+..    .+.+.||||+||+||-|+.|+.||......+..       
T Consensus       256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~-------  328 (576)
T KOG0585|consen  256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF-------  328 (576)
T ss_pred             eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH-------
Confidence            99876322111    112245999999999987632    345889999999999999999999765433321       


Q ss_pred             HHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       618 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                              ..|+...+.-+...+..+.+.+||+++|.+||++|.+..+|....-
T Consensus       329 --------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  329 --------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             --------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence                    2334444444445566788999999999999999999999886653

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.2e-36  Score=315.05  Aligned_cols=246  Identities=26%  Similarity=0.394  Sum_probs=197.8

Q ss_pred             cccccCcEEEEEEEcC---CCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          408 VIGCGGSGNVYKGFLP---DRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .||+|+||.||+|.+.   ++..||+|.+.... ....+.|.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999753   35569999887543 344567999999999999999999999875 456799999999999


Q ss_pred             hhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc--eee
Q 004702          484 LFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTV  560 (735)
Q Consensus       484 L~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~--~~~  560 (735)
                      |.+++.. ...+++..+++++.|+++||+|||+++   ++||||||+|||++.++.+||+|||+++....+....  ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999975 457999999999999999999999998   9999999999999999999999999998654332211  111


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      ..++..|+|||.+....++.++||||||+++|||++ |+.||......+..       ..+...         .....+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~---------~~~~~~~  221 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQG---------KRLDCPA  221 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCC---------CCCCCCC
Confidence            223578999999988889999999999999999997 99998765433211       111111         1111223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ..+.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            3457899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=317.28  Aligned_cols=251  Identities=27%  Similarity=0.434  Sum_probs=201.5

Q ss_pred             cccccccccCcEEEEEEEcCC----CcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc------
Q 004702          404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV------  471 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------  471 (735)
                      .+.+.||+|+||.||+|.+..    +..||||+++.  ......+.+.+|+..++.++||||+++++++.....      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            456789999999999998542    36799998874  334556789999999999999999999999876554      


Q ss_pred             eeEEEEecCCCchhHHhhhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          472 PLLVYEFVGNGTLFEHIHKK------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                      .++||||+++++|..++...      ..+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcc
Confidence            78999999999999998542      36899999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCcccc-eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhccc
Q 004702          546 ASKLVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQN  623 (735)
Q Consensus       546 ls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  623 (735)
                      +++......... .....++..|+|||.+....++.++||||||+++|||++ |..||......+.       ...+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~-------~~~~~~~  231 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI-------YDYLRHG  231 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcC
Confidence            998764332221 112235678999999998899999999999999999999 8888865443221       1111111


Q ss_pred             chhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          624 RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       624 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      .         ....+...+.++.+++.+||+.+|.+|||+.||++.|+++
T Consensus       232 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 N---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             C---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1         1111234557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-37  Score=337.45  Aligned_cols=258  Identities=19%  Similarity=0.225  Sum_probs=198.4

Q ss_pred             hhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          401 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      ..+.+.+.||+|+||.||++.. ..++.||+|+..      ...+.+|+.+|++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            3466678999999999999985 467889999743      345679999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      . ++|..++.....+++..++.|+.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++...........
T Consensus       166 ~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~  241 (391)
T PHA03212        166 K-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY  241 (391)
T ss_pred             C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence            5 689999988788999999999999999999999998   999999999999999999999999999754322222233


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHH----HHHHHHHHHHHhcc----------cch
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE----ERSLAMNFLSSLKQ----------NRL  625 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~----------~~~  625 (735)
                      ...||+.|+|||++.+..++.++||||||++||||++|+.|+.......    ........+.....          ..+
T Consensus       242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~  321 (391)
T PHA03212        242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL  321 (391)
T ss_pred             cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence            4569999999999999899999999999999999999998876432111    00111111111100          000


Q ss_pred             hhHh----hhcccCC-------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 LEIL----DNRIVND-------GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 ~~~~----d~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+.    .......       .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000    0000000       01124567899999999999999999999884

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7e-37  Score=321.07  Aligned_cols=252  Identities=26%  Similarity=0.375  Sum_probs=204.9

Q ss_pred             hhccccccccccCcEEEEEEEcC------CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      ....+.++||+|+||.||++...      ++..+|+|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            34456779999999999999632      356799999887777778899999999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCe
Q 004702          475 VYEFVGNGTLFEHIHKKG---------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP  539 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~---------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~  539 (735)
                      ||||+++++|.+++....               .+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            999999999999997542               4889999999999999999999998   9999999999999999999


Q ss_pred             EEeeccCCcccCCCcccc-eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHH
Q 004702          540 KVSDFGASKLVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFL  617 (735)
Q Consensus       540 kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~  617 (735)
                      ||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....     
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-----  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC-----  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH-----
Confidence            999999987654322211 112235678999999999899999999999999999998 8888865443321111     


Q ss_pred             HHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       618 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                        ....         .....+...+..+.+|+.+||+.+|.+||++.||++.|+
T Consensus       237 --~~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 --ITQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --HHcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence              1000         001112234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=317.70  Aligned_cols=247  Identities=29%  Similarity=0.420  Sum_probs=197.7

Q ss_pred             ccccccCcEEEEEEEcCC-Cc--EEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLPD-RT--PVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~-~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||.||+|.+.+ +.  .+++|.++. ......+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            469999999999998654 33  468888764 3445567889999999999 799999999999999999999999999


Q ss_pred             CchhHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          482 GTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       482 gsL~~~l~~~~----------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                      ++|.+++....                .+++.+++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999997532                4789999999999999999999988   9999999999999999999999999


Q ss_pred             CCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccc
Q 004702          546 ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNR  624 (735)
Q Consensus       546 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  624 (735)
                      ++......  ........+..|+|||++....++.++||||||+++|||++ |..||......+.       ...+..  
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~--  226 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------YEKLPQ--  226 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-------HHHHhC--
Confidence            98643211  11111224567999999988889999999999999999997 9999865432211       111111  


Q ss_pred             hhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          625 LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       625 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                             ....+.......++.+|+.+||+.+|.+|||+.+++..|+.++
T Consensus       227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 -------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                   1111112234467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=320.10  Aligned_cols=293  Identities=23%  Similarity=0.301  Sum_probs=213.0

Q ss_pred             ccceeecccccCCCCccccccCHHHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHH
Q 004702          373 SILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVL  452 (735)
Q Consensus       373 ~~~~~~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~  452 (735)
                      +.+++.+..+..+.+.....+-.+.-...+..+.+.||+|.||+||+|.+. |+.||||++...++   ..+.+|.++.+
T Consensus       183 stl~Dll~~~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYq  258 (513)
T KOG2052|consen  183 STLKDLLDDLETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQ  258 (513)
T ss_pred             ccHHHHHHhhccCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHH
Confidence            334443433333333333333334444556677889999999999999996 56699999875544   44567777766


Q ss_pred             h--cCCCceEEEceEEeecC----ceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCe
Q 004702          453 Q--INRRNVVRLLGCCLETQ----VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHS-----ETNVPI  521 (735)
Q Consensus       453 ~--l~h~niv~l~g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~-----~~~~~i  521 (735)
                      .  |+|+||+.+++.-..++    .+|||.+|.+.|+|+|||.. ..++....++++..+|.||++||.     +++|.|
T Consensus       259 TvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaI  337 (513)
T KOG2052|consen  259 TVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAI  337 (513)
T ss_pred             HHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchh
Confidence            5  69999999998865543    57999999999999999987 589999999999999999999996     467889


Q ss_pred             eecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc---ceeeeccccCccCcccccCCC------CCccccchhHHHHHH
Q 004702          522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ---NCTVVQGTLGYLDPEYLQTCK------LTDKSDVYSFGVVLV  592 (735)
Q Consensus       522 vH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~ksDVyS~Gvvl~  592 (735)
                      .|||||++||||..+++.-|+|+|||.....+...   ......||.+|||||++...-      .-..+||||||+|||
T Consensus       338 AHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlW  417 (513)
T KOG2052|consen  338 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLW  417 (513)
T ss_pred             hccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHH
Confidence            99999999999999999999999999876544211   223346999999999986531      223689999999999


Q ss_pred             HHHhC----------CccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 004702          593 ELLTG----------KMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPT  662 (735)
Q Consensus       593 elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  662 (735)
                      |+...          +.||+...+.+....  +..+.+-.+++...+.++   ....+.+..+.+||+.||..+|.-|-|
T Consensus       418 EiarRc~~ggi~eey~~Pyyd~Vp~DPs~e--eMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRlt  492 (513)
T KOG2052|consen  418 EIARRCESGGIVEEYQLPYYDVVPSDPSFE--EMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLT  492 (513)
T ss_pred             HHHHHhhcCCEehhhcCCcccCCCCCCCHH--HHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhH
Confidence            98752          246655444332111  111111112222222211   123467788999999999999999999


Q ss_pred             HHHHHHHHHhhhh
Q 004702          663 MKEVSLELQGRLS  675 (735)
Q Consensus       663 ~~ev~~~L~~~~~  675 (735)
                      +-.+-+.|.++.+
T Consensus       493 ALriKKtl~~l~~  505 (513)
T KOG2052|consen  493 ALRIKKTLAKLSN  505 (513)
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999988764

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-37  Score=331.74  Aligned_cols=245  Identities=27%  Similarity=0.343  Sum_probs=207.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+++-||+|+.|.|-.|+. ..|+.+|||++...   .......+.+|+.+|+.+.||||++|++++.....+|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            34577899999999999984 57999999987643   223344567899999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|-|.+++..++++++....+++.||+.|+.|.|..+   |+||||||+|+|||..+++||+|||+|.+-..+..-  
T Consensus        94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL--  168 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL--  168 (786)
T ss_pred             cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCccc--
Confidence            999999999999999999999999999999999999999   999999999999999999999999999876544332  


Q ss_pred             eeeccccCccCcccccCCCCC-ccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~-~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....|.+.|.+||++.+..|. .++||||.||||+.||||+.||.++.-       ...+..++.+..          +.
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LLlKV~~G~f----------~M  231 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLLLKVQRGVF----------EM  231 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCcc----------cC
Confidence            334699999999999998876 489999999999999999999974422       222222222221          22


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +...+.+.++|+.+||..||..|.|++||++.
T Consensus       232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            44566889999999999999999999999865

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-36  Score=321.22  Aligned_cols=253  Identities=26%  Similarity=0.358  Sum_probs=203.4

Q ss_pred             cccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          404 NYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.||+|+||.||+|...      ....+++|.+... .....+++.+|+.+++.++||||+++++.+...+..++||
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV   82 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence            45678999999999999843      2356888887643 3445678999999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 004702          477 EFVGNGTLFEHIHKK------------------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANIL  532 (735)
Q Consensus       477 E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NIL  532 (735)
                      ||+.+++|.+++...                        ..+++..++.++.|++.||+|||+.+   |+||||||+|||
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nil  159 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVL  159 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEE
Confidence            999999999998642                        24789999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHH
Q 004702          533 LDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEER  610 (735)
Q Consensus       533 l~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~  610 (735)
                      +++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....+.+..
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            999999999999999865332221 1122335678999999988889999999999999999999 98888654433211


Q ss_pred             HHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          611 SLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      .       ..         ........+...+.++.+++.+||+.+|++||++.|+++.|++++.
T Consensus       240 ~-------~~---------~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         240 N-------LL---------KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             H-------HH---------hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            1       11         1111111223345689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9e-37  Score=343.74  Aligned_cols=247  Identities=22%  Similarity=0.226  Sum_probs=202.6

Q ss_pred             ccccccccccCcEEEEEEEcC-C-CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-D-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.++||+|+||.||++... + +..||+|++...+......+.+|+.+|+.++||||+++++++...+..+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            566789999999999999743 3 57788888766666666778899999999999999999999999999999999999


Q ss_pred             CCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc-
Q 004702          481 NGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI-  555 (735)
Q Consensus       481 ~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~-  555 (735)
                      +|+|.++++.    ..++++..+..++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+++....... 
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            9999988864    346899999999999999999999998   99999999999999999999999999987643322 


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+..       ..+..+.         ..
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~-------~~~~~~~---------~~  289 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM-------QQVLYGK---------YD  289 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC---------CC
Confidence            1223345899999999999999999999999999999999999999654332211       1110010         01


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +.+...+.++.+|+.+||+.+|++||++.+++.
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            112234567999999999999999999999874

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.3e-37  Score=322.33  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=202.3

Q ss_pred             hccccccccccCcEEEEEEEcCC------CcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.+.||+|+||.||+|...+      +..||||+++... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            44567789999999999998532      4679999987543 3345678899999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC
Q 004702          475 VYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT  538 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~  538 (735)
                      ++||+.+++|.+++...                ..+++..+++++.|++.||+|||+.+   |+||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            99999999999998532                34788899999999999999999998   999999999999999999


Q ss_pred             eEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHH
Q 004702          539 PKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNF  616 (735)
Q Consensus       539 ~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~  616 (735)
                      +||+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |..||......+.       
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------  235 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV-------  235 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------
Confidence            99999999886543221 11222335779999999988889999999999999999998 7778765433221       


Q ss_pred             HHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          617 LSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       617 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      ...+....         ....+...+..+.+|+.+||+.+|.+||++.||+..|+.
T Consensus       236 ~~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11111111         111223455778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-36  Score=326.89  Aligned_cols=250  Identities=22%  Similarity=0.256  Sum_probs=198.3

Q ss_pred             ccccccccccCcEEEEEEEc----CCCcEEEEEEeecc----ChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCcee
Q 004702          403 NNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKFV----DQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~  473 (735)
                      +.+.+.||+|+||.||++..    .++..||+|.++..    .....+.+.+|+.++.+++ |+||+++++++...+..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            34567899999999999874    35788999988642    2233456788999999994 899999999999999999


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+++|+|.+++.....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus        82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            99999999999999988888999999999999999999999998   999999999999999999999999999865433


Q ss_pred             cccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .........||+.|+|||.+.+. .++.++||||||++||||++|+.||............   ...+..      .+  
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~---~~~~~~------~~--  227 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV---SRRILK------CD--  227 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH---HHHHhc------CC--
Confidence            33333345699999999998865 4788999999999999999999999643322111111   111100      01  


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                        ...+......+.+++.+||+.||++||     ++.++++
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 --PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence              111223456789999999999999999     5556553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.6e-37  Score=322.08  Aligned_cols=255  Identities=26%  Similarity=0.375  Sum_probs=205.6

Q ss_pred             hhccccccccccCcEEEEEEEcC------CCcEEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCce
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~  472 (735)
                      ..+.+.+.||+|+||.||++...      ....+|+|.++. .......++.+|+.++.++ +|+||+++++++...+..
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            34456679999999999999853      236799998774 3344566789999999999 799999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC
Q 004702          473 LLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN  536 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~  536 (735)
                      ++||||+++|+|.++++..                ..+++..+++++.|++.||+|||+.+   |+||||||+|||++++
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~  168 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTED  168 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCC
Confidence            9999999999999999642                46899999999999999999999988   9999999999999999


Q ss_pred             CCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHH
Q 004702          537 CTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAM  614 (735)
Q Consensus       537 ~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~  614 (735)
                      +.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+....  
T Consensus       169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--  246 (293)
T cd05053         169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL--  246 (293)
T ss_pred             CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH--
Confidence            99999999999876433221 1222335678999999998899999999999999999998 8888865443321111  


Q ss_pred             HHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          615 NFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       615 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                           +.         .....+.+......+.+|+.+||+.+|++|||+.|+++.|+.++
T Consensus       247 -----~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         247 -----LK---------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -----HH---------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                 11         11111222334568899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.8e-37  Score=334.55  Aligned_cols=261  Identities=23%  Similarity=0.336  Sum_probs=207.2

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcC-CCceEEEceEEe
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQIN-RRNVVRLLGCCL  467 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~  467 (735)
                      .+++...+.+.++||+|+||.||+|++.      .+..||||+++.. .....+.+++|+.+|.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4555566667889999999999999853      2457999998753 2333567899999999997 999999999999


Q ss_pred             ecCceeEEEEecCCCchhHHhhhc--------------------------------------------------------
Q 004702          468 ETQVPLLVYEFVGNGTLFEHIHKK--------------------------------------------------------  491 (735)
Q Consensus       468 ~~~~~~lV~E~~~~gsL~~~l~~~--------------------------------------------------------  491 (735)
                      ..+..++||||+++|+|.++++..                                                        
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            999999999999999999999643                                                        


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 004702          492 ------------------------------------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA  529 (735)
Q Consensus       492 ------------------------------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~  529 (735)
                                                                ..+++..+++++.|+++||+|||+.+   |+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                      13677888999999999999999988   999999999


Q ss_pred             cEEEcCCCCeEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChH
Q 004702          530 NILLDENCTPKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPE  607 (735)
Q Consensus       530 NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~  607 (735)
                      |||+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986532221 11122346788999999998889999999999999999998 88888654322


Q ss_pred             HHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          608 EERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       608 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                      +..   ..   .+..         ......+...+.++.+|+.+||+.+|.+||+++||++.|+.++
T Consensus       349 ~~~---~~---~~~~---------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 EQF---YN---AIKR---------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHH---HH---HHHc---------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            211   00   0111         1111112234578999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-36  Score=319.51  Aligned_cols=257  Identities=24%  Similarity=0.356  Sum_probs=207.4

Q ss_pred             hhhccccccccccCcEEEEEEEcCC-----CcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEee-cCce
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLPD-----RTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE-TQVP  472 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~~-----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~  472 (735)
                      ...+.+.++||+|+||.||+|...+     +..|++|+++. ......+.+.+|+.+++.++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3445667899999999999999765     67899998764 345557788999999999999999999998876 4678


Q ss_pred             eEEEEecCCCchhHHhhhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeec
Q 004702          473 LLVYEFVGNGTLFEHIHKK--------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF  544 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~--------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF  544 (735)
                      ++++||+++++|.+++...        ..+++..++.++.|++.||+|||+.+   ++|+||||+|||+++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999999753        45899999999999999999999988   999999999999999999999999


Q ss_pred             cCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcc
Q 004702          545 GASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQ  622 (735)
Q Consensus       545 Gls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  622 (735)
                      |+++.+...... ......++..|+|||++....++.++||||||+++||+++ |+.||....+.+...       .+..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-------YLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH-------HHHc
Confidence            999865433221 1122346778999999998889999999999999999999 999986654322111       1111


Q ss_pred             cchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       623 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      .         .........+.++.+++.+||+.+|++|||+.||++.|+.+.+
T Consensus       235 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         235 G---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             C---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            0         0111122234678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.2e-36  Score=326.24  Aligned_cols=239  Identities=26%  Similarity=0.299  Sum_probs=192.7

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHH-HHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELV-VVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||+||++... ++..||||++...   ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999854 6889999998642   2223345555554 56789999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|.+++.....+++..+..++.||++||+|||+++   |+||||||+||||++++.+||+|||+++...... ......
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTSTF  156 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccccc
Confidence            999999988888999999999999999999999998   9999999999999999999999999987542221 222334


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...       .+..        ...  ......
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-------~i~~--------~~~--~~~~~~  219 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD-------NILN--------KPL--RLKPNI  219 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH-------HHHc--------CCC--CCCCCC
Confidence            58999999999999999999999999999999999999997654322111       1111        000  011123


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEV  666 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev  666 (735)
                      +..+.+++.+||+.+|.+||++++.
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~  244 (323)
T cd05575         220 SVSARHLLEGLLQKDRTKRLGAKDD  244 (323)
T ss_pred             CHHHHHHHHHHhhcCHHhCCCCCCC
Confidence            5678999999999999999998643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-36  Score=314.15  Aligned_cols=247  Identities=26%  Similarity=0.393  Sum_probs=205.4

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.+.+.||.|+||.||++... ++.||+|+++.... ..+++.+|+.+++.++|+||+++++++......++||||+++
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            4456789999999999999875 67899999876544 567899999999999999999999999998999999999999


Q ss_pred             CchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          482 GTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       482 gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      ++|.+++....  .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.......    
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----  157 (256)
T cd05039          85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----  157 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc----
Confidence            99999998764  7999999999999999999999998   99999999999999999999999999987632221    


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....+..|+|||.+....++.++||||||+++|||++ |..||......+...       ....         ......+
T Consensus       158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~~---------~~~~~~~  221 (256)
T cd05039         158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------HVEK---------GYRMEAP  221 (256)
T ss_pred             cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-------HHhc---------CCCCCCc
Confidence            2235678999999998899999999999999999998 998986553322111       1111         1111112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ...+.++.+++.+||+.+|++|||+.|++++|+.+
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            23457899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-36  Score=314.83  Aligned_cols=251  Identities=24%  Similarity=0.362  Sum_probs=202.7

Q ss_pred             hhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      ..+.+.+.||+|++|.||++...++..+|+|++.... ...+.+.+|+.++++++|+|++++++++. .+..++||||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            3456678999999999999998777789999876433 23467889999999999999999999875 456789999999


Q ss_pred             CCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          481 NGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       481 ~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|.++++..  ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++...........
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence            99999999764  35899999999999999999999988   99999999999999999999999999986643322222


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||......+...       .+...         .....
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~---------~~~~~  224 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE-------QVERG---------YRMPC  224 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcC---------CCCCC
Confidence            22346778999999998899999999999999999999 888886544322111       11110         01111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      +...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            23455789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=313.89  Aligned_cols=260  Identities=24%  Similarity=0.328  Sum_probs=210.3

Q ss_pred             cccccccCcEEEEEEEc-CCCcEEEEEEee--ccChhHHHHHHHHHHHHHhcCCCceEEEceEEee-----cCceeEEEE
Q 004702          406 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSK--FVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE-----TQVPLLVYE  477 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lV~E  477 (735)
                      .+.||+|++|.|.++.. .++..||||++.  ..+....++.++|+++|+.++|+||+.++.....     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            46799999999999984 568999999988  5677778889999999999999999999998865     346799999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC-ccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID-AIQ  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~-~~~  556 (735)
                      +| .-+|...++.++.|+.....-++.|+++||+|+|+.+   |+||||||.|+|++.+..+||+|||+|+..... ...
T Consensus       107 lM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~  182 (359)
T KOG0660|consen  107 LM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDG  182 (359)
T ss_pred             HH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCccc
Confidence            99 5599999999888999999999999999999999999   999999999999999999999999999987532 223


Q ss_pred             ceeeeccccCccCccccc-CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh------
Q 004702          557 NCTVVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL------  629 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~-~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  629 (735)
                      ..+...-|..|.|||.+. ...|+.+.||||.|++|.||++|++-|.+....+...++........+..+..+-      
T Consensus       183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~  262 (359)
T KOG0660|consen  183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARP  262 (359)
T ss_pred             chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHH
Confidence            345667899999999875 4679999999999999999999999998877766666655443333222222211      


Q ss_pred             --hhc-ccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          630 --DNR-IVNDGN-----KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       630 --d~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                        ... .....+     ....+...+|+.+||..||.+|+|++|.++.
T Consensus       263 yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  263 YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence              100 001111     1233678899999999999999999998754

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.9e-36  Score=315.07  Aligned_cols=254  Identities=23%  Similarity=0.348  Sum_probs=205.6

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.++||+|+||.||+|+. .++..||||+++.   .+......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence            34567899999999999985 4688999998753   3445566789999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          479 VGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       479 ~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      +++++|.+++..    ...+++..++.++.|+++||+|||+++   ++|+||||+|||++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999988853    345899999999999999999999998   9999999999999999999999999988765332


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      .. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..    +...+....        ..
T Consensus       161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~----~~~~~~~~~--------~~  226 (267)
T cd08228         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FS----LCQKIEQCD--------YP  226 (267)
T ss_pred             HH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HH----HHHHHhcCC--------CC
Confidence            21 123358889999999998889999999999999999999999986543211 11    111111100        00


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ..........+.+++.+||+.+|++||++.||++.|+.+
T Consensus       227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            111223457799999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=335.01  Aligned_cols=250  Identities=25%  Similarity=0.297  Sum_probs=204.7

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||++... ++..||||+++..   .......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY   82 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence            445679999999999999854 6889999998743   224456788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc----
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA----  554 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~----  554 (735)
                      +++++|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||++.......    
T Consensus        83 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          83 MPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            999999999988888999999999999999999999988   9999999999999999999999999998664332    


Q ss_pred             ------------------------ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHH
Q 004702          555 ------------------------IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER  610 (735)
Q Consensus       555 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~  610 (735)
                                              ........||+.|+|||.+.+..++.++||||||++||||++|+.||......+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                    11222345899999999999999999999999999999999999999766533321


Q ss_pred             HHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 004702          611 SLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPT-MKEVSLE  669 (735)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~~  669 (735)
                      .....+    .         .....+.....+.++.+|+.+||+ +|.+||+ +.|+++.
T Consensus       240 ~~i~~~----~---------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         240 NKIINW----K---------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHhcc----C---------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            111100    0         001111111245788999999997 9999999 9998864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-36  Score=319.61  Aligned_cols=266  Identities=28%  Similarity=0.340  Sum_probs=204.1

Q ss_pred             cccccccccCcEEEEEEEc-----CCCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecC--ceeEE
Q 004702          404 NYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQ--VPLLV  475 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV  475 (735)
                      .+.++||+|+||+||++..     .++..||+|.++... ......|.+|+++|+.++||||+++++++...+  ..++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            4567899999999987652     357789999887533 345677889999999999999999999887643  57899


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||+++++|.+++... .+++.+++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  162 (283)
T cd05080          87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  162 (283)
T ss_pred             ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence            9999999999999764 5999999999999999999999998   99999999999999999999999999987643222


Q ss_pred             cc--eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          556 QN--CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       556 ~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      ..  .....++..|+|||.+....++.++||||||+++|||++|..|+........ ..............+.+.++...
T Consensus       163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T cd05080         163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGM  241 (283)
T ss_pred             hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCC
Confidence            11  1122356679999999988899999999999999999999999754332110 00000000011112222222222


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                      ..+.+...+.++.+++.+||+.+|++|||+++|++.|+.+.
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            22223345678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-36  Score=323.19  Aligned_cols=256  Identities=28%  Similarity=0.409  Sum_probs=202.7

Q ss_pred             hccccccccccCcEEEEEEEcC-CCc--EEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRT--PVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.+.||+|+||.||+|... ++.  .+++|+++. ........+.+|+.++.++ +|+||+++++++...+..++||
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~   87 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   87 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence            3456789999999999999854 343  467777664 3344567888999999999 8999999999999999999999


Q ss_pred             EecCCCchhHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 004702          477 EFVGNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPK  540 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k  540 (735)
                      ||+++++|.++++...                .+++.+++.++.|++.||+|||+.+   |+||||||+|||+++++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEE
Confidence            9999999999997532                5789999999999999999999998   99999999999999999999


Q ss_pred             EeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHH
Q 004702          541 VSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSS  619 (735)
Q Consensus       541 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  619 (735)
                      |+|||+++.....  .......++..|+|||++....++.++||||||+++|||+| |..||......+..       ..
T Consensus       165 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~  235 (303)
T cd05088         165 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------EK  235 (303)
T ss_pred             eCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH-------HH
Confidence            9999998643211  11111224668999999988889999999999999999998 99998654332211       11


Q ss_pred             hcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       620 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      +...         ...+.+...+..+.+|+.+||+.+|++||++.+++..|+.++....
T Consensus       236 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         236 LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             HhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            1110         1111122244678999999999999999999999999998766543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-36  Score=333.87  Aligned_cols=250  Identities=20%  Similarity=0.267  Sum_probs=198.1

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.||+|+||+||+|.. .++..||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~   83 (381)
T cd05626           4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (381)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence            3467899999999999984 46789999998642   3345667899999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc----
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI----  555 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~----  555 (735)
                      ++|+|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+||||+.++++||+|||+++.+.....    
T Consensus        84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          84 PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            99999999988888999999999999999999999998   99999999999999999999999999764311000    


Q ss_pred             ------------------------------------------cceeeeccccCccCcccccCCCCCccccchhHHHHHHH
Q 004702          556 ------------------------------------------QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVE  593 (735)
Q Consensus       556 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~e  593 (735)
                                                                .......||+.|+|||.+.+..++.++||||||+++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                      00112459999999999998899999999999999999


Q ss_pred             HHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHH--cccCCCCCCCCHHHHHHH
Q 004702          594 LLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAAR--CISVRGEERPTMKEVSLE  669 (735)
Q Consensus       594 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPt~~ev~~~  669 (735)
                      |++|+.||......+......      ..       ...+..+.......++.+|+.+  |+..++..||++.|++..
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~------~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVI------NW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHH------cc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            999999997654433211110      00       0001111112244677888887  455666679999998864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=331.92  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=209.6

Q ss_pred             cccccccccCcEEEEEEEcCC--C--cEEEEEEeeccChh-HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          404 NYADVIGCGGSGNVYKGFLPD--R--TPVAVKKSKFVDQA-KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.|+||+|.||.|++|.|..  |  -.||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||||+
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            356789999999999998753  3  35899999865544 67899999999999999999999999988 677899999


Q ss_pred             cCCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          479 VGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       479 ~~~gsL~~~l~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      ++.|+|.+.|++  +..|....+-.++.|||+||.||.+++   +|||||.++|+||-....+||+||||.+.+......
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            999999999987  356788888899999999999999999   999999999999999999999999999987644322


Q ss_pred             -ceee-eccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          557 -NCTV-VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       557 -~~~~-~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                       .+.. ..-...|.|||.+....++.+||||+|||+||||+| |..||.......                +++.+|..-
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~e  332 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAGE  332 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhccccc
Confidence             2221 224678999999999999999999999999999999 788987654432                334455555


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      ..+.++.+++.+++++++||..+|++|||+..|.+.+-
T Consensus       333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            55567788999999999999999999999999975543

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-36  Score=312.71  Aligned_cols=247  Identities=28%  Similarity=0.405  Sum_probs=199.4

Q ss_pred             ccccccCcEEEEEEEcCC----CcEEEEEEeeccCh-hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLPD----RTPVAVKKSKFVDQ-AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||.||+|++..    +..+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999997432    26799998774333 35678899999999999999999999876 4567999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc--ee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CT  559 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~--~~  559 (735)
                      ++|.+++.....+++..++.++.|++.||+|||..+   ++|+||||+|||++.++.+||+|||+++.........  ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence            999999988878999999999999999999999998   9999999999999999999999999998764332221  11


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ...++..|+|||.+....++.++||||||+++|||++ |+.||......+.   .    ..+....         ..+.+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~----~~~~~~~---------~~~~~  220 (257)
T cd05060         157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---I----AMLESGE---------RLPRP  220 (257)
T ss_pred             CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---H----HHHHcCC---------cCCCC
Confidence            1224568999999998899999999999999999998 8999865433221   1    1111111         01112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            23456889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-36  Score=326.35  Aligned_cols=241  Identities=24%  Similarity=0.308  Sum_probs=196.4

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||+||+|... ++..||||.++..   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999854 5788999988642   334456678899998866 799999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      ++|..++.....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~  156 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTF  156 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccc
Confidence            999999988888999999999999999999999998   9999999999999999999999999987543222 122334


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .|++.|+|||++.+..++.++||||||+++|||++|+.||......+...       .+...        ..  ..+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-------~i~~~--------~~--~~p~~~  219 (321)
T cd05591         157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE-------SILHD--------DV--LYPVWL  219 (321)
T ss_pred             ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH-------HHHcC--------CC--CCCCCC
Confidence            58999999999999899999999999999999999999997654432111       11111        00  011123


Q ss_pred             HHHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERP-------TMKEVSL  668 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RP-------t~~ev~~  668 (735)
                      ..++.+|+.+||+.+|++||       ++.++++
T Consensus       220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            46788999999999999999       6666653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-36  Score=315.11  Aligned_cols=255  Identities=26%  Similarity=0.396  Sum_probs=207.6

Q ss_pred             HHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      +....+.+.++||+|+||.||++..+++..||||.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            3344556778999999999999998888889999887433 335678999999999999999999999998889999999


Q ss_pred             ecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          478 FVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       478 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |+++++|.+++...  ..+++..++.++.|++.||+|||+++   ++|+||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999999765  36899999999999999999999998   99999999999999999999999999987653322


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      ........+..|+|||.+.+..++.++||||||++++||++ |+.||........   ...    +..         ...
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~----~~~---------~~~  222 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQ----VER---------GYR  222 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHc---------CCC
Confidence            22222335678999999998889999999999999999999 8999865433221   111    110         011


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      ...+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            11122235679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-36  Score=326.18  Aligned_cols=238  Identities=24%  Similarity=0.314  Sum_probs=195.1

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||+||++... ++..||||.++..   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999854 5788999988642   234456778898888876 699999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .....
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~~  156 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTSTF  156 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccccc
Confidence            999999988888999999999999999999999998   99999999999999999999999999875422211 12234


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...       .+....        .  ..+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-------~i~~~~--------~--~~~~~~  219 (320)
T cd05590         157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE-------AILNDE--------V--VYPTWL  219 (320)
T ss_pred             ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH-------HHhcCC--------C--CCCCCC
Confidence            58999999999999899999999999999999999999997654332111       111111        0  111224


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKE  665 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~e  665 (735)
                      ..++.+++.+||+.||.+||++.+
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         220 SQDAVDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCC
Confidence            467899999999999999999854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.6e-37  Score=329.47  Aligned_cols=238  Identities=26%  Similarity=0.272  Sum_probs=196.3

Q ss_pred             ccccccCcEEEEEEEc----CCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          407 DVIGCGGSGNVYKGFL----PDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.||+|+||.||++..    ..+..||+|+++...  ......+.+|+++|++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4799999999999874    357899999987432  2334567789999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +|+|.+++.....+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++....... ....
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~  157 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYS  157 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ceec
Confidence            9999999988888999999999999999999999998   99999999999999999999999999886543321 2233


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..|++.|+|||.+....++.++||||||+++|||++|+.||......+...       .+....          ...+..
T Consensus       158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-------~i~~~~----------~~~p~~  220 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT-------MILKAK----------LGMPQF  220 (318)
T ss_pred             ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH-------HHHcCC----------CCCCCC
Confidence            458999999999998889999999999999999999999997554322111       111110          011223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKE  665 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~e  665 (735)
                      ...++.+|+.+||+.||++||++.+
T Consensus       221 ~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 LSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            4567899999999999999999766

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=321.70  Aligned_cols=261  Identities=24%  Similarity=0.321  Sum_probs=202.2

Q ss_pred             HhhhccccccccccCcEEEEEEEcCC---------------CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEE
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFLPD---------------RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRL  462 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l  462 (735)
                      +...+.+.+.||+|+||.||++...+               ...||+|+++.. .....+.|.+|++++++++|+||+++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            34456677899999999999987532               224899988653 44456779999999999999999999


Q ss_pred             ceEEeecCceeEEEEecCCCchhHHhhhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 004702          463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKG------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN  530 (735)
Q Consensus       463 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~N  530 (735)
                      ++++...+..++||||+++++|.+++....            .+++..+++++.|++.||+|||+.+   ++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence            999999999999999999999999986531            3788999999999999999999998   9999999999


Q ss_pred             EEEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh--CCccCCCCChH
Q 004702          531 ILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT--GKMALLSDKPE  607 (735)
Q Consensus       531 ILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt--G~~p~~~~~~~  607 (735)
                      ||+++++.+||+|||++......... ......++..|+|||.+....++.++||||||++++||++  +..||......
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            99999999999999999865432211 1122235678999999998899999999999999999998  55676554332


Q ss_pred             HHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          608 EERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       608 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      +.......+....         ........+...+..+.+|+.+||+.+|++||++.+|++.|+
T Consensus       240 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QVIENTGEFFRNQ---------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHhhhhc---------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            2211111111000         000111112223468999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-37  Score=333.90  Aligned_cols=248  Identities=25%  Similarity=0.305  Sum_probs=199.0

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.++||+|+||+||++... ++..||||+++..   .......+.+|+.+|..++||||+++++++.+.+..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL   83 (364)
T ss_pred             eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence            45679999999999999854 5889999998742   2344566788999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc---
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ---  556 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~---  556 (735)
                      ++|+|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+......   
T Consensus        84 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          84 PGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            99999999988888999999999999999999999999   999999999999999999999999998754321100   


Q ss_pred             ----------------------------------ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCC
Q 004702          557 ----------------------------------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL  602 (735)
Q Consensus       557 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~  602 (735)
                                                        ......||+.|+|||++....++.++||||||+++|||++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence                                              0012348999999999999999999999999999999999999997


Q ss_pred             CCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 004702          603 SDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPT---MKEVSL  668 (735)
Q Consensus       603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~  668 (735)
                      .....+.......    ..         ..+..+.....++++.+|+.+|+. +|.+|++   +.|++.
T Consensus       241 ~~~~~~~~~~i~~----~~---------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         241 SDNPQETYRKIIN----WK---------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCHHHHHHHHHc----CC---------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            6554332111100    00         000011111234678899999996 9999998   777765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-36  Score=321.87  Aligned_cols=262  Identities=26%  Similarity=0.359  Sum_probs=209.2

Q ss_pred             HHhhhccccccccccCcEEEEEEEcC--------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEe
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCL  467 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~  467 (735)
                      +....+.+.+.||+|+||.||++...        ++..||+|.++.. ......++.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            44445567789999999999999631        2347999987643 345567899999999999 8999999999999


Q ss_pred             ecCceeEEEEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 004702          468 ETQVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANI  531 (735)
Q Consensus       468 ~~~~~~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NI  531 (735)
                      .....++||||+++++|.+++...                ..+++..++.++.|+++||+|||+.+   |+||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            999999999999999999999753                24788899999999999999999998   99999999999


Q ss_pred             EEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHH
Q 004702          532 LLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEE  609 (735)
Q Consensus       532 Ll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~  609 (735)
                      |+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            9999999999999999876432222 1222345678999999998889999999999999999998 7777754433221


Q ss_pred             HHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          610 RSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      .       ..+....         ....+...+.++.+|+.+||+.+|.+|||+.||++.|++++....
T Consensus       249 ~-------~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         249 F-------KLLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             H-------HHHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence            1       1111111         111122345789999999999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.7e-37  Score=331.17  Aligned_cols=249  Identities=19%  Similarity=0.246  Sum_probs=201.6

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||++.. .++..||+|+++..   .....+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            34567999999999999985 46889999998743   233456688899999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++|+|.+++... ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..........
T Consensus        83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            9999999999876 67999999999999999999999998   9999999999999999999999999998765443333


Q ss_pred             eeeeccccCccCccccc------CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          558 CTVVQGTLGYLDPEYLQ------TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~------~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      .....||+.|+|||++.      ...++.++||||||++||||++|+.||............      +.....      
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~~~~------  227 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI------MNFQRF------  227 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH------HcCCCc------
Confidence            33446899999999986      456788999999999999999999999765443321111      110000      


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       +..+.....+.++.+|+..||+ +|.+|||+.+++.
T Consensus       228 -~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 -LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             -cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence             0011112345678899999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.1e-36  Score=313.76  Aligned_cols=255  Identities=24%  Similarity=0.396  Sum_probs=206.9

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ++....+.+.+.||+|+||.||++...++..+++|.++.. ....+.+.+|+.++++++|+||+++.+.+.. ...+++|
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            3445566778899999999999999877888999987643 3345788999999999999999999999887 7789999


Q ss_pred             EecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          477 EFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       477 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||+++++|.+++...  ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999763  45889999999999999999999988   9999999999999999999999999998664332


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      ........++..|+|||++....++.++|+||||+++++|++ |+.||.........       ..+...         .
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~---------~  220 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERG---------Y  220 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCC---------C
Confidence            222222335678999999998889999999999999999999 88888654332211       111111         1


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      ..+.....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            111123345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-36  Score=320.73  Aligned_cols=260  Identities=22%  Similarity=0.278  Sum_probs=194.0

Q ss_pred             ccccccccccCcEEEEEEEc--CCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhc---CCCceEEEceEEee-----cC
Q 004702          403 NNYADVIGCGGSGNVYKGFL--PDRTPVAVKKSKFVD--QAKIDEFINELVVVLQI---NRRNVVRLLGCCLE-----TQ  470 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~  470 (735)
                      +.+.+.||+|+||+||++..  .++..||+|+++...  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            45667899999999999985  346789999876432  22334566777777665   69999999999853     34


Q ss_pred             ceeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK  548 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~  548 (735)
                      ..++||||+. ++|.+++...  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            6789999996 6899998753  45899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh-
Q 004702          549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE-  627 (735)
Q Consensus       549 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  627 (735)
                      .....  .......|++.|+|||.+....++.++||||||+++|||++|+.||......+................+.. 
T Consensus       159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            65433  222334589999999999888999999999999999999999999977655443222211110000000000 


Q ss_pred             --Hhhhccc--CC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          628 --ILDNRIV--ND-----GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       628 --~~d~~~~--~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                        +......  ..     ........+.+|+.+||+.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence              0000000  00     01123467789999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.4e-36  Score=315.16  Aligned_cols=257  Identities=23%  Similarity=0.353  Sum_probs=206.6

Q ss_pred             hhhccccccccccCcEEEEEEEcCC----CcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      ...+.+.+.||+|+||.||+|...+    ...|+||...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3445677899999999999998543    3468999877544 5566789999999999999999999998865 45689


Q ss_pred             EEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          475 VYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      ||||+++++|.+++... ..+++..++.++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999999864 45899999999999999999999988   999999999999999999999999999876544


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .........++..|+|||.+....++.++||||||+++|||++ |..||......+...   .    +....        
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~---~----~~~~~--------  225 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG---R----IENGE--------  225 (270)
T ss_pred             cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---H----HHcCC--------
Confidence            3222223335578999999988889999999999999999996 999986554332111   1    11111        


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                       ....+...+..+.+++.+||..+|.+|||+.++++.|+.++..
T Consensus       226 -~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         226 -RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             0011223456899999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.8e-36  Score=317.46  Aligned_cols=250  Identities=25%  Similarity=0.386  Sum_probs=199.5

Q ss_pred             ccccccccccCcEEEEEEEcCC------CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      +.+.+.||+|++|.||+|...+      +..|++|..... .......|.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   87 (277)
T cd05036           8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL   87 (277)
T ss_pred             cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence            4456789999999999998643      567899987643 344456799999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---CeEEeecc
Q 004702          476 YEFVGNGTLFEHIHKKG-------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC---TPKVSDFG  545 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFG  545 (735)
                      |||+++++|.+++....       .+++..+++++.||+.||+|||+.+   ++||||||+|||++.++   .+||+|||
T Consensus        88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg  164 (277)
T cd05036          88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFG  164 (277)
T ss_pred             EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCc
Confidence            99999999999997642       5899999999999999999999998   99999999999998654   59999999


Q ss_pred             CCcccCCCcccc-eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhccc
Q 004702          546 ASKLVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQN  623 (735)
Q Consensus       546 ls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  623 (735)
                      +++......... ......+..|+|||++.+..++.++||||||+++|||++ |..||......+...    .       
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~----~-------  233 (277)
T cd05036         165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME----F-------  233 (277)
T ss_pred             cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----H-------
Confidence            998763222111 111223568999999998899999999999999999997 888986544332111    1       


Q ss_pred             chhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          624 RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       624 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                           +......+.+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       234 -----~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 -----VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -----HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                 1111111122334568899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-37  Score=311.61  Aligned_cols=247  Identities=22%  Similarity=0.375  Sum_probs=209.6

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      ++.|.+.||+|.||+|-++.. ..|+.||||.++.   .++++.-.+.+|++||+.|+||||+.++.+|...+..+||||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            345567899999999999984 6799999997754   566677778899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |..+|.|++++.+.+.|++.....++.||..|+.|.|.++   ++|||||.+|||||.|+++||+||||+.++..+..  
T Consensus       134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf--  208 (668)
T KOG0611|consen  134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF--  208 (668)
T ss_pred             ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccccH--
Confidence            9999999999999999999999999999999999999999   99999999999999999999999999998765433  


Q ss_pred             eeeeccccCccCcccccCCCCC-ccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~-~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      .+.+.|++.|.+||++.+..|. +..|-|||||+||.|+.|..||.....   ..++    +.+..+..        .. 
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lv----rQIs~GaY--------rE-  272 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLV----RQISRGAY--------RE-  272 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHH----HHhhcccc--------cC-
Confidence            3456799999999999998875 689999999999999999999965432   1222    22222211        11 


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                        .+.+....-||++||-.||++|.|+.+|...+-
T Consensus       273 --P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  273 --PETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             --CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence              233456778999999999999999999987653

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.5e-36  Score=320.56  Aligned_cols=256  Identities=23%  Similarity=0.364  Sum_probs=204.6

Q ss_pred             hhhccccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCc
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQV  471 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  471 (735)
                      .....+.+.||+|+||.||++...      .+..||||+++.. .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            334566789999999999999731      2457999987753 344457789999999999 79999999999999999


Q ss_pred             eeEEEEecCCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          472 PLLVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      .++||||+++|+|.++++...  .+++.+++.++.|++.||+|||+.+   |+|+||||+|||+++++.+||+|||+++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999997643  3899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       550 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ....... ......++..|+|||.+....++.++||||||+++|||++ |+.||......+..      ......     
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~------~~~~~~-----  259 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKLIKE-----  259 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH------HHHHHc-----
Confidence            6433221 1112235678999999998899999999999999999998 99998654332211      111111     


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                          ......+...+.++.+++.+||+.+|++|||+.||++.|+++
T Consensus       260 ----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         260 ----GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ----CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                111111122346799999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-36  Score=311.79  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=202.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC-----hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD-----QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      +...+.||+|++|.||++.. .++..+|+|.+....     ......+.+|+.++++++||||+++++++...+..++||
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            34567999999999999985 468899999876421     223467889999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      ||+++++|.+++.....+++..+.+++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||+++........
T Consensus        84 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            99999999999988888999999999999999999999998   999999999999999999999999998765432111


Q ss_pred             ce--eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          557 NC--TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       557 ~~--~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      ..  ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+...   .            .......
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~------------~~~~~~~  225 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF---K------------IATQPTN  225 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH---H------------HhccCCC
Confidence            11  23447889999999999889999999999999999999999986543322110   0            0011111


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ...+......+.+++.+||+.+|.+|||+.|++..
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            12233455678999999999999999999998853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.7e-36  Score=316.32  Aligned_cols=255  Identities=26%  Similarity=0.395  Sum_probs=202.7

Q ss_pred             ccccccccccCcEEEEEEEc-CCCc----EEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRT----PVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ..+.++||+|+||+||+|.+ .++.    .||+|.++. ......+++.+|+.+++.++|+||+++++++... ..+++|
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~   87 (279)
T cd05109           9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVT   87 (279)
T ss_pred             eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEE
Confidence            34567899999999999984 3343    489998864 3444567889999999999999999999998754 467999


Q ss_pred             EecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+++|+|.++++.. ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        88 ~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~  164 (279)
T cd05109          88 QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET  164 (279)
T ss_pred             EcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence            999999999999874 56999999999999999999999998   99999999999999999999999999987653322


Q ss_pred             cc-eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          556 QN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       556 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      .. .....++..|+|||.+.+..++.++||||||+++|||++ |..||..........    .+   ..         ..
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~---~~---------~~  228 (279)
T cd05109         165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD----LL---EK---------GE  228 (279)
T ss_pred             eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HH---HC---------CC
Confidence            11 112235678999999998899999999999999999998 888886543322111    11   11         11


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ..+.....+.++.+++.+||+.+|++||++.++++.|+.+.+..
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            11112234567899999999999999999999999998775543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-36  Score=313.22  Aligned_cols=238  Identities=24%  Similarity=0.409  Sum_probs=190.8

Q ss_pred             ccccccCcEEEEEEEcCC-------------CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          407 DVIGCGGSGNVYKGFLPD-------------RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      +.||+|+||.||+|++..             ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2258888877655556678899999999999999999999999998999


Q ss_pred             EEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC-------eEEeecc
Q 004702          474 LVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT-------PKVSDFG  545 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-------~kl~DFG  545 (735)
                      +||||+++++|..++... ..+++..+++++.|+++||+|||+.+   |+||||||+|||++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998754 56999999999999999999999998   999999999999987664       8999999


Q ss_pred             CCcccCCCcccceeeeccccCccCccccc-CCCCCccccchhHHHHHHHHH-hCCccCCCCChHHHHHHHHHHHHHhccc
Q 004702          546 ASKLVPIDAIQNCTVVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVLVELL-TGKMALLSDKPEEERSLAMNFLSSLKQN  623 (735)
Q Consensus       546 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDVyS~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~  623 (735)
                      ++......     ....++..|+|||.+. ...++.++||||||++||||+ +|..|+......+...    +.    ..
T Consensus       158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----~~----~~  224 (262)
T cd05077         158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----FY----EG  224 (262)
T ss_pred             CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH----HH----hc
Confidence            98755322     1234788999999886 467899999999999999998 4777775433222111    10    00


Q ss_pred             chhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          624 RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       624 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      ..      ..    ......++.+|+.+||+.+|.+||++.+|++.|
T Consensus       225 ~~------~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         225 QC------ML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             Cc------cC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            00      00    111235789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.6e-36  Score=315.72  Aligned_cols=253  Identities=23%  Similarity=0.335  Sum_probs=202.7

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||.||+|+. .++..||+|+++.........+.+|+.++++++||||+++++.+...+..++||||++
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~   89 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG   89 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence            345667899999999999985 5678899999876555556678899999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +++|.++++....+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++....... ....
T Consensus        90 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~  165 (267)
T cd06646          90 GGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKS  165 (267)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCc
Confidence            9999999988788999999999999999999999988   99999999999999999999999999986642221 1223


Q ss_pred             eccccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          561 VQGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       561 ~~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ..++..|+|||.+.   ...++.++||||||+++|||++|+.||....+.+...       .+.....   ..+..  ..
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~---~~~~~--~~  233 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF---QPPKL--KD  233 (267)
T ss_pred             cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC---CCCCC--cc
Confidence            45888999999874   3457889999999999999999999986443221110       0000000   00000  01


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      ....+..+.+++.+||+.+|++|||+.++++.|
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            123456899999999999999999999988643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.4e-36  Score=314.93  Aligned_cols=253  Identities=24%  Similarity=0.379  Sum_probs=203.9

Q ss_pred             hccccccccccCcEEEEEEEcCC-C---cEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPD-R---TPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.+.||+|+||.||+|.... +   ..||||.++.. ......+|..|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            34567899999999999998643 2   36999998753 4556778999999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+++++|.+++... +.+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            999999999999764 56899999999999999999999998   99999999999999999999999999876543221


Q ss_pred             cc-eee-e--ccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          556 QN-CTV-V--QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       556 ~~-~~~-~--~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      .. ... .  ..+..|+|||.+....++.++||||||+++|||++ |..||......+..       ..+...       
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~-------~~i~~~-------  227 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-------NAIEQD-------  227 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcC-------
Confidence            11 111 1  12457999999999999999999999999999887 99998765433211       111110       


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                        ...+.+.+.+..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       228 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 --YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              01111223456789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-36  Score=326.15  Aligned_cols=243  Identities=25%  Similarity=0.301  Sum_probs=193.1

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||+||++... ++..||+|.++..   .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999854 5788999998742   334456677899888776 799999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|..++.....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....... .....
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~~  156 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTF  156 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccccc
Confidence            999999988888999999999999999999999998   99999999999999999999999999875322111 12234


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHH--HHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE--RSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||........  ..........+.        ....  ..+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~--------~~~~--~~p~  226 (329)
T cd05618         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--------EKQI--RIPR  226 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh--------cCCC--CCCC
Confidence            589999999999999999999999999999999999999953211110  000011111111        1111  1223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCH
Q 004702          640 QQLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                      ....++.+|+.+||+.||++||+.
T Consensus       227 ~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         227 SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCHHHHHHHHHHhcCCHHHcCCC
Confidence            345678899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.4e-36  Score=323.41  Aligned_cols=264  Identities=25%  Similarity=0.350  Sum_probs=210.0

Q ss_pred             HHHHHhhhccccccccccCcEEEEEEEcC--------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEce
Q 004702          395 EEEIKTVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLG  464 (735)
Q Consensus       395 ~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g  464 (735)
                      ..++...++.+.+.||+|+||.||++...        ....||+|.++.. .....+++.+|+.+++++ +||||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            34566667788899999999999999732        1236899987643 344567899999999999 7999999999


Q ss_pred             EEeecCceeEEEEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 004702          465 CCLETQVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKS  528 (735)
Q Consensus       465 ~~~~~~~~~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~  528 (735)
                      ++...+..++||||+++|+|.+++...                ..+++..++.++.|+++||+|||+.+   |+||||||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp  162 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAA  162 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccccc
Confidence            999999999999999999999999753                24788999999999999999999998   99999999


Q ss_pred             CcEEEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCCh
Q 004702          529 ANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKP  606 (735)
Q Consensus       529 ~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~  606 (735)
                      +|||+++++.+||+|||+++........ ......++..|+|||.+....++.++||||||++||||++ |..||.....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999999999999999999865432211 1122234568999999999899999999999999999998 7888865433


Q ss_pred             HHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          607 EEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       607 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      .+..       ..+...         ...+.+...+.++.+|+.+||+.+|.+|||+.|+++.|+.+....
T Consensus       243 ~~~~-------~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         243 EELF-------KLLKEG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHH-------HHHHcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            2211       111111         111112234567899999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1e-36  Score=333.19  Aligned_cols=259  Identities=25%  Similarity=0.314  Sum_probs=201.8

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC-----ceeEE
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-----VPLLV  475 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV  475 (735)
                      ...++||+|+||.||++.. .++..||||++...  +....+.+.+|+.+++.++|+||+++++++...+     ..++|
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            3467899999999999985 56889999988642  3345677889999999999999999999998776     78999


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||+. ++|.+.+.....+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99996 588888887788999999999999999999999998   99999999999999999999999999987644333


Q ss_pred             cceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh--------
Q 004702          556 QNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL--------  626 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------  626 (735)
                      .......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+.+....+...   +......        
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~g~~~~~~~~~~~~~  235 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDL---LGTPSLEAMRSACEG  235 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH---cCCCCHHHHHHhhHH
Confidence            333344578999999998764 5789999999999999999999999766554332222111   1100000        


Q ss_pred             ---hHhhhcccC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          627 ---EILDNRIVN-------DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       627 ---~~~d~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                         .+.......       ........++.+|+.+||+.||.+|||+.|++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence               000000000       0111224678899999999999999999998764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.1e-36  Score=317.51  Aligned_cols=256  Identities=26%  Similarity=0.339  Sum_probs=202.4

Q ss_pred             hhhccccccccccCcEEEEEEEcCC------CcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      ...+.+.++||+|+||.||+|...+      +..||+|.++... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            3455667899999999999997432      4579999876433 33455788999999999999999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 004702          473 LLVYEFVGNGTLFEHIHKK----------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVS  542 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~  542 (735)
                      ++||||+++|+|.+++...          ..+++..+++++.|++.||+|||+++   |+||||||+|||+++++.+||+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence            9999999999999999752          23567888999999999999999998   9999999999999999999999


Q ss_pred             eccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHh
Q 004702          543 DFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSL  620 (735)
Q Consensus       543 DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  620 (735)
                      |||+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||......+...       .+
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~  234 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK-------FV  234 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HH
Confidence            99999865432221 1122235678999999998899999999999999999999 777886543322111       11


Q ss_pred             cccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       621 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                      .....         ...+...+..+.+++.+||+.+|++|||+.++++.|++.+
T Consensus       235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 MDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11100         1112233468999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-36  Score=316.11  Aligned_cols=254  Identities=28%  Similarity=0.370  Sum_probs=203.9

Q ss_pred             HhhhccccccccccCcEEEEEEEcCC------CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV  471 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  471 (735)
                      ....+.+.+.||+|+||.||+|...+      +..||+|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            33445567899999999999998542      367999997643 33456678999999999999999999999999999


Q ss_pred             eeEEEEecCCCchhHHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 004702          472 PLLVYEFVGNGTLFEHIHKK----------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV  541 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl  541 (735)
                      .++||||+++++|.+++...          ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            99999999999999999753          24788999999999999999999988   999999999999999999999


Q ss_pred             eeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHH
Q 004702          542 SDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSS  619 (735)
Q Consensus       542 ~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  619 (735)
                      +|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.||......+...       .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-------~  233 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK-------F  233 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH-------H
Confidence            99999886543322 11222346789999999988889999999999999999998 888886544322111       1


Q ss_pred             hcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       620 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      +.....         ...+...+.++.+++.+||+.+|++|||+.+++..|+
T Consensus       234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 VIDGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111111         1112223578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-36  Score=323.66  Aligned_cols=236  Identities=26%  Similarity=0.346  Sum_probs=194.3

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||+||++... ++..||||.++..   .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999865 4788999998742   234456678899999888 699999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      ++|..++.....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....... .....
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  156 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTSTF  156 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccce
Confidence            999999988888999999999999999999999998   99999999999999999999999999875322211 12234


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .|++.|+|||.+.+..++.++||||||+++|||++|+.||......+..       ..+....        .  ..+...
T Consensus       157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-------~~i~~~~--------~--~~~~~~  219 (318)
T cd05570         157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-------QSILEDE--------V--RYPRWL  219 (318)
T ss_pred             ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-------HHHHcCC--------C--CCCCcC
Confidence            5899999999999999999999999999999999999999755432211       1111110        0  112234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCH
Q 004702          642 LKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~  663 (735)
                      +.++.+|+.+||+.+|.+||++
T Consensus       220 ~~~~~~li~~~l~~dP~~R~s~  241 (318)
T cd05570         220 SKEAKSILKSFLTKNPEKRLGC  241 (318)
T ss_pred             CHHHHHHHHHHccCCHHHcCCC
Confidence            5678999999999999999999

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.8e-36  Score=312.86  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=205.8

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||.||++.. .++..++||.+..   .+.....++.+|+.+++.++|+||+++++++.+.+..+++|||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL   83 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence            34567899999999999984 5788999998764   2344557889999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          479 VGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       479 ~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      +++++|.+++..    ...+++..++.++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999998864    356899999999999999999999998   9999999999999999999999999988664332


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      .. .....++..|+|||.+.+..++.++||||||+++|||++|..||....... ...    ...+.     ..   ...
T Consensus       161 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~----~~~~~-----~~---~~~  226 (267)
T cd08229         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSL----CKKIE-----QC---DYP  226 (267)
T ss_pred             cc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHH----hhhhh-----cC---CCC
Confidence            21 223458899999999998889999999999999999999999986443211 111    11111     00   000


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      .......+.++.+++.+||+.+|++||||.+|++.++++
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            111223557899999999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6e-36  Score=309.10  Aligned_cols=246  Identities=26%  Similarity=0.386  Sum_probs=203.8

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.||+|++|.||++... ++..|++|.+..  ......+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE   82 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence            45678999999999999854 678899998763  345667889999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          481 NGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       481 ~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|.+++...  ..+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++........ .
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~  158 (256)
T cd08529          83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-A  158 (256)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch-h
Confidence            99999999874  57899999999999999999999988   999999999999999999999999998876533222 2


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....|++.|+|||++.+..++.++||||||+++|||++|+.||......+.   ..    .....         ......
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~~~---------~~~~~~  222 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---IL----KIIRG---------VFPPVS  222 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHcC---------CCCCCc
Confidence            234588999999999998999999999999999999999999975543221   11    11111         111112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ......+.+++.+||+.+|++||++.++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            2445789999999999999999999998853

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.1e-36  Score=313.75  Aligned_cols=253  Identities=25%  Similarity=0.382  Sum_probs=204.3

Q ss_pred             hccccccccccCcEEEEEEEcC----CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.+.||+|+||.||+|...    .+..+|+|.++.. .....+.|.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT   84 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            3456789999999999999853    2347999987643 3445678899999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+++++|.+++... ..+++.+++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++.+.....
T Consensus        85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            999999999999765 56899999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ccee--eeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          556 QNCT--VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       556 ~~~~--~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      ...+  ...++..|++||++.+..++.++||||||+++||+++ |+.||......+..       ..+...         
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~-------~~~~~~---------  225 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-------KAIEEG---------  225 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH-------HHHhCC---------
Confidence            2211  1223568999999998899999999999999999887 99998655432211       111111         


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ...+.....+..+.+++.+||+.+|.+||+|.++++.|+.+
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            00111223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.6e-36  Score=322.42  Aligned_cols=240  Identities=25%  Similarity=0.323  Sum_probs=194.1

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHh-cCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQ-INRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.||+|+||+||+|... ++..||||.++..   .....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999864 4788999988743   12334566778888876 5899999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... .....
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  156 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCTF  156 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceeee
Confidence            999999988778999999999999999999999998   99999999999999999999999999875322211 22334


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...       .+...      .+    ..+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~-------~i~~~------~~----~~~~~~  219 (316)
T cd05619         157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ-------SIRMD------NP----CYPRWL  219 (316)
T ss_pred             cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhC------CC----CCCccC
Confidence            58999999999999899999999999999999999999997654322111       11100      00    011123


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHH-HHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMK-EVS  667 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~-ev~  667 (735)
                      ..++.+++.+||+.+|++||++. ++.
T Consensus       220 ~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         220 TREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            46788999999999999999997 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-36  Score=326.17  Aligned_cols=243  Identities=25%  Similarity=0.310  Sum_probs=193.4

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||.||++... ++..||+|.++..   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999854 5788999998742   233456678899999988 799999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|.+++.....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~  156 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTSTF  156 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccccc
Confidence            999999988888999999999999999999999998   9999999999999999999999999987532111 122234


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHH--HHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE--ERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||......+  ...........+        .....  ..+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~p~  226 (329)
T cd05588         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------LEKQI--RIPR  226 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--------HcCCC--CCCC
Confidence            58999999999999999999999999999999999999996322111  000000111111        11111  1122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCH
Q 004702          640 QQLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                      ..+.++.+++.+||+.+|.+||++
T Consensus       227 ~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         227 SLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCC
Confidence            345678999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-36  Score=316.54  Aligned_cols=248  Identities=25%  Similarity=0.282  Sum_probs=198.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +...++||+|+||+||++.. .++..||+|++....   ......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            34567899999999999985 468899999886422   22345678899999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          479 VGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       479 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +++|+|.+++...  ..+++..+..++.|+++||.|||+.+   |+||||||+||++++++.++|+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-  157 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence            9999999888653  46899999999999999999999998   99999999999999999999999999987543322 


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                       .....|++.|+|||.+.+..++.++||||||+++|||++|+.||............   ...+..          ....
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---~~~~~~----------~~~~  223 (285)
T cd05605         158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---ERRVKE----------DQEE  223 (285)
T ss_pred             -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH---HHHhhh----------cccc
Confidence             12335899999999999889999999999999999999999999754332211111   111110          0111


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      .+...+..+.+|+.+||+.||.+||     ++.+++.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            2234567889999999999999999     6666543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.2e-36  Score=310.10  Aligned_cols=254  Identities=24%  Similarity=0.338  Sum_probs=206.9

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||.||+|... ++..||+|.++.   .+....+.+.+|++++++++|+||+++++.+...+..++||||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   83 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence            456789999999999999965 788999998753   3344467889999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          479 VGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       479 ~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      +++++|.+++..    ...+++.+++.++.|+++||+|||+.+   |+|+||+|+||+++.++.+||+|||+++......
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            999999999864    245899999999999999999999998   9999999999999999999999999988654322


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      .. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .    .....+..         ...
T Consensus       161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~----~~~~~~~~---------~~~  225 (267)
T cd08224         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-Y----SLCKKIEK---------CDY  225 (267)
T ss_pred             cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-H----HHHhhhhc---------CCC
Confidence            21 223458889999999998889999999999999999999999986443111 0    01111111         111


Q ss_pred             CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          635 NDGNK-QQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       635 ~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                      .+.+. .....+.+++.+||+.+|++|||+.+|+++|+.+.
T Consensus       226 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         226 PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            11122 44568899999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-36  Score=328.22  Aligned_cols=243  Identities=21%  Similarity=0.324  Sum_probs=191.8

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      +.++||+|+||+||++... ++..||||.+... .....+.+.+|+++++.++|+||+++++++...+..++||||+.++
T Consensus        78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  157 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG  157 (353)
T ss_pred             hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence            3568999999999999854 6889999998643 3344577899999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      +|.+.    ..+.+..+..++.||+.||+|||+.+   |+||||||+||||++++.+||+|||+++.+..... ......
T Consensus       158 ~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~~  229 (353)
T PLN00034        158 SLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSSV  229 (353)
T ss_pred             ccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-cccccc
Confidence            98653    24567788899999999999999998   99999999999999999999999999987643221 122345


Q ss_pred             cccCccCcccccC-----CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          563 GTLGYLDPEYLQT-----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       563 gt~~y~aPE~~~~-----~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      |+..|+|||.+..     ...+.++||||||++||||++|+.||......+......    ....         ......
T Consensus       230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----~~~~---------~~~~~~  296 (353)
T PLN00034        230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC----AICM---------SQPPEA  296 (353)
T ss_pred             cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH----HHhc---------cCCCCC
Confidence            8999999998753     234568999999999999999999997433222111111    0000         001111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ......++.+|+.+||+.+|++|||+.||++
T Consensus       297 ~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        297 PATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2334578999999999999999999999885

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-36  Score=330.92  Aligned_cols=251  Identities=24%  Similarity=0.314  Sum_probs=200.5

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.++||+|+||.||++... ++..||+|.+...   .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            4456779999999999999854 5788999998642   23344567899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++|+|.+++... .+++..+..++.|++.||+|||+.+   |+||||||+||||++++.+||+|||++..........
T Consensus       124 y~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         124 YMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence            99999999998764 6889999999999999999999998   9999999999999999999999999998764333222


Q ss_pred             eeeeccccCccCcccccCC----CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          558 CTVVQGTLGYLDPEYLQTC----KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~----~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      .....||+.|+|||.+...    .++.++||||||++||||++|+.||...........   .   ....       ..+
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~---i---~~~~-------~~~  266 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK---I---MDHK-------NSL  266 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH---H---HcCC-------CcC
Confidence            2345699999999998653    478899999999999999999999976543221111   0   0000       001


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEE--RPTMKEVSLE  669 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~  669 (735)
                      ..+.....+.++.+|+.+||+.+|.+  ||++.|++..
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            11112234578899999999999987  9999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-36  Score=322.95  Aligned_cols=240  Identities=28%  Similarity=0.338  Sum_probs=194.2

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||.||++... ++..||+|.++..   .....+.+..|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999864 5788999998742   123445667788888754 899999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|.+++.....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF  156 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceecc
Confidence            999999988888999999999999999999999998   9999999999999999999999999987432211 122345


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||......+..       ..+...      .+    ..+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~-------~~~~~~------~~----~~~~~~  219 (316)
T cd05620         157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF-------ESIRVD------TP----HYPRWI  219 (316)
T ss_pred             CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhC------CC----CCCCCC
Confidence            6899999999999999999999999999999999999999765432211       111110      00    111123


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHH-HHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMK-EVS  667 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~-ev~  667 (735)
                      ..++.+|+.+||+.||.+||++. +++
T Consensus       220 ~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         220 TKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            46788999999999999999985 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.3e-36  Score=322.92  Aligned_cols=240  Identities=25%  Similarity=0.312  Sum_probs=195.8

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCC-ceEEEceEEeecCceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRR-NVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~E  477 (735)
                      +.+.+.||+|+||.||+|... ++..||||+++..   .....+.+..|..++..++|+ +|+++++++...+..++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            345678999999999999855 4678999988642   334566788999999999765 58889999998999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++|+|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ..
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~  157 (324)
T cd05587          82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT  157 (324)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence            9999999999988888999999999999999999999998   9999999999999999999999999987532211 12


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+...       .+...        .  ...
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~-------~i~~~--------~--~~~  220 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-------SIMEH--------N--VSY  220 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-------HHHcC--------C--CCC
Confidence            234458999999999999999999999999999999999999997654322111       11110        0  111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                      +...+.++.+++.+||+.+|.+|++.
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         221 PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            22345678899999999999999987

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6e-36  Score=319.44  Aligned_cols=259  Identities=25%  Similarity=0.350  Sum_probs=205.7

Q ss_pred             hhhccccccccccCcEEEEEEEcC--------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeec
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLET  469 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  469 (735)
                      ...+.+.+.||+|+||.||++...        ....+|+|.++.. ......++.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            344557789999999999999732        2456899987743 345567889999999999 699999999999998


Q ss_pred             CceeEEEEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 004702          470 QVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL  533 (735)
Q Consensus       470 ~~~~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl  533 (735)
                      +..++||||+++|+|.+++...                ..+++..+++++.|++.||+|||+.+   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            8999999999999999999753                34889999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHH
Q 004702          534 DENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERS  611 (735)
Q Consensus       534 ~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~  611 (735)
                      ++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999999866432211 1112224568999999998889999999999999999999 888886543322111


Q ss_pred             HHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                             .+....         ..+.+...+.++.+|+.+||+.+|++|||+.|+++.|+.+....
T Consensus       248 -------~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         248 -------LLREGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             -------HHHcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence                   111111         01112234467889999999999999999999999999877644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-37  Score=293.37  Aligned_cols=244  Identities=25%  Similarity=0.335  Sum_probs=204.4

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      ++++.||+|.||.||.|+. +++..||+|++...   ......++.+|+++.+.|+||||+++++++.+....||++||.
T Consensus        25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya  104 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA  104 (281)
T ss_pred             cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence            3578999999999999985 45778999987542   2223456789999999999999999999999999999999999


Q ss_pred             CCCchhHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIH--KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      .+|.|...|+  ....+++.....+..|+|.||.|+|..+   +|||||||+|+|++.++..||+|||-+..-+.   ..
T Consensus       105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~---~k  178 (281)
T KOG0580|consen  105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS---NK  178 (281)
T ss_pred             CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC---CC
Confidence            9999999999  4567999999999999999999999999   99999999999999999999999999886542   23


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||..|++||...+...+.+.|+|++|++.+|++.|.+||......+.-.       .+..   .++.       .
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk-------rI~k---~~~~-------~  241 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK-------RIRK---VDLK-------F  241 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH-------HHHH---cccc-------C
Confidence            344569999999999999999999999999999999999999997654322111       1111   1111       1


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      +...+...+++|.+|+..+|.+|.+..|+++.-
T Consensus       242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  242 PSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             CcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence            234557889999999999999999999988653

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-36  Score=315.49  Aligned_cols=238  Identities=25%  Similarity=0.396  Sum_probs=189.9

Q ss_pred             cccccCcEEEEEEEcCC-------------------------CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEE
Q 004702          408 VIGCGGSGNVYKGFLPD-------------------------RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL  462 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  462 (735)
                      .||+|+||.||+|.+..                         ...|++|.+..........|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999997421                         13588898876555556788999999999999999999


Q ss_pred             ceEEeecCceeEEEEecCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----
Q 004702          463 LGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC----  537 (735)
Q Consensus       463 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----  537 (735)
                      ++++.+....++||||+++|+|..++.. ...+++..+++++.|+++||+|||+++   |+||||||+|||+++.+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999975 467899999999999999999999988   99999999999997643    


Q ss_pred             ---CeEEeeccCCcccCCCcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHH-hCCccCCCCChHHHHHH
Q 004702          538 ---TPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELL-TGKMALLSDKPEEERSL  612 (735)
Q Consensus       538 ---~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~ell-tG~~p~~~~~~~~~~~~  612 (735)
                         .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....+.+... 
T Consensus       159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-  232 (274)
T ss_pred             ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-
Confidence               3799999988644221     12246788999998865 56899999999999999995 6888886554332111 


Q ss_pred             HHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          613 AMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       613 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                         +..            ....  .+.....++.+++.+||+.+|++|||+.+|++.|+
T Consensus       233 ---~~~------------~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         233 ---FYE------------KKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ---HHH------------hccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence               110            0000  01112346889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.7e-36  Score=317.97  Aligned_cols=258  Identities=26%  Similarity=0.366  Sum_probs=203.1

Q ss_pred             hccccccccccCcEEEEEEEcCC-----------------CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEc
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPD-----------------RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLL  463 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~  463 (735)
                      .+.+.+.||+|+||.||++...+                 +..||+|++... .....+++.+|+.++++++||||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   85 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL   85 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            45567899999999999987542                 245899987743 345567899999999999999999999


Q ss_pred             eEEeecCceeEEEEecCCCchhHHhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 004702          464 GCCLETQVPLLVYEFVGNGTLFEHIHKKG-----------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANIL  532 (735)
Q Consensus       464 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NIL  532 (735)
                      +++..++..++||||+++++|.+++....           .+++..++.++.|++.||+|||+.+   |+|+||||+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nil  162 (296)
T cd05051          86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhcee
Confidence            99999999999999999999999997754           6899999999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh--CCccCCCCChHHH
Q 004702          533 LDENCTPKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT--GKMALLSDKPEEE  609 (735)
Q Consensus       533 l~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt--G~~p~~~~~~~~~  609 (735)
                      +++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++  +..||......+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV  242 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence            99999999999999886543221 11223346778999999998889999999999999999998  6667754332221


Q ss_pred             HHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          610 RSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                         ...........      ......+.+...+.++.+|+.+||+.+|.+|||+.||++.|+
T Consensus       243 ---~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         243 ---IENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ---HHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence               11111111110      011111112234468999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.2e-36  Score=310.92  Aligned_cols=250  Identities=30%  Similarity=0.424  Sum_probs=195.9

Q ss_pred             ccccccCcEEEEEEEcC----CCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEee-cCceeEEEEecC
Q 004702          407 DVIGCGGSGNVYKGFLP----DRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE-TQVPLLVYEFVG  480 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~----~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~E~~~  480 (735)
                      ++||+|+||.||+|.+.    +...||||++.. ......+.+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    235799998754 344557788999999999999999999998764 556889999999


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc---
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ---  556 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~---  556 (735)
                      +++|.+++... ..+++..++.++.|+++||+|||+.+   ++||||||+|||+++++.+||+|||+++........   
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999764 45788889999999999999999988   999999999999999999999999999865432111   


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCc-cCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM-ALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      ......++..|+|||.+....++.++||||||+++|||++|.. ||......+   ....    +....         ..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~----~~~~~---------~~  221 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY----LLQGR---------RL  221 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HhcCC---------CC
Confidence            1112345778999999988899999999999999999999654 554332221   1111    10000         01


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ..+...+..+.+++.+||+.+|++||++.||++.|++++.
T Consensus       222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            1112234678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.3e-36  Score=315.13  Aligned_cols=239  Identities=22%  Similarity=0.257  Sum_probs=191.3

Q ss_pred             ccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          409 IGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       409 lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      ||+|+||+||++.. .++..||+|++....   ....+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999985 467899999986422   22346678899999999999999999999999999999999999999


Q ss_pred             hHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          485 FEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       485 ~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      .+++..    ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            988753    356899999999999999999999998   99999999999999999999999999976543322 1223


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||............   ...        +....  ...+..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~--------~~~~~--~~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---KQR--------ILNDS--VTYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH---HHh--------hcccC--CCCccc
Confidence            45899999999999999999999999999999999999999654322111100   000        01110  011223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                      .+..+.+++.+||+.+|++||+++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~  247 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFR  247 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCC
Confidence            557889999999999999999543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.2e-36  Score=313.45  Aligned_cols=246  Identities=22%  Similarity=0.274  Sum_probs=195.0

Q ss_pred             ccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          409 IGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       409 lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      ||+|+||+||++.. .++..+|+|++....   ......+..|++++++++||||+++++.+......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999985 458899999876321   22234556799999999999999999999999999999999999999


Q ss_pred             hHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          485 FEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       485 ~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      .+++...  ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            9888654  35899999999999999999999998   9999999999999999999999999988664322  223345


Q ss_pred             cccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHH
Q 004702          563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL  642 (735)
Q Consensus       563 gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  642 (735)
                      |+..|+|||++.+..++.++||||||+++|||++|+.||...........   .....        +...... .....+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~---~~~~~--------~~~~~~~-~~~~~~  223 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE---LKRRT--------LEDEVKF-EHQNFT  223 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH---HHHHh--------hcccccc-ccccCC
Confidence            89999999999988899999999999999999999999865432211111   11111        1101100 011345


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          643 KEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       643 ~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      .++.+|+.+||+.+|++||+++|+++.+.
T Consensus       224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         224 EESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             HHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            67899999999999999999988764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.8e-36  Score=328.59  Aligned_cols=250  Identities=24%  Similarity=0.310  Sum_probs=195.5

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.||+|+||+||++.. .++..||||+++..   .......+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~   83 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL   83 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence            3567899999999999985 45789999998643   2334466788999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc----
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI----  555 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~----  555 (735)
                      ++|+|.+++.+...+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.....    
T Consensus        84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          84 PGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            99999999998888999999999999999999999998   99999999999999999999999999875432110    


Q ss_pred             ------------------------------cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCC
Q 004702          556 ------------------------------QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDK  605 (735)
Q Consensus       556 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~  605 (735)
                                                    .......||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                                          00123459999999999999999999999999999999999999997654


Q ss_pred             hHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 004702          606 PEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCIS--VRGEERPTMKEVSLE  669 (735)
Q Consensus       606 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~ev~~~  669 (735)
                      ..+....+..+    +.         .+..+.......++.+++.+++.  .++..||++.||++.
T Consensus       241 ~~~~~~~i~~~----~~---------~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         241 PQETYKKVMNW----KE---------TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHHHHHHHHcC----cC---------cccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            43321111100    00         00000011233567777777553  234456899998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-36  Score=316.78  Aligned_cols=268  Identities=24%  Similarity=0.304  Sum_probs=202.3

Q ss_pred             hccccccccccCcEEEEEEEc-----CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--Ccee
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPL  473 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~  473 (735)
                      ++...+.||+|+||.||++.+     .++..||+|.++.. .....+.+.+|+.++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            344567899999999999973     34778999998744 344457899999999999999999999998875  5678


Q ss_pred             EEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          474 LVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      +||||+++++|.+++.+. ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999999764 46899999999999999999999998   99999999999999999999999999987643


Q ss_pred             Cccc--ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          553 DAIQ--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       553 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||++++.|............ .............+.+.
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMI-GPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhc-ccccccccHHHHHHHHH
Confidence            2221  11223467789999999888899999999999999999998766432211000000 00000000000011111


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      .....+.....+.++.+|+.+||+.+|++|||+.++++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111111223557899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.8e-36  Score=323.86  Aligned_cols=244  Identities=25%  Similarity=0.291  Sum_probs=194.4

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||+||++.. .++..||+|.++..   .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999985 45788999998742   234456788999999888 699999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|..++.....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTF  156 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceecc
Confidence            999999988788999999999999999999999998   9999999999999999999999999987532211 122334


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||++.+..++.++||||||++||||++|+.||..................+.        ....  ..+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~--~~p~~~  226 (327)
T cd05617         157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--------EKPI--RIPRFL  226 (327)
T ss_pred             cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--------hCCC--CCCCCC
Confidence            589999999999999999999999999999999999999964322111111111111111        1110  112234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                      +..+.+++.+||+.||.+||++.
T Consensus       227 ~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         227 SVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCC
Confidence            46788999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.6e-36  Score=325.22  Aligned_cols=259  Identities=28%  Similarity=0.355  Sum_probs=202.3

Q ss_pred             HhhhccccccccccCcEEEEEEEc------CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeec-
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLET-  469 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-  469 (735)
                      ....+.+.++||+|+||+||+|..      ..++.||||+++.. .......+.+|+.+|.++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            344567788999999999999973      34678999998753 344466788999999999 689999999988654 


Q ss_pred             CceeEEEEecCCCchhHHhhhc----------------------------------------------------------
Q 004702          470 QVPLLVYEFVGNGTLFEHIHKK----------------------------------------------------------  491 (735)
Q Consensus       470 ~~~~lV~E~~~~gsL~~~l~~~----------------------------------------------------------  491 (735)
                      ...++||||+++|+|.+++...                                                          
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            4578999999999999998642                                                          


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-ceeee
Q 004702          492 ---------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVV  561 (735)
Q Consensus       492 ---------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~  561 (735)
                               ..+++.++++++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||++......... .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                     13688889999999999999999998   999999999999999999999999999865322211 11122


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      .++..|+|||.+....++.++||||||+++|||++ |..||........      +...+.....         ...+..
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~---------~~~~~~  306 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTR---------MRAPDY  306 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCC---------CCCCCC
Confidence            35678999999988899999999999999999997 8888865432211      1111111110         011112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ...++.+++.+||+.+|++|||+.||++.|+.+++
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            33578999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-36  Score=309.33  Aligned_cols=246  Identities=33%  Similarity=0.463  Sum_probs=204.1

Q ss_pred             ccccccCcEEEEEEEcCC----CcEEEEEEeeccChh-HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLPD----RTPVAVKKSKFVDQA-KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||.||++....    +..|++|.++..... ..+.+.+|+.++..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998653    788999998754433 367889999999999999999999999999999999999999


Q ss_pred             CchhHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          482 GTLFEHIHKK---------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       482 gsL~~~l~~~---------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++|.+++...         ..+++..++.++.|++.||+|||+++   ++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999875         77999999999999999999999998   99999999999999999999999999987754


Q ss_pred             Ccc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          553 DAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       553 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      ... .......++..|+|||.+....++.++||||||++++||++ |..||......+..       ..+...       
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~-------  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL-------EYLRKG-------  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcC-------
Confidence            321 12233447889999999988899999999999999999999 58888765332211       111111       


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                        .....+...+.++.+++.+||+.+|++|||+.|++..|+
T Consensus       224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              111122334678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.8e-36  Score=320.58  Aligned_cols=237  Identities=25%  Similarity=0.294  Sum_probs=191.0

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHH-HHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELV-VVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||.||++... ++..||+|.+...   .......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999864 5788999987642   2233445555554 67889999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      ++|..++.....+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++...... ......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTF  156 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccccc
Confidence            999999988788999999999999999999999998   9999999999999999999999999987532211 122334


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .|++.|+|||.+.+..++.++||||||+++|||++|+.||.........       ..+..        ...  ..+...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-------~~i~~--------~~~--~~~~~~  219 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY-------DNILH--------KPL--QLPGGK  219 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH-------HHHhc--------CCC--CCCCCC
Confidence            5899999999999889999999999999999999999999765332211       11111        111  112234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                      ..++.+++.+||+.+|.+||+..
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         220 TVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CHHHHHHHHHHccCCHhhcCCCC
Confidence            46789999999999999999865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-36  Score=325.14  Aligned_cols=243  Identities=26%  Similarity=0.304  Sum_probs=195.0

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHH-HHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELV-VVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||+||++.. .++..||+|++...   .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999984 46889999988642   2333455566654 56789999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|..++.....+++..+..++.||+.||+|||+.+   |+||||||+||||++++.+||+|||+++...... ......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~  156 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTF  156 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcccc
Confidence            999999988888999999999999999999999998   9999999999999999999999999987532211 122334


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .|++.|+|||.+.+..++.++||||||+++|||++|+.||......+...       .+...        ..  ......
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~-------~~~~~--------~~--~~~~~~  219 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD-------NILHK--------PL--VLRPGA  219 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH-------HHHcC--------Cc--cCCCCC
Confidence            58999999999999999999999999999999999999997654332111       11110        00  001123


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      ...+.+++.+||+.+|.+||++++.++.+
T Consensus       220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         220 SLTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             CHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence            46788999999999999999987544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-36  Score=322.07  Aligned_cols=247  Identities=24%  Similarity=0.314  Sum_probs=210.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc-eeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV-PLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV~E~  478 (735)
                      +...+++|+|+||.++..+. .+...+++|++...  .....+...+|+.++++++|||||.+.+.+.+++. .+|||+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            34467899999999998874 35678999987743  34445578899999999999999999999999888 8999999


Q ss_pred             cCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          479 VGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       479 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      ++||+|.+.|.+.  ..++++++.+|+.|++.|+.|||++.   |+|||||+.|||++.+..+||+|||+|+.+..+...
T Consensus        86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            9999999999865  46899999999999999999999888   999999999999999999999999999998766533


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                       ...+.||+.||.||.+.+.+|..|+||||||+++|||++-+.+|.......   ++...            . +....+
T Consensus       163 -a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki------------~-~~~~~P  225 (426)
T KOG0589|consen  163 -ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKI------------N-RGLYSP  225 (426)
T ss_pred             -hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHH------------h-hccCCC
Confidence             234569999999999999999999999999999999999999997654432   22111            1 112344


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+..++.++..|+..||+.+|+.||++.+++.+
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            566788999999999999999999999999987

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-36  Score=310.77  Aligned_cols=251  Identities=32%  Similarity=0.488  Sum_probs=201.7

Q ss_pred             cccccccccCcEEEEEEEcCC-CcEEEEEEeeccChhHHH--HHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          404 NYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKID--EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.||+|+||+||+++... +..+|+|.+.........  ...+|+.++++++||||++++++.......++|||++.
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            456799999999999999654 568999998876554433  34569999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +++|.+++.....+++..++.++.|+++||++||+.+   |+|+||||+||++++++.++|+|||.+.... ........
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~  157 (260)
T PF00069_consen   82 GGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNP  157 (260)
T ss_dssp             TEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSS
T ss_pred             ccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccccc
Confidence            9999999997788999999999999999999999998   9999999999999999999999999998642 12223334


Q ss_pred             eccccCccCccccc-CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          561 VQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       561 ~~gt~~y~aPE~~~-~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      ..++..|+|||.+. ....+.++||||||+++|+|++|..||................   . .....   . ..  ...
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~---~-~~~~~---~-~~--~~~  227 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL---K-RPLPS---S-SQ--QSR  227 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH---H-THHHH---H-TT--SHT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc---c-ccccc---c-cc--ccc
Confidence            55899999999998 8889999999999999999999999997653222222211111   0 00000   0 00  000


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....++.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  228 EKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11278999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-36  Score=307.02  Aligned_cols=246  Identities=30%  Similarity=0.463  Sum_probs=200.9

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccCh-hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchh
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ-AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLF  485 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  485 (735)
                      ++||+|+||.||++...++..|++|+++.... .....+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999977789999998775433 35678999999999999999999999999999999999999999999


Q ss_pred             HHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce-eeecc
Q 004702          486 EHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC-TVVQG  563 (735)
Q Consensus       486 ~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~-~~~~g  563 (735)
                      +++... ..+++..++.++.+++.+|+|||+++   ++||||||+|||++.++.+||+|||++........... .....
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999764 56899999999999999999999998   99999999999999999999999999886542221111 11224


Q ss_pred             ccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHH
Q 004702          564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL  642 (735)
Q Consensus       564 t~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  642 (735)
                      +..|+|||.+.+..++.++||||||++++||++ |..||............       .         .......+...+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-------~---------~~~~~~~~~~~~  221 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-------E---------SGYRMPAPQLCP  221 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-------h---------cCCCCCCCccCC
Confidence            567999999998899999999999999999999 78887655432211111       0         000111123345


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          643 KEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       643 ~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      .++.+++.+||+.+|++|||+.||++.|+
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            68999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.7e-36  Score=318.58  Aligned_cols=259  Identities=22%  Similarity=0.297  Sum_probs=195.2

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||+||+|... ++..||||+++... ......+.+|+.+++.++||||+++++++......++||||+.
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH   86 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence            455679999999999999864 67889999986432 2233467889999999999999999999999999999999995


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                       ++|.+++... ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... ....
T Consensus        87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~  161 (303)
T cd07869          87 -TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYS  161 (303)
T ss_pred             -cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccCC
Confidence             5787777654 56899999999999999999999998   9999999999999999999999999987543221 1222


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc---hhhH-----hh
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR---LLEI-----LD  630 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~d  630 (735)
                      ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........  ........+....   +...     .+
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhccccc
Confidence            3458899999998865 4588899999999999999999999976543221  1111111111000   0000     00


Q ss_pred             h-ccc--CCCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 N-RIV--NDGN-------KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 ~-~~~--~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      + ...  ....       ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0 000  0000       012356789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.4e-36  Score=310.38  Aligned_cols=248  Identities=29%  Similarity=0.464  Sum_probs=201.2

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ..+.+.||+|+||.||++.+.++..+|+|+++.... ...+|.+|++++++++||||+++++++......++||||++++
T Consensus         6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd05112           6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG   84 (256)
T ss_pred             eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence            456778999999999999887778899998764322 3457899999999999999999999999999999999999999


Q ss_pred             chhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|.+++... ..++++.++.++.|++.+|+|||+.+   ++|+||||+||+++.++.+||+|||+++.............
T Consensus        85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05112          85 CLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT  161 (256)
T ss_pred             cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence            999999764 56899999999999999999999998   99999999999999999999999999886543322222222


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      .++.+|+|||.+.+..++.++||||||+++|||++ |+.||......+.       ...+....  ..       ..+..
T Consensus       162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~--~~-------~~~~~  225 (256)
T cd05112         162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-------VETINAGF--RL-------YKPRL  225 (256)
T ss_pred             ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH-------HHHHhCCC--CC-------CCCCC
Confidence            35678999999998899999999999999999998 8888865433221       11111110  00       00112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      .+..+.+|+.+||+.+|++|||+.|++++|
T Consensus       226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            346799999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.6e-37  Score=308.36  Aligned_cols=255  Identities=25%  Similarity=0.310  Sum_probs=197.8

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC-----ceeEEEEe
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-----VPLLVYEF  478 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~E~  478 (735)
                      -.+++|.|+||.||+|++. .+..||||++-...+..    -.|+.+|+.+.|||||+|+.++....     ..-+||||
T Consensus        28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             eeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            3569999999999999954 46899999976433321    36999999999999999998886532     23599999


Q ss_pred             cCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEeeccCCcccCCC
Q 004702          479 VGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-CTPKVSDFGASKLVPID  553 (735)
Q Consensus       479 ~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGls~~~~~~  553 (735)
                      |+. +|.+.++.    +..++...+.-+..||.+||+|||+.+   |+||||||.|+|+|.+ +.+||+|||.|+.+...
T Consensus       104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            976 99999985    467888888889999999999999988   9999999999999965 89999999999988765


Q ss_pred             cccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh------
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL------  626 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  626 (735)
                      +..  .....|..|+|||.+.+ ..|+.+.||||.|+|+.||+-|++-|.+....+....+...+..-..+.+.      
T Consensus       180 epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  180 EPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             CCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            554  34457899999998876 569999999999999999999999998766655444433322111111111      


Q ss_pred             -hHhhhcccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          627 -EILDNRIVND-----GNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       627 -~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                       +...+++...     .......+..+|+.++|+.+|.+|.++.|++..
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence             1111222211     223455789999999999999999999998853

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.7e-36  Score=310.53  Aligned_cols=244  Identities=25%  Similarity=0.364  Sum_probs=196.8

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchh
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLF  485 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  485 (735)
                      .+||+|+||.||+|.. .++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            4899999999999984 457789999988766667788999999999999999999999999999999999999999999


Q ss_pred             HHhhhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEeeccCCcccCCCcccceeee
Q 004702          486 EHIHKK-GNL--SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       486 ~~l~~~-~~l--~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +++... ..+  ++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.+||+|||++........ .....
T Consensus        94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~  169 (268)
T cd06624          94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETF  169 (268)
T ss_pred             HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccccC
Confidence            999864 445  88889999999999999999998   999999999999976 67999999999876543221 12223


Q ss_pred             ccccCccCcccccCC--CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          562 QGTLGYLDPEYLQTC--KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~--~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      .++..|+|||++...  .++.++||||||+++|+|++|+.||............    ...          .......+.
T Consensus       170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~----~~~----------~~~~~~~~~  235 (268)
T cd06624         170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK----VGM----------FKIHPEIPE  235 (268)
T ss_pred             CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh----hhh----------hccCCCCCc
Confidence            478999999998664  3788999999999999999999998643322111000    000          001111223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....++.+++.+||+.+|.+|||+.||+.
T Consensus       236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         236 SLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            34567899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.9e-36  Score=321.45  Aligned_cols=239  Identities=25%  Similarity=0.323  Sum_probs=195.0

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEe
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.+.||+|+||+||++... ++..||||.++..   .....+.+..|..++..+ +|++|+++++++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            45678999999999999854 5678999988742   233345667788888877 579999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|+|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....... ..
T Consensus        83 ~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~-~~  158 (323)
T cd05616          83 VNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TT  158 (323)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-cc
Confidence            999999999988888999999999999999999999998   99999999999999999999999999875432221 22


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....||+.|+|||++....++.++||||||+++|||++|+.||......+....       +        .....  ..+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~-------i--------~~~~~--~~p  221 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-------I--------MEHNV--AYP  221 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH-------H--------HhCCC--CCC
Confidence            334589999999999999999999999999999999999999976543321111       1        11111  112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                      ...+.++.+|+.+||+.+|.+|++.
T Consensus       222 ~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CcCCHHHHHHHHHHcccCHHhcCCC
Confidence            2345678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6e-36  Score=309.53  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=200.7

Q ss_pred             ccccccCcEEEEEEEcCC--C--cEEEEEEeeccCh-hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLPD--R--TPVAVKKSKFVDQ-AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|++|.||+|.+.+  +  ..||||.++.... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  2  3689999876555 667889999999999999999999999988 888999999999


Q ss_pred             CchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc--c
Q 004702          482 GTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ--N  557 (735)
Q Consensus       482 gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~--~  557 (735)
                      ++|.+++.+..  .+++..++.++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999998753  6899999999999999999999998   999999999999999999999999999876542211  1


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      .....++..|+|||++....++.++||||||+++|||++ |+.||......+....   ...   ..         ....
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~~---~~---------~~~~  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK---IDK---EG---------ERLE  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHh---cC---------CcCC
Confidence            112346789999999999899999999999999999999 9999865543321111   100   00         0011


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      .+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            12234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.1e-36  Score=330.68  Aligned_cols=247  Identities=22%  Similarity=0.287  Sum_probs=195.0

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.++||+|+||+||++.. .++..||+|++...   .......+.+|+.++++++||||+++++.+.+.+..++||||+
T Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~   83 (382)
T cd05625           4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI   83 (382)
T ss_pred             EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence            3467899999999999985 46788999998643   2344567889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc-----
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA-----  554 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~-----  554 (735)
                      ++|+|.+++.....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++..+....     
T Consensus        84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          84 PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            99999999988788999999999999999999999998   9999999999999999999999999975321000     


Q ss_pred             -----------------------------------------ccceeeeccccCccCcccccCCCCCccccchhHHHHHHH
Q 004702          555 -----------------------------------------IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVE  593 (735)
Q Consensus       555 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~e  593 (735)
                                                               ........||+.|+|||++.+..++.++||||||++|||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                     000112358999999999999999999999999999999


Q ss_pred             HHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHH
Q 004702          594 LLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPT---MKEVS  667 (735)
Q Consensus       594 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~  667 (735)
                      |++|+.||....+.+.......+             ......+......+++.+++.+++ .+|.+|++   +.|++
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~-------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINW-------------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHcc-------------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence            99999999765543321111100             001111111233466778888876 59999998   65554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4e-36  Score=327.58  Aligned_cols=250  Identities=25%  Similarity=0.327  Sum_probs=198.3

Q ss_pred             hhccccccccccCcEEEEEEEcC-CCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ..+.+.++||+|+||.||++... ++..+|+|.+..   ......+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            34556779999999999999864 578899998763   22334456789999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      ||+++|+|.+++... .+++..+..++.||+.||+|||+.+   |+||||||+||||++++.+||+|||++.........
T Consensus       123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            999999999999654 6899999999999999999999998   999999999999999999999999999876433222


Q ss_pred             ceeeeccccCccCcccccCC----CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          557 NCTVVQGTLGYLDPEYLQTC----KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~----~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      ......||+.|+|||.+...    .++.++||||||++||||++|+.||..........               .+++..
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~---------------~i~~~~  263 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS---------------KIMDHK  263 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH---------------HHHhCC
Confidence            22345699999999998754    37889999999999999999999997654322111               111111


Q ss_pred             --ccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 004702          633 --IVNDGNKQQLKEVAKLAARCISVRGEE--RPTMKEVSLE  669 (735)
Q Consensus       633 --~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~  669 (735)
                        +..+.....+..+.+++.+||+.++.+  |||+.|+++.
T Consensus       264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              111112234567889999999855543  8899888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5e-36  Score=338.01  Aligned_cols=249  Identities=25%  Similarity=0.309  Sum_probs=201.1

Q ss_pred             hccccccccccCcEEEEEEE-cCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC--------
Q 004702          402 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ--------  470 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------  470 (735)
                      .+.+.++||+|+||+||++. ..++..||||.+..  ........+.+|+.++..++|+||+++...+...+        
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            55677899999999999998 45689999998764  34556677889999999999999999987765432        


Q ss_pred             ceeEEEEecCCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccC
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA  546 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl  546 (735)
                      ..++||||+++|+|.++++..    ..+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEeccc
Confidence            357999999999999999753    46899999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          547 SKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       547 s~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                      ++....... .......||+.|+|||.+.+..++.++||||||++||||++|+.||......+..       ....... 
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~-------~~~~~~~-  261 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM-------HKTLAGR-  261 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHhcCC-
Confidence            986543221 1223345899999999999999999999999999999999999999654332211       1111111 


Q ss_pred             hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       626 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                              ..+.+...+.++.+|+.+||+.+|.+||++.+++..
T Consensus       262 --------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 --------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                    111223445789999999999999999999999764

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=330.13  Aligned_cols=250  Identities=24%  Similarity=0.259  Sum_probs=197.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.++||+|+||+||++.. .++..||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~   82 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF   82 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence            34567899999999999984 46889999987642   234456788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc---
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI---  555 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~---  555 (735)
                      +++|+|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.....   
T Consensus        83 ~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          83 LPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            999999999988888999999999999999999999999   99999999999999999999999999863311000   


Q ss_pred             ----------c---------------------------------ceeeeccccCccCcccccCCCCCccccchhHHHHHH
Q 004702          556 ----------Q---------------------------------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLV  592 (735)
Q Consensus       556 ----------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~  592 (735)
                                .                                 ......||+.|+|||++.+..++.++||||||++||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                      0                                 001235899999999999989999999999999999


Q ss_pred             HHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 004702          593 ELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEER---PTMKEVSLE  669 (735)
Q Consensus       593 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ev~~~  669 (735)
                      ||++|+.||......+.......+      .       ..+..+.......++.+|+.+||. +|.+|   +++.|++..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~------~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINW------R-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHcc------C-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            999999999765443221111100      0       000001111234678899999997 67665   588887764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.6e-36  Score=309.21  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=199.0

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEe-ecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL-ETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||.||++... +..||+|..+...  ..+.|.+|+.++++++|+|++++++++. ..+..++||||++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            4556789999999999999865 6779999876432  3567899999999999999999999765 4457899999999


Q ss_pred             CCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          481 NGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       481 ~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|.+++++..  .+++..++.++.|++.||+|||+++   |+||||||+||++++++.+||+|||+++......    
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----  156 (256)
T cd05082          84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----  156 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence            999999997653  4899999999999999999999998   9999999999999999999999999988643222    


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....++..|+|||++....++.++||||||+++|||++ |+.||......+.       ...+..+         .....
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~-------~~~~~~~---------~~~~~  220 (256)
T cd05082         157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKG---------YKMDA  220 (256)
T ss_pred             CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcC---------CCCCC
Confidence            12235678999999998899999999999999999998 8888864432221       1111111         11111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ....+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            223457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.3e-36  Score=323.02  Aligned_cols=244  Identities=25%  Similarity=0.302  Sum_probs=194.4

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeeccC---hhHHHHHHHHH-HHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---QAKIDEFINEL-VVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.||+|+||+||++... ++..||+|.+....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999854 56789999886421   22233444444 457889999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      ++|.+++.....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~  156 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTF  156 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcccc
Confidence            999999988888999999999999999999999998   9999999999999999999999999987543221 122334


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||++.+..++.++||||||+++|||++|+.||......+...       .+..        ...  ......
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-------~i~~--------~~~--~~~~~~  219 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD-------NILN--------KPL--QLKPNI  219 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH-------HHHh--------CCc--CCCCCC
Confidence            58999999999999999999999999999999999999997654432111       1100        000  111234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      ...+.+++.+||+.+|.+||++.+.+.++.
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i~  249 (325)
T cd05602         220 TNSARHLLEGLLQKDRTKRLGAKDDFMEIK  249 (325)
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence            567899999999999999999886554433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.2e-36  Score=321.37  Aligned_cols=239  Identities=25%  Similarity=0.312  Sum_probs=191.2

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHH---HhcCCCceEEEceEEeecCceeEEE
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVV---LQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.++||+|+||.||++... ++..||||.++..   .....+.+.+|+.++   +.++||||+++++++...+..++||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            35678999999999999854 5889999998742   233345666676655   5678999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      ||+++++|..+++. ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...... .
T Consensus        82 E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~  156 (324)
T cd05589          82 EYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D  156 (324)
T ss_pred             cCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence            99999999988865 47999999999999999999999998   9999999999999999999999999987542221 1


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+...       .+...        ..  .
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~-------~i~~~--------~~--~  219 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD-------SIVND--------EV--R  219 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhC--------CC--C
Confidence            1233458999999999999999999999999999999999999997654332111       11110        00  1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                      .+...+..+.+++.+||+.+|.+||++.
T Consensus       220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~  247 (324)
T cd05589         220 YPRFLSREAISIMRRLLRRNPERRLGSG  247 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence            1223456788999999999999999644

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.6e-36  Score=315.12  Aligned_cols=247  Identities=24%  Similarity=0.381  Sum_probs=202.4

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||+|+||.||+|.. .++..|++|.+........+.+.+|+.+++.++|+||+++++.+......++||||+++
T Consensus        22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~  101 (296)
T cd06654          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (296)
T ss_pred             eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence            34556899999999999984 46789999998766556667889999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      ++|.+++.+ ..+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......... ....
T Consensus       102 ~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~  176 (296)
T cd06654         102 GSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTM  176 (296)
T ss_pred             CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc-cCcc
Confidence            999999865 46899999999999999999999998   999999999999999999999999998865432211 1223


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .+++.|+|||.+.+..++.++||||||+++|||++|+.||....+....  .    .....        .......+...
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~----~~~~~--------~~~~~~~~~~~  242 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y----LIATN--------GTPELQNPEKL  242 (296)
T ss_pred             cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--H----HHhcC--------CCCCCCCcccc
Confidence            5889999999999888999999999999999999999999755432211  0    00000        00001112334


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+.+++.+||..+|++|||+.||+.
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         243 SAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            567899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.4e-36  Score=315.17  Aligned_cols=259  Identities=23%  Similarity=0.348  Sum_probs=201.1

Q ss_pred             hccccccccccCcEEEEEEEcC-----------------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEc
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-----------------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLL  463 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~  463 (735)
                      .+.+.+.||+|+||.||++...                 +...||+|+++.. .....++|.+|+.+++.++|+||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   85 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL   85 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            3456789999999999998532                 2346899988743 444567899999999999999999999


Q ss_pred             eEEeecCceeEEEEecCCCchhHHhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 004702          464 GCCLETQVPLLVYEFVGNGTLFEHIHKK-----------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANIL  532 (735)
Q Consensus       464 g~~~~~~~~~lV~E~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NIL  532 (735)
                      +++...+..++||||+++++|.+++...           ..+++..+++++.|++.||+|||+.+   |+|+||||+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nil  162 (296)
T cd05095          86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCL  162 (296)
T ss_pred             EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEE
Confidence            9999999999999999999999999753           23778899999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeeccCCcccCCCcccc-eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh--CCccCCCCChHHH
Q 004702          533 LDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT--GKMALLSDKPEEE  609 (735)
Q Consensus       533 l~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt--G~~p~~~~~~~~~  609 (735)
                      +++++.+||+|||+++.+....... .....++..|++||......++.++||||||+++|||++  |..||......+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            9999999999999998654332211 112234678999999888889999999999999999998  6678765433322


Q ss_pred             HHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          610 RSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      ......+.   ...      ......+.+...+..+.+|+.+||+.+|.+||++.||++.|++
T Consensus       243 ~~~~~~~~---~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         243 IENTGEFF---RDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHH---hhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11111111   000      0001111122344788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-35  Score=309.42  Aligned_cols=249  Identities=25%  Similarity=0.311  Sum_probs=191.9

Q ss_pred             cccccCcEEEEEEEcCC---CcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          408 VIGCGGSGNVYKGFLPD---RTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .||+|+||.||+|...+   +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            68999999999998543   3578999887533 3344678899999999999999999999999889999999999999


Q ss_pred             hhHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc-
Q 004702          484 LFEHIHKK-----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-  557 (735)
Q Consensus       484 L~~~l~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~-  557 (735)
                      |.+++...     ..+++..+++++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++......... 
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            99999753     24677888899999999999999998   9999999999999999999999999997654332211 


Q ss_pred             eeeeccccCccCcccccCC-------CCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          558 CTVVQGTLGYLDPEYLQTC-------KLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~-------~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      .....++..|+|||++...       .++.++||||||+++|||++ |+.||......+.....      .. .....+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~------~~-~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT------VR-EQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH------hh-cccCCCC
Confidence            1223467889999988642       35789999999999999997 99998655433221110      00 0011111


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      ++.+    .......+.+++.+|| .+|++|||+.||++.|+
T Consensus       232 ~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111    1123356788999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=328.23  Aligned_cols=243  Identities=26%  Similarity=0.386  Sum_probs=206.5

Q ss_pred             cccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchhH
Q 004702          408 VIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE  486 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  486 (735)
                      +||+|.+|+||.|+.. +...+|||-+...+....+-..+|+.+.++|+|+|||+++|.+.+++..-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            7999999999999954 466799999888777778889999999999999999999999999999999999999999999


Q ss_pred             Hhhhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEeeccCCcccCCCcccceeeec
Q 004702          487 HIHKK-GNL--SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       487 ~l~~~-~~l--~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      +|+.+ +++  ++..+-.+.+||++||.|||.+.   |||||||-+||||+ -.|.+||+|||-++.+.. ...-...+.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETFT  737 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETFT  737 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCccccccc
Confidence            99875 677  78888899999999999999999   99999999999996 578999999999987642 222333456


Q ss_pred             cccCccCcccccCC--CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          563 GTLGYLDPEYLQTC--KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       563 gt~~y~aPE~~~~~--~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ||+.|||||++..+  .|..++||||||+++.||.||++||.........    .|          .+---....+.+.+
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----MF----------kVGmyKvHP~iPee  803 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----MF----------KVGMYKVHPPIPEE  803 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh----hh----------hhcceecCCCCcHH
Confidence            99999999999764  5899999999999999999999999765543321    11          11112233455778


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+.+...+|.+|+.++|.+||++.++++
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            8899999999999999999999999875

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.6e-37  Score=326.78  Aligned_cols=245  Identities=25%  Similarity=0.407  Sum_probs=203.0

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEee----ccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc--eeEEE
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSK----FVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV--PLLVY  476 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lV~  476 (735)
                      .|.++||+|+|-+||||... .|-.||--.++    .......+.|..|+.+|+.|+||||++++..+.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            45679999999999999864 35566643222    2345567899999999999999999999999987665  67999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |.+..|+|..|+++.+.++.+.+..|+.||++||.|||++. +||||||||-+||+|+ ..|.|||+|+|||..+.... 
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            99999999999999999999999999999999999999986 8999999999999997 56899999999999875432 


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                        ...+.|||.|||||++. ..|++..||||||+.++||+|+..||..-....  ...+...+.++...+..+-|     
T Consensus       201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QIYKKV~SGiKP~sl~kV~d-----  270 (632)
T KOG0584|consen  201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QIYKKVTSGIKPAALSKVKD-----  270 (632)
T ss_pred             --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HHHHHHHcCCCHHHhhccCC-----
Confidence              23377999999999988 689999999999999999999999986543322  23344444444444444433     


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                             ++++++|.+||.. ..+|||+.|++.
T Consensus       271 -------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  271 -------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence                   5789999999999 999999999884

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.3e-36  Score=314.62  Aligned_cols=251  Identities=27%  Similarity=0.405  Sum_probs=201.1

Q ss_pred             ccccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      +.+.+.||+|+||.||++...      ++..||+|.++.. ......+|.+|+.++++++||||+++++++..++..++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv   86 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL   86 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence            445678999999999999853      4678999988753 344457799999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 004702          476 YEFVGNGTLFEHIHKK----------------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL  533 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl  533 (735)
                      |||+++++|.+++...                      ..+++..++.++.|++.||+|||+.+   ++||||||+|||+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~  163 (288)
T cd05050          87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLV  163 (288)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEe
Confidence            9999999999999743                      24788899999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHH
Q 004702          534 DENCTPKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERS  611 (735)
Q Consensus       534 ~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~  611 (735)
                      ++++.+||+|||+++....... ........+..|+|||.+.+..++.++||||||+++|||++ |..||......+.  
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~--  241 (288)
T cd05050         164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV--  241 (288)
T ss_pred             cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            9999999999999876532221 11112234678999999998899999999999999999998 8788865443321  


Q ss_pred             HHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                           ...+......         ..+...+.++.+|+.+||+.+|++|||+.||++.|++
T Consensus       242 -----~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         242 -----IYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -----HHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                 1111111111         1122345689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=318.19  Aligned_cols=237  Identities=28%  Similarity=0.401  Sum_probs=197.7

Q ss_pred             cccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          408 VIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .||.|+||.||.+.. .+...||||++...   ....+.++++|+..|.+++|||++.+-|++..+...|||||||- |+
T Consensus        33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GS  111 (948)
T KOG0577|consen   33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GS  111 (948)
T ss_pred             HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-cc
Confidence            699999999999984 56788999998753   44567899999999999999999999999999999999999995 57


Q ss_pred             hhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          484 LFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       484 L~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      -.|++.- ++++-+..+..|..+.+.||+|||+.+   .||||||+.||||++.+.|||+|||.+.++...     ..+.
T Consensus       112 AsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-----nsFv  183 (948)
T KOG0577|consen  112 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-----NSFV  183 (948)
T ss_pred             HHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-----hccc
Confidence            7777753 467999999999999999999999999   999999999999999999999999999876432     3456


Q ss_pred             cccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          563 GTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       563 gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      ||+.|||||++.   .+.|+.|.||||||++..||.-.++|++....       +..+-.+.++.        -..-...
T Consensus       184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALYHIAQNe--------sPtLqs~  248 (948)
T KOG0577|consen  184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNE--------SPTLQSN  248 (948)
T ss_pred             CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHHHHHhcC--------CCCCCCc
Confidence            999999999875   47899999999999999999999999865432       11222221111        1111245


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +++..+.+++..||+.-|.+|||..++++
T Consensus       249 eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  249 EWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            78889999999999999999999988764

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.6e-36  Score=330.67  Aligned_cols=250  Identities=22%  Similarity=0.286  Sum_probs=197.3

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||++.. .++..||||.+...   .......+.+|+.+|++++|+||+++++.+.+.+..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            34567899999999999984 45889999987642   223456688999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC-----
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID-----  553 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~-----  553 (735)
                      +++|+|.+++.....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...     
T Consensus        83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            999999999988888999999999999999999999998   999999999999999999999999997532100     


Q ss_pred             -------------------------------------cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh
Q 004702          554 -------------------------------------AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT  596 (735)
Q Consensus       554 -------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt  596 (735)
                                                           .........||+.|||||++.+..++.++||||||++||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                 0000112458999999999999999999999999999999999


Q ss_pred             CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 004702          597 GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP---TMKEVSLE  669 (735)
Q Consensus       597 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~ev~~~  669 (735)
                      |+.||......+.......    ..         .....+.....+.++.+++.+|+ .+|.+|+   |+.|++..
T Consensus       240 G~~Pf~~~~~~~~~~~i~~----~~---------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         240 GQPPFLADTPAETQLKVIN----WE---------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhc----cC---------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999976654332111100    00         00001111123456778888876 5999999   77877754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.5e-36  Score=313.80  Aligned_cols=267  Identities=26%  Similarity=0.365  Sum_probs=205.6

Q ss_pred             ccccccccccCcEEEEEEEcC-----CCcEEEEEEeeccChh-HHHHHHHHHHHHHhcCCCceEEEceEEee--cCceeE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQA-KIDEFINELVVVLQINRRNVVRLLGCCLE--TQVPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l  474 (735)
                      ..+.+.||+|+||.||++.+.     .+..+|||.++..... ..++|.+|+++++.++|+||+++++++..  ....++
T Consensus         6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05038           6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL   85 (284)
T ss_pred             chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence            345678999999999999853     3678999998754443 56789999999999999999999999877  557899


Q ss_pred             EEEecCCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          475 VYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      ||||+++++|.+++.... .+++..++.++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++......
T Consensus        86 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          86 IMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             EEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            999999999999998753 6999999999999999999999998   999999999999999999999999999876532


Q ss_pred             ccc--ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          554 AIQ--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       554 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      ...  ......++..|++||.+....++.++||||||+++|||++|+.|+............ ..........+.+.+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG-IAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccc-cccccccHHHHHHHHHc
Confidence            221  111223566799999999889999999999999999999999987543221100000 00000000111122222


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ......+...+.++.+|+.+||+.+|++|||+.||+++|+.+
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            222222233457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-36  Score=298.01  Aligned_cols=257  Identities=20%  Similarity=0.231  Sum_probs=200.5

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeeccChhH--HHHHHHHHHHHHhcCCCceEEEceEEeec--CceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~E~~~~  481 (735)
                      ..|++|.||.||+|+. ++++.||+|+++...+..  --..++|+.+|.+.+|||||.+-.+....  +..||||||++.
T Consensus        82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh  161 (419)
T KOG0663|consen   82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH  161 (419)
T ss_pred             hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence            3699999999999985 457889999988643221  22357999999999999999998876543  468999999976


Q ss_pred             CchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                       +|..++... +++...++.-+..|+++||+|||.+.   |+|||||++|+|+.+.|.+||+|||+|+.+... ....+.
T Consensus       162 -DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T~  236 (419)
T KOG0663|consen  162 -DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYTP  236 (419)
T ss_pred             -hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC-cccCcc
Confidence             899988875 48999999999999999999999998   999999999999999999999999999988654 344566


Q ss_pred             eccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH-----h-----
Q 004702          561 VQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI-----L-----  629 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-----  629 (735)
                      ..-|..|.|||.+.+. .|+...|+||+|+|+.||+++++-|......+....+...+..-.+..+..+     +     
T Consensus       237 lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f  316 (419)
T KOG0663|consen  237 LVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTF  316 (419)
T ss_pred             eEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcccc
Confidence            6789999999998874 5999999999999999999999988877666655544332211111111100     0     


Q ss_pred             ----hhcccCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          630 ----DNRIVNDGNKQ-QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       630 ----d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                          ...+...+... ..+.-.+|+..+|..||.+|.|+.|.++
T Consensus       317 ~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  317 SEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                01111111111 3366789999999999999999998764

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.7e-35  Score=309.26  Aligned_cols=246  Identities=22%  Similarity=0.293  Sum_probs=199.1

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      +.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++.+...+..++||||+++++
T Consensus         9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~   88 (282)
T cd06643           9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA   88 (282)
T ss_pred             HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence            4567999999999999865 467789998877667778889999999999999999999999999999999999999999


Q ss_pred             hhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          484 LFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       484 L~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      |..++.. ...+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++....... .......
T Consensus        89 l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~  164 (282)
T cd06643          89 VDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFI  164 (282)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccccccc
Confidence            9998865 467999999999999999999999998   9999999999999999999999999987653221 1222345


Q ss_pred             cccCccCccccc-----CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          563 GTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       563 gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ++..|+|||++.     +..++.++||||||+++|||++|+.||......+...   ...   . ...     +.  ...
T Consensus       165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---~~~---~-~~~-----~~--~~~  230 (282)
T cd06643         165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL---KIA---K-SEP-----PT--LAQ  230 (282)
T ss_pred             ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH---HHh---h-cCC-----CC--CCC
Confidence            889999999884     4457889999999999999999999986544322111   110   0 000     00  011


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +...+.++.+++.+||+.+|.+||++.++++
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2234568999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.6e-35  Score=307.93  Aligned_cols=248  Identities=23%  Similarity=0.373  Sum_probs=201.9

Q ss_pred             cccccccccCcEEEEEEEcCCCcEEEEEEeeccC------hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD------QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      ...+.||+|+||+||+|...++..+|+|.++...      ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (265)
T cd06631           3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME   82 (265)
T ss_pred             cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence            4567899999999999998788999999876321      2334668899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc---
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA---  554 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~---  554 (735)
                      |+++++|.+++.+...+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||++.......   
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          83 FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            9999999999988778999999999999999999999988   9999999999999999999999999987653211   


Q ss_pred             --ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          555 --IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       555 --~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                        ........++..|+|||.+.+..++.++||||||+++|||++|+.||............      ....        .
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~--------~  225 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------GAHR--------G  225 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------hhcc--------C
Confidence              11122345889999999999989999999999999999999999999654332211000      0000        0


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .....+.....++.+++.+||+.+|.+||++.|++.
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            011122335577899999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-35  Score=310.38  Aligned_cols=250  Identities=28%  Similarity=0.375  Sum_probs=201.3

Q ss_pred             cccccccccCcEEEEEEEcC------CCcEEEEEEeeccChh-HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          404 NYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFVDQA-KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ...+.||+|+||+||+++.+      +...|++|.+...... ..+++.+|+.++++++|+||+++++++.+.+..++||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   87 (275)
T cd05046           8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL   87 (275)
T ss_pred             eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence            34568999999999999853      2457899987654333 5678999999999999999999999999989999999


Q ss_pred             EecCCCchhHHhhhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCC
Q 004702          477 EFVGNGTLFEHIHKKG---------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS  547 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~---------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls  547 (735)
                      ||+++++|.+++....         .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~  164 (275)
T cd05046          88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLS  164 (275)
T ss_pred             EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccc
Confidence            9999999999998654         6899999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       548 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                      +..............++..|+|||.+.+...+.++||||||+++++|++ |..||.......       .........+ 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~~~-  236 (275)
T cd05046         165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGKL-  236 (275)
T ss_pred             cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcCCc-
Confidence            7553332222233346778999999988889999999999999999999 777875433221       1111111111 


Q ss_pred             hHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       627 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                             ........+..+.+++.+||+.+|.+|||+.|++..|.
T Consensus       237 -------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         237 -------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                   11112234468999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=309.98  Aligned_cols=256  Identities=27%  Similarity=0.374  Sum_probs=204.8

Q ss_pred             hccccccccccCcEEEEEEEcCC-Cc----EEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPD-RT----PVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .+.+.+.||+|+||+||+|...+ +.    .+|+|..... ......++.+|+.++++++||||+++++++.. ...++|
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v   86 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI   86 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence            34566899999999999998543 32    5899987644 34456788999999999999999999999987 788999


Q ss_pred             EEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          476 YEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |||+++|+|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            9999999999999874 56999999999999999999999988   9999999999999999999999999998765332


Q ss_pred             ccce-eeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          555 IQNC-TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       555 ~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .... ....++..|+|||.+....++.++||||||+++|||++ |+.||......+...       .+....        
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~--------  228 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD-------LLEKGE--------  228 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-------HHhCCC--------
Confidence            2111 11223568999999988899999999999999999999 999987654332111       111110        


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                       ....+......+.+++.+||..+|.+|||+.++++.|+.+.+..
T Consensus       229 -~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         229 -RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence             01111223357889999999999999999999999999886643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.5e-35  Score=308.45  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=201.6

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||+|+||.||++.. .++..||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus        11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~   90 (267)
T cd06645          11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG   90 (267)
T ss_pred             HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence            34567899999999999985 46888999998766656667788999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      ++|.+++...+.+++.+++.++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++....... ......
T Consensus        91 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~  166 (267)
T cd06645          91 GSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRKSF  166 (267)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccccc
Confidence            999999988888999999999999999999999998   9999999999999999999999999987654221 222334


Q ss_pred             ccccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          562 QGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       562 ~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      .|+..|+|||.+.   ...++.++||||||+++|||++|+.||....+.......       ......   .+...  ..
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-------~~~~~~---~~~~~--~~  234 (267)
T cd06645         167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------TKSNFQ---PPKLK--DK  234 (267)
T ss_pred             cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-------hccCCC---CCccc--cc
Confidence            5899999999874   456888999999999999999999998655432211100       000000   00000  01


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+..+.+++.+||+.+|++|||+.+|++
T Consensus       235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            123457889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.7e-35  Score=315.11  Aligned_cols=260  Identities=25%  Similarity=0.343  Sum_probs=200.8

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.+.||+|+||.||++... ++..+|+|.++.. ......++.+|++++++++||||+++++++...+..++||||+++
T Consensus         4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~   83 (308)
T cd06615           4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   83 (308)
T ss_pred             eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence            45678999999999999854 5778888887643 344456788999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ++|.++++....+++..+..++.|+++||+|||+. +   ++|+||||+|||+++++.+||+|||++........   ..
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~  157 (308)
T cd06615          84 GSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NS  157 (308)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccccc---cc
Confidence            99999998888899999999999999999999984 6   99999999999999999999999999876532211   22


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc-----------------c
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ-----------------N  623 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-----------------~  623 (735)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||.....................                 .
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence            45889999999998888999999999999999999999998644322211111000000000                 0


Q ss_pred             chhhHhhhcccC---CC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          624 RLLEILDNRIVN---DG-NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       624 ~~~~~~d~~~~~---~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ...++.+.....   .. ......++.+++.+||+.+|++|||+.||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000111110000   00 01244679999999999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-35  Score=318.47  Aligned_cols=241  Identities=24%  Similarity=0.326  Sum_probs=195.7

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .++.++||+|+||+||++.. .++..||+|+++..   .....+.+..|..++..+. |++|+++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            35667999999999999985 46889999998742   2334566788999998886 5778889999999899999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++|+|.+++.....+++.+++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....... .
T Consensus        82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-~  157 (323)
T cd05615          82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-T  157 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc-c
Confidence            9999999999988888999999999999999999999998   99999999999999999999999999875432221 1


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........   .    +        .....  ..
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~---~----i--------~~~~~--~~  220 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ---S----I--------MEHNV--SY  220 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---H----H--------HhCCC--CC
Confidence            223458999999999999899999999999999999999999997654322111   1    1        11111  11


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                      +...+.++.+++.+||+.+|.+|++..
T Consensus       221 p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         221 PKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             CccCCHHHHHHHHHHcccCHhhCCCCC
Confidence            223456789999999999999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-35  Score=308.75  Aligned_cols=247  Identities=27%  Similarity=0.400  Sum_probs=197.7

Q ss_pred             ccccccCcEEEEEEEcCC-------CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          407 DVIGCGGSGNVYKGFLPD-------RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.||+|+||.||+|...+       +..+|||.+... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998643       247899987543 234567889999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-----CeEEeeccC
Q 004702          479 VGNGTLFEHIHKK-------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-----TPKVSDFGA  546 (735)
Q Consensus       479 ~~~gsL~~~l~~~-------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-----~~kl~DFGl  546 (735)
                      +++++|.+++...       ..+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999742       34789999999999999999999988   99999999999999877     899999999


Q ss_pred             CcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccc
Q 004702          547 SKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNR  624 (735)
Q Consensus       547 s~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  624 (735)
                      ++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+...       .+... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~-------~~~~~-  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ-------HVTAG-  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH-------HHhcC-
Confidence            8765432211 1112235678999999999999999999999999999998 999986543322111       11111 


Q ss_pred             hhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          625 LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       625 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                              .....+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus       230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                    0111123345788999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.6e-36  Score=308.14  Aligned_cols=237  Identities=25%  Similarity=0.416  Sum_probs=190.7

Q ss_pred             ccccccCcEEEEEEEcCCCc-----------EEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          407 DVIGCGGSGNVYKGFLPDRT-----------PVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999975433           4777876544333 6788999999999999999999999988 778999


Q ss_pred             EEecCCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-------CeEEeeccCC
Q 004702          476 YEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-------TPKVSDFGAS  547 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-------~~kl~DFGls  547 (735)
                      |||+++|+|.+++.... .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999998765 7999999999999999999999988   99999999999999887       7999999999


Q ss_pred             cccCCCcccceeeeccccCccCcccccCC--CCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccc
Q 004702          548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTC--KLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNR  624 (735)
Q Consensus       548 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  624 (735)
                      .....     .....++..|+|||++...  .++.++||||||+++|||++ |..|+......+....    .   ....
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~----~---~~~~  223 (259)
T cd05037         156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF----Y---QDQH  223 (259)
T ss_pred             ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH----H---hcCC
Confidence            86543     1123367789999999876  78999999999999999999 4667655432221111    0   0000


Q ss_pred             hhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          625 LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       625 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                             ..    +......+.+++.+||..+|.+|||+.+|++.|+
T Consensus       224 -------~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 -------RL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -------CC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                   00    0011268899999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-36  Score=323.56  Aligned_cols=238  Identities=27%  Similarity=0.341  Sum_probs=200.1

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeec---cChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEe
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF---VDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +|..+||+|.||+|+++.++ ++..+|||.+++   ....+++..+.|..++...+ ||.++.|+.++...++.++||||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            45679999999999999865 467899999875   34566788889999988875 99999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +.||++..+. +.+.+++..+.-++.+|+.||.|||+++   |||||||.+|||||.+|.+||+|||+++...... ...
T Consensus       451 ~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g-~~T  525 (694)
T KOG0694|consen  451 VAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG-DRT  525 (694)
T ss_pred             cCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCC-Ccc
Confidence            9999944433 4467999999999999999999999999   9999999999999999999999999998643222 234


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....||+.|||||++.+..|+...|-|||||+|||||.|+.||..+.+++...-+               +...  ...+
T Consensus       526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI---------------~~d~--~~yP  588 (694)
T KOG0694|consen  526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI---------------VNDE--VRYP  588 (694)
T ss_pred             ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---------------hcCC--CCCC
Confidence            5577999999999999999999999999999999999999999877665533222               1111  1123


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                      ...+.+...|+.++|..+|++|.-+
T Consensus       589 ~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  589 RFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CcccHHHHHHHHHHhccCcccccCC
Confidence            4556788999999999999999877

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.6e-35  Score=310.01  Aligned_cols=244  Identities=24%  Similarity=0.284  Sum_probs=195.7

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      ...++||+|+||+||++.. .++..+|+|.+....   ......+.+|+.+|++++|+||+++.+.+..++..++||||+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05632           3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence            3456899999999999985 467889999876432   233456788999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  157 (285)
T cd05632          83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--  157 (285)
T ss_pred             cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--
Confidence            999999888653  46999999999999999999999998   99999999999999999999999999876543221  


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.............   .......          ...
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~---~~~~~~~----------~~~  224 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---RRVLETE----------EVY  224 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---Hhhhccc----------ccc
Confidence            123458999999999998899999999999999999999999997654432211111   1110000          011


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKE  665 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~e  665 (735)
                      ......++.+|+.+||+.+|++||++.|
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~  252 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQE  252 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence            2234467889999999999999999543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.9e-35  Score=311.11  Aligned_cols=247  Identities=25%  Similarity=0.310  Sum_probs=197.3

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      ...++||+|+||+||++... ++..||+|++...   .......+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus         3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05630           3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence            34568999999999999854 6789999987642   2223456788999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      ++++|.+++...  ..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++......... 
T Consensus        83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-  158 (285)
T cd05630          83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-  158 (285)
T ss_pred             CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc-
Confidence            999999998653  35899999999999999999999988   999999999999999999999999998765433221 


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                       ....|+..|+|||.+.+..++.++||||||+++|||++|+.||..............+.....             ...
T Consensus       159 -~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------~~~  224 (285)
T cd05630         159 -KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------EEY  224 (285)
T ss_pred             -cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-------------hhc
Confidence             223589999999999998999999999999999999999999975432211111111111000             011


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPT-----MKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  668 (735)
                      ......++.+|+.+||+.+|++|||     +.|+++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            2234467899999999999999999     667664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-35  Score=324.45  Aligned_cols=255  Identities=25%  Similarity=0.317  Sum_probs=199.1

Q ss_pred             HhhhccccccccccCcEEEEEEEcC-CCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      ....+.+.+.||+|+||.||++... ++..+|+|.+..   ........+.+|+.+++.++||||+++++.+.+.+..++
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3345566789999999999999854 578899998763   223345567899999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||||+++|+|.+++... .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++......
T Consensus       121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            99999999999998764 5889999999999999999999999   9999999999999999999999999998765433


Q ss_pred             ccceeeeccccCccCcccccCC----CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTC----KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      ........||+.|+|||++...    .++.++||||||++||||++|+.||...........      .+.....     
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~------i~~~~~~-----  265 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK------IMNHKNS-----  265 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH------HHcCCCc-----
Confidence            3333345699999999998754    378899999999999999999999976543221111      1110000     


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEE--RPTMKEVSLEL  670 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~L  670 (735)
                        +..+.....+.++.+++.+||+.++.+  ||++.|+++..
T Consensus       266 --~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         266 --LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             --ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence              111112235577889999999844432  67888877643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.6e-35  Score=304.55  Aligned_cols=246  Identities=21%  Similarity=0.290  Sum_probs=201.4

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.++||+|+||.||++... ++..+|+|.++. ......+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG   82 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence            45678999999999999854 678899998764 3344567788999999999999999999999999999999999999


Q ss_pred             CchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          482 GTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       482 gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      ++|.+++...  ..+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++........ ...
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~  158 (255)
T cd08219          83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YAC  158 (255)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-ccc
Confidence            9999988653  45899999999999999999999998   99999999999999999999999999986643222 122


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|+.||.........       ..+..+..         ...+.
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~---------~~~~~  222 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-------LKVCQGSY---------KPLPS  222 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH-------HHHhcCCC---------CCCCc
Confidence            345889999999999888999999999999999999999999754332211       11111111         11122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ..+..+.+|+.+||+.+|++|||+.||+.+
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            345678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-35  Score=316.55  Aligned_cols=261  Identities=19%  Similarity=0.282  Sum_probs=198.4

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +...+.||+|+||.||+|... ++..||+|.++... ......+.+|+.++++++||||+++++++..++..++||||++
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   87 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD   87 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence            455678999999999999854 57789999887432 2234567899999999999999999999999999999999997


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      + +|.+++... ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....... ...
T Consensus        88 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~  162 (309)
T cd07872          88 K-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYS  162 (309)
T ss_pred             C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-ccc
Confidence            5 888887654 45899999999999999999999998   99999999999999999999999999876533221 112


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh------h--
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL------D--  630 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------d--  630 (735)
                      ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+................+..+.      +  
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence            2347899999998865 568899999999999999999999997665544333222211110000000000      0  


Q ss_pred             -hcccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 -NRIVN----DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 -~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       +....    ........++.+|+.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             00000    001123467889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-35  Score=305.91  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=200.8

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccCh---------hHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQ---------AKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      +.+...||+|++|.||+|.. .++..+|+|.+.....         ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            44667899999999999985 4578899998754221         1235688999999999999999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++||||+++++|.+++.....+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEA  158 (267)
T ss_pred             EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence            999999999999999988888999999999999999999999998   99999999999999999999999999887642


Q ss_pred             Cccc-----ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          553 DAIQ-----NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       553 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ....     ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........   ...    ...     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~~-----  226 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---IFK----IGE-----  226 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---HHH----Hhc-----
Confidence            2111     11123478899999999988899999999999999999999999965432211   100    000     


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                          ......+...+..+.+++.+||+.+|.+||++.||++
T Consensus       227 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 ----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                0111122344578899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-36  Score=309.92  Aligned_cols=239  Identities=22%  Similarity=0.382  Sum_probs=190.9

Q ss_pred             ccccccCcEEEEEEEcCC--------CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          407 DVIGCGGSGNVYKGFLPD--------RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.||+|+||.||+|....        ...|++|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998532        234888887655555667889999999999999999999999998999999999


Q ss_pred             cCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC--------eEEeeccCCcc
Q 004702          479 VGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT--------PKVSDFGASKL  549 (735)
Q Consensus       479 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl~DFGls~~  549 (735)
                      +++|+|.++++.. ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.        +|++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999765 46899999999999999999999998   999999999999987765        59999999875


Q ss_pred             cCCCcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCC-ccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          550 VPIDAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGK-MALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       550 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ....     ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+..........    +.   .      
T Consensus       158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~----~~---~------  219 (258)
T cd05078         158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ----FY---E------  219 (258)
T ss_pred             cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH----HH---H------
Confidence            4321     22347889999999986 45899999999999999999985 4543322221111    00   0      


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                         ..  ...+.....++.+|+.+||+.+|++|||++++++.|+
T Consensus       220 ---~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 ---DR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---cc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               00  0111123357899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=318.95  Aligned_cols=252  Identities=23%  Similarity=0.292  Sum_probs=196.4

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||++... ++..||+|.+..   ......+.+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            445779999999999999854 588999999864   2333456688999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++|+|.+++.+ ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..........
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999999976 457999999999999999999999999   9999999999999999999999999987654433323


Q ss_pred             eeeeccccCccCcccccC-----CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          558 CTVVQGTLGYLDPEYLQT-----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~-----~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .....||+.|+|||++..     ..++.++||||||+++|||++|+.||......+.....      ........+    
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i------~~~~~~~~~----  229 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHKEHFQF----  229 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH------HcCCCcccC----
Confidence            333458999999999863     45788999999999999999999999765433221111      100000000    


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCC--CCCCCHHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRG--EERPTMKEVSLE  669 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p--~~RPt~~ev~~~  669 (735)
                        .......+..+.+++.+|+..++  ..||++.+++..
T Consensus       230 --~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 --PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             --CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence              11111245678888988876533  347788887765

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-35  Score=300.03  Aligned_cols=259  Identities=22%  Similarity=0.275  Sum_probs=201.0

Q ss_pred             cccccccCcEEEEEEE-cCCCcEEEEEEeeccCh--hHHHHHHHHHHHHHhcCCCc-eEEEceEEeecC------ceeEE
Q 004702          406 ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQ--AKIDEFINELVVVLQINRRN-VVRLLGCCLETQ------VPLLV  475 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------~~~lV  475 (735)
                      .++||+|+||+||+|+ ..+|..||+|+++....  .--...++|+.+|+.|+|+| |++|++++...+      ..++|
T Consensus        16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence            3579999999999998 55688999999875433  23345679999999999999 999999998877      78899


Q ss_pred             EEecCCCchhHHhhhcC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          476 YEFVGNGTLFEHIHKKG----NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      +||+.. +|..++....    .++...+..+..||+.||+|||+++   |+||||||.||||++++.+||+|||+|+...
T Consensus        96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~  171 (323)
T KOG0594|consen   96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFS  171 (323)
T ss_pred             EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhc
Confidence            999954 8999998653    5777889999999999999999999   9999999999999999999999999999765


Q ss_pred             CCcccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh-
Q 004702          552 IDAIQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL-  629 (735)
Q Consensus       552 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  629 (735)
                      ..... .+..++|..|.|||.+.+. .|+...||||+|+++.||++++.-|....+.+....+...+..-.+..+..+. 
T Consensus       172 ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~  250 (323)
T KOG0594|consen  172 IPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS  250 (323)
T ss_pred             CCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence            43322 3445689999999999876 79999999999999999999998887776644433332222222222222111 


Q ss_pred             --hhcc--cCCC-CHHH-------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          630 --DNRI--VNDG-NKQQ-------LKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       630 --d~~~--~~~~-~~~~-------~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                        +...  .... +...       .....+++.+||+.+|.+|.+++.++.+
T Consensus       251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence              1110  0000 1111       1368899999999999999999998864

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.3e-35  Score=308.26  Aligned_cols=248  Identities=23%  Similarity=0.363  Sum_probs=196.4

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.++||+|+||.||++.. .++..||+|.+... .....+++.+|+.++++++||||+++++.+...+..++||||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG   83 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence            4567899999999999984 56788999987643 344557799999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      ++|..+.    .+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||++.......   ....
T Consensus        84 ~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (279)
T cd06619          84 GSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTY  153 (279)
T ss_pred             CChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCC
Confidence            9986553    4788899999999999999999998   9999999999999999999999999998654321   1234


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .++..|+|||.+.+..++.++||||||+++|+|++|+.||......+...........+        .+...........
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~  225 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI--------VDEDPPVLPVGQF  225 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH--------hccCCCCCCCCcC
Confidence            58999999999999899999999999999999999999986532221111111111111        1110000011223


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ..++.+++.+||+.+|++||++.|+++.
T Consensus       226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         226 SEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            4678999999999999999999998864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.9e-35  Score=309.43  Aligned_cols=259  Identities=25%  Similarity=0.343  Sum_probs=204.4

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.+.||+|+||+||++.. .++..||+|++... .....+.+.+|+++++.++||||+++++.+...+..++||||+
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM   85 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence            345567899999999999985 45788999987643 3444678899999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      ++++|.+++...+.+++..+..++.+++.+|.|||+. +   ++||||||+||++++++.++|+|||++........   
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~---  159 (284)
T cd06620          86 DCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---  159 (284)
T ss_pred             CCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhcc---
Confidence            9999999998878899999999999999999999974 5   99999999999999999999999999875432211   


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHH-HHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSL-AMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.... ...+...     +..+.........
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~  234 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----LQQIVQEPPPRLP  234 (284)
T ss_pred             CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH-----HHHHhhccCCCCC
Confidence            224589999999999888999999999999999999999999975543211110 0000000     0111111000111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      ....+.++.+|+.+||+.+|++|||+.||++...
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            1225567999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.3e-35  Score=303.62  Aligned_cols=247  Identities=33%  Similarity=0.473  Sum_probs=201.8

Q ss_pred             ccccccccCcEEEEEEEcCC-----CcEEEEEEeeccChh-HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          405 YADVIGCGGSGNVYKGFLPD-----RTPVAVKKSKFVDQA-KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.||.|+||.||++...+     +..||+|.++..... ..+.+.+|+.++..++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            56789999999999998654     378999998754433 577899999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          479 VGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~--l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +++++|.+++.....  +++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            999999999987544  999999999999999999999998   999999999999999999999999999876544322


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      ......++..|+|||.+....++.++||||||++++||++ |..||......+..       .......         ..
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~-------~~~~~~~---------~~  223 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL-------EYLKKGY---------RL  223 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcCC---------CC
Confidence            2222337789999999988889999999999999999999 77777553322211       1111111         11


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      ......+.++.+++.+||+.+|++|||+.|+++.|
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11222457899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.1e-35  Score=310.30  Aligned_cols=247  Identities=24%  Similarity=0.399  Sum_probs=203.0

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||.|++|.||+|.. .++..|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  100 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG  100 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence            34456899999999999984 56889999998766555677889999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      ++|.+++... .+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......... ....
T Consensus       101 ~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~  175 (296)
T cd06655         101 GSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTM  175 (296)
T ss_pred             CcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCc
Confidence            9999988654 6899999999999999999999998   999999999999999999999999998865433221 1223


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .++..|+|||.+.+..++.++||||||+++|+|++|+.||............       .....       .....+...
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~-------~~~~~-------~~~~~~~~~  241 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGT-------PELQNPEKL  241 (296)
T ss_pred             CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhcCC-------cccCCcccC
Confidence            5888999999999888999999999999999999999999765443321111       00000       000112234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+.+++.+||..+|.+|||+.+|+.
T Consensus       242 ~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         242 SPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            567889999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.9e-35  Score=319.27  Aligned_cols=257  Identities=25%  Similarity=0.343  Sum_probs=194.8

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------ce
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------VP  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~  472 (735)
                      .+.+.+.||+|+||.||++.. ..+..||||++..  ........+.+|+.+++.++||||+++++++....      ..
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  101 (359)
T cd07876          22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV  101 (359)
T ss_pred             ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence            345567999999999999985 4588999999863  33445677889999999999999999999986543      46


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++||||+.+ +|.+.++.  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         102 YLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             EEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            899999965 66666643  4889999999999999999999998   99999999999999999999999999976432


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc---------
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN---------  623 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------  623 (735)
                      ..  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...   .....+...         
T Consensus       176 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  250 (359)
T cd07876         176 NF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN---KVIEQLGTPSAEFMNRLQ  250 (359)
T ss_pred             Cc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCcHHHHHHHH
Confidence            22  1223458999999999999999999999999999999999999997654322111   111111000         


Q ss_pred             -chhhHhhhc--cc----------------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          624 -RLLEILDNR--IV----------------NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       624 -~~~~~~d~~--~~----------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                       .+.......  ..                .........++.+|+.+||+.||++|||+.|++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence             000000000  00                00011124578999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-35  Score=302.20  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=204.6

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++||||+++++++...+..+++|||+++
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~   84 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG   84 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence            445678999999999999854 5778999998876666778899999999999999999999999999999999999999


Q ss_pred             CchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ++|.+++... ..+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++....... .....
T Consensus        85 ~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~  160 (262)
T cd06613          85 GSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRKS  160 (262)
T ss_pred             CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-hcccc
Confidence            9999999876 78999999999999999999999998   9999999999999999999999999987654321 11223


Q ss_pred             eccccCccCcccccCC---CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          561 VQGTLGYLDPEYLQTC---KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~---~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ..++..|+|||.+...   .++.++||||||+++|||++|+.||............       .....    .+ .....
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~-------~~~~~----~~-~~~~~  228 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI-------SKSNF----PP-PKLKD  228 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhccC----CC-ccccc
Confidence            4578899999999776   8899999999999999999999998765433221110       00000    00 00111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....+.++.+++.+||+.+|.+|||+.+|+.
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2345678999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.9e-35  Score=305.82  Aligned_cols=249  Identities=24%  Similarity=0.312  Sum_probs=189.5

Q ss_pred             cccccCcEEEEEEEcCC---CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          408 VIGCGGSGNVYKGFLPD---RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .||+|+||+||+|...+   ...+++|.+... .......|.+|+.+++.++|+||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            68999999999997533   346888876543 34445678999999999999999999999999999999999999999


Q ss_pred             hhHHhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-c
Q 004702          484 LFEHIHKKG-----NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-N  557 (735)
Q Consensus       484 L~~~l~~~~-----~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~  557 (735)
                      |.+++....     ..++...+.++.|++.||+|||+.+   |+||||||+|||+++++++||+|||+++........ .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999997642     3467888999999999999999998   999999999999999999999999998754332211 1


Q ss_pred             eeeeccccCccCcccccC-------CCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          558 CTVVQGTLGYLDPEYLQT-------CKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |..||....+.+.   ....   ... ....+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~~---~~~-~~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LKQV---VRE-QDIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HHHH---hhc-cCccCC
Confidence            122235678999998643       457789999999999999999 6778765443221   1111   111 111111


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      .+.+    .......+.+++..|| .+|++|||+.||++.|.
T Consensus       232 ~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111    2234466778889998 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-35  Score=330.18  Aligned_cols=255  Identities=20%  Similarity=0.257  Sum_probs=190.2

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--------Cce
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--------QVP  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~  472 (735)
                      .+.+.++||+|+||.||+|.. ..+..||||++....    ....+|+.+|+.++||||+++++++...        ...
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            455678999999999999985 457899999875422    2234799999999999999999886432        135


Q ss_pred             eEEEEecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEeeccCC
Q 004702          473 LLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-TPKVSDFGAS  547 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGls  547 (735)
                      ++||||+++ +|.+++..    ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++ .+||+|||++
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccc
Confidence            689999975 77776643    467999999999999999999999998   99999999999998654 7999999999


Q ss_pred             cccCCCcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          548 KLVPIDAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       548 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                      +.+.....  .....||+.|+|||++.+ ..++.++||||||++||||++|+.||......+.....   ...+......
T Consensus       219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i---~~~~~~p~~~  293 (440)
T PTZ00036        219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI---IQVLGTPTED  293 (440)
T ss_pred             hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCCHH
Confidence            87643322  123458999999998865 46899999999999999999999999766544322221   1111111000


Q ss_pred             h--Hhhhc-------------ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          627 E--ILDNR-------------IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       627 ~--~~d~~-------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .  ...+.             +....+...+.++.+|+.+||+.+|.+|||+.|++..
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0  00000             0000111234678999999999999999999998854

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.6e-35  Score=301.57  Aligned_cols=247  Identities=26%  Similarity=0.347  Sum_probs=203.5

Q ss_pred             ccccccccccCcEEEEEEE-cCCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.++||.|+||.||.++ ..++..+++|++...  ......++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            3456799999999999987 445788999987643  4556678899999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      ++++|.+++...  ..+++.++..++.|++++|+|||+.+   ++|+||+|+||++++++.+||+|||++........ .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~  157 (256)
T cd08221          82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M  157 (256)
T ss_pred             CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence            999999999865  46899999999999999999999998   99999999999999999999999999987644332 2


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....+++.|+|||.+.+..++.++||||||+++|||++|..||......+...       .+.....         ...
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~-------~~~~~~~---------~~~  221 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV-------KIVQGNY---------TPV  221 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHcCCC---------CCC
Confidence            233458999999999998889999999999999999999999986543322111       1111111         111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ....+.++.+++.+||+.+|.+||++.++++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            23345678999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.2e-35  Score=303.00  Aligned_cols=246  Identities=25%  Similarity=0.346  Sum_probs=201.7

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-----hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-----QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      +...+.||+|++|+||+|... ++..|++|.+....     ....+.+.+|+.+++.++|+||+++++++......++||
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            345678999999999999965 78899999876433     345678899999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      ||+++++|.+++.....+++..+..++.|+++||+|||+.+   |+|+||+|+||+++.++.+||+|||++.......  
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--  156 (258)
T ss_pred             EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence            99999999999988778999999999999999999999998   9999999999999999999999999988654332  


Q ss_pred             ceeeeccccCccCcccccCCC-CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCK-LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~-~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      ......++..|++||.+.... ++.++|+||||+++|+|++|+.||......+...   .   ......         ..
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~---~---~~~~~~---------~~  221 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF---K---IGRSKE---------LP  221 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH---H---HHhccc---------CC
Confidence            223345888999999987766 8999999999999999999999986543211110   0   000000         01


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+......+.+++.+||+.+|.+||++.+++.
T Consensus       222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            112234567899999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-35  Score=323.65  Aligned_cols=263  Identities=24%  Similarity=0.299  Sum_probs=202.0

Q ss_pred             HHhhhccccccccccCcEEEEEEEcC---CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLP---DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      +....+.+.+.||+|+||.||++...   .+..||+|.+...     ..+.+|+.+|++++||||+++++++......++
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            33445777889999999999999743   3567899987542     234589999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |||++. ++|.+++.....+++..++.|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++.......
T Consensus       164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            999995 689999977778999999999999999999999998   9999999999999999999999999997654332


Q ss_pred             c-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch--------
Q 004702          555 I-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL--------  625 (735)
Q Consensus       555 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  625 (735)
                      . .......||+.|+|||++....++.++||||||++||||++|+.||..................+.....        
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            2 2223456999999999999999999999999999999999999999765443222222222222111100        


Q ss_pred             --hhH---hhhcccCCCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          626 --LEI---LDNRIVNDGN-------KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       626 --~~~---~d~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                        ...   ..........       .....++.+++.+||..+|++|||+.|++..
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence              000   0000000000       1123568899999999999999999998864

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.6e-35  Score=317.02  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=196.4

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.++||+|+||+||++... .+..+|+|.+...   .......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey   82 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY   82 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence            345679999999999999865 4678999987632   233345578899999999999999999999999999999999


Q ss_pred             cCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++|+|.+++.+ ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....+....
T Consensus        83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            999999999987 467899999999999999999999998   9999999999999999999999999987654333333


Q ss_pred             eeeeccccCccCccccc-----CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          558 CTVVQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .....||+.|+|||++.     ...++.++||||||++||||++|+.||......+.....      ........     
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i------~~~~~~~~-----  228 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHKERFQ-----  228 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH------hCCCcccc-----
Confidence            33346999999999986     346888999999999999999999999765433321111      11000000     


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGE--ERPTMKEVSLE  669 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~--~RPt~~ev~~~  669 (735)
                       ........+.++.+|+.+|+..++.  .|+++.|+++.
T Consensus       229 -~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 -FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             0111123456788899998865444  36888888755

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.6e-35  Score=310.18  Aligned_cols=260  Identities=22%  Similarity=0.301  Sum_probs=191.6

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhc---CCCceEEEceEEeec-----Cc
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQI---NRRNVVRLLGCCLET-----QV  471 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~-----~~  471 (735)
                      +.+.+.||+|+||+||++... ++..||+|.++...  ......+.+|+.+++.+   +||||+++++++...     ..
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            345678999999999999854 68889999876422  22233456677766655   799999999987642     35


Q ss_pred             eeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          472 PLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      .++||||+.+ +|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus        82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcccc
Confidence            7899999974 888888764  35899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       550 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+................+....
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         158 YSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             ccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            643221  223457899999999998899999999999999999999999987654433222211111000000000000


Q ss_pred             ---hhcc-------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          630 ---DNRI-------VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       630 ---d~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                         ....       ..........++.+|+.+||+.||++|||+.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               0000       00011123467899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.6e-35  Score=302.49  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=201.7

Q ss_pred             ccccccccccCcEEEEEEEcCC-CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||+|+||.||++...+ +..+++|.++....  .+++.+|+.++++++|+||+++++.+......++++||+++
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            4556789999999999999764 78899998865432  67899999999999999999999999999999999999999


Q ss_pred             CchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ++|.+++.. ...+++..++.++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++........ ....
T Consensus        83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~  158 (256)
T cd06612          83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRNT  158 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-cccc
Confidence            999999975 457899999999999999999999998   99999999999999999999999999887643321 2223


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..++..|+|||++.+..++.++||||||+++|||++|+.||...........       .....       ......+..
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~-------~~~~~~~~~  224 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNKP-------PPTLSDPEK  224 (256)
T ss_pred             ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccCC-------CCCCCchhh
Confidence            4478899999999998999999999999999999999999865433221100       00000       000111223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...++.+++.+||+.+|++|||+.||++
T Consensus       225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            4567899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.5e-35  Score=339.82  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=202.2

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.++||+|+||.||+|... .++.||||+++..   .....++|.+|+.++++++||||+++++++.+.+..++||||
T Consensus         4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY   83 (932)
T PRK13184          4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY   83 (932)
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence            345679999999999999854 5889999998642   233456799999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCC
Q 004702          479 VGNGTLFEHIHKK-----------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS  547 (735)
Q Consensus       479 ~~~gsL~~~l~~~-----------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls  547 (735)
                      +++++|.+++...           ..+++..+++++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999998641           24567788999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCcc-----------------cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHH
Q 004702          548 KLVPIDAI-----------------QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER  610 (735)
Q Consensus       548 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~  610 (735)
                      +.......                 .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            86521110                 0011235899999999999999999999999999999999999999653221110


Q ss_pred             HHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhhh
Q 004702          611 SLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP-TMKEVSLELQGRLSL  676 (735)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~~~~~  676 (735)
                           ....+        .++... ....+.+..+.+++.+||+.+|++|| ++.++++.|+..+..
T Consensus       241 -----~~~~i--------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        241 -----YRDVI--------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             -----hhhhc--------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                 00000        000000 00123456789999999999999996 577788888877653

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.8e-35  Score=312.35  Aligned_cols=261  Identities=21%  Similarity=0.302  Sum_probs=198.7

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||.||+|... ++..||+|.++... ......+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~   87 (301)
T cd07873           8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   87 (301)
T ss_pred             eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence            445678999999999999854 57889999886432 2334567889999999999999999999999999999999997


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                       ++|.+++... ..+++..+..++.|+++||+|||+.+   |+|+||||+|||+++++.+||+|||++........ ...
T Consensus        88 -~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~  162 (301)
T cd07873          88 -KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYS  162 (301)
T ss_pred             -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-ccc
Confidence             5898888754 56899999999999999999999998   99999999999999999999999999976533221 112


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh-------
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN-------  631 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-------  631 (735)
                      ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+................+..++..       
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN  242 (301)
T ss_pred             ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence            2347889999998865 45788999999999999999999999766544332222221111111111111110       


Q ss_pred             --cccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 --RIVN----DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 --~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                        ....    ......+..+.+|+.+||+.||.+|||+.|++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              0000    001123457889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=319.61  Aligned_cols=236  Identities=25%  Similarity=0.312  Sum_probs=187.7

Q ss_pred             ccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc---CCCceEEEceEEeecCceeEEEEecCC
Q 004702          409 IGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI---NRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       409 lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ||+|+||+||++... ++..||||++...   .......+..|..++..+   +||||++++..+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999854 5889999997642   223344556677777665   699999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|.+++.....+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++....... .....
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~~  156 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTF  156 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccCc
Confidence            999999988888999999999999999999999998   99999999999999999999999999875432221 12334


Q ss_pred             ccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          562 QGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      .||+.|+|||.+.+. .++.++||||||++||||++|+.||......+..       ..+.....      .+.   ...
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~~------~~~---~~~  220 (330)
T cd05586         157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-------RNIAFGKV------RFP---KNV  220 (330)
T ss_pred             cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-------HHHHcCCC------CCC---Ccc
Confidence            589999999998754 4899999999999999999999999765432211       11111110      000   112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                      ...++.+++.+||+.+|.+||++.
T Consensus       221 ~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         221 LSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             CCHHHHHHHHHHcCCCHHHCCCCC
Confidence            346788999999999999999644

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.8e-35  Score=304.40  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=199.7

Q ss_pred             cccccccccCcEEEEEEEcCC--CcEEEEEEeec----------cChhHHHHHHHHHHHHHh-cCCCceEEEceEEeecC
Q 004702          404 NYADVIGCGGSGNVYKGFLPD--RTPVAVKKSKF----------VDQAKIDEFINELVVVLQ-INRRNVVRLLGCCLETQ  470 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~--~~~vavK~~~~----------~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~  470 (735)
                      .+.+.||+|+||.||+|....  +..+|+|.+..          .......++.+|+.++.+ ++||||+++++++.+.+
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   82 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND   82 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence            456789999999999999755  67899998653          233345678889988865 79999999999999999


Q ss_pred             ceeEEEEecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          471 VPLLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                      ..++||||+++++|.+++..    ...+++..+++++.|++.+|.|||+ .+   ++|+||+|+|||++.++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEeccc
Confidence            99999999999999988743    3568999999999999999999996 55   9999999999999999999999999


Q ss_pred             CCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          546 ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       546 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                      ++.......  ......++..|++||.+.+..++.++||||||+++|||++|+.||..........       .+..   
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~-------~~~~---  227 (269)
T cd08528         160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT-------KIVE---  227 (269)
T ss_pred             ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH-------HHhh---
Confidence            998765432  2234458899999999998889999999999999999999999986543322111       1111   


Q ss_pred             hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       626 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                           .............++.+++.+||+.+|++||++.||..+|+
T Consensus       228 -----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 -----AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -----ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                 11111111124467899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.5e-35  Score=317.01  Aligned_cols=252  Identities=23%  Similarity=0.285  Sum_probs=196.4

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||+++.. ++..||+|.+...   .......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey   82 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY   82 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            345678999999999999854 5788999987642   233455678899999999999999999999999999999999


Q ss_pred             cCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++|+|.+++.. ...+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++....+....
T Consensus        83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            999999999987 467899999999999999999999998   9999999999999999999999999998765443333


Q ss_pred             eeeeccccCccCcccccC-----CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          558 CTVVQGTLGYLDPEYLQT-----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~-----~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .....|++.|+|||++.+     ..++.++||||||++||||++|+.||......+.....      ........     
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i------~~~~~~~~-----  228 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHEERFQ-----  228 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH------HcCCCccc-----
Confidence            333569999999999875     46788999999999999999999999765433211111      00000000     


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEE--RPTMKEVSLE  669 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~  669 (735)
                       ........+.++.+++.+|+..++.+  |+++.++++.
T Consensus       229 -~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 -FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence             01111223567889999999865543  4567766543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-35  Score=323.01  Aligned_cols=248  Identities=25%  Similarity=0.309  Sum_probs=195.9

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.||+|+||+||++... ++..||||+++..   .......+.+|+.++.+++|+||+++++.+.+.+..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~   83 (360)
T cd05627           4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL   83 (360)
T ss_pred             eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            34578999999999999854 5889999998642   2334567888999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc----
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI----  555 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~----  555 (735)
                      ++|+|.+++.+...+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++.......    
T Consensus        84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          84 PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             CCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            99999999988888999999999999999999999998   99999999999999999999999999875421100    


Q ss_pred             ------------------------------cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCC
Q 004702          556 ------------------------------QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDK  605 (735)
Q Consensus       556 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~  605 (735)
                                                    .......||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                                          00112358999999999999999999999999999999999999997665


Q ss_pred             hHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          606 PEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       606 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +.+....+..+    .         ..+..+.......++.+|+.+++ .+|.+|++...+.+
T Consensus       241 ~~~~~~~i~~~----~---------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  289 (360)
T cd05627         241 PQETYRKVMNW----K---------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEE  289 (360)
T ss_pred             HHHHHHHHHcC----C---------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHH
Confidence            43322111100    0         00000111123467888888877 49999997543333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.1e-35  Score=310.43  Aligned_cols=247  Identities=25%  Similarity=0.389  Sum_probs=202.3

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus        21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  100 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence            44567899999999999984 57889999998766556667789999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      ++|.+++.+ ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......... ....
T Consensus       101 ~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~  175 (297)
T cd06656         101 GSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTM  175 (297)
T ss_pred             CCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCcc
Confidence            999999865 46899999999999999999999998   999999999999999999999999998865433221 1223


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+......      ...        ........+...
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~--------~~~~~~~~~~~~  241 (297)
T cd06656         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IAT--------NGTPELQNPERL  241 (297)
T ss_pred             cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------ecc--------CCCCCCCCcccc
Confidence            478899999999998899999999999999999999999965433211000      000        000001112334


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+.+++.+||+.+|++||++.+|++
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         242 SAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            567889999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.4e-35  Score=304.16  Aligned_cols=249  Identities=23%  Similarity=0.291  Sum_probs=188.5

Q ss_pred             cccccCcEEEEEEEcCCC---cEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          408 VIGCGGSGNVYKGFLPDR---TPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .||+|+||.||+|...++   ..+++|.++.. .....+.|.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999975433   34566766543 34456789999999999999999999999999999999999999999


Q ss_pred             hhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC-cccce
Q 004702          484 LFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID-AIQNC  558 (735)
Q Consensus       484 L~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~-~~~~~  558 (735)
                      |.+++++.    ..+++..++.++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||++...... .....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999764    34667788899999999999999988   999999999999999999999999998643221 11122


Q ss_pred             eeeccccCccCcccccC-------CCCCccccchhHHHHHHHHHhC-CccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          559 TVVQGTLGYLDPEYLQT-------CKLTDKSDVYSFGVVLVELLTG-KMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~-------~~~~~ksDVyS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ ..||......+.   .....   . +....+.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~~~---~-~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV---LNHVI---K-DQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH---h-hcccccCC
Confidence            23457889999998753       3467899999999999999974 567654433221   11111   1 11112222


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      +.+..    .....+.+++..|| .+|++||++.||++.|.
T Consensus       232 ~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22221    23467788999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.9e-35  Score=311.54  Aligned_cols=252  Identities=27%  Similarity=0.430  Sum_probs=198.9

Q ss_pred             ccccccccCcEEEEEEEcC-CCc----EEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRT----PVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      ..+.||+|+||.||+|... ++.    .||+|.+... ......++.+|+.+++.++||||+++++++... ..++++||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence            4568999999999999853 333    4788887643 334445788999999999999999999998754 46799999


Q ss_pred             cCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-
Q 004702          479 VGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-  556 (735)
Q Consensus       479 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-  556 (735)
                      +++|+|.+++... ..+++..++.++.|++.||+|||+.+   |+|+||||+|||+++++.+||+|||+++........ 
T Consensus        90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  166 (303)
T cd05110          90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY  166 (303)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCccccc
Confidence            9999999999765 46899999999999999999999998   999999999999999999999999999876433221 


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....       +....         ..
T Consensus       167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~---------~~  230 (303)
T cd05110         167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-------LEKGE---------RL  230 (303)
T ss_pred             ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHCCC---------CC
Confidence            1122335678999999998899999999999999999998 8889865432221111       11110         01


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .........+.+++.+||..+|++||++.++++.|+.+...
T Consensus       231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            11122345789999999999999999999999999986544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-34  Score=302.00  Aligned_cols=247  Identities=24%  Similarity=0.373  Sum_probs=194.9

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc-----ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-----DQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  474 (735)
                      +...++||+|+||.||++.. ..+..|++|++...     .....+.+.+|+.++++++||||+++++++...  ...++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            34567999999999999985 45889999987632     223456788999999999999999999988753  56789


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      +|||+++++|.+++.....+++...+.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          84 FMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            9999999999999988778999999999999999999999988   9999999999999999999999999987653211


Q ss_pred             c--cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          555 I--QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       555 ~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .  .......++..|+|||.+.+..++.++||||||+++|||++|+.||.........   ..   ...         ..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~---~~---~~~---------~~  225 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI---FK---IAT---------QP  225 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH---HH---Hhc---------CC
Confidence            1  1112344788999999999988999999999999999999999998654322111   00   000         00


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .....+....+.+.+++ +||..+|++||+++||+.
T Consensus       226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            01112233445667777 688899999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-35  Score=304.03  Aligned_cols=244  Identities=26%  Similarity=0.379  Sum_probs=201.2

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.+.||.|++|.||+|... ++..||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   83 (274)
T cd06609           4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG   83 (274)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence            45578999999999999854 57889999886533 44567788999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      ++|.+++... .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++....... .....
T Consensus        84 ~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~  158 (274)
T cd06609          84 GSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNTF  158 (274)
T ss_pred             CcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-ccccc
Confidence            9999999865 7999999999999999999999998   99999999999999999999999999987654321 22234


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH-
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ-  640 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~-  640 (735)
                      .++..|+|||++.+..++.++||||||+++|||++|+.||....+....       ..+...         ........ 
T Consensus       159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-------~~~~~~---------~~~~~~~~~  222 (274)
T cd06609         159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-------FLIPKN---------NPPSLEGNK  222 (274)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-------HHhhhc---------CCCCCcccc
Confidence            5788999999999888999999999999999999999999654432211       011111         00111111 


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+.++.+++.+||..+|++|||++++++
T Consensus       223 ~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         223 FSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            4567899999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.3e-34  Score=305.80  Aligned_cols=248  Identities=22%  Similarity=0.293  Sum_probs=200.5

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.++||+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG   93 (292)
T ss_pred             hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence            345678999999999999864 4788999998877777788899999999999999999999999999999999999999


Q ss_pred             CchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ++|..++.+ ...+++..++.++.|++.+|+|||+.+   ++||||||+||+++.++.+||+|||++...... ......
T Consensus        94 ~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~  169 (292)
T cd06644          94 GAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRRDS  169 (292)
T ss_pred             CcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-ccccce
Confidence            999988765 357899999999999999999999988   999999999999999999999999998754322 122233


Q ss_pred             eccccCccCccccc-----CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          561 VQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       561 ~~gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      ..++..|+|||++.     ...++.++||||||+++|||++|+.||......+.   ....    .....     +.  .
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~----~~~~~-----~~--~  235 (292)
T cd06644         170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKI----AKSEP-----PT--L  235 (292)
T ss_pred             ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH---HHHH----hcCCC-----cc--C
Confidence            45889999999884     34578899999999999999999999865443221   1111    00000     00  0


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+...+.++.+++.+||+.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            112234567899999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-35  Score=308.06  Aligned_cols=263  Identities=25%  Similarity=0.269  Sum_probs=203.5

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||.||++... ++..|++|+++..  .....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            456778999999999999865 5788999987642  3334577899999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      +++.|..++.....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++............
T Consensus        83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          83 ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            98877777766677999999999999999999999998   999999999999999999999999999876544332333


Q ss_pred             eeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc--------------c
Q 004702          560 VVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN--------------R  624 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------------~  624 (735)
                      ...++..|+|||++... .++.++||||||+++|+|++|+.||......+...........+...              .
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            44578899999999887 88999999999999999999999987554332221111111110000              0


Q ss_pred             hhhHhhhcc-cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 LLEILDNRI-VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ~~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .....+... ....+...+.++.+|+.+||+.+|++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000000000 00011123578999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.4e-35  Score=306.71  Aligned_cols=261  Identities=23%  Similarity=0.256  Sum_probs=200.6

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||.||++... ++..||+|++....  ....+.+.+|+.++++++|+||+++++++......++||||+
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   82 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC   82 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence            345678999999999999865 58899999876432  223456789999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      ++++|..++.....+++..++.++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||++........ ...
T Consensus        83 ~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~  158 (286)
T cd07847          83 DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYT  158 (286)
T ss_pred             CccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-ccc
Confidence            99999888877678999999999999999999999988   99999999999999999999999999987643321 122


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh--------
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD--------  630 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--------  630 (735)
                      ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...........+.. ...++.+        
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP-RHQQIFSTNQFFKGL  237 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-HHhhhcccccccccc
Confidence            2347889999999875 56889999999999999999999999765544332221111110000 0000000        


Q ss_pred             --hcccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 --NRIVNDG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 --~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                        +......     ....+..+.+|+.+||+.+|++|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence              0000000     0123467899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.2e-36  Score=289.20  Aligned_cols=247  Identities=25%  Similarity=0.346  Sum_probs=204.2

Q ss_pred             ccccccccCcEEEEEEEc-CCCcEEEEEEeeccC--------hhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeE
Q 004702          405 YADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD--------QAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  474 (735)
                      -.++||.|..+.|-+... ..+..+|+|++....        ..-.+.-.+|+.+|+++ .||+|+.+.+++......++
T Consensus        21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl  100 (411)
T KOG0599|consen   21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL  100 (411)
T ss_pred             hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence            356899999999988764 467889999875321        12234556899999998 59999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |+|.|+.|.|.++|.+.-.++++...+|+.|+.+|+.|||..+   ||||||||+|||+|++.++||+|||++..+....
T Consensus       101 VFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge  177 (411)
T KOG0599|consen  101 VFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGE  177 (411)
T ss_pred             hhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCch
Confidence            9999999999999999999999999999999999999999999   9999999999999999999999999999876543


Q ss_pred             ccceeeeccccCccCccccc------CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH
Q 004702          555 IQNCTVVQGTLGYLDPEYLQ------TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI  628 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (735)
                        ......||++|+|||.+.      ...|+...|.|+.||+||.|+.|.+||+.....       -.++.+.+++.   
T Consensus       178 --kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-------lMLR~ImeGky---  245 (411)
T KOG0599|consen  178 --KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-------LMLRMIMEGKY---  245 (411)
T ss_pred             --hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-------HHHHHHHhccc---
Confidence              334567999999999874      346888999999999999999999999754221       11222222221   


Q ss_pred             hhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       629 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                         +...+...+.+.+..+||.+||+.||.+|.|++|++..
T Consensus       246 ---qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  246 ---QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             ---ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence               22344566778899999999999999999999999865

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.8e-34  Score=302.22  Aligned_cols=244  Identities=26%  Similarity=0.381  Sum_probs=202.2

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ..+.||+|+||.||+|... .+..||||.+... .......+.+|+.++++++|+||+++++++.+....++||||++++
T Consensus         8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06640           8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence            4567999999999999864 5788999987743 3455678999999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      +|.+++.. ..+++.++..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........ ......
T Consensus        88 ~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~  162 (277)
T cd06640          88 SALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFV  162 (277)
T ss_pred             cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cccccc
Confidence            99999865 46899999999999999999999988   99999999999999999999999999976643221 122335


Q ss_pred             cccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHH
Q 004702          563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL  642 (735)
Q Consensus       563 gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  642 (735)
                      ++..|+|||++.+..++.++||||||+++|||++|+.||....+.....       ..         ............+
T Consensus       163 ~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~---------~~~~~~~~~~~~~  226 (277)
T cd06640         163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LI---------PKNNPPTLTGEFS  226 (277)
T ss_pred             CcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hh---------hcCCCCCCchhhh
Confidence            7889999999998889999999999999999999999986544322110       00         1111122234566


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          643 KEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       643 ~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ..+.+++.+||+.+|++||++.+++..
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         227 KPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            789999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.3e-35  Score=318.41  Aligned_cols=258  Identities=23%  Similarity=0.335  Sum_probs=195.3

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------cee
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------VPL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~  473 (735)
                      +...+.||+|+||.||++.. ..+..||||++..  ........+.+|+.+++.++||||+++++++....      ..+
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   98 (355)
T cd07874          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY   98 (355)
T ss_pred             eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence            44567899999999999985 3578899998864  23445677889999999999999999999886432      468


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+.+ +|.+.+..  .+++..+..++.|+++||+|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus        99 lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~  172 (355)
T cd07874          99 LVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_pred             EEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence            99999965 67776654  4889999999999999999999998   999999999999999999999999999865432


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHH--------HHHHhcccch
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN--------FLSSLKQNRL  625 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~  625 (735)
                      .  ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+.......        +...+.. .+
T Consensus       173 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  249 (355)
T cd07874         173 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-TV  249 (355)
T ss_pred             c--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH-HH
Confidence            2  22234589999999999998999999999999999999999999976544332211110        0000000 00


Q ss_pred             hhHhhh----------c-----c---cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          626 LEILDN----------R-----I---VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       626 ~~~~d~----------~-----~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ...++.          .     .   ..........++.+|+.+||+.||++|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000000          0     0   000111234678999999999999999999998864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.7e-35  Score=306.63  Aligned_cols=244  Identities=27%  Similarity=0.395  Sum_probs=199.6

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ..+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++......++||||++++
T Consensus         8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06642           8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence            3467999999999999854 5778999987643 3445677899999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      +|.+++.. ..+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++........ ......
T Consensus        88 ~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~  162 (277)
T cd06642          88 SALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTFV  162 (277)
T ss_pred             cHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-hhhccc
Confidence            99998865 46899999999999999999999988   99999999999999999999999999986643221 112234


Q ss_pred             cccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHH
Q 004702          563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL  642 (735)
Q Consensus       563 gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  642 (735)
                      ++..|+|||++.+..++.++||||||+++|||++|+.|+....+.....       .+...         .........+
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~---------~~~~~~~~~~  226 (277)
T cd06642         163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIPKN---------SPPTLEGQYS  226 (277)
T ss_pred             CcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhhcC---------CCCCCCcccC
Confidence            7889999999999899999999999999999999999986443322110       01110         0111122345


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          643 KEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       643 ~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .++.+++.+||+.+|++||++.+|+..
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         227 KPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            678999999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=311.81  Aligned_cols=249  Identities=24%  Similarity=0.304  Sum_probs=212.4

Q ss_pred             hccccccccccCcEEEEEEEcCC-CcEEEEEEeeccCh---hHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQ---AKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.+.||+|.||.||+++.+. +..+|+|.+.....   ...+.+.+|+.+|+++. |||||.+.+.+......++||
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm  115 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM  115 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence            45567899999999999999654 89999998865333   34578899999999998 999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC----CCCeEEeeccCCcccCC
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE----NCTPKVSDFGASKLVPI  552 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~DFGls~~~~~  552 (735)
                      |++.+|.|.+.+... .+++.....++.|++.+++|||+.+   |+||||||+|+|+..    ++.+|++|||++.....
T Consensus       116 EL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  116 ELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            999999999999876 4999999999999999999999998   999999999999963    34799999999998765


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                        ........||+.|+|||.+....|+.+.||||+|+++|.|++|..||......+....       +...+      ..
T Consensus       192 --~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-------i~~~~------~~  256 (382)
T KOG0032|consen  192 --GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-------ILRGD------FD  256 (382)
T ss_pred             --CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-------HHcCC------CC
Confidence              3445667799999999999999999999999999999999999999987765443221       11111      12


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ...+........+.+++..++..||.+|+|+.++++.
T Consensus       257 f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  257 FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            3344456677899999999999999999999999983

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.1e-35  Score=303.72  Aligned_cols=245  Identities=27%  Similarity=0.394  Sum_probs=193.6

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeec------CceeEE
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLET------QVPLLV  475 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~~~~lV  475 (735)
                      .+.+.||+|+||.||+|... ++..||+|.+.... .....+.+|+.++.++ +|+||+++++++...      ...++|
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   87 (272)
T cd06637           9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV   87 (272)
T ss_pred             hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence            34568999999999999854 57889999886543 3346788999999998 699999999998753      357899


Q ss_pred             EEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          476 YEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~  164 (272)
T cd06637          88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  164 (272)
T ss_pred             EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence            9999999999999863  46899999999999999999999998   999999999999999999999999999865332


Q ss_pred             cccceeeeccccCccCccccc-----CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI  628 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (735)
                      . .......|+..|+|||++.     ...++.++||||||+++|||++|+.||...........       .....    
T Consensus       165 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-------~~~~~----  232 (272)
T cd06637         165 V-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------IPRNP----  232 (272)
T ss_pred             c-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-------HhcCC----
Confidence            2 1223345889999999986     34588899999999999999999999865433221110       00000    


Q ss_pred             hhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       629 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       ..   .......+.++.+|+.+||+.+|.+|||+.|+++
T Consensus       233 -~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         233 -AP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -CC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             00   0011123467899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.3e-35  Score=301.05  Aligned_cols=243  Identities=27%  Similarity=0.436  Sum_probs=197.2

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      +.+.+.||+|+||.||++.. .+..||+|+.+...  ..+.+.+|+.++++++||||+++++++... ..++||||++++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~   83 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKG   83 (254)
T ss_pred             ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCC
Confidence            45678999999999999975 56779999876432  346789999999999999999999998765 468999999999


Q ss_pred             chhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          483 TLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       483 sL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +|.+++...  ..+++..++.++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||++.......    ..
T Consensus        84 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~  156 (254)
T cd05083          84 NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DN  156 (254)
T ss_pred             CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----CC
Confidence            999999764  35899999999999999999999988   9999999999999999999999999987543221    11


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |+.||......+...       .+..         ....+...
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~---------~~~~~~~~  220 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE-------CVEK---------GYRMEPPE  220 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH-------HHhC---------CCCCCCCC
Confidence            234568999999998899999999999999999998 888886554332111       1111         11111122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      ..+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            345778999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.7e-34  Score=298.63  Aligned_cols=246  Identities=23%  Similarity=0.326  Sum_probs=198.9

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEee-cCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE-TQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~E~  478 (735)
                      +.+.+.||+|++|.||++... ++..||+|++..  ......+.+.+|+.++++++|+|++++++.+.. ....++||||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            456789999999999999854 578899999864  234456678899999999999999999988764 3457899999


Q ss_pred             cCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          479 VGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       479 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +++++|.+++...  ..+++.+++.++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++........ 
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-  157 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-  157 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence            9999999999763  46899999999999999999999998   99999999999999999999999999986643222 


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      ......+++.|+|||.+.+..++.++||||||++++||++|+.||........   ..    .+....         ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~~----~~~~~~---------~~~  221 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL---VY----RIIEGK---------LPP  221 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HH----HHHhcC---------CCC
Confidence            22234578999999999999999999999999999999999999864432211   00    011111         111


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+.....++.+++.+||+.+|++|||+.++++
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         222 MPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            22345578999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-34  Score=314.83  Aligned_cols=258  Identities=23%  Similarity=0.334  Sum_probs=195.4

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeec------Cce
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLET------QVP  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~  472 (735)
                      .+.+.+.||+|+||.||++.. ..+..||||++..  ........+.+|+.+++.++||||+++++++...      ...
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~  104 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  104 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence            345567999999999999984 4578899999864  2344566788999999999999999999987543      356


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++||||+.+ +|.+.+..  .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       105 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         105 YIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             EEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            899999965 77777754  4889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHH--------HHHhcccc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF--------LSSLKQNR  624 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  624 (735)
                      ..  ......+|..|+|||.+.+..++.++||||||++||||++|+.||......+........        ...+.. .
T Consensus       179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  255 (364)
T cd07875         179 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-T  255 (364)
T ss_pred             CC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH-H
Confidence            22  222345899999999999999999999999999999999999999766543322221110        000000 0


Q ss_pred             hhhHhhh--------------ccc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 LLEILDN--------------RIV----NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ~~~~~d~--------------~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +...+..              ...    .........++.+|+.+||+.||.+|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000000              000    0011112357889999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.2e-35  Score=312.56  Aligned_cols=254  Identities=20%  Similarity=0.241  Sum_probs=193.8

Q ss_pred             cccccccc--CcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          405 YADVIGCG--GSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       405 ~~~~lG~G--~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.++||+|  +|++||++.. .++..||+|+++..  .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45689999  7899999985 56889999998643  3344556778999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-  556 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-  556 (735)
                      ++|+|.+++...  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.++++||+........... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999653  45899999999999999999999998   999999999999999999999999865433211100 


Q ss_pred             -----ceeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          557 -----NCTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       557 -----~~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                           ......++..|+|||++.+  ..++.++||||||+++|||++|+.||..........   ....    ..+...+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~----~~~~~~~  231 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL---EKLN----GTVPCLL  231 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH---HHhc----CCccccc
Confidence                 0111236778999999876  468999999999999999999999996543222110   0000    0000000


Q ss_pred             h-------------------h-----------------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          630 D-------------------N-----------------RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       630 d-------------------~-----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +                   .                 ....+........+.+|+.+||+.||++|||+.||++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0                   0                 0000112234568899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.5e-34  Score=309.07  Aligned_cols=193  Identities=24%  Similarity=0.331  Sum_probs=158.9

Q ss_pred             cccccccCcEEEEEEEcC---CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEee--cCceeEEEEecC
Q 004702          406 ADVIGCGGSGNVYKGFLP---DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE--TQVPLLVYEFVG  480 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~~~  480 (735)
                      ..+||+|+||+||+|...   ++..||+|.++...  ....+.+|+.+|++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            458999999999999854   45789999886432  23457789999999999999999998864  345789999985


Q ss_pred             CCchhHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCCeEEeeccCC
Q 004702          481 NGTLFEHIHKK---------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGAS  547 (735)
Q Consensus       481 ~gsL~~~l~~~---------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGls  547 (735)
                       ++|.+++...         ..+++..+..++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4888877532         25889999999999999999999998   9999999999999    45678999999999


Q ss_pred             cccCCCccc--ceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCC
Q 004702          548 KLVPIDAIQ--NCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSD  604 (735)
Q Consensus       548 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~  604 (735)
                      +........  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876433221  2233458999999999876 45899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-34  Score=299.37  Aligned_cols=246  Identities=24%  Similarity=0.343  Sum_probs=196.4

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc-----ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeEE
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-----DQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLV  475 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV  475 (735)
                      .+.++||+|+||.||+|.. .++..||||.+...     .....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (265)
T cd06652           5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF   84 (265)
T ss_pred             eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence            4567999999999999985 45889999987532     223456788999999999999999999988763  457899


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||+++++|.+++.....+++...++++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||+++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            999999999999988778999999999999999999999998   99999999999999999999999999886532111


Q ss_pred             --cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          556 --QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       556 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                        .......++..|+|||.+.+..++.++||||||+++|||++|+.||.........      .....         ...
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~---------~~~  226 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIAT---------QPT  226 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH------HHHhc---------CCC
Confidence              1122345888999999998888999999999999999999999998654322211      00000         001


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....+......+.+++.+||. +|++||++.||++
T Consensus       227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            112234455678889999994 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-34  Score=298.77  Aligned_cols=246  Identities=21%  Similarity=0.298  Sum_probs=201.8

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||.||++.. .++..||+|++..  ......+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            34567899999999999984 4678899998764  23445678899999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      .+++|.+++...  ..+++.++++++.|++.||+|||+.+   ++|+||+|+|||++.++.+||+|||++........ .
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~  157 (256)
T cd08218          82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L  157 (256)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence            999999999764  35899999999999999999999998   99999999999999999999999999986543221 1


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....|++.|+|||.+.+..++.++||||||+++++|++|+.||......+..   ..    ...+.         ....
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~---~~----~~~~~---------~~~~  221 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV---LK----IIRGS---------YPPV  221 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH---HH----HhcCC---------CCCC
Confidence            12234788999999999889999999999999999999999998654332211   11    00110         1112


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +.....++.+++.+||+.+|.+||++.+|++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            2344567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-34  Score=300.18  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=201.8

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeeccC------hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD------QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ...+.||+|++|.||++.. .++..||+|.++...      ....+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~   82 (268)
T cd06630           3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV   82 (268)
T ss_pred             cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence            3457899999999999984 568899999876432      223567899999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-TPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGls~~~~~~~~  555 (735)
                      ||+++++|.+++.+..++++..++.++.|++.||+|||+.+   ++|+||||+||+++.++ .+||+|||++........
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          83 EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             eccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            99999999999988888999999999999999999999998   99999999999998765 599999999887643321


Q ss_pred             c---ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          556 Q---NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       556 ~---~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .   ......++..|+|||.+.+..++.++||||||+++++|++|+.||............            ..+....
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~  227 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI------------FKIASAT  227 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH------------HHHhccC
Confidence            1   112235788999999998888999999999999999999999998644322111111            0111111


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+.+.....++.+++.+||+.+|.+|||+.|++.
T Consensus       228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            112233455678999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=303.06  Aligned_cols=249  Identities=22%  Similarity=0.303  Sum_probs=202.1

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||.|+||.||++... ++..+|+|..+.......+.|.+|+.++++++||||+++++.+......++||||+++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG   86 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence            345568999999999999864 5788999998877777788899999999999999999999999999999999999999


Q ss_pred             CchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ++|.+++... ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++........ ....
T Consensus        87 ~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~  162 (280)
T cd06611          87 GALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRDT  162 (280)
T ss_pred             CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-ccce
Confidence            9999998764 57999999999999999999999998   99999999999999999999999999876533221 2223


Q ss_pred             eccccCccCccccc-----CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          561 VQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       561 ~~gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      ..+++.|++||.+.     ...++.++||||||+++|||++|+.||.........   .    .+.....     +.  .
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~---~----~~~~~~~-----~~--~  228 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---L----KILKSEP-----PT--L  228 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH---H----HHhcCCC-----CC--c
Confidence            45899999999874     345778999999999999999999998654332211   1    1111000     00  0


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ..+.....++.+++.+||+.+|.+||++.+|++.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            1122345678999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.7e-35  Score=306.07  Aligned_cols=260  Identities=22%  Similarity=0.285  Sum_probs=195.8

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.||+|++|.||+|... ++..||||+++..  +....+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS   82 (285)
T ss_pred             eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence            45678999999999999854 6889999987643  23334678899999999999999999999999999999999997


Q ss_pred             CCchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          481 NGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       481 ~gsL~~~l~~~---~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                       ++|.+++...   ..+++..++.++.|+++||+|||+.+   |+|+||||+|||+++++.+||+|||++....... ..
T Consensus        83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~  157 (285)
T cd07861          83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV  157 (285)
T ss_pred             -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence             6888888643   46899999999999999999999998   9999999999999999999999999987654322 11


Q ss_pred             eeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc---hhhHhh--h
Q 004702          558 CTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR---LLEILD--N  631 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d--~  631 (735)
                      .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+................   ...+.+  .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            222346889999998865 4578899999999999999999999976543322111100000000000   000000  0


Q ss_pred             cc-------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 RI-------VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 ~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..       ........+.++.+++.+||+.||.+|||+.+|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00       00001123467889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=298.89  Aligned_cols=245  Identities=23%  Similarity=0.364  Sum_probs=207.6

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      +.++||+|+||.|||+..+ .|..||||++..  ..+.+++++|+.+|++...|++|+++|.+.....+|+||||+..|+
T Consensus        37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            3568999999999999854 589999999764  4457889999999999999999999999999999999999999999


Q ss_pred             hhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          484 LFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       484 L~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      +.+.++- +++|++..+..++...++||+|||...   -||||||+.||||+.+|.+||+|||.+..+..... ....+.
T Consensus       115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNTVI  190 (502)
T KOG0574|consen  115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNTVI  190 (502)
T ss_pred             HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCccc
Confidence            9999985 478999999999999999999999988   89999999999999999999999999986653322 334467


Q ss_pred             cccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHH
Q 004702          563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL  642 (735)
Q Consensus       563 gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  642 (735)
                      ||+.|||||++..-.|..++||||||++..||..|++||....+....-.       +.       ..+.-.-..+.+++
T Consensus       191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------IP-------T~PPPTF~KPE~WS  256 (502)
T KOG0574|consen  191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------IP-------TKPPPTFKKPEEWS  256 (502)
T ss_pred             cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------cc-------CCCCCCCCChHhhh
Confidence            99999999999999999999999999999999999999976654321100       00       01111122356788


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          643 KEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       643 ~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .++.++++.||-.+|++|-|+.++++.
T Consensus       257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  257 SEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            999999999999999999999988764

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.9e-35  Score=315.56  Aligned_cols=257  Identities=22%  Similarity=0.356  Sum_probs=191.3

Q ss_pred             hhhccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      ...+.+.+.||+|+||.||+|... .+..||+|....      .....|+.++++++||||+++++++......++|||+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            344667789999999999999865 467899997432      2235799999999999999999999999999999999


Q ss_pred             cCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +. ++|.+++.. ...+++..++.|+.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  .
T Consensus       139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~  212 (357)
T PHA03209        139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--A  212 (357)
T ss_pred             cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc--c
Confidence            95 688888865 367999999999999999999999998   9999999999999999999999999997543221  2


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHH-------HHHHHHHhcc--cc----
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSL-------AMNFLSSLKQ--NR----  624 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~-------~~~~~~~~~~--~~----  624 (735)
                      .....||..|+|||++.+..++.++||||||++||||+++..++....+......       .......+..  ..    
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            2234589999999999999999999999999999999997666543322111111       1111111100  00    


Q ss_pred             -----hhhHhhhccc--CC-------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 -----LLEILDNRIV--ND-------GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 -----~~~~~d~~~~--~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                           ....++....  ..       .......++.+|+.+||+.||.+|||+.||+.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                 0000000000  00       00112345677999999999999999999875

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.3e-35  Score=308.22  Aligned_cols=244  Identities=24%  Similarity=0.358  Sum_probs=200.3

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchh
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLF  485 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  485 (735)
                      ..||+|+||.||++.. .++..||||++........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            4699999999999985 457889999987666666778999999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeecccc
Q 004702          486 EHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL  565 (735)
Q Consensus       486 ~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~  565 (735)
                      +++.. ..+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++........ ......++.
T Consensus       108 ~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~  182 (292)
T cd06658         108 DIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGTP  182 (292)
T ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecCc
Confidence            98854 46899999999999999999999998   99999999999999999999999999876543222 222345889


Q ss_pred             CccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHH
Q 004702          566 GYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV  645 (735)
Q Consensus       566 ~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  645 (735)
                      .|+|||.+....++.++||||||+++|||++|+.||...........   +.         ..+.+...  ........+
T Consensus       183 ~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~---------~~~~~~~~--~~~~~~~~~  248 (292)
T cd06658         183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IR---------DNLPPRVK--DSHKVSSVL  248 (292)
T ss_pred             cccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---------hcCCCccc--cccccCHHH
Confidence            99999999988899999999999999999999999875443221111   00         00111110  111234578


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHH
Q 004702          646 AKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       646 ~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+++.+||..+|.+|||+.|+++.
T Consensus       249 ~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         249 RGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHccCChhHCcCHHHHhhC
Confidence            899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-34  Score=303.34  Aligned_cols=247  Identities=24%  Similarity=0.355  Sum_probs=198.9

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||.||++... .+..||+|.++.. .......+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            345678999999999999865 6889999987643 44556789999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          481 NGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       481 ~gsL~~~l~~~---~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +++|..++...   ..+++..+..++.|++.||.|||+. +   |+|+||||+||+++.++.+||+|||++........ 
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (286)
T cd06622          83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-  158 (286)
T ss_pred             CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence            99999998763   3799999999999999999999974 6   99999999999999999999999999876532221 


Q ss_pred             ceeeeccccCccCcccccCC------CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          557 NCTVVQGTLGYLDPEYLQTC------KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~------~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                        ....++..|+|||.+.+.      .++.++||||||+++|||++|+.||...........    .        ..+.+
T Consensus       159 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~----~--------~~~~~  224 (286)
T cd06622         159 --KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ----L--------SAIVD  224 (286)
T ss_pred             --ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH----H--------HHHhh
Confidence              223478899999998554      357899999999999999999999865432221111    0        11111


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      . .....+.....++.+++.+||+.+|++||++.+++.
T Consensus       225 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         225 G-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             c-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1 011123345678899999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-35  Score=323.70  Aligned_cols=258  Identities=21%  Similarity=0.280  Sum_probs=194.0

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||.||++... .+..||||...      ...+.+|+.+|++++|+||+++++++...+..++|||++.
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~  243 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR  243 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence            3456679999999999999865 47789999643      2346789999999999999999999999999999999995


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-ce
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NC  558 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~  558 (735)
                       ++|.+++... ..+++.+++.|+.|+++||+|||+++   |+||||||+||||+.++.+||+|||+++........ ..
T Consensus       244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence             6888888654 57999999999999999999999998   999999999999999999999999999865432211 12


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHH-H---HHHHHHHHHhcc--c--------c
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE-R---SLAMNFLSSLKQ--N--------R  624 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~-~---~~~~~~~~~~~~--~--------~  624 (735)
                      ....||+.|+|||++.+..++.++||||||++||||++|..++........ .   ......+.....  .        +
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            234599999999999999999999999999999999998876654321110 0   111111111100  0        0


Q ss_pred             hhhHhhhc----cc----CCCC---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          625 LLEILDNR----IV----NDGN---KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       625 ~~~~~d~~----~~----~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +.......    ..    ....   ......+.+|+.+||+.||.+|||+.||++.
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000000    00    0000   0123468899999999999999999999863

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=336.39  Aligned_cols=263  Identities=28%  Similarity=0.393  Sum_probs=216.5

Q ss_pred             HHHHHhhhccccccccccCcEEEEEEEcC--------CCcEEEEEEeec-cChhHHHHHHHHHHHHHhcC-CCceEEEce
Q 004702          395 EEEIKTVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKF-VDQAKIDEFINELVVVLQIN-RRNVVRLLG  464 (735)
Q Consensus       395 ~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~g  464 (735)
                      ..|+......+.+.||+|.||.|++|...        ....||||.++. ....+.+.+..|+++|+.+. |+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            45565555567779999999999999843        145699999874 44567889999999999995 999999999


Q ss_pred             EEeecCceeEEEEecCCCchhHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 004702          465 CCLETQVPLLVYEFVGNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKS  528 (735)
Q Consensus       465 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~  528 (735)
                      +|...+..++|+||+..|+|.++|+..+                .++...++.++.|||.|++||++..   +|||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999998764                4899999999999999999999998   99999999


Q ss_pred             CcEEEcCCCCeEEeeccCCcccCCCcccceeeec--cccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCC
Q 004702          529 ANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDK  605 (735)
Q Consensus       529 ~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~  605 (735)
                      +||||.++..+||+|||+++..............  -...|||||.+....|+.|||||||||+||||+| |..|+....
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999976554444322222  3567999999999999999999999999999999 778886532


Q ss_pred             hHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          606 PEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       606 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ..++      +...++         .....+.+..+..+++++|+.||+.+|++||++.|+++.|+..+.
T Consensus       527 ~~~~------l~~~l~---------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  527 PTEE------LLEFLK---------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             cHHH------HHHHHh---------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            2221      111222         223334455667899999999999999999999999999998654

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2e-34  Score=299.08  Aligned_cols=250  Identities=27%  Similarity=0.361  Sum_probs=202.4

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccCh--hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ--AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +...+.||+|+||.||+|... ++..|++|.++....  ...+.+.+|+.+++.++|+||+++++.....+..++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            445678999999999999854 678899999875443  46788999999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      ++++|.+++.....+++..+..|+.|+++||+|||+.+   |+|+||+|+||++++++.+||+|||++............
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence            99999999988777999999999999999999999998   999999999999999999999999999876543322211


Q ss_pred             ---eeccccCccCcccccCCC---CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          560 ---VVQGTLGYLDPEYLQTCK---LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       560 ---~~~gt~~y~aPE~~~~~~---~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                         ...++..|++||++....   .+.++||||||+++|||++|+.||...........  .    ....       ...
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~--~----~~~~-------~~~  225 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF--H----VGAG-------HKP  225 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH--H----HhcC-------CCC
Confidence               245788999999998766   88999999999999999999999965432111100  0    0000       000


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+........+.+++.+||+.+|++|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00111123567889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5e-35  Score=307.65  Aligned_cols=261  Identities=24%  Similarity=0.309  Sum_probs=199.9

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.++||+|+||.||++... ++..||+|++....  ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV   82 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence            345678999999999999965 57899999865422  223567889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      ++++|.++......+++..++.++.|+++||+|||+.+   |+|+||+|+||++++++.+||+|||++....... ....
T Consensus        83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~  158 (286)
T cd07846          83 DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYT  158 (286)
T ss_pred             CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccC
Confidence            99999888877667999999999999999999999998   9999999999999999999999999988654332 2223


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh------hc
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD------NR  632 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d------~~  632 (735)
                      ...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+...........+.. ......+      ..
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP-RHQEIFQKNPLFAGM  237 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch-hhHHHhccchHhhcc
Confidence            3447889999998875 45788999999999999999999888655433221111111110000 0000000      00


Q ss_pred             ccCC---------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 IVND---------GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 ~~~~---------~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....         .....+..+.+|+.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0000         01123567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-34  Score=301.69  Aligned_cols=251  Identities=23%  Similarity=0.356  Sum_probs=198.5

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeeccC----------hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD----------QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      ...+.||+|+||.||+|.. .++..||+|.++...          ....+.+.+|+.++++++|+||+++++++...+..
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   83 (272)
T cd06629           4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL   83 (272)
T ss_pred             eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence            4467899999999999984 468889999875311          11235678899999999999999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          84 SIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             EEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999999999988888999999999999999999999998   99999999999999999999999999986543


Q ss_pred             Cccc-ceeeeccccCccCcccccCCC--CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          553 DAIQ-NCTVVQGTLGYLDPEYLQTCK--LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       553 ~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      .... ......++..|+|||.+....  ++.++||||||+++|||++|..||......+..      ...... ...   
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~-~~~---  230 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM------FKLGNK-RSA---  230 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH------HHhhcc-ccC---
Confidence            2211 122345889999999987654  889999999999999999999998543322110      000000 000   


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       ...........+.++.+++.+||+.+|++|||+.+|++
T Consensus       231 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         231 -PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             -CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence             00111112234578999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.5e-34  Score=301.95  Aligned_cols=251  Identities=27%  Similarity=0.395  Sum_probs=197.6

Q ss_pred             cccccccccCcEEEEEEEcC----CCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------c
Q 004702          404 NYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------V  471 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~  471 (735)
                      .+.++||+|+||.||+|.+.    .+..||||.++.  ......+++.+|+.++++++||||+++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            34678999999999999853    357899998764  24456778999999999999999999999886532      3


Q ss_pred             eeEEEEecCCCchhHHhhhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          472 PLLVYEFVGNGTLFEHIHKK------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                      +++++||+.+|+|.+++...      ..+++..+++++.|++.||+|||+.+   |+||||||+||++++++.+||+|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccc
Confidence            47899999999999887532      25789999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhccc
Q 004702          546 ASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQN  623 (735)
Q Consensus       546 ls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  623 (735)
                      +++........ ......++..|++||.+....++.++||||||+++|||++ |+.||......+.   ...    +...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~----~~~~  231 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNY----LIKG  231 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHH----HHcC
Confidence            99866433211 1122235678999999998889999999999999999999 8888765433221   111    1110


Q ss_pred             chhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          624 RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       624 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ..         .......+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       232 ~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NR---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00         011123446899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-34  Score=303.95  Aligned_cols=259  Identities=21%  Similarity=0.245  Sum_probs=201.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||.||+|.. .++..|++|++....  ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            45667899999999999985 468899999987543  344578899999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          480 GNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       480 ~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                       +++|.+++... ..+++.+++.++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++...........
T Consensus        82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence             99999998753 57999999999999999999999998   99999999999999999999999999987654432223


Q ss_pred             eeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch---h--------
Q 004702          559 TVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL---L--------  626 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~--------  626 (735)
                      ....++..|+|||.+.+. .++.++||||||++++||++|+.+|......+..   ......+.....   .        
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccCcchh
Confidence            334589999999988654 4689999999999999999997777554432221   111111111000   0        


Q ss_pred             -hHhhhcc----cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          627 -EILDNRI----VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       627 -~~~d~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       .+..+..    ..+...+...++.+++.+||+.+|.+|||+++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             0000000    00001123478899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=326.51  Aligned_cols=258  Identities=19%  Similarity=0.251  Sum_probs=190.8

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCC------CceEEEceEEeec-Ccee
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR------RNVVRLLGCCLET-QVPL  473 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~g~~~~~-~~~~  473 (735)
                      .+.+.++||+|+||+||++.. ..+..||||+++.... ...++..|+.++..++|      .+++++++++... ...+
T Consensus       130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            455667999999999999985 4578899999864322 23455667777777655      4588898888754 4678


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCC---------------
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENC---------------  537 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~---------------  537 (735)
                      +|||++ +++|.+++.+...+++..+..|+.||+.||+|||++ +   ||||||||+||||+.++               
T Consensus       209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            999988 678999998888899999999999999999999984 7   99999999999998765               


Q ss_pred             -CeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHH
Q 004702          538 -TPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF  616 (735)
Q Consensus       538 -~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~  616 (735)
                       .+||+|||++....    .......||+.|+|||++.+..++.++|||||||+||||++|+.||......+........
T Consensus       285 ~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~  360 (467)
T PTZ00284        285 CRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT  360 (467)
T ss_pred             ceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence             49999999876432    1223456899999999999999999999999999999999999999765544333222211


Q ss_pred             HHHhcc--------cchhhHhhh----------c----ccCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          617 LSSLKQ--------NRLLEILDN----------R----IVND---GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       617 ~~~~~~--------~~~~~~~d~----------~----~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+..        ....++.+.          .    +...   ........+.+|+.+||+.||++|||+.|+++
T Consensus       361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence            100000        000000000          0    0000   00112356789999999999999999999885

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.6e-35  Score=338.16  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=197.4

Q ss_pred             HHhhhccccccccccCcEEEEEEEcC-CCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--Cce
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVP  472 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~  472 (735)
                      +....+.+.+.||+|+||+||++... .+..||+|.+..  ........|..|+.+|++|+|||||++++++...  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            33345667789999999999999854 467889998764  3445567899999999999999999999988653  468


Q ss_pred             eEEEEecCCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCcEEEcC---------
Q 004702          473 LLVYEFVGNGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETN----VPIIHRDVKSANILLDE---------  535 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~----~~ivH~Dlk~~NILl~~---------  535 (735)
                      +|||||+++++|.++|...    ..+++..++.|+.||+.||+|||+.+.    .+||||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999999752    579999999999999999999998542    34999999999999964         


Q ss_pred             --------CCCeEEeeccCCcccCCCcccceeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccCCCCC
Q 004702          536 --------NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMALLSDK  605 (735)
Q Consensus       536 --------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~~~~~  605 (735)
                              ...+||+|||++..+.....  .....||+.|+|||++..  ..++.++||||||+|||||++|+.||....
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                    23489999999987643322  223458999999999854  458899999999999999999999996543


Q ss_pred             hHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          606 PEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       606 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....      ++..+....       .+.   ....+.++.+||.+||+.+|.+||++.|++.
T Consensus       248 ~~~q------li~~lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 NFSQ------LISELKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cHHH------HHHHHhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            3221      111111110       000   1123467899999999999999999999984

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-34  Score=306.77  Aligned_cols=243  Identities=25%  Similarity=0.379  Sum_probs=199.3

Q ss_pred             cccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchhH
Q 004702          408 VIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE  486 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  486 (735)
                      .||+|+||.||++.. .++..||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++|..
T Consensus        28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~  107 (297)
T cd06659          28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD  107 (297)
T ss_pred             hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence            699999999999985 4688999999876555556778899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccC
Q 004702          487 HIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG  566 (735)
Q Consensus       487 ~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~  566 (735)
                      ++.. ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....+.. ......++..
T Consensus       108 ~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~  182 (297)
T cd06659         108 IVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPY  182 (297)
T ss_pred             HHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecCcc
Confidence            8755 46899999999999999999999998   99999999999999999999999999876543322 1223458899


Q ss_pred             ccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHH
Q 004702          567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVA  646 (735)
Q Consensus       567 y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~  646 (735)
                      |+|||++.+..++.++||||||+++|||++|+.||......+...       .+.....     ..  ..........+.
T Consensus       183 y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~-----~~--~~~~~~~~~~l~  248 (297)
T cd06659         183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-------RLRDSPP-----PK--LKNAHKISPVLR  248 (297)
T ss_pred             ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhccCC-----CC--ccccCCCCHHHH
Confidence            999999998889999999999999999999999997554332111       1111000     00  000112345788


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHH
Q 004702          647 KLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       647 ~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +++.+||+.+|++||++.+|++.
T Consensus       249 ~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         249 DFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHhcCCcccCcCHHHHhhC
Confidence            99999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=288.51  Aligned_cols=248  Identities=24%  Similarity=0.325  Sum_probs=202.1

Q ss_pred             ccccccccccCcEEEEEEE-cCCCcEEEEEEee--ccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSK--FVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.++||+|.|+.||+.. ...|+.+|+|.+.  .......+++.+|+.|.+.|+||||++|.....+....+||+|+|
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m   92 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   92 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence            3456789999999999986 4567888888754  233446778889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEeeccCCcccCCCccc
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGls~~~~~~~~~  556 (735)
                      .|++|..-|-.+...++..+-....||+++|.|.|.++   |||||+||.|+||..   .--+||+|||++..+...  .
T Consensus        93 ~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g--~  167 (355)
T KOG0033|consen   93 TGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG--E  167 (355)
T ss_pred             cchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCc--c
Confidence            99999877776667888889999999999999999999   999999999999953   345899999999987632  2


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      ......||++|||||++...+|+..+|||+-||+|+-||.|..||+.......       .+.+..+..      .+..+
T Consensus       168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl-------ye~I~~g~y------d~~~~  234 (355)
T KOG0033|consen  168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YEQIKAGAY------DYPSP  234 (355)
T ss_pred             ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH-------HHHHhcccc------CCCCc
Confidence            33445699999999999999999999999999999999999999987433221       111221111      11122


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ......++..+|+.+||..||.+|.|+.|.+.
T Consensus       235 ~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  235 EWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            33456678999999999999999999999774

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-34  Score=305.37  Aligned_cols=252  Identities=24%  Similarity=0.286  Sum_probs=201.2

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.||+|+||.||++... .+..|++|.+....   ....+.+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV   83 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence            45678999999999999854 56789999876432   334567889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc----
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI----  555 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~----  555 (735)
                      ++++|.+++.....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.......    
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          84 EGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            99999999988888999999999999999999999998   99999999999999999999999999874211100    


Q ss_pred             ----------cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          556 ----------QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       556 ----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                                .......++..|+|||.+....++.++||||||+++|||++|+.||......+...       .......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~-------~~~~~~~  233 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG-------QVISDDI  233 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhccc
Confidence                      01112347889999999988899999999999999999999999997544322111       1100000


Q ss_pred             hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       626 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                         ..+    ......+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       234 ---~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         234 ---EWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ---CCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence               000    0011345678999999999999999998777777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.7e-34  Score=305.92  Aligned_cols=256  Identities=20%  Similarity=0.264  Sum_probs=185.7

Q ss_pred             ccccccCcEEEEEEEcC---CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEee--cCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLP---DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE--TQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~~~~  481 (735)
                      .+||+|+||+||+|...   ++..||+|.++...  ....+.+|+.++++++||||+++++++..  ....++||||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            47999999999999854   34689999876432  23457889999999999999999998854  4567899999865


Q ss_pred             CchhHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCCeEEeeccCCc
Q 004702          482 GTLFEHIHKK---------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASK  548 (735)
Q Consensus       482 gsL~~~l~~~---------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGls~  548 (735)
                       +|.+++...         ..+++..+..++.|++.||+|||+.+   |+||||||+|||+    ++++++||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             777776421         25889999999999999999999998   9999999999999    566789999999998


Q ss_pred             ccCCCccc--ceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHH------HHHHHHHHHH
Q 004702          549 LVPIDAIQ--NCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE------RSLAMNFLSS  619 (735)
Q Consensus       549 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~------~~~~~~~~~~  619 (735)
                      ........  ......+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||........      ..........
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            76433221  2233458999999999876 4589999999999999999999999864332111      0011111111


Q ss_pred             hccc---chh---------hHhh----hcc--------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          620 LKQN---RLL---------EILD----NRI--------VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       620 ~~~~---~~~---------~~~d----~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +...   .+.         ....    ...        ...........+.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            1000   000         0000    000        00001112345888999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.8e-34  Score=296.75  Aligned_cols=245  Identities=25%  Similarity=0.364  Sum_probs=199.5

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEee--cCceeEEEEe
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE--TQVPLLVYEF  478 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~  478 (735)
                      .+.+.||.|+||.||++.. .++..+|+|.++.  ......+.+.+|+.++++++|+||+++++++..  ....+++|||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            4567899999999999984 4678899998763  345556788999999999999999999998764  3467899999


Q ss_pred             cCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          479 VGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLH-----SETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       479 ~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH-----~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      +++++|.+++..    ...+++..++.++.|+++||+|||     +.+   |+|+||||+||++++++.+||+|||++..
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999975    357999999999999999999999     655   99999999999999999999999999987


Q ss_pred             cCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       550 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      ....... .....++..|++||.+....++.++||||||+++|+|++|+.||......+.       ...+...      
T Consensus       160 ~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~------  225 (265)
T cd08217         160 LGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL-------ASKIKEG------  225 (265)
T ss_pred             ccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH-------HHHHhcC------
Confidence            6543321 2234589999999999988899999999999999999999999876542211       1111111      


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                         .....+...+.++.+++.+||+.+|++|||+.+|++
T Consensus       226 ---~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         226 ---KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ---CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               111223345578999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=296.84  Aligned_cols=258  Identities=22%  Similarity=0.336  Sum_probs=215.1

Q ss_pred             hhccccccccccCcEEEEEEEcCC------CcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEee-cCce
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE-TQVP  472 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~  472 (735)
                      .+.+...++-+|.||.||.|.+.+      .+.|.+|.++. ..+-+...++.|..++..+.|||++.+.+++.+ .+.+
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            334455689999999999997643      45577887763 566678889999999999999999999999876 4578


Q ss_pred             eEEEEecCCCchhHHhhh-----c---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeec
Q 004702          473 LLVYEFVGNGTLFEHIHK-----K---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF  544 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~-----~---~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF  544 (735)
                      +++|.++.-|+|..||..     .   +.++..+...++.|++.|++|||.++   +||.||.++|.+||+..++||+|-
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDs  440 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDS  440 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccc
Confidence            999999999999999982     1   46888899999999999999999999   999999999999999999999999


Q ss_pred             cCCccc-CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcc
Q 004702          545 GASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQ  622 (735)
Q Consensus       545 Gls~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  622 (735)
                      .+++.+ +.|..-.......+..||+||.+.+..|+.++|||||||+||||+| |+.|+....+.|.....+        
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk--------  512 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK--------  512 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh--------
Confidence            999865 4444333334446889999999999999999999999999999999 999998887776443322        


Q ss_pred             cchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       623 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                              .......+..++.+|..+|.-||...|++||+++|++.-|.++-..+
T Consensus       513 --------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  513 --------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             --------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence                    12223345568899999999999999999999999999998876544

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.1e-34  Score=300.96  Aligned_cols=243  Identities=23%  Similarity=0.368  Sum_probs=200.9

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchh
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLF  485 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  485 (735)
                      +.||+|++|.||++.. .++..+++|+++.......+.+.+|+.+++.++||||+++++++...+..++|+||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            5899999999999984 568889999987666666777899999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeecccc
Q 004702          486 EHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL  565 (735)
Q Consensus       486 ~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~  565 (735)
                      +++.. ..+++..+..++.|++.||+|||+.+   |+||||+|+||+++.++.+||+|||++.....+... .....|+.
T Consensus       105 ~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~  179 (285)
T cd06648         105 DIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLVGTP  179 (285)
T ss_pred             HHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-cccccCCc
Confidence            99987 57999999999999999999999998   999999999999999999999999988765433221 22345889


Q ss_pred             CccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHH
Q 004702          566 GYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV  645 (735)
Q Consensus       566 ~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  645 (735)
                      .|+|||.+.+..++.++||||||+++|||++|+.||....+.+...       .+....     .+..  .........+
T Consensus       180 ~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~-------~~~~~~-----~~~~--~~~~~~~~~l  245 (285)
T cd06648         180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK-------RIRDNL-----PPKL--KNLHKVSPRL  245 (285)
T ss_pred             cccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH-------HHHhcC-----CCCC--cccccCCHHH
Confidence            9999999988889999999999999999999999987644322111       111100     0000  0111244679


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHH
Q 004702          646 AKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       646 ~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+++.+||+.+|++|||+.++++
T Consensus       246 ~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         246 RSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHHHcccChhhCcCHHHHcc
Confidence            99999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.1e-34  Score=296.65  Aligned_cols=249  Identities=25%  Similarity=0.348  Sum_probs=206.1

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeeccCh-hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ-AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.+.||+|++|.||+++.. ++..|+||++..... ...+.+.+|+..+.+++|+||+++++++...+..++||||+++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence            45679999999999999865 488999999876443 4567899999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ++|.+++.....+++..++.++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||++.......... ..
T Consensus        84 ~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~~  159 (264)
T cd06623          84 GSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NT  159 (264)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-cc
Confidence            9999999887889999999999999999999999 88   9999999999999999999999999998765333221 23


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||...............    ...         ........
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~---------~~~~~~~~  226 (264)
T cd06623         160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDG---------PPPSLPAE  226 (264)
T ss_pred             eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----hcC---------CCCCCCcc
Confidence            45789999999999989999999999999999999999998665421111111111    111         01111222


Q ss_pred             -HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          641 -QLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       641 -~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                       .+..+.+++.+||+.+|++||++.|+++.
T Consensus       227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         227 EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             55789999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.3e-34  Score=302.46  Aligned_cols=241  Identities=24%  Similarity=0.330  Sum_probs=199.2

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||.||++... ++..||+|.++..   .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY   82 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence            345679999999999999854 5789999987642   234467788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++++|.+++.....+++..+..++.|++.||+|||+.+   |+|+||+|+||||++++.+||+|||++......    .
T Consensus        83 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~  155 (290)
T cd05580          83 VPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T  155 (290)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence            999999999988888999999999999999999999988   999999999999999999999999999876543    2


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....+++.|+|||.+.+...+.++||||||+++|+|++|+.||......+....       +...        .  ...+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~--------~--~~~~  218 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK-------ILEG--------K--VRFP  218 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HhcC--------C--ccCC
Confidence            233588999999999888899999999999999999999999865542211110       0011        0  0112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERP-----TMKEVS  667 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~  667 (735)
                      ......+.+++.+||+.+|.+||     +++|++
T Consensus       219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            22356889999999999999999     555544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.2e-34  Score=295.29  Aligned_cols=245  Identities=25%  Similarity=0.337  Sum_probs=199.0

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|++|.||++.. .++..+|||.+...  .....+.+.+|+.++++++||||+++++.+...+..++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            34567899999999999985 46788999987643  3445678999999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEeeccCCcccCCCccc
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-CTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGls~~~~~~~~~  556 (735)
                      ++++|.+++...  ..+++..+++++.|++++|+|||+++   ++|+||||+||+++++ ..+||+|||++........ 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-  157 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-  157 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence            999999999864  45899999999999999999999998   9999999999999855 4589999999987643322 


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                       .....++..|+|||.+....++.++||||||+++|+|++|+.||........   ....    ....         ...
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~----~~~~---------~~~  220 (256)
T cd08220         158 -AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKI----MSGT---------FAP  220 (256)
T ss_pred             -ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHH----HhcC---------CCC
Confidence             1224578899999999988899999999999999999999999865433221   1111    0000         011


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .......++.+++.+||+.+|.+|||+.|++.
T Consensus       221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            12234567899999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-34  Score=304.99  Aligned_cols=261  Identities=23%  Similarity=0.233  Sum_probs=198.2

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChh-----HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQA-----KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      +.+.+.||+|++|.||+|... ++..|+||+++.....     ....+.+|+.++++++|+||+++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            345678999999999999854 6889999998754322     3455678999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+ +++|.+++.... .+++..++.++.||++||+|||+.+   |+|+||||+|||++.++.+||+|||+++.......
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            999 899999998765 7999999999999999999999998   99999999999999999999999999987643321


Q ss_pred             cceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc------hhhH
Q 004702          556 QNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR------LLEI  628 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  628 (735)
                      . .....++..|+|||.+.+ ..++.++||||||++++||++|..+|......+................      +...
T Consensus       158 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         158 K-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             c-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence            1 122346788999998854 4678999999999999999999777765443322211111100000000      0000


Q ss_pred             hhhcccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          629 LDNRIVND-----GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       629 ~d~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ........     .......++.+++.+||+.+|++|||+.||+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00000000     01223567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-34  Score=299.33  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=200.6

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.+.||+|++|.||++... ++..|++|.+... .....+++.+|++++++++||||+++++.+...+..++|+||+++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG   83 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence            34568999999999999865 5788999987654 345567889999999999999999999999999999999999999


Q ss_pred             CchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          482 GTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       482 gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      ++|.+++... ..+++..+.+++.|+++||+|||+ .+   ++|+||||+||++++++.+||+|||.+..........  
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~--  158 (265)
T cd06605          84 GSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT--  158 (265)
T ss_pred             CcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc--
Confidence            9999999876 789999999999999999999999 77   9999999999999999999999999987653222111  


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                       ..++..|+|||.+.+..++.++||||||+++|+|++|+.||......... . ......+        +.... .....
T Consensus       159 -~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~-~~~~~~~--------~~~~~-~~~~~  226 (265)
T cd06605         159 -FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-I-FELLQYI--------VNEPP-PRLPS  226 (265)
T ss_pred             -ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-H-HHHHHHH--------hcCCC-CCCCh
Confidence             45888999999999989999999999999999999999998654211100 0 0111111        11100 01111


Q ss_pred             -HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          640 -QQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       640 -~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       ....++.+++.+||..+|++|||+.|++.
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence             15577999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.7e-34  Score=301.76  Aligned_cols=243  Identities=27%  Similarity=0.369  Sum_probs=195.4

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +...+.||+|+||+||+|... ++..||+|++...   .....+++.+|+.+++.++||||+++++++...+..++||||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            445578999999999999854 6889999987632   334456789999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +. |+|.+++.. ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++......    
T Consensus        97 ~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----  168 (307)
T cd06607          97 CL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----  168 (307)
T ss_pred             hC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence            96 577777654 457999999999999999999999998   999999999999999999999999998765422    


Q ss_pred             eeeeccccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          558 CTVVQGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                       ....++..|+|||.+.   ...++.++||||||+++|||++|+.||..........   .    +...        ...
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~---~----~~~~--------~~~  232 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---H----IAQN--------DSP  232 (307)
T ss_pred             -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH---H----HhcC--------CCC
Confidence             1234788999999874   4568899999999999999999999986543322110   0    0000        000


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ..........+.+++.+||+.+|++||++.+|+..
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            11122355689999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-35  Score=308.14  Aligned_cols=250  Identities=23%  Similarity=0.288  Sum_probs=202.6

Q ss_pred             hhhccccccccccCcEEEEEEEcCCCcEEEEEEee--ccChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEE
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSK--FVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ...+.+.++||+||.+.||++...+.+.+|+|++.  ..+.+...-|.+|+.+|.+|+ |.+|++|++|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            33445567899999999999998888889999865  467778899999999999995 899999999999999999999


Q ss_pred             EecCCCchhHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~-l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |+- +-+|..+|+++.. ++.-.+..+..|++.++.++|.++   |||-||||.|+|+-.. .+||+|||+|..+..+.+
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccCcccc
Confidence            987 4599999988643 332377789999999999999999   9999999999999764 899999999998887765


Q ss_pred             ccee-eeccccCccCcccccCCC-----------CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc
Q 004702          556 QNCT-VVQGTLGYLDPEYLQTCK-----------LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN  623 (735)
Q Consensus       556 ~~~~-~~~gt~~y~aPE~~~~~~-----------~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  623 (735)
                      .... ...||+.||+||.+....           .+.+|||||||++||+|+.|+.||....     +.+         .
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~---------a  580 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI---------A  580 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH---------H
Confidence            5433 345999999999885432           5579999999999999999999985321     111         2


Q ss_pred             chhhHhhhcccCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          624 RLLEILDNRIVNDGNKQ-QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       624 ~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ++..+.|+....+++.- ...++.++|+.||+.||.+||+..||++
T Consensus       581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            44556666543333321 1133999999999999999999999885

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-34  Score=305.68  Aligned_cols=249  Identities=23%  Similarity=0.293  Sum_probs=198.7

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeeccCh---hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ---AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.||+|++|.||++... ++..+|+|.+.....   ...+.+.+|+++++.++|+||+++++.+......++||||+
T Consensus         4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   83 (316)
T cd05574           4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC   83 (316)
T ss_pred             EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence            45578999999999999865 488999998865322   35567889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-  556 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-  556 (735)
                      .+++|.+++...  ..+++..+..++.|+++||+|||+.+   ++|+||||+||+|+.++.++|+|||++......... 
T Consensus        84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999764  56899999999999999999999998   999999999999999999999999998754321110 


Q ss_pred             ---------------------------ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHH
Q 004702          557 ---------------------------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE  609 (735)
Q Consensus       557 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~  609 (735)
                                                 ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                       01123478899999999988899999999999999999999999865443221


Q ss_pred             HHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          610 RSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      .               ..+.+...........+.++.+++.+||+.+|++|||.+..+++|
T Consensus       241 ~---------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l  286 (316)
T cd05574         241 F---------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI  286 (316)
T ss_pred             H---------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence            1               111111111111222567899999999999999999944444333

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.3e-34  Score=296.87  Aligned_cols=246  Identities=26%  Similarity=0.396  Sum_probs=200.4

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||.||+|.. .++..||||..... .......+.+|+.++.+++||||+++++++..+...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            34556899999999999985 46788999987643 23455778899999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +++|.+++.. ..+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++........ ....
T Consensus        86 ~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~  160 (277)
T cd06641          86 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNT  160 (277)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-hhcc
Confidence            9999999865 46899999999999999999999998   99999999999999999999999999876543221 1222


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|..||..........       .+...         ........
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~---------~~~~~~~~  224 (277)
T cd06641         161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF-------LIPKN---------NPPTLEGN  224 (277)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH-------HHhcC---------CCCCCCcc
Confidence            357889999999998889999999999999999999999986543221110       01110         01111223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+.++.+++.+||+.+|.+||++.+++..
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         225 YSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            45678999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.9e-34  Score=301.62  Aligned_cols=249  Identities=25%  Similarity=0.389  Sum_probs=202.4

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      ++.+.+.||+|+||.||++.. .++..|++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   99 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA   99 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence            344567899999999999984 4678899999876555566788999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +++|.+++.+. .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++........ ....
T Consensus       100 ~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~  174 (293)
T cd06647         100 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST  174 (293)
T ss_pred             CCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cccc
Confidence            99999998754 5889999999999999999999998   99999999999999999999999999876543322 1122


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..+++.|++||.+....++.++||||||+++|||++|+.||......+.....      ..        ...........
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~--------~~~~~~~~~~~  240 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------AT--------NGTPELQNPEK  240 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hc--------CCCCCCCCccc
Confidence            35888999999998888999999999999999999999999654332211000      00        00000111223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ....+.+++.+||+.+|++||++.+++..
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            45678999999999999999999998854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.5e-34  Score=303.86  Aligned_cols=259  Identities=20%  Similarity=0.278  Sum_probs=195.6

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||.||++... ++..+|+|+++..  .......+.+|+.++++++||||+++++++.+....++|+||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            345678999999999999854 6888999987642  2223456788999999999999999999999999999999999


Q ss_pred             CCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          480 GNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       480 ~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      . ++|.+++.. ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++....... ..
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~  156 (284)
T cd07839          82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CY  156 (284)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-Cc
Confidence            6 578887765 467999999999999999999999998   99999999999999999999999999986543221 12


Q ss_pred             eeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc------hhhHhhh
Q 004702          559 TVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR------LLEILDN  631 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~d~  631 (735)
                      ....++..|+|||.+.+. .++.++||||||+++|||++|..|+......+..  ............      +....+.
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHhhhcccc
Confidence            233478899999988764 4789999999999999999999987544332211  111111111000      0000010


Q ss_pred             cccC---------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 RIVN---------DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 ~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....         +.....+.++.+++.+||+.+|.+|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000         011123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-34  Score=312.05  Aligned_cols=257  Identities=21%  Similarity=0.290  Sum_probs=191.7

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec------Ccee
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLET------QVPL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~  473 (735)
                      +...+.||+|+||+||++.. .++..||||++...  .....+.+.+|+.+|++++||||+++++++...      ...+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07878          17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY   96 (343)
T ss_pred             hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence            44457899999999999984 46788999998642  223456678999999999999999999887543      3468


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +++|++ +++|.+++.. ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        97 ~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  171 (343)
T cd07878          97 LVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE  171 (343)
T ss_pred             EEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence            999988 7789887754 46999999999999999999999998   999999999999999999999999999865432


Q ss_pred             cccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH--------HHhcccc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL--------SSLKQNR  624 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  624 (735)
                          .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.........        ..+....
T Consensus       172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07878         172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH  247 (343)
T ss_pred             ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence                123458999999999876 568999999999999999999999996554332211111100        0000000


Q ss_pred             hhhHhhhc-ccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 LLEILDNR-IVNDG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ~~~~~d~~-~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....+... .....     .....+.+.+|+.+||+.||.+|||+.|++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000 00000     0012245789999999999999999999885

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6e-34  Score=295.94  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=201.6

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||.|+||+||+|.. .++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|||+++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   82 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS   82 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence            45677899999999999984 467889999876432 3356789999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-
Q 004702          481 NGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-  556 (735)
Q Consensus       481 ~gsL~~~l~~~---~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-  556 (735)
                      +++|.+++...   ..+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++......... 
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            99999999764   45899999999999999999999998   999999999999999999999999998766433222 


Q ss_pred             --ceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          557 --NCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       557 --~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                        ......++..|+|||++... .++.++||||||+++|||++|+.||........      +.......      .+.+
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~------~~~~  227 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQND------PPSL  227 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCC------CCCc
Confidence              12233588999999998876 789999999999999999999999965433221      11111110      0011


Q ss_pred             cCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          634 VNDG-NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       634 ~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .... ....+.++.+++.+||+.+|++|||+.+|++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1110 1244578899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.8e-34  Score=300.28  Aligned_cols=248  Identities=24%  Similarity=0.326  Sum_probs=192.6

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEe-----ecCceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCL-----ETQVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~lV  475 (735)
                      +.+.+.||+|+||.||++.. .++..+|+|.++.... ...++.+|+.+++.+ +||||+++++++.     .++..++|
T Consensus        20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   98 (286)
T cd06638          20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV   98 (286)
T ss_pred             eeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence            34557899999999999985 4578899998764322 235678899999999 6999999999885     34468999


Q ss_pred             EEecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          476 YEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      |||+++++|.+++..    ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++...
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            999999999998753    256889999999999999999999988   9999999999999999999999999988664


Q ss_pred             CCcccceeeeccccCccCcccccC-----CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          552 IDAIQNCTVVQGTLGYLDPEYLQT-----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       552 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                      ..... .....|++.|+|||++..     ..++.++||||||+++|||++|+.||.........   .    ........
T Consensus       176 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~---~----~~~~~~~~  247 (286)
T cd06638         176 STRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---F----KIPRNPPP  247 (286)
T ss_pred             cCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH---h----hccccCCC
Confidence            32221 223458999999998753     45788999999999999999999998755332211   0    00000000


Q ss_pred             hHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       627 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ...+       +.....++.+|+.+||+.+|++|||+.||++.
T Consensus       248 ~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         248 TLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0001       11234578999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=300.27  Aligned_cols=260  Identities=22%  Similarity=0.274  Sum_probs=199.3

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeEEEEec
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFV  479 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~E~~  479 (735)
                      +.+.||.|++|.||+|... ++..+|+|++...  .......+.+|+.++++++|+|++++++++...  +..++||||+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            4568999999999999865 5788999998764  234456788999999999999999999999988  7899999999


Q ss_pred             CCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          480 GNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       480 ~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      ++ +|.+++... ..+++..++.++.|+++||+|||+.+   ++|+||||+||++++++.+||+|||++...........
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          83 DH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             cc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            75 898888765 57999999999999999999999998   99999999999999999999999999987654432223


Q ss_pred             eeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH--------h
Q 004702          559 TVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI--------L  629 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~  629 (735)
                      +...++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......................+..+        .
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            33446889999997764 46889999999999999999999999765543322222111100000000000        0


Q ss_pred             ------hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          630 ------DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       630 ------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                            ...+........+.++.+++.+||+.+|.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  000000000112567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-33  Score=297.73  Aligned_cols=245  Identities=26%  Similarity=0.403  Sum_probs=201.6

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      +.+.||+|++|.||++... ++..|++|.+..... ..+.+.+|++++++++|+||+++++.+......++|+||+++++
T Consensus        23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~  101 (286)
T cd06614          23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS  101 (286)
T ss_pred             HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence            3468999999999999976 678899999876544 56778999999999999999999999999999999999999999


Q ss_pred             hhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          484 LFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       484 L~~~l~~~~-~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      |.+++.... .+++..++.++.|++.||+|||+.+   |+|+||+|+||+++.++.+||+|||++........ ......
T Consensus       102 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  177 (286)
T cd06614         102 LTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSVV  177 (286)
T ss_pred             HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcccc
Confidence            999998876 8999999999999999999999988   99999999999999999999999999876543221 112234


Q ss_pred             cccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHH
Q 004702          563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL  642 (735)
Q Consensus       563 gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  642 (735)
                      ++..|++||.+.+..++.++||||||+++|+|++|+.||....+.......       .......       .......+
T Consensus       178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~-------~~~~~~~~  243 (286)
T cd06614         178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI-------TTKGIPP-------LKNPEKWS  243 (286)
T ss_pred             CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhcCCCC-------CcchhhCC
Confidence            788999999998888999999999999999999999998755443211110       0000000       01112245


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          643 KEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       643 ~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+.+++.+||+.+|.+|||+.+|+.
T Consensus       244 ~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         244 PEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhh
Confidence            67999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-34  Score=301.20  Aligned_cols=259  Identities=20%  Similarity=0.292  Sum_probs=193.9

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|++|.||+|... ++..||||.+.... ......+.+|+.++++++|+||+++++++.+.+..++||||+.
T Consensus         7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07844           7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD   86 (291)
T ss_pred             eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence            345678999999999999864 67899999876432 2223457789999999999999999999999999999999997


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      + +|.+++... ..+++.....++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++....... ...
T Consensus        87 ~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~  161 (291)
T cd07844          87 T-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYS  161 (291)
T ss_pred             C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-ccc
Confidence            5 899988764 46899999999999999999999998   99999999999999999999999999875432211 112


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc---cchhhHhh-----
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ---NRLLEILD-----  630 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d-----  630 (735)
                      ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  ........+..   ..+..+..     
T Consensus       162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhccccc
Confidence            2346889999998865 4588999999999999999999999865442111  11111111110   00000000     


Q ss_pred             ---------hcccCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 ---------NRIVND-GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 ---------~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                               ..+... .......++.+++.+||+.+|++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                     000000 00111267789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.6e-34  Score=294.35  Aligned_cols=237  Identities=24%  Similarity=0.287  Sum_probs=194.3

Q ss_pred             ccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          409 IGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       409 lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      ||.|++|.||+++.. .+..+++|.+...   .....+.+.+|+.+++.++||||+++++.+.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999965 4788999987642   233456789999999999999999999999999999999999999999


Q ss_pred             hHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccc
Q 004702          485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT  564 (735)
Q Consensus       485 ~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt  564 (735)
                      .+++.+...+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++.......  ......++
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~  155 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT  155 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence            999988878999999999999999999999988   9999999999999999999999999998765432  12233578


Q ss_pred             cCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHH
Q 004702          565 LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE  644 (735)
Q Consensus       565 ~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  644 (735)
                      ..|++||.+....++.++|+||||+++|||++|+.||........ ....            .+.+.......+.....+
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~------------~~~~~~~~~~~~~~~~~~  222 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EIYN------------DILKGNGKLEFPNYIDKA  222 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HHHH------------HHhccCCCCCCCcccCHH
Confidence            899999999888899999999999999999999999976542111 1110            111101111122223578


Q ss_pred             HHHHHHHcccCCCCCCCCH
Q 004702          645 VAKLAARCISVRGEERPTM  663 (735)
Q Consensus       645 l~~li~~cl~~~p~~RPt~  663 (735)
                      +.+++.+||+.+|++||++
T Consensus       223 ~~~~i~~~l~~~p~~R~~~  241 (262)
T cd05572         223 AKDLIKQLLRRNPEERLGN  241 (262)
T ss_pred             HHHHHHHHccCChhhCcCC
Confidence            9999999999999999993

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.8e-34  Score=300.39  Aligned_cols=261  Identities=20%  Similarity=0.224  Sum_probs=197.2

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~E  477 (735)
                      +.+.+.||.|+||.||+|... ++..+++|.++...  ......+.+|+.++.+++||||+++++++...  ...++|||
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e   86 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME   86 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence            344578999999999999965 57889999887433  22234577899999999999999999998877  78999999


Q ss_pred             ecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          478 FVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      |+. ++|.+++... ..+++..++.++.|++.||+|||+.+   ++|+||||+|||+++++.+||+|||++........ 
T Consensus        87 ~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  161 (293)
T cd07843          87 YVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-  161 (293)
T ss_pred             hcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-
Confidence            997 4999988764 45999999999999999999999998   99999999999999999999999999987654321 


Q ss_pred             ceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc-------------
Q 004702          557 NCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ-------------  622 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------------  622 (735)
                      ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+..............             
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            12233478899999988754 4689999999999999999999999765443322221111000000             


Q ss_pred             -cchhhHhhhcccCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          623 -NRLLEILDNRIVNDGNKQ-QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       623 -~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       ..........+....+.. ....+.+++.+||+.+|++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence             000000000111111111 3567889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4e-34  Score=296.56  Aligned_cols=245  Identities=27%  Similarity=0.337  Sum_probs=199.7

Q ss_pred             ccccCcEEEEEEEcCC-CcEEEEEEeeccCh---hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          409 IGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQ---AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       409 lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      ||+|+||.||++...+ +..+++|.+.....   ...+.+.+|+.++++++||||+++++.+......++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999764 88999998864332   4567788999999999999999999999999999999999999999


Q ss_pred             hHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc-------cc
Q 004702          485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI-------QN  557 (735)
Q Consensus       485 ~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~-------~~  557 (735)
                      .+++.....+++..++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++........       ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            999988778999999999999999999999998   99999999999999999999999999876533211       12


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....++..|++||.+.....+.++||||||++++||++|+.||......+...       .+....        .....
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-------~~~~~~--------~~~~~  222 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ-------NILNGK--------IEWPE  222 (265)
T ss_pred             ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhcCC--------cCCCc
Confidence            223457889999999988889999999999999999999999987554332111       111100        00111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      ....+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            1112578899999999999999999977776665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.5e-34  Score=297.99  Aligned_cols=242  Identities=22%  Similarity=0.259  Sum_probs=188.3

Q ss_pred             cccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHHHH---HhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          408 VIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELVVV---LQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +||+|+||.||++.. .++..+|+|.+....   ......+.+|..++   ...+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999985 457899999875421   22223344554443   34479999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +++|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++........   ..
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~  154 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HA  154 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---cC
Confidence            9999999988888999999999999999999999998   99999999999999999999999999875532211   22


Q ss_pred             eccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          561 VQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      ..|+..|+|||.+.+ ..++.++||||||++++||++|..||.......... ....   .          .......+.
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~---~----------~~~~~~~~~  220 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRM---T----------LTVNVELPD  220 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHH---h----------hcCCcCCcc
Confidence            358999999998864 568899999999999999999999996543322111 1000   0          001111223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 004702          640 QQLKEVAKLAARCISVRGEERP-----TMKEVSLE  669 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~  669 (735)
                      ..+.++.+++.+||+.+|.+||     +++|+++.
T Consensus       221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            4557899999999999999999     57777553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.7e-34  Score=301.86  Aligned_cols=255  Identities=18%  Similarity=0.231  Sum_probs=186.0

Q ss_pred             hhccccccccccCcEEEEEEEcCCC----cEEEEEEeeccChhH-----------HHHHHHHHHHHHhcCCCceEEEceE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPDR----TPVAVKKSKFVDQAK-----------IDEFINELVVVLQINRRNVVRLLGC  465 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~~----~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g~  465 (735)
                      ..+.+.++||+|+||+||+|...++    ..+|+|.........           ......++..+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            3466778999999999999986543    455666533222111           0112334455667789999999998


Q ss_pred             EeecC----ceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 004702          466 CLETQ----VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV  541 (735)
Q Consensus       466 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl  541 (735)
                      +....    ..++++|++. .++.+.+......++..+..|+.|+++||+|||+.+   |+||||||+|||++.++.+||
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence            76544    3367777764 367777766555788899999999999999999998   999999999999999999999


Q ss_pred             eeccCCcccCCCcc------cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHH--HHH
Q 004702          542 SDFGASKLVPIDAI------QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER--SLA  613 (735)
Q Consensus       542 ~DFGls~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~--~~~  613 (735)
                      +|||+++.+.....      .......||+.|+|||.+.+..++.++||||||++||||++|+.||.........  ...
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            99999986642211      1112235999999999999999999999999999999999999999765322211  111


Q ss_pred             HHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       614 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      ..++..+...++        .   ....++++.+++..||+.+|++||++.++.+.|
T Consensus       248 ~~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        248 CDFIKRLHEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHhhhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            122222222111        1   112347799999999999999999999999876

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.2e-33  Score=300.11  Aligned_cols=245  Identities=27%  Similarity=0.369  Sum_probs=196.5

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      ...+.||+|+||.||+++. .++..||+|++...   ......++.+|+.++++++|||++++++++.+....++||||+
T Consensus        28 ~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  107 (317)
T cd06635          28 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC  107 (317)
T ss_pred             hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCC
Confidence            3456899999999999985 46789999987632   2344567889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          480 GNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       480 ~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      . |+|.+++.. ...+++.++..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++......     
T Consensus       108 ~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-----  178 (317)
T cd06635         108 L-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-----  178 (317)
T ss_pred             C-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-----
Confidence            6 477777754 467999999999999999999999998   999999999999999999999999998754322     


Q ss_pred             eeeccccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          559 TVVQGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      ....++..|+|||++.   ...++.++||||||+++|||++|+.||..........   .            +.......
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---~------------~~~~~~~~  243 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---H------------IAQNESPT  243 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH---H------------HHhccCCC
Confidence            2234788999999874   4568899999999999999999999986543222111   0            00111111


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      ......+..+.+|+.+||+.+|.+||++.+|+..+..
T Consensus       244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            1122345678999999999999999999999986654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.1e-34  Score=309.40  Aligned_cols=259  Identities=24%  Similarity=0.287  Sum_probs=203.0

Q ss_pred             hccccccccccCcEEEEEEE-cCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-C-----CceEEEceEEeecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-R-----RNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~l  474 (735)
                      +|.+.++||+|+||.|-++. ...++.||||++++... -..+-..|+.+|..|+ |     -|+|++++++...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            66778999999999999998 45689999999986433 3566678999999997 4     489999999999999999


Q ss_pred             EEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC--CCeEEeeccCCccc
Q 004702          475 VYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN--CTPKVSDFGASKLV  550 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~DFGls~~~  550 (735)
                      |+|.++. +|+++|+.+  ..++...+..|+.||+.||.+||+.+   |||+||||+||||.+-  ..+||+|||.|...
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999954 999999986  56999999999999999999999999   9999999999999643  36999999999875


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc--------
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ--------  622 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------  622 (735)
                      .....    ...-+..|+|||++.+.+|+.+.|+||||+|+.||++|.+-|....+.+....+.+++-....        
T Consensus       342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            43221    333578999999999999999999999999999999998888777666655544433211100        


Q ss_pred             -cchhhH-----------------------------hhhcccC--------CCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 004702          623 -NRLLEI-----------------------------LDNRIVN--------DGNKQQLKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       623 -~~~~~~-----------------------------~d~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                       .+..+-                             .+.....        ......-..+.+++.+||..||.+|+|..
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence             000000                             0000000        00112335689999999999999999999


Q ss_pred             HHHHH
Q 004702          665 EVSLE  669 (735)
Q Consensus       665 ev~~~  669 (735)
                      |+++.
T Consensus       498 qal~H  502 (586)
T KOG0667|consen  498 QALNH  502 (586)
T ss_pred             HHhcC
Confidence            98864

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-33  Score=288.92  Aligned_cols=246  Identities=28%  Similarity=0.399  Sum_probs=203.7

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ...+.||+|++|.||++... ++..+++|++..........+.+|+.++++++|+||+++++.+......++++||++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~   82 (253)
T cd05122           3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG   82 (253)
T ss_pred             eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence            34578999999999999965 68889999987665556788999999999999999999999999999999999999999


Q ss_pred             chhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|.+++... ..+++..+..++.|++.+|+|||+.+   ++|+||+|+||++++++.+||+|||.+........  ....
T Consensus        83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~  157 (253)
T cd05122          83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM  157 (253)
T ss_pred             cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence            999999876 68999999999999999999999988   99999999999999999999999999987654332  2334


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .++..|++||.+.....+.++||||||+++++|++|+.||............       .......+       ......
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~-------~~~~~~  223 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-------ATNGPPGL-------RNPEKW  223 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-------HhcCCCCc-------Cccccc
Confidence            5889999999999888999999999999999999999998654332211110       00000000       011112


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+.+++.+||+.+|++|||+.|+++
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            567999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.3e-34  Score=299.63  Aligned_cols=257  Identities=22%  Similarity=0.300  Sum_probs=194.8

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      ...+.||+|++|.||+|+.. ++..||||+++...  ......+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (284)
T cd07860           3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   82 (284)
T ss_pred             eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence            34568999999999999854 68899999876432  2234578899999999999999999999999999999999995


Q ss_pred             CCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          481 NGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       481 ~gsL~~~l~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                       ++|.+++..  ...+++..++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++........ ..
T Consensus        83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~  157 (284)
T cd07860          83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY  157 (284)
T ss_pred             -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence             689888865  356899999999999999999999998   99999999999999999999999999876543221 12


Q ss_pred             eeeccccCccCcccccCCC-CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc--ch----hhHhh-
Q 004702          559 TVVQGTLGYLDPEYLQTCK-LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN--RL----LEILD-  630 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~-~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~d-  630 (735)
                      ....++..|+|||.+.+.. ++.++||||||+++|||+||+.||......+....   ........  .+    ..+.+ 
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR---IFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHHhCCCChhhhhhhhHHHHH
Confidence            2234688999999887644 68899999999999999999999976543322111   11111100  00    00000 


Q ss_pred             ----hcccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 ----NRIVN----DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 ----~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                          +....    ........++.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                00000    001123356889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-34  Score=299.71  Aligned_cols=256  Identities=21%  Similarity=0.272  Sum_probs=196.1

Q ss_pred             ccccccccCcEEEEEEEc-CCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          405 YADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.||.|++|.||+|.. .++..||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||||++ 
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence            456899999999999985 468999999886432  2334678899999999999999999999999999999999995 


Q ss_pred             CchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          482 GTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       482 gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      ++|.+++....  .+++..++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||+++........ ..
T Consensus        82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~  157 (283)
T cd07835          82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YT  157 (283)
T ss_pred             cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-cC
Confidence            68999987764  7999999999999999999999988   999999999999999999999999999765432211 12


Q ss_pred             eeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc--c----hh---hHh
Q 004702          560 VVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN--R----LL---EIL  629 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~----~~---~~~  629 (735)
                      ...++..|+|||++.+. .++.++||||||+++|||++|+.||...........   ........  .    +.   +..
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR---IFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhhhhhchhhh
Confidence            22468899999987654 578899999999999999999999976544322111   11111000  0    00   000


Q ss_pred             hh--ccc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          630 DN--RIV----NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       630 d~--~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..  ...    .......+..+.+++.+||+.+|.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00  000    0001123367889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=296.11  Aligned_cols=245  Identities=22%  Similarity=0.371  Sum_probs=198.0

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcC---CCceEEEceEEeecCceeEEEEe
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQIN---RRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.+.||+|+||.||+|.. .++..||+|.++.. .....+++.+|+.++++++   |||++++++++......++||||
T Consensus         4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~   83 (277)
T cd06917           4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY   83 (277)
T ss_pred             hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence            3456899999999999985 56889999987643 3445677889999999997   99999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++++|.+++... .+++..++.++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++........ ..
T Consensus        84 ~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~  158 (277)
T cd06917          84 AEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KR  158 (277)
T ss_pred             CCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-cc
Confidence            9999999998664 7999999999999999999999998   99999999999999999999999999987654332 22


Q ss_pred             eeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....|+..|+|||.+.. ..++.++||||||+++|+|++|+.||..........       .+....     .+.+..  
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~~-----~~~~~~--  224 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKSK-----PPRLED--  224 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccCC-----CCCCCc--
Confidence            23458899999998865 457889999999999999999999996543322110       010000     011111  


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       ...+.++.+++.+||+.+|++||++.|++.
T Consensus       225 -~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         225 -NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence             114567899999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-33  Score=297.08  Aligned_cols=245  Identities=24%  Similarity=0.323  Sum_probs=189.2

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHH-HHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVV-VLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.||+|+||.||++... ++..||+|+++.. ......++..|+.+ ++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD   83 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence            45678999999999999854 6899999988743 22334456666665 667789999999999999999999999996


Q ss_pred             CCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          481 NGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       481 ~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                       ++|.+++..    ...+++..++.++.|++.||+|||++ +   ++||||||+|||++.++.+||+|||+++.......
T Consensus        84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (283)
T cd06617          84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA  159 (283)
T ss_pred             -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence             688877754    24689999999999999999999987 6   99999999999999999999999999986543221


Q ss_pred             cceeeeccccCccCcccccC----CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          556 QNCTVVQGTLGYLDPEYLQT----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~----~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                        .+...++..|+|||.+..    ..++.++|+||||+++|||++|+.||.......  .....            .+..
T Consensus       160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~------------~~~~  223 (283)
T cd06617         160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLKQ------------VVEE  223 (283)
T ss_pred             --cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHHH------------HHhc
Confidence              122357889999998864    457889999999999999999999985422111  01110            1100


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..........+.++.+++.+||+.+|++||++.+|+.
T Consensus       224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000001124567999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.8e-33  Score=296.87  Aligned_cols=254  Identities=26%  Similarity=0.333  Sum_probs=195.7

Q ss_pred             HHHHhhhcc--ccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecC-
Q 004702          396 EEIKTVTNN--YADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQ-  470 (735)
Q Consensus       396 ~ei~~~~~~--~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-  470 (735)
                      .++.+.+.+  +.+.||+|+||.||++.. .++..+|+|.+..... ....+.+|+.++.++ +||||+++++++...+ 
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            344444433  456899999999999985 4678899998764322 245677899999998 7999999999987543 


Q ss_pred             ----ceeEEEEecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEe
Q 004702          471 ----VPLLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVS  542 (735)
Q Consensus       471 ----~~~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~  542 (735)
                          ..++||||+++++|.++++.    ...+++..++.++.|++.||+|||+.+   |+|+||||+||++++++.+||+
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence                57999999999999998863    357899999999999999999999988   9999999999999999999999


Q ss_pred             eccCCcccCCCcccceeeeccccCccCcccccCC-----CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH
Q 004702          543 DFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC-----KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL  617 (735)
Q Consensus       543 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~  617 (735)
                      |||+++........ .....|+..|+|||.+...     .++.++||||||+++|||++|+.||..........      
T Consensus       171 dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~------  243 (291)
T cd06639         171 DFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF------  243 (291)
T ss_pred             ecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH------
Confidence            99998865432211 1223478899999988643     36889999999999999999999987654322111      


Q ss_pred             HHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       618 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       .+.......+.       ........+.+|+.+||+.+|++||++.|+++
T Consensus       244 -~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         244 -KIPRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -HHhcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             01111000010       11234467999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=310.67  Aligned_cols=246  Identities=21%  Similarity=0.332  Sum_probs=201.8

Q ss_pred             cccccccCcEEEEEEEcCCCc-EEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          406 ADVIGCGGSGNVYKGFLPDRT-PVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      ...||.|+||.||++..++.. ..|-|.+......+.++|+-|++||....||+||+|++.+..++.+|++.|||.||-+
T Consensus        37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV  116 (1187)
T KOG0579|consen   37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV  116 (1187)
T ss_pred             HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence            446899999999999876544 3466777777888899999999999999999999999999999999999999999999


Q ss_pred             hHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeecc
Q 004702          485 FEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG  563 (735)
Q Consensus       485 ~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~g  563 (735)
                      ..++-.- ..|++.++.-+..|++.||.|||+++   |||||||+.|||++-+|.++|+|||.+..... .......+.|
T Consensus       117 DaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDsFIG  192 (1187)
T KOG0579|consen  117 DAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDSFIG  192 (1187)
T ss_pred             hHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHhhhccccC
Confidence            8887653 67999999999999999999999999   99999999999999999999999999865321 2233345679


Q ss_pred             ccCccCcccc-----cCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          564 TLGYLDPEYL-----QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       564 t~~y~aPE~~-----~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      |+.|||||+.     ...+|..++||||||++|.||..+.+|-....+..       .+-.+....-..+       -.+
T Consensus       193 TPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-------VllKiaKSePPTL-------lqP  258 (1187)
T KOG0579|consen  193 TPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLKIAKSEPPTL-------LQP  258 (1187)
T ss_pred             CcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-------HHHHHhhcCCCcc-------cCc
Confidence            9999999976     46789999999999999999999998865443321       1111111111111       124


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ..+...+.+++.+||..||..||++.++++.
T Consensus       259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            4677889999999999999999999998853

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.8e-34  Score=294.96  Aligned_cols=243  Identities=25%  Similarity=0.264  Sum_probs=200.9

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||.|+||.||++... ++..||+|.+...   .....+.+.+|++++++++||||+++++.+.+....++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            345678999999999999865 5888999988643   234567899999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +.+++|.+++.....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......  ..
T Consensus        82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~  156 (258)
T cd05578          82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT  156 (258)
T ss_pred             CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence            999999999988778999999999999999999999998   9999999999999999999999999988764332  22


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....|+..|+|||.+....++.++|+||||+++|+|++|+.||...........    ......          .....+
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~----------~~~~~~  222 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQET----------ADVLYP  222 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhcc----------ccccCc
Confidence            334588899999999988899999999999999999999999976543211111    111110          111122


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                      ...+..+.+++.+||+.+|.+||++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~  248 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDN  248 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCcc
Confidence            33457899999999999999999994

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.9e-33  Score=290.04  Aligned_cols=248  Identities=24%  Similarity=0.361  Sum_probs=204.5

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeEEEEe
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEF  478 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~E~  478 (735)
                      ...+.||+|++|.||+|... ++..|++|.+....  ....+.+.+|+.++++++|+||+++++.+...  ...++|+||
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   82 (260)
T cd06606           3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY   82 (260)
T ss_pred             eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence            34578999999999999965 68889999876543  35578899999999999999999999999988  889999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-c
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-N  557 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~  557 (735)
                      +++++|.+++.....+++..++.++.|++++|+|||+.+   ++|+||+|+||+++.++.+||+|||.+......... .
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          83 VSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            999999999988778999999999999999999999988   999999999999999999999999998876544321 1


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....++..|++||.+.....+.++||||||+++++|++|..||.......  ...    ..+        .........
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----~~~--------~~~~~~~~~  225 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AAL----YKI--------GSSGEPPEI  225 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHH----Hhc--------cccCCCcCC
Confidence            223458889999999998889999999999999999999999987654111  111    011        111111122


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +......+.+++.+||+.+|++||++.+++.
T Consensus       226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            2334678999999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-33  Score=294.04  Aligned_cols=251  Identities=25%  Similarity=0.306  Sum_probs=196.4

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC--ceeEEEEecC
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ--VPLLVYEFVG  480 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~E~~~  480 (735)
                      +.+.||.|++|.||++... ++..+|+|.+... ......++.+|++++++++||||+++++++.+..  ..++||||++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            4568999999999999964 5788999987743 3345677899999999999999999999986543  6799999999


Q ss_pred             CCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          481 NGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       481 ~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +++|.+++..    ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++........ 
T Consensus        85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  160 (287)
T cd06621          85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-  160 (287)
T ss_pred             CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence            9999988754    346899999999999999999999998   99999999999999999999999999876532221 


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChH--HHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPE--EERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                        ....++..|+|||.+.+..++.++||||||+++|||++|+.||......  ......    ..+.......+.+.   
T Consensus       161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~---  231 (287)
T cd06621         161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL----SYIVNMPNPELKDE---  231 (287)
T ss_pred             --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH----HHHhcCCchhhccC---
Confidence              1234788999999999989999999999999999999999998755321  111111    11111111111100   


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ........+.+.+++.+||+.+|.+|||+.||++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0111234578999999999999999999999886

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.7e-33  Score=295.61  Aligned_cols=260  Identities=20%  Similarity=0.278  Sum_probs=197.8

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.+.||.|++|.||+|+.. ++..||||.++... ....+.+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK   82 (284)
T ss_pred             eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence            45678999999999999964 58889999887543 23356678899999999999999999999999999999999975


Q ss_pred             CchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          482 GTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       482 gsL~~~l~~~---~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                       +|.+++...   ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++....... ..
T Consensus        83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~  157 (284)
T cd07836          83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TF  157 (284)
T ss_pred             -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cc
Confidence             888888653   36899999999999999999999998   99999999999999999999999999976543221 11


Q ss_pred             eeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh-----hc
Q 004702          559 TVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD-----NR  632 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----~~  632 (735)
                      ....++..|++||.+.+ ..++.++||||||+++|||++|+.||......+................+..+.+     ..
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            22347889999998865 4578899999999999999999999876554433222211111010111110000     00


Q ss_pred             cc-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 IV-------NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 ~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..       .......+..+.+++.+||+.+|.+||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00       0001123467889999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.7e-33  Score=295.48  Aligned_cols=246  Identities=25%  Similarity=0.366  Sum_probs=193.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEee------cCceeE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLE------TQVPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~l  474 (735)
                      +.+.+.||+|+||.||+|.. .++..+|+|...... ....++..|+.+++++ +|+||+++++++..      ....++
T Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   96 (282)
T cd06636          18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL   96 (282)
T ss_pred             hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence            34457899999999999985 457889999876433 3456788899999998 69999999999863      356799


Q ss_pred             EEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          475 VYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ||||+++|+|.+++...  ..+++..++.++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++.....
T Consensus        97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~  173 (282)
T cd06636          97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence            99999999999999763  45889999999999999999999998   99999999999999999999999999876532


Q ss_pred             CcccceeeeccccCccCccccc-----CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ... ......|+..|+|||.+.     ...++.++||||||+++|||++|+.||....+.+....               
T Consensus       174 ~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~---------------  237 (282)
T cd06636         174 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL---------------  237 (282)
T ss_pred             ccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh---------------
Confidence            211 122345889999999875     34678899999999999999999999965443221110               


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +.............+.++.+|+.+||+.+|.+|||+.||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00000001111234568999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.7e-33  Score=295.54  Aligned_cols=259  Identities=20%  Similarity=0.233  Sum_probs=192.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..++||||+.
T Consensus         7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07870           7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH   86 (291)
T ss_pred             eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence            34567899999999999985 468899999886432 2223467889999999999999999999999999999999996


Q ss_pred             CCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                       ++|.+++.. ...+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||+++........ ..
T Consensus        87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~  161 (291)
T cd07870          87 -TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-YS  161 (291)
T ss_pred             -CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-CC
Confidence             677766654 356889999999999999999999998   999999999999999999999999998764322111 12


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc--c-----------h
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN--R-----------L  625 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~-----------~  625 (735)
                      ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........  .....+..+...  .           .
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhhhccccc
Confidence            2347889999999875 4588899999999999999999999975443211  111111111100  0           0


Q ss_pred             hhHhhhcccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 LEILDNRIVND-----GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 ~~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...........     ........+.+++.+|++.+|.+|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000000     00112457889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-33  Score=290.79  Aligned_cols=245  Identities=24%  Similarity=0.268  Sum_probs=193.2

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHHH-HHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELVV-VLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.||+|+||.||++.. .++..||+|.++...   ......+..|..+ ..+.+|+||+++++++...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999985 457899999876432   2223344455444 4556899999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      ++|.+++.....+++..+.+++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++....     ....
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~  153 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF  153 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence            999999988788999999999999999999999998   99999999999999999999999999876432     1223


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .++..|++||.+.+..++.++||||||+++|||++|..||......+..       ..+......      .........
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~------~~~~~~~~~  220 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-------DNILSRRIN------WPEEVKEFC  220 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhcccC------CCCcccccC
Confidence            4788999999998888999999999999999999999999654432211       111111000      001111234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      +.++.+++.+||+.+|++||++.++.+.|..
T Consensus       221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             CHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            5789999999999999999988777665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-33  Score=291.99  Aligned_cols=245  Identities=23%  Similarity=0.351  Sum_probs=197.8

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.||+|+||.||++... ++..+|+|.+...  .....+.+.+|+.++++++|+||+++++.+...+..++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD   82 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence            45678999999999999864 5788999987642  22345678899999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEeeccCCcccCCCcccc
Q 004702          481 NGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-TPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       481 ~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++|.+++....  .+++..++.++.|+++||+|||+.+   ++|+||||+||++++++ .+||+|||.+........ .
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~  158 (257)
T cd08225          83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-L  158 (257)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc-c
Confidence            999999997643  5799999999999999999999998   99999999999999875 469999999886643221 1


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....|++.|+|||.+....++.++||||||+++|||++|+.||......+.   ..    ......+         .+.
T Consensus       159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~~~~~---------~~~  222 (257)
T cd08225         159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---VL----KICQGYF---------API  222 (257)
T ss_pred             ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH----HHhcccC---------CCC
Confidence            2233588999999999888899999999999999999999999865432221   11    0111111         111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ......++.+++.+||+.+|++|||+.||++
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2233467999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-33  Score=298.72  Aligned_cols=263  Identities=24%  Similarity=0.287  Sum_probs=195.8

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecC--------
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQ--------  470 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------  470 (735)
                      .+.+.+.||+|+||.||+|... ++..||+|+++...  ......+.+|+.++++++||||+++++++.+..        
T Consensus         8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            3445678999999999999964 57889999987432  233456778999999999999999999987654        


Q ss_pred             --ceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCC
Q 004702          471 --VPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS  547 (735)
Q Consensus       471 --~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls  547 (735)
                        ..++|+||+++ +|..++... ..+++..++.++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||++
T Consensus        88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccccc
Confidence              78999999976 677777654 46999999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          548 KLVPIDAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       548 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                      ...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+................+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            8765433222223346788999998764 457899999999999999999999987554333222211111000000000


Q ss_pred             hHhh--------hcc-----cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          627 EILD--------NRI-----VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       627 ~~~d--------~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+..        ...     ........+..+.+++.+||+.+|.+|||+.+|+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000        000     00001123567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=291.89  Aligned_cols=247  Identities=28%  Similarity=0.406  Sum_probs=195.4

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecC------ceeE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQ------VPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~------~~~l  474 (735)
                      +.+.+.||+|++|.||+|... ++..+++|.+..... ..+++.+|+.+++++ +|+||+++++++....      ..++
T Consensus         8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l   86 (275)
T cd06608           8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL   86 (275)
T ss_pred             eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence            445679999999999999964 577899998775443 356789999999999 6999999999997654      4799


Q ss_pred             EEEecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          475 VYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      ||||+++++|.+++..    ...+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceec
Confidence            9999999999998865    357899999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCcccceeeeccccCccCcccccC-----CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQT-----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                      .... .......++..|+|||.+..     ..++.++||||||++|++|++|+.||.........   ..    +.....
T Consensus       164 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~----~~~~~~  235 (275)
T cd06608         164 DSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL---FK----IPRNPP  235 (275)
T ss_pred             ccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH---HH----hhccCC
Confidence            4322 12223448889999998753     34678999999999999999999999654322111   11    111100


Q ss_pred             hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                           +.  .........++.+|+.+||+.||++|||+.+|++
T Consensus       236 -----~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         236 -----PT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -----CC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 00  1112235578999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-33  Score=289.52  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=198.0

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc-----ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-----DQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  474 (735)
                      +.+.+.||+|+||.||++.. .++..||+|.+...     .......+.+|++++++++|+||+++++++.+.  ...++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            45678999999999999985 45889999986431     234456788999999999999999999998764  45789


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |+||+++++|.+++.....+++..+++++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          84 FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            9999999999999988778999999999999999999999998   9999999999999999999999999998653211


Q ss_pred             c--cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          555 I--QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       555 ~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .  .......++..|+|||.+.+..++.++||||||+++|||++|+.||......+..      ...         ....
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~---------~~~~  225 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI------FKI---------ATQP  225 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH------HHH---------HcCC
Confidence            1  1112345889999999999888999999999999999999999998654322211      101         1011


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .....+....+++.+++.+||+ +|..||+..+++.
T Consensus       226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1122234456789999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3e-33  Score=295.38  Aligned_cols=243  Identities=24%  Similarity=0.361  Sum_probs=199.1

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchh
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLF  485 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  485 (735)
                      .+||+|+||.||++.. .++..||||++..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            4799999999999986 468899999987655666778999999999999999999999999999999999999999999


Q ss_pred             HHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeecccc
Q 004702          486 EHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL  565 (735)
Q Consensus       486 ~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~  565 (735)
                      +++.. ..+++..+..++.|++.+|+|||+.+   ++|+||+|+||++++++.++|+|||++....... .......++.
T Consensus       106 ~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~  180 (292)
T cd06657         106 DIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTP  180 (292)
T ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccCc
Confidence            98754 46899999999999999999999998   9999999999999999999999999987654322 1223345889


Q ss_pred             CccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHH
Q 004702          566 GYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV  645 (735)
Q Consensus       566 ~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  645 (735)
                      .|++||.+....++.++||||||+++|||++|+.||......+......   ...         .....  ........+
T Consensus       181 ~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~~~---------~~~~~--~~~~~~~~l  246 (292)
T cd06657         181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DNL---------PPKLK--NLHKVSPSL  246 (292)
T ss_pred             cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hhC---------CcccC--CcccCCHHH
Confidence            9999999988889999999999999999999999987543332211110   000         00000  011234578


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHH
Q 004702          646 AKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       646 ~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+++.+||+.+|.+||++.+|+.
T Consensus       247 ~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         247 KGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHhCCcccCcCHHHHhc
Confidence            89999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-33  Score=287.11  Aligned_cols=244  Identities=23%  Similarity=0.284  Sum_probs=201.9

Q ss_pred             cccccccCcEEEEEEEcCC-CcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          406 ADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.||.|.-|+||++.+.+ +..+|+|.+...   ......+...|-+||+.++||.++.|++.+..+...+||||||+|
T Consensus        82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG  161 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG  161 (459)
T ss_pred             HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence            4579999999999999765 488999998753   344556667799999999999999999999999999999999999


Q ss_pred             CchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC-------
Q 004702          482 GTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI-------  552 (735)
Q Consensus       482 gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~-------  552 (735)
                      |+|+.+++++  +.+++..+.-++.+++-||+|||..|   ||+|||||+||||.++|.+.|+||.|+.....       
T Consensus       162 GdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s  238 (459)
T KOG0610|consen  162 GDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKS  238 (459)
T ss_pred             ccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeecc
Confidence            9999999875  56999999999999999999999999   99999999999999999999999998753310       


Q ss_pred             --------------------------C-cc---------------------cceeeeccccCccCcccccCCCCCccccc
Q 004702          553 --------------------------D-AI---------------------QNCTVVQGTLGYLDPEYLQTCKLTDKSDV  584 (735)
Q Consensus       553 --------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV  584 (735)
                                                . ..                     ......+||-.|+|||++.+...+.+.|-
T Consensus       239 ~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW  318 (459)
T KOG0610|consen  239 SSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW  318 (459)
T ss_pred             CCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH
Confidence                                      0 00                     00112358999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCC--
Q 004702          585 YSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPT--  662 (735)
Q Consensus       585 yS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt--  662 (735)
                      |+|||+|||||.|+.||......+..               ..++-..+.-+...+.+..+.+||++.|.+||.+|..  
T Consensus       319 WtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~  383 (459)
T KOG0610|consen  319 WTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK  383 (459)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccc
Confidence            99999999999999999877654432               2233333333334466788999999999999999998  


Q ss_pred             --HHHHH
Q 004702          663 --MKEVS  667 (735)
Q Consensus       663 --~~ev~  667 (735)
                        +.||-
T Consensus       384 rGA~eIK  390 (459)
T KOG0610|consen  384 RGAAEIK  390 (459)
T ss_pred             cchHHhh
Confidence              55544

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=299.96  Aligned_cols=262  Identities=22%  Similarity=0.266  Sum_probs=194.5

Q ss_pred             ccccccccccCcEEEEEEEcC---CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP---DRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  474 (735)
                      +.+.+.||+|+||.||+|...   .+..||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            345678999999999999964   47899999987532   33456778999999999999999999999988  78999


Q ss_pred             EEEecCCCchhHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC----CCCeEEeecc
Q 004702          475 VYEFVGNGTLFEHIHKK-----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE----NCTPKVSDFG  545 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~DFG  545 (735)
                      ||||+++ +|.+++...     ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999975 676666432     36899999999999999999999998   999999999999999    9999999999


Q ss_pred             CCcccCCCcc--cceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHH------HHHHHHH
Q 004702          546 ASKLVPIDAI--QNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE------RSLAMNF  616 (735)
Q Consensus       546 ls~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~------~~~~~~~  616 (735)
                      ++........  .......++..|+|||.+.+ ..++.++||||||++|+||++|+.||........      .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9987643222  12223457889999998766 4588999999999999999999999875443220      0111111


Q ss_pred             HHHhccc------------chhhHhhhcccCCCC-----------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          617 LSSLKQN------------RLLEILDNRIVNDGN-----------KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       617 ~~~~~~~------------~~~~~~d~~~~~~~~-----------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+...            ......+........           .....++.+++.+||+.+|++|||+.|++.
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1111100            000000000000000           023357899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.9e-33  Score=288.88  Aligned_cols=243  Identities=25%  Similarity=0.324  Sum_probs=201.9

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.||+|++|.||++.. .++..+++|.+...  ......++.+|+.+++.++|+||+++++++......++||||++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP   82 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence            4567899999999999974 46788999987643  34556778899999999999999999999999999999999999


Q ss_pred             CCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          481 NGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       481 ~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +++|.+++.+    ...+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||+++......  
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~--  157 (256)
T cd08530          83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--  157 (256)
T ss_pred             CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence            9999999876    356899999999999999999999998   9999999999999999999999999998765441  


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                       .....++..|++||.+.+..++.++|+||||+++|||++|+.||......+...       ....         .....
T Consensus       158 -~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~-------~~~~---------~~~~~  220 (256)
T cd08530         158 -AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY-------KVQR---------GKYPP  220 (256)
T ss_pred             -cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhc---------CCCCC
Confidence             122347889999999999899999999999999999999999986554322111       1111         11112


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .......++.+++.+||+.+|++|||+.|+++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            22345678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.9e-33  Score=293.55  Aligned_cols=258  Identities=21%  Similarity=0.224  Sum_probs=192.8

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcC-CCceEEEceEEeec--CceeEEEEe
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQIN-RRNVVRLLGCCLET--QVPLLVYEF  478 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~E~  478 (735)
                      .+.+.||+|+||.||++.. .++..||+|+++.. .........+|+.++.++. |+||+++++++.+.  +..++||||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            3567899999999999985 46788999987643 2222334567888898885 99999999999987  889999999


Q ss_pred             cCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +. ++|.+++... ..+++..++.++.|++.||+|||+.+   ++||||||+||+++. +.+||+|||+++........ 
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~-  155 (282)
T cd07831          82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY-  155 (282)
T ss_pred             CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence            96 5888888753 57899999999999999999999998   999999999999999 99999999999876433221 


Q ss_pred             eeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH--------HHhcccchhhH
Q 004702          558 CTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL--------SSLKQNRLLEI  628 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~  628 (735)
                       ....++..|+|||.+.. ..++.++||||||+++|||++|+.||......+.........        ...........
T Consensus       156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence             22347889999997654 567889999999999999999999997654433221111100        00000000000


Q ss_pred             hhhcccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          629 LDNRIVN----DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       629 ~d~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+....    ......+.++.+|+.+||+.+|++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000    001234578999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.5e-33  Score=293.56  Aligned_cols=244  Identities=23%  Similarity=0.262  Sum_probs=193.4

Q ss_pred             ccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          409 IGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       409 lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      ||+|+||+||++.. .++..+|+|.+...   .......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999974 46889999987642   223345678899999999999999999999999999999999999999


Q ss_pred             hHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          485 FEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       485 ~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      .+++....  .+++..++.++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++........  .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccccc
Confidence            99998765  7999999999999999999999998   99999999999999999999999999876543221  22334


Q ss_pred             cccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHH
Q 004702          563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL  642 (735)
Q Consensus       563 gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  642 (735)
                      ++..|++||.+.+..++.++||||||+++++|++|+.||............   ......          .....+....
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~----------~~~~~~~~~~  222 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRRTLE----------MAVEYPDKFS  222 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hhcccc----------ccccCCccCC
Confidence            788999999998888999999999999999999999999654331111110   000000          0011122345


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHH-HHHHH
Q 004702          643 KEVAKLAARCISVRGEERPTMKE-VSLEL  670 (735)
Q Consensus       643 ~~l~~li~~cl~~~p~~RPt~~e-v~~~L  670 (735)
                      ..+.+++.+||+.+|.+||+.+| .++.|
T Consensus       223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~l  251 (277)
T cd05577         223 PEAKDLCEALLQKDPEKRLGCRGGSADEV  251 (277)
T ss_pred             HHHHHHHHHHccCChhHccCCCcccHHHH
Confidence            67899999999999999996555 43333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-34  Score=320.36  Aligned_cols=263  Identities=16%  Similarity=0.245  Sum_probs=187.4

Q ss_pred             hhccccccccccCcEEEEEEEcCC--CcEEEEE------------------EeeccChhHHHHHHHHHHHHHhcCCCceE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPD--RTPVAVK------------------KSKFVDQAKIDEFINELVVVLQINRRNVV  460 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~niv  460 (735)
                      ..+.+.+.||+|+||+||++.++.  +...++|                  +++ ........+.+|+.+|++++||||+
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcC
Confidence            346667899999999999986432  1111111                  111 1223355688999999999999999


Q ss_pred             EEceEEeecCceeEEEEecCCCchhHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC
Q 004702          461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKK-----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE  535 (735)
Q Consensus       461 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~  535 (735)
                      ++++++...+..++|+|++. ++|.+++...     .......+..|+.||+.||+|||+++   |+||||||+||||+.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence            99999999999999999985 5777776542     23446677889999999999999998   999999999999999


Q ss_pred             CCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHH
Q 004702          536 NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN  615 (735)
Q Consensus       536 ~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~  615 (735)
                      ++.+||+|||+++.+............||..|+|||.+.+..++.++||||||++||||++|..++..............
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            99999999999987654433333345699999999999999999999999999999999998865433222111111111


Q ss_pred             HHHHhcc---------cchhhHhhhcccCCCC---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          616 FLSSLKQ---------NRLLEILDNRIVNDGN---------KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       616 ~~~~~~~---------~~~~~~~d~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+..+..         .++.+.++........         ......+.+++.+||+.||.+|||+.|++.
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1111110         0111111111000000         012245778899999999999999999975

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.9e-33  Score=296.07  Aligned_cols=247  Identities=27%  Similarity=0.356  Sum_probs=191.4

Q ss_pred             cccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEecCCC
Q 004702          406 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      .++||+|+||.||++.. .++..+|+|++... .......+.+|+.++.++. |+||+++++++......+++|||+.. 
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence            45799999999999985 45789999987643 2345667889999999996 99999999999998899999999854 


Q ss_pred             chhHHh---h--hcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          483 TLFEHI---H--KKGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       483 sL~~~l---~--~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +|.++.   .  ....+++..+..++.|++.||+|||+. +   |+||||||+|||++.++.+||+|||+++........
T Consensus        88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  164 (288)
T cd06616          88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK  164 (288)
T ss_pred             CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence            554433   2  235799999999999999999999985 6   999999999999999999999999998765432221


Q ss_pred             ceeeeccccCccCcccccCC---CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          557 NCTVVQGTLGYLDPEYLQTC---KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~---~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                        ....|+..|+|||.+...   .++.++||||||+++|||++|+.||.....     .......... ..     .+.+
T Consensus       165 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~~-----~~~~  231 (288)
T cd06616         165 --TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-GD-----PPIL  231 (288)
T ss_pred             --ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-CC-----CCcC
Confidence              223488899999998776   689999999999999999999999864321     0011111110 00     0111


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ........+.++.+|+.+||+.+|++|||+.+|+..
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            112223456789999999999999999999998864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2e-33  Score=296.07  Aligned_cols=253  Identities=23%  Similarity=0.251  Sum_probs=200.9

Q ss_pred             cccccccccCcEEEEEEEc----CCCcEEEEEEeeccC----hhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeE
Q 004702          404 NYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKFVD----QAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.||+|++|.||++..    .++..||||.++...    ....+.+.+|+.++.++ +||||+++++.+......++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            4567899999999999874    356789999876432    22345688999999999 59999999999998889999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||||+++++|.+++.....+++..+..++.|++++|+|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            9999999999999987778999999999999999999999988   9999999999999999999999999988764433


Q ss_pred             ccceeeeccccCccCcccccCCC--CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCK--LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      ........|+..|+|||.+.+..  .+.++||||||+++|||++|..||.........   ..+....        ... 
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~--------~~~-  227 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ---SEISRRI--------LKS-  227 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH---HHHHHHH--------Hcc-
Confidence            22223345889999999987655  788999999999999999999998543221110   0111100        000 


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                       ....+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       228 -~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence             011122344678999999999999999999998887775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.8e-33  Score=303.47  Aligned_cols=262  Identities=24%  Similarity=0.314  Sum_probs=196.7

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeec--cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeec--CceeEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF--VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLET--QVPLLVY  476 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~lV~  476 (735)
                      +.+.+.||+|+||.||+|... ++..+|+|++..  ........+.+|+.+++++ +||||+++++++...  ...++||
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF   88 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence            344578999999999999864 578899998753  2334456678899999999 999999999998654  3679999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc-
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI-  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~-  555 (735)
                      ||+. ++|..++... .+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....... 
T Consensus        89 e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          89 EYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN  163 (337)
T ss_pred             cccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence            9997 5999988765 7899999999999999999999998   99999999999999999999999999986643321 


Q ss_pred             ---cceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHH--------Hhccc
Q 004702          556 ---QNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS--------SLKQN  623 (735)
Q Consensus       556 ---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~~  623 (735)
                         .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||......+..........        .+...
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP  243 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence               12223458899999998765 5678899999999999999999999865544332221111100        00000


Q ss_pred             chhhHhhhcc------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          624 RLLEILDNRI------VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       624 ~~~~~~d~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ....+++...      ........+.++.+++.+||+.+|++|||+.+++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0001111000      000011235678999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-33  Score=287.03  Aligned_cols=246  Identities=25%  Similarity=0.377  Sum_probs=203.2

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccCh--hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ--AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|++|.||++... ++..|++|.+.....  ...+.+.+|++++++++|+|++++++++...+..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            345678999999999999854 578899999875543  56678999999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      ++++|.+++.....+++..++.++.|++.+|.|||+.+   |+||||||+||+++.++.+||+|||++......... ..
T Consensus        82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~  157 (254)
T cd06627          82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA  157 (254)
T ss_pred             CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence            99999999988888999999999999999999999998   999999999999999999999999999876543321 22


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      ...++..|+|||...+...+.++||||||+++|+|++|+.||.........      .. ....         .....+.
T Consensus       158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~------~~-~~~~---------~~~~~~~  221 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL------FR-IVQD---------DHPPLPE  221 (254)
T ss_pred             ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH------HH-Hhcc---------CCCCCCC
Confidence            345788999999998888899999999999999999999998654321111      00 0000         0111122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .....+.+++.+||+.+|++|||+.+++.
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            34568899999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.6e-33  Score=304.12  Aligned_cols=255  Identities=23%  Similarity=0.340  Sum_probs=195.9

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeec------Ccee
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLET------QVPL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~  473 (735)
                      +...+.||+|+||.||++.. .++..||||.+..  .+......+.+|+.++++++|+||+++++++...      ...+
T Consensus        18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   97 (353)
T cd07850          18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY   97 (353)
T ss_pred             eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence            44467899999999999984 4688999998753  3444556788999999999999999999988643      3468


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+. ++|.+.+...  +++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  171 (353)
T cd07850          98 LVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  171 (353)
T ss_pred             EEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence            9999995 5888888654  899999999999999999999998   999999999999999999999999999876433


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc--c-------
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN--R-------  624 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~-------  624 (735)
                      ..  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........   ....+...  .       
T Consensus       172 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         172 FM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK---IIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhcCCCCHHHHHHhhh
Confidence            22  2233478899999999999999999999999999999999999976543222111   11111000  0       


Q ss_pred             ----------------hhhHhhhccc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 ----------------LLEILDNRIV----NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ----------------~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                                      +.++......    .........++.+++.+||+.||++|||+.|++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                            0001000000    0001234567899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.4e-34  Score=304.65  Aligned_cols=263  Identities=24%  Similarity=0.277  Sum_probs=204.2

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecC-----ceeE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-----VPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l  474 (735)
                      +.+.+.||.|++|.||+++.. .+..||||++....  ....+.+.+|+.+++.++|+||+++++++....     ..++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            456678999999999999965 48899999887533  445678899999999999999999999988765     7899


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||||+. ++|.+++.....+++..++.++.|+++||+|||+.+   |+|+||||.|||++.++.+||+|||++.......
T Consensus        82 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          82 VTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE  157 (330)
T ss_pred             Eecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence            999997 589999988778999999999999999999999998   9999999999999999999999999998765432


Q ss_pred             c--cceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc--------c
Q 004702          555 I--QNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ--------N  623 (735)
Q Consensus       555 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~  623 (735)
                      .  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+..............        .
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence            1  122334578899999999887 7999999999999999999999999776554432222221111000        0


Q ss_pred             chhhHhhhc-ccC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          624 RLLEILDNR-IVN-----DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       624 ~~~~~~d~~-~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .....+... ...     ......+..+.+++.+||+.+|.+|||+.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            011111100 000     0011234678999999999999999999998854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-33  Score=304.40  Aligned_cols=262  Identities=22%  Similarity=0.265  Sum_probs=197.8

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC-----ceeE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-----VPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l  474 (735)
                      +...+.||+|+||+||++.. .++..||||+++..  .......+.+|+.+++.++|+||+++++++....     ..++
T Consensus         7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l   86 (337)
T cd07858           7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI   86 (337)
T ss_pred             eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence            34466899999999999984 46889999987642  3334566788999999999999999999876543     4799


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||||+. ++|.+++.....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        87 v~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          87 VYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            999995 689999988788999999999999999999999998   9999999999999999999999999998764332


Q ss_pred             ccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhc--------ccch
Q 004702          555 IQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK--------QNRL  625 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~  625 (735)
                       .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||....................        ....
T Consensus       163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence             12223347889999998765 4688999999999999999999999865533222221111110000        0001


Q ss_pred             hhHhhhcc---c---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          626 LEILDNRI---V---NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       626 ~~~~d~~~---~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ...+....   .   .......+.++.+++.+||+.+|++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            10000000   0   00012345778999999999999999999998865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.3e-33  Score=298.77  Aligned_cols=261  Identities=24%  Similarity=0.274  Sum_probs=194.5

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~E  477 (735)
                      +.+.+.||+|+||.||+|... ++..||+|+++...  ......+.+|+.++++++|+||+++++++...  +..++|||
T Consensus         9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (309)
T cd07845           9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME   88 (309)
T ss_pred             eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence            345678999999999999864 58899999886432  22234567899999999999999999998765  46799999


Q ss_pred             ecCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          478 FVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      |+.+ +|.+++.. ...+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++....... .
T Consensus        89 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~  163 (309)
T cd07845          89 YCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-K  163 (309)
T ss_pred             cCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc-C
Confidence            9964 88888875 367999999999999999999999999   9999999999999999999999999998765332 1


Q ss_pred             ceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh-----
Q 004702          557 NCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD-----  630 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----  630 (735)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+................+....+     
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            1222335788999998865 5588999999999999999999999976554433222221110000000000000     


Q ss_pred             ----hcccCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 ----NRIVNDG----NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 ----~~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                          +......    .....+++.+++.+||+.||++|||+.|++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                0000000    0113567889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=304.28  Aligned_cols=259  Identities=22%  Similarity=0.296  Sum_probs=194.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC-----ceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-----VPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV  475 (735)
                      +.+.++||+|+||.||+|.. .++..||||+++.. .......+.+|+.++++++|+||+++++++....     ..++|
T Consensus         7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   86 (336)
T cd07849           7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV   86 (336)
T ss_pred             eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence            44567999999999999984 46889999998643 2334567889999999999999999999876543     47899


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      +||+.+ +|.+++.. ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        87 ~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          87 QELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             ehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence            999964 88877754 47999999999999999999999998   99999999999999999999999999886543221


Q ss_pred             c--ceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc---chhhHh
Q 004702          556 Q--NCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN---RLLEIL  629 (735)
Q Consensus       556 ~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  629 (735)
                      .  ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..........   .+...+...   .+..+.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LILGVLGTPSQEDLNCII  238 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCCHHHHHHhh
Confidence            1  1123457899999998754 568999999999999999999999996543322111   111111110   111111


Q ss_pred             hhc---------ccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          630 DNR---------IVNDG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       630 d~~---------~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +..         .....     ......++.+++.+||+.+|++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000         00000     01234678999999999999999999998865

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.9e-33  Score=287.05  Aligned_cols=245  Identities=28%  Similarity=0.373  Sum_probs=202.4

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.||+|+||.||++... ++..+++|++...  .......+.+|+++++.++|+|++++++.+...+..++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~   82 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD   82 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence            45678999999999999864 5788999998754  33566788999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          481 NGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       481 ~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +++|.+++...    ..+++..++.++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||++....... .
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~  158 (258)
T cd08215          83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D  158 (258)
T ss_pred             CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence            99999999864    67999999999999999999999998   9999999999999999999999999998764432 1


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      ......|++.|+|||.+....++.++||||||+++++|++|+.||......+..   .    ......         ...
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---~----~~~~~~---------~~~  222 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA---L----KILKGQ---------YPP  222 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH---H----HHhcCC---------CCC
Confidence            222345888999999999888999999999999999999999998655422211   1    111111         111


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+.....++.+++.+||+.+|++|||+.|+++
T Consensus       223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            12234567899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3e-33  Score=295.59  Aligned_cols=258  Identities=20%  Similarity=0.237  Sum_probs=192.9

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCc-----ee
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQV-----PL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~-----~~  473 (735)
                      +...+.||+|+||.||+|... ++..||||+.+...  ......+.+|+.+++.++ ||||+++++++...+.     .+
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            345678999999999999854 68899999876432  223467889999999995 6999999999887665     79


Q ss_pred             EEEEecCCCchhHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEeeccCC
Q 004702          474 LVYEFVGNGTLFEHIHKK-----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NCTPKVSDFGAS  547 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGls  547 (735)
                      +||||+++ +|.+++...     ..+++..++.++.||++||+|||+.+   |+||||||+||+++. ++.+||+|||++
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccc
Confidence            99999985 888888643     35799999999999999999999998   999999999999998 889999999998


Q ss_pred             cccCCCcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc--
Q 004702          548 KLVPIDAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR--  624 (735)
Q Consensus       548 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--  624 (735)
                      +....... ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||......+....   +...+....  
T Consensus       159 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~  234 (295)
T cd07837         159 RAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH---IFKLLGTPTEQ  234 (295)
T ss_pred             eecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHhCCCChh
Confidence            86533211 1122346889999998865 4578999999999999999999999976544332211   111111000  


Q ss_pred             -hh---hHhh----hcc----cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 -LL---EILD----NRI----VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 -~~---~~~d----~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       ..   ...+    +..    ..........++.+++.+||+.+|.+||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             00   0000    000    00001124567899999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=293.31  Aligned_cols=259  Identities=21%  Similarity=0.242  Sum_probs=199.6

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeeccCh--hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ--AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ..+.||+|++|.||++... ++..+++|+++....  .....+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            4568999999999999864 688899998764322  3456788999999999999999999999999999999999975


Q ss_pred             CchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                       +|.+++... ..+++..++.++.|+++||+|||+.+   |+|+||||+||++++++.+||+|||.+....... .....
T Consensus        83 -~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~  157 (283)
T cd05118          83 -DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH  157 (283)
T ss_pred             -CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence             888888764 57999999999999999999999998   9999999999999999999999999988765433 12223


Q ss_pred             eccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh---------
Q 004702          561 VQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD---------  630 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---------  630 (735)
                      ..++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+................+..+.+         
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            3478899999998776 789999999999999999999999876554332221111100000000000000         


Q ss_pred             --hcc--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 --NRI--VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 --~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                        ...  ........+.++.+++.+||+.+|.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              000  00111234678999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.6e-33  Score=300.87  Aligned_cols=259  Identities=23%  Similarity=0.280  Sum_probs=195.6

Q ss_pred             cccccccCcEEEEEEEcC-CCcEEEEEEeeccChhH--------------HHHHHHHHHHHHhcCCCceEEEceEEeecC
Q 004702          406 ADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAK--------------IDEFINELVVVLQINRRNVVRLLGCCLETQ  470 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  470 (735)
                      .+.||.|+||+||++... ++..||||+++......              ...+.+|+.++++++|+||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            467999999999999854 68899999876432211              124778999999999999999999999999


Q ss_pred             ceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      ..++||||+. ++|.+++.....+++.....++.|++.||+|||+.+   |+|+||+|+||+++.++.+||+|||+++..
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~  169 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRY  169 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeec
Confidence            9999999996 699999988778999999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCc-------------ccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHH
Q 004702          551 PIDA-------------IQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF  616 (735)
Q Consensus       551 ~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~  616 (735)
                      ....             ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+........
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~  249 (335)
T PTZ00024        170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL  249 (335)
T ss_pred             ccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            4111             1111223467889999998764 4788999999999999999999999766544322211111


Q ss_pred             HHHhcccchhhHhh--------hcc---cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          617 LSSLKQNRLLEILD--------NRI---VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       617 ~~~~~~~~~~~~~d--------~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ........+....+        ...   ........+.++.+++.+||+.+|++|||+.|++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             hCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            11000000000000        000   00001122467889999999999999999999885

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=292.17  Aligned_cols=244  Identities=23%  Similarity=0.305  Sum_probs=207.4

Q ss_pred             ccccccccccCcEEEEEEE-cCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      |++.+-||+|-|..|-+++ .-.|..||||++.+  .+......+.+|+..|+.++|||||+||.+......+|||+|+-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            4556789999999998887 45799999999875  34445667889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE-cCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL-DENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      .+|+|++||-+. ..+.+....+++.||+.|+.|.|+.+   +|||||||+||.+ ..-|.+||.|||++..+.....  
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k--  174 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK--  174 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch--
Confidence            999999999764 57999999999999999999999999   9999999999977 5678899999999987754432  


Q ss_pred             eeeeccccCccCcccccCCCCC-ccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~-~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      .+...|.+.|-|||++.+..|. ++.|||||||+||.|+.|+.||......+..               ..|+|-.+  .
T Consensus       175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCKY--t  237 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCKY--T  237 (864)
T ss_pred             hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcccc--c
Confidence            3445699999999999998876 5889999999999999999999876555433               33444333  3


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+...+.+..+||..||..||++|.+.+||+.
T Consensus       238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            35567889999999999999999999999874

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-33  Score=290.94  Aligned_cols=259  Identities=21%  Similarity=0.244  Sum_probs=195.2

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeeccCh-hHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEecC
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ-AKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.||+|++|+||+|+.. ++..|+||++..... .......+|+..+++++ |+||+++++++...+..++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            45678999999999999975 478899998764322 22334567999999999 999999999999999999999999 


Q ss_pred             CCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          481 NGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       481 ~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|.+++....  .+++..++.++.|++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++........  .
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  155 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y  155 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence            889999988764  7899999999999999999999998   99999999999999999999999999986543222  1


Q ss_pred             eeeccccCccCccccc-CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc------hhhHhhh
Q 004702          559 TVVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR------LLEILDN  631 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~-~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~d~  631 (735)
                      ....++..|+|||.+. ...++.++||||||+++|||++|+.||......+................      +....+.
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            2234788999999875 45688999999999999999999999866544332211111000000000      0000000


Q ss_pred             ccc-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 RIV-------NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 ~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+.       ..........+.+++.+||+.+|++|||+.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000       0000111467899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.4e-33  Score=292.50  Aligned_cols=243  Identities=23%  Similarity=0.275  Sum_probs=192.8

Q ss_pred             cccccccccCcEEEEEEEc----CCCcEEEEEEeeccC----hhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeE
Q 004702          404 NYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKFVD----QAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.||+|+||.||++..    .++..||+|.++...    ....+.+.+|+.++.++ +|+||+++++++..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            4567899999999999985    367889999886422    22346678899999999 58999999999998888999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||||+++++|.+++.....+++..+..++.|+++||+|||+.+   ++||||+|+|||+++++.+||+|||+++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            9999999999999988888999999999999999999999998   9999999999999999999999999998764433


Q ss_pred             ccceeeeccccCccCcccccCC--CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTC--KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      ........|+..|+|||.+...  .++.++||||||+++|+|++|+.||............   ......          
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---~~~~~~----------  226 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI---SRRILK----------  226 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH---HHHhhc----------
Confidence            3333344588999999998753  4778999999999999999999998643221111100   000000          


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPT  662 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  662 (735)
                      ...+.+......+.+++.+||+.+|++||+
T Consensus       227 ~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~  256 (290)
T cd05613         227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLG  256 (290)
T ss_pred             cCCCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence            001112234567899999999999999983

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8.3e-33  Score=289.93  Aligned_cols=241  Identities=23%  Similarity=0.266  Sum_probs=188.1

Q ss_pred             cccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHH---HHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          408 VIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELV---VVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +||+|+||.||++.. ..++.||+|.+....   ......+.+|..   +++..+||||+++++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 457899999876421   111223444443   4455689999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +++|.+++.....+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||++........   ..
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~~  154 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HA  154 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---cC
Confidence            9999999988788999999999999999999999998   99999999999999999999999999876532211   22


Q ss_pred             eccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          561 VQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      ..|+..|+|||.+.+. .++.++||||||+++|||++|+.||............    ....          ....+.+.
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~----------~~~~~~~~  220 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL----------TMAVELPD  220 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhh----------ccCCCCCC
Confidence            3589999999998754 6899999999999999999999999754322211110    0000          00011122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          640 QQLKEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      ..+.++.+++.+||..+|.+||     ++.++++
T Consensus       221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            2357899999999999999999     8888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-33  Score=290.38  Aligned_cols=256  Identities=23%  Similarity=0.297  Sum_probs=195.0

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhc---CCCceEEEceEEeecCc-----e
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQI---NRRNVVRLLGCCLETQV-----P  472 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~  472 (735)
                      .+.++||+|+||.||+|... ++..||+|+++..  .......+.+|+.+++++   +|+||+++++++...+.     .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            34678999999999999976 4889999998642  222234566788777666   59999999999988776     8


Q ss_pred             eEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          473 LLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      +++|||+. ++|.+++...  ..+++..++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++...
T Consensus        82 ~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          82 TLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             EEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence            99999996 4898888764  35899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh---
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE---  627 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  627 (735)
                      ......  ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+...   .+...........   
T Consensus       158 ~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  232 (287)
T cd07838         158 SFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD---KIFDVIGLPSEEEWPR  232 (287)
T ss_pred             cCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH---HHHHHcCCCChHhcCC
Confidence            433221  22347889999999999899999999999999999999998887654433221   1221111100000   


Q ss_pred             -------Hhhhccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          628 -------ILDNRIV---NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       628 -------~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                             .......   ..........+.+++.+||+.+|.+||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                   0000000   1111234577889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2e-33  Score=302.72  Aligned_cols=263  Identities=21%  Similarity=0.294  Sum_probs=198.3

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEee----cCceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLE----TQVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV  475 (735)
                      +.+.+.||+|+||.||++.. .++..||+|++...  .......+.+|+.+|++++||||+++++++..    ....++|
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv   86 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV   86 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence            34457899999999999985 46889999987643  22345677889999999999999999998753    3467899


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||+. ++|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++........
T Consensus        87 ~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          87 MDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             Eehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99995 689999987778999999999999999999999998   99999999999999999999999999976543221


Q ss_pred             c---ceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHH--------HHHhccc
Q 004702          556 Q---NCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF--------LSSLKQN  623 (735)
Q Consensus       556 ~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~  623 (735)
                      .   ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...............        .......
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence            1   1123458889999998865 56889999999999999999999999765443322211111        0111111


Q ss_pred             chhhHhhhc-ccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          624 RLLEILDNR-IVNDG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       624 ~~~~~~d~~-~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+.+..+.. .....     ....+.++.+++.+||+.+|++|||+.+++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            111111100 00000     12235789999999999999999999988763

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.7e-33  Score=294.13  Aligned_cols=258  Identities=21%  Similarity=0.257  Sum_probs=193.8

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|++|+||+|... +++.||+|+++...  ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL   83 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence            345678999999999999864 67889999876432  233467889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEeeccCCcccCCCccc
Q 004702          480 GNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       480 ~~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGls~~~~~~~~~  556 (735)
                      + ++|.+++....  .+++..+..++.||+.||+|||+++   ++|+||+|+||++++ +..+||+|||++........ 
T Consensus        84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-  158 (294)
T PLN00009         84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-  158 (294)
T ss_pred             c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence            6 58888876543  3578888999999999999999998   999999999999985 56799999999986543221 


Q ss_pred             ceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc--h-------h
Q 004702          557 NCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR--L-------L  626 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~-------~  626 (735)
                      ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+...   .....+....  .       .
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF---KIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChhhccccccch
Confidence            1223347889999998866 457899999999999999999999997654433221   1111111100  0       0


Q ss_pred             hHhh--hcccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          627 EILD--NRIVN----DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       627 ~~~d--~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....  +....    ......+.++.+++.+||+.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000  00000    001123466889999999999999999999985

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.7e-33  Score=296.60  Aligned_cols=259  Identities=20%  Similarity=0.257  Sum_probs=193.7

Q ss_pred             ccccc--CcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          408 VIGCG--GSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       408 ~lG~G--~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      .||+|  +||+||++.. ..++.||+|.+..  ......+.+.+|+.+++.++||||+++++++...+..++||||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            56666  9999999985 4689999998764  23445678889999999999999999999999999999999999999


Q ss_pred             chhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc---
Q 004702          483 TLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN---  557 (735)
Q Consensus       483 sL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~---  557 (735)
                      +|.+++...  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++||+.+..........   
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            999999864  45899999999999999999999998   9999999999999999999999998654332111100   


Q ss_pred             ---eeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHH--------------HH
Q 004702          558 ---CTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF--------------LS  618 (735)
Q Consensus       558 ---~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------------~~  618 (735)
                         .....++..|+|||++.+  ..++.++||||||+++|||++|+.||......+........              ..
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES  241 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence               001124567999999876  34789999999999999999999999655432211100000              00


Q ss_pred             H-----------hcccch-----hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          619 S-----------LKQNRL-----LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       619 ~-----------~~~~~~-----~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .           +.+..+     ..+.+..+..+........+.+|+.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            0           000000     00111111222234566789999999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.4e-33  Score=295.08  Aligned_cols=262  Identities=21%  Similarity=0.278  Sum_probs=192.8

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc--------
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQV--------  471 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--------  471 (735)
                      +.+.+.||+|+||.||++... ++..||||++....  ......+.+|+.++++++||||+++++++...+.        
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   93 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS   93 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence            345678999999999999854 58899999876432  2223456789999999999999999999876543        


Q ss_pred             eeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          472 PLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      .++||||+.+ +|.+.+... ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++...
T Consensus        94 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          94 FYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             EEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            4999999964 788877654 37899999999999999999999998   999999999999999999999999999866


Q ss_pred             CCCccc---ceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          551 PIDAIQ---NCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       551 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                      ......   ......++..|+|||.+.+. .++.++||||||+++|||++|..||.........................
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP  249 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            432211   11233478899999988654 47889999999999999999999987665443333222221111110000


Q ss_pred             -----hHhhhc-ccCCC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          627 -----EILDNR-IVNDG---------NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       627 -----~~~d~~-~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                           +..+.. .....         .......+.+|+.+||+.+|.+|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                 000000 00000         0011246779999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-32  Score=293.42  Aligned_cols=241  Identities=26%  Similarity=0.367  Sum_probs=193.0

Q ss_pred             cccccccCcEEEEEEEcC-CCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          406 ADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.||+|+||.||+|+.. ++..+|+|.+..   .......++.+|+++++.++|+|++++++++......++||||+. 
T Consensus        20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-   98 (308)
T cd06634          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-   98 (308)
T ss_pred             HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence            457999999999999854 578899998763   233445678899999999999999999999999999999999996 


Q ss_pred             CchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      |+|.+++.. ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......     ..
T Consensus        99 ~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~  170 (308)
T cd06634          99 GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NX  170 (308)
T ss_pred             CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-----cc
Confidence            588777754 456899999999999999999999998   999999999999999999999999998765322     22


Q ss_pred             eccccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          561 VQGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       561 ~~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ..++..|+|||.+.   ...++.++||||||+++|||++|+.||......+....       +....        .....
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~--------~~~~~  235 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------IAQNE--------SPALQ  235 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH-------HhhcC--------CCCcC
Confidence            34788999999874   35678899999999999999999999865433221110       00000        00111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      .......+.+|+.+||+.+|++||++.+|+...
T Consensus       236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            223456789999999999999999999988653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.1e-32  Score=290.67  Aligned_cols=240  Identities=28%  Similarity=0.373  Sum_probs=191.8

Q ss_pred             cccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          406 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.||+|+||+||+|+. .++..|++|++...   .......+.+|+.+++.++|||++++++++.+....++||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            35799999999999985 45788999987642   33445678899999999999999999999999999999999996 


Q ss_pred             CchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ++|.+++.. ...+++.+++.++.|++.+|+|||+.+   ++|+||+|+||++++++.+||+|||++.....     ...
T Consensus       105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~  176 (313)
T cd06633         105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANS  176 (313)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCC
Confidence            577777764 457999999999999999999999998   99999999999999999999999999864322     123


Q ss_pred             eccccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          561 VQGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       561 ~~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ..|+..|+|||++.   ...++.++||||||+++|||++|..||...........   .    .....        ....
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~---~----~~~~~--------~~~~  241 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---I----AQNDS--------PTLQ  241 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---H----HhcCC--------CCCC
Confidence            45888999999984   45688899999999999999999999866543221110   0    00000        0011


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .......+.+|+.+||+.+|.+||++.+++..
T Consensus       242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            12234568999999999999999999998853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.4e-32  Score=293.31  Aligned_cols=258  Identities=19%  Similarity=0.209  Sum_probs=194.7

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .+.+|.|+++.||++.. ++..||||+++..  .....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            44556666666676655 6889999998753  45667789999999999999999999999999999999999999999


Q ss_pred             hhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc------
Q 004702          484 LFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI------  555 (735)
Q Consensus       484 L~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~------  555 (735)
                      |.+++...  ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||.+........      
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            99999864  46889999999999999999999998   99999999999999999999999998875432111      


Q ss_pred             cceeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHh----cccchhh--
Q 004702          556 QNCTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL----KQNRLLE--  627 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~--  627 (735)
                      .......++..|+|||.+..  ..++.++||||||+++|||++|+.||........  .........    .......  
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhc
Confidence            11122346788999999876  4588999999999999999999999976543221  111100000    0000000  


Q ss_pred             ---------Hhhh----cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          628 ---------ILDN----RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       628 ---------~~d~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                               ..++    ............++.+|+.+||+.+|++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                     0000    00111123345678999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-32  Score=286.31  Aligned_cols=233  Identities=25%  Similarity=0.324  Sum_probs=183.9

Q ss_pred             ccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCCCchhH
Q 004702          409 IGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE  486 (735)
Q Consensus       409 lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  486 (735)
                      ||+|+||.||++.. .++..+|+|..........     |+.....+ +||||+++++.+...+..++||||+++++|.+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~   98 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD   98 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence            69999999999985 4578889998764322211     22222222 79999999999999999999999999999999


Q ss_pred             HhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEeeccCCcccCCCcccceeeecccc
Q 004702          487 HIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-TPKVSDFGASKLVPIDAIQNCTVVQGTL  565 (735)
Q Consensus       487 ~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGls~~~~~~~~~~~~~~~gt~  565 (735)
                      ++.....+++..++.++.|+++||+|||+.+   ++||||||+||+++.++ .++|+|||+++......     ...++.
T Consensus        99 ~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~  170 (267)
T PHA03390         99 LLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CYDGTL  170 (267)
T ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cCCCCC
Confidence            9988778999999999999999999999998   99999999999999988 99999999988654322     234889


Q ss_pred             CccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHH
Q 004702          566 GYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV  645 (735)
Q Consensus       566 ~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  645 (735)
                      .|+|||++.+..++.++||||||+++|||++|+.||......+ ... ..+....         ..  ........+..+
T Consensus       171 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~-~~~~~~~---------~~--~~~~~~~~~~~~  237 (267)
T PHA03390        171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDL-ESLLKRQ---------QK--KLPFIKNVSKNA  237 (267)
T ss_pred             cccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhH-HHHHHhh---------cc--cCCcccccCHHH
Confidence            9999999999899999999999999999999999997443221 111 0111000         00  011122455789


Q ss_pred             HHHHHHcccCCCCCCCC-HHHHH
Q 004702          646 AKLAARCISVRGEERPT-MKEVS  667 (735)
Q Consensus       646 ~~li~~cl~~~p~~RPt-~~ev~  667 (735)
                      .+++.+||+.+|.+||+ +.|++
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l  260 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEII  260 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHh
Confidence            99999999999999996 57776

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=288.80  Aligned_cols=259  Identities=24%  Similarity=0.303  Sum_probs=198.9

Q ss_pred             ccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          405 YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.||+|++|.||+|+.. ++..+|+|.+....  ....+.+.+|+.++++++|+||+++++++.+.+..++||||++ 
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-   81 (282)
T ss_pred             eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence            4568999999999999965 48899999887542  3345678899999999999999999999999999999999997 


Q ss_pred             CchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ++|.+++... ..+++..+++++.|+++||+|||+.+   |+||||+|+||++++++.+||+|||+++....... ....
T Consensus        82 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~  157 (282)
T cd07829          82 MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH  157 (282)
T ss_pred             cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence            5999999876 57999999999999999999999998   99999999999999999999999999987643322 1222


Q ss_pred             eccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh--------h
Q 004702          561 VQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD--------N  631 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--------~  631 (735)
                      ..++..|+|||.+... .++.++||||||+++|||++|+.||......+................+..+.+        +
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            3357789999998776 789999999999999999999999866544332221111110000000000000        0


Q ss_pred             cccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 RIVN----DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 ~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....    .........+.+++.+||+.+|++||++.+|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000    001112467999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.3e-32  Score=291.16  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=191.5

Q ss_pred             ccccccccccCcEEEEEEEcCC-CcEEEEEEeeccC-hhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVD-QAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||.||++..++ +..||||.++... .....++..|+.++.++. ||||+++++++.+....++||||+
T Consensus        17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   96 (296)
T cd06618          17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM   96 (296)
T ss_pred             heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence            3456799999999999999765 8899999987532 334556777887776665 999999999999999999999998


Q ss_pred             CCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      . ++|.+++.. ...+++..+..++.|+++||+|||+. +   |+||||+|+||++++++.+||+|||++..+...... 
T Consensus        97 ~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~-  171 (296)
T cd06618          97 S-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK-  171 (296)
T ss_pred             C-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence            5 477777655 35799999999999999999999974 6   999999999999999999999999998765432221 


Q ss_pred             eeeeccccCccCcccccCCC----CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          558 CTVVQGTLGYLDPEYLQTCK----LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~----~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                       ....++..|+|||.+....    ++.++||||||+++|||++|+.||.......  ....   ..+.. ...     . 
T Consensus       172 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~---~~~~~-~~~-----~-  238 (296)
T cd06618         172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLT---KILQE-EPP-----S-  238 (296)
T ss_pred             -cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHH---HHhcC-CCC-----C-
Confidence             2234788999999987553    7889999999999999999999986432211  0110   00111 000     0 


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                       .+.......++.+|+.+||+.+|++||++.++++.
T Consensus       239 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 -LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             01111245678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-32  Score=288.49  Aligned_cols=245  Identities=25%  Similarity=0.357  Sum_probs=200.5

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeec---cChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF---VDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      +.+.+.||+|+||.||++... ++..||+|.+..   ......+.+.+|+.++++++ |+||+++++++...+..++|||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            345678999999999999864 688999998764   23344567889999999999 9999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc--
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI--  555 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~--  555 (735)
                      ++++++|.+++.....+++..++.|+.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........  
T Consensus        83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            9999999999998888999999999999999999999998   99999999999999999999999999886543221  


Q ss_pred             -----------------cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHH
Q 004702          556 -----------------QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS  618 (735)
Q Consensus       556 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~  618 (735)
                                       .......++..|++||.+....++.++||||||+++++|++|+.||.........   ..   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~---  233 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF---QK---  233 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH---HH---
Confidence                             1122234788999999998888999999999999999999999998755421111   00   


Q ss_pred             HhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHH
Q 004702          619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTM----KEVS  667 (735)
Q Consensus       619 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~ev~  667 (735)
                               +.+  .....+...+..+.+++.+||+.+|.+||++    .+++
T Consensus       234 ---------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll  275 (280)
T cd05581         234 ---------ILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK  275 (280)
T ss_pred             ---------HHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence                     000  1111222335778999999999999999999    5554

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.8e-32  Score=294.94  Aligned_cols=260  Identities=20%  Similarity=0.249  Sum_probs=192.1

Q ss_pred             cccccccccCcEEEEEEEcC-C--CcEEEEEEeecc--ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeec----Ccee
Q 004702          404 NYADVIGCGGSGNVYKGFLP-D--RTPVAVKKSKFV--DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLET----QVPL  473 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~~~  473 (735)
                      .+.+.||+|+||.||++... .  +..||+|++...  .....+.+.+|+.+++++ +||||+++++.....    ...+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            45678999999999999854 3  678999987642  233356788999999999 599999999875432    3567


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +++||+. ++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        83 ~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          83 LYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            8889885 689999988788999999999999999999999998   999999999999999999999999999865432


Q ss_pred             ccc---ceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH--------HHhc
Q 004702          554 AIQ---NCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL--------SSLK  621 (735)
Q Consensus       554 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~  621 (735)
                      ...   ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||................        ..+.
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            211   1123458899999998765 568999999999999999999999987654332221111110        0000


Q ss_pred             ccchhhHhhhc-ccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004702          622 QNRLLEILDNR-IVND-----GNKQQLKEVAKLAARCISVRGEERPTMKEVS  667 (735)
Q Consensus       622 ~~~~~~~~d~~-~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  667 (735)
                      ........... ....     ........+.+++.+||+.+|.+|||+.|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll  290 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL  290 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            00000000000 0000     0011246789999999999999999999986

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-32  Score=292.67  Aligned_cols=262  Identities=21%  Similarity=0.242  Sum_probs=191.5

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccCh--hHHHHHHHHHHHHHhcCCCceEEEceEEeecC--------c
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ--AKIDEFINELVVVLQINRRNVVRLLGCCLETQ--------V  471 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------~  471 (735)
                      +.+.+.||+|+||.||+|... ++..+|||++.....  .....+.+|+++++.++||||+++++++.+..        .
T Consensus        10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   89 (311)
T cd07866          10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS   89 (311)
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence            445678999999999999854 578899998764322  22346778999999999999999999875543        4


Q ss_pred             eeEEEEecCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          472 PLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      .++||||+.. +|...+.. ...+++..+..++.|+++||+|||+.+   |+|+||||+|||+++++.+||+|||+++..
T Consensus        90 ~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          90 VYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             EEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            5899999965 67776654 357999999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCcc----------cceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHH
Q 004702          551 PIDAI----------QNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS  619 (735)
Q Consensus       551 ~~~~~----------~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  619 (735)
                      .....          ...+...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT  245 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            43221          11123457888999998765 45889999999999999999999998755443322221111100


Q ss_pred             hcccch------hhHhhhcccCCC-------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          620 LKQNRL------LEILDNRIVNDG-------NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       620 ~~~~~~------~~~~d~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .....+      ....+.......       .......+.+++.+||+.+|.+|||+.|++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000000      000000000000       0112367889999999999999999998874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-32  Score=295.98  Aligned_cols=256  Identities=21%  Similarity=0.287  Sum_probs=189.5

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------ceeE
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------VPLL  474 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l  474 (735)
                      ...+.||+|+||.||+|.. .++..||||+++..  .......+.+|+.+++.++||||+++++++....      ..++
T Consensus        18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l   97 (342)
T cd07879          18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL   97 (342)
T ss_pred             EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence            3456899999999999985 46889999987642  2233456889999999999999999999987543      3589


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |+||+.. +|..++.  ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        98 v~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~  171 (342)
T cd07879          98 VMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM  171 (342)
T ss_pred             Eeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC
Confidence            9999964 7776653  36899999999999999999999998   9999999999999999999999999988653221


Q ss_pred             ccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHH--------HHHhcccch
Q 004702          555 IQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF--------LSSLKQNRL  625 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~  625 (735)
                          ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............        ...+.....
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         172 ----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             ----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence                22347889999999876 46889999999999999999999999765433221111110        000000000


Q ss_pred             hhHhhh-cccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          626 LEILDN-RIVNDG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       626 ~~~~d~-~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ...... ......     ......++.+|+.+||+.+|.+||++.|++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000 000000     01123568899999999999999999999853

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-33  Score=267.75  Aligned_cols=245  Identities=24%  Similarity=0.359  Sum_probs=192.3

Q ss_pred             cccccccCcEEEEEEEcC-CCcEEEEEEeec-cChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEecCCC
Q 004702          406 ADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF-VDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ...||.|..|.|++.+.. .+..+|||.+.. .+.++.++++..+.++..-+ .|+||+.+|++..+...++.||.|.. 
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence            456999999999999854 588899999874 45666777888887766654 79999999999999999999999853 


Q ss_pred             chhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      -++.+++. .+++++..+-++...+.+||.||..+++  |+|||+||+|||+|+.|++|++|||++-.+-....+  +..
T Consensus       176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--trs  251 (391)
T KOG0983|consen  176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--TRS  251 (391)
T ss_pred             HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeeccccc--ccc
Confidence            45555554 3678998888999999999999998874  999999999999999999999999999877544333  334


Q ss_pred             ccccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          562 QGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       562 ~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      .|-+.|||||.+.   ...|..++||||||+.|+||.||+.||.....+-+      .+..+..+     .-+.+..  .
T Consensus       252 AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln~-----ePP~L~~--~  318 (391)
T KOG0983|consen  252 AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLNE-----EPPLLPG--H  318 (391)
T ss_pred             cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHhc-----CCCCCCc--c
Confidence            4999999999885   34688899999999999999999999976433211      01111000     0011111  2


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+..+.+++..||+.|+.+||...++++
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            236788999999999999999999999875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.7e-33  Score=316.65  Aligned_cols=251  Identities=28%  Similarity=0.391  Sum_probs=189.1

Q ss_pred             hhhccccc--cccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec------
Q 004702          400 TVTNNYAD--VIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLET------  469 (735)
Q Consensus       400 ~~~~~~~~--~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------  469 (735)
                      +....|.+  +||+||||.|||++. -||+.+|||++... .......+.+|+.+|++|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            33444544  899999999999984 48999999998743 445567788999999999999999987432110      


Q ss_pred             --------------------------------------------------------------------------------
Q 004702          470 --------------------------------------------------------------------------------  469 (735)
Q Consensus       470 --------------------------------------------------------------------------------  469 (735)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CceeEEEEecCCCchhHHhhhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 004702          470 ---------------------------------QVPLLVYEFVGNGTLFEHIHKKGNL-SWERRLRITAETAGVLSYLHS  515 (735)
Q Consensus       470 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~~~l-~~~~~~~i~~qia~~L~yLH~  515 (735)
                                                       ..+||-||||+.-+|.+++..+... .....++++.||++||+|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                             1136889999988888888776544 467789999999999999999


Q ss_pred             cCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC-----------------CCcccceeeeccccCccCcccccCC--
Q 004702          516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP-----------------IDAIQNCTVVQGTLGYLDPEYLQTC--  576 (735)
Q Consensus       516 ~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~--  576 (735)
                      .+   ||||||||.||+||++..|||+|||++....                 .......+...||.-|+|||.+.+.  
T Consensus       716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            99   9999999999999999999999999998621                 0112234556799999999999765  


Q ss_pred             -CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccC
Q 004702          577 -KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISV  655 (735)
Q Consensus       577 -~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~  655 (735)
                       .|+.|+|+|||||||+||+.   ||...  .| +.   ..+..++.+.+..-      ..+..+..+.-+.+|.++++.
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--ME-Ra---~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~h  857 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGTS--ME-RA---SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSH  857 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCch--HH-HH---HHHHhcccCCCCCC------cccccccchHHHHHHHHHhcC
Confidence             49999999999999999985   44322  11 11   12233333332221      112233445667899999999


Q ss_pred             CCCCCCCHHHHHH
Q 004702          656 RGEERPTMKEVSL  668 (735)
Q Consensus       656 ~p~~RPt~~ev~~  668 (735)
                      ||.+|||+.|++.
T Consensus       858 dP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  858 DPSKRPTATELLN  870 (1351)
T ss_pred             CCccCCCHHHHhh
Confidence            9999999999874

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3e-32  Score=282.48  Aligned_cols=245  Identities=20%  Similarity=0.237  Sum_probs=192.6

Q ss_pred             ccccccccccCcEEEEEEEcCC-CcEEEEEEeec-----cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKF-----VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      +.+.++||+|+||.||++.... +..+++|.++.     .......++..|+.+++.++||||+++++++.+....++||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            4567899999999999998543 34455555442     22334456778999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          477 EFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       477 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ||+++++|.+++..    ...+++..++.++.|+++||.|||+.+   ++|+||||+||++++ +.+||+|||+++....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999998864    356999999999999999999999998   999999999999976 4699999999876543


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      ... ......|+..|+|||.+....++.++|+||||+++|+|++|..||........   ..    ....         .
T Consensus       158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---~~----~~~~---------~  220 (260)
T cd08222         158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV---VL----RIVE---------G  220 (260)
T ss_pred             Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH----HHHc---------C
Confidence            221 12234578899999999888899999999999999999999999854332111   10    0000         0


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .....+...+.++.+++.+||+.+|++||++.|+++
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            111123355678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-32  Score=278.75  Aligned_cols=236  Identities=28%  Similarity=0.336  Sum_probs=194.8

Q ss_pred             ccccCcEEEEEEEcC-CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          409 IGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       409 lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      ||+|+||.||++... ++..+++|.++...   ....+.+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999865 47889999876432   23566888999999999999999999999999999999999999999


Q ss_pred             hHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccc
Q 004702          485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT  564 (735)
Q Consensus       485 ~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt  564 (735)
                      .+++.....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT  156 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence            999988878999999999999999999999988   9999999999999999999999999988754321 122334578


Q ss_pred             cCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHH
Q 004702          565 LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE  644 (735)
Q Consensus       565 ~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  644 (735)
                      ..|++||.+.+...+.++|+||||+++|||++|+.||......+.   .    ..+...        .  ...+...+..
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~----~~~~~~--------~--~~~~~~~~~~  219 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---Y----EKILKD--------P--LRFPEFLSPE  219 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHhcC--------C--CCCCCCCCHH
Confidence            899999999888899999999999999999999999965433111   1    111110        0  1112223567


Q ss_pred             HHHHHHHcccCCCCCCCCHHH
Q 004702          645 VAKLAARCISVRGEERPTMKE  665 (735)
Q Consensus       645 l~~li~~cl~~~p~~RPt~~e  665 (735)
                      +.+++.+||..+|++||++++
T Consensus       220 l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         220 ARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHhcCCHhhCCCccc
Confidence            899999999999999999965

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-34  Score=323.56  Aligned_cols=245  Identities=26%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             cccccccCcEEEEEEE-cCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          406 ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      +..||.|.||.||-+. .++|...|+|-++.  ..........+|+.+|..|+|||+|+++|+-.+.+..+|.|||+++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            4589999999999998 56688899997653  33444566789999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc---cccee
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA---IQNCT  559 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~---~~~~~  559 (735)
                      +|.+.+......++.....+-.|++.|++|||+++   ||||||||.||||+.++.+|++|||.|..+....   .....
T Consensus      1320 sLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1320 SLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred             cHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence            99999988777777777888999999999999999   9999999999999999999999999999875442   12223


Q ss_pred             eeccccCccCcccccCC---CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          560 VVQGTLGYLDPEYLQTC---KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~---~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      ...||+.|||||.+.+.   ....+.||||||+|++||+||+.||.....+-   .++.-..   .         .-...
T Consensus      1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V~---~---------gh~Pq 1461 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHVA---A---------GHKPQ 1461 (1509)
T ss_pred             hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHHh---c---------cCCCC
Confidence            45699999999999753   35668999999999999999999996433211   1111111   1         11122


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+...+.+-.+++.+||..||++|-++.|+++
T Consensus      1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             CchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            34456778899999999999999988876654

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-32  Score=295.87  Aligned_cols=259  Identities=23%  Similarity=0.322  Sum_probs=193.7

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeec-----------
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET-----------  469 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----------  469 (735)
                      ++.+.+.||.|+||.||+|.. .++..||+|++........+.+.+|+.+++.++||||+++++++...           
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL   85 (342)
T ss_pred             ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence            344567899999999999985 45789999998766666677889999999999999999999776543           


Q ss_pred             ---CceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEeecc
Q 004702          470 ---QVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFG  545 (735)
Q Consensus       470 ---~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFG  545 (735)
                         ...++||||++ ++|.+++.. ..+++..+..++.|+++||.|||+.+   |+||||||+||+++ ++..+||+|||
T Consensus        86 ~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          86 TELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcc
Confidence               34689999997 589888864 46899999999999999999999998   99999999999997 55678999999


Q ss_pred             CCcccCCCccc--ceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc
Q 004702          546 ASKLVPIDAIQ--NCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ  622 (735)
Q Consensus       546 ls~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  622 (735)
                      +++........  ......++..|+|||.+.. ..++.++||||||+++|||++|+.||....+.+.....   ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~  237 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI---LESVPV  237 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCC
Confidence            99765322111  1122347889999997654 56888999999999999999999999765543322211   111100


Q ss_pred             c------chhhHhhh-----cccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          623 N------RLLEILDN-----RIVNDG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       623 ~------~~~~~~d~-----~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .      ........     ......     ......++.+++.+||+.+|.+|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0      00000000     000000     0123467889999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-32  Score=293.03  Aligned_cols=245  Identities=24%  Similarity=0.343  Sum_probs=203.0

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|.|++|..++. ..+..||||.+.+  .+....+.+.+|+.+|+.|+|||||+++.+......+|+||||.
T Consensus        58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya  137 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA  137 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence            34567899999999999984 4588999998875  34444566889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      .+|.++++|.+.+...+.....++.|+..|++|+|++.   |+|||||++||||+.+.++||+|||++..+...  ....
T Consensus       138 ~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~lq  212 (596)
T KOG0586|consen  138 SGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LMLQ  212 (596)
T ss_pred             cCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc--cccc
Confidence            99999999999988989999999999999999999999   999999999999999999999999999987532  2334


Q ss_pred             eeccccCccCcccccCCCC-CccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          560 VVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~-~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ...|++.|.|||++.+.++ .++.|+||+|++||.|+.|..||....-.+.+..               .+-..+..  +
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r---------------vl~gk~rI--p  275 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR---------------VLRGKYRI--P  275 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch---------------heeeeecc--c
Confidence            4569999999999998765 4699999999999999999999975433221110               11111111  1


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .-...+..+|++++|-++|.+|+++.++.+.
T Consensus       276 ~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  276 FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            1233567889999999999999999998753

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=6.8e-33  Score=300.35  Aligned_cols=267  Identities=25%  Similarity=0.355  Sum_probs=200.6

Q ss_pred             ccccccccCcEEEEEEE-cCCCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEee------cCceeEEE
Q 004702          405 YADVIGCGGSGNVYKGF-LPDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE------TQVPLLVY  476 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lV~  476 (735)
                      ..+.||+|+||.||+|+ ...|+.||||..+. ......+....|+++|++++|+|||++++.-.+      ...+++||
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm   96 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM   96 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence            45789999999999999 56799999998775 234456778899999999999999999988654      34678999


Q ss_pred             EecCCCchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCC--CeEEeeccCCcc
Q 004702          477 EFVGNGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD--ENC--TPKVSDFGASKL  549 (735)
Q Consensus       477 E~~~~gsL~~~l~~~---~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~--~~kl~DFGls~~  549 (735)
                      ||+.+|+|...|.+.   ..|++...+.++.++..||.|||.++   |+||||||.||++-  +++  ..||+|||.|+-
T Consensus        97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            999999999999865   46999999999999999999999998   99999999999994  333  479999999998


Q ss_pred             cCCCcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH
Q 004702          550 VPIDAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI  628 (735)
Q Consensus       550 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (735)
                      +..+.  ..+...||..|++||.+.. ..|+...|.||||+++|+.+||..||.........-..++-...-+...+.-.
T Consensus       174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            86554  6677789999999999984 78999999999999999999999999654433211111111111111110000


Q ss_pred             hhhc----c--------cCCCCHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHhhhhh
Q 004702          629 LDNR----I--------VNDGNKQQLKEVAKLAARCISVRGEERP--TMKEVSLELQGRLSL  676 (735)
Q Consensus       629 ~d~~----~--------~~~~~~~~~~~l~~li~~cl~~~p~~RP--t~~ev~~~L~~~~~~  676 (735)
                      .++.    +        ...........+-..+..+|..+|++|-  ...+...++.++++.
T Consensus       252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            0000    0        0111223334566677777888888888  666666666666654

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=7.5e-32  Score=291.70  Aligned_cols=256  Identities=22%  Similarity=0.291  Sum_probs=190.3

Q ss_pred             ccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec------CceeEE
Q 004702          405 YADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLET------QVPLLV  475 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV  475 (735)
                      +.+.||+|+||.||++.. .++..||+|+++..  .....+.+.+|+.++.+++||||+++++++...      ...+++
T Consensus        21 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv  100 (345)
T cd07877          21 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV  100 (345)
T ss_pred             EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEE
Confidence            346899999999999984 56889999988642  233356788999999999999999999987643      235788


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ++++ +++|.+++... .+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||+++.....  
T Consensus       101 ~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--  173 (345)
T cd07877         101 THLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--  173 (345)
T ss_pred             ehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc--
Confidence            8876 77998887654 6999999999999999999999998   999999999999999999999999998864322  


Q ss_pred             cceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHH--------HHHhcccchh
Q 004702          556 QNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF--------LSSLKQNRLL  626 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~  626 (735)
                        .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............        ...+......
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (345)
T cd07877         174 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  251 (345)
T ss_pred             --ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence              123357889999998866 56888999999999999999999998654433221111110        0000000000


Q ss_pred             hH---hhhcccC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          627 EI---LDNRIVN---DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       627 ~~---~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ..   +......   ........++.+++.+||+.+|.+||++.+++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            00   0000000   0000134578899999999999999999988754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.98  E-value=8.4e-32  Score=289.17  Aligned_cols=257  Identities=21%  Similarity=0.263  Sum_probs=193.0

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEee-cCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE-TQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~E~  478 (735)
                      +.+.+.||.|+||.||++.. .++..||||++..  ......+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus        12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~   91 (328)
T cd07856          12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL   91 (328)
T ss_pred             eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence            34567999999999999984 4788999998753  223345678899999999999999999998865 5578899999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      + +++|.++++. ..+++..+..++.|+++||+|||+.+   |+||||+|+|||+++++.+||+|||++.......    
T Consensus        92 ~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~----  162 (328)
T cd07856          92 L-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQM----  162 (328)
T ss_pred             h-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCc----
Confidence            8 5689888865 46888889999999999999999998   9999999999999999999999999988543221    


Q ss_pred             eeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHH--------HHHhcccchhhHh
Q 004702          559 TVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF--------LSSLKQNRLLEIL  629 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~  629 (735)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............        ..........+.+
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd07856         163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV  242 (328)
T ss_pred             CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence            22346889999998766 56899999999999999999999999765443222111111        1111011111111


Q ss_pred             hhc-ccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          630 DNR-IVNDGN-----KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       630 d~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ... .....+     .....++.+++.+||+.+|++|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            100 000111     113468899999999999999999998864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.98  E-value=9.2e-33  Score=283.83  Aligned_cols=241  Identities=24%  Similarity=0.285  Sum_probs=197.4

Q ss_pred             cccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          406 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      -++||+|+||.||-... ..|..+|.|++...   ........++|-.+|.+++.+.||.|-..+...+.++||+..|.|
T Consensus       190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG  269 (591)
T ss_pred             eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence            35999999999999874 45888898876532   223344567999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          482 GTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       482 gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      |+|.-+|.+.+  .+++..++-++.+|+-||++||...   ||+|||||+|||||+.|+++|+|+|||..++....... 
T Consensus       270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~-  345 (591)
T KOG0986|consen  270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG-  345 (591)
T ss_pred             CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcccc-
Confidence            99999997654  7999999999999999999999999   99999999999999999999999999998876655433 


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                       ..||.+|||||++.+..|+...|-||||++||||+.|+.||...........+.+   .+.+          ...+.+.
T Consensus       346 -rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr---r~~~----------~~~ey~~  411 (591)
T KOG0986|consen  346 -RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR---RTLE----------DPEEYSD  411 (591)
T ss_pred             -ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH---HHhc----------chhhccc
Confidence             3699999999999999999999999999999999999999965433222211110   0000          0112344


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHH
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                      ..+++...|....|+.||.+|.-.+
T Consensus       412 kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  412 KFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ccCHHHHHHHHHHHccCHHHhccCC
Confidence            5667889999999999999996544

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=9.3e-32  Score=290.72  Aligned_cols=257  Identities=23%  Similarity=0.293  Sum_probs=192.6

Q ss_pred             ccccccccccCcEEEEEEE-cCCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------cee
Q 004702          403 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------VPL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~  473 (735)
                      +...+.||+|+||.||++. ..++..||||++...  .....+.+.+|+.+|++++||||+++++++....      ..+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07880          17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY   96 (343)
T ss_pred             eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence            3446689999999999998 456889999987532  2333456889999999999999999999887554      348


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+   |+||||||+||++++++.+||+|||++......
T Consensus        97 lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  171 (343)
T cd07880          97 LVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE  171 (343)
T ss_pred             EEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence            999998 6789888864 57999999999999999999999998   999999999999999999999999999865432


Q ss_pred             cccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHH--------HHHHHhcccc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM--------NFLSSLKQNR  624 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~~  624 (735)
                      .    ....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.............        .+...+....
T Consensus       172 ~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07880         172 M----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED  247 (343)
T ss_pred             c----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence            1    22347889999998876 468899999999999999999999997554322111110        0111111110


Q ss_pred             hhhHhhh--ccc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 LLEILDN--RIV----NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ~~~~~d~--~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .......  ...    .........++.+++.+|++.+|++|||+.+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000  000    0001123456889999999999999999999884

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=3.3e-32  Score=294.29  Aligned_cols=256  Identities=23%  Similarity=0.296  Sum_probs=194.0

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc------eeE
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV------PLL  474 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~l  474 (735)
                      .+.+.||+|++|.||+|... ++..||||++...  .....+.+.+|+.++++++|+||+++++++...+.      .++
T Consensus        18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   97 (343)
T cd07851          18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL   97 (343)
T ss_pred             EEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence            44578999999999999864 5788999987642  33345677889999999999999999998766554      799


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||++...... 
T Consensus        98 v~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-  171 (343)
T cd07851          98 VTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-  171 (343)
T ss_pred             EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence            99998 5699998876 46999999999999999999999998   999999999999999999999999999865432 


Q ss_pred             ccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH--------HHhcccch
Q 004702          555 IQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL--------SSLKQNRL  625 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~  625 (735)
                         .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.........        ..+.....
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence               223357889999998865 467889999999999999999999997654433222111110        00000000


Q ss_pred             hhHhhhcccC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 LEILDNRIVN------DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 ~~~~d~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+......      ......+.++.+++.+||+.+|++|||+.||+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0010000000      000112568999999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=2.4e-32  Score=269.30  Aligned_cols=254  Identities=20%  Similarity=0.318  Sum_probs=201.3

Q ss_pred             cccccccCcEEEEEEE-cCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEecCCCc
Q 004702          406 ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .++||+|+++.|--++ +..+..+|||++.+..........+|++++.+.+ |+||++|+.++.++...|||||.|.||.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            4689999999998886 6788999999998776677788999999999985 9999999999999999999999999999


Q ss_pred             hhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEeeccCCcccC--CC----c
Q 004702          484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT---PKVSDFGASKLVP--ID----A  554 (735)
Q Consensus       484 L~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGls~~~~--~~----~  554 (735)
                      |..+|+++..+++..+.++.++|+.||.|||.++   |.||||||+|||-.....   +||+||.|..-+.  .+    .
T Consensus       163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            9999999999999999999999999999999999   999999999999975543   7999998865431  11    1


Q ss_pred             ccceeeeccccCccCccccc-----CCCCCccccchhHHHHHHHHHhCCccCCCCChHH--------HHHHHHHHHHHhc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE--------ERSLAMNFLSSLK  621 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~--------~~~~~~~~~~~~~  621 (735)
                      ........|+..|||||+..     ...|+.+.|.||||||||-||+|..||...-..+        -+.-....+..++
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ  319 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ  319 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence            22223356899999999763     2458889999999999999999999996543321        1111112222222


Q ss_pred             ccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          622 QNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       622 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +++.. +     ........+.+..+|+...|..++.+|.++.+++.
T Consensus       320 EGkYe-F-----PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  320 EGKYE-F-----PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccCCc-C-----ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            22211 0     11123445678889999999999999999988876

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=1.7e-32  Score=269.64  Aligned_cols=263  Identities=22%  Similarity=0.263  Sum_probs=191.6

Q ss_pred             cccccccccCcEEEEEEEcC---C--CcEEEEEEeeccCh--hHHHHHHHHHHHHHhcCCCceEEEceEEee-cCceeEE
Q 004702          404 NYADVIGCGGSGNVYKGFLP---D--RTPVAVKKSKFVDQ--AKIDEFINELVVVLQINRRNVVRLLGCCLE-TQVPLLV  475 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV  475 (735)
                      .....||+|.+|.|||++-.   +  ...+|||+++....  .-.....+|+.+++.++||||+.|..++.. +...+|+
T Consensus        27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~  106 (438)
T KOG0666|consen   27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL  106 (438)
T ss_pred             hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence            34568999999999999632   2  23689999874321  223456799999999999999999999988 6788999


Q ss_pred             EEecCCCchhHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC----CCeEEeeccC
Q 004702          476 YEFVGNGTLFEHIHKK-----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN----CTPKVSDFGA  546 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGl  546 (735)
                      +||.+. +|.+.|+-.     ..++...+..|+.||+.|+.|||++=   |+||||||.||||..+    |.+||+|||+
T Consensus       107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999977 888888632     46889999999999999999999988   9999999999999877    8999999999


Q ss_pred             CcccCCCccc--ceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHH------HHHHHHH
Q 004702          547 SKLVPIDAIQ--NCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER------SLAMNFL  617 (735)
Q Consensus       547 s~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~------~~~~~~~  617 (735)
                      ++++...-..  ....+.-|+.|.|||.+.+. .||.+.|||+.|+++.||+|-++.|......-..      .....++
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            9988543222  23345679999999998875 5999999999999999999988777543221111      1111222


Q ss_pred             HHhcc---cchhhHh----------hh--cccCCC--------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          618 SSLKQ---NRLLEIL----------DN--RIVNDG--------NKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       618 ~~~~~---~~~~~~~----------d~--~~~~~~--------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      ..+..   .++..+.          +-  ......        .....+...+|+.++|+.||.+|.|+.+.++..
T Consensus       263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            22211   1111100          00  000000        000112367899999999999999999987643

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-32  Score=268.55  Aligned_cols=237  Identities=24%  Similarity=0.299  Sum_probs=200.6

Q ss_pred             cccccccccCcEEEEEEE-cCCCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .|.++||+|.||+|.+.+ ...++.+|+|++++   ....+...-+.|-.+|+..+||.+..|...+...+.+++||||.
T Consensus       171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya  250 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA  250 (516)
T ss_pred             hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence            355799999999999998 44688999998874   45666677788999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      .||.|.-+|.....+++....-+-.+|+.||.|||+++   ||.||||.+|.|||.+|.+||+|||+++.--. ......
T Consensus       251 nGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~t~k  326 (516)
T KOG0690|consen  251 NGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGDTTK  326 (516)
T ss_pred             cCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc-ccceec
Confidence            99999999998889999999999999999999999998   99999999999999999999999999985322 223345


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      ...||+.|+|||++....|..+.|-|.+|||+|||+.|+.||+....+....++.               -..  ..++.
T Consensus       327 TFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl---------------~ed--~kFPr  389 (516)
T KOG0690|consen  327 TFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL---------------MED--LKFPR  389 (516)
T ss_pred             cccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH---------------hhh--ccCCc
Confidence            5779999999999999999999999999999999999999998765433222221               111  12244


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC
Q 004702          640 QQLKEVAKLAARCISVRGEERP  661 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RP  661 (735)
                      ...++...|+...|..||.+|.
T Consensus       390 ~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  390 TLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             cCCHHHHHHHHHHhhcChHhhc
Confidence            4557788899999999999995

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=3e-31  Score=271.35  Aligned_cols=222  Identities=24%  Similarity=0.235  Sum_probs=179.2

Q ss_pred             cCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchhHHhhh
Q 004702          412 GGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK  490 (735)
Q Consensus       412 G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  490 (735)
                      |.+|.||++.. .++..+|+|+++...     .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999985 467889999986532     233455556667799999999999999999999999999999999988


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccCccCc
Q 004702          491 KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDP  570 (735)
Q Consensus       491 ~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aP  570 (735)
                      ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.++++|||++......    .....++..|+||
T Consensus        79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aP  151 (237)
T cd05576          79 FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAP  151 (237)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCC
Confidence            778999999999999999999999998   999999999999999999999999987655322    1122356789999


Q ss_pred             ccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHH
Q 004702          571 EYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAA  650 (735)
Q Consensus       571 E~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~  650 (735)
                      |.+....++.++||||||++++||++|+.|+.......            ..         ......+......+.+++.
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~---------~~~~~~~~~~~~~~~~li~  210 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT---------HTTLNIPEWVSEEARSLLQ  210 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc---------ccccCCcccCCHHHHHHHH
Confidence            99988889999999999999999999998764321100            00         0000112234467899999


Q ss_pred             HcccCCCCCCCCHHHH
Q 004702          651 RCISVRGEERPTMKEV  666 (735)
Q Consensus       651 ~cl~~~p~~RPt~~ev  666 (735)
                      +||+.||++||++.+.
T Consensus       211 ~~l~~dp~~R~~~~~~  226 (237)
T cd05576         211 QLLQFNPTERLGAGVA  226 (237)
T ss_pred             HHccCCHHHhcCCCcc
Confidence            9999999999997544

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=8e-31  Score=305.69  Aligned_cols=143  Identities=28%  Similarity=0.333  Sum_probs=129.7

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.++||+|+||+||+|... ++..||||+++..   .......+..|+.++..++||||+++++++...+..+|||||
T Consensus         6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy   85 (669)
T cd05610           6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY   85 (669)
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence            345678999999999999865 6889999998642   344457788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCc
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK  548 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~  548 (735)
                      +.+++|.+++.....+++..++.|+.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        86 ~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          86 LIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999988778999999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5e-32  Score=274.63  Aligned_cols=246  Identities=26%  Similarity=0.333  Sum_probs=203.8

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcCC-CcEEEEEEeec---cChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecC
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKF---VDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQ  470 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~  470 (735)
                      ..|+....+|..+||+|+||+|.++..++ .+.+|||+++.   ....+.+--+.|-++|.... -|.+++|..++..-+
T Consensus       344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            45666677899999999999999997544 56799998874   23344555567888887775 578999999999999


Q ss_pred             ceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      .+|+||||+.+|+|--++++-+.+.+..++-+|.+||-||-|||+++   ||.||||.+|||||.++.+||+|||+++.-
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999999999999999999999999999999999999999999   999999999999999999999999999853


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      -.+ ........||+.|+|||++..++|....|-|||||+||||+.|+.||....+.+...               .|.+
T Consensus       501 i~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~---------------aI~e  564 (683)
T KOG0696|consen  501 IFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---------------AIME  564 (683)
T ss_pred             ccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHHH
Confidence            222 223345679999999999999999999999999999999999999998765544322               1222


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPT  662 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  662 (735)
                      ...  ..+...+.+...+....|...|.+|.-
T Consensus       565 hnv--syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  565 HNV--SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence            222  234556678889999999999999953

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=8.7e-31  Score=267.02  Aligned_cols=238  Identities=30%  Similarity=0.386  Sum_probs=194.9

Q ss_pred             CcEEEEEEEcCC-CcEEEEEEeeccChhH-HHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchhHHhhh
Q 004702          413 GSGNVYKGFLPD-RTPVAVKKSKFVDQAK-IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK  490 (735)
Q Consensus       413 ~~g~Vy~g~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  490 (735)
                      +||.||+++..+ +..+++|++....... .+.+.+|++.+++++|+||+++++.+......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999764 8899999987655444 68899999999999999999999999999999999999999999999987


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccCccCc
Q 004702          491 KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDP  570 (735)
Q Consensus       491 ~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aP  570 (735)
                      ...+++..++.++.+++++|.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  ......++..|++|
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p  155 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP  155 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence            766999999999999999999999998   9999999999999999999999999998765432  22334578899999


Q ss_pred             ccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHH
Q 004702          571 EYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAA  650 (735)
Q Consensus       571 E~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~  650 (735)
                      |.+....++.++||||||+++++|++|..||......+.   .   ...+.......       .........++.+++.
T Consensus       156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~---~---~~~~~~~~~~~-------~~~~~~~~~~~~~~i~  222 (244)
T smart00220      156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE---L---FKKIGKPKPPF-------PPPEWKISPEAKDLIR  222 (244)
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---H---HHHHhccCCCC-------ccccccCCHHHHHHHH
Confidence            999988899999999999999999999999865322111   1   11111110000       0000014568999999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 004702          651 RCISVRGEERPTMKEVSL  668 (735)
Q Consensus       651 ~cl~~~p~~RPt~~ev~~  668 (735)
                      +||..+|++||++.++++
T Consensus       223 ~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      223 KLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHccCCchhccCHHHHhh
Confidence            999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-32  Score=265.83  Aligned_cols=258  Identities=25%  Similarity=0.347  Sum_probs=196.7

Q ss_pred             cccccCHHHHHhhhccccccccccCcEEEEEEEc-CCCcEEEEEEeec-cChhHHHHHHHHHHHHHh-cCCCceEEEceE
Q 004702          389 KAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF-VDQAKIDEFINELVVVLQ-INRRNVVRLLGC  465 (735)
Q Consensus       389 ~~~~~~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~  465 (735)
                      ....|+.+.|++.     ..||.|+||+|+|-.. +.|..+|||+++. ....+..+++.|.+...+ -+.||||+++|.
T Consensus        57 ~~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   57 HLHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            4445666555543     3699999999999874 4689999999885 344667888888876555 468999999999


Q ss_pred             EeecCceeEEEEecCCCchhHHhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 004702          466 CLETQVPLLVYEFVGNGTLFEHIH-----KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPK  540 (735)
Q Consensus       466 ~~~~~~~~lV~E~~~~gsL~~~l~-----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k  540 (735)
                      +..++..|+-||.|. -+|..+-+     ++..+++..+-.|..-..+||.||...-+  |||||+||+||||+..|.+|
T Consensus       132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEe
Confidence            999999999999994 46654433     24578999888999999999999988653  99999999999999999999


Q ss_pred             EeeccCCcccCCCcccceeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHH
Q 004702          541 VSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS  618 (735)
Q Consensus       541 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~  618 (735)
                      |+|||++-.+.....  .+...|-..|||||.+..  ..|..+|||||||++|+|+.||+.|+..-..     ...+ +.
T Consensus       209 LCDFGIcGqLv~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeq-l~  280 (361)
T KOG1006|consen  209 LCDFGICGQLVDSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQ-LC  280 (361)
T ss_pred             eecccchHhHHHHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHH-HH
Confidence            999999976643322  233458899999998853  4588999999999999999999999854322     1111 11


Q ss_pred             HhcccchhhHhhhcc-c-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          619 SLKQNRLLEILDNRI-V-NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       619 ~~~~~~~~~~~d~~~-~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+..+      |+.+ . .....+....+..++.-||.+|-.+||.+.++.+
T Consensus       281 ~Vv~g------dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  281 QVVIG------DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHcC------CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            11111      1111 1 1223457788999999999999999999998764

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=7.6e-32  Score=280.49  Aligned_cols=250  Identities=24%  Similarity=0.341  Sum_probs=199.1

Q ss_pred             HHHhhhcccc-ccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          397 EIKTVTNNYA-DVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       397 ei~~~~~~~~-~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      |+...-..|. ++||+|-||+||-|+. +.|+.||||.+.+  ...++.+++.+|+.||.+++||.||.|.-.+...+..
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv  638 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV  638 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence            3333333343 5899999999999984 5799999998764  2334457889999999999999999999999999999


Q ss_pred             eEEEEecCCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CCeEEeeccCC
Q 004702          473 LLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN---CTPKVSDFGAS  547 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFGls  547 (735)
                      ++|||.+.| +..+.|-.  ++.|++....-++.||+.||.|||.++   |+|+||||+||||...   -++||+|||++
T Consensus       639 FVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  639 FVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             EEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccce
Confidence            999999954 55555543  478999999999999999999999999   9999999999999643   47999999999


Q ss_pred             cccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       548 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ++++....  ...+.||+.|+|||++++..|...-|+||.||++|--|+|..||..+.+..+.  +.+..          
T Consensus       715 RiIgEksF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNAa----------  780 (888)
T KOG4236|consen  715 RIIGEKSF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNAA----------  780 (888)
T ss_pred             eecchhhh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhccc----------
Confidence            99875443  34567999999999999999999999999999999999999999765433221  11110          


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVS  667 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  667 (735)
                      ++   +......+...+..+||...|+..-.+|-+...-+
T Consensus       781 FM---yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  781 FM---YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             cc---cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            00   11222356667888999999999999998877654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.8e-32  Score=274.52  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=197.1

Q ss_pred             hccccccccccCcEEEEEEE-cCCCcEEEEEEeec--cC-----hhHHHHHHHHHHHHHhcCCCceEEEceEEe-ecCce
Q 004702          402 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKF--VD-----QAKIDEFINELVVVLQINRRNVVRLLGCCL-ETQVP  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~--~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~  472 (735)
                      ++-+..+||+|||++|||+. +...+.||+|+-..  ..     ..-.+...+|..|.+.|.||.||++++++. +.+..
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            34445689999999999998 55678899997432  11     112344568999999999999999999986 45577


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEeeccCCcc
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NCTPKVSDFGASKL  549 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGls~~  549 (735)
                      +-|+||++|.+|.-+|++...+++..+..|+.||+.||.||.... +||||-||||.||||-+   -|.+||.||||+++
T Consensus       544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            899999999999999999999999999999999999999999875 89999999999999954   56799999999999


Q ss_pred             cCCCccc------ceeeeccccCccCcccccCC----CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHH
Q 004702          550 VPIDAIQ------NCTVVQGTLGYLDPEYLQTC----KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS  619 (735)
Q Consensus       550 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  619 (735)
                      +..+...      ......||..|++||.+.-+    .++.|.||||.||++|..+.|++||.......+.         
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI---------  693 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI---------  693 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH---------
Confidence            8755433      23345699999999988543    5788999999999999999999999765443211         


Q ss_pred             hcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004702          620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVS  667 (735)
Q Consensus       620 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  667 (735)
                      +.++.+....+  +.-+..+....+...+|++||+..-++|....++.
T Consensus       694 LqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  694 LQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             Hhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            11111111111  11112234557788999999999999998876654

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-32  Score=302.88  Aligned_cols=248  Identities=26%  Similarity=0.311  Sum_probs=206.1

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.++||+|+||.|..++.+ .+..+|+|+++.   ....+..-|..|-.+|..-+.+-|+.|...+.+..++|+||||
T Consensus        77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY  156 (1317)
T KOG0612|consen   77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY  156 (1317)
T ss_pred             hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence            345679999999999999864 577899999875   4456667899999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      |+||+|..++.+...+++..+..++.+|..||.-||+.|   +|||||||+|||||..|.+||+|||.+..+..+..-..
T Consensus       157 ~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s  233 (1317)
T KOG0612|consen  157 MPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS  233 (1317)
T ss_pred             ccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence            999999999998888999999999999999999999999   99999999999999999999999999998886666666


Q ss_pred             eeeccccCccCcccccC-----CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          559 TVVQGTLGYLDPEYLQT-----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~-----~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      ...+|||.|++||++..     +.|....|-||+||++|||+.|..||+.+.-.+.-..+++-...             +
T Consensus       234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~-------------l  300 (1317)
T KOG0612|consen  234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES-------------L  300 (1317)
T ss_pred             ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh-------------c
Confidence            66779999999999853     56899999999999999999999999876554443333221111             1


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHH
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPT---MKEVS  667 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~  667 (735)
                      .-+...+.+++..+||.+.+. +|+.|..   +.++-
T Consensus       301 ~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  301 SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            111123467888999998884 6777776   55543

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=237.65  Aligned_cols=258  Identities=21%  Similarity=0.293  Sum_probs=194.2

Q ss_pred             cccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          406 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      .++||+|.+|+||||+. +.++.||+|+++..  ++.--...++|+.+|+.+.|+|||++++....+....+|+||+.. 
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence            35899999999999984 45788999998743  333456788999999999999999999999999999999999954 


Q ss_pred             chhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|..+... ++.++.+....++.|+++||.|.|+++   +.||||||.|.||+.|+.+|++|||+++.+.....- ....
T Consensus        86 dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrc-ysae  161 (292)
T KOG0662|consen   86 DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-YSAE  161 (292)
T ss_pred             HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEe-eece
Confidence            77777765 477999999999999999999999999   999999999999999999999999999987654322 2334


Q ss_pred             ccccCccCcccccCCC-CCccccchhHHHHHHHHHhCCcc-CCCCChHHHHHHHHHHHHHhcccchh---hHhhhcccCC
Q 004702          562 QGTLGYLDPEYLQTCK-LTDKSDVYSFGVVLVELLTGKMA-LLSDKPEEERSLAMNFLSSLKQNRLL---EILDNRIVND  636 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~-~~~ksDVyS~Gvvl~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~d~~~~~~  636 (735)
                      .-|..|.+|.++.+.+ |+...|+||-|+++.||.....| |......+....+.+.+....++.+.   .+.|......
T Consensus       162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~  241 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI  241 (292)
T ss_pred             eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence            4789999999988754 88899999999999999985444 44433333222222222222233222   2222222221


Q ss_pred             CC--H---H----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          637 GN--K---Q----QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       637 ~~--~---~----~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+  .   .    ....-++|+...+.-+|.+|.++++.++
T Consensus       242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11  1   1    1123467888888899999999887654

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-31  Score=259.29  Aligned_cols=244  Identities=23%  Similarity=0.287  Sum_probs=193.0

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEee----cCceeEEEEecC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLE----TQVPLLVYEFVG  480 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lV~E~~~  480 (735)
                      ++||-|-.|.|-.... ..++.+|+|.+...     ....+|+++.-.. .|||||.+++++..    ..-+++|||.|+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me  142 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME  142 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence            6899999999998874 45788999987643     3345788775554 59999999998753    345689999999


Q ss_pred             CCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCCeEEeeccCCcccCCCcc
Q 004702          481 NGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       481 ~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||.|...+.+++  .+++.++-.|..||..|+.|||+.+   |.||||||+|+|..   .|-.+||+|||+++....  .
T Consensus       143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--~  217 (400)
T KOG0604|consen  143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--P  217 (400)
T ss_pred             chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCC--C
Confidence            999999998874  5999999999999999999999999   99999999999996   456799999999996532  2


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      .......-|+.|.|||++...+|+...|+||+||++|-||.|.+||+...... .+.  .....+..+.      .....
T Consensus       218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-isp--gMk~rI~~gq------y~FP~  288 (400)
T KOG0604|consen  218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISP--GMKRRIRTGQ------YEFPE  288 (400)
T ss_pred             ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-CCh--hHHhHhhccC------ccCCC
Confidence            23344567999999999999999999999999999999999999998765421 111  1111111111      11223


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +.....++...++|+.+|..+|.+|.|+.|++..
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            3455677889999999999999999999998753

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-30  Score=285.82  Aligned_cols=247  Identities=26%  Similarity=0.367  Sum_probs=200.2

Q ss_pred             cccccccccCcEEEEEEE-cCCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEee-----cCceeEEE
Q 004702          404 NYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLE-----TQVPLLVY  476 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----~~~~~lV~  476 (735)
                      .|.++||+|.+|.||+++ .++++.+|+|++... ....+++..|.++|+.+ +|||++.++|++..     ++.+||||
T Consensus        22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM  100 (953)
T KOG0587|consen   22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM  100 (953)
T ss_pred             EEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence            456799999999999998 567888888887643 33345666788898887 59999999999874     56789999


Q ss_pred             EecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          477 EFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       477 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |||.+|+..|+++..  ..+.|..+..|+.+++.||.+||...   ++|||||-.|||++.++.+||.|||++..+....
T Consensus       101 EfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~  177 (953)
T KOG0587|consen  101 EFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV  177 (953)
T ss_pred             eccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence            999999999999864  57999999999999999999999999   9999999999999999999999999998764332


Q ss_pred             ccceeeeccccCccCcccccC-----CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          555 IQNCTVVQGTLGYLDPEYLQT-----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      ... ....||+.|||||++.-     ..|+..+|+||||++..||--|.+|+.+..+....       -.+..       
T Consensus       178 grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-------F~IpR-------  242 (953)
T KOG0587|consen  178 GRR-NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------FLIPR-------  242 (953)
T ss_pred             ccc-cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-------ccCCC-------
Confidence            222 33459999999999853     34777999999999999999999999876553311       11111       


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+......+..+.+++.++|..||..|.++||++.++++.
T Consensus       243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            1112222356788999999999999999999999998753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-31  Score=282.18  Aligned_cols=235  Identities=24%  Similarity=0.332  Sum_probs=189.9

Q ss_pred             cccccccccCcEEEEEEE-cCCCcEEEEEEeeccChhHHHHHHHHHHHHHh-cCCCceEEEceEEeecCceeEEEEecCC
Q 004702          404 NYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQ-INRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+...+|.|+|+.|-.+. ...+...++|++...    ..+-.+|+.++.. -+||||+++.+.+.+....++|||.+.+
T Consensus       325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g  400 (612)
T KOG0603|consen  325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG  400 (612)
T ss_pred             ccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence            345579999999998887 455778899987654    1223456655544 4799999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE-cCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL-DENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +-|.+.+....... ..+..|+.+|+.|+.|||+++   +|||||||+|||+ ++.++++|+|||.++....+    ...
T Consensus       401 ~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~t  472 (612)
T KOG0603|consen  401 GELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDT  472 (612)
T ss_pred             cHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh----hcc
Confidence            98888887665444 778889999999999999999   9999999999999 58899999999999977654    222


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..-|..|.|||++...+|++++|+||||++||+||+|+.||.......      +....+.            ...+...
T Consensus       473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i~------------~~~~s~~  534 (612)
T KOG0603|consen  473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRIQ------------MPKFSEC  534 (612)
T ss_pred             cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhhc------------CCccccc
Confidence            346889999999999999999999999999999999999997654331      1111111            1222345


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+.+.++|+.+||+.+|.+||+|.|+..
T Consensus       535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  535 VSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            6688999999999999999999999874

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=6.9e-30  Score=283.53  Aligned_cols=255  Identities=21%  Similarity=0.235  Sum_probs=178.1

Q ss_pred             ccccccccccCcEEEEEEEc-----------------CCCcEEEEEEeeccChhHHHHHH--------------HHHHHH
Q 004702          403 NNYADVIGCGGSGNVYKGFL-----------------PDRTPVAVKKSKFVDQAKIDEFI--------------NELVVV  451 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-----------------~~~~~vavK~~~~~~~~~~~~~~--------------~E~~~l  451 (735)
                      +.+.++||+|+||+||+|.+                 .+++.||||+++.......++|+              .|+.++
T Consensus       147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l  226 (507)
T PLN03224        147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC  226 (507)
T ss_pred             ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence            44567999999999999963                 23467999998765444444444              466677


Q ss_pred             HhcCCCce-----EEEceEEee--------cCceeEEEEecCCCchhHHhhhc------------------------CCC
Q 004702          452 LQINRRNV-----VRLLGCCLE--------TQVPLLVYEFVGNGTLFEHIHKK------------------------GNL  494 (735)
Q Consensus       452 ~~l~h~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~------------------------~~l  494 (735)
                      .+++|.++     +++++++..        .+..+|||||+++++|.++++..                        ..+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            77776654     677787753        34679999999999999988642                        124


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccCccCccccc
Q 004702          495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ  574 (735)
Q Consensus       495 ~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~  574 (735)
                      ++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||+++.+............+++.|+|||.+.
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            67788899999999999999998   999999999999999999999999999765433222222233578999999875


Q ss_pred             CCCC----------------------CccccchhHHHHHHHHHhCCc-cCCCCChHHHH----HHHHHHHHHhcccchhh
Q 004702          575 TCKL----------------------TDKSDVYSFGVVLVELLTGKM-ALLSDKPEEER----SLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       575 ~~~~----------------------~~ksDVyS~Gvvl~elltG~~-p~~~~~~~~~~----~~~~~~~~~~~~~~~~~  627 (735)
                      ....                      ..+.||||+|++|+||++|.. |+.........    ......+......    
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~----  459 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ----  459 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc----
Confidence            4321                      235799999999999999875 55322111100    0000011111111    


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRG---EERPTMKEVSL  668 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~ev~~  668 (735)
                          ....+..........+|+.++|..+|   .+|+|+.|+++
T Consensus       460 ----~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 ----KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ----CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                11111122345678899999999766   68999999875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-31  Score=265.83  Aligned_cols=268  Identities=21%  Similarity=0.285  Sum_probs=203.8

Q ss_pred             ccCHHHHHhhhccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCC--C----ceEEEce
Q 004702          392 IFTEEEIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINR--R----NVVRLLG  464 (735)
Q Consensus       392 ~~~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~g  464 (735)
                      ++...+....++.+.+.+|+|.||.|-+.... .+..||||+++.+... .+..+-|+++|.++.+  |    -+|.+.+
T Consensus        80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            44444555566667789999999999998754 3688999998876554 4556779999999953  2    2788889


Q ss_pred             EEeecCceeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-------
Q 004702          465 CCLETQVPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-------  535 (735)
Q Consensus       465 ~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-------  535 (735)
                      ++.-.++.++|+|.+ |.++.++|..+  .+++..++..|+.|++++++|||+.+   ++|-||||+|||+.+       
T Consensus       159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~  234 (415)
T KOG0671|consen  159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTY  234 (415)
T ss_pred             hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEe
Confidence            999999999999998 66999999886  57889999999999999999999999   999999999999932       


Q ss_pred             -------------CCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCC
Q 004702          536 -------------NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL  602 (735)
Q Consensus       536 -------------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~  602 (735)
                                   +..+||+|||.+.....+.    ..+.-|..|.|||++.+-.++..+||||+|+||.||.+|...|+
T Consensus       235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq  310 (415)
T KOG0671|consen  235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ  310 (415)
T ss_pred             ccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence                         3358999999998754332    34557899999999999999999999999999999999999998


Q ss_pred             CCChHHHHHHHHHHHHHhcccchhhH----------hh---------------hcc----cCCCCHHHHHHHHHHHHHcc
Q 004702          603 SDKPEEERSLAMNFLSSLKQNRLLEI----------LD---------------NRI----VNDGNKQQLKEVAKLAARCI  653 (735)
Q Consensus       603 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------~d---------------~~~----~~~~~~~~~~~l~~li~~cl  653 (735)
                      .....|....-...+..+...-+...          +|               +..    .-.....+..+|.+|+.+||
T Consensus       311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL  390 (415)
T KOG0671|consen  311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML  390 (415)
T ss_pred             cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence            77655533221111111110000000          00               000    00112334467999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 004702          654 SVRGEERPTMKEVSL  668 (735)
Q Consensus       654 ~~~p~~RPt~~ev~~  668 (735)
                      ..||.+|+|++|++.
T Consensus       391 ~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  391 EFDPARRITLREALS  405 (415)
T ss_pred             ccCccccccHHHHhc
Confidence            999999999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.3e-31  Score=256.17  Aligned_cols=258  Identities=21%  Similarity=0.307  Sum_probs=195.2

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--------CceeEE
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLET--------QVPLLV  475 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~~lV  475 (735)
                      .+||+|.||+||+++.+ .++.||+|++-..  ...--...++|+.+|..|.|+|++.++..|...        ...++|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            37999999999999854 5677899875432  222235568999999999999999999887542        246899


Q ss_pred             EEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          476 YEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |.+++. +|.-+|... ..++...+.++..++..||.|+|...   |+|||+|+.|+||+.++.+||+|||+++.+....
T Consensus       103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~  178 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSK  178 (376)
T ss_pred             HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceeccc
Confidence            999976 888888765 67999999999999999999999999   9999999999999999999999999998764322


Q ss_pred             ---ccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch-----
Q 004702          555 ---IQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL-----  625 (735)
Q Consensus       555 ---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  625 (735)
                         ....+...-|+.|++||.+.+ .+|+++.|||.-|+++.||+|+.+.+..........++......+..+.+     
T Consensus       179 n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~  258 (376)
T KOG0669|consen  179 NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDN  258 (376)
T ss_pred             ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCccc
Confidence               222344556999999998876 57999999999999999999999888776655544444433222222211     


Q ss_pred             ---hhHhhhc-ccCC---CCHHHH------HHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 ---LEILDNR-IVND---GNKQQL------KEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 ---~~~~d~~-~~~~---~~~~~~------~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                         .+.+... +...   .-.+..      .+..+|+..++..||.+|+++.+++.
T Consensus       259 lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  259 LPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             chHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence               1111000 0000   001111      36789999999999999999998874

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.6e-29  Score=287.62  Aligned_cols=255  Identities=20%  Similarity=0.206  Sum_probs=165.2

Q ss_pred             ccccccccccCcEEEEEEEcC-C----CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceE------EeecCc
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-D----RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC------CLETQV  471 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~~~~~  471 (735)
                      +.+.++||+|+||.||+|.+. +    +..||||++......  +.+.+|  .+....+.+++.++..      ......
T Consensus       134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence            445679999999999999964 4    688999987643221  222222  1222222222222211      234567


Q ss_pred             eeEEEEecCCCchhHHhhhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 004702          472 PLLVYEFVGNGTLFEHIHKKGN--------------------LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANI  531 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NI  531 (735)
                      .++||||+.+++|.+++.....                    .....+..++.|++.||+|||+.+   |+||||||+||
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NI  286 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNI  286 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHE
Confidence            8999999999999999875421                    112345679999999999999998   99999999999


Q ss_pred             EEcC-CCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCC----------------------CCCccccchhHH
Q 004702          532 LLDE-NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC----------------------KLTDKSDVYSFG  588 (735)
Q Consensus       532 Ll~~-~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksDVyS~G  588 (735)
                      ||++ ++.+||+|||+++.+............+++.|||||.+...                      .++.++||||||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            9985 67999999999986644333333445689999999965321                      244567999999


Q ss_pred             HHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc--cchhhHhhhcccCCC------CHHHHHHHHHHHHHcccCCCCCC
Q 004702          589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ--NRLLEILDNRIVNDG------NKQQLKEVAKLAARCISVRGEER  660 (735)
Q Consensus       589 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~d~~~~~~~------~~~~~~~l~~li~~cl~~~p~~R  660 (735)
                      ++||||+++..++...    ...+...+ .....  ..+...+.+....+.      .........+|+.+||+.||++|
T Consensus       367 viL~el~~~~~~~~~~----~~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        367 LIFLQMAFPNLRSDSN----LIQFNRQL-KRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             HHHHHHHhCcCCCchH----HHHHHHHH-HhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            9999999976653211    11111100 00000  011111111100000      00011245689999999999999


Q ss_pred             CCHHHHHHH
Q 004702          661 PTMKEVSLE  669 (735)
Q Consensus       661 Pt~~ev~~~  669 (735)
                      ||+.|+++.
T Consensus       442 ~ta~e~L~H  450 (566)
T PLN03225        442 ISAKAALAH  450 (566)
T ss_pred             CCHHHHhCC
Confidence            999999864

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.8e-30  Score=271.59  Aligned_cols=206  Identities=26%  Similarity=0.357  Sum_probs=175.7

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      +-||-|+||+|.++.. +....+|.|.+++.+   ..+......|-.||..-..+-||+|+..+.+.+.+|+||+|++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            4699999999999874 446678999877543   344556778999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC---------CC
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP---------ID  553 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~---------~~  553 (735)
                      ++-.+|.+.+.+.+..+..++.++.-|+++.|.-+   +|||||||+|||||.+|.+||.||||+.-+.         ..
T Consensus       715 DmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~g  791 (1034)
T KOG0608|consen  715 DMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEG  791 (1034)
T ss_pred             cHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCC
Confidence            99999999999999999999999999999999999   9999999999999999999999999975321         00


Q ss_pred             c--------------------------------ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccC
Q 004702          554 A--------------------------------IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL  601 (735)
Q Consensus       554 ~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~  601 (735)
                      .                                .-......||+.|+|||++....++..+|.||.||||+||+.|+.||
T Consensus       792 dH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf  871 (1034)
T KOG0608|consen  792 DHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPF  871 (1034)
T ss_pred             CccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCc
Confidence            0                                00011235999999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHHHH
Q 004702          602 LSDKPEEERSLAMN  615 (735)
Q Consensus       602 ~~~~~~~~~~~~~~  615 (735)
                      ....+.+....+.+
T Consensus       872 ~~~tp~~tq~kv~n  885 (1034)
T KOG0608|consen  872 LADTPGETQYKVIN  885 (1034)
T ss_pred             cCCCCCcceeeeee
Confidence            98888775544433

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=271.34  Aligned_cols=236  Identities=23%  Similarity=0.315  Sum_probs=203.9

Q ss_pred             ccccccCcEEEEEEEcCCCcE-EEEEEee---ccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          407 DVIGCGGSGNVYKGFLPDRTP-VAVKKSK---FVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~-vavK~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      .-||-|+||.|-+...+.... +|+|.++   .++..+.+....|-.+|...+.|.||+|+-.+.+....|++||-+-||
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            369999999999988665443 6766544   577788888999999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeec
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ  562 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~  562 (735)
                      .|...|.+++.+......-++.-+++|++|||+++   ||+|||||+|.+||.+|-+||.|||+++.+....  .+-...
T Consensus       506 ElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwTFc  580 (732)
T KOG0614|consen  506 ELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTFC  580 (732)
T ss_pred             hhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC--ceeeec
Confidence            99999999999999999999999999999999999   9999999999999999999999999999876443  334567


Q ss_pred             cccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHH
Q 004702          563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL  642 (735)
Q Consensus       563 gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  642 (735)
                      ||+.|.|||++.+.....+.|.||||++++||++|.+||....+...-+++..-+..+               +++....
T Consensus       581 GTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------------~~Pr~I~  645 (732)
T KOG0614|consen  581 GTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------------EFPRRIT  645 (732)
T ss_pred             CCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---------------hcccccc
Confidence            9999999999999999999999999999999999999998877765555443322222               2344556


Q ss_pred             HHHHHHHHHcccCCCCCCCC
Q 004702          643 KEVAKLAARCISVRGEERPT  662 (735)
Q Consensus       643 ~~l~~li~~cl~~~p~~RPt  662 (735)
                      +...+|+++....+|.+|.-
T Consensus       646 k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  646 KTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hhHHHHHHHHHhcCcHhhhc
Confidence            77889999999999999976

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.6e-31  Score=252.98  Aligned_cols=261  Identities=23%  Similarity=0.302  Sum_probs=207.8

Q ss_pred             cccccccCcEEEEEEEc-CCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecC-----ceeEEEE
Q 004702          406 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-----VPLLVYE  477 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~E  477 (735)
                      .+-||-|+||.||..+. ++++.||+|++.+.-  -..-+.+.+|+++|..++|.|++..++......     +.|+|.|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            45799999999999985 468999999987543  334567889999999999999999998766543     4578899


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      .|. .+|+.+|-..+.++.+.+.-++.||++||+|||+.+   |+||||||.|.|++.|..+||+|||+++....++...
T Consensus       138 LmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h  213 (449)
T KOG0664|consen  138 LMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN  213 (449)
T ss_pred             HHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence            884 489998888889999999999999999999999999   9999999999999999999999999999888787777


Q ss_pred             eeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhc--------ccchhhH
Q 004702          558 CTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK--------QNRLLEI  628 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~  628 (735)
                      ++...-|..|.|||.+.+ ..|+.+.||||.|+++.||+..+.-|....+.+...++.+.+..-.        ++....+
T Consensus       214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~  293 (449)
T KOG0664|consen  214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV  293 (449)
T ss_pred             hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence            777778999999999987 4699999999999999999999999988888777666554322111        1111112


Q ss_pred             hhhcccC---------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          629 LDNRIVN---------DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       629 ~d~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      +......         ..+...-.+...+...++..+|+.|.+..+.+..+
T Consensus       294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            2111110         11112234566788889999999999988877654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-29  Score=234.06  Aligned_cols=195  Identities=25%  Similarity=0.364  Sum_probs=162.2

Q ss_pred             cccccccCcEEEEEEEc-CCCcEEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCCC
Q 004702          406 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      .+.||+|++|.|-+-++ .+|...|+|+++. .+.+...+.+.|+.+..+- ..|.+|.++|........++.||.|. -
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence            35799999999988764 5688999999874 4555567778888876554 68999999999999999999999995 4


Q ss_pred             chhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          483 TLFEHIH----KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       483 sL~~~l~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +|..+-+    +.+.+++..+-+|+..+.+||.|||++-+  +||||+||+||||+.+|++||+|||++-.+.+....  
T Consensus       130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk--  205 (282)
T KOG0984|consen  130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK--  205 (282)
T ss_pred             hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhhHH--
Confidence            7765543    45789999999999999999999999764  999999999999999999999999999877543322  


Q ss_pred             eeeccccCccCcccccC----CCCCccccchhHHHHHHHHHhCCccCCCCC
Q 004702          559 TVVQGTLGYLDPEYLQT----CKLTDKSDVYSFGVVLVELLTGKMALLSDK  605 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~----~~~~~ksDVyS~Gvvl~elltG~~p~~~~~  605 (735)
                      +...|-..|||||.+..    ..|+.||||||||+++.||.+++.||....
T Consensus       206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            22348889999998753    478999999999999999999999986543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=276.52  Aligned_cols=239  Identities=25%  Similarity=0.326  Sum_probs=183.4

Q ss_pred             cccccccCcEE-EEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          406 ADVIGCGGSGN-VYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       406 ~~~lG~G~~g~-Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .+++|.|+.|+ ||+|... ++.||||++-.   +...-..+|+..|..- .|||||++++.-.+....||..|.|. -+
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS  588 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence            45899999886 6999984 67899998652   2233446899999887 59999999999999999999999995 59


Q ss_pred             hhHHhhhc-C---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-----CCCeEEeeccCCcccCCCc
Q 004702          484 LFEHIHKK-G---NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-----NCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       484 L~~~l~~~-~---~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DFGls~~~~~~~  554 (735)
                      |.+++... .   ...-...+.++.|+++||++||+.+   ||||||||.||||+.     ..+++|+|||+++.+..+.
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            99999873 1   1111345778899999999999988   999999999999975     3579999999999987654


Q ss_pred             ccc--eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhC-CccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          555 IQN--CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG-KMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       555 ~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      ...  .....||-+|+|||.+....-+.+.||||||+|+|+.++| ..||......+ .+...    ..  ..+..    
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~----~~--~~L~~----  734 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILT----GN--YTLVH----  734 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhc----Cc--cceee----
Confidence            433  3345699999999999998888899999999999999996 78886443221 11110    00  00000    


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       + .+ ..+.  +..+||.+|++++|..||++.+|+.
T Consensus       735 -L-~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 -L-EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -e-cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence             0 00 1111  7889999999999999999999984

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.5e-27  Score=236.93  Aligned_cols=209  Identities=36%  Similarity=0.545  Sum_probs=184.0

Q ss_pred             ccccCcEEEEEEEcCC-CcEEEEEEeeccChh-HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchhH
Q 004702          409 IGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQA-KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE  486 (735)
Q Consensus       409 lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  486 (735)
                      ||+|.+|.||++...+ +..+++|+....... ..+.+.+|+..++.+.|++|+++++++......+++||++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 888999998754432 45778999999999999999999999999899999999999999999


Q ss_pred             Hhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEeeccCCcccCCCcccceeeeccc
Q 004702          487 HIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NCTPKVSDFGASKLVPIDAIQNCTVVQGT  564 (735)
Q Consensus       487 ~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGls~~~~~~~~~~~~~~~gt  564 (735)
                      ++... ..+++..++.++.+++++|++||+.+   ++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence            99876 57999999999999999999999998   999999999999999 89999999999986643321 12234478


Q ss_pred             cCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHH
Q 004702          565 LGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK  643 (735)
Q Consensus       565 ~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  643 (735)
                      ..|++||.+... ..+.++|+|+||+++++|                                                .
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~  188 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------P  188 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------H
Confidence            899999999887 888999999999999999                                                3


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          644 EVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       644 ~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+.+++.+|++.+|++||++.++++.
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            67889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.9e-28  Score=237.96  Aligned_cols=245  Identities=25%  Similarity=0.299  Sum_probs=192.5

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeec---cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEe
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF---VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      ++..+||+|++.+|..+.+. ..+.+|+|++++   .+.++++-...|-.+..+- +||.+|.|..++..+..+++|.||
T Consensus       253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey  332 (593)
T KOG0695|consen  253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY  332 (593)
T ss_pred             eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence            34568999999999999865 467789998764   2334455555676666665 799999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|+|--++++...++++.+.-+..+|..||.|||+.+   ||.||||.+|+|||..+.+||.|+|+++.--.+. ...
T Consensus       333 v~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~g-d~t  408 (593)
T KOG0695|consen  333 VNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-DTT  408 (593)
T ss_pred             ecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCC-ccc
Confidence            999999999998889999999999999999999999999   9999999999999999999999999998532222 123


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHH-HHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER-SLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....||+.|+|||++.+..|.-..|-|+|||+++||+.|+.||.-....... +-....+.        -+++.++..  
T Consensus       409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq--------vilekqiri--  478 (593)
T KOG0695|consen  409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ--------VILEKQIRI--  478 (593)
T ss_pred             ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH--------HHhhhcccc--
Confidence            4467999999999999999999999999999999999999999633211111 11111111        123333322  


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCC
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPT  662 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt  662 (735)
                      +...+.....+++.-|++||.+|..
T Consensus       479 prslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  479 PRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             cceeehhhHHHHHHhhcCCcHHhcC
Confidence            2233456677899999999999854

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.3e-26  Score=233.95  Aligned_cols=197  Identities=33%  Similarity=0.467  Sum_probs=173.2

Q ss_pred             cccccccccCcEEEEEEEcCC-CcEEEEEEeeccChh-HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          404 NYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQA-KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.+.||+|++|.||++...+ +..+++|........ ..+.+.+|++.+.+++|+|++++++++......++++|++.+
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            356789999999999999765 788999998765444 678899999999999999999999999998999999999999


Q ss_pred             CchhHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~~~~-l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ++|.+++..... +++..+..++.+++.+|.+||+.+   ++|+||++.||+++.++.++|+|||++.............
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999987666 899999999999999999999998   9999999999999999999999999998775442112233


Q ss_pred             eccccCccCcccc-cCCCCCccccchhHHHHHHHHHhCCccCCC
Q 004702          561 VQGTLGYLDPEYL-QTCKLTDKSDVYSFGVVLVELLTGKMALLS  603 (735)
Q Consensus       561 ~~gt~~y~aPE~~-~~~~~~~ksDVyS~Gvvl~elltG~~p~~~  603 (735)
                      ..++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4578899999998 667788899999999999999999999955

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=5e-27  Score=221.97  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=189.6

Q ss_pred             ccccccccCcEEEEEEE-cCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEeec--CceeEEEEecC
Q 004702          405 YADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLET--QVPLLVYEFVG  480 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~E~~~  480 (735)
                      +.+++|+|.+++||.|. ..++..++||.++...   .+.+.+|+.+|..|. ||||++|++...+.  ..+.||+||+.
T Consensus        42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~  118 (338)
T KOG0668|consen   42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN  118 (338)
T ss_pred             HHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence            34589999999999998 5678889999988654   455779999999997 99999999998764  46789999998


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      +.+...+-   +.++...+...+.|+++||.|.|+.|   |+|||+||.|++||. ...++|+|+|+|.+......... 
T Consensus       119 n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV-  191 (338)
T KOG0668|consen  119 NTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-  191 (338)
T ss_pred             cccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCceeee-
Confidence            86554443   56888889999999999999999999   999999999999985 55699999999998755443322 


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc---------------
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN---------------  623 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------------  623 (735)
                       ...+..|.-||.+.. ..|...-|+||||++|.+|+-.+.||.......+ +++ .....+...               
T Consensus       192 -RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLV-kIakVLGt~el~~Yl~KY~i~Ldp  268 (338)
T KOG0668|consen  192 -RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLV-KIAKVLGTDELYAYLNKYQIDLDP  268 (338)
T ss_pred             -eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHH-HHHHHhChHHHHHHHHHHccCCCh
Confidence             235667889998865 5588899999999999999999999986654322 111 111111111               


Q ss_pred             chhhHhhhccc-------CCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          624 RLLEILDNRIV-------NDGNKQ-QLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       624 ~~~~~~d~~~~-------~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +...++.....       ...+.. ..++..+|+.+.|..|-++|||++|....
T Consensus       269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            11222211111       111111 23788999999999999999999997753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-28  Score=262.66  Aligned_cols=248  Identities=25%  Similarity=0.346  Sum_probs=204.7

Q ss_pred             ccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          405 YADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      +...+|.|.+|.|||++. ..+...|+|.++.....+..-..+|+-+++.-+||||+.++|.+...+..|+.|||+.+|+
T Consensus        19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs   98 (829)
T KOG0576|consen   19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS   98 (829)
T ss_pred             heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence            356899999999999984 4688899999998777777788899999999999999999999999999999999999999


Q ss_pred             hhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeecc
Q 004702          484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG  563 (735)
Q Consensus       484 L~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~g  563 (735)
                      |.+.-+-.+++++.++....++.++||+|||+.+   -+|||||-.|||+++.+.+|++|||.+..+... ........|
T Consensus        99 lQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-i~KrksfiG  174 (829)
T KOG0576|consen   99 LQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKRKSFIG  174 (829)
T ss_pred             ccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-hhhhhcccC
Confidence            9999998899999999999999999999999999   899999999999999999999999998765432 223345679


Q ss_pred             ccCccCcccc---cCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          564 TLGYLDPEYL---QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       564 t~~y~aPE~~---~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      |+.|||||+.   ..+.|..++|||++|+...||-.-+.|.+...+...  +...-.+..+..++         . -...
T Consensus       175 tpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--l~LmTkS~~qpp~l---------k-Dk~k  242 (829)
T KOG0576|consen  175 TPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--LFLMTKSGFQPPTL---------K-DKTK  242 (829)
T ss_pred             CccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--HHHhhccCCCCCcc---------c-CCcc
Confidence            9999999976   456799999999999999999888888766544321  11111111111111         1 1234


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+.+.++++.++..+|++|||+..++.
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee
Confidence            5678999999999999999999987653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=5.2e-27  Score=232.75  Aligned_cols=253  Identities=25%  Similarity=0.346  Sum_probs=188.0

Q ss_pred             cccccCcEEEEEEE-cCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------ceeEEEEe
Q 004702          408 VIGCGGSGNVYKGF-LPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------VPLLVYEF  478 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV~E~  478 (735)
                      .+|.|.. .|-.+. .-.+++||+|++..  .+....+...+|+.++..++|+||++++.++....      ..|+|||+
T Consensus        24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~  102 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL  102 (369)
T ss_pred             ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence            5777777 444443 23478899998653  34445667789999999999999999999987544      45899999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      | ..+|...++.  .++-+.+..|+.|++.|++|||+.+   |+||||||+||++..+..+||.|||+++....+  ...
T Consensus       103 m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~m  174 (369)
T KOG0665|consen  103 M-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMM  174 (369)
T ss_pred             h-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc--ccc
Confidence            9 4589888873  4778889999999999999999999   999999999999999999999999999975444  345


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHH--------HHHhccc-------
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF--------LSSLKQN-------  623 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~-------  623 (735)
                      +....|..|.|||++.+..+.+..||||+|+++.||++|+.-|.+....+.-.....+        ...+...       
T Consensus       175 tpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~  254 (369)
T KOG0665|consen  175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVEN  254 (369)
T ss_pred             CchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhc
Confidence            6667899999999999988999999999999999999999888644333222221111        1111100       


Q ss_pred             -------chhhH-hhhc--ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          624 -------RLLEI-LDNR--IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       624 -------~~~~~-~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                             ...+. .|..  ...+.+.-....+.+|+.+||-.+|++|.++++++..
T Consensus       255 ~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  255 RPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             ChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                   00000 0000  0111222233567899999999999999999988753

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-25  Score=230.38  Aligned_cols=130  Identities=25%  Similarity=0.343  Sum_probs=109.4

Q ss_pred             hhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-----C---CceEEEceEEeec--
Q 004702          401 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-----R---RNVVRLLGCCLET--  469 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~~~~--  469 (735)
                      .+|...++||-|-|++||++.. .+.+.||+|+.+.... -.+..+.|+++|++++     |   ..||+|++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            6677788999999999999974 4567899999875432 3466789999999984     3   4699999998754  


Q ss_pred             --CceeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 004702          470 --QVPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD  534 (735)
Q Consensus       470 --~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~  534 (735)
                        .+.+||+|++ |.+|..+|...  +.++...+.+|+.||+.||.|||.+.+  |||-||||+|||+.
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~  222 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLC  222 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeee
Confidence              4779999999 66888888764  679999999999999999999999874  99999999999993

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-26  Score=243.21  Aligned_cols=192  Identities=23%  Similarity=0.337  Sum_probs=164.0

Q ss_pred             cccccccCcEEEEEEEcCC-CcEEEEEEeeccC--------hhHHHHHHHHHHHHHhcC---CCceEEEceEEeecCcee
Q 004702          406 ADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVD--------QAKIDEFINELVVVLQIN---RRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~  473 (735)
                      .+.+|.|+||.|+.++.+. ...|+||.+.+..        ..+....--|+.||..++   |+||++++.++.+.+..|
T Consensus       566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy  645 (772)
T KOG1152|consen  566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY  645 (772)
T ss_pred             eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence            4589999999999999654 5668888765321        111222346999999998   999999999999999999


Q ss_pred             EEEEec-CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          474 LVYEFV-GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       474 lV~E~~-~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      |+||-. ++-+|.++|.-+..+++.....|+.|++.|+++||+++   |||||||-+|+.|+.+|-+||+|||.+.+...
T Consensus       646 l~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ks  722 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS  722 (772)
T ss_pred             EEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcC
Confidence            999976 45699999999899999999999999999999999999   99999999999999999999999999987643


Q ss_pred             CcccceeeeccccCccCcccccCCCCC-ccccchhHHHHHHHHHhCCccCCC
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLS  603 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVyS~Gvvl~elltG~~p~~~  603 (735)
                      .   .....+||..|.|||++.+..|- ..-|||++|++||.++....||+.
T Consensus       723 g---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  723 G---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             C---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            3   34556799999999999988765 467999999999999999888863

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=3.5e-26  Score=238.54  Aligned_cols=270  Identities=19%  Similarity=0.219  Sum_probs=207.2

Q ss_pred             cccCHHHHHhhhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCC------CceEEEc
Q 004702          391 KIFTEEEIKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR------RNVVRLL  463 (735)
Q Consensus       391 ~~~~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~  463 (735)
                      ......|+....|...-..|+|-|++|-.|.. ..+..||||++++.. .-.+.=+.|+++|++|+.      -|+++|+
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            34456677777777778899999999999984 347799999988532 223445689999999963      5899999


Q ss_pred             eEEeecCceeEEEEecCCCchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CCe
Q 004702          464 GCCLETQVPLLVYEFVGNGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-CTP  539 (735)
Q Consensus       464 g~~~~~~~~~lV~E~~~~gsL~~~l~~~---~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~  539 (735)
                      -.|...++++||+|-+ ..+|.+.|++.   -.|....+..++.|+.-||..|...+   |+|.||||+||||++. ..+
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence            9999999999999988 45899999875   35888999999999999999999998   9999999999999865 468


Q ss_pred             EEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHH
Q 004702          540 KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS  619 (735)
Q Consensus       540 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~  619 (735)
                      ||||||.|.........   ...-+..|.|||++.+..|+...|+||.||.||||.||+.-|.........-+.+.....
T Consensus       577 KLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  577 KLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK  653 (752)
T ss_pred             eeccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence            99999999877654432   233466899999999999999999999999999999999988776655544443332111


Q ss_pred             h-----cccch---------------------------hh-----------HhhhcccCCCCHHHHHHHHHHHHHcccCC
Q 004702          620 L-----KQNRL---------------------------LE-----------ILDNRIVNDGNKQQLKEVAKLAARCISVR  656 (735)
Q Consensus       620 ~-----~~~~~---------------------------~~-----------~~d~~~~~~~~~~~~~~l~~li~~cl~~~  656 (735)
                      +     +.+.+                           +.           ++..+-...........|.+|+..||.+|
T Consensus       654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence            1     10000                           00           00001112223445578999999999999


Q ss_pred             CCCCCCHHHHHH
Q 004702          657 GEERPTMKEVSL  668 (735)
Q Consensus       657 p~~RPt~~ev~~  668 (735)
                      |++|.|..|++.
T Consensus       734 P~KRit~nqAL~  745 (752)
T KOG0670|consen  734 PEKRITVNQALK  745 (752)
T ss_pred             hhhcCCHHHHhc
Confidence            999999998774

>PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding

Probab=99.93  E-value=4.7e-26  Score=201.21  Aligned_cols=104  Identities=41%  Similarity=0.845  Sum_probs=90.7

Q ss_pred             CCCCCCCCCCeeecccCcCCCCCCCCCCCceeecCCCCCCccccccCCccEEEEee-ccEEEEEeeecceeccCCCCccc
Q 004702           21 KPRCPNRCGDVEIPYPFGTKRGCFLNKDFLITCNDTLNPPKPFLRKSSIEVVNISI-DGHLNVMQYTAKVCYDAKGYSVD   99 (735)
Q Consensus        21 ~~~C~~~CG~v~IpYPFg~~~~C~~~~~F~l~C~~~~~~~~~~~~~~~~~v~~is~-~~~~~v~~~~~~~c~~~~~~~~~   99 (735)
                      +++||++||||+|||||||++||+++|+|+|+|++++++|++++.+++++|++|+| +++++|..++++.|+........
T Consensus         1 ~~~C~~~CGnv~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~~~~~~~~~~~~~~   80 (106)
T PF13947_consen    1 KPGCPSSCGNVSIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPISSNCYSSSSSNSS   80 (106)
T ss_pred             CCCCCCccCCEeecCCCccCCCCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEeccccceecCCCCccc
Confidence            57999999999999999999999998999999999877888888889999999999 89999999999999888765432


Q ss_pred             -CCCCcccccceEEecCCCeEEEEccce
Q 004702          100 -SNLPYITLSKFTFSRTGNKFVVIGCDS  126 (735)
Q Consensus       100 -~~~~~~~~~pf~~s~~~n~~~~~gC~~  126 (735)
                       .++++.  .||.+|+.+|+|+++||++
T Consensus        81 ~~~~~~~--~~~~~s~~~N~~~~~GC~t  106 (106)
T PF13947_consen   81 NSNLSLN--GPFFFSSSSNKFTVVGCNT  106 (106)
T ss_pred             ccEEeec--CCceEccCCcEEEEECCCC
Confidence             223322  4899999999999999985

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-25  Score=216.87  Aligned_cols=252  Identities=17%  Similarity=0.284  Sum_probs=185.4

Q ss_pred             ccccccccccCcEEEEEEEcCC-CcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceE-EeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGC-CLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lV~E~~  479 (735)
                      +++.+.||+|.||.+.++..+. ++.+++|.+.. ......+|.+|...--.| .|.||+.-+.. +...+..++++||+
T Consensus        26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a  104 (378)
T KOG1345|consen   26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA  104 (378)
T ss_pred             hhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence            4567799999999999998654 67788887653 344578899998876666 48999987765 45566778999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD--ENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +.|+|.+.+... .+.+..-.+++.|++.||.|+|+++   +||||||.+||||-  +..++||+|||+.+....-.   
T Consensus       105 P~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV---  177 (378)
T KOG1345|consen  105 PRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV---  177 (378)
T ss_pred             ccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCcee---
Confidence            999999988663 5788888999999999999999999   99999999999993  45589999999988653211   


Q ss_pred             eeeeccccCccCcccccCC-----CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          558 CTVVQGTLGYLDPEYLQTC-----KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~-----~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                       .....+..|.+||.....     ...+.+|||.||++++..+||+.||...... +.... +|....+ ++...+  ++
T Consensus       178 -~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~-~~~~w~~-rk~~~~--P~  251 (378)
T KOG1345|consen  178 -KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYW-EWEQWLK-RKNPAL--PK  251 (378)
T ss_pred             -hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHH-HHHHHhc-ccCccC--ch
Confidence             122356689999976542     3567899999999999999999999743222 22222 2222221 111111  11


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      .    ....++.+..+.++-|..++++|--..++.+....
T Consensus       252 ~----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~  287 (378)
T KOG1345|consen  252 K----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC  287 (378)
T ss_pred             h----hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence            1    12344678889999999999999777776655443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=9.4e-26  Score=269.51  Aligned_cols=194  Identities=19%  Similarity=0.219  Sum_probs=139.5

Q ss_pred             hcCC-CceEEEceEE-------eecCceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 004702          453 QINR-RNVVRLLGCC-------LETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIH  523 (735)
Q Consensus       453 ~l~h-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH  523 (735)
                      .++| +||+++++++       .+.+..++++|++ +++|.++|... ..+++.+++.++.||++||+|||+++   |+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence            3455 5788888876       2334567889987 56999999753 56999999999999999999999998   999


Q ss_pred             cCCCCCcEEEcC-------------------CCCeEEeeccCCcccCCCc---------------ccceeeeccccCccC
Q 004702          524 RDVKSANILLDE-------------------NCTPKVSDFGASKLVPIDA---------------IQNCTVVQGTLGYLD  569 (735)
Q Consensus       524 ~Dlk~~NILl~~-------------------~~~~kl~DFGls~~~~~~~---------------~~~~~~~~gt~~y~a  569 (735)
                      |||||+||||+.                   ++.+||+|||+++......               ........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999954                   4456677777765421100               000111347888999


Q ss_pred             cccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHH
Q 004702          570 PEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLA  649 (735)
Q Consensus       570 PE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li  649 (735)
                      ||++.+..++.++|||||||+||||++|..|+....     ....    .+...    .+.+     .......+...++
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~----~~~~~----~~~~-----~~~~~~~~~~~~~  245 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMS----SLRHR----VLPP-----QILLNWPKEASFC  245 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHH----HHHHh----hcCh-----hhhhcCHHHHHHH
Confidence            999999999999999999999999999887753211     0000    00000    0111     0111234567889


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 004702          650 ARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       650 ~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+||+.+|.+||+|.||++
T Consensus       246 ~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHhCCCChhhCcChHHHhh
Confidence            9999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=2.2e-24  Score=209.70  Aligned_cols=168  Identities=19%  Similarity=0.233  Sum_probs=128.4

Q ss_pred             CchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      |+|.++++.. ..+++..++.|+.|+++||+|||+.+         ||+|||++.++.+|+  ||+++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899999874 56999999999999999999999976         999999999999999  99988654322      


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..|++.|||||++.+..++.++||||||+++|||++|+.||.......  ..............      +. .......
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~------~~-~~~~~~~  134 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADD------PR-DRSNLES  134 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCC------cc-ccccHHH
Confidence            248899999999999999999999999999999999999986432211  11111111111100      00 0001122


Q ss_pred             HHH--HHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          641 QLK--EVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       641 ~~~--~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ...  ++.+++.+||+.+|.+||++.|+++.+..+..
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            223  69999999999999999999999999876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=8.7e-25  Score=225.03  Aligned_cols=256  Identities=22%  Similarity=0.319  Sum_probs=188.4

Q ss_pred             ccccccccCcEEEEEEEcC----CCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEec
Q 004702          405 YADVIGCGGSGNVYKGFLP----DRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      ..++||+|.|++||++++.    ..+.||+|.+.....  .....+|+++|..+. +.||+++.++....+...+|+||+
T Consensus        40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~  117 (418)
T KOG1167|consen   40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF  117 (418)
T ss_pred             hhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence            3568999999999999853    467899999775443  345789999999995 899999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEeeccCCcccCCCc----
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDA----  554 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGls~~~~~~~----  554 (735)
                      +.....++...   ++...+..++..+++||+++|.++   ||||||||.|+|.+ ..++-.|.|||++.......    
T Consensus       118 ~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~  191 (418)
T KOG1167|consen  118 EHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH  191 (418)
T ss_pred             CccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence            99888887754   778999999999999999999999   99999999999998 45678999999987210000    


Q ss_pred             ---------------------------------------ccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHH
Q 004702          555 ---------------------------------------IQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVEL  594 (735)
Q Consensus       555 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~el  594 (735)
                                                             ........||++|.|||++.. ...+.++||||.||+++-+
T Consensus       192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsl  271 (418)
T KOG1167|consen  192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSL  271 (418)
T ss_pred             hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehh
Confidence                                                   000112349999999998865 5688999999999999999


Q ss_pred             HhCCccCCCCChHHHH-HHHHH-H----HHHh--cccc-----------hhhH------hh-hc---------ccCCCCH
Q 004702          595 LTGKMALLSDKPEEER-SLAMN-F----LSSL--KQNR-----------LLEI------LD-NR---------IVNDGNK  639 (735)
Q Consensus       595 ltG~~p~~~~~~~~~~-~~~~~-~----~~~~--~~~~-----------~~~~------~d-~~---------~~~~~~~  639 (735)
                      ++++.||......-.. ..+.. |    ++..  -.++           +.+.      ++ ..         ....+..
T Consensus       272 ls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d  351 (418)
T KOG1167|consen  272 LSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSD  351 (418)
T ss_pred             hccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccc
Confidence            9999999754332111 00000 0    0000  0011           0000      00 00         0011112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+..+.+|+.+|+..||.+|.|+++.++
T Consensus       352 ~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  352 VFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            23347899999999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=4.1e-23  Score=205.63  Aligned_cols=277  Identities=16%  Similarity=0.181  Sum_probs=215.9

Q ss_pred             hhhccccccccccCcEEEEEEE-cCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEE
Q 004702          400 TVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      ...+..+++||+|+||+++.|+ +-++.+||||.-..  ..+..++..|....+.|. .++|..++.+..++....||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3456678999999999999998 66789999997432  233456677888888886 5899999999999999999999


Q ss_pred             ecCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-----CCCeEEeeccCCcccC
Q 004702          478 FVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-----NCTPKVSDFGASKLVP  551 (735)
Q Consensus       478 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DFGls~~~~  551 (735)
                      .+ |.+|+|++.- ...++.++++.||+|++.-++|+|++.   +|.|||||+|+||..     ...+.|+|||+++.+.
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            98 7799988863 367999999999999999999999999   999999999999963     3468999999999875


Q ss_pred             CCcccc------eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          552 IDAIQN------CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       552 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                      +..+..      .....||.+||+--...+.+.+.+.|.-|||-|++..|-|..||........+.....+-..-+...+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i  260 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI  260 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence            443332      23345999999999999999999999999999999999999999877655433322221111111122


Q ss_pred             hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhccCCccccccccccC
Q 004702          626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESN  691 (735)
Q Consensus       626 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~~~~  691 (735)
                      .++         ....+.++..-+...-+++-.+-|...-+...+..++.......+.-.++....
T Consensus       261 ~~L---------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln  317 (449)
T KOG1165|consen  261 EVL---------CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN  317 (449)
T ss_pred             HHH---------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence            222         223456777788888888999999999999989988888776665555555544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=5.6e-23  Score=196.17  Aligned_cols=273  Identities=19%  Similarity=0.220  Sum_probs=213.4

Q ss_pred             HHhhhccccccccccCcEEEEEEE-cCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCC-CceEEEceEEeecCceeEE
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV  475 (735)
                      |..-.+.+.+.||.|+||.+|.|. ..+|..||||.-+.  .....+..-|..+...|++ ..|..+..+..+.....+|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            344456677899999999999998 67899999998543  2334567789999999986 6788888888899999999


Q ss_pred             EEecCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEeeccCCcccC
Q 004702          476 YEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NCTPKVSDFGASKLVP  551 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGls~~~~  551 (735)
                      |+.+ +.+|++++.- ...++..+.+.++-|++.-++|+|.++   +|||||||+|+|..-   ...+.++|||+++.+.
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9998 7799998863 467999999999999999999999999   999999999999963   3468999999998764


Q ss_pred             CCccc------ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          552 IDAIQ------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       552 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                      +..+.      ..+...||.+|.+--...+.+.+...|.-|+|.+|..+.-|..||.........+...           
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE-----------  234 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE-----------  234 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH-----------
Confidence            33221      2233459999999999888899999999999999999999999998876654433322           


Q ss_pred             hhHhhhccc---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhccCCcccccccc
Q 004702          626 LEILDNRIV---NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNV  688 (735)
Q Consensus       626 ~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~~~~~~~~~~~  688 (735)
                       .|.+..+.   .......+.++.-.+..|-..--++-|...-+-+.+.-++..++...+++.++.
T Consensus       235 -kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~  299 (341)
T KOG1163|consen  235 -KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWT  299 (341)
T ss_pred             -HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHH
Confidence             22222111   111233457788899999999999999998888888877777766555555443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=2.8e-22  Score=214.30  Aligned_cols=260  Identities=22%  Similarity=0.237  Sum_probs=195.5

Q ss_pred             hccccccccccCcEEEEEEEcCCC--cEEEEEEeeccChhHHHHHHHHHHHHHhcCC----CceEEEceEE-eecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDR--TPVAVKKSKFVDQAKIDEFINELVVVLQINR----RNVVRLLGCC-LETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l  474 (735)
                      .+.+.+.||+|+||.||++.....  ..+|+|............+..|..++..+.+    +++..++... ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            456778999999999999986553  4788887665433333367788888888873    6888888888 47778899


Q ss_pred             EEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-----CCeEEeeccCC
Q 004702          475 VYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-----CTPKVSDFGAS  547 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-----~~~kl~DFGls  547 (735)
                      ||+.+ +.+|.++....  +.++..+.++|+.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 77999988654  57999999999999999999999999   9999999999999754     46999999999


Q ss_pred             c--ccCCCcc----c--c-eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHH
Q 004702          548 K--LVPIDAI----Q--N-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS  618 (735)
Q Consensus       548 ~--~~~~~~~----~--~-~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~  618 (735)
                      +  ....+..    .  . .....||.+|.++....+.+.+.+.|+||++.++.||+.|..||.................
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  3321111    1  1 2235599999999999999999999999999999999999999965543332221111111


Q ss_pred             HhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       619 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ..       ....     .....+.++.++...+-+.+..++|....+...|+......
T Consensus       255 ~~-------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  255 KL-------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hh-------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            00       0000     11123345666666666799999999999999988776654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=7.1e-24  Score=205.19  Aligned_cols=248  Identities=19%  Similarity=0.277  Sum_probs=192.2

Q ss_pred             cccccccccCcEEEEEEEcCCCcEEEEEEee--ccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSK--FVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++..+|.+.-.|+.|+|++.++. +++|+++  ........+|..|.-.|+-+.||||+.++|.|.....+.++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            45567888899999999997665 5556544  34444457899999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          482 GTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       482 gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      |+|+..|++..  .++..++.+++.++|+|++|||+... -|.---|.+..++||++.+++|+= +-.++     +.+..
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kf-----sfqe~  344 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQEV  344 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-cccee-----eeecc
Confidence            99999999763  46788999999999999999999872 233446899999999999988851 11111     01111


Q ss_pred             eeccccCccCcccccCCCCC---ccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          560 VVQGTLGYLDPEYLQTCKLT---DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~---~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      ...-.+.||+||.++..+-.   .++|+|||+++||||.|...||....+.+-...               +.-..+...
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---------------ialeglrv~  409 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---------------IALEGLRVH  409 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---------------hhhcccccc
Confidence            12246899999999876533   479999999999999999999987766553221               112223333


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                      .+...+..+.+|+.-|++.||.+||.+..|+-.|++.+
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            45566778899999999999999999999999998754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.1e-22  Score=214.73  Aligned_cols=161  Identities=18%  Similarity=0.136  Sum_probs=125.5

Q ss_pred             hccccccccccCcEEEEEEEcC--CCcEEEEEEeecc-----ChhHHHHHHHHHHHHHhcCCCceEE-EceEEeecCcee
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP--DRTPVAVKKSKFV-----DQAKIDEFINELVVVLQINRRNVVR-LLGCCLETQVPL  473 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~  473 (735)
                      .+.+.++||+|+||+||+|...  ++..||||++...     .....+.|.+|+++|++++|+|+++ ++.    .+..+
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~   94 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDG   94 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcE
Confidence            3566789999999999999854  5677899986532     2334567899999999999999985 443    24579


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV-KSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      +||||+++++|... ...   .   ...++.|++++|+|||+.+   |+|||| ||+|||++.++++||+|||+++.+..
T Consensus        95 LVmE~~~G~~L~~~-~~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         95 LVRGWTEGVPLHLA-RPH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             EEEEccCCCCHHHh-Ccc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            99999999999632 111   1   2467899999999999998   999999 99999999999999999999997643


Q ss_pred             Ccc-------cceeeeccccCccCcccccCC
Q 004702          553 DAI-------QNCTVVQGTLGYLDPEYLQTC  576 (735)
Q Consensus       553 ~~~-------~~~~~~~gt~~y~aPE~~~~~  576 (735)
                      ...       ...+...+++.|++||++...
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            221       112345688899999998643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=2.9e-20  Score=197.42  Aligned_cols=257  Identities=29%  Similarity=0.398  Sum_probs=195.5

Q ss_pred             cccccccccCcEEEEEEEcCCCcEEEEEEeeccChh---HHHHHHHHHHHHHhcCCC-ceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQA---KIDEFINELVVVLQINRR-NVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.||.|+|+.||++...  ..+++|.+......   ....|.+|+.++..+.|+ +|++++..+......++++|++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            34568999999999999876  77899987643222   477899999999999988 7999999997777789999999


Q ss_pred             CCCchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEeeccCCcccCCCcc
Q 004702          480 GNGTLFEHIHKKG---NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-TPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       480 ~~gsL~~~l~~~~---~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGls~~~~~~~~  555 (735)
                      .+++|.+++....   .+.......++.|++.++.|+|+.+   ++||||||+||+++... .+++.|||+++.......
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            9999997777664   7999999999999999999999999   99999999999999988 699999999986543332


Q ss_pred             c-----ceeeeccccCccCcccccC---CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          556 Q-----NCTVVQGTLGYLDPEYLQT---CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       556 ~-----~~~~~~gt~~y~aPE~~~~---~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      .     ......|+..|++||.+..   .......|+||+|++++++++|..|+...............+..........
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence            2     2345569999999999987   5788999999999999999999999655442100000101110110000000


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                          .............+.+++..++..+|..|.++.+....
T Consensus       238 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         238 ----PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ----ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                00000001223578889999999999999999987765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.7e-21  Score=221.23  Aligned_cols=252  Identities=21%  Similarity=0.260  Sum_probs=185.8

Q ss_pred             ccccccccCcEEEEEEE-cCCCcEEEEEEee-----ccChhHH-HHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          405 YADVIGCGGSGNVYKGF-LPDRTPVAVKKSK-----FVDQAKI-DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~-----~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      ...++|.|++|.|+... .......+.|..+     ....... ..+..|+.+-..++|+|++..+....+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            35589999999777765 3333334444322     1111111 125668888888999999888877777666666699


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc--
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI--  555 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~--  555 (735)
                      |+++ +|..++.....++...+-.+++|++.|++|||+.+   |.|||||++|+++..++.+||+|||.+..+..+-.  
T Consensus       402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence            9999 99999988778999999999999999999999999   99999999999999999999999999876643322  


Q ss_pred             -cceeeeccccCccCcccccCCCCCc-cccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          556 -QNCTVVQGTLGYLDPEYLQTCKLTD-KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       556 -~~~~~~~gt~~y~aPE~~~~~~~~~-ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                       .......|+..|+|||.+...+|.+ ..||||.|+++..|++|+.||......+......     ...... .+..  -
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-----~~~~~~-~~~~--~  549 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-----NYSDQR-NIFE--G  549 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-----cccccc-cccc--C
Confidence             3445567999999999999999887 5799999999999999999996554433221000     000000 0000  0


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ........+.+-+.++.++|+.+|.+|.|+.+|++
T Consensus       550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00011234466788999999999999999999874

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=2.3e-20  Score=183.25  Aligned_cols=139  Identities=17%  Similarity=0.140  Sum_probs=109.2

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccChh--H-------HH-----------------HHHHHHHHHHhcCCCce
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQA--K-------ID-----------------EFINELVVVLQINRRNV  459 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~h~ni  459 (735)
                      ...||+|+||.||+|...+|..||||+++.....  .       ..                 ...+|+.+|.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999888999999998643211  0       01                 12349999999987776


Q ss_pred             EEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCcEEEcCCCC
Q 004702          460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL-HSETNVPIIHRDVKSANILLDENCT  538 (735)
Q Consensus       460 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~ivH~Dlk~~NILl~~~~~  538 (735)
                      .....+.  ....+|||||+++++|...+.....+++.....++.|++.+|.|| |+.+   |+||||||+|||+++ +.
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~-~~  155 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD-GK  155 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC-Cc
Confidence            4333222  123389999999887766544456799999999999999999999 6878   999999999999984 68


Q ss_pred             eEEeeccCCccc
Q 004702          539 PKVSDFGASKLV  550 (735)
Q Consensus       539 ~kl~DFGls~~~  550 (735)
                      ++|+|||++...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=3e-19  Score=175.80  Aligned_cols=140  Identities=21%  Similarity=0.183  Sum_probs=111.2

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccChh--------------------------HHHHHHHHHHHHHhcCCCce
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQA--------------------------KIDEFINELVVVLQINRRNV  459 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  459 (735)
                      ...||+|++|.||+|...+|+.||||.++.....                          ....+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4579999999999999778999999987743210                          01223578999999999987


Q ss_pred             EEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCC
Q 004702          460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENCT  538 (735)
Q Consensus       460 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~  538 (735)
                      .....+...  ..+|||||++++++.........++.....+++.|++.+|.+||+ .+   |+||||||+|||++ ++.
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence            443333322  348999999888655443344568889999999999999999999 88   99999999999999 789


Q ss_pred             eEEeeccCCcccC
Q 004702          539 PKVSDFGASKLVP  551 (735)
Q Consensus       539 ~kl~DFGls~~~~  551 (735)
                      ++|+|||++....
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=8.2e-20  Score=198.15  Aligned_cols=216  Identities=23%  Similarity=0.372  Sum_probs=164.8

Q ss_pred             HHhcCCCceEEEceEEeecCceeEEEEecCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eecCCCC
Q 004702          451 VLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPI-IHRDVKS  528 (735)
Q Consensus       451 l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i-vH~Dlk~  528 (735)
                      |+++.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ...+++.-...++.+|++||+|||+..   | .|+.|++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence            4578999999999999999999999999999999999987 467899999999999999999999865   5 9999999


Q ss_pred             CcEEEcCCCCeEEeeccCCcccCC-CcccceeeeccccCccCcccccCC-------CCCccccchhHHHHHHHHHhCCcc
Q 004702          529 ANILLDENCTPKVSDFGASKLVPI-DAIQNCTVVQGTLGYLDPEYLQTC-------KLTDKSDVYSFGVVLVELLTGKMA  600 (735)
Q Consensus       529 ~NILl~~~~~~kl~DFGls~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDVyS~Gvvl~elltG~~p  600 (735)
                      .|.++|....+||+|||+...... ..........-...|.|||.+...       ..+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            999999999999999999887642 111112222356689999998763       146789999999999999999999


Q ss_pred             CCCCChHHHH-HHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          601 LLSDKPEEER-SLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       601 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      |......+.. ..+..    ++. .....+-+.+...  .+..+++..++.+||..+|.+||++.+|-..++.+...
T Consensus       158 ~~~~~~~~~~~eii~~----~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILR----VKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccccCChHHHHHH----HHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9754333222 11111    111 0000111111111  13445799999999999999999999999998876654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=1.4e-19  Score=179.74  Aligned_cols=172  Identities=12%  Similarity=0.103  Sum_probs=131.0

Q ss_pred             HHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccCh---hHHHH------HHHHHHHHHhcCCCceEEEceEEee
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ---AKIDE------FINELVVVLQINRRNVVRLLGCCLE  468 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~h~niv~l~g~~~~  468 (735)
                      +-...++..++||.|+||.||.... ++..+|||.++....   .....      +.+|+..+.+++|++|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3445566678999999999999655 566899999864322   22222      5789999999999999998888654


Q ss_pred             c--------CceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 004702          469 T--------QVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPK  540 (735)
Q Consensus       469 ~--------~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k  540 (735)
                      .        ...+|||||++|.+|.++..    ++.    ....+++.+|..||..+   ++|||+||.||++++++ ++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EE
Confidence            3        35789999999999988742    332    24569999999999999   99999999999999988 99


Q ss_pred             EeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHH
Q 004702          541 VSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELL  595 (735)
Q Consensus       541 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ell  595 (735)
                      |+|||.......+....             .+.....+..++|+||||+++.-+.
T Consensus       175 liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence            99999887553221111             1334445667999999999988765

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.78  E-value=1.9e-19  Score=203.50  Aligned_cols=249  Identities=20%  Similarity=0.252  Sum_probs=182.4

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeec-cChhHHHHHHHHHHH--HHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKF-VDQAKIDEFINELVV--VLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      ...+.+.||++.|=+|.+++.+.|. |+||.+-. ...-..+.|.++++-  ...++|||.+++.-+-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            3456789999999999999988887 88887643 334445555554433  5556899999998886666777888888


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc--cCCCccc
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQ  556 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~--~~~~~~~  556 (735)
                      ..+ +|+|.|..+.-+...+..=|+.|++.||.-.|..+   |.|||||.+||||+.-+-+.|+||..-+.  ++.|...
T Consensus       103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            865 99999988877888888889999999999999999   99999999999999999999999987653  3334333


Q ss_pred             ceeee----ccccCccCcccccCC----------C-CCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHh
Q 004702          557 NCTVV----QGTLGYLDPEYLQTC----------K-LTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSL  620 (735)
Q Consensus       557 ~~~~~----~gt~~y~aPE~~~~~----------~-~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  620 (735)
                      ..+..    ..-..|+|||.+...          . ++++-||||+|+++.||++ |+++|...      ++. .+... 
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~-aYr~~-  250 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLL-AYRSG-  250 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHH-hHhcc-
Confidence            33322    234579999977431          2 6789999999999999999 67776321      111 11000 


Q ss_pred             cccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       621 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      ........+ ..+       +...+++|+..|++.||.+|.++.+.++.-.
T Consensus       251 ~~~~~e~~L-e~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  251 NADDPEQLL-EKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             CccCHHHHH-HhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence            000111111 111       1136889999999999999999999998743

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.2e-18  Score=167.43  Aligned_cols=186  Identities=15%  Similarity=0.101  Sum_probs=138.6

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccCh----hHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEecC
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ----AKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      ...|++|+||+||.+.. ++.+++.+.+.....    .....|.+|+++|++|+ |+++++++++    +..+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            45899999999997765 567788777654322    11235789999999995 4889999886    34699999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEEcCCCCeEEeeccCCcccCCCccc---
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV-KSANILLDENCTPKVSDFGASKLVPIDAIQ---  556 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~DFGls~~~~~~~~~---  556 (735)
                      +.+|...+..       ....++.|++++|+++|+++   |+|||| ||.|||++.++.++|+|||++.........   
T Consensus        82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             CccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            9888754421       12457889999999999999   999999 799999999999999999999865432210   


Q ss_pred             -c--------eeeeccccCccCcccccCC-CCC-ccccchhHHHHHHHHHhCCccCCCCCh
Q 004702          557 -N--------CTVVQGTLGYLDPEYLQTC-KLT-DKSDVYSFGVVLVELLTGKMALLSDKP  606 (735)
Q Consensus       557 -~--------~~~~~gt~~y~aPE~~~~~-~~~-~ksDVyS~Gvvl~elltG~~p~~~~~~  606 (735)
                       .        ......++.|++|+-..-. ..+ ...+-++-|.-+|.++|+..+...+.+
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence             0        0012257777887754321 223 467888999999999999988776544

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=3e-18  Score=169.77  Aligned_cols=134  Identities=19%  Similarity=0.208  Sum_probs=105.9

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-----CCCceEEEceEEeecC---c-eeEEE
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-----NRRNVVRLLGCCLETQ---V-PLLVY  476 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~lV~  476 (735)
                      .++||+|+||.||.  .++....+||++........+++.+|+.+++.+     .||||++++|++.++.   . ..+|+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            45899999999996  333333478987765444567899999999999     5799999999998864   3 33789


Q ss_pred             Ee--cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCcEEEcC----CCCeEEeeccCC
Q 004702          477 EF--VGNGTLFEHIHKKGNLSWERRLRITAETAGVL-SYLHSETNVPIIHRDVKSANILLDE----NCTPKVSDFGAS  547 (735)
Q Consensus       477 E~--~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L-~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~DFGls  547 (735)
                      ||  ..+++|.+++.+. .+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    +.+++|+||+.+
T Consensus        85 e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             cCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            99  5578999999764 45555  35678888777 9999999   999999999999974    347999995443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.6e-19  Score=195.38  Aligned_cols=225  Identities=26%  Similarity=0.264  Sum_probs=182.1

Q ss_pred             cccccCcEEEEEEE----cCCCcEEEEEEeeccCh--hHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEecC
Q 004702          408 VIGCGGSGNVYKGF----LPDRTPVAVKKSKFVDQ--AKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      ++|+|.||.|+...    .+.+..+|+|.++....  ........|..++...+ ||.+|++...+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999998764    23466677776553211  11124566888888887 9999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +|.|...+.+...+..........+++-+++++|+.+   |+|||+|++||+++.+|.+|+.|||+++..-.....    
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----  153 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence            9999999988888888888889999999999999999   999999999999999999999999999876433322    


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                       .||..|||||++.  .....+|-||||++++||+||..||..   +... .               |+  ......+.+
T Consensus       154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~~-~---------------Il--~~~~~~p~~  209 (612)
T KOG0603|consen  154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTMK-R---------------IL--KAELEMPRE  209 (612)
T ss_pred             -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHHH-H---------------Hh--hhccCCchh
Confidence             6899999999998  677899999999999999999999965   1110 0               10  111234566


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCH
Q 004702          641 QLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                      .......++.+++..+|.+|--.
T Consensus       210 l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  210 LSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhHHHHHHHHHHHhhCHHHHhcc
Confidence            77888899999999999999765

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.75  E-value=3.7e-18  Score=174.62  Aligned_cols=228  Identities=19%  Similarity=0.238  Sum_probs=145.6

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCC----------CceEEEceEEe--
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINR----------RNVVRLLGCCL--  467 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~g~~~--  467 (735)
                      ...+.||.|+++.||.++.. .++.+|+|.....   .....+++.+|.-....+.+          -.++.-++...  
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            34668999999999999965 4889999986532   23346677777654444322          11111111111  


Q ss_pred             -------ec---C-----ceeEEEEecCCCchhHHhhh---cC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 004702          468 -------ET---Q-----VPLLVYEFVGNGTLFEHIHK---KG----NLSWERRLRITAETAGVLSYLHSETNVPIIHRD  525 (735)
Q Consensus       468 -------~~---~-----~~~lV~E~~~~gsL~~~l~~---~~----~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~D  525 (735)
                             ..   .     ..+++|+-+ .++|.+++.-   ..    .+....++.+..|+++.+++||+.+   ++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence                   11   1     226788877 4588877642   21    2344556677799999999999999   99999


Q ss_pred             CCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccC--------CCCCccccchhHHHHHHHHHhC
Q 004702          526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT--------CKLTDKSDVYSFGVVLVELLTG  597 (735)
Q Consensus       526 lk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVyS~Gvvl~elltG  597 (735)
                      |||+|+|++.+|.++|+||+...........    ...+..|.+||....        ..++.+.|.|+||+++|.|+++
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            9999999999999999999877654322111    234578999997643        3578899999999999999999


Q ss_pred             CccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCC
Q 004702          598 KMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEER  660 (735)
Q Consensus       598 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  660 (735)
                      ..||....+......                    ....-. +.++.+..||..+|+.+|.+|
T Consensus       247 ~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999975533221100                    111223 677889999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=6.2e-18  Score=195.61  Aligned_cols=205  Identities=23%  Similarity=0.218  Sum_probs=162.0

Q ss_pred             cccccCHHHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC---CCceEEEceE
Q 004702          389 KAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN---RRNVVRLLGC  465 (735)
Q Consensus       389 ~~~~~~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~  465 (735)
                      +....+.-++...++.+.+.||+|+||+||+|...+++.||+|.-+....-   +|.=-.+++.+|+   -+-|..+..+
T Consensus       686 ~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a  762 (974)
T KOG1166|consen  686 KLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSA  762 (974)
T ss_pred             ccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHH
Confidence            334445556666667778899999999999999888999999986543221   1222223334444   2445555555


Q ss_pred             EeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-------CCCC
Q 004702          466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-------ENCT  538 (735)
Q Consensus       466 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-------~~~~  538 (735)
                      ..-.+.-+||+||.+.|+|.+++...+.++|...+.++.|+++.++.||..+   |||+||||+|+||.       ++.-
T Consensus       763 ~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  763 HVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             HccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccc
Confidence            5566777899999999999999998889999999999999999999999999   99999999999994       3446


Q ss_pred             eEEeeccCCcccCC-CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCc
Q 004702          539 PKVSDFGASKLVPI-DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM  599 (735)
Q Consensus       539 ~kl~DFGls~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~  599 (735)
                      ++|+|||-+..+.. ..........+|-.+-.+|+..+..++...|.|.|+.+++-||-|+.
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            89999999875532 11234566778999999999999999999999999999999999875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.71  E-value=3.9e-18  Score=181.40  Aligned_cols=171  Identities=26%  Similarity=0.386  Sum_probs=130.3

Q ss_pred             ceeEEEEecCCCchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCC
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS  547 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~---~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls  547 (735)
                      .+++.|+++...+|.++|..+   ...++...+.++.|++.|++|   ++   .+|+|+||.||++..+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999754   357888899999999999999   66   999999999999999999999999998


Q ss_pred             cccCCCc-----ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhc
Q 004702          548 KLVPIDA-----IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLK  621 (735)
Q Consensus       548 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  621 (735)
                      .......     ....+...||..||+||.+.+..|+.|+||||||++|+||+. =..++.          .......++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhh
Confidence            8765444     334455679999999999999999999999999999999997 222211          011112222


Q ss_pred             ccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 004702          622 QNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV  666 (735)
Q Consensus       622 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev  666 (735)
                      .+.+.        ..+ ...-++-+.|+.+++.+.|.+||++.++
T Consensus       474 ~g~ip--------~~~-~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  474 DGIIP--------PEF-LQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             cCCCC--------hHH-hhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence            22222        111 1111344679999999999999954443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1e-16  Score=160.73  Aligned_cols=134  Identities=19%  Similarity=0.297  Sum_probs=112.6

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccC--h------hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD--Q------AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.||+|++|.||+|.. .+..+++|+.....  .      .....+.+|+.++..++|++|.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4799999999999987 56678888754321  1      1234578899999999999987777777777788999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      +++++|.+++....   + .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986542   2 88899999999999999998   99999999999999 78899999999874

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=1.2e-16  Score=162.16  Aligned_cols=141  Identities=19%  Similarity=0.173  Sum_probs=110.8

Q ss_pred             ccccccccccCcEEEEEEE--cCCCcEEEEEEeeccChh------------------------HHHHHHHHHHHHHhcCC
Q 004702          403 NNYADVIGCGGSGNVYKGF--LPDRTPVAVKKSKFVDQA------------------------KIDEFINELVVVLQINR  456 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h  456 (735)
                      +.+.+.||+|+||.||+|.  ..++..||||+++.....                        ....+..|+.++.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            3456789999999999998  568999999987643210                        11235679999999976


Q ss_pred             C--ceEEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 004702          457 R--NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD  534 (735)
Q Consensus       457 ~--niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~  534 (735)
                      .  .+.+++++    ...++||||+++.+|...+.....+.......++.|++.+|++||+.+.  |+||||||+||+++
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli~  183 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILVH  183 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEEE
Confidence            3  34455543    2358999999998887766444556677788999999999999999863  99999999999999


Q ss_pred             CCCCeEEeeccCCccc
Q 004702          535 ENCTPKVSDFGASKLV  550 (735)
Q Consensus       535 ~~~~~kl~DFGls~~~  550 (735)
                       ++.++|+|||.+...
T Consensus       184 -~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 -DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCCEEEEEChhhhcc
Confidence             789999999998754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=1.4e-16  Score=162.69  Aligned_cols=200  Identities=19%  Similarity=0.209  Sum_probs=143.6

Q ss_pred             CCCceEEEceEEee---------------------------cCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHH
Q 004702          455 NRRNVVRLLGCCLE---------------------------TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETA  507 (735)
Q Consensus       455 ~h~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia  507 (735)
                      +|||||++++++.+                           ....|+||..... +|.+++..+ ..+.....-|+.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence            68999988887653                           1245788887744 899999765 456667777999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCcEEEc--CCC--CeEEeeccCCcccCC-----CcccceeeeccccCccCcccccCCC-
Q 004702          508 GVLSYLHSETNVPIIHRDVKSANILLD--ENC--TPKVSDFGASKLVPI-----DAIQNCTVVQGTLGYLDPEYLQTCK-  577 (735)
Q Consensus       508 ~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~--~~kl~DFGls~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~-  577 (735)
                      +|+.|||.++   |.|||+|++||||.  ++.  .+.|+|||.+-.-..     +........-|....||||+..... 
T Consensus       352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            9999999999   99999999999993  333  478999998653221     1111222234778899999886532 


Q ss_pred             -----CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHc
Q 004702          578 -----LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARC  652 (735)
Q Consensus       578 -----~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~c  652 (735)
                           .-.|+|.|+.|.+.||+++...||+....... +     .+.+++..+         ...+...+..+++|+...
T Consensus       429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~-----~r~Yqe~qL---------Palp~~vpp~~rqlV~~l  493 (598)
T KOG4158|consen  429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-D-----TRTYQESQL---------PALPSRVPPVARQLVFDL  493 (598)
T ss_pred             CceeeccchhhhhhhhhhHHHHhccCCcccccchhee-c-----hhhhhhhhC---------CCCcccCChHHHHHHHHH
Confidence                 23499999999999999999999987322110 0     011222222         222445567889999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhh
Q 004702          653 ISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       653 l~~~p~~RPt~~ev~~~L~~~~  674 (735)
                      |+.||.+|++..-....|.-.+
T Consensus       494 L~r~pskRvsp~iAANvl~LsL  515 (598)
T KOG4158|consen  494 LKRDPSKRVSPNIAANVLNLSL  515 (598)
T ss_pred             hcCCccccCCccHHHhHHHHHH
Confidence            9999999999888777776443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.68  E-value=3.1e-16  Score=155.69  Aligned_cols=130  Identities=18%  Similarity=0.277  Sum_probs=105.9

Q ss_pred             cccccCcEEEEEEEcCCCcEEEEEEeeccC--------hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVD--------QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +||+|+||.||+|.+ ++..|++|......        ......+.+|++++..++|+++.....+....+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 46779999754211        112356778999999999887655555555666779999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      ++++|.+++.....       .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.+++.|||++..
T Consensus        80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998765321       78999999999999998   99999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.68  E-value=4.7e-16  Score=154.29  Aligned_cols=136  Identities=20%  Similarity=0.243  Sum_probs=108.0

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccCh----------------------hHHHHHHHHHHHHHhcCCCc--
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ----------------------AKIDEFINELVVVLQINRRN--  458 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~n--  458 (735)
                      +.+.+.||+|+||.||++...+++.||||++.....                      .....+..|+.++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            556789999999999999988899999998653210                      01123567889999998874  


Q ss_pred             eEEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC
Q 004702          459 VVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT  538 (735)
Q Consensus       459 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~  538 (735)
                      ++++++    ....++||||+++++|......      .....++.+++.++.++|+.+   |+||||||+||++++++.
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCc
Confidence            444443    2456899999999998765431      345678899999999999988   999999999999999999


Q ss_pred             eEEeeccCCcccC
Q 004702          539 PKVSDFGASKLVP  551 (735)
Q Consensus       539 ~kl~DFGls~~~~  551 (735)
                      ++|+|||++....
T Consensus       164 ~~liDfg~~~~~~  176 (198)
T cd05144         164 IYIIDWPQMVSTD  176 (198)
T ss_pred             EEEEECCccccCC
Confidence            9999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=3.9e-16  Score=178.28  Aligned_cols=133  Identities=18%  Similarity=0.293  Sum_probs=109.3

Q ss_pred             ccccccccCcEEEEEEEcCCCcEEEEEEeec-cC------hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          405 YADVIGCGGSGNVYKGFLPDRTPVAVKKSKF-VD------QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~-~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      ..++||+|+||+||+|.+.+...++.+++.. ..      ....+.+.+|++++..++|++++....+.......++|||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            3578999999999999876554333222221 11      1223568899999999999999888877777778899999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      |+++++|.+++.        ....++.+++++|.+||+.+   ++||||||+|||+ +++.++|+|||+++.
T Consensus       417 ~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        417 YIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             ecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            999999999885        45779999999999999998   9999999999999 577999999999985

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.63  E-value=3.5e-16  Score=177.47  Aligned_cols=203  Identities=26%  Similarity=0.357  Sum_probs=144.6

Q ss_pred             cccccccCcEEEEEEEcCC-CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          406 ADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      .+.|..|++|.||..+.+. .+++|+|+ .+.+     .      ++     +||+.+-      +.++.|      |+-
T Consensus        88 IklisngAygavylvrh~~trqrfa~ki-Nkq~-----l------il-----Rnilt~a------~npfvv------gDc  138 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----L------IL-----RNILTFA------GNPFVV------GDC  138 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcc-cccc-----h------hh-----hcccccc------CCccee------chh
Confidence            4578999999999998653 55677743 2111     0      01     1122221      222333      455


Q ss_pred             hHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc---------
Q 004702          485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI---------  555 (735)
Q Consensus       485 ~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~---------  555 (735)
                      ...++..++++...        +.+++|||+.+   |+|||+||+|.||+.-|.+|+.|||+++.......         
T Consensus       139 ~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~  207 (1205)
T KOG0606|consen  139 ATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE  207 (1205)
T ss_pred             hhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence            56666555665544        78899999998   99999999999999999999999999875422110         


Q ss_pred             ---c--ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          556 ---Q--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       556 ---~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                         +  ....+.||+.|+|||++..+.|....|.|++|+++||.+.|..||..+.+++.......              |
T Consensus       208 k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis--------------d  273 (1205)
T KOG0606|consen  208 KDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--------------D  273 (1205)
T ss_pred             HHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh--------------h
Confidence               0  12235699999999999999999999999999999999999999999888764433211              1


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPT  662 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  662 (735)
                      .....+.......++++++.+.|+.+|..|--
T Consensus       274 ~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  274 DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            11112223445678999999999999999953

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=9.2e-15  Score=143.56  Aligned_cols=136  Identities=21%  Similarity=0.291  Sum_probs=98.3

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccChh--HHHHH----------------------HHHHHHHHhcCCCc--e
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQA--KIDEF----------------------INELVVVLQINRRN--V  459 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n--i  459 (735)
                      .+.||+|+||+||++...++..||||..+.....  ....+                      ..|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999987642211  11111                      24566666665433  4


Q ss_pred             EEEceEEeecCceeEEEEecCCCchhHH-hhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCC
Q 004702          460 VRLLGCCLETQVPLLVYEFVGNGTLFEH-IHKKGNLSWERRLRITAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENC  537 (735)
Q Consensus       460 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~  537 (735)
                      .+.+++    ...++||||++++.+... +... ... .....++.+++.++.++|+ .+   |+|+||||+||+++ ++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence            444443    345899999998544321 2111 111 6678899999999999999 77   99999999999999 88


Q ss_pred             CeEEeeccCCcccC
Q 004702          538 TPKVSDFGASKLVP  551 (735)
Q Consensus       538 ~~kl~DFGls~~~~  551 (735)
                      .++|+|||.+....
T Consensus       152 ~~~liDfg~a~~~~  165 (187)
T cd05119         152 KVYIIDVPQAVEID  165 (187)
T ss_pred             cEEEEECccccccc
Confidence            99999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins

Probab=99.58  E-value=4.3e-15  Score=128.29  Aligned_cols=76  Identities=37%  Similarity=0.554  Sum_probs=62.4

Q ss_pred             CCCcCCcCceeeecCCCc-ceeEEEEeeccCCccccCCCCceeeeeecCCcccccccccccCCCCCccceEEeeeeccc
Q 004702          155 NGSCVGTGCCQIEIPGGL-KELEVEAFSFKNHTKVSSFNPCTYAFVVDQSQFHFTSNYLALGGIRDEFPMVLDWEIITD  232 (735)
Q Consensus       155 ~~~Csg~gCCq~~i~~~l-~~~~~~~~~~~~~~~~~~~~~c~~a~~~~~~~~~~~~~~~~~~~~~~~~p~~l~w~~~~~  232 (735)
                      +++|+|++||||.||.++ +.|.+++....+.  ....++|+||||+|+.||.++..++......+.+||+|+|.|...
T Consensus         1 n~~CsG~~CCQt~iP~~~~qv~~~~i~~~~~~--~~~~~~Ck~AFL~d~~~~~~n~t~p~~~~~~~y~pv~L~W~i~t~   77 (103)
T PF08488_consen    1 NSSCSGIGCCQTSIPSGLLQVFNVTIESTDGN--NQTSNGCKVAFLVDEDWFSSNITDPEDFHAMGYVPVVLDWFIDTS   77 (103)
T ss_pred             CCccCCcceeccCCCCCCceEEEEEeEecCCC--cccCCCceEEEEeccccccccCCChHHhccCCeeEEEEEEEEecC
Confidence            468999999999999975 6788888765432  234589999999999999998887766666788999999999754

WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.57  E-value=2e-14  Score=135.09  Aligned_cols=134  Identities=21%  Similarity=0.218  Sum_probs=113.7

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCC--CceEEEceEEeecCceeEEEEecCCCc
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR--RNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .+.||+|.++.||++...+ ..+++|.......  ...+.+|+.++..++|  .++++++++....+..+++|||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            3579999999999999755 6799998765433  5678899999999987  589999988887788999999998877


Q ss_pred             hhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       484 L~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      +..+       +......++.+++++|++||.....+++|+||+|+|||+++.+.+++.|||.+..
T Consensus        80 ~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            7654       5677788999999999999986545599999999999999989999999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=5.5e-14  Score=143.12  Aligned_cols=135  Identities=18%  Similarity=0.229  Sum_probs=105.0

Q ss_pred             cccc-ccCcEEEEEEEcCCCcEEEEEEeecc-------------ChhHHHHHHHHHHHHHhcCCCce--EEEceEEeecC
Q 004702          407 DVIG-CGGSGNVYKGFLPDRTPVAVKKSKFV-------------DQAKIDEFINELVVVLQINRRNV--VRLLGCCLETQ  470 (735)
Q Consensus       407 ~~lG-~G~~g~Vy~g~~~~~~~vavK~~~~~-------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~~  470 (735)
                      .+|| .|+.|+||+.... +..++||+....             .......+.+|+.++.+|+|++|  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4787 8899999998875 567888876421             11233567889999999998875  67777654332


Q ss_pred             ----ceeEEEEecCC-CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          471 ----VPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       471 ----~~~lV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                          ..++|||++++ .+|.+++... .++..    .+.+++.+|.+||+.+   |+||||||.|||++.++.++|+|||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECC
Confidence                23599999997 6898888653 45544    3568999999999999   9999999999999998899999999


Q ss_pred             CCccc
Q 004702          546 ASKLV  550 (735)
Q Consensus       546 ls~~~  550 (735)
                      .+...
T Consensus       188 ~~~~~  192 (239)
T PRK01723        188 RGELR  192 (239)
T ss_pred             CcccC
Confidence            98753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1.7e-15  Score=172.48  Aligned_cols=250  Identities=22%  Similarity=0.263  Sum_probs=188.6

Q ss_pred             hhccccccccccCcEEEEEEEcCC--CcEEEEEEeeccC--hhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPD--RTPVAVKKSKFVD--QAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV  475 (735)
                      ..+.+.+.||+|+|+.|-......  ...+|+|.+....  ....+....|..+-+.+. |+|++.+++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            344556679999999998876533  4456666655432  333344556888888887 99999999999999999999


Q ss_pred             EEecCCCchhHHh-hhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCcEEEcCCC-CeEEeeccCCcccC
Q 004702          476 YEFVGNGTLFEHI-HKKG-NLSWERRLRITAETAGVLSYLH-SETNVPIIHRDVKSANILLDENC-TPKVSDFGASKLVP  551 (735)
Q Consensus       476 ~E~~~~gsL~~~l-~~~~-~l~~~~~~~i~~qia~~L~yLH-~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGls~~~~  551 (735)
                      .|+..++++.+.+ +... ..+....-.++.|+..++.|+| ..+   +.|+||||+|.+++..+ ..|++|||++..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999988 5443 6777788899999999999999 777   99999999999999999 99999999998775


Q ss_pred             C--Ccccceeeecc-ccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          552 I--DAIQNCTVVQG-TLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       552 ~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      .  ..........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+.........              ...
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------~~~  242 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------YSS  242 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------cee
Confidence            5  33333444568 9999999999884 4566899999999999999999998654433211              011


Q ss_pred             Hhhhcc--cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004702          628 ILDNRI--VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVS  667 (735)
Q Consensus       628 ~~d~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  667 (735)
                      ......  .............++..+++..+|..|.+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ecccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            111110  0111223345677888899999999999988865

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=1.5e-12  Score=144.09  Aligned_cols=138  Identities=18%  Similarity=0.174  Sum_probs=99.7

Q ss_pred             cccccCcEEEEEEEcCCCcEEEEEEeeccChhHH----------------------------------------HHHHHH
Q 004702          408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI----------------------------------------DEFINE  447 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~E  447 (735)
                      .||+|++|.||+|++.+|+.||||+.+..-....                                        -+|.+|
T Consensus       124 plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~E  203 (437)
T TIGR01982       124 PLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRRE  203 (437)
T ss_pred             ceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHH
Confidence            6999999999999999999999998754321111                                        124556


Q ss_pred             HHHHHhcC----CCceEEEceEEe-ecCceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHH-HHHHHHhcCCCC
Q 004702          448 LVVVLQIN----RRNVVRLLGCCL-ETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAG-VLSYLHSETNVP  520 (735)
Q Consensus       448 ~~~l~~l~----h~niv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~-~L~yLH~~~~~~  520 (735)
                      +..+.+++    |.+-+.+-..+. .....+|||||++|++|.++.... ..+   .+.+++.++++ .+..+|..+   
T Consensus       204 a~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g---  277 (437)
T TIGR01982       204 AANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG---  277 (437)
T ss_pred             HHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC---
Confidence            66555552    322233333332 234568999999999998877532 122   24556666666 478899888   


Q ss_pred             eeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          521 IIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       521 ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      ++|+|+||.||++++++++++.|||++..+.
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999998664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=8.1e-13  Score=132.53  Aligned_cols=200  Identities=21%  Similarity=0.298  Sum_probs=141.2

Q ss_pred             HHHHHhcCCCceEEEceEEeecC-----ceeEEEEecCCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 004702          448 LVVVLQINRRNVVRLLGCCLETQ-----VPLLVYEFVGNGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETN  518 (735)
Q Consensus       448 ~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~  518 (735)
                      +..|.++-|-|||++..++.+..     ...++.|||+-|+|..+|++.    ..+......+|+-||+.||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            44566778999999998876543     467999999999999999864    46888888999999999999999975 


Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC----CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHH
Q 004702          519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPI----DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVEL  594 (735)
Q Consensus       519 ~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~el  594 (735)
                      +||+|+++..+-|++..++-+||.- +.-.....    ..........+-++|.+||+=.....+..+|||+||+..+||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            8999999999999999998888842 11111100    000111123367899999998888888999999999999999


Q ss_pred             HhCCccC-CCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          595 LTGKMAL-LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       595 ltG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .-+..-- ......+....+...+-.+         .       +    ..-+.++..|++..|..||+|++++..
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i~~l---------e-------n----~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVIIGL---------E-------N----GLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhheeec---------c-------C----ccccCcCcccccCCCCCCcchhhhhcC
Confidence            8876432 1111111111110000000         0       0    112457889999999999999987643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=1.2e-12  Score=142.51  Aligned_cols=250  Identities=22%  Similarity=0.229  Sum_probs=181.8

Q ss_pred             HHHhhhccccccccc--cCcEEEEEEEc---CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcC-CCceEEEceEEee
Q 004702          397 EIKTVTNNYADVIGC--GGSGNVYKGFL---PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLE  468 (735)
Q Consensus       397 ei~~~~~~~~~~lG~--G~~g~Vy~g~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~  468 (735)
                      +.......+.+.+|.  |.+|.||++..   .+...+|+|+-+.  ........=++|+...+.++ |+|.++....+..
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            444555566778999  99999999985   3567899997443  22233333456777667775 9999998888888


Q ss_pred             cCceeEEEEecCCCchhHHhhhcCC-CCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEe
Q 004702          469 TQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAG----VLSYLHSETNVPIIHRDVKSANILLDEN-CTPKVS  542 (735)
Q Consensus       469 ~~~~~lV~E~~~~gsL~~~l~~~~~-l~~~~~~~i~~qia~----~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~  542 (735)
                      .+..++-.|++ +.+|..+.+.... ++...++.++.+...    ||.++|+..   ++|-|+||.||++..+ ...++.
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence            89989999988 4688888887644 777778888888888    999999998   9999999999999998 889999


Q ss_pred             eccCCcccCCCcccc----eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHH
Q 004702          543 DFGASKLVPIDAIQN----CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS  618 (735)
Q Consensus       543 DFGls~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~  618 (735)
                      |||+...+.......    .....|...|++||..++ .++.++|+|+||.++++...+...........        +.
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W~  336 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS--------WS  336 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC--------cc
Confidence            999988776443221    112247889999999876 68889999999999999998776543221100        00


Q ss_pred             HhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004702          619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVS  667 (735)
Q Consensus       619 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  667 (735)
                      .++.  +      .+..++......++..++..+++.+|..|++.+.+.
T Consensus       337 ~~r~--~------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  337 QLRQ--G------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             cccc--c------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            0000  0      011122222335566699999999999999887654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.24  E-value=2.3e-11  Score=117.26  Aligned_cols=130  Identities=17%  Similarity=0.137  Sum_probs=95.9

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceE-EEceEEeecCceeEEEEecCCCchh
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVV-RLLGCCLETQVPLLVYEFVGNGTLF  485 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~~~gsL~  485 (735)
                      +.|+.|.++.||++... +..+++|....... ....+.+|+.++..+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            46788999999999865 66799998654322 223467899999988765543 454443  33458999999998776


Q ss_pred             HHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          486 EHIHKKGNLSWERRLRITAETAGVLSYLHSET--NVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       486 ~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      +..        .....++.+++++|+.||+..  ...++|+|++|.||+++ ++.++++||+.+..
T Consensus        80 ~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            430        112345679999999999986  22359999999999999 56899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.19  E-value=2.4e-10  Score=111.38  Aligned_cols=136  Identities=17%  Similarity=0.142  Sum_probs=98.2

Q ss_pred             ccccccCcEEEEEEEcCC-------CcEEEEEEeecc-------------C---------hhHHHHHH----HHHHHHHh
Q 004702          407 DVIGCGGSGNVYKGFLPD-------RTPVAVKKSKFV-------------D---------QAKIDEFI----NELVVVLQ  453 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~  453 (735)
                      ..||.|.-+.||.|...+       +..+|||..+..             +         ......+.    +|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998553       478999964310             0         01122333    79999999


Q ss_pred             cCC--CceEEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCc
Q 004702          454 INR--RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL-HSETNVPIIHRDVKSAN  530 (735)
Q Consensus       454 l~h--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~ivH~Dlk~~N  530 (735)
                      +..  -++.+++++    ...+|||||+.+..+....-....++..+...+..+++.+|..| |..+   |||+||++.|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~N  155 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYN  155 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence            864  456666654    45689999997654422221223455666778889999999999 7888   9999999999


Q ss_pred             EEEcCCCCeEEeeccCCccc
Q 004702          531 ILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       531 ILl~~~~~~kl~DFGls~~~  550 (735)
                      ||+++ +.+.|+|||.+...
T Consensus       156 IL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         156 MLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             EEEEC-CcEEEEECCCceeC
Confidence            99974 57999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.16  E-value=5.3e-10  Score=123.16  Aligned_cols=166  Identities=19%  Similarity=0.187  Sum_probs=124.8

Q ss_pred             cCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHH
Q 004702          422 LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR  501 (735)
Q Consensus       422 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~  501 (735)
                      ..++.+|.|+..+.......+...+-++.|+.++||||++++.....++..|||+|.+.  .|..++++..   ....--
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~  108 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVCL  108 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHHH
Confidence            44677888888776655555667788999999999999999999999999999999875  5777776533   445556


Q ss_pred             HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCcc
Q 004702          502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK  581 (735)
Q Consensus       502 i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k  581 (735)
                      .+.||+.||.|||..++  ++|++|....|+|++.|..||++|.++.....-.. ......--..|..|+.+....  -.
T Consensus       109 Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s  183 (690)
T KOG1243|consen  109 GLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WS  183 (690)
T ss_pred             HHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cc
Confidence            78899999999997664  99999999999999999999999988754321110 001111122455665543322  24


Q ss_pred             ccchhHHHHHHHHHhC
Q 004702          582 SDVYSFGVVLVELLTG  597 (735)
Q Consensus       582 sDVyS~Gvvl~elltG  597 (735)
                      .|.|-||+++||++.|
T Consensus       184 ~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhhHHHHHHHHhCc
Confidence            6999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.14  E-value=2.3e-10  Score=128.10  Aligned_cols=135  Identities=14%  Similarity=0.104  Sum_probs=89.6

Q ss_pred             cccccCcEEEEEEEcCC-CcEEEEEEeeccChh------------------------------HH----------HHHHH
Q 004702          408 VIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQA------------------------------KI----------DEFIN  446 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~~------------------------------~~----------~~~~~  446 (735)
                      .||+|++|.||+|++++ |+.||||+.+..-..                              -.          -+|.+
T Consensus       126 PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~  205 (537)
T PRK04750        126 PLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMR  205 (537)
T ss_pred             hhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHH
Confidence            79999999999999887 999999987632110                              00          12344


Q ss_pred             HHHHHHhcC----CCceEEEceEEee-cCceeEEEEecCCCchhHHh--hhcC----CCCHHHHHHHHHHHHHHHHHHHh
Q 004702          447 ELVVVLQIN----RRNVVRLLGCCLE-TQVPLLVYEFVGNGTLFEHI--HKKG----NLSWERRLRITAETAGVLSYLHS  515 (735)
Q Consensus       447 E~~~l~~l~----h~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~----~l~~~~~~~i~~qia~~L~yLH~  515 (735)
                      |+..+.+++    +.+.+.+-.++.+ ....+|||||+.|+.|.++-  ...+    .+.......++.|       ++.
T Consensus       206 Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~  278 (537)
T PRK04750        206 EAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFR  278 (537)
T ss_pred             HHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHh
Confidence            555555542    3333333333322 34568999999999997742  2222    1222222333333       344


Q ss_pred             cCCCCeeecCCCCCcEEEcCCC----CeEEeeccCCcccCC
Q 004702          516 ETNVPIIHRDVKSANILLDENC----TPKVSDFGASKLVPI  552 (735)
Q Consensus       516 ~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGls~~~~~  552 (735)
                      .+   ++|+|+||.||+++.++    ++++.|||+...+..
T Consensus       279 ~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        279 DG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             CC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            66   99999999999999888    999999999887643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.11  E-value=5.7e-11  Score=129.64  Aligned_cols=259  Identities=21%  Similarity=0.217  Sum_probs=179.8

Q ss_pred             ccccccCHHH-HHhhhcccc--ccccccCcEEEEEEEc--CCCcEEEEEEeeccChhHHHH--HHHHHHHHHhc-CCCce
Q 004702          388 EKAKIFTEEE-IKTVTNNYA--DVIGCGGSGNVYKGFL--PDRTPVAVKKSKFVDQAKIDE--FINELVVVLQI-NRRNV  459 (735)
Q Consensus       388 ~~~~~~~~~e-i~~~~~~~~--~~lG~G~~g~Vy~g~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~ni  459 (735)
                      ...++|...+ ....+..|.  ..||.|.|+.|++...  .++..+++|.+...-.....+  -+.|+.+...+ .|.++
T Consensus       249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc
Confidence            3445555555 333344454  4799999999999763  467788999776533332222  24566666665 48888


Q ss_pred             EEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CC
Q 004702          460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-CT  538 (735)
Q Consensus       460 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~  538 (735)
                      ++....+...+..++--||++++++...+.-...+....++++..|++.++.++|+..   ++|+|+||+||++..+ +.
T Consensus       329 ~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  329 VGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFF  405 (524)
T ss_pred             CCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhh
Confidence            8887777777777899999999988877755567888899999999999999999988   9999999999999886 78


Q ss_pred             eEEeeccCCcccCCCcccceeeeccccCc-cCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH
Q 004702          539 PKVSDFGASKLVPIDAIQNCTVVQGTLGY-LDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL  617 (735)
Q Consensus       539 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~  617 (735)
                      .++.|||....+..   ........+..| .+++......+-.+.|+||||.-+.|.+++..--....            
T Consensus       406 ~~~~~~~~~t~~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------------  470 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------------  470 (524)
T ss_pred             hhccccccccccce---ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc------------
Confidence            89999999864221   111111223334 35666667788899999999999999999865321110            


Q ss_pred             HHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       618 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                            .+..+....+ ...+. ...++..+...++..++..||.+.++....+.
T Consensus       471 ------~~~~i~~~~~-p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  471 ------QSLTIRSGDT-PNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ------cceeeecccc-cCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                  0011111111 11111 22667788899999999999999887765553

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.10  E-value=4.9e-10  Score=112.90  Aligned_cols=142  Identities=20%  Similarity=0.250  Sum_probs=110.7

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccCh-hHHHHHHHHHHHHHhcCCC--ceEEEceEEeec---CceeEEEEecC
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ-AKIDEFINELVVVLQINRR--NVVRLLGCCLET---QVPLLVYEFVG  480 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~---~~~~lV~E~~~  480 (735)
                      +.|+.|..+.||++...++..+++|....... ....++.+|+++++.+++.  ++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46889999999999887767899998654322 1345788999999999763  456677776553   25689999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-------------------------------------------  517 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~-------------------------------------------  517 (735)
                      +.+|.+.+.. ..++..++..++.+++++|+.||+..                                           
T Consensus        84 G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          84 GRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence            9888776642 45778888889999999999998531                                           


Q ss_pred             ----------CCCeeecCCCCCcEEEcC--CCCeEEeeccCCcc
Q 004702          518 ----------NVPIIHRDVKSANILLDE--NCTPKVSDFGASKL  549 (735)
Q Consensus       518 ----------~~~ivH~Dlk~~NILl~~--~~~~kl~DFGls~~  549 (735)
                                ...++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      134799999999999998  66689999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.01  E-value=3.2e-09  Score=99.92  Aligned_cols=131  Identities=19%  Similarity=0.270  Sum_probs=99.2

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEE-eec-cChh------HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKK-SKF-VDQA------KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~-~~~-~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+|+-+.+|.+.+.+.. +++|. +.+ ....      ..+...+|+.++.+++--.|.-.+-+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999764433 55553 221 1111      134567899999998765554444455567777899999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      +++-.|.+.+...       ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998888888664       3567778888889999999   99999999999998774 99999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.97  E-value=1.6e-08  Score=108.16  Aligned_cols=165  Identities=18%  Similarity=0.214  Sum_probs=126.6

Q ss_pred             EEEEEEE-cCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEe----ecCceeEEEEecCC-CchhHHh
Q 004702          415 GNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL----ETQVPLLVYEFVGN-GTLFEHI  488 (735)
Q Consensus       415 g~Vy~g~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~l  488 (735)
                      .+.||+. ..||..+.+|+++............-++.++++.|.|||++..++.    .+...++||+|.+. ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            5678887 4578899999984332222223345678899999999999998876    24467899999875 4777655


Q ss_pred             hhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          489 HKK---------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       489 ~~~---------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      ...               ..+++..+|.++.|++.||.++|+.|   +.-+-|.+++||++.+.+++|+..|....+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            321               24778999999999999999999999   888999999999999999999999988766544


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCcc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMA  600 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p  600 (735)
                      ....               +   +--.+-|.=.||.+++.|.||...
T Consensus       447 ~~~~---------------l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 PTEP---------------L---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCcc---------------h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            3111               1   112367888999999999999653

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.91  E-value=1.3e-08  Score=95.31  Aligned_cols=140  Identities=20%  Similarity=0.255  Sum_probs=101.2

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEE-eec-c------ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKK-SKF-V------DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~-~~~-~------~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      ..+|-+|+-+.|+++.+. |+...||. ..+ .      ..-.....++|+.+|.+++--.|.-..-++.+...-.|+||
T Consensus        12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            347889999999999885 45455553 211 1      11224567789999998876555444445566666789999


Q ss_pred             ecCC-CchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---CeEEeeccCCcc
Q 004702          478 FVGN-GTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC---TPKVSDFGASKL  549 (735)
Q Consensus       478 ~~~~-gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGls~~  549 (735)
                      |+++ .++.+++...  ..........++..|-+.+.-||..+   |+|+||..+||+|..++   .+.++|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            9966 4888888764  22333333678889999999999999   99999999999996443   458999999874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.87  E-value=3.2e-10  Score=129.83  Aligned_cols=239  Identities=23%  Similarity=0.283  Sum_probs=168.8

Q ss_pred             cccccCcEEEEEEEcC-CCcEEEEEEee---ccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          408 VIGCGGSGNVYKGFLP-DRTPVAVKKSK---FVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~-~~~~vavK~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      -+-+|.++.++...-. .+...++|...   .....+.+....+-.++-..++|-++....-+.......||++|..+++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~  890 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD  890 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence            5678888888876522 23333333322   1222223333344444444556777766655556677899999999999


Q ss_pred             hhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC-----------
Q 004702          484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI-----------  552 (735)
Q Consensus       484 L~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~-----------  552 (735)
                      |...|+..+..+.......+..+..+++|||+..   +.|+|++|.|+|+..++..+++|||.......           
T Consensus       891 ~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~  967 (1205)
T KOG0606|consen  891 LPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPS  967 (1205)
T ss_pred             chhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCCccccc
Confidence            9999998877777777777788899999999987   99999999999999999999999984322100           


Q ss_pred             -------------------CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHH
Q 004702          553 -------------------DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA  613 (735)
Q Consensus       553 -------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~  613 (735)
                                         +.........||+.|.+||.+.+......+|.|++|++++|.++|..||....+....   
T Consensus       968 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f--- 1044 (1205)
T KOG0606|consen  968 SSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF--- 1044 (1205)
T ss_pred             ccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh---
Confidence                               0001122345899999999999999999999999999999999999999766553321   


Q ss_pred             HHHHHHhcccchhhHhhhccc-CCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 004702          614 MNFLSSLKQNRLLEILDNRIV-NDGNKQQLKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       614 ~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                          ..        ++...+. ...+.+...+..+++.+.+..+|.+|-.+.
T Consensus      1045 ----~n--------i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1045 ----EN--------ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             ----hc--------cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence                11        1111111 122344557788999999999999998876

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=3.8e-08  Score=95.66  Aligned_cols=125  Identities=24%  Similarity=0.250  Sum_probs=82.3

Q ss_pred             EEEEEEcCCCcEEEEEEeecc---------------C-----------hhHHHHHHHHHHHHHhcCCC--ceEEEceEEe
Q 004702          416 NVYKGFLPDRTPVAVKKSKFV---------------D-----------QAKIDEFINELVVVLQINRR--NVVRLLGCCL  467 (735)
Q Consensus       416 ~Vy~g~~~~~~~vavK~~~~~---------------~-----------~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~  467 (735)
                      .||.|...++..+|||..+..               .           ........+|++.|.++...  ++.+++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999888999999964321               0           00123356799999999876  566776542 


Q ss_pred             ecCceeEEEEecC--CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCcEEEcCCCCeEEeec
Q 004702          468 ETQVPLLVYEFVG--NGTLFEHIHKKGNLSWERRLRITAETAGVLSY-LHSETNVPIIHRDVKSANILLDENCTPKVSDF  544 (735)
Q Consensus       468 ~~~~~~lV~E~~~--~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~y-LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF  544 (735)
                         ...|||||++  +..+..+....  ++......++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|+||
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--G
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEec
Confidence               4479999998  54454433221  2244556677888885555 57877   9999999999999988 9999999


Q ss_pred             cCCccc
Q 004702          545 GASKLV  550 (735)
Q Consensus       545 Gls~~~  550 (735)
                      |.+...
T Consensus       151 ~qav~~  156 (188)
T PF01163_consen  151 GQAVDS  156 (188)
T ss_dssp             TTEEET
T ss_pred             Ccceec
Confidence            987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.79  E-value=7.6e-08  Score=99.23  Aligned_cols=131  Identities=13%  Similarity=0.088  Sum_probs=95.7

Q ss_pred             EEEEEEEcCCCcEEEEEEeeccChhH-HH----------HHHHHHHHHHhcCCCce--EEEceEEee-----cCceeEEE
Q 004702          415 GNVYKGFLPDRTPVAVKKSKFVDQAK-ID----------EFINELVVVLQINRRNV--VRLLGCCLE-----TQVPLLVY  476 (735)
Q Consensus       415 g~Vy~g~~~~~~~vavK~~~~~~~~~-~~----------~~~~E~~~l~~l~h~ni--v~l~g~~~~-----~~~~~lV~  476 (735)
                      ..|.+..+ +|..+.||+........ .+          .+.+|...+.++...+|  +.++++...     ....+||+
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            34666655 46679999764322111 11          36788888888854333  344555543     22468999


Q ss_pred             EecCCC-chhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-------CCCeEEeeccC
Q 004702          477 EFVGNG-TLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-------NCTPKVSDFGA  546 (735)
Q Consensus       477 E~~~~g-sL~~~l~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-------~~~~kl~DFGl  546 (735)
                      |++++- +|.+++..  ....+...+..++.+++..++-||..+   |+|+|+++.||||+.       +..+.|+||+.
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            999876 89998864  245566778899999999999999999   999999999999975       46899999998


Q ss_pred             Ccc
Q 004702          547 SKL  549 (735)
Q Consensus       547 s~~  549 (735)
                      ++.
T Consensus       192 ~~~  194 (268)
T PRK15123        192 AQI  194 (268)
T ss_pred             ccc
Confidence            864

>KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms]

Probab=98.77  E-value=7.3e-09  Score=123.48  Aligned_cols=77  Identities=32%  Similarity=0.738  Sum_probs=60.7

Q ss_pred             ccccc-ccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCC--CcCCCCCCccceeccC
Q 004702          233 KTCEE-AKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCT--HICDNIPGSYTCRCRK  309 (735)
Q Consensus       233 ~~C~~-~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~  309 (735)
                      ..|+. ...|.+ ++|.++++|....++|.|+|+.||+|..+...   +|+||..   +.|.  +.|.|++|+|.|.|.+
T Consensus      3897 ~~CEi~~epC~s-nPC~~GgtCip~~n~f~CnC~~gyTG~~Ce~~---Gi~eCs~---n~C~~gg~C~n~~gsf~CncT~ 3969 (4289)
T KOG1219|consen 3897 NHCEIDLEPCAS-NPCLTGGTCIPFYNGFLCNCPNGYTGKRCEAR---GISECSK---NVCGTGGQCINIPGSFHCNCTP 3969 (4289)
T ss_pred             cccccccccccC-CCCCCCCEEEecCCCeeEeCCCCccCceeecc---ccccccc---ccccCCceeeccCCceEeccCh
Confidence            35653 445864 55999999999999999999999999773322   3999973   5665  7999999999999999


Q ss_pred             CCCCCCC
Q 004702          310 GFHGDGR  316 (735)
Q Consensus       310 g~~~~~~  316 (735)
                      |+.|...
T Consensus      3970 g~~gr~c 3976 (4289)
T KOG1219|consen 3970 GILGRTC 3976 (4289)
T ss_pred             hHhcccC
Confidence            9987643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.64  E-value=1.9e-07  Score=93.25  Aligned_cols=134  Identities=20%  Similarity=0.219  Sum_probs=96.5

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccC----------------------hhHHHHHHHHHHHHHhcCCC--c
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD----------------------QAKIDEFINELVVVLQINRR--N  458 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n  458 (735)
                      ..+++.||-|.-+.||.|....+.++|||.-+...                      ........+|+++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            44678999999999999999999999999532110                      00122346799999999755  6


Q ss_pred             eEEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC
Q 004702          459 VVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT  538 (735)
Q Consensus       459 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~  538 (735)
                      |.+.+++    +...+|||++++-.|...-     ++.+..-.|+..|++-+.-+-..+   |||+|+.+-|||+++++.
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~  240 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence            7777654    4568999999886554432     123334444555555555555666   999999999999999999


Q ss_pred             eEEeeccCCc
Q 004702          539 PKVSDFGASK  548 (735)
Q Consensus       539 ~kl~DFGls~  548 (735)
                      +.++||--+.
T Consensus       241 ~~vIDwPQ~v  250 (304)
T COG0478         241 IVVIDWPQAV  250 (304)
T ss_pred             EEEEeCcccc
Confidence            9999997554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.57  E-value=3.7e-07  Score=90.99  Aligned_cols=107  Identities=16%  Similarity=0.172  Sum_probs=86.0

Q ss_pred             HHHHHHHHHHHHhcCCC--ceEEEceEEeecC----ceeEEEEecCCC-chhHHhhhcCCCCHHHHHHHHHHHHHHHHHH
Q 004702          441 IDEFINELVVVLQINRR--NVVRLLGCCLETQ----VPLLVYEFVGNG-TLFEHIHKKGNLSWERRLRITAETAGVLSYL  513 (735)
Q Consensus       441 ~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~qia~~L~yL  513 (735)
                      .....+|...+..+...  .+++.+++.....    ..+||+|++++- +|.+++.....++......++.++++.++-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            34577888888777543  3456666665533    347999999874 8999998755577788899999999999999


Q ss_pred             HhcCCCCeeecCCCCCcEEEcCCC---CeEEeeccCCccc
Q 004702          514 HSETNVPIIHRDVKSANILLDENC---TPKVSDFGASKLV  550 (735)
Q Consensus       514 H~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGls~~~  550 (735)
                      |..+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999   99999999999999887   8999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.51  E-value=1.6e-06  Score=84.85  Aligned_cols=137  Identities=16%  Similarity=0.078  Sum_probs=102.3

Q ss_pred             ccccCcEEEEEEEcCCCcEEEEEEeecc------ChhHHHHHHHHHHHHHhcCCCc--eEEEceEEeecC----ceeEEE
Q 004702          409 IGCGGSGNVYKGFLPDRTPVAVKKSKFV------DQAKIDEFINELVVVLQINRRN--VVRLLGCCLETQ----VPLLVY  476 (735)
Q Consensus       409 lG~G~~g~Vy~g~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~----~~~lV~  476 (735)
                      -|+||-+-|+.-.+.+. .+-+|+-...      -+.....|.+|+..|.+|...+  +.+++.......    .-+||+
T Consensus        26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            45688899999776544 6888875411      1334678999999999986432  455552222211    357999


Q ss_pred             EecCC-CchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC--eEEeeccCCcc
Q 004702          477 EFVGN-GTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT--PKVSDFGASKL  549 (735)
Q Consensus       477 E~~~~-gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DFGls~~  549 (735)
                      |-+.+ -+|.+++.+.  .+.+...+..++.++++.++-||+.+   +.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97753 4888888663  35678888899999999999999999   999999999999986666  99999987664

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.50  E-value=8.6e-07  Score=92.80  Aligned_cols=262  Identities=15%  Similarity=0.140  Sum_probs=156.4

Q ss_pred             ccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEE-------eecCceeEEE
Q 004702          405 YADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCC-------LETQVPLLVY  476 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~-------~~~~~~~lV~  476 (735)
                      .+..||+|+.+.+|-.--- +..|| |+...-......+.   +..|... .||-+-.-+.+=       ......-++|
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh-hchhh-eeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4668999999999964211 12233 43332222222222   2223232 344332211111       1112245677


Q ss_pred             EecCCC-chhHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          477 EFVGNG-TLFEHIHK------KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       477 E~~~~g-sL~~~l~~------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      ..+++. -+..+...      -....|.-.++.+..+|.+.+.||..+   .+-+|+.++|+||.++..+.|.|-..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            777654 22222221      145789999999999999999999999   88999999999999999999998654443


Q ss_pred             cCCCcccceeeeccccCccCccccc-----CCCCCccccchhHHHHHHHHHhC-CccCCCCChHHHHHHHHHHHHHhccc
Q 004702          550 VPIDAIQNCTVVQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTG-KMALLSDKPEEERSLAMNFLSSLKQN  623 (735)
Q Consensus       550 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~  623 (735)
                      -..+  .......|...|.+||.-.     +..-+..+|.|.||+++++||.| +.||.............  -..+..+
T Consensus       167 ~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~--E~~Ia~g  242 (637)
T COG4248         167 NANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL--ETDIAHG  242 (637)
T ss_pred             ccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc--hhhhhcc
Confidence            3222  2223345889999999654     44567789999999999999986 88885432111000000  0001111


Q ss_pred             chhhHhhhcc-----cCCCC-HHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHhhhhhcc
Q 004702          624 RLLEILDNRI-----VNDGN-KQQLKEVAKLAARCISV--RGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       624 ~~~~~~d~~~-----~~~~~-~~~~~~l~~li~~cl~~--~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ......+.+.     ..+.+ .-.++.+..|..+|+..  ++.-|||++..+..|..+.+++.
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            1111111111     01112 12346788899999965  35689999999999988777655

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.48  E-value=4.2e-08  Score=108.86  Aligned_cols=152  Identities=20%  Similarity=0.250  Sum_probs=104.8

Q ss_pred             HHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc--------ceeeeccccCccCccccc
Q 004702          503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ--------NCTVVQGTLGYLDPEYLQ  574 (735)
Q Consensus       503 ~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~--------~~~~~~gt~~y~aPE~~~  574 (735)
                      +.+++.||.|+|...+  +||++|.|++|.++.++..||+.|+++.........        .....+-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3455699999998764  999999999999999999999999987655331111        111123466899999999


Q ss_pred             CCCCCccccchhHHHHHHHHHhCCccC-CCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcc
Q 004702          575 TCKLTDKSDVYSFGVVLVELLTGKMAL-LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCI  653 (735)
Q Consensus       575 ~~~~~~ksDVyS~Gvvl~elltG~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl  653 (735)
                      ....+.++|+||+|++++.+..|.++. ............             ...+..-......+.+.++.+=+.+++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHh
Confidence            988999999999999999999554443 222111110000             001111111122456678999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 004702          654 SVRGEERPTMKEVSLE  669 (735)
Q Consensus       654 ~~~p~~RPt~~ev~~~  669 (735)
                      ..++.-||++.++...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            9999999988776543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.29  E-value=5.4e-06  Score=92.62  Aligned_cols=141  Identities=16%  Similarity=0.163  Sum_probs=91.1

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhH------------------------------HH----------HHHH
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAK------------------------------ID----------EFIN  446 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~  446 (735)
                      +-|+.++-|.||+|++++|+.||||+.+..-...                              .+          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            3699999999999999999999999754321111                              01          1334


Q ss_pred             HHHHHHhcC-----CCceEEEceEEeecCceeEEEEecCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 004702          447 ELVVVLQIN-----RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVP  520 (735)
Q Consensus       447 E~~~l~~l~-----h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~  520 (735)
                      |...+.+++     .+++.-.-=+..-....+|+|||++|-.+.+...- ...++...+.....++.  +..+-..+   
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg---  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG---  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC---
Confidence            444444442     23332222222234566899999999888887432 24455443333332222  22233345   


Q ss_pred             eeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          521 IIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       521 ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++|.|..|.||+++.++++-+.|||+...+..
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            99999999999999999999999999876643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.18  E-value=2e-05  Score=79.51  Aligned_cols=137  Identities=13%  Similarity=0.142  Sum_probs=83.7

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc--eEEEceEEeecCceeEEEEecCCCc-
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN--VVRLLGCCLETQVPLLVYEFVGNGT-  483 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~E~~~~gs-  483 (735)
                      ..||+|..+.||+.   .+..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            36899999999984   24457788765422  2345678999999886543  4677777777777789999998863 


Q ss_pred             hhHHh---------------------hhc--CCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCeeecCCC
Q 004702          484 LFEHI---------------------HKK--GNLSWERRLR-ITA----------ETAG-VLSYLHSE-TNVPIIHRDVK  527 (735)
Q Consensus       484 L~~~l---------------------~~~--~~l~~~~~~~-i~~----------qia~-~L~yLH~~-~~~~ivH~Dlk  527 (735)
                      +...+                     |.-  .......... +..          ++.+ ...+|... ....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            21111                     110  0111111110 000          0111 12222221 12346899999


Q ss_pred             CCcEEEcCCCCeEEeeccCCcc
Q 004702          528 SANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       528 ~~NILl~~~~~~kl~DFGls~~  549 (735)
                      |.||++++++ +.|+||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999887 99999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.16  E-value=2.1e-05  Score=78.07  Aligned_cols=134  Identities=20%  Similarity=0.208  Sum_probs=91.0

Q ss_pred             cccccCcEEEEEEEcCCCcEEEEEEeeccChhH-------------------HH-----HHHHHHHHHHhcCCC--ceEE
Q 004702          408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAK-------------------ID-----EFINELVVVLQINRR--NVVR  461 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~-------------------~~-----~~~~E~~~l~~l~h~--niv~  461 (735)
                      .|.+|.-+.||+|...++..+|||+.+......                   ..     -..+|+..|+++...  .+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            577888899999998889999999865321110                   00     123567777776432  3334


Q ss_pred             EceEEeecCceeEEEEecCCC-chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCCe
Q 004702          462 LLGCCLETQVPLLVYEFVGNG-TLFEHIHKKGNLSWERRLRITAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENCTP  539 (735)
Q Consensus       462 l~g~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~  539 (735)
                      .+++.    ...|||||+... .-.-.|+. -++.......+..++++.+.-|-. .+   +||+||..-|||+. ++.+
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeE
Confidence            44332    337999999653 11122222 223444677788888888888877 55   99999999999999 7799


Q ss_pred             EEeeccCCccc
Q 004702          540 KVSDFGASKLV  550 (735)
Q Consensus       540 kl~DFGls~~~  550 (735)
                      .|+|||-+...
T Consensus       206 ~iID~~QaV~~  216 (268)
T COG1718         206 YIIDVSQAVTI  216 (268)
T ss_pred             EEEECcccccc
Confidence            99999987754

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.10  E-value=3.3e-05  Score=79.17  Aligned_cols=132  Identities=14%  Similarity=0.095  Sum_probs=81.4

Q ss_pred             cEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEecCCCchhHHhh---
Q 004702          414 SGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH---  489 (735)
Q Consensus       414 ~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~---  489 (735)
                      -..||+....+ ..+.||+.....   ..+..+|++++..+. +--+.+++++....+..++|||+++|.+|.....   
T Consensus        12 ~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~   87 (244)
T cd05150          12 GATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELE   87 (244)
T ss_pred             cCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccC
Confidence            37899987654 678888865433   335667888888874 3446677887776667899999999877764321   


Q ss_pred             ----------------hcC----CCC--HHHHHHHHH--------------------HHHHHHHHHHhc----CCCCeee
Q 004702          490 ----------------KKG----NLS--WERRLRITA--------------------ETAGVLSYLHSE----TNVPIIH  523 (735)
Q Consensus       490 ----------------~~~----~l~--~~~~~~i~~--------------------qia~~L~yLH~~----~~~~ivH  523 (735)
                                      ...    ++.  ....+....                    .+...+..|-..    ..+.++|
T Consensus        88 ~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H  167 (244)
T cd05150          88 PERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTH  167 (244)
T ss_pred             HHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEEC
Confidence                            000    010  001110000                    011112222111    1244899


Q ss_pred             cCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          524 RDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       524 ~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      +|+.|.|||++++..+.|+||+.+..
T Consensus       168 gD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         168 GDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CCCCCccEEEeCCcEEEEEEcccccc
Confidence            99999999999987789999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.08  E-value=1.2e-05  Score=78.60  Aligned_cols=102  Identities=23%  Similarity=0.334  Sum_probs=83.8

Q ss_pred             HHHHHHHHhcCC-CceEEEceEEeecCceeEEEEecCCCchhH---HhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 004702          445 INELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLFE---HIHKKGNLSWERRLRITAETAGVLSYLHSETNVP  520 (735)
Q Consensus       445 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~---~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~  520 (735)
                      .+|..+|+.+++ +++++++|.|-.    ++|.||...+++..   .+.+....+|..|.+||.++++.+.+|++....+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            368888999987 699999999943    78999998776542   1222235789999999999999999999876556


Q ss_pred             eeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          521 IIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       521 ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      +.-.|++++|+-+++++++|+.|.......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.07  E-value=1.2e-06  Score=96.34  Aligned_cols=179  Identities=19%  Similarity=0.083  Sum_probs=129.6

Q ss_pred             cccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc-eEEEceEEeecCceeEEEEecCCC-chh
Q 004702          408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN-VVRLLGCCLETQVPLLVYEFVGNG-TLF  485 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E~~~~g-sL~  485 (735)
                      -+++|+.++++|.+-...+.+..+.+...     ....-++++|.+++||| .+..++-+..+...+++++++..+ +-.
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~  323 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA  323 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence            46789999999976433333334443321     34456889999999999 777777777788889999999877 222


Q ss_pred             H-HhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccc
Q 004702          486 E-HIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT  564 (735)
Q Consensus       486 ~-~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt  564 (735)
                      . .......+...+...+...-+++|++||+.-   -+|+|    |||..+ ...|..||+....+....  ......++
T Consensus       324 ~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~  393 (829)
T KOG0576|consen  324 LEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGT  393 (829)
T ss_pred             ccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--ccccCCCC
Confidence            1 1111123444555667777889999999964   58998    888776 478999999887665433  22344589


Q ss_pred             cCccCcccccCCCCCccccchhHHHHHHHHHhCCccC
Q 004702          565 LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL  601 (735)
Q Consensus       565 ~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~  601 (735)
                      +.|+|||......+..+-|+|++|+--.++--|-.|-
T Consensus       394 ~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  394 PEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            9999999999999999999999998777776666553

>KOG1214 consensus Nidogen and related basement membrane protein proteins [Cell wall/membrane/envelope biogenesis; Extracellular structures]

Probab=98.06  E-value=2.7e-06  Score=94.41  Aligned_cols=72  Identities=36%  Similarity=0.907  Sum_probs=55.0

Q ss_pred             ccCC-CCCCCCCCC--cc-CCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCC--CcCCCCCCccceeccCCCCC
Q 004702          240 ICGL-NASCDTPKD--NT-STSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHG  313 (735)
Q Consensus       240 ~C~~-~~~C~~~~~--c~-~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~  313 (735)
                      .|.. .+.|.-++.  |. ..++.|.|.|.|||.|+.   ..|+|+|||.   +..|.  ++|.|++|++.|.|.+||.|
T Consensus       785 ~Ce~g~h~C~i~g~a~c~~hGgs~y~C~CLPGfsGDG---~~c~dvDeC~---psrChp~A~CyntpgsfsC~C~pGy~G  858 (1289)
T KOG1214|consen  785 PCEDGSHTCAIAGQARCVHHGGSTYSCACLPGFSGDG---HQCTDVDECS---PSRCHPAATCYNTPGSFSCRCQPGYYG  858 (1289)
T ss_pred             ccccCccccCcCCceEEEecCCceEEEeecCCccCCc---cccccccccC---ccccCCCceEecCCCcceeecccCccC
Confidence            3554 255654332  33 345679999999999965   4599999997   35676  69999999999999999999


Q ss_pred             CCCC
Q 004702          314 DGRK  317 (735)
Q Consensus       314 ~~~~  317 (735)
                      ++..
T Consensus       859 DGf~  862 (1289)
T KOG1214|consen  859 DGFQ  862 (1289)
T ss_pred             CCce
Confidence            9863

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.05  E-value=3.1e-05  Score=78.30  Aligned_cols=140  Identities=20%  Similarity=0.205  Sum_probs=83.0

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCC--ceEEEceEEee---cCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR--NVVRLLGCCLE---TQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~---~~~~~lV~E~~~~  481 (735)
                      +.|+.|..+.||+....+ ..+++|.....  .....+.+|..++..+...  .+.+++.....   ....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            468889999999999877 58999986543  4456777888888888543  35667764433   2346899999998


Q ss_pred             CchhH----------------Hhh---hc----CCCCHHH---------HHHH------------HHHHHH-HHHHHHhc
Q 004702          482 GTLFE----------------HIH---KK----GNLSWER---------RLRI------------TAETAG-VLSYLHSE  516 (735)
Q Consensus       482 gsL~~----------------~l~---~~----~~l~~~~---------~~~i------------~~qia~-~L~yLH~~  516 (735)
                      ..+..                .+.   ..    ..+....         ....            ...+.+ .+..++..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87776                111   11    0111100         0000            112222 33333321


Q ss_pred             ----CCCCeeecCCCCCcEEEc-CCCCeEEeeccCCcc
Q 004702          517 ----TNVPIIHRDVKSANILLD-ENCTPKVSDFGASKL  549 (735)
Q Consensus       517 ----~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGls~~  549 (735)
                          ....++|+|+.+.|||++ +++.+-|.||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                334599999999999999 556667999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.00  E-value=0.00012  Score=71.97  Aligned_cols=132  Identities=22%  Similarity=0.307  Sum_probs=93.3

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccC----------------hhHHHHHHHHHHHHHhcC------CCceEEEc
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD----------------QAKIDEFINELVVVLQIN------RRNVVRLL  463 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~  463 (735)
                      ...||+|+.-.||.  .++.....||+++...                .....++.+|+.-..++.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45899999999997  4556667888776544                223456667776666555      78999999


Q ss_pred             eEEeecCceeEEEEecCC--C----chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 004702          464 GCCLETQVPLLVYEFVGN--G----TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC  537 (735)
Q Consensus       464 g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~  537 (735)
                      |+...+..+-+|+|.+.+  |    +|.+++++. .++. ...+.+.   +-..||-..+   |+.+||+|.||++..+.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEEecC
Confidence            999999989999998753  2    678888554 4555 4444443   4456777777   99999999999996332


Q ss_pred             ----CeEEee-ccCC
Q 004702          538 ----TPKVSD-FGAS  547 (735)
Q Consensus       538 ----~~kl~D-FGls  547 (735)
                          .+.|+| ||..
T Consensus       156 ~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  156 SGEFRLVLIDGLGEK  170 (199)
T ss_pred             CCceEEEEEeCCCCc
Confidence                456665 4433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.97  E-value=0.00012  Score=72.08  Aligned_cols=130  Identities=14%  Similarity=0.131  Sum_probs=79.1

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHH---------HHHHHHHhcCC---CceEEEceEEee-----c
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFI---------NELVVVLQINR---RNVVRLLGCCLE-----T  469 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~---------~E~~~l~~l~h---~niv~l~g~~~~-----~  469 (735)
                      +++-......|.+-.. ++..+.+|..+.......+.|.         +++..+..++.   .....++.+...     .
T Consensus        37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~  115 (229)
T PF06176_consen   37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT  115 (229)
T ss_pred             EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence            3444444445555444 4566888876554333222222         23333333322   222332222221     2


Q ss_pred             CceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          470 QVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       470 ~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      ...+|||||++|..|.++..    ++.    .++..+++++.-||..|   ++|+|..|.|++++++ .+++.||+..+.
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccccc
Confidence            34468999999987766542    222    24566778899999999   9999999999999966 499999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.85  E-value=9.8e-05  Score=82.38  Aligned_cols=138  Identities=17%  Similarity=0.117  Sum_probs=88.8

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChh-------------------------------------HHHHHHHHHH
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQA-------------------------------------KIDEFINELV  449 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~E~~  449 (735)
                      +-|+.-+.|.||++++++|..||||.-+..-+.                                     ..-+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            369999999999999999999999964321111                                     0112445554


Q ss_pred             HHHh----cCCCc------eEEEceEEeecCceeEEEEecCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 004702          450 VVLQ----INRRN------VVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETN  518 (735)
Q Consensus       450 ~l~~----l~h~n------iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~  518 (735)
                      ...+    +.|-+      |.+++--+  .....|+||||+|..+.+.-.- ...++...+..-+.+...-+-+  ..| 
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf--~~G-  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF--KTG-  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH--hcC-
Confidence            4333    23444      33333222  3356899999999877665432 2346666554444443222222  234 


Q ss_pred             CCeeecCCCCCcEEEcC----CCCeEEeeccCCcccC
Q 004702          519 VPIIHRDVKSANILLDE----NCTPKVSDFGASKLVP  551 (735)
Q Consensus       519 ~~ivH~Dlk~~NILl~~----~~~~kl~DFGls~~~~  551 (735)
                        ++|.|=.|.||++..    +..+.+-|||+...+.
T Consensus       322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             --CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence              999999999999983    6789999999988654

>PLN02876 acyl-CoA dehydrogenase

Probab=97.84  E-value=0.00012  Score=88.28  Aligned_cols=78  Identities=12%  Similarity=0.192  Sum_probs=55.6

Q ss_pred             ccccccCcEEEEEEEcCCC---cEEEEEEeeccC-hhHHHHHHHHHHHHHhcC-CCce--EEEceEEeec---CceeEEE
Q 004702          407 DVIGCGGSGNVYKGFLPDR---TPVAVKKSKFVD-QAKIDEFINELVVVLQIN-RRNV--VRLLGCCLET---QVPLLVY  476 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV~  476 (735)
                      +.|+.|.+..+|+....++   ..+++|+..... ......+.+|+.+|+.+. |.+|  .++++++.+.   +.+++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            4678899999999876553   357777754321 123356789999999996 6664  7888887664   4679999


Q ss_pred             EecCCCch
Q 004702          477 EFVGNGTL  484 (735)
Q Consensus       477 E~~~~gsL  484 (735)
                      ||+++..+
T Consensus       124 E~v~G~~~  131 (822)
T PLN02876        124 EYLEGRIF  131 (822)
T ss_pred             EecCCccc
Confidence            99987643

>PF12662 cEGF: Complement Clr-like EGF-like

Probab=97.78  E-value=1.7e-05  Score=48.38  Aligned_cols=24  Identities=38%  Similarity=0.996  Sum_probs=21.2

Q ss_pred             cceeeCCCCCCCCCCCCCCccccCC
Q 004702          259 GYRCKCNKGYEGNPYLSDGCRDVNE  283 (735)
Q Consensus       259 ~y~C~C~~Gy~gn~y~~~gC~di~e  283 (735)
                      +|.|.|++||+.++ ....|+||||
T Consensus         1 sy~C~C~~Gy~l~~-d~~~C~DIdE   24 (24)
T PF12662_consen    1 SYTCSCPPGYQLSP-DGRSCEDIDE   24 (24)
T ss_pred             CEEeeCCCCCcCCC-CCCccccCCC
Confidence            69999999999887 5578999997

>PRK10593 hypothetical protein; Provisional

Probab=97.75  E-value=0.00035  Score=73.75  Aligned_cols=76  Identities=8%  Similarity=0.019  Sum_probs=55.6

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCC---CceEEEceEEee---cCceeEEEEec
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR---RNVVRLLGCCLE---TQVPLLVYEFV  479 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~---~~~~~lV~E~~  479 (735)
                      .+.||.|..+.||+....+++ +++|..+..  .....|..|...|+.|..   -.+.++++++..   .+..+||||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            346999999999998766664 666664321  123578899999998854   367888887754   35689999999


Q ss_pred             CCCch
Q 004702          480 GNGTL  484 (735)
Q Consensus       480 ~~gsL  484 (735)
                      ++.++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            88765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.66  E-value=0.00023  Score=72.42  Aligned_cols=73  Identities=15%  Similarity=0.189  Sum_probs=44.7

Q ss_pred             ccccccCcE-EEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCC---ceEEEceEEeec---CceeEEEEec
Q 004702          407 DVIGCGGSG-NVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR---NVVRLLGCCLET---QVPLLVYEFV  479 (735)
Q Consensus       407 ~~lG~G~~g-~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~---~~~~lV~E~~  479 (735)
                      +.|+.|+.. .||+.    +..+++|..+..  ....++.+|.++|..+...   -+.++++.....   ...++|||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            346766665 58874    234667764432  2245788899999887532   344444443322   2458899999


Q ss_pred             CCCchh
Q 004702          480 GNGTLF  485 (735)
Q Consensus       480 ~~gsL~  485 (735)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987664

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms]

Probab=97.60  E-value=7.2e-05  Score=90.95  Aligned_cols=73  Identities=30%  Similarity=0.777  Sum_probs=59.5

Q ss_pred             ccccc-cccCCCCCCCCCCCccCC-CCcceeeCCCCCCCCCCCCCCc-cccCCccCCCCCCCC--CcCCCCCCccceecc
Q 004702          234 TCEEA-KICGLNASCDTPKDNTST-SSGYRCKCNKGYEGNPYLSDGC-RDVNECEDPSRNNCT--HICDNIPGSYTCRCR  308 (735)
Q Consensus       234 ~C~~~-~~C~~~~~C~~~~~c~~~-~~~y~C~C~~Gy~gn~y~~~gC-~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~  308 (735)
                      -|.-. +.|.. ..|+++++|... .+||.|.|++.|.|+-     | ++++.|..   +||-  ++|.-..++|.|.|+
T Consensus      3859 gC~l~~d~C~~-npCqhgG~C~~~~~ggy~CkCpsqysG~~-----CEi~~epC~s---nPC~~GgtCip~~n~f~CnC~ 3929 (4289)
T KOG1219|consen 3859 GCSLLTDPCND-NPCQHGGTCISQPKGGYKCKCPSQYSGNH-----CEIDLEPCAS---NPCLTGGTCIPFYNGFLCNCP 3929 (4289)
T ss_pred             ccccccccccc-CcccCCCEecCCCCCceEEeCcccccCcc-----cccccccccC---CCCCCCCEEEecCCCeeEeCC
Confidence            46543 66854 559999999765 5789999999999987     7 47899974   5665  799999999999999


Q ss_pred             CCCCCCC
Q 004702          309 KGFHGDG  315 (735)
Q Consensus       309 ~g~~~~~  315 (735)
                      .||+|.-
T Consensus      3930 ~gyTG~~ 3936 (4289)
T KOG1219|consen 3930 NGYTGKR 3936 (4289)
T ss_pred             CCccCce
Confidence            9999873

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.55  E-value=0.00024  Score=83.83  Aligned_cols=196  Identities=19%  Similarity=0.182  Sum_probs=140.2

Q ss_pred             HHHHHHHHhcCCCceEEEceEEeecCc----eeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 004702          445 INELVVVLQINRRNVVRLLGCCLETQV----PLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP  520 (735)
Q Consensus       445 ~~E~~~l~~l~h~niv~l~g~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~  520 (735)
                      .-|+..+..+.|+|++.++++..+...    ..+..|++..-++...+.....++....+.+..++.+||+|+|+..   
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~---  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS---  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc---
Confidence            346777888899999999999876542    2345577888888888888888999999999999999999999986   


Q ss_pred             eeecCCCCC---cEEEcCCCCeEEe--eccCCcccCCCcccceeeeccccCccCcccccCCCCCc--cccchhHHHHHHH
Q 004702          521 IIHRDVKSA---NILLDENCTPKVS--DFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD--KSDVYSFGVVLVE  593 (735)
Q Consensus       521 ivH~Dlk~~---NILl~~~~~~kl~--DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDVyS~Gvvl~e  593 (735)
                      ..|.-|..+   +-.++..+.+.++  ||+.++..+.......  ..-+..|.+||......+..  ..|+|.+|.++..
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence            666655555   5555667777777  9998887654332221  22455777888776655444  4799999999999


Q ss_pred             HHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          594 LLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       594 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                      +..|..+-.....                  ...+++..        ....+.+...+|+..++++|+...+++...-
T Consensus       385 ~~~~~~i~~~~~~------------------~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  385 LSQGEDISEKSAV------------------PVSLLDVL--------STSELLDALPKCLDEDSEERLSALELLTHPF  436 (1351)
T ss_pred             hhhcCcccccccc------------------hhhhhccc--------cchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence            9988654321111                  01111110        1115677888999999999999999886543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.50  E-value=0.00066  Score=64.04  Aligned_cols=126  Identities=15%  Similarity=0.162  Sum_probs=85.1

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceE-EEceEEeecCceeEEEEecCCCch
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVV-RLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      .+.|++|.+|.||+|.+.++ .+|+|+-+.  ......+..|+++|..+.-.++. +++.+..    .++.|||+.|-.|
T Consensus        27 ~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L   99 (201)
T COG2112          27 EKELAKGTTSVVYLGEWRGG-EVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL   99 (201)
T ss_pred             hhhhhcccccEEEEeeccCc-eEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence            45899999999999998654 688887543  33356788999999988766653 4444432    2456999988777


Q ss_pred             hHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC-C-CcEEEcCCCCeEEeeccCCcc
Q 004702          485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK-S-ANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       485 ~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk-~-~NILl~~~~~~kl~DFGls~~  549 (735)
                      .+.-...   +.++++    .+++.---|...+   |-|+.|. | .||++.++ .+.|+||.-|..
T Consensus       100 ~~~~~~~---~rk~l~----~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112         100 GKLEIGG---DRKHLL----RVLEKAYKLDRLG---IEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcc---cHHHHH----HHHHHHHHHHHhc---cchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            6655321   233333    3444433444556   8999887 3 45555554 899999998873

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.49  E-value=0.001  Score=67.69  Aligned_cols=73  Identities=19%  Similarity=0.171  Sum_probs=46.5

Q ss_pred             ccccccCcEEEEEEEcCC--CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc-eEEEceEEeecCceeEEEEecCCCc
Q 004702          407 DVIGCGGSGNVYKGFLPD--RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN-VVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      +.|..|-...+|+....+  +..+++|........ ..+..+|+.++..+...+ .+++++...    ..+||||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            356677788999988664  567888876532221 122346888888885433 344444332    248999998876


Q ss_pred             h
Q 004702          484 L  484 (735)
Q Consensus       484 L  484 (735)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.48  E-value=0.0012  Score=64.34  Aligned_cols=125  Identities=27%  Similarity=0.345  Sum_probs=87.7

Q ss_pred             hhccccccccccCc-EEEEEEEcCCCcEEEEEEeec---c---------Ch---------hHHHHHHHHHHHHHhc---C
Q 004702          401 VTNNYADVIGCGGS-GNVYKGFLPDRTPVAVKKSKF---V---------DQ---------AKIDEFINELVVVLQI---N  455 (735)
Q Consensus       401 ~~~~~~~~lG~G~~-g~Vy~g~~~~~~~vavK~~~~---~---------~~---------~~~~~~~~E~~~l~~l---~  455 (735)
                      ....|.+.||.|.. |.|||.... |..+|+|..+.   .         ..         .....|..|.+...+|   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            55667889999999 999999985 55899998322   0         00         1223577888776666   4


Q ss_pred             CCce--EEEceEEeecC------------------ceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 004702          456 RRNV--VRLLGCCLETQ------------------VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHS  515 (735)
Q Consensus       456 h~ni--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~  515 (735)
                      +.++  |+.+||..-..                  ...||.||++...         .+.    .+-+.++.+-|..+|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILHK  182 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHHH
Confidence            5566  89999974331                  1246777775432         122    2334567777889999


Q ss_pred             cCCCCeeecCCCCCcEEEcCCCCeEEeeccCC
Q 004702          516 ETNVPIIHRDVKSANILLDENCTPKVSDFGAS  547 (735)
Q Consensus       516 ~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls  547 (735)
                      .+   |+-+|+++.|..     .-||+|||.+
T Consensus       183 ~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 LG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CC---eeeccCcccccc-----CCEEEecccC
Confidence            99   999999999986     5689999864

>PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins

Probab=97.36  E-value=5.4e-05  Score=54.15  Aligned_cols=33  Identities=39%  Similarity=1.005  Sum_probs=29.0

Q ss_pred             ccCCccCCCCCCCC--CcCCCCCCccceeccCCCCC
Q 004702          280 DVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHG  313 (735)
Q Consensus       280 di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~  313 (735)
                      |||||.... +.|.  +.|.|+.|+|.|.|++||..
T Consensus         1 DidEC~~~~-~~C~~~~~C~N~~Gsy~C~C~~Gy~~   35 (42)
T PF07645_consen    1 DIDECAEGP-HNCPENGTCVNTEGSYSCSCPPGYEL   35 (42)
T ss_dssp             ESSTTTTTS-SSSSTTSEEEEETTEEEEEESTTEEE
T ss_pred             CccccCCCC-CcCCCCCEEEcCCCCEEeeCCCCcEE
Confidence            799999764 6776  79999999999999999983

Many of these proteins require calcium for their biological function and a calcium-binding site has been found at the N terminus of some EGF-like domains []. Calcium-binding may be crucial for numerous protein-protein interactions. For human coagulation factor IX it has been shown [] that the calcium-ligands form a pentagonal bipyramid. The first, third and fourth conserved negatively charged or polar residues are side chain ligands. The latter is possibly hydroxylated (see aspartic acid and asparagine hydroxylation site) []. A conserved aromatic residue, as well as the second conserved negative residue, are thought to be involved in stabilising the calcium-binding site. As in non-calcium binding EGF-like domains, there are six conserved cysteines and the structure of both types is very similar as calcium-binding induces only strictly local structural changes []. +------------------+ +---------+ | | | | nxnnC-x(3,14)-C-x(3,7)-CxxbxxxxaxC-x(1,6)-C-x(8,13)-Cx | | +------------------+ 'n': negatively charged or polar residue [DEQN] 'b': possibly beta-hydroxylated residue [DN] 'a': aromatic amino acid 'C': cysteine, involved in disulphide bond 'x': any amino acid. ; GO: 0005509 calcium ion binding; PDB: 2VJ3_A 1TOZ_A 1LMJ_A 1UZQ_A 1UZK_A 1UZJ_B 1UZP_A 1EMO_A 1EMN_A 2RR0_A ....

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.28  E-value=0.0012  Score=68.24  Aligned_cols=135  Identities=13%  Similarity=0.085  Sum_probs=76.0

Q ss_pred             ccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCce-EEEceEEeecCceeEEEEecCCCchhHH
Q 004702          409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNV-VRLLGCCLETQVPLLVYEFVGNGTLFEH  487 (735)
Q Consensus       409 lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~~  487 (735)
                      +..|-...+|+... ++..+++|........-.-+..+|..+++.+....+ .++++..    ..++||||++|..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence            45577788998873 456788887543222111234678888888864333 3344432    23789999988665321


Q ss_pred             -----------------hhhc----CCCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCeeecCCCCCcE
Q 004702          488 -----------------IHKK----GNLSWERR-LRITAE---------TAGVLSYLHSE-----TNVPIIHRDVKSANI  531 (735)
Q Consensus       488 -----------------l~~~----~~l~~~~~-~~i~~q---------ia~~L~yLH~~-----~~~~ivH~Dlk~~NI  531 (735)
                                       ||..    .+++.... .....+         +.+.+..+-..     ....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             1111    11222211 111111         11222222221     123489999999999


Q ss_pred             EEcCCCCeEEeeccCCcc
Q 004702          532 LLDENCTPKVSDFGASKL  549 (735)
Q Consensus       532 Ll~~~~~~kl~DFGls~~  549 (735)
                      ++++++ ++|+||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999876 78999988763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG4260 consensus Uncharacterized conserved protein [Function unknown]

Probab=97.27  E-value=0.00028  Score=69.30  Aligned_cols=38  Identities=37%  Similarity=0.965  Sum_probs=31.9

Q ss_pred             CCccccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          276 DGCRDVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       276 ~gC~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      .+|.|||||... ..+|.  +.|+|+.|||.|.+.+||...
T Consensus       231 ~gCvDvnEC~~e-p~~c~~~qfCvNteGSf~C~dk~Gy~~g  270 (350)
T KOG4260|consen  231 EGCVDVNECQNE-PAPCKAHQFCVNTEGSFKCEDKEGYKKG  270 (350)
T ss_pred             cccccHHHHhcC-CCCCChhheeecCCCceEecccccccCC
Confidence            457799999864 47787  689999999999999999764

>KOG4260 consensus Uncharacterized conserved protein [Function unknown]

Probab=97.20  E-value=0.00017  Score=70.79  Aligned_cols=80  Identities=25%  Similarity=0.647  Sum_probs=60.2

Q ss_pred             EEeeeeccccccccccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc-cCCccCCCCCCCCCcCCCCCC
Q 004702          224 VLDWEIITDKTCEEAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD-VNECEDPSRNNCTHICDNIPG  301 (735)
Q Consensus       224 ~l~w~~~~~~~C~~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d-i~eC~~~~~~~c~~~C~n~~g  301 (735)
                      .-+|.+. ..-|.|+++|.. ...|....-|+|+.++|.|.+.+||.+.   .+.|+- .+.|..++     ..|.|+++
T Consensus       223 kkGW~ld-e~gCvDvnEC~~ep~~c~~~qfCvNteGSf~C~dk~Gy~~g---~d~C~~~~d~~~~kn-----~~c~ni~~  293 (350)
T KOG4260|consen  223 KKGWKLD-EEGCVDVNECQNEPAPCKAHQFCVNTEGSFKCEDKEGYKKG---VDECQFCADVCASKN-----RPCMNIDG  293 (350)
T ss_pred             cccceec-ccccccHHHHhcCCCCCChhheeecCCCceEecccccccCC---hHHhhhhhhhcccCC-----CCcccCCc
Confidence            4579876 458999999987 6679888899999999999999999772   233332 12232221     57999999


Q ss_pred             ccceeccCCCC
Q 004702          302 SYTCRCRKGFH  312 (735)
Q Consensus       302 ~y~C~c~~g~~  312 (735)
                      .|.|.|..++.
T Consensus       294 ~~r~v~f~~~~  304 (350)
T KOG4260|consen  294 QYRCVCFSGLI  304 (350)
T ss_pred             cEEEEecccce
Confidence            99999987764

>PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins

Probab=97.19  E-value=0.00011  Score=52.64  Aligned_cols=35  Identities=29%  Similarity=0.629  Sum_probs=30.0

Q ss_pred             cccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCC
Q 004702          237 EAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGN  271 (735)
Q Consensus       237 ~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn  271 (735)
                      |++||.. .+.|..++.|.++.++|.|.|++||..+
T Consensus         1 DidEC~~~~~~C~~~~~C~N~~Gsy~C~C~~Gy~~~   36 (42)
T PF07645_consen    1 DIDECAEGPHNCPENGTCVNTEGSYSCSCPPGYELN   36 (42)
T ss_dssp             ESSTTTTTSSSSSTTSEEEEETTEEEEEESTTEEEC
T ss_pred             CccccCCCCCcCCCCCEEEcCCCCEEeeCCCCcEEC
Confidence            4678877 5679888999999999999999999843

Many of these proteins require calcium for their biological function and a calcium-binding site has been found at the N terminus of some EGF-like domains []. Calcium-binding may be crucial for numerous protein-protein interactions. For human coagulation factor IX it has been shown [] that the calcium-ligands form a pentagonal bipyramid. The first, third and fourth conserved negatively charged or polar residues are side chain ligands. The latter is possibly hydroxylated (see aspartic acid and asparagine hydroxylation site) []. A conserved aromatic residue, as well as the second conserved negative residue, are thought to be involved in stabilising the calcium-binding site. As in non-calcium binding EGF-like domains, there are six conserved cysteines and the structure of both types is very similar as calcium-binding induces only strictly local structural changes []. +------------------+ +---------+ | | | | nxnnC-x(3,14)-C-x(3,7)-CxxbxxxxaxC-x(1,6)-C-x(8,13)-Cx | | +------------------+ 'n': negatively charged or polar residue [DEQN] 'b': possibly beta-hydroxylated residue [DN] 'a': aromatic amino acid 'C': cysteine, involved in disulphide bond 'x': any amino acid. ; GO: 0005509 calcium ion binding; PDB: 2VJ3_A 1TOZ_A 1LMJ_A 1UZQ_A 1UZK_A 1UZJ_B 1UZP_A 1EMO_A 1EMN_A 2RR0_A ....

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.16  E-value=0.0094  Score=64.99  Aligned_cols=74  Identities=16%  Similarity=0.107  Sum_probs=53.4

Q ss_pred             ccccccCcEEEEEEEcCCC-cEEEEEEeecc----C---hhHHHHHHHHHHHHHhcC---CCceEEEceEEeecCceeEE
Q 004702          407 DVIGCGGSGNVYKGFLPDR-TPVAVKKSKFV----D---QAKIDEFINELVVVLQIN---RRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~-~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV  475 (735)
                      +.||.|.+..||+....++ +.|+||.....    .   +-..+.+..|.+.|..+.   ..++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            4689999999999998776 48999974311    1   224566777888887763   3467778776  44557899


Q ss_pred             EEecCCC
Q 004702          476 YEFVGNG  482 (735)
Q Consensus       476 ~E~~~~g  482 (735)
                      ||++++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9999864

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.06  E-value=0.004  Score=65.69  Aligned_cols=138  Identities=22%  Similarity=0.192  Sum_probs=82.4

Q ss_pred             cccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc--eEEEceE------EeecCceeEEEEec
Q 004702          408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN--VVRLLGC------CLETQVPLLVYEFV  479 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~E~~  479 (735)
                      .|..|....+|+....++ .+++|+....   ..++...|+.++..+.+.+  +.+++..      ....+..++|++|+
T Consensus        21 ~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          21 GISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             cccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            566777788999876544 5888876542   2345667788777775432  4444432      12345668999999


Q ss_pred             CCCchhH----Hh----------hhc-C----------CCCHHHHH----------HHHHHHHHHHHHHHhc----CCCC
Q 004702          480 GNGTLFE----HI----------HKK-G----------NLSWERRL----------RITAETAGVLSYLHSE----TNVP  520 (735)
Q Consensus       480 ~~gsL~~----~l----------~~~-~----------~l~~~~~~----------~i~~qia~~L~yLH~~----~~~~  520 (735)
                      +|..+..    .+          |.. .          ...|....          .....+...+.++...    -...
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            8866532    11          100 0          01121111          0111233445555531    1234


Q ss_pred             eeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          521 IIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       521 ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      ++|+|+.|.|||++++..+.|.||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            99999999999999987778999987763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins

Probab=96.93  E-value=0.00025  Score=48.55  Aligned_cols=30  Identities=37%  Similarity=0.909  Sum_probs=23.9

Q ss_pred             CCCCCCCCCccCCCCcceeeCCCCCCCCCC
Q 004702          244 NASCDTPKDNTSTSSGYRCKCNKGYEGNPY  273 (735)
Q Consensus       244 ~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y  273 (735)
                      ++.|..+++|.++.++|.|.|++||.|+.+
T Consensus         5 ~~~C~~nA~C~~~~~~~~C~C~~Gy~GdG~   34 (36)
T PF12947_consen    5 NGGCHPNATCTNTGGSYTCTCKPGYEGDGF   34 (36)
T ss_dssp             GGGS-TTCEEEE-TTSEEEEE-CEEECCST
T ss_pred             CCCCCCCcEeecCCCCEEeECCCCCccCCc
Confidence            567888899999999999999999999864

; PDB: 2NPR_A 1N1I_C 1B9W_A 1YO8_A 2RHP_A.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.84  E-value=0.0062  Score=64.50  Aligned_cols=137  Identities=26%  Similarity=0.306  Sum_probs=80.1

Q ss_pred             cccccCcEEEEEEEcCC-------CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCce-EEEceEEeecCceeEEEEec
Q 004702          408 VIGCGGSGNVYKGFLPD-------RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNV-VRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~  479 (735)
                      .|..|-...+|+....+       +..+++|...... ....+..+|..++..+....+ .++++...    ..+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhee
Confidence            34456666889887655       4678888865432 223445678888888764333 34555443    24689999


Q ss_pred             CCCchhHH-----------------hhhc-CCC--------C--HHHHHH--------------------------HHHH
Q 004702          480 GNGTLFEH-----------------IHKK-GNL--------S--WERRLR--------------------------ITAE  505 (735)
Q Consensus       480 ~~gsL~~~-----------------l~~~-~~l--------~--~~~~~~--------------------------i~~q  505 (735)
                      +|..+...                 +|.. ...        +  +..+.+                          +..+
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88766431                 0110 010        0  111111                          1112


Q ss_pred             HHHHHHHHHh------cCCCCeeecCCCCCcEEEcCC----CCeEEeeccCCcc
Q 004702          506 TAGVLSYLHS------ETNVPIIHRDVKSANILLDEN----CTPKVSDFGASKL  549 (735)
Q Consensus       506 ia~~L~yLH~------~~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGls~~  549 (735)
                      +.+.+..|..      .....++|+|+.+.|||++++    +.++++||..+..
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            2223344432      133458999999999999984    7899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.82  E-value=0.019  Score=61.23  Aligned_cols=138  Identities=17%  Similarity=0.148  Sum_probs=74.6

Q ss_pred             cccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc--eEEEce------EEeecCceeEEEEec
Q 004702          408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN--VVRLLG------CCLETQVPLLVYEFV  479 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g------~~~~~~~~~lV~E~~  479 (735)
                      .|..|....+|+....++ .+++|+......   +....|+.++..|...+  +.+++.      +....+.+++++||+
T Consensus        29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         29 GIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             hhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            466677778999876655 588887652222   23334555555543211  333332      122345678999999


Q ss_pred             CCCchh-----------HHh---hhc-C----------CCCH-HHHHH------------HH-HHHHHHHHHHHhc----
Q 004702          480 GNGTLF-----------EHI---HKK-G----------NLSW-ERRLR------------IT-AETAGVLSYLHSE----  516 (735)
Q Consensus       480 ~~gsL~-----------~~l---~~~-~----------~l~~-~~~~~------------i~-~qia~~L~yLH~~----  516 (735)
                      +|..+.           +.|   |.. .          .+.| ...+.            .+ ..+...++.+...    
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            886431           111   110 0          0111 11111            11 1111222333211    


Q ss_pred             CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       517 ~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      -...++|+|+.+.|||++++...-|+||+.+..
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            123599999999999999776568999998763

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.71  E-value=0.012  Score=61.34  Aligned_cols=31  Identities=26%  Similarity=0.562  Sum_probs=25.6

Q ss_pred             CCeeecCCCCCcEEEcCCCC-eEEeeccCCcc
Q 004702          519 VPIIHRDVKSANILLDENCT-PKVSDFGASKL  549 (735)
Q Consensus       519 ~~ivH~Dlk~~NILl~~~~~-~kl~DFGls~~  549 (735)
                      +.++|+|+++.|||++++++ .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999997555 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.44  E-value=0.019  Score=60.48  Aligned_cols=139  Identities=21%  Similarity=0.242  Sum_probs=93.3

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeec-----cChh-------------------HH-H-HHHHHHHHHHhcCCCce
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKF-----VDQA-------------------KI-D-EFINELVVVLQINRRNV  459 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~-----~~~~-------------------~~-~-~~~~E~~~l~~l~h~ni  459 (735)
                      .-.|..|.-+.||.+.-.+|..+|||+.+.     .+..                   .. . -..+|+..|++|+...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            346889999999999999999999996431     1111                   00 0 12357778888865444


Q ss_pred             EEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCe
Q 004702          460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP  539 (735)
Q Consensus       460 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~  539 (735)
                      .-.--...  ...+|||+|+....-..-.-+...++...+..+-.|++.-+.-|.+...  +||.||.--|+|+.++ .+
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~LyhdG-~l  303 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYHDG-KL  303 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEECC-EE
Confidence            32111111  1237999999632211111122467777888888999999998887764  9999999999999765 78


Q ss_pred             EEeeccCCcc
Q 004702          540 KVSDFGASKL  549 (735)
Q Consensus       540 kl~DFGls~~  549 (735)
                      .|+|-+-+.-
T Consensus       304 yiIDVSQSVE  313 (520)
T KOG2270|consen  304 YIIDVSQSVE  313 (520)
T ss_pred             EEEEcccccc
Confidence            9999876653

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.43  E-value=0.067  Score=56.77  Aligned_cols=139  Identities=19%  Similarity=0.176  Sum_probs=79.3

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc--eEEEceE------EeecCceeEEEEe
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN--VVRLLGC------CLETQVPLLVYEF  478 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~E~  478 (735)
                      +.++.|-...+|+....++ .+++|+.+....  .++...|++++..|....  +.+++..      ....+..++|+||
T Consensus        28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             cccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            3566777788999876555 477787654221  233455667776664322  3444432      1224567899999


Q ss_pred             cCCCchhH--------------Hhhhc-CC-----------CCHHHHH------------HHHHHHHHHHHHHHh----c
Q 004702          479 VGNGTLFE--------------HIHKK-GN-----------LSWERRL------------RITAETAGVLSYLHS----E  516 (735)
Q Consensus       479 ~~~gsL~~--------------~l~~~-~~-----------l~~~~~~------------~i~~qia~~L~yLH~----~  516 (735)
                      ++|..+..              .+|.. ..           -.|....            .....+.+.+++|..    .
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            98754321              11110 00           0111110            011123344555543    1


Q ss_pred             CCCCeeecCCCCCcEEEcCCCCeEEeeccCCc
Q 004702          517 TNVPIIHRDVKSANILLDENCTPKVSDFGASK  548 (735)
Q Consensus       517 ~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~  548 (735)
                      ....++|+|+.+.||+++++..+.|.||+.+.
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            23459999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG4289 consensus Cadherin EGF LAG seven-pass G-type receptor [Signal transduction mechanisms]

Probab=96.38  E-value=0.0027  Score=75.07  Aligned_cols=70  Identities=30%  Similarity=0.792  Sum_probs=52.3

Q ss_pred             ccc-cccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc---cCCccCCCCCCCC--CcCCCCC-Ccccee
Q 004702          234 TCE-EAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD---VNECEDPSRNNCT--HICDNIP-GSYTCR  306 (735)
Q Consensus       234 ~C~-~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d---i~eC~~~~~~~c~--~~C~n~~-g~y~C~  306 (735)
                      .|+ .++.|.+ +.|.+++.|..-.+||+|.|.+||+|.-     |.-   .-.|..   .-|.  ++|.|.. |++.|.
T Consensus      1234 ~CeTeiDlCYs-~pC~nng~C~srEggYtCeCrpg~tGeh-----CEvs~~agrCvp---GvC~nggtC~~~~nggf~c~ 1304 (2531)
T KOG4289|consen 1234 YCETEIDLCYS-GPCGNNGRCRSREGGYTCECRPGFTGEH-----CEVSARAGRCVP---GVCKNGGTCVNLLNGGFCCH 1304 (2531)
T ss_pred             cccchhHhhhc-CCCCCCCceEEecCceeEEecCCccccc-----eeeecccCcccc---ceecCCCEEeecCCCceecc
Confidence            454 4677864 6699999999999999999999999976     541   233432   2343  7898887 789999


Q ss_pred             ccCCCC
Q 004702          307 CRKGFH  312 (735)
Q Consensus       307 c~~g~~  312 (735)
                      |+.|.-
T Consensus      1305 Cp~ge~ 1310 (2531)
T KOG4289|consen 1305 CPYGEF 1310 (2531)
T ss_pred             CCCccc
Confidence            998843

>KOG1214 consensus Nidogen and related basement membrane protein proteins [Cell wall/membrane/envelope biogenesis; Extracellular structures]

Probab=96.31  E-value=0.0033  Score=70.71  Aligned_cols=84  Identities=30%  Similarity=0.715  Sum_probs=63.3

Q ss_pred             cccccccccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCcc------ccCCccCCCCCCCC----CcCCCC
Q 004702          231 TDKTCEEAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCR------DVNECEDPSRNNCT----HICDNI  299 (735)
Q Consensus       231 ~~~~C~~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~------di~eC~~~~~~~c~----~~C~n~  299 (735)
                      ++.+|.+.++|+. ++.|..++.|.+..++|+|.|..||+-.. ....|.      -++.|... .+.|.    ..|.-.
T Consensus       727 dgr~c~d~~eca~~~~~CGp~s~Cin~pg~~rceC~~gy~F~d-d~~tCV~i~~pap~n~Ce~g-~h~C~i~g~a~c~~h  804 (1289)
T KOG1214|consen  727 DGRNCVDENECATGFHRCGPNSVCINLPGSYRCECRSGYEFAD-DRHTCVLITPPAPANPCEDG-SHTCAIAGQARCVHH  804 (1289)
T ss_pred             CCCCCCChhhhccCCCCCCCCceeecCCCceeEEEeecceecc-CCcceEEecCCCCCCccccC-ccccCcCCceEEEec
Confidence            4468999999988 88999999999999999999999987432 223574      34667653 24554    355554


Q ss_pred             C-CccceeccCCCCCCCC
Q 004702          300 P-GSYTCRCRKGFHGDGR  316 (735)
Q Consensus       300 ~-g~y~C~c~~g~~~~~~  316 (735)
                      - +.|.|.|-+||.|++.
T Consensus       805 Ggs~y~C~CLPGfsGDG~  822 (1289)
T KOG1214|consen  805 GGSTYSCACLPGFSGDGH  822 (1289)
T ss_pred             CCceEEEeecCCccCCcc
Confidence            4 5799999999999975

>PLN02236 choline kinase

Probab=96.30  E-value=0.027  Score=60.78  Aligned_cols=134  Identities=21%  Similarity=0.247  Sum_probs=75.7

Q ss_pred             ccCcEEEEEEEcCC-----CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceE-EEceEEeecCceeEEEEecCCCch
Q 004702          411 CGGSGNVYKGFLPD-----RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVV-RLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       411 ~G~~g~Vy~g~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      .|-.-.+|+....+     +..|++|.........+ +-.+|..+++.+...++. ++++.+.. +   .|+||+++.+|
T Consensus        46 gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g~~l  120 (344)
T PLN02236         46 GAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHARTL  120 (344)
T ss_pred             CcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCCCCC
Confidence            35666788876432     35788887654332222 225788888888654443 45555432 2   58999977666


Q ss_pred             hHH-----------------hhhcC------CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-cCCC
Q 004702          485 FEH-----------------IHKKG------NLSWERRLRITAET-----------------AGVLSYL----HS-ETNV  519 (735)
Q Consensus       485 ~~~-----------------l~~~~------~l~~~~~~~i~~qi-----------------a~~L~yL----H~-~~~~  519 (735)
                      ...                 +|+..      ...+.++.+++.++                 ...+..|    .. ....
T Consensus       121 ~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~  200 (344)
T PLN02236        121 SAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEI  200 (344)
T ss_pred             CHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCc
Confidence            421                 11111      11133333332221                 1112222    21 1123


Q ss_pred             CeeecCCCCCcEEEcC-CCCeEEeeccCCcc
Q 004702          520 PIIHRDVKSANILLDE-NCTPKVSDFGASKL  549 (735)
Q Consensus       520 ~ivH~Dlk~~NILl~~-~~~~kl~DFGls~~  549 (735)
                      -++|+|+++.|||+++ ++.++|+||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            4899999999999986 46899999988763

>smart00179 EGF_CA Calcium-binding EGF-like domain

Probab=96.30  E-value=0.0043  Score=43.22  Aligned_cols=34  Identities=29%  Similarity=0.739  Sum_probs=26.4

Q ss_pred             ccccCCCCCCCCCCCccCCCCcceeeCCCCCC-CC
Q 004702          238 AKICGLNASCDTPKDNTSTSSGYRCKCNKGYE-GN  271 (735)
Q Consensus       238 ~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~-gn  271 (735)
                      .++|.....|.+++.|.+..++|.|.|++||. |.
T Consensus         2 ~~~C~~~~~C~~~~~C~~~~g~~~C~C~~g~~~g~   36 (39)
T smart00179        2 IDECASGNPCQNGGTCVNTVGSYRCECPPGYTDGR   36 (39)
T ss_pred             cccCcCCCCcCCCCEeECCCCCeEeECCCCCccCC
Confidence            34565434688777888888999999999998 54

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.26  E-value=0.045  Score=57.70  Aligned_cols=126  Identities=18%  Similarity=0.314  Sum_probs=75.9

Q ss_pred             CcEEEEEEee-ccChhHHHHHHHHHHHHHhcCC--CceEEEceEEeecC--ceeEEEEecCCCchhH-------------
Q 004702          425 RTPVAVKKSK-FVDQAKIDEFINELVVVLQINR--RNVVRLLGCCLETQ--VPLLVYEFVGNGTLFE-------------  486 (735)
Q Consensus       425 ~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~-------------  486 (735)
                      ++.+++.+-. ...........+|+.+|+.+.-  --+.+.++.|.++.  .++.||+|.++..+.+             
T Consensus        48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~  127 (321)
T COG3173          48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL  127 (321)
T ss_pred             CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence            5667777321 2333445566788888888754  34556677777666  7799999998732221             


Q ss_pred             -----Hhhhc-----------CC---------CCHHHHHHHH--------HHHHHHHHHHHhcC-----CCCeeecCCCC
Q 004702          487 -----HIHKK-----------GN---------LSWERRLRIT--------AETAGVLSYLHSET-----NVPIIHRDVKS  528 (735)
Q Consensus       487 -----~l~~~-----------~~---------l~~~~~~~i~--------~qia~~L~yLH~~~-----~~~ivH~Dlk~  528 (735)
                           +|..-           ..         -.|...++.+        -....-..+|+.+.     .+.++|+|+.+
T Consensus       128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~  207 (321)
T COG3173         128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP  207 (321)
T ss_pred             HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence                 11100           00         0011111100        11223344555443     24699999999


Q ss_pred             CcEEEcCCCCeEEeeccCCccc
Q 004702          529 ANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       529 ~NILl~~~~~~kl~DFGls~~~  550 (735)
                      .||+|+++.-+-|.||+++..-
T Consensus       208 gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         208 GNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CCEEEeCCCeeEEEeccccccC
Confidence            9999998888999999998753

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.26  E-value=0.00055  Score=82.51  Aligned_cols=156  Identities=14%  Similarity=-0.005  Sum_probs=112.0

Q ss_pred             HHHHHHHHhcCCCceEEEceEEee--cCceeEEEEecCCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC-
Q 004702          445 INELVVVLQINRRNVVRLLGCCLE--TQVPLLVYEFVGNGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSET-  517 (735)
Q Consensus       445 ~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~-  517 (735)
                      +.|...++...|+++.....-...  ....+.+++++..|.+.+.|-+.    ..+...-....-.+......-.|+.. 
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            344444555678888766544432  23558899999999999988653    33444444444444455666666543 


Q ss_pred             -CCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh
Q 004702          518 -NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT  596 (735)
Q Consensus       518 -~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt  596 (735)
                       +..-+|++||+.|.+|..+.++|+.++|+.+...... .......+++.|+.|+......++.++|+|..+..++++-.
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence             2347899999999999999999999999999443222 22233447888999999999999999999999999999887


Q ss_pred             CCccC
Q 004702          597 GKMAL  601 (735)
Q Consensus       597 G~~p~  601 (735)
                      |..+|
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            76654

>KOG4289 consensus Cadherin EGF LAG seven-pass G-type receptor [Signal transduction mechanisms]

Probab=96.22  E-value=0.0028  Score=74.98  Aligned_cols=50  Identities=38%  Similarity=1.077  Sum_probs=43.3

Q ss_pred             CCcceeeCCCCCCCCCCCCCCcc-ccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          257 SSGYRCKCNKGYEGNPYLSDGCR-DVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       257 ~~~y~C~C~~Gy~gn~y~~~gC~-di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      .+|.+|.|++||+|.-     |. .||+|-.   .+|.  +.|....|+|+|.|.+||+|.
T Consensus      1219 vnglrCrCPpGFTgd~-----CeTeiDlCYs---~pC~nng~C~srEggYtCeCrpg~tGe 1271 (2531)
T KOG4289|consen 1219 VNGLRCRCPPGFTGDY-----CETEIDLCYS---GPCGNNGRCRSREGGYTCECRPGFTGE 1271 (2531)
T ss_pred             cCceeEeCCCCCCccc-----ccchhHhhhc---CCCCCCCceEEecCceeEEecCCcccc
Confidence            4799999999999974     75 6999974   5676  799999999999999999986

>PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins

Probab=96.20  E-value=0.0011  Score=44.21  Aligned_cols=26  Identities=31%  Similarity=0.856  Sum_probs=22.8

Q ss_pred             CCCCCCCccCCC-CcceeeCCCCCCCC
Q 004702          246 SCDTPKDNTSTS-SGYRCKCNKGYEGN  271 (735)
Q Consensus       246 ~C~~~~~c~~~~-~~y~C~C~~Gy~gn  271 (735)
                      .|.++++|.... .+|.|.|++||+|.
T Consensus         5 ~C~n~g~C~~~~~~~y~C~C~~G~~G~   31 (32)
T PF00008_consen    5 PCQNGGTCIDLPGGGYTCECPPGYTGK   31 (32)
T ss_dssp             SSTTTEEEEEESTSEEEEEEBTTEEST
T ss_pred             cCCCCeEEEeCCCCCEEeECCCCCccC
Confidence            688888888777 89999999999984

The list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied. The functional significance of EGF domains in what appear to be unrelated proteins is not yet clear. However, a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase). The EGF domain includes six cysteine residues which have been shown (in EGF) to be involved in disulphide bonds. The main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet. Subdomains between the conserved cysteines vary in length.; GO: 0005515 protein binding; PDB: 1WHE_A 1CCF_A 1APO_A 1WHF_A 2VJ3_A 1TOZ_A 4D90_B 3CFW_A 1EDM_B 1IXA_A ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.20  E-value=0.031  Score=58.42  Aligned_cols=72  Identities=18%  Similarity=0.195  Sum_probs=47.4

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC---CCceEEEceEEeecCceeEEEEecCCC
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN---RRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      +.|+.|....+|+.. .++..+.||.-.   ......|..|.+-|+.|.   --.+.+++++....+..+||+||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            467888889999987 567789999865   333456778888888884   345888999888878889999999765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.12  E-value=0.0059  Score=63.06  Aligned_cols=133  Identities=18%  Similarity=0.230  Sum_probs=88.6

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeecc-----------------Chh-----HHHHHHHHHHHHHhcCCC--c
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFV-----------------DQA-----KIDEFINELVVVLQINRR--N  458 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~-----------------~~~-----~~~~~~~E~~~l~~l~h~--n  458 (735)
                      ..+++.||-|.-+.||.+...+|.+.++|.-+..                 ...     ..-...+|+..|+.|..+  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            3467899999999999999999999988842210                 000     011235688888887532  2


Q ss_pred             eEEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC
Q 004702          459 VVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT  538 (735)
Q Consensus       459 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~  538 (735)
                      |.+.++    .+..++|||++.+-.|...-+-   .+..+   +...+..-+.-|-.++   +||+|..-=||+|+++..
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v---~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRHV---EDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeeec---CChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEecCCC
Confidence            444443    3456899999987666544321   22222   2233333345566667   999999999999999999


Q ss_pred             eEEeeccCCc
Q 004702          539 PKVSDFGASK  548 (735)
Q Consensus       539 ~kl~DFGls~  548 (735)
                      ++++||--..
T Consensus       241 i~vIDFPQmv  250 (465)
T KOG2268|consen  241 IVVIDFPQMV  250 (465)
T ss_pred             EEEeechHhh
Confidence            9999997543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	735
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-43
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-42
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-39
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-31
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-30
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-30
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-29
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-23
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-19
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-19
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-18
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-14
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-14
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-14
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-14
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-14
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-14
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-14
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-13
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-13
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-13
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-13
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-13
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-06
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-06
3soa_A	444	Full-Length Human Camkii Length = 444		7e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-04
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-04
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-04
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-04
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		8e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-04
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		9e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  174 bits (441), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 110/288 (38%), Positives = 166/288 (57%), Gaps = 12/288 (4%)
Query: 397 EIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           +++  TNN+    +IG G  G VYKG L D   VA+K+ +  + ++  E     +  L  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEIETLSF 91
Query: 455 NRR-NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG----NLSWERRLRITAETAGV 509
            R  ++V L+G C E    +L+Y+++ NG L  H++       ++SWE+RL I    A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL-VPIDAIQNCTVVQGTLGYL 568
           L YLH+     IIHRDVKS NILLDEN  PK++DFG SK    +D      VV+GTLGY+
Sbjct: 152 LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI 628
           DPEY    +LT+KSDVYSFGVVL E+L  + A++   P E  +LA   + S    +L +I
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL 676
           +D  + +    + L++    A +C+++  E+RP+M +V  +L+  L L
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  171 bits (433), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 109/288 (37%), Positives = 165/288 (57%), Gaps = 12/288 (4%)
Query: 397 EIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           +++  TNN+    +IG G  G VYKG L D   VA+K+ +  + ++  E     +  L  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEIETLSF 91
Query: 455 NRR-NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG----NLSWERRLRITAETAGV 509
            R  ++V L+G C E    +L+Y+++ NG L  H++       ++SWE+RL I    A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL-VPIDAIQNCTVVQGTLGYL 568
           L YLH+     IIHRDVKS NILLDEN  PK++DFG SK    +       VV+GTLGY+
Sbjct: 152 LHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI 628
           DPEY    +LT+KSDVYSFGVVL E+L  + A++   P E  +LA   + S    +L +I
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL 676
           +D  + +    + L++    A +C+++  E+RP+M +V  +L+  L L
Sbjct: 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  166 bits (420), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 103/291 (35%), Positives = 168/291 (57%), Gaps = 9/291 (3%)
Query: 391 KIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKF-VDQAKIDEFINE 447
           K F+  E++  ++N+++  ++G GG G VYKG L D T VAVK+ K    Q    +F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 448 LVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT----LFEHIHKKGNLSWERRLRIT 503
           + ++     RN++RL G C+     LLVY ++ NG+    L E    +  L W +R RI 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
             +A  L+YLH   +  IIHRDVK+ANILLDE     V DFG +KL+          V+G
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 205
Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL-LSDKPEEERSLAMNFLSS-LK 621
           T+G++ PEYL T K ++K+DV+ +GV+L+EL+TG+ A  L+    ++  + ++++   LK
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 265
Query: 622 QNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG 672
           + +L  ++D  +  +   ++++++ ++A  C      ERP M EV   L+G
Sbjct: 266 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  161 bits (407), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 101/291 (34%), Positives = 165/291 (56%), Gaps = 9/291 (3%)
Query: 391 KIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKF-VDQAKIDEFINE 447
           K F+  E++  ++N+ +  ++G GG G VYKG L D   VAVK+ K    Q    +F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 448 LVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT----LFEHIHKKGNLSWERRLRIT 503
           + ++     RN++RL G C+     LLVY ++ NG+    L E    +  L W +R RI 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
             +A  L+YLH   +  IIHRDVK+ANILLDE     V DFG +KL+          V+G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 197
Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL-LSDKPEEERSLAMNFLSS-LK 621
            +G++ PEYL T K ++K+DV+ +GV+L+EL+TG+ A  L+    ++  + ++++   LK
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 622 QNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG 672
           + +L  ++D  +  +   ++++++ ++A  C      ERP M EV   L+G
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  132 bits (331), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 98/296 (33%), Positives = 162/296 (54%), Gaps = 25/296 (8%)
Query: 393 FTEEEIKTVTNNY--------ADVIGCGGSGNVYKGFLPDRTPVAVKK-SKFVD---QAK 440
           F+  E+K VTNN+         + +G GG G VYKG++ + T VAVKK +  VD   +  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 441 IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH---KKGNLSWE 497
             +F  E+ V+ +    N+V LLG   +     LVY ++ NG+L + +        LSW 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP--IDAI 555
            R +I    A  +++LH   +   IHRD+KSANILLDE  T K+SDFG ++        +
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
               +V GT  Y+ PE L+  ++T KSD+YSFGVVL+E++TG +  + +  E +  L + 
Sbjct: 191 MXSRIV-GTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIK 247
Query: 616 FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
                ++  + + +D ++ ND +   ++ +  +A++C+  +  +RP +K+V   LQ
Sbjct: 248 EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 98/296 (33%), Positives = 162/296 (54%), Gaps = 25/296 (8%)
Query: 393 FTEEEIKTVTNNY--------ADVIGCGGSGNVYKGFLPDRTPVAVKK-SKFVD---QAK 440
           F+  E+K VTNN+         + +G GG G VYKG++ + T VAVKK +  VD   +  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 441 IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH---KKGNLSWE 497
             +F  E+ V+ +    N+V LLG   +     LVY ++ NG+L + +        LSW 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP--IDAI 555
            R +I    A  +++LH   +   IHRD+KSANILLDE  T K+SDFG ++        +
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
               +V GT  Y+ PE L+  ++T KSD+YSFGVVL+E++TG +  + +  E +  L + 
Sbjct: 185 MXXRIV-GTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIK 241
Query: 616 FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
                ++  + + +D ++ ND +   ++ +  +A++C+  +  +RP +K+V   LQ
Sbjct: 242 EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 98/296 (33%), Positives = 162/296 (54%), Gaps = 25/296 (8%)
Query: 393 FTEEEIKTVTNNY--------ADVIGCGGSGNVYKGFLPDRTPVAVKK-SKFVD---QAK 440
           F+  E+K VTNN+         + +G GG G VYKG++ + T VAVKK +  VD   +  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 441 IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH---KKGNLSWE 497
             +F  E+ V+ +    N+V LLG   +     LVY ++ NG+L + +        LSW 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP--IDAI 555
            R +I    A  +++LH   +   IHRD+KSANILLDE  T K+SDFG ++        +
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
               +V GT  Y+ PE L+  ++T KSD+YSFGVVL+E++TG +  + +  E +  L + 
Sbjct: 191 MXXRIV-GTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIK 247
Query: 616 FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
                ++  + + +D ++ ND +   ++ +  +A++C+  +  +RP +K+V   LQ
Sbjct: 248 EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  126 bits (316), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 98/296 (33%), Positives = 156/296 (52%), Gaps = 25/296 (8%)
Query: 393 FTEEEIKTVTNNY--------ADVIGCGGSGNVYKGFLPDRTPVAVKK-SKFVD---QAK 440
           F+  E+K VTNN+         +  G GG G VYKG++ + T VAVKK +  VD   +  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 441 IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH---KKGNLSWE 497
             +F  E+ V  +    N+V LLG   +     LVY +  NG+L + +        LSW 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP--IDAI 555
            R +I    A  +++LH   +   IHRD+KSANILLDE  T K+SDFG ++        +
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
               +V GT  Y  PE L+  ++T KSD+YSFGVVL+E++TG +  + +  E +  L + 
Sbjct: 182 XXSRIV-GTTAYXAPEALRG-EITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIK 238
Query: 616 FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
                ++  + + +D +  ND +   ++    +A++C+  +  +RP +K+V   LQ
Sbjct: 239 EEIEDEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 107/198 (54%), Gaps = 8/198 (4%)
Query: 404 NYADVIGCGGSGNVYKGFLPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           N  + IG G  G V++      + VAVK    +     +++EF+ E+ ++ ++   N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKG---NLSWERRLRITAETAGVLSYLHSETN 518
            +G   +     +V E++  G+L+  +HK G    L   RRL +  + A  ++YLH+  N
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
            PI+HRD+KS N+L+D+  T KV DFG S+L             GT  ++ PE L+    
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK-ASXFLXSKXAAGTPEWMAPEVLRDEPS 216
Query: 579 TDKSDVYSFGVVLVELLT 596
            +KSDVYSFGV+L EL T
Sbjct: 217 NEKSDVYSFGVILWELAT 234

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 108/198 (54%), Gaps = 8/198 (4%)
Query: 404 NYADVIGCGGSGNVYKGFLPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           N  + IG G  G V++      + VAVK    +     +++EF+ E+ ++ ++   N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKG---NLSWERRLRITAETAGVLSYLHSETN 518
            +G   +     +V E++  G+L+  +HK G    L   RRL +  + A  ++YLH+  N
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
            PI+HR++KS N+L+D+  T KV DFG S+L       +     GT  ++ PE L+    
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 579 TDKSDVYSFGVVLVELLT 596
            +KSDVYSFGV+L EL T
Sbjct: 217 NEKSDVYSFGVILWELAT 234

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 119/225 (52%), Gaps = 26/225 (11%)
Query: 393 FTEEEIKTVTNN---YADVIGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQA-------KI 441
           F +  + T+ +N   Y   IG GG G V+KG  + D++ VA+K     D         K 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRL 500
            EF  E+ ++  +N  N+V+L G  L    P +V EFV  G L+  +  K + + W  +L
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCT--PKVSDFGASKLVPIDAI 555
           R+  + A  + Y+ ++ N PI+HRD++S NI L   DEN     KV+DFG S+     ++
Sbjct: 126 RLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSV 180
Query: 556 QNCTVVQGTLGYLDPEYL--QTCKLTDKSDVYSFGVVLVELLTGK 598
            + + + G   ++ PE +  +    T+K+D YSF ++L  +LTG+
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 119/225 (52%), Gaps = 26/225 (11%)
Query: 393 FTEEEIKTVTNN---YADVIGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQA-------KI 441
           F +  + T+ +N   Y   IG GG G V+KG  + D++ VA+K     D         K 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRL 500
            EF  E+ ++  +N  N+V+L G  L    P +V EFV  G L+  +  K + + W  +L
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCT--PKVSDFGASKLVPIDAI 555
           R+  + A  + Y+ ++ N PI+HRD++S NI L   DEN     KV+DFG S+     ++
Sbjct: 126 RLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSV 180
Query: 556 QNCTVVQGTLGYLDPEYL--QTCKLTDKSDVYSFGVVLVELLTGK 598
            + + + G   ++ PE +  +    T+K+D YSF ++L  +LTG+
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 118/225 (52%), Gaps = 26/225 (11%)
Query: 393 FTEEEIKTVTNN---YADVIGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQA-------KI 441
           F +  + T+ +N   Y   IG GG G V+KG  + D++ VA+K     D         K 
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRL 500
            EF  E+ ++  +N  N+V+L G  L    P +V EFV  G L+  +  K + + W  +L
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCT--PKVSDFGASKLVPIDAI 555
           R+  + A  + Y+ ++ N PI+HRD++S NI L   DEN     KV+DF  S+     ++
Sbjct: 126 RLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSV 180
Query: 556 QNCTVVQGTLGYLDPEYL--QTCKLTDKSDVYSFGVVLVELLTGK 598
            + + + G   ++ PE +  +    T+K+D YSF ++L  +LTG+
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 109/199 (54%), Gaps = 14/199 (7%)
Query: 408 VIGCGGSGNVYKGFLPDRT-----PVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVV 460
           VIG G  G VYKG L   +     PVA+K  K+ + ++ ++D F+ E  ++ Q +  N++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNII 109
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNV 519
           RL G   + +  +++ E++ NG L + + +K G  S    L++     G+ + +    N+
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS---VLQLVGMLRGIAAGMKYLANM 166
Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCK 577
             +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 578 LTDKSDVYSFGVVLVELLT 596
            T  SDV+SFG+V+ E++T
Sbjct: 227 FTSASDVWSFGIVMWEVMT 245

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 12/210 (5%)
Query: 404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
            +   IG G  G V+ G+  ++  VA+K  K    ++ D+FI E  V+++++   +V+L 
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLY 88
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G CLE     LV+EF+ +G L +++  ++G  + E  L +  +    ++YL       +I
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N L+ EN   KVSDFG ++ V  D   + T  +  + +  PE     + + KS
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 583 DVYSFGVVLVELLT-GKMALLSDKPEEERS 611
           DV+SFGV++ E+ + GK+      P E RS
Sbjct: 206 DVWSFGVLMWEVFSEGKI------PYENRS 229

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 117/211 (55%), Gaps = 14/211 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
            +   IG G  G V+ G+  ++  VA+K  +    ++ ++FI E  V+++++   +V+L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 68
Query: 464 GCCLETQVPL-LVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           G CLE Q P+ LV+EF+ +G L +++  ++G  + E  L +  +    ++YL   +   +
Sbjct: 69  GVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAS---V 124
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           IHRD+ + N L+ EN   KVSDFG ++ V  D   + T  +  + +  PE     + + K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 582 SDVYSFGVVLVELLT-GKMALLSDKPEEERS 611
           SDV+SFGV++ E+ + GK+      P E RS
Sbjct: 185 SDVWSFGVLMWEVFSEGKI------PYENRS 209

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 149/302 (49%), Gaps = 29/302 (9%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + +L S+
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +     D++ N T  +  + ++  E L
Sbjct: 154 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 574 QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI 633
           QT K T KSDV+SFGV+L EL+T       D    + ++ +     L+  RLL+      
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-----LQGRRLLQ------ 259
Query: 634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGV 693
             +     L EV     +C   + E RP+  E+   +    S    G++Y+  N     V
Sbjct: 260 -PEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFSTFI-GEHYVHVNATYVNV 314
Query: 694 QE 695
           +E
Sbjct: 315 KE 316

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/302 (28%), Positives = 149/302 (49%), Gaps = 29/302 (9%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + +L S+
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 153
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +     D++ N T  +  + ++  E L
Sbjct: 154 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 574 QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI 633
           QT K T KSDV+SFGV+L EL+T       D    + ++ +     L+  RLL+      
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-----LQGRRLLQ------ 259
Query: 634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGV 693
             +     L EV     +C   + E RP+  E+   +    S    G++Y+  N     V
Sbjct: 260 -PEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFSTFI-GEHYVHVNATYVNV 314
Query: 694 QE 695
           +E
Sbjct: 315 KE 316

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 114/203 (56%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + +L S+
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +     D++ N T  +  + ++  E L
Sbjct: 212 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 112/210 (53%), Gaps = 12/210 (5%)
Query: 404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
            +   IG G  G V+ G+  ++  VA+K  +    ++ D FI E  V+++++   +V+L 
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLY 68
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G CLE     LV+EF+ +G L +++  ++G  + E  L +  +    ++YL       +I
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N L+ EN   KVSDFG ++ V  D   + T  +  + +  PE     + + KS
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 583 DVYSFGVVLVELLT-GKMALLSDKPEEERS 611
           DV+SFGV++ E+ + GK+      P E RS
Sbjct: 186 DVWSFGVLMWEVFSEGKI------PYENRS 209

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 112/210 (53%), Gaps = 12/210 (5%)
Query: 404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
            +   IG G  G V+ G+  ++  VA+K  +    ++ D FI E  V+++++   +V+L 
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLY 71
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G CLE     LV+EF+ +G L +++  ++G  + E  L +  +    ++YL       +I
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N L+ EN   KVSDFG ++ V  D   + T  +  + +  PE     + + KS
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 583 DVYSFGVVLVELLT-GKMALLSDKPEEERS 611
           DV+SFGV++ E+ + GK+      P E RS
Sbjct: 189 DVWSFGVLMWEVFSEGKI------PYENRS 212

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 112/210 (53%), Gaps = 12/210 (5%)
Query: 404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
            +   IG G  G V+ G+  ++  VA+K  +    ++ D FI E  V+++++   +V+L 
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLY 66
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G CLE     LV+EF+ +G L +++  ++G  + E  L +  +    ++YL       +I
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N L+ EN   KVSDFG ++ V  D   + T  +  + +  PE     + + KS
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 583 DVYSFGVVLVELLT-GKMALLSDKPEEERS 611
           DV+SFGV++ E+ + GK+      P E RS
Sbjct: 184 DVWSFGVLMWEVFSEGKI------PYENRS 207

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 114/203 (56%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + +L S+
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 157
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +     D++ N T  +  + ++  E L
Sbjct: 158 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 215 QTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 114/203 (56%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + +L S+
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +     D++ N T  +  + ++  E L
Sbjct: 153 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 114/203 (56%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + +L S+
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 150
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +     D++ N T  +  + ++  E L
Sbjct: 151 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 114/203 (56%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + +L S+
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 152
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +     D++ N T  +  + ++  E L
Sbjct: 153 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  +S    L +  + +  + YL  +     IHRD+
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 135
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 195
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 196 FGVLLWEIATYGMS 209

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  +S    L +  + +  + YL  +     IHRD+
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 198 FGVLLWEIATYGMS 211

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  +S    L +  + +  + YL  +     IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 198 FGVLLWEIATYGMS 211

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  +S    L +  + +  + YL  +     IHRD+
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 198 FGVLLWEIATYGMS 211

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  +S    L +  + +  + YL  +     IHRD+
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 135
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 195
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 196 FGVLLWEIATYGMS 209

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  +S    L +  + +  + YL  +     IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 198 FGVLLWEIATYGMS 211

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  +S    L +  + +  + YL  +     IHRD+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 142
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 202
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 203 FGVLLWEIATYGMS 216

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  +S    L +  + +  + YL  +     IHRD+
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 135
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 195
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 196 FGVLLWEIATYGMS 209

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + YL S+
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +      ++ N T  +  + ++  E L
Sbjct: 152 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 111/210 (52%), Gaps = 12/210 (5%)
Query: 404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
            +   IG G  G V+ G+  ++  VA+K  +    ++ D FI E  V+++++   +V+L 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLY 69
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G CLE     LV EF+ +G L +++  ++G  + E  L +  +    ++YL       +I
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N L+ EN   KVSDFG ++ V  D   + T  +  + +  PE     + + KS
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 583 DVYSFGVVLVELLT-GKMALLSDKPEEERS 611
           DV+SFGV++ E+ + GK+      P E RS
Sbjct: 187 DVWSFGVLMWEVFSEGKI------PYENRS 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G   +
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 469 TQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +     ++ + I  +TA  + YLH+++   IIHRD+K
Sbjct: 92  PQLAI-VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLK 147
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQ---TCKLTDKSD 583
           S NI L E+ T K+ DFG A++            + G++ ++ PE ++   +   + +SD
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 584 VYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           VY+FG+VL EL+TG++   S+    ++ + M    SL  + L ++  N           K
Sbjct: 208 VYAFGIVLYELMTGQLP-YSNINNRDQIIEMVGRGSLSPD-LSKVRSN---------CPK 256
Query: 644 EVAKLAARCISVRGEERPTMKEVSLELQ 671
            + +L A C+  + +ERP+   +  E++
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 142
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 202
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 203 FGVLLWEIATYGMS 216

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 139
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWA 199
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 200 FGVLLWEIATYGMS 213

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + YL S+
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 170
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +      ++ N T  +  + ++  E L
Sbjct: 171 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 228 QTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 150
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 151 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 210
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 211 FGVLLWEIATYGMS 224

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + YL S+
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 144
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +      ++ N T  +  + ++  E L
Sbjct: 145 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 202 QTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 138
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWA 198
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 199 FGVLLWEIATYGMS 212

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 133/268 (49%), Gaps = 20/268 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G    
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 469 TQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +     ++ + I  +TA  + YLH+++   IIHRD+K
Sbjct: 92  PQLAI-VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLK 147
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQ---TCKLTDKSD 583
           S NI L E+ T K+ DFG A++            + G++ ++ PE ++   +   + +SD
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 584 VYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           VY+FG+VL EL+TG++   S+    ++ + M    SL  + L ++  N           K
Sbjct: 208 VYAFGIVLYELMTGQLP-YSNINNRDQIIEMVGRGSLSPD-LSKVRSN---------CPK 256
Query: 644 EVAKLAARCISVRGEERPTMKEVSLELQ 671
            + +L A C+  + +ERP+   +  E++
Sbjct: 257 RMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 139
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 199
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 200 FGVLLWEIATYGMS 213

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 142
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 202
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 203 FGVLLWEIATYGMS 216

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 138
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 198
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 199 FGVLLWEIATYGMS 212

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 139
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 199
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 200 FGVLLWEIATYGMS 213

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + YL S+
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 151
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +      ++ N T  +  + ++  E L
Sbjct: 152 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 142
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 202
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 203 FGVLLWEIATYGMS 216

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + YL S+
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +      ++ N T  +  + ++  E L
Sbjct: 148 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + YL S+
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +      ++ N T  +  + ++  E L
Sbjct: 153 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 143/304 (47%), Gaps = 35/304 (11%)
Query: 389 KAKIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFVDQAKID- 442
           + +I  E E+K V      V+G G  G VYKG ++P+    + PVA+K        K + 
Sbjct: 8   QLRILKETELKRVK-----VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 62
Query: 443 EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLR 501
           EF++E +++  ++  ++VRLLG CL   +  LV + + +G L E++H+ K N+  +  L 
Sbjct: 63  EFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLN 121
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTV 560
              + A  + YL       ++HRD+ + N+L+      K++DFG ++L+  D  + N   
Sbjct: 122 WCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 178
Query: 561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
            +  + ++  E +   K T +SDV+S+GV + EL+T         P  E    +     L
Sbjct: 179 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 238
Query: 621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNG 680
            Q  +  I               +V  +  +C  +  + RP  KE++ E      +  + 
Sbjct: 239 PQPPICTI---------------DVYMVMVKCWMIDADSRPKFKELAAEFS---RMARDP 280
Query: 681 QYYL 684
           Q YL
Sbjct: 281 QRYL 284

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + YL S+
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 152
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +      ++ N T  +  + ++  E L
Sbjct: 153 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 142
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 202
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 203 FGVLLWEIATYGMS 216

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 198 FGVLLWEIATYGMS 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 137
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 197
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 198 FGVLLWEIATYGMS 211

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + YL S+
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 150
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +      ++ N T  +  + ++  E L
Sbjct: 151 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + YL S+
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 149
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +      ++ N T  +  + ++  E L
Sbjct: 150 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 141
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 201
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 202 FGVLLWEIATYGMS 215

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 13/203 (6%)
Query: 404 NYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRN 458
           ++ +VIG G  G VY G L D    +   AVK  ++  D  ++ +F+ E +++   +  N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 459 VVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLHSE 516
           V+ LLG CL ++  PL+V  ++ +G L   I ++  N + +  +    + A  + YL S+
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 171
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPEYL 573
                +HRD+ + N +LDE  T KV+DFG ++ +      ++ N T  +  + ++  E L
Sbjct: 172 K---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 574 QTCKLTDKSDVYSFGVVLVELLT 596
           QT K T KSDV+SFGV+L EL+T
Sbjct: 229 QTQKFTTKSDVWSFGVLLWELMT 251

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  +S    L +  + +  + YL  +     IHR++
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNL 344
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 405 FGVLLWEIATYGMS 418

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 133/268 (49%), Gaps = 20/268 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G   +
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 469 TQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +     ++ + I  +TA  + YLH+++   IIHRD+K
Sbjct: 80  PQLAI-VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLK 135
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQ---TCKLTDKSD 583
           S NI L E+ T K+ DFG A+             + G++ ++ PE ++   +   + +SD
Sbjct: 136 SNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 195
Query: 584 VYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           VY+FG+VL EL+TG++   S+    ++ + M    SL  + L ++  N           K
Sbjct: 196 VYAFGIVLYELMTGQLP-YSNINNRDQIIEMVGRGSLSPD-LSKVRSN---------CPK 244
Query: 644 EVAKLAARCISVRGEERPTMKEVSLELQ 671
            + +L A C+  + +ERP+   +  E++
Sbjct: 245 RMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 143/304 (47%), Gaps = 35/304 (11%)
Query: 389 KAKIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFVDQAKID- 442
           + +I  E E+K V      V+G G  G VYKG ++P+    + PVA+K        K + 
Sbjct: 31  QLRILKETELKRVK-----VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 85
Query: 443 EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLR 501
           EF++E +++  ++  ++VRLLG CL   +  LV + + +G L E++H+ K N+  +  L 
Sbjct: 86  EFMDEALIMASMDHPHLVRLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLLLN 144
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTV 560
              + A  + YL       ++HRD+ + N+L+      K++DFG ++L+  D  + N   
Sbjct: 145 WCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 201
Query: 561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
            +  + ++  E +   K T +SDV+S+GV + EL+T         P  E    +     L
Sbjct: 202 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL 261
Query: 621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNG 680
            Q  +  I               +V  +  +C  +  + RP  KE++ E      +  + 
Sbjct: 262 PQPPICTI---------------DVYMVMVKCWMIDADSRPKFKELAAEFS---RMARDP 303
Query: 681 QYYL 684
           Q YL
Sbjct: 304 QRYL 307

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 142/309 (45%), Gaps = 40/309 (12%)
Query: 377 QELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFV 436
           QE +K+  +    +  + E E   V    +  IG G  G VYKG       VAVK  K V
Sbjct: 14  QEKNKIRPRGQRDSSYYWEIEASEVM--LSTRIGSGSFGTVYKGKW--HGDVAVKILKVV 69
Query: 437 DQA--KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH-KKGN 493
           D    +   F NE+ V+ +    N++  +G   +  + + V ++    +L++H+H ++  
Sbjct: 70  DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAI-VTQWCEGSSLYKHLHVQETK 128
Query: 494 LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPI 552
               + + I  +TA  + YLH++    IIHRD+KS NI L E  T K+ DFG A+     
Sbjct: 129 FQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185
Query: 553 DAIQNCTVVQGTLGYLDPEYLQTC---KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE 609
              Q      G++ ++ PE ++       + +SDVYS+G+VL EL+TG++        ++
Sbjct: 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ 245
Query: 610 ------RSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTM 663
                 R  A   LS L +N                   K + +L A C+    EERP  
Sbjct: 246 IIFMVGRGYASPDLSKLYKN-----------------CPKAMKRLVADCVKKVKEERPLF 288
Query: 664 KEV--SLEL 670
            ++  S+EL
Sbjct: 289 PQILSSIEL 297

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/308 (25%), Positives = 145/308 (47%), Gaps = 29/308 (9%)
Query: 380 SKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQA 439
           S +  Q  +K     E E+   T    + +G G  G V+ G+    T VAVK  K    +
Sbjct: 2   SHMQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS 61
Query: 440 KIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSW 496
             D F+ E  ++ Q+  + +VRL      TQ P+ ++ E++ NG+L + +       L+ 
Sbjct: 62  P-DAFLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTI 118
Query: 497 ERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ 556
            + L + A+ A  ++++        IHRD+++ANIL+ +  + K++DFG ++L+  +   
Sbjct: 119 NKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 175
Query: 557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAM 614
                +  + +  PE +     T KSDV+SFG++L E++T G++       PE  ++L  
Sbjct: 176 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 235
Query: 615 NFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL 674
            +               R+V   N  +  E+ +L   C   R E+RPT   +   L+   
Sbjct: 236 GY---------------RMVRPDNCPE--ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 278
Query: 675 SLMSNGQY 682
           +  + GQY
Sbjct: 279 T-ATEGQY 285

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 131/293 (44%), Gaps = 25/293 (8%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY+G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                ++ EF+  G L +++ +  +  ++    L +  + +  + YL  +     IHR++
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRNL 383
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSDV++
Sbjct: 384 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 443
Query: 587 FGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVA 646
           FGV+L E+ T                 M+    +  +++ E+L+     +  +   ++V 
Sbjct: 444 FGVLLWEIAT---------------YGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 488
Query: 647 KLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYF 699
           +L   C      +RP+  E+    +      S     + D VE    +E  YF
Sbjct: 489 ELMRACWQWNPSDRPSFAEIHQAFETMFQESS-----ISDEVEKELGKENLYF 536

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 32/277 (11%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G   +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +      + + I  +TA  + YLH+++   IIHRD+K
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 131
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK----- 581
           S NI L E+ T K+ DFG A++            + G++ ++ PE     ++ DK     
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKNPYSF 188
Query: 582 -SDVYSFGVVLVELLTGKMAL--LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
            SDVY+FG+VL EL+TG++    ++++ +    +   +LS           D   V    
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------DLSKVRSNC 238
Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEV--SLELQGR 673
            + +K   +L A C+  + +ERP   ++  S+EL  R
Sbjct: 239 PKAMK---RLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 120/225 (53%), Gaps = 19/225 (8%)
Query: 382 LHGQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSK 434
           + G +  +A  +I  E E++ V      V+G G  G VYKG ++PD    + PVA+K  +
Sbjct: 1   MSGAAPNQALLRILKETELRKVK-----VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLR 55
Query: 435 FVDQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KG 492
                K + E ++E  V+  +    V RLLG CL + V L V + +  G L +H+ + +G
Sbjct: 56  ENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRG 114
Query: 493 NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI 552
            L  +  L    + A  +SYL    +V ++HRD+ + N+L+      K++DFG ++L+ I
Sbjct: 115 RLGSQDLLNWCMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 171
Query: 553 DAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           D  + +    +  + ++  E +   + T +SDV+S+GV + EL+T
Sbjct: 172 DETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 143/303 (47%), Gaps = 29/303 (9%)
Query: 385 QSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEF 444
           Q  +K     E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F
Sbjct: 5   QKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAF 63
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLR 501
           + E  ++ Q+  + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L 
Sbjct: 64  LAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 121
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
           + A+ A  ++++        IHRD+++ANIL+ +  + K++DFG ++L+  +        
Sbjct: 122 MAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 178
Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSS 619
           +  + +  PE +     T KSDV+SFG++L E++T G++       PE  ++L   +   
Sbjct: 179 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--- 235
Query: 620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSN 679
                       R+V   N  +  E+ +L   C   R E+RPT   +   L+   +  + 
Sbjct: 236 ------------RMVRPDNCPE--ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT-ATE 280
Query: 680 GQY 682
           GQY
Sbjct: 281 GQY 283

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 134/277 (48%), Gaps = 32/277 (11%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G   +
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +      + + I  +TA  + YLH+++   IIHRD+K
Sbjct: 96  PQLAI-VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 151
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK----- 581
           S NI L E+ T K+ DFG A++            + G++ ++ PE +   ++ DK     
Sbjct: 152 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSF 208
Query: 582 -SDVYSFGVVLVELLTGKMAL--LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
            SDVY+FG+VL EL+TG++    ++++ +    +   +LS           D   V    
Sbjct: 209 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------DLSKVRSNC 258
Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEV--SLELQGR 673
            + +K   +L A C+  + +ERP   ++  S+EL  R
Sbjct: 259 PKAMK---RLMAECLKKKRDERPLFPQILASIELLAR 292

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 134/277 (48%), Gaps = 32/277 (11%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G   +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +      + + I  +TA  + YLH+++   IIHRD+K
Sbjct: 104 PQLAI-VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 159
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK----- 581
           S NI L E+ T K+ DFG A++            + G++ ++ PE +   ++ DK     
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSF 216
Query: 582 -SDVYSFGVVLVELLTGKMAL--LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
            SDVY+FG+VL EL+TG++    ++++ +    +   +LS           D   V    
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------DLSKVRSNC 266
Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEV--SLELQGR 673
            + +K   +L A C+  + +ERP   ++  S+EL  R
Sbjct: 267 PKAMK---RLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 143/303 (47%), Gaps = 29/303 (9%)
Query: 385 QSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEF 444
           Q  +K     E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F
Sbjct: 3   QKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAF 61
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLR 501
           + E  ++ Q+  + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L 
Sbjct: 62  LAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
           + A+ A  ++++        IHRD+++ANIL+ +  + K++DFG ++L+  +        
Sbjct: 120 MAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 176
Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSS 619
           +  + +  PE +     T KSDV+SFG++L E++T G++       PE  ++L   +   
Sbjct: 177 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--- 233
Query: 620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSN 679
                       R+V   N  +  E+ +L   C   R E+RPT   +   L+   +  + 
Sbjct: 234 ------------RMVRPDNCPE--ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT-ATE 278
Query: 680 GQY 682
           GQY
Sbjct: 279 GQY 281

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 397 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFI----NELVVVL 452
           EI        ++IG GG G VY+ F      VAVK ++      I + I     E  +  
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDE-VAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 453 QINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSY 512
            +   N++ L G CL+     LV EF   G L   +  K  +  +  +    + A  ++Y
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNY 120
Query: 513 LHSETNVPIIHRDVKSANILLDE--------NCTPKVSDFGASKLVPIDAIQNCTVVQ-- 562
           LH E  VPIIHRD+KS+NIL+ +        N   K++DFG ++          T +   
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAA 175
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           G   ++ PE ++    +  SDV+S+GV+L ELLTG++
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 32/277 (11%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G   +
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +      + + I  +TA  + YLH+++   IIHRD+K
Sbjct: 78  PQLAI-VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 133
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK----- 581
           S NI L E+ T K+ DFG A+             + G++ ++ PE +   ++ DK     
Sbjct: 134 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSF 190
Query: 582 -SDVYSFGVVLVELLTGKMAL--LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
            SDVY+FG+VL EL+TG++    ++++ +    +   +LS           D   V    
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------DLSKVRSNC 240
Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEV--SLELQGR 673
            + +K   +L A C+  + +ERP   ++  S+EL  R
Sbjct: 241 PKAMK---RLMAECLKKKRDERPLFPQILASIELLAR 274

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 135/283 (47%), Gaps = 28/283 (9%)
Query: 385 QSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEF 444
           Q  +K     E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F
Sbjct: 3   QKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAF 61
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLR 501
           + E  ++ Q+  + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L 
Sbjct: 62  LAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
           + A+ A  ++++        IHRD+++ANIL+ +  + K++DFG ++L+  +        
Sbjct: 120 MAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 176
Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSS 619
           +  + +  PE +     T KSDV+SFG++L E++T G++       PE  ++L   +   
Sbjct: 177 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--- 233
Query: 620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPT 662
                       R+V   N  +  E+ +L   C   R E+RPT
Sbjct: 234 ------------RMVRPDNCPE--ELYQLMRLCWKERPEDRPT 262

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 32/277 (11%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G   +
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +      + + I  +TA  + YLH+++   IIHRD+K
Sbjct: 81  PQLAI-VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 136
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK----- 581
           S NI L E+ T K+ DFG A+             + G++ ++ PE +   ++ DK     
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSF 193
Query: 582 -SDVYSFGVVLVELLTGKMAL--LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
            SDVY+FG+VL EL+TG++    ++++ +    +   +LS           D   V    
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------DLSKVRSNC 243
Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEV--SLELQGR 673
            + +K   +L A C+  + +ERP   ++  S+EL  R
Sbjct: 244 PKAMK---RLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 135/283 (47%), Gaps = 28/283 (9%)
Query: 385 QSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEF 444
           Q  +K     E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F
Sbjct: 2   QKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAF 60
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLR 501
           + E  ++ Q+  + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L 
Sbjct: 61  LAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 118
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
           + A+ A  ++++        IHRD+++ANIL+ +  + K++DFG ++L+  +        
Sbjct: 119 MAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 175
Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSS 619
           +  + +  PE +     T KSDV+SFG++L E++T G++       PE  ++L   +   
Sbjct: 176 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--- 232
Query: 620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPT 662
                       R+V   N  +  E+ +L   C   R E+RPT
Sbjct: 233 ------------RMVRPDNCPE--ELYQLMRLCWKERPEDRPT 261

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 32/277 (11%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G   +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +      + + I  +TA  + YLH+++   IIHRD+K
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 131
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK----- 581
           S NI L E+ T K+ DFG A+             + G++ ++ PE +   ++ DK     
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSF 188
Query: 582 -SDVYSFGVVLVELLTGKMAL--LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
            SDVY+FG+VL EL+TG++    ++++ +    +   +LS           D   V    
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------DLSKVRSNC 238
Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEV--SLELQGR 673
            + +K   +L A C+  + +ERP   ++  S+EL  R
Sbjct: 239 PKAMK---RLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 32/277 (11%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G   +
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +      + + I  +TA  + YLH+++   IIHRD+K
Sbjct: 81  PQLAI-VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 136
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK----- 581
           S NI L E+ T K+ DFG A+             + G++ ++ PE +   ++ DK     
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSF 193
Query: 582 -SDVYSFGVVLVELLTGKMAL--LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
            SDVY+FG+VL EL+TG++    ++++ +    +   +LS           D   V    
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------DLSKVRSNC 243
Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEV--SLELQGR 673
            + +K   +L A C+  + +ERP   ++  S+EL  R
Sbjct: 244 PKAMK---RLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 32/277 (11%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G   +
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +      + + I  +TA  + YLH+++   IIHRD+K
Sbjct: 103 PQLAI-VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 158
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK----- 581
           S NI L E+ T K+ DFG A+             + G++ ++ PE +   ++ DK     
Sbjct: 159 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSF 215
Query: 582 -SDVYSFGVVLVELLTGKMAL--LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
            SDVY+FG+VL EL+TG++    ++++ +    +   +LS           D   V    
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------DLSKVRSNC 265
Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEV--SLELQGR 673
            + +K   +L A C+  + +ERP   ++  S+EL  R
Sbjct: 266 PKAMK---RLMAECLKKKRDERPLFPQILASIELLAR 299

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 140/293 (47%), Gaps = 29/293 (9%)
Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F+ E  ++ Q+
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 65
Query: 455 NRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLS 511
             + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L + A+ A  ++
Sbjct: 66  QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           ++        IHRD+++ANIL+ +  + K++DFG ++L+  +        +  + +  PE
Sbjct: 124 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 180
Query: 572 YLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEIL 629
            +     T KSDV+SFG++L E++T G++       PE  ++L   +             
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------- 227
Query: 630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQY 682
             R+V   N  +  E+ +L   C   R E+RPT   +   L+   +  + GQY
Sbjct: 228 --RMVRPDNCPE--ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT-ATEGQY 275

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 32/277 (11%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G   +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +      + + I  +TA  + YLH+++   IIHRD+K
Sbjct: 104 PQLAI-VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 159
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK----- 581
           S NI L E+ T K+ DFG A+             + G++ ++ PE +   ++ DK     
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSF 216
Query: 582 -SDVYSFGVVLVELLTGKMAL--LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
            SDVY+FG+VL EL+TG++    ++++ +    +   +LS           D   V    
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------DLSKVRSNC 266
Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEV--SLELQGR 673
            + +K   +L A C+  + +ERP   ++  S+EL  R
Sbjct: 267 PKAMK---RLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 132/277 (47%), Gaps = 32/277 (11%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G    
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            Q+ + V ++    +L+ H+H  +      + + I  +TA  + YLH+++   IIHRD+K
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLK 131
Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK----- 581
           S NI L E+ T K+ DFG A+             + G++ ++ PE +   ++ DK     
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI---RMQDKNPYSF 188
Query: 582 -SDVYSFGVVLVELLTGKMAL--LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
            SDVY+FG+VL EL+TG++    ++++ +    +   +LS           D   V    
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------DLSKVRSNC 238
Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEV--SLELQGR 673
            + +K   +L A C+  + +ERP   ++  S+EL  R
Sbjct: 239 PKAMK---RLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 141/292 (48%), Gaps = 31/292 (10%)
Query: 397 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR 456
           E+   T    + +G G +G V+ G+    T VAVK  K    +  D F+ E  ++ Q+  
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQH 67
Query: 457 RNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYL 513
           + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L + A+ A  ++++
Sbjct: 68  QRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 514 HSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL 573
                   IHRD+++ANIL+ +  + K++DFG ++L+           +  + +  PE +
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAI 182
Query: 574 QTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEILDN 631
                T KSDV+SFG++L E++T G++       PE  ++L   +               
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------------- 227
Query: 632 RIVNDGN-KQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQY 682
           R+V   N  ++L ++ +L   C   R E+RPT   +   L+   +  + GQY
Sbjct: 228 RMVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFT-ATEGQY 275

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F+ E  ++ Q+
Sbjct: 16  EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 74
Query: 455 NRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLS 511
             + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L + A+ A  ++
Sbjct: 75  QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 132
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           ++        IHRD+++ANIL+ +  + K++DFG ++L+  +        +  + +  PE
Sbjct: 133 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 189
Query: 572 YLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEIL 629
            +     T KSDV+SFG++L E++T G++       PE  ++L   +             
Sbjct: 190 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------- 236
Query: 630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPT 662
             R+V   N  +  E+ +L   C   R E+RPT
Sbjct: 237 --RMVRPDNCPE--ELYQLMRLCWKERPEDRPT 265

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 471 VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           +P +V E+V   TL + +H +G ++ +R + + A+    L++ H      IIHRDVK AN
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPAN 146
Query: 531 ILLDENCTPKVSDFGASKLVPI--DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           I++      KV DFG ++ +    +++     V GT  YL PE  +   +  +SDVYS G
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFL------SSLKQNRLLEILDNRIV-----NDG 637
            VL E+LTG+     D P+   S+A   +       S +   L   LD  ++     N  
Sbjct: 207 CVLYEVLTGEPPFTGDSPD---SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPE 263
Query: 638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNG 680
           N+ Q    A++ A  + V   E P   +V  + + R SL+S+ 
Sbjct: 264 NRYQT--AAEMRADLVRVHNGEPPEAPKVLTDAE-RTSLLSSA 303

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 115/222 (51%), Gaps = 16/222 (7%)
Query: 385 QSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFL--PDR--TPVAVK--KSKFVDQ 438
           +     + FT E I+    +   +IG G SG V  G L  P +   PVA+K  K+ + ++
Sbjct: 34  EPGRAGRSFTRE-IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER 92
Query: 439 AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL--FEHIHKKGNLSW 496
            + D F++E  ++ Q +  N++RL G     ++ ++V E++ NG+L  F   H  G  + 
Sbjct: 93  QRRD-FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTI 150
Query: 497 ERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ 556
              +++     GV + +   +++  +HRD+ + N+L+D N   KVSDFG S+++  D   
Sbjct: 151 ---MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 557 NCTVVQGTLG--YLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
             T   G +   +  PE +     +  SDV+SFGVV+ E+L 
Sbjct: 208 AXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F+ E  ++ Q+
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 65
Query: 455 NRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLS 511
             + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L + A+ A  ++
Sbjct: 66  QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           ++        IHRD+++ANIL+ +  + K++DFG ++L+  +        +  + +  PE
Sbjct: 124 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 180
Query: 572 YLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEIL 629
            +     T KSDV+SFG++L E++T G++       PE  ++L   +             
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------- 227
Query: 630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPT 662
             R+V   N  +  E+ +L   C   R E+RPT
Sbjct: 228 --RMVRPDNCPE--ELYQLMRLCWKERPEDRPT 256

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F+ E  ++ Q+
Sbjct: 9   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 67
Query: 455 NRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLS 511
             + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L + A+ A  ++
Sbjct: 68  QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 125
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           ++        IHRD+++ANIL+ +  + K++DFG ++L+  +        +  + +  PE
Sbjct: 126 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 182
Query: 572 YLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEIL 629
            +     T KSDV+SFG++L E++T G++       PE  ++L   +             
Sbjct: 183 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------- 229
Query: 630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPT 662
             R+V   N  +  E+ +L   C   R E+RPT
Sbjct: 230 --RMVRPDNCPE--ELYQLMRLCWKERPEDRPT 258

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 115/222 (51%), Gaps = 16/222 (7%)
Query: 385 QSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFL--PDR--TPVAVK--KSKFVDQ 438
           +     + FT E I+    +   +IG G SG V  G L  P +   PVA+K  K+ + ++
Sbjct: 34  EPGRAGRSFTRE-IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER 92
Query: 439 AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL--FEHIHKKGNLSW 496
            + D F++E  ++ Q +  N++RL G     ++ ++V E++ NG+L  F   H  G  + 
Sbjct: 93  QRRD-FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTI 150
Query: 497 ERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ 556
              +++     GV + +   +++  +HRD+ + N+L+D N   KVSDFG S+++  D   
Sbjct: 151 ---MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207
Query: 557 NCTVVQGTLG--YLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
             T   G +   +  PE +     +  SDV+SFGVV+ E+L 
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 97/194 (50%), Gaps = 5/194 (2%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G VY G     +     K+   D  +++EF+ E  V+ +I   N+V+LLG C  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 469 TQVPLLVYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
                +V E++  G L +++ +  +  ++    L +  + +  + YL  +     IHRD+
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN---FIHRDL 156
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
            + N L+ EN   KV+DFG S+L+  D        +  + +  PE L     + KSDV++
Sbjct: 157 AARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWA 216
Query: 587 FGVVLVELLTGKMA 600
           FGV+L E+ T  M+
Sbjct: 217 FGVLLWEIATYGMS 230

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F+ E  ++ Q+
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 65
Query: 455 NRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLS 511
             + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L + A+ A  ++
Sbjct: 66  QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           ++        IHRD+++ANIL+ +  + K++DFG ++L+  +        +  + +  PE
Sbjct: 124 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 572 YLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEIL 629
            +     T KSDV+SFG++L E++T G++       PE  ++L   +             
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------- 227
Query: 630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPT 662
             R+V   N  +  E+ +L   C   R E+RPT
Sbjct: 228 --RMVRPDNCPE--ELYQLMRLCWKERPEDRPT 256

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 406 ADVIGCGGSGNVYKGFLPDRTPVAVK---KSKFVDQAKIDE----FINELVVVLQINRRN 458
            D +G GG   VY   L + T + +K   K+ F+   + +E    F  E+    Q++ +N
Sbjct: 16  VDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 459 VVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETN 518
           +V ++    E     LV E++   TL E+I   G LS +  +  T +    + + H   +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           + I+HRD+K  NIL+D N T K+ DFG +K +   ++     V GT+ Y  PE  +    
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189
Query: 579 TDKSDVYSFGVVLVELLTGK 598
            + +D+YS G+VL E+L G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F+ E  ++ Q+
Sbjct: 2   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 60
Query: 455 NRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLS 511
             + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L + A+ A  ++
Sbjct: 61  QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 118
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           ++        IHRD+++ANIL+ +  + K++DFG ++L+  +        +  + +  PE
Sbjct: 119 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 175
Query: 572 YLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEIL 629
            +     T KSDV+SFG++L E++T G++       PE  ++L   +             
Sbjct: 176 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------- 222
Query: 630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPT 662
             R+V   N  +  E+ +L   C   R E+RPT
Sbjct: 223 --RMVRPDNCPE--ELYQLMRLCWKERPEDRPT 251

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 107/205 (52%), Gaps = 9/205 (4%)
Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F+ E  ++ Q+
Sbjct: 8   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 66
Query: 455 NRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLS 511
             + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L + A+ A  ++
Sbjct: 67  QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 124
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           ++        IHRD+++ANIL+ +  + K++DFG ++L+  +        +  + +  PE
Sbjct: 125 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 181
Query: 572 YLQTCKLTDKSDVYSFGVVLVELLT 596
            +     T KSDV+SFG++L E++T
Sbjct: 182 AINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 49/138 (35%), Positives = 75/138 (54%), Gaps = 5/138 (3%)
Query: 471 VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           +P +V E+V   TL + +H +G ++ +R + + A+    L++ H      IIHRDVK AN
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPAN 146
Query: 531 ILLDENCTPKVSDFGASKLVPI--DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           IL+      KV DFG ++ +    +++     V GT  YL PE  +   +  +SDVYS G
Sbjct: 147 ILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 589 VVLVELLTGKMALLSDKP 606
            VL E+LTG+     D P
Sbjct: 207 CVLYEVLTGEPPFTGDSP 224

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 75/138 (54%), Gaps = 5/138 (3%)
Query: 471 VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           +P +V E+V   TL + +H +G ++ +R + + A+    L++ H      IIHRDVK AN
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPAN 146
Query: 531 ILLDENCTPKVSDFGASKLVPI--DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           I++      KV DFG ++ +    +++     V GT  YL PE  +   +  +SDVYS G
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 589 VVLVELLTGKMALLSDKP 606
            VL E+LTG+     D P
Sbjct: 207 CVLYEVLTGEPPFTGDSP 224

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 75/138 (54%), Gaps = 5/138 (3%)
Query: 471 VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           +P +V E+V   TL + +H +G ++ +R + + A+    L++ H      IIHRDVK AN
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPAN 146
Query: 531 ILLDENCTPKVSDFGASKLVPI--DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           I++      KV DFG ++ +    +++     V GT  YL PE  +   +  +SDVYS G
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 589 VVLVELLTGKMALLSDKP 606
            VL E+LTG+     D P
Sbjct: 207 CVLYEVLTGEPPFTGDSP 224

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 6/193 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V  G    +  VA+K  K    ++ DEFI E  V++ ++   +V+L G C +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            +   ++ E++ NG L  ++ + +     ++ L +  +    + YL S+     +HRD+ 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 131
Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           + N L+++    KVSDFG S+ V  D   +    +  + +  PE L   K + KSD+++F
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 191
Query: 588 GVVLVELLT-GKM 599
           GV++ E+ + GKM
Sbjct: 192 GVLMWEIYSLGKM 204

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 6/193 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V  G    +  VA+K  K    ++ DEFI E  V++ ++   +V+L G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            +   ++ E++ NG L  ++ + +     ++ L +  +    + YL S+     +HRD+ 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 147
Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           + N L+++    KVSDFG S+ V  D   +    +  + +  PE L   K + KSD+++F
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 207
Query: 588 GVVLVELLT-GKM 599
           GV++ E+ + GKM
Sbjct: 208 GVLMWEIYSLGKM 220

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 75/138 (54%), Gaps = 5/138 (3%)
Query: 471 VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           +P +V E+V   TL + +H +G ++ +R + + A+    L++ H      IIHRDVK AN
Sbjct: 90  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPAN 146
Query: 531 ILLDENCTPKVSDFGASKLVPI--DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           I++      KV DFG ++ +    +++     V GT  YL PE  +   +  +SDVYS G
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 589 VVLVELLTGKMALLSDKP 606
            VL E+LTG+     D P
Sbjct: 207 CVLYEVLTGEPPFTGDSP 224

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/138 (34%), Positives = 75/138 (54%), Gaps = 5/138 (3%)
Query: 471 VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           +P +V E+V   TL + +H +G ++ +R + + A+    L++ H      IIHRDVK AN
Sbjct: 107 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPAN 163
Query: 531 ILLDENCTPKVSDFGASKLVPI--DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           I++      KV DFG ++ +    +++     V GT  YL PE  +   +  +SDVYS G
Sbjct: 164 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 223
Query: 589 VVLVELLTGKMALLSDKP 606
            VL E+LTG+     D P
Sbjct: 224 CVLYEVLTGEPPFTGDSP 241

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 6/193 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V  G    +  VA+K  K    ++ DEFI E  V++ ++   +V+L G C +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            +   ++ E++ NG L  ++ + +     ++ L +  +    + YL S+     +HRD+ 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 138
Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           + N L+++    KVSDFG S+ V  D   +    +  + +  PE L   K + KSD+++F
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 198
Query: 588 GVVLVELLT-GKM 599
           GV++ E+ + GKM
Sbjct: 199 GVLMWEIYSLGKM 211

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 6/193 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V  G    +  VA+K  K    ++ DEFI E  V++ ++   +V+L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            +   ++ E++ NG L  ++ + +     ++ L +  +    + YL S+     +HRD+ 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 132
Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           + N L+++    KVSDFG S+ V  D   +    +  + +  PE L   K + KSD+++F
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 192
Query: 588 GVVLVELLT-GKM 599
           GV++ E+ + GKM
Sbjct: 193 GVLMWEIYSLGKM 205

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 6/193 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V  G    +  VA+K  K    ++ DEFI E  V++ ++   +V+L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            +   ++ E++ NG L  ++ + +     ++ L +  +    + YL S+     +HRD+ 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 127
Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           + N L+++    KVSDFG S+ V  D   +    +  + +  PE L   K + KSD+++F
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187
Query: 588 GVVLVELLT-GKM 599
           GV++ E+ + GKM
Sbjct: 188 GVLMWEIYSLGKM 200

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 6/193 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V  G    +  VA+K  K    ++ DEFI E  V++ ++   +V+L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            +   ++ E++ NG L  ++ + +     ++ L +  +    + YL S+     +HRD+ 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 132
Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           + N L+++    KVSDFG S+ V  D   +    +  + +  PE L   K + KSD+++F
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAF 192
Query: 588 GVVLVELLT-GKM 599
           GV++ E+ + GKM
Sbjct: 193 GVLMWEIYSLGKM 205

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           E E+   T    + +G G  G V+ G+    T VAVK  K    +  D F+ E  ++ Q+
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQL 61
Query: 455 NRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLS 511
             + +VRL      TQ P+ ++ E++ NG+L + +       L+  + L + A+ A  ++
Sbjct: 62  QHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 119
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           ++        IHR++++ANIL+ +  + K++DFG ++L+  +        +  + +  PE
Sbjct: 120 FIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 176
Query: 572 YLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEIL 629
            +     T KSDV+SFG++L E++T G++       PE  ++L   +             
Sbjct: 177 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------- 223
Query: 630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPT 662
             R+V   N  +  E+ +L   C   R E+RPT
Sbjct: 224 --RMVRPDNCPE--ELYQLMRLCWKERPEDRPT 252

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 27/264 (10%)
Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           +V+G G  G V K     +  VA+K+ +   +++   FI EL  + ++N  N+V+L G C
Sbjct: 14  EVVGRGAFGVVCKAKWRAKD-VAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGNLSW---ERRLRITAETAGVLSYLHSETNVPIIH 523
           L      LV E+   G+L+  +H    L +      +    + +  ++YLHS     +IH
Sbjct: 71  LNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 524 RDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+K  N+LL    T  K+ DFG +     D   + T  +G+  ++ PE  +    ++K 
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+S+G++L E++T +      KP +E              R++  + N       K   
Sbjct: 185 DVFSWGIILWEVITRR------KPFDE--------IGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 643 KEVAKLAARCISVRGEERPTMKEV 666
           K +  L  RC S    +RP+M+E+
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEI 254

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 129/257 (50%), Gaps = 23/257 (8%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G+  + T VAVK  K      +  F+ E  ++  +    +VRL     +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 469 TQVPLLVYEFVGNGTLFEHIH--KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
            +   ++ EF+  G+L + +   + G +   + +  +A+ A  ++Y+  +     IHRD+
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 135
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           ++AN+L+ E+   K++DFG ++++  +        +  + +  PE +     T KS+V+S
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWS 195
Query: 587 FGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV 645
           FG++L E++T GK+      P   R+ A + +S+L Q   +  ++N         +L ++
Sbjct: 196 FGILLYEIVTYGKI------PYPGRTNA-DVMSALSQGYRMPRMEN------CPDELYDI 242
Query: 646 AKLAARCISVRGEERPT 662
            K+   C   + EERPT
Sbjct: 243 MKM---CWKEKAEERPT 256

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 101/193 (52%), Gaps = 6/193 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V  G    +  VA+K  K    ++ DEFI E  V++ ++   +V+L G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 469 TQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
            +   ++ E++ NG L  ++ + +     ++ L +  +    + YL S+     +HRD+ 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 147
Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           + N L+++    KVSDFG S+ V  D   +    +  + +  PE L   K + KSD+++F
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 207
Query: 588 GVVLVELLT-GKM 599
           GV++ E+ + GKM
Sbjct: 208 GVLMWEIYSLGKM 220

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 125/264 (47%), Gaps = 27/264 (10%)
Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           +V+G G  G V K     +  VA+K+ +   +++   FI EL  + ++N  N+V+L G C
Sbjct: 15  EVVGRGAFGVVCKAKWRAKD-VAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGNLSW---ERRLRITAETAGVLSYLHSETNVPIIH 523
           L      LV E+   G+L+  +H    L +      +    + +  ++YLHS     +IH
Sbjct: 72  LNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 524 RDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+K  N+LL    T  K+ DFG +     D   + T  +G+  ++ PE  +    ++K 
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 185
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+S+G++L E++T +      KP +E              R++  + N       K   
Sbjct: 186 DVFSWGIILWEVITRR------KPFDE--------IGGPAFRIMWAVHNGTRPPLIKNLP 231
Query: 643 KEVAKLAARCISVRGEERPTMKEV 666
           K +  L  RC S    +RP+M+E+
Sbjct: 232 KPIESLMTRCWSKDPSQRPSMEEI 255

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 116/262 (44%), Gaps = 27/262 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF---VDQAKID-EFINELVVVLQINRRNVVRLLG 464
           +G G  GNVY      R  +   K  F   +++A ++ +   E+ +   +   N++RL G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
              +     L+ E+   GT++  + K      +R      E A  LSY HS+    +IHR
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHR 129
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+K  N+LL      K++DFG S   P       T + GTL YL PE ++     +K D+
Sbjct: 130 DIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGRMHDEKVDL 186
Query: 585 YSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE 644
           +S GV+  E L GK       P E    A  +  + K+   +E      V +G +     
Sbjct: 187 WSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTEGARD---- 232
Query: 645 VAKLAARCISVRGEERPTMKEV 666
              L +R +     +RP ++EV
Sbjct: 233 ---LISRLLKHNPSQRPMLREV 251

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 128/257 (49%), Gaps = 23/257 (8%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G+  + T VAVK  K      +  F+ E  ++  +    +VRL      
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 469 TQVPLLVYEFVGNGTLFEHIH--KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
            +   ++ E++  G+L + +   + G +   + +  +A+ A  ++Y+  +     IHRD+
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 136
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           ++AN+L+ E+   K++DFG ++++  +        +  + +  PE +     T KSDV+S
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWS 196
Query: 587 FGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV 645
           FG++L E++T GK+      P   R+ A + +++L Q   +  ++N         +L ++
Sbjct: 197 FGILLYEIVTYGKI------PYPGRTNA-DVMTALSQGYRMPRVEN------CPDELYDI 243
Query: 646 AKLAARCISVRGEERPT 662
            K+   C   + EERPT
Sbjct: 244 MKM---CWKEKAEERPT 257

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 17  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 129 R---VIHRDIKPENLLLGSAGELKIADFGWSCHAPSS---RRTTLSGTLDYLPPEMIEGR 182
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 232
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 233 GARD-------LISRLLKHNPSQRPMLREV 255

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 16  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 128 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 181
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 231
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 232 GARD-------LISRLLKHNPSQRPMLREV 254

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 21  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 133 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEXIEGR 186
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 187 XHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 236
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 237 GARD-------LISRLLKHNPSQRPXLREV 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 19  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 131 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 184
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 234
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 235 GARD-------LISRLLKHNPSQRPMLREV 257

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 21  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 133 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 186
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 236
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 237 GARD-------LISRLLKHNPSQRPMLREV 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 15  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 66
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 67  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 126
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 127 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 180
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 181 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 230
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 231 GARD-------LISRLLKHNPSQRPMLREV 253

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 20  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 71
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 131
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 132 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 185
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 235
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 236 GARD-------LISRLLKHNPSQRPMLREV 258

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 42  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 94  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 153
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 154 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 207
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 257
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 258 GARD-------LISRLLKHNPSQRPMLREV 280

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 146/313 (46%), Gaps = 41/313 (13%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 2   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 56
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L++ + +  G L +++ + K N+
Sbjct: 57  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNI 115
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL  + A
Sbjct: 116 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGA 170
Query: 555 IQNCTVVQG---TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS 611
            +     +G    + ++  E +     T +SDV+S+GV + EL+T         P  E S
Sbjct: 171 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230
Query: 612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
             +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E  
Sbjct: 231 SILEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS 275
Query: 672 GRLSLMSNGQYYL 684
               +  + Q YL
Sbjct: 276 ---KMARDPQRYL 285

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 19  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 131 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 184
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 234
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 235 GARD-------LISRLLKHNPSQRPMLREV 257

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 33  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 84
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 85  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 144
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 145 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 198
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 199 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 248
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 249 GARD-------LISRLLKHNPSQRPMLREV 271

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 146/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 3   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 57
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L++ + +  G L +++ + K N+
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 116
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 117 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 174 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 234 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 276
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 277 -KMARDPQRYL 286

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 146/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 5   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 59
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L++ + +  G L +++ + K N+
Sbjct: 60  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 118
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 119 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 175
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 176 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 235
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 236 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 278
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 279 -KMARDPQRYL 288

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 120/275 (43%), Gaps = 25/275 (9%)
Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLG 464
           +VIG G +  V   +  P +  VA+K+      Q  +DE + E+  + Q +  N+V    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 465 CCLETQVPLLVYEFVGNGTLFE---HI-----HKKGNLSWERRLRITAETAGVLSYLHSE 516
             +      LV + +  G++ +   HI     HK G L       I  E    L YLH  
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI--DAIQNCT--VVQGTLGYLDPEY 572
                IHRDVK+ NILL E+ + +++DFG S  +    D  +N       GT  ++ PE 
Sbjct: 141 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 573 LQTCKLTD-KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN 631
           ++  +  D K+D++SFG+  +EL TG        P       M  L    QN    +   
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-------MKVLMLTLQNDPPSLETG 250
Query: 632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
               +  K+  K   K+ + C+    E+RPT  E+
Sbjct: 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 285

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           VIG G  G V  G L  P +  VAV     K  + ++ + D F+ E  ++ Q +  NVV 
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRD-FLCEASIMGQFDHPNVVH 108
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVP 520
           L G     +  ++V EF+ NG L   + K  G  +    +++     G+ + +    ++ 
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFT---VIQLVGMLRGIAAGMRYLADMG 165
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPID--AIQNCTVVQGTLGYLDPEYLQTCKL 578
            +HRD+ + NIL++ N   KVSDFG S+++  D  A+   T  +  + +  PE +Q  K 
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKF 225
Query: 579 TDKSDVYSFGVVLVELLT 596
           T  SDV+S+G+V+ E+++
Sbjct: 226 TSASDVWSYGIVMWEVMS 243

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 129/292 (44%), Gaps = 32/292 (10%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ 438
           ++ L G +++ +++  EE    +     D IG G  G VYKG   D     V   K +D 
Sbjct: 2   MAHLRGFANQHSRVDPEELFTKL-----DRIGKGSFGEVYKGI--DNHTKEVVAIKIIDL 54
Query: 439 AKIDEFI----NELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNL 494
            + ++ I     E+ V+ Q +   + R  G  L++    ++ E++G G+  + + K G L
Sbjct: 55  EEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL-KPGPL 113
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
                  I  E    L YLHSE     IHRD+K+AN+LL E    K++DFG +  +    
Sbjct: 114 EETYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 170
Query: 555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM 614
           I+    V GT  ++ PE ++      K+D++S G+  +EL  G      + P        
Sbjct: 171 IKRNXFV-GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG------EPPN------- 216
Query: 615 NFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              S L   R+L ++          Q  K   +    C++     RPT KE+
Sbjct: 217 ---SDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKEL 265

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 26  GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 80
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 81  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 139
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 140 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 196
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 197 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 256
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 257 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 299
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 300 -KMARDPQRYL 309

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 125/276 (45%), Gaps = 27/276 (9%)
Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLG 464
           +VIG G +  V   +  P +  VA+K+      Q  +DE + E+  + Q +  N+V    
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 465 CCLETQVPLLVYEFVGNGTLFE---HI-----HKKGNLSWERRLRITAETAGVLSYLHSE 516
             +      LV + +  G++ +   HI     HK G L       I  E    L YLH  
Sbjct: 76  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 135
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI--DAIQNCT--VVQGTLGYLDPEY 572
                IHRDVK+ NILL E+ + +++DFG S  +    D  +N       GT  ++ PE 
Sbjct: 136 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 192
Query: 573 LQTCKLTD-KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM-NFLSSLKQNRLLEILD 630
           ++  +  D K+D++SFG+  +EL TG        P +   L + N   SL+      + D
Sbjct: 193 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG----VQD 248
Query: 631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
             ++    K+  K   K+ + C+    E+RPT  E+
Sbjct: 249 KEML----KKYGKSFRKMISLCLQKDPEKRPTAAEL 280

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 16  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 128 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTELCGTLDYLPPEMIEGR 181
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 231
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 232 GARD-------LISRLLKHNPSQRPMLREV 254

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 21  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   G +++ + K      +R      E A  LSY HS+
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 133 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 186
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 236
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 237 GARD-------LISRLLKHNPSQRPMLREV 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 16  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 128 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTXLCGTLDYLPPEMIEGR 181
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 231
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 232 GARD-------LISRLLKHNPSQRPMLREV 254

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 1   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNI 114
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 232 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 274
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 275 -KMARDPQRYL 284

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 146/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 1   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L++ + +  G L +++ + K N+
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 114
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 232 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 274
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 275 -KMARDPQRYL 284

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 146/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 3   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 57
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L++ + +  G L +++ + K N+
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 116
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 117 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 173
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 174 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 234 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 276
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 277 -KMARDPQRYL 286

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 141/304 (46%), Gaps = 39/304 (12%)
Query: 391 KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFVDQAKID-EF 444
           +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +     K + E 
Sbjct: 14  RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 68
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           ++E  V+  ++  +V RLLG CL + V L++ + +  G L +++ + K N+  +  L   
Sbjct: 69  LDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWC 127
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            + A  ++YL       ++HRD+ + N+L+      K++DFG +KL  + A +     +G
Sbjct: 128 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEG 182
Query: 564 ---TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
               + ++  E +     T +SDV+S+GV + EL+T         P  E S  +     L
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 242
Query: 621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNG 680
            Q  +  I               +V  +  +C  +  + RP  +E+ +E      +  + 
Sbjct: 243 PQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDP 284
Query: 681 QYYL 684
           Q YL
Sbjct: 285 QRYL 288

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 146/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 2   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 56
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L++ + +  G L +++ + K N+
Sbjct: 57  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 115
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 116 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 172
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 173 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 232
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 233 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 275
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 276 -KMARDPQRYL 285

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 146/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 3   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 57
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L++ + +  G L +++ + K N+
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 116
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 117 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 174 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 234 LEKGERLPQPPICTI---------------DVYMIMRKCWMIDADSRPKFRELIIEFS-- 276
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 277 -KMARDPQRYL 286

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 146/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 4   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 58
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L++ + +  G L +++ + K N+
Sbjct: 59  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 117
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 118 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 175 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 235 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 277
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 278 -KMARDPQRYL 287

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 110
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E++ NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGF 168
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 3   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 57
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 116
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 117 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 173
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 174 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 234 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 276
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 277 -KMARDPQRYL 286

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 7   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 61
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 62  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 120
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 121 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 177
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 178 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 237
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 238 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 280
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 281 -KMARDPQRYL 290

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 21  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 133 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEGR 186
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 236
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 237 GARD-------LISRLLKHNPSQRPMLREV 259

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 4   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 58
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 59  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 117
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 118 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 175 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 235 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 277
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 278 -KMARDPQRYL 287

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 1   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 114
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 171
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 232 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 274
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 275 -KMARDPQRYL 284

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 8   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 62
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 121
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 122 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 179 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 239 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 281
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 282 -KMARDPQRYL 291

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 111/209 (53%), Gaps = 15/209 (7%)
Query: 399 KTVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKK-SKFVDQAKIDEFINELVVVLQ 453
           + V  +   VIG G  G VY G   D    R   A+K  S+  +  +++ F+ E +++  
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 454 INRRNVVRLLGCCLETQ-VPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLS 511
           +N  NV+ L+G  L  + +P ++  ++ +G L + I   + N + +  +    + A  + 
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID----AIQNCTVVQGTLGY 567
           YL  +     +HRD+ + N +LDE+ T KV+DFG ++ + +D    ++Q     +  + +
Sbjct: 139 YLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVKW 194
Query: 568 LDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
              E LQT + T KSDV+SFGV+L ELLT
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 17  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 129 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEGR 182
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 232
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 233 GARD-------LISRLLKHNPSQRPMLREV 255

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 4   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 58
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 59  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 117
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 118 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 175 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 235 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 277
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 278 -KMARDPQRYL 287

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 26/201 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            ++SKF+   K+             +   E+ +   +  
Sbjct: 20  LGKGKFGNVYLA--------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK 131
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL  N   K++DFG S   P       T + GTL YL PE ++  
Sbjct: 132 R---VIHRDIKPENLLLGSNGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 185
Query: 577 KLTDKSDVYSFGVVLVELLTG 597
              +K D++S GV+  E L G
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVG 206

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 8   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 62
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 121
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 122 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 178
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 179 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 239 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 281
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 282 -KMARDPQRYL 291

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 113/270 (41%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 21  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   G +++ + K      +R      E A  LSY HS+
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P         + GTL YL PE ++  
Sbjct: 133 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRXXLXGTLDYLPPEMIEGR 186
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 236
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 237 GARD-------LISRLLKHNPSQRPMLREV 259

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 16  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 128 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEGR 181
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 231
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 232 GARD-------LISRLLKHNPSQRPMLREV 254

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 1   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 114
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 232 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 274
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 275 -KMARDPQRYL 284

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 37/289 (12%)
Query: 382 LHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI 441
           L+ QS +  ++FT+ E           IG G  G V+KG   D     V   K +D  + 
Sbjct: 18  LYFQSMDPEELFTKLE----------KIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEA 65
Query: 442 DEFI----NELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWE 497
           ++ I     E+ V+ Q +   V +  G  L+     ++ E++G G+  + + + G L   
Sbjct: 66  EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDET 124
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
           +   I  E    L YLHSE     IHRD+K+AN+LL E+   K++DFG +  +    I+ 
Sbjct: 125 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 181
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL 617
            T V GT  ++ PE ++      K+D++S G+  +EL  G       +P       M  L
Sbjct: 182 NTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG-------EPPHSELHPMKVL 233
Query: 618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
             + +N       N    +GN    K + +    C++     RPT KE+
Sbjct: 234 FLIPKN-------NPPTLEGNYS--KPLKEFVEACLNKEPSFRPTAKEL 273

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 110
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E++ NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 3   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 57
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 116
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 117 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 173
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 174 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 233
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 234 LEKGERLPQPPICTI---------------DVYMIMRKCWMIDADSRPKFRELIIEFS-- 276
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 277 -KMARDPQRYL 286

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 140/302 (46%), Gaps = 35/302 (11%)
Query: 391 KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFVDQAKID-EF 444
           +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +     K + E 
Sbjct: 4   RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 58
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+  +  L   
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWC 117
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQ 562
            + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  +  + +    +
Sbjct: 118 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++  E +     T +SDV+S+GV + EL+T         P  E S  +     L Q
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 234
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQY 682
             +  I               +V  +  +C  +  + RP  +E+ +E      +  + Q 
Sbjct: 235 PPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQR 276
Query: 683 YL 684
           YL
Sbjct: 277 YL 278

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 110
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E++ NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 110
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E++ NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 110
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E++ NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 40  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 98
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E++ NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 99  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 156
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K T
Sbjct: 157 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 216
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 217 SASDVWSYGIVLWEVMS 233

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 16  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++  
Sbjct: 128 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEGR 181
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 231
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 232 GARD-------LISRLLKHNPSQRPMLREV 254

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 50  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 108
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E++ NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 109 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 166
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K T
Sbjct: 167 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 226
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 227 SASDVWSYGIVLWEVMS 243

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 4   GEAPNQALLRILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 58
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 59  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 117
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 118 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 174
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 175 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 234
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 235 LEKGERLPQPPICTI---------------DVYMIMRKCWMIDADSRPKFRELIIEFS-- 277
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 278 -KMARDPQRYL 287

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 113/270 (41%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 19  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P         + GTL YL PE ++  
Sbjct: 131 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRAALCGTLDYLPPEMIEGR 184
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 234
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 235 GARD-------LISRLLKHNPSQRPMLREV 257

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 81
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E++ NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 82  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K T
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 200 SASDVWSYGIVLWEVMS 216

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 113/270 (41%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 19  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P     +     GTL YL PE ++  
Sbjct: 131 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC---GTLDYLPPEMIEGR 184
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 234
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 235 GARD-------LISRLLKHNPSQRPMLREV 257

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 116/262 (44%), Gaps = 27/262 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF---VDQAKID-EFINELVVVLQINRRNVVRLLG 464
           +G G  GNVY     +   +   K  F   +++A ++ +   E+ +   +   N++RL G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
              ++    L+ E+   GT++  + K      +R      E A  LSY HS+    +IHR
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK---VIHR 132
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+K  N+LL      K++DFG S   P         + GTL YL PE ++     +K D+
Sbjct: 133 DIKPENLLLGSAGELKIADFGWSVHAPSS---RRAALCGTLDYLPPEMIEGRMHDEKVDL 189
Query: 585 YSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE 644
           +S GV+  E L GK       P E    A  +  + K+   +E      V +G +     
Sbjct: 190 WSLGVLCYEFLVGK------PPFE----ANTYQDTYKRISRVEFTFPDFVTEGARD---- 235
Query: 645 VAKLAARCISVRGEERPTMKEV 666
              L +R +     +RP ++EV
Sbjct: 236 ---LISRLLKHNPSQRPMLREV 254

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 113/270 (41%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 16  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P         + GTL YL PE ++  
Sbjct: 128 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRAALCGTLDYLPPEMIEGR 181
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 231
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 232 GARD-------LISRLLKHNPSQRPMLREV 254

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 18  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 129
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K+++FG S   P       T + GTL YL PE ++  
Sbjct: 130 R---VIHRDIKPENLLLGSAGELKIANFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 183
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 233
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 234 GARD-------LISRLLKHNPSQRPMLREV 256

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 113/270 (41%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 42  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 94  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 153
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P     +     GTL YL PE ++  
Sbjct: 154 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC---GTLDYLPPEMIEGR 207
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 257
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 258 GARD-------LISRLLKHNPSQRPMLREV 280

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 140/302 (46%), Gaps = 35/302 (11%)
Query: 391 KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFVDQAKID-EF 444
           +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +     K + E 
Sbjct: 20  RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 74
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+  +  L   
Sbjct: 75  LDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWC 133
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQ 562
            + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  +  + +    +
Sbjct: 134 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 190
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++  E +     T +SDV+S+GV + EL+T         P  E S  +     L Q
Sbjct: 191 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 250
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQY 682
             +  I               +V  +  +C  +  + RP  +E+ +E      +  + Q 
Sbjct: 251 PPICTI---------------DVYMIMRKCWMIDADSRPKFRELIIEFS---KMARDPQR 292
Query: 683 YL 684
           YL
Sbjct: 293 YL 294

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 140/302 (46%), Gaps = 35/302 (11%)
Query: 391 KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFVDQAKID-EF 444
           +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +     K + E 
Sbjct: 7   RILKETEFKKIK-----VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 61
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+  +  L   
Sbjct: 62  LDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWC 120
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQ 562
            + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  +  + +    +
Sbjct: 121 VQIAEGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++  E +     T +SDV+S+GV + EL+T         P  E S  +     L Q
Sbjct: 178 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 237
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQY 682
             +  I               +V  +  +C  +  + RP  +E+ +E      +  + Q 
Sbjct: 238 PPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQR 279
Query: 683 YL 684
           YL
Sbjct: 280 YL 281

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 96/190 (50%), Gaps = 9/190 (4%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKID-EFINELVVVLQINRRNVVRLLGCC 466
           IG G  G V+ G L  D T VAVK  +      +  +F+ E  ++ Q +  N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            + Q   +V E V  G     +  +G  L  +  L++  + A  + YL S+     IHRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCT--VVQGTLGYLDPEYLQTCKLTDKSD 583
           + + N L+ E    K+SDFG S+    D +   +  + Q  + +  PE L   + + +SD
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 584 VYSFGVVLVE 593
           V+SFG++L E
Sbjct: 298 VWSFGILLWE 307

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 1   GEAPNQALLRILKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 114
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 232 LEKGERLPQPPICTI---------------DVYMIMRKCWMIDADSRPKFRELIIEFS-- 274
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 275 -KMARDPQRYL 284

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 19  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K+++FG S   P       T + GTL YL PE ++  
Sbjct: 131 R---VIHRDIKPENLLLGSAGELKIANFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGR 184
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 234
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 235 GARD-------LISRLLKHNPSQRPMLREV 257

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 113/270 (41%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 17  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P         + GTL YL PE ++  
Sbjct: 129 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRDTLCGTLDYLPPEMIEGR 182
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 232
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 233 GARD-------LISRLLKHNPSQRPMLREV 255

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 7/169 (4%)
Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI 488
            +KK   V   +++   +E +++  +    ++R+ G   + Q   ++ +++  G LF  +
Sbjct: 38  VLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL 97
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            K             AE    L YLHS+    II+RD+K  NILLD+N   K++DFG +K
Sbjct: 98  RKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK 154
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
            VP      C    GT  Y+ PE + T       D +SFG+++ E+L G
Sbjct: 155 YVPDVTYXLC----GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 113/270 (41%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 18  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 129
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P         + GTL YL PE ++  
Sbjct: 130 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRXXLCGTLDYLPPEMIEGR 183
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 233
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 234 GARD-------LISRLLKHNPSQRPMLREV 256

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 110
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E++ NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG ++++  D     T   G +   +  PE +   K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 116/217 (53%), Gaps = 21/217 (9%)
Query: 390 AKIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFVDQAKIDEF 444
           A+IF E E++ +      V+G G  G V+KG ++P+    + PV +K  +  D++    F
Sbjct: 7   ARIFKETELRKLK-----VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSF 59
Query: 445 ---INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRL 500
               + ++ +  ++  ++VRLLG C  + + L V +++  G+L +H+ + +G L  +  L
Sbjct: 60  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLL 118
Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC-T 559
               + A  + YL       ++HR++ + N+LL      +V+DFG + L+P D  Q   +
Sbjct: 119 NWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
             +  + ++  E +   K T +SDV+S+GV + EL+T
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 96/190 (50%), Gaps = 9/190 (4%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKID-EFINELVVVLQINRRNVVRLLGCC 466
           IG G  G V+ G L  D T VAVK  +      +  +F+ E  ++ Q +  N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            + Q   +V E V  G     +  +G  L  +  L++  + A  + YL S+     IHRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCT--VVQGTLGYLDPEYLQTCKLTDKSD 583
           + + N L+ E    K+SDFG S+    D +   +  + Q  + +  PE L   + + +SD
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 584 VYSFGVVLVE 593
           V+SFG++L E
Sbjct: 298 VWSFGILLWE 307

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 116/217 (53%), Gaps = 21/217 (9%)
Query: 390 AKIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFVDQAKIDEF 444
           A+IF E E++ +      V+G G  G V+KG ++P+    + PV +K  +  D++    F
Sbjct: 25  ARIFKETELRKLK-----VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSF 77
Query: 445 ---INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRL 500
               + ++ +  ++  ++VRLLG C  + + L V +++  G+L +H+ + +G L  +  L
Sbjct: 78  QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLL 136
Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC-T 559
               + A  + YL       ++HR++ + N+LL      +V+DFG + L+P D  Q   +
Sbjct: 137 NWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 193
Query: 560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
             +  + ++  E +   K T +SDV+S+GV + EL+T
Sbjct: 194 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 113/270 (41%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 16  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P         + GTL YL PE ++  
Sbjct: 128 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRXXLCGTLDYLPPEMIEGR 181
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 231
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 232 GARD-------LISRLLKHNPSQRPMLREV 254

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 113/270 (41%), Gaps = 43/270 (15%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            K+SKF+   K+             +   E+ +   +  
Sbjct: 19  LGKGKFGNVYLA--------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P         + GTL YL PE ++  
Sbjct: 131 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRXXLCGTLDYLPPEMIEGR 184
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
              +K D++S GV+  E L GK       P E    A  +  + K+   +E      V +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGK------PPFE----ANTYQETYKRISRVEFTFPDFVTE 234
Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           G +        L +R +     +RP ++EV
Sbjct: 235 GARD-------LISRLLKHNPSQRPMLREV 257

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 6/193 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V  G    +  VAVK  K    ++ DEF  E   +++++   +V+  G C +
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
                +V E++ NG L  ++   G  L   + L +  +    +++L S      IHRD+ 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLA 131
Query: 528 SANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           + N L+D +   KVSDFG ++ V  D   +    +  + +  PE     K + KSDV++F
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF 191
Query: 588 GVVLVELLT-GKM 599
           G+++ E+ + GKM
Sbjct: 192 GILMWEVFSLGKM 204

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 119/262 (45%), Gaps = 27/262 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFI----NELVVVLQINRRNVVRLLG 464
           IG G  G V+KG   D     V   K +D  + ++ I     E+ V+ Q +   V +  G
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
             L+     ++ E++G G+  + + + G L   +   I  E    L YLHSE     IHR
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK---IHR 128
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+K+AN+LL E+   K++DFG +  +    I+  T V GT  ++ PE ++      K+D+
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADI 187
Query: 585 YSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE 644
           +S G+  +EL  G       +P       M  L  + +N       N    +GN    K 
Sbjct: 188 WSLGITAIELARG-------EPPHSELHPMKVLFLIPKN-------NPPTLEGNYS--KP 231
Query: 645 VAKLAARCISVRGEERPTMKEV 666
           + +    C++     RPT KE+
Sbjct: 232 LKEFVEACLNKEPSFRPTAKEL 253

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 145/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+  G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 8   GEAPNQALLRILKETEFKKIK-----VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 62
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L++ + +  G L +++ + K N+
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 121
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 122 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 179 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 239 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 281
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 282 -KMARDPQRYL 291

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 110
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E++ NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG  +++  D     T   G +   +  PE +   K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G SG VY    +     VA+++     Q K +  INE++V+ +    N+V  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 468 ETQVPLLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
                 +V E++  G+L + + +    +G ++      +  E    L +LHS     +IH
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQ---VIH 139
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+KS NILL  + + K++DFG    +  +  +  T+V GT  ++ PE +       K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 584 VYSFGVVLVELLTGKMALLSDKP 606
           ++S G++ +E++ G+   L++ P
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENP 221

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 110
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E + NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGA 168
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 110
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E + NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 408 VIGCGGSGNVYKGFL--PDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V  G L  P +  ++V     K  + ++ + D F+ E  ++ Q +  N++R
Sbjct: 23  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIR 81
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L G   +++  ++V E + NG+L   + K    +    +++     G+ S +   +++  
Sbjct: 82  LEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKLT 579
           +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K T
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+S+G+VL E+++
Sbjct: 200 SASDVWSYGIVLWEVMS 216

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 450 VVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           +++++N   +V+L     +T+  L L+ +F+  G LF  + K+   + E      AE A 
Sbjct: 79  ILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 137
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            L +LHS   + II+RD+K  NILLDE    K++DFG SK   ID  +      GT+ Y+
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 193
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM-------NFLSSLK 621
            PE +     T  +D +SFGV++ E+LTG +       +E  ++ +        FLS   
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA 253
Query: 622 QNRLLEILDNRIVNDGNK 639
           Q+ LL +L  R  N  N+
Sbjct: 254 QS-LLRMLFKR--NPANR 268

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 408 VIGCGGSGNVYKGFLPDRTP------VAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
           VIG G  G V  G L  + P      VA+K  K+ + D+ + D F++E  ++ Q +  N+
Sbjct: 36  VIGVGEFGEVCSGRL--KVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 92
Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETN 518
           + L G   + +  +++ E++ NG+L   + K  G  +    +++     G+ S +   ++
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT---VIQLVGMLRGIGSGMKYLSD 149
Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTC 576
           +  +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   
Sbjct: 150 MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 209
Query: 577 KLTDKSDVYSFGVVLVELLT 596
           K T  SDV+S+G+V+ E+++
Sbjct: 210 KFTSASDVWSYGIVMWEVMS 229

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 26/201 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            ++SKF+   K+             +   E+ +   +  
Sbjct: 20  LGKGKFGNVYLA--------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL G   +     L+ E+   GT++  + K      +R      E A  LSY HS+
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK 131
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL  N   K++DFG S   P           GTL YL PE ++  
Sbjct: 132 R---VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC---GTLDYLPPEMIEGR 185
Query: 577 KLTDKSDVYSFGVVLVELLTG 597
              +K D++S GV+  E L G
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVG 206

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 14  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 66
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 67  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 126
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+DE    +V+DFG +K V     
Sbjct: 127 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTW 183
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 184 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 144/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+  G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 1   GEAPNQALLRILKETEFKKIK-----VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 114
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 115 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 232 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 274
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 275 -KMARDPQRYL 284

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 144/311 (46%), Gaps = 37/311 (11%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+  G  G VYKG ++P+    + PVA+K+ +  
Sbjct: 8   GEAPNQALLRILKETEFKKIK-----VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 62
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 63  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 121
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+  + 
Sbjct: 122 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 178
Query: 555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
            + +    +  + ++  E +     T +SDV+S+GV + EL+T         P  E S  
Sbjct: 179 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 238
Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E    
Sbjct: 239 LEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS-- 281
Query: 674 LSLMSNGQYYL 684
             +  + Q YL
Sbjct: 282 -KMARDPQRYL 291

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 408 VIGCGGSGNVYKGFLPDRTP------VAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
           VIG G  G V  G L  + P      VA+K  K+ + D+ + D F++E  ++ Q +  N+
Sbjct: 21  VIGVGEFGEVCSGRL--KVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 77
Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETN 518
           + L G   + +  +++ E++ NG+L   + K  G  +    +++     G+ S +   ++
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT---VIQLVGMLRGIGSGMKYLSD 134
Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTC 576
           +  +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 194
Query: 577 KLTDKSDVYSFGVVLVELLT 596
           K T  SDV+S+G+V+ E+++
Sbjct: 195 KFTSASDVWSYGIVMWEVMS 214

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 408 VIGCGGSGNVYKGFL--PDRT--PVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           VIG G  G V  G L  P +   PVA+K  K  + ++ + D F+ E  ++ Q +  N++ 
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIH 87
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVP 520
           L G   +++  ++V E++ NG+L   + K  G  +    +++     G+ + +   +++ 
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFT---VIQLVGMLRGISAGMKYLSDMG 144
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTCKL 578
            +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   K 
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 579 TDKSDVYSFGVVLVELLT 596
           T  SDV+S+G+V+ E+++
Sbjct: 205 TSASDVWSYGIVMWEVVS 222

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 408 VIGCGGSGNVYKGFLPDRTP------VAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
           VIG G  G V  G L  + P      VA+K  K+ + D+ + D F++E  ++ Q +  N+
Sbjct: 15  VIGVGEFGEVCSGRL--KVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNI 71
Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETN 518
           + L G   + +  +++ E++ NG+L   + K  G  +    +++     G+ S +   ++
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT---VIQLVGMLRGIGSGMKYLSD 128
Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--YLDPEYLQTC 576
           +  +HRD+ + NIL++ N   KVSDFG S+++  D     T   G +   +  PE +   
Sbjct: 129 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 188
Query: 577 KLTDKSDVYSFGVVLVELLT 596
           K T  SDV+S+G+V+ E+++
Sbjct: 189 KFTSASDVWSYGIVMWEVMS 208

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ EF+  G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLR 104
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           E++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 105 EYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 161
Query: 545 GASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 162 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 221
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 222 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 278
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 279 RPSFRDLALRV 289

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 450 VVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           +++++N   +V+L     +T+  L L+ +F+  G LF  + K+   + E      AE A 
Sbjct: 80  ILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 138
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            L +LHS   + II+RD+K  NILLDE    K++DFG SK   ID  +      GT+ Y+
Sbjct: 139 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 194
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM-------NFLSSLK 621
            PE +     T  +D +SFGV++ E+LTG +       +E  ++ +        FLS   
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA 254
Query: 622 QNRLLEILDNRIVNDGNK 639
           Q+ LL +L  R  N  N+
Sbjct: 255 QS-LLRMLFKR--NPANR 269

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 450 VVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           +++++N   +V+L     +T+  L L+ +F+  G LF  + K+   + E      AE A 
Sbjct: 79  ILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 137
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            L +LHS   + II+RD+K  NILLDE    K++DFG SK   ID  +      GT+ Y+
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 193
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM-------NFLSSLK 621
            PE +     T  +D +SFGV++ E+LTG +       +E  ++ +        FLS   
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEA 253
Query: 622 QNRLLEILDNRIVNDGNK 639
           Q+ LL +L  R  N  N+
Sbjct: 254 QS-LLRMLFKR--NPANR 268

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 397 EIKTVTNNYADV---------IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFI-- 445
           ++  + NN AD          IG G  G V+KG   D     V   K +D  + ++ I  
Sbjct: 10  QVPGMQNNIADPEELFTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIED 67
Query: 446 --NELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRIT 503
              E+ V+ Q +   V +  G  L+     ++ E++G G+  + + + G     +   + 
Sbjct: 68  IQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL-RAGPFDEFQIATML 126
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            E    L YLHSE     IHRD+K+AN+LL E    K++DFG +  +    I+  T V G
Sbjct: 127 KEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-G 182
Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           T  ++ PE +Q      K+D++S G+  +EL  G+
Sbjct: 183 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G SG VY    +     VA+++     Q K +  INE++V+ +    N+V  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 468 ETQVPLLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
                 +V E++  G+L + + +    +G ++      +  E    L +LHS     +IH
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQ---VIH 139
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+KS NILL  + + K++DFG  +++ P  + ++  V  GT  ++ PE +       K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV--GTPYWMAPEVVTRKAYGPKV 197
Query: 583 DVYSFGVVLVELLTGKMALLSDKP 606
           D++S G++ +E++ G+   L++ P
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENP 221

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 35/218 (16%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           V+G G  G V K     D    A+KK +  ++ K+   ++E++++  +N + VVR     
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 467 LETQ-------------VPLLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLS 511
           LE +                +  E+  NGTL++ IH + NL+ +R    R+  +    LS
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALS 130
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV--PIDAIQ-----------NC 558
           Y+HS+    IIHRD+K  NI +DE+   K+ DFG +K V   +D ++           N 
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 559 TVVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVLVELL 595
           T   GT  Y+  E L  T    +K D+YS G++  E++
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 119/262 (45%), Gaps = 27/262 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD----QAKIDEFINELVVVLQINRRNVVRLLG 464
           IG G  G V+KG   D     V   K +D    + +I++   E+ V+ Q +   V +  G
Sbjct: 30  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
             L+     ++ E++G G+  + + + G L   +   I  E    L YLHSE     IHR
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK---IHR 143
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+K+AN+LL E+   K++DFG +  +    I+    V GT  ++ PE ++      K+D+
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDSKADI 202
Query: 585 YSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE 644
           +S G+  +EL  G       +P       M  L  + +N       N    +GN    K 
Sbjct: 203 WSLGITAIELARG-------EPPHSELHPMKVLFLIPKN-------NPPTLEGNYS--KP 246
Query: 645 VAKLAARCISVRGEERPTMKEV 666
           + +    C++     RPT KE+
Sbjct: 247 LKEFVEACLNKEPSFRPTAKEL 268

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G SG VY    +     VA+++     Q K +  INE++V+ +    N+V  L   L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 468 ETQVPLLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
                 +V E++  G+L + + +    +G ++      +  E    L +LHS     +IH
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQ---VIH 140
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+KS NILL  + + K++DFG  +++ P  + ++  V  GT  ++ PE +       K 
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV--GTPYWMAPEVVTRKAYGPKV 198
Query: 583 DVYSFGVVLVELLTGKMALLSDKP 606
           D++S G++ +E++ G+   L++ P
Sbjct: 199 DIWSLGIMAIEMIEGEPPYLNENP 222

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 144/313 (46%), Gaps = 41/313 (13%)
Query: 384 GQSSEKA--KIFTEEEIKTVTNNYADVIGCGGSGNVYKG-FLPD----RTPVAVKKSKFV 436
           G++  +A  +I  E E K +      V+G G  G VYKG ++P+    + PVA+ + +  
Sbjct: 35  GEAPNQALLRILKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREA 89
Query: 437 DQAKID-EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNL 494
              K + E ++E  V+  ++  +V RLLG CL + V L+  + +  G L +++ + K N+
Sbjct: 90  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 148
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
             +  L    + A  ++YL       ++HRD+ + N+L+      K++DFG +KL  + A
Sbjct: 149 GSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL--LGA 203
Query: 555 IQNCTVVQG---TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS 611
            +     +G    + ++  E +     T +SDV+S+GV + EL+T         P  E S
Sbjct: 204 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263
Query: 612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
             +     L Q  +  I               +V  +  +C  +  + RP  +E+ +E  
Sbjct: 264 SILEKGERLPQPPICTI---------------DVYMIMVKCWMIDADSRPKFRELIIEFS 308
Query: 672 GRLSLMSNGQYYL 684
               +  + Q YL
Sbjct: 309 ---KMARDPQRYL 318

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 408 VIGCGGSGNVYKGFL--PDRTP--VAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           VIG G  G V  G L  P +    VA+K  KS + ++ + D F++E  ++ Q +  NV+ 
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNVIH 98
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVP 520
           L G   ++   +++ EF+ NG+L   + +  G  +  + + +    A  + YL    ++ 
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 155
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG-----YLDPEYLQT 575
            +HRD+ + NIL++ N   KVSDFG S+ +  D   + T      G     +  PE +Q 
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLE-DDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 576 CKLTDKSDVYSFGVVLVELLT 596
            K T  SDV+S+G+V+ E+++
Sbjct: 215 RKFTSASDVWSYGIVMWEVMS 235

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADVIGCGG--SGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V+      +GN Y   + D       K K 
Sbjct: 27  LKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    KV+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 32/244 (13%)
Query: 380 SKLHGQSSEKAKIFTEEEIKTVTNNYADVI-----GCGGSGNVY----KGFLP--DRTPV 428
           S L G   E  + F++  +  +     D++     G G  G V+       LP  D+  V
Sbjct: 17  SGLQGHIIENPQYFSDACVHHIKRR--DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLV 74
Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL--FE 486
           AVK  K   ++   +F  E  ++  +  +++VR  G C E +  L+V+E++ +G L  F 
Sbjct: 75  AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134
Query: 487 HIH-------------KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
             H               G L   + L + ++ A  + YL     +  +HRD+ + N L+
Sbjct: 135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLV 191
Query: 534 DENCTPKVSDFGASK-LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLV 592
            +    K+ DFG S+ +   D  +        + ++ PE +   K T +SDV+SFGVVL 
Sbjct: 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 251
Query: 593 ELLT 596
           E+ T
Sbjct: 252 EIFT 255

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K  + +  + F+ E  V+ ++    +V+L     E
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR----ITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G+L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 252 EPI-YIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG  +L+  +        +  + +  PE     + T KSDV
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 366 WSFGILLTELTT 377

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ +I    +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR----ITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G+L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 85  EPI-YIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 199 WSFGILLTELTT 210

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 118/262 (45%), Gaps = 27/262 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFI----NELVVVLQINRRNVVRLLG 464
           IG G  G V+KG   D     V   K +D  + ++ I     E+ V+ Q +   V +  G
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
             L+     ++ E++G G+  + + + G L   +   I  E    L YLHSE     IHR
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK---IHR 128
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+K+AN+LL E+   K++DFG +  +    I+    V GT  ++ PE ++      K+D+
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDSKADI 187
Query: 585 YSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE 644
           +S G+  +EL  G       +P       M  L  + +N       N    +GN    K 
Sbjct: 188 WSLGITAIELARG-------EPPHSELHPMKVLFLIPKN-------NPPTLEGNYS--KP 231
Query: 645 VAKLAARCISVRGEERPTMKEV 666
           + +    C++     RPT KE+
Sbjct: 232 LKEFVEACLNKEPSFRPTAKEL 253

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 28  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 80
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 81  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 140
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 141 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 197
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 198 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G SG VY    +     VA+++     Q K +  INE++V+ +    N+V  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 468 ETQVPLLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
                 +V E++  G+L + + +    +G ++      +  E    L +LHS     +IH
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQ---VIH 139
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+KS NILL  + + K++DFG  +++ P  + ++  V  GT  ++ PE +       K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV--GTPYWMAPEVVTRKAYGPKV 197
Query: 583 DVYSFGVVLVELLTGKMALLSDKP 606
           D++S G++ +E++ G+   L++ P
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENP 221

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 21/195 (10%)
Query: 409 IGCGGSGNV----YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           IG G  G+V    Y+G       VAVK  K  + A    F+ E  V+ Q+   N+V+LLG
Sbjct: 201 IGKGEFGDVMLGDYRG-----NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPI 521
             +E +  L +V E++  G+L +++  +G   L  +  L+ + +    + YL        
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 310
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           +HRD+ + N+L+ E+   KVSDFG +K    +A       +  + +  PE L+  K + K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFG++L E+ +
Sbjct: 367 SDVWSFGILLWEIYS 381

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 21/195 (10%)
Query: 409 IGCGGSGNV----YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           IG G  G+V    Y+G       VAVK  K  + A    F+ E  V+ Q+   N+V+LLG
Sbjct: 29  IGKGEFGDVMLGDYRG-----NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPI 521
             +E +  L +V E++  G+L +++  +G   L  +  L+ + +    + YL        
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 138
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           +HRD+ + N+L+ E+   KVSDFG +K    +A       +  + +  PE L+  K + K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFG++L E+ +
Sbjct: 195 SDVWSFGILLWEIYS 209

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 48  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 100
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 101 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 160
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 161 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATW 217
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 218 TLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---- 192
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                + GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 193 GRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G SG VY    +     VA+++     Q K +  INE++V+ +    N+V  L   L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 468 ETQVPLLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
                 +V E++  G+L + + +    +G ++      +  E    L +LHS     +IH
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQ---VIH 140
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           R++KS NILL  + + K++DFG    +  +  +  T+V GT  ++ PE +       K D
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 199
Query: 584 VYSFGVVLVELLTGKMALLSDKP 606
           ++S G++ +E++ G+   L++ P
Sbjct: 200 IWSLGIMAIEMIEGEPPYLNENP 222

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---- 192
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                + GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 193 GRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 406 ADV-IGCGGSGNVYKGFLPDRTP---VAVKKSKF-VDQAKIDEFINELVVVLQINRRNVV 460
           AD+ +GCG  G+V +G    R     VA+K  K   ++A  +E + E  ++ Q++   +V
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEH-IHKKGNLSWERRLRITAETAGVLSYLHSETNV 519
           RL+G C + +  +LV E  G G L +  + K+  +       +  + +  + YL  +   
Sbjct: 74  RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCK 577
             +HRD+ + N+LL      K+SDFG SK +  D         G   L +  PE +   K
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 578 LTDKSDVYSFGVVLVELLT 596
            + +SDV+S+GV + E L+
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 100/193 (51%), Gaps = 21/193 (10%)
Query: 409 IGCGGSGNV----YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           IG G  G+V    Y+G       VAVK  K  + A    F+ E  V+ Q+   N+V+LLG
Sbjct: 14  IGKGEFGDVMLGDYRG-----NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPI 521
             +E +  L +V E++  G+L +++  +G   L  +  L+ + +    + YL        
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 123
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           +HRD+ + N+L+ E+   KVSDFG +K    +A       +  + +  PE L+  K + K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 582 SDVYSFGVVLVEL 594
           SDV+SFG++L E+
Sbjct: 180 SDVWSFGILLWEI 192

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ ++    +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR----ITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G+L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 85  EPI-YIVIEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 199 WSFGILLTELTT 210

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ ++    +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR----ITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G+L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 85  EPI-YIVIEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 199 WSFGILLTELTT 210

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  +
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFA 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ ++    +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR----ITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G+L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 85  EPI-YIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 199 WSFGILLTELTT 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K       + F+ E  V+ ++    +V+L     E
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR----ITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G+L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 76  EPI-YIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 190 WSFGILLTELTT 201

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K       + F+ E  V+ ++    +V+L     E
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR----ITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G+L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 74  EPI-YIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 188 WSFGILLTELTT 199

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ ++  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 409 IGCGGSGNVY----KGFLP--DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+       LP  D+  VAVK  K   ++   +F  E  ++  +  +++VR 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 463 LGCCLETQVPLLVYEFVGNGTL--FEHIH-------------KKGNLSWERRLRITAETA 507
            G C E +  L+V+E++ +G L  F   H               G L   + L + ++ A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 508 GVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK-LVPIDAIQNCTVVQGTLG 566
             + YL     +  +HRD+ + N L+ +    K+ DFG S+ +   D  +        + 
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           ++ PE +   K T +SDV+SFGVVL E+ T
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 7/190 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K       + F+ E  V+ ++    +V+L     E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
             +  +V E++  G+L + +  +    L   + + + A+ A  ++Y+     +  +HRD+
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           ++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 587 FGVVLVELLT 596
           FG++L EL T
Sbjct: 450 FGILLTELTT 459

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADVIGCGG--SGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V+      +GN Y   + D       K K 
Sbjct: 27  LKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E++  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    KV+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 99/193 (51%), Gaps = 21/193 (10%)
Query: 409 IGCGGSGNV----YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           IG G  G+V    Y+G       VAVK  K  + A    F+ E  V+ Q+   N+V+LLG
Sbjct: 20  IGKGEFGDVMLGDYRG-----NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPI 521
             +E +  L +V E++  G+L +++  +G   L  +  L+ + +    + YL        
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 129
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           +HRD+ + N+L+ E+   KVSDFG +K    +A       +  + +  PE L+    + K
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFSTK 185
Query: 582 SDVYSFGVVLVEL 594
           SDV+SFG++L E+
Sbjct: 186 SDVWSFGILLWEI 198

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+++D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADVIGCGG--SGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V+      +GN Y   + D       K K 
Sbjct: 27  LKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E++  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    KV+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 109 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 165
Query: 545 GASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 166 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 225
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 226 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 282
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 283 RPSFRDLALRV 293

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 193 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 7/190 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K       + F+ E  V+ ++    +V+L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
             +  +V E++  G+L + +  +    L   + + + A+ A  ++Y+     +  +HRD+
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           ++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 587 FGVVLVELLT 596
           FG++L EL T
Sbjct: 367 FGILLTELTT 376

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 409 IGCGGSGNVY----KGFLP--DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+       LP  D+  VAVK  K   ++   +F  E  ++  +  +++VR 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 463 LGCCLETQVPLLVYEFVGNGTL--FEHIH-------------KKGNLSWERRLRITAETA 507
            G C E +  L+V+E++ +G L  F   H               G L   + L + ++ A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 508 GVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK-LVPIDAIQNCTVVQGTLG 566
             + YL     +  +HRD+ + N L+ +    K+ DFG S+ +   D  +        + 
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           ++ PE +   K T +SDV+SFGVVL E+ T
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 133 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 189
Query: 545 GASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 190 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 250 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 306
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 307 RPSFRDLALRV 317

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 158
Query: 545 GASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 159 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 219 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 275
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 276 RPSFRDLALRV 286

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 7/190 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K       + F+ E  V+ ++    +V+L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
             +  +V E++  G+L + +  +    L   + + + A+ A  ++Y+     +  +HRD+
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           ++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 587 FGVVLVELLT 596
           FG++L EL T
Sbjct: 367 FGILLTELTT 376

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G   
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 405 YADVIGCGGSGNVYKGFLPD---RTPVAVKKSK-FVDQAKIDEFINELVVVLQINRR-NV 459
           + DVIG G  G V K  +     R   A+K+ K +  +    +F  EL V+ ++    N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS---YLHSE 516
           + LLG C       L  E+  +G L + + K   L  +    I   TA  LS    LH  
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 517 TNVP----------IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
            +V            IHRD+ + NIL+ EN   K++DFG S+   +        V+ T+G
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTMG 201
Query: 567 YLDPEYLQTCKL-----TDKSDVYSFGVVLVELLT 596
            L   ++    L     T  SDV+S+GV+L E+++
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 405 YADVIGCGGSGNVYKGFLPD---RTPVAVKKSK-FVDQAKIDEFINELVVVLQINRR-NV 459
           + DVIG G  G V K  +     R   A+K+ K +  +    +F  EL V+ ++    N+
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS---YLHSE 516
           + LLG C       L  E+  +G L + + K   L  +    I   TA  LS    LH  
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 517 TNVP----------IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
            +V            IHRD+ + NIL+ EN   K++DFG S+   +        V+ T+G
Sbjct: 139 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTMG 191
Query: 567 YLDPEYLQTCKL-----TDKSDVYSFGVVLVELLT 596
            L   ++    L     T  SDV+S+GV+L E+++
Sbjct: 192 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 107 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 163
Query: 545 GASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 164 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 223
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 224 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 280
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 281 RPSFRDLALRV 291

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ +R   +  L    +T   L  V E+   G LF H+ ++   S +R     AE    
Sbjct: 63  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 122
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHSE NV  ++RD+K  N++LD++   K++DFG  K    + I++   ++   GT  
Sbjct: 123 LDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFCGTPE 176
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           YL PE L+        D +  GVV+ E++ G++   +   E+
Sbjct: 177 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 105 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 161
Query: 545 GASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 162 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 221
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 222 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 278
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 279 RPSFRDLALRV 289

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V  +    +GN Y   + D       K K 
Sbjct: 20  LKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-------KQKV 72
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 73  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS 132
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 133 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 189
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 190 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V  +    +GN Y   + D       K K 
Sbjct: 28  LKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-------KQKV 80
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 81  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS 140
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 141 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 197
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 198 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G   
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V  +    +GN Y   + D       K K 
Sbjct: 28  LKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-------KQKV 80
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 81  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS 140
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 141 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 197
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 198 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V  +    +GN Y   + D       K K 
Sbjct: 28  LKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-------KQKV 80
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 81  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS 140
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 141 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 197
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 198 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G   
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 108 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 164
Query: 545 GASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 165 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 224
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 225 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 281
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 282 RPSFRDLALRV 292

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 409 IGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G V KG+           V + K++  D A  DE + E  V+ Q++   +VR++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G C E +  +LV E    G L +++ +  ++  +  + +  + +  + YL  E+N   +H
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FVH 134
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D         G   + +  PE +   K + K
Sbjct: 135 RDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSK 194
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFGV++ E  +
Sbjct: 195 SDVWSFGVLMWEAFS 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ +R   +  L    +T   L  V E+   G LF H+ ++   S +R     AE    
Sbjct: 62  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 121
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHSE NV  ++RD+K  N++LD++   K++DFG  K    + I++   ++   GT  
Sbjct: 122 LDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFCGTPE 175
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           YL PE L+        D +  GVV+ E++ G++   +   E+
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 100 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 156
Query: 545 GASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 157 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 216
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 217 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 273
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 274 RPSFRDLALRV 284

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V  +    +GN Y   + D       K K 
Sbjct: 48  LKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-------KQKV 100
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 101 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS 160
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 161 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 217
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 218 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 120 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 176
Query: 545 GASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 177 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 236
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 237 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 293
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 294 RPSFRDLALRV 304

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ +R   +  L    +T   L  V E+   G LF H+ ++   S +R     AE    
Sbjct: 61  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 120
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHSE NV  ++RD+K  N++LD++   K++DFG  K    + I++   ++   GT  
Sbjct: 121 LDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKXFCGTPE 174
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           YL PE L+        D +  GVV+ E++ G++   +   E+
Sbjct: 175 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 216

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 147 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 199
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 234

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ ++    +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR----ITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G+L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 85  EPI-YIVCEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 199 WSFGILLTELTT 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 98/190 (51%), Gaps = 7/190 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ ++    +V+L     E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
             +  +V E++  G+L + +  +    L   + + ++A+ A  ++Y+     +  +HRD+
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           ++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 587 FGVVLVELLT 596
           FG++L EL T
Sbjct: 198 FGILLTELTT 207

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 158
Query: 545 GASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 159 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 219 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 275
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 276 RPSFRDLALRV 286

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 409 IGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G V KG+           V + K++  D A  DE + E  V+ Q++   +VR++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G C E +  +LV E    G L +++ +  ++  +  + +  + +  + YL  E+N   +H
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FVH 150
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D         G   + +  PE +   K + K
Sbjct: 151 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 210
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFGV++ E  +
Sbjct: 211 SDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 409 IGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G V KG+           V + K++  D A  DE + E  V+ Q++   +VR++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G C E +  +LV E    G L +++ +  ++  +  + +  + +  + YL  E+N   +H
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FVH 150
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D         G   + +  PE +   K + K
Sbjct: 151 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 210
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFGV++ E  +
Sbjct: 211 SDVWSFGVLMWEAFS 225

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 22  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 74
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G   
Sbjct: 75  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 134
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 135 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 191
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 192 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 409 IGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G V KG+           V + K++  D A  DE + E  V+ Q++   +VR++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G C E +  +LV E    G L +++ +  ++  +  + +  + +  + YL  E+N   +H
Sbjct: 73  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FVH 128
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D         G   + +  PE +   K + K
Sbjct: 129 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 188
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFGV++ E  +
Sbjct: 189 SDVWSFGVLMWEAFS 203

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 122/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 158
Query: 545 GASKLVPIDA--IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D    +     +  + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 219 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 275
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 276 RPSFRDLALRV 286

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 98/190 (51%), Gaps = 7/190 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ ++    +V+L     E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
             +  +V E++  G+L + +  +    L   + + ++A+ A  ++Y+     +  +HRD+
Sbjct: 82  EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRDL 137
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           ++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 587 FGVVLVELLT 596
           FG++L EL T
Sbjct: 198 FGILLTELTT 207

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 409 IGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G V KG+           V + K++  D A  DE + E  V+ Q++   +VR++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G C E +  +LV E    G L +++ +  ++  +  + +  + +  + YL  E+N   +H
Sbjct: 93  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FVH 148
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D         G   + +  PE +   K + K
Sbjct: 149 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 208
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFGV++ E  +
Sbjct: 209 SDVWSFGVLMWEAFS 223

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 120 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 176
Query: 545 GASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 177 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 236
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 237 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 293
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 294 RPSFRDLALRV 304

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 7/190 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K       + F+ E  V+ ++    +V+L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
             +  +V E++  G+L + +  +    L   + + + A+ A  ++Y+     +  +HRD+
Sbjct: 251 EPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           ++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 587 FGVVLVELLT 596
           FG++L EL T
Sbjct: 367 FGILLTELTT 376

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 48  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 100
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G   
Sbjct: 101 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX 160
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 161 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 217
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 218 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 409 IGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G V KG+           V + K++  D A  DE + E  V+ Q++   +VR++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G C E +  +LV E    G L +++ +  ++  +  + +  + +  + YL  E+N   +H
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FVH 134
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D         G   + +  PE +   K + K
Sbjct: 135 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 194
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFGV++ E  +
Sbjct: 195 SDVWSFGVLMWEAFS 209

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 101 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 157
Query: 545 GASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 158 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 217
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 218 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 274
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 275 RPSFRDLALRV 285

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ ++    +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR----ITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 85  EPI-YIVMEYMSKGCLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 199 WSFGILLTELTT 210

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 97/190 (51%), Gaps = 7/190 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ ++    +V+L     E
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
             +  +V E++  G+L + +  +    L   + + + A+ A  ++Y+     +  +HRD+
Sbjct: 75  EPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 130
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           ++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV+S
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 190
Query: 587 FGVVLVELLT 596
           FG++L EL T
Sbjct: 191 FGILLTELTT 200

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 106 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 162
Query: 545 GASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 163 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 222
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 223 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 279
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 280 RPSFRDLALRV 290

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADVIGCGG--SGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V+      +GN Y   + D       K K 
Sbjct: 27  LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 193 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADVIGCGG--SGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V+      +GN Y   + D       K K 
Sbjct: 27  LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 193 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 11/192 (5%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K       + F+ E  V+ ++    +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR----ITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G+L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 85  EPI-YIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+ +ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 199 WSFGILLTELTT 210

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ +R   +  L    +T   L  V E+   G LF H+ ++   S +R     AE    
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 260
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHSE NV  ++RD+K  N++LD++   K++DFG  K    + I++   ++   GT  
Sbjct: 261 LDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFCGTPE 314
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           YL PE L+        D +  GVV+ E++ G++   +   E+
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 136
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 193
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 194 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADVIGCGG--SGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V+      +GN Y   + D       K K 
Sbjct: 27  LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 409 IGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G V KG+           V + K++  D A  DE + E  V+ Q++   +VR++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G C E +  +LV E    G L +++ +  ++  +  + +  + +  + YL  E+N   +H
Sbjct: 437 GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FVH 492
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDA--IQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D    +  T  +  + +  PE +   K + K
Sbjct: 493 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 552
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFGV++ E  +
Sbjct: 553 SDVWSFGVLMWEAFS 567

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 409 IGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G V KG+           V + K++  D A  DE + E  V+ Q++   +VR++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G C E +  +LV E    G L +++ +  ++  +  + +  + +  + YL  E+N   +H
Sbjct: 85  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FVH 140
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D         G   + +  PE +   K + K
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 200
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFGV++ E  +
Sbjct: 201 SDVWSFGVLMWEAFS 215

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 409 IGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G V KG+           V + K++  D A  DE + E  V+ Q++   +VR++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G C E +  +LV E    G L +++ +  ++  +  + +  + +  + YL  E+N   +H
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FVH 130
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D         G   + +  PE +   K + K
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFGV++ E  +
Sbjct: 191 SDVWSFGVLMWEAFS 205

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 409 IGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +G G  G V KG+           V + K++  D A  DE + E  V+ Q++   +VR++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G C E +  +LV E    G L +++ +  ++  +  + +  + +  + YL  E+N   +H
Sbjct: 438 GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FVH 493
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDA--IQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D    +  T  +  + +  PE +   K + K
Sbjct: 494 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 553
Query: 582 SDVYSFGVVLVELLT 596
           SDV+SFGV++ E  +
Sbjct: 554 SDVWSFGVLMWEAFS 568

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ +R   +  L    +T   L  V E+   G LF H+ ++   S +R     AE    
Sbjct: 204 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA 263
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHSE NV  ++RD+K  N++LD++   K++DFG  K    + I++   ++   GT  
Sbjct: 264 LDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFCGTPE 317
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           YL PE L+        D +  GVV+ E++ G++   +   E+
Sbjct: 318 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 359

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 138 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 191 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 225

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 193 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADVIGCGG--SGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V+      +GN Y   + D       K K 
Sbjct: 13  LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-------KQKV 65
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 66  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS 125
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 126 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 182
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 183 TLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL P  + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 147 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 199
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 136
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 193
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 194 GRTWTLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ ++    +V+L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR----ITAETAGVLSYLHSETNVPIIHR 524
             +  +V E++  G L + +  KG +    RL     + A+ A  ++Y+     +  +HR
Sbjct: 85  EPI-YIVTEYMSKGCLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 199 WSFGILLTELTT 210

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 97/190 (51%), Gaps = 7/190 (3%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  V+ ++    +V+L     E
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
             +  +V E++  G+L + +  +    L   + + + A+ A  ++Y+     +  +HRD+
Sbjct: 78  EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 133
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           ++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV+S
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 193
Query: 587 FGVVLVELLT 596
           FG++L EL T
Sbjct: 194 FGILLTELTT 203

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V  +    +GN Y   + D       K K 
Sbjct: 28  LKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-------KQKV 80
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+   G +F H+ + G  S
Sbjct: 81  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS 140
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+++D+    KV+DFG +K V     
Sbjct: 141 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW 197
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 198 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 144 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 196
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 197 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 231

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 146 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 198
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 233

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 140 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 192
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 227

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 153 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 205
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 240

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 143 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 195
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 196 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 230

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 146 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 198
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 233

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 175 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 227
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 262

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 153 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 205
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 240

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 35/218 (16%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           V+G G  G V K     D    A+KK +  ++ K+   ++E++++  +N + VVR     
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 467 LETQ-------------VPLLVYEFVGNGTLFEHIHKKGNLSWER--RLRITAETAGVLS 511
           LE +                +  E+  N TL++ IH + NL+ +R    R+  +    LS
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSE-NLNQQRDEYWRLFRQILEALS 130
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV--PIDAIQ-----------NC 558
           Y+HS+    IIHRD+K  NI +DE+   K+ DFG +K V   +D ++           N 
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 559 TVVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVLVELL 595
           T   GT  Y+  E L  T    +K D+YS G++  E++
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 406 ADV-IGCGGSGNVYKGFLPDRTP---VAVKKSKF-VDQAKIDEFINELVVVLQINRRNVV 460
           AD+ +GCG  G+V +G    R     VA+K  K   ++A  +E + E  ++ Q++   +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEH-IHKKGNLSWERRLRITAETAGVLSYLHSETNV 519
           RL+G C + +  +LV E  G G L +  + K+  +       +  + +  + YL  +   
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN-- 456
Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCK 577
             +HR++ + N+LL      K+SDFG SK +  D         G   L +  PE +   K
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 578 LTDKSDVYSFGVVLVELLT 596
            + +SDV+S+GV + E L+
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   +V+L     +     +V E+   G +F H+ + 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 135
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+++D+    KV+DFG +K V 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK 192
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 193 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 408 VIGCGGSGNVYKGFL--PDRTP--VAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           VIG G  G V  G L  P +    VA+K  KS + ++ + D F++E  ++ Q +  NV+ 
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNVIH 72
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVP 520
           L G   ++   +++ EF+ NG+L   + +  G  +  + + +    A  + YL    ++ 
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG-----YLDPEYLQT 575
            +HR + + NIL++ N   KVSDFG S+ +  D   + T      G     +  PE +Q 
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLE-DDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 576 CKLTDKSDVYSFGVVLVELLT 596
            K T  SDV+S+G+V+ E+++
Sbjct: 189 RKFTSASDVWSYGIVMWEVMS 209

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 121/263 (46%), Gaps = 28/263 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+       T VAVK  K      ++ F+ E  V+  +    +V+L      
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 252
Query: 469 TQVPL-LVYEFVGNGTLFEHIH--KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
           T+ P+ ++ EF+  G+L + +   +       + +  +A+ A  ++++        IHRD
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 309
Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           +++ANIL+  +   K++DFG ++++  +        +  + +  PE +     T KSDV+
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 586 SFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           SFG++L+E++T G++       PE  R+L   +     +N                   +
Sbjct: 370 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN-----------------CPE 412
Query: 644 EVAKLAARCISVRGEERPTMKEV 666
           E+  +  RC   R EERPT + +
Sbjct: 413 ELYNIMMRCWKNRPEERPTFEYI 435

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   +V+L     +     +V E+   G +F H+ + 
Sbjct: 76  KQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 135
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+++D+    KV+DFG +K V 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK 192
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 193 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 121/268 (45%), Gaps = 29/268 (10%)
Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVD----QAKIDEFINELVVVLQINRRNVVRLL 463
           IG G    VY+   L D  PVA+KK +  D    +A+ D  I E+ ++ Q+N  NV++  
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHPNVIKYY 98
Query: 464 GCCLETQVPLLVYEFVGNGTL---FEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNV 519
              +E     +V E    G L    +H  K+  L  ER + +   +    L ++HS    
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
            ++HRD+K AN+ +      K+ D G  +          ++V GT  Y+ PE +      
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 214
Query: 580 DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD-NRIVNDGN 638
            KSD++S G +L E+   +     DK        MN  S  K+   +E  D   + +D  
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYGDK--------MNLYSLCKK---IEQCDYPPLPSDHY 263
Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEV 666
            ++L+++  +   CI+   E+RP +  V
Sbjct: 264 SEELRQLVNM---CINPDPEKRPDVTYV 288

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 96/194 (49%), Gaps = 13/194 (6%)
Query: 450 VVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           ++  +N   VV+L     +T+  L L+ +F+  G LF  + K+   + E      AE A 
Sbjct: 83  ILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL 141
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            L +LHS   + II+RD+K  NILLDE    K++DFG SK   ID  +      GT+ Y+
Sbjct: 142 GLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEA-IDHEKKAYSFCGTVEYM 197
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM-------NFLSSLK 621
            PE +     +  +D +S+GV++ E+LTG +       +E  +L +        FLS+  
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEA 257
Query: 622 QNRLLEILDNRIVN 635
           Q+ L  +      N
Sbjct: 258 QSLLRALFKRNPAN 271

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 405 YADVIGCGGSGNVYKGFLPD---RTPVAVKKSK-FVDQAKIDEFINELVVVLQINRR-NV 459
           + DVIG G  G V K  +     R   A+K+ K +  +    +F  EL V+ ++    N+
Sbjct: 26  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS---YLHSE 516
           + LLG C       L  E+  +G L + + K   L  +    I   TA  LS    LH  
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 517 TNVP----------IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
            +V            IHR++ + NIL+ EN   K++DFG S+   +        V+ T+G
Sbjct: 146 ADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTMG 198
Query: 567 YLDPEYLQTCKL-----TDKSDVYSFGVVLVELLT 596
            L   ++    L     T  SDV+S+GV+L E+++
Sbjct: 199 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V  +    +GN Y   + D       K K 
Sbjct: 20  LKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILD-------KQKV 72
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G   
Sbjct: 73  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX 132
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 133 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 189
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 190 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  +   +N   +V+L     +     +V E+   G +F H+ + 
Sbjct: 77  KQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRI 136
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+L+D+    KV+DFG +K V 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK 193
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 194 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           L K    S   A++   + IKT+ T ++  V  +    SGN Y   + D       K K 
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G  S
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT   L PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 83/169 (49%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L  C  + +       +  NG L ++I 
Sbjct: 70  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIR 129
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 130 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 186
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 187 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 140/304 (46%), Gaps = 40/304 (13%)
Query: 408 VIGCGGSGNVYKGFLPDR----TPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           ++G G  G+V +  L         VAVK  K+  +  + I+EF+ E   + + +  +V +
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 462 LLGCCLETQ------VPLLVYEFVGNGTLFEHI------HKKGNLSWERRLRITAETAGV 509
           L+G  L ++      +P+++  F+ +G L   +          NL  +  +R   + A  
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYL 568
           + YL S      IHRD+ + N +L E+ T  V+DFG S K+   D  +     +  + +L
Sbjct: 150 MEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI 628
             E L     T  SDV++FGV + E++T      +     E +   N+L  +  NRL + 
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI---ENAEIYNYL--IGGNRLKQ- 260
Query: 629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ---GRLSLMSNGQYYLR 685
                      + ++EV  L  +C S   ++RP+   + +EL+   G LS++S  Q  L 
Sbjct: 261 ---------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY 311
Query: 686 DNVE 689
            N+E
Sbjct: 312 INIE 315

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADVIGCGG--SGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V+      +GN Y   + D       K K 
Sbjct: 27  LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G   
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADVIGCGG--SGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V+      +GN Y   + D       K K 
Sbjct: 27  LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-------KQKV 79
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G   
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX 139
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 197 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 17/187 (9%)
Query: 424 DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT 483
           D+  VAVK  K        +F  E  ++  +   ++V+  G C+E    ++V+E++ +G 
Sbjct: 42  DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 101
Query: 484 LFEHIHKKG-------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L + +   G              L+  + L I  + A  + YL S+     +HRD+ + N
Sbjct: 102 LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRN 158
Query: 531 ILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGV 589
            L+ EN   K+ DFG S+ V   D  +        + ++ PE +   K T +SDV+S GV
Sbjct: 159 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 218
Query: 590 VLVELLT 596
           VL E+ T
Sbjct: 219 VLWEIFT 225

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 121/251 (48%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 486 EHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++ K K  +   + L+ T++    + YL ++     IHR++ + NIL++     K+ DF
Sbjct: 103 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRNLATRNILVENENRVKIGDF 159
Query: 545 GASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 160 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 219
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 220 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 276
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 277 RPSFRDLALRV 287

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 17/231 (7%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKTV-TNNYADVIGCGG--SGNVYKGFLPDRTPVAVKKSKF 435
           L K    +   A +   E IKT+ T ++  V+      +GN Y   + D       K K 
Sbjct: 28  LKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILD-------KQKV 80
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           V   +I+  +NE  ++  +N   +V+L     +     +V E+V  G +F H+ + G   
Sbjct: 81  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX 140
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
                   A+      YLHS   + +I+RD+K  N+L+D+    +V+DFG +K V     
Sbjct: 141 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 197
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 198 XLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 35/247 (14%)
Query: 390 AKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPD---RTPVAVKKSKFVDQA---KIDE 443
           A++F +++ + + ++  + IG G  G VY  F  D      VA+KK  +  +    K  +
Sbjct: 44  AELFFKDDPEKLFSDLRE-IGHGSFGAVY--FARDVRNSEVVAIKKMSYSGKQSNEKWQD 100
Query: 444 FINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF-VGNGTLFEHIHKKGNLSWERRLRI 502
            I E+  + ++   N ++  GC L      LV E+ +G+ +    +HKK      + + I
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEI 156
Query: 503 TAETAGVL---SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT 559
            A T G L   +YLHS     +IHRDVK+ NILL E    K+ DFG++ ++   A  N  
Sbjct: 157 AAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXF 210
Query: 560 VVQGTLGYLDPEYLQTC---KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF 616
           V  GT  ++ PE +      +   K DV+S G+  +EL   K  L +         AM+ 
Sbjct: 211 V--GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSA 261
Query: 617 LSSLKQN 623
           L  + QN
Sbjct: 262 LYHIAQN 268

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 121/263 (46%), Gaps = 28/263 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+       T VAVK  K      ++ F+ E  V+  +    +V+L      
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 79
Query: 469 TQVPL-LVYEFVGNGTLFEHIH--KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
           T+ P+ ++ EF+  G+L + +   +       + +  +A+ A  ++++        IHRD
Sbjct: 80  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 136
Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           +++ANIL+  +   K++DFG ++++  +        +  + +  PE +     T KSDV+
Sbjct: 137 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 586 SFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           SFG++L+E++T G++       PE  R+L   +     +N                   +
Sbjct: 197 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN-----------------CPE 239
Query: 644 EVAKLAARCISVRGEERPTMKEV 666
           E+  +  RC   R EERPT + +
Sbjct: 240 ELYNIMMRCWKNRPEERPTFEYI 262

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 409 IGCGGSGNVYK------GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+K      G +  R  + ++    +  A  ++ I EL V+ + N   +V  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G         +  E +  G+L + + K G +  +   +++      L+YL  +    I+
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 127
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRDVK +NIL++     K+ DFG S  + ID++ N  V  GT  Y+ PE LQ    + +S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQGTHYSVQS 184
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF 616
           D++S G+ LVE+  G+  +    P + + L + F
Sbjct: 185 DIWSMGLSLVEMAVGRYPI---PPPDAKELELMF 215

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVY----KGFLPDR--TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY    KG + D   T VA+K  ++     +  EF+NE  V+ + N  +VVR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L++ E +  G L  ++                S  + +++  E A  ++
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL++      +HRD+ + N  + E+ T K+ DFG ++    D  +     +G  G     
Sbjct: 140 YLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 192
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SDV+SFGVVL E+ T     L+++P
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQP 227

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   +V+L     +     +V E+   G +F H+ + 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 135
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+++D+    +V+DFG +K V 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK 192
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 193 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 409 IGCGGSGNVYK------GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+K      G +  R  + ++    +  A  ++ I EL V+ + N   +V  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G         +  E +  G+L + + K G +  +   +++      L+YL  +    I+
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 127
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRDVK +NIL++     K+ DFG S  + ID++ N  V  GT  Y+ PE LQ    + +S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQGTHYSVQS 184
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF 616
           D++S G+ LVE+  G+  +    P + + L + F
Sbjct: 185 DIWSMGLSLVEMAVGRYPI---PPPDAKELELMF 215

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 118/245 (48%), Gaps = 31/245 (12%)
Query: 390 AKIFTEEEIKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQA---KIDEFI 445
           A++F +++ + + ++  + IG G  G VY    + +   VA+KK  +  +    K  + I
Sbjct: 5   AELFFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 63
Query: 446 NELVVVLQINRRNVVRLLGCCLETQVPLLVYEF-VGNGTLFEHIHKKGNLSWERRLRITA 504
            E+  + ++   N ++  GC L      LV E+ +G+ +    +HKK      + + I A
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPL----QEVEIAA 119
Query: 505 ETAGVL---SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
            T G L   +YLHS     +IHRDVK+ NILL E    K+ DFG++ ++   A  N  V 
Sbjct: 120 VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFV- 172
Query: 562 QGTLGYLDPEYLQTC---KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
            GT  ++ PE +      +   K DV+S G+  +EL   K  L +         AM+ L 
Sbjct: 173 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALY 224
Query: 619 SLKQN 623
            + QN
Sbjct: 225 HIAQN 229

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 135/298 (45%), Gaps = 37/298 (12%)
Query: 392 IFTEEEIKTVTNNYADVIGCGGSGNV---YKGFLPDRTP--VAVKKSKFVDQAKIDEFIN 446
           IF E  +K ++      +G G  G+V       L D T   VAVK+ +     +  +F  
Sbjct: 6   IFEERHLKYISQ-----LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 447 ELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           E+ ++  ++   +V+  G       Q   LV E++ +G L + + + +  L   R L  +
Sbjct: 61  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 120
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV-- 561
           ++    + YL S      +HRD+ + NIL++     K++DFG +KL+P+D  ++  VV  
Sbjct: 121 SQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVRE 175
Query: 562 --QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS 619
             Q  + +  PE L     + +SDV+SFGVVL EL T       DK     S +  FL  
Sbjct: 176 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-----YCDK---SCSPSAEFLRM 227
Query: 620 LKQNRLLEILDNRIVNDGNKQQL-------KEVAKLAARCISVRGEERPTMKEVSLEL 670
           +   R +  L   +      Q+L        EV +L   C +   ++RP+   +  +L
Sbjct: 228 MGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 285

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI----------DEFINELVVVLQINRRN 458
           +G G  G V+K        V+ K S  V   K+          ++ I EL V+ + N   
Sbjct: 76  LGAGNGGVVFK--------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 459 VVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETN 518
           +V   G         +  E +  G+L + + K G +  +   +++      L+YL  +  
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
             I+HRDVK +NIL++     K+ DFG S  + ID++ N  V  GT  Y+ PE LQ    
Sbjct: 188 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQGTHY 242
Query: 579 TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF 616
           + +SD++S G+ LVE+  G+  +    P + + L + F
Sbjct: 243 SVQSDIWSMGLSLVEMAVGRYPI---PPPDAKELELMF 277

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   +V+L     +     +V E+   G +F H+ + 
Sbjct: 76  KQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 135
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+++D+    +V+DFG +K V 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK 192
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 193 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 409 IGCGGSGNVYK------GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+K      G +  R  + ++    +  A  ++ I EL V+ + N   +V  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G         +  E +  G+L + + K G +  +   +++      L+YL  +    I+
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 127
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRDVK +NIL++     K+ DFG S  + ID++ N  V  GT  Y+ PE LQ    + +S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQGTHYSVQS 184
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF 616
           D++S G+ LVE+  G+  +    P + + L + F
Sbjct: 185 DIWSMGLSLVEMAVGRYPI---PPPDAKELELMF 215

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 409 IGCGGSGNVYK------GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+K      G +  R  + ++    +  A  ++ I EL V+ + N   +V  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G         +  E +  G+L + + K G +  +   +++      L+YL  +    I+
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 127
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRDVK +NIL++     K+ DFG S  + ID++ N  V  GT  Y+ PE LQ    + +S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQGTHYSVQS 184
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF 616
           D++S G+ LVE+  G+  +    P + + L + F
Sbjct: 185 DIWSMGLSLVEMAVGRYPI---PPPDAKELELMF 215

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 14/224 (6%)
Query: 376 RQELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKF 435
           R++L KL   S  K      EE+  V       +G G  G+VYK    +   +   K   
Sbjct: 12  RRQLKKLDEDSLTKQP----EEVFDVLEK----LGEGSYGSVYKAIHKETGQIVAIKQVP 63
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH-KKGNL 494
           V+ + + E I E+ ++ Q +  +VV+  G   +     +V E+ G G++ + I  +   L
Sbjct: 64  VE-SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL 122
Query: 495 SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA 554
           + +    I   T   L YLH       IHRD+K+ NILL+     K++DFG +  +  D 
Sbjct: 123 TEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQL-TDX 178
Query: 555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           +     V GT  ++ PE +Q       +D++S G+  +E+  GK
Sbjct: 179 MAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 18/214 (8%)
Query: 409 IGCGGSGNVYK------GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+K      G +  R  + ++    +  A  ++ I EL V+ + N   +V  
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGF 96
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G         +  E +  G+L + + K G +  +   +++      L+YL  +    I+
Sbjct: 97  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 154
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRDVK +NIL++     K+ DFG S  + ID++ N  V  GT  Y+ PE LQ    + +S
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQGTHYSVQS 211
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF 616
           D++S G+ LVE+  G+  +    P + + L + F
Sbjct: 212 DIWSMGLSLVEMAVGRYPI---PPPDAKELELMF 242

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   + +L     +     +V E+   G +F H+ + 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 136
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+++D+    KV+DFG +K V 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK 193
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 194 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 96/191 (50%), Gaps = 9/191 (4%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+ G     T VA+K  K    +  + F+ E  ++ ++    +V+L     E
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 469 TQVPLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
             +  +V E++  G+L + + K G    L     + + A+ A  ++Y+     +  IHRD
Sbjct: 76  EPI-YIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           ++SANIL+      K++DFG ++L+  +        +  + +  PE     + T KSDV+
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 586 SFGVVLVELLT 596
           SFG++L EL+T
Sbjct: 191 SFGILLTELVT 201

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   + +L     +     +V E+   G +F H+ + 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 136
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G  S        A+      YLHS   + +I+RD+K  N+++D+    KV+DFG +K V 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK 193
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 194 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   +V+L     +     +V E+   G +F H+ + 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 135
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G           A+      YLHS   + +I+RD+K  N+++D+    KV+DFG +K V 
Sbjct: 136 GRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK 192
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 193 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 20/190 (10%)
Query: 424 DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT 483
           D+  VAVK  K    A   +F  E  ++  +   ++V+  G C +    ++V+E++ +G 
Sbjct: 44  DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 103
Query: 484 L--FEHIH--------------KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
           L  F   H               KG L   + L I ++ A  + YL S+     +HRD+ 
Sbjct: 104 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLA 160
Query: 528 SANILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           + N L+  N   K+ DFG S+ V   D  +        + ++ PE +   K T +SDV+S
Sbjct: 161 TRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 220
Query: 587 FGVVLVELLT 596
           FGV+L E+ T
Sbjct: 221 FGVILWEIFT 230

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 119/251 (47%), Gaps = 14/251 (5%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLF 485
           VAVKK +   +  + +F  E+ ++  +   N+V+  G C     +   L+ E++  G+L 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 486 EHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           +++      +   + L+ T++    + YL ++     IHRD+ + NIL++     K+ DF
Sbjct: 105 DYLQAHAERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 161
Query: 545 GASKLVPIDAIQNCTVVQGT--LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL 602
           G +K++P D         G   + +  PE L   K +  SDV+SFGVVL EL T      
Sbjct: 162 GLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 221
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDN--RIVN-DGNKQQLKEVAKLAARCISVRGEE 659
           S   E  R +  +    +    L+E+L N  R+   DG      E+  +   C +    +
Sbjct: 222 SPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD---EIYMIMTECWNNNVNQ 278
Query: 660 RPTMKEVSLEL 670
           RP+ ++++L +
Sbjct: 279 RPSFRDLALRV 289

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTP------VAVK--KSKFVDQAKIDEFINE 447
           +EI        +VIG G  G V +G L  + P      VA+K  K  + ++ +  EF++E
Sbjct: 9   KEIDVSYVKIEEVIGAGEFGEVCRGRL--KAPGKKESCVAIKTLKGGYTERQR-REFLSE 65
Query: 448 LVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAET 506
             ++ Q    N++RL G    +   +++ EF+ NG L   +    G  +    +++    
Sbjct: 66  ASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFT---VIQLVGML 122
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
            G+ S +     +  +HRD+ + NIL++ N   KVSDFG S+   ++   +      +LG
Sbjct: 123 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRF--LEENSSDPTYTSSLG 180
Query: 567 ------YLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                 +  PE +   K T  SD +S+G+V+ E+++
Sbjct: 181 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 15/218 (6%)
Query: 409 IGCGGSGNVYK------GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+K      G +  R  + ++    +  A  ++ I EL V+ + N   +V  
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G         +  E +  G+L + + K G +  +   +++      L+YL  +    I+
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 127
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRDVK +NIL++     K+ DFG S  + ID++ N  V  GT  Y+ PE LQ    + +S
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQGTHYSVQS 184
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
           D++S G+ LVE+  G+  +     +E+    M     L
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELL 222

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 90/179 (50%), Gaps = 5/179 (2%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVK      Q + +   NE+V++      NVV +    L  +   ++ EF+  G L + 
Sbjct: 73  VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD- 131
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I  +  L+ E+   +       L+YLH++    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 132 IVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFC 188
Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             +  D  +   +V GT  ++ PE +       + D++S G++++E++ G+    SD P
Sbjct: 189 AQISKDVPKRKXLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 392 IFTEEEIKTVTNNYADVIGCGGSGNV---YKGFLPDRTP--VAVKKSKFVDQAKIDEFIN 446
           IF E  +K ++      +G G  G+V       L D T   VAVK+ +     +  +F  
Sbjct: 3   IFEERHLKYISQ-----LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 57
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVP--LLVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           E+ ++  ++   +V+  G       P   LV E++ +G L + + + +  L   R L  +
Sbjct: 58  EIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 117
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV-- 561
           ++    + YL S      +HRD+ + NIL++     K++DFG +KL+P+D  ++  VV  
Sbjct: 118 SQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDXXVVRE 172
Query: 562 --QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
             Q  + +  PE L     + +SDV+SFGVVL EL T
Sbjct: 173 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKID----EFINELVVVLQINRRNVVRLLG 464
           +G G  GNVY         +   K  F  Q + +    +   E+ +   +   N++R+  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
              + +   L+ EF   G L++ + K G    +R      E A  L Y H      +IHR
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHR 139
Query: 525 DVKSANILLDENCTPKVSDFGASKLVP-IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           D+K  N+L+      K++DFG S   P +     C    GTL YL PE ++     +K D
Sbjct: 140 DIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTHDEKVD 195
Query: 584 VYSFGVVLVELLTG 597
           ++  GV+  E L G
Sbjct: 196 LWCAGVLCYEFLVG 209

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 423 PDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV 479
           P+R T VAVK  K    +  + + I+E+ ++  I + +N++ LLG C +     ++ E+ 
Sbjct: 57  PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 480 GNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             G L E++  +                  LS +  +    + A  + YL S+     IH
Sbjct: 117 SKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+ + N+L+ E+   K++DFG A  +  ID  +  T  +  + ++ PE L     T +S
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+SFGV+L E+ T   +     P EE               L ++L      D      
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEE---------------LFKLLKEGHRMDKPSNCT 278
Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQY 682
            E+  +   C      +RPT K++  +L   ++L SN +Y
Sbjct: 279 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEY 318

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKID----EFINELVVVLQINRRNVVRLLG 464
           +G G  GNVY         +   K  F  Q + +    +   E+ +   +   N++R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
              + +   L+ EF   G L++ + K G    +R      E A  L Y H      +IHR
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHR 138
Query: 525 DVKSANILLDENCTPKVSDFGASKLVP-IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           D+K  N+L+      K++DFG S   P +     C    GTL YL PE ++     +K D
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTHDEKVD 194
Query: 584 VYSFGVVLVELLTG 597
           ++  GV+  E L G
Sbjct: 195 LWCAGVLCYEFLVG 208

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTP------VAVK--KSKFVDQAKIDEFINE 447
           +EI        +VIG G  G V +G L  + P      VA+K  K  + ++ +  EF++E
Sbjct: 11  KEIDVSYVKIEEVIGAGEFGEVCRGRL--KAPGKKESCVAIKTLKGGYTERQR-REFLSE 67
Query: 448 LVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAET 506
             ++ Q    N++RL G    +   +++ EF+ NG L   +    G  +    +++    
Sbjct: 68  ASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFT---VIQLVGML 124
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
            G+ S +     +  +HRD+ + NIL++ N   KVSDFG S+   ++   +      +LG
Sbjct: 125 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRF--LEENSSDPTETSSLG 182
Query: 567 ------YLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                 +  PE +   K T  SD +S+G+V+ E+++
Sbjct: 183 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 408 VIGCGGSGNVYKGFLPDR----TPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVR 461
           ++G G  G+V +G L         VAVK  K     Q +I+EF++E   +   +  NV+R
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 462 LLGCCLETQV-----PLLVYEFVGNGTLFEHI------HKKGNLSWERRLRITAETAGVL 510
           LLG C+E        P+++  F+  G L  ++          ++  +  L+   + A  +
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 511 SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYLD 569
            YL   +N   +HRD+ + N +L ++ T  V+DFG S K+   D  +   + +  + ++ 
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 570 PEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
            E L     T KSDV++FGV + E+ T  M
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATRGM 247

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 135/298 (45%), Gaps = 37/298 (12%)
Query: 392 IFTEEEIKTVTNNYADVIGCGGSGNV---YKGFLPDRTP--VAVKKSKFVDQAKIDEFIN 446
           IF E  +K ++      +G G  G+V       L D T   VAVK+ +     +  +F  
Sbjct: 19  IFEERHLKYISQ-----LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 73
Query: 447 ELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           E+ ++  ++   +V+  G       Q   LV E++ +G L + + + +  L   R L  +
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV-- 561
           ++    + YL S      +HRD+ + NIL++     K++DFG +KL+P+D  ++  VV  
Sbjct: 134 SQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVRE 188
Query: 562 --QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS 619
             Q  + +  PE L     + +SDV+SFGVVL EL T       DK     S +  FL  
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-----YCDK---SCSPSAEFLRM 240
Query: 620 LKQNRLLEILDNRIVNDGNKQQL-------KEVAKLAARCISVRGEERPTMKEVSLEL 670
           +   R +  L   +      Q+L        EV +L   C +   ++RP+   +  +L
Sbjct: 241 MGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 46/293 (15%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ  R   +  L    +T   L  V E+   G LF H+ ++   + ER     AE    
Sbjct: 63  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 122
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHS     +++RD+K  N++LD++   K++DFG  K    + I +   ++   GT  
Sbjct: 123 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGTPE 175
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL 626
           YL PE L+        D +  GVV+ E++ G++   +   + ER   +  +  ++  R L
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFPRTL 233
Query: 627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEER----PT-MKEVSLELQGRLSLMSNGQ 681
                            E   L A  +    ++R    P+  KEV   ++ R  L  N Q
Sbjct: 234 S---------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEV---MEHRFFLSINWQ 275
Query: 682 YYLRDNV------ESNGVQETEYFTSTFYECRNGIGSHTTPTDGYDSVQQLEL 728
             ++  +      +     +T YF   F      I    TP D YDS+  LEL
Sbjct: 276 DVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITI----TPPDRYDSLGLLEL 324

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ  R   +  L    +T   L  V E+   G LF H+ ++   + ER     AE    
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHS     +++RD+K  N++LD++   K++DFG  K    + I +   ++   GT  
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPE 170
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL 626
           YL PE L+        D +  GVV+ E++ G++   +   + ER   +  +  ++  R L
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFPRTL 228

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 46/293 (15%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ  R   +  L    +T   L  V E+   G LF H+ ++   + ER     AE    
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHS     +++RD+K  N++LD++   K++DFG  K    + I +   ++   GT  
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGTPE 170
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL 626
           YL PE L+        D +  GVV+ E++ G++   +   + ER   +  +  ++  R L
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFPRTL 228
Query: 627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEER----PT-MKEVSLELQGRLSLMSNGQ 681
                            E   L A  +    ++R    P+  KEV   ++ R  L  N Q
Sbjct: 229 S---------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEV---MEHRFFLSINWQ 270
Query: 682 YYLRDNV------ESNGVQETEYFTSTFYECRNGIGSHTTPTDGYDSVQQLEL 728
             ++  +      +     +T YF   F      I    TP D YDS+  LEL
Sbjct: 271 DVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITI----TPPDRYDSLGLLEL 319

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 90/179 (50%), Gaps = 5/179 (2%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVKK     Q + +   NE+V++   +  NVV +    L      +V EF+  G L + 
Sbjct: 73  VAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTD- 131
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I     ++ E+   +       LSYLH++    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 132 IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFC 188
Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             V  +  +   +V GT  ++ PE +       + D++S G++++E++ G+    ++ P
Sbjct: 189 AQVSKEVPKRKXLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 246

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 46/293 (15%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ  R   +  L    +T   L  V E+   G LF H+ ++   + ER     AE    
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHS     +++RD+K  N++LD++   K++DFG  K    + I +   ++   GT  
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPE 170
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL 626
           YL PE L+        D +  GVV+ E++ G++   +   + ER   +  +  ++  R L
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFPRTL 228
Query: 627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEER----PT-MKEVSLELQGRLSLMSNGQ 681
                            E   L A  +    ++R    P+  KEV   ++ R  L  N Q
Sbjct: 229 S---------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEV---MEHRFFLSINWQ 270
Query: 682 YYLRDNV------ESNGVQETEYFTSTFYECRNGIGSHTTPTDGYDSVQQLEL 728
             ++  +      +     +T YF   F      I    TP D YDS+  LEL
Sbjct: 271 DVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITI----TPPDRYDSLGLLEL 319

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 55  EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 171
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 213

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 409 IGCGGSGNVYK------GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+K      G +  R  + ++    +  A  ++ I EL V+ + N   +V  
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGF 88
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G         +  E +  G+L + + K G +  +   +++      L+YL  +    I+
Sbjct: 89  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 146
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRDVK +NIL++     K+ DFG S  + ID++ N  V  GT  Y+ PE LQ    + +S
Sbjct: 147 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV--GTRSYMSPERLQGTHYSVQS 203
Query: 583 DVYSFGVVLVELLTGK 598
           D++S G+ LVE+  G+
Sbjct: 204 DIWSMGLSLVEMAVGR 219

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 46/293 (15%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ  R   +  L    +T   L  V E+   G LF H+ ++   + ER     AE    
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 120
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHS     +++RD+K  N++LD++   K++DFG  K    + I +   ++   GT  
Sbjct: 121 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPE 173
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL 626
           YL PE L+        D +  GVV+ E++ G++   +   + ER   +  +  ++  R L
Sbjct: 174 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFPRTL 231
Query: 627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEER----PT-MKEVSLELQGRLSLMSNGQ 681
                            E   L A  +    ++R    P+  KEV   ++ R  L  N Q
Sbjct: 232 S---------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEV---MEHRFFLSINWQ 273
Query: 682 YYLRDNV------ESNGVQETEYFTSTFYECRNGIGSHTTPTDGYDSVQQLEL 728
             ++  +      +     +T YF   F      I    TP D YDS+  LEL
Sbjct: 274 DVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITI----TPPDRYDSLGLLEL 322

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ  R   +  L    +T   L  V E+   G LF H+ ++   + ER     AE    
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHS     +++RD+K  N++LD++   K++DFG  K    + I +   ++   GT  
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGTPE 170
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL 626
           YL PE L+        D +  GVV+ E++ G++   +   + ER   +  +  ++  R L
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFPRTL 228

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 54  EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           VLQ  R   +  L    +T   L  V E+   G LF H+ ++   + ER     AE    
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLG 566
           L YLHS     +++RD+K  N++LD++   K++DFG  K    + I +   ++   GT  
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKXFCGTPE 170
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL 626
           YL PE L+        D +  GVV+ E++ G++   +   + ER   +  +  ++  R L
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--DHERLFELILMEEIRFPRTL 228

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVYKGFLPD------RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY+G   D       T VAVK  ++     +  EF+NE  V+      +VVR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L+V E + +G L  ++            +   + +  +++ AE A  ++
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL+++     +HRD+ + N ++  + T K+ DFG ++    D  +     +G  G     
Sbjct: 145 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETAYYRKGGKGLLPVR 197
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SD++SFGVVL E+ +     L+++P
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS-----LAEQP 232

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 7/175 (4%)
Query: 432 KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK 491
           K K V   +I+  +NE  ++  +N   + +L     +     +V E+   G +F H+ + 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 136
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
           G           A+      YLHS   + +I+RD+K  N+++D+    KV+DFG +K V 
Sbjct: 137 GRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK 193
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
                 C    GT  YL PE + +       D ++ GV++ E+  G     +D+P
Sbjct: 194 GRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 124/274 (45%), Gaps = 37/274 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 486 EHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 291
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSNGQY 682
              C      +RPT K++  +L   L+L +N +Y
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEY 325

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           N+V+L     +     LV E +  G LFE I KK + S      I  +    +S++H   
Sbjct: 67  NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH--- 123
Query: 518 NVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ 574
           +V ++HRD+K  N+L    ++N   K+ DFG ++L P D  Q       TL Y  PE L 
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLN 182
Query: 575 TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSL 612
                +  D++S GV+L  +L+G++   S     +RSL
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQS----HDRSL 216

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 83/169 (49%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 65  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR 124
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 125 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 181
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L     +  SD+++ G ++ +L+ G
Sbjct: 182 LSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 37/271 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 486 EHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +N T  +  + ++ PE L     T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 291
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSN 679
              C      +RPT K++  +L   L+L +N
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTP---VAVK-KSKFVDQAKIDEFINELVVV 451
           E+I+ + + + DV+G G    V      D+     VA+K  +K   + K     NE+ V+
Sbjct: 14  EDIRDIYD-FRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 70
Query: 452 LQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS 511
            +I   N+V L           L+ + V  G LF+ I +KG  +     R+  +    + 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 512 YLHSETNVPIIHRDVKSANIL---LDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
           YLH   ++ I+HRD+K  N+L   LDE+    +SDFG SK+   D     +   GT GY+
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYV 185
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
            PE L     +   D +S GV+   LL G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 392 IFTEEEIKTVTNNYADVIGCGGSGNV---YKGFLPDRTP--VAVKKSKFVDQAKIDEFIN 446
           IF E  +K ++      +G G  G+V       L D T   VAVK+ +     +  +F  
Sbjct: 7   IFEERHLKYISQ-----LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 61
Query: 447 ELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           E+ ++  ++   +V+  G       Q   LV E++ +G L + + + +  L   R L  +
Sbjct: 62  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 121
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV-- 561
           ++    + YL S      +HRD+ + NIL++     K++DFG +KL+P+D  ++  VV  
Sbjct: 122 SQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVRE 176
Query: 562 --QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
             Q  + +  PE L     + +SDV+SFGVVL EL T
Sbjct: 177 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 65  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 124
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 125 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 181
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 182 LSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 486 EHIHKKGNLSWERRLRI----------------TAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +     E    I                T + A  + YL S+     IHRD+ + 
Sbjct: 130 EYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 291
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSNGQY 682
              C      +RPT K++  +L   L+L +N +Y
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEY 325

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 213

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 409 IGCGGSGNVYKGFLPD------RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY+G   D       T VAVK  ++     +  EF+NE  V+      +VVR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L+V E + +G L  ++            +   + +  +++ AE A  ++
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL+++     +HRD+ + N ++  + T K+ DFG ++    D  +     +G  G     
Sbjct: 145 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 197
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVEL 594
           ++ PE L+    T  SD++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 409 IGCGGSGNVYKGFLPD------RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY+G   D       T VAVK  ++     +  EF+NE  V+      +VVR
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L+V E + +G L  ++            +   + +  +++ AE A  ++
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL+++     +HRD+ + N ++  + T K+ DFG ++    D  +     +G  G     
Sbjct: 142 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 194
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVEL 594
           ++ PE L+    T  SD++SFGVVL E+
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 405 YADVIGCGGSGNVYKGFLPDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLL 463
           + +V+G G  G   K    +   V V K     D+     F+ E+ V+  +   NV++ +
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   + +    + E++  GTL   I        W +R+    + A  ++YLHS     II
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---II 130
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLV--------------PIDAIQNCTVVQGTLGYL 568
           HRD+ S N L+ EN    V+DFG ++L+                D  +  TVV G   ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV-GNPYWM 189
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELL 595
            PE +      +K DV+SFG+VL E++
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTP---VAVK-KSKFVDQAKIDEFINELVVV 451
           E+I+ + + + DV+G G    V      D+     VA+K  +K   + K     NE+ V+
Sbjct: 14  EDIRDIYD-FRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 452 LQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS 511
            +I   N+V L           L+ + V  G LF+ I +KG  +     R+  +    + 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 512 YLHSETNVPIIHRDVKSANIL---LDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
           YLH   ++ I+HRD+K  N+L   LDE+    +SDFG SK+   D     +   GT GY+
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYV 185
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
            PE L     +   D +S GV+   LL G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 63  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 122
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 123 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 180 LSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 409 IGCGGSGNVYKGFLPD------RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY+G   D       T VAVK  ++     +  EF+NE  V+      +VVR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L+V E + +G L  ++            +   + +  +++ AE A  ++
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL+++     +HRD+ + N ++  + T K+ DFG ++    D  +     +G  G     
Sbjct: 145 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 197
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVEL 594
           ++ PE L+    T  SD++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTP---VAVK-KSKFVDQAKIDEFINELVVV 451
           E+I+ + + + DV+G G    V      D+     VA+K  +K   + K     NE+ V+
Sbjct: 14  EDIRDIYD-FRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 452 LQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS 511
            +I   N+V L           L+ + V  G LF+ I +KG  +     R+  +    + 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 512 YLHSETNVPIIHRDVKSANIL---LDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
           YLH   ++ I+HRD+K  N+L   LDE+    +SDFG SK+   D     +   GT GY+
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYV 185
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
            PE L     +   D +S GV+   LL G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTP---VAVK-KSKFVDQAKIDEFINELVVV 451
           E+I+ + + + DV+G G    V      D+     VA+K  +K   + K     NE+ V+
Sbjct: 14  EDIRDIYD-FRDVLGTGAFSEVI--LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 452 LQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS 511
            +I   N+V L           L+ + V  G LF+ I +KG  +     R+  +    + 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 512 YLHSETNVPIIHRDVKSANIL---LDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
           YLH   ++ I+HRD+K  N+L   LDE+    +SDFG SK+   D     +   GT GY+
Sbjct: 131 YLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYV 185
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
            PE L     +   D +S GV+   LL G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 66  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 125
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 126 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 182
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 183 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 68  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 127
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 128 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 184
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 185 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 63  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 122
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 123 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 180 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 65  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 124
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 125 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 181
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 182 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 423 PDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV 479
           P+R T VAVK  K    +  + + I+E+ ++  I + +N++ LLG C +     ++ E+ 
Sbjct: 98  PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 157
Query: 480 GNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             G L E++  +                  LS +  +    + A  + YL S+     IH
Sbjct: 158 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 214
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+ + N+L+ E+   K++DFG A  +  ID  +  T  +  + ++ PE L     T +S
Sbjct: 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+SFGV+L E+ T   +     P EE               L ++L      D      
Sbjct: 275 DVWSFGVLLWEIFTLGGSPYPGVPVEE---------------LFKLLKEGHRMDKPSNCT 319
Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQ 681
            E+  +   C      +RPT K++  +L   ++L SN +
Sbjct: 320 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 65  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 124
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 125 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 181
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 182 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 63  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 122
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 123 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 180 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 65  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 124
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 125 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 181
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 182 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 43  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 102
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 103 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 159
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 160 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 42  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 101
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 102 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 158
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 159 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 63  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 122
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 123 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 180 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 65  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 124
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 125 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 181
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 182 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 55  EICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 213

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 66  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 125
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 126 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 182
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 183 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 40  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 99
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 100 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 156
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 157 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 213

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 119/263 (45%), Gaps = 38/263 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE 468
           +G G  G V+       T VAVK  K      ++ F+ E  V+  +    +V+L      
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 246
Query: 469 TQVPL-LVYEFVGNGTLFEHIH--KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
           T+ P+ ++ EF+  G+L + +   +       + +  +A+ A  ++++        IHRD
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 303
Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           +++ANIL+  +   K++DFG +++            +  + +  PE +     T KSDV+
Sbjct: 304 LRAANILVSASLVCKIADFGLARV----------GAKFPIKWTAPEAINFGSFTIKSDVW 353
Query: 586 SFGVVLVELLT-GKMALLS-DKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           SFG++L+E++T G++       PE  R+L   +     +N                   +
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN-----------------CPE 396
Query: 644 EVAKLAARCISVRGEERPTMKEV 666
           E+  +  RC   R EERPT + +
Sbjct: 397 ELYNIMMRCWKNRPEERPTFEYI 419

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 54  EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 13/206 (6%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI----DEFINELVVVLQINRRNVVRLLG 464
           +G G +G V      +R        K VD  +     +    E+ +   +N  NVV+  G
Sbjct: 14  LGEGAAGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
              E  +  L  E+   G LF+ I     +      R   +    + YLH    + I HR
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTLGYLDPEYLQTCKL-TDKS 582
           D+K  N+LLDE    K+SDFG + +   +  +     + GTL Y+ PE L+  +   +  
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEE 608
           DV+S G+VL  +L G++    D+P +
Sbjct: 189 DVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 409 IGCGGSGNVYKGFLPD------RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY+G   D       T VAVK  ++     +  EF+NE  V+      +VVR
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L+V E + +G L  ++            +   + +  +++ AE A  ++
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL+++     +HRD+ + N ++  + T K+ DFG ++    D  +     +G  G     
Sbjct: 144 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 196
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVEL 594
           ++ PE L+    T  SD++SFGVVL E+
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 62  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 121
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 122 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 178
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 179 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 47  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 106
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 107 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 163
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 164 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 41  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 100
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 101 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 157
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 158 LSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 5/179 (2%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVKK     Q + +   NE+V++      NVV +    L      +V EF+  G L + 
Sbjct: 179 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD- 237
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I     ++ E+   +       LS LH++    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 238 IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC 294
Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             V  +  +   +V GT  ++ PE +       + D++S G++++E++ G+    ++ P
Sbjct: 295 AQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           V+G G  G V K     D    A+KK +  ++ K+   ++E+ ++  +N + VVR     
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVXLLASLNHQYVVRYYAAW 71
Query: 467 LETQ-------------VPLLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLS 511
           LE +                +  E+  N TL++ IH + NL+ +R    R+  +    LS
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE-NLNQQRDEYWRLFRQILEALS 130
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV--PIDAIQ-----------NC 558
           Y+HS+    IIHR++K  NI +DE+   K+ DFG +K V   +D ++           N 
Sbjct: 131 YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 559 TVVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVLVELL 595
           T   GT  Y+  E L  T    +K D YS G++  E +
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 13/187 (6%)
Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL-VYEFVGNGTLFEH 487
            VKK    D   ID    E  V  Q +    +  L  C +T+  L  V E+V  G L  H
Sbjct: 84  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 143
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           + ++  L  E     +AE +  L+YLH      II+RD+K  N+LLD     K++D+G  
Sbjct: 144 MQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC 200
Query: 548 K--LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL---- 601
           K  L P D     +   GT  Y+ PE L+        D ++ GV++ E++ G+       
Sbjct: 201 KEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257
Query: 602 LSDKPEE 608
            SD P++
Sbjct: 258 SSDNPDQ 264

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 64/136 (47%), Gaps = 5/136 (3%)
Query: 463 LGCCLETQVPLL-VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L CC +T   L  V EFV  G L  HI K       R     AE    L +LH +    I
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---I 145
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           I+RD+K  N+LLD     K++DFG  K    + +   T   GT  Y+ PE LQ       
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQEMLYGPA 204
Query: 582 SDVYSFGVVLVELLTG 597
            D ++ GV+L E+L G
Sbjct: 205 VDWWAMGVLLYEMLCG 220

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 409 IGCGGSGNVYKGFLPD------RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY+G   D       T VAVK  ++     +  EF+NE  V+      +VVR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L+V E + +G L  ++            +   + +  +++ AE A  ++
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL+++     +HRD+ + N ++  + T K+ DFG ++    D  +     +G  G     
Sbjct: 145 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 197
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVEL 594
           ++ PE L+    T  SD++SFGVVL E+
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 53  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 112
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 113 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 211

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 5/179 (2%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVKK     Q + +   NE+V++      NVV +    L      +V EF+  G L + 
Sbjct: 102 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD- 160
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I     ++ E+   +       LS LH++    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 161 IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC 217
Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             V  +  +   +V GT  ++ PE +       + D++S G++++E++ G+    ++ P
Sbjct: 218 AQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 213

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 15/196 (7%)
Query: 409 IGCGGSGNVYK------GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+K      G +  R  + ++    +  A  ++ I EL V+ + N   +V  
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGF 72
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G         +  E +  G+L + + K G +  +   +++      L+YL  +    I+
Sbjct: 73  YGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IM 130
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRDVK +NIL++     K+ DFG S  + ID + N  V  GT  Y+ PE LQ    + +S
Sbjct: 131 HRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEMANEFV--GTRSYMSPERLQGTHYSVQS 187
Query: 583 DVYSFGVVLVELLTGK 598
           D++S G+ LVE+  G+
Sbjct: 188 DIWSMGLSLVEMAVGR 203

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 4/169 (2%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           ++K   + + K+     E  V+ +++    V+L     + +       +  NG L ++I 
Sbjct: 62  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 121
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K G+         TAE    L YLH +    IIHRD+K  NILL+E+   +++DFG +K+
Sbjct: 122 KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV 178
Query: 550 VPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  ++ Q       GT  Y+ PE L        SD+++ G ++ +L+ G
Sbjct: 179 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 213

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 423 PDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV 479
           P+R T VAVK  K    +  + + I+E+ ++  I + +N++ LLG C +     ++ E+ 
Sbjct: 46  PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 105
Query: 480 GNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             G L E++  +                  LS +  +    + A  + YL S+     IH
Sbjct: 106 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 162
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+ + N+L+ E+   K++DFG A  +  ID  +  T  +  + ++ PE L     T +S
Sbjct: 163 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 222
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+SFGV+L E+ T   +     P EE               L ++L      D      
Sbjct: 223 DVWSFGVLLWEIFTLGGSPYPGVPVEE---------------LFKLLKEGHRMDKPSNCT 267
Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQ 681
            E+  +   C      +RPT K++  +L   ++L SN +
Sbjct: 268 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 306

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 7/164 (4%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ +   +N  NVV+  G   E  +  L  E+   G LF+ I     +      R   + 
Sbjct: 54  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTL 565
              + YLH    + I HRD+K  N+LLDE    K+SDFG + +   +  +     + GTL
Sbjct: 114 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 566 GYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
            Y+ PE L+  +   +  DV+S G+VL  +L G++    D+P +
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSD 212

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 423 PDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV 479
           P+R T VAVK  K    +  + + I+E+ ++  I + +N++ LLG C +     ++ E+ 
Sbjct: 49  PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 108
Query: 480 GNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             G L E++  +                  LS +  +    + A  + YL S+     IH
Sbjct: 109 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 165
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+ + N+L+ E+   K++DFG A  +  ID  +  T  +  + ++ PE L     T +S
Sbjct: 166 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 225
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+SFGV+L E+ T   +     P EE               L ++L      D      
Sbjct: 226 DVWSFGVLLWEIFTLGGSPYPGVPVEE---------------LFKLLKEGHRMDKPSNCT 270
Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQ 681
            E+  +   C      +RPT K++  +L   ++L SN +
Sbjct: 271 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 309

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 423 PDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV 479
           P+R T VAVK  K    +  + + I+E+ ++  I + +N++ LLG C +     ++ E+ 
Sbjct: 42  PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 101
Query: 480 GNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             G L E++  +                  LS +  +    + A  + YL S+     IH
Sbjct: 102 SKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 158
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+ + N+L+ E+   K++DFG A  +  ID  +  T  +  + ++ PE L     T +S
Sbjct: 159 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+SFGV+L E+ T   +     P EE               L ++L      D      
Sbjct: 219 DVWSFGVLLWEIFTLGGSPYPGVPVEE---------------LFKLLKEGHRMDKPSNCT 263
Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQ 681
            E+  +   C      +RPT K++  +L   ++L SN +
Sbjct: 264 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 302

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 122/271 (45%), Gaps = 37/271 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 59  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 118
Query: 486 EHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 119 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 175
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 176 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 235
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 236 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 280
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSN 679
              C      +RPT K++  +L   L+L +N
Sbjct: 281 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 311

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 26/201 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKI------------DEFINELVVVLQINR 456
           +G G  GNVY            KKS F+   K+             +   E+ +   ++ 
Sbjct: 31  LGKGKFGNVYLA--------REKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            N++RL     + +   L+ E+   G L++ + K      +R   I  E A  L Y H +
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGK 142
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               +IHRD+K  N+LL      K++DFG S   P  +++  T+  GTL YL PE ++  
Sbjct: 143 K---VIHRDIKPENLLLGLKGELKIADFGWSVHAP--SLRRKTMC-GTLDYLPPEMIEGR 196
Query: 577 KLTDKSDVYSFGVVLVELLTG 597
              +K D++  GV+  ELL G
Sbjct: 197 MHNEKVDLWCIGVLCYELLVG 217

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 5/179 (2%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVKK     Q + +   NE+V++      NVV +    L      +V EF+  G L + 
Sbjct: 52  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD- 110
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I     ++ E+   +       LS LH++    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 111 IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC 167
Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             V  +  +   +V GT  ++ PE +       + D++S G++++E++ G+    ++ P
Sbjct: 168 AQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 225

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 5/179 (2%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVKK     Q + +   NE+V++      NVV +    L      +V EF+  G L + 
Sbjct: 59  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD- 117
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I     ++ E+   +       LS LH++    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 118 IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC 174
Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             V  +  +   +V GT  ++ PE +       + D++S G++++E++ G+    ++ P
Sbjct: 175 AQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 232

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 423 PDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV 479
           P+R T VAVK  K    +  + + I+E+ ++  I + +N++ LLG C +     ++ E+ 
Sbjct: 57  PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 480 GNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             G L E++  +                  LS +  +    + A  + YL S+     IH
Sbjct: 117 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+ + N+L+ E+   K++DFG A  +  ID  +  T  +  + ++ PE L     T +S
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+SFGV+L E+ T   +     P EE               L ++L      D      
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEE---------------LFKLLKEGHRMDKPSNCT 278
Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQ 681
            E+  +   C      +RPT K++  +L   ++L SN +
Sbjct: 279 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 317

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 13/187 (6%)
Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL-VYEFVGNGTLFEH 487
            VKK    D   ID    E  V  Q +    +  L  C +T+  L  V E+V  G L  H
Sbjct: 52  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 111
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           + ++  L  E     +AE +  L+YLH      II+RD+K  N+LLD     K++D+G  
Sbjct: 112 MQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC 168
Query: 548 K--LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL---- 601
           K  L P D     +   GT  Y+ PE L+        D ++ GV++ E++ G+       
Sbjct: 169 KEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 225
Query: 602 LSDKPEE 608
            SD P++
Sbjct: 226 SSDNPDQ 232

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 423 PDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV 479
           P+R T VAVK  K    +  + + I+E+ ++  I + +N++ LLG C +     ++ E+ 
Sbjct: 57  PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 480 GNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             G L E++  +                  LS +  +    + A  + YL S+     IH
Sbjct: 117 SKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+ + N+L+ E+   K++DFG A  +  ID  +  T  +  + ++ PE L     T +S
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+SFGV+L E+ T   +     P EE               L ++L      D      
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEE---------------LFKLLKEGHRMDKPSNCT 278
Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQ 681
            E+  +   C      +RPT K++  +L   ++L SN +
Sbjct: 279 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 317

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 13/187 (6%)
Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL-VYEFVGNGTLFEH 487
            VKK    D   ID    E  V  Q +    +  L  C +T+  L  V E+V  G L  H
Sbjct: 41  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 100
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           + ++  L  E     +AE +  L+YLH      II+RD+K  N+LLD     K++D+G  
Sbjct: 101 MQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC 157
Query: 548 K--LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL---- 601
           K  L P D     +   GT  Y+ PE L+        D ++ GV++ E++ G+       
Sbjct: 158 KEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214
Query: 602 LSDKPEE 608
            SD P++
Sbjct: 215 SSDNPDQ 221

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 5/179 (2%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVKK     Q + +   NE+V++      NVV +    L      +V EF+  G L + 
Sbjct: 57  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD- 115
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I     ++ E+   +       LS LH++    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 116 IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC 172
Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             V  +  +   +V GT  ++ PE +       + D++S G++++E++ G+    ++ P
Sbjct: 173 AQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 230

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 89/173 (51%), Gaps = 9/173 (5%)
Query: 430 VKKSKFVDQAKIDEFI-NELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEH 487
           +KK+  V +AK  E    E  V+  I +   +  L    +T+  L L+ +++  G LF H
Sbjct: 90  LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH 149
Query: 488 IHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA 546
           + ++   + E  ++I   E    L +LH    + II+RD+K  NILLD N    ++DFG 
Sbjct: 150 LSQRERFT-EHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 205
Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL-TDKS-DVYSFGVVLVELLTG 597
           SK    D  +      GT+ Y+ P+ ++      DK+ D +S GV++ ELLTG
Sbjct: 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 423 PDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV 479
           P+R T VAVK  K    +  + + I+E+ ++  I + +N++ LLG C +     ++ E+ 
Sbjct: 50  PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 109
Query: 480 GNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             G L E++  +                  LS +  +    + A  + YL S+     IH
Sbjct: 110 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 166
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+ + N+L+ E+   K++DFG A  +  ID  +  T  +  + ++ PE L     T +S
Sbjct: 167 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 226
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+SFGV+L E+ T   +     P EE               L ++L      D      
Sbjct: 227 DVWSFGVLLWEIFTLGGSPYPGVPVEE---------------LFKLLKEGHRMDKPSNCT 271
Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQ 681
            E+  +   C      +RPT K++  +L   ++L SN +
Sbjct: 272 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 310

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 15/148 (10%)
Query: 458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           +++ L+     +    LV++ +  G LF+++ +K  LS +    I       +S+LH+  
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
              I+HRD+K  NILLD+N   ++SDFG S  L P + ++      GT GYL PE L+ C
Sbjct: 221 ---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GTPGYLAPEILK-C 273
Query: 577 KLTD-------KSDVYSFGVVLVELLTG 597
            + +       + D+++ GV+L  LL G
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 123/273 (45%), Gaps = 37/273 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 57  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 116
Query: 486 EHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 117 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLTAR 173
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 174 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 233
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 234 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 278
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSNGQ 681
              C      +RPT K++  +L   L+L +N +
Sbjct: 279 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTNQE 311

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 122/271 (45%), Gaps = 37/271 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 486 EHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 178
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 179 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 238
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 239 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 283
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSN 679
              C      +RPT K++  +L   L+L +N
Sbjct: 284 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 314

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 13/187 (6%)
Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL-VYEFVGNGTLFEH 487
            VKK    D   ID    E  V  Q +    +  L  C +T+  L  V E+V  G L  H
Sbjct: 37  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 96
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           + ++  L  E     +AE +  L+YLH      II+RD+K  N+LLD     K++D+G  
Sbjct: 97  MQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC 153
Query: 548 K--LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL---- 601
           K  L P D     +   GT  Y+ PE L+        D ++ GV++ E++ G+       
Sbjct: 154 KEGLRPGDT---TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 210
Query: 602 LSDKPEE 608
            SD P++
Sbjct: 211 SSDNPDQ 217

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGC 465
           +++G G  G VYKG       +A  K   V   + +E   E+ ++ +  + RN+    G 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 466 CLETQVP------LLVYEFVGNGTLFEHI-HKKGN-LSWERRLRITAETAGVLSYLHSET 517
            ++   P       LV EF G G++ + I + KGN L  E    I  E    LS+LH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
              +IHRD+K  N+LL EN   K+ DFG S  +     +  T + GT  ++ PE +   +
Sbjct: 150 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 205
Query: 578 LTD-----KSDVYSFGVVLVELLTGKMALLSDKP 606
             D     KSD++S G+  +E+  G   L    P
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 423 PDR-TPVAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV 479
           P+R T VAVK  K    +  + + I+E+ ++  I + +N++ LLG C +     ++ E+ 
Sbjct: 57  PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 480 GNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             G L E++  +                  LS +  +    + A  + YL S+     IH
Sbjct: 117 SKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+ + N+L+ E+   K++DFG A  +  ID  +  T  +  + ++ PE L     T +S
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+SFGV+L E+ T   +     P EE               L ++L      D      
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEE---------------LFKLLKEGHRMDKPSNCT 278
Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQ 681
            E+  +   C      +RPT K++  +L   ++L SN +
Sbjct: 279 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 317

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 5/179 (2%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           VAVKK     Q + +   NE+V++      NVV +    L      +V EF+  G L + 
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD- 106
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
           I     ++ E+   +       LS LH++    +IHRD+KS +ILL  +   K+SDFG  
Sbjct: 107 IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC 163
Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
             V  +  +   +V GT  ++ PE +       + D++S G++++E++ G+    ++ P
Sbjct: 164 AQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 122/271 (45%), Gaps = 37/271 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 486 EHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 291
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSN 679
              C      +RPT K++  +L   L+L +N
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 409 IGCGGSGNVYKG-FLPDRTP---VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLL 463
           IG G  G+V++G ++    P   VA+K  K      + E F+ E + + Q +  ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   E  V  ++ E    G L   +  +K +L     +    + +  L+YL S+     +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FV 133
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N+L+  N   K+ DFG S+ +        +  +  + ++ PE +   + T  S
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSAS 193
Query: 583 DVYSFGVVLVELL 595
           DV+ FGV + E+L
Sbjct: 194 DVWMFGVCMWEIL 206

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 25/200 (12%)
Query: 409 IGCGGSGNVY----KGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +G G +  VY    KG    + P A+K  K     KI     E+ V+L+++  N+++L  
Sbjct: 61  LGRGATSIVYRCKQKG---TQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKL-K 114
Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
              ET   + LV E V  G LF+ I +KG  S         +    ++YLH      I+H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVH 171
Query: 524 RDVKSANILLDENCTP------KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
           RD+K  N+L     TP      K++DFG SK+V    +     V GT GY  PE L+ C 
Sbjct: 172 RDLKPENLLY---ATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCAPEILRGCA 226
Query: 578 LTDKSDVYSFGVVLVELLTG 597
              + D++S G++   LL G
Sbjct: 227 YGPEVDMWSVGIITYILLCG 246

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 122/271 (45%), Gaps = 37/271 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 70  VAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 486 EHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 291
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSN 679
              C      +RPT K++  +L   L+L +N
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 409 IGCGGSGNVYKG-FLPDRTP---VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLL 463
           IG G  G+V++G ++    P   VA+K  K      + E F+ E + + Q +  ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   E  V  ++ E    G L   +  +K +L     +    + +  L+YL S+     +
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 161
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N+L+  N   K+ DFG S+ +        +  +  + ++ PE +   + T  S
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 221
Query: 583 DVYSFGVVLVELL 595
           DV+ FGV + E+L
Sbjct: 222 DVWMFGVCMWEIL 234

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 32/216 (14%)
Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINE--LVVVLQINRRNVVRLLG 464
           ++IG G  G VYKG L +R PVAVK   F ++     FINE  +  V  +   N+ R + 
Sbjct: 19  ELIGRGRYGAVYKGSLDER-PVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIV 74
Query: 465 CCLETQVP-----LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-- 517
                        LLV E+  NG+L +++    +  W    R+       L+YLH+E   
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-DWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 518 ----NVPIIHRDVKSANILLDENCTPKVSDFGAS------KLVPIDAIQNCTVVQ-GTLG 566
                  I HRD+ S N+L+  + T  +SDFG S      +LV      N  + + GT+ 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 567 YLDPEYLQ-TCKLTD------KSDVYSFGVVLVELL 595
           Y+ PE L+    L D      + D+Y+ G++  E+ 
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 409 IGCGGSGNVYKG-FLPDRTP---VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLL 463
           IG G  G+V++G ++    P   VA+K  K      + E F+ E + + Q +  ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   E  V  ++ E    G L   +  +K +L     +    + +  L+YL S+     +
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 136
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N+L+  N   K+ DFG S+ +        +  +  + ++ PE +   + T  S
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 196
Query: 583 DVYSFGVVLVELL 595
           DV+ FGV + E+L
Sbjct: 197 DVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 409 IGCGGSGNVYKG-FLPDRTP---VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLL 463
           IG G  G+V++G ++    P   VA+K  K      + E F+ E + + Q +  ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   E  V  ++ E    G L   +  +K +L     +    + +  L+YL S+     +
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 130
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N+L+  N   K+ DFG S+ +        +  +  + ++ PE +   + T  S
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 190
Query: 583 DVYSFGVVLVELL 595
           DV+ FGV + E+L
Sbjct: 191 DVWMFGVCMWEIL 203

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 122/271 (45%), Gaps = 37/271 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR 129
Query: 486 EHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 291
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSN 679
              C      +RPT K++  +L   L+L +N
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 409 IGCGGSGNVYKG-FLPDRTP---VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLL 463
           IG G  G+V++G ++    P   VA+K  K      + E F+ E + + Q +  ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   E  V  ++ E    G L   +  +K +L     +    + +  L+YL S+     +
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 135
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N+L+  N   K+ DFG S+ +        +  +  + ++ PE +   + T  S
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 195
Query: 583 DVYSFGVVLVELL 595
           DV+ FGV + E+L
Sbjct: 196 DVWMFGVCMWEIL 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 409 IGCGGSGNVYKG-FLPDRTP---VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLL 463
           IG G  G+V++G ++    P   VA+K  K      + E F+ E + + Q +  ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   E  V  ++ E    G L   +  +K +L     +    + +  L+YL S+     +
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 138
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N+L+  N   K+ DFG S+ +        +  +  + ++ PE +   + T  S
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 198
Query: 583 DVYSFGVVLVELL 595
           DV+ FGV + E+L
Sbjct: 199 DVWMFGVCMWEIL 211

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 409 IGCGGSGNVYKG-FLPDRTP---VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLL 463
           IG G  G+V++G ++    P   VA+K  K      + E F+ E + + Q +  ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   E  V  ++ E    G L   +  +K +L     +    + +  L+YL S+     +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 133
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N+L+  N   K+ DFG S+ +        +  +  + ++ PE +   + T  S
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 193
Query: 583 DVYSFGVVLVELL 595
           DV+ FGV + E+L
Sbjct: 194 DVWMFGVCMWEIL 206

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVYKGFLPD------RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY+G   D       T VAVK  ++     +  EF+NE  V+      +VVR
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L+V E + +G L  ++            +   + +  +++ AE A  ++
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL+++     +HR++ + N ++  + T K+ DFG ++    D  +     +G  G     
Sbjct: 146 YLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 198
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SD++SFGVVL E+ +     L+++P
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITS-----LAEQP 233

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 409 IGCGGSGNVYKG-FLPDRTP---VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLL 463
           IG G  G+V++G ++    P   VA+K  K      + E F+ E + + Q +  ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   E  V  ++ E    G L   +  +K +L     +    + +  L+YL S+     +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FV 133
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N+L+  N   K+ DFG S+ +        +  +  + ++ PE +   + T  S
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 193
Query: 583 DVYSFGVVLVELL 595
           DV+ FGV + E+L
Sbjct: 194 DVWMFGVCMWEIL 206

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 122/271 (45%), Gaps = 37/271 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 486 EHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 232
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 293 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 337
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSN 679
              C      +RPT K++  +L   L+L +N
Sbjct: 338 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 409 IGCGGSGNVYKGFLPD------RTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           +G G  G VY+G   D       T VAVK  ++     +  EF+NE  V+      +VVR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHK----------KGNLSWERRLRITAETAGVLS 511
           LLG   + Q  L+V E + +G L  ++            +   + +  +++ AE A  ++
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG----- 566
           YL+++     +HR++ + N ++  + T K+ DFG ++    D  +     +G  G     
Sbjct: 145 YLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 197
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
           ++ PE L+    T  SD++SFGVVL E+ +     L+++P
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS-----LAEQP 232

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 39/226 (17%)
Query: 405 YADVIGCGGSGNVYKGFLPDRTP------VAVKKSKFVDQAKID---EFINELVVVLQIN 455
           Y   IG G  G V++   P   P      VAVK  K  ++A  D   +F  E  ++ + +
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALMAEFD 108
Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN---------------------- 493
             N+V+LLG C   +   L++E++  G L E +                           
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 494 --LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK-LV 550
             LS   +L I  + A  ++YL        +HRD+ + N L+ EN   K++DFG S+ + 
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
             D  +        + ++ PE +   + T +SDV+++GVVL E+ +
Sbjct: 226 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVA-------VKKSKFVDQAKIDEFINEL 448
           + +K    N+  V+G G  G V    L DR           +KK   +    ++  + E 
Sbjct: 14  DRVKLTDFNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMVEK 70
Query: 449 VVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETA 507
            V+  +++   +  L  C +T   L  V E+V  G L  HI + G     + +   AE +
Sbjct: 71  RVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 130
Query: 508 GVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGY 567
             L +LH      II+RD+K  N++LD     K++DFG  K   +D +       GT  Y
Sbjct: 131 IGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFC-GTPDY 186
Query: 568 LDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           + PE +         D +++GV+L E+L G+
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 87/177 (49%), Gaps = 14/177 (7%)
Query: 428 VAVK--KSKFVDQAK-IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
           VAVK  K   + Q + +D+FI E+  +  ++ RN++RL G  L   + + V E    G+L
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 107
Query: 485 FEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
            + + K +G+       R   + A  + YL S+     IHRD+ + N+LL      K+ D
Sbjct: 108 LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 164
Query: 544 FGASKLVPIDAIQNCTVVQG----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           FG  + +P +   +  V+Q        +  PE L+T   +  SD + FGV L E+ T
Sbjct: 165 FGLMRALPQN--DDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 407 DVIGCGGSGNV-YKGFLPDRTPVAVKKSKFVDQ-AKIDEFIN-ELVVVLQINRRNVVRLL 463
           D +   GSGN      + D+    +   K++++ A IDE +  E++    +   N+VR  
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSW-ERRLRITAETAGVLSYLHSETNVPII 522
              L      ++ E+   G L+E I   G  S  E R       +GV SY HS   + I 
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV-SYCHS---MQIC 138
Query: 523 HRDVKSANILLDENCTP--KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
           HRD+K  N LLD +  P  K+ DFG SK   + +    TV  GT  Y+ PE L   +   
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEYDG 196
Query: 581 K-SDVYSFGVVLVELLTGKMALLSDKPEEER 610
           K +DV+S GV L  +L G      + PEE R
Sbjct: 197 KIADVWSCGVTLYVMLVGAYPF--EDPEEPR 225

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 409 IGCGGSGNVYKG-FLPDRTP---VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLL 463
           IG G  G+V++G ++    P   VA+K  K      + E F+ E + + Q +  ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   E  V  ++ E    G L   +  +K +L     +    + +  L+YL S+     +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FV 513
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N+L+  N   K+ DFG S+ +        +  +  + ++ PE +   + T  S
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 583 DVYSFGVVLVELL 595
           DV+ FGV + E+L
Sbjct: 574 DVWMFGVCMWEIL 586

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 37/271 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++ E+   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 486 EHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   +++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 187 NVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 291
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSN 679
              C      +RPT K++  +L   L+L +N
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 87/177 (49%), Gaps = 14/177 (7%)
Query: 428 VAVK--KSKFVDQAK-IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
           VAVK  K   + Q + +D+FI E+  +  ++ RN++RL G  L   + + V E    G+L
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 485 FEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
            + + K +G+       R   + A  + YL S+     IHRD+ + N+LL      K+ D
Sbjct: 98  LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 154
Query: 544 FGASKLVPIDAIQNCTVVQG----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           FG  + +P +   +  V+Q        +  PE L+T   +  SD + FGV L E+ T
Sbjct: 155 FGLMRALPQN--DDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 14/177 (7%)
Query: 428 VAVK--KSKFVDQAK-IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
           VAVK  K   + Q + +D+FI E+  +  ++ RN++RL G  L   + + V E    G+L
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 107
Query: 485 FEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
            + + K +G+       R   + A  + YL S+     IHRD+ + N+LL      K+ D
Sbjct: 108 LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 164
Query: 544 FGASKLVPID----AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           FG  + +P +     +Q    V     +  PE L+T   +  SD + FGV L E+ T
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQA-KIDEFIN-ELVVVLQINRRNVVRLLGCC 466
           IG G  G      + D+    +   K++++  KIDE +  E++    +   N+VR     
Sbjct: 27  IGAGNFG--VARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGNLSW-ERRLRITAETAGVLSYLHSETNVPIIHRD 525
           L      +V E+   G LFE I   G  S  E R       +GV SY H+   + + HRD
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV-SYAHA---MQVAHRD 140
Query: 526 VKSANILLDENCTP--KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK-S 582
           +K  N LLD +  P  K++DFG SK   + +     V  GT  Y+ PE L   +   K +
Sbjct: 141 LKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV--GTPAYIAPEVLLKKEYDGKVA 198
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSL 612
           DV+S GV L  +L G  A   + PEE ++ 
Sbjct: 199 DVWSCGVTLYVMLVG--AYPFEDPEEPKNF 226

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 14/177 (7%)
Query: 428 VAVK--KSKFVDQAK-IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
           VAVK  K   + Q + +D+FI E+  +  ++ RN++RL G  L   + + V E    G+L
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 101
Query: 485 FEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
            + + K +G+       R   + A  + YL S+     IHRD+ + N+LL      K+ D
Sbjct: 102 LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 158
Query: 544 FGASKLVPID----AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           FG  + +P +     +Q    V     +  PE L+T   +  SD + FGV L E+ T
Sbjct: 159 FGLMRALPQNDDHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 14/177 (7%)
Query: 428 VAVK--KSKFVDQAK-IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
           VAVK  K   + Q + +D+FI E+  +  ++ RN++RL G  L   + + V E    G+L
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 101
Query: 485 FEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
            + + K +G+       R   + A  + YL S+     IHRD+ + N+LL      K+ D
Sbjct: 102 LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 158
Query: 544 FGASKLVPID----AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           FG  + +P +     +Q    V     +  PE L+T   +  SD + FGV L E+ T
Sbjct: 159 FGLMRALPQNDDHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 7/196 (3%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           V+G G  G VY G  L ++  +A+K+    D         E+ +   +  +N+V+ LG  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
            E     +  E V  G+L   +  K     +    I   T  +L  L    +  I+HRD+
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 527 KSANILLDE-NCTPKVSDFGASKLVPIDAIQNCT-VVQGTLGYLDPEYLQTCK--LTDKS 582
           K  N+L++  +   K+SDFG SK   +  I  CT    GTL Y+ PE +          +
Sbjct: 149 KGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 583 DVYSFGVVLVELLTGK 598
           D++S G  ++E+ TGK
Sbjct: 207 DIWSLGCTIIEMATGK 222

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 409 IGCGGSGNVY----KGFLPDRTPVAVKKSKFV------DQAKIDEF----INELVVVLQI 454
           +G G  G V     K    ++    +KKS+F       D   I++F     NE+ ++  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 455 NRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLH 514
           +  N+++L     + +   LV EF   G LFE I  +          I  +    + YLH
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 515 SETNVPIIHRDVKSANILLDEN---CTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
                 I+HRD+K  NILL+        K+ DFG S     D      +  GT  Y+ PE
Sbjct: 164 KHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GTAYYIAPE 218
Query: 572 YLQTCKLTDKSDVYSFGVVLVELLTG 597
            L+  K  +K DV+S GV++  LL G
Sbjct: 219 VLKK-KYNEKCDVWSCGVIMYILLCG 243

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 14/177 (7%)
Query: 428 VAVK--KSKFVDQAK-IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
           VAVK  K   + Q + +D+FI E+  +  ++ RN++RL G  L   + + V E    G+L
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 485 FEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
            + + K +G+       R   + A  + YL S+     IHRD+ + N+LL      K+ D
Sbjct: 98  LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 154
Query: 544 FGASKLVPID----AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           FG  + +P +     +Q    V     +  PE L+T   +  SD + FGV L E+ T
Sbjct: 155 FGLMRALPQNDDHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 14/177 (7%)
Query: 428 VAVK--KSKFVDQAK-IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
           VAVK  K   + Q + +D+FI E+  +  ++ RN++RL G  L   + + V E    G+L
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL 97
Query: 485 FEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
            + + K +G+       R   + A  + YL S+     IHRD+ + N+LL      K+ D
Sbjct: 98  LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD 154
Query: 544 FGASKLVPID----AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           FG  + +P +     +Q    V     +  PE L+T   +  SD + FGV L E+ T
Sbjct: 155 FGLMRALPQNDDHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 84/169 (49%), Gaps = 9/169 (5%)
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWE--RRLR 501
           +NE  ++ ++N R VV L     ET+  L LV   +  G L  HI+  G   +   R + 
Sbjct: 232 LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
             AE    L  LH E    I++RD+K  NILLD++   ++SD G +  VP        V 
Sbjct: 291 YAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV- 346
Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER 610
            GT+GY+ PE ++  + T   D ++ G +L E++ G+      K + +R
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 82/156 (52%), Gaps = 10/156 (6%)
Query: 446 NELVVVLQINRRNVVRLLGCCLETQVP--LLVYEFVGNGTLFEHIHKKGNLSWERRLRIT 503
            E+ ++  +   ++++  GCC +       LV E+V  G+L +++  + ++   + L   
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFA 140
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ- 562
            +    ++YLH++     IHRD+ + N+LLD +   K+ DFG +K VP +  +   V + 
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEXYRVRED 196
Query: 563 --GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
               + +  PE L+  K    SDV+SFGV L ELLT
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 7/196 (3%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           V+G G  G VY G  L ++  +A+K+    D         E+ +   +  +N+V+ LG  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
            E     +  E V  G+L   +  K     +    I   T  +L  L    +  I+HRD+
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 134
Query: 527 KSANILLDE-NCTPKVSDFGASKLVPIDAIQNCT-VVQGTLGYLDPEYLQTCK--LTDKS 582
           K  N+L++  +   K+SDFG SK   +  I  CT    GTL Y+ PE +          +
Sbjct: 135 KGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 192
Query: 583 DVYSFGVVLVELLTGK 598
           D++S G  ++E+ TGK
Sbjct: 193 DIWSLGCTIIEMATGK 208

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 9/170 (5%)
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWE--RRLR 501
           +NE  ++ ++N R VV L     ET+  L LV   +  G L  HI+  G   +   R + 
Sbjct: 232 LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
             AE    L  LH E    I++RD+K  NILLD++   ++SD G +  VP        V 
Sbjct: 291 YAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV- 346
Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS 611
            GT+GY+ PE ++  + T   D ++ G +L E++ G+      K + +R 
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDE-----FINELVVVLQINRRNVVRL 462
           ++G G  G V K    DR        K +++A          + E+ ++ +++  N+++L
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
                ++    +V E    G LF+ I K+   S     RI  +    ++Y+H      I+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IV 143
Query: 523 HRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
           HRD+K  NILL   +++C  K+ DFG S     +      +  GT  Y+ PE L+     
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRGT-YD 200
Query: 580 DKSDVYSFGVVLVELLTG 597
           +K DV+S GV+L  LL+G
Sbjct: 201 EKCDVWSAGVILYILLSG 218

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDE-----FINELVVVLQINRRNVVRL 462
           ++G G  G V K    DR        K +++A          + E+ ++ +++  N+++L
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
                ++    +V E    G LF+ I K+   S     RI  +    ++Y+H      I+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IV 143
Query: 523 HRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCK 577
           HRD+K  NILL   +++C  K+ DFG S        QN  +    GT  Y+ PE L+   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQ----QNTKMKDRIGTAYYIAPEVLRGT- 198
Query: 578 LTDKSDVYSFGVVLVELLTG 597
             +K DV+S GV+L  LL+G
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 413 GSGNV-YKGFLPDRTPVAVKKSKFVDQA-KIDEFIN-ELVVVLQINRRNVVRLLGCCLET 469
           GSGN      + D+    +   K++++  KIDE +  E++    +   N+VR     L  
Sbjct: 27  GSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTP 86
Query: 470 QVPLLVYEFVGNGTLFEHIHKKGNLSW-ERRLRITAETAGVLSYLHSETNVPIIHRDVKS 528
               +V E+   G LFE I   G  S  E R       +GV SY H+   + + HRD+K 
Sbjct: 87  THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHA---MQVCHRDLKL 142
Query: 529 ANILLDENCTP--KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK-SDVY 585
            N LLD +  P  K+ DFG SK   + +    TV  GT  Y+ PE L   +   K +DV+
Sbjct: 143 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLKKEYDGKVADVW 200
Query: 586 SFGVVLVELLTGKMALLSDKPEEERSL 612
           S GV L  +L G  A   + PEE ++ 
Sbjct: 201 SCGVTLYVMLVG--AYPFEDPEEPKNF 225

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 5/160 (3%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           ++ I EL V+ + N   +V   G         +  E +  G+L + + +   +  E   +
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 118
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
           ++      L+YL  +    I+HRDVK +NIL++     K+ DFG S  + ID++ N  V 
Sbjct: 119 VSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFV- 174
Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL 601
            GT  Y+ PE LQ    + +SD++S G+ LVEL  G+  +
Sbjct: 175 -GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 13/147 (8%)
Query: 458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           N+++L           LV++ +  G LF+++ +K  LS +   +I      V+  LH   
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH--- 128
Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
            + I+HRD+K  NILLD++   K++DFG S    +D  +    V GT  YL PE ++ C 
Sbjct: 129 KLNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLREVCGTPSYLAPEIIE-CS 185
Query: 578 LTD-------KSDVYSFGVVLVELLTG 597
           + D       + D++S GV++  LL G
Sbjct: 186 MNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDE-----FINELVVVLQINRRNVVRL 462
           ++G G  G V K    DR        K +++A          + E+ ++ +++  N+++L
Sbjct: 29  MLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
                ++    +V E    G LF+ I K+   S     RI  +    ++Y+H      I+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IV 143
Query: 523 HRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLGYLDPEYLQTC 576
           HRD+K  NILL   +++C  K+ DFG S        Q  T ++   GT  Y+ PE L+  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLST-----CFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 577 KLTDKSDVYSFGVVLVELLTG 597
              +K DV+S GV+L  LL+G
Sbjct: 199 -YDEKCDVWSAGVILYILLSG 218

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 13/147 (8%)
Query: 458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           N+++L           LV++ +  G LF+++ +K  LS +   +I      V+  LH   
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH--- 141
Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
            + I+HRD+K  NILLD++   K++DFG S    +D  +    V GT  YL PE ++ C 
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLRSVCGTPSYLAPEIIE-CS 198
Query: 578 LTD-------KSDVYSFGVVLVELLTG 597
           + D       + D++S GV++  LL G
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 70/146 (47%), Gaps = 7/146 (4%)
Query: 465 CCLETQVPLL-VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           C  +T+  L  V E++  G L  HI         R     AE    L +LHS+    I++
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVY 141
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPI-DAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+K  NILLD++   K++DFG  K   + DA  N     GT  Y+ PE L   K     
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC--GTPDYIAPEILLGQKYNHSV 199
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEE 608
           D +SFGV+L E+L G+        EE
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEE 225

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 441 IDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLFEHIHK-KGNLSWE 497
           I +   E+ ++  +   N+V+  G C E       L+ EF+ +G+L E++ K K  ++ +
Sbjct: 67  IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK 126
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
           ++L+   +    + YL S   V   HRD+ + N+L++     K+ DFG +K +  D  + 
Sbjct: 127 QQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EX 182
Query: 558 CTVV---QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
            TV       + +  PE L   K    SDV+SFGV L ELLT
Sbjct: 183 XTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 441 IDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLFEHIHK-KGNLSWE 497
           I +   E+ ++  +   N+V+  G C E       L+ EF+ +G+L E++ K K  ++ +
Sbjct: 55  IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK 114
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
           ++L+   +    + YL S   V   HRD+ + N+L++     K+ DFG +K +  D  + 
Sbjct: 115 QQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EX 170
Query: 558 CTVV---QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
            TV       + +  PE L   K    SDV+SFGV L ELLT
Sbjct: 171 XTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 112/266 (42%), Gaps = 44/266 (16%)
Query: 428 VAVKKSKFVDQAKIDE-FINELVVVLQINRR-NVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    A   E  ++EL ++  + +  N+V LLG C      L++ E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 486 EHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVP----------IIHRDVKSANILLD 534
             + +K   L  +    I   TA     LH  + V            IHRDV + N+LL 
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198
Query: 535 ENCTPKVSDFGASKLVPIDAIQNCTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVV 590
                K+ DFG ++ +  D+     +V+G     + ++ PE +  C  T +SDV+S+G++
Sbjct: 199 NGHVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 591 LVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL-----KEV 645
           L E+                SL +N    +  N        ++V DG +        K +
Sbjct: 256 LWEIF---------------SLGLNPYPGILVNSKFY----KLVKDGYQMAQPAFAPKNI 296
Query: 646 AKLAARCISVRGEERPTMKEVSLELQ 671
             +   C ++    RPT +++   LQ
Sbjct: 297 YSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 121/271 (44%), Gaps = 37/271 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++  +   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR 129
Query: 486 EHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 291
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSN 679
              C      +RPT K++  +L   L+L +N
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 116/265 (43%), Gaps = 46/265 (17%)
Query: 428 VAVKKSKFVDQAKIDE-FINELVVVLQINRR-NVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    A   E  ++EL ++  + +  N+V LLG C      L++ E+   G L 
Sbjct: 71  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 130
Query: 486 EHIHKKGNLSWERR----------LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE 535
             + +K     ++           L  +++ A  +++L S+     IHRDV + N+LL  
Sbjct: 131 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 187
Query: 536 NCTPKVSDFGASKLVPIDAIQNCTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVL 591
               K+ DFG ++ +  D+     +V+G     + ++ PE +  C  T +SDV+S+G++L
Sbjct: 188 GHVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 244
Query: 592 VELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL-----KEVA 646
            E+                SL +N    +  N        ++V DG +        K + 
Sbjct: 245 WEIF---------------SLGLNPYPGILVNSKF----YKLVKDGYQMAQPAFAPKNIY 285
Query: 647 KLAARCISVRGEERPTMKEVSLELQ 671
            +   C ++    RPT +++   LQ
Sbjct: 286 SIMQACWALEPTHRPTFQQICSFLQ 310

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 9/218 (4%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVY----KGFLPDRTPVAVKKSKFVDQAKIDEFINELVVV 451
           + +K    N+  V+G G  G V     KG         +KK   +    ++  + E  V+
Sbjct: 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 395
Query: 452 LQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVL 510
               +   +  L  C +T   L  V E+V  G L  HI + G       +   AE A  L
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 455
Query: 511 SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDP 570
            +L S+    II+RD+K  N++LD     K++DFG  K    D +       GT  Y+ P
Sbjct: 456 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC-GTPDYIAP 511
Query: 571 EYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           E +         D ++FGV+L E+L G+     +  +E
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 13/147 (8%)
Query: 458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           N+++L           LV++ +  G LF+++ +K  LS +   +I      V+  LH   
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH--- 141
Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
            + I+HRD+K  NILLD++   K++DFG S    +D  +    V GT  YL PE ++ C 
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFS--CQLDPGEKLREVCGTPSYLAPEIIE-CS 198
Query: 578 LTD-------KSDVYSFGVVLVELLTG 597
           + D       + D++S GV++  LL G
Sbjct: 199 MNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 116/265 (43%), Gaps = 46/265 (17%)
Query: 428 VAVKKSKFVDQAKIDE-FINELVVVLQINRR-NVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    A   E  ++EL ++  + +  N+V LLG C      L++ E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 486 EHIHKKGNLSWERR----------LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE 535
             + +K     ++           L  +++ A  +++L S+     IHRDV + N+LL  
Sbjct: 139 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 195
Query: 536 NCTPKVSDFGASKLVPIDAIQNCTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVL 591
               K+ DFG ++ +  D+     +V+G     + ++ PE +  C  T +SDV+S+G++L
Sbjct: 196 GHVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 252
Query: 592 VELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL-----KEVA 646
            E+                SL +N    +  N        ++V DG +        K + 
Sbjct: 253 WEIF---------------SLGLNPYPGILVNSKF----YKLVKDGYQMAQPAFAPKNIY 293
Query: 647 KLAARCISVRGEERPTMKEVSLELQ 671
            +   C ++    RPT +++   LQ
Sbjct: 294 SIMQACWALEPTHRPTFQQICSFLQ 318

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 82/156 (52%), Gaps = 10/156 (6%)
Query: 446 NELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRIT 503
            E+ ++  +   ++V+  GCC +   +   LV E+V  G+L +++  +  +   + L   
Sbjct: 59  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFA 117
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ- 562
            +    ++YLH++     IHR + + N+LLD +   K+ DFG +K VP +  +   V + 
Sbjct: 118 QQICEGMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVRED 173
Query: 563 --GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
               + +  PE L+ CK    SDV+SFGV L ELLT
Sbjct: 174 GDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 82/156 (52%), Gaps = 10/156 (6%)
Query: 446 NELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRIT 503
            E+ ++  +   ++V+  GCC +   +   LV E+V  G+L +++  +  +   + L   
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFA 118
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ- 562
            +    ++YLH++     IHR + + N+LLD +   K+ DFG +K VP +  +   V + 
Sbjct: 119 QQICEGMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVRED 174
Query: 563 --GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
               + +  PE L+ CK    SDV+SFGV L ELLT
Sbjct: 175 GDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 446 NELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAE 505
           NE+ V+ +I   N+V L           LV + V  G LF+ I +KG  + +    +  +
Sbjct: 69  NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ 128
Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
               + YLH    + I+HRD+K  N+L    DE     +SDFG SK+     + +     
Sbjct: 129 VLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTAC-- 183
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           GT GY+ PE L     +   D +S GV+   LL G
Sbjct: 184 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 409 IGCGGSGNVYKG-FLPDRTP---VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLL 463
           IG G  G+V++G ++    P   VA+K  K      + E F+ E + + Q +  ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   E  V  ++ E    G L   +  +K +L     +    + +  L+YL S+     +
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FV 133
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N+L+      K+ DFG S+ +        +  +  + ++ PE +   + T  S
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 193
Query: 583 DVYSFGVVLVELL 595
           DV+ FGV + E+L
Sbjct: 194 DVWMFGVCMWEIL 206

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 121/271 (44%), Gaps = 37/271 (13%)
Query: 428 VAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    +  + + ++E+ ++  I + +N++ LLG C +     ++  +   G L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR 129
Query: 486 EHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
           E++  +                  ++++  +  T + A  + YL S+     IHRD+ + 
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186
Query: 530 NILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFG 588
           N+L+ EN   K++DFG ++ +  ID  +  T  +  + ++ PE L     T +SDV+SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKL 648
           V++ E+ T   +     P EE               L ++L      D       E+  +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEE---------------LFKLLKEGHRMDKPANCTNELYMM 291
Query: 649 AARCISVRGEERPTMKEVSLELQGRLSLMSN 679
              C      +RPT K++  +L   L+L +N
Sbjct: 292 MRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 446 NELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAE 505
           NE+ V+ +I   N+V L      T    LV + V  G LF+ I ++G  + +    +  +
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ 114
Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQN--CTV 560
               + YLH      I+HRD+K  N+L    +EN    ++DFG SK+      QN   + 
Sbjct: 115 VLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME-----QNGIMST 166
Query: 561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
             GT GY+ PE L     +   D +S GV+   LL G
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 70/146 (47%), Gaps = 7/146 (4%)
Query: 465 CCLETQVPLL-VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           C  +T+  L  V E++  G L  HI         R     AE    L +LHS+    I++
Sbjct: 86  CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVY 142
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPI-DAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           RD+K  NILLD++   K++DFG  K   + DA  N     GT  Y+ PE L   K     
Sbjct: 143 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC--GTPDYIAPEILLGQKYNHSV 200
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEE 608
           D +SFGV+L E+L G+        EE
Sbjct: 201 DWWSFGVLLYEMLIGQSPFHGQDEEE 226

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 9/218 (4%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVY----KGFLPDRTPVAVKKSKFVDQAKIDEFINELVVV 451
           + +K    N+  V+G G  G V     KG         +KK   +    ++  + E  V+
Sbjct: 15  DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 74
Query: 452 LQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVL 510
               +   +  L  C +T   L  V E+V  G L  HI + G       +   AE A  L
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 511 SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDP 570
            +L S+    II+RD+K  N++LD     K++DFG  K    D +       GT  Y+ P
Sbjct: 135 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC-GTPDYIAP 190
Query: 571 EYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           E +         D ++FGV+L E+L G+     +  +E
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 128/287 (44%), Gaps = 27/287 (9%)
Query: 434 KFVDQAKID-----EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI 488
           K +D+ +++     +   E+ ++  +N  N+V+L       +   L+ E+   G +F+++
Sbjct: 46  KIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL 105
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
              G +  +       +    + Y H +    I+HRD+K+ N+LLD +   K++DFG S 
Sbjct: 106 VAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSN 162
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPE 607
              +          G   Y  PE  Q  K    + DV+S GV+L  L++G +       +
Sbjct: 163 EFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
Query: 608 EERSLAMN-------FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEE- 659
           E R   +        ++S+  +N L   L   ++N   +  L+++ K   R I+   EE 
Sbjct: 221 ELRERVLRGKYRIPFYMSTDCENLLKRFL---VLNPIKRGTLEQIMK--DRWINAGHEED 275
Query: 660 --RPTMK-EVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTF 703
             +P ++ E+ +  Q R+ +M    Y   +  ES    + +  T+T+
Sbjct: 276 ELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEITATY 322

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 409 IGCGGSGNVYKGFLPDR-TPVAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRL---- 462
           +G GG G V +    D    VA+K+ +     K  E +  E+ ++ ++N  NVV      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 463 --LGCCLETQVPLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSET 517
             L       +PLL  E+   G L +++++  N   L       + ++ +  L YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 518 NVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ 574
              IIHRD+K  NI+L    +    K+ D G +K   +D  + CT   GTL YL PE L+
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLAPELLE 196
Query: 575 TCKLTDKSDVYSFGVVLVELLTG 597
             K T   D +SFG +  E +TG
Sbjct: 197 QKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 409 IGCGGSGNVYKGFLPDR-TPVAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRL---- 462
           +G GG G V +    D    VA+K+ +     K  E +  E+ ++ ++N  NVV      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 463 --LGCCLETQVPLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSET 517
             L       +PLL  E+   G L +++++  N   L       + ++ +  L YLH   
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 142
Query: 518 NVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ 574
              IIHRD+K  NI+L    +    K+ D G +K   +D  + CT   GTL YL PE L+
Sbjct: 143 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLAPELLE 197
Query: 575 TCKLTDKSDVYSFGVVLVELLTG 597
             K T   D +SFG +  E +TG
Sbjct: 198 QKKYTVTVDYWSFGTLAFECITG 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 409 IGCGGSGNVYKG-FLPDRTP---VAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLL 463
           IG G  G+V++G ++    P   VA+K  K      + E F+ E + + Q +  ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G   E  V  ++ E    G L   +  +K +L     +    + +  L+YL S+     +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FV 513
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+ + N+L+      K+ DFG S+ +        +  +  + ++ PE +   + T  S
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 583 DVYSFGVVLVELL 595
           DV+ FGV + E+L
Sbjct: 574 DVWMFGVCMWEIL 586

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 404 NYADVIGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINR 456
           N    +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I  
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 457 R-NVVRLLGCCLETQVPLLVY-EFVGNGTLFEHIHKKGN------------LSWERRLRI 502
             NVV LLG C +   PL+V  EF   G L  ++  K N            L+ E  +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
           + + A  + +L S      IHRD+ + NILL E    K+ DFG ++    D  ++   V+
Sbjct: 150 SFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKIXDFGLAR----DIYKDPDYVR 202
Query: 563 G-----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                  L ++ PE +     T +SDV+SFGV+L E+ +
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 129/287 (44%), Gaps = 27/287 (9%)
Query: 434 KFVDQAKID-----EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI 488
           K +D+ +++     +   E+ ++  +N  N+V+L       +   L+ E+   G +F+++
Sbjct: 43  KIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL 102
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
              G +  +       +    + Y H +    I+HRD+K+ N+LLD +   K++DFG S 
Sbjct: 103 VAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSN 159
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD-KSDVYSFGVVLVELLTGKMALLSDKPE 607
              +          G+  Y  PE  Q  K    + DV+S GV+L  L++G +       +
Sbjct: 160 EFTVGG--KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 217
Query: 608 EERSLAMN-------FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEE- 659
           E R   +        ++S+  +N L   L   ++N   +  L+++ K   R I+   EE 
Sbjct: 218 ELRERVLRGKYRIPFYMSTDCENLLKRFL---VLNPIKRGTLEQIMK--DRWINAGHEED 272
Query: 660 --RPTMK-EVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFTSTF 703
             +P ++ E+ +  Q R+ +M    Y   +  ES    + +  T+T+
Sbjct: 273 ELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEITATY 319

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 116/269 (43%), Gaps = 50/269 (18%)
Query: 428 VAVKKSKFVDQAKIDE-FINELVVVLQINRR-NVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    A   E  ++EL ++  + +  N+V LLG C      L++ E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 486 EHIHKKG--------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANI 531
             + +K                LS    L  +++ A  +++L S+     IHRDV + N+
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 195
Query: 532 LLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT----LGYLDPEYLQTCKLTDKSDVYSF 587
           LL      K+ DFG ++ +  D+     +V+G     + ++ PE +  C  T +SDV+S+
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252
Query: 588 GVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL----- 642
           G++L E+                SL +N    +  N        ++V DG +        
Sbjct: 253 GILLWEIF---------------SLGLNPYPGILVNSKFY----KLVKDGYQMAQPAFAP 293
Query: 643 KEVAKLAARCISVRGEERPTMKEVSLELQ 671
           K +  +   C ++    RPT +++   LQ
Sbjct: 294 KNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 446 NELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRIT 503
            E+ ++  +   ++++  GCC +   +   LV E+V  G+L +++  + ++   + L   
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFA 123
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ- 562
            +    ++YLHS+     IHR++ + N+LLD +   K+ DFG +K VP +  +   V + 
Sbjct: 124 QQICEGMAYLHSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVRED 179
Query: 563 --GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
               + +  PE L+  K    SDV+SFGV L ELLT
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 116/271 (42%), Gaps = 52/271 (19%)
Query: 428 VAVKKSKFVDQAKIDE-FINELVVVLQINRR-NVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    A   E  ++EL ++  + +  N+V LLG C      L++ E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 486 EHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA 529
             + +K                  LS    L  +++ A  +++L S+     IHRDV + 
Sbjct: 139 NFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKN---CIHRDVAAR 195
Query: 530 NILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT----LGYLDPEYLQTCKLTDKSDVY 585
           N+LL      K+ DFG ++ +  D+     +V+G     + ++ PE +  C  T +SDV+
Sbjct: 196 NVLLTNGHVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 252
Query: 586 SFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL--- 642
           S+G++L E+                SL +N    +  N        ++V DG +      
Sbjct: 253 SYGILLWEIF---------------SLGLNPYPGILVNSKF----YKLVKDGYQMAQPAF 293
Query: 643 --KEVAKLAARCISVRGEERPTMKEVSLELQ 671
             K +  +   C ++    RPT +++   LQ
Sbjct: 294 APKNIYSIMQACWALEPTHRPTFQQICSFLQ 324

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 408 VIGCGGSGNVYKGFLP----DRTPVAVKKSK---FVDQAKIDEFINELVVVLQINRRNVV 460
           ++G G  G VY+G       ++  VAVK  K    +D    ++F++E V++  ++  ++V
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHPHIV 76
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNV 519
           +L+G  +E +   ++ E    G L  ++ + K +L     +  + +    ++YL S   +
Sbjct: 77  KLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---I 132
Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
             +HRD+   NIL+      K+ DFG S+ +  +     +V +  + ++ PE +   + T
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+ F V + E+L+
Sbjct: 193 TASDVWMFAVCMWEILS 209

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 446 NELVVVLQINRRNVVRLLGCCLET--QVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRIT 503
            E+ ++  +   ++++  GCC +   +   LV E+V  G+L +++  + ++   + L   
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFA 123
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ- 562
            +    ++YLH++     IHR++ + N+LLD +   K+ DFG +K VP +  +   V + 
Sbjct: 124 QQICEGMAYLHAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVRED 179
Query: 563 --GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
               + +  PE L+  K    SDV+SFGV L ELLT
Sbjct: 180 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 408 VIGCGGSGNVYKGFLP----DRTPVAVKKSK---FVDQAKIDEFINELVVVLQINRRNVV 460
           ++G G  G VY+G       ++  VAVK  K    +D    ++F++E V++  ++  ++V
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHPHIV 72
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNV 519
           +L+G  +E +   ++ E    G L  ++ + K +L     +  + +    ++YL S   +
Sbjct: 73  KLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---I 128
Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
             +HRD+   NIL+      K+ DFG S+ +  +     +V +  + ++ PE +   + T
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+ F V + E+L+
Sbjct: 189 TASDVWMFAVCMWEILS 205

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 408 VIGCGGSGNVYKGFLP----DRTPVAVKKSK---FVDQAKIDEFINELVVVLQINRRNVV 460
           ++G G  G VY+G       ++  VAVK  K    +D    ++F++E V++  ++  ++V
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHPHIV 88
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNV 519
           +L+G  +E +   ++ E    G L  ++ + K +L     +  + +    ++YL S   +
Sbjct: 89  KLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---I 144
Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
             +HRD+   NIL+      K+ DFG S+ +  +     +V +  + ++ PE +   + T
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 580 DKSDVYSFGVVLVELLT 596
             SDV+ F V + E+L+
Sbjct: 205 TASDVWMFAVCMWEILS 221

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 10/164 (6%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERR- 499
           +E   E+ V+  +   N+V+      E     +V ++   G LF+ I+ +KG L  E + 
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV--PIDAIQN 557
           L    +    L ++H      I+HRD+KS NI L ++ T ++ DFG ++++   ++  + 
Sbjct: 128 LDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL 601
           C    GT  YL PE  +     +KSD+++ G VL EL T K A 
Sbjct: 185 CI---GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF 225

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 99/220 (45%), Gaps = 16/220 (7%)
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           ++ + + +   E+ ++  +N  N+V+L       +   LV E+   G +F+++   G + 
Sbjct: 52  LNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
            +       +    + Y H +    I+HRD+K+ N+LLD +   K++DFG S        
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-- 166
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM 614
                  G+  Y  PE  Q  K    + DV+S GV+L  L++G +       +E R   +
Sbjct: 167 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 226
Query: 615 N-------FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAK 647
                   ++S+  +N L + L   I+N   +  L+++ K
Sbjct: 227 RGKYRIPFYMSTDCENLLKKFL---ILNPSKRGTLEQIMK 263

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 409 IGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINRR-NVV 460
           +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I    NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 461 RLLGCCLETQVPLLV-YEFVGNGTLFEHIHKKGN--------------LSWERRLRITAE 505
            LLG C +   PL+V  EF   G L  ++  K N              L+ E  +  + +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG-- 563
            A  + +L S      IHRD+ + NILL E    K+ DFG ++ +  D      V +G  
Sbjct: 157 VAKGMEFLASRKX---IHRDLAARNILLSEKNVVKICDFGLARDIXKDP---DXVRKGDA 210
Query: 564 --TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
              L ++ PE +     T +SDV+SFGV+L E+ +
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 105/235 (44%), Gaps = 32/235 (13%)
Query: 434 KFVDQAKID-----EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI 488
           K +D+ +++     +   E+ ++  +N  N+V+L       +   LV E+   G +F+++
Sbjct: 46  KIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL 105
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
              G +  +       +    + Y H +    I+HRD+K+ N+LLD +   K++DFG S 
Sbjct: 106 VAHGRMKEKEARAKFRQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSN 162
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPE 607
              +          G+  Y  PE  Q  K    + DV+S GV+L  L++G +       +
Sbjct: 163 EFTVG--NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
Query: 608 EERSLAMN-------FLSS--------------LKQNRLLEILDNRIVNDGNKQQ 641
           E R   +        ++S+              +K+  L +I+ +R +N G++++
Sbjct: 221 ELRERVLRGKYRIPFYMSTDCENLLKKLLVLNPIKRGSLEQIMKDRWMNVGHEEE 275

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 413 GSGNV-YKGFLPDRTPVAVKKSKFVDQA-KIDEFIN-ELVVVLQINRRNVVRLLGCCLET 469
           GSGN      + D+    +   K++++  KIDE +  E++    +   N+VR     L  
Sbjct: 28  GSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTP 87
Query: 470 QVPLLVYEFVGNGTLFEHIHKKGNLSW-ERRLRITAETAGVLSYLHSETNVPIIHRDVKS 528
               +V E+   G LFE I   G  S  E R       +GV SY H+   + + HRD+K 
Sbjct: 88  THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHA---MQVCHRDLKL 143
Query: 529 ANILLDENCTP--KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK-SDVY 585
            N LLD +  P  K+  FG SK   + +    TV  GT  Y+ PE L   +   K +DV+
Sbjct: 144 ENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLKKEYDGKVADVW 201
Query: 586 SFGVVLVELLTGKMALLSDKPEEERSL 612
           S GV L  +L G  A   + PEE ++ 
Sbjct: 202 SCGVTLYVMLVG--AYPFEDPEEPKNF 226

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 123/279 (44%), Gaps = 58/279 (20%)
Query: 426 TPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
           T VAVK  K     +++ + ++E  V+ Q+N  +V++L G C +    LL+ E+   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 485 -------------------------FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNV 519
                                     +H  ++  L+    +    + +  + YL     +
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA-LTMGDLISFAWQISQGMQYL---AEM 169
Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
            ++HRD+ + NIL+ E    K+SDFG S+    D  +  + V+ + G +  +++    L 
Sbjct: 170 SLVHRDLAARNILVAEGRKMKISDFGLSR----DVYEEDSXVKRSQGRIPVKWMAIESLF 225
Query: 580 D-----KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD--NR 632
           D     +SDV+SFGV+L E++T               L  N    +   RL  +L   +R
Sbjct: 226 DHIYTTQSDVWSFGVLLWEIVT---------------LGGNPYPGIPPERLFNLLKTGHR 270
Query: 633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
           +    N  +  E+ +L  +C     ++RP   ++S +L+
Sbjct: 271 MERPDNCSE--EMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 99/220 (45%), Gaps = 16/220 (7%)
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           ++ + + +   E+ ++  +N  N+V+L       +   LV E+   G +F+++   G + 
Sbjct: 52  LNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
            +       +    + Y H +    I+HRD+K+ N+LLD +   K++DFG S        
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-- 166
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM 614
                  G+  Y  PE  Q  K    + DV+S GV+L  L++G +       +E R   +
Sbjct: 167 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 226
Query: 615 N-------FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAK 647
                   ++S+  +N L + L   I+N   +  L+++ K
Sbjct: 227 RGKYRIPFYMSTDCENLLKKFL---ILNPSKRGTLEQIMK 263

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 404 NYADVIGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINR 456
           N    +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I  
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 457 R-NVVRLLGCCLETQVPLLVY-EFVGNGTLFEHIHKKGN------------LSWERRLRI 502
             NVV LLG C +   PL+V  EF   G L  ++  K N            L+ E  +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
           + + A  + +L S      IHRD+ + NILL E    K+ DFG ++    D  ++   V+
Sbjct: 150 SFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVR 202
Query: 563 G-----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                  L ++ PE +     T +SDV+SFGV+L E+ +
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 99/220 (45%), Gaps = 16/220 (7%)
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           ++ + + +   E+ ++  +N  N+V+L       +   LV E+   G +F+++   G + 
Sbjct: 52  LNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
            +       +    + Y H +    I+HRD+K+ N+LLD +   K++DFG S        
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-- 166
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM 614
                  G+  Y  PE  Q  K    + DV+S GV+L  L++G +       +E R   +
Sbjct: 167 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 226
Query: 615 N-------FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAK 647
                   ++S+  +N L + L   I+N   +  L+++ K
Sbjct: 227 RGKYRIPFYMSTDCENLLKKFL---ILNPSKRGTLEQIMK 263

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 123/279 (44%), Gaps = 58/279 (20%)
Query: 426 TPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
           T VAVK  K     +++ + ++E  V+ Q+N  +V++L G C +    LL+ E+   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 485 -------------------------FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNV 519
                                     +H  ++  L+    +    + +  + YL     +
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA-LTMGDLISFAWQISQGMQYL---AEM 169
Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
            ++HRD+ + NIL+ E    K+SDFG S+    D  +  + V+ + G +  +++    L 
Sbjct: 170 KLVHRDLAARNILVAEGRKMKISDFGLSR----DVYEEDSXVKRSQGRIPVKWMAIESLF 225
Query: 580 D-----KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD--NR 632
           D     +SDV+SFGV+L E++T               L  N    +   RL  +L   +R
Sbjct: 226 DHIYTTQSDVWSFGVLLWEIVT---------------LGGNPYPGIPPERLFNLLKTGHR 270
Query: 633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
           +    N  +  E+ +L  +C     ++RP   ++S +L+
Sbjct: 271 MERPDNCSE--EMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 24/224 (10%)
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           ++ + + +   E+ ++  +N  N+V+L       +   LV E+   G +F+++   G + 
Sbjct: 52  LNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV----P 551
            +       +    + Y H +    I+HRD+K+ N+LLD +   K++DFG S        
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK 168
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPEEER 610
           +DA   C    G   Y  PE  Q  K    + DV+S GV+L  L++G +       +E R
Sbjct: 169 LDAF--C----GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 222
Query: 611 SLAMN-------FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAK 647
              +        ++S+  +N L + L   I+N   +  L+++ K
Sbjct: 223 ERVLRGKYRIPFYMSTDCENLLKKFL---ILNPSKRGTLEQIMK 263

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 123/279 (44%), Gaps = 58/279 (20%)
Query: 426 TPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
           T VAVK  K     +++ + ++E  V+ Q+N  +V++L G C +    LL+ E+   G+L
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 485 -------------------------FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNV 519
                                     +H  ++  L+    +    + +  + YL     +
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA-LTMGDLISFAWQISQGMQYL---AEM 169
Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
            ++HRD+ + NIL+ E    K+SDFG S+    D  +  + V+ + G +  +++    L 
Sbjct: 170 KLVHRDLAARNILVAEGRKMKISDFGLSR----DVYEEDSYVKRSQGRIPVKWMAIESLF 225
Query: 580 D-----KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD--NR 632
           D     +SDV+SFGV+L E++T               L  N    +   RL  +L   +R
Sbjct: 226 DHIYTTQSDVWSFGVLLWEIVT---------------LGGNPYPGIPPERLFNLLKTGHR 270
Query: 633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
           +    N  +  E+ +L  +C     ++RP   ++S +L+
Sbjct: 271 MERPDNCSE--EMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 8/172 (4%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           + K K V++ ++     EL ++  +    +V L     + +   +V + +  G L  H+ 
Sbjct: 48  MNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ 107
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           +  +   E       E    L YL ++    IIHRD+K  NILLDE+    ++DF  + +
Sbjct: 108 QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAM 164
Query: 550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS---DVYSFGVVLVELLTGK 598
           +P +     T + GT  Y+ PE   + K    S   D +S GV   ELL G+
Sbjct: 165 LPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 121/279 (43%), Gaps = 49/279 (17%)
Query: 407 DVIGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           ++IG GG G V+K     D     +K+ K+ ++    +   E+  + +++  N+V   GC
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGC 72
Query: 466 C----------------LETQVPLLVYEFVGNGTLFEHIHKKGNLSWER--RLRITAETA 507
                             +T+   +  EF   GTL + I K+     ++   L +  +  
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 508 GVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGY 567
             + Y+HS+    +I+RD+K +NI L +    K+ DFG    +  D  +  +  +GTL Y
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS--KGTLRY 187
Query: 568 LDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE 627
           + PE + +     + D+Y+ G++L ELL      + D   E       F + L+   + +
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLH-----VCDTAFE----TSKFFTDLRDGIISD 238
Query: 628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           I D            K+   L  + +S + E+RP   E+
Sbjct: 239 IFD------------KKEKTLLQKLLSKKPEDRPNTSEI 265

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNVYKGFLPDRT---PVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y  +  IG G  G V   F  D      VAVKK    F +Q        ELV++ 
Sbjct: 19  TVLKRYQQLKPIGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 76
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + IH +  L  ER   +  + 
Sbjct: 77  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHME--LDHERMSYLLYQM 133
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++    + +    VV  T  
Sbjct: 134 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVV--TRY 188
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ EL+ G +
Sbjct: 189 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 221

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 10/127 (7%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           L+ E++  G LF  + ++G    +      AE +  L +LH +    II+RD+K  NI+L
Sbjct: 98  LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIML 154
Query: 534 DENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLGYLDPEYLQTCKLTDKSDVYSFGVV 590
           +     K++DFG  K    ++I + TV     GT+ Y+ PE L         D +S G +
Sbjct: 155 NHQGHVKLTDFGLCK----ESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210
Query: 591 LVELLTG 597
           + ++LTG
Sbjct: 211 MYDMLTG 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 10/127 (7%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           L+ E++  G LF  + ++G    +      AE +  L +LH +    II+RD+K  NI+L
Sbjct: 98  LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIML 154
Query: 534 DENCTPKVSDFGASKLVPIDAIQNCTVVQ---GTLGYLDPEYLQTCKLTDKSDVYSFGVV 590
           +     K++DFG  K    ++I + TV     GT+ Y+ PE L         D +S G +
Sbjct: 155 NHQGHVKLTDFGLCK----ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210
Query: 591 LVELLTG 597
           + ++LTG
Sbjct: 211 MYDMLTG 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 100/220 (45%), Gaps = 16/220 (7%)
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           ++ + + +   E+ ++  +N  N+V+L       +   LV E+   G +F+++   G   
Sbjct: 45  LNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--- 101
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
           W +     A+   ++S +       I+HRD+K+ N+LLD +   K++DFG S        
Sbjct: 102 WMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-- 159
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM 614
                  G+  Y  PE  Q  K    + DV+S GV+L  L++G +       +E R   +
Sbjct: 160 NKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 219
Query: 615 N-------FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAK 647
                   ++S+  +N L + L   I+N   +  L+++ K
Sbjct: 220 RGKYRIPFYMSTDCENLLKKFL---ILNPSKRGTLEQIMK 256

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 113/279 (40%), Gaps = 52/279 (18%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ ++N +N+V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKLNHQNIV 111
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           R +G  L++    ++ E +  G L      K  L   R       +  +L  LH   ++ 
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 521 ----------IIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQG---- 563
                      IHRD+ + N LL         K+ DFG ++    D  +     +G    
Sbjct: 166 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 221
Query: 564 -TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++ PE       T K+D +SFGV+L E+                SL      S   
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKSN 266
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
             +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 267 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 305

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 52/279 (18%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK     + +Q ++D F+ E +++ + N +N+V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD-FLMEALIISKFNHQNIV 111
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           R +G  L++    ++ E +  G L      K  L   R       +  +L  LH   ++ 
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 521 ----------IIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQG---- 563
                      IHRD+ + N LL         K+ DFG ++    D  +     +G    
Sbjct: 166 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 221
Query: 564 -TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++ PE       T K+D +SFGV+L E+                SL      S   
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKSN 266
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
             +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 267 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 305

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 413 GSGNV-YKGFLPDRTPVAVKKSKFVDQA-KIDEFIN-ELVVVLQINRRNVVRLLGCCLET 469
           GSGN      + D+    +   K++++  KIDE +  E++    +   N+VR     L  
Sbjct: 28  GSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTP 87
Query: 470 QVPLLVYEFVGNGTLFEHIHKKGNLSW-ERRLRITAETAGVLSYLHSETNVPIIHRDVKS 528
               +V E+   G LFE I   G  S  E R       +GV SY H+   + + HRD+K 
Sbjct: 88  THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHA---MQVCHRDLKL 143
Query: 529 ANILLDENCTP--KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK-SDVY 585
            N LLD +  P  K+  FG SK   + +    TV  GT  Y+ PE L   +   K +DV+
Sbjct: 144 ENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV--GTPAYIAPEVLLKKEYDGKVADVW 201
Query: 586 SFGVVLVELLTGKMALLSDKPEEERSL 612
           S GV L  +L G  A   + PEE ++ 
Sbjct: 202 SCGVTLYVMLVG--AYPFEDPEEPKNF 226

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 385 QSSEKAKIFTEEEIKTVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSK-FVDQAK 440
           +SS K KI  E+       +  D+  IG G  G+V K    P    +AVK+ +  VD+ +
Sbjct: 4   ESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE 63
Query: 441 IDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK------KGN 493
             + + +L VV++ +    +V+  G         +  E +   T F+  +K         
Sbjct: 64  QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS--TSFDKFYKYVYSVLDDV 121
Query: 494 LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID 553
           +  E   +IT  T   L++L  + N+ IIHRD+K +NILLD +   K+ DFG S  + +D
Sbjct: 122 IPEEILGKITLATVKALNHL--KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL-VD 178
Query: 554 AIQNCTVVQGTLGYLDPEYLQTCKLTD----KSDVYSFGVVLVELLTGK 598
           +I   T   G   Y+ PE +           +SDV+S G+ L EL TG+
Sbjct: 179 SIAK-TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 401 VTNNYADV--IGCGGSGNVY----KGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           +++ Y  V  +G G  G V     K    +R    +KKS     +     ++E+ V+ Q+
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 455 NRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLH 514
           +  N+++L     + +   LV E    G LF+ I  +   S      I  +     +YLH
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLH 138
Query: 515 SETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
                 I+HRD+K  N+LL+    +   K+ DFG S    +       +  GT  Y+ PE
Sbjct: 139 KHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYIAPE 193
Query: 572 YLQTCKLTDKSDVYSFGVVLVELLTG 597
            L+  K  +K DV+S GV+L  LL G
Sbjct: 194 VLRK-KYDEKCDVWSCGVILYILLCG 218

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 33/214 (15%)
Query: 455 NRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWER--RLRITAETAGVLSY 512
           N +N  R    CL  Q+     EF   GTL + I K+     ++   L +  +    + Y
Sbjct: 97  NSKNSSRSKTKCLFIQM-----EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 151
Query: 513 LHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
           +HS+    +IHRD+K +NI L +    K+ DFG    +  D  +  T  +GTL Y+ PE 
Sbjct: 152 IHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRYMSPEQ 206
Query: 573 LQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR 632
           + +     + D+Y+ G++L ELL      + D   E       F + L+   + +I D  
Sbjct: 207 ISSQDYGKEVDLYALGLILAELLH-----VCDTAFE----TSKFFTDLRDGIISDIFD-- 255
Query: 633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                     K+   L  + +S + E+RP   E+
Sbjct: 256 ----------KKEKTLLQKLLSKKPEDRPNTSEI 279

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 99/220 (45%), Gaps = 16/220 (7%)
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           ++ + + +   E+ ++  +N  N+V+L       +   LV E+   G +F+++   G + 
Sbjct: 52  LNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK 111
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
            +       +    + Y H +    I+HRD+K+ N+LLD +   K++DFG S        
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-- 166
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM 614
                  G+  Y  PE  Q  K    + DV+S GV+L  L++G +       +E R   +
Sbjct: 167 NKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 226
Query: 615 N-------FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAK 647
                   ++S+  +N L + L   I+N   +  L+++ K
Sbjct: 227 RGKYRIPFYMSTDCENLLKKFL---ILNPSKRGTLEQIMK 263

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 116/280 (41%), Gaps = 54/280 (19%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ ++N +N+V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKLNHQNIV 97
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETA-GVLSYLHSETNV 519
           R +G  L++    ++ E +  G L   +        E R R +  ++  +L  LH   ++
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 150
Query: 520 P----------IIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQG--- 563
                       IHRD+ + N LL         K+ DFG ++    D  +     +G   
Sbjct: 151 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCA 206
Query: 564 --TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK 621
              + ++ PE       T K+D +SFGV+L E+                SL      S  
Sbjct: 207 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKS 251
Query: 622 QNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
              +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 252 NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 291

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 128/306 (41%), Gaps = 50/306 (16%)
Query: 404 NYADVIGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINR 456
           N    +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I  
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 457 R-NVVRLLGCCLETQVPLLV-YEFVGNGTLFEHIHKKGN---------------LSWERR 499
             NVV LLG C +   PL+V  EF   G L  ++  K N               L+ E  
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT 559
           +  + + A  + +L S      IHRD+ + NILL E    K+ DFG ++ +  D      
Sbjct: 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD---X 204
Query: 560 VVQG----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
           V +G     L ++ PE +     T +SDV+SFGV+L E+ +     L   P     +   
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDEE 259
Query: 616 FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS 675
           F   LK+   +   D             E+ +    C      +RPT  E+ +E  G L 
Sbjct: 260 FCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSEL-VEHLGNL- 308
Query: 676 LMSNGQ 681
           L +N Q
Sbjct: 309 LQANAQ 314

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 52/279 (18%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ + N +N+V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 111
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           R +G  L++    ++ E +  G L      K  L   R       +  +L  LH   ++ 
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 521 ----------IIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQG---- 563
                      IHRD+ + N LL         K+ DFG ++    D  +     +G    
Sbjct: 166 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 221
Query: 564 -TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++ PE       T K+D +SFGV+L E+                SL      S   
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKSN 266
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
             +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 267 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 305

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 409 IGCGGSGNVY----KGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +G G  G V     K    +R    +KKS     +     ++E+ V+ Q++  N+++L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
              + +   LV E    G LF+ I  +   S      I  +     +YLH      I+HR
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN---IVHR 128
Query: 525 DVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           D+K  N+LL+    +   K+ DFG S    +       +  GT  Y+ PE L+  K  +K
Sbjct: 129 DLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYIAPEVLRK-KYDEK 185
Query: 582 SDVYSFGVVLVELLTG 597
            DV+S GV+L  LL G
Sbjct: 186 CDVWSCGVILYILLCG 201

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 124/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E +     LF+ I ++G L  E       +    + + H   
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 131
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 132 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 188
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 227
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 228 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQ 257

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSW-ERRLRITAE 505
           E++    +   N+VR     L      +V E+   G LFE I   G  S  E R      
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 124
Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTP--KVSDFGASKLVPIDAIQNCTVVQG 563
            +GV SY H+   + + HRD+K  N LLD +  P  K+ DFG SK   + +    TV  G
Sbjct: 125 ISGV-SYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--G 178
Query: 564 TLGYLDPEYLQTCKLTDK-SDVYSFGVVLVELLTGKMALLSDKPEEERSL 612
           T  Y+ PE L   +   K +DV+S GV L  +L G  A   + PEE ++ 
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG--AYPFEDPEEPKNF 226

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 54/280 (19%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ + N +N+V
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 103
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETA-GVLSYLHSETNV 519
           R +G  L++    ++ E +  G L   +        E R R +  ++  +L  LH   ++
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 156
Query: 520 P----------IIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQG--- 563
                       IHRD+ + N LL         K+ DFG ++    D  +     +G   
Sbjct: 157 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCA 212
Query: 564 --TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK 621
              + ++ PE       T K+D +SFGV+L E+                SL      S  
Sbjct: 213 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKS 257
Query: 622 QNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
              +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 258 NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 297

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 52/279 (18%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ + N +N+V
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 88
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           R +G  L++    ++ E +  G L      K  L   R       +  +L  LH   ++ 
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIA 142
Query: 521 ----------IIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQG---- 563
                      IHRD+ + N LL         K+ DFG ++    D  +     +G    
Sbjct: 143 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 198
Query: 564 -TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++ PE       T K+D +SFGV+L E+                SL      S   
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKSN 243
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
             +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 244 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 282

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 52/279 (18%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ + N +N+V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 97
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           R +G  L++    ++ E +  G L      K  L   R       +  +L  LH   ++ 
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 521 ----------IIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQG---- 563
                      IHRD+ + N LL         K+ DFG ++    D  +     +G    
Sbjct: 152 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 207
Query: 564 -TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++ PE       T K+D +SFGV+L E+                SL      S   
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKSN 252
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
             +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 253 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 291

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 52/279 (18%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ + N +N+V
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 96
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           R +G  L++    ++ E +  G L      K  L   R       +  +L  LH   ++ 
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 521 ----------IIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQG---- 563
                      IHRD+ + N LL         K+ DFG ++    D  +     +G    
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 206
Query: 564 -TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++ PE       T K+D +SFGV+L E+                SL      S   
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKSN 251
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
             +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 252 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 290

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 52/279 (18%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ + N +N+V
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 96
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           R +G  L++    ++ E +  G L      K  L   R       +  +L  LH   ++ 
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 521 ----------IIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQG---- 563
                      IHRD+ + N LL         K+ DFG ++    D  +     +G    
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 206
Query: 564 -TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++ PE       T K+D +SFGV+L E+                SL      S   
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKSN 251
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
             +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 252 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 290

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 27/225 (12%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTP------VAVKKSKFVDQAKI-DEFINEL 448
           +EI      + + +G    G VYKG L    P      VA+K  K   +  + +EF +E 
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 80
Query: 449 VVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI-----HK-----------KG 492
           ++  ++   NVV LLG   + Q   +++ +  +G L E +     H            K 
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 493 NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV-P 551
            L     + + A+ A  + YL S     ++H+D+ + N+L+ +    K+SD G  + V  
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
            D  +        + ++ PE +   K +  SD++S+GVVL E+ +
Sbjct: 198 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 27/225 (12%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTP------VAVKKSKFVDQAKI-DEFINEL 448
           +EI      + + +G    G VYKG L    P      VA+K  K   +  + +EF +E 
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 449 VVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI-----HK-----------KG 492
           ++  ++   NVV LLG   + Q   +++ +  +G L E +     H            K 
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 493 NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV-P 551
            L     + + A+ A  + YL S     ++H+D+ + N+L+ +    K+SD G  + V  
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
            D  +        + ++ PE +   K +  SD++S+GVVL E+ +
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 52/279 (18%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ + N +N+V
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 137
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           R +G  L++    ++ E +  G L      K  L   R       +  +L  LH   ++ 
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 521 ----------IIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQG---- 563
                      IHRD+ + N LL         K+ DFG ++    D  +     +G    
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAM 247
Query: 564 -TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++ PE       T K+D +SFGV+L E+                SL      S   
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKSN 292
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
             +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 293 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 331

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 109/275 (39%), Gaps = 44/275 (16%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ + N +N+V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 97
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           R +G  L++    ++ E +  G L      K  L   R       +  +L  LH   ++ 
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 521 ----------IIHRDVKSANILLD---ENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLG 566
                      IHRD+ + N LL         K+ DFG A  +      +        + 
Sbjct: 152 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK 211
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL 626
           ++ PE       T K+D +SFGV+L E+                SL      S     +L
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKSNQEVL 256
Query: 627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
           E + +    D  K     V ++  +C   + E+RP
Sbjct: 257 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 291

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 6/133 (4%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANIL 532
            +V E+V  G LF++I K G L  +   R+  +    + Y H      ++HRD+K  N+L
Sbjct: 92  FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVL 148
Query: 533 LDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVL 591
           LD +   K++DFG S ++        +   G+  Y  PE +        + D++S GV+L
Sbjct: 149 LDAHMNAKIADFGLSNMMSDGEFLRXSC--GSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206
Query: 592 VELLTGKMALLSD 604
             LL G +    D
Sbjct: 207 YALLCGTLPFDDD 219

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 52/279 (18%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ + N +N+V
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 113
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           R +G  L++    ++ E +  G L      K  L   R       +  +L  LH   ++ 
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIA 167
Query: 521 ----------IIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQG---- 563
                      IHRD+ + N LL         K+ DFG ++    D  +     +G    
Sbjct: 168 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 223
Query: 564 -TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++ PE       T K+D +SFGV+L E+                SL      S   
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKSN 268
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
             +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 269 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 307

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 177
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 177
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 132
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 133 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 189
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 228
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 229 --RQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 52/279 (18%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ + N +N+V
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 123
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           R +G  L++    ++ E +  G L      K  L   R       +  +L  LH   ++ 
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDL------KSFLRETRPRPSQPSSLAMLDLLHVARDIA 177
Query: 521 ----------IIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQG---- 563
                      IHRD+ + N LL         K+ DFG ++    D  +     +G    
Sbjct: 178 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAM 233
Query: 564 -TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ 622
             + ++ PE       T K+D +SFGV+L E+                SL      S   
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKSN 278
Query: 623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
             +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 279 QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 317

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 54/280 (19%)
Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVV 460
           +G G  G VY+G +      P    VAVK    V  +Q ++D F+ E +++ + N +N+V
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIV 114
Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETA-GVLSYLHSETNV 519
           R +G  L++    ++ E +  G L   +        E R R +  ++  +L  LH   ++
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLR-------ETRPRPSQPSSLAMLDLLHVARDI 167
Query: 520 P----------IIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQG--- 563
                       IHRD+ + N LL         K+ DFG ++    D  +     +G   
Sbjct: 168 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCA 223
Query: 564 --TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK 621
              + ++ PE       T K+D +SFGV+L E+                SL      S  
Sbjct: 224 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF---------------SLGYMPYPSKS 268
Query: 622 QNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
              +LE + +    D  K     V ++  +C   + E+RP
Sbjct: 269 NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP 308

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 147
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 148 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 204
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 243
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 244 --RQRVSSECQHLIRWCLALRPSDRPTFEEI 272

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 184
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIGGQVFF 223
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 224 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 174
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 175 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 231
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 270
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 271 --RQRVSSECQHLIRWCLALRPSDRPTFEEI 299

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 146
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 147 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 203
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 242
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 243 --RQRVSSECQHLIRWCLALRPSDRPTFEEI 271

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 409 IGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINRR-NVV 460
           +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I    NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 461 RLLGCCLETQVPLLVY-EFVGNGTLFEHIHKKGN----------------LSWERRLRIT 503
            LLG C +   PL+V  EF   G L  ++  K N                L+ E  +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            + A  + +L S      IHRD+ + NILL E    K+ DFG ++ +  D      V +G
Sbjct: 146 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD---XVRKG 199
Query: 564 ----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                L ++ PE +     T +SDV+SFGV+L E+ +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 131/290 (45%), Gaps = 43/290 (14%)
Query: 391 KIFTEEEIKTVTNNY--ADVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID-- 442
           K+   +E + + + Y    ++G GG G+VY G  + D  PVA+K   K +  D  ++   
Sbjct: 31  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 90
Query: 443 -EFINELVVVLQINR--RNVVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWER 498
                E+V++ +++     V+RLL         +L+ E       LF+ I ++G L  E 
Sbjct: 91  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 150
Query: 499 RLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQN 557
                 +    + + H   N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +  
Sbjct: 151 ARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY- 205
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF 616
            T   GT  Y  PE+++  +   +S  V+S G++L +++ G +    D+           
Sbjct: 206 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------- 253
Query: 617 LSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                     EI+  ++     ++   E   L   C+++R  +RPT +E+
Sbjct: 254 ----------EIIRGQVFF--RQRVSSECQHLIRWCLALRPSDRPTFEEI 291

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 9/225 (4%)
Query: 404 NYADVIGCGGSGNVYKG-FLPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNV 459
           ++  VIG G  G V       +    AVK   K   + + +    ++E  V+L+  +   
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 460 VRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETN 518
           +  L    +T   L  V +++  G LF H+ ++      R     AE A  L YLHS   
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS--- 157
Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           + I++RD+K  NILLD      ++DFG  K   I+     +   GT  YL PE L     
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 579 TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN 623
               D +  G VL E+L G     S    E     +N    LK N
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 261

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 127/303 (41%), Gaps = 53/303 (17%)
Query: 409 IGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINRR-NVV 460
           +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I    NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 461 RLLGCCLETQVPLLVY-EFVGNGTLFEHIHKKGN----------------LSWERRLRIT 503
            LLG C +   PL+V  EF   G L  ++  K N                L+ E  +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            + A  + +L S      IHRD+ + NILL E    K+ DFG ++    D  ++   V+ 
Sbjct: 146 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRK 198
Query: 564 -----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
                 L ++ PE +     T +SDV+SFGV+L E+ +     L   P     +   F  
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDEEFCR 253
Query: 619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS 678
            LK+   +   D             E+ +    C      +RPT  E+ +E  G L L +
Sbjct: 254 RLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSEL-VEHLGNL-LQA 302
Query: 679 NGQ 681
           N Q
Sbjct: 303 NAQ 305

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 184
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 223
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 224 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 147
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 148 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 204
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 243
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 244 --RQRVSXECQHLIRWCLALRPSDRPTFEEIQ 273

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 128 NXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 184
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 223
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 224 --RQRVSXECQHLIRWCLALRPSDRPTFEEIQ 253

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 115/278 (41%), Gaps = 59/278 (21%)
Query: 428 VAVKKSKFVDQAKIDE-FINELVVVLQINRR-NVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           VAVK  K    A   E  ++EL ++  + +  N+V LLG C      L++ E+   G L 
Sbjct: 64  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 123
Query: 486 EHIHKKGN-----------------------LSWERRLRITAETAGVLSYLHSETNVPII 522
             + +K                         L     L  +++ A  +++L S+     I
Sbjct: 124 NFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CI 180
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT----LGYLDPEYLQTCKL 578
           HRDV + N+LL      K+ DFG ++ +  D+     +V+G     + ++ PE +  C  
Sbjct: 181 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWMAPESIFDCVY 237
Query: 579 TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
           T +SDV+S+G++L E+                SL +N    +  N        ++V DG 
Sbjct: 238 TVQSDVWSYGILLWEIF---------------SLGLNPYPGILVNSKF----YKLVKDGY 278
Query: 639 KQQL-----KEVAKLAARCISVRGEERPTMKEVSLELQ 671
           +        K +  +   C ++    RPT +++   LQ
Sbjct: 279 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 316

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 160
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 161 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 217
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIGGQVFF 256
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 257 --RQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 130
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 131 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 187
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 226
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 227 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQ 256

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 173
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 228
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 159
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 160 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 216
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIGGQVFF 255
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 256 --RQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 409 IGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINRR-NVV 460
           +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I    NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 461 RLLGCCLETQVPLLV-YEFVGNGTLFEHIHKKGN----------------LSWERRLRIT 503
            LLG C +   PL+V  EF   G L  ++  K N                L+ E  +  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            + A  + +L S      IHRD+ + NILL E    K+ DFG ++ +  D      V +G
Sbjct: 146 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD---XVRKG 199
Query: 564 ----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                L ++ PE +     T +SDV+SFGV+L E+ +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 146
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 147 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 203
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 242
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 243 --RQRVSXECQHLIRWCLALRPSDRPTFEEIQ 272

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 132
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 133 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 189
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 228
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 229 --RQRVSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 400 TVTNNYADV--IGCGGSGNVYKGFLPDRT---PVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y  +  IG G  G V   F  D      VAVKK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQQLKPIGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + IH +  L  ER   +  + 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++    + +    VV  T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           Y  PE +         D++S G ++ EL+ G
Sbjct: 191 YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 10/182 (5%)
Query: 444 FINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRI 502
           F  E  ++   N   VV+L     + +   +V E++  G L   +        W R    
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-- 173
Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
           TAE    L  +HS   +  IHRDVK  N+LLD++   K++DFG    +  + +  C    
Sbjct: 174 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 563 GTLGYLDPEYLQT----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
           GT  Y+ PE L++         + D +S GV L E+L G     +D      S  MN  +
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290
Query: 619 SL 620
           SL
Sbjct: 291 SL 292

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 131
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 132 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 188
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 227
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 228 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQ 257

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 159
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 160 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 216
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIGGQVFF 255
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 256 --RQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 147
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 148 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 204
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 243
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 244 --RQRVSXECQHLIRWCLALRPXDRPTFEEIQ 273

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 160
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 161 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 217
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIGGQVFF 256
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 257 --RQRVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 132
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 133 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 189
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 228
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 229 --RQRVSSECQHLIRWCLALRPSDRPTFEEIQ 258

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 10/182 (5%)
Query: 444 FINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRI 502
           F  E  ++   N   VV+L     + +   +V E++  G L   +        W R    
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-- 178
Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
           TAE    L  +HS   +  IHRDVK  N+LLD++   K++DFG    +  + +  C    
Sbjct: 179 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 563 GTLGYLDPEYLQT----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
           GT  Y+ PE L++         + D +S GV L E+L G     +D      S  MN  +
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 295
Query: 619 SL 620
           SL
Sbjct: 296 SL 297

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 409 IGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINRR-NVV 460
           +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I    NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 461 RLLGCCLETQVPLLV-YEFVGNGTLFEHIHKKGN----------------LSWERRLRIT 503
            LLG C +   PL+V  EF   G L  ++  K N                L+ E  +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            + A  + +L S      IHRD+ + NILL E    K+ DFG ++ +  D      V +G
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD---XVRKG 208
Query: 564 ----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                L ++ PE +     T +SDV+SFGV+L E+ +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 160
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 161 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 217
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIGGQVFF 256
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 257 --RQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 154
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 155 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 211
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 212 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 250
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 251 --RQRVSXECQHLIRWCLALRPSDRPTFEEIQ 280

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 10/182 (5%)
Query: 444 FINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRI 502
           F  E  ++   N   VV+L     + +   +V E++  G L   +        W R    
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY-- 178
Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
           TAE    L  +HS   +  IHRDVK  N+LLD++   K++DFG    +  + +  C    
Sbjct: 179 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 563 GTLGYLDPEYLQT----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
           GT  Y+ PE L++         + D +S GV L E+L G     +D      S  MN  +
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 295
Query: 619 SL 620
           SL
Sbjct: 296 SL 297

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 160
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 161 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 217
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIGGQVFF 256
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 257 --RQRVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 159
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 160 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 216
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIGGQVFF 255
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 256 --RQRVSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 14/171 (8%)
Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
           ++ + + +   E+ +   +N  N+V+L       +   LV E+   G +F+++   G   
Sbjct: 52  LNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXK 111
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV----P 551
            +       +    + Y H +    I+HRD+K+ N+LLD +   K++DFG S        
Sbjct: 112 EKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK 168
Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMAL 601
           +DA   C    G   Y  PE  Q  K    + DV+S GV+L  L++G +  
Sbjct: 169 LDAF--C----GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 127/303 (41%), Gaps = 53/303 (17%)
Query: 409 IGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINRR-NVV 460
           +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I    NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 461 RLLGCCLETQVPLLVY-EFVGNGTLFEHIHKKGN----------------LSWERRLRIT 503
            LLG C +   PL+V  EF   G L  ++  K N                L+ E  +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            + A  + +L S      IHRD+ + NILL E    K+ DFG ++    D  ++   V+ 
Sbjct: 146 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRK 198
Query: 564 -----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
                 L ++ PE +     T +SDV+SFGV+L E+ +     L   P     +   F  
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDEEFCR 253
Query: 619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS 678
            LK+   +   D             E+ +    C      +RPT  E+ +E  G L L +
Sbjct: 254 RLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSEL-VEHLGNL-LQA 302
Query: 679 NGQ 681
           N Q
Sbjct: 303 NAQ 305

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 9/166 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E       + 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPK----VSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS   + I H D+K  NI+L +   PK    + DFG +    ID       + 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIF 178
Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 159
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 160 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY--TDFDGTRVYSPPEWIRYH 216
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 255
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++   E   L   C+++R  +RPT +E+
Sbjct: 256 --RQRVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 127/303 (41%), Gaps = 53/303 (17%)
Query: 409 IGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINRR-NVV 460
           +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I    NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 461 RLLGCCLETQVPLLVY-EFVGNGTLFEHIHKKGN----------------LSWERRLRIT 503
            LLG C +   PL+V  EF   G L  ++  K N                L+ E  +  +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            + A  + +L S      IHRD+ + NILL E    K+ DFG ++    D  ++   V+ 
Sbjct: 157 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRK 209
Query: 564 -----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
                 L ++ PE +     T +SDV+SFGV+L E+ +     L   P     +   F  
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDEEFCR 264
Query: 619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS 678
            LK+   +   D             E+ +    C      +RPT  E+ +E  G L L +
Sbjct: 265 RLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSEL-VEHLGNL-LQA 313
Query: 679 NGQ 681
           N Q
Sbjct: 314 NAQ 316

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 127/303 (41%), Gaps = 53/303 (17%)
Query: 409 IGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINRR-NVV 460
           +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I    NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 461 RLLGCCLETQVPLLVY-EFVGNGTLFEHIHKKGN----------------LSWERRLRIT 503
            LLG C +   PL+V  EF   G L  ++  K N                L+ E  +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            + A  + +L S      IHRD+ + NILL E    K+ DFG ++    D  ++   V+ 
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRK 207
Query: 564 -----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
                 L ++ PE +     T +SDV+SFGV+L E+ +     L   P     +   F  
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDEEFCR 262
Query: 619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS 678
            LK+   +   D             E+ +    C      +RPT  E+ +E  G L L +
Sbjct: 263 RLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSEL-VEHLGNL-LQA 311
Query: 679 NGQ 681
           N Q
Sbjct: 312 NAQ 314

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 409 IGCGGSGNVYK-GFLPDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINR-RNVVRLLGC 465
           +G G  G V+K  F      +AVK+ +   ++ +    + +L VVL+ +    +V+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRL--RITAETAGVLSYLHSETNVPIIH 523
            +      +  E +G  T  E + K+       R+  ++T      L YL  +  V  IH
Sbjct: 93  FITNTDVFIAMELMG--TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV--IH 148
Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD--- 580
           RDVK +NILLDE    K+ DFG S  +  D  ++ +   G   Y+ PE +     T    
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKPDY 206
Query: 581 --KSDVYSFGVVLVELLTGK 598
             ++DV+S G+ LVEL TG+
Sbjct: 207 DIRADVWSLGISLVELATGQ 226

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 173
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 228
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           +E   E+ ++ Q+   NV+ L          +L+ E V  G LF+ + +K +LS E    
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP----KVSDFGASKLVPIDAIQN 557
              +    ++YLH++    I H D+K  NI+L +   P    K+ DFG +  +  D ++ 
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF 175
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
             +  GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 127/303 (41%), Gaps = 53/303 (17%)
Query: 409 IGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINRR-NVV 460
           +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I    NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 461 RLLGCCLETQVPLLVY-EFVGNGTLFEHIHKKGN----------------LSWERRLRIT 503
            LLG C +   PL+V  EF   G L  ++  K N                L+ E  +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            + A  + +L S      IHRD+ + NILL E    K+ DFG ++    D  ++   V+ 
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDXVRK 207
Query: 564 -----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
                 L ++ PE +     T +SDV+SFGV+L E+ +     L   P     +   F  
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDEEFCR 262
Query: 619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS 678
            LK+   +   D             E+ +    C      +RPT  E+ +E  G L L +
Sbjct: 263 RLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSEL-VEHLGNL-LQA 311
Query: 679 NGQ 681
           N Q
Sbjct: 312 NAQ 314

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           +E   E+ ++ Q+   NV+ L          +L+ E V  G LF+ + +K +LS E    
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP----KVSDFGASKLVPIDAIQN 557
              +    ++YLH++    I H D+K  NI+L +   P    K+ DFG +  +  D ++ 
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF 175
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
             +  GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 15/195 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGC 465
           +G G  G VYK    ++    +  +K +D   + ++++++ E+ ++   +  N+V+LL  
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRIT-AETAGVLSYLHSETNVPIIHR 524
                   ++ EF   G +   + +      E ++++   +T   L+YLH      IIHR
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHR 159
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD---- 580
           D+K+ NIL   +   K++DFG S       IQ      GT  ++ PE +      D    
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 581 -KSDVYSFGVVLVEL 594
            K+DV+S G+ L+E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E  +  ++   N+VRL     E     LV++ V  G LFE I  +   S         + 
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 137
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
              ++Y HS     I+HR++K  N+LL    +    K++DFG +  + ++  +      G
Sbjct: 138 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 192
Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           T GYL PE L+    +   D+++ GV+L  LL G
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           +E   E+ ++ Q+   NV+ L          +L+ E V  G LF+ + +K +LS E    
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP----KVSDFGASKLVPIDAIQN 557
              +    ++YLH++    I H D+K  NI+L +   P    K+ DFG +  +  D ++ 
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF 175
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
             +  GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 37/218 (16%)
Query: 409 IGCGGSGNVYKG--FLPDRTP----VAVKKSK-FVDQAKIDEFINELVVVLQINRR-NVV 460
           +G G  G V +   F  D+T     VAVK  K     ++    ++EL +++ I    NVV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 461 RLLGCCLETQVPLLV-YEFVGNGTLFEHIHKKGN----------------LSWERRLRIT 503
            LLG C +   PL+V  EF   G L  ++  K N                L+ E  +  +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            + A  + +L S      IHRD+ + NILL E    K+ DFG ++    D  ++   V+ 
Sbjct: 192 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRK 244
Query: 564 -----TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                 L ++ PE +     T +SDV+SFGV+L E+ +
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           +E   E+ ++ Q+   NV+ L          +L+ E V  G LF+ + +K +LS E    
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP----KVSDFGASKLVPIDAIQN 557
              +    ++YLH++    I H D+K  NI+L +   P    K+ DFG +  +  D ++ 
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF 175
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
             +  GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 41/272 (15%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 459 VVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           V+RLL         +L+ E       LF+ I ++G L  E       +    + + H   
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 174
Query: 518 NVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +   T   GT  Y  PE+++  
Sbjct: 175 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYH 231
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
           +   +S  V+S G++L +++ G +    D+                     EI+  ++  
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVFF 270
Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVS 667
              ++   E   L   C+++R  +RPT +E+ 
Sbjct: 271 --RQRVSXECQHLIRWCLALRPSDRPTFEEIQ 300

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 116/245 (47%), Gaps = 34/245 (13%)
Query: 434 KFVDQAKIDEFINELVVVLQINRR-NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG 492
           K +D++K D    E+ ++L+  +  N++ L     + +   LV E +  G L + I ++ 
Sbjct: 58  KVIDKSKRDPS-EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK 116
Query: 493 NLSWERRLRITAETAG-VLSYLHSETNVPIIHRDVKSANIL-LDENCTP---KVSDFGAS 547
             S ER       T G  + YLHS+    ++HRD+K +NIL +DE+  P   ++ DFG +
Sbjct: 117 FFS-EREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 548 KLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL--- 602
           K +     +N  ++    T  ++ PE L+     +  D++S G++L  +L G        
Sbjct: 173 KQL---RAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGP 229
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAK-LAARCISVRGEERP 661
           SD PEE        L+ +   +         ++ GN   + E AK L ++ + V   +R 
Sbjct: 230 SDTPEE-------ILTRIGSGKF-------TLSGGNWNTVSETAKDLVSKMLHVDPHQRL 275
Query: 662 TMKEV 666
           T K+V
Sbjct: 276 TAKQV 280

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/258 (23%), Positives = 114/258 (44%), Gaps = 29/258 (11%)
Query: 403 NNYADV--IGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNV 459
           + Y D+  +GCGG+G V+     D    VA+KK    D   +   + E+ ++ +++  N+
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 460 VRL--------------LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAE 505
           V++              +G   E     +V E++   T   ++ ++G L  E       +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLLEEHARLFMYQ 128
Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAIQNCTVVQG- 563
               L Y+HS     ++HRD+K AN+ ++ E+   K+ DFG ++++         + +G 
Sbjct: 129 LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 564 -TLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK 621
            T  Y  P  L +    T   D+++ G +  E+LTGK         E+  L +  +  + 
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 622 Q---NRLLEILDNRIVND 636
           +     LL ++   I ND
Sbjct: 246 EEDRQELLSVIPVYIRND 263

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 131/290 (45%), Gaps = 43/290 (14%)
Query: 391 KIFTEEEIKTVTNNY--ADVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID-- 442
           K+   +E + + + Y    ++G GG G+VY G  + D  PVA+K   K +  D  ++   
Sbjct: 44  KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 103
Query: 443 -EFINELVVVLQINR--RNVVRLLGCCLETQVPLLVYEFVGN-GTLFEHIHKKGNLSWER 498
                E+V++ +++     V+RLL         +L+ E       LF+ I ++G L  E 
Sbjct: 104 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 163
Query: 499 RLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP-KVSDFGASKLVPIDAIQN 557
                 +    + + H   N  ++HRD+K  NIL+D N    K+ DFG+  L+  D +  
Sbjct: 164 ARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVY- 218
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF 616
            T   GT  Y  PE+++  +   +S  V+S G++L +++ G +    D+           
Sbjct: 219 -TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------- 266
Query: 617 LSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                     EI+  ++     ++   E   L   C+++R  +RPT +E+
Sbjct: 267 ----------EIIRGQVFF--RQRVSXECQHLIRWCLALRPSDRPTFEEI 304

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 15/195 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGC 465
           +G G  G VYK    ++    +  +K +D   + ++++++ E+ ++   +  N+V+LL  
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRIT-AETAGVLSYLHSETNVPIIHR 524
                   ++ EF   G +   + +      E ++++   +T   L+YLH      IIHR
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHR 159
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD---- 580
           D+K+ NIL   +   K++DFG S       IQ      GT  ++ PE +      D    
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 581 -KSDVYSFGVVLVEL 594
            K+DV+S G+ L+E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           +E   E+ ++ Q+   NV+ L          +L+ E V  G LF+ + +K +LS E    
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP----KVSDFGASKLVPIDAIQN 557
              +    ++YLH++    I H D+K  NI+L +   P    K+ DFG +  +  D ++ 
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF 175
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
             +  GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E  +  ++   N+VRL     E     LV++ V  G LFE I  +   S         + 
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 114
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
              ++Y HS     I+HR++K  N+LL    +    K++DFG +  + ++  +      G
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 169
Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           T GYL PE L+    +   D+++ GV+L  LL G
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 136
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 191
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 224

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 15/195 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGC 465
           +G G  G VYK    ++    +  +K +D   + ++++++ E+ ++   +  N+V+LL  
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRIT-AETAGVLSYLHSETNVPIIHR 524
                   ++ EF   G +   + +      E ++++   +T   L+YLH      IIHR
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHR 159
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD---- 580
           D+K+ NIL   +   K++DFG S       IQ      GT  ++ PE +      D    
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 218
Query: 581 -KSDVYSFGVVLVEL 594
            K+DV+S G+ L+E+
Sbjct: 219 YKADVWSLGITLIEM 233

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 129
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 184
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 217

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 20  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 77
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 78  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 134
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 135 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 189
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 190 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 136
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 137 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 191
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 224

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 72
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 129
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 130 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 184
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 185 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 217

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 9/159 (5%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           +  + E+ ++ Q++  N+++L     +     LV E    G LF+ I  +   S     R
Sbjct: 77  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 136
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNC 558
           I  +    ++Y+H      I+HRD+K  N+LL+   ++   ++ DFG S     +A +  
Sbjct: 137 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKM 191
Query: 559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
               GT  Y+ PE L      +K DV+S GV+L  LL+G
Sbjct: 192 KDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 229

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 128
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 183
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E  +  ++   N+VRL     E     LV++ V  G LFE I  +   S         + 
Sbjct: 54  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 113
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
              ++Y HS     I+HR++K  N+LL    +    K++DFG +  + ++  +      G
Sbjct: 114 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 168
Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           T GYL PE L+    +   D+++ GV+L  LL G
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 400 TVTNNYADV--IGCGGSGNVYKGF--LPDRTPVAVKK--SKFVDQAKIDEFINELVVVLQ 453
           TV   Y ++  IG G  G V   +  + +R  VA+KK    F +Q        ELV++  
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVVAAYDAILERN-VAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 454 INRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETA 507
           +N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  +  
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMSYLLYQML 136
Query: 508 GVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGY 567
             + +LHS     IIHRD+K +NI++  + T K+ DFG ++      +    VV  T  Y
Sbjct: 137 VGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRYY 191
Query: 568 LDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
             PE +      +  D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E  +  ++   N+VRL     E     LV++ V  G LFE I  +   S         + 
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 114
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
              ++Y HS     I+HR++K  N+LL    +    K++DFG +  + ++  +      G
Sbjct: 115 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAG 169
Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           T GYL PE L+    +   D+++ GV+L  LL G
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 9/165 (5%)
Query: 438 QAKIDEFINELVVVLQINRRNVVRLLGCCLE-TQVPL-LVYEFVGNGTLFEHIHK----K 491
           +A+    ++E+ ++ ++   N+VR     ++ T   L +V E+   G L   I K    +
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 492 GNLSWERRLRITAETAGVLSYLH--SETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
             L  E  LR+  +    L   H  S+    ++HRD+K AN+ LD     K+ DFG +++
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVEL 594
           +  D     T V GT  Y+ PE +      +KSD++S G +L EL
Sbjct: 166 LNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 116/245 (47%), Gaps = 34/245 (13%)
Query: 434 KFVDQAKIDEFINELVVVLQINRR-NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG 492
           K +D++K D    E+ ++L+  +  N++ L     + +   LV E +  G L + I ++ 
Sbjct: 58  KVIDKSKRDPS-EEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK 116
Query: 493 NLSWERRLRITAETAG-VLSYLHSETNVPIIHRDVKSANIL-LDENCTP---KVSDFGAS 547
             S ER       T G  + YLHS+    ++HRD+K +NIL +DE+  P   ++ DFG +
Sbjct: 117 FFS-EREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFA 172
Query: 548 KLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALL--- 602
           K +     +N  ++    T  ++ PE L+     +  D++S G++L  +L G        
Sbjct: 173 KQL---RAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGP 229
Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAK-LAARCISVRGEERP 661
           SD PEE        L+ +   +         ++ GN   + E AK L ++ + V   +R 
Sbjct: 230 SDTPEE-------ILTRIGSGKF-------TLSGGNWNTVSETAKDLVSKMLHVDPHQRL 275
Query: 662 TMKEV 666
           T K+V
Sbjct: 276 TAKQV 280

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 9/171 (5%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           + K +   +   +  + E+ ++ Q++  N+++L     +     LV E    G LF+ I 
Sbjct: 83  ISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 142
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGA 546
            +   S     RI  +    ++Y+H      I+HRD+K  N+LL+   ++   ++ DFG 
Sbjct: 143 SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 199
Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           S     +A +      GT  Y+ PE L      +K DV+S GV+L  LL+G
Sbjct: 200 S--THFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 247

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 9/171 (5%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           + K +   +   +  + E+ ++ Q++  N+++L     +     LV E    G LF+ I 
Sbjct: 82  ISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 141
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGA 546
            +   S     RI  +    ++Y+H      I+HRD+K  N+LL+   ++   ++ DFG 
Sbjct: 142 SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 198
Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           S     +A +      GT  Y+ PE L      +K DV+S GV+L  LL+G
Sbjct: 199 S--THFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 246

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 9/159 (5%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           +  + E+ ++ Q++  N+++L     +     LV E    G LF+ I  +   S     R
Sbjct: 71  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 130
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNC 558
           I  +    ++Y+H      I+HRD+K  N+LL+   ++   ++ DFG S     +A +  
Sbjct: 131 IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKM 185
Query: 559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
               GT  Y+ PE L      +K DV+S GV+L  LL+G
Sbjct: 186 KDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  + T K+ DFG ++      +    VV  T  
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 79/182 (43%), Gaps = 14/182 (7%)
Query: 425 RTPVAVKKSKFVDQAKI-----DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV 479
           +TP     +K ++  K+      +   E  +   +   N+VRL     E     LV++ V
Sbjct: 53  KTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLV 112
Query: 480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-- 537
             G LFE I  +   S         +    ++++H      I+HRD+K  N+LL   C  
Sbjct: 113 TGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD---IVHRDLKPENLLLASKCKG 169
Query: 538 -TPKVSDFGASKLVPIDAIQNCTV-VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELL 595
              K++DFG +  + +   Q       GT GYL PE L+        D+++ GV+L  LL
Sbjct: 170 AAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILL 227
Query: 596 TG 597
            G
Sbjct: 228 VG 229

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 127/307 (41%), Gaps = 52/307 (16%)
Query: 404 NYADVIGCGGSGNVYK----GFLPDRTPVAVKKSKFVDQAKIDE---FINELVVVLQI-N 455
           ++   +G G  G V +    G +     + V        A + E    ++EL V+  + N
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN------------------LSWE 497
             N+V LLG C      L++ E+   G L   + +K +                  L  E
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
             L  + + A  +++L S+     IHRD+ + NILL      K+ DFG ++ +  D+   
Sbjct: 169 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDS--- 222
Query: 558 CTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
             VV+G     + ++ PE +  C  T +SDV+S+G+ L EL +     L   P     + 
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-----LGSSPYPGMPVD 277
Query: 614 MNFLSSLKQN-RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG 672
             F   +K+  R+L            +    E+  +   C      +RPT K++   ++ 
Sbjct: 278 SKFYKMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327
Query: 673 RLSLMSN 679
           ++S  +N
Sbjct: 328 QISESTN 334

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L +R  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  + T K+ DFG ++      +    VV  T  
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           Y  PE +      +  D++S GV++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 6/170 (3%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE-HI 488
           V KS  +   + ++   E+ +   ++  +VV   G   +     +V E     +L E H 
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            +K     E R  +     GV  YLH   N  +IHRD+K  N+ L+++   K+ DFG + 
Sbjct: 135 RRKAVTEPEARYFMRQTIQGV-QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLAT 190
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            +  D  +  T+  GT  Y+ PE L     + + D++S G +L  LL GK
Sbjct: 191 KIEFDGERKKTLC-GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 22/224 (9%)
Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +G G    VYKG   ++T    VA+K+ K   ++      I E+ ++ ++   N+VRL  
Sbjct: 13  LGNGTYATVYKGL--NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITA----ETAGVLSYLHSETN 518
                    LV+EF+ N  L +++  +  GN      L +      +    L++ H    
Sbjct: 71  VIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTC 576
             I+HRD+K  N+L+++    K+ DFG ++   +P++   +  V   TL Y  P+ L   
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV---TLWYRAPDVLMGS 183
Query: 577 KLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS 619
           +    S D++S G +L E++TGK        EE+  L  + + +
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 127/307 (41%), Gaps = 52/307 (16%)
Query: 404 NYADVIGCGGSGNVYK----GFLPDRTPVAVKKSKFVDQAKIDE---FINELVVVLQI-N 455
           ++   +G G  G V +    G +     + V        A + E    ++EL V+  + N
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN------------------LSWE 497
             N+V LLG C      L++ E+   G L   + +K +                  L  E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
             L  + + A  +++L S+     IHRD+ + NILL      K+ DFG ++ +  D+   
Sbjct: 146 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 199
Query: 558 CTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
             VV+G     + ++ PE +  C  T +SDV+S+G+ L EL +     L   P     + 
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-----LGSSPYPGMPVD 254
Query: 614 MNFLSSLKQN-RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG 672
             F   +K+  R+L            +    E+  +   C      +RPT K++   ++ 
Sbjct: 255 SKFYKMIKEGFRMLS----------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 673 RLSLMSN 679
           ++S  +N
Sbjct: 305 QISESTN 311

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 6/130 (4%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANIL 532
            +V E+V  G LF++I K G +      R+  +    + Y H      ++HRD+K  N+L
Sbjct: 87  FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVL 143
Query: 533 LDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVL 591
           LD +   K++DFG S ++        +   G+  Y  PE +        + D++S GV+L
Sbjct: 144 LDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
Query: 592 VELLTGKMAL 601
             LL G +  
Sbjct: 202 YALLCGTLPF 211

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 127/307 (41%), Gaps = 52/307 (16%)
Query: 404 NYADVIGCGGSGNVYK----GFLPDRTPVAVKKSKFVDQAKIDE---FINELVVVLQI-N 455
           ++   +G G  G V +    G +     + V        A + E    ++EL V+  + N
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN------------------LSWE 497
             N+V LLG C      L++ E+   G L   + +K +                  L  E
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
             L  + + A  +++L S+     IHRD+ + NILL      K+ DFG ++ +  D+   
Sbjct: 169 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 222
Query: 558 CTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
             VV+G     + ++ PE +  C  T +SDV+S+G+ L EL +     L   P     + 
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-----LGSSPYPGMPVD 277
Query: 614 MNFLSSLKQN-RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG 672
             F   +K+  R+L            +    E+  +   C      +RPT K++   ++ 
Sbjct: 278 SKFYKMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327
Query: 673 RLSLMSN 679
           ++S  +N
Sbjct: 328 QISESTN 334

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD----QAKIDEFINELVVVLQINRRNVVRLLG 464
           +G G  G+V+   + +R+    +  K ++    Q  +++   E+ V+  ++  N++++  
Sbjct: 30  LGSGAFGDVH--LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 465 CCLETQVPLLVYEFVGNGTLFEHI---HKKGN-LSWERRLRITAETAGVLSYLHSETNVP 520
              +     +V E    G L E I     +G  LS      +  +    L+Y HS+    
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--- 144
Query: 521 IIHRDVKSANILLDENCTP----KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
           ++H+D+K  NIL  ++ +P    K+ DFG ++L   D  ++ T   GT  Y+ PE  +  
Sbjct: 145 VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPEVFKR- 200
Query: 577 KLTDKSDVYSFGVVLVELLTG 597
            +T K D++S GVV+  LLTG
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTG 221

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 15/164 (9%)
Query: 438 QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH-----IHKKG 492
           ++K D+F NEL ++  I     +   G         ++YE++ N ++ +      +  K 
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 493 NLSWERRLRITAETAGVL---SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
              +     I      VL   SY+H+E N  I HRDVK +NIL+D+N   K+SDFG S+ 
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 550 VPIDAIQNCTVVQGTLGYLDPEYL--QTCKLTDKSDVYSFGVVL 591
           +    I+     +GT  ++ PE+   ++     K D++S G+ L
Sbjct: 202 MVDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 83/171 (48%), Gaps = 9/171 (5%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           +E   E+ ++ Q+   N++ L          +L+ E V  G LF+ + +K +LS E    
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP----KVSDFGASKLVPIDAIQN 557
              +    ++YLH++    I H D+K  NI+L +   P    K+ DFG +  +  D ++ 
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF 175
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
             +  GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L +R  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           Y  PE +      +  D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 127/307 (41%), Gaps = 52/307 (16%)
Query: 404 NYADVIGCGGSGNVYK----GFLPDRTPVAVKKSKFVDQAKIDE---FINELVVVLQI-N 455
           ++   +G G  G V +    G +     + V        A + E    ++EL V+  + N
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN------------------LSWE 497
             N+V LLG C      L++ E+   G L   + +K +                  L  E
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
             L  + + A  +++L S+     IHRD+ + NILL      K+ DFG ++ +  D+   
Sbjct: 164 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 217
Query: 558 CTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
             VV+G     + ++ PE +  C  T +SDV+S+G+ L EL +     L   P     + 
Sbjct: 218 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-----LGSSPYPGMPVD 272
Query: 614 MNFLSSLKQN-RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG 672
             F   +K+  R+L            +    E+  +   C      +RPT K++   ++ 
Sbjct: 273 SKFYKMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 322
Query: 673 RLSLMSN 679
           ++S  +N
Sbjct: 323 QISESTN 329

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 12/232 (5%)
Query: 397 EIKTVTNNYADVIGCGGSGNV----YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVL 452
           ++K    +   VIG G  G V    +K          + K + + ++    F  E  ++ 
Sbjct: 71  QMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 453 QINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSY 512
             N   VV+L     + +   +V E++  G L  ++    ++  +     TAE    L  
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDA 189
Query: 513 LHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
           +HS   + +IHRDVK  N+LLD++   K++DFG    +    + +C    GT  Y+ PE 
Sbjct: 190 IHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEV 246
Query: 573 LQT----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
           L++         + D +S GV L E+L G     +D      S  M+  +SL
Sbjct: 247 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 298

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L +R  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           Y  PE +      +  D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 394 TEEEIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVV 451
            E  I    N+++   +IG GG G VY     D   +   K   +D+ +I     E    
Sbjct: 179 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGE---T 233
Query: 452 LQINRRNVVRLL--GCC---------LETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERR 499
           L +N R ++ L+  G C           T   L  + + +  G L  H+ + G  S    
Sbjct: 234 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM 293
Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA----SKLVPIDAI 555
               AE    L ++H   N  +++RD+K ANILLDE+   ++SD G     SK  P  ++
Sbjct: 294 RFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 350
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTG 597
                  GT GY+ PE LQ     D S D +S G +L +LL G
Sbjct: 351 -------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/307 (23%), Positives = 127/307 (41%), Gaps = 52/307 (16%)
Query: 404 NYADVIGCGGSGNVYK----GFLPDRTPVAVKKSKFVDQAKIDE---FINELVVVLQI-N 455
           ++   +G G  G V +    G +     + V        A + E    ++EL V+  + N
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN------------------LSWE 497
             N+V LLG C      L++ E+   G L   + +K +                  L  E
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
             L  + + A  +++L S+     IHRD+ + NILL      K+ DFG ++ +  D+   
Sbjct: 162 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 215
Query: 558 CTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
             VV+G     + ++ PE +  C  T +SDV+S+G+ L EL +     L   P     + 
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-----LGSSPYPGMPVD 270
Query: 614 MNFLSSLKQN-RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG 672
             F   +K+  R+L            +    E+  +   C      +RPT K++   ++ 
Sbjct: 271 SKFYKMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320
Query: 673 RLSLMSN 679
           ++S  +N
Sbjct: 321 QISESTN 327

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 103/238 (43%), Gaps = 34/238 (14%)
Query: 394 TEEEIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVV 451
            E  I    N+++   +IG GG G VY     D   +   K   +D+ +I     E    
Sbjct: 180 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGE---T 234
Query: 452 LQINRRNVVRLL--GCC---------LETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERR 499
           L +N R ++ L+  G C           T   L  + + +  G L  H+ + G  S    
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM 294
Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA----SKLVPIDAI 555
               AE    L ++H   N  +++RD+K ANILLDE+   ++SD G     SK  P  ++
Sbjct: 295 RFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 351
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSL 612
                  GT GY+ PE LQ     D S D +S G +L +LL G       K +++  +
Sbjct: 352 -------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  + T K+ DFG ++      +    VV  T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 66/147 (44%), Gaps = 7/147 (4%)
Query: 454 INRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL 513
           +   N+VRL     E     LV++ V  G LFE I  +   S         +    + + 
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 514 HSETNVPIIHRDVKSANILLDENC---TPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDP 570
           H    + ++HRD+K  N+LL   C     K++DFG +  V  D  Q      GT GYL P
Sbjct: 120 H---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYLSP 175
Query: 571 EYLQTCKLTDKSDVYSFGVVLVELLTG 597
           E L+        D+++ GV+L  LL G
Sbjct: 176 EVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           TV   Y ++  IG G  G V   Y   L     +      F +Q        ELV++  +
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 455 NRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  +   
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 138
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  Y 
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 193
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
            PE +      +  D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 103/238 (43%), Gaps = 34/238 (14%)
Query: 394 TEEEIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVV 451
            E  I    N+++   +IG GG G VY     D   +   K   +D+ +I     E    
Sbjct: 180 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGE---T 234
Query: 452 LQINRRNVVRLL--GCC---------LETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERR 499
           L +N R ++ L+  G C           T   L  + + +  G L  H+ + G  S    
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM 294
Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA----SKLVPIDAI 555
               AE    L ++H   N  +++RD+K ANILLDE+   ++SD G     SK  P  ++
Sbjct: 295 RFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 351
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSL 612
                  GT GY+ PE LQ     D S D +S G +L +LL G       K +++  +
Sbjct: 352 -------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 103/238 (43%), Gaps = 34/238 (14%)
Query: 394 TEEEIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVV 451
            E  I    N+++   +IG GG G VY     D   +   K   +D+ +I     E    
Sbjct: 180 VELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGE---T 234
Query: 452 LQINRRNVVRLL--GCC---------LETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERR 499
           L +N R ++ L+  G C           T   L  + + +  G L  H+ + G  S    
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM 294
Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA----SKLVPIDAI 555
               AE    L ++H   N  +++RD+K ANILLDE+   ++SD G     SK  P  ++
Sbjct: 295 RFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 351
Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSL 612
                  GT GY+ PE LQ     D S D +S G +L +LL G       K +++  +
Sbjct: 352 -------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           TV   Y ++  IG G  G V   Y   L     +      F +Q        ELV++  +
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 455 NRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  +   
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 137
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 192
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
            PE +      +  D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 19/209 (9%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           TV   Y ++  IG G  G V   Y   L     +      F +Q        ELV++  +
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 455 NRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  +   
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 137
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 192
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
            PE +      +  D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 413 GSGNVYKG-FLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV 471
           G+G  Y   F+  R   + ++   V + +I+  +N   ++ +I   N++ L         
Sbjct: 49  GTGKEYAAKFIKKRRLXSSRRG--VSREEIEREVN---ILREIRHPNIITLHDIFENKTD 103
Query: 472 PLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANI 531
            +L+ E V  G LF+ + +K +L+ +   +   +    + YLHS+    I H D+K  NI
Sbjct: 104 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENI 160
Query: 532 LLDENCTP----KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L +   P    K+ DFG +    I+A      + GT  ++ PE +    L  ++D++S 
Sbjct: 161 MLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI 218
Query: 588 GVVLVELLTGKMALLSDKPEE 608
           GV+   LL+G    L +  +E
Sbjct: 219 GVITYILLSGASPFLGETKQE 239

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 6/130 (4%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANIL 532
            +V E+V  G LF++I K G +      R+  +    + Y H      ++HRD+K  N+L
Sbjct: 87  FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVL 143
Query: 533 LDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVL 591
           LD +   K++DFG S ++        +   G+  Y  PE +        + D++S GV+L
Sbjct: 144 LDAHMNAKIADFGLSNMMSDGEFLRDSC--GSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
Query: 592 VELLTGKMAL 601
             LL G +  
Sbjct: 202 YALLCGTLPF 211

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 9/171 (5%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           +E   E+ ++ +I   N++ L          +L+ E V  G LF+ + +K +L+ +   +
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 119
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP----KVSDFGASKLVPIDAIQN 557
              +    + YLHS+    I H D+K  NI+L +   P    K+ DFG +    I+A   
Sbjct: 120 FLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNE 174
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
              + GT  ++ PE +    L  ++D++S GV+   LL+G    L +  +E
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 225

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 9/165 (5%)
Query: 438 QAKIDEFINELVVVLQINRRNVVRLLGCCLE-TQVPL-LVYEFVGNGTLFEHIHK----K 491
           +A+    ++E+ ++ ++   N+VR     ++ T   L +V E+   G L   I K    +
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 492 GNLSWERRLRITAETAGVLSYLH--SETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
             L  E  LR+  +    L   H  S+    ++HRD+K AN+ LD     K+ DFG +++
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVEL 594
           +  D       V GT  Y+ PE +      +KSD++S G +L EL
Sbjct: 166 LNHDTSFAKAFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 9/171 (5%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           +E   E+ ++ +I   N++ L          +L+ E V  G LF+ + +K +L+ +   +
Sbjct: 53  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 112
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP----KVSDFGASKLVPIDAIQN 557
              +    + YLHS+    I H D+K  NI+L +   P    K+ DFG +    I+A   
Sbjct: 113 FLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNE 167
Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
              + GT  ++ PE +    L  ++D++S GV+   LL+G    L +  +E
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 218

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 6/170 (3%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE-HI 488
           V KS  +   + ++   E+ +   +  ++VV   G   +     +V E     +L E H 
Sbjct: 74  VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 133
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            +K     E R  +     G   YLH      +IHRD+K  N+ L+E+   K+ DFG + 
Sbjct: 134 RRKALTEPEARYYLRQIVLGC-QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT 189
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            V  D  +   V+ GT  Y+ PE L     + + DV+S G ++  LL GK
Sbjct: 190 KVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 6/170 (3%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE-HI 488
           V KS  +   + ++   E+ +   +  ++VV   G   +     +V E     +L E H 
Sbjct: 72  VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 131
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            +K     E R  +     G   YLH      +IHRD+K  N+ L+E+   K+ DFG + 
Sbjct: 132 RRKALTEPEARYYLRQIVLGC-QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT 187
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            V  D  +   V+ GT  Y+ PE L     + + DV+S G ++  LL GK
Sbjct: 188 KVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 6/170 (3%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE-HI 488
           V KS  +   + ++   E+ +   +  ++VV   G   +     +V E     +L E H 
Sbjct: 48  VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 107
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            +K     E R  +     G   YLH      +IHRD+K  N+ L+E+   K+ DFG + 
Sbjct: 108 RRKALTEPEARYYLRQIVLGC-QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT 163
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            V  D  +   V+ GT  Y+ PE L     + + DV+S G ++  LL GK
Sbjct: 164 KVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNL-SWERRLRITAETAGVLSYLHS------- 515
           G  LE ++  L+  F   G+L +++  KGN+ +W     +    +  LSYLH        
Sbjct: 81  GSNLEVEL-WLITAFHDKGSLTDYL--KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 516 ETNVP-IIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYL 573
           E + P I HRD KS N+LL  + T  ++DFG A +  P     +     GT  Y+ PE L
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVL 197
Query: 574 QTCKLTDKS-----DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI 628
           +      +      D+Y+ G+VL EL++   A  +D P +E  L   F   + Q+  LE 
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCKA--ADGPVDEYMLP--FEEEIGQHPSLEE 253
Query: 629 LDNRIVNDGNKQQLKE----VAKLAARCISV 655
           L   +V+   +  +K+       LA  C+++
Sbjct: 254 LQEVVVHKKMRPTIKDHWLKHPGLAQLCVTI 284

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMSYLLYQM 128
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  + T K+ DFG ++      +    VV  T  
Sbjct: 129 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRY 183
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  + T K+ DFG ++      +    VV  T  
Sbjct: 136 LXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 6/170 (3%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE-HI 488
           V KS  +   + ++   E+ +   ++  +VV   G   +     +V E     +L E H 
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            +K     E R  +     GV  YLH   N  +IHRD+K  N+ L+++   K+ DFG + 
Sbjct: 135 RRKAVTEPEARYFMRQTIQGV-QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLAT 190
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            +  D  +    + GT  Y+ PE L     + + D++S G +L  LL GK
Sbjct: 191 KIEFDG-ERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 6/170 (3%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE-HI 488
           V KS  +   + ++   E+ +   +  ++VV   G   +     +V E     +L E H 
Sbjct: 50  VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 109
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            +K     E R  +     G   YLH      +IHRD+K  N+ L+E+   K+ DFG + 
Sbjct: 110 RRKALTEPEARYYLRQIVLGC-QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT 165
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            V  D  +  T+  GT  Y+ PE L     + + DV+S G ++  LL GK
Sbjct: 166 KVEYDGERKKTLC-GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L DR  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVL-DRN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   LV E + +  L + I  +  L  ER   +  + 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  + T K+ DFG ++      +    VV  T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           Y  PE +      +  D++S G ++ E++  K+
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 223

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 124/278 (44%), Gaps = 47/278 (16%)
Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFIN---ELVVVLQIN----R 456
           ++G GG G V+ G  L DR  VA+K   +++ +  + + + +    E+ ++ ++      
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 457 RNVVRLLGCCLETQ--VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLH 514
             V+RLL    ETQ    L++   +    LF++I +KG L          +    + + H
Sbjct: 98  PGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 515 SETNVPIIHRDVKSANILLD--ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
           S     ++HRD+K  NIL+D    C  K+ DFG+  L+     +  T   GT  Y  PE+
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCA-KLIDFGSGALL---HDEPYTDFDGTRVYSPPEW 209
Query: 573 LQTCKLTD-KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN 631
           +   +     + V+S G++L +++ G +    D+                     EIL+ 
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------------------EILEA 248
Query: 632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE 669
            +    +     +   L  RC++ +   RP+++E+ L+
Sbjct: 249 ELHFPAHVS--PDCCALIRRCLAPKPSSRPSLEEILLD 284

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 6/170 (3%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE-HI 488
           V KS  +   + ++   E+ +   +  ++VV   G   +     +V E     +L E H 
Sbjct: 50  VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 109
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            +K     E R  +     G   YLH      +IHRD+K  N+ L+E+   K+ DFG + 
Sbjct: 110 RRKALTEPEARYYLRQIVLGC-QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT 165
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            V  D  +  T+  GT  Y+ PE L     + + DV+S G ++  LL GK
Sbjct: 166 KVEYDGERKKTLC-GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLPDR-TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR----L 462
           IG G  G V   +   R T VA+KK S F  Q      + E+ ++L+    NV+     L
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               LE    + + + +    L++ + K   LS +       +    L Y+HS     ++
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLL-KSQQLSNDHICYFLYQILRGLKYIHSAN---VL 166
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPI--DAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
           HRD+K +N+L++  C  K+ DFG +++     D     T    T  Y  PE +   K   
Sbjct: 167 HRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYT 226
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 227 KSIDIWSVGCILAEMLSNR 245

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 6/170 (3%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE-HI 488
           V KS  +   + ++   E+ +   +  ++VV   G   +     +V E     +L E H 
Sbjct: 54  VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 113
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            +K     E R  +     G   YLH      +IHRD+K  N+ L+E+   K+ DFG + 
Sbjct: 114 RRKALTEPEARYYLRQIVLGC-QYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT 169
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            V  D  +  T+  GT  Y+ PE L     + + DV+S G ++  LL GK
Sbjct: 170 KVEYDGERKKTLC-GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 443 EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRI 502
           + + E+ V+  ++  N+++L     + +   LV E    G LF+ I  +   +      I
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI 141
Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCT 559
             +    ++YLH      I+HRD+K  N+LL+   ++   K+ DFG S +      +N  
Sbjct: 142 IKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV-----FENQK 193
Query: 560 VVQGTLG---YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
            ++  LG   Y+ PE L+  K  +K DV+S GV+L  LL G
Sbjct: 194 KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAG 233

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 6/171 (3%)
Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE-H 487
            V KS  +   + ++   E+ +   ++  +VV   G   +     +V E     +L E H
Sbjct: 58  VVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELH 117
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
             +K     E R  +     GV  YLH   N  +IHRD+K  N+ L+++   K+ DFG +
Sbjct: 118 KRRKAVTEPEARYFMRQTIQGV-QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA 173
Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
             +  D  +   +  GT  Y+ PE L     + + D++S G +L  LL GK
Sbjct: 174 TKIEFDGERKKDLC-GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 66/130 (50%), Gaps = 7/130 (5%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANIL 532
           ++V E+ G G LF++I +K  ++ +   R   +    + Y H      I+HRD+K  N+L
Sbjct: 85  VMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLL 140
Query: 533 LDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVL 591
           LD+N   K++DFG S ++        +   G+  Y  PE +        + DV+S G+VL
Sbjct: 141 LDDNLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198
Query: 592 VELLTGKMAL 601
             +L G++  
Sbjct: 199 YVMLVGRLPF 208

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L +R  VA+KK    F +Q        ELV++ 
Sbjct: 23  TVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERN-VAIKKLSRPFQNQTHAKRAYRELVLMK 80
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  + 
Sbjct: 81  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQM 137
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  
Sbjct: 138 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV--TRY 192
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           Y  PE +      +  D++S G ++ E++ G
Sbjct: 193 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           TV   Y ++  IG G  G V   Y   L     +      F +Q        ELV++  +
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 455 NRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  +   
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 137
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYR 192
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
            PE +      +  D++S G ++ E++  K+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHKI 223

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 11/199 (5%)
Query: 406 ADVIGCGGSGNVYKG-FLPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
            +++G G    VY+   +     VA+K   K        +    NE+ +  Q+   +++ 
Sbjct: 16  GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR--ITAETAGVLSYLHSETNV 519
           L     ++    LV E   NG +  ++  +     E   R  +     G+L YLHS    
Sbjct: 76  LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML-YLHSHG-- 132
Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
            I+HRD+  +N+LL  N   K++DFG +  + +   ++ T+  GT  Y+ PE        
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHG 190
Query: 580 DKSDVYSFGVVLVELLTGK 598
            +SDV+S G +   LL G+
Sbjct: 191 LESDVWSLGCMFYTLLIGR 209

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 6/170 (3%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE-HI 488
           V KS  +   + ++   E+ +   ++  +VV   G   +     +V E     +L E H 
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            +K     E R  +     GV  YLH   N  +IHRD+K  N+ L+++   K+ DFG + 
Sbjct: 135 RRKAVTEPEARYFMRQTIQGV-QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLAT 190
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            +  D  +   +  GT  Y+ PE L     + + D++S G +L  LL GK
Sbjct: 191 KIEFDGERKKDLC-GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 9/165 (5%)
Query: 438 QAKIDEFINELVVVLQINRRNVVRLLGCCLE-TQVPL-LVYEFVGNGTLFEHIHK----K 491
           +A+    ++E+ ++ ++   N+VR     ++ T   L +V E+   G L   I K    +
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 492 GNLSWERRLRITAETAGVLSYLH--SETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
             L  E  LR+  +    L   H  S+    ++HRD+K AN+ LD     K+ DFG +++
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVEL 594
           +  D       V GT  Y+ PE +      +KSD++S G +L EL
Sbjct: 166 LNHDEDFAKEFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 97/195 (49%), Gaps = 15/195 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGC 465
           +G G  G VYK    ++   A+  +K ++   + +++++I E+ ++   +   +V+LLG 
Sbjct: 27  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRIT-AETAGVLSYLHSETNVPIIHR 524
                   ++ EF   G +   + +      E ++++   +    L++LHS+    IIHR
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHR 141
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD---- 580
           D+K+ N+L+      +++DFG S    +  +Q      GT  ++ PE +    + D    
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 200
Query: 581 -KSDVYSFGVVLVEL 594
            K+D++S G+ L+E+
Sbjct: 201 YKADIWSLGITLIEM 215

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 79/191 (41%), Gaps = 19/191 (9%)
Query: 430 VKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
           + K   + + ++  F  E  V++  +RR + +L     +     LV E+   G L   + 
Sbjct: 94  MNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLS 153
Query: 490 KKGNLSWERRLRITAETAG-----VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
           K G        RI AE A      ++  + S   +  +HRD+K  NILLD     +++DF
Sbjct: 154 KFGE-------RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADF 206
Query: 545 GASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS-------DVYSFGVVLVELLTG 597
           G+   +  D      V  GT  YL PE LQ       +       D ++ GV   E+  G
Sbjct: 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
Query: 598 KMALLSDKPEE 608
           +    +D   E
Sbjct: 267 QTPFYADSTAE 277

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
           +  + E+ ++ Q++  N+ +L     +     LV E    G LF+ I  +   S     R
Sbjct: 71  ESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 130
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNC 558
           I  +    ++Y H      I+HRD+K  N+LL+   ++   ++ DFG S     +A +  
Sbjct: 131 IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKX 185
Query: 559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
               GT  Y+ PE L      +K DV+S GV+L  LL+G
Sbjct: 186 KDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L +R  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  + T K+ DFG ++      +    VV  T  
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           Y  PE +      +  D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 97/195 (49%), Gaps = 15/195 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGC 465
           +G G  G VYK    ++   A+  +K ++   + +++++I E+ ++   +   +V+LLG 
Sbjct: 19  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRIT-AETAGVLSYLHSETNVPIIHR 524
                   ++ EF   G +   + +      E ++++   +    L++LHS+    IIHR
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHR 133
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD---- 580
           D+K+ N+L+      +++DFG S    +  +Q      GT  ++ PE +    + D    
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 192
Query: 581 -KSDVYSFGVVLVEL 594
            K+D++S G+ L+E+
Sbjct: 193 YKADIWSLGITLIEM 207

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 104/228 (45%), Gaps = 43/228 (18%)
Query: 405 YADVIGCGGSGNVYKG--FLPDRTPVAVK------KSKFVDQAKIDEFINELVVVLQI-N 455
           +  V+G G  G V     +   +T V+++      K K  D ++ +  ++EL ++ Q+ +
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGS 107
Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN---------------------- 493
             N+V LLG C  +    L++E+   G L  ++  K                        
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 494 -LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI 552
            L++E  L    + A  + +L  ++    +HRD+ + N+L+      K+ DFG ++ +  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 553 DAIQNCTVVQGT----LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           D+     VV+G     + ++ PE L     T KSDV+S+G++L E+ +
Sbjct: 225 DS---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 41/242 (16%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG---NLSWER 498
           + F     ++ +++ +++V   G C+     +LV EFV  G+L  ++ K     N+ W  
Sbjct: 57  ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW-- 114
Query: 499 RLRITAETAGVLSYLHSETNVPIIHRDVKSANILL-----DENCTP---KVSDFGAS-KL 549
           +L +  + A  + +L   T   +IH +V + NILL      +   P   K+SD G S  +
Sbjct: 115 KLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 550 VPIDAIQNCTVVQGTLGYLDPEYLQTCK-LTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           +P D      ++Q  + ++ PE ++  K L   +D +SFG  L E+ +G      DKP  
Sbjct: 172 LPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG-----GDKP-- 218
Query: 609 ERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL 668
                   LS+L   R L+  ++R  +     +  E+A L   C+    + RP+ + +  
Sbjct: 219 --------LSALDSQRKLQFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268
Query: 669 EL 670
           +L
Sbjct: 269 DL 270

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           TV   Y ++  IG G  G V   Y   L     +      F +Q        ELV++  +
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 80
Query: 455 NRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  +   
Sbjct: 81  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 137
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  Y 
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYR 192
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
            PE +      +  D++S G ++ E++  K+
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHKI 223

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 11/130 (8%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L++ E +  G LF  I ++G+ ++  R    I  +    + +LHS     I HRDVK  N
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPEN 139
Query: 531 ILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L    +++   K++DFG +K    +A+Q       T  Y+ PE L   K     D++S 
Sbjct: 140 LLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY---TPYYVAPEVLGPEKYDKSCDMWSL 196
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 197 GVIMYILLCG 206

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 11/130 (8%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L++ E +  G LF  I ++G+ ++  R    I  +    + +LHS     I HRDVK  N
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPEN 158
Query: 531 ILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L    +++   K++DFG +K    +A+Q       T  Y+ PE L   K     D++S 
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY---TPYYVAPEVLGPEKYDKSCDMWSL 215
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 216 GVIMYILLCG 225

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L +R  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  + T K+ DFG ++      +    VV  T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           Y  PE +      +  D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 87/174 (50%), Gaps = 12/174 (6%)
Query: 438 QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL--VYEFVGNGTLFEHIHKKGNLS 495
           +  I++   E+ ++ +++  NVV+L+    +     L  V+E V  G + E    K    
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS-KLVPIDA 554
            + R        G+  YLH +    IIHRD+K +N+L+ E+   K++DFG S +    DA
Sbjct: 137 DQARFYFQDLIKGI-EYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 555 IQNCTVVQGTLGYLDPEYLQTCK--LTDKS-DVYSFGVVLVELLTGKMALLSDK 605
           + + TV  GT  ++ PE L   +   + K+ DV++ GV L   + G+   + ++
Sbjct: 193 LLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           TV   Y ++  IG G  G V   Y   L     +      F +Q        ELV++  +
Sbjct: 26  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 85
Query: 455 NRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  +   
Sbjct: 86  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 142
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  Y 
Sbjct: 143 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 197
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
            PE +      +  D++S G ++ E++  K+
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHKI 228

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 118/278 (42%), Gaps = 24/278 (8%)
Query: 408 VIGCGGSGNVYKGFLPDR-TPVAVKKSKFVDQAKIDEFI--NELVVVLQINRRNVVRLLG 464
           ++G G  G V K    D    VA+KK    D  K+ + I   E+ ++ Q+   N+V LL 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
            C + +   LV+EFV +  L +       L ++   +   +    + + HS     IIHR
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHR 148
Query: 525 DVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYL-QTCKLTDKS 582
           D+K  NIL+ ++   K+ DFG A  L     + +  V   T  Y  PE L    K     
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRWYRAPELLVGDVKYGKAV 206
Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN--------------RLLEI 628
           DV++ G ++ E+  G+     D   ++    M  L +L                 RL EI
Sbjct: 207 DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEI 266
Query: 629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
            +   +     +  + V  LA +C+ +  ++RP   E+
Sbjct: 267 KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 22/186 (11%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET------NVPII-HRDV 526
           L+  F   G+L + + K   +SW     I    A  L+YLH +       + P I HRD+
Sbjct: 99  LITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDI 157
Query: 527 KSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG---YLDPEYLQTCKLTDKS- 582
           KS N+LL  N T  ++DFG +  +  +A ++     G +G   Y+ PE L+      +  
Sbjct: 158 KSKNVLLKNNLTACIADFGLA--LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDA 215
Query: 583 ----DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
               D+Y+ G+VL EL +   A  +D P +E  L   F   + Q+  LE +   +V+   
Sbjct: 216 FLRIDMYAMGLVLWELASRCTA--ADGPVDEYMLP--FEEEIGQHPSLEDMQEVVVHKKK 271
Query: 639 KQQLKE 644
           +  L++
Sbjct: 272 RPVLRD 277

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI 454
           TV   Y ++  IG G  G V   Y   L     +      F +Q        ELV++  +
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 74
Query: 455 NRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  +   
Sbjct: 75  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 131
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  Y 
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 186
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
            PE +      +  D++S G ++ E++  K+
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHKI 217

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 41/242 (16%)
Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG---NLSWER 498
           + F     ++ +++ +++V   G C      +LV EFV  G+L  ++ K     N+ W  
Sbjct: 57  ESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW-- 114
Query: 499 RLRITAETAGVLSYLHSETNVPIIHRDVKSANILL-----DENCTP---KVSDFGAS-KL 549
           +L +  + A  + +L   T   +IH +V + NILL      +   P   K+SD G S  +
Sbjct: 115 KLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 550 VPIDAIQNCTVVQGTLGYLDPEYLQTCK-LTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
           +P D      ++Q  + ++ PE ++  K L   +D +SFG  L E+ +G      DKP  
Sbjct: 172 LPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG-----GDKP-- 218
Query: 609 ERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL 668
                   LS+L   R L+  ++R  +     +  E+A L   C+    + RP+ + +  
Sbjct: 219 --------LSALDSQRKLQFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR 268
Query: 669 EL 670
           +L
Sbjct: 269 DL 270

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/299 (21%), Positives = 119/299 (39%), Gaps = 39/299 (13%)
Query: 385 QSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEF 444
           ++S+ +    E +I        ++IG G  G VY G       + +   +  ++ ++  F
Sbjct: 17  KASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAF 76
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRIT 503
             E++   Q    NVV  +G C+      ++       TL+  +   K  L   +  +I 
Sbjct: 77  KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIA 136
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI-------Q 556
            E    + YLH++    I+H+D+KS N+  D N    ++DFG   L  I  +        
Sbjct: 137 QEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFG---LFSISGVLQAGRRED 189
Query: 557 NCTVVQGTLGYLDPEYLQTCK---------LTDKSDVYSFGVVLVELLTGKMALLSDKPE 607
              +  G L +L PE ++             +  SDV++ G +  EL   +      K +
Sbjct: 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF---KTQ 246
Query: 608 EERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
              ++     + +K N L +I              KE++ +   C +   EERPT  ++
Sbjct: 247 PAEAIIWQMGTGMKPN-LSQI-----------GMGKEISDILLFCWAFEQEERPTFTKL 293

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 114/265 (43%), Gaps = 21/265 (7%)
Query: 366 FFEQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYAD-----VIGCGGSGNVYKG 420
            +++   S LR+E + L  +  E AK FT + +K +  +  D     VIG G  G V   
Sbjct: 37  LYDECNNSPLRREKNIL--EYLEWAKPFTSK-VKQMRLHREDFEILKVIGRGAFGEVAVV 93
Query: 421 FLPDRTPV----AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY 476
            L +   V     + K + + +A+   F  E  V++  + + +  L     +     LV 
Sbjct: 94  KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153
Query: 477 EFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIHRDVKSANILLDE 535
           ++   G L   + K  +   E   R   AE    +  +H    +  +HRD+K  NIL+D 
Sbjct: 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDM 210
Query: 536 NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC-----KLTDKSDVYSFGVV 590
           N   +++DFG+   +  D     +V  GT  Y+ PE LQ       +   + D +S GV 
Sbjct: 211 NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 591 LVELLTGKMALLSDKPEEERSLAMN 615
           + E+L G+    ++   E     MN
Sbjct: 271 MYEMLYGETPFYAESLVETYGKIMN 295

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 21/140 (15%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           LV+E +  G++  HIHK+ + +      +  + A  L +LH   N  I HRD+K  NIL 
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILC 144
Query: 534 DE--NCTP-KVSDFGASKLVPIDAIQNCTVVQ--------GTLGYLDPEYLQT----CKL 578
           +     +P K+ DFG    + ++   +C+ +         G+  Y+ PE ++       +
Sbjct: 145 EHPNQVSPVKICDFGLGSGIKLNG--DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 579 TDKS-DVYSFGVVLVELLTG 597
            DK  D++S GV+L  LL+G
Sbjct: 203 YDKRCDLWSLGVILYILLSG 222

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHK--KGNLSWE--RRLR 501
           E  ++ +++ R +V L     ET+  L LV   +  G +  HI+   + N  ++  R + 
Sbjct: 235 EKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV- 560
            TA+    L +LH      II+RD+K  N+LLD++   ++SD G +  V + A Q  T  
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKG 348
Query: 561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
             GT G++ PE L   +     D ++ GV L E++  +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHK--KGNLSWE--RRLR 501
           E  ++ +++ R +V L     ET+  L LV   +  G +  HI+   + N  ++  R + 
Sbjct: 235 EKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV- 560
            TA+    L +LH      II+RD+K  N+LLD++   ++SD G +  V + A Q  T  
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKG 348
Query: 561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
             GT G++ PE L   +     D ++ GV L E++  +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 79/159 (49%), Gaps = 25/159 (15%)
Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
           +N++ L+    +     LV+E +  G++  HI K+ + +     R+  + A  L +LH++
Sbjct: 71  KNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTK 130
Query: 517 TNVPIIHRDVKSANILLD--ENCTP-KVSDFGASKLVPIDAIQNCTVVQ--------GTL 565
               I HRD+K  NIL +  E  +P K+ DF     + ++   +CT +         G+ 
Sbjct: 131 G---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLN--NSCTPITTPELTTPCGSA 185
Query: 566 GYLDPEYLQTCKLTDKS-------DVYSFGVVLVELLTG 597
            Y+ PE ++    TD++       D++S GVVL  +L+G
Sbjct: 186 EYMAPEVVEV--FTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHK--KGNLSWE--RRLR 501
           E  ++ +++ R +V L     ET+  L LV   +  G +  HI+   + N  ++  R + 
Sbjct: 235 EKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV- 560
            TA+    L +LH      II+RD+K  N+LLD++   ++SD G +  V + A Q  T  
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKG 348
Query: 561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
             GT G++ PE L   +     D ++ GV L E++  +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHK--KGNLSWE--RRLR 501
           E  ++ +++ R +V L     ET+  L LV   +  G +  HI+   + N  ++  R + 
Sbjct: 235 EKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV- 560
            TA+    L +LH      II+RD+K  N+LLD++   ++SD G +  V + A Q  T  
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKG 348
Query: 561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
             GT G++ PE L   +     D ++ GV L E++  +
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 400 TVTNNYADV--IGCGGSGNV---YKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVL 452
           TV   Y ++  IG G  G V   Y   L +R  VA+KK    F +Q        ELV++ 
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAIL-ERN-VAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 453 QINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
            +N +N++ LL          E Q   +V E + +  L + I  +  L  ER   +  + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMSYLLYQM 135
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              + +LHS     IIHRD+K +NI++  + T K+ DFG ++      +    VV  T  
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVV--TRY 190
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           Y  PE +      +  D++S G ++ E++ G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 406 ADVIGCGGSGNVYKGFLPDRTPV-AVKKSKFVDQAK-IDEFINELVVVLQINRRNVVRLL 463
           +D++G G + NV++G       + A+K    +   + +D  + E  V+ ++N +N+V+L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 464 GCCLETQV--PLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETN 518
               ET     +L+ EF   G+L+  + +  N   L     L +  +  G +++L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 519 VPIIHRDVKSANILL----DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ 574
             I+HR++K  NI+     D     K++DFGA++ +  D  +    + GT  YL P+  +
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVXLYGTEEYLHPDMYE 188
Query: 575 TCKLTDKS--------DVYSFGVVLVELLTGKMAL 601
              L            D++S GV      TG +  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 409 IGCGGSGNV---YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR-NVVRLLG 464
           +G G  G V   Y      +  + +   K + ++ +   I   +  L++ R  ++++L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
                   ++V E+ GN  LF++I ++  +S +   R   +    + Y H      I+HR
Sbjct: 82  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHR 137
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT--DKS 582
           D+K  N+LLDE+   K++DFG S ++        +   G+  Y  PE + + KL    + 
Sbjct: 138 DLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPEVI-SGKLYAGPEV 194
Query: 583 DVYSFGVVLVELLTGKM 599
           DV+S GV+L  +L  ++
Sbjct: 195 DVWSCGVILYVMLCRRL 211

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 409 IGCGGSGNV---YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR-NVVRLLG 464
           +G G  G V   Y      +  + +   K + ++ +   I   +  L++ R  ++++L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
                   ++V E+ GN  LF++I ++  +S +   R   +    + Y H      I+HR
Sbjct: 81  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHR 136
Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT--DKS 582
           D+K  N+LLDE+   K++DFG S ++        +   G+  Y  PE + + KL    + 
Sbjct: 137 DLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPEVI-SGKLYAGPEV 193
Query: 583 DVYSFGVVLVELLTGKM 599
           DV+S GV+L  +L  ++
Sbjct: 194 DVWSCGVILYVMLCRRL 210

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 14/107 (13%)
Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG-----------ASK 548
           L I  + A  + +LHS+    ++HRD+K +NI    +   KV DFG            + 
Sbjct: 121 LHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELL 595
           L P+ A    T   GT  Y+ PE +     + K D++S G++L ELL
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 406 ADVIGCGGSGNVYKGFLPDRTPV-AVKKSKFVDQAK-IDEFINELVVVLQINRRNVVRLL 463
           +D++G G + NV++G       + A+K    +   + +D  + E  V+ ++N +N+V+L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 464 GCCLETQV--PLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETN 518
               ET     +L+ EF   G+L+  + +  N   L     L +  +  G +++L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 519 VPIIHRDVKSANILL----DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ 574
             I+HR++K  NI+     D     K++DFGA++ +  D  +    + GT  YL P+  +
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMYE 188
Query: 575 TCKLTDKS--------DVYSFGVVLVELLTGKMAL 601
              L            D++S GV      TG +  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           +G G  G VYK        VA+K+ +    D+      I E+ ++ +++  N+V L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 467 LETQVPLLVYEFVGNG---TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
              +   LV+EF+       L E+  K G    + ++ +     GV ++ H      I+H
Sbjct: 89  HSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRGV-AHCHQHR---ILH 142
Query: 524 RDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           RD+K  N+L++ +   K++DFG ++   +P+ +  +  V   TL Y  P+ L   K    
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV---TLWYRAPDVLMGSKKYST 199
Query: 582 S-DVYSFGVVLVELLTGK 598
           S D++S G +  E++TGK
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVV--LQINRRNVVRLLG 464
           IG GGS  V++     +   A+K       D   +D + NE+  +  LQ +   ++RL  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLS-WERRLRITAETAGVLSYLHSETNVPIIH 523
             +  Q   +V E  GN  L   + KK ++  WER+    +    +L  +H+     I+H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVH 178
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVP--IDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
            D+K AN L+ +    K+ DFG A+++ P     +++  V  GT+ Y+ PE ++    + 
Sbjct: 179 SDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDMSSSR 235
Query: 581 KS-----------DVYSFGVVLVELLTGK 598
           ++           DV+S G +L  +  GK
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           +G G  G VYK        VA+K+ +    D+      I E+ ++ +++  N+V L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 467 LETQVPLLVYEFVGNG---TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
              +   LV+EF+       L E+  K G    + ++ +     GV ++ H      I+H
Sbjct: 89  HSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRGV-AHCHQHR---ILH 142
Query: 524 RDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           RD+K  N+L++ +   K++DFG ++   +P+ +  +  V   TL Y  P+ L   K    
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV---TLWYRAPDVLMGSKKYST 199
Query: 582 S-DVYSFGVVLVELLTGK 598
           S D++S G +  E++TGK
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVV--LQINRRNVVRLLG 464
           IG GGS  V++     +   A+K       D   +D + NE+  +  LQ +   ++RL  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLS-WERRLRITAETAGVLSYLHSETNVPIIH 523
             +  Q   +V E  GN  L   + KK ++  WER+    +    +L  +H+     I+H
Sbjct: 77  YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVH 131
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVP--IDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
            D+K AN L+ +    K+ DFG A+++ P     +++  V  GT+ Y+ PE ++    + 
Sbjct: 132 SDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDMSSSR 188
Query: 581 KS-----------DVYSFGVVLVELLTGK 598
           ++           DV+S G +L  +  GK
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 438 QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWE 497
           Q +I+  I+ L +   +   ++++L          ++V E+ GN  LF++I ++  +S +
Sbjct: 48  QGRIEREISYLRL---LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQ 103
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
              R   +    + Y H      I+HRD+K  N+LLDE+   K++DFG S ++       
Sbjct: 104 EARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK 160
Query: 558 CTVVQGTLGYLDPEYLQTCKLT--DKSDVYSFGVVLVELLTGKM 599
            +   G+  Y  PE + + KL    + DV+S GV+L  +L  ++
Sbjct: 161 TSC--GSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRL 201

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 82/164 (50%), Gaps = 12/164 (7%)
Query: 438 QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWE 497
           Q +I+  I+ L +   +   ++++L          ++V E+ GN  LF++I ++  +S +
Sbjct: 52  QGRIEREISYLRL---LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQ 107
Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
              R   +    + Y H      I+HRD+K  N+LLDE+   K++DFG S ++       
Sbjct: 108 EARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK 164
Query: 558 CTVVQGTLGYLDPEYLQTCKLT--DKSDVYSFGVVLVELLTGKM 599
            +   G+  Y  PE + + KL    + DV+S GV+L  +L  ++
Sbjct: 165 TSC--GSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRL 205

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 50/226 (22%)
Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKK--SKFVDQAKIDEFINELVVVLQIN-RRNVVRL 462
           +G G  G V+K    DR     VAVKK    F +         E++++ +++   N+V L
Sbjct: 17  LGKGAYGIVWKSI--DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 463 LGCCL--ETQVPLLVYEF-------VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL 513
           L        +   LV+++       V    + E +HK+          +  +   V+ YL
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ---------YVVYQLIKVIKYL 125
Query: 514 HSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL----------VPIDAIQN------ 557
           HS     ++HRD+K +NILL+  C  KV+DFG S+           +P+   +N      
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 558 ----CTVVQGTLGYLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
                T    T  Y  PE  L + K T   D++S G +L E+L GK
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 144
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 205 KSIDIWSVGCILAEMLSNR 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 148
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 209 KSIDIWSVGCILAEMLSNR 227

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVV--LQINRRNVVRLLG 464
           IG GGS  V++     +   A+K       D   +D + NE+  +  LQ +   ++RL  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLS-WERRLRITAETAGVLSYLHSETNVPIIH 523
             +  Q   +V E  GN  L   + KK ++  WER+    +    +L  +H+     I+H
Sbjct: 96  YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVH 150
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVP--IDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
            D+K AN L+ +    K+ DFG A+++ P     +++  V  GT+ Y+ PE ++    + 
Sbjct: 151 SDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDMSSSR 207
Query: 581 KS-----------DVYSFGVVLVELLTGK 598
           ++           DV+S G +L  +  GK
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 146
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 207 KSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 144
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 205 KSIDIWSVGCILAEMLSNR 223

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 394 TEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRT--PVAVKK--SKFVDQAKIDEFINELV 449
           T  E++ V  +   V G G  G V    +  RT   VA+KK    F  +        EL 
Sbjct: 19  TAWEVRAVYRDLQPV-GSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 76
Query: 450 VVLQINRRNVVRLLGCCLETQVP------LLVYEFVGN--GTLFEHIHKKGNLSWERRLR 501
           ++  +   NV+ LL      +         LV  F+G   G L +H      L  +R   
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH----EKLGEDRIQF 132
Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
           +  +    L Y+H+     IIHRD+K  N+ ++E+C  K+ DFG ++    D+     VV
Sbjct: 133 LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMXGXVV 187
Query: 562 QGTLGYLDPEY-LQTCKLTDKSDVYSFGVVLVELLTGK 598
             T  Y  PE  L   + T   D++S G ++ E++TGK
Sbjct: 188 --TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 151
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 211
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 212 KSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 152
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 153 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 212
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 213 KSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 143
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 144 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 203
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 204 KSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 150
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 211 KSIDIWSVGCILAEMLSNR 229

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVV--LQINRRNVVRLLG 464
           IG GGS  V++     +   A+K       D   +D + NE+  +  LQ +   ++RL  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLS-WERRLRITAETAGVLSYLHSETNVPIIH 523
             +  Q   +V E  GN  L   + KK ++  WER+    +    +L  +H+     I+H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVH 178
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVP--IDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
            D+K AN L+ +    K+ DFG A+++ P     +++  V  GT+ Y+ PE ++    + 
Sbjct: 179 SDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDMSSSR 235
Query: 581 KS-----------DVYSFGVVLVELLTGK 598
           ++           DV+S G +L  +  GK
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 166
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 167 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 226
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 227 KSIDIWSVGCILAEMLSNR 245

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 154
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 155 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 214
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 215 KSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 146
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 207 KSIDIWSVGCILAEMLSNR 225

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 87/212 (41%), Gaps = 21/212 (9%)
Query: 402 TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR--- 456
           T+ Y  V  IG G  G VYK   P        KS  V   +    I+ +  V  + R   
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 457 ---RNVVRLLGCCLETQVP-----LLVYEFVGNG--TLFEHIHKKGNLSWERRLRITAET 506
               NVVRL+  C  ++        LV+E V     T  +     G L  E    +  + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQF 121
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              L +LH+     I+HRD+K  NIL+    T K++DFG +++       +  VV  TL 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV--TLW 176
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           Y  PE L         D++S G +  E+   K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVV--LQINRRNVVRLLG 464
           IG GGS  V++     +   A+K       D   +D + NE+  +  LQ +   ++RL  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLS-WERRLRITAETAGVLSYLHSETNVPIIH 523
             +  Q   +V E  GN  L   + KK ++  WER+    +    +L  +H+     I+H
Sbjct: 96  YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVH 150
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVP--IDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
            D+K AN L+ +    K+ DFG A+++ P     +++  V  GT+ Y+ PE ++    + 
Sbjct: 151 SDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQV--GTVNYMPPEAIKDMSSSR 207
Query: 581 KS-----------DVYSFGVVLVELLTGK 598
           ++           DV+S G +L  +  GK
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 65/143 (45%), Gaps = 7/143 (4%)
Query: 458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           N+VRL     E     LV++ V  G LFE I  +   S         +    +++ H   
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 518 NVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ 574
              I+HRD+K  N+LL    +    K++DFG +  V  D  Q      GT GYL PE L+
Sbjct: 124 ---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYLSPEVLR 179
Query: 575 TCKLTDKSDVYSFGVVLVELLTG 597
                   D+++ GV+L  LL G
Sbjct: 180 KDPYGKPVDMWACGVILYILLVG 202

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 150
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 210
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 211 KSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 151
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 211
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 212 KSIDIWSVGCILAEMLSNR 230

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 66/147 (44%), Gaps = 7/147 (4%)
Query: 454 INRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL 513
           +   N+VRL     E     LV++ V  G LFE I  +   S         +    +++ 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 514 HSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDP 570
           H      I+HRD+K  N+LL    +    K++DFG +  V  D  Q      GT GYL P
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYLSP 175
Query: 571 EYLQTCKLTDKSDVYSFGVVLVELLTG 597
           E L+        D+++ GV+L  LL G
Sbjct: 176 EVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVV--LQINRRNVVRLLG 464
           IG GGS  V++     +   A+K       D   +D + NE+  +  LQ +   ++RL  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLS-WERRLRITAETAGVLSYLHSETNVPIIH 523
             +  Q   +V E  GN  L   + KK ++  WER+    +    +L  +H+     I+H
Sbjct: 80  YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVH 134
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVP--IDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
            D+K AN L+ +    K+ DFG A+++ P     +++  V  GT+ Y+ PE ++    + 
Sbjct: 135 SDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDMSSSR 191
Query: 581 KS-----------DVYSFGVVLVELLTGK 598
           ++           DV+S G +L  +  GK
Sbjct: 192 ENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 378 ELSKLHGQSSEKAKIFTEEEIKTVTNNYADVI---------GCGGSGNVYKGFLPDRTPV 428
           +L +L  ++ +   +   E++K V   Y + +         G G  G V++        +
Sbjct: 40  KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRLGRGSFGEVHR--------M 91
Query: 429 AVKKSKF---VDQAKIDEF-INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
             K++ F   V + +++ F + ELV    ++   +V L G   E     +  E +  G+L
Sbjct: 92  KDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 151
Query: 485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT-PKVSD 543
            + I + G L  +R L    +    L YLH+     I+H DVK+ N+LL  + +   + D
Sbjct: 152 GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCD 208
Query: 544 FGASKLVPIDAIQNCTV----VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           FG +  +  D +    +    + GT  ++ PE +       K D++S   +++ +L G
Sbjct: 209 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L     N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 148
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 209 KSIDIWSVGCILAEMLSNR 227

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC----- 576
           +HRD+K  N+LLD N   +++DFG+   +  D     +V  GT  Y+ PE LQ       
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
           K   + D +S GV + E+L G+    ++   E     MN
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 311

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 378 ELSKLHGQSSEKAKIFTEEEIKTVTNNYAD---------VIGCGGSGNVYKGFLPDRTPV 428
           +L +L  ++ +   +   E++K V   Y +          +G G  G V++        +
Sbjct: 26  KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHR--------M 77
Query: 429 AVKKSKF---VDQAKIDEF-INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
             K++ F   V + +++ F + ELV    ++   +V L G   E     +  E +  G+L
Sbjct: 78  KDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137
Query: 485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT-PKVSD 543
            + I + G L  +R L    +    L YLH+     I+H DVK+ N+LL  + +   + D
Sbjct: 138 GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCD 194
Query: 544 FGASKLVPIDAIQNCTV----VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           FG +  +  D +    +    + GT  ++ PE +       K D++S   +++ +L G
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVV--LQINRRNVVRLLG 464
           IG GGS  V++     +   A+K       D   +D + NE+  +  LQ +   ++RL  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLS-WERRLRITAETAGVLSYLHSETNVPIIH 523
             +  Q   +V E  GN  L   + KK ++  WER+    +    +L  +H+     I+H
Sbjct: 76  YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVH 130
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVP--IDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
            D+K AN L+ +    K+ DFG A+++ P     +++  V  GT+ Y+ PE ++    + 
Sbjct: 131 SDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDMSSSR 187
Query: 581 KS-----------DVYSFGVVLVELLTGK 598
           ++           DV+S G +L  +  GK
Sbjct: 188 ENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA++K S F  Q      + E+ ++L+    N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 150
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 211 KSIDIWSVGCILAEMLSNR 229

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC----- 576
           +HRD+K  N+LLD N   +++DFG+   +  D     +V  GT  Y+ PE LQ       
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
           K   + D +S GV + E+L G+    ++   E     MN
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 90/185 (48%), Gaps = 17/185 (9%)
Query: 434 KFVDQAKIDEFINELVVVLQINRR-NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG 492
           K +D++K D    E+ ++L+  +  N++ L     + +   +V E +  G L + I ++ 
Sbjct: 53  KIIDKSKRDP-TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK 111
Query: 493 NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANIL-LDENCTP---KVSDFGASK 548
             S      +       + YLH++    ++HRD+K +NIL +DE+  P   ++ DFG +K
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 549 LVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLS--- 603
            +     +N  ++    T  ++ PE L+        D++S GV+L  +LTG     +   
Sbjct: 169 QL---RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225
Query: 604 DKPEE 608
           D PEE
Sbjct: 226 DTPEE 230

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 86/212 (40%), Gaps = 21/212 (9%)
Query: 402 TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR--- 456
           T+ Y  V  IG G  G VYK   P        KS  V   +    I+ +  V  + R   
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 457 ---RNVVRLLGCCLETQVP-----LLVYEFVGNG--TLFEHIHKKGNLSWERRLRITAET 506
               NVVRL+  C  ++        LV+E V     T  +     G L  E    +  + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQF 121
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              L +LH+     I+HRD+K  NIL+    T K++DFG +++          VV  TL 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV--TLW 176
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           Y  PE L         D++S G +  E+   K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 397 EIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTP---VAVKKSKFVDQAKIDEFIN----- 446
           ++K+    Y   D +G G    VYK    D+     VA+KK K   +++  + IN     
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKAR--DKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITA-- 504
           E+ ++ +++  N++ LL          LV++F+   T  E I K  +L       I A  
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPS-HIKAYM 118
Query: 505 -ETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV--PIDAIQNCTVV 561
             T   L YLH      I+HRD+K  N+LLDEN   K++DFG +K    P  A  +  V 
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV- 174
Query: 562 QGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELL 595
             T  Y  PE L   ++     D+++ G +L ELL
Sbjct: 175 --TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL-KCQHLSNDHICYFLYQILRGLKYIHSAN---VL 150
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+  C  K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 211 KSIDIWSVGCILAEMLSNR 229

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 378 ELSKLHGQSSEKAKIFTEEEIKTVTNNYAD---------VIGCGGSGNVYKGFLPDRTPV 428
           +L +L  ++ +   +   E++K V   Y +          +G G  G V++        +
Sbjct: 42  KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHR--------M 93
Query: 429 AVKKSKF---VDQAKIDEF-INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL 484
             K++ F   V + +++ F + ELV    ++   +V L G   E     +  E +  G+L
Sbjct: 94  KDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 153
Query: 485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT-PKVSD 543
            + I + G L  +R L    +    L YLH+     I+H DVK+ N+LL  + +   + D
Sbjct: 154 GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCD 210
Query: 544 FGASKLVPIDAIQNCTV----VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           FG +  +  D +    +    + GT  ++ PE +       K D++S   +++ +L G
Sbjct: 211 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVV--LQINRRNVVRLLG 464
           IG GGS  V++     +   A+K       D   +D + NE+  +  LQ +   ++RL  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLS-WERRLRITAETAGVLSYLHSETNVPIIH 523
             +  Q   +V E  GN  L   + KK ++  WER+    +    +L  +H+     I+H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVH 178
Query: 524 RDVKSANILLDENCTPKVSDFG-ASKLVP--IDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
            D+K AN L+ +    K+ DFG A+++ P     +++  V  G + Y+ PE ++    + 
Sbjct: 179 SDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV--GAVNYMPPEAIKDMSSSR 235
Query: 581 KS-----------DVYSFGVVLVELLTGK 598
           ++           DV+S G +L  +  GK
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 161
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K     +  + T    T  Y+ PE L   K     D++S 
Sbjct: 162 LLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 219
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 220 GVIMYILLCG 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 86/212 (40%), Gaps = 21/212 (9%)
Query: 402 TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR--- 456
           T+ Y  V  IG G  G VYK   P        KS  V   +    I+ +  V  + R   
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEA 62
Query: 457 ---RNVVRLLGCCLETQVP-----LLVYEFVGNG--TLFEHIHKKGNLSWERRLRITAET 506
               NVVRL+  C  ++        LV+E V     T  +     G L  E    +  + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQF 121
Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              L +LH+     I+HRD+K  NIL+    T K++DFG +++          VV  TL 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV--TLW 176
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           Y  PE L         D++S G +  E+   K
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 21/140 (15%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           LV+E +  G++  HIHK+ + +      +  + A  L +LH   N  I HRD+K  NIL 
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILC 144
Query: 534 DE--NCTP-KVSDFGASKLVPIDAIQNCTVVQ--------GTLGYLDPEYLQT----CKL 578
           +     +P K+ DF     + ++   +C+ +         G+  Y+ PE ++       +
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNG--DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 579 TDKS-DVYSFGVVLVELLTG 597
            DK  D++S GV+L  LL+G
Sbjct: 203 YDKRCDLWSLGVILYILLSG 222

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 153
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K     +  + T    T  Y+ PE L   K     D++S 
Sbjct: 154 LLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 211
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 212 GVIMYILLCG 221

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 151
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K     +  + T    T  Y+ PE L   K     D++S 
Sbjct: 152 LLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 209
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 210 GVIMYILLCG 219

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 152
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K     +  + T    T  Y+ PE L   K     D++S 
Sbjct: 153 LLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 210
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 211 GVIMYILLCG 220

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 14/107 (13%)
Query: 500 LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG-----------ASK 548
           L I  + A  + +LHS+    ++HRD+K +NI    +   KV DFG            + 
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELL 595
           L P+ A        GT  Y+ PE +     + K D++S G++L ELL
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 146
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K     +  + T    T  Y+ PE L   K     D++S 
Sbjct: 147 LLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 204
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 205 GVIMYILLCG 214

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 147
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K     +  + T    T  Y+ PE L   K     D++S 
Sbjct: 148 LLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 206 GVIMYILLCG 215

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 145
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K     +  + T    T  Y+ PE L   K     D++S 
Sbjct: 146 LLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 204 GVIMYILLCG 213

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 99/235 (42%), Gaps = 24/235 (10%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKT---VTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKK 432
           ++  H  S E+   + +E  KT   V   Y ++  +G G  G+V   F       VAVKK
Sbjct: 1   MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 60
Query: 433 SKFVDQAKID--EFINELVVVLQINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTL 484
                Q+ I       EL ++  +   NV+ LL          E     LV   +G    
Sbjct: 61  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-- 118
Query: 485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
             +I K   L+ +    +  +    L Y+HS     IIHRD+K +N+ ++E+C  K+ DF
Sbjct: 119 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 175
Query: 545 GASKLVPIDAIQNCTVVQGTLGYLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           G ++          T    T  Y  PE  L         D++S G ++ ELLTG+
Sbjct: 176 GLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 191
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K     +  + T    T  Y+ PE L   K     D++S 
Sbjct: 192 LLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 250 GVIMYILLCG 259

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 147
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K     +  + T    T  Y+ PE L   K     D++S 
Sbjct: 148 LLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 206 GVIMYILLCG 215

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 10/130 (7%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 197
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K     +  + T    T  Y+ PE L   K     D++S 
Sbjct: 198 LLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 255
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 256 GVIMYILLCG 265

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 99/235 (42%), Gaps = 24/235 (10%)
Query: 379 LSKLHGQSSEKAKIFTEEEIKT---VTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKK 432
           ++  H  S E+   + +E  KT   V   Y ++  +G G  G+V   F       VAVKK
Sbjct: 1   MAHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKK 60
Query: 433 SKFVDQAKID--EFINELVVVLQINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTL 484
                Q+ I       EL ++  +   NV+ LL          E     LV   +G    
Sbjct: 61  LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-- 118
Query: 485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
             +I K   L+ +    +  +    L Y+HS     IIHRD+K +N+ ++E+C  K+ DF
Sbjct: 119 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 175
Query: 545 GASKLVPIDAIQNCTVVQGTLGYLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           G ++          T    T  Y  PE  L         D++S G ++ ELLTG+
Sbjct: 176 GLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +Y D++     G+ Y          A+K+    +Q   +E   E  +    N  N++RL+
Sbjct: 43  SYVDLVEGLHDGHFY----------ALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 464 GCCLE----TQVPLLVYEFVGNGTLFEHIHK---KGN-LSWERRLRITAETAGVLSYLHS 515
             CL          L+  F   GTL+  I +   KGN L+ ++ L +       L  +H+
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA--------IQNCTVVQGTLGY 567
           +      HRD+K  NILL +   P + D G+     I          +Q+    + T+ Y
Sbjct: 153 KGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 568 LDPEYLQT---CKLTDKSDVYSFGVVLVELLTGK 598
             PE       C + +++DV+S G VL  ++ G+
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 85/215 (39%), Gaps = 24/215 (11%)
Query: 402 TNNYADV--IGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN--RR 457
           T+ Y  V  IG G  G VYK   P        KS  V           +  V ++   RR
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 458 -------NVVRLLGCCLETQVP-----LLVYEFVGNG--TLFEHIHKKGNLSWERRLRIT 503
                  NVVRL+  C  ++        LV+E V     T  +     G L  E    + 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126
Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            +    L +LH+     I+HRD+K  NIL+    T K++DFG +++          VV  
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-- 181
Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           TL Y  PE L         D++S G +  E+   K
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 21/223 (9%)
Query: 386 SSEKAKIFTEEEIKTVTNNY---ADVIGCGGSGNV----YKGFLPDRTPVAVKKSKFVDQ 438
           SS +  ++ +   K   N Y    + IG G  G V     KG    R    + K  FV+ 
Sbjct: 8   SSGRENLYFQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY-FVED 66
Query: 439 AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWER 498
             +D F  E+ ++  ++  N++RL     +     LV E    G LFE +  K       
Sbjct: 67  --VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD 124
Query: 499 RLRITAETAGVLSYLHSETNVPIIHRDVKSANILL--DENCTP-KVSDFG-ASKLVPIDA 554
             RI  +    ++Y H    + + HRD+K  N L   D   +P K+ DFG A++  P   
Sbjct: 125 AARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 181
Query: 555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           ++      GT  Y+ P+ L+      + D +S GV++  LL G
Sbjct: 182 MRTKV---GTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCG 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  ++ DFG ++     A +  T    T  Y  
Sbjct: 136 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGYVATRWYRA 188
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELL GK
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 9/148 (6%)
Query: 454 INRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL 513
           +   N+VRL     E     L+++ V  G LFE I  +   S         +    + + 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 137
Query: 514 HSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTV-VQGTLGYLD 569
           H    + ++HRD+K  N+LL    +    K++DFG +  + ++  Q       GT GYL 
Sbjct: 138 H---QMGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLS 192
Query: 570 PEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           PE L+        D+++ GV+L  LL G
Sbjct: 193 PEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 14/196 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFV---DQAKIDEF-INELVVVLQINRRNVVRLLG 464
           IG G  G V+K    D   +   K KF+   D   I +  + E+ ++ Q+   N+V LL 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIK-KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
                +   LV+E+  +  L E    +  +       IT +T   +++ H       IHR
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHR 126
Query: 525 DVKSANILLDENCTPKVSDFGASKLV--PIDAIQNCTVVQGTLGYLDPEYL-QTCKLTDK 581
           DVK  NIL+ ++   K+ DFG ++L+  P D   +      T  Y  PE L    +    
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV---ATRWYRSPELLVGDTQYGPP 183
Query: 582 SDVYSFGVVLVELLTG 597
            DV++ G V  ELL+G
Sbjct: 184 VDVWAIGCVFAELLSG 199

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 14/132 (10%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 145
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVY 585
           +L      N   K++DFG +K    +   + ++ +   T  Y+ PE L   K     D++
Sbjct: 146 LLYTSKRPNAILKLTDFGFAK----ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 586 SFGVVLVELLTG 597
           S GV++  LL G
Sbjct: 202 SLGVIMYILLCG 213

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 409 IGCGGSGNVYKGFLPDRT--PVAVKKSKFVDQAKI--DEFINELVVVLQINRRNVVRLLG 464
           +G G  G+V    +  R+   VA+KK     Q++I       EL+++  +   NV+ LL 
Sbjct: 50  VGSGAYGSVCSA-IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 108
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPI 521
                      Y+F       +   +K      S E+   +  +    L Y+HS     +
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---V 165
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           +HRD+K  N+ ++E+C  K+ DFG ++    DA     VV  T  Y  PE + +    ++
Sbjct: 166 VHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVV--TRWYRAPEVILSWMHYNQ 221
Query: 582 S-DVYSFGVVLVELLTGK 598
           + D++S G ++ E+LTGK
Sbjct: 222 TVDIWSVGCIMAEMLTGK 239

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 407 DVIGCGGSGNVYK-GFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           +++G G  G V+K         +A K  K       +E  NE+ V+ Q++  N+++L   
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
                  +LV E+V  G LF+ I  +  NL+    +    +    + ++H    + I+H 
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHL 211
Query: 525 DVKSANIL-LDENCTP-KVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           D+K  NIL ++ +    K+ DFG A +  P + ++   V  GT  +L PE +    ++  
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK---VNFGTPEFLAPEVVNYDFVSFP 268
Query: 582 SDVYSFGVVLVELLTGKMALLSDKPEE 608
           +D++S GV+   LL+G    L D   E
Sbjct: 269 TDMWSVGVIAYMLLSGLSPFLGDNDAE 295

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 24/230 (10%)
Query: 384 GQSSEKAKIFTEEEIKT---VTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKFVD 437
           G S E+   + +E  KT   V   Y ++  +G G  G+V   F       VAVKK     
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 438 QAKID--EFINELVVVLQINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIH 489
           Q+ I       EL ++  +   NV+ LL          E     LV   +G      +I 
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIV 128
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K   L+ +    +  +    L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++ 
Sbjct: 129 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR- 184
Query: 550 VPIDAIQNCTVVQGTLGYLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
                    T    T  Y  PE  L         D++S G ++ ELLTG+
Sbjct: 185 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 39/216 (18%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 10  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL-------- 513
           LL   + T+  L +        +FEH+H+      +           + SYL        
Sbjct: 66  LLDV-IHTENKLYL--------VFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 514 --HSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLD 569
             HS     ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  
Sbjct: 117 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRA 170
Query: 570 PEYLQTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
           PE L  CK    + D++S G +  E++T +     D
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 9/116 (7%)
Query: 484 LFEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVS 542
            ++ +  KG    E  L +I       L +LHS+ +V  IHRDVK +N+L++     K+ 
Sbjct: 139 FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMC 196
Query: 543 DFGASKLVPIDAIQNCTVVQGTLGYLDPEY----LQTCKLTDKSDVYSFGVVLVEL 594
           DFG S  + +D++   T+  G   Y+ PE     L     + KSD++S G+ ++EL
Sbjct: 197 DFGISGYL-VDSVAK-TIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRA 197
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRA 197
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYRA 197
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-----NVPIIHRDVKS 528
           LV ++  +G+LF+++++   ++ E  +++   TA  L++LH E         I HRD+KS
Sbjct: 84  LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 142
Query: 529 ANILLDENCTPKVSDFGA-----SKLVPIDAIQNCTVVQGTLGYLDPEYL------QTCK 577
            NIL+ +N T  ++D G      S    ID   N  V  GT  Y+ PE L      +  +
Sbjct: 143 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPEVLDDSINMKHFE 200
Query: 578 LTDKSDVYSFGVVLVEL 594
              ++D+Y+ G+V  E+
Sbjct: 201 SFKRADIYAMGLVFWEI 217

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 19/137 (13%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-----NVPIIHRDVKS 528
           L+ ++  NG+L++++ K   L  +  L++   +   L +LH+E         I HRD+KS
Sbjct: 112 LITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170
Query: 529 ANILLDENCTPKVSDFG-ASKLVP----IDAIQNCTVVQGTLGYLDPEYLQTCKLTDK-- 581
            NIL+ +N T  ++D G A K +     +D   N  V  GT  Y+ PE L      +   
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV--GTKRYMPPEVLDESLNRNHFQ 228
Query: 582 ----SDVYSFGVVLVEL 594
               +D+YSFG++L E+
Sbjct: 229 SYIMADMYSFGLILWEV 245

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 11  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      LS+ HS
Sbjct: 67  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL 175
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-----NVPIIHRDVKS 528
           LV ++  +G+LF+++++   ++ E  +++   TA  L++LH E         I HRD+KS
Sbjct: 81  LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 139
Query: 529 ANILLDENCTPKVSDFGA-----SKLVPIDAIQNCTVVQGTLGYLDPEYL------QTCK 577
            NIL+ +N T  ++D G      S    ID   N  V  GT  Y+ PE L      +  +
Sbjct: 140 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPEVLDDSINMKHFE 197
Query: 578 LTDKSDVYSFGVVLVEL 594
              ++D+Y+ G+V  E+
Sbjct: 198 SFKRADIYAMGLVFWEI 214

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 58/119 (48%), Gaps = 7/119 (5%)
Query: 484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
           L + IH    L+ E       +    L Y+HS     +IHRD+K +N+L++ENC  K+ D
Sbjct: 146 LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGD 202
Query: 544 FGASKLV---PIDAIQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGK 598
           FG ++ +   P +     T    T  Y  PE + +  + T   D++S G +  E+L  +
Sbjct: 203 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-----NVPIIHRDVKS 528
           LV ++  +G+LF+++++   ++ E  +++   TA  L++LH E         I HRD+KS
Sbjct: 117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175
Query: 529 ANILLDENCTPKVSDFGA-----SKLVPIDAIQNCTVVQGTLGYLDPEYL------QTCK 577
            NIL+ +N T  ++D G      S    ID   N  V  GT  Y+ PE L      +  +
Sbjct: 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPEVLDDSINMKHFE 233
Query: 578 LTDKSDVYSFGVVLVEL 594
              ++D+Y+ G+V  E+
Sbjct: 234 SFKRADIYAMGLVFWEI 250

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-----NVPIIHRDVKS 528
           LV ++  +G+LF+++++   ++ E  +++   TA  L++LH E         I HRD+KS
Sbjct: 79  LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 137
Query: 529 ANILLDENCTPKVSDFGA-----SKLVPIDAIQNCTVVQGTLGYLDPEYL------QTCK 577
            NIL+ +N T  ++D G      S    ID   N  V  GT  Y+ PE L      +  +
Sbjct: 138 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPEVLDDSINMKHFE 195
Query: 578 LTDKSDVYSFGVVLVEL 594
              ++D+Y+ G+V  E+
Sbjct: 196 SFKRADIYAMGLVFWEI 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-----NVPIIHRDVKS 528
           LV ++  +G+LF+++++   ++ E  +++   TA  L++LH E         I HRD+KS
Sbjct: 104 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 162
Query: 529 ANILLDENCTPKVSDFGA-----SKLVPIDAIQNCTVVQGTLGYLDPEYL------QTCK 577
            NIL+ +N T  ++D G      S    ID   N  V  GT  Y+ PE L      +  +
Sbjct: 163 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPEVLDDSINMKHFE 220
Query: 578 LTDKSDVYSFGVVLVEL 594
              ++D+Y+ G+V  E+
Sbjct: 221 SFKRADIYAMGLVFWEI 237

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYL 568
           L YLHS+    I+H+D+K  N+LL    T K+S  G A  L P  A   C   QG+  + 
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 569 DPEYLQTCKLTD--KSDVYSFGVVLVELLTG 597
            PE           K D++S GV L  + TG
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 409 IGCGGSGNVYKGFLPDRT--PVAVKKSKFVDQAKI--DEFINELVVVLQINRRNVVRLLG 464
           +G G  G+V    +  R+   VA+KK     Q++I       EL+++  +   NV+ LL 
Sbjct: 32  VGSGAYGSVCSA-IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPI 521
                      Y+F       +   +K      S E+   +  +    L Y+HS     +
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---V 147
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           +HRD+K  N+ ++E+C  K+ DFG ++    DA     VV  T  Y  PE + +    ++
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVV--TRWYRAPEVILSWMHYNQ 203
Query: 582 S-DVYSFGVVLVELLTGK 598
           + D++S G ++ E+LTGK
Sbjct: 204 TVDIWSVGCIMAEMLTGK 221

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 71/137 (51%), Gaps = 19/137 (13%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-----NVPIIHRDVKS 528
           LV ++  +G+LF+++++   ++ E  +++   TA  L++LH E         I HRD+KS
Sbjct: 78  LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 529 ANILLDENCTPKVSDFGA-----SKLVPIDAIQNCTVVQGTLGYLDPEYL------QTCK 577
            NIL+ +N T  ++D G      S    ID   N  V  GT  Y+ PE L      +  +
Sbjct: 137 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV--GTKRYMAPEVLDDSINMKHFE 194
Query: 578 LTDKSDVYSFGVVLVEL 594
              ++D+Y+ G+V  E+
Sbjct: 195 SFKRADIYAMGLVFWEI 211

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 58/119 (48%), Gaps = 7/119 (5%)
Query: 484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
           L + IH    L+ E       +    L Y+HS     +IHRD+K +N+L++ENC  K+ D
Sbjct: 145 LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGD 201
Query: 544 FGASKLV---PIDAIQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGK 598
           FG ++ +   P +     T    T  Y  PE + +  + T   D++S G +  E+L  +
Sbjct: 202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLL 463
           IG G  G V+K    +R     VA+K+ +  D  +      + E+ ++ ++  +N+VRL 
Sbjct: 10  IGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
                 +   LV+EF             G+L  E       +    L + HS     ++H
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124
Query: 524 RDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           RD+K  N+L++ N   K++DFG ++   +P+       V   TL Y  P+ L   KL   
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV---TLWYRPPDVLFGAKLYST 181
Query: 582 S-DVYSFGVVLVELLTGKMALL 602
           S D++S G +  EL      L 
Sbjct: 182 SIDMWSAGCIFAELANAARPLF 203

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 150
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+     K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 211 KSIDIWSVGCILAEMLSNR 229

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 87/185 (47%), Gaps = 17/185 (9%)
Query: 434 KFVDQAKIDEFINELVVVLQINRR-NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG 492
           K +D++K D    E+ ++L+  +  N++ L     + +   +V E    G L + I ++ 
Sbjct: 53  KIIDKSKRDP-TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK 111
Query: 493 NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANIL-LDENCTP---KVSDFGASK 548
             S      +       + YLH++    ++HRD+K +NIL +DE+  P   ++ DFG +K
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 549 LVPIDAIQNCTVVQG--TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLS--- 603
            +     +N  +     T  ++ PE L+        D++S GV+L   LTG     +   
Sbjct: 169 QL---RAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD 225
Query: 604 DKPEE 608
           D PEE
Sbjct: 226 DTPEE 230

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGXVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 210
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 11  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 67  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 175
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 157 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 209
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 13  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 68
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 69  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 177
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 12  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 67
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 68  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL 176
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 150 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 202
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 150 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 202
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 14  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 70  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 178
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 13  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 68
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 69  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 177
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 150 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 202
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 24/228 (10%)
Query: 386 SSEKAKIFTEEEIKT---VTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQA 439
           S E+   + +E  KT   V   Y ++  +G G  G+V   F       VAVKK     Q+
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 440 KID--EFINELVVVLQINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKK 491
            I       EL ++  +   NV+ LL          E     LV   +G      +I K 
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIVKX 119
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
             L+ +    +  +    L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 173
Query: 552 IDAIQNCTVVQGTLGYLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
                  T    T  Y  PE  L         D++S G ++ ELLTG+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 157 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 209
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 148 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 200
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 210
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 143 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 195
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 14  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 70  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 178
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 144 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 196
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 136 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 188
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 137 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 189
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 18/199 (9%)
Query: 407 DVIGCGGSGNV----YKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           + IG G  G V     KG    R    + K  FV+   +D F  E+ ++  ++  N++RL
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY-FVED--VDRFKQEIEIMKSLDHPNIIRL 71
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
                +     LV E    G LFE +  K         RI  +    ++Y H    + + 
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVA 128
Query: 523 HRDVKSANILL--DENCTP-KVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           HRD+K  N L   D   +P K+ DFG A++  P   ++      GT  Y+ P+ L+    
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQVLEGL-Y 184
Query: 579 TDKSDVYSFGVVLVELLTG 597
             + D +S GV++  LL G
Sbjct: 185 GPECDEWSAGVMMYVLLCG 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 13  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 68
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 69  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 124 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 177
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 12  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 67
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 68  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 176
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 146
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+     K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 147 HRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 207 KSIDIWSVGCILAEMLSNR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 186
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 192
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 14  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 462 LLGCCLETQVPLLVYEFVGNG-TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           LL          LV+EF+      F        +          +    L++ HS     
Sbjct: 70  LLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L  CK 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEILLGCKY 183
Query: 579 TDKS-DVYSFGVVLVELLTGKMALLSD 604
              + D++S G +  E++T +     D
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 186
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 11  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 67  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 175
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 140 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 192
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 18  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 73
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 74  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL 182
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 11  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 67  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 175
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 12  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 67
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 68  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 176
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 186
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 11  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 67  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 175
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFLP-DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 150
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+     K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 211 KSIDIWSVGCILAEMLSNR 229

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 140 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 192
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 161 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 213
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 15  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 70
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 71  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 179
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 15  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 70
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 71  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL 179
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 211

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 146
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+     K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 207 KSIDIWSVGCILAEMLSNR 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 135 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 187
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 145 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 197
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 10  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 66  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 174
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 135 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 187
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 195
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 12  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 67
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 68  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 176
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 11  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 67  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL 175
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + +   +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 166
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+     K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 167 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 226
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 227 KSIDIWSVGCILAEMLSNR 245

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 10  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 66  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEIL 174
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKF---VDQAKIDEF-INELVVV 451
           EE+   T+     +G G  G V++        +  K++ F   V + +++ F   EL+  
Sbjct: 90  EEVHWATHQLR--LGRGSFGEVHR--------MEDKQTGFQCAVKKVRLEVFRAEELMAC 139
Query: 452 LQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS 511
             +    +V L G   E     +  E +  G+L + + ++G L  +R L    +    L 
Sbjct: 140 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLE 199
Query: 512 YLHSETNVPIIHRDVKSANILLDENCT-PKVSDFGASKLVPIDAIQNCTV----VQGTLG 566
           YLHS     I+H DVK+ N+LL  + +   + DFG +  +  D +    +    + GT  
Sbjct: 200 YLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET 256
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           ++ PE +       K DV+S   +++ +L G
Sbjct: 257 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 14  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 462 LLGCCLETQVPLLVYEFVG-NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           LL          LV+EF+  +   F        +          +    L++ HS     
Sbjct: 70  LLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L  CK 
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEILLGCKY 183
Query: 579 TDKS-DVYSFGVVLVELLTGKMALLSD 604
              + D++S G +  E++T +     D
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 10  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 66  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL 174
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 61/130 (46%), Gaps = 11/130 (8%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           +V E +  G LF+ +     L          +    + YLH      IIHRD+K  N+LL
Sbjct: 230 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLL 286
Query: 534 ---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL---QTCKLTDKSDVYSF 587
              +E+C  K++DFG SK++   ++     + GT  YL PE L    T       D +S 
Sbjct: 287 SSQEEDCLIKITDFGHSKILGETSLMR--TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 344
Query: 588 GVVLVELLTG 597
           GV+L   L+G
Sbjct: 345 GVILFICLSG 354

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L     N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 148
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+     K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 149 HRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 209 KSIDIWSVGCILAEMLSNR 227

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 11  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 67  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL 175
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 61/130 (46%), Gaps = 11/130 (8%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           +V E +  G LF+ +     L          +    + YLH      IIHRD+K  N+LL
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLL 272
Query: 534 ---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL---QTCKLTDKSDVYSF 587
              +E+C  K++DFG SK++   ++     + GT  YL PE L    T       D +S 
Sbjct: 273 SSQEEDCLIKITDFGHSKILGETSLMR--TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 588 GVVLVELLTG 597
           GV+L   L+G
Sbjct: 331 GVILFICLSG 340

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 10  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 66  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL 174
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
             CK    + D++S G +  E++T +     D
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 59/130 (45%), Gaps = 10/130 (7%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHS---INIAHRDVKPEN 191
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K     +  + T    T  Y+ PE L   K     D +S 
Sbjct: 192 LLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSL 249
Query: 588 GVVLVELLTG 597
           GV+   LL G
Sbjct: 250 GVIXYILLCG 259

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 21/207 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 12  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 67
Query: 462 LLGCCLETQVPLLVYEFVG-NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           LL          LV+EF+  +   F        +          +    L++ HS     
Sbjct: 68  LLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 124
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L  CK 
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEILLGCKY 181
Query: 579 TDKS-DVYSFGVVLVELLTGKMALLSD 604
              + D++S G +  E++T +     D
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGD 208

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 409 IGCGGSGNVYKGFL-PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRL---- 462
           IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+    N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
               +E    + + + +    L++ + K  +LS +       +    L Y+HS     ++
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VL 146
Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKLTD 580
           HRD+K +N+LL+     K+ DFG +++   D      + +   T  Y  PE +   K   
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 581 KS-DVYSFGVVLVELLTGK 598
           KS D++S G +L E+L+ +
Sbjct: 207 KSIDIWSVGCILAEMLSNR 225

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 66/136 (48%), Gaps = 23/136 (16%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITA------ETAGVLSYLHSETNVPIIHRDVK 527
           +V E +  G LF+ +   GN    +RL+         +    + YLH      IIHRD+K
Sbjct: 97  IVLELMEGGELFDKV--VGN----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLK 147
Query: 528 SANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL---QTCKLTDK 581
             N+LL   +E+C  K++DFG SK++   ++     + GT  YL PE L    T      
Sbjct: 148 PENVLLSSQEEDCLIKITDFGHSKILGETSLMR--TLCGTPTYLAPEVLVSVGTAGYNRA 205
Query: 582 SDVYSFGVVLVELLTG 597
            D +S GV+L   L+G
Sbjct: 206 VDCWSLGVILFICLSG 221

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 12/174 (6%)
Query: 428 VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEH 487
           +  KK    D  K++    E  +   +   N+VRL     E     L+++ V  G LFE 
Sbjct: 44  INTKKLSARDHQKLE---REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFED 100
Query: 488 IHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDF 544
           I  +   S         +    + + H    + ++HR++K  N+LL    +    K++DF
Sbjct: 101 IVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADF 157
Query: 545 GASKLVPIDAIQNCTV-VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           G +  + ++  Q       GT GYL PE L+        D+++ GV+L  LL G
Sbjct: 158 GLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITA 504
           I E+ ++ ++N  N+V+LL          LV+EF     L + + K  + S    + +  
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPL 104
Query: 505 ETAGV------LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQ 556
             + +      L++ HS     ++HRD+K  N+L++     K++DFG ++   VP+    
Sbjct: 105 IKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 161
Query: 557 NCTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
           +  V   TL Y  PE L  CK    + D++S G +  E++T +     D
Sbjct: 162 HEVV---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITA 504
           I E+ ++ ++N  N+V+LL          LV+EF     L + + K  + S    + +  
Sbjct: 49  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPL 103
Query: 505 ETAGV------LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQ 556
             + +      L++ HS     ++HRD+K  N+L++     K++DFG ++   VP+    
Sbjct: 104 IKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160
Query: 557 NCTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
           +  V   TL Y  PE L  CK    + D++S G +  E++T +     D
Sbjct: 161 HEVV---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 61/130 (46%), Gaps = 11/130 (8%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL 533
           +V E +  G LF+ +     L          +    + YLH      IIHRD+K  N+LL
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLL 147
Query: 534 ---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL---QTCKLTDKSDVYSF 587
              +E+C  K++DFG SK++   ++     + GT  YL PE L    T       D +S 
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMR--TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 205
Query: 588 GVVLVELLTG 597
           GV+L   L+G
Sbjct: 206 GVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 66/136 (48%), Gaps = 23/136 (16%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITA------ETAGVLSYLHSETNVPIIHRDVK 527
           +V E +  G LF+ +   GN    +RL+         +    + YLH      IIHRD+K
Sbjct: 90  IVLELMEGGELFDKV--VGN----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLK 140
Query: 528 SANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL---QTCKLTDK 581
             N+LL   +E+C  K++DFG SK++   ++     + GT  YL PE L    T      
Sbjct: 141 PENVLLSSQEEDCLIKITDFGHSKILGETSLMR--TLCGTPTYLAPEVLVSVGTAGYNRA 198
Query: 582 SDVYSFGVVLVELLTG 597
            D +S GV+L   L+G
Sbjct: 199 VDCWSLGVILFICLSG 214

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 66/136 (48%), Gaps = 23/136 (16%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITA------ETAGVLSYLHSETNVPIIHRDVK 527
           +V E +  G LF+ +   GN    +RL+         +    + YLH      IIHRD+K
Sbjct: 91  IVLELMEGGELFDKV--VGN----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLK 141
Query: 528 SANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL---QTCKLTDK 581
             N+LL   +E+C  K++DFG SK++   ++     + GT  YL PE L    T      
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKILGETSLMR--TLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 582 SDVYSFGVVLVELLTG 597
            D +S GV+L   L+G
Sbjct: 200 VDCWSLGVILFICLSG 215

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 25/203 (12%)
Query: 409 IGCGGSGNV---YKGFLPDRTPVAVKKSKFVDQAKID--EFINELVVVLQINRRNVVRLL 463
           +G G  G+V   Y   L  R  VAVKK     Q+ I       EL ++  +   NV+ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 464 -----GCCLE--TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
                   +E  ++V  LV   +G      +I K   LS E    +  +    L Y+HS 
Sbjct: 94  DVFTPATSIEDFSEV-YLVTTLMGAD--LNNIVKSQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE-YLQT 575
               IIHRD+K +N+ ++E+   ++ DFG ++     A +  T    T  Y  PE  L  
Sbjct: 151 G---IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRAPEIMLNW 203
Query: 576 CKLTDKSDVYSFGVVLVELLTGK 598
                  D++S G ++ ELL GK
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 66/136 (48%), Gaps = 23/136 (16%)
Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITA------ETAGVLSYLHSETNVPIIHRDVK 527
           +V E +  G LF+ +   GN    +RL+         +    + YLH      IIHRD+K
Sbjct: 91  IVLELMEGGELFDKV--VGN----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLK 141
Query: 528 SANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL---QTCKLTDK 581
             N+LL   +E+C  K++DFG SK++   ++     + GT  YL PE L    T      
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKILGETSLMR--TLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 582 SDVYSFGVVLVELLTG 597
            D +S GV+L   L+G
Sbjct: 200 VDCWSLGVILFICLSG 215

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 11  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 462 LLGCCLETQVPLLVYEFVGNGTL-FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           LL          LV+EF+      F        +          +    L++ HS     
Sbjct: 67  LLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L  CK 
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEILLGCKY 180
Query: 579 TDKS-DVYSFGVVLVELLTGKMALLSD 604
              + D++S G +  E++T +     D
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 13  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 68
Query: 462 LLGCCLETQVPLLVYEFVGNGTL-FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           LL          LV+EF+      F        +          +    L++ HS     
Sbjct: 69  LLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 125
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L  CK 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEILLGCKY 182
Query: 579 TDKS-DVYSFGVVLVELLTGKMALLSD 604
              + D++S G +  E++T +     D
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGD 209

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++          T    T  Y  
Sbjct: 167 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRA 219
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 14  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 462 LLGCCLETQVPLLVYEFVGNGTL-FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           LL          LV+EF+      F        +          +    L++ HS     
Sbjct: 70  LLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L  CK 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEILLGCKY 183
Query: 579 TDKS-DVYSFGVVLVELLTGKMALLSD 604
              + D++S G +  E++T +     D
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 9/116 (7%)
Query: 484 LFEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVS 542
            ++ +  KG    E  L +I       L +LHS+ +V  IHRDVK +N+L++     K+ 
Sbjct: 95  FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMC 152
Query: 543 DFGASKLVPIDAIQNCTVVQGTLGYLDPEY----LQTCKLTDKSDVYSFGVVLVEL 594
           DFG S  +  D  ++     G   Y+ PE     L     + KSD++S G+ ++EL
Sbjct: 153 DFGISGYLVDDVAKDIDA--GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 407 DVIGCGGSGN-VYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN--RRNVVRLL 463
           DV+G G  G  VY+G   +R  VAVK+       +   F +  V +L+ +    NV+R  
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRD-VAVKRI----LPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPI 521
               + Q   +  E     TL E++ +K   +L  E    +   T+G L++LHS   + I
Sbjct: 85  CTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSG-LAHLHS---LNI 139
Query: 522 IHRDVKSANILLD-ENCTPK----VSDFGASKLVPI--DAIQNCTVVQGTLGYLDPEYL- 573
           +HRD+K  NIL+   N   K    +SDFG  K + +   +    + V GT G++ PE L 
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 574 QTCK--LTDKSDVYSFGVVLVELLT 596
           + CK   T   D++S G V   +++
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 44/85 (51%), Gaps = 10/85 (11%)
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC---------TVVQGTLGYLDPE 571
           +IHRD+K +N+L++ NC  KV DFG ++++   A  N          T    T  Y  PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 572 -YLQTCKLTDKSDVYSFGVVLVELL 595
             L + K +   DV+S G +L EL 
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++    D +        T  Y  
Sbjct: 158 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMXGXV---ATRWYRA 210
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 31/220 (14%)
Query: 399 KTVTNNYADV--IGCGGSGNVYKGFLPDRTPVAVKK-SKFVDQAKIDEFINELVVVLQIN 455
           +TV    A V  +G G  G V++G     + VAVK  S   +Q+   E   E+   + + 
Sbjct: 4   RTVARQVALVECVGKGRYGEVWRGLWHGES-VAVKIFSSRDEQSWFRE--TEIYNTVLLR 60
Query: 456 RRNVVRLLGCCL-----ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVL 510
             N++  +   +      TQ+ L+ + +  +G+L++ + ++  L     LR+    A  L
Sbjct: 61  HDNILGFIASDMTSRNSSTQLWLITH-YHEHGSLYDFLQRQ-TLEPHLALRLAVSAACGL 118
Query: 511 SYLHSET-----NVPIIHRDVKSANILLDENCTPKVSDFGASKLVP-----IDAIQNCTV 560
           ++LH E         I HRD KS N+L+  N    ++D G + +       +D   N  V
Sbjct: 119 AHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV 178
Query: 561 VQGTLGYLDPEYLQTCKLTD------KSDVYSFGVVLVEL 594
             GT  Y+ PE L     TD       +D+++FG+VL E+
Sbjct: 179 --GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 44/85 (51%), Gaps = 10/85 (11%)
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC---------TVVQGTLGYLDPE 571
           +IHRD+K +N+L++ NC  KV DFG ++++   A  N          T    T  Y  PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 572 -YLQTCKLTDKSDVYSFGVVLVELL 595
             L + K +   DV+S G +L EL 
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ D+G ++          T    T  Y  
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++               T  Y  
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++               T  Y  
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++               T  Y  
Sbjct: 134 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRWYRA 186
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 45/80 (56%), Gaps = 9/80 (11%)
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG-----TLGYLDPEYLQTC 576
           IHRD+ + NILL EN   K+ DFG ++    D  +N   V+       L ++ PE +   
Sbjct: 221 IHRDLAARNILLSENNVVKICDFGLAR----DIYKNPDYVRKGDTRLPLKWMAPESIFDK 276
Query: 577 KLTDKSDVYSFGVVLVELLT 596
             + KSDV+S+GV+L E+ +
Sbjct: 277 IYSTKSDVWSYGVLLWEIFS 296

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++    D +        T  Y  
Sbjct: 161 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMXGYV---ATRWYRA 213
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 458 NVVRLLGCCL------ETQVPLLVYEFVGNG--TLFEHIHKKGNLSWERRLRITAETAGV 509
           NVVRL   C       ET++  LV+E V     T  + + + G +  E    +  +    
Sbjct: 75  NVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQLLRG 132
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L +LHS     ++HRD+K  NIL+  +   K++DFG +++          VV  TL Y  
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRA 187
Query: 570 PEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE L         D++S G +  E+   K
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKF---VDQAKIDEF-INELVVV 451
           EE+   T+     +G G  G V++        +  K++ F   V + +++ F   EL+  
Sbjct: 71  EEVHWATHQLR--LGRGSFGEVHR--------MEDKQTGFQCAVKKVRLEVFRAEELMAC 120
Query: 452 LQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS 511
             +    +V L G   E     +  E +  G+L + + ++G L  +R L    +    L 
Sbjct: 121 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLE 180
Query: 512 YLHSETNVPIIHRDVKSANILLDENCT-PKVSDFGASKLVPIDAIQNCTV----VQGTLG 566
           YLHS     I+H DVK+ N+LL  + +   + DFG +  +  D +    +    + GT  
Sbjct: 181 YLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET 237
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           ++ PE +       K DV+S   +++ +L G
Sbjct: 238 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+   ++ DFG ++     A +  T    T  Y  
Sbjct: 144 LKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRA 196
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELL GK
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLL 463
           IG G  G V+K    +R     VA+K+ +  D  +      + E+ ++ ++  +N+VRL 
Sbjct: 10  IGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
                 +   LV+EF             G+L  E       +    L + HS     ++H
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124
Query: 524 RDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           RD+K  N+L++ N   K+++FG ++   +P+       V   TL Y  P+ L   KL   
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---TLWYRPPDVLFGAKLYST 181
Query: 582 S-DVYSFGVVLVELLTGKMALL 602
           S D++S G +  EL      L 
Sbjct: 182 SIDMWSAGCIFAELANAGRPLF 203

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 112/255 (43%), Gaps = 40/255 (15%)
Query: 424 DRTPVAVK---KSKFVDQAKID---EFINELVVVLQINR--RNVVRLLGCCLETQVPLLV 475
           D  PVA+K   K +  D  ++        E+V++ +++     V+RLL         +L+
Sbjct: 75  DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 134
Query: 476 YEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD 534
            E       LF+ I ++G L  E       +    + + H   N  ++HRD+K  NIL+D
Sbjct: 135 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILID 191
Query: 535 ENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLV 592
            N    K+ DFG+  L+  D +   T   GT  Y  PE+++  +   +S  V+S G++L 
Sbjct: 192 LNRGELKLIDFGSGALLK-DTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLY 248
Query: 593 ELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARC 652
           +++ G +    D+                     EI+  ++     ++   E   L   C
Sbjct: 249 DMVCGDIPFEHDE---------------------EIIRGQVFF--RQRVSSECQHLIRWC 285
Query: 653 ISVRGEERPTMKEVS 667
           +++R  +RPT +E+ 
Sbjct: 286 LALRPSDRPTFEEIQ 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 458 NVVRLLGCCL------ETQVPLLVYEFVGNG--TLFEHIHKKGNLSWERRLRITAETAGV 509
           NVVRL   C       ET++  LV+E V     T  + + + G +  E    +  +    
Sbjct: 75  NVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQLLRG 132
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L +LHS     ++HRD+K  NIL+  +   K++DFG +++          VV  TL Y  
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRA 187
Query: 570 PEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE L         D++S G +  E+   K
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 458 NVVRLLGCCL------ETQVPLLVYEFVGNG--TLFEHIHKKGNLSWERRLRITAETAGV 509
           NVVRL   C       ET++  LV+E V     T  + + + G +  E    +  +    
Sbjct: 75  NVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQLLRG 132
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L +LHS     ++HRD+K  NIL+  +   K++DFG +++          VV  TL Y  
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRA 187
Query: 570 PEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE L         D++S G +  E+   K
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 14  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 69
Query: 462 LLGCCLETQVPLLVYEFVGNG-TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
           LL          LV+E V      F        +          +    L++ HS     
Sbjct: 70  LLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L  CK 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV---TLWYRAPEILLGCKY 183
Query: 579 TDKS-DVYSFGVVLVELLTGKMALLSD 604
              + D++S G +  E++T +     D
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGD 210

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            L++LHS+    ++H DVK ANI L      K+ DFG   LV +       V +G   Y+
Sbjct: 169 ALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYM 223
Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVEL 594
            PE LQ    T  +DV+S G+ ++E+
Sbjct: 224 APELLQGSYGT-AADVFSLGLTILEV 248

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 15/232 (6%)
Query: 407 DVIGCGGSGNVYKGF--LPDRTPVAVKKSKFVDQAKID-EFINELVVVLQINRRNVVRLL 463
           D +G G    VYKG   L D   VA+K+ +   +       I E+ ++  +   N+V L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPII 522
                 +   LV+E++ +  L +++   GN+     +++   +    L+Y H +    ++
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VL 122
Query: 523 HRDVKSANILLDENCTPKVSDFGA--SKLVPIDAIQNCTVVQGTLGYLDPE-YLQTCKLT 579
           HRD+K  N+L++E    K++DFG   +K +P     N  V   TL Y  P+  L +   +
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---TLWYRPPDILLGSTDYS 179
Query: 580 DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN 631
            + D++  G +  E+ TG+        EE+       L +  +     IL N
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT-------VVQ--GTLGYLDPE 571
           +IHRD+K +N+L++ NC  KV DFG ++++   A  N         +V+   T  Y  PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 572 -YLQTCKLTDKSDVYSFGVVLVELLTGK 598
             L + K +   DV+S G +L EL   +
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 404 NYADVI---GCGGSGNVYKGFLPDRTPVAVKKSKFVDQA-KIDEFI--NELVVVLQINRR 457
           +Y D++   G G  G V++    ++    V  +KF++    +D++   NE+ ++ Q++  
Sbjct: 51  DYYDILEELGSGAFGVVHRCV--EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108
Query: 458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSE 516
            ++ L     +    +L+ EF+  G LF+ I  +   +S    +    +    L ++H  
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 517 TNVPIIHRDVKSANILLD--ENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYL 573
           +   I+H D+K  NI+ +  +  + K+ DFG A+KL P + ++   V   T  +  PE +
Sbjct: 169 S---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIV 222
Query: 574 QTCKLTDKSDVYSFGVVLVELLTG 597
               +   +D+++ GV+   LL+G
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 86/205 (41%), Gaps = 27/205 (13%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD----QAKIDEFINELVVVLQINRRNVVRLLG 464
           IG G    VYKG L   T V V   +  D    +++   F  E   +  +   N+VR   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 465 CCLET----QVPLLVYEFVGNGTLFEHIHK------KGNLSWERRLRITAETAGVLSYLH 514
               T    +  +LV E   +GTL  ++ +      K   SW R++         L +LH
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQFLH 146
Query: 515 SETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL 573
           + T  PIIHRD+K  NI +     + K+ D G   L  +        V GT  +  PE  
Sbjct: 147 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLG---LATLKRASFAKAVIGTPEFXAPEXY 202
Query: 574 QTCKLTDKSDVYSFGVVLVELLTGK 598
           +  K  +  DVY+FG   +E  T +
Sbjct: 203 EE-KYDESVDVYAFGXCXLEXATSE 226

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 25/182 (13%)
Query: 434 KFVDQAKI--------DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLF 485
           K VD AK         ++   E  +   +   ++V LL       +  +V+EF+    L 
Sbjct: 55  KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLC 114
Query: 486 EHIHKKGNLSWERRLRITA----ETAGVLSYLHSETNVPIIHRDVKSANILL--DENCTP 539
             I K+ +  +     + +    +    L Y H      IIHRDVK  N+LL   EN  P
Sbjct: 115 FEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAP 171
Query: 540 -KVSDFGASKLVPIDAIQNCTVVQGTLG---YLDPEYLQTCKLTDKSDVYSFGVVLVELL 595
            K+ DFG    V I   ++  V  G +G   ++ PE ++        DV+  GV+L  LL
Sbjct: 172 VKLGDFG----VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL 227
Query: 596 TG 597
           +G
Sbjct: 228 SG 229

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 96/230 (41%), Gaps = 24/230 (10%)
Query: 384 GQSSEKAKIFTEEEIKT---VTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKFVD 437
           G S E+   + +E  KT   V   Y ++  +G G  G+V   F       VAVKK     
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 438 QAKID--EFINELVVVLQINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIH 489
           Q+ I       EL ++  +   NV+ LL          E     LV   +G      +I 
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIV 128
Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           K   L+ +    +  +    L Y+HS     IIHRD+K +N+ ++E+   K+ DFG ++ 
Sbjct: 129 KCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR- 184
Query: 550 VPIDAIQNCTVVQGTLGYLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
                    T    T  Y  PE  L         D++S G ++ ELLTG+
Sbjct: 185 ---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+  FG ++          T    T  Y  
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+   K+ DFG ++          T    T  Y  
Sbjct: 140 LKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRA 192
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+   K+ DFG ++          T    T  Y  
Sbjct: 144 LKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRA 196
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ DF  ++          T    T  Y  
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ D G ++          T    T  Y  
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ D G ++          T    T  Y  
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 10/96 (10%)
Query: 510 LSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASKLV--PIDAIQNCTVVQG 563
           + YLH+     ++HRD+K ANIL+     E    K++D G ++L   P+  + +   V  
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 564 TLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
           T  Y  PE L   +   K+ D+++ G +  ELLT +
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+   K+ DFG ++          T    T  Y  
Sbjct: 143 LKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRA 195
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+   K+ DFG ++          T    T  Y  
Sbjct: 143 LKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRA 195
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+   K+ DFG ++          T    T  Y  
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 433 SKFVDQAKIDE-FINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK 490
           +KFV     D+  + + + +L I R RN++ L       +  ++++EF+    +FE I+ 
Sbjct: 35  AKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT 94
Query: 491 KGNLSWERRL-RITAETAGVLSYLHSETNVPIIHRDVKSANILLD--ENCTPKVSDFG-A 546
                 ER +     +    L +LHS     I H D++  NI+     + T K+ +FG A
Sbjct: 95  SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSD 604
            +L P D   N  ++     Y  PE  Q   ++  +D++S G ++  LL+G    L++
Sbjct: 152 RQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 18  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 73
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 74  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL 182
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
              K    + D++S G +  E++T +     D
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 214

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 409 IGCGGSGNVYKGFLPDRTP-----VAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           IG G  G VYK     R       VA+KK +   + +      I E+ ++ ++N  N+V+
Sbjct: 11  IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 66
Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV------LSYLHS 515
           LL          LV+EF     L + + K  + S    + +    + +      L++ HS
Sbjct: 67  LLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEYL 573
                ++HRD+K  N+L++     K++DFG ++   VP+    +  V   TL Y  PE L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL 175
Query: 574 QTCKLTDKS-DVYSFGVVLVELLTGKMALLSD 604
              K    + D++S G +  E++T +     D
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRRALFPGD 207

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 473 LLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANI 531
           +++YEF+  G LFE +  + N +S +  +    +    L ++H E N   +H D+K  NI
Sbjct: 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-ENNY--VHLDLKPENI 286
Query: 532 LLDENCTP--KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGV 589
           +     +   K+ DFG +    +D  Q+  V  GT  +  PE  +   +   +D++S GV
Sbjct: 287 MFTTKRSNELKLIDFGLT--AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 590 VLVELLTG 597
           +   LL+G
Sbjct: 345 LSYILLSG 352

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           L Y+HS     IIHRD+K +N+ ++E+C  K+ D G ++          T    T  Y  
Sbjct: 138 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMTGYVATRWYRA 190
Query: 570 PE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           PE  L         D++S G ++ ELLTG+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 473 LLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANI 531
           +++YEF+  G LFE +  + N +S +  +    +    L ++H E N   +H D+K  NI
Sbjct: 124 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-ENN--YVHLDLKPENI 180
Query: 532 LLDENCTP--KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGV 589
           +     +   K+ DFG +    +D  Q+  V  GT  +  PE  +   +   +D++S GV
Sbjct: 181 MFTTKRSNELKLIDFGLT--AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 238
Query: 590 VLVELLTG 597
           +   LL+G
Sbjct: 239 LSYILLSG 246

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAV----KKSK-----FVDQAKIDEFINELVVVLQINRRNV 459
           +G G  G V+     ++    V    KK K     +++  K+ +   E+ ++ ++   N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 460 VRLLGCCLETQVPLLVYEFVGNGT-LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETN 518
           +++L          LV E  G+G  LF  I +   L       I  +    + YL  +  
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD- 150
Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
             IIHRD+K  NI++ E+ T K+ DFG++    ++  +      GT+ Y  PE L     
Sbjct: 151 --IIHRDIKDENIVIAEDFTIKLIDFGSAAY--LERGKLFYTFCGTIEYCAPEVLMGNPY 206
Query: 579 TDKS-DVYSFGVVLVELL 595
                +++S GV L  L+
Sbjct: 207 RGPELEMWSLGVTLYTLV 224

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/122 (27%), Positives = 53/122 (43%), Gaps = 3/122 (2%)
Query: 484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
           L   + ++G L+  R + I  +   + S L +       HRDVK  NIL+  +    + D
Sbjct: 121 LAAXLRRQGPLAPPRAVAIVRQ---IGSALDAAHAAGATHRDVKPENILVSADDFAYLVD 177
Query: 544 FGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLS 603
           FG +     + +       GTL Y  PE       T ++D+Y+   VL E LTG      
Sbjct: 178 FGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
Query: 604 DK 605
           D+
Sbjct: 238 DQ 239

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 44/243 (18%)
Query: 408 VIGCGGSGNV-YKGFLPDRTPVAVKKS--KFVDQAKIDEFINELVVVLQINRR-NVVRLL 463
           ++G G SG V ++G    R PVAVK+    F D A     + E+ ++ + +   NV+R  
Sbjct: 40  ILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIA-----LMEIKLLTESDDHPNVIRYY 93
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKG----NLSWERR---LRITAETAGVLSYLHSE 516
            C   T   L +   + N  L + +  K     NL  ++    + +  + A  +++LHS 
Sbjct: 94  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 517 TNVPIIHRDVKSANILLD-------------ENCTPKVSDFGASKLVPIDAIQ-----NC 558
             + IIHRD+K  NIL+              EN    +SDFG  K   +D+ Q     N 
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNL 207
Query: 559 TVVQGTLGYLDPEYLQTC---KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
               GT G+  PE L+     +LT   D++S G V   +L+       DK   E ++   
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 267
Query: 616 FLS 618
             S
Sbjct: 268 IFS 270

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 44/243 (18%)
Query: 408 VIGCGGSGNV-YKGFLPDRTPVAVKKS--KFVDQAKIDEFINELVVVLQINRR-NVVRLL 463
           ++G G SG V ++G    R PVAVK+    F D A     + E+ ++ + +   NV+R  
Sbjct: 40  ILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIA-----LMEIKLLTESDDHPNVIRYY 93
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKG----NLSWERR---LRITAETAGVLSYLHSE 516
            C   T   L +   + N  L + +  K     NL  ++    + +  + A  +++LHS 
Sbjct: 94  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 151
Query: 517 TNVPIIHRDVKSANILLD-------------ENCTPKVSDFGASKLVPIDAIQ-----NC 558
             + IIHRD+K  NIL+              EN    +SDFG  K   +D+ Q     N 
Sbjct: 152 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNL 207
Query: 559 TVVQGTLGYLDPEYLQTC---KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
               GT G+  PE L+     +LT   D++S G V   +L+       DK   E ++   
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG 267
Query: 616 FLS 618
             S
Sbjct: 268 IFS 270

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 9/80 (11%)
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG-----TLGYLDPEYLQTC 576
           IHRD+ + NILL E    K+ DFG ++    D  ++   V+       L ++ PE +   
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDARLPLKWMAPETIFDR 268
Query: 577 KLTDKSDVYSFGVVLVELLT 596
             T +SDV+SFGV+L E+ +
Sbjct: 269 VYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 9/80 (11%)
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG-----TLGYLDPEYLQTC 576
           IHRD+ + NILL E    K+ DFG ++    D  ++   V+       L ++ PE +   
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDARLPLKWMAPETIFDR 270
Query: 577 KLTDKSDVYSFGVVLVELLT 596
             T +SDV+SFGV+L E+ +
Sbjct: 271 VYTIQSDVWSFGVLLWEIFS 290

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 24/228 (10%)
Query: 386 SSEKAKIFTEEEIKT---VTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQA 439
           S E+   + +E  KT   V   Y ++  +G G  G+V   F       VAVKK     Q+
Sbjct: 2   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 440 KID--EFINELVVVLQINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKK 491
            I       EL ++  +   NV+ LL          E     LV   +G      +I K 
Sbjct: 62  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD--LNNIVKS 119
Query: 492 GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
             L+ +    +  +    L Y+HS     IIHRD+K +N+ ++E+   K+ DFG  +   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCR--- 173
Query: 552 IDAIQNCTVVQGTLGYLDPE-YLQTCKLTDKSDVYSFGVVLVELLTGK 598
                  T    T  Y  PE  L         D++S G ++ ELLTG+
Sbjct: 174 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 18/111 (16%)
Query: 500 LRITAETAGVLSYLHSET-----NVPIIHRDVKSANILLDENCTPKVSDFGASKLVP--- 551
           LRI    A  L++LH E         I HRD+KS NIL+ +N    ++D G + +     
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 552 --IDAIQNCTVVQGTLGYLDPEYLQTCKLTD------KSDVYSFGVVLVEL 594
             +D   N  V  GT  Y+ PE L      D      + D+++FG+VL E+
Sbjct: 168 NQLDVGNNPRV--GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 9/80 (11%)
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG-----TLGYLDPEYLQTC 576
           IHRD+ + NILL E    K+ DFG ++    D  ++   V+       L ++ PE +   
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDARLPLKWMAPETIFDR 275
Query: 577 KLTDKSDVYSFGVVLVELLT 596
             T +SDV+SFGV+L E+ +
Sbjct: 276 VYTIQSDVWSFGVLLWEIFS 295

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 64/141 (45%), Gaps = 22/141 (15%)
Query: 470 QVPLLVYEFVGNGTLFEHIHK---KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDV 526
           Q   L+   +  G L E + K   +G LS +  L+I  +T   + ++H +   PIIHRD+
Sbjct: 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDL 164
Query: 527 KSANILLDENCTPKVSDFGAS----------------KLVPIDAIQNCTVVQGTLGYLDP 570
           K  N+LL    T K+ DFG++                 LV  +  +N T +  T   +D 
Sbjct: 165 KVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID- 223
Query: 571 EYLQTCKLTDKSDVYSFGVVL 591
                  + +K D+++ G +L
Sbjct: 224 -LYSNFPIGEKQDIWALGCIL 243

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 9/80 (11%)
Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG-----TLGYLDPEYLQTC 576
           IHRD+ + NILL E    K+ DFG ++    D  ++   V+       L ++ PE +   
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDARLPLKWMAPETIFDR 277
Query: 577 KLTDKSDVYSFGVVLVELLT 596
             T +SDV+SFGV+L E+ +
Sbjct: 278 VYTIQSDVWSFGVLLWEIFS 297

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 18/111 (16%)
Query: 500 LRITAETAGVLSYLHSET-----NVPIIHRDVKSANILLDENCTPKVSDFGASKLVP--- 551
           LRI    A  L++LH E         I HRD+KS NIL+ +N    ++D G + +     
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 552 --IDAIQNCTVVQGTLGYLDPEYLQTCKLTD------KSDVYSFGVVLVEL 594
             +D   N  V  GT  Y+ PE L      D      + D+++FG+VL E+
Sbjct: 168 NQLDVGNNPRV--GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 55/116 (47%), Gaps = 9/116 (7%)
Query: 484 LFEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVS 542
            ++ +  KG    E  L +I       L +LHS+ +V  IHRDVK +N+L++     K  
Sbjct: 122 FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKXC 179
Query: 543 DFGASKLVPIDAIQNCTVVQGTLGYLDPEY----LQTCKLTDKSDVYSFGVVLVEL 594
           DFG S  +  D  ++     G   Y  PE     L     + KSD++S G+  +EL
Sbjct: 180 DFGISGYLVDDVAKDIDA--GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 25/201 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           IG G  G VYK         A+KK +    D+      I E+ ++ ++   N+V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 467 LETQVPLLVYEFVGNGTLFEHIHK---------KGNLSWERRLRITAETAGVLSYLHSET 517
              +  +LV         FEH+ +         +G L          +    ++Y H   
Sbjct: 70  HTKKRLVLV---------FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ-TC 576
              ++HRD+K  N+L++     K++DFG ++   I  ++  T    TL Y  P+ L  + 
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 577 KLTDKSDVYSFGVVLVELLTG 597
           K +   D++S G +  E++ G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 25/201 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           IG G  G VYK         A+KK +    D+      I E+ ++ ++   N+V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 467 LETQVPLLVYEFVGNGTLFEHIHK---------KGNLSWERRLRITAETAGVLSYLHSET 517
              +  +LV         FEH+ +         +G L          +    ++Y H   
Sbjct: 70  HTKKRLVLV---------FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ-TC 576
              ++HRD+K  N+L++     K++DFG ++   I  ++  T    TL Y  P+ L  + 
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 577 KLTDKSDVYSFGVVLVELLTG 597
           K +   D++S G +  E++ G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 18/111 (16%)
Query: 500 LRITAETAGVLSYLHSET-----NVPIIHRDVKSANILLDENCTPKVSDFGASKLVP--- 551
           LRI    A  L++LH E         I HRD+KS NIL+ +N    ++D G + +     
Sbjct: 137 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 196
Query: 552 --IDAIQNCTVVQGTLGYLDPEYLQTCKLTD------KSDVYSFGVVLVEL 594
             +D   N  V  GT  Y+ PE L      D      + D+++FG+VL E+
Sbjct: 197 NQLDVGNNPRV--GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 91/197 (46%), Gaps = 16/197 (8%)
Query: 409 IGCGGSGNVYKGF--LPDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLG 464
           +G G  G VYK    + + T VA+K+ +    ++      I E+ ++ ++  RN++ L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNET-VAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
                    L++E+  N  L +++ K  ++S         +    +++ HS      +HR
Sbjct: 101 VIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHR 156
Query: 525 DVKSANILL---DENCTP--KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
           D+K  N+LL   D + TP  K+ DFG ++   I  I+  T    TL Y  PE L   +  
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEIITLWYRPPEILLGSRHY 215
Query: 580 DKS-DVYSFGVVLVELL 595
             S D++S   +  E+L
Sbjct: 216 STSVDIWSIACIWAEML 232

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 25/201 (12%)
Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           IG G  G VYK         A+KK +    D+      I E+ ++ ++   N+V+L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 467 LETQVPLLVYEFVGNGTLFEHIHK---------KGNLSWERRLRITAETAGVLSYLHSET 517
              +  +LV         FEH+ +         +G L          +    ++Y H   
Sbjct: 70  HTKKRLVLV---------FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ-TC 576
              ++HRD+K  N+L++     K++DFG ++   I  ++  T    TL Y  P+ L  + 
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 577 KLTDKSDVYSFGVVLVELLTG 597
           K +   D++S G +  E++ G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 59/295 (20%)
Query: 408 VIGCGGSGNV-YKGFLPDRTPVAVKKS--KFVDQAKIDEFINELVVVLQINRR-NVVRLL 463
           ++G G SG V ++G    R PVAVK+    F D A     + E+ ++ + +   NV+R  
Sbjct: 22  ILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIA-----LMEIKLLTESDDHPNVIRYY 75
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKG----NLSWERR---LRITAETAGVLSYLHSE 516
            C   T   L +   + N  L + +  K     NL  ++    + +  + A  +++LHS 
Sbjct: 76  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 517 TNVPIIHRDVKSANILLD-------------ENCTPKVSDFGASKLVPIDAIQ-----NC 558
             + IIHRD+K  NIL+              EN    +SDFG  K   +D+ Q     N 
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQSSFRTNL 189
Query: 559 TVVQGTLGYLDPEYLQTC-------KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS 611
               GT G+  PE L+         +LT   D++S G V   +L+       DK   E +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           +      SL + + L           ++  + E   L ++ I     +RPT  +V
Sbjct: 250 IIRGIF-SLDEMKCLH----------DRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 59/295 (20%)
Query: 408 VIGCGGSGNV-YKGFLPDRTPVAVKKS--KFVDQAKIDEFINELVVVLQINRR-NVVRLL 463
           ++G G SG V ++G    R PVAVK+    F D A     + E+ ++ + +   NV+R  
Sbjct: 22  ILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIA-----LMEIKLLTESDDHPNVIRYY 75
Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKG----NLSWERR---LRITAETAGVLSYLHSE 516
            C   T   L +   + N  L + +  K     NL  ++    + +  + A  +++LHS 
Sbjct: 76  -CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133
Query: 517 TNVPIIHRDVKSANILLD-------------ENCTPKVSDFGASKLVPIDAIQ-----NC 558
             + IIHRD+K  NIL+              EN    +SDFG  K   +D+ Q     N 
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLDSGQXXFRXNL 189
Query: 559 TVVQGTLGYLDPEYLQTC-------KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS 611
               GT G+  PE L+         +LT   D++S G V   +L+       DK   E +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           +      SL + + L           ++  + E   L ++ I     +RPT  +V
Sbjct: 250 IIRGIF-SLDEMKCLH----------DRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 18/192 (9%)
Query: 371 GGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF--LPDRT 426
            GS    +  K H  S   A +        + + Y    +IG G  G+V + +  L  R 
Sbjct: 21  SGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRV 80
Query: 427 PVAVKKSKFVDQAKID--EFINELVVVLQINRRNVVRLLGCCLETQVP-----LLVYEFV 479
            VA+KK   V +  ID    + E+ ++ ++N  +VV++L   +   V       +V E  
Sbjct: 81  -VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA 139
Query: 480 GNGTLFEHIHKKGNLSWERRLRITAETAGV-LSYLHSETNVPIIHRDVKSANILLDENCT 538
            +   F+ + +      E  ++       V + Y+HS     I+HRD+K AN L++++C+
Sbjct: 140 DSD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCS 194
Query: 539 PKVSDFGASKLV 550
            KV DFG ++ V
Sbjct: 195 VKVCDFGLARTV 206

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 19/176 (10%)
Query: 443 EFINELVVVLQINRR--NVVRLLGCCLETQVPLLVYEFVGNGTLFEH-IHKKGNLSWERR 499
           E ++E + VL++ +    V+ L      T   +L+ E+   G +F   + +   +  E  
Sbjct: 74  EILHE-IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND 132
Query: 500 -LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP----KVSDFGASKLVPIDA 554
            +R+  +    + YLH      I+H D+K  NILL  +  P    K+ DFG S+ +    
Sbjct: 133 VIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRKIG--- 185
Query: 555 IQNCTV--VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
              C +  + GT  YL PE L    +T  +D+++ G++   LLT     + +  +E
Sbjct: 186 -HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 58/130 (44%), Gaps = 31/130 (23%)
Query: 473 LLVYEFVGNGTLFEHIHKKGNLSWERR--LRITAETAGVLSYLHSETNVPIIHRDVKSAN 530
           L+V E +  G LF  I  +G+ ++  R    I       + YLHS   + I HRDVK  N
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 147
Query: 531 ILLDE---NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSF 587
           +L      N   K++DFG +K               T G    +Y ++C      D++S 
Sbjct: 148 LLYTSKRPNAILKLTDFGFAK--------------ETTG---EKYDKSC------DMWSL 184
Query: 588 GVVLVELLTG 597
           GV++  LL G
Sbjct: 185 GVIMYILLCG 194

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 404 NYAD--VIGCGGSGNVYKGFLPDRTP-VAVKKSKFVDQAKIDEFIN-ELVVVLQINRRNV 459
           +Y D  VIG G  G VY+  L D    VA+KK   V Q K   F N EL ++ +++  N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQGK--AFKNRELQIMRKLDHCNI 75
Query: 460 VRL---------------LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITA 504
           VRL               L   L+  VP  VY    +     +   K  L          
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLD-YVPATVYRVARH-----YSRAKQTLPVIYVKLYMY 129
Query: 505 ETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
           +    L+Y+HS     I HRD+K  N+LLD +    K+ DFG++K + +    N + +  
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSXICS 185
Query: 564 TLGYLDPEYL-QTCKLTDKSDVYSFGVVLVELLTGKMALLSD 604
              Y  PE +      T   DV+S G VL ELL G+     D
Sbjct: 186 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 38/212 (17%)
Query: 408 VIGCGGSGNVYKGFLPDRTP---VAVK----KSKFVDQAKIDEFINELV---------VV 451
           +IG G  G V K +  DR     VA+K    K  F++QA+I+  + EL+          +
Sbjct: 61  LIGKGSFGQVVKAY--DRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 452 LQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS 511
           + + R  + R   C +   +   +Y+ + N T F  +    +L+  R+      TA  L 
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRN-TNFRGV----SLNLTRKFAQQMCTA--LL 171
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVS-----DFGASKLVPIDAIQNCTVVQGTLG 566
           +L +   + IIH D+K  NILL   C PK S     DFG+S  +     Q    +Q    
Sbjct: 172 FL-ATPELSIIHCDLKPENILL---CNPKRSAIKIVDFGSSCQLGQRIYQX---IQSRF- 223
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           Y  PE L         D++S G +LVE+ TG+
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 60/124 (48%), Gaps = 7/124 (5%)
Query: 510 LSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
           L+Y+HS     I HRD+K  N+LLD +    K+ DFG++K + +    N + +     Y 
Sbjct: 214 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRY-YR 268
Query: 569 DPEYL-QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE 627
            PE +      T   DV+S G VL ELL G+     D   ++    +  L +  + ++ E
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 328
Query: 628 ILDN 631
           +  N
Sbjct: 329 MNPN 332

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 38/212 (17%)
Query: 408 VIGCGGSGNVYKGFLPDRTP---VAVK----KSKFVDQAKIDEFINELV---------VV 451
           +IG G  G V K +  DR     VA+K    K  F++QA+I+  + EL+          +
Sbjct: 61  LIGKGSFGQVVKAY--DRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 452 LQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS 511
           + + R  + R   C +   +   +Y+ + N T F  +    +L+  R+      TA  L 
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRN-TNFRGV----SLNLTRKFAQQMCTA--LL 171
Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPK-----VSDFGASKLVPIDAIQNCTVVQGTLG 566
           +L +   + IIH D+K  NILL   C PK     + DFG+S  +     Q    +Q    
Sbjct: 172 FL-ATPELSIIHCDLKPENILL---CNPKRXAIKIVDFGSSCQLGQRIYQX---IQSRF- 223
Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           Y  PE L         D++S G +LVE+ TG+
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFIN-ELVVVLQINRRNVVRLLGCC 466
           VIG G  G V++  L +   VA+KK   V Q K   F N EL ++  +   NVV L    
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKK---VLQDK--RFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 467 L-----ETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITA----ETAGVLSYLHSE 516
                 + +V L LV E+V   T++        L     + +      +    L+Y+HS 
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS- 159
Query: 517 TNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL-Q 574
             + I HRD+K  N+LLD  +   K+ DFG++K++ I    N + +     Y  PE +  
Sbjct: 160 --IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPNVSXICSRY-YRAPELIFG 215
Query: 575 TCKLTDKSDVYSFGVVLVELLTGK 598
               T   D++S G V+ EL+ G+
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ 239
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	735
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-108
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-99
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-93
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-55
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-51
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-51
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-51
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-51
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-51
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-47
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-46
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-45
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-33
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-32
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-31
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-30
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-30
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-30
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-30
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-30
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-28
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-28
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-27
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-27
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-26
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-19
1lmj_A	86	Fibrillin 1; EGF, calcium, microfibril, neonatal,	1e-18
1lmj_A	86	Fibrillin 1; EGF, calcium, microfibril, neonatal,	1e-09
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-16
1dx5_I	118	Thrombomodulin; serine proteinase, EGF-like domain	2e-16
1dx5_I	118	Thrombomodulin; serine proteinase, EGF-like domain	8e-11
1dx5_I	118	Thrombomodulin; serine proteinase, EGF-like domain	2e-06
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-16
1uzk_A	162	Fibrillin-1; glycoprotein, extra-cellular matrix,	3e-16
1uzk_A	162	Fibrillin-1; glycoprotein, extra-cellular matrix,	2e-12
1uzk_A	162	Fibrillin-1; glycoprotein, extra-cellular matrix,	5e-12
1uzk_A	162	Fibrillin-1; glycoprotein, extra-cellular matrix,	2e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-16
1emn_A	82	Fibrillin; extracellular matrix, calcium-binding,	4e-16
1emn_A	82	Fibrillin; extracellular matrix, calcium-binding,	1e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
2w2n_E	107	LDL receptor, low-density lipoprotein receptor; hy	5e-15
2w2n_E	107	LDL receptor, low-density lipoprotein receptor; hy	6e-13
2bou_A	143	EGF-like module containing mucin-like hormone rece	6e-15
2bou_A	143	EGF-like module containing mucin-like hormone rece	3e-13
2bou_A	143	EGF-like module containing mucin-like hormone rece	7e-04
1z6c_A	87	Vitamin K-dependent protein S; EGF module, blood c	2e-14
1z6c_A	87	Vitamin K-dependent protein S; EGF module, blood c	9e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-13
2w86_A	147	Fibrillin-1, fibrillin1; phosphoprotein, EGF-like	7e-13
2w86_A	147	Fibrillin-1, fibrillin1; phosphoprotein, EGF-like	7e-08
2w86_A	147	Fibrillin-1, fibrillin1; phosphoprotein, EGF-like	4e-07
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-12
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-11
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-10
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-10
1aut_L	114	Activated protein C; serine proteinase, plasma cal	2e-10
1aut_L	114	Activated protein C; serine proteinase, plasma cal	3e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-10
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-10
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-10
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-10
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-09
1z1y_A	186	Ookinete surface protein PVS25; four EGF-like doma	1e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-09
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-09
3p5b_L	400	Low density lipoprotein receptor variant; B-propel	2e-09
3p5b_L	400	Low density lipoprotein receptor variant; B-propel	1e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-09
1apq_A	53	Complement protease C1R; EGF, calcium binding, ser	4e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-09
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-09
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-08
1yo8_A	634	Thrombospondin-2; EGF, Ca(2+)-binding domains, lec	4e-08
1yo8_A	634	Thrombospondin-2; EGF, Ca(2+)-binding domains, lec	4e-07
3v65_B	386	Low-density lipoprotein receptor-related protein;	4e-08
3v65_B	386	Low-density lipoprotein receptor-related protein;	3e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-07
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-07
2vj3_A	135	Neurogenic locus notch homolog protein 1; transcri	3e-07
2vj3_A	135	Neurogenic locus notch homolog protein 1; transcri	6e-06
2vj3_A	135	Neurogenic locus notch homolog protein 1; transcri	5e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-07
2c4f_L	142	Coagulation factor VII precursor; blood coagulatio	9e-07
2vh0_B	134	Activated factor XA light chain; serine protease,	9e-07
2vh0_B	134	Activated factor XA light chain; serine protease,	3e-06
1nfu_B	195	Coagulation factor XA, light chain; hydrolase; HET	1e-06
1nfu_B	195	Coagulation factor XA, light chain; hydrolase; HET	3e-05
1x7a_L	146	Coagulation factor IX, light chain; inhibition, bl	1e-06
4d90_A	143	EGF-like repeat and discoidin I-like domain-conta	3e-06
4d90_A	143	EGF-like repeat and discoidin I-like domain-conta	7e-05
3h5c_B	317	Vitamin K-dependent protein Z; protein Z-protein Z	9e-06
3v64_C	349	Agrin; beta propeller, laminin-G, signaling, prote	1e-05
1nzi_A	159	Complement C1S component; calcium, innate immunity	2e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-05
2vj2_A	169	Jagged-1; signalling, polymorphism, glycoprotein,	4e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-04
1tpg_A	91	T-plasminogen activator F1-G; plasminogen activati	2e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-04
1kig_L	51	Factor XA; glycoprotein, serine protease, plasma,	3e-04
2jkh_L	55	Factor X light chain; plasma, calcium, zymogen, se	4e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-04
1kli_L	69	Factor VIIA; extrinsic coagulation pathway, serine	7e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  331 bits (852), Expect = e-108
 Identities = 111/301 (36%), Positives = 166/301 (55%), Gaps = 10/301 (3%)

Query: 383 HGQSSEKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAK 440
                 ++      +++  TNN+    +IG G  G VYKG L D   VA+K+        
Sbjct: 19  SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG 78

Query: 441 IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN----LSW 496
           I+EF  E+  +      ++V L+G C E    +L+Y+++ NG L  H++        +SW
Sbjct: 79  IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138

Query: 497 ERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ 556
           E+RL I    A  L YLH+     IIHRDVKS NILLDEN  PK++DFG SK        
Sbjct: 139 EQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195

Query: 557 NC-TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
           +  TVV+GTLGY+DPEY    +LT+KSDVYSFGVVL E+L  + A++   P E  +LA  
Sbjct: 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255

Query: 616 FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS 675
            + S    +L +I+D  + +    + L++    A +C+++  E+RP+M +V  +L+  L 
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

Query: 676 L 676
           L
Sbjct: 316 L 316

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  308 bits (792), Expect = 2e-99
 Identities = 99/288 (34%), Positives = 161/288 (55%), Gaps = 13/288 (4%)

Query: 390 AKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKK-SKFVDQAKIDEFIN 446
            K F+  E++  ++N+++  ++G GG G VYKG L D T VAVK+  +   Q    +F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH----KKGNLSWERRLRI 502
           E+ ++     RN++RL G C+     LLVY ++ NG++   +      +  L W +R RI
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
              +A  L+YLH   +  IIHRDVK+ANILLDE     V DFG +KL+        T V+
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS---- 618
           GT+G++ PEYL T K ++K+DV+ +GV+L+EL+TG+ A    +   +    +  L     
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD--VMLLDWVKG 254

Query: 619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
            LK+ +L  ++D  +  +   ++++++ ++A  C      ERP M EV
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  290 bits (745), Expect = 8e-93
 Identities = 99/309 (32%), Positives = 158/309 (51%), Gaps = 29/309 (9%)

Query: 386 SSEKAKIFTEEEIKTVTNN--------YADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD 437
           S  +   F+  E+K VTNN          + +G GG G VYKG++ + T VAVKK   + 
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMV 66

Query: 438 QAKI----DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN 493
                    +F  E+ V+ +    N+V LLG   +     LVY ++ NG+L + +     
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126

Query: 494 ---LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV 550
              LSW  R +I    A  +++LH       IHRD+KSANILLDE  T K+SDFG ++  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARAS 183

Query: 551 PIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE 609
              A     + + GT  Y+ PE L   ++T KSD+YSFGVVL+E++TG  A+  D+  E 
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV--DEHREP 240

Query: 610 RSL---AMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           + L            +  + + +D ++ ND +   ++ +  +A++C+  +  +RP +K+V
Sbjct: 241 QLLLDIKEEIEDE--EKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

Query: 667 SLELQGRLS 675
              LQ   +
Sbjct: 298 QQLLQEMTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  211 bits (539), Expect = 1e-62
 Identities = 67/319 (21%), Positives = 113/319 (35%), Gaps = 34/319 (10%)

Query: 380 SKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQA 439
              H  SS           +++     +V   G  G V+K  L +   VAVK     D+ 
Sbjct: 3   HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQ 61

Query: 440 KIDEFINELVVVLQINRRNVVRLLGCCLETQVP----LLVYEFVGNGTLFEHIHKKGNLS 495
              +   E+  +  +   N+++ +G             L+  F   G+L + +     +S
Sbjct: 62  S-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVS 119

Query: 496 WERRLRITAETAGVLSYLHSET-------NVPIIHRDVKSANILLDENCTPKVSDFGASK 548
           W     I    A  L+YLH +           I HRD+KS N+LL  N T  ++DFG + 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 549 LVPIDAIQ-NCTVVQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALL 602
                    +     GT  Y+ PE L+           + D+Y+ G+VL EL +   A  
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

Query: 603 SDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG----------NKQQLKEVAKLAARC 652
               E      + F   + Q+  LE +   +V+                +  + +    C
Sbjct: 240 GPVDEYM----LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295

Query: 653 ISVRGEERPTMKEVSLELQ 671
                E R +   V   + 
Sbjct: 296 WDHDAEARLSAGCVGERIT 314

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (489), Expect = 9e-56
 Identities = 69/271 (25%), Positives = 125/271 (46%), Gaps = 31/271 (11%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           +V+G G  G V K        VA+K+     +++   FI EL  + ++N  N+V+L G C
Sbjct: 14  EVVGRGAFGVVCKAKWRA-KDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 467 LETQVPL-LVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPII 522
           L    P+ LV E+   G+L+  +H        +    +    + +  ++YLHS     +I
Sbjct: 71  LN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127

Query: 523 HRDVKSANILLDENCT-PKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           HRD+K  N+LL    T  K+ DFG +  +      + T  +G+  ++ PE  +    ++K
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQ----THMTNNKGSAAWMAPEVFEGSNYSEK 183

Query: 582 SDVYSFGVVLVELLTGKMALLSDKP-EEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ 640
            DV+S+G++L E++T +       P +E    A   + ++       ++ N         
Sbjct: 184 CDVFSWGIILWEVITRRK------PFDEIGGPAFRIMWAVHNGTRPPLIKN--------- 228

Query: 641 QLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
             K +  L  RC S    +RP+M+E+   + 
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  189 bits (483), Expect = 4e-55
 Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 40/283 (14%)

Query: 407 DVIGCGGSGNVYKGFLPDR-TPVAVKK-------SKFVDQAKIDEFINELVVVLQINRRN 458
             IG GG G V+KG L    + VA+K         +     K  EF  E+ ++  +N  N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 459 VVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSET 517
           +V+L G       P +V EFV  G L+  +  K + + W  +LR+  + A  + Y+ ++ 
Sbjct: 85  IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ- 141

Query: 518 NVPIIHRDVKSANILLDE-----NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
           N PI+HRD++S NI L           KV+DFG S+        + + + G   ++ PE 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV----HSVSGLLGNFQWMAPET 197

Query: 573 LQTCKL--TDKSDVYSFGVVLVELLTGKMALLSDKP-EEERSLAMNFLSSLKQNRL-LEI 628
           +   +   T+K+D YSF ++L  +LTG+       P +E     + F++ +++  L   I
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEG------PFDEYSYGKIKFINMIREEGLRPTI 251

Query: 629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
            ++             +  +   C S   ++RP    +  EL 
Sbjct: 252 PED---------CPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  190 bits (484), Expect = 5e-55
 Identities = 81/308 (26%), Positives = 141/308 (45%), Gaps = 31/308 (10%)

Query: 373 SILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVK- 431
            +   ++        + A    + +I     N  + IG G  G V++      + VAVK 
Sbjct: 9   PMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-SDVAVKI 67

Query: 432 -KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK 490
              +     +++EF+ E+ ++ ++   N+V  +G   +     +V E++  G+L+  +HK
Sbjct: 68  LMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK 127

Query: 491 KGN---LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
            G    L   RRL +  + A  ++YLH+  N PI+HR++KS N+L+D+  T KV DFG S
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186

Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPE 607
           +L     + + +   GT  ++ PE L+     +KSDVYSFGV+L EL T +       P 
Sbjct: 187 RLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ------PW 239

Query: 608 EERSLAMNFLSS----LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTM 663
                 +N          + + LEI  N            +VA +   C +    +RP+ 
Sbjct: 240 GN----LNPAQVVAAVGFKCKRLEIPRN---------LNPQVAAIIEGCWTNEPWKRPSF 286

Query: 664 KEVSLELQ 671
             +   L+
Sbjct: 287 ATIMDLLR 294

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  181 bits (461), Expect = 3e-52
 Identities = 73/276 (26%), Positives = 114/276 (41%), Gaps = 32/276 (11%)

Query: 408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ----AKIDEFINELVVVLQINRRNVVRLL 463
           +IG GG G VY+ F      VAVK ++          I+    E  +   +   N++ L 
Sbjct: 14  IIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           G CL+     LV EF   G L   +  K  +  +  +    + A  ++YLH E  VPIIH
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 524 RDVKSANILLDE--------NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT 575
           RD+KS+NIL+ +        N   K++DFG ++        +     G   ++ PE ++ 
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAYAWMAPEVIRA 188

Query: 576 CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
              +  SDV+S+GV+L ELLTG++      P                   L I       
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEV------PFRGIDGLAVAYGVAMNKLALPIPST---- 238

Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
                  +  AKL   C +     RP+   +  +L 
Sbjct: 239 -----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  179 bits (457), Expect = 5e-51
 Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 49/287 (17%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           ++IG G  G VY G       VA++    +  ++ ++  F  E++   Q    NVV  +G
Sbjct: 39  ELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIH 523
            C+      ++       TL+  +      L   +  +I  E    + YLH++    I+H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILH 153

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQN----CTVVQGTLGYLDPEYLQTCKL- 578
           +D+KS N+  D      ++DFG   +  +           +  G L +L PE ++     
Sbjct: 154 KDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 579 --------TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD 630
                   +  SDV++ G +  EL   +       P +         + + Q        
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREW------PFKT----QPAEAIIWQ-------- 254

Query: 631 NRIVNDGNKQQL------KEVAKLAARCISVRGEERPTMKEVSLELQ 671
              +  G K  L      KE++ +   C +   EERPT  ++   L+
Sbjct: 255 ---MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  180 bits (457), Expect = 7e-51
 Identities = 69/303 (22%), Positives = 115/303 (37%), Gaps = 47/303 (15%)

Query: 408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR---RNVVRLLG 464
           +IG G  G VYKG L D  PVAVK   F    +   FINE   + ++      N+ R + 
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKV--FSFANR-QNFINE-KNIYRVPLMEHDNIARFIV 74

Query: 465 CCLETQVP-----LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNV 519
                        LLV E+  NG+L +++       W    R+       L+YLH+E   
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPR 133

Query: 520 ------PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-------NCTVVQGTLG 566
                  I HRD+ S N+L+  + T  +SDFG S  +  + +              GT+ 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193

Query: 567 YLDPEYLQ-------TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS 619
           Y+ PE L+             + D+Y+ G++  E+      L   +   E  +A  F + 
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA--FQTE 251

Query: 620 LKQNRLLEILDNRIVNDG-----------NKQQLKEVAKLAARCISVRGEERPTMKEVSL 668
           +  +   E +   +  +            N   ++ + +    C     E R T +    
Sbjct: 252 VGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311

Query: 669 ELQ 671
            + 
Sbjct: 312 RMA 314

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  178 bits (453), Expect = 7e-51
 Identities = 71/272 (26%), Positives = 129/272 (47%), Gaps = 28/272 (10%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           IG G  G VYKG       VAVK          ++  F NE+ V+ +    N++  +G  
Sbjct: 32  IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 467 LETQVPL-LVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHR 524
             T   L +V ++    +L+ H+H        ++ + I  +TA  + YLH++    IIHR
Sbjct: 90  --TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHR 144

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNC-TVVQGTLGYLDPEYLQ---TCKLTD 580
           D+KS NI L E+ T K+ DFG +      +  +    + G++ ++ PE ++   +   + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 581 KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL-KQNRLLEILDNRIVNDGNK 639
           +SDVY+FG+VL EL+TG++      P    +     +  + + +   ++   R       
Sbjct: 205 QSDVYAFGIVLYELMTGQL------PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP--- 255

Query: 640 QQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
              K + +L A C+  + +ERP+   +  E++
Sbjct: 256 ---KRMKRLMAECLKKKRDERPSFPRILAEIE 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  177 bits (451), Expect = 8e-51
 Identities = 51/273 (18%), Positives = 102/273 (37%), Gaps = 32/273 (11%)

Query: 408 VIGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGC 465
            +    SG ++KG       + VK  K       K  +F  E   +   +  NV+ +LG 
Sbjct: 17  KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 466 CLETQVPLL--VYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPI 521
           C     P    +  ++  G+L+  +H+  N  +   + ++   + A  +++LH+     I
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LI 134

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ---TCKL 578
               + S ++++DE+ T ++S                        ++ PE LQ       
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDTN 188

Query: 579 TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
              +D++SF V+L EL+T ++      P  + S     +    +     I          
Sbjct: 189 RRSADMWSFAVLLWELVTREV------PFADLSNMEIGMKVALEGLRPTIPPG------- 235

Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
                 V+KL   C++    +RP    +   L+
Sbjct: 236 --ISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  169 bits (430), Expect = 2e-47
 Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 32/279 (11%)

Query: 408 VIGCGGSGNVYKGFLPDRT-PVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           V+G G  G   K    +    + +K+    D+     F+ E+ V+  +   NV++ +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            + +    + E++  GTL   I    +   W +R+    + A  ++YLHS     IIHRD
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRD 133

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQ-------------NCTVVQGTLGYLDPEY 572
           + S N L+ EN    V+DFG ++L+  +  Q                 V G   ++ PE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

Query: 573 LQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR 632
           +      +K DV+SFG+VL E++    A       +     M+F  +++         N 
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNA-----DPDYLPRTMDFGLNVRGFLDRYCPPN- 247

Query: 633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
                          +  RC  +  E+RP+  ++   L+
Sbjct: 248 --------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  167 bits (424), Expect = 2e-46
 Identities = 68/332 (20%), Positives = 122/332 (36%), Gaps = 44/332 (13%)

Query: 372 GSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVK 431
           G  LR  + +     S        +            IG G  G V+ G       VAVK
Sbjct: 8   GESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG-EKVAVK 66

Query: 432 KSKFVDQAKIDEFINELVVVLQINRR--NVVRLLGCCLETQVP----LLVYEFVGNGTLF 485
              F    +   +  E  +   +  R  N++  +   ++         L+ ++  NG+L+
Sbjct: 67  V--FFTTEE-ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY 123

Query: 486 EHIHKKGNLSWERRLRITAETAGVLSYLHSET-----NVPIIHRDVKSANILLDENCTPK 540
           +++     L  +  L++   +   L +LH+E         I HRD+KS NIL+ +N T  
Sbjct: 124 DYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182

Query: 541 VSDFGASKLV-----PIDAIQNCTVVQGTLGYLDPE------YLQTCKLTDKSDVYSFGV 589
           ++D G +         +D   N  V  GT  Y+ PE           +    +D+YSFG+
Sbjct: 183 IADLGLAVKFISDTNEVDIPPNTRV--GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240

Query: 590 VLVELLTG----------KMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK 639
           +L E+             ++      P +     M  +  +K+ R     +    ++   
Sbjct: 241 ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR-PSFPNRWSSDEC-- 297

Query: 640 QQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
             L+++ KL   C +     R T   V   L 
Sbjct: 298 --LRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  164 bits (417), Expect = 1e-45
 Identities = 61/295 (20%), Positives = 110/295 (37%), Gaps = 40/295 (13%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR--NVVRLLG 464
           + +G G  G V++G       VAVK   F  + +   +  E  +   +  R  N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSWQG-ENVAVKI--FSSRDE-KSWFRETELYNTVMLRHENILGFIA 69

Query: 465 CCLETQVP----LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET--- 517
             + ++       L+  +   G+L++++     L     LRI    A  L++LH E    
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 518 --NVPIIHRDVKSANILLDENCTPKVSDFGASKLV---PIDAIQNCTVVQGTLGYLDPE- 571
                I HRD+KS NIL+ +N    ++D G + +                GT  Y+ PE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

Query: 572 -----YLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL 626
                 +       + D+++FG+VL E+    +   S+   E+      F   +  +   
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV---SNGIVEDYKPP--FYDVVPNDPSF 243

Query: 627 EILDNRIVNDG----------NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
           E +   +  D           +   L  +AKL   C       R T   +   L 
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  163 bits (413), Expect = 1e-44
 Identities = 59/295 (20%), Positives = 117/295 (39%), Gaps = 40/295 (13%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR--NVVRLLG 464
           + IG G  G V++G       VAVK   F  + +   +  E  +   +  R  N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKWRGEE-VAVKI--FSSREE-RSWFREAEIYQTVMLRHENILGFIA 103

Query: 465 CCLETQVP----LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET--- 517
              +         LV ++  +G+LF+++++   ++ E  +++   TA  L++LH E    
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 518 --NVPIIHRDVKSANILLDENCTPKVSDFGASKL---VPIDAIQNCTVVQGTLGYLDPEY 572
                I HRD+KS NIL+ +N T  ++D G +                  GT  Y+ PE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

Query: 573 L------QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL 626
           L      +  +   ++D+Y+ G+V  E+          +  +     + +   +  +  +
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ-----LPYYDLVPSDPSV 277

Query: 627 EILDNRIVNDG----------NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
           E +   +              + + L+ +AK+   C    G  R T   +   L 
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  136 bits (345), Expect = 4e-36
 Identities = 64/275 (23%), Positives = 106/275 (38%), Gaps = 39/275 (14%)

Query: 405 YADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAK--IDEFINELVVVLQINRRNVVR 461
           +   IG G    VYKG        VA  + +     K     F  E  ++  +   N+VR
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 462 LLGCCLETQVP----LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
                  T       +LV E + +GTL  ++ +   +  +       +    L +LH+  
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR- 148

Query: 518 NVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
             PIIHRD+K  NI +     + K+ D G + L           V GT  ++ PE  +  
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE- 204

Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
           K  +  DVY+FG+ ++E+ T +         E ++ A  +               R V  
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYS-----ECQNAAQIY---------------RRVTS 244

Query: 637 GNKQQL------KEVAKLAARCISVRGEERPTMKE 665
           G K          EV ++   CI    +ER ++K+
Sbjct: 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  136 bits (345), Expect = 7e-36
 Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 9/197 (4%)

Query: 407 DVIGCGGSGNVYKGF--LPDRTPVAVK--KSKFV-DQAKIDEFINELVVVLQINRRNVVR 461
           D +G GG   VY     + +   VA+K         +  +  F  E+    Q++ +N+V 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNI-KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           ++    E     LV E++   TL E+I   G LS +  +  T +    + + H      I
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---I 132

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           +HRD+K  NIL+D N T K+ DFG +K +   ++     V GT+ Y  PE  +     + 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 582 SDVYSFGVVLVELLTGK 598
           +D+YS G+VL E+L G+
Sbjct: 193 TDIYSIGIVLYEMLVGE 209

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  129 bits (327), Expect = 2e-33
 Identities = 70/314 (22%), Positives = 119/314 (37%), Gaps = 40/314 (12%)

Query: 377 QELSKLHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKK- 432
           Q +        +  K    +       N+     IG G    VY+   L D  PVA+KK 
Sbjct: 6   QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65

Query: 433 --SKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI-- 488
                +D     + I E+ ++ Q+N  NV++     +E     +V E    G L   I  
Sbjct: 66  QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125

Query: 489 --HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA 546
              +K  +      +   +    L ++HS     ++HRD+K AN+ +      K+ D G 
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGL 182

Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP 606
            +          ++V GT  Y+ PE +       KSD++S G +L E+   +     D  
Sbjct: 183 GRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-- 239

Query: 607 EEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL------KEVAKLAARCISVRGEER 660
                  MN  S          L  +I    +   L      +E+ +L   CI+   E+R
Sbjct: 240 ------KMNLYS----------LCKKIEQ-CDYPPLPSDHYSEELRQLVNMCINPDPEKR 282

Query: 661 PTMKEVSLELQGRL 674
           P +  V  ++  R+
Sbjct: 283 PDVTYV-YDVAKRM 295

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  128 bits (325), Expect = 4e-33
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 17/204 (8%)

Query: 407 DVIGCGGSGNVYKGF--LPDRTPVAVK--KSKFV-DQAKIDEFINELVVVLQINRRNVVR 461
           +++G GG   V+        R  VAVK  ++    D +    F  E      +N   +V 
Sbjct: 18  EILGFGGMSEVHLARDLRDHR-DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 462 LL--GC--CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           +   G        +P +V E+V   TL + +H +G ++ +R + + A+    L++ H   
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG 136

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI---QNCTVVQGTLGYLDPEYLQ 574
              IIHRDVK ANI++      KV DFG ++ +        Q   V+ GT  YL PE  +
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPEQAR 192

Query: 575 TCKLTDKSDVYSFGVVLVELLTGK 598
              +  +SDVYS G VL E+LTG+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  128 bits (325), Expect = 6e-33
 Identities = 60/219 (27%), Positives = 109/219 (49%), Gaps = 23/219 (10%)

Query: 389 KAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVK--KSKFVDQAKI 441
             +I  E E K +      V+G G  G VYKG         + PVA+K  +     +A  
Sbjct: 8   LLRILKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN- 61

Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRL 500
            E ++E  V+  ++  +V RLLG CL + V  L+ + +  G L +++ + K N+  +  L
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLL 120

Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV 560
               + A  ++YL  +    ++HRD+ + N+L+      K++DFG +KL+  +  +    
Sbjct: 121 NWCVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKEYH 175

Query: 561 VQGT---LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
            +G    + ++  E +     T +SDV+S+GV + EL+T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  133 bits (336), Expect = 1e-32
 Identities = 49/201 (24%), Positives = 79/201 (39%), Gaps = 22/201 (10%)

Query: 407 DVIGCGGSGNVYKGF---LPDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRL 462
             I  GG G +Y      +  R PV +K      D       + E   + ++   ++V++
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGR-PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 463 L-----GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
                        V  +V E+VG  +L         L     +    E    LSYLHS  
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHS-- 200

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
            + +++ D+K  NI+L E    K+ D GA        I +   + GT G+  PE ++T  
Sbjct: 201 -IGLVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINSFGYLYGTPGFQAPEIVRT-G 252

Query: 578 LTDKSDVYSFGVVLVELLTGK 598
            T  +D+Y+ G  L  L    
Sbjct: 253 PTVATDIYTVGRTLAALTLDL 273

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  126 bits (319), Expect = 4e-32
 Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 23/224 (10%)

Query: 384 GQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPD-----RTPVAVK--KSKFV 436
           G     A+IF E E++ +      V+G G  G V+KG         + PV +K  + K  
Sbjct: 1   GAMKVLARIFKETELRKL-----KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG 55

Query: 437 DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLS 495
            Q+      + ++ +  ++  ++VRLLG C  + +  LV +++  G+L +H+ + +G L 
Sbjct: 56  RQSF-QAVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALG 113

Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
            +  L    + A  + YL  E    ++HR++ + N+LL      +V+DFG + L+P D  
Sbjct: 114 PQLLLNWGVQIAKGMYYL-EEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170

Query: 556 QNCTVVQGT---LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           Q   +       + ++  E +   K T +SDV+S+GV + EL+T
Sbjct: 171 Q--LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  125 bits (317), Expect = 5e-32
 Identities = 47/197 (23%), Positives = 78/197 (39%), Gaps = 9/197 (4%)

Query: 407 DVIGCGGSGNVYKGF--LPDRTPVAVK--KSKFV-DQAKIDEFINELVVVLQINRRNVVR 461
            ++G GG G+VY+    + +R  VA+K        D         E     ++   +VV 
Sbjct: 40  RLVGRGGMGDVYEAEDTVRER-IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           +           +    +    L   + ++G L+  R + I  +    L   H+      
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---A 155

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
            HRDVK  NIL+  +    + DFG +     + +       GTL Y+ PE       T +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 582 SDVYSFGVVLVELLTGK 598
           +D+Y+   VL E LTG 
Sbjct: 216 ADIYALTCVLYECLTGS 232

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  127 bits (321), Expect = 5e-32
 Identities = 73/279 (26%), Positives = 116/279 (41%), Gaps = 42/279 (15%)

Query: 407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSK-FVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           + IG G  G V+ G L  D T VAVK  +  +      +F+ E  ++ Q +  N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIH 523
            C + Q   +V E V  G     +  +G  L  +  L++  + A  + YL S+     IH
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIH 236

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL-----DPEYLQTCKL 578
           RD+ + N L+ E    K+SDFG S+              G L  +      PE L   + 
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVY----AASGGLRQVPVKWTAPEALNYGRY 292

Query: 579 TDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG 637
           + +SDV+SFG++L E  + G        P    S               +  +   V  G
Sbjct: 293 SSESDVWSFGILLWETFSLGAS------PYPNLSNQ-------------QTREF--VEKG 331

Query: 638 NKQQL-----KEVAKLAARCISVRGEERPTMKEVSLELQ 671
            +          V +L  +C +    +RP+   +  ELQ
Sbjct: 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  126 bits (319), Expect = 5e-32
 Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 11/223 (4%)

Query: 383 HGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQA 439
           H   S    + TE         Y     IG G  G         D     +K+      +
Sbjct: 4   HHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63

Query: 440 K--IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI--HKKGNLS 495
               +E   E+ V+  +   N+V+      E     +V ++   G LF+ I   K     
Sbjct: 64  SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123

Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
            ++ L    +    L ++H      I+HRD+KS NI L ++ T ++ DFG ++++     
Sbjct: 124 EDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180

Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
                + GT  YL PE  +     +KSD+++ G VL EL T K
Sbjct: 181 LARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  124 bits (314), Expect = 1e-31
 Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 12/197 (6%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKID--EFINELVVVLQINR-RNVVRL 462
             +G G  G V+K     D    AVK+S    +   D    + E+    ++ +    VRL
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR-ITAETAGVLSYLHSETNVPI 521
                E  +  L  E  G  +L +H    G    E ++     +T   L++LHS+    +
Sbjct: 123 EQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---L 178

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           +H DVK ANI L      K+ DFG      +       V +G   Y+ PE LQ       
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQEGDPRYMAPELLQG-SYGTA 235

Query: 582 SDVYSFGVVLVELLTGK 598
           +DV+S G+ ++E+    
Sbjct: 236 ADVFSLGLTILEVACNM 252

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  126 bits (318), Expect = 1e-31
 Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 27/242 (11%)

Query: 377 QELSKLHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVAVK--- 431
            +   L     +KA     E I      Y+    IG GGS  V++     +   A+K   
Sbjct: 30  MDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 89

Query: 432 KSKFVDQAKIDEFINE--LVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH 489
             +  D   +D + NE   +  LQ +   ++RL    +  Q   +V E  GN  L   + 
Sbjct: 90  LEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK 147

Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
           KK ++    R          +  +H      I+H D+K AN L+ +    K+ DFG +  
Sbjct: 148 KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQ 203

Query: 550 VPID--AIQNCTVVQGTLGYLDPEYLQ-----------TCKLTDKSDVYSFGVVLVELLT 596
           +  D  ++   + V G + Y+ PE ++             K++ KSDV+S G +L  +  
Sbjct: 204 MQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262

Query: 597 GK 598
           GK
Sbjct: 263 GK 264

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  124 bits (314), Expect = 1e-31
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 27/223 (12%)

Query: 396 EEIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVAVK---KSKFVDQAKIDEFINELVV 450
           + +      Y+    IG GGS  V++     +   A+K     +  D   +D + NE+  
Sbjct: 21  QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAY 79

Query: 451 --VLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
              LQ +   ++RL    +  Q   +V E  GN  L   + KK ++    R         
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE 138

Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID--AIQNCTVVQGTLG 566
            +  +H      I+H D+K AN L+ +    K+ DFG +  +  D  ++   + V GT+ 
Sbjct: 139 AVHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV-GTVN 193

Query: 567 YLDPEYLQ-----------TCKLTDKSDVYSFGVVLVELLTGK 598
           Y+ PE ++             K++ KSDV+S G +L  +  GK
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  124 bits (313), Expect = 1e-31
 Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 48/289 (16%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
            V+G G  G V K     D    A+KK +   + K+   ++E++++  +N + VVR    
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAA 70

Query: 466 CLETQVPL-------------LVYEFVGNGTLFEHIHKKGNLSWERR-LRITAETAGVLS 511
            LE +  +             +  E+  NGTL++ IH +          R+  +    LS
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130

Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--------- 562
           Y+HS+    IIHRD+K  NI +DE+   K+ DFG +K V           Q         
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187

Query: 563 ----GTLGYLDPEYLQTCKLTD-KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL 617
               GT  Y+  E L      + K D+YS G++  E++                  M  +
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FST----GMERV 235

Query: 618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           + LK+ R + I      +D   +  K   K+    I     +RP  + +
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEK---KIIRLLIDHDPNKRPGARTL 281

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  124 bits (313), Expect = 3e-31
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 25/210 (11%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVK---KSKFVDQAKIDEFINELVV--VLQINRRNVVR 461
             IG GGS  V++     +   A+K     +  D   +D + NE+     LQ +   ++R
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           L    +  Q   +V E  GN  L   + KK ++    R          +  +H      I
Sbjct: 74  LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 129

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPID--AIQNCTVVQGTLGYLDPEYLQ----- 574
           +H D+K AN L+ +    K+ DFG +  +  D  ++   + V GT+ Y+ PE ++     
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSS 187

Query: 575 ------TCKLTDKSDVYSFGVVLVELLTGK 598
                   K++ KSDV+S G +L  +  GK
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  122 bits (309), Expect = 6e-31
 Identities = 74/300 (24%), Positives = 132/300 (44%), Gaps = 38/300 (12%)

Query: 392 IFTEEEIKTVTNNYADVIGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQAKIDEFIN 446
            F E  +K     +   +G G  G+V               VAVKK +   +  + +F  
Sbjct: 37  QFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 91

Query: 447 ELVVVLQINRRNVVRLLGCCLET-QVPL-LVYEFVGNGTLFEHIHK-KGNLSWERRLRIT 503
           E+ ++  +   N+V+  G C    +  L L+ E++  G+L +++ K K  +   + L+ T
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
           ++    + YL ++     IHRD+ + NIL++     K+ DFG +K++P D  +    V+ 
Sbjct: 152 SQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEYYKVKE 206

Query: 564 TLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
             G        PE L   K +  SDV+SFGVVL EL T      S   E  R +  +   
Sbjct: 207 P-GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265

Query: 619 SLKQNRLLEILDNRIVNDGNKQQL-------KEVAKLAARCISVRGEERPTMKEVSLELQ 671
            +    L+E+L N         +L        E+  +   C +    +RP+ ++++L + 
Sbjct: 266 QMIVFHLIELLKNN-------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  121 bits (307), Expect = 6e-31
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)

Query: 408 VIGCGGSGNVYKGFLPDR---TPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
            +G G  G V KG+   +     VAVK  K++  D A  DE + E  V+ Q++   +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           +G C      +LV E    G L +++ +  ++  +  + +  + +  + YL  E+N   +
Sbjct: 84  IGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FV 139

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT----LGYLDPEYLQTCKL 578
           HRD+ + N+LL      K+SDFG SK +  D  +N    Q      + +  PE +   K 
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 579 TDKSDVYSFGVVLVELLT 596
           + KSDV+SFGV++ E  +
Sbjct: 198 SSKSDVWSFGVLMWEAFS 215

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  122 bits (307), Expect = 6e-31
 Identities = 76/302 (25%), Positives = 133/302 (44%), Gaps = 38/302 (12%)

Query: 390 AKIFTEEEIKTVTNNYADVIGCGGSGNVYKGF---LPDR--TPVAVKKSKFVDQAKIDEF 444
              F E  +K     +   +G G  G+V       L D     VAVKK +   +  + +F
Sbjct: 4   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 58

Query: 445 INELVVVLQINRRNVVRLLGCCLETQV-PL-LVYEFVGNGTLFEHIHK-KGNLSWERRLR 501
             E+ ++  +   N+V+  G C       L L+ E++  G+L +++ K K  +   + L+
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
            T++    + YL ++     IHRD+ + NIL++     K+ DFG +K++P D  +    V
Sbjct: 119 YTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQD--KEFFKV 173

Query: 562 QGTLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF 616
           +   G        PE L   K +  SDV+SFGVVL EL T      S   E  R +  + 
Sbjct: 174 KEP-GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232

Query: 617 LSSLKQNRLLEILDNRIVNDGNKQQL-------KEVAKLAARCISVRGEERPTMKEVSLE 669
              +    L+E+L N         +L        E+  +   C +    +RP+ ++++L 
Sbjct: 233 QGQMIVFHLIELLKNN-------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285

Query: 670 LQ 671
           + 
Sbjct: 286 VD 287

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  122 bits (309), Expect = 7e-31
 Identities = 60/219 (27%), Positives = 109/219 (49%), Gaps = 23/219 (10%)

Query: 389 KAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPD-----RTPVAVK--KSKFVDQAKI 441
             +I  E E K +      V+G G  G VYKG         + PVA+K  +     +A  
Sbjct: 8   LLRILKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN- 61

Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRL 500
            E ++E  V+  ++  +V RLLG CL + V  L+ + +  G L +++ + K N+  +  L
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLL 120

Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV 560
               + A  ++YL  +    ++HRD+ + N+L+      K++DFG +KL+  +  +    
Sbjct: 121 NWCVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKEYH 175

Query: 561 VQGT---LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT 596
            +G    + ++  E +     T +SDV+S+GV + EL+T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  122 bits (309), Expect = 7e-31
 Identities = 83/341 (24%), Positives = 140/341 (41%), Gaps = 48/341 (14%)

Query: 384 GQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLP-----DRTPVAVKKSKFVDQ 438
             + +   IF E  +K     Y   +G G  G+V               VAVK+ +    
Sbjct: 11  LYACQDPTIFEERHLK-----YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP 65

Query: 439 AKIDEFINELVVVLQINRRNVVRLLGCCLETQV-PL-LVYEFVGNGTLFEHIHK-KGNLS 495
            +  +F  E+ ++  ++   +V+  G         L LV E++ +G L + + + +  L 
Sbjct: 66  DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125

Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
             R L  +++    + YL S      +HRD+ + NIL++     K++DFG +KL+P+D  
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD-- 180

Query: 556 QNCTVVQGTLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP---- 606
           ++  VV+   G        PE L     + +SDV+SFGVVL EL T       DK     
Sbjct: 181 KDYYVVR-EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-----YCDKSCSPS 234

Query: 607 EEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL-------KEVAKLAARCISVRGEE 659
            E   +          +RLLE+L+         Q+L        EV +L   C +   ++
Sbjct: 235 AEFLRMMGCERDVPALSRLLELLEEG-------QRLPAPPACPAEVHELMKLCWAPSPQD 287

Query: 660 RPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGVQETEYFT 700
           RP+   +  +L   L   S G           G   +  F+
Sbjct: 288 RPSFSALGPQLD-MLWSGSRGCETHAFTAHPEGKHHSLSFS 327

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  122 bits (309), Expect = 2e-30
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 19/215 (8%)

Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDR----TPVAVK--KSKFVDQAKIDEFINEL 448
                ++  ++ +VIG G  G VY G L D        AVK              F+ E 
Sbjct: 83  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEG 141

Query: 449 VVVLQINRRNVVRLLGCCLETQVPLL-VYEFVGNGTLFEHIHK-KGNLSWERRLRITAET 506
           +++   +  NV+ LLG CL ++   L V  ++ +G L   I     N + +  +    + 
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
           A  + +L +      +HRD+ + N +LDE  T KV+DFG ++   +   +  +V   T  
Sbjct: 202 AKGMKFL-ASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEFDSVHNKTGA 256

Query: 567 YL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT 596
            L       E LQT K T KSDV+SFGV+L EL+T
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  120 bits (302), Expect = 3e-30
 Identities = 60/201 (29%), Positives = 105/201 (52%), Gaps = 20/201 (9%)

Query: 408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
            +G G  G V+ G+    T VAVK  K       D F+ E  ++ Q+  + +VRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77

Query: 468 ETQVPLL-VYEFVGNGTLFEHI--HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
            TQ P+  + E++ NG+L + +       L+  + L + A+ A  ++++  E N   IHR
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERNY--IHR 133

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL-----DPEYLQTCKLT 579
           D+++ANIL+ +  + K++DFG ++L+  +     T  +G           PE +     T
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAK--FPIKWTAPEAINYGTFT 188

Query: 580 DKSDVYSFGVVLVELLT-GKM 599
            KSDV+SFG++L E++T G++
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI 209

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  124 bits (313), Expect = 3e-30
 Identities = 60/193 (31%), Positives = 98/193 (50%), Gaps = 7/193 (3%)

Query: 407 DVIGCGGSGNVYKGFLPDR-TPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
             +G G  G VY+G        VAVK  K  D  +++EF+ E  V+ +I   N+V+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 466 CLETQVPLLVYEFVGNGTLFEHI--HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           C       ++ EF+  G L +++    +  +S    L +  + +  + YL  +     IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           R++ + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401

Query: 584 VYSFGVVLVELLT 596
           V++FGV+L E+ T
Sbjct: 402 VWAFGVLLWEIAT 414

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  120 bits (302), Expect = 3e-30
 Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 18/201 (8%)

Query: 408 VIGCGGSGNVYKGFLPDR-TPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
            +G G  G VY+G        VAVK  K  D  +++EF+ E  V+ +I   N+V+LLG C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 467 LETQVPLLVYEFVGNGTLFEHI--HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
                  ++ EF+  G L +++    +  +S    L +  + +  + YL  + N   IHR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNF--IHR 135

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL-----DPEYLQTCKLT 579
           D+ + N L+ EN   KV+DFG S+L+  D     T               PE L   K +
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 580 DKSDVYSFGVVLVELLT-GKM 599
            KSDV++FGV+L E+ T G  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS 211

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  123 bits (311), Expect = 3e-30
 Identities = 50/196 (25%), Positives = 97/196 (49%), Gaps = 15/196 (7%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             +G G  G V+       T VAVK  K      ++ F+ E  V+  +    +V+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 467 LETQVPL-LVYEFVGNGTLFEHI--HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             T+ P+ ++ EF+  G+L + +   +       + +  +A+ A  ++++        IH
Sbjct: 253 --TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG---YLDPEYLQTCKLTD 580
           RD+++ANIL+  +   K++DFG ++++  +     T  +G      +  PE +     T 
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 581 KSDVYSFGVVLVELLT 596
           KSDV+SFG++L+E++T
Sbjct: 365 KSDVWSFGILLMEIVT 380

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  120 bits (304), Expect = 4e-30
 Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 26/238 (10%)

Query: 368 EQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGF-LPDRT 426
           E N G +L ++L  +  +  E+    T +            +G G  G V++        
Sbjct: 35  EDNEGVLLTEKLKPVDYEYREEVHWMTHQPR----------VGRGSFGEVHRMKDKQTGF 84

Query: 427 PVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE 486
             AVKK +            ELV    ++   +V L G   E     +  E +  G+L +
Sbjct: 85  QCAVKKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139

Query: 487 HIHKKGNLSWERRLR-ITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-CTPKVSDF 544
            I + G L  E R      +    L YLH+     I+H DVK+ N+LL  +     + DF
Sbjct: 140 LIKQMGCLP-EDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDF 195

Query: 545 GASKLVPIDAIQNCTV----VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           G +  +  D +    +    + GT  ++ PE +       K D++S   +++ +L G 
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  118 bits (299), Expect = 4e-30
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             +G G  G V  G    +  VAVK  K       DEF  E   +++++   +V+  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            +     +V E++ NG L  ++   G  L   + L +  +    +++L        IHRD
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL-ESHQF--IHRD 129

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL---GYLDPEYLQTCKLTDKS 582
           + + N L+D +   KVSDFG ++ V  D         GT     +  PE     K + KS
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186

Query: 583 DVYSFGVVLVELLT-GKM 599
           DV++FG+++ E+ + GKM
Sbjct: 187 DVWAFGILMWEVFSLGKM 204

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  119 bits (300), Expect = 5e-30
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 16/198 (8%)

Query: 408 VIGCGGSGNVYKG-FLPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
            +G G  GNVY       +  +A+K   K++        +   E+ +   +   N++RL 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 464 GCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G        + L+ E+   GT++  + K      +R      E A  LSY HS+    +I
Sbjct: 76  GY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VI 131

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTVVQGTLGYLDPEYLQTCKLTD 580
           HRD+K  N+LL      K++DFG S   P  + +   C    GTL YL PE ++     +
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC----GTLDYLPPEMIEGRMHDE 186

Query: 581 KSDVYSFGVVLVELLTGK 598
           K D++S GV+  E L GK
Sbjct: 187 KVDLWSLGVLCYEFLVGK 204

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  122 bits (309), Expect = 5e-30
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 7/192 (3%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             +G G  G V+ G     T VA+K  K       + F+ E  V+ ++    +V+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 467 LETQVPLLVYEFVGNGTLFEHI--HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
            E  +  +V E++  G+L + +       L   + + + A+ A  ++Y+        +HR
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364

Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 365 WSFGILLTELTT 376

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  119 bits (301), Expect = 5e-30
 Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 34/288 (11%)

Query: 408 VIGCGGSGNVYKGFLPDR----TPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           VIG G  G VY G   D+       A+K        Q     F+ E +++  +N  NV+ 
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA-FLREGLLMRGLNHPNVLA 86

Query: 462 LLGCCLETQ-VPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNV 519
           L+G  L  + +P ++  ++ +G L + I   + N + +  +    + A  + YL +E   
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL-AEQK- 144

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL-----DPEYLQ 574
             +HRD+ + N +LDE+ T KV+DFG ++   I   +  +V Q     L       E LQ
Sbjct: 145 -FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWTALESLQ 201

Query: 575 TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV 634
           T + T KSDV+SFGV+L ELLT         P        +    L Q R L   +    
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLT-----RGAPPYRHID-PFDLTHFLAQGRRLPQPEY--- 252

Query: 635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQY 682
                     + ++  +C       RPT + +  E++  +S +    Y
Sbjct: 253 ------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  119 bits (300), Expect = 5e-30
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 12/198 (6%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             +G G  G V  G    +  VA+K  K       DEFI E  V++ ++   +V+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 467 LETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            + +   ++ E++ NG L  ++ + +     ++ L +  +    + YL        +HRD
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQF--LHRD 145

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL---GYLDPEYLQTCKLTDKS 582
           + + N L+++    KVSDFG S+ V  D     T   G+     +  PE L   K + KS
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKS 202

Query: 583 DVYSFGVVLVELLT-GKM 599
           D+++FGV++ E+ + GKM
Sbjct: 203 DIWAFGVLMWEIYSLGKM 220

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  118 bits (298), Expect = 7e-30
 Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 12/198 (6%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             IG G  G V+ G+  ++  VA+K  +       ++FI E  V+++++   +V+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 467 LETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
           LE     LV EF+ +G L +++   +G  + E  L +  +    ++YL  E  V  IHRD
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EEACV--IHRD 129

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL---GYLDPEYLQTCKLTDKS 582
           + + N L+ EN   KVSDFG ++ V  D     T   GT     +  PE     + + KS
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRYSSKS 186

Query: 583 DVYSFGVVLVELLT-GKM 599
           DV+SFGV++ E+ + GK+
Sbjct: 187 DVWSFGVLMWEVFSEGKI 204

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  118 bits (298), Expect = 7e-30
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 12/202 (5%)

Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLG 464
            IG G  G   K     D   +  K+  +  + +A+    ++E+ ++ ++   N+VR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 465 CCLETQVPLL--VYEFVGNGTLFEHI----HKKGNLSWERRLRITAETAGVLSYLHS--E 516
             ++     L  V E+   G L   I     ++  L  E  LR+  +    L   H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
               ++HRD+K AN+ LD     K+ DFG ++++  D     T V GT  Y+ PE +   
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191

Query: 577 KLTDKSDVYSFGVVLVELLTGK 598
              +KSD++S G +L EL    
Sbjct: 192 SYNEKSDIWSLGCLLYELCALM 213

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  119 bits (300), Expect = 7e-30
 Identities = 59/288 (20%), Positives = 109/288 (37%), Gaps = 49/288 (17%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAK-IDEFINELVVVLQINRRNVVRLLG 464
             +G GG G V++     D    A+K+ +  ++    ++ + E+  + ++    +VR   
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 465 CCLE---------TQVPLLVY---EFVGNGTLFEHI-HKKGNLSWERR--LRITAETAGV 509
             LE         +   + +Y   +      L + +  +      ER   L I  + A  
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV-----------PIDAIQNC 558
           + +LHS+    ++HRD+K +NI    +   KV DFG    +           P+ A    
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
           T   GT  Y+ PE +     + K D++S G++L ELL                    F +
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------------------PFST 229

Query: 619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
            +++ R L  + N        Q+      +    +S    ERP    +
Sbjct: 230 QMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  119 bits (300), Expect = 7e-30
 Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 40/304 (13%)

Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDR----TPVAVK--KSKFVDQAKIDEFINEL 448
                ++  ++ +VIG G  G VY G L D        AVK              F+ E 
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEG 77

Query: 449 VVVLQINRRNVVRLLGCCLETQVPLL-VYEFVGNGTLFEHIHK-KGNLSWERRLRITAET 506
           +++   +  NV+ LLG CL ++   L V  ++ +G L   I     N + +  +    + 
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC---TVVQG 563
           A  + YL +      +HRD+ + N +LDE  T KV+DFG ++      + +    +V   
Sbjct: 138 AKGMKYL-ASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD-----MYDKEYYSVHNK 189

Query: 564 TLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
           T   L       E LQT K T KSDV+SFGV+L EL+T         P  + +   +   
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTF-DITV 243

Query: 619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS 678
            L Q R L   +              + ++  +C   + E RP+  E+   +    S   
Sbjct: 244 YLLQGRRLLQPEY---------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294

Query: 679 NGQY 682
              Y
Sbjct: 295 GEHY 298

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  119 bits (299), Expect = 1e-29
 Identities = 60/279 (21%), Positives = 110/279 (39%), Gaps = 37/279 (13%)

Query: 408 VIGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
            +G GG   V     L D    A+K+    +Q   +E   E  +    N  N++RL+  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 467 LETQVP----LLVYEFVGNGTLFEHI----HKKGNLSWERRLRITAETAGVLSYLHSETN 518
           L  +       L+  F   GTL+  I     K   L+ ++ L +       L  +H++  
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-- 153

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQ------GTLGYLDP 570
               HRD+K  NILL +   P + D G+     + ++  +    +Q       T+ Y  P
Sbjct: 154 -GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 571 EYLQT---CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE 627
           E       C + +++DV+S G VL  ++ G+       P +      + + +L     L 
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG------PYDMVFQKGDSV-ALAVQNQLS 265

Query: 628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           I  +   +         + +L    ++V   +RP +  +
Sbjct: 266 IPQSPRHSS-------ALWQLLNSMMTVDPHQRPHIPLL 297

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  118 bits (297), Expect = 2e-29
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 13/227 (5%)

Query: 380 SKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQ 438
           S    +  +      E + +   N    V+G G  G VY G  L ++  +A+K+    D 
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 439 AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI-HKKGNLSWE 497
                   E+ +   +  +N+V+ LG   E     +  E V  G+L   +  K G L   
Sbjct: 61  RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120

Query: 498 RRL--RITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDA 554
            +     T +    L YLH      I+HRD+K  N+L++  +   K+SDFG SK   +  
Sbjct: 121 EQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAG 175

Query: 555 IQNCTV-VQGTLGYLDPEYLQTCKL--TDKSDVYSFGVVLVELLTGK 598
           I  CT    GTL Y+ PE +          +D++S G  ++E+ TGK
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  118 bits (298), Expect = 2e-29
 Identities = 72/300 (24%), Positives = 121/300 (40%), Gaps = 40/300 (13%)

Query: 392 IFTEEEIKTVTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSK-FVDQAKIDEFI 445
           +F +  +K         +G G  G V               VAVK  K          + 
Sbjct: 27  VFHKRYLK-----KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK 81

Query: 446 NELVVVLQINRRNVVRLLGCCLETQVP--LLVYEFVGNGTLFEHIHKKGNLSWERRLRIT 503
            E+ ++  +   ++++  GCC +       LV E+V  G+L +++  + ++   + L   
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFA 140

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
            +    ++YLH++     IHRD+ + N+LLD +   K+ DFG +K VP         V+ 
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRVRE 195

Query: 564 TLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
             G        PE L+  K    SDV+SFGV L ELLT   +  S   +    + +    
Sbjct: 196 D-GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-G 253

Query: 619 SLKQNRLLEILDNRIVNDGNKQQL-------KEVAKLAARCISVRGEERPTMKEVSLELQ 671
            +   RL E+L+         ++L        EV  L   C       RPT + +   L+
Sbjct: 254 QMTVLRLTELLERG-------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  122 bits (308), Expect = 2e-29
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 7/192 (3%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             +G G  G V+ G     T VA+K  K       + F+ E  V+ ++    +V+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 467 LETQVPLLVYEFVGNGTLFEHI--HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
            E  +  +V E++  G+L + +       L   + + + A+ A  ++Y+        +HR
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 387

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447

Query: 585 YSFGVVLVELLT 596
           +SFG++L EL T
Sbjct: 448 WSFGILLTELTT 459

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  117 bits (296), Expect = 3e-29
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 30/213 (14%)

Query: 407 DVIGCGGSGNVYKGFLPDR----TPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVV 460
            ++G G  G+V +  L         VAVK  K+  +  + I+EF+ E   + + +  +V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 461 RLLGCCLETQ------VPLLVYEFVGNGTLFEHI------HKKGNLSWERRLRITAETAG 508
           +L+G  L ++      +P+++  F+ +G L   +          NL  +  +R   + A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            + YL S  N   IHRD+ + N +L E+ T  V+DFG S+             QG    L
Sbjct: 149 GMEYL-SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCASKL 201

Query: 569 -----DPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                  E L     T  SDV++FGV + E++T
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  116 bits (293), Expect = 3e-29
 Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 49/278 (17%)

Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           +IG GG G V+K     D     +K+   V     ++   E+  + +++  N+V   GC 
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNN-EKAEREVKALAKLDHVNIVHYNGCW 73

Query: 467 LETQVPL----------------LVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAG 508
                                  +  EF   GTL + I K+    L     L +  +   
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133

Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL 568
            + Y+HS+    +I+RD+K +NI L +    K+ DFG    +  D  +  +   GTL Y+
Sbjct: 134 GVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLRYM 188

Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI 628
            PE + +     + D+Y+ G++L ELL             E S    F + L+   + +I
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELLHVC------DTAFETS---KFFTDLRDGIISDI 239

Query: 629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
            D            K+   L  + +S + E+RP   E+
Sbjct: 240 FD------------KKEKTLLQKLLSKKPEDRPNTSEI 265

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  116 bits (292), Expect = 7e-29
 Identities = 68/303 (22%), Positives = 117/303 (38%), Gaps = 44/303 (14%)

Query: 392 IFTEEEIKTVTNNYADVIGCGGSGNVYKGFLP-----DRTPVAVK--KSKFVDQAKIDEF 444
            F +  +K         +G G  G V               VAVK  K +       D  
Sbjct: 17  HFEKRFLK-----RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-L 70

Query: 445 INELVVVLQINRRNVVRLLGCCLETQV-PL-LVYEFVGNGTLFEHIHK-KGNLSWERRLR 501
             E+ ++  +   N+V+  G C E     + L+ EF+ +G+L E++ K K  ++ +++L+
Sbjct: 71  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
              +    + YL S      +HRD+ + N+L++     K+ DFG +K +  D  +    V
Sbjct: 131 YAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD--KEYYTV 185

Query: 562 QGTLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMN 615
           +            PE L   K    SDV+SFGV L ELLT       S        +   
Sbjct: 186 KDD-RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGP 242

Query: 616 FLSSLKQNRLLEILDNRIVNDGNKQQL-------KEVAKLAARCISVRGEERPTMKEVSL 668
               +   RL+  L          ++L        EV +L  +C   +   R + + +  
Sbjct: 243 THGQMTVTRLVNTLKEG-------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

Query: 669 ELQ 671
             +
Sbjct: 296 GFE 298

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  116 bits (293), Expect = 8e-29
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 29/212 (13%)

Query: 407 DVIGCGGSGNVYKGFLPDR----TPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVV 460
            ++G G  G+V +G L         VAVK  K     Q +I+EF++E   +   +  NV+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 461 RLLGCCLETQ-----VPLLVYEFVGNGTLFEHI------HKKGNLSWERRLRITAETAGV 509
           RLLG C+E        P+++  F+  G L  ++          ++  +  L+   + A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL- 568
           + YL S  N   +HRD+ + N +L ++ T  V+DFG SK             QG +  + 
Sbjct: 160 MEYL-SNRN--FLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAKMP 212

Query: 569 ----DPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                 E L     T KSDV++FGV + E+ T
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  118 bits (298), Expect = 1e-28
 Identities = 60/273 (21%), Positives = 106/273 (38%), Gaps = 34/273 (12%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR-RNVVRLLGC 465
           DV+G G  G +    + D   VAVK+   +          E+ ++ + +   NV+R    
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVIRYFCT 86

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR-ITAETAGVLSYLHSETNVPIIHR 524
             + Q   +  E     TL E++ +K           +  +T   L++LHS     I+HR
Sbjct: 87  EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHR 142

Query: 525 DVKSANILLDE-----NCTPKVSDFGASKLVPID--AIQNCTVVQGTLGYLDPEYLQTC- 576
           D+K  NIL+            +SDFG  K + +   +    + V GT G++ PE L    
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202

Query: 577 --KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV 634
               T   D++S G V   +++          + +     N L        L    +   
Sbjct: 203 KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANILLGACSLDCLHPEKH--- 255

Query: 635 NDGNKQQLKEVAK-LAARCISVRGEERPTMKEV 666
                     +A+ L  + I++  ++RP+ K V
Sbjct: 256 -------EDVIARELIEKMIAMDPQKRPSAKHV 281

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  115 bits (290), Expect = 1e-28
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 20/216 (9%)

Query: 395 EEEIKTVTNNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSK---FVDQAKIDEFINE 447
           E++++ +     + +G G  G V +G           VAVK  K         +D+FI E
Sbjct: 17  EKDLRLL-----EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71

Query: 448 LVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAET 506
           +  +  ++ RN++RL G  L   +  +V E    G+L + + K +G+       R   + 
Sbjct: 72  VNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
           A  + YL        IHRD+ + N+LL      K+ DFG  + +P +           + 
Sbjct: 131 AEGMGYL-ESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187

Query: 567 Y--LDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKM 599
           +    PE L+T   +  SD + FGV L E+ T G+ 
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  115 bits (289), Expect = 1e-28
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 14/197 (7%)

Query: 408 VIGCGGSGNVYKG-FLPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
            +G G  GNVY      ++  +A+K   KS+   +    +   E+ +   +   N++R+ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 464 GCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
                 +  + L+ EF   G L++ + K G    +R      E A  L Y H      +I
Sbjct: 81  NY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VI 136

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDK 581
           HRD+K  N+L+      K++DFG S   P    +  C    GTL YL PE ++     +K
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEGKTHDEK 192

Query: 582 SDVYSFGVVLVELLTGK 598
            D++  GV+  E L G 
Sbjct: 193 VDLWCAGVLCYEFLVGM 209

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  115 bits (291), Expect = 2e-28
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 20/206 (9%)

Query: 407 DVIGCGGSGNVYKGFLPDR----TPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVV 460
            +IG G SG V  G L        PVA+K  K+ + ++ + D F++E  ++ Q +  N++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNII 113

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNV 519
           RL G     ++ ++V E++ NG+L   +    G  +  + + +       + YL S+   
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDLGY 172

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL-----DPEYLQ 574
             +HRD+ + N+L+D N   KVSDFG S+++  D          T G +      PE + 
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD---PDAAYTTTGGKIPIRWTAPEAIA 227

Query: 575 TCKLTDKSDVYSFGVVLVELLT-GKM 599
               +  SDV+SFGVV+ E+L  G+ 
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGER 253

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  116 bits (292), Expect = 2e-28
 Identities = 44/224 (19%), Positives = 80/224 (35%), Gaps = 45/224 (20%)

Query: 408 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKFVDQAKI----DEFINELVVVLQINR 456
            +  G    +               A+K   KS    +       ++ I+          
Sbjct: 38  TLNQGKFNKIILCEKDNKF-----YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92

Query: 457 ----------RNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAE 505
                        +   G  +     + ++YE++ N ++ +       L       I  +
Sbjct: 93  ELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 506 TAGV--------LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ- 556
                        SY+H+E N  I HRDVK +NIL+D+N   K+SDFG S+ +    I+ 
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209

Query: 557 NCTVVQGTLGYLDPEYLQTCKLTD--KSDVYSFGVVLVELLTGK 598
           +     GT  ++ PE+       +  K D++S G+ L  +    
Sbjct: 210 SR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  115 bits (290), Expect = 3e-28
 Identities = 63/205 (30%), Positives = 109/205 (53%), Gaps = 17/205 (8%)

Query: 407 DVIGCGGSGNVYKGFL-----PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
            VIG G  G VYKG L         PVA+K  K+ + ++ ++D F+ E  ++ Q +  N+
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 108

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETN 518
           +RL G   + +  +++ E++ NG L + + +  G  S  + + +    A  + YL +  N
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-ANMN 167

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT---LGYLDPEYLQT 575
              +HRD+ + NIL++ N   KVSDFG S+++  D  +      G    + +  PE +  
Sbjct: 168 Y--VHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAISY 224

Query: 576 CKLTDKSDVYSFGVVLVELLT-GKM 599
            K T  SDV+SFG+V+ E++T G+ 
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGER 249

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (290), Expect = 4e-28
 Identities = 33/298 (11%), Positives = 74/298 (24%), Gaps = 53/298 (17%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           + +  G    V+    +      A+K         +++++          ++   +    
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 463 LGCCLETQVP--------------------------LLVYEFVG------NGTLFEHIHK 490
                                               LL+             TL      
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 491 KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV 550
           +G+        +TA+   + + L S+    ++H      N+ +  +    + D  A   V
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 551 PIDAIQNCTVVQGTLGYLDPEYLQ--TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
                         + Y   E+L   T   T   + +  G+ +  +    +      P  
Sbjct: 245 G----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300

Query: 609 ERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           + S     L     + L       + +         V  L  R ++     R    E 
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPD--------FVKTLIGRFLNFDRRRRLLPLEA 350

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  115 bits (291), Expect = 4e-28
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 20/206 (9%)

Query: 407 DVIGCGGSGNVYKGFLP----DRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVV 460
            V+G G  G V  G L         VA+K  K  + ++ + D F+ E  ++ Q +  N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNII 109

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNV 519
           RL G   +++  ++V E++ NG+L   + K     +  + + +    A  + YL S+   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL-SDMGY 168

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL-----DPEYLQ 574
             +HRD+ + NIL++ N   KVSDFG  +++  D            G +      PE + 
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDD---PEAAYTTRGGKIPIRWTSPEAIA 223

Query: 575 TCKLTDKSDVYSFGVVLVELLT-GKM 599
             K T  SDV+S+G+VL E+++ G+ 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGER 249

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  113 bits (284), Expect = 7e-28
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 13/196 (6%)

Query: 409 IGCGGSGNVYKGFL---PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           +GCG  G+V +G       +  VA+K  K         +E + E  ++ Q++   +VRL+
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYIVRLI 76

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G C    + +LV E  G G L + +   +  +       +  + +  + YL  E N   +
Sbjct: 77  GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN--FV 132

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL--GYLDPEYLQTCKLTD 580
           HRD+ + N+LL      K+SDFG SK +  D         G     +  PE +   K + 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192

Query: 581 KSDVYSFGVVLVELLT 596
           +SDV+S+GV + E L+
Sbjct: 193 RSDVWSYGVTMWEALS 208

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  113 bits (284), Expect = 7e-28
 Identities = 55/192 (28%), Positives = 100/192 (52%), Gaps = 8/192 (4%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G SG VY    +     VA+++     Q K +  INE++V+ +    N+V  L   L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 468 ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
                 +V E++  G+L + +  +  +   +   +  E    L +LHS     +IHRD+K
Sbjct: 88  VGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIK 143

Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           S NILL  + + K++DFG  +++ P  + ++ T+V GT  ++ PE +       K D++S
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMV-GTPYWMAPEVVTRKAYGPKVDIWS 201

Query: 587 FGVVLVELLTGK 598
            G++ +E++ G+
Sbjct: 202 LGIMAIEMIEGE 213

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  112 bits (283), Expect = 8e-28
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 35/204 (17%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             IG G  G+V  G       VAVK  K  + A    F+ E  V+ Q+   N+V+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDYRG-NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 467 LETQVPL-LVYEFVGNGTLFEHI--HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           +E +  L +V E++  G+L +++    +  L  +  L+ + +    + YL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140

Query: 524 RDVKSANILLDENCTPKVSDFGASKLV---------PID--AIQNCTVVQGTLGYLDPEY 572
           RD+ + N+L+ E+   KVSDFG +K           P+   A               PE 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA---------------PEA 185

Query: 573 LQTCKLTDKSDVYSFGVVLVELLT 596
           L+  K + KSDV+SFG++L E+ +
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYS 209

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (289), Expect = 9e-28
 Identities = 26/234 (11%), Positives = 62/234 (26%), Gaps = 45/234 (19%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINE--------------- 447
            V+G        +           V     ++      I +   E               
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 448 -------LVVVLQINRRNVVRLLGCCLETQVPLLVYEFV-----------GNGTLFEHIH 489
                  +     +      +++   L+ +   ++  F                L  H  
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
              +L    RL++T +   +L+ LH      ++H  ++  +I+LD+     ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 550 VPIDAIQNCTVVQGTLGYLDPEYL-----QTCKLTDKSDVYSFGVVLVELLTGK 598
               A+                 L         +T   D ++ G+ +  +    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  112 bits (282), Expect = 1e-27
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 22/202 (10%)

Query: 407 DVIGCGGSGNVYKGFLPD----RTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVV 460
             IG G  G+V++G           VA+K  K+   D  + ++F+ E + + Q +  ++V
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIV 79

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNV 519
           +L+G   E  V  ++ E    G L   +   K +L     +    + +  L+YL      
Sbjct: 80  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKR- 136

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL-----DPEYLQ 574
             +HRD+ + N+L+  N   K+ DFG S+      +++ T  + + G L      PE + 
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKLPIKWMAPESIN 190

Query: 575 TCKLTDKSDVYSFGVVLVELLT 596
             + T  SDV+ FGV + E+L 
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  112 bits (282), Expect = 1e-27
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 23/206 (11%)

Query: 407 DVIGCGGSGNVYKGFL----PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVV 460
            ++G G  G VY+G       ++  VAVK  K       K ++F++E V++  ++  ++V
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPHIV 76

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNV 519
           +L+G   E     ++ E    G L  ++ + K +L     +  + +    ++YL    N 
Sbjct: 77  KLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL-ESINC 134

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL-----DPEYLQ 574
             +HRD+   NIL+      K+ DFG S+      I++    + ++  L      PE + 
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRY-----IEDEDYYKASVTRLPIKWMSPESIN 187

Query: 575 TCKLTDKSDVYSFGVVLVELLT-GKM 599
             + T  SDV+ F V + E+L+ GK 
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQ 213

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (284), Expect = 1e-27
 Identities = 78/315 (24%), Positives = 132/315 (41%), Gaps = 48/315 (15%)

Query: 408 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
            +G G  G VY+G           T VA+K        + +I+ F+NE  V+ + N  +V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHV 90

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTL----------FEHIHKKGNLSWERRLRITAETAGV 509
           VRLLG   + Q  L++ E +  G L            +       S  + +++  E A  
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL- 568
           ++YL++      +HRD+ + N ++ E+ T K+ DFG ++    D  +     +G  G L 
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 203

Query: 569 ----DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR 624
                PE L+    T  SDV+SFGVVL E+ T     L+++P +  S     L  + +  
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQPYQGLS-NEQVLRFVMEGG 257

Query: 625 LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYYL 684
           LL+  DN             + +L   C     + RP+  E+   ++  +        + 
Sbjct: 258 LLDKPDN---------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308

Query: 685 RDNVESNGVQETEYF 699
               E N + E E  
Sbjct: 309 YS--EENKLPEPEEL 321

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  115 bits (290), Expect = 1e-27
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 35/204 (17%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             IG G  G+V  G       VAVK  K  + A    F+ E  V+ Q+   N+V+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDYRG-NKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 467 LETQVPL-LVYEFVGNGTLFEHI--HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
           +E +  L +V E++  G+L +++    +  L  +  L+ + +    + YL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312

Query: 524 RDVKSANILLDENCTPKVSDFGASKLV---------PID--AIQNCTVVQGTLGYLDPEY 572
           RD+ + N+L+ E+   KVSDFG +K           P+   A               PE 
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA---------------PEA 357

Query: 573 LQTCKLTDKSDVYSFGVVLVELLT 596
           L+  K + KSDV+SFG++L E+ +
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYS 381

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  112 bits (282), Expect = 2e-27
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           D++G G + NV++G         A+K      F+    +D  + E  V+ ++N +N+V+L
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKL 72

Query: 463 LGC--CLETQVPLLVYEFVGNGTLFEHIHKKGNLSW--ERRLR-ITAETAGVLSYLHSET 517
                   T+  +L+ EF   G+L+  + +  N     E     +  +  G +++L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132

Query: 518 NVPIIHRDVKSANILL----DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL 573
              I+HR++K  NI+     D     K++DFGA++ +  D  +    + GT  YL P+  
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMY 187

Query: 574 QTCKLTD--------KSDVYSFGVVLVELLTGK 598
           +   L            D++S GV      TG 
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  116 bits (292), Expect = 3e-27
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 11/196 (5%)

Query: 408 VIGCGGSGNVYKGFLP---DRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLL 463
            +GCG  G+V +G       +  VA+K  K   ++A  +E + E  ++ Q++   +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPII 522
           G C    + +LV E  G G L + +   +  +       +  + +  + YL  E N   +
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN--FV 458

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGY--LDPEYLQTCKLTD 580
           HR++ + N+LL      K+SDFG SK +  D         G        PE +   K + 
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 581 KSDVYSFGVVLVELLT 596
           +SDV+S+GV + E L+
Sbjct: 519 RSDVWSYGVTMWEALS 534

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  112 bits (282), Expect = 3e-27
 Identities = 69/308 (22%), Positives = 121/308 (39%), Gaps = 57/308 (18%)

Query: 408 VIGCGGSGNVYKGFLPD--------RTPVAVK--KSKFVDQAKIDEFINELVVVLQINR- 456
            +G G  G V                  VAVK  K    ++   D  ++E+ ++  I + 
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKH 100

Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTL----------------FEHIHKKGNLSWERRL 500
           +N++ LLG C +     ++ E+   G L                  +   +  ++++  +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV 560
             T + A  + YL +      IHRD+ + N+L+ EN   K++DFG ++    D       
Sbjct: 161 SCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 213

Query: 561 VQGTLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAM 614
            + T G L      PE L     T +SDV+SFGV++ E+ T G        P        
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS------PYPGIP-VE 266

Query: 615 NFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL 674
                LK+   ++   N            E+  +   C      +RPT K++  +L   L
Sbjct: 267 ELFKLLKEGHRMDKPAN---------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317

Query: 675 SLMSNGQY 682
           +L +N +Y
Sbjct: 318 TLTTNEEY 325

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  112 bits (281), Expect = 3e-27
 Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 8/192 (4%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL 467
           IG G +G V           VAVK      Q + +   NE+V++      NVV +    L
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 468 ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVK 527
             +   ++ EF+  G L + I  +  L+ E+   +       L+YLH++    +IHRD+K
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIK 168

Query: 528 SANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
           S +ILL  +   K+SDFG  +++      +  ++V GT  ++ PE +       + D++S
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRK-SLV-GTPYWMAPEVISRSLYATEVDIWS 226

Query: 587 FGVVLVELLTGK 598
            G++++E++ G+
Sbjct: 227 LGIMVIEMVDGE 238

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  116 bits (291), Expect = 4e-27
 Identities = 52/202 (25%), Positives = 93/202 (46%), Gaps = 22/202 (10%)

Query: 407 DVIGCGGSGNVYKGFLPDR----TPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVV 460
             IG G  G+V++G           VA+K  K+   D  + ++F+ E + + Q +  ++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIV 454

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNV 519
           +L+G   E  V  ++ E    G L   +   K +L     +    + +  L+YL      
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL-ESKR- 511

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL-----DPEYLQ 574
             +HRD+ + N+L+  N   K+ DFG S+      +++ T  + + G L      PE + 
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRY-----MEDSTYYKASKGKLPIKWMAPESIN 565

Query: 575 TCKLTDKSDVYSFGVVLVELLT 596
             + T  SDV+ FGV + E+L 
Sbjct: 566 FRRFTSASDVWMFGVCMWEILM 587

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  112 bits (281), Expect = 5e-27
 Identities = 43/252 (17%), Positives = 74/252 (29%), Gaps = 31/252 (12%)

Query: 375 LRQELSKLHGQSSEKAK---IFTEEEIKTVTNNYA--DVIGCGGSGNVYKGFLPDRTPVA 429
           L + +S        + K   I  + E +  +       ++G G    VY+    D     
Sbjct: 34  LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93

Query: 430 VKKS---KFVDQAKIDEF---INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT 483
            K+    K    A   EF      +  +    +   ++     L     +LV E    GT
Sbjct: 94  NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153

Query: 484 LFEHIHKKGNLSWER-----RLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT 538
           L   I+   N   +       +        ++  +H      IIH D+K  N +L     
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFL 210

Query: 539 P-----------KVSDFGASK-LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYS 586
                        + D G S  +         T    T G+   E L       + D + 
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270

Query: 587 FGVVLVELLTGK 598
               +  +L G 
Sbjct: 271 VAATVYCMLFGT 282

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (282), Expect = 5e-27
 Identities = 35/240 (14%), Positives = 68/240 (28%), Gaps = 56/240 (23%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK--------KSKFVDQAK----------------- 440
            V+G        +           V          S  + Q K                 
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 441 ---IDEFINELVVVLQINRRNVVRLLGCCLETQVP---LLVYEFVGN-----GTLFEHIH 489
                 FI    +V    ++ ++R+     +  V     L      N       L  H  
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL 549
              +L    RL++T +   +L+ LH      ++H  ++  +I+LD+     ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254

Query: 550 VPIDAIQNCTVVQGTLGYLDPEYLQT-----------CKLTDKSDVYSFGVVLVELLTGK 598
                     V   + G+  PE                 +T   D ++ G+V+  +    
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  115 bits (290), Expect = 5e-27
 Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 27/248 (10%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           + +G GG G V +         VA+K+  + +     + +  E+ ++ ++N  NVV    
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR- 78

Query: 465 CCLETQ-------VPLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLH 514
              +         +PLL  E+   G L +++++  N   L       + ++ +  L YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 515 SETNVPIIHRDVKSANILLDENCTP---KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
                 IIHRD+K  NI+L         K+ D G +K +     + CT   GTL YL PE
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAPE 193

Query: 572 YLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN 631
            L+  K T   D +SFG +  E +TG        P       + +   +++     I+  
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFR------PFLPNWQPVQWHGKVREKSNEHIVVY 247

Query: 632 RIVNDGNK 639
             +    K
Sbjct: 248 DDLTGAVK 255

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  114 bits (287), Expect = 6e-27
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 15/218 (6%)

Query: 391 KIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEF 444
            +F +      ++ Y    V+G G  G V            AVK   K +   +   +  
Sbjct: 14  GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITA 504
           + E+ ++ Q++  N+++L     +     LV E    G LF+ I  +   S     RI  
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133

Query: 505 ETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVV 561
           +    ++Y+H      I+HRD+K  N+LL    ++   ++ DFG S     +A +     
Sbjct: 134 QVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDK 188

Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
            GT  Y+ PE L      +K DV+S GV+L  LL+G  
Sbjct: 189 IGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCP 225

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  111 bits (279), Expect = 6e-27
 Identities = 65/217 (29%), Positives = 92/217 (42%), Gaps = 38/217 (17%)

Query: 407 DVIGCGGSGNVYKGFL---PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINR-RNVV 460
           DVIG G  G V K  +     R   A+K  K         D F  EL V+ ++    N++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 89

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS--------- 511
            LLG C       L  E+  +G L + + K   L  +    I   TA  LS         
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 512 -------YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT 564
                  YL S+     IHRD+ + NIL+ EN   K++DFG S+            V+ T
Sbjct: 150 DVARGMDYL-SQKQ--FIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 199

Query: 565 LGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           +G L       E L     T  SDV+S+GV+L E+++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (278), Expect = 7e-27
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 22/228 (9%)

Query: 376 RQELSKLHGQSSEK--AKIFTEEEIKTVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKK 432
           R++L KL   S  K   ++F   E           +G G  G+VYK         VA+K+
Sbjct: 12  RRQLKKLDEDSLTKQPEEVFDVLE----------KLGEGSYGSVYKAIHKETGQIVAIKQ 61

Query: 433 SKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG 492
                   + E I E+ ++ Q +  +VV+  G   +     +V E+ G G++ + I  + 
Sbjct: 62  VPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN 119

Query: 493 NLSWERRLR-ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLV 550
               E  +  I   T   L YLH       IHRD+K+ NILL+     K++DFG A +L 
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176

Query: 551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
              A +N TV+ GT  ++ PE +Q       +D++S G+  +E+  GK
Sbjct: 177 DTMAKRN-TVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  110 bits (277), Expect = 9e-27
 Identities = 73/304 (24%), Positives = 111/304 (36%), Gaps = 55/304 (18%)

Query: 408 VIGCGGSGNVYKGFL------PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINR-RN 458
            +G G  G V +              VAVK  K            ++EL +++ I    N
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGHHLN 92

Query: 459 VVRLLGCCLETQVPLLV-YEFVGNGTL----------------FEHIHKKGNLSWERRLR 501
           VV LLG C +   PL+V  EF   G L                      K  L+ E  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
            + + A  + +L +      IHRD+ + NILL E    K+ DFG ++    D  ++   V
Sbjct: 153 YSFQVAKGMEFL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYV 205

Query: 562 QGTLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMN 615
           +     L      PE +     T +SDV+SFGV+L E+ + G        P     +   
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVKIDEE 259

Query: 616 FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS 675
           F   LK+   +   D             E+ +    C      +RPT  E+   L   L 
Sbjct: 260 FCRRLKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

Query: 676 LMSN 679
             + 
Sbjct: 311 ANAQ 314

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  111 bits (279), Expect = 1e-26
 Identities = 65/313 (20%), Positives = 114/313 (36%), Gaps = 61/313 (19%)

Query: 408 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKFVDQAKIDEFINELVVVLQINR-RN 458
           V+G G  G V                VAVK  K K     +    ++EL ++ Q+    N
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHEN 110

Query: 459 VVRLLGCCLETQVPLLVYEFVGNGTL-----------------------FEHIHKKGNLS 495
           +V LLG C  +    L++E+   G L                        E       L+
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
           +E  L    + A  + +L    +   +HRD+ + N+L+      K+ DFG ++    D +
Sbjct: 171 FEDLLCFAYQVAKGMEFL-EFKS--CVHRDLAARNVLVTHGKVVKICDFGLAR----DIM 223

Query: 556 QNCTVVQGTLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEE 609
            +   V      L      PE L     T KSDV+S+G++L E+ + G        P   
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------PYPG 277

Query: 610 RSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE 669
             +  NF   ++    ++               +E+  +   C +    +RP+   ++  
Sbjct: 278 IPVDANFYKLIQNGFKMDQPFY---------ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

Query: 670 LQGRLSLMSNGQY 682
           L  +L+      Y
Sbjct: 329 LGCQLADAEEAMY 341

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  113 bits (285), Expect = 1e-26
 Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 16/232 (6%)

Query: 377 QELSKLHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK-- 431
           +E     G       +F   +   ++  Y     +G G  G V            A+K  
Sbjct: 11  RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70

Query: 432 -KSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK 490
            K+  V  +   + + E+ V+  ++  N+++L     + +   LV E    G LF+ I  
Sbjct: 71  RKTS-VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129

Query: 491 KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGAS 547
           +   +      I  +    ++YLH      I+HRD+K  N+LL   +++   K+ DFG S
Sbjct: 130 RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186

Query: 548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
            +   +  +      GT  Y+ PE L+  K  +K DV+S GV+L  LL G  
Sbjct: 187 AV--FENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYP 235

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  109 bits (275), Expect = 1e-26
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 9/195 (4%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLG 464
           + IG G  G V+KG     +  VA+K       + +I++   E+ V+ Q +   V +  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
             L+     ++ E++G G+    + + G L   +   I  E    L YLHSE     IHR
Sbjct: 88  SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEK---KIHR 143

Query: 525 DVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           D+K+AN+LL E+   K++DFG A +L      +N T V GT  ++ PE ++      K+D
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN-TFV-GTPFWMAPEVIKQSAYDSKAD 201

Query: 584 VYSFGVVLVELLTGK 598
           ++S G+  +EL  G+
Sbjct: 202 IWSLGITAIELARGE 216

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (279), Expect = 2e-26
 Identities = 59/303 (19%), Positives = 117/303 (38%), Gaps = 40/303 (13%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           D++G G + NV++G         A+K      F+    +D  + E  V+ ++N +N+V+L
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKL 72

Query: 463 LGC--CLETQVPLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSET 517
                   T+  +L+ EF   G+L+  + +  N   L     L +  +  G +++L    
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132

Query: 518 NVPIIHRDVKSANILL----DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL 573
              I+HR++K  NI+     D     K++DFGA++ +  D  +    + GT  YL P+  
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMY 187

Query: 574 QTCKLTD--------KSDVYSFGVVLVELLTGK------------MALLSDKPEEERSLA 613
           +   L            D++S GV      TG               ++      + S A
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR 673
           ++ +   +   +    D  +    ++     +  + A  +    E+     +   E    
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

Query: 674 LSL 676
           L  
Sbjct: 308 LHR 310

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  110 bits (277), Expect = 2e-26
 Identities = 77/323 (23%), Positives = 134/323 (41%), Gaps = 47/323 (14%)

Query: 377 QELSKLHGQSSEKAKIF--TEEEIKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKK- 432
           Q+  +L    ++K K+    +++ + +       +G G  G V+K    P    +A K  
Sbjct: 12  QQRKRLEAFLTQKQKVGELKDDDFEKI-----SELGAGNGGVVFKVSHKPSGLVMARKLI 66

Query: 433 SKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKG 492
              +  A  ++ I EL V+ + N   +V   G         +  E +  G+L + + KK 
Sbjct: 67  HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKA 125

Query: 493 NLSWERRL-RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS-KLV 550
               E+ L +++      L+YL  +    I+HRDVK +NIL++     K+ DFG S +L+
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183

Query: 551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK------------ 598
             D++ N + V GT  Y+ PE LQ    + +SD++S G+ LVE+  G+            
Sbjct: 184 --DSMAN-SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239

Query: 599 -----------MALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL----- 642
                                 R L    + S     + E+LD  IVN+   +       
Sbjct: 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD-YIVNEPPPKLPSGVFS 298

Query: 643 KEVAKLAARCISVRGEERPTMKE 665
            E      +C+     ER  +K+
Sbjct: 299 LEFQDFVNKCLIKNPAERADLKQ 321

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  110 bits (277), Expect = 2e-26
 Identities = 68/304 (22%), Positives = 120/304 (39%), Gaps = 55/304 (18%)

Query: 408 VIGCGGSGNVYKGFL--------PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINR- 456
            +G G  G V              +   VAVK  K    ++   D  ++E+ ++  I + 
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKH 146

Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTL----------------FEHIHKKGNLSWERRL 500
           +N++ LLG C +     ++ E+   G L                  +   +  ++++  +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV 560
             T + A  + YL +      IHRD+ + N+L+ EN   K++DFG ++    D       
Sbjct: 207 SCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 259

Query: 561 VQGTLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN 615
            + T G L      PE L     T +SDV+SFGV++ E+ T     L   P         
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-----LGGSPYPGIP-VEE 313

Query: 616 FLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS 675
               LK+   ++   N            E+  +   C      +RPT K++  +L   L+
Sbjct: 314 LFKLLKEGHRMDKPAN---------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364

Query: 676 LMSN 679
           L +N
Sbjct: 365 LTTN 368

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  107 bits (269), Expect = 6e-26
 Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 11/196 (5%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +G G    VY+   +     VA+K   K        +    NE+ +  Q+   +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLR-ITAETAGVLSYLHSETNVPII 522
              E    + LV E   NG +  ++  +     E   R    +    + YLHS     I+
Sbjct: 79  Y-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---IL 134

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+  +N+LL  N   K++DFG +  + +   ++ T+  GT  Y+ PE         +S
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHGLES 193

Query: 583 DVYSFGVVLVELLTGK 598
           DV+S G +   LL G+
Sbjct: 194 DVWSLGCMFYTLLIGR 209

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  109 bits (274), Expect = 7e-26
 Identities = 76/327 (23%), Positives = 127/327 (38%), Gaps = 59/327 (18%)

Query: 408 VIGCGGSGNVYKGFLPD--------RTPVAVK--KSKFVDQAKIDEFINELVVVLQINR- 456
            +G G  G V                T VAVK  KS   ++   D  I+E+ ++  I + 
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGKH 134

Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTL----------------FEHIHKKGNLSWERRL 500
           +N++ LLG C +     ++ E+   G L                    + +  LS +  +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV 560
               + A  + YL +      IHRD+ + N+L+ E+   K++DFG ++    D       
Sbjct: 195 SCAYQVARGMEYL-ASKK--CIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247

Query: 561 VQGTLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAM 614
            + T G L      PE L     T +SDV+SFGV+L E+ T G        P     +  
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------PYPGVPVE- 300

Query: 615 NFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL 674
                LK+   ++   N            E+  +   C      +RPT K++  +L   +
Sbjct: 301 ELFKLLKEGHRMDKPSN---------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351

Query: 675 SLMSNGQ--YYLRDNVESNGVQETEYF 699
           +L SN +  YY   +     +  TE  
Sbjct: 352 ALTSNQEMGYYHHHHHHDYDIPTTENL 378

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  107 bits (269), Expect = 7e-26
 Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 10/195 (5%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +G GG    ++      +   A K   KS  +   + ++   E+ +   +  ++VV   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
              E    + +V E     +L E   ++  L+         +      YLH      +IH
Sbjct: 83  F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIH 138

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+K  N+ L+E+   K+ DFG +  V  D  +   +  GT  Y+ PE L     + + D
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEVD 197

Query: 584 VYSFGVVLVELLTGK 598
           V+S G ++  LL GK
Sbjct: 198 VWSIGCIMYTLLVGK 212

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  107 bits (269), Expect = 7e-26
 Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 18/204 (8%)

Query: 407 DVIGCGGSGNVYKG-FLPDRTPVAVKKSKF-VDQAKIDEFINELVVVL-QINRRNVVRLL 463
             +G G  G V K   +P    +AVK+ +  V+  +    + +L + +  ++    V   
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 464 GCCL-ETQVPLLVYEFVGNGT--LFEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNV 519
           G    E  V  +  E +       ++ +  KG    E  L +I       L +LHS+ + 
Sbjct: 73  GALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 130

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYLDPE----YLQ 574
            +IHRDVK +N+L++     K+ DFG S  LV  D +       G   Y+ PE     L 
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDA-GCKPYMAPERINPELN 186

Query: 575 TCKLTDKSDVYSFGVVLVELLTGK 598
               + KSD++S G+ ++EL   +
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILR 210

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  108 bits (271), Expect = 8e-26
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 31/212 (14%)

Query: 408 VIGCGGSGNVYKGFL------PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
            +G G  G VY+G +      P    VAVK       +Q ++D F+ E +++ + N +N+
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNI 95

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFE-------HIHKKGNLSWERRLRITAETAGVLSY 512
           VR +G  L++    ++ E +  G L            +  +L+    L +  + A    Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 513 LHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL- 568
           L  E +   IHRD+ + N LL         K+ DFG ++    D  +     +G    L 
Sbjct: 156 L-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLP 208

Query: 569 ----DPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                PE       T K+D +SFGV+L E+ +
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  108 bits (271), Expect = 8e-26
 Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 12/196 (6%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +G GG    ++      +   A K   KS  +   + ++   E+ +   +  ++VV   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGNLS-WERRLRITAETAGVLSYLHSETNVPII 522
              E    + +V E     +L E   ++  L+  E R     +      YLH      +I
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VI 163

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+K  N+ L+E+   K+ DFG +  V  D  +   +  GT  Y+ PE L     + + 
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEV 222

Query: 583 DVYSFGVVLVELLTGK 598
           DV+S G ++  LL GK
Sbjct: 223 DVWSIGCIMYTLLVGK 238

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (268), Expect = 1e-25
 Identities = 45/200 (22%), Positives = 97/200 (48%), Gaps = 13/200 (6%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
             +G G  G VYK          A K  +   + +++++I E+ ++   +   +V+LLG 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR-ITAETAGVLSYLHSETNVPIIHR 524
                   ++ EF   G +   + +      E +++ +  +    L++LHS+    IIHR
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHR 141

Query: 525 DVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD--- 580
           D+K+ N+L+      +++DFG ++K +     ++ + + GT  ++ PE +    + D   
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD-SFI-GTPYWMAPEVVMCETMKDTPY 199

Query: 581 --KSDVYSFGVVLVELLTGK 598
             K+D++S G+ L+E+   +
Sbjct: 200 DYKADIWSLGITLIEMAQIE 219

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  106 bits (268), Expect = 1e-25
 Identities = 67/305 (21%), Positives = 113/305 (37%), Gaps = 56/305 (18%)

Query: 408 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKFVDQAKIDEFINELVVVLQINR-RN 458
            +G G  G V +              VAVK  K       +    ++EL V+  +    N
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHMN 88

Query: 459 VVRLLGCCLETQVPLLVYEFVGNGTL------------------FEHIHKKGNLSWERRL 500
           +V LLG C      L++ E+   G L                        +  L  E  L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV 560
             + + A  +++L +  N   IHRD+ + NILL      K+ DFG ++    D   +   
Sbjct: 149 SFSYQVAKGMAFL-ASKN--CIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSNY 201

Query: 561 VQGTLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAM 614
           V      L      PE +  C  T +SDV+S+G+ L EL + G        P     +  
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------PYPGMPVDS 255

Query: 615 NFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL 674
            F   +K+   +   ++            E+  +   C      +RPT K++   ++ ++
Sbjct: 256 KFYKMIKEGFRMLSPEH--APA-------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

Query: 675 SLMSN 679
           S  +N
Sbjct: 307 SESTN 311

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  108 bits (271), Expect = 1e-25
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 31/212 (14%)

Query: 408 VIGCGGSGNVYKGFL------PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
            +G G  G VY+G +      P    VAVK       +Q ++D F+ E +++ + N +N+
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNI 136

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFE-------HIHKKGNLSWERRLRITAETAGVLSY 512
           VR +G  L++    ++ E +  G L            +  +L+    L +  + A    Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 513 LHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYL- 568
           L  E +   IHRD+ + N LL         K+ DFG ++    D  +     +G    L 
Sbjct: 197 L-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLP 249

Query: 569 ----DPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                PE       T K+D +SFGV+L E+ +
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (268), Expect = 1e-25
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 45/226 (19%)

Query: 408 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
            +G G  G V K            T VAVK  K         D  ++E  V+ Q+N  +V
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQVNHPHV 88

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTL------------------------FEHIHKKGNLS 495
           ++L G C +    LL+ E+   G+L                              +  L+
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
               +    + +  + YL +E    ++HRD+ + NIL+ E    K+SDFG S+    D  
Sbjct: 149 MGDLISFAWQISQGMQYL-AEMK--LVHRDLAARNILVAEGRKMKISDFGLSR----DVY 201

Query: 556 QNCTVVQGTLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT 596
           +  + V+ + G +       E L     T +SDV+SFGV+L E++T
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  107 bits (268), Expect = 2e-25
 Identities = 66/231 (28%), Positives = 102/231 (44%), Gaps = 25/231 (10%)

Query: 385 QSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKG-FLPDRTPVAVKK-SKFVDQAK 440
           +SS K KI  E+       +      IG G  G+V K    P    +AVK+    VD+ +
Sbjct: 4   ESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE 63

Query: 441 IDEFINELVVVL-QINRRNVVRLLGCCL-ETQVPLLVYEFVGNGTLFEHIHKKGNLSWER 498
             + + +L VV+   +   +V+  G    E     +  E +     F+  +K      + 
Sbjct: 64  QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMELMSTS--FDKFYKYVYSVLDD 120

Query: 499 RL------RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS-KLVP 551
            +      +IT  T   L++L       IIHRD+K +NILLD +   K+ DFG S +LV 
Sbjct: 121 VIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV- 177

Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTD----KSDVYSFGVVLVELLTGK 598
            D+I       G   Y+ PE +           +SDV+S G+ L EL TG+
Sbjct: 178 -DSIAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  106 bits (267), Expect = 2e-25
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 36/217 (16%)

Query: 408 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKFVDQAKIDEFINELVVVLQINR-RN 458
            +G G  G V +              VAVK  KS      K    ++EL ++  + +  N
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHEN 111

Query: 459 VVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN--------------LSWERRLRITA 504
           +V LLG C      L++ E+   G L   + +K                 S    L  ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 505 ETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT 564
           + A  +++L +  N   IHRDV + N+LL      K+ DFG ++    D + +   +   
Sbjct: 172 QVAQGMAFL-ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKG 224

Query: 565 LGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT 596
              L      PE +  C  T +SDV+S+G++L E+ +
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  106 bits (266), Expect = 3e-25
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 34/219 (15%)

Query: 408 VIGCGGSGNVYKGFL------PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVR 461
            +G G  G V+           D+  VAVK  K   ++   +F  E  ++  +  +++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 462 LLGCCLETQVPLLVYEFVGNGTL---------------FEHIHKKGNLSWERRLRITAET 506
             G C E +  L+V+E++ +G L                      G L   + L + ++ 
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
           A  + YL +  +   +HRD+ + N L+ +    K+ DFG S+ +          V G   
Sbjct: 168 AAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGR-T 220

Query: 567 YL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT-GKM 599
            L      PE +   K T +SDV+SFGVVL E+ T GK 
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  105 bits (263), Expect = 4e-25
 Identities = 47/220 (21%), Positives = 85/220 (38%), Gaps = 36/220 (16%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDE--FINELVVVLQINR-RNVVRL 462
           + IG G  G+V+K     D    A+K+SK      +DE   + E+     + +  +VVR 
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSW---ERRLR-ITAETAGVLSYLHSETN 518
                E    L+  E+   G+L + I +   +     E  L+ +  +    L Y+HS + 
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS- 135

Query: 519 VPIIHRDVKSANILLDEN-------------------CTPKVSDFGASKLVPIDAIQNCT 559
             ++H D+K +NI +                         K+ D G         I +  
Sbjct: 136 --LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-----ISSPQ 188

Query: 560 VVQGTLGYLDPEYLQ-TCKLTDKSDVYSFGVVLVELLTGK 598
           V +G   +L  E LQ       K+D+++  + +V     +
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  105 bits (263), Expect = 7e-25
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 16/202 (7%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKF-VDQAKIDEFINELVVVL-QINRRNVVRLL 463
             +G G  G V+K         +AVK+ +   ++ +    + +L VVL   +   +V+  
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRL-RITAETAGVLSYLHSETNVPII 522
           G  +      +  E +G          +G +  ER L ++T      L YL  +    +I
Sbjct: 91  GTFITNTDVFIAMELMGTCAEKLKKRMQGPIP-ERILGKMTVAIVKALYYLKEKHG--VI 147

Query: 523 HRDVKSANILLDENCTPKVSDFGAS-KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD- 580
           HRDVK +NILLDE    K+ DFG S +LV  D         G   Y+ PE +     T  
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSA-GCAAYMAPERIDPPDPTKP 204

Query: 581 ----KSDVYSFGVVLVELLTGK 598
               ++DV+S G+ LVEL TG+
Sbjct: 205 DYDIRADVWSLGISLVELATGQ 226

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  106 bits (267), Expect = 9e-25
 Identities = 69/294 (23%), Positives = 109/294 (37%), Gaps = 55/294 (18%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQ--INRRNVVRLLG 464
            ++G G SG V         PVAVK+   +     D  + E + +L    +  NV+R   
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALME-IKLLTESDDHPNVIRYY- 75

Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV-------LSYLHSE 516
           C   T   L +  E      L + +  K       +L+       +       +++LHS 
Sbjct: 76  CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134

Query: 517 TNVPIIHRDVKSANILLD-------------ENCTPKVSDFGASKLVPIDAIQNCTVVQ- 562
               IIHRD+K  NIL+              EN    +SDFG  K +        T +  
Sbjct: 135 K---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191

Query: 563 --GTLGYLDPEYLQ-------TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA 613
             GT G+  PE L+         +LT   D++S G V   +L+       DK   E    
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---- 247

Query: 614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAK-LAARCISVRGEERPTMKEV 666
            N +  +     ++ L +R +           A  L ++ I     +RPT  +V
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAE--------ATDLISQMIDHDPLKRPTAMKV 293

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (260), Expect = 1e-24
 Identities = 48/222 (21%), Positives = 85/222 (38%), Gaps = 47/222 (21%)

Query: 407 DVIGCGGSGNVYKGFL--------PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN 458
           + +G G    ++KG             T V +K      +   + F     ++ +++ ++
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 459 VVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSET 517
           +V   G C+     +LV EFV  G+L  ++ K K  ++   +L +  + A  + +L  E 
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL-EEN 132

Query: 518 NVPIIHRDVKSANILLD--------ENCTPKVSDFGASKLV--------PID--AIQNCT 559
            +  IH +V + NILL              K+SD G S  V         I         
Sbjct: 133 TL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP----- 185

Query: 560 VVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLT-GKM 599
                     PE ++  K     +D +SFG  L E+ + G  
Sbjct: 186 ----------PECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  103 bits (260), Expect = 1e-24
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 35/219 (15%)

Query: 409 IGCGGSGNVYKGFL------PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           +G G  G V+           D+  VAVK  K    A   +F  E  ++  +   ++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 463 LGCCLETQVPLLVYEFVGNGTLFE----------------HIHKKGNLSWERRLRITAET 506
            G C +    ++V+E++ +G L +                    KG L   + L I ++ 
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
           A  + YL +  +   +HRD+ + N L+  N   K+ DFG S+ V            G   
Sbjct: 143 ASGMVYL-ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDV----YSTDYYRVGGHT 195

Query: 567 YL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT-GKM 599
            L      PE +   K T +SDV+SFGV+L E+ T GK 
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  107 bits (268), Expect = 1e-24
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 20/225 (8%)

Query: 383 HGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFV 436
           H   S   +    +   T    Y    ++G G  G V K      +   AVK   K+   
Sbjct: 4   HHHHSSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-A 60

Query: 437 DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSW 496
                   + E+ ++ +++  N+++L     ++    +V E    G LF+ I K+   S 
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS- 119

Query: 497 ERR-LRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPI 552
           E    RI  +    ++Y+H      I+HRD+K  NILL   +++C  K+ DFG S     
Sbjct: 120 EHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--F 174

Query: 553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
                     GT  Y+ PE L+     +K DV+S GV+L  LL+G
Sbjct: 175 QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG 218

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  102 bits (256), Expect = 4e-24
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 37/218 (16%)

Query: 408 VIGCGGSGNVYKGFL------PDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
            +G    G VYKG L           VA+K  K K     + + F +E ++  ++   NV
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHPNV 74

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTL----------------FEHIHKKGNLSWERRLRIT 503
           V LLG   + Q   +++ +  +G L                 +    K  L     + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
           A+ A  + YL S  +  ++H+D+ + N+L+ +    K+SD G  +   + A     +   
Sbjct: 135 AQIAAGMEYL-SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFRE--VYAADYYKL--L 187

Query: 564 TLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT 596
               L      PE +   K +  SD++S+GVVL E+ +
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (259), Expect = 6e-24
 Identities = 49/238 (20%), Positives = 77/238 (32%), Gaps = 22/238 (9%)

Query: 379 LSKLHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGS--GNVYKGF-LPDRTPVAVKKS 433
           ++  H    E                Y    VIG G      V      P    V V++ 
Sbjct: 1   MAHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI 60

Query: 434 KFVDQAK--IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFE--HIH 489
                +   +     EL V    N  N+V      +      +V  F+  G+  +    H
Sbjct: 61  NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH 120

Query: 490 KKGNLSWERRLR-ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG-AS 547
               ++ E  +  I       L Y+H       +HR VK+++IL+  +    +S      
Sbjct: 121 FMDGMN-ELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176

Query: 548 KLVPIDAIQNCTVVQ-----GTLGYLDPEYLQTCKL--TDKSDVYSFGVVLVELLTGK 598
            ++     Q             L +L PE LQ        KSD+YS G+   EL  G 
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  102 bits (255), Expect = 9e-24
 Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 46/290 (15%)

Query: 408 VIGCGGSGNVYKG-FLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR-RNVVRLLGC 465
           V+  GG   VY+   +      A+K+    ++ K    I E+  + +++   N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 466 CLETQVP-------LLVYEFVGNGTLFEHIHK---KGNLSWERRLRITAETAGVLSYLHS 515
               +          L+   +  G L E + K   +G LS +  L+I  +T   + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ-----------GT 564
           +   PIIHRD+K  N+LL    T K+ DFG++  +      + +  +            T
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 565 LGYLDPE---YLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK 621
             Y  PE         + +K D+++ G +L  L   +       P E+ +          
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH------PFEDGA---------- 257

Query: 622 QNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
               L I++ +     +  Q      L    + V  EER ++ EV  +LQ
Sbjct: 258 ---KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  104 bits (262), Expect = 9e-24
 Identities = 59/228 (25%), Positives = 94/228 (41%), Gaps = 27/228 (11%)

Query: 392 IFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVD-------- 437
           ++  ++   +  +Y     +G G  G V         +  A+K   KS+F          
Sbjct: 25  MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84

Query: 438 --QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
             +   +E  NE+ ++  ++  N+++L     + +   LV EF   G LFE I  +    
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144

Query: 496 WERR-LRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVP 551
            E     I  +    + YLH      I+HRD+K  NILL   +     K+ DFG S    
Sbjct: 145 -ECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF-- 198

Query: 552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
                      GT  Y+ PE L+  K  +K DV+S GV++  LL G  
Sbjct: 199 FSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  101 bits (254), Expect = 1e-23
 Identities = 53/305 (17%), Positives = 104/305 (34%), Gaps = 40/305 (13%)

Query: 381 KLHGQSSEKAKIFTEEEIKTVTN--NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ 438
           +L  +   + K+  E +                       K            +S     
Sbjct: 40  RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL 99

Query: 439 AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY---EFVGNGTLFEHIHKKGNLS 495
           +         V + +++  +    +G    +   + +Y   +      L + ++++ +L 
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159

Query: 496 WERR---LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG------- 545
                  L I  + A  + +LHS+    ++HRD+K +NI    +   KV DFG       
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216

Query: 546 ----ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL 601
                + L P+ A    T   GT  Y+ PE +     + K D++S G++L ELL      
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF--- 273

Query: 602 LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP 661
                + ER             R++  + N        Q+  +   +    +S    ERP
Sbjct: 274 ---STQMERV------------RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318

Query: 662 TMKEV 666
              ++
Sbjct: 319 EATDI 323

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (252), Expect = 2e-23
 Identities = 75/276 (27%), Positives = 118/276 (42%), Gaps = 29/276 (10%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +VIG G +  V   +  P +  VA+K+      Q  +DE + E+  + Q +  N+V    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR---------ITAETAGVLSYLHS 515
             +      LV + +  G++   I K      E +           I  E    L YLH 
Sbjct: 81  SFVVKDELWLVMKLLSGGSVL-DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNC----TVVQGTLGYLDP 570
                 IHRDVK+ NILL E+ + +++DFG ++ L     I       T V GT  ++ P
Sbjct: 140 NG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAP 195

Query: 571 EYLQTCKLTD-KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL 629
           E ++  +  D K+D++SFG+  +EL TG  A     P       M  L    QN    + 
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGA-APYHKYP------PMKVLMLTLQNDPPSLE 248

Query: 630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKE 665
                 +  K+  K   K+ + C+    E+RPT  E
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (250), Expect = 2e-23
 Identities = 36/260 (13%), Positives = 76/260 (29%), Gaps = 49/260 (18%)

Query: 407 DVIGCGGSGNVYKGF--LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
              G       ++      DR  VA+        +    + E ++  + + +I++  V R
Sbjct: 37  IFHGGVPPLQFWQALDTALDR-QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           +L         L+V E++  G+L E      + S    +R     A      H      +
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRA---GV 150

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
                  + + +  +    ++                     T+   +P+          
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYP------------------ATMPDANPQ---------- 182

Query: 582 SDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ 641
            D+   G  L  LL  +  L         + A    +        + ++   ++     Q
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAG-------QPIEPADIDRDIPFQ 235

Query: 642 LKEVAKLAARCISVRGEERP 661
           +  V   AAR +   G  R 
Sbjct: 236 ISAV---AARSVQGDGGIRS 252

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  100 bits (252), Expect = 2e-23
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR-RNVVRLLG 464
           +++G G  G VYKG  +      A+K    V   + +E   E+ ++ + +  RN+    G
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYG 88

Query: 465 CCLETQVPL------LVYEFVGNGTLFE--HIHKKGNLSWERRLR-ITAETAGVLSYLHS 515
             ++   P       LV EF G G++ +     K   L  E  +  I  E    LS+LH 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK-EEWIAYICREILRGLSHLHQ 147

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQ 574
                +IHRD+K  N+LL EN   K+ DFG +++L      +N T + GT  ++ PE + 
Sbjct: 148 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-TFI-GTPYWMAPEVIA 202

Query: 575 TCKLTD-----KSDVYSFGVVLVELLTGK 598
             +  D     KSD++S G+  +E+  G 
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGA 231

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  100 bits (251), Expect = 4e-23
 Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 45/226 (19%)

Query: 408 VIGCGGSGNVYKGFLPD------RTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNV 459
            IG G  G V++   P        T VAVK  K +     + D F  E  ++ + +  N+
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPNI 112

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTL------------------------FEHIHKKGNLS 495
           V+LLG C   +   L++E++  G L                                 LS
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
              +L I  + A  ++YL SE     +HRD+ + N L+ EN   K++DFG S+    +  
Sbjct: 173 CAEQLCIARQVAAGMAYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSR----NIY 225

Query: 556 QNCTVVQGTLGYL-----DPEYLQTCKLTDKSDVYSFGVVLVELLT 596
                       +      PE +   + T +SDV+++GVVL E+ +
Sbjct: 226 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 17/200 (8%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEF---INELVVVLQINRRNVVRL 462
             IG G  G VY    + +   VA+KK  +  +   +++   I E+  + ++   N ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            GC L      LV E+            K  L       +T      L+YLHS     +I
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MI 176

Query: 523 HRDVKSANILLDENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD- 580
           HRDVK+ NILL E    K+ DFG AS + P +     + V GT  ++ PE +        
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-----SFV-GTPYWMAPEVILAMDEGQY 230

Query: 581 --KSDVYSFGVVLVELLTGK 598
             K DV+S G+  +EL   K
Sbjct: 231 DGKVDVWSLGITCIELAERK 250

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (250), Expect = 1e-22
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 27/208 (12%)

Query: 408 VIGCGGSGNVYKGFLPDRT---PVAVK---KSKFV-----DQAKIDEFINELVVVLQINR 456
            +G G  G V   F  +R     VA++   K KF      +         E+ ++ ++N 
Sbjct: 142 TLGSGACGEVKLAF--ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR-ITAETAGVLSYLHS 515
             ++++           +V E +  G LF+ +     L  E   +    +    + YLH 
Sbjct: 200 PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK-EATCKLYFYQMLLAVQYLHE 257

Query: 516 ETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
                IIHRD+K  N+LL   +E+C  K++DFG SK++   ++   T+  GT  YL PE 
Sbjct: 258 NG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-TLC-GTPTYLAPEV 312

Query: 573 LQTCKL---TDKSDVYSFGVVLVELLTG 597
           L +          D +S GV+L   L+G
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSG 340

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 16/225 (7%)

Query: 382 LHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKF 435
           +H      +         T    Y    ++G G  G V K      +   AVK   K+  
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS- 59

Query: 436 VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLS 495
                    + E+ ++ +++  N+++L     ++    +V E    G LF+ I K+   S
Sbjct: 60  AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS 119

Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPI 552
                RI  +    ++Y+H      I+HRD+K  NILL   +++C  K+ DFG S     
Sbjct: 120 EHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--F 174

Query: 553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
                     GT  Y+ PE L+     +K DV+S GV+L  LL+G
Sbjct: 175 QQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 98.0 bits (244), Expect = 3e-22
 Identities = 58/271 (21%), Positives = 92/271 (33%), Gaps = 58/271 (21%)

Query: 383 HGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK-----KSK 434
           H  S  +   F    +  +   Y     IG G  G V        R   A+K     K +
Sbjct: 6   HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65

Query: 435 FVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNL 494
            ++   ++    E+ ++ +++  N+ RL     + Q   LV E    G L + ++   + 
Sbjct: 66  QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125

Query: 495 SWERRLRITAETA----------------------------------------GVLSYLH 514
           S  +      +T                                           L YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185

Query: 515 SETNVPIIHRDVKSANILL--DENCTPKVSDFGASKLVPI---DAIQNCTVVQGTLGYLD 569
           ++    I HRD+K  N L   +++   K+ DFG SK             T   GT  ++ 
Sbjct: 186 NQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

Query: 570 PEYLQTC--KLTDKSDVYSFGVVLVELLTGK 598
           PE L T       K D +S GV+L  LL G 
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 97.9 bits (244), Expect = 6e-22
 Identities = 54/206 (26%), Positives = 80/206 (38%), Gaps = 23/206 (11%)

Query: 408 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVV 460
           VIG G    V     K         A+K   K   + + ++  F  E  V++  +RR + 
Sbjct: 68  VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124

Query: 461 RLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETN 518
           +L     + +  L LV E+   G L   + K G        R   AE    +  +H    
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG- 182

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
              +HRD+K  NILLD     +++DFG+   +  D      V  GT  YL PE LQ    
Sbjct: 183 --YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240

Query: 579 TDKSDVY-------SFGVVLVELLTG 597
              +  Y       + GV   E+  G
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYG 266

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 95.3 bits (238), Expect = 1e-21
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 20/199 (10%)

Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           V+G G    V+           A+K   KS     + ++   NE+ V+ +I   N+V L 
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72

Query: 464 GCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLR-ITAETAGVLSYLHSETNVPI 521
               E+     LV + V  G LF+ I ++G  + E+    +  +    + YLH      I
Sbjct: 73  DIY-ESTTHYYLVMQLVSGGELFDRILERGVYT-EKDASLVIQQVLSAVKYLHENG---I 127

Query: 522 IHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
           +HRD+K  N+L    +EN    ++DFG SK+     +   T   GT GY+ PE L     
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS--TAC-GTPGYVAPEVLAQKPY 184

Query: 579 TDKSDVYSFGVVLVELLTG 597
           +   D +S GV+   LL G
Sbjct: 185 SKAVDCWSIGVITYILLCG 203

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 22/203 (10%)

Query: 408 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVV 460
           ++G G    V               A+K   K   + + K+     E  V+ +++    V
Sbjct: 37  ILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93

Query: 461 RLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETN 518
           +L     +    L     +  NG L ++I K G+   E   R  TAE    L YLH +  
Sbjct: 94  KLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRFYTAEIVSALEYLHGKG- 150

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTVVQGTLGYLDPEYLQTC 576
             IIHRD+K  NILL+E+   +++DFG +K++  ++ Q    + V GT  Y+ PE L   
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPELLTE- 206

Query: 577 KLTDKS-DVYSFGVVLVELLTGK 598
           K   KS D+++ G ++ +L+ G 
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGL 229

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 19/200 (9%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           IG G    V     +     VA+K   K++ ++   + +   E+ ++  +N  N+V+L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHPNIVKLFE 81

Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             +ET+  L L+ E+   G +F+++   G +  +       +    + Y H +    I+H
Sbjct: 82  V-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVH 137

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTVVQGTLGYLDPEYLQTCKLTD- 580
           RD+K+ N+LLD +   K++DFG S    +    +  C    G   Y  PE  Q  K  D 
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAPELFQG-KKYDG 192

Query: 581 -KSDVYSFGVVLVELLTGKM 599
            + DV+S GV+L  L++G +
Sbjct: 193 PEVDVWSLGVILYTLVSGSL 212

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 24/208 (11%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFIN-ELVVVLQINRRNVVR 461
           D++G G  G V +          AVK   K K       +  +  E+ ++ ++  +NV++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 462 LLG-CCLETQVPL-LVYEFVGNGT--LFEHIHKKGNLSWE-RRL---RITAETAGVLSYL 513
           L+     E +  + +V E+   G   + + + +K     +        I       L YL
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG-----LEYL 125

Query: 514 HSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTLGYLDPEY 572
           HS+    I+H+D+K  N+LL    T K+S  G ++ +   A  + C   QG+  +  PE 
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 573 LQTCKLTD--KSDVYSFGVVLVELLTGK 598
                     K D++S GV L  + TG 
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 93.6 bits (233), Expect = 6e-21
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 34/212 (16%)

Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFIN---ELVVVLQIN--RRN 458
           ++G GG G+VY G  + D  PVA+K   K +  D  ++        E+V++ +++     
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 459 VVRLLGCCLETQVPL-LVYEFV-GNGTLFEHIHKKGNLSWERRLR------ITAETAGVL 510
           V+RLL    E      L+ E       LF+ I ++G L  E   R      + A     +
Sbjct: 110 VIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSFFWQVLEA-----V 162

Query: 511 SYLHSETNVPIIHRDVKSANILLDEN-CTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
            + H+     ++HRD+K  NIL+D N    K+ DFG+  L+  D     T   GT  Y  
Sbjct: 163 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-D--TVYTDFDGTRVYSP 216

Query: 570 PEYLQTCKLTD--KSDVYSFGVVLVELLTGKM 599
           PE+++         + V+S G++L +++ G +
Sbjct: 217 PEWIR-YHRYHGRSAAVWSLGILLYDMVCGDI 247

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 92.7 bits (231), Expect = 7e-21
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 26/219 (11%)

Query: 399 KTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKID------EFIN 446
                NY   +++G G S  V +    P     AVK    +     +  +        + 
Sbjct: 13  HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72

Query: 447 ELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAE 505
           E+ ++ +++   N+++L           LV++ +  G LF+++ +K  LS E+  R    
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS-EKETRKIMR 131

Query: 506 T-AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT 564
               V+  LH      I+HRD+K  NILLD++   K++DFG S    +D  +    V GT
Sbjct: 132 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGT 186

Query: 565 LGYLDPEYLQTCKLTDKS------DVYSFGVVLVELLTG 597
             YL PE ++     +        D++S GV++  LL G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 93.1 bits (232), Expect = 9e-21
 Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 14/197 (7%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLG 464
             +G G      K          AVK    + +        E+  +       N+V+L  
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQKEITALKLCEGHPNIVKLHE 73

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERR-LRITAETAGVLSYLHSETNVPIIH 523
              +     LV E +  G LFE I KK + S E     I  +    +S++H      ++H
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKKHFS-ETEASYIMRKLVSAVSHMHDVG---VVH 129

Query: 524 RDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
           RD+K  N+L    ++N   K+ DFG ++L P D     T    TL Y  PE L      +
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYDE 188

Query: 581 KSDVYSFGVVLVELLTG 597
             D++S GV+L  +L+G
Sbjct: 189 SCDLWSLGVILYTMLSG 205

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 29/219 (13%)

Query: 399 KTVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKFV-----DQAKIDEFI 445
           K + + Y     +G G  G V   F  +R     VA+K   K KF      +        
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAF--ERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63

Query: 446 NELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR-ITA 504
            E+ ++ ++N   ++++     + +   +V E +  G LF+ +     L  E   +    
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLK-EATCKLYFY 121

Query: 505 ETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVV 561
           +    + YLH      IIHRD+K  N+LL   +E+C  K++DFG SK++   ++   T+ 
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-TLC 177

Query: 562 QGTLGYLDPEYLQTCKL---TDKSDVYSFGVVLVELLTG 597
            GT  YL PE L +          D +S GV+L   L+G
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 17/228 (7%)

Query: 380 SKLHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KS 433
           S   GQ   +   F        ++NY   + +G G    V +          A K     
Sbjct: 6   SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65

Query: 434 KFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN 493
           K +      +   E  +  ++   N+VRL     E     LV++ V  G LFE I  +  
Sbjct: 66  K-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124

Query: 494 LSWERRLRITAET-AGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKL 549
            S E       +     ++Y HS     I+HR++K  N+LL    +    K++DFG +  
Sbjct: 125 YS-EADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

Query: 550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
             ++  +      GT GYL PE L+    +   D+++ GV+L  LL G
Sbjct: 181 --VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 50/205 (24%), Positives = 79/205 (38%), Gaps = 19/205 (9%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDE--FINELVVVLQINRRNVV 460
           +VIG G    V +          AVK    +KF     +       E  +   +   ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 461 RLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSW---ERRLRITAET-AGVLSYLHS 515
            LL     +   L +V+EF+    L   I K+ +  +   E             L Y H 
Sbjct: 90  ELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 516 ETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
                IIHRDVK   +LL   + +   K+  FG +  +    +     V GT  ++ PE 
Sbjct: 149 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEV 204

Query: 573 LQTCKLTDKSDVYSFGVVLVELLTG 597
           ++        DV+  GV+L  LL+G
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSG 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 57/209 (27%), Positives = 82/209 (39%), Gaps = 39/209 (18%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFIN----ELVVVLQINRRNVVRLL 463
           +G G  G V           VAVK    VD  +  +       E+ +   +N  NVV+  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 464 GCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLR------ITAETAGVLSYLHSE 516
           G          L  E+   G LF+ I     +  E   +      +       + YLH  
Sbjct: 72  GH-RREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFFHQLMAG-----VVYLHGI 124

Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN------CTVVQGTLGYLDP 570
               I HRD+K  N+LLDE    K+SDFG + +      +       C    GTL Y+ P
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMC----GTLPYVAP 176

Query: 571 EYLQTCKLTD--KSDVYSFGVVLVELLTG 597
           E L+  +       DV+S G+VL  +L G
Sbjct: 177 ELLK-RREFHAEPVDVWSCGIVLTAMLAG 204

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 63/251 (25%), Positives = 110/251 (43%), Gaps = 38/251 (15%)

Query: 373 SILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVA 429
           S+L + L                ++ +     Y    ++G GG G V+ G  L DR  VA
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60

Query: 430 VK---KSKFVDQAKIDEFIN---ELVVVLQINRR----NVVRLLGCCLETQVPL-LVYEF 478
           +K   +++ +  + + + +    E+ ++ ++        V+RLL    ETQ    LV E 
Sbjct: 61  IKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLER 119

Query: 479 VGNGT-LFEHIHKKGNLSWERRLR------ITAETAGVLSYLHSETNVPIIHRDVKSANI 531
                 LF++I +KG L  E   R      + A     + + HS     ++HRD+K  NI
Sbjct: 120 PLPAQDLFDYITEKGPLG-EGPSRCFFGQVVAA-----IQHCHSRG---VVHRDIKDENI 170

Query: 532 LLD-ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD--KSDVYSFG 588
           L+D      K+ DFG+  L+  D  +  T   GT  Y  PE++          + V+S G
Sbjct: 171 LIDLRRGCAKLIDFGSGALLH-D--EPYTDFDGTRVYSPPEWISR-HQYHALPATVWSLG 226

Query: 589 VVLVELLTGKM 599
           ++L +++ G +
Sbjct: 227 ILLYDMVCGDI 237

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 51/199 (25%), Positives = 78/199 (39%), Gaps = 18/199 (9%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
           + IG G  G V        R   A K   K    D   +D F  E+ ++  ++  N++RL
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRL 71

Query: 463 LGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
                E    + LV E    G LFE +  K         RI  +    ++Y H      +
Sbjct: 72  YETF-EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---V 127

Query: 522 IHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
            HRD+K  N L      +   K+ DFG +        +      GT  Y+ P+ L+    
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKVGTPYYVSPQVLEG-LY 184

Query: 579 TDKSDVYSFGVVLVELLTG 597
             + D +S GV++  LL G
Sbjct: 185 GPECDEWSAGVMMYVLLCG 203

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 30/206 (14%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +G G  G V  G        VAVK   + K      + +   E+  +      ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLR------ITAETAGVLSYLHSET 517
             + T     +V E+V  G LF++I K G +  E   R      ++A     + Y H   
Sbjct: 79  V-ISTPTDFFMVMEYVSGGELFDYICKHGRVE-EMEARRLFQQILSA-----VDYCHRHM 131

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTVVQGTLGYLDPEYLQT 575
              ++HRD+K  N+LLD +   K++DFG S ++         C    G+  Y  PE +  
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVIS- 183

Query: 576 CKLTD--KSDVYSFGVVLVELLTGKM 599
            +L    + D++S GV+L  LL G +
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTL 209

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 29/212 (13%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQI-NRRNVVR 461
           DV+G G    V     L      AVK   K     ++++     E+ ++ Q    RNV+ 
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV---FREVEMLYQCQGHRNVLE 75

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERR-LRITAETAGVLSYLHSETNVP 520
           L+    E     LV+E +  G++  HIHK+ + + E     +  + A  L +LH++    
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN-ELEASVVVQDVASALDFLHNKG--- 131

Query: 521 IIHRDVKSANILL---DENCTPKVSDFGASKLV-------PIDAIQNCTVVQGTLGYLDP 570
           I HRD+K  NIL    ++    K+ DF     +       PI   +  T   G+  Y+ P
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAP 190

Query: 571 EYLQTCKLTDKS-----DVYSFGVVLVELLTG 597
           E ++             D++S GV+L  LL+G
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.0 bits (236), Expect = 3e-20
 Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 18/201 (8%)

Query: 408 VIGCGGSGNVYKGFLPDRTPV-AVK---KSKFVDQAKIDEFINE---LVVVLQINRRNVV 460
           +IG GG G VY     D   + A+K   K +   +      +NE   L +V   +   +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 461 RLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETN 518
            +      T   L  + + +  G L  H+ + G  S E  +R   AE    L ++H+   
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAEIILGLEHMHNRF- 312

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
             +++RD+K ANILLDE+   ++SD G +             V GT GY+ PE LQ    
Sbjct: 313 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVA 367

Query: 579 TDKS-DVYSFGVVLVELLTGK 598
            D S D +S G +L +LL G 
Sbjct: 368 YDSSADWFSLGCMLFKLLRGH 388

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 57/209 (27%), Positives = 82/209 (39%), Gaps = 39/209 (18%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFIN----ELVVVLQINRRNVVRLL 463
           +G G  G V           VAVK    VD  +  +       E+ +   +N  NVV+  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 464 GCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLR------ITAETAGVLSYLHSE 516
           G          L  E+   G LF+ I     +  E   +      +       + YLH  
Sbjct: 72  GH-RREGNIQYLFLEYCSGGELFDRIEPDIGMP-EPDAQRFFHQLMAG-----VVYLHGI 124

Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN------CTVVQGTLGYLDP 570
               I HRD+K  N+LLDE    K+SDFG + +      +       C    GTL Y+ P
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMC----GTLPYVAP 176

Query: 571 EYLQTCKLTD--KSDVYSFGVVLVELLTG 597
           E L+  +       DV+S G+VL  +L G
Sbjct: 177 ELLK-RREFHAEPVDVWSCGIVLTAMLAG 204

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 31/252 (12%)

Query: 368 EQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGFLPDR 425
           ++   +  +   +        + ++      K     Y   DVIG G S  V +     R
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCV--HR 116

Query: 426 T---PVAVK---KSKFVDQAKIDEFINELVVV-LQINRR-----NVVRLLGCCLETQVPL 473
                 AVK    +      +  E + E       I R+     +++ L+    E+   +
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFM 175

Query: 474 -LVYEFVGNGTLFEHIHKKGNLSWERRLRITAET-AGVLSYLHSETNVPIIHRDVKSANI 531
            LV++ +  G LF+++ +K  LS E+  R    +    +S+LH+     I+HRD+K  NI
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALS-EKETRSIMRSLLEAVSFLHANN---IVHRDLKPENI 231

Query: 532 LLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD------KSDVY 585
           LLD+N   ++SDFG S  +         +  GT GYL PE L+            + D++
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEKLR-ELC-GTPGYLAPEILKCSMDETHPGYGKEVDLW 289

Query: 586 SFGVVLVELLTG 597
           + GV+L  LL G
Sbjct: 290 ACGVILFTLLAG 301

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 20/204 (9%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFIN-----ELVVVLQINRRNV 459
           +G G  G V+          V VK   K K ++   I++        E+ ++ ++   N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 460 VRLLGCCLETQVPL-LVYEFVGNGT-LFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           +++L    E Q    LV E  G+G  LF  I +   L       I  +    + YL  + 
Sbjct: 92  IKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
              IIHRD+K  NI++ E+ T K+ DFG++  +    +       GT+ Y  PE L    
Sbjct: 151 ---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIEYCAPEVLM-GN 204

Query: 578 LTD--KSDVYSFGVVLVELLTGKM 599
                + +++S GV L  L+  + 
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEEN 228

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 25/231 (10%)

Query: 381 KLHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSK 434
             H   S   +    +   T+ + +     +G G  G+V+            +K   K +
Sbjct: 2   HHHHHHSSGRENLYFQ--GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR 59

Query: 435 FVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHI----H 489
              Q  +++   E+ V+  ++  N++++     E    + +V E    G L E I     
Sbjct: 60  S--QVPMEQIEAEIEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQA 116

Query: 490 KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGA 546
           +   LS      +  +    L+Y HS+    ++H+D+K  NIL      +   K+ DFG 
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGL 173

Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           ++L    + ++ T   GT  Y+ PE  +   +T K D++S GVV+  LLTG
Sbjct: 174 AEL--FKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTG 221

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 92.1 bits (229), Expect = 7e-20
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 21/204 (10%)

Query: 408 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVV 460
           VIG G  G V     K         A+K   K + + +A+   F  E  V++  + + + 
Sbjct: 81  VIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137

Query: 461 RLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETN 518
            L     +    L LV ++   G L   + K  +   E   R   AE    +  +H    
Sbjct: 138 TLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH- 195

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
              +HRD+K  NIL+D N   +++DFG+   +  D     +V  GT  Y+ PE LQ  + 
Sbjct: 196 --YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253

Query: 579 TDKS-----DVYSFGVVLVELLTG 597
                    D +S GV + E+L G
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYG 277

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)

Query: 399 KTVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKFVDQAKIDEFINELVV 450
              ++NY   + +G G    V +     +T     A K     K +      +   E  +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCV--HKTTGLEFAAKIINTKK-LSARDFQKLEREARI 58

Query: 451 VLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET-AGV 509
             ++   N+VRL     E     LV++ V  G LFE I  +   S E       +     
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-EADASHCIQQILES 117

Query: 510 LSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
           ++Y HS     I+HR++K  N+LL    +    K++DFG +    ++  +      GT G
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFAGTPG 172

Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           YL PE L+    +   D+++ GV+L  LL G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 91.4 bits (227), Expect = 2e-19
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 17/200 (8%)

Query: 408 VIGCGGSGNVYKGFLPDRTPV-AVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           V+G GG G V    +     + A K   K +   +      +NE  ++ ++N R VV L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249

Query: 464 GCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSW-ERRLRI-TAETAGVLSYLHSETNVP 520
               ET+  L LV   +  G L  HI+  G   + E R     AE    L  LH E    
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--- 306

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTVVQGTLGYLDPEYLQTCKL 578
           I++RD+K  NILLD++   ++SD G +  VP             GT+GY+ PE ++  + 
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV----GTVGYMAPEVVKNERY 362

Query: 579 TDKSDVYSFGVVLVELLTGK 598
           T   D ++ G +L E++ G+
Sbjct: 363 TFSPDWWALGCLLYEMIAGQ 382

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 90.4 bits (225), Expect = 2e-19
 Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 12/198 (6%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           + +G G    V +   +      A     +K +      +   E  +   +   N+VRL 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET-AGVLSYLHSETNVPII 522
               E     L+++ V  G LFE I  +   S E       +     + + H      ++
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYS-EADASHCIQQILEAVLHCHQMG---VV 132

Query: 523 HRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
           HR++K  N+LL    +    K++DFG +  V  +         GT GYL PE L+     
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKDPYG 191

Query: 580 DKSDVYSFGVVLVELLTG 597
              D+++ GV+L  LL G
Sbjct: 192 KPVDLWACGVILYILLVG 209

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 31/205 (15%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +G G  G V        +  VA+K   +              E+  +  +   ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLR------ITAETAGVLSYLHSET 517
             + T   + +V E+ G G LF++I +K  ++ E   R      I A     + Y H   
Sbjct: 77  V-ITTPTDIVMVIEYAG-GELFDYIVEKKRMT-EDEGRRFFQQIICA-----IEYCHRHK 128

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTVVQGTLGYLDPEYLQT 575
              I+HRD+K  N+LLD+N   K++DFG S ++         C    G+  Y  PE +  
Sbjct: 129 ---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVING 181

Query: 576 CKLTD--KSDVYSFGVVLVELLTGK 598
            KL    + DV+S G+VL  +L G+
Sbjct: 182 -KLYAGPEVDVWSCGIVLYVMLVGR 205

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 21/200 (10%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
             +G G +  VY+      + P A+K   K+             E+ V+L+++  N+++L
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKL 113

Query: 463 LGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAET-AGVLSYLHSETNVP 520
                ET   + LV E V  G LF+ I +KG  S ER      +     ++YLH      
Sbjct: 114 KEIF-ETPTEISLVLELVTGGELFDRIVEKGYYS-ERDAADAVKQILEAVAYLHENG--- 168

Query: 521 IIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
           I+HRD+K  N+L      +   K++DFG SK+  ++       V GT GY  PE L+ C 
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVCGTPGYCAPEILRGCA 226

Query: 578 LTDKSDVYSFGVVLVELLTG 597
              + D++S G++   LL G
Sbjct: 227 YGPEVDMWSVGIITYILLCG 246

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 26/216 (12%)

Query: 399 KTVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKFVDQAK---IDEFINE 447
           + V + Y   + +G G    V K    +++     A K   K +     +    +E   E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65

Query: 448 LVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           + ++ Q+   N++ L     E +  + L+ E V  G LF+ + +K +LS E       + 
Sbjct: 66  VSILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQ 123

Query: 507 -AGVLSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASKLVPIDAIQNCTVV 561
               ++YLH++    I H D+K  NI+L          K+ DFG +    I+       +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNI 178

Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
            GT  ++ PE +    L  ++D++S GV+   LL+G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 26/216 (12%)

Query: 399 KTVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKFV---DQAKIDEFINE 447
           + V + Y   + +G G    V K    +++     A K   K +          +E   E
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65

Query: 448 LVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           + ++ Q+   NV+ L     E +  + L+ E V  G LF+ + +K +LS E       + 
Sbjct: 66  VSILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQ 123

Query: 507 -AGVLSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASKLVPIDAIQNCTVV 561
               ++YLH++    I H D+K  NI+L          K+ DFG +    I+       +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNI 178

Query: 562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
            GT  ++ PE +    L  ++D++S GV+   LL+G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 27/231 (11%)

Query: 383 HGQSSEKAKIFTEEEIKT--VTNNY---ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFV 436
           H  SS    +F   E K   VT++Y     V+G G +G V + F        A+K     
Sbjct: 6   HHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-- 63

Query: 437 DQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVP----LLVYEFVGNGTLFEHIHKK 491
                 +   E+    Q +   ++V +L             L++ E +  G LF  I ++
Sbjct: 64  ---DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120

Query: 492 GNLSW-ERR-LRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGA 546
           G+ ++ ER    I  +    + +LHS     I HRDVK  N+L    +++   K++DFG 
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177

Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +K    +A+Q  T    T  Y+ PE L   K     D++S GV++  LL G
Sbjct: 178 AKETTQNALQ--TPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 26/215 (12%)

Query: 400 TVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKFVDQAK---IDEFINEL 448
            V ++Y   + +G G    V K     +      A K   K +     +    +E   E+
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCR--QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59

Query: 449 VVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERR-LRITAET 506
            ++ +I   N++ L     E +  + L+ E V  G LF+ + +K +L+ E    +   + 
Sbjct: 60  NILREIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLT-EDEATQFLKQI 117

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASKLVPIDAIQNCTVVQ 562
              + YLHS+    I H D+K  NI+L      N   K+ DFG +    I+A      + 
Sbjct: 118 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF 172

Query: 563 GTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           GT  ++ PE +    L  ++D++S GV+   LL+G
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 90.6 bits (225), Expect = 4e-19
 Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 14/200 (7%)

Query: 408 VIGCGGSGNVYKGFLPDRTPV-AVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           V+G GG G V+   +     + A K   K +   +      + E  ++ +++ R +V L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251

Query: 464 GCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSW---ERRLRI-TAETAGVLSYLHSETN 518
               ET+  L LV   +  G +  HI+     +    E R    TA+    L +LH    
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
             II+RD+K  N+LLD++   ++SD G +  +     +      GT G++ PE L   + 
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEY 366

Query: 579 TDKSDVYSFGVVLVELLTGK 598
               D ++ GV L E++  +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 14/131 (10%)

Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIHRDVKSANIL 532
           +V + +  G L  H+ +  +   E  +++   E    L YL ++    IIHRD+K  NIL
Sbjct: 92  MVVDLLLGGDLRYHLQQNVHFK-EETVKLFICELVMALDYLQNQR---IIHRDMKPDNIL 147

Query: 533 LDENCTPKVSDFGASKLVPIDAIQN--CTVVQGTLGYLDPEYLQTCKLT--DKS-DVYSF 587
           LDE+    ++DF  + ++P +           GT  Y+ PE   + K      + D +S 
Sbjct: 148 LDEHGHVHITDFNIAAMLPRETQITTMA----GTKPYMAPEMFSSRKGAGYSFAVDWWSL 203

Query: 588 GVVLVELLTGK 598
           GV   ELL G+
Sbjct: 204 GVTAYELLRGR 214

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 18/206 (8%)

Query: 401 VTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR- 456
            T+ Y   + IG G      +          AVK    +D++K D    E+ ++L+  + 
Sbjct: 20  FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPT-EEIEILLRYGQH 75

Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR-ITAETAGVLSYLHS 515
            N++ L     + +   +V E +  G L + I ++   S ER    +       + YLH+
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS-EREASAVLFTITKTVEYLHA 134

Query: 516 ETNVPIIHRDVKSANILL---DENCTP-KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           +    ++HRD+K +NIL      N    ++ DFG +K +  +     T    T  ++ PE
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE 190

Query: 572 YLQTCKLTDKSDVYSFGVVLVELLTG 597
            L+        D++S GV+L  +LTG
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTG 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 89.0 bits (221), Expect = 6e-19
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 22/203 (10%)

Query: 408 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVV 460
           VIG G  G V     K     R   A+K   K + + ++    F  E  ++   N   VV
Sbjct: 76  VIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132

Query: 461 RLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETN 518
           +L     +    L +V E++  G L   +    ++  E+  R  TAE    L  +HS   
Sbjct: 133 QLF-YAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVP-EKWARFYTAEVVLALDAIHSMG- 188

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
              IHRDVK  N+LLD++   K++DFG    +  + +  C    GT  Y+ PE L++   
Sbjct: 189 --FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246

Query: 579 T---DKS-DVYSFGVVLVELLTG 597
                +  D +S GV L E+L G
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVG 269

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 88.2 bits (219), Expect = 6e-19
 Identities = 62/203 (30%), Positives = 90/203 (44%), Gaps = 30/203 (14%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKI-DEFIN-ELVVVLQINRRNVVRLLGC 465
           IG G  G          +  VAVK   ++++    DE +  E++    +   N+VR    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVK---YIERGAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 466 CLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLR------ITAETAGVLSYLHSETN 518
            + T   L ++ E+   G L+E I   G  S E   R      ++      +SY HS   
Sbjct: 85  -ILTPTHLAIIMEYASGGELYERICNAGRFS-EDEARFFFQQLLSG-----VSYCHSMQ- 136

Query: 519 VPIIHRDVKSANILLDENCTP--KVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
             I HRD+K  N LLD +  P  K+ DFG SK   + +    TV  GT  Y+ PE L   
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLR- 191

Query: 577 KLTD--KSDVYSFGVVLVELLTG 597
           +  D   +DV+S GV L  +L G
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVG 214

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.1 bits (221), Expect = 8e-19
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 30/206 (14%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +G G  G V  G        VAVK   + K      + +   E+  +      ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 465 CCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLR------ITAETAGVLSYLHSET 517
             + T   + +V E+V  G LF++I K G L  E+  R      ++      + Y H   
Sbjct: 84  V-ISTPSDIFMVMEYVSGGELFDYICKNGRLD-EKESRRLFQQILSG-----VDYCHRHM 136

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTVVQGTLGYLDPEYLQT 575
              ++HRD+K  N+LLD +   K++DFG S ++         C    G+  Y  PE +  
Sbjct: 137 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVISG 189

Query: 576 CKLTD--KSDVYSFGVVLVELLTGKM 599
            +L    + D++S GV+L  LL G +
Sbjct: 190 -RLYAGPEVDIWSSGVILYALLCGTL 214

>1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Length = 86

 Score = 80.0 bits (198), Expect = 1e-18
 Identities = 22/88 (25%), Positives = 33/88 (37%), Gaps = 8/88 (9%)

Query: 235 CEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTH 294
           C  +        C       +T   + CKC++GYE    +   C D++EC+         
Sbjct: 6   CRISPDLCGRGQC------VNTPGDFECKCDEGYESGFMMMKNCMDIDECQRDPLLCRGG 59

Query: 295 ICDNIPGSYTCRCRKGFHGDGRKDGGGC 322
           +C N  GSY C C  G       +   C
Sbjct: 60  VCHNTEGSYRCECPPGHQLSP--NISAC 85

>1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Length = 86

 Score = 54.6 bits (132), Expect = 1e-09
 Identities = 11/44 (25%), Positives = 17/44 (38%), Gaps = 1/44 (2%)

Query: 280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCT 323
           D++EC           C N PG + C+C +G+          C 
Sbjct: 2   DIDECRISPDLCGRGQCVNTPGDFECKCDEGYESGF-MMMKNCM 44

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 66/238 (27%), Positives = 97/238 (40%), Gaps = 55/238 (23%)

Query: 403 NNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKI-------------DE 443
           N Y   D IG G  G V   +   D T  A+K   K K + QA                 
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 444 FINELVVVLQINR----------RNVVRL---LGCCLETQVPLLVYEFVGNGTLFEHIHK 490
            I     + Q+ +           NVV+L   L    E  +  +V+E V  G + E +  
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVME-VPT 130

Query: 491 KGNLSWERRLR------ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
              LS E + R      I       + YLH +    IIHRD+K +N+L+ E+   K++DF
Sbjct: 131 LKPLS-EDQARFYFQDLIKG-----IEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADF 181

Query: 545 GASKL-VPIDAIQNCTVVQGTLGYLDPEYLQTCKLT---DKSDVYSFGVVLVELLTGK 598
           G S      DA+ + TV  GT  ++ PE L   +        DV++ GV L   + G+
Sbjct: 182 GVSNEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 52/172 (30%), Positives = 80/172 (46%), Gaps = 7/172 (4%)

Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEH 487
            +KK   V + ++   + E  V+       +  L     +T   L  V E+   G LF H
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFH 238

Query: 488 IHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA 546
           + ++   S E R R   AE    L YLHSE N  +++RD+K  N++LD++   K++DFG 
Sbjct: 239 LSRERVFS-EDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGL 295

Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            K   I          GT  YL PE L+        D +  GVV+ E++ G+
Sbjct: 296 CKE-GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 26/214 (12%)

Query: 401 VTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVK---KSKFVDQAK---IDEFINELV 449
           V + Y   + +G G    V K    +++     A K   K +     +    ++   E+ 
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCR--EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 450 VVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERR-LRITAETA 507
           ++ +I   NV+ L     E +  + L+ E V  G LF+ + +K +L+ E        +  
Sbjct: 67  ILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLT-EEEATEFLKQIL 124

Query: 508 GVLSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
             + YLHS     I H D+K  NI+L          K+ DFG +    ID       + G
Sbjct: 125 NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIFG 179

Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           T  ++ PE +    L  ++D++S GV+   LL+G
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 84.8 bits (210), Expect = 1e-17
 Identities = 43/211 (20%), Positives = 89/211 (42%), Gaps = 23/211 (10%)

Query: 399 KTVTNNY--ADVIGCGGSGNVYKGFLPDRT---PVAVK---KSKFVDQAKIDEFINELVV 450
            +V + Y   + +G G  G V++    ++        K       +D        NE+ +
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCV--EKATGRVFVAKFINTPYPLD---KYTVKNEISI 101

Query: 451 VLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERR-LRITAETAG 508
           + Q++   ++ L     E +  + L+ EF+  G LF+ I  +     E   +    +   
Sbjct: 102 MNQLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160

Query: 509 VLSYLHSETNVPIIHRDVKSANILL--DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
            L ++H  +   I+H D+K  NI+    +  + K+ DFG +    ++  +   V   T  
Sbjct: 161 GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAE 215

Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           +  PE +    +   +D+++ GV+   LL+G
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 23/200 (11%)

Query: 408 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVV 460
            +G G  G V     K         A+K   K K V   +I+  +NE  ++  +N   +V
Sbjct: 48  TLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104

Query: 461 RLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETN 518
           +L     +    L +V E+V  G +F H+ + G  S E   R   A+      YLHS   
Sbjct: 105 KLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLD- 161

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
             +I+RD+K  N+L+D+    +V+DFG +K V       C    GT   L PE + + K 
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILS-KG 214

Query: 579 TDKS-DVYSFGVVLVELLTG 597
            +K+ D ++ GV++ E+  G
Sbjct: 215 YNKAVDWWALGVLIYEMAAG 234

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 50/214 (23%), Positives = 91/214 (42%), Gaps = 30/214 (14%)

Query: 399 KTVTNNY--ADVIGCGGSGNVYKGFLPDRTPVAVKKS-------KFVDQAKIDE--FINE 447
           K +   Y  A+ +G G  G V++          V+ S       KFV     D+     E
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHR---------CVETSSKKTYMAKFVKVKGTDQVLVKKE 51

Query: 448 LVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERR-LRITAE 505
           + ++     RN++ L     E+   L +++EF+    +FE I+       ER  +    +
Sbjct: 52  ISILNIARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILL--DENCTPKVSDFGASKLVPIDAIQNCTVVQG 563
               L +LHS     I H D++  NI+     + T K+ +FG ++   +    N  ++  
Sbjct: 111 VCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLFT 165

Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
              Y  PE  Q   ++  +D++S G ++  LL+G
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 48/205 (23%), Positives = 90/205 (43%), Gaps = 29/205 (14%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKS-------KFVDQAK---IDEFINELVVVLQINR 456
           +++G G  G V+K           + +       K +        +E  NE+ V+ Q++ 
Sbjct: 95  EILGGGRFGQVHK---------CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145

Query: 457 RNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERR-LRITAETAGVLSYLH 514
            N+++L     E++  + LV E+V  G LF+ I  +     E   +    +    + ++H
Sbjct: 146 ANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 515 SETNVPIIHRDVKSANILL--DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
                 I+H D+K  NIL    +    K+ DFG ++       +   V  GT  +L PE 
Sbjct: 205 QMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNFGTPEFLAPEV 259

Query: 573 LQTCKLTDKSDVYSFGVVLVELLTG 597
           +    ++  +D++S GV+   LL+G
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSG 284

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 23/203 (11%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR-RNVVRLLG 464
            V+G G +G V + F    +   A+K  +        +   E+ +  + ++  ++VR++ 
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVD 122

Query: 465 CCLETQVP-----LLVYEFVGNGTLFEHIHKKGNLSW-ERR-LRITAETAGVLSYLHSET 517
              E         L+V E +  G LF  I  +G+ ++ ER    I       + YLHS  
Sbjct: 123 VY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181

Query: 518 NVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQ 574
              I HRDVK  N+L      N   K++DFG +K        + T    T  Y+ PE L 
Sbjct: 182 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLG 236

Query: 575 TCKLTDKSDVYSFGVVLVELLTG 597
             K     D++S GV++  LL G
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCG 259

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 82.2 bits (204), Expect = 3e-17
 Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 14/199 (7%)

Query: 408 VIGCGGSGNVY---KGFLPDRTPV-AVK--KSKFVDQAKIDEFINELVVVLQINRRNVVR 461
           V+G G  G V+   K    D   + A+K  K   +          E  +++++N   +V+
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 462 LLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNV 519
           L     +T+  L L+ +F+  G LF  + K+   + E  ++   AE A  L +LHS    
Sbjct: 91  LH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLAELALALDHLHSLG-- 146

Query: 520 PIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
            II+RD+K  NILLDE    K++DFG SK   ID  +      GT+ Y+ PE +     T
Sbjct: 147 -IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204

Query: 580 DKSDVYSFGVVLVELLTGK 598
             +D +SFGV++ E+LTG 
Sbjct: 205 QSADWWSFGVLMFEMLTGT 223

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 25/225 (11%)

Query: 389 KAKIFTEEEIKTVTNNY---ADVIGCGGSGNVYKGFLPDRT---PVAVK--KSKFVDQAK 440
             +    + ++   N Y   +  +G G    V +     ++     A K  K +   Q  
Sbjct: 14  GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCI--SKSTGQEYAAKFLKKRRRGQDC 71

Query: 441 IDEFINELVVVLQIN-RRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKK--GNLSW 496
             E ++E+ V+        V+ L     E    + L+ E+   G +F     +    +S 
Sbjct: 72  RAEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVS- 129

Query: 497 ERR-LRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPI 552
           E   +R+  +    + YLH      I+H D+K  NILL         K+ DFG S+   I
Sbjct: 130 ENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--I 184

Query: 553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
                   + GT  YL PE L    +T  +D+++ G++   LLT 
Sbjct: 185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 43/128 (33%), Positives = 68/128 (53%), Gaps = 7/128 (5%)

Query: 474 LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIHRDVKSANIL 532
           L+ +++  G LF H+ ++   + E  ++I   E    L +LH      II+RD+K  NIL
Sbjct: 136 LILDYINGGELFTHLSQRERFT-EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENIL 191

Query: 533 LDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL-TDKS-DVYSFGVV 590
           LD N    ++DFG SK    D  +      GT+ Y+ P+ ++      DK+ D +S GV+
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251

Query: 591 LVELLTGK 598
           + ELLTG 
Sbjct: 252 MYELLTGA 259

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 7/172 (4%)

Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEH 487
            VKK    D   ID    E  V  Q +    +  L  C +T+  L  V E+V  G L  H
Sbjct: 41  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 100

Query: 488 IHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA 546
           + ++  L  E   R  +AE +  L+YLH      II+RD+K  N+LLD     K++D+G 
Sbjct: 101 MQRQRKLP-EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM 156

Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            K          T   GT  Y+ PE L+        D ++ GV++ E++ G+
Sbjct: 157 CKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 82.2 bits (203), Expect = 2e-16
 Identities = 45/214 (21%), Positives = 88/214 (41%), Gaps = 29/214 (13%)

Query: 399 KTVTNNY--ADVIGCGGSGNVYKGFLPDRTPVAVKKS-------KFVDQAK---IDEFIN 446
             V ++Y   + +G G  G V++           +++       KFV        +    
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHR---------VTERATGNNFAAKFVMTPHESDKETVRK 203

Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAE 505
           E+  +  +    +V L     +    +++YEF+  G LFE +  +   +S +  +    +
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTP--KVSDFGASKLVPIDAIQNCTVVQG 563
               L ++H       +H D+K  NI+     +   K+ DFG +    +D  Q+  V  G
Sbjct: 264 VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTG 318

Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           T  +  PE  +   +   +D++S GV+   LL+G
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A Length = 118

 Score = 75.1 bits (185), Expect = 2e-16
 Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 9/91 (9%)

Query: 234 TCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDG--CRDVNECEDPSRNN 291
              E   C +  +      +   ++   C+C +GY     L DG  C D++ECE+     
Sbjct: 35  IPHEPHRCQMFCNQTACPADCDPNTQASCECPEGYI----LDDGFICTDIDECENG--GF 88

Query: 292 CTHICDNIPGSYTCRCRKGFHGDGRKDGGGC 322
           C+ +C N+PG++ C C       G+  G  C
Sbjct: 89  CSGVCHNLPGTFECICGPDSALAGQ-IGTDC 118

>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A Length = 118

 Score = 58.9 bits (143), Expect = 8e-11
 Identities = 17/68 (25%), Positives = 25/68 (36%), Gaps = 9/68 (13%)

Query: 256 TSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDG 315
             + Y C C +G+   P+    C+            C   CD      +C C +G+  D 
Sbjct: 20  DQTSYLCVCAEGFAPIPHEPHRCQMFCNQ-----TACPADCDP-NTQASCECPEGYILD- 72

Query: 316 RKDGGGCT 323
             DG  CT
Sbjct: 73  --DGFICT 78

>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A Length = 118

 Score = 46.6 bits (111), Expect = 2e-06
 Identities = 13/44 (29%), Positives = 18/44 (40%), Gaps = 5/44 (11%)

Query: 280 DVNECEDPSRNNCTHICDNI-PGSYTCRCRKGFHGDGRKDGGGC 322
            V+ C    R NC + C  +   SY C C +GF      +   C
Sbjct: 3   PVDPC---FRANCEYQCQPLDQTSYLCVCAEGFAPIP-HEPHRC 42

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 7/138 (5%)

Query: 463 LGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVP 520
           L    +T   L L+ E++  G LF  + ++G    E       AE +  L +LH +    
Sbjct: 86  LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM-EDTACFYLAEISMALGHLHQKG--- 141

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
           II+RD+K  NI+L+     K++DFG  K   I          GT+ Y+ PE L       
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200

Query: 581 KSDVYSFGVVLVELLTGK 598
             D +S G ++ ++LTG 
Sbjct: 201 AVDWWSLGALMYDMLTGA 218

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 7/172 (4%)

Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEH 487
            VKK    D   ID    E  V  Q +    +  L  C +T+  L  V E+V  G L  H
Sbjct: 84  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 143

Query: 488 IHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA 546
           + ++  L  E   R  +AE +  L+YLH      II+RD+K  N+LLD     K++D+G 
Sbjct: 144 MQRQRKLP-EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM 199

Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            K          T   GT  Y+ PE L+        D ++ GV++ E++ G+
Sbjct: 200 CKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162

 Score = 75.9 bits (187), Expect = 3e-16
 Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 3/92 (3%)

Query: 231 TDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRN 290
           +  +C  +        C+      ++     C   +G+  NP  +    D++EC++    
Sbjct: 73  SKASCCCSLGKAWGTPCEMCPAVNTSEYKILCPGGEGFRPNPI-TVILEDIDECQELPGL 131

Query: 291 NCTHICDNIPGSYTCRCRKGFHGDGRKDGGGC 322
                C N  GS+ CRC  G++ +   D   C
Sbjct: 132 CQGGKCINTFGSFQCRCPTGYYLNE--DTRVC 161

>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162

 Score = 64.7 bits (158), Expect = 2e-12
 Identities = 8/83 (9%), Positives = 15/83 (18%), Gaps = 11/83 (13%)

Query: 241 CGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIP 300
           C L+            +    C    G   +      C         +        +   
Sbjct: 49  CYLDIRP------RGDNGDTACSNEIGVGVS---KASCCCSLGKAWGTPCEMCPAVNTSE 99

Query: 301 GSYTCRCRKGFHGDGRKDGGGCT 323
               C   +GF  +         
Sbjct: 100 YKILCPGGEGFRPNP--ITVILE 120

>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162

 Score = 63.5 bits (155), Expect = 5e-12
 Identities = 16/81 (19%), Positives = 21/81 (25%), Gaps = 12/81 (14%)

Query: 235 CEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTH 294
           C +   C  + +C       +T   Y C C   +E NP    GC D              
Sbjct: 6   CLDPTTCI-SGNC------VNTPGSYICDCPPDFELNPT-RVGCVDTRSGNCY----LDI 53

Query: 295 ICDNIPGSYTCRCRKGFHGDG 315
                 G   C    G     
Sbjct: 54  RPRGDNGDTACSNEIGVGVSK 74

>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 18/44 (40%), Positives = 21/44 (47%), Gaps = 3/44 (6%)

Query: 280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCT 323
           DVNEC DP+    +  C N PGSY C C   F  +      GC 
Sbjct: 2   DVNECLDPT-TCISGNCVNTPGSYICDCPPDFELNP--TRVGCV 42

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 51/138 (36%), Positives = 66/138 (47%), Gaps = 7/138 (5%)

Query: 463 LGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVP 520
           L CC +T   L  V EFV  G L  HI K      E R R   AE    L +LH +    
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-EARARFYAAEIISALMFLHDKG--- 144

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
           II+RD+K  N+LLD     K++DFG  K    + +   T   GT  Y+ PE LQ      
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQEMLYGP 203

Query: 581 KSDVYSFGVVLVELLTGK 598
             D ++ GV+L E+L G 
Sbjct: 204 AVDWWAMGVLLYEMLCGH 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 49/151 (32%), Positives = 72/151 (47%), Gaps = 10/151 (6%)

Query: 451 VLQINRRN--VVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAET 506
           VL +   +  +  +  C  +T+  L  V E++  G L  HI          R     AE 
Sbjct: 70  VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD-LSRATFYAAEI 127

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              L +LHS+    I++RD+K  NILLD++   K++DFG  K   +   +  T   GT  
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPD 183

Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTG 597
           Y+ PE L   K     D +SFGV+L E+L G
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 80.0 bits (198), Expect = 4e-16
 Identities = 47/138 (34%), Positives = 61/138 (44%), Gaps = 7/138 (5%)

Query: 463 LGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVP 520
           L    +T   L  V +++  G LF H+ ++     E R R   AE A  L YLHS     
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFL-EPRARFYAAEIASALGYLHSLN--- 159

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
           I++RD+K  NILLD      ++DFG  K          T   GT  YL PE L       
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHKQPYDR 218

Query: 581 KSDVYSFGVVLVELLTGK 598
             D +  G VL E+L G 
Sbjct: 219 TVDWWCLGAVLYEMLYGL 236

>1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Length = 82

 Score = 72.6 bits (179), Expect = 4e-16
 Identities = 23/88 (26%), Positives = 34/88 (38%), Gaps = 14/88 (15%)

Query: 235 CEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTH 294
           C+E  +C  +  C       +T   YRC+C  GY       + C D +EC   +      
Sbjct: 8   CKEPDVCK-HGQC------INTDGSYRCECPFGYILA---GNECVDTDECSVGN-PCGNG 56

Query: 295 ICDNIPGSYTCRCRKGFHGDGRKDGGGC 322
            C N+ G + C C +GF          C
Sbjct: 57  TCKNVIGGFECTCEEGFEPG---PMMTC 81

>1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Length = 82

 Score = 57.2 bits (139), Expect = 1e-10
 Identities = 13/39 (33%), Positives = 18/39 (46%), Gaps = 1/39 (2%)

Query: 278 CRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGR 316
             D++EC++P        C N  GSY C C  G+   G 
Sbjct: 2   AVDMDECKEP-DVCKHGQCINTDGSYRCECPFGYILAGN 39

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 7/138 (5%)

Query: 463 LGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETNVP 520
           L    +T   L  V E+   G LF H+ ++   + E R R   AE    L YLHS     
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARFYGAEIVSALEYLHSRD--- 125

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
           +++RD+K  N++LD++   K++DFG  K    D     T   GT  YL PE L+      
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGR 184

Query: 581 KSDVYSFGVVLVELLTGK 598
             D +  GVV+ E++ G+
Sbjct: 185 AVDWWGLGVVMYEMMCGR 202

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.3 bits (194), Expect = 7e-16
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 23/200 (11%)

Query: 408 VIGCGGSGNVY----KGFLPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVV 460
            +G G  G V+    +    +    A+K   K   V   +++   +E +++  +    ++
Sbjct: 13  TLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69

Query: 461 RLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAETAGVLSYLHSETN 518
           R+ G   +    + ++ +++  G LF  + K          +   AE    L YLHS+  
Sbjct: 70  RMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFP-NPVAKFYAAEVCLALEYLHSKD- 126

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKL 578
             II+RD+K  NILLD+N   K++DFG +K VP      C    GT  Y+ PE + T K 
Sbjct: 127 --IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVST-KP 179

Query: 579 TDKS-DVYSFGVVLVELLTG 597
            +KS D +SFG+++ E+L G
Sbjct: 180 YNKSIDWWSFGILIYEMLAG 199

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 80.5 bits (198), Expect = 8e-16
 Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 7/172 (4%)

Query: 429 AVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-LVYEFVGNGTLFEH 487
            +KK   +    ++  + E  V+    +   +  L  C +T   L  V E+V  G L  H
Sbjct: 373 ILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 432

Query: 488 IHKKGNLSWERRLRI-TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA 546
           I + G    E       AE A  L +L S+    II+RD+K  N++LD     K++DFG 
Sbjct: 433 IQQVGRFK-EPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 488

Query: 547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
            K    D +   T   GT  Y+ PE +         D ++FGV+L E+L G+
Sbjct: 489 CKENIWDGVTTKTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 10/152 (6%)

Query: 451 VLQINRRN--VVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRI-TAET 506
           VL +  +   + +L   C +T   L  V E+V  G L  HI + G    E       AE 
Sbjct: 73  VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHAVFYAAEI 130

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
           A  L +L S+    II+RD+K  N++LD     K++DFG  K    D +   T   GT  
Sbjct: 131 AIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPD 186

Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           Y+ PE +         D ++FGV+L E+L G+
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 23/211 (10%)

Query: 401 VTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQ--IN 455
             ++Y  V  +G G    V++   + +   V VK  K V + KI     E + +L+    
Sbjct: 34  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KRE-IKILENLRG 89

Query: 456 RRNVVRLLGCCL--ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL 513
             N++ L        ++ P LV+E V N    +       L+         E    L Y 
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYC 146

Query: 514 HSETNVPIIHRDVKSANILLD-ENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPE 571
           HS     I+HRDVK  N+++D E+   ++ D+G A    P     N  V   +  +  PE
Sbjct: 147 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA--SRYFKGPE 200

Query: 572 YLQTCKLTDKS-DVYSFGVVLVELLTGKMAL 601
            L   ++ D S D++S G +L  ++  K   
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A Length = 107

 Score = 70.4 bits (173), Expect = 5e-15
 Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 8/66 (12%)

Query: 254 TSTSSGYRCKCNKGYEGNPYLSDG-CRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGF- 311
                GY C C  G++         C D++EC+DP  + C+ +C N+ G Y C+C +GF 
Sbjct: 44  NDLKIGYECLCPDGFQLVA---QRRCEDIDECQDP--DTCSQLCVNLEGGYKCQCEEGFQ 98

Query: 312 -HGDGR 316
                +
Sbjct: 99  LDPHTK 104

>2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A Length = 107

 Score = 64.7 bits (158), Expect = 6e-13
 Identities = 17/76 (22%), Positives = 26/76 (34%), Gaps = 15/76 (19%)

Query: 256 TSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFH--G 313
             S Y     +          G    NEC D +   C+++C+++   Y C C  GF    
Sbjct: 9   PMSDYDIPTTENLYF-----QGAMGTNECLD-NNGGCSYVCNDLKIGYECLCPDGFQLVA 62

Query: 314 DGR-------KDGGGC 322
             R       +D   C
Sbjct: 63  QRRCEDIDECQDPDTC 78

>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Length = 143

 Score = 71.4 bits (175), Expect = 6e-15
 Identities = 24/98 (24%), Positives = 35/98 (35%), Gaps = 21/98 (21%)

Query: 238 AKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDG----CRDVNECEDPSRNNC- 292
           A+ C  ++SC          +   C+CN G+     +       C D+NEC   S+ +C 
Sbjct: 6   ARWCPQDSSC---------VNATACRCNPGFSSFSEIITTPMETCDDINECATLSKVSCG 56

Query: 293 -THICDNIPGSYTCRCRKGFHGDGRK------DGGGCT 323
               C N  GSY C C  G+                C 
Sbjct: 57  KFSDCWNTEGSYDCVCSPGYEPVSGAKTFKNESENTCQ 94

>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Length = 143

 Score = 66.8 bits (163), Expect = 3e-13
 Identities = 28/84 (33%), Positives = 38/84 (45%), Gaps = 16/84 (19%)

Query: 241 CGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDG-------CRDVNECEDPSRNNC- 292
           CG  + C     NT  S  Y C C+ GYE               C+DV+EC    ++ C 
Sbjct: 55  CGKFSDCW----NTEGS--YDCVCSPGYEPVSGAKTFKNESENTCQDVDECSS-GQHQCD 107

Query: 293 -THICDNIPGSYTCRCRKGFHGDG 315
            + +C N  GSY+CRCR G+    
Sbjct: 108 SSTVCFNTVGSYSCRCRPGWKPRH 131

>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Length = 143

 Score = 39.4 bits (92), Expect = 7e-04
 Identities = 9/45 (20%), Positives = 15/45 (33%), Gaps = 7/45 (15%)

Query: 241 CGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECE 285
           C  +  C       +T   Y C+C  G++         +    CE
Sbjct: 106 CDSSTVC------FNTVGSYSCRCRPGWKPRHG-IPNNQKDTVCE 143

>1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} Length = 87

 Score = 68.5 bits (168), Expect = 2e-14
 Identities = 23/64 (35%), Positives = 32/64 (50%), Gaps = 12/64 (18%)

Query: 259 GYRCKCNKGYEGNPYLSDG--CRDVNECEDPSRNNCTHICDNIPGSYTCRC--RKGF--H 312
            + C+C +GY  N        C D++EC +   N C  +C N PG YTC C  +KGF   
Sbjct: 24  DFECECPEGYRYNL---KSKSCEDIDECSE---NMCAQLCVNYPGGYTCYCDGKKGFKLA 77

Query: 313 GDGR 316
            D +
Sbjct: 78  QDQK 81

>1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} Length = 87

 Score = 51.9 bits (125), Expect = 9e-09
 Identities = 14/45 (31%), Positives = 21/45 (46%), Gaps = 2/45 (4%)

Query: 279 RDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCT 323
           +DV+EC        T +C NIPG + C C +G+  +       C 
Sbjct: 1   KDVDECSLKPSICGTAVCKNIPGDFECECPEGYRYNL--KSKSCE 43

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.5 bits (183), Expect = 3e-14
 Identities = 69/267 (25%), Positives = 111/267 (41%), Gaps = 25/267 (9%)

Query: 349 WLHFLWTRRRHMKLKEKFFEQNG-GSILRQELSKLHGQSSEKAKI-FTEEEIK----TVT 402
            LHFL+         +  F Q     +    ++K +  S  K    F   E+     TV 
Sbjct: 2   SLHFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVL 61

Query: 403 NNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKID--EFINELVVVLQINRR 457
             Y ++  IG G  G V   +       VA+KK     Q +        ELV++  +N +
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 458 NVVRLL-----GCCLETQVPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS 511
           N++ LL        LE    + LV E +    L + I     L  ER   +  +    + 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIK 178

Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    VV  T  Y  PE
Sbjct: 179 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE 233

Query: 572 YLQTCKLTDKSDVYSFGVVLVELLTGK 598
            +      +  D++S G ++ E++  K
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHK 260

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 23/230 (10%)

Query: 384 GQSSEKAKIFTEEEIK----TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKFV 436
           G  S++   F   EI     TV   Y ++  IG G  G V   +       VA+KK    
Sbjct: 2   GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 61

Query: 437 DQAKID--EFINELVVVLQINRRNVVRLL-----GCCLETQVPL-LVYEFVGNGTLFEHI 488
            Q +        ELV++  +N +N++ LL        LE    + +V E +    L + I
Sbjct: 62  FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI 120

Query: 489 HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
                L  ER   +  +    + +LHS   +  IHRD+K +NI++  +CT K+ DFG ++
Sbjct: 121 QM--ELDHERMSYLLYQMLCGIKHLHS-AGI--IHRDLKPSNIVVKSDCTLKILDFGLAR 175

Query: 549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
                 +    VV  T  Y  PE +      +  D++S G ++ E++ G 
Sbjct: 176 TAGTSFMMTPYVV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 40/222 (18%)

Query: 399 KTVTNNYAD--VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFIN-ELVVVLQIN 455
           +     Y +  VIG G  G V++  L +   VA+KK   V Q K   F N EL ++  + 
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK---VLQDK--RFKNRELQIMRIVK 90

Query: 456 RRNVVRLLGCCLETQVPL------LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
             NVV L                 LV E+V      E +++      + +  +      +
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKL 145

Query: 510 --------LSYLHSETNVPIIHRDVKSANILLDENCTP-KVSDFG-ASKLVPIDAIQNCT 559
                   L+Y+HS   + I HRD+K  N+LLD      K+ DFG A  L+  +      
Sbjct: 146 YMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---V 199

Query: 560 --VVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGK 598
             +   +  Y  PE +      T   D++S G V+ EL+ G+
Sbjct: 200 SYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.1 bits (172), Expect = 6e-13
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 25/236 (10%)

Query: 379 LSKLHGQSSEKAKIFTEEEIK----TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVK 431
           ++  H   S++   F  +E+      V   Y ++  +G G  G+V   F       VAVK
Sbjct: 1   MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60

Query: 432 KSKFVDQAKID--EFINELVVVLQINRRNVVRLLGCCLETQVPL------LVYEFVGNGT 483
           K     Q+ I       EL ++  +   NV+ LL      +         LV   +G   
Sbjct: 61  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG--A 118

Query: 484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD 543
              +I K   L+ +    +  +    L Y+HS     IIHRD+K +N+ ++E+C  K+ D
Sbjct: 119 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 175

Query: 544 FGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
           FG ++           V   T  Y  PE +      +++ D++S G ++ ELLTG+
Sbjct: 176 FGLAR--HTADEMTGYVA--TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Length = 147

 Score = 65.4 bits (160), Expect = 7e-13
 Identities = 21/77 (27%), Positives = 27/77 (35%), Gaps = 4/77 (5%)

Query: 246 SCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTC 305
           S      +  T       C KGY         C D++ECE         +C N  GS+ C
Sbjct: 74  SLGAAWGSPCTLCQVDPICGKGYSRIKGTQ--CEDIDECEVFPGVCKNGLCVNTRGSFKC 131

Query: 306 RCRKGFHGDGRKDGGGC 322
           +C  G   D    G  C
Sbjct: 132 QCPSGMTLDA--TGRIC 146

>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Length = 147

 Score = 51.2 bits (123), Expect = 7e-08
 Identities = 10/87 (11%), Positives = 18/87 (20%), Gaps = 26/87 (29%)

Query: 259 GYRCKCNKGYEGNPYLSDGCRDVNEC----------------------EDPSRNNCTHIC 296
            + C+C+     +P     C +  +                       +  S        
Sbjct: 23  SFICECSSESTLDPT-KTICIETIKGTCWQTVIDGRCEININGATLKSQCCSSLGAAWGS 81

Query: 297 DNIPGSYTCRCRKGFHGDGRKDGGGCT 323
                     C KG+       G  C 
Sbjct: 82  PCTLCQVDPICGKGYSRI---KGTQCE 105

>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Length = 147

 Score = 49.3 bits (118), Expect = 4e-07
 Identities = 14/45 (31%), Positives = 18/45 (40%), Gaps = 4/45 (8%)

Query: 280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCTP 324
           D++ECE  S      +C N PGS+ C C      D       C  
Sbjct: 3   DIDECE--SSPCINGVCKNSPGSFICECSSESTLDP--TKTICIE 43

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 69.7 bits (171), Expect = 9e-13
 Identities = 66/222 (29%), Positives = 98/222 (44%), Gaps = 39/222 (17%)

Query: 399 KTVTNNYAD--VIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFIN-ELVVVLQI 454
           +    +Y D  VIG G  G VY+  L      VA+KK   V Q K   F N EL ++ ++
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDK--RFKNRELQIMRKL 104

Query: 455 NRRNVVRLLGCCLETQ-----VPL-LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
           +  N+VRL      +      V L LV ++V   T++             +  +      
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARH----YSRAKQTLPVIYVK 159

Query: 509 V--------LSYLHSETNVPIIHRDVKSANILLDENCTP-KVSDFG-ASKLVPIDAIQNC 558
           +        L+Y+HS     I HRD+K  N+LLD +    K+ DFG A +LV  +   N 
Sbjct: 160 LYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NV 214

Query: 559 T-VVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGK 598
           + +   +  Y  PE +      T   DV+S G VL ELL G+
Sbjct: 215 SYIC--SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 57/215 (26%), Positives = 84/215 (39%), Gaps = 44/215 (20%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK----KSKFVDQAKIDEFINELVVVLQIN------ 455
            VIG G  G V K +       VA+K    + +F  QA       E+ ++  +       
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EIRILEHLRKQDKDN 157

Query: 456 RRNVVRLLGC-------CLETQVPLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAE 505
             NV+ +L         C+        +E +    L+E I KK      S     +    
Sbjct: 158 TMNVIHMLENFTFRNHICM-------TFELLSM-NLYELI-KKNKFQGFSLPLVRKFAHS 208

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTP--KVSDFGASKLVPIDAIQNCTVVQG 563
               L  LH      IIH D+K  NILL +      KV DFG+S     +  +  T +Q 
Sbjct: 209 ILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQ- 261

Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           +  Y  PE +   +     D++S G +L ELLTG 
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 48/196 (24%), Positives = 75/196 (38%), Gaps = 26/196 (13%)

Query: 485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF 544
                 K  L+ E  +  + + A  + +L S      IHRD+ + NILL E    K+ DF
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDF 237

Query: 545 GASKLVPIDAIQNCTVVQGTLGYLD-----PEYLQTCKLTDKSDVYSFGVVLVELLTGKM 599
           G ++    D  ++   V+     L      PE +     T +SDV+SFGV+L E+ +   
Sbjct: 238 GLAR----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--- 290

Query: 600 ALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEE 659
             L   P     +   F   LK+   +   D             E+ +    C      +
Sbjct: 291 --LGASPYPGVKIDEEFCRRLKEGTRMRAPDY---------TTPEMYQTMLDCWHGEPSQ 339

Query: 660 RPTMKEVSLELQGRLS 675
           RPT  E+   L   L 
Sbjct: 340 RPTFSELVEHLGNLLQ 355

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 34/151 (22%), Positives = 54/151 (35%), Gaps = 16/151 (10%)

Query: 407 DVIGCGGSGNVYKGFL------PDRTPVAVKKSK-FVDQAKIDEFINELVVVLQINR-RN 458
             +G G  G V +              VAVK  K     ++    ++EL +++ I    N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 459 VVRLLGCCLETQVPLLV-YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
           VV LLG C +   PL+V  EF   G L  ++         +R            +   + 
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-------KRNEFVPYKTKGARFRQGKD 140

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASK 548
            V  I  D+K     +  + +   S F   K
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 25/222 (11%)

Query: 393 FTEEEIK----TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKID--E 443
           F  +E+      V   Y D+  +G G  G V           VA+KK     Q+++    
Sbjct: 11  FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 70

Query: 444 FINELVVVLQINRRNVVRLLGCCLETQVPL------LVYEFVGNGTLFEHIHKKGNLSWE 497
              EL ++  +   NV+ LL      +         LV  F+G  T    + K   L  +
Sbjct: 71  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG--TDLGKLMKHEKLGED 128

Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
           R   +  +    L Y+H+     IIHRD+K  N+ ++E+C  K+ DFG ++    D+   
Sbjct: 129 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMT 183

Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
             VV  T  Y  PE +       ++ D++S G ++ E++TGK
Sbjct: 184 GYVV--TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 59/232 (25%)

Query: 400 TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFIN---------E 447
            V   Y ++  IG G  G V   +   ++  VA+KK        I  F +         E
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQTYCQRTLRE 75

Query: 448 LVVVLQINRRNVVRLLGCCLETQVPL---------LVYEFVGNGTLFEHIHKKGNLSWER 498
           + ++L+    N++ +     +              +V + +   T    + K  +LS + 
Sbjct: 76  IKILLRFRHENIIGIN----DIIRAPTIEQMKDVYIVQDLME--TDLYKLLKTQHLSNDH 129

Query: 499 R-------LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP 551
                   LR        L Y+HS     ++HRD+K +N+LL+  C  K+ DFG +++  
Sbjct: 130 ICYFLYQILR-------GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179

Query: 552 IDAIQNCT----VVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
            D          V   T  Y  PE +   K   KS D++S G +L E+L+ +
Sbjct: 180 PDHDHTGFLTEYVA--TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 45/222 (20%), Positives = 86/222 (38%), Gaps = 44/222 (19%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK----KSKFVDQA----KIDEFINELVVVLQ--IN 455
             +G G    V+    + + T VA+K       + + A    K+ + +N+     +  + 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 456 RRNVVRLLGC-----------CLETQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRI 502
             ++++LL              +       V+E +G   L   I K  +  +      +I
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVM-------VFEVLGE-NLLALIKKYEHRGIPLIYVKQI 136

Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP------KVSDFGASKLVPIDAIQ 556
           + +    L Y+H      IIH D+K  N+L++   +P      K++D G +         
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-- 192

Query: 557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
               +Q T  Y  PE L        +D++S   ++ EL+TG 
Sbjct: 193 -TNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 66.4 bits (163), Expect = 5e-12
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 20/207 (9%)

Query: 403 NNYA--DVIGCGGSGNVYKGFLPDRTP---VAVKKSKFVDQAKIDEFIN--ELVVVLQIN 455
             Y     IG G  G V+K    +R     VA+KK    +   + + I   E+ ++ Q+ 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60

Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHI-HKKGNLSWERRLRITAETAGVLSYLH 514
             N+V LL      +   LV+E+  + T+   +   +  +       IT +T   +++ H
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 515 SETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT--VVQGTLGYLDPEY 572
                  IHRDVK  NIL+ ++   K+ DFG ++L+           V   T  Y  PE 
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA--TRWYRSPEL 173

Query: 573 LQTCKLTDKS-DVYSFGVVLVELLTGK 598
           L          DV++ G V  ELL+G 
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 66.6 bits (163), Expect = 7e-12
 Identities = 49/219 (22%), Positives = 85/219 (38%), Gaps = 26/219 (11%)

Query: 400 TVTNNYADV--IGCGGSGNVYKGFLPDRTPVAVKK--SKFVDQAKIDEFIN--------- 446
            + + Y     I  G  G V  G   +  PVA+K+  +   D   ++   +         
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPL-----LVYEFVGNGTLFEHIH-KKGNLSWERRL 500
           E+ ++   +  N++ L    +  + P      LV E +    L + IH ++  +S +   
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQ 137

Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV 560
                    L  LH      ++HRD+   NILL +N    + DF  ++    DA +   V
Sbjct: 138 YFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194

Query: 561 VQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
                 Y  PE +   K   K  D++S G V+ E+   K
Sbjct: 195 T--HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 66.5 bits (163), Expect = 8e-12
 Identities = 48/229 (20%), Positives = 89/229 (38%), Gaps = 39/229 (17%)

Query: 395 EEEIKTVTNNYAD--VIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEF--INELV 449
           +E  +   + +    + G G  G V  G        VA+KK   V Q        +  + 
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPRFRNRELQIMQ 71

Query: 450 VVLQINRRNVVRLLGCCLETQVP-------LLVYEFVGNGTLFEHIHKKGNLSWERRLRI 502
            +  ++  N+V+L                  +V E+V      + +H+     + R++  
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAP 126

Query: 503 TAETAGV--------LSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFG-ASKLVPI 552
                 V        +  LH  + V + HRD+K  N+L++  + T K+ DFG A KL P 
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185

Query: 553 DAIQNCT--VVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGK 598
           +        +   +  Y  PE +   +  T   D++S G +  E++ G+
Sbjct: 186 EPN---VAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 26/213 (12%)

Query: 400 TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKID--EFINELVVVLQI 454
            +   Y     +G G  G+V           VA+KK     Q++I       EL+++  +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80

Query: 455 NRRNVVRLLGCCLETQVPL------LVYEFVGNGTLFEHIHK--KGNLSWERRLRITAET 506
              NV+ LL                LV  F+        + K      S E+   +  + 
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGLKFSEEKIQYLVYQM 135

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG 566
              L Y+HS   V  +HRD+K  N+ ++E+C  K+ DFG ++    DA     VV  T  
Sbjct: 136 LKGLKYIHS-AGV--VHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV--TRW 188

Query: 567 YLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
           Y  PE + +    +++ D++S G ++ E+LTGK
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 30/222 (13%)

Query: 400 TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR 456
            + + Y D+  +GCGG+G V+          VA+KK    D   +   + E+ ++ +++ 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH 67

Query: 457 RNVVRLL------GCCLETQVPL--------LVYEFVGNGTLFEHIHKKGNLSWERRLRI 502
            N+V++       G  L   V          +V E++   T   ++ ++G L  E     
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME--TDLANVLEQGPLLEEHARLF 125

Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAIQNCT-- 559
             +    L Y+HS  NV  +HRD+K AN+ ++ E+   K+ DFG ++++           
Sbjct: 126 MYQLLRGLKYIHS-ANV--LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 560 --VVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
             +V  T  Y  P  L +     K+ D+++ G +  E+LTGK
Sbjct: 183 EGLV--TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 44/202 (21%)

Query: 408 VIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR-RNVVRLLGC 465
           V+G G +G V + F    +   A+K  +        +   E+ +  + ++  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 79

Query: 466 CLETQVP-----LLVYEFVGNGTLFEHIHKKGNLSW-ERR-LRITAETAGVLSYLHSETN 518
             E         L+V E +  G LF  I  +G+ ++ ER    I       + YLHS   
Sbjct: 80  Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 137

Query: 519 VPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT 575
             I HRDVK  N+L      N   K++DFG +K                      +Y ++
Sbjct: 138 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-----------------TGEKYDKS 178

Query: 576 CKLTDKSDVYSFGVVLVELLTG 597
           C      D++S GV++  LL G
Sbjct: 179 C------DMWSLGVIMYILLCG 194

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 40/214 (18%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK----KSKFVDQAKIDEFINELVVVLQIN------ 455
            +IG G  G V K +   ++  VA+K    K  F++QA+I     E+ ++  +N      
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----EVRLLELMNKHDTEM 114

Query: 456 RRNVVRLLGC-------CLETQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAET 506
           +  +V L          CL       V+E +    L++ +       +S     +   + 
Sbjct: 115 KYYIVHLKRHFMFRNHLCL-------VFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQM 166

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILL--DENCTPKVSDFGASKLVPIDAIQNCTVVQGT 564
              L +L +   + IIH D+K  NILL   +    K+ DFG+S        +    +Q +
Sbjct: 167 CTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQYIQ-S 221

Query: 565 LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
             Y  PE L         D++S G +LVE+ TG+
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 20/207 (9%)

Query: 403 NNYA--DVIGCGGSGNVYKGFLPDRT---PVAVKKSKFVDQAKIDEFIN--ELVVVLQIN 455
             Y    ++G G  G V K    ++     VA+KK    D  K+ + I   E+ ++ Q+ 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCR--NKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82

Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLH 514
             N+V LL  C + +   LV+EFV + T+ + +    N L ++   +   +    + + H
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141

Query: 515 SETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT--VVQGTLGYLDPEY 572
           S     IIHRD+K  NIL+ ++   K+ DFG ++ +     +     V   T  Y  PE 
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA--TRWYRAPEL 195

Query: 573 LQTCKLTDKS-DVYSFGVVLVELLTGK 598
           L       K+ DV++ G ++ E+  G+
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 13/99 (13%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLG--- 566
           +  LH  +NV  IHRD+K +N+L++ NC  KV DFG ++++   A  N        G   
Sbjct: 125 VKVLHG-SNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 567 ------YLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
                 Y  PE + T     ++ DV+S G +L EL   +
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 48/219 (21%), Positives = 92/219 (42%), Gaps = 43/219 (19%)

Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           +G G  G+VYK    D       A+K+ +    +       E+ ++ ++   NV+ L   
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKV 86

Query: 466 CLETQVPL--LVYEFVGNGTLFEH------IHKKGNLSWERRLRITAET---------AG 508
            L        L++++       EH         + + + ++ +++              G
Sbjct: 87  FLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140

Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTP----KVSDFGASKL--VPIDAIQNCT--V 560
            + YLH+     ++HRD+K ANIL+          K++D G ++L   P+  + +    V
Sbjct: 141 -IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 561 VQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
           V  T  Y  PE L   +   K+ D+++ G +  ELLT +
Sbjct: 197 V--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Length = 114

 Score = 57.8 bits (140), Expect = 2e-10
 Identities = 20/85 (23%), Positives = 28/85 (32%), Gaps = 13/85 (15%)

Query: 232 DKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGC-RDVNECEDPSRN 290
                 A +C  + +C            + C C  G+EG       C R+V+       N
Sbjct: 13  PLEHPCASLCCGHGTC------IDGIGSFSCDCRSGWEG-----RFCQREVSFLNCSLDN 61

Query: 291 N-CTHICDNIPGSYTCRCRKGFHGD 314
             CTH C    G   C C  G+   
Sbjct: 62  GGCTHYCLEEVGWRRCSCAPGYKLG 86

>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Length = 114

 Score = 40.1 bits (94), Expect = 3e-04
 Identities = 10/44 (22%), Positives = 17/44 (38%), Gaps = 7/44 (15%)

Query: 278 CRDVNECEDPSRNNCT-------HICDNIPGSYTCRCRKGFHGD 314
             D ++C      +           C +  GS++C CR G+ G 
Sbjct: 3   HVDGDQCLVLPLEHPCASLCCGHGTCIDGIGSFSCDCRSGWEGR 46

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.6 bits (151), Expect = 4e-10
 Identities = 88/617 (14%), Positives = 168/617 (27%), Gaps = 206/617 (33%)

Query: 198 FVVDQSQF-------HFTSNYLALGGIRD-EFPMVLDW--EIITDKTCEEAKICGLNASC 247
           F   + Q+        F   +     + + +   V D    I++ +  +   I       
Sbjct: 9   FETGEHQYQYKDILSVFEDAF-----VDNFDCKDVQDMPKSILSKEEIDH--IIMS---- 57

Query: 248 DTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVN----------ECEDPSRNNCTHICD 297
                 + T   +    +K  E      +    +N          E   PS     +I  
Sbjct: 58  --KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI-- 113

Query: 298 NIPGSYTCRCRKGFHGDGR--KDGGGCTPNQYTVIKVAL---------------GVGISF 340
                     R   + D +            Y  ++ AL               G G + 
Sbjct: 114 --------EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKT- 164

Query: 341 VVAIMS-------------ISWLHFLWTRRRHMKLKEKFFEQNGGSILRQELSKLHGQSS 387
            VA+               I WL+    +  +             ++L   L KL  Q  
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNL---KNCNSP----------ETVLEM-LQKLLYQ-- 208

Query: 388 EKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINE 447
                        +  N+        S N     +  R      +++     K   + N 
Sbjct: 209 -------------IDPNWTS--RSDHSSN-----IKLRIHSI--QAELRRLLKSKPYENC 246

Query: 448 LVVVLQINRRNVVRL--LGC-CLETQVPLLVYEFVGNGTLFEH--IHKKGNLSWERRLRI 502
           L+V+L +          L C  L T     V +F+   T       H    L+       
Sbjct: 247 LLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT------- 299

Query: 503 TAETAGVLS-YLH-SETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--- 557
             E   +L  YL     ++P   R+V + N          +S    S    +    N   
Sbjct: 300 PDEVKSLLLKYLDCRPQDLP---REVLTTNPRR-------LSIIAESIRDGLATWDNWKH 349

Query: 558 ------CTVVQGTLGYLDPEYLQTCKLTDKSDVY-SFGV----VLVELLTGKMALL-SDK 605
                  T+++ +L  L+P   +          +    V      +  +   ++L+  D 
Sbjct: 350 VNCDKLTTIIESSLNVLEPAEYRKM--------FDRLSVFPPSAHIPTIL--LSLIWFDV 399

Query: 606 PEEERSLAMNFL--SSL--KQN--RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEE 659
            + +  + +N L   SL  KQ     + I             L+   KL         E 
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPS---------IYLELKVKL---------EN 441

Query: 660 RPTMKEVSLELQGRLSLMSNGQYYLRDNVESNGV---QETEYFTSTFYECRNGIGSHTTP 716
              +    ++            Y +    +S+ +      +YF S  +     IG H   
Sbjct: 442 EYALHRSIVD-----------HYNIPKTFDSDDLIPPYLDQYFYS--H-----IGHHLKN 483

Query: 717 TDGYDSVQQLELMAFDY 733
            +  + +    ++  D+
Sbjct: 484 IEHPERMTLFRMVFLDF 500

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 61.1 bits (149), Expect = 4e-10
 Identities = 46/207 (22%), Positives = 89/207 (42%), Gaps = 26/207 (12%)

Query: 407 DVIGCGGSGNVYKGFLPDRTP---VAVKKSKFVDQAKIDEF----INELVVVLQINRRNV 459
             +G G  G VYK    D      VA+K+ + ++  + +      I E+ ++ ++  RN+
Sbjct: 40  TKLGEGTYGEVYKAI--DTVTNETVAIKRIR-LEHEE-EGVPGTAIREVSLLKELQHRNI 95

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNV 519
           + L           L++E+     L +++ K  ++S         +    +++ HS    
Sbjct: 96  IELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR-- 152

Query: 520 PIIHRDVKSANILLDENCTP-----KVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEY 572
             +HRD+K  N+LL  +        K+ DFG ++   +PI    +  ++  TL Y  PE 
Sbjct: 153 -CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH-EII--TLWYRPPEI 208

Query: 573 LQTCKLTDKS-DVYSFGVVLVELLTGK 598
           L   +    S D++S   +  E+L   
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 60.7 bits (148), Expect = 5e-10
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 39/224 (17%)

Query: 397 EIKTVTNNYA--DVIGCGGSGNVYKGFLPDRT---PVAVKKSKFVDQAKIDEFIN----- 446
           ++K+    Y   D +G G    VYK    D+     VA+KK K   +++  + IN     
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKAR--DKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61

Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV---------GNGTLFEHIHKKGNLSWE 497
           E+ ++ +++  N++ LL          LV++F+          N  +    H K   ++ 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK---AYM 118

Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAI 555
                     G L YLH      I+HRD+K  N+LLDEN   K++DFG +K    P  A 
Sbjct: 119 LMT-----LQG-LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169

Query: 556 QNCTVVQGTLGYLDPEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
            +  VV  T  Y  PE L   ++     D+++ G +L ELL   
Sbjct: 170 THQ-VV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 60.3 bits (147), Expect = 7e-10
 Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 56/224 (25%)

Query: 409 IGCGGSGNVYKGFLPDRT---PVAVKKSKFVDQAKIDEF----INELVVVLQINRRNVVR 461
           IG G  G V+K     R     VA+KK    +  K + F    + E+ ++  +   NVV 
Sbjct: 25  IGQGTFGEVFKAR--HRKTGQKVALKKVLM-ENEK-EGFPITALREIKILQLLKHENVVN 80

Query: 462 LLGCCLETQVPL--------LVYEFV---------GNGTLFEHIHKKGNLSWERRLRITA 504
           L+  C     P         LV++F               F     K      + L    
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK---RVMQML---- 133

Query: 505 ETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNC---T 559
              G L Y+H      I+HRD+K+AN+L+  +   K++DFG ++   +  ++  N     
Sbjct: 134 -LNG-LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188

Query: 560 VVQGTLGYLDPEYLQTCKLTDKS-----DVYSFGVVLVELLTGK 598
           VV  TL Y  PE L    L ++      D++  G ++ E+ T  
Sbjct: 189 VV--TLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRS 226

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 59.5 bits (145), Expect = 1e-09
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 37/208 (17%)

Query: 409 IGCGGSGNVYKGFLPDRT--PVAVKKSKFVDQAKIDEF----INELVVVLQINRRNVVRL 462
           +G G  G VYK    D     VA+K+ + +D    +      I E+ ++ +++  N+V L
Sbjct: 29  VGEGTYGVVYKAK--DSQGRIVALKRIR-LDAED-EGIPSTAIREISLLKELHHPNIVSL 84

Query: 463 LGCCLETQVPLLVYEFV---------GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL 513
           +      +   LV+EF+          N T  +    K    +  +L       G +++ 
Sbjct: 85  IDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIK---IYLYQL-----LRG-VAHC 135

Query: 514 HSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPE 571
           H      I+HRD+K  N+L++ +   K++DFG ++   +P+ +  +  VV  TL Y  P+
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE-VV--TLWYRAPD 189

Query: 572 YLQTCKLTDKS-DVYSFGVVLVELLTGK 598
            L   K    S D++S G +  E++TGK
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A Length = 186

 Score = 57.4 bits (137), Expect = 1e-09
 Identities = 18/84 (21%), Positives = 26/84 (30%), Gaps = 1/84 (1%)

Query: 232 DKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRN- 290
               +  +      S +   +  S      C C  G   NP     C    E        
Sbjct: 88  TCVLDVCQYXNCGESGECIVEYLSEIQSAGCSCAIGXVPNPEDEXXCTXTGETACQLXCN 147

Query: 291 NCTHICDNIPGSYTCRCRKGFHGD 314
               +C N+ G Y C+C +GF  D
Sbjct: 148 TDNEVCXNVEGVYXCQCMEGFTFD 171

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 30/110 (27%), Positives = 44/110 (40%), Gaps = 24/110 (21%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLD 569
           + YLHS   +  +HRD+K +NILL+  C  KV+DFG S+           +        +
Sbjct: 122 IKYLHS-GGL--LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 570 PEYLQTCKLTD---------------------KSDVYSFGVVLVELLTGK 598
                   LTD                       D++S G +L E+L GK
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 56/268 (20%), Positives = 97/268 (36%), Gaps = 59/268 (22%)

Query: 383 HGQSSEKAKIFTEEEIK-TVTNNYADV--IGCGGSGNVYKGF-LPDRTPVAVKK-----S 433
           H  SS +  ++ +      V +NY     IG G  G VY  +       VA+KK      
Sbjct: 5   HHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE 64

Query: 434 KFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL-----LVYEFVGNGT-LFEH 487
             +D  +I   + E+ ++ ++    ++RL    +   +       +V E     + L + 
Sbjct: 65  DLIDCKRI---LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD--SDLKKL 119

Query: 488 IHKKGNLSWERR-------LRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPK 540
                 L+ E         L          +++H      IIHRD+K AN LL+++C+ K
Sbjct: 120 FKTPIFLTEEHIKTILYNLLL-------GENFIHE---SGIIHRDLKPANCLLNQDCSVK 169

Query: 541 VSDFG-ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD------------------- 580
           V DFG A  +           ++              +LT                    
Sbjct: 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229

Query: 581 -KS-DVYSFGVVLVELLTGKMALLSDKP 606
            KS D++S G +  ELL    + ++D  
Sbjct: 230 TKSIDIWSTGCIFAELLNMLQSHINDPT 257

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 24/206 (11%)

Query: 409 IGCGGSGNVYKGFLPDRT--PVAVKKSKFVDQAK-------IDEFINELVVVLQINRRNV 459
           IG G  G V+K          VA+K+ + V   +       I E +  L  +      NV
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIRE-VAVLRHLETFEHPNV 76

Query: 460 VRLLGCCLETQVPL-----LVYEFVGN--GTLFEHIHKKGNLSWERRLRITAETAGVLSY 512
           VRL   C  ++        LV+E V     T  +    +  +  E    +  +    L +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDF 135

Query: 513 LHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
           LHS     ++HRD+K  NIL+  +   K++DFG +++          VV  TL Y  PE 
Sbjct: 136 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEV 190

Query: 573 LQTCKLTDKSDVYSFGVVLVELLTGK 598
           L         D++S G +  E+   K
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMFRRK 216

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 58.3 bits (142), Expect = 2e-09
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 39/209 (18%)

Query: 409 IGCGGSGNVYKGFLPDRT--PVAVKKSKFVDQAKIDEFIN-----ELVVVLQINRRNVVR 461
           IG G  G VYK    +      A+KK +   +   DE I      E+ ++ ++   N+V+
Sbjct: 10  IGEGTYGVVYKAQ--NNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64

Query: 462 LLGCCLETQVPLLVYEFV---------GNGTLFEHIHKKGNLSWERRLRITAETAGVLSY 512
           L       +  +LV+E +               E +  K   S+  +L       G ++Y
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK---SFLLQL-----LNG-IAY 115

Query: 513 LHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDP 570
            H      ++HRD+K  N+L++     K++DFG ++   +P+    +  +V  TL Y  P
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-IV--TLWYRAP 169

Query: 571 EYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
           + L   K    + D++S G +  E++ G 
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L Length = 400

 Score = 59.1 bits (142), Expect = 2e-09
 Identities = 33/145 (22%), Positives = 55/145 (37%), Gaps = 9/145 (6%)

Query: 256 TSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDG 315
              GY C C  G++        C D++EC+DP    C+ +C N+ G Y C+C +GF  D 
Sbjct: 17  LKIGYECLCPDGFQLVAQRR--CEDIDECQDPDT--CSQLCVNLEGGYKCQCEEGFQLDP 72

Query: 316 ----RKDGGGCTPNQYTVIKVALGVGISFVVAIMSISWLHFLWTRRRHMKLKEKFF-EQN 370
                K  G      +T       + +        I  L  +      +     ++ + +
Sbjct: 73  HTKACKAVGSIAYLFFTNRHEVRKMTLDRSEYTSLIPNLRNVVALDTEVASNRIYWSDLS 132

Query: 371 GGSILRQELSKLHGQSSEKAKIFTE 395
              I   +L + HG SS    I  +
Sbjct: 133 QRMICSTQLDRAHGVSSYDTVISRD 157

>3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L Length = 400

 Score = 43.7 bits (102), Expect = 1e-04
 Identities = 12/36 (33%), Positives = 20/36 (55%), Gaps = 1/36 (2%)

Query: 282 NECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRK 317
           NEC D +   C+H+C+++   Y C C  GF    ++
Sbjct: 1   NECLD-NNGGCSHVCNDLKIGYECLCPDGFQLVAQR 35

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 9/92 (9%)

Query: 510 LSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFG-ASKLVPIDAIQNCTVVQGTLGY 567
           + ++HS   + I HRD+K  N+L++ ++ T K+ DFG A KL+P +      +   +  Y
Sbjct: 154 VGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA-YIC--SRFY 207

Query: 568 LDPEYLQTCKL-TDKSDVYSFGVVLVELLTGK 598
             PE +      T   D++S G V  EL+ GK
Sbjct: 208 RAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 Length = 53

 Score = 52.1 bits (125), Expect = 4e-09
 Identities = 15/46 (32%), Positives = 21/46 (45%), Gaps = 9/46 (19%)

Query: 280 DVNECEDPSRNN-------CTHICDNIPGSYTCRCRKGF--HGDGR 316
           D++EC   S++        C H+C N  G Y C CR G+    D  
Sbjct: 3   DLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQEDRH 48

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 44/189 (23%), Positives = 81/189 (42%), Gaps = 16/189 (8%)

Query: 368 EQNGGSILRQELSKLHGQSSEKAKIFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPD 424
               GS    +  K H  S   A +        + + Y    +IG G  G+V + +   +
Sbjct: 18  HTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLE 77

Query: 425 RTPVAVKKSKFVDQAKID--EFINELVVVLQINRRNVVRLLGCCLETQVPL-----LVYE 477
           +  VA+KK   V +  ID    + E+ ++ ++N  +VV++L   +   V       +V E
Sbjct: 78  KRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137

Query: 478 FVGNGT-LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN 536
                +   +       L+      +       + Y+HS   +  +HRD+K AN L++++
Sbjct: 138 IAD--SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS-AGI--LHRDLKPANCLVNQD 192

Query: 537 CTPKVSDFG 545
           C+ KV DFG
Sbjct: 193 CSVKVCDFG 201

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 56.8 bits (138), Expect = 7e-09
 Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 26/208 (12%)

Query: 409 IGCGGSGNVYKGFLPDRTP---VAVKKSKFVDQAKIDEFIN-----ELVVVLQINR---R 457
           IG G  G VYK    D      VA+K  +  +       +      E+ ++ ++      
Sbjct: 17  IGVGAYGTVYKAR--DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 458 NVVRLLGCCLETQVPL-----LVYEFVGN--GTLFEHIHKKGNLSWERRLRITAETAGVL 510
           NVVRL+  C  ++        LV+E V     T  +     G L  E    +  +    L
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQFLRGL 133

Query: 511 SYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDP 570
            +LH+     I+HRD+K  NIL+    T K++DFG +++          VV  TL Y  P
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYRAP 188

Query: 571 EYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           E L         D++S G +  E+   K
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 56.4 bits (137), Expect = 9e-09
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 38/213 (17%)

Query: 409 IGCGGSGNVYKGFLPDRT---PVAVKKSKFVDQAKIDEF----INELVVVLQINRRNVVR 461
           IG G  G V+K    +R     VA+K+ + +D    +      + E+ ++ ++  +N+VR
Sbjct: 10  IGEGTYGTVFKAK--NRETHEIVALKRVR-LDDDD-EGVPSSALREICLLKELKHKNIVR 65

Query: 462 LLGCCLETQVPLLVYEFV---------GNGTLFEHIHKKGNLSWERRLRITAETAGVLSY 512
           L       +   LV+EF                +    K   S+  +L       G L +
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK---SFLFQL-----LKG-LGF 116

Query: 513 LHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDP 570
            HS     ++HRD+K  N+L++ N   K+++FG ++   +P+       VV  TL Y  P
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VV--TLWYRPP 170

Query: 571 EYLQTCKLTDKS-DVYSFGVVLVELLTGKMALL 602
           + L   KL   S D++S G +  EL      L 
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 37/210 (17%)

Query: 407 DVIGCGGSGNVYKGFLPDRT--PVAVKKSKFVDQAKIDEF----INELVVVLQINRRNVV 460
           D +G G    VYKG     T   VA+K+ +   +   +      I E+ ++  +   N+V
Sbjct: 8   DKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIV 63

Query: 461 RLLGCCLETQVPLLVYEFV---------GNGTLFEHIHKKGNLSWERRLRITAETAGVLS 511
            L       +   LV+E++           G +    + K    +  +L       G L+
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVK---LFLFQL-----LRG-LA 114

Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLD 569
           Y H +    ++HRD+K  N+L++E    K++DFG ++   +P     N  VV  TL Y  
Sbjct: 115 YCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE-VV--TLWYRP 168

Query: 570 PEYLQTCKLTDKS-DVYSFGVVLVELLTGK 598
           P+ L          D++  G +  E+ TG+
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 44/233 (18%), Positives = 80/233 (34%), Gaps = 62/233 (26%)

Query: 407 DVIGCGGSGNVYKGF--LPDRTPVAVK----KSKFVDQAKIDEFINELVVVLQIN----- 455
             +G G  G V +       ++ VA+K      K+ + A++     E+ V+ +I      
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-----EINVLKKIKEKDKE 79

Query: 456 -RRNVVRLLGC-------CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRL--RITAE 505
            +   V +          C+        +E +G    FE + +     +       +  +
Sbjct: 80  NKFLCVLMSDWFNFHGHMCI-------AFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQ 131

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTP-------------------KVSDFGA 546
               L +LH      + H D+K  NIL   +                      +V+DFG+
Sbjct: 132 LCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188

Query: 547 SKLVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           +        ++  T+V  T  Y  PE +         DV+S G +L E   G 
Sbjct: 189 A----TFDHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 21/88 (23%), Positives = 30/88 (34%), Gaps = 18/88 (20%)

Query: 241 CGLNASCDTPKDNTSTSSG-YRC-KCNKGYEGNPYLSDGCRDVNECEDPSRNNCT----- 293
           C   A C      +S   G + C  C  G+ GN      C D++EC     + C      
Sbjct: 11  CFPGAQC------SSFPDGSWSCGFCPVGFLGNGT---HCEDLDECAL-VPDICFSTSKV 60

Query: 294 HICDNIPGSYTC-RCRKGFHGDGRKDGG 320
             C N    + C  C   + G+     G
Sbjct: 61  PRCVNTQPGFHCLPCPPRYRGNQPVGVG 88

>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 26/106 (24%), Positives = 35/106 (33%), Gaps = 20/106 (18%)

Query: 234 TCEEAKICGLNASCDTPKDNTS----TSSGYRCK-CNKGYEGNPYLSDG----------C 278
            CE+   C L                T  G+ C  C   Y GN  +  G          C
Sbjct: 40  HCEDLDECALVPDICFSTSKVPRCVNTQPGFHCLPCPPRYRGNQPVGVGLEAAKTEKQVC 99

Query: 279 RDVNECEDPSRN-----NCTHICDNIPGSYTCRCRKGFHGDGRKDG 319
              N C+D + N      C ++       Y C C+ G+ GDG   G
Sbjct: 100 EPENPCKDKTHNCHKHAECIYLGHFSDPMYKCECQTGYAGDGLICG 145

>3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} Length = 386

 Score = 55.2 bits (132), Expect = 4e-08
 Identities = 19/62 (30%), Positives = 27/62 (43%), Gaps = 7/62 (11%)

Query: 256 TSSGYRCKCNKGYEGNPYLSDG--CRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHG 313
                +C C+ GY       DG  C+DVNEC +     C+  C N  G++ C C  G+  
Sbjct: 20  IRGAVQCTCHTGYR---LTEDGRTCQDVNECAEEG--YCSQGCTNSEGAFQCWCEAGYEL 74

Query: 314 DG 315
             
Sbjct: 75  RP 76

>3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} Length = 386

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 11/47 (23%), Positives = 15/47 (31%), Gaps = 3/47 (6%)

Query: 280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCTPNQ 326
               C + +   C   C  I G+  C C  G+      DG  C    
Sbjct: 2   GEENC-NVNNGGCAQKCQMIRGAVQCTCHTGYRLTE--DGRTCQDVN 45

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.5 bits (130), Expect = 5e-08
 Identities = 33/191 (17%), Positives = 55/191 (28%), Gaps = 51/191 (26%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKKSKFVD--------QAKIDEFINELVVVLQINRR--- 457
           IG G  G V++    D TPVA+K              Q   +E + E+++  +++     
Sbjct: 28  IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 458 ------NVVRLLGCCL------------------------------ETQVPLLVYEFVGN 481
                   + L                                   +     +V EF   
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV 541
           G   E +  K   S      I  +    L+   +       HRD+   N+LL +    K+
Sbjct: 147 GIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKL 203

Query: 542 SDFGASKLVPI 552
                 K   I
Sbjct: 204 HYTLNGKSSTI 214

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 66/368 (17%), Positives = 116/368 (31%), Gaps = 133/368 (36%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQI--------NRR 457
           +G G    V+  + +  +  VA+K  KS    +   +  ++E+ ++  +        NR 
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 458 NVVRLLGC-----------CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRL------ 500
            VV+LL             C+       V+E +G+  L + I K    S  + L      
Sbjct: 102 MVVQLLDDFKISGVNGTHICM-------VFEVLGH-HLLKWIIK----SNYQGLPLPCVK 149

Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILL--------------------------- 533
           +I  +    L YLH++    IIH D+K  NILL                           
Sbjct: 150 KIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 534 ----------------------DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
                                  E    K++D G +  V          +Q T  Y   E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQ-TRQYRSLE 263

Query: 572 YLQTCKLTDKSDVYSFGVVLVELLTGK---------------------MALLSDKPEE-- 608
            L        +D++S   +  EL TG                      + LL   P +  
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323

Query: 609 ----------ERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGE 658
                      +   +  ++ LK   L E+L  +   + ++++           + +  E
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFLLPMLELIPE 381

Query: 659 ERPTMKEV 666
           +R T  E 
Sbjct: 382 KRATAAEC 389

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 52.6 bits (127), Expect = 2e-07
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 26/207 (12%)

Query: 407 DVIGCGGSGNVYKGFLPDRT---PVAVKKSKFVDQAKIDEF----INELVVVLQINRRNV 459
           + +G G    VYKG   ++T    VA+K+ K   +   +      I E+ ++ ++   N+
Sbjct: 11  EKLGNGTYATVYKGL--NKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENI 65

Query: 460 VRLLGCCLETQVPLLVYEFVGN--GTLFEH---IHKKGNLSWERRLRITAETAGVLSYLH 514
           VRL           LV+EF+ N      +     +    L          +    L++ H
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125

Query: 515 SETNVPIIHRDVKSANILLDENCTPKVSDFGASKL--VPIDAIQNCTVVQGTLGYLDPEY 572
                 I+HRD+K  N+L+++    K+ DFG ++   +P++   +  VV  TL Y  P+ 
Sbjct: 126 ENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE-VV--TLWYRAPDV 179

Query: 573 LQTCKLTDKS-DVYSFGVVLVELLTGK 598
           L   +    S D++S G +L E++TGK
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGK 206

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 54/237 (22%), Positives = 84/237 (35%), Gaps = 66/237 (27%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK----KSKFVDQAKIDEFINELVVVLQIN-----R 456
             +G G  G V     + ++   AVK      K+   AKI     E  ++ +I       
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-----EADILKKIQNDDINN 95

Query: 457 RNVVRLLGC-------CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRL--RITAETA 507
            N+V+  G        CL       ++E +G  +L+E I +     +          E  
Sbjct: 96  NNIVKYHGKFMYYDHMCL-------IFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEIL 147

Query: 508 GVLSYLHSETNVPIIHRDVKSANILLDENCTP-------------------------KVS 542
             L+YL   +   + H D+K  NILLD+                             K+ 
Sbjct: 148 KALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 543 DFGASKLVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK 598
           DFG +            +++  T  Y  PE +        SD++SFG VL EL TG 
Sbjct: 205 DFGCA----TFKSDYHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135

 Score = 49.1 bits (118), Expect = 3e-07
 Identities = 23/76 (30%), Positives = 33/76 (43%), Gaps = 15/76 (19%)

Query: 241 CGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGC-RDVNECE-DPSRNNCTHICDN 298
           C     C       +T   + C+C +GY G       C  DVNEC  +P +N+ T  C +
Sbjct: 15  CEHAGKC------INTLGSFECQCLQGYTG-----PRCEIDVNECVSNPCQNDAT--CLD 61

Query: 299 IPGSYTCRCRKGFHGD 314
             G + C C  G+ G 
Sbjct: 62  QIGEFQCICMPGYEGV 77

>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135

 Score = 45.3 bits (108), Expect = 6e-06
 Identities = 17/59 (28%), Positives = 24/59 (40%), Gaps = 11/59 (18%)

Query: 259 GYRCKCNKGYEGNPYLSDGC-RDVNECEDPSRNNCTH--ICDNIPGSYTCRCRKGFHGD 314
            ++C C  GYEG       C  + +EC     + C H   C +    + C C  GF G 
Sbjct: 65  EFQCICMPGYEG-----VHCEVNTDECAS---SPCLHNGRCLDKINEFQCECPTGFTGH 115

>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135

 Score = 43.0 bits (102), Expect = 5e-05
 Identities = 15/39 (38%), Positives = 22/39 (56%), Gaps = 3/39 (7%)

Query: 278 CRDVNECEDPSRNNCTH--ICDNIPGSYTCRCRKGFHGD 314
            +DV+EC   + N C H   C N  GS+ C+C +G+ G 
Sbjct: 2   AQDVDECSLGA-NPCEHAGKCINTLGSFECQCLQGYTGP 39

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 51.1 bits (123), Expect = 6e-07
 Identities = 51/239 (21%), Positives = 89/239 (37%), Gaps = 74/239 (30%)

Query: 407 DVIGCGGSGNVYKGF--LPDRTPVAVK----KSKFVDQAKIDEFINELVVVLQINRR--- 457
           D +G G  G V +          VAVK      ++ + A+      E+ V+  +N     
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-----EIQVLEHLNTTDPN 74

Query: 458 ---NVVRLLGC-------CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRL--RITAE 505
                V++L         C+       V+E +G  + ++ I + G L +      ++  +
Sbjct: 75  STFRCVQMLEWFEHHGHICI-------VFELLGL-STYDFIKENGFLPFRLDHIRKMAYQ 126

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTP-------------------KVSDFGA 546
               +++LHS     + H D+K  NIL  ++                      KV DFG+
Sbjct: 127 ICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183

Query: 547 SKLVPIDAIQN-CTVVQGTLGYLDPE------YLQTCKLTDKSDVYSFGVVLVELLTGK 598
           +        ++  T+V  T  Y  PE      + Q C      DV+S G +L+E   G 
Sbjct: 184 A----TYDDEHHSTLVS-TRHYRAPEVILALGWSQPC------DVWSIGCILIEYYLGF 231

>2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Length = 142

 Score = 48.1 bits (115), Expect = 9e-07
 Identities = 14/60 (23%), Positives = 22/60 (36%), Gaps = 9/60 (15%)

Query: 259 GYRCKCNKGYEGNPYLSDGC-RDVNECEDPSRNN--CTHICDNIPGS-YTCRCRKGFHGD 314
            Y C C   +EG       C    ++       N  C   C +  G+  +CRC +G+   
Sbjct: 67  SYICFCLPAFEGR-----NCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLL 121

>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134

 Score = 47.7 bits (114), Expect = 9e-07
 Identities = 13/57 (22%), Positives = 19/57 (33%), Gaps = 6/57 (10%)

Query: 259 GYRCKCNKGYEGNPYLSDGC-RDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGD 314
            Y C C +G+EG       C     +       +C   C     S  C C +G+   
Sbjct: 62  EYTCTCLEGFEG-----KNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLA 113

>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134

 Score = 46.1 bits (110), Expect = 3e-06
 Identities = 20/81 (24%), Positives = 31/81 (38%), Gaps = 9/81 (11%)

Query: 236 EEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTH- 294
           EE K   L   C     +   +       +K  E      +  +D ++CE    + C + 
Sbjct: 1   EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEF----WNKYKDGDQCET---SPCQNQ 53

Query: 295 -ICDNIPGSYTCRCRKGFHGD 314
             C +  G YTC C +GF G 
Sbjct: 54  GKCKDGLGEYTCTCLEGFEGK 74

>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 15/75 (20%), Positives = 21/75 (28%), Gaps = 12/75 (16%)

Query: 241 CGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGC-RDVNECEDPSRNNCTHICDNI 299
           C     C            Y C C +G+EG       C     +       +C   C   
Sbjct: 50  CQNQGKC------KDGLGEYTCTCLEGFEG-----KNCELFTRKLCSLDNGDCDQFCHEE 98

Query: 300 PGSYTCRCRKGFHGD 314
             S  C C +G+   
Sbjct: 99  QNSVVCSCARGYTLA 113

>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 13/90 (14%), Positives = 19/90 (21%), Gaps = 14/90 (15%)

Query: 228 EIITDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNEC-ED 286
           E+ T K C        +  C          +   C C +GY      +D  +        
Sbjct: 77  ELFTRKLCSL-DNGDCDQFC------HEEQNSVVCSCARGYTL----ADNGKACIPTGPY 125

Query: 287 PSRNNCTHICDNIPGSYTCRCRKGFHGDGR 316
           P                      G   D  
Sbjct: 126 PCGKQTL--ERRKRSVAQATSSSGEAPDSI 153

>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Length = 146

 Score = 47.3 bits (113), Expect = 1e-06
 Identities = 12/57 (21%), Positives = 14/57 (24%), Gaps = 7/57 (12%)

Query: 259 GYRCKCNKGYEGNPYLSDGC-RDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGD 314
            Y C C  G+EG       C  D        R               C C  G+   
Sbjct: 68  SYECWCQVGFEG-----KNCELDATCNIKNGRCKQFC-KTGADSKVLCSCTTGYRLA 118

>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 23/77 (29%), Positives = 35/77 (45%), Gaps = 10/77 (12%)

Query: 241 CGLNASC-DTPKDNTSTSSGYRCKCNKGYEGNPYLSDGC-RDVNECE-DPSRNNCTHICD 297
           C    +C  +      T  GY CKC +G+ G       C  ++NECE +P +N     C 
Sbjct: 60  CHNGGTCEISEAYRGDTFIGYVCKCPRGFNG-----IHCQHNINECEVEPCKNGGI--CT 112

Query: 298 NIPGSYTCRCRKGFHGD 314
           ++  +Y+C C   F G 
Sbjct: 113 DLVANYSCECPGEFMGR 129

>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143

 Score = 42.4 bits (100), Expect = 7e-05
 Identities = 15/88 (17%), Positives = 24/88 (27%), Gaps = 18/88 (20%)

Query: 241 CGLNASCDTPKDNTSTSSGYRCKCNKGYEG--------NPYLSDGCRDVNECE-DPSRNN 291
           C     C            + C+C  G+               +       C  +P  N 
Sbjct: 8   CENGGICL----PGLADGSFSCECPDGFTDPNCSSVVEVASDEEEPTSAGPCTPNPCHNG 63

Query: 292 --CTHI---CDNIPGSYTCRCRKGFHGD 314
             C        +    Y C+C +GF+G 
Sbjct: 64  GTCEISEAYRGDTFIGYVCKCPRGFNGI 91

>3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} Length = 317

 Score = 47.4 bits (113), Expect = 9e-06
 Identities = 28/86 (32%), Positives = 35/86 (40%), Gaps = 13/86 (15%)

Query: 241 CGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGC-RDVNECEDPSRNNCTHICDNI 299
           C  N SC   +D+     GY C C+ GYEG       C    NEC     + C H C   
Sbjct: 13  CLHNGSC---QDS---IWGYTCTCSPGYEG-----SNCELAKNECHPERTDGCQHFCLPG 61

Query: 300 PGSYTCRCRKGF-HGDGRKDGGGCTP 324
             SYTC C +G+  G+  K       
Sbjct: 62  QESYTCSCAQGYRLGEDHKQCVPHDQ 87

>3v64_C Agrin; beta propeller, laminin-G, signaling, protein binding; HET: NAG; 2.85A {Rattus norvegicus} Length = 349

 Score = 47.2 bits (111), Expect = 1e-05
 Identities = 13/45 (28%), Positives = 18/45 (40%), Gaps = 4/45 (8%)

Query: 281 VNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCTPN 325
           VNEC +     C+  C N  G++ C C  G+      D   C   
Sbjct: 1   VNECAEEG--YCSQGCTNSEGAFQCWCEAGYELRP--DRRSCKAL 41

>1nzi_A Complement C1S component; calcium, innate immunity, modular structure, CUB, EGF, hydrolase; 1.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 Length = 159

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 15/41 (36%), Positives = 20/41 (48%), Gaps = 2/41 (4%)

Query: 278 CRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGF--HGDGR 316
             D+NEC D     C+H C+N  G Y C C   +  H D +
Sbjct: 114 ATDINECTDFVDVPCSHFCNNFIGGYFCSCPPEYFLHDDMK 154

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 35/148 (23%), Positives = 63/148 (42%), Gaps = 16/148 (10%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVV--VLQINRRNVVRLLGC 465
           IG G  G +Y G  +     VA+K      + K  + + E  +  +LQ     +  +   
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLEN--VKTKHPQLLYESKIYRILQ-GGTGIPNVRWF 71

Query: 466 CLETQVPLLVYEFVGN--GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
            +E    +LV + +G     LF    +K  LS +  L +  +    + ++HS++    +H
Sbjct: 72  GVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKS---FLH 126

Query: 524 RDVKSANILLDENCTPK---VSDFGASK 548
           RD+K  N L+          + DFG +K
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 16/60 (26%), Positives = 24/60 (40%), Gaps = 11/60 (18%)

Query: 259 GYRCKCNKGYEGNPYLSDGC-RDVNECEDPS--RNNCTHIC-DNIPGSYTCRCRKGFHGD 314
            ++C C   + G       C +D+N C       N  T  C +  P  Y C C +G+ G 
Sbjct: 113 PWQCLCETNWGG-----QLCDKDLNYCGTHQPCLNGGT--CSNTGPDKYQCSCPEGYSGP 165

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 28/150 (18%), Positives = 58/150 (38%), Gaps = 18/150 (12%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR--RNVVRLLGC 465
           IG G  G +++G  L +   VA+K      ++   +  +E     ++      +  +   
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDE-YRTYKLLAGCTGIPNVYYF 74

Query: 466 CLETQVPLLVYEFVGN--GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             E    +LV + +G     L +   +K   S +       +    +  +H ++   +++
Sbjct: 75  GQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEKS---LVY 129

Query: 524 RDVKSANILLDENCTPK-----VSDFGASK 548
           RD+K  N L+    +       V DFG  K
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 37/148 (25%), Positives = 61/148 (41%), Gaps = 16/148 (10%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVV--VLQINRRNVVRLLGC 465
           IG G  G++Y G  +     VA+K      + K  +   E  +  ++Q     +  +  C
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQ-GGVGIPTIRWC 73

Query: 466 CLETQVPLLVYEFVGN--GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
             E    ++V E +G     LF    +K   S +  L +  +    + Y+HS+     IH
Sbjct: 74  GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHSKN---FIH 128

Query: 524 RDVKSANILLDENCTPK---VSDFGASK 548
           RDVK  N L+          + DFG +K
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A Length = 91

 Score = 40.2 bits (94), Expect = 2e-04
 Identities = 13/56 (23%), Positives = 17/56 (30%), Gaps = 6/56 (10%)

Query: 260 YRCKCNKGYEGNPYLSDGCRDVNECED-PSRNNCTHICDNIPGSYTCRCRKGFHGD 314
             C CN G             V  C +    N  T         + C+C +GF G 
Sbjct: 32  EYCWCNSGRAQC-----HSVPVKSCSEPRCFNGGTCQQALYFSDFVCQCPEGFAGK 82

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 32/165 (19%), Positives = 63/165 (38%), Gaps = 30/165 (18%)

Query: 409 IGCGGSGNVYKGFLPDRTPVAVKK-----------------SKFVDQAKIDEFINELVVV 451
           IG GG G +Y   +     V                      KF  +A   E I + +  
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 452 LQINRRNVVRLLGCCLETQVPL----LVYEFVGN--GTLFEHIHKKGNLSWERRLRITAE 505
            ++    V +  G  L  +       ++ +  G+    ++E   K+   S +  L+++  
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR--FSRKTVLQLSLR 160

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV--SDFGASK 548
              +L Y+H       +H D+K++N+LL+     +V   D+G + 
Sbjct: 161 ILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 Length = 51

 Score = 38.1 bits (89), Expect = 3e-04
 Identities = 8/33 (24%), Positives = 11/33 (33%), Gaps = 4/33 (12%)

Query: 288 SRNN--CTHICDNIPGSYTCRCRKGF--HGDGR 316
           S +N  C   C        C C  G+    D +
Sbjct: 2   SLDNGGCDQFCREERSEVRCSCAHGYVLGDDSK 34

>2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... Length = 55

 Score = 37.7 bits (88), Expect = 4e-04
 Identities = 11/41 (26%), Positives = 16/41 (39%), Gaps = 8/41 (19%)

Query: 288 SRNN--CTHICDNIPGSYTCRCRKGF--HGDGRKDGGGCTP 324
           S +N  C   C     S  C C +G+    +G+     C P
Sbjct: 5   SLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKA----CIP 41

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 33/149 (22%), Positives = 58/149 (38%), Gaps = 16/149 (10%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCC 466
           IGCG  G +  G  L     VA+K      +++  +   E     Q+ +   + ++    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEP--MKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 467 LETQVPLLVYEFVGN--GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
              +   +V E +G     LF+   +    S +  L I  +    + Y+HS+    +I+R
Sbjct: 75  PCGKYNAMVLELLGPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVHSKN---LIYR 129

Query: 525 DVKSANILLDENCTPKVS-----DFGASK 548
           DVK  N L+              DF  +K
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 25/164 (15%), Positives = 53/164 (32%), Gaps = 28/164 (17%)

Query: 409 IGCGGSGNVYKGF---------LPDRTPVAVK----------KSKFVDQAKIDEFINELV 449
                 G +Y+            P +   ++K          +  F  +A     +N+  
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 450 VVLQINRRNVVRLLGC-CLETQVPLLVYEFVGN--GTLFEHIHKKGNLSWERRLRITAET 506
            +       +   +G    + +   LV   +G    +  +   K   LS    L++    
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKH-VLSERSVLQVACRL 168

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV--SDFGASK 548
              L +LH       +H +V + NI +D     +V  + +G + 
Sbjct: 169 LDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 34/161 (21%), Positives = 56/161 (34%), Gaps = 25/161 (15%)

Query: 409 IGCGGSGNVYKGF-LPDRTPVAVKK--------------SKFVDQAKIDEFINELVVVLQ 453
           IG GG G +Y  F        A                  KF  +    + I + +   Q
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 454 INRRNVVRLLGC----CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGV 509
           ++   +    G             +V E +G   L +   + G       L++      V
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDV 163

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKV--SDFGASK 548
           L Y+H       +H D+K+AN+LL      +V  +D+G S 
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L* Length = 69

 Score = 37.5 bits (87), Expect = 7e-04
 Identities = 15/52 (28%), Positives = 20/52 (38%), Gaps = 12/52 (23%)

Query: 278 CRDVNECEDPSRNN--CTHICDNIPGS-YTCRCRKGF--HGDGRKDGGGCTP 324
             D   C      N  C   C +  G+  +CRC +G+    DG      CTP
Sbjct: 2   KDDQLIC---VNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVS----CTP 46

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	735
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.58
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
1emn_A	82	Fibrillin; extracellular matrix, calcium-binding,	99.1
1lmj_A	86	Fibrillin 1; EGF, calcium, microfibril, neonatal,	99.08
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.04
1z6c_A	87	Vitamin K-dependent protein S; EGF module, blood c	98.97
2w2n_E	107	LDL receptor, low-density lipoprotein receptor; hy	98.95
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.95
1x7a_L	146	Coagulation factor IX, light chain; inhibition, bl	98.92
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.88
2bou_A	143	EGF-like module containing mucin-like hormone rece	98.83
1nfu_B	195	Coagulation factor XA, light chain; hydrolase; HET	98.74
1aut_L	114	Activated protein C; serine proteinase, plasma cal	98.69
3h5c_B	317	Vitamin K-dependent protein Z; protein Z-protein Z	98.69
3p5b_L	400	Low density lipoprotein receptor variant; B-propel	98.65
2vh0_B	134	Activated factor XA light chain; serine protease,	98.64
2vj3_A	135	Neurogenic locus notch homolog protein 1; transcri	98.63
2c4f_L	142	Coagulation factor VII precursor; blood coagulatio	98.57
3v65_B	386	Low-density lipoprotein receptor-related protein;	98.56
1yo8_A	634	Thrombospondin-2; EGF, Ca(2+)-binding domains, lec	98.54
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.52
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.43
4d90_A	143	EGF-like repeat and discoidin I-like domain-conta	98.42
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.35
2vj3_A	135	Neurogenic locus notch homolog protein 1; transcri	98.29
1dx5_I	118	Thrombomodulin; serine proteinase, EGF-like domain	98.27
2w86_A	147	Fibrillin-1, fibrillin1; phosphoprotein, EGF-like	98.25
1yo8_A	634	Thrombospondin-2; EGF, Ca(2+)-binding domains, lec	98.25
2bou_A	143	EGF-like module containing mucin-like hormone rece	98.24
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.22
1n7d_A	699	LDL receptor, low-density lipoprotein receptor; fa	98.2
1z1y_A	186	Ookinete surface protein PVS25; four EGF-like doma	98.18
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.13
3m0c_C	791	LDL receptor, low-density lipoprotein receptor; pr	98.13
1z1y_A	186	Ookinete surface protein PVS25; four EGF-like doma	98.13
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.09
1uzk_A	162	Fibrillin-1; glycoprotein, extra-cellular matrix,	97.92
1uzk_A	162	Fibrillin-1; glycoprotein, extra-cellular matrix,	97.92
1dx5_I	118	Thrombomodulin; serine proteinase, EGF-like domain	97.89
4d90_A	143	EGF-like repeat and discoidin I-like domain-conta	97.89
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.84
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.76
1tpg_A	91	T-plasminogen activator F1-G; plasminogen activati	97.63
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.55
1apq_A	53	Complement protease C1R; EGF, calcium binding, ser	97.5
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.49
2jkh_L	55	Factor X light chain; plasma, calcium, zymogen, se	97.42
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.39
2k2s_B	61	Micronemal protein 6; microneme protein complex, c	97.39
1kli_L	69	Factor VIIA; extrinsic coagulation pathway, serine	97.28
2vj2_A	169	Jagged-1; signalling, polymorphism, glycoprotein,	97.19
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.18
1kig_L	51	Factor XA; glycoprotein, serine protease, plasma,	97.16
1edm_B	39	Factor IX; epidermal growth factor, EGF, calcium-	96.99
2wph_E	59	Coagulation factor IXA light chain; serine proteas	96.98
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.92
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.89
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.89
2bz6_L	53	Blood coagulation factor VIIA; serine protease, en	96.86
3u7u_G	55	Neuregulin 1; signaling protein, transferase-trans	96.82
1emn_A	82	Fibrillin; extracellular matrix, calcium-binding,	96.78
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.77
1egf_A	53	Epidermal growth factor; NMR {Mus musculus} SCOP:	96.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.71
1gl4_A	285	Nidogen-1, entactin; immunoglobulin-like domain, e	96.69
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.67
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.52
1kli_L	69	Factor VIIA; extrinsic coagulation pathway, serine	96.48
2w2n_E	107	LDL receptor, low-density lipoprotein receptor; hy	96.42
1apq_A	53	Complement protease C1R; EGF, calcium binding, ser	96.35
1a3p_A	45	Epidermal growth factor; disulfide connectivities,	96.27
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.27
2jkh_L	55	Factor X light chain; plasma, calcium, zymogen, se	96.23
1tpg_A	91	T-plasminogen activator F1-G; plasminogen activati	96.21
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.2
1hae_A	63	Heregulin-alpha; growth factor; NMR {Homo sapiens}	96.18
1lmj_A	86	Fibrillin 1; EGF, calcium, microfibril, neonatal,	96.15
1edm_B	39	Factor IX; epidermal growth factor, EGF, calcium-	96.12
2w86_A	147	Fibrillin-1, fibrillin1; phosphoprotein, EGF-like	95.92
1x7a_L	146	Coagulation factor IX, light chain; inhibition, bl	95.76
3p5b_L	400	Low density lipoprotein receptor variant; B-propel	95.69
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.63
1egf_A	53	Epidermal growth factor; NMR {Mus musculus} SCOP:	95.59
2kl7_A	71	Fibulin-4; secreted, calcium, disease mutation, di	95.57
4fbr_A	267	Lectin, myxobacterial hemagglutinin; beta-barrel,	95.49
2kl7_A	71	Fibulin-4; secreted, calcium, disease mutation, di	95.49
1g1s_A	162	P-selectin; selectin, lectin, EGF, sulphated, SLEX	95.44
4fbr_A	267	Lectin, myxobacterial hemagglutinin; beta-barrel,	95.42
1k36_A	46	Epiregulin; EGF-like fold, hormone/growth factor c	95.42
2k2s_B	61	Micronemal protein 6; microneme protein complex, c	95.33
1gl4_A	285	Nidogen-1, entactin; immunoglobulin-like domain, e	95.31
1kig_L	51	Factor XA; glycoprotein, serine protease, plasma,	95.05
3h5c_B	317	Vitamin K-dependent protein Z; protein Z-protein Z	95.03
1n7d_A	699	LDL receptor, low-density lipoprotein receptor; fa	94.97
1nql_B	53	Epidermal growth factor; cell surface receptor, ty	94.69
3fcs_B	690	Integrin beta-3; beta propeller, rossmann fold, EG	94.44
1z6c_A	87	Vitamin K-dependent protein S; EGF module, blood c	94.33
3u7u_G	55	Neuregulin 1; signaling protein, transferase-trans	94.28
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.88
1nzi_A	159	Complement C1S component; calcium, innate immunity	93.77
3m0c_C	791	LDL receptor, low-density lipoprotein receptor; pr	93.77
1szb_A	170	Mannose binding lectin-associated serine protease-	93.61
1k36_A	46	Epiregulin; EGF-like fold, hormone/growth factor c	93.61
2gy5_A	423	Angiopoietin-1 receptor; ligand-binding domain, tr	93.53
2wg3_C	463	Hedgehog-interacting protein; lipoprotein, develop	93.37
3v65_B	386	Low-density lipoprotein receptor-related protein;	93.19
1aut_L	114	Activated protein C; serine proteinase, plasma cal	93.1
2vh0_B	134	Activated factor XA light chain; serine protease,	93.02
3fcs_B	690	Integrin beta-3; beta propeller, rossmann fold, EG	92.86
1ob1_C	99	Major merozoite surface protein; immune system, im	92.75
3f1s_B	283	Vitamin K-dependent protein Z; PZ, ZPI, complex, s	92.61
3v64_C	349	Agrin; beta propeller, laminin-G, signaling, prote	92.56
1nfu_B	195	Coagulation factor XA, light chain; hydrolase; HET	92.53
2wph_E	59	Coagulation factor IXA light chain; serine proteas	92.51
2ygq_A	324	WIF-1, WNT inhibitory factor 1; signaling protein,	92.39
1n1i_A	105	Merozoite surface protein-1; MSP1, malaria, surfac	92.19
2bz6_L	53	Blood coagulation factor VIIA; serine protease, en	92.06
3ca7_A	52	Protein spitz; argos, EGF, developmental protein,	92.01
2ygq_A	324	WIF-1, WNT inhibitory factor 1; signaling protein,	91.92
3ca7_A	52	Protein spitz; argos, EGF, developmental protein,	91.63
3mes_A	424	Choline kinase; malaria, structural genomics, stru	91.58
1a3p_A	45	Epidermal growth factor; disulfide connectivities,	91.58
2gy5_A	423	Angiopoietin-1 receptor; ligand-binding domain, tr	91.47
3k6s_B	687	Integrin beta-2; cell receptor, adhesion molecule,	91.42
1szb_A	170	Mannose binding lectin-associated serine protease-	91.27
2c4f_L	142	Coagulation factor VII precursor; blood coagulatio	90.85
3ltf_D	58	Protein spitz; receptor-ligand complex ectodomain	90.23
2vj2_A	169	Jagged-1; signalling, polymorphism, glycoprotein,	90.1
3cfw_A	164	L-selectin; EGF, cell adhesion, EGF-like domain, g	89.91
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.57
3f1s_B	283	Vitamin K-dependent protein Z; PZ, ZPI, complex, s	89.42
3v64_C	349	Agrin; beta propeller, laminin-G, signaling, prote	88.99
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.07
1q4g_A	553	Prostaglandin G/H synthase 1; cyclooxygenase, non-	87.97
3nt1_A	587	Prostaglandin-endoperoxide synthase 2; prostagland	86.89
3e50_C	50	Protransforming growth factor alpha; IDE, TGF-alph	86.64
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.21
1nzi_A	159	Complement C1S component; calcium, innate immunity	84.72
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.58
2fd6_A	122	Urokinase-type plasminogen activator; UPAR, ATF, A	84.46
1nql_B	53	Epidermal growth factor; cell surface receptor, ty	84.39
2rnl_A	50	Amphiregulin; AR, colorectum cell-derived growth f	81.85
1ijq_A	316	LDL receptor, low-density lipoprotein receptor; be	81.24
4aqs_A	525	Laminin subunit beta-1; cell adhesion; HET: NAG BM	80.68
4a0p_A	628	LRP6, LRP-6, low-density lipoprotein receptor-rela	80.22
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.14

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.9e-54  Score=450.00  Aligned_cols=258  Identities=26%  Similarity=0.362  Sum_probs=216.2

Q ss_pred             hhhccccccccccCcEEEEEEEcC------CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      ...+.+.+.||+|+||+||+|.+.      ++..||||+++.......++|.+|+++|++++|||||+++|++.+.+..+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            344557789999999999999863      36789999999888888899999999999999999999999999999999


Q ss_pred             EEEEecCCCchhHHhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 004702          474 LVYEFVGNGTLFEHIHKK-------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPK  540 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k  540 (735)
                      |||||+++|+|.++|+..             ..++|.++++|+.|||+||+|||+++   ||||||||+||||++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence            999999999999999753             36999999999999999999999998   99999999999999999999


Q ss_pred             EeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHH
Q 004702          541 VSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLS  618 (735)
Q Consensus       541 l~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  618 (735)
                      |+|||+|+........ ......||+.|||||.+.+..++.|+|||||||+||||+| |+.||......+..       .
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~-------~  241 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-------E  241 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------H
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------H
Confidence            9999999876543322 2223458999999999999999999999999999999999 89999765543311       1


Q ss_pred             HhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       619 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .+..+.         ..+.+...++++.+|+.+||+.||++||||.||++.|+++.+.
T Consensus       242 ~i~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          242 CITQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            111111         1122344567899999999999999999999999999987654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.9e-54  Score=452.45  Aligned_cols=258  Identities=24%  Similarity=0.353  Sum_probs=215.2

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLET  469 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  469 (735)
                      ||...+..|.+.||+|+||+||+|.+.      ++..||||+++.. .....++|.+|+.+|++++|||||+++|++.+.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            455566778899999999999999863      4678999998753 334467899999999999999999999999999


Q ss_pred             CceeEEEEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 004702          470 QVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL  533 (735)
Q Consensus       470 ~~~~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl  533 (735)
                      +..+|||||+++|+|.++|+..                ..++|.++++|+.|||+||+|||+++   ||||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEE
Confidence            9999999999999999999642                35899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCCcccCCCc-ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHH
Q 004702          534 DENCTPKVSDFGASKLVPIDA-IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERS  611 (735)
Q Consensus       534 ~~~~~~kl~DFGls~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~  611 (735)
                      ++++++||+|||+++...... ....+...||++|||||++.+..++.++|||||||+||||+| |+.||......+.  
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~--  256 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV--  256 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH--
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            999999999999998764332 223344569999999999999999999999999999999999 8999976554321  


Q ss_pred             HHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                           ...+..         ....+.+...+.++.+|+.+||+.||++||||.||++.|+.+
T Consensus       257 -----~~~i~~---------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          257 -----VEMIRN---------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -----HHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -----HHHHHc---------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                 111111         112223445667899999999999999999999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.9e-53  Score=451.39  Aligned_cols=256  Identities=25%  Similarity=0.371  Sum_probs=209.9

Q ss_pred             hccccccccccCcEEEEEEEcC------CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      ...+.++||+|+||+||+|.+.      ++..||||+++..+....++|.+|+++|++++|||||+++|++.+.+..+||
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV  121 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV  121 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3456779999999999999864      4678999999988888889999999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 004702          476 YEFVGNGTLFEHIHKK---------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPK  540 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k  540 (735)
                      |||+++|+|.++|+..               .+++|.++++|+.|||+||+|||+++   ||||||||+||||++++.+|
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~K  198 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK  198 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEE
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEE
Confidence            9999999999999753               35999999999999999999999998   99999999999999999999


Q ss_pred             EeeccCCcccCCCc-ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHH
Q 004702          541 VSDFGASKLVPIDA-IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLS  618 (735)
Q Consensus       541 l~DFGls~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  618 (735)
                      |+|||+++...... ....+...||+.|||||++.+..++.++|||||||+||||+| |+.||......+...       
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~-------  271 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID-------  271 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH-------
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH-------
Confidence            99999999764432 223344569999999999999999999999999999999999 899997665433211       


Q ss_pred             HhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       619 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .+..+         ...+.+...++++.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus       272 ~i~~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 CITQG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHcC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            11111         11122334567899999999999999999999999999988754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-52  Score=440.38  Aligned_cols=264  Identities=27%  Similarity=0.410  Sum_probs=209.0

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      +||......+.+.||+|+||+||+|++++  .||||+++.  .+....+.|.+|+.+|++++|||||+++|++.+ +..+
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            34555566778899999999999999754  599998864  345667889999999999999999999999865 5679


Q ss_pred             EEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          474 LVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      |||||+++|+|.++|+.. ..+++.++++|+.|||+||+|||+++   ||||||||+||||++++++||+|||+|+....
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            999999999999999764 57999999999999999999999998   99999999999999999999999999987653


Q ss_pred             Cc-ccceeeeccccCccCcccccC---CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH
Q 004702          553 DA-IQNCTVVQGTLGYLDPEYLQT---CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI  628 (735)
Q Consensus       553 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (735)
                      .. ........||+.|||||++..   ..|+.|+|||||||+||||+||+.||...........      .+..+.    
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~------~~~~~~----  254 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF------MVGRGY----  254 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH------HHHTTC----
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH------HHhcCC----
Confidence            22 223345579999999999864   4589999999999999999999999976544322111      111100    


Q ss_pred             hhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       629 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      ..+. ....+...+.++.+|+.+||+.+|++||||.||++.|+.+...
T Consensus       255 ~~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          255 ASPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             CCCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             CCCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            0010 0112334567899999999999999999999999999876543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.4e-51  Score=438.98  Aligned_cols=266  Identities=27%  Similarity=0.338  Sum_probs=219.3

Q ss_pred             CHHHHHhhhccccccccccCcEEEEEEEcCC------CcEEEEEEeec-cChhHHHHHHHHHHHHHhcCC-CceEEEceE
Q 004702          394 TEEEIKTVTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKF-VDQAKIDEFINELVVVLQINR-RNVVRLLGC  465 (735)
Q Consensus       394 ~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~  465 (735)
                      +.+||....+.+.+.||+|+||+||+|.+.+      ++.||||+++. ......++|.+|+.+|++++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            3467777788889999999999999998532      35799999875 345557789999999999975 899999999


Q ss_pred             Eeec-CceeEEEEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 004702          466 CLET-QVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKS  528 (735)
Q Consensus       466 ~~~~-~~~~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~  528 (735)
                      |.+. +..+|||||+++|+|.++|+..                ..+++.+++.|+.|||+||+|||+++   ||||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence            9765 5679999999999999999753                34899999999999999999999999   99999999


Q ss_pred             CcEEEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCCh
Q 004702          529 ANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKP  606 (735)
Q Consensus       529 ~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~  606 (735)
                      +||||++++.+||+|||+|+.+..+... ......||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999977544332 2334568999999999999999999999999999999998 8999976543


Q ss_pred             HHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          607 EEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       607 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      .+.      +...+..         ....+.+...++++.+|+.+||+.||++|||+.||++.|+.+++..
T Consensus       294 ~~~------~~~~i~~---------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          294 DEE------FCRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             SHH------HHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHH------HHHHHHc---------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            221      1111111         1112223345678999999999999999999999999999988653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.3e-50  Score=416.54  Aligned_cols=246  Identities=24%  Similarity=0.353  Sum_probs=200.8

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEee----cCceeEEE
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE----TQVPLLVY  476 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~  476 (735)
                      .|.++||+|+||+||+|.. .++..||||++..  ......+.|.+|+.+|++++|||||++++++..    .+..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            4567899999999999985 4588999999864  455667889999999999999999999999865    34579999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+++|+|.++|++...+++..+..|+.||+.||+|||+++ ++||||||||+||||+ +++.+||+|||+|+.....  
T Consensus       109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~--  185 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--  185 (290)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC--
Confidence            99999999999998889999999999999999999999976 4699999999999998 4789999999999864332  


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                       ......||+.|||||++.+ .++.++|||||||+||||+||+.||........      ....+..+....        
T Consensus       186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~------~~~~i~~~~~~~--------  249 (290)
T 3fpq_A          186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA--------  249 (290)
T ss_dssp             -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG--------
T ss_pred             -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH------HHHHHHcCCCCC--------
Confidence             2344579999999998875 699999999999999999999999965443221      111111111100        


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+...++++.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            011123357899999999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.7e-50  Score=423.04  Aligned_cols=253  Identities=21%  Similarity=0.223  Sum_probs=208.0

Q ss_pred             cccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      .+.++||+|+||+||+|+. .++..||||+++....     +.+|+.+|++++|||||++++++.+.+..+|||||+++|
T Consensus        61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            4456899999999999985 4689999999875322     247999999999999999999999999999999999999


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEeeccCCcccCCCccc----c
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-TPKVSDFGASKLVPIDAIQ----N  557 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGls~~~~~~~~~----~  557 (735)
                      +|.++|++.+.+++..+..|+.||+.||+|||+++   ||||||||+||||+.++ .+||+|||+|+.+..+...    .
T Consensus       136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence            99999998889999999999999999999999999   99999999999999887 6999999999977543221    1


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|||||++.+..++.++|||||||+||||++|+.||......+....+   .    ...       ....+.
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~----~~~-------~~~~~~  278 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI---A----SEP-------PPIREI  278 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH---H----HSC-------CGGGGS
T ss_pred             CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH---H----cCC-------CCchhc
Confidence            22346999999999999999999999999999999999999999765433211111   0    000       000112


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      +...++++.+|+.+||+.||.+|||+.||++.|...+....
T Consensus       279 ~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            33456789999999999999999999999999998877654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.6e-50  Score=423.94  Aligned_cols=247  Identities=24%  Similarity=0.346  Sum_probs=207.6

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||+|+||+||+|+. .+++.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..||||||+++
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  155 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  155 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            44567899999999999985 46899999999765555567789999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|.+++.. ..+++.++..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++.+..+.. ..+..
T Consensus       156 g~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~  230 (346)
T 4fih_A          156 GALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL  230 (346)
T ss_dssp             EEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCC
T ss_pred             CcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-ccccc
Confidence            999999976 46999999999999999999999999   99999999999999999999999999997754332 23345


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|||||++.+..|+.++|||||||+||||++|+.||......+....+       ....     .+.  .......
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------~~~~-----~~~--~~~~~~~  296 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDNL-----PPR--LKNLHKV  296 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHSS-----CCC--CSCGGGS
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HcCC-----CCC--CCccccC
Confidence            6999999999999999999999999999999999999999765443321111       1100     000  1112234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ++++.+|+.+||+.||++|||+.|+++
T Consensus       297 s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          297 SPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            578999999999999999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-49  Score=423.95  Aligned_cols=248  Identities=21%  Similarity=0.302  Sum_probs=202.6

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.+.+.||+|+||+||+++. .+++.||||+++.  ......+.|.+|+.+|++++|||||++++++.+.+..||||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            355678999999999999984 5689999999864  3556678899999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          479 VGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       479 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +++|+|.++|...  ..+++.+++.|+.||+.||+|||+++   ||||||||+||||++++.+||+|||+++.+.... .
T Consensus       105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~  180 (350)
T 4b9d_A          105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E  180 (350)
T ss_dssp             CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred             CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence            9999999999754  45789999999999999999999999   9999999999999999999999999999764322 1


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      ..+...||+.|||||++.+..|+.++|||||||+||||++|+.||......+...       .+        +.... .+
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~-------~i--------~~~~~-~~  244 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL-------KI--------ISGSF-PP  244 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HH--------HHTCC-CC
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH-------HH--------HcCCC-CC
Confidence            2234569999999999999999999999999999999999999997654433211       11        11111 11


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+...+.++.+|+.+||+.||++|||+.|+++.
T Consensus       245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            223455789999999999999999999999763

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.5e-50  Score=422.82  Aligned_cols=267  Identities=22%  Similarity=0.256  Sum_probs=198.8

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC----ceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ----VPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||+|++ +++.||||+++..... ...+..|+..+.+++|||||+++|++.+.+    ..+|||||
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            45678999999999999998 5788999998653322 122334566667899999999999998764    46899999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE-----TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +++|+|.++|+.. .++|..+++|+.|+++||+|||++     ..++||||||||+||||++++++||+|||+++.....
T Consensus        83 ~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  161 (303)
T 3hmm_A           83 HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             CTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             CCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence            9999999999764 699999999999999999999987     1235999999999999999999999999999876433


Q ss_pred             ccc---ceeeeccccCccCcccccCC------CCCccccchhHHHHHHHHHhCCccCCCCChHHH----H----HHHHHH
Q 004702          554 AIQ---NCTVVQGTLGYLDPEYLQTC------KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE----R----SLAMNF  616 (735)
Q Consensus       554 ~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~----~----~~~~~~  616 (735)
                      ...   ......||+.|||||++.+.      .++.|+||||||++||||+||+.|+......+.    .    ......
T Consensus       162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~  241 (303)
T 3hmm_A          162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence            221   12234699999999998754      477899999999999999999877643221100    0    000011


Q ss_pred             HHHhcccchhhHhhhcccC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          617 LSSLKQNRLLEILDNRIVN-DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       617 ~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      ...+....    +++.+.. ....+.+..+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus       242 ~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          242 RKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            11111110    1111111 11235667899999999999999999999999999987654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.2e-49  Score=413.73  Aligned_cols=246  Identities=22%  Similarity=0.307  Sum_probs=209.1

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.++||+|+||+||+++. .+++.||||++...   +....+.+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            66788999999999999984 56899999998642   234467889999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc-cc
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI-QN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~-~~  557 (735)
                      +++|+|.++|.+.+.+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+..+.. ..
T Consensus       114 ~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~  190 (311)
T 4aw0_A          114 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR  190 (311)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence            999999999998889999999999999999999999999   99999999999999999999999999998754322 23


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|||||++.+..|+.++|||||||+||||++|+.||......+....       +..        ..+  ..
T Consensus       191 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~-------i~~--------~~~--~~  253 (311)
T 4aw0_A          191 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK-------IIK--------LEY--DF  253 (311)
T ss_dssp             BCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHH--------TCC--CC
T ss_pred             ccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHc--------CCC--CC
Confidence            3456799999999999999999999999999999999999999976544332111       111        111  11


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +...++++.+|+.+||+.||.+|||+.|++.
T Consensus       254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          254 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            2234568899999999999999999999753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=424.62  Aligned_cols=247  Identities=24%  Similarity=0.356  Sum_probs=208.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||+|+||+||+|+. .+++.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||+++
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            45667899999999999985 46899999999876666667889999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      |+|.++++. ..+++.++..|+.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++.+...... ....
T Consensus       233 G~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~~~~  307 (423)
T 4fie_A          233 GALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSL  307 (423)
T ss_dssp             EEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-BCCC
T ss_pred             CcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-cccc
Confidence            999999975 46999999999999999999999999   999999999999999999999999999977544322 3345


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|||||++.+..|+.++|||||||+||||++|+.||......+....+       ...     ..+.  .......
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i-------~~~-----~~~~--~~~~~~~  373 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------RDN-----LPPR--LKNLHKV  373 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHS-----CCCC--CSCTTSS
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HcC-----CCCC--CcccccC
Confidence            6999999999999999999999999999999999999999765543321111       111     0001  1112234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +.++.+|+.+||+.||++|||+.|+++
T Consensus       374 s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          374 SPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            578999999999999999999998764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.8e-48  Score=401.04  Aligned_cols=244  Identities=21%  Similarity=0.293  Sum_probs=192.4

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||+||++.. .+++.||||+++..   .....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            356678999999999999985 46899999998642   23345678999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+ +|+|.+++.+.+.+++..+..++.||+.||+|||+++   |+||||||+||||++++++||+|||+|+......  .
T Consensus        94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~  167 (275)
T 3hyh_A           94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--F  167 (275)
T ss_dssp             CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC--c
Confidence            99 6899999999889999999999999999999999999   9999999999999999999999999998764332  2


Q ss_pred             eeeeccccCccCcccccCCCC-CccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~-~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      .....||+.|||||.+.+..+ +.++|||||||+||||++|+.||......+..       ..+....          ..
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~-------~~i~~~~----------~~  230 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF-------KNISNGV----------YT  230 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTC----------CC
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHcCC----------CC
Confidence            234569999999999998876 57999999999999999999999765432211       1111111          11


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+...++++.+|+.+||+.||++|||+.|+++
T Consensus       231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            12234577899999999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.1e-48  Score=407.61  Aligned_cols=242  Identities=26%  Similarity=0.276  Sum_probs=195.5

Q ss_pred             hccccccccccCcEEEEEEEc----CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .+.+.+.||+|+||+||+++.    ..++.||||+++..  .......+.+|+.+|++++|||||++++++.+.+..+||
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv  104 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI  104 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            356788999999999999974    24678999988642  222345688999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||+++|+|.++|.+.+.+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.......
T Consensus       105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred             EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence            999999999999999889999999999999999999999999   99999999999999999999999999986543222


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                       ......||+.|||||.+.+..++.++|||||||+||||++|+.||......+....+       ...        .  .
T Consensus       182 -~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------~~~--------~--~  243 (304)
T 3ubd_A          182 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-------LKA--------K--L  243 (304)
T ss_dssp             -CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHC--------C--C
T ss_pred             -cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-------HcC--------C--C
Confidence             223456999999999999999999999999999999999999999765443321111       111        1  1


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                      ..+...++++.+|+.+||+.||++|||+.
T Consensus       244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~  272 (304)
T 3ubd_A          244 GMPQFLSPEAQSLLRMLFKRNPANRLGAG  272 (304)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHHCCCCC
Confidence            12233457899999999999999999964

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.7e-46  Score=394.38  Aligned_cols=245  Identities=22%  Similarity=0.318  Sum_probs=186.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc---------
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV---------  471 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---------  471 (735)
                      +.+.+.||+|+||+||+|+. .++..||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+.         
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            45567999999999999985 56889999998753 44456789999999999999999999999876543         


Q ss_pred             ---eeEEEEecCCCchhHHhhhcCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          472 ---PLLVYEFVGNGTLFEHIHKKGN---LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       472 ---~~lV~E~~~~gsL~~~l~~~~~---l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                         .++||||+++|+|.+++.....   ..+..++.|+.||++||+|||+++   |+||||||+||||+.++.+||+|||
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCc
Confidence               6899999999999999987643   456778899999999999999999   9999999999999999999999999


Q ss_pred             CCcccCCCccc-----------ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHH
Q 004702          546 ASKLVPIDAIQ-----------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM  614 (735)
Q Consensus       546 ls~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~  614 (735)
                      +|+.+..+...           ..+...||+.|||||.+.+..|+.++|||||||+||||++   ||...  .+...   
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~---  235 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVR---  235 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH---
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHH---
Confidence            99876543221           1233469999999999999999999999999999999996   66421  11111   


Q ss_pred             HHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          615 NFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       615 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       .+..+......         +......+.+.+|+.+||+.||.+|||+.|+++
T Consensus       236 -~~~~~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          236 -TLTDVRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HHHHHHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             11111111111         111233456788999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=394.90  Aligned_cols=262  Identities=20%  Similarity=0.248  Sum_probs=203.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEee------cCcee
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE------TQVPL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~  473 (735)
                      +.+.+.||+|+||+||+|+. .+++.||||+++.  ......+.+++|+.+|++++|||||++++++..      .+..+
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            55678999999999999985 5689999999864  334556788999999999999999999998764      35679


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      |||||++ |+|.+++...+.+++..+..|+.||+.||+|||+++   ||||||||+|||++.++.+||+|||+++.+...
T Consensus       136 ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             EEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            9999995 689999998889999999999999999999999999   999999999999999999999999999876432


Q ss_pred             c---ccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc-----
Q 004702          554 A---IQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR-----  624 (735)
Q Consensus       554 ~---~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  624 (735)
                      .   ........||+.|||||++.+. .++.++||||+||+||||++|+.||......+....+...........     
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence            2   1223445799999999998775 568999999999999999999999987665544333322211100000     


Q ss_pred             ---hhhHhhhc-ccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 ---LLEILDNR-IVNDGN-----KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ---~~~~~d~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                         ....+... .....+     ...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               00000000 000001     112467889999999999999999998764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.6e-44  Score=379.94  Aligned_cols=271  Identities=40%  Similarity=0.621  Sum_probs=232.3

Q ss_pred             cccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .+.+.||+|+||+||+|...++..||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus        42 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  121 (321)
T 2qkw_B           42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN  121 (321)
T ss_dssp             SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred             CccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence            34568999999999999988899999999887766778889999999999999999999999999999999999999999


Q ss_pred             hhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC-cccce
Q 004702          484 LFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID-AIQNC  558 (735)
Q Consensus       484 L~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~-~~~~~  558 (735)
                      |.+++...    ..+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++..... .....
T Consensus       122 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  198 (321)
T 2qkw_B          122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS  198 (321)
T ss_dssp             TGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred             HHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            99999764    25999999999999999999999998   999999999999999999999999999865422 22223


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||....+.+......+.........+..++++.......
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (321)
T 2qkw_B          199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR  278 (321)
T ss_dssp             CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSC
T ss_pred             cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccC
Confidence            34458999999999998899999999999999999999999997665544444443333344445555666666666677


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      .+.+..+.+++.+||+.||++|||+.||++.|+.+++..
T Consensus       279 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          279 PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            888999999999999999999999999999999987653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5e-43  Score=400.40  Aligned_cols=249  Identities=18%  Similarity=0.251  Sum_probs=209.5

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||+||++.. .++..||||+++.......+.+.+|+.+|+.++|||||++++++.+.+..+|||||++
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~  237 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  237 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence            356678999999999999985 5689999999987777778889999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC--CCeEEeeccCCcccCCCcccc
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN--CTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +|+|.++|... ..+++.++..++.||+.||+|||+++   |+||||||+||||+.+  +.+||+|||+++.+....  .
T Consensus       238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~  312 (573)
T 3uto_A          238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S  312 (573)
T ss_dssp             CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--E
T ss_pred             CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC--c
Confidence            99999999754 67999999999999999999999999   9999999999999854  799999999999875432  2


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|||||++.+..|+.++|||||||+||||++|+.||......+....       +....      .......
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~-------i~~~~------~~~~~~~  379 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN-------VKSCD------WNMDDSA  379 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-------HHTTC------CCCCSGG
T ss_pred             eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-------HHhCC------CCCCccc
Confidence            3445699999999999999999999999999999999999999976654332211       11110      0011111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1234567899999999999999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.7e-43  Score=377.50  Aligned_cols=196  Identities=23%  Similarity=0.343  Sum_probs=167.2

Q ss_pred             ccccccccccCcEEEEEEEcC----CCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      +.+.++||+|+||+||+|+.+    .+..||||++....  ....+.+|+++|+.+ +||||+++++++.+.+..++|||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            556789999999999999742    46789999886543  345678999999998 69999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEeeccCCcccCCCcc-
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-CTPKVSDFGASKLVPIDAI-  555 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGls~~~~~~~~-  555 (735)
                      |+++|+|.+++.   .+++.++..++.||+.||+|||+++   |+||||||+||||+.+ +.+||+|||+|+....... 
T Consensus       101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A          101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred             CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence            999999999984   5999999999999999999999999   9999999999999876 7999999999986532211 


Q ss_pred             --------------------------cceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCCh
Q 004702          556 --------------------------QNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKP  606 (735)
Q Consensus       556 --------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~  606 (735)
                                                ...+...||+.|||||++.+. .++.++||||+||+||||++|+.||.....
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                      112234699999999998775 589999999999999999999999976554

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.4e-43  Score=374.06  Aligned_cols=284  Identities=36%  Similarity=0.583  Sum_probs=232.7

Q ss_pred             cccccCHHHHHhhhccc--cccccccCcEEEEEEEcCCCcEEEEEEeeccCh-hHHHHHHHHHHHHHhcCCCceEEEceE
Q 004702          389 KAKIFTEEEIKTVTNNY--ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ-AKIDEFINELVVVLQINRRNVVRLLGC  465 (735)
Q Consensus       389 ~~~~~~~~ei~~~~~~~--~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~  465 (735)
                      ..+.++..++.....+|  .++||+|+||.||+|...++..||||+++.... .....+.+|+.++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            34567777777776665  469999999999999988899999999875332 223368899999999999999999999


Q ss_pred             EeecCceeEEEEecCCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 004702          466 CLETQVPLLVYEFVGNGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV  541 (735)
Q Consensus       466 ~~~~~~~~lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl  541 (735)
                      +...+..++||||+++|+|.+++...    ..+++..++.|+.|++.||+|||+....+|+||||||+|||+++++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            99999999999999999999999864    34999999999999999999999992222999999999999999999999


Q ss_pred             eeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCCh--HHHHHHHHHHHHH
Q 004702          542 SDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP--EEERSLAMNFLSS  619 (735)
Q Consensus       542 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~  619 (735)
                      +|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||.....  ........+....
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            99999998765554445556699999999999888999999999999999999999999952110  0111122222233


Q ss_pred             hcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       620 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      .....+..+.+.........+.+..+.+++.+||+.+|.+|||+.||++.|+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            34445566666666677788889999999999999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=366.61  Aligned_cols=260  Identities=25%  Similarity=0.353  Sum_probs=214.8

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.++||+|+||+||++.. .++..||+|++...+....+.|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   90 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK   90 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence            345678999999999999985 4688999999887788888999999999999999999999999999999999999999


Q ss_pred             CCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc--
Q 004702          481 NGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--  557 (735)
Q Consensus       481 ~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~--  557 (735)
                      +++|.++++. ...+++..++.|+.|+++||+|||+++   |+||||||+||||+.++.+||+|||+++.........  
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence            9999999987 467999999999999999999999999   9999999999999999999999999998764332211  


Q ss_pred             -----------eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          558 -----------CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       558 -----------~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                                 .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..........          .....
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------~~~~~  237 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------GLNVR  237 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------SBCHH
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------hhhhh
Confidence                       113459999999999999999999999999999999999999886433221100          00111


Q ss_pred             hHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       627 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ...+...    +...+..+.+|+.+||+.||++|||+.||++.|+.+.....
T Consensus       238 ~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          238 GFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             HHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence            1111111    12234578999999999999999999999999999887654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.1e-42  Score=392.83  Aligned_cols=240  Identities=23%  Similarity=0.236  Sum_probs=194.0

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHH---HHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEF---INELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      +.+.++||+|+||+||+++. .++..||||+++...   ......+   ..++.+++.++|||||++++++.+.+..+||
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV  270 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI  270 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence            34567999999999999985 468999999986321   1112223   3446677788999999999999999999999


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||++||+|.++|.+.+.+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus       271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~  347 (689)
T 3v5w_A          271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  347 (689)
T ss_dssp             ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCCC
Confidence            999999999999999889999999999999999999999999   99999999999999999999999999987654332


Q ss_pred             cceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          556 QNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                         ....||+.|||||++.. ..|+.++|+|||||+||||++|+.||......+.....    ..        ++...  
T Consensus       348 ---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~----~~--------i~~~~--  410 (689)
T 3v5w_A          348 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RM--------TLTMA--  410 (689)
T ss_dssp             ---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH----HH--------HHHCC--
T ss_pred             ---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----Hh--------hcCCC--
Confidence               33569999999999964 57999999999999999999999999653322211111    01        11111  


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPT  662 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt  662 (735)
                      ...+...+.++.+|+.+||+.||.+|++
T Consensus       411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~  438 (689)
T 3v5w_A          411 VELPDSFSPELRSLLEGLLQRDVNRRLG  438 (689)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCGGGCTT
T ss_pred             CCCCccCCHHHHHHHHHHccCCHhHCCC
Confidence            1122345578999999999999999998

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.4e-42  Score=363.67  Aligned_cols=262  Identities=28%  Similarity=0.405  Sum_probs=206.9

Q ss_pred             HHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      +....+.+.+.||+|+||+||++.. ++..||||++...  .....+++.+|+.+|++++||||+++++++...+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3344566778999999999999987 5778999998643  455567899999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          476 YEFVGNGTLFEHIHKKG---NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      |||+++|+|.+++....   .+++..++.++.|++.||+|||+.+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            99999999999998754   3999999999999999999999976 4699999999999999999999999999986543


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+......               ...
T Consensus       192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~---------------~~~  255 (309)
T 3p86_A          192 TF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG---------------FKC  255 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---------------HSC
T ss_pred             cc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------hcC
Confidence            22 12234469999999999999999999999999999999999999997654433211110               000


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      .....+...+.++.+|+.+||+.+|.+|||+.||++.|+.+++..
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            111222344568999999999999999999999999999987654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=367.12  Aligned_cols=263  Identities=25%  Similarity=0.373  Sum_probs=215.4

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcC----CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV  471 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  471 (735)
                      ++....+.+.++||+|+||+||+|...    .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            344556667789999999999999864    3456999998753 55567789999999999999999999999999999


Q ss_pred             eeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          472 PLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      .++||||+++++|.++++.. ..+++..++.|+.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999999754 57999999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccc--ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          551 PIDAIQ--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       551 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ......  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....       +       
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-------~-------  267 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS-------V-------  267 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-------H-------
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-------H-------
Confidence            543222  2222346788999999998899999999999999999999 9999976544332111       1       


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                        ......+.+...+.++.+|+.+||+.+|.+|||+.||++.|+.+++...
T Consensus       268 --~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          268 --EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             --HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             --HcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence              1111122233455789999999999999999999999999999887544

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.7e-43  Score=367.84  Aligned_cols=269  Identities=25%  Similarity=0.391  Sum_probs=212.7

Q ss_pred             HHhhhccccccccccCcEEEEEEEc-----CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--C
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET--Q  470 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~  470 (735)
                      +....+.+.+.||+|+||+||++.+     .++..||||+++.......+.+.+|+.++++++||||+++++++...  .
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            3445566788999999999999984     35789999999887788888999999999999999999999998654  4


Q ss_pred             ceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      ..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            579999999999999999875 45999999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCcc--cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc----
Q 004702          550 VPIDAI--QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN----  623 (735)
Q Consensus       550 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----  623 (735)
                      ......  .......++..|+|||.+.+..++.++||||||+++|||++|..|+......        +.......    
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~  235 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQ  235 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------HHHHHCTTCCTH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------HHhhhcCccccc
Confidence            654322  1222334778899999999999999999999999999999999887532111        01111100    


Q ss_pred             ----chhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          624 ----RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       624 ----~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                          .+.+.+......+.+...+.++.+|+.+||+.+|++|||+.||++.|+.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence                111222222223334455678999999999999999999999999999987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.8e-42  Score=372.78  Aligned_cols=260  Identities=25%  Similarity=0.356  Sum_probs=214.2

Q ss_pred             hhhccccccccccCcEEEEEEEc--------CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeec
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFL--------PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLET  469 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  469 (735)
                      ...+.+.+.||+|+||+||+|..        .++..||||+++.. .....+.+.+|+.+|+++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            34456678999999999999974        23457999998754 445567899999999999 899999999999999


Q ss_pred             CceeEEEEecCCCchhHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 004702          470 QVPLLVYEFVGNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL  533 (735)
Q Consensus       470 ~~~~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl  533 (735)
                      +..++||||+++|+|.+++....                .+++..++.++.||+.||+|||+++   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            99999999999999999998642                4899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHH
Q 004702          534 DENCTPKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERS  611 (735)
Q Consensus       534 ~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~  611 (735)
                      +.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||++||||++ |+.||......+...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999986643222 22233447889999999999999999999999999999999 999987654332111


Q ss_pred             HHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                             .+         ........+...+.++.+|+.+||+.+|.+|||+.|+++.|+.++....
T Consensus       317 -------~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          317 -------LL---------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             -------HH---------HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             -------HH---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence                   11         1111122233455789999999999999999999999999999887654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.6e-42  Score=354.93  Aligned_cols=260  Identities=24%  Similarity=0.328  Sum_probs=215.1

Q ss_pred             HHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      +....+.+.+.||+|+||.||++...++..||+|+++.... ..+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            34455667789999999999999988888999999875433 34678999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          478 FVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      |+++++|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.........
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            99999999999875 45999999999999999999999998   999999999999999999999999999876554443


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....       +...         ...
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~~---------~~~  224 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK-------VSQG---------HRL  224 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------HHTT---------CCC
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-------HHcC---------CCC
Confidence            3344456788999999998899999999999999999999 9999876544332111       1110         011


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ..+...+..+.+|+.+||+.+|.+|||+.|+++.|+.+....
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            112223467899999999999999999999999999876543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.4e-42  Score=384.09  Aligned_cols=261  Identities=23%  Similarity=0.370  Sum_probs=217.0

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .++....+.+.+.||+|+||+||+|.++++..||||+++... ...++|.+|+.+|++++||||+++++++. .+..++|
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            455566677788999999999999999888899999987543 34678999999999999999999999986 5678999


Q ss_pred             EEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          476 YEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      |||+++|+|.++++..  ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            9999999999999854  36899999999999999999999998   999999999999999999999999999876543


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .........+++.|+|||.+....++.++||||||++||||++ |+.||......+....       +.         ..
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------i~---------~~  401 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-------LE---------RG  401 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-------HH---------HT
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HH---------cC
Confidence            3222333446789999999998899999999999999999999 9999976544332111       11         11


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ...+.+...+.++.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus       402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            111223345578999999999999999999999999999876543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5e-42  Score=373.64  Aligned_cols=261  Identities=23%  Similarity=0.353  Sum_probs=204.7

Q ss_pred             HHhhhccccccccccCcEEEEEEEcC----CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      +....+.+.++||+|+||+||+|...    ++..||||+++.. .....++|.+|+.+|++++||||+++++++.+.+..
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            34455667889999999999999864    5678999998753 455677899999999999999999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          473 LLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      ++||||+++|+|.++++.. ..+++..++.++.|+++||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999999875 47999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCcccc--eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhH
Q 004702          552 IDAIQN--CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEI  628 (735)
Q Consensus       552 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (735)
                      ......  .....+++.|+|||.+.+..++.++||||||++||||++ |+.||......+..                ..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~----------------~~  262 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------KA  262 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH----------------HH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------HH
Confidence            432221  122235788999999999999999999999999999998 99999765433211                11


Q ss_pred             hhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       629 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      +......+.+...+.++.+|+.+||+.+|.+||++.||++.|+.+++..
T Consensus       263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            1111222223345578999999999999999999999999999987643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.2e-42  Score=375.90  Aligned_cols=261  Identities=26%  Similarity=0.386  Sum_probs=214.7

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      ++....+.+.+.||+|+||+||+|... ++..||||.++.. .....++|.+|+.+|++++||||+++++++...+..++
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            344445667789999999999999975 6889999998753 34455678999999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          475 VYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      ||||+++|+|.++++.. ..+++..++.++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            99999999999999865 46999999999999999999999999   999999999999999999999999999865433


Q ss_pred             cccce-eeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          554 AIQNC-TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       554 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      ..... ....+++.|+|||.+....++.++||||||++||||++ |..||......+....                +..
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~----------------~~~  330 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF----------------VEK  330 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH----------------HHT
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----------------HHc
Confidence            22111 12235778999999998899999999999999999999 9999876544332111                111


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      ....+.+...+.++.+|+.+||+.+|++|||+.+|++.|+.+.+.
T Consensus       331 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          331 GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            111122233456899999999999999999999999999988764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.6e-41  Score=355.33  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=207.7

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||+||++.. .++..||||++........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus        21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  100 (297)
T 3fxz_A           21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (297)
T ss_dssp             TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence            455678999999999999984 5688999999876655567788999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +|+|.+++... .+++..++.++.|++.||+|||+++   |+||||||+||||+.++.+||+|||++......... ...
T Consensus       101 ~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~  175 (297)
T 3fxz_A          101 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST  175 (297)
T ss_dssp             TCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-BCC
T ss_pred             CCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-cCC
Confidence            99999999765 6999999999999999999999998   999999999999999999999999999876543332 233


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||............   ...           .......+..
T Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~-----------~~~~~~~~~~  241 (297)
T 3fxz_A          176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATN-----------GTPELQNPEK  241 (297)
T ss_dssp             CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHH-----------CSCCCSCGGG
T ss_pred             ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhC-----------CCCCCCCccc
Confidence            46999999999999999999999999999999999999999765443321111   000           0001111223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+..+.+|+.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            4567899999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7e-42  Score=355.08  Aligned_cols=255  Identities=27%  Similarity=0.420  Sum_probs=213.2

Q ss_pred             hhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      ..+.+.+.||+|+||+||++...++..||+|+++.... ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            34566789999999999999988888999999875433 34678999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      +++|.+++... ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...........
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  165 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  165 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence            99999999764 56999999999999999999999999   999999999999999999999999999876544333333


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ...+++.|+|||.+....++.++||||||+++|||++ |+.||......+....       +..         ......+
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~-------~~~---------~~~~~~~  229 (269)
T 4hcu_A          166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-------IST---------GFRLYKP  229 (269)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------HHT---------TCCCCCC
T ss_pred             CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-------Hhc---------CccCCCC
Confidence            4457788999999998899999999999999999999 8999876544332111       111         1111112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ...+..+.+|+.+||+.+|.+|||+.|+++.|+.+.+
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            2335679999999999999999999999999998765

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1e-41  Score=356.51  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=213.7

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ++....+.+.+.||+|+||+||++...++..||||+++.... ..+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            344455667789999999999999988888999999875433 3467899999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+++++|.+++.. ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A           99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            99999999999987 467999999999999999999999998   99999999999999999999999999987654433


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.....       ..         ...
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-------~~---------~~~  239 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------AQ---------GLR  239 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-------HT---------TCC
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH-------hc---------ccC
Confidence            33333447788999999998899999999999999999998 99999765543322111       11         111


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      ...+...+..+.+|+.+||+.+|.+|||+.|+++.|+.++..
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            111222346789999999999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.7e-40  Score=351.52  Aligned_cols=280  Identities=34%  Similarity=0.539  Sum_probs=226.8

Q ss_pred             cccccCHHHHHhhhcccc--------ccccccCcEEEEEEEcCCCcEEEEEEeecc----ChhHHHHHHHHHHHHHhcCC
Q 004702          389 KAKIFTEEEIKTVTNNYA--------DVIGCGGSGNVYKGFLPDRTPVAVKKSKFV----DQAKIDEFINELVVVLQINR  456 (735)
Q Consensus       389 ~~~~~~~~ei~~~~~~~~--------~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h  456 (735)
                      ....|+..++++++.+|.        +.||+|+||.||+|.. ++..||||++...    .....+.+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            456789999999999886        4599999999999987 5788999987642    23456789999999999999


Q ss_pred             CceEEEceEEeecCceeEEEEecCCCchhHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 004702          457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK---KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL  533 (735)
Q Consensus       457 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~---~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl  533 (735)
                      |||+++++++...+..++||||+++++|.+++..   ...+++..++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999974   356999999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHH
Q 004702          534 DENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSL  612 (735)
Q Consensus       534 ~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~  612 (735)
                      ++++.+||+|||+++........ ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||...........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            99999999999999876433222 2223458999999998875 588999999999999999999999976543322111


Q ss_pred             HHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          613 AMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       613 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ...... .....+.+.++..+ .......+..+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus       246 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 IKEEIE-DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHH-TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHhh-hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            111110 11223344444433 33466778899999999999999999999999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.4e-41  Score=354.93  Aligned_cols=262  Identities=25%  Similarity=0.359  Sum_probs=210.1

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||.||++.. .++..||+|++..   ......+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   91 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME   91 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence            455678999999999999984 4688999998753   344556789999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.........
T Consensus        92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            9999999999998888999999999999999999999998   9999999999999999999999999998765444334


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..      ...+.. .....     ....
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~-~~~~~-----~~~~  236 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQD-SVPNV-----TTDV  236 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSS-CCCCH-----HHHS
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhc-cCCCc-----chhc
Confidence            44456999999999999999999999999999999999999999765443211      111111 11000     0011


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhhhcc
Q 004702          638 NKQQLKEVAKLAARCISVRGEERP-TMKEVSLELQGRLSLMS  678 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~~~~~~~  678 (735)
                      ....+..+.+++.+||+.+|.+|| ++.++.+.|+.++....
T Consensus       237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            223456799999999999999999 89999999998765443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.3e-42  Score=364.49  Aligned_cols=271  Identities=23%  Similarity=0.274  Sum_probs=207.2

Q ss_pred             hhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc----eeEEE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV----PLLVY  476 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~lV~  476 (735)
                      ..+.+.++||+|+||+||+|... +..||||+++.... ....+..|+.++++++||||+++++++.....    .++||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            34566789999999999999875 68899999875433 34456679999999999999999999987553    69999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeeecCCCCCcEEEcCCCCeEEeeccC
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE----------TNVPIIHRDVKSANILLDENCTPKVSDFGA  546 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~----------~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl  546 (735)
                      ||+++|+|.++++.. .+++..++.++.|++.||+|||+.          +   |+||||||+||||+.++.+||+|||+
T Consensus       102 e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          102 AFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCc
Confidence            999999999999764 599999999999999999999998          7   99999999999999999999999999


Q ss_pred             CcccCCCccc-ceeeeccccCccCcccccC-----CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHh
Q 004702          547 SKLVPIDAIQ-NCTVVQGTLGYLDPEYLQT-----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL  620 (735)
Q Consensus       547 s~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  620 (735)
                      ++........ ......||+.|+|||.+.+     ..++.++||||||+++|||++|+.||...................
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  257 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP  257 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence            9876543222 2233468999999999886     356678999999999999999999997543322111110000000


Q ss_pred             cccchhhHh-hhcccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          621 KQNRLLEIL-DNRIVND-----GNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       621 ~~~~~~~~~-d~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ....+.+.+ .......     .....+.++.+|+.+||+.||++|||+.||++.|+.+.+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            000011111 0000000     12245677999999999999999999999999999987643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.5e-41  Score=356.09  Aligned_cols=259  Identities=24%  Similarity=0.360  Sum_probs=213.0

Q ss_pred             cccCHHHHHhhhcc------------ccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCC
Q 004702          391 KIFTEEEIKTVTNN------------YADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR  457 (735)
Q Consensus       391 ~~~~~~ei~~~~~~------------~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  457 (735)
                      ..++.++++.++..            ..+.||+|+||.||+|... ++..||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45677777766643            3458999999999999865 6899999999876666678899999999999999


Q ss_pred             ceEEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC
Q 004702          458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC  537 (735)
Q Consensus       458 niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~  537 (735)
                      ||+++++++...+..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.+   |+||||||+||||+.++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~  178 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDG  178 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCC
Confidence            999999999999999999999999999999875 46999999999999999999999998   99999999999999999


Q ss_pred             CeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH
Q 004702          538 TPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL  617 (735)
Q Consensus       538 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~  617 (735)
                      .+||+|||++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....     
T Consensus       179 ~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~-----  252 (321)
T 2c30_A          179 RVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-----  252 (321)
T ss_dssp             CEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----
T ss_pred             cEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----
Confidence            9999999999876543222 2345699999999999999999999999999999999999999976544332111     


Q ss_pred             HHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          618 SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       618 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                        +....     .+.+  ......+.++.+|+.+||+.||++|||+.|+++
T Consensus       253 --~~~~~-----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          253 --LRDSP-----PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             --HHHSS-----CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --HhcCC-----CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              11100     0000  011223467899999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.6e-41  Score=358.69  Aligned_cols=245  Identities=22%  Similarity=0.340  Sum_probs=206.6

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.+.+.||+|+||.||+|.. .++..||||++..  .+....+.+.+|+.+|+.++||||+++++++...+..++||||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            355678999999999999985 6789999999864  3556677899999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++++|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        96 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~  170 (328)
T 3fe3_A           96 ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--L  170 (328)
T ss_dssp             CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--G
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--c
Confidence            999999999988889999999999999999999999998   99999999999999999999999999987654322  2


Q ss_pred             eeeccccCccCcccccCCCCC-ccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~-~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....||+.|+|||.+.+..+. .++||||||++||||++|+.||......+.....       ..        ...  ..
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i-------~~--------~~~--~~  233 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV-------LR--------GKY--RI  233 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HH--------CCC--CC
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-------Hh--------CCC--CC
Confidence            334599999999999887765 7999999999999999999999765443321111       11        111  11


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2224567899999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-41  Score=367.43  Aligned_cols=264  Identities=27%  Similarity=0.349  Sum_probs=217.8

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcC--------CCcEEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceE
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGC  465 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~  465 (735)
                      .++....+.+.+.||+|+||+||+|...        .+..||||+++. ......+.+.+|+++++++ +||||++++++
T Consensus        64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            3555566777889999999999999842        235799999875 3455668899999999999 89999999999


Q ss_pred             EeecCceeEEEEecCCCchhHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 004702          466 CLETQVPLLVYEFVGNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA  529 (735)
Q Consensus       466 ~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~  529 (735)
                      +...+..++||||+++|+|.+++....                .+++..++.|+.|++.||+|||+.+   |+||||||+
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~  220 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR  220 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc
Confidence            999999999999999999999998653                4999999999999999999999998   999999999


Q ss_pred             cEEEcCCCCeEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChH
Q 004702          530 NILLDENCTPKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPE  607 (735)
Q Consensus       530 NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~  607 (735)
                      ||||++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987643322 22233457889999999999999999999999999999999 99998765433


Q ss_pred             HHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          608 EERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       608 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      +..       ..+..         ......+...+.++.+|+.+||+.+|++|||+.||++.|+.++....
T Consensus       301 ~~~-------~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          301 ELF-------KLLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HHH-------HHHHT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHH-------HHHHc---------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            211       11111         11111223345789999999999999999999999999999987655

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.5e-42  Score=386.08  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=218.7

Q ss_pred             CHHHHHhhhccccccccccCcEEEEEEEcCC-CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          394 TEEEIKTVTNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       394 ~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      ...++....+.+.++||+|+||.||+|.+.. +..||||+++... ...++|.+|+.+|++++||||+++++++...+..
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            3345666667788899999999999999764 7889999987543 3467899999999999999999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          473 LLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      ++||||+++|+|.++++..  ..+++..++.|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceec
Confidence            9999999999999999864  46999999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      ..+.........+++.|+|||.+....++.++||||||++||||++ |+.||......+..                +.+
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~----------------~~~  432 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------------ELL  432 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH----------------HHH
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH----------------HHH
Confidence            5443333333446789999999998899999999999999999999 89998765433211                111


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ........+...+.++.+|+.+||+.+|.+|||+.||++.|+.++.
T Consensus       433 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            1222222333456789999999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2e-41  Score=378.41  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=210.1

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .++....+.+.+.||+|+||+||+|.+.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++|
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            345555667788999999999999999888889999987543 235789999999999999999999999876 678999


Q ss_pred             EEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          476 YEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      |||+++|+|.+++...  ..+++..++.++.|++.||+|||+++   |+||||||+||||++++.+||+|||+++.....
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            9999999999999753  56999999999999999999999998   999999999999999999999999999876544


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .........+++.|+|||.+....++.++||||||++||||++ |+.||......+...       .+.         ..
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-------~i~---------~~  397 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------QVE---------RG  397 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HHH---------TT
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHH---------cC
Confidence            3333334457889999999998899999999999999999999 899987654433111       111         11


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ...+.+...+..+.+|+.+||+.+|++|||+.+|++.|+.+....
T Consensus       398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            111223345678999999999999999999999999999877543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.4e-41  Score=366.25  Aligned_cols=265  Identities=27%  Similarity=0.338  Sum_probs=214.1

Q ss_pred             HHHHHhhhccccccccccCcEEEEEEEc------CCCcEEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEE
Q 004702          395 EEEIKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCC  466 (735)
Q Consensus       395 ~~ei~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~  466 (735)
                      ..++....+.+.+.||+|+||.||+|.+      .++..||||+++. ......+.+.+|+.++.++ +||||+++++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            3445555667788999999999999973      3457899999875 3445567899999999999 789999999999


Q ss_pred             eecCc-eeEEEEecCCCchhHHhhhcCC----------------------------------------------------
Q 004702          467 LETQV-PLLVYEFVGNGTLFEHIHKKGN----------------------------------------------------  493 (735)
Q Consensus       467 ~~~~~-~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------  493 (735)
                      .+.+. .++||||+++|+|.++++....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            87654 8999999999999999976432                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc-cce
Q 004702          494 --------------LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI-QNC  558 (735)
Q Consensus       494 --------------l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~-~~~  558 (735)
                                    +++..++.++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++....... ...
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                          899999999999999999999998   99999999999999999999999999987643322 223


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+...      ..+.         .......
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~~~~---------~~~~~~~  317 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------RRLK---------EGTRMRA  317 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH------HHHH---------HTCCCCC
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH------HHHH---------cCCCCCC
Confidence            34558999999999999999999999999999999998 999997654332111      1111         1111112


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      +...+.++.+|+.+||+.+|.+|||+.||++.|+.++...
T Consensus       318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence            2234567999999999999999999999999999988654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=368.97  Aligned_cols=261  Identities=23%  Similarity=0.339  Sum_probs=211.9

Q ss_pred             HHhhhccccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ  470 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  470 (735)
                      +....+.+.+.||+|+||+||+|.+.      ++..||||+++.. ......++.+|+.++++++||||+++++++....
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            33445667889999999999999843      3568999998643 4556678999999999999999999999999999


Q ss_pred             ceeEEEEecCCCchhHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---CeE
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK-------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC---TPK  540 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~k  540 (735)
                      ..++||||+++|+|.+++...       ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence            999999999999999999864       35999999999999999999999999   99999999999999544   599


Q ss_pred             EeeccCCcccCCCc-ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHH
Q 004702          541 VSDFGASKLVPIDA-IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLS  618 (735)
Q Consensus       541 l~DFGls~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  618 (735)
                      |+|||+++...... ........||+.|+|||.+.+..++.++||||||++||||++ |+.||......+...       
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~-------  297 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE-------  297 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-------
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------
Confidence            99999997543221 122233457899999999999999999999999999999998 999987654432111       


Q ss_pred             HhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       619 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      .+..         ......+...+..+.+|+.+||+.+|.+|||+.||++.|+.+.+..
T Consensus       298 ~i~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          298 FVTS---------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHc---------CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            1111         1111122334567999999999999999999999999999877654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.1e-41  Score=374.29  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=208.6

Q ss_pred             HhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC-ceeEEEE
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-VPLLVYE  477 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~E  477 (735)
                      ....+.+.+.||+|+||+||+|.+. +..||||+++...  ..+.|.+|+.+|++++||||+++++++.+.+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3344556789999999999999985 6789999987543  4578999999999999999999999987765 7899999


Q ss_pred             ecCCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          478 FVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |+++|+|.+++....  .+++..++.++.|++.||+|||+++   |+||||||+||||++++.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            999999999998754  3799999999999999999999998   999999999999999999999999999854322  


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                        .....+++.|+|||.+.+..++.++||||||++||||++ |+.||......+...       .+         .....
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-------~i---------~~~~~  404 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------RV---------EKGYK  404 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-------HH---------HTTCC
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HH---------HcCCC
Confidence              122347889999999999999999999999999999999 999997654332111       11         11111


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .+.+...+.++.+|+.+||+.+|.+|||+.+|++.|+.+...
T Consensus       405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            222334567899999999999999999999999999987754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.8e-41  Score=351.96  Aligned_cols=260  Identities=21%  Similarity=0.326  Sum_probs=201.4

Q ss_pred             HhhhccccccccccCcEEEEEEEcCC----CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      ....+.+.+.||+|+||.||+|....    +..||+|+.+.. .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            34456678899999999999998643    456999997753 4455678999999999999999999999974 56679


Q ss_pred             EEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          474 LVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      +||||+++++|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999999999999865 47999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      ..........+++.|+|||.+....++.++||||||+++|||++ |..||......+....       +...        
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~-------i~~~--------  233 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------IENG--------  233 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTT--------
T ss_pred             ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH-------HHcC--------
Confidence            43333334457889999999998899999999999999999997 9999876544332111       1111        


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                       .....+...+..+.+|+.+||+.+|.+|||+.||++.|+.++...+
T Consensus       234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          234 -ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence             1111223445789999999999999999999999999999887643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.3e-41  Score=355.70  Aligned_cols=260  Identities=25%  Similarity=0.357  Sum_probs=214.3

Q ss_pred             HHhhhccccccccccCcEEEEEEEc------CCCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ  470 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  470 (735)
                      +....+.+.+.||+|+||.||++..      .++..||||+++. ......+.+.+|+.++++++||||+++++++.+.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            3344556678999999999999984      2357899999875 34556788999999999999999999999999999


Q ss_pred             ceeEEEEecCCCchhHHhhhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 004702          471 VPLLVYEFVGNGTLFEHIHKKGN------------------------LSWERRLRITAETAGVLSYLHSETNVPIIHRDV  526 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dl  526 (735)
                      ..++||||+++++|.+++.....                        +++..++.++.|+++||+|||+++   |+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence            99999999999999999986533                        899999999999999999999998   999999


Q ss_pred             CCCcEEEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCC
Q 004702          527 KSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSD  604 (735)
Q Consensus       527 k~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~  604 (735)
                      ||+|||+++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876433221 2223347889999999998889999999999999999999 99999765


Q ss_pred             ChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          605 KPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       605 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      ...+....                +........+...+.++.+|+.+||+.||.+|||+.||++.|+.++..
T Consensus       257 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          257 PPERLFNL----------------LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CGGGHHHH----------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CHHHHHHH----------------hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            44332111                111111122334557899999999999999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.9e-41  Score=351.50  Aligned_cols=264  Identities=26%  Similarity=0.387  Sum_probs=220.8

Q ss_pred             CHHHHHhhhccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          394 TEEEIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       394 ~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      ...++....+.+.+.||+|+||+||++... ++..||||+++.. ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            344556666777889999999999999865 4788999998753 34567899999999999999999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          473 LLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999999999864  45999999999999999999999999   999999999999999999999999999877


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      ............+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........                .+
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~----------------~~  225 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----------------LL  225 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH----------------HH
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------HH
Confidence            6554444444557889999999998899999999999999999999 888986654332111                11


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ........+...+.++.+|+.+||+.+|.+|||+.||++.|+.++...
T Consensus       226 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            111122223344578999999999999999999999999999887654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.2e-41  Score=346.23  Aligned_cols=255  Identities=27%  Similarity=0.419  Sum_probs=212.3

Q ss_pred             hhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      ..+.+.+.||+|+||.||++...++..||+|+++.... ..+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            34566789999999999999988888999999875433 34678999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      +++|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...........
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  163 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence            99999999875 56899999999999999999999998   999999999999999999999999999876543322223


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ...+++.|+|||.+....++.++||||||+++|||++ |+.||......+...       .+...         .....+
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~i~~~---------~~~~~~  227 (267)
T 3t9t_A          164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-------DISTG---------FRLYKP  227 (267)
T ss_dssp             STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-------HHHTT---------CCCCCC
T ss_pred             cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH-------HHhcC---------CcCCCC
Confidence            3447789999999998899999999999999999999 899987654332111       11111         011112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ...+..+.+|+.+||+.+|.+|||+.|+++.|+.+.+
T Consensus       228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            2335678999999999999999999999999998765

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-40  Score=353.50  Aligned_cols=264  Identities=24%  Similarity=0.369  Sum_probs=216.4

Q ss_pred             HHHhhhccccccccccCcEEEEEEEc------CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEee
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLE  468 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~  468 (735)
                      ++....+.+.+.||+|+||.||++..      .++..||||+++.. .....+.+.+|+.+++++ +||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34455667788999999999999974      34678999998753 345567899999999999 99999999999999


Q ss_pred             cCceeEEEEecCCCchhHHhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 004702          469 TQVPLLVYEFVGNGTLFEHIHKKG------------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN  530 (735)
Q Consensus       469 ~~~~~lV~E~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~N  530 (735)
                      .+..++||||+++|+|.+++....                  .+++..++.++.|++.||+|||+++   |+||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence            999999999999999999998653                  4899999999999999999999998   9999999999


Q ss_pred             EEEcCCCCeEEeeccCCcccCCCcccc-eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHH
Q 004702          531 ILLDENCTPKVSDFGASKLVPIDAIQN-CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEE  608 (735)
Q Consensus       531 ILl~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~  608 (735)
                      ||++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            999999999999999998765443221 223347889999999998899999999999999999999 999986654322


Q ss_pred             HHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          609 ERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ...               ..+........+...+.++.+|+.+||+.||.+|||+.||++.|+.++....
T Consensus       256 ~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          256 KFY---------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             HHH---------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             HHH---------------HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            111               1111111111223345789999999999999999999999999999887654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-41  Score=359.39  Aligned_cols=260  Identities=26%  Similarity=0.352  Sum_probs=211.7

Q ss_pred             hhhccccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      ...+.+.+.||+|+||.||++...      ++..||||.++.. .....+.+.+|+.++++++||||+++++++...+..
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            344556789999999999999864      3478999998753 445567899999999999999999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 004702          473 LLVYEFVGNGTLFEHIHKK------------------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKS  528 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~  528 (735)
                      ++||||+++++|.+++...                        ..+++..++.++.||++||+|||+++   |+||||||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp  202 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  202 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCc
Confidence            9999999999999999763                        56999999999999999999999998   99999999


Q ss_pred             CcEEEcCCCCeEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCCh
Q 004702          529 ANILLDENCTPKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKP  606 (735)
Q Consensus       529 ~NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~  606 (735)
                      +||||+.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            999999999999999999986543222 22233457899999999998899999999999999999999 9999976544


Q ss_pred             HHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          607 EEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       607 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      .+..       ..+.....         ...+...+.++.+|+.+||+.+|.+|||+.+|++.|+.+.....
T Consensus       283 ~~~~-------~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          283 EEVI-------YYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             HHHH-------HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             HHHH-------HHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            3211       11111111         11122345689999999999999999999999999999876544

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-40  Score=347.83  Aligned_cols=260  Identities=25%  Similarity=0.405  Sum_probs=213.5

Q ss_pred             HHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      +....+.+.+.||+|+||.||+|...++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   87 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE   87 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence            3444566788999999999999998888899999987543 23578899999999999999999999986 456799999


Q ss_pred             ecCCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          478 FVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |+++++|.+++....  .+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||++........
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999999997643  6999999999999999999999998   99999999999999999999999999987754433


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..       ..+...         ..
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~---------~~  228 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-------QNLERG---------YR  228 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTT---------CC
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH-------HHHhcc---------cC
Confidence            33333447889999999998889999999999999999999 89998765443211       111111         11


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ...+...+.++.+|+.+||+.+|++|||+.++++.|+.++....
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence            11122345789999999999999999999999999999887644

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.5e-40  Score=352.82  Aligned_cols=247  Identities=24%  Similarity=0.301  Sum_probs=205.6

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.++||+|+||+||++... ++..||||+++..   .....+.+.+|+.+|+.++||||+++++++...+..++|||
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E   85 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence            3456679999999999999854 6889999998743   23346678899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++|+|.+++.....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....... .
T Consensus        86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~  161 (337)
T 1o6l_A           86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T  161 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-c
Confidence            9999999999998888999999999999999999999998   99999999999999999999999999986432221 2


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....       +.        ....  ..
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-------i~--------~~~~--~~  224 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-------IL--------MEEI--RF  224 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HH--------HCCC--CC
T ss_pred             ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH-------HH--------cCCC--CC
Confidence            2345699999999999999999999999999999999999999976543321111       10        1111  11


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERP-----TMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~  669 (735)
                      +...+.++.+|+.+||+.||.+||     ++.||++.
T Consensus       225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            223457889999999999999999     88887753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8e-41  Score=357.63  Aligned_cols=257  Identities=24%  Similarity=0.390  Sum_probs=203.9

Q ss_pred             hhhccccccccccCcEEEEEEEcC-CCc----EEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLP-DRT----PVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      ...+.+.++||+|+||+||+|... ++.    .||+|.++. ......+.|.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            334566789999999999999853 343    368887754 23345678999999999999999999999998755 68


Q ss_pred             EEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          474 LVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      +|+||+.+|+|.+++... ..+++..++.|+.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999999874 67999999999999999999999998   99999999999999999999999999987654


Q ss_pred             Cccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          553 DAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       553 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      .... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..                ..+.
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----------------~~~~  233 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----------------SILE  233 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------HHHH
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH----------------HHHH
Confidence            3322 2233447889999999999999999999999999999999 99999765443311                1111


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .......+...+.++.+|+.+||+.+|.+|||+.||++.|+.+...
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            1112222334556899999999999999999999999999987754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.7e-40  Score=346.28  Aligned_cols=262  Identities=15%  Similarity=0.160  Sum_probs=212.6

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEec
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.+.||+|+||.||+|.. .++..||||++....  ..+.+.+|+.+++.+ +|+|++++++++......++||||+
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            455678999999999999984 678899999886432  234678899999999 7999999999999999999999999


Q ss_pred             CCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC-----eEEeeccCCcccCCC
Q 004702          480 GNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT-----PKVSDFGASKLVPID  553 (735)
Q Consensus       480 ~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~DFGls~~~~~~  553 (735)
                       +++|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+||||+.++.     +||+|||+++.....
T Consensus        89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence             99999999875 46999999999999999999999998   999999999999987765     999999999876543


Q ss_pred             ccc------ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          554 AIQ------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       554 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ...      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........................
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  244 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence            221      22345699999999999999999999999999999999999999977543332222222211111111111


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      .         ....+.++.+|+.+||+.+|.+|||+.+|++.|+.+++...
T Consensus       245 ~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          245 L---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             H---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             H---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            1         11234689999999999999999999999999999987655

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.5e-41  Score=354.22  Aligned_cols=272  Identities=24%  Similarity=0.313  Sum_probs=211.6

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEc-----CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLET  469 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  469 (735)
                      ..+....+.+.+.||+|+||.||++.+     .++..||||+++.. .....+.+.+|+.++++++||||+++++++...
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            334445566778999999999999983     46789999998743 334467889999999999999999999999876


Q ss_pred             --CceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccC
Q 004702          470 --QVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA  546 (735)
Q Consensus       470 --~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl  546 (735)
                        ...++||||+++++|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccc
Confidence              5679999999999999999654 67999999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCcc--cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHH----h
Q 004702          547 SKLVPIDAI--QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS----L  620 (735)
Q Consensus       547 s~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~----~  620 (735)
                      +........  .......||..|+|||.+.+..++.++||||||+++|||++|..|+......     .......    .
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~  247 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL-----FLKMIGPTHGQM  247 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCGGG
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH-----HhhccCCccccc
Confidence            987654332  1223345788899999999989999999999999999999999886322110     0000000    0


Q ss_pred             cccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       621 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ....+...+......+.+...+.++.+|+.+||+.||.+|||+.|+++.|+.+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            0011112222222223344556789999999999999999999999999998763

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.1e-41  Score=382.76  Aligned_cols=261  Identities=25%  Similarity=0.352  Sum_probs=216.0

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .++....+.+.++||+|+||+||+|.+.++..||||+++... ...++|++|+.+|++++||||+++++++.+ +..+||
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            445556667788999999999999999888889999987543 235789999999999999999999999876 678999


Q ss_pred             EEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          476 YEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      |||+.+|+|.++|+..  ..+++..++.|+.||+.||+|||+++   |+||||||+||||++++.+||+|||+++.....
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999999753  56999999999999999999999998   999999999999999999999999999876543


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .........++..|+|||.+....++.++||||||++||||++ |+.||......+...       .+..         .
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~-------~i~~---------~  480 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-------QVER---------G  480 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH-------HHHT---------T
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHc---------C
Confidence            3222233446789999999998899999999999999999999 899987654433111       1111         1


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      .....+...+.++.+||.+||+.+|++|||+.+|++.|+.++...
T Consensus       481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            111222345578999999999999999999999999999876543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.3e-40  Score=345.55  Aligned_cols=252  Identities=28%  Similarity=0.418  Sum_probs=197.5

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeeccCh----hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ----AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.++||+|+||.||++... +..||||+++....    ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME   86 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred             heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence            4556789999999999999975 78899998764322    235678899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--------CCCeEEeeccCCcc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE--------NCTPKVSDFGASKL  549 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~--------~~~~kl~DFGls~~  549 (735)
                      |+++++|.+++.. ..+++..++.++.|++.||+|||+++..+|+||||||+|||++.        ++.+||+|||+++.
T Consensus        87 ~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           87 FARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             CCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             cCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence            9999999999864 57999999999999999999999988666999999999999986        77899999999986


Q ss_pred             cCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       550 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      ......   ....|++.|+|||.+.+..++.++||||||+++|||++|+.||..........               .+.
T Consensus       166 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---------------~~~  227 (271)
T 3dtc_A          166 WHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY---------------GVA  227 (271)
T ss_dssp             -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH---------------HHH
T ss_pred             cccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------hhh
Confidence            543322   23458999999999999899999999999999999999999997654332111               011


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ........+...+.++.+|+.+||+.+|.+|||+.|+++.|+.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            11111222334457899999999999999999999999999863

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.6e-40  Score=359.09  Aligned_cols=268  Identities=16%  Similarity=0.242  Sum_probs=209.1

Q ss_pred             hhccccccccccCcEEEEEEEcCC------CcEEEEEEeeccChhHH-----------HHHHHHHHHHHhcCCCceEEEc
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKFVDQAKI-----------DEFINELVVVLQINRRNVVRLL  463 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~  463 (735)
                      ..+.+.++||+|+||+||+|.+..      +..||||++........           ..++.|+..+..++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            356677899999999999998654      46799999875443211           1234566677788999999999


Q ss_pred             eEEeec----CceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CC
Q 004702          464 GCCLET----QVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD--EN  536 (735)
Q Consensus       464 g~~~~~----~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~  536 (735)
                      +++...    ...+|||||+ +++|.+++... ..+++..++.|+.||+.||+|||+++   |+||||||+||||+  .+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCT
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCC
Confidence            998875    4579999999 99999999876 67999999999999999999999998   99999999999999  88


Q ss_pred             CCeEEeeccCCcccCCCcccc------eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHH
Q 004702          537 CTPKVSDFGASKLVPIDAIQN------CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER  610 (735)
Q Consensus       537 ~~~kl~DFGls~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~  610 (735)
                      +.+||+|||+++.+.......      .....||+.|+|||.+.+..++.++||||||++||||++|+.||.........
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            999999999998764332211      12344999999999999999999999999999999999999999743222211


Q ss_pred             HHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          611 SLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                        ... ........+.++++..+..   ...+.++.+|+.+||+.+|.+||++.+|++.|+.++....
T Consensus       271 --~~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          271 --VRD-SKIRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             --HHH-HHHHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             --HHH-HHHHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence              111 1111122344444443321   1234688999999999999999999999999999988765

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.1e-40  Score=355.40  Aligned_cols=263  Identities=25%  Similarity=0.365  Sum_probs=215.9

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcC--------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEE
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLP--------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCC  466 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~  466 (735)
                      ++....+.+.+.||+|+||.||++...        ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            445556777889999999999999853        4678999998753 455677899999999999 899999999999


Q ss_pred             eecCceeEEEEecCCCchhHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 004702          467 LETQVPLLVYEFVGNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN  530 (735)
Q Consensus       467 ~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~N  530 (735)
                      ...+..++||||+++++|.+++....                .+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence            99999999999999999999998653                3899999999999999999999998   9999999999


Q ss_pred             EEEcCCCCeEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHH
Q 004702          531 ILLDENCTPKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEE  608 (735)
Q Consensus       531 ILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~  608 (735)
                      |||+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            9999999999999999987654322 22233447889999999988889999999999999999999 999987654332


Q ss_pred             HHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          609 ERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ...       .+...         .....+...+.++.+|+.+||+.+|.+|||+.||++.|+.++....
T Consensus       268 ~~~-------~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          268 LFK-------LLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHH-------HHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHH-------HHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            111       11111         1111223345689999999999999999999999999999987655

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1e-40  Score=355.87  Aligned_cols=259  Identities=25%  Similarity=0.367  Sum_probs=197.9

Q ss_pred             hhhccccccccccCcEEEEEEEcCCCc----EEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce-
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLPDRT----PVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP-  472 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-  472 (735)
                      ...+.+.+.||+|+||+||+|......    .||||+++..  .....+.+.+|+.++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            335566789999999999999865432    7999998643  455678899999999999999999999999877654 


Q ss_pred             -----eEEEEecCCCchhHHhhhcC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 004702          473 -----LLVYEFVGNGTLFEHIHKKG------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV  541 (735)
Q Consensus       473 -----~lV~E~~~~gsL~~~l~~~~------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl  541 (735)
                           ++||||+.+|+|.+++....      .+++..++.|+.|++.||+|||+++   |+||||||+||||++++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 89999999999999997542      6999999999999999999999998   999999999999999999999


Q ss_pred             eeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHH
Q 004702          542 SDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSS  619 (735)
Q Consensus       542 ~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  619 (735)
                      +|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.....      
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------  252 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL------  252 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH------
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH------
Confidence            99999987643322 22233447889999999999999999999999999999999 89998765443321111      


Q ss_pred             hcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       620 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                                ........+...+.++.+|+.+||+.||.+|||+.++++.|++++...
T Consensus       253 ----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          253 ----------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             ----------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ----------hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                      001111223344578999999999999999999999999999988754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.6e-40  Score=351.48  Aligned_cols=260  Identities=17%  Similarity=0.172  Sum_probs=209.7

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||+||+|.. .++..||||.+.....  .+.+.+|+.+++++ +||||+++++++...+..++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A           11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            45677999999999999984 5788999999875432  34688999999999 9999999999999999999999999 


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC-----eEEeeccCCcccCCCc
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT-----PKVSDFGASKLVPIDA  554 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~DFGls~~~~~~~  554 (735)
                      +++|.+++... ..+++..++.|+.|++.||+|||+.+   |+||||||+||||+.++.     +||+|||+++......
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            99999999863 68999999999999999999999998   999999999999998877     9999999998764332


Q ss_pred             cc------ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH
Q 004702          555 IQ------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI  628 (735)
Q Consensus       555 ~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (735)
                      ..      ......||+.|+|||.+.+..++.++||||||++||||++|+.||......+................... 
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-  243 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV-  243 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH-
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHH-
Confidence            21      12345699999999999999999999999999999999999999976543332222211111110000000 


Q ss_pred             hhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       629 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      +        ....+ ++.+|+.+||+.+|.+||++.+|++.|+.+++...
T Consensus       244 ~--------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          244 L--------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             H--------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             H--------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            0        00122 89999999999999999999999999998887765

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=358.75  Aligned_cols=265  Identities=23%  Similarity=0.347  Sum_probs=211.7

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEc------CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEe
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCL  467 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~  467 (735)
                      .++....+.+.+.||+|+||.||+|..      .++..||||.++.. .....+.+.+|+.++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            345556677788999999999999985      24567999998743 334457889999999999 8999999999999


Q ss_pred             ecCceeEEEEecCCCchhHHhhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 004702          468 ETQVPLLVYEFVGNGTLFEHIHKKG-----------------------NLSWERRLRITAETAGVLSYLHSETNVPIIHR  524 (735)
Q Consensus       468 ~~~~~~lV~E~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~  524 (735)
                      ..+..++||||+++|+|.+++....                       .+++..++.++.|++.||+|||+++   |+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            9999999999999999999997642                       3799999999999999999999998   9999


Q ss_pred             CCCCCcEEEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCC
Q 004702          525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALL  602 (735)
Q Consensus       525 Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~  602 (735)
                      ||||+||||+.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||++||||++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999999876433322 2223457889999999998899999999999999999998 999997


Q ss_pred             CCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          603 SDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      .........               ..+........+...+.++.+|+.+||+.||.+|||+.||++.|+.++....
T Consensus       277 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          277 GIPVDANFY---------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             TCCCSHHHH---------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             cCCcHHHHH---------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            654322111               1111111122223345789999999999999999999999999999877654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-40  Score=351.44  Aligned_cols=249  Identities=22%  Similarity=0.262  Sum_probs=205.2

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccCh------hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ------AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.+.||+|+||.||++... ++..||+|.++....      ...+.+.+|+.+|++++||||+++++++......++
T Consensus        12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3566789999999999999854 688999998875332      136788999999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----CeEEeeccCCccc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC----TPKVSDFGASKLV  550 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGls~~~  550 (735)
                      ||||+++++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||+++..
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           92 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            9999999999999988888999999999999999999999998   99999999999999877    8999999999876


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      .....  .....||+.|+|||.+....++.++||||||+++|||++|+.||......+.....    ..........   
T Consensus       169 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----~~~~~~~~~~---  239 (326)
T 2y0a_A          169 DFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV----SAVNYEFEDE---  239 (326)
T ss_dssp             CTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH----HHTCCCCCHH---
T ss_pred             CCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH----HhcCCCcCcc---
Confidence            53322  23345999999999999989999999999999999999999999765443321111    0000000000   


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                            .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       240 ------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          240 ------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             ------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  00123467889999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7e-41  Score=358.75  Aligned_cols=265  Identities=23%  Similarity=0.347  Sum_probs=213.8

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcCC------CcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEe
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLPD------RTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCL  467 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~  467 (735)
                      .++....+.+.+.||+|+||.||+|....      ...||+|.++.. .....+.+.+|+.+++++ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34445566677899999999999998532      247999998754 445567899999999999 8999999999999


Q ss_pred             ecCceeEEEEecCCCchhHHhhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 004702          468 ETQVPLLVYEFVGNGTLFEHIHKK--------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL  533 (735)
Q Consensus       468 ~~~~~~lV~E~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl  533 (735)
                      ..+..++||||+++|+|.+++...              ..+++..++.++.|++.||+|||+++   |+||||||+||||
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence            999999999999999999999753              35899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHH
Q 004702          534 DENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERS  611 (735)
Q Consensus       534 ~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~  611 (735)
                      +.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            99999999999999866433222 1223447889999999998899999999999999999999 888986544322111


Q ss_pred             HHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                                     .++........+...+..+.+|+.+||+.+|.+|||+.||++.|+.+.....
T Consensus       278 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  329 (333)
T 2i1m_A          278 ---------------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR  329 (333)
T ss_dssp             ---------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---------------HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence                           1111111111122335678999999999999999999999999998876543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=347.44  Aligned_cols=267  Identities=21%  Similarity=0.309  Sum_probs=210.7

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecC--ceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQ--VPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~E  477 (735)
                      .+.+.++||+|+||+||+|... ++..||||+++... ....+.+.+|+.+|++++||||+++++++....  ..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence            3556789999999999999865 48899999987533 334677889999999999999999999998765  6799999


Q ss_pred             ecCCCchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCCeEEeeccCCccc
Q 004702          478 FVGNGTLFEHIHKKG---NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASKLV  550 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGls~~~  550 (735)
                      |+++++|.+++....   .+++..++.++.|++.||+|||+.+   |+||||||+||||    +.++.+||+|||+++..
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (319)
T ss_dssp             CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred             CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence            999999999998653   3999999999999999999999998   9999999999999    77888999999999876


Q ss_pred             CCCcccceeeeccccCccCccccc--------CCCCCccccchhHHHHHHHHHhCCccCCCCChHHH-HHHHHHHHHHhc
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQ--------TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE-RSLAMNFLSSLK  621 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~  621 (735)
                      .....  .....||+.|+|||.+.        +..++.++||||||+++|||++|+.||........ ............
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            54332  22345899999999886        56789999999999999999999999965443222 222222222211


Q ss_pred             ccchhhH---h--------hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          622 QNRLLEI---L--------DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       622 ~~~~~~~---~--------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ...+..+   .        +..............+.+|+.+||+.||++|||+.|+++...+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            1111000   0        00111234567788999999999999999999999999988863

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4e-40  Score=356.44  Aligned_cols=248  Identities=23%  Similarity=0.278  Sum_probs=204.6

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChh------HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQA------KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      +.+.+.||+|+||+||++... ++..||+|.++.....      ..+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            556789999999999999854 6889999998753321      357789999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----CeEEeeccCCcccC
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC----TPKVSDFGASKLVP  551 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGls~~~~  551 (735)
                      |||+++|+|.+++.....+++..+..++.||+.||+|||+.+   |+||||||+|||+++++    .+||+|||+++...
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           94 LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            999999999999988888999999999999999999999998   99999999999998776    79999999998765


Q ss_pred             CCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       552 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......+....       +......  .+.
T Consensus       171 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~-------i~~~~~~--~~~  239 (361)
T 2yab_A          171 DGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------ITAVSYD--FDE  239 (361)
T ss_dssp             TTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-------HHTTCCC--CCH
T ss_pred             CCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhcCCC--CCc
Confidence            432  22344599999999999998999999999999999999999999976544332111       1111000  000


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                          +.....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       240 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          240 ----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                001123467899999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.2e-40  Score=351.53  Aligned_cols=270  Identities=25%  Similarity=0.304  Sum_probs=214.2

Q ss_pred             cccccccccCcEEEEEEEcC-----CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeEE
Q 004702          404 NYADVIGCGGSGNVYKGFLP-----DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLV  475 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV  475 (735)
                      .+.+.||+|+||+||++.+.     ++..||||+++.. .....+.+.+|+.+|++++||||+++++++.+.  ...++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            56789999999999988642     5788999998753 445577899999999999999999999999874  567899


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||+++++|.+++... .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  189 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE  189 (318)
T ss_dssp             ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred             EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence            9999999999999765 5999999999999999999999999   99999999999999999999999999987754322


Q ss_pred             c--ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          556 Q--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       556 ~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      .  ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ..............+.+.+....
T Consensus       190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  268 (318)
T 3lxp_A          190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELLERGE  268 (318)
T ss_dssp             EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHHHTTC
T ss_pred             ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHHhccc
Confidence            1  22334578889999999998999999999999999999999999864321110 00000000001112223333333


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ....+...+.++.+|+.+||+.+|.+|||+.||++.|+.+.+.+.
T Consensus       269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            334445566789999999999999999999999999999887765

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-40  Score=344.46  Aligned_cols=255  Identities=26%  Similarity=0.414  Sum_probs=210.9

Q ss_pred             cccc-cccccCcEEEEEEEcC---CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          404 NYAD-VIGCGGSGNVYKGFLP---DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       404 ~~~~-~lG~G~~g~Vy~g~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.+ .||+|+||.||+|...   ++..||||+++.. .....+.+.+|+.++++++||||+++++++ ..+..++||||
T Consensus        12 ~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~   90 (287)
T 1u59_A           12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEM   90 (287)
T ss_dssp             EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred             hhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEe
Confidence            3444 8999999999999853   5778999998763 455678899999999999999999999999 55678999999


Q ss_pred             cCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++++|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.........
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  167 (287)
T 1u59_A           91 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  167 (287)
T ss_dssp             CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             CCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence            9999999999754 56999999999999999999999998   9999999999999999999999999998765332221


Q ss_pred             --eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          558 --CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       558 --~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                        .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+...       .+...         ..
T Consensus       168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------~i~~~---------~~  231 (287)
T 1u59_A          168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-------FIEQG---------KR  231 (287)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-------HHHTT---------CC
T ss_pred             eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-------HHhcC---------Cc
Confidence              222346889999999998889999999999999999999 999997654433211       11111         11


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ...+...+.++.+|+.+||+.+|.+||++.||++.|+.++....
T Consensus       232 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          232 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            12233455789999999999999999999999999999988766

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.5e-40  Score=347.74  Aligned_cols=258  Identities=22%  Similarity=0.285  Sum_probs=199.4

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHh--cCCCceEEEceEEeec----CceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQ--INRRNVVRLLGCCLET----QVPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~~~~lV  475 (735)
                      .+.+.+.||+|+||+||+|.. ++..||||++...   ....+..|.+++..  ++||||+++++++...    ...++|
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv   84 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI   84 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence            455678999999999999987 5888999998643   34566677777776  7999999999997653    457899


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCcEEEcCCCCeEEeeccCC
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLH--------SETNVPIIHRDVKSANILLDENCTPKVSDFGAS  547 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls  547 (735)
                      |||+++|+|.++++. ..+++..+++++.|++.||+|||        +.+   |+||||||+||||+.++.+||+|||++
T Consensus        85 ~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           85 THYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             ECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             hhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999965 47999999999999999999999        766   999999999999999999999999999


Q ss_pred             cccCCCcccc---eeeeccccCccCcccccCC------CCCccccchhHHHHHHHHHhC----------CccCCCCChHH
Q 004702          548 KLVPIDAIQN---CTVVQGTLGYLDPEYLQTC------KLTDKSDVYSFGVVLVELLTG----------KMALLSDKPEE  608 (735)
Q Consensus       548 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDVyS~Gvvl~elltG----------~~p~~~~~~~~  608 (735)
                      +.........   .....||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            8654332221   2223699999999999876      456799999999999999999          78876543322


Q ss_pred             HHHHHHHHHHHhcccchhhHhhhccc-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          609 ERSLAMNFLSSLKQNRLLEILDNRIV-NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      .....  ..........    .+... .......+.++.+|+.+||+.||.+|||+.||++.|+.+
T Consensus       241 ~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFED--MRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHH--HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhh--hhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            11111  1111100000    00000 011235678899999999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-40  Score=355.44  Aligned_cols=273  Identities=26%  Similarity=0.325  Sum_probs=215.1

Q ss_pred             hhccccccccccCcEEEEEEEc-----CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEee--cCcee
Q 004702          401 VTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE--TQVPL  473 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~  473 (735)
                      ..+.+.+.||+|+||.||++.+     .++..||||++........+.+.+|+.++++++||||+++++++..  ....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4556778999999999999983     4578899999988777778889999999999999999999999874  45688


Q ss_pred             EEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          474 LVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      +||||+++++|.+++... ..+++..++.|+.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            999999999999999873 56999999999999999999999998   99999999999999999999999999987654


Q ss_pred             Cccc--ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          553 DAIQ--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       553 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      ....  ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||............ ..........+.+.+.
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRLLELLE  258 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHHHH
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHHHHHhh
Confidence            3322  222345788899999999988999999999999999999999998643221100000 0000000011222233


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      .......+...+.++.+|+.+||+.||.+|||+.||++.|+.+....
T Consensus       259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            33333344556678999999999999999999999999999876544

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.4e-40  Score=353.33  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=200.9

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccCh-hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ-AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||+||++... ++..||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus         9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   88 (323)
T 3tki_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (323)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence            456779999999999999854 788999999864332 334678899999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc-cccee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA-IQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~-~~~~~  559 (735)
                      +++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.... .....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  165 (323)
T 3tki_A           89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  165 (323)
T ss_dssp             TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence            9999999988888999999999999999999999998   9999999999999999999999999998654222 22223


Q ss_pred             eeccccCccCcccccCCCC-CccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          560 VVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~-~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ...||+.|+|||.+.+..+ +.++||||||++||||++|+.||.........  ...+   .         .........
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~---~---------~~~~~~~~~  231 (323)
T 3tki_A          166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW---K---------EKKTYLNPW  231 (323)
T ss_dssp             SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHH---H---------TTCTTSTTG
T ss_pred             CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHH---h---------cccccCCcc
Confidence            4569999999999987765 78999999999999999999999755432211  1000   0         011111111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .....++.+|+.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          232 KKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            234567889999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-40  Score=344.62  Aligned_cols=259  Identities=25%  Similarity=0.338  Sum_probs=208.3

Q ss_pred             ccccccccccCcEEEEEEEcC-CC---cEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce-eEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DR---TPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP-LLVY  476 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lV~  476 (735)
                      +...++||+|+||+||+|... ++   ..||+|+++. ......+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            344579999999999999843 22   3699999875 3445678899999999999999999999999876654 9999


Q ss_pred             EecCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+.+++|.+++.. ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus       103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            99999999999987 367899999999999999999999998   99999999999999999999999999986643321


Q ss_pred             ---cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          556 ---QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       556 ---~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                         .......+++.|+|||.+.+..++.++||||||+++|||++|..|+.........  .             ..+...
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~--~-------------~~~~~~  244 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL--T-------------HFLAQG  244 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH--H-------------HHHHTT
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH--H-------------HHhhcC
Confidence               1222345789999999999999999999999999999999966665443322211  1             111111


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhccC
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSN  679 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~~  679 (735)
                      .....+...+..+.+|+.+||+.+|.+|||+.|+++.|+.+++.+..
T Consensus       245 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            11112233456799999999999999999999999999999887653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.8e-40  Score=341.68  Aligned_cols=251  Identities=20%  Similarity=0.270  Sum_probs=206.7

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec--CceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLET--QVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~E  477 (735)
                      .+.+.+.||+|+||+||+|... +..||||+++..  .....+.|.+|+.++++++||||+++++++...  +..++|||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            4556789999999999999985 788999998753  455667899999999999999999999999877  67899999


Q ss_pred             ecCCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          478 FVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |+++|+|.+++....  .+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||.|||+.......  
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~--  166 (271)
T 3kmu_A           90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP--  166 (271)
T ss_dssp             CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT--
T ss_pred             ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeeccc--
Confidence            999999999998764  5899999999999999999999875 56999999999999999999999999987653322  


Q ss_pred             cceeeeccccCccCcccccCCCCCc---cccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTD---KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~---ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                          ...||+.|+|||.+.+..++.   ++||||||+++|||++|+.||......+...               .+....
T Consensus       167 ----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---------------~~~~~~  227 (271)
T 3kmu_A          167 ----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM---------------KVALEG  227 (271)
T ss_dssp             ----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH---------------HHHHSC
T ss_pred             ----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH---------------HHHhcC
Confidence                234899999999998765544   8999999999999999999997654433211               111111


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      .....+...+.++.+++.+||+.+|.+|||+.|+++.|+.+.+
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          228 LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1122233455789999999999999999999999999998753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.9e-41  Score=349.97  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=205.5

Q ss_pred             hhhccccccccccCcEEEEEEEcCC-C-------cEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLPD-R-------TPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV  471 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  471 (735)
                      ...+.+.+.||+|+||+||+|.... +       ..||+|++........+.+.+|+.++++++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3455677899999999999998543 2       4699999887767777889999999999999999999999999999


Q ss_pred             eeEEEEecCCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC--------eEEe
Q 004702          472 PLLVYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT--------PKVS  542 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl~  542 (735)
                      .++||||+++++|.+++.... .+++..++.++.|++.||+|||+++   |+||||||+||||+.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence            999999999999999998764 3999999999999999999999999   999999999999998887        9999


Q ss_pred             eccCCcccCCCcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhc
Q 004702          543 DFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK  621 (735)
Q Consensus       543 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  621 (735)
                      |||++......     ....|++.|+|||.+.+ ..++.++||||||+++|||++|..|+...........   ....  
T Consensus       164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~---~~~~--  233 (289)
T 4fvq_A          164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ---FYED--  233 (289)
T ss_dssp             CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---HHHT--
T ss_pred             cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH---Hhhc--
Confidence            99999765322     22348899999999987 6799999999999999999996655544333221110   0000  


Q ss_pred             ccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          622 QNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       622 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .        .    ..+...+.++.+|+.+||+.||.+|||+.|+++.|+.++..
T Consensus       234 ~--------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          234 R--------H----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             T--------C----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             c--------C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            0        0    00111235688999999999999999999999999987764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-40  Score=352.05  Aligned_cols=262  Identities=26%  Similarity=0.387  Sum_probs=207.3

Q ss_pred             HHhhhccccccccccCcEEEEEEEcCC-----CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLPD-----RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV  471 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  471 (735)
                      +....+.+.++||+|+||+||+|....     +..||||+++.. .......+.+|+.++++++||||+++++++...+.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            334445566899999999999998543     235999998753 44556789999999999999999999999999999


Q ss_pred             eeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          472 PLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      .++||||+++++|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999865 67999999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccc--ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          551 PIDAIQ--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       551 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ......  ......+++.|+|||.+....++.++||||||+++|||++ |+.||......+..       ..+..     
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-------~~~~~-----  265 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-------KAIND-----  265 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHT-----
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHHC-----
Confidence            543221  1222346789999999999899999999999999999999 99999765443211       11111     


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                          ......+...+.++.+|+.+||+.+|.+||++.||++.|+.++....
T Consensus       266 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          266 ----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             ----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                11111223345789999999999999999999999999999886543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.3e-40  Score=365.33  Aligned_cols=252  Identities=23%  Similarity=0.282  Sum_probs=204.4

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.++||+|+||+||+++.. ++..||||+++...   ....+.+.+|..++..++||||+++++++.+.+..++||||
T Consensus        76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey  155 (437)
T 4aw2_A           76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY  155 (437)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence            445679999999999999965 47889999987422   12233488999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++|+|.+++.. ...+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++....+....
T Consensus       156 ~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~  232 (437)
T 4aw2_A          156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  232 (437)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             CCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence            999999999987 468999999999999999999999999   9999999999999999999999999998765544444


Q ss_pred             eeeeccccCccCccccc-----CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          558 CTVVQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .....||+.|+|||++.     ...++.++||||||++||||++|+.||......+....+......+            
T Consensus       233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------  300 (437)
T 4aw2_A          233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF------------  300 (437)
T ss_dssp             CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC------------
T ss_pred             cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc------------
Confidence            44457999999999987     5678999999999999999999999998765444322221110000            


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEE--RPTMKEVSLE  669 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~  669 (735)
                      .........+.++.+|+.+||..+|++  ||++.|+++.
T Consensus       301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            001111224567899999999888887  9999988753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-40  Score=348.93  Aligned_cols=249  Identities=20%  Similarity=0.276  Sum_probs=204.9

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||+||++... ++..||+|.++.. ....+.+.+|+.+|+.++||||+++++++.+.+..++||||++
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   84 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence            3456789999999999999854 5788999988754 3445678899999999999999999999999999999999999


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--CCCeEEeeccCCcccCCCcccc
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE--NCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++......  .
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~  159 (321)
T 1tki_A           85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N  159 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--c
Confidence            99999999765 47999999999999999999999998   999999999999987  7899999999998765433  2


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|..||......+.....   .    .....  .+.    +.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~----~~~~~--~~~----~~  226 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI---M----NAEYT--FDE----EA  226 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---H----HTCCC--CCH----HH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH---H----cCCCC--CCh----hh
Confidence            33456999999999999888999999999999999999999999765443221111   1    10000  000    00


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          227 FKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            01234678999999999999999999999874

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-39  Score=353.14  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=206.9

Q ss_pred             hhccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      ..+.+.+.||+|+||.||++.. .++..||+|++..  ......+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            3466778999999999999985 4688999999864  345566789999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CCeEEeeccCCcccCCCc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN---CTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFGls~~~~~~~  554 (735)
                      |+++|+|.+++.....+++..++.++.||+.||+|||+++   |+||||||+|||++.+   +.+||+|||++.......
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            9999999999988888999999999999999999999998   9999999999999865   459999999998765332


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                        ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...       .+.....      ...
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~~~~------~~~  250 (362)
T 2bdw_A          186 --AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA-------QIKAGAY------DYP  250 (362)
T ss_dssp             --SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCC------CCC
T ss_pred             --ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHhCCC------CCC
Confidence              2233569999999999999899999999999999999999999997654332111       1111110      000


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .......+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11112345678999999999999999999998764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.8e-40  Score=343.48  Aligned_cols=257  Identities=22%  Similarity=0.343  Sum_probs=206.6

Q ss_pred             hccccccccccCcEEEEEEEcCC----CcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.+.||+|+||+||+|...+    +..||+|.++.. .....+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   91 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIM   91 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEE
Confidence            45567899999999999998532    235999998753 45567889999999999999999999999765 4568999


Q ss_pred             EecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+++++|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred             ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence            999999999999765 46999999999999999999999998   99999999999999999999999999987654433


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.....       ..         ...
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-------~~---------~~~  232 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-------EK---------GDR  232 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-------HH---------TCC
T ss_pred             cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-------hc---------CCC
Confidence            33344457889999999998899999999999999999998 99999765443321111       00         001


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ...+...+..+.+|+.+||+.+|.+|||+.|+++.|+.+++...
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  276 (281)
T 3cc6_A          233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK  276 (281)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence            11122345679999999999999999999999999999876543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.4e-40  Score=348.63  Aligned_cols=261  Identities=20%  Similarity=0.282  Sum_probs=201.3

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||+||++...++..||+|+++..  .....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus        23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  102 (311)
T 3niz_A           23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME  102 (311)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred             hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence            4556799999999999999888999999998643  23335778899999999999999999999999999999999997


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      + +|.+++... ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ...
T Consensus       103 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~  177 (311)
T 3niz_A          103 K-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYT  177 (311)
T ss_dssp             E-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----
T ss_pred             C-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc-ccc
Confidence            5 888887764 46999999999999999999999998   99999999999999999999999999987643322 223


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh------hhc
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL------DNR  632 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------d~~  632 (735)
                      ...||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+................+....      +..
T Consensus       178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  257 (311)
T 3niz_A          178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT  257 (311)
T ss_dssp             CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCC
T ss_pred             CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcc
Confidence            3458999999999876 568999999999999999999999997665544333222211111111110000      000


Q ss_pred             --ccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 --IVNDG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 --~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                        .....     ......++.+|+.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              00000     1123367899999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=355.94  Aligned_cols=268  Identities=25%  Similarity=0.379  Sum_probs=214.9

Q ss_pred             HhhhccccccccccCcEEEEEEEc-----CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC--c
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFL-----PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ--V  471 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~  471 (735)
                      ....+.+.+.||+|+||.||++.+     .++..||||++........+.+.+|+.++++++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            344556778999999999999983     358899999998777777889999999999999999999999987654  6


Q ss_pred             eeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          472 PLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      .++||||+++++|.+++... ..+++..++.++.|+++||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            78999999999999999875 46999999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccc--ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc------
Q 004702          551 PIDAIQ--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ------  622 (735)
Q Consensus       551 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------  622 (735)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++|..|+......        +......      
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--------~~~~~~~~~~~~~  267 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQM  267 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--------HHHHHCTTCCTHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--------HHHhhccccchhh
Confidence            543321  122234678899999999888999999999999999999999887532110        1111100      


Q ss_pred             --cchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          623 --NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       623 --~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                        ..+.+.+......+.+...+.++.+|+.+||+.+|.+|||+.||++.|+.+++.+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence              0111222222222233445678999999999999999999999999999987764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=360.14  Aligned_cols=250  Identities=20%  Similarity=0.250  Sum_probs=205.3

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.+.+.||+|+||+||++.. .++..+|+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   91 (444)
T 3soa_A           12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL   91 (444)
T ss_dssp             HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence            456678999999999999984 56889999998643  344567789999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCCeEEeeccCCcccCCCcc
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGls~~~~~~~~  555 (735)
                      +.+|+|.+.+.....+++..+..++.||+.||+|||+++   |+||||||+|||++   +++.+||+|||+++.......
T Consensus        92 ~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           92 VTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            999999999998889999999999999999999999998   99999999999998   567899999999987654322


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                       ......||+.|+|||.+.+..++.++||||||++||+|++|+.||......+...       .+.....      ....
T Consensus       169 -~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~-------~i~~~~~------~~~~  234 (444)
T 3soa_A          169 -AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ-------QIKAGAY------DFPS  234 (444)
T ss_dssp             -BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHHTCC------CCCT
T ss_pred             -eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHhCCC------CCCc
Confidence             2234569999999999999999999999999999999999999997654332211       1111110      0011


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +.....++++.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111234578999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.1e-40  Score=380.97  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=205.9

Q ss_pred             ccccccCcEEEEEEEc---CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFL---PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.||+|+||+||+|.+   ..+..||||+++.  .+....++|.+|+.+|++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            3799999999999964   2457899999875  334456889999999999999999999999864 557899999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc--ccee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI--QNCT  559 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~--~~~~  559 (735)
                      |+|.+++.....+++..++.|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+..+..  ....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            999999998888999999999999999999999998   99999999999999999999999999987654332  2223


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ...+|+.|+|||++....++.++||||||++||||++ |+.||......+...       .+         ........+
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-------~i---------~~~~~~~~p  594 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-------ML---------EKGERMGCP  594 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HH---------HTTCCCCCC
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HH---------HcCCCCCCC
Confidence            3446889999999999999999999999999999998 999997665433211       11         111112223


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ...+.++.+|+.+||+.||++|||+.+|++.|+.+...+.
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~  634 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  634 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence            3456789999999999999999999999999998876543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.5e-40  Score=344.69  Aligned_cols=263  Identities=27%  Similarity=0.438  Sum_probs=200.5

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      .||....+.+.+.||+|+||+||+|...+  .||||+++.  ......+.|.+|+.++++++||||++++++. .....+
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            35556667788899999999999998644  599998864  3455678899999999999999999999965 455679


Q ss_pred             EEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          474 LVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      +||||+++++|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence            999999999999999654 57999999999999999999999998   99999999999999999999999999986543


Q ss_pred             C-cccceeeeccccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH
Q 004702          553 D-AIQNCTVVQGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI  628 (735)
Q Consensus       553 ~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (735)
                      . .........||+.|+|||.+.   ...++.++||||||+++|||++|+.||......+...      ..+....... 
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~~~-  245 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII------EMVGRGSLSP-  245 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH------HHHHHTSCCC-
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH------HHhcccccCc-
Confidence            2 122233456899999999986   5678889999999999999999999997654433211      1111111100 


Q ss_pred             hhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       629 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                         . ........+.++.+|+.+||+.+|.+|||+.||++.|+.+.+
T Consensus       246 ---~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          246 ---D-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ---C-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---c-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence               0 011122345789999999999999999999999999998754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=354.62  Aligned_cols=245  Identities=24%  Similarity=0.304  Sum_probs=199.2

Q ss_pred             HHhhhccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCce
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~  472 (735)
                      +....+.+.++||+|+||+||+++. .++..||||+++..   .....+.+.+|..+|..+ +||||+++++++...+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            3334556678999999999999985 45889999998742   334456788999999988 699999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++||||+++|+|.+++.....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            999999999999999998889999999999999999999999998   99999999999999999999999999986432


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+               +...
T Consensus       177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i---------------~~~~  240 (353)
T 3txo_A          177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI---------------LNDE  240 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---------------HHCC
T ss_pred             CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH---------------HcCC
Confidence            22 2233456999999999999889999999999999999999999999766543321111               1111


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                      .  ..+.....++.+|+.+||+.+|.+||++
T Consensus       241 ~--~~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          241 V--VYPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             C--CCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             C--CCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence            1  1122345678999999999999999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-40  Score=358.66  Aligned_cols=257  Identities=30%  Similarity=0.421  Sum_probs=198.4

Q ss_pred             ccccccccccCcEEEEEEEcC--CC--cEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEee-cCceeEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP--DR--TPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE-TQVPLLVY  476 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~--~~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~  476 (735)
                      +.+.++||+|+||+||+|.+.  ++  ..||||.++. ......++|.+|+.++++++||||+++++++.. .+..++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            455679999999999999853  22  3689998864 345567889999999999999999999999765 45789999


Q ss_pred             EecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+++|+|.+++... ..+++..++.++.|+++||+|||+++   |+||||||+||||++++.+||+|||+++.......
T Consensus       171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccccc
Confidence            999999999999865 46899999999999999999999998   99999999999999999999999999986643221


Q ss_pred             c---ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          556 Q---NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       556 ~---~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      .   ......+++.|+|||.+.+..++.++||||||++||||++ |..||......+....       +....       
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-------~~~~~-------  313 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------LLQGR-------  313 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-------HHTTC-------
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-------HHcCC-------
Confidence            1   1233447889999999999999999999999999999999 5666654433221111       11110       


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                        ....+...+..+.+|+.+||+.+|++|||+.||++.|+.++..+.
T Consensus       314 --~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          314 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence              111122345679999999999999999999999999999987765

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.3e-40  Score=353.68  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=200.4

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCC--CceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINR--RNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||.||++...++..||||++..  ......+.+.+|+.+|.+++|  +||+++++++...+..++|||
T Consensus        10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e   89 (343)
T 3dbq_A           10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME   89 (343)
T ss_dssp             EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe
Confidence            4556789999999999999988899999999864  345566889999999999987  999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-  556 (735)
                       +.+++|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+||||+ ++.+||+|||+++........ 
T Consensus        90 -~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  164 (343)
T 3dbq_A           90 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  164 (343)
T ss_dssp             -CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred             -CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence             458899999999889999999999999999999999998   99999999999997 568999999999876543322 


Q ss_pred             ceeeeccccCccCcccccC-----------CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          557 NCTVVQGTLGYLDPEYLQT-----------CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                      ......||+.|+|||++.+           ..++.++||||||++||||++|+.||........              .+
T Consensus       165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------------~~  230 (343)
T 3dbq_A          165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------------KL  230 (343)
T ss_dssp             -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--------------HH
T ss_pred             cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH--------------HH
Confidence            2234569999999999864           6788999999999999999999999965432211              11


Q ss_pred             hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       626 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      ..++++......+.....++.+|+.+||+.||.+|||+.|+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            122222222222333346789999999999999999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=354.78  Aligned_cols=249  Identities=19%  Similarity=0.246  Sum_probs=207.0

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||.||+|... ++..||+|.+..........+.+|+.+|++++||||+++++++.+....++||||++
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  131 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  131 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence            3556789999999999999854 688999999887666667789999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--CCCeEEeeccCCcccCCCcccc
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE--NCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +|+|.+++... ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++.......  
T Consensus       132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--  206 (387)
T 1kob_A          132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--  206 (387)
T ss_dssp             CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred             CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc--
Confidence            99999999865 47999999999999999999999998   999999999999974  56799999999987654332  


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|+|||.+.+..++.++||||||++||||++|+.||......+....       +....      .......
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~-------i~~~~------~~~~~~~  273 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN-------VKRCD------WEFDEDA  273 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-------HHHCC------CCCCSST
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH-------HHhCC------CCCCccc
Confidence            2334699999999999999999999999999999999999999976544322111       11100      0011111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            2234578999999999999999999999885

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.4e-39  Score=342.91  Aligned_cols=258  Identities=29%  Similarity=0.401  Sum_probs=204.9

Q ss_pred             hccccccccccCcEEEEEEEcCC----CcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEee-cCceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE-TQVPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV  475 (735)
                      .+.+.++||+|+||+||+|...+    ...+|+|.++. ......+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            45567899999999999998543    23589998875 445567889999999999999999999998654 5578999


Q ss_pred             EEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          476 YEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |||+++++|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            9999999999999764 56899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             c---cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCC-ccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          555 I---QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK-MALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       555 ~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      .   .......+|+.|+|||.+.+..++.++||||||+++|||++|. .||......+....   .    ..        
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~----~~--------  247 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---L----LQ--------  247 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---H----HT--------
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---H----hc--------
Confidence            2   1223345788999999999999999999999999999999955 45543332221110   0    00        


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                       ......+...+..+.+++.+||+.+|.+|||+.|+++.|+.+++.+.
T Consensus       248 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          248 -GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             -CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence             00111122234679999999999999999999999999999887654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=344.45  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=199.0

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      .+.+.++||+|+||+||++... +..||||++..  ....+.|.+|+.++++++||||+++++++.  +..++||||+++
T Consensus         9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~   83 (307)
T 2eva_A            9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG   83 (307)
T ss_dssp             GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred             HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence            3456779999999999999875 67899999864  344678999999999999999999999876  457899999999


Q ss_pred             CchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC-eEEeeccCCcccCCCcccc
Q 004702          482 GTLFEHIHKKG---NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT-PKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       482 gsL~~~l~~~~---~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-~kl~DFGls~~~~~~~~~~  557 (735)
                      ++|.+++....   .+++..++.++.|+++||+|||+.+..+|+||||||+||||+.++. +||+|||++......    
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----  159 (307)
T 2eva_A           84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----  159 (307)
T ss_dssp             CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence            99999998654   4789999999999999999999932223999999999999998886 799999999765322    


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  ...   ....         ......
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~---~~~~---------~~~~~~  225 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMW---AVHN---------GTRPPL  225 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHH---HHHT---------TCCCCC
T ss_pred             cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHH---HHhc---------CCCCCc
Confidence            22335899999999999999999999999999999999999999654332211  000   0000         011111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ....+..+.+|+.+||+.+|.+|||+.||++.|+.+.....
T Consensus       226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            22345678999999999999999999999999999876654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-39  Score=342.85  Aligned_cols=257  Identities=28%  Similarity=0.374  Sum_probs=209.0

Q ss_pred             hccccc-cccccCcEEEEEEEc---CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          402 TNNYAD-VIGCGGSGNVYKGFL---PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       402 ~~~~~~-~lG~G~~g~Vy~g~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .+.+.+ .||+|+||+||+|.+   ..+..||||+++..  .....+++.+|+.++++++||||+++++++ ..+..++|
T Consensus        17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv   95 (291)
T 1xbb_A           17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV   95 (291)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence            344556 899999999999953   34678999998753  233467899999999999999999999999 66778999


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||+++++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence            999999999999998888999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             cc--eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          556 QN--CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       556 ~~--~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      ..  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+...       .+...         
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~~~---------  236 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-------MLEKG---------  236 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-------HHHTT---------
T ss_pred             cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-------HHHcC---------
Confidence            21  222346789999999998889999999999999999999 999997654432111       11111         


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      .....+...+.++.+|+.+||+.||.+||++.+|++.|+.++....
T Consensus       237 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          237 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            1112223445789999999999999999999999999999887654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.6e-39  Score=341.70  Aligned_cols=259  Identities=21%  Similarity=0.274  Sum_probs=200.5

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||+||++... ++..||||+++..  .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   83 (292)
T 3o0g_A            4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence            456679999999999999854 6889999998743  3444578899999999999999999999999999999999999


Q ss_pred             CCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          480 GNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       480 ~~gsL~~~l~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      ++ +|.+.+. ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        84 ~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  158 (292)
T 3o0g_A           84 DQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY  158 (292)
T ss_dssp             SE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CC
T ss_pred             CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cc
Confidence            76 5555554 4578999999999999999999999998   99999999999999999999999999987643322 22


Q ss_pred             eeeccccCccCcccccCCC-CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc---chhhHh---hh
Q 004702          559 TVVQGTLGYLDPEYLQTCK-LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN---RLLEIL---DN  631 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~-~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---d~  631 (735)
                      ....||+.|+|||.+.+.. ++.++||||||+++|||++|..|+........  ............   .+....   +.
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhcccccc
Confidence            3345899999999998765 89999999999999999999888765443322  122222221111   100000   00


Q ss_pred             ---------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 ---------RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 ---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                               ............++.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                     0001111234567899999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.8e-40  Score=349.63  Aligned_cols=248  Identities=24%  Similarity=0.327  Sum_probs=181.2

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEecCCCch
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      ++||+|+||+||++... ++..||||++...   ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            58999999999999864 6889999998643   3466789999999997 99999999999999999999999999999


Q ss_pred             hHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---CeEEeeccCCcccCCCcccceeee
Q 004702          485 FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC---TPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       485 ~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      .+++.....+++..++.|+.|++.||+|||+++   |+||||||+|||++.++   .+||+|||+++....... .....
T Consensus        94 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~  169 (325)
T 3kn6_A           94 FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTP  169 (325)
T ss_dssp             HHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccccc
Confidence            999999889999999999999999999999998   99999999999997665   799999999986643322 22334


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||.+.+..++.++||||||+++|||++|+.||..................+......      ...+.....
T Consensus       170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~~~  243 (325)
T 3kn6_A          170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEAWKNV  243 (325)
T ss_dssp             --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHHHHTS
T ss_pred             CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcccccCC
Confidence            58999999999999999999999999999999999999997543321111111112222111110      000111234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVS  667 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~  667 (735)
                      +.++.+|+.+||+.||.+|||+.|++
T Consensus       244 s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          244 SQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             CHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             CHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            57899999999999999999999876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=353.61  Aligned_cols=245  Identities=24%  Similarity=0.294  Sum_probs=199.5

Q ss_pred             cccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          406 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      .++||+|+||.||++.. .++..||+|+++.......+.+.+|+.+|++++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            45799999999999985 56889999999877777788899999999999999999999999999999999999999999


Q ss_pred             hHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE--cCCCCeEEeeccCCcccCCCcccceeee
Q 004702          485 FEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL--DENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       485 ~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl--~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      .+++... ..+++..++.++.||++||+|||+.+   |+||||||+||||  +.++.+||+|||+++.......  ....
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~  248 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVN  248 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccc
Confidence            9988754 46999999999999999999999999   9999999999999  5678899999999987654322  2234


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||.+....++.++||||||++||||++|+.||......+....   ....    ..      ..........
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---i~~~----~~------~~~~~~~~~~  315 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN---ILAC----RW------DLEDEEFQDI  315 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHHT----CC------CSCSGGGTTS
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhc----cC------CCChhhhccC
Confidence            599999999999998999999999999999999999999976654332111   1110    00      0001111234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +.++.+|+.+||+.+|.+|||+.|+++
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            568899999999999999999999987

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9.7e-40  Score=342.64  Aligned_cols=261  Identities=20%  Similarity=0.276  Sum_probs=200.2

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccCh--hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ--AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||+||++...++..||+|+++....  ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (288)
T 1ob3_A            4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD   83 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence            456779999999999999988899999999865332  234678899999999999999999999999999999999997


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      + +|.+++... ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++....... ...
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  158 (288)
T 1ob3_A           84 Q-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT  158 (288)
T ss_dssp             E-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccc
Confidence            5 999988764 67999999999999999999999998   99999999999999999999999999986543221 223


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH-----hhhcc
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI-----LDNRI  633 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~d~~~  633 (735)
                      ...||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+................+...     .++..
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T 1ob3_A          159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (288)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence            3458999999999876 45899999999999999999999999766544332222111100000000000     00000


Q ss_pred             c-------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          634 V-------NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       634 ~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .       .......+.++.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0       0011224567899999999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.7e-39  Score=355.69  Aligned_cols=249  Identities=23%  Similarity=0.338  Sum_probs=200.4

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcC--CCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQIN--RRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||+||++...++..||||++..  ......+.+.+|+.+|.+++  ||||+++++++...+..++|||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E  136 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  136 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence            3566789999999999999988899999999864  34566788999999999996  5999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-  556 (735)
                       +.+++|.+++.....+++..++.++.||+.||+|||+.+   |+||||||+||||+ ++.+||+|||+++.+...... 
T Consensus       137 -~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             -CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             -cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence             568899999998888999999999999999999999998   99999999999996 578999999999876543322 


Q ss_pred             ceeeeccccCccCcccccC-----------CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          557 NCTVVQGTLGYLDPEYLQT-----------CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                      ......||+.|+|||++.+           ..++.++||||||++||||++|+.||........              .+
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--------------~~  277 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------------KL  277 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--------------HH
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH--------------HH
Confidence            2234469999999999865           4688999999999999999999999965432211              01


Q ss_pred             hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       626 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ..+++.......+.....++.+|+.+||+.||.+|||+.||++.
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            12222222222222234678999999999999999999999865

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.3e-39  Score=339.30  Aligned_cols=253  Identities=28%  Similarity=0.438  Sum_probs=202.2

Q ss_pred             hhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChh---H----HHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          401 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQA---K----IDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~---~----~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      ..+.+.+.||+|+||+||++.. .++..||||++......   .    .+.+.+|+.++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            3455678999999999999985 57889999998643221   1    167899999999999999999999986544  


Q ss_pred             eEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC-----eEEeeccC
Q 004702          473 LLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT-----PKVSDFGA  546 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~DFGl  546 (735)
                      ++||||+++++|.+++... ..+++..++.++.|++.||+|||+++ .+|+||||||+|||++.++.     +||+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~  175 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL  175 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence            7999999999999888754 57999999999999999999999976 46999999999999987776     99999999


Q ss_pred             CcccCCCcccceeeeccccCccCccccc--CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc
Q 004702          547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQ--TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR  624 (735)
Q Consensus       547 s~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  624 (735)
                      ++....    ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||............     .     
T Consensus       176 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-----~-----  241 (287)
T 4f0f_A          176 SQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN-----M-----  241 (287)
T ss_dssp             CBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH-----H-----
T ss_pred             cccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH-----H-----
Confidence            985432    233456899999999984  456789999999999999999999999755433221110     0     


Q ss_pred             hhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          625 LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       625 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                         +.........+...+.++.+|+.+||+.||.+|||+.||++.|+++
T Consensus       242 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          242 ---IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ---HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ---HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence               1111112222334557899999999999999999999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=342.21  Aligned_cols=262  Identities=24%  Similarity=0.246  Sum_probs=201.3

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||+||++... ++..||||++...  .....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (311)
T 4agu_A            5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC   84 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence            455679999999999999864 5889999987643  3344577889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      ++++|.+++.....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........ ...
T Consensus        85 ~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  160 (311)
T 4agu_A           85 DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYD  160 (311)
T ss_dssp             SEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             CCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccC
Confidence            99999999988888999999999999999999999998   99999999999999999999999999987653222 223


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc------
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR------  632 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~------  632 (735)
                      ...||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+........................      
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            3458999999999876 678999999999999999999999998766554433322211111000000000000      


Q ss_pred             ccC---CC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 IVN---DG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 ~~~---~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +..   ..     ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000   00     0123467899999999999999999999885

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.2e-40  Score=347.42  Aligned_cols=264  Identities=27%  Similarity=0.345  Sum_probs=213.2

Q ss_pred             HHHhhhccccccccccCcEEEEEEEc------CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhc-CCCceEEEceEEee
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLE  468 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~  468 (735)
                      ++....+.+.+.||+|+||+||++..      .++..||||+++.. .....+.+.+|+.++.++ +||||+++++++..
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            34445566778999999999999973      34678999998753 445567899999999999 78999999999887


Q ss_pred             cC-ceeEEEEecCCCchhHHhhhcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 004702          469 TQ-VPLLVYEFVGNGTLFEHIHKKGN----------------LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANI  531 (735)
Q Consensus       469 ~~-~~~lV~E~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NI  531 (735)
                      .+ ..++||||+++++|.+++.....                +++..++.++.|++.||+|||+.+   |+||||||+||
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Ni  179 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI  179 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceE
Confidence            55 48999999999999999987543                899999999999999999999998   99999999999


Q ss_pred             EEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHH
Q 004702          532 LLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEE  609 (735)
Q Consensus       532 Ll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~  609 (735)
                      ||+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            9999999999999999876443222 2233457889999999999899999999999999999998 9999866543221


Q ss_pred             HHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          610 RSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      .  .    ..+...         .....+...+.++.+++.+||+.+|.+|||+.||++.|+.+++...
T Consensus       260 ~--~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          260 F--C----RRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             H--H----HHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             H--H----HHhccC---------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            1  1    111111         1111122345679999999999999999999999999999887654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.9e-40  Score=349.75  Aligned_cols=262  Identities=25%  Similarity=0.343  Sum_probs=212.8

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEee
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLE  468 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~  468 (735)
                      .++....+.+.+.||+|+||.||+|...      .+..||||++... .......+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            3444556677889999999999999754      3678999998753 34556779999999999999999999999999


Q ss_pred             cCceeEEEEecCCCchhHHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC
Q 004702          469 TQVPLLVYEFVGNGTLFEHIHKK----------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT  538 (735)
Q Consensus       469 ~~~~~lV~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~  538 (735)
                      .+..++||||+++|+|.+++...          ..+++..++.++.|++.||+|||+++   |+||||||+||||+.++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCe
Confidence            99999999999999999999753          45799999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHH
Q 004702          539 PKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNF  616 (735)
Q Consensus       539 ~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~  616 (735)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+...     
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-----  251 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-----  251 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH-----
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH-----
Confidence            99999999986543221 11222346889999999998899999999999999999999 888886654332111     


Q ss_pred             HHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          617 LSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       617 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                        .+....         ....+...+..+.+|+.+||+.+|.+|||+.|+++.|+.++..
T Consensus       252 --~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          252 --FVMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             --HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             --HHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence              111111         1112234456799999999999999999999999999987654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=342.61  Aligned_cols=247  Identities=24%  Similarity=0.338  Sum_probs=195.2

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccCh--------------------------hHHHHHHHHHHHHHhc
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQ--------------------------AKIDEFINELVVVLQI  454 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l  454 (735)
                      .+.+.+.||+|+||.||++.. .++..||||++.....                          ...+.+.+|+.+|+++
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            455678999999999999985 4688999999864321                          1245688999999999


Q ss_pred             CCCceEEEceEEee--cCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 004702          455 NRRNVVRLLGCCLE--TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANIL  532 (735)
Q Consensus       455 ~h~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NIL  532 (735)
                      +||||+++++++.+  .+..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+++   |+||||||+|||
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil  169 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL  169 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence            99999999999986  5678999999999999887643 57999999999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCCC---CCccccchhHHHHHHHHHhCCccCCCCChHHH
Q 004702          533 LDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK---LTDKSDVYSFGVVLVELLTGKMALLSDKPEEE  609 (735)
Q Consensus       533 l~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~  609 (735)
                      ++.++.+||+|||+++....... ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||........
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            99999999999999987653322 223346999999999998755   47789999999999999999999976543221


Q ss_pred             HHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          610 RSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .       ..+..        .....+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus       249 ~-------~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          249 H-------SKIKS--------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             H-------HHHHH--------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             H-------HHHhc--------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            1       11111        11111111234567999999999999999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-39  Score=347.70  Aligned_cols=248  Identities=22%  Similarity=0.293  Sum_probs=194.6

Q ss_pred             hhhccccccccccCcEEEEEEEc----CCCcEEEEEEeecc----ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKFV----DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV  471 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  471 (735)
                      ...+.+.++||+|+||.||++..    .++..||+|+++..    .......+.+|+.+|++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            34566778999999999999986    46889999998753    23345668899999999999999999999999999


Q ss_pred             eeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          472 PLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      .++||||+++++|.+++.....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            9999999999999999998888999999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       552 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      .... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....   .            +..
T Consensus       173 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i------------~~~  236 (327)
T 3a62_A          173 HDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK---I------------LKC  236 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---H------------HHT
T ss_pred             cCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH---H------------HhC
Confidence            2221 12234589999999999998999999999999999999999999976544321111   1            111


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      ..  ..+...+.++.+|+.+||+.+|.+||     ++.|+++
T Consensus       237 ~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 KL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            11  11223456889999999999999999     5555543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=376.05  Aligned_cols=251  Identities=25%  Similarity=0.406  Sum_probs=204.9

Q ss_pred             cccccCcEEEEEEEcC---CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          408 VIGCGGSGNVYKGFLP---DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .||+|+||.||+|.+.   ++..||||+++.. .....++|.+|+.+|++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999753   4567999998753 34457889999999999999999999999876 56899999999999


Q ss_pred             hhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc--eee
Q 004702          484 LFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTV  560 (735)
Q Consensus       484 L~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~--~~~  560 (735)
                      |.+++... ..+++..++.|+.||+.||+|||+++   |+||||||+||||++++.+||+|||+++....+....  ...
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999764 56999999999999999999999998   9999999999999999999999999998765332221  122


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      ..+++.|+|||++....++.++||||||++||||++ |+.||......+...       .+..         ....+.+.
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~-------~i~~---------~~~~~~p~  562 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-------FIEQ---------GKRMECPP  562 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH-------HHHT---------TCCCCCCT
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHc---------CCCCCCCC
Confidence            336789999999998999999999999999999998 999997665433211       1111         11122233


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ..+.++.+||.+||+.+|++||++.+|++.|+.+.....
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence            456789999999999999999999999999999876654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.9e-40  Score=352.95  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=203.4

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcE----EEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTP----VAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .+.+.++||+|+||+||+|... ++..    ||+|.+... .....+.+.+|+.++++++||||+++++++. ++..++|
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v   92 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV   92 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence            3456679999999999999854 3443    778876532 2333456789999999999999999999886 5668899


Q ss_pred             EEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          476 YEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |||+.+|+|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++......
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD  169 (325)
T ss_dssp             EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred             EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence            9999999999999874 57999999999999999999999998   9999999999999999999999999998775433


Q ss_pred             cc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          555 IQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       555 ~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.....                ...
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----------------~~~  233 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL----------------EKG  233 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH----------------HTT
T ss_pred             ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH----------------HcC
Confidence            22 2334557889999999998899999999999999999999 99999765443321111                111


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .....+...+.++.+|+.+||+.+|.+|||+.||++.|+.+...
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            11111222345688999999999999999999999999987654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.2e-39  Score=354.15  Aligned_cols=248  Identities=25%  Similarity=0.303  Sum_probs=198.2

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.++||+|+||+||+++.. ++..||||+++..   .....+.+.+|..+|.++ +||||+++++++.+.+..++||
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~  132 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI  132 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence            4556789999999999999854 5788999998743   333445678899999887 8999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      ||+++|+|.+++.....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...... .
T Consensus       133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~  208 (396)
T 4dc2_A          133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D  208 (396)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred             EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCC-C
Confidence            99999999999998889999999999999999999999999   9999999999999999999999999998633222 2


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHH--HHHHHHHHhcccchhhHhhhccc
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS--LAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      ......||+.|+|||++.+..++.++||||||++||||++|+.||......+...  ........        +....+ 
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~~~-  279 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEKQI-  279 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH--------HHHCCC-
T ss_pred             ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH--------Hhcccc-
Confidence            2334569999999999999999999999999999999999999996433221110  00001111        111111 


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                       ..+...+.++.+|+.+||+.||.+||++
T Consensus       280 -~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 -RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence             1223345788999999999999999996

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-39  Score=343.65  Aligned_cols=242  Identities=25%  Similarity=0.337  Sum_probs=203.2

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||++... ++..||+|.++..   .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~   87 (318)
T 1fot_A            8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   87 (318)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence            456779999999999999854 6889999998743   123456788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|+|.+++.....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....    .
T Consensus        88 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~----~  160 (318)
T 1fot_A           88 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T  160 (318)
T ss_dssp             CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----B
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc----c
Confidence            999999999998888999999999999999999999998   999999999999999999999999999875432    2


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....               ++....  ..+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---------------i~~~~~--~~p  223 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK---------------ILNAEL--RFP  223 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---------------HHHCCC--CCC
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---------------HHhCCC--CCC
Confidence            234699999999999999999999999999999999999999976544321111               111111  112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      ...+.++.+|+.+||+.+|.+||     ++.||++
T Consensus       224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            23446789999999999999999     7777664

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.1e-39  Score=346.57  Aligned_cols=256  Identities=28%  Similarity=0.411  Sum_probs=205.8

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcE--EEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTP--VAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~--vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.+.||+|+||.||++... ++..  ||||+++. ......+.+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~  105 (327)
T 1fvr_A           26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI  105 (327)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence            4556789999999999999854 4554  48998874 3344567789999999999 8999999999999999999999


Q ss_pred             EecCCCchhHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeE
Q 004702          477 EFVGNGTLFEHIHKKG----------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPK  540 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k  540 (735)
                      ||+++++|.+++....                .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+|
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~k  182 (327)
T 1fvr_A          106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK  182 (327)
T ss_dssp             CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEE
T ss_pred             ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEE
Confidence            9999999999997653                6999999999999999999999998   99999999999999999999


Q ss_pred             EeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHH
Q 004702          541 VSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSS  619 (735)
Q Consensus       541 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  619 (735)
                      |+|||+++.....  .......+++.|+|||.+....++.++||||||+++|||++ |+.||......+.       ...
T Consensus       183 L~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------~~~  253 (327)
T 1fvr_A          183 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------YEK  253 (327)
T ss_dssp             ECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHH
T ss_pred             EcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-------HHH
Confidence            9999998754322  11223347889999999998889999999999999999998 9999976543321       111


Q ss_pred             hcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       620 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      +...         .....+...+.++.+|+.+||+.+|.+|||+.|+++.|+.++....
T Consensus       254 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          254 LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             GGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             hhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            1111         1112223345789999999999999999999999999999887644

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.5e-39  Score=345.29  Aligned_cols=261  Identities=26%  Similarity=0.397  Sum_probs=201.5

Q ss_pred             HhhhccccccccccCcEEEEEEEcC----CCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC--
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ--  470 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--  470 (735)
                      ....+.+.+.||+|+||.||+|...    .+..||||+++.  ......+.+.+|+.++++++||||+++++++.+.+  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3445566789999999999999753    244799999864  34556778999999999999999999999998755  


Q ss_pred             ---ceeEEEEecCCCchhHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 004702          471 ---VPLLVYEFVGNGTLFEHIHK------KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV  541 (735)
Q Consensus       471 ---~~~lV~E~~~~gsL~~~l~~------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl  541 (735)
                         ..++||||+++++|.+++..      ...+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence               35999999999999999942      356999999999999999999999998   999999999999999999999


Q ss_pred             eeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHH
Q 004702          542 SDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSS  619 (735)
Q Consensus       542 ~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~  619 (735)
                      +|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+....       
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------  261 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY-------  261 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-------
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH-------
Confidence            99999987643322 22233457889999999999999999999999999999999 8888866544332111       


Q ss_pred             hcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       620 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      +..         ......+...+.++.+|+.+||+.+|.+|||+.+|++.|+.++....
T Consensus       262 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          262 LLH---------GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             HHT---------TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HHc---------CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            000         11111223345689999999999999999999999999999887653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=344.51  Aligned_cols=246  Identities=22%  Similarity=0.215  Sum_probs=194.6

Q ss_pred             HHhhhccccccccccCcEEEEEEEcC-CCcEEEEEEeec--cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCcee
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF--VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  473 (735)
                      +....+.+.++||+|+||+||+|... ++..||||++..  ........+..|+..+.++ +||||+++++++.+.+..+
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            33445667789999999999999865 789999998764  3344455666677666655 8999999999999999999


Q ss_pred             EEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          474 LVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      +||||+ +++|.+++... ..+++..++.|+.|++.||+|||+.+   |+||||||+||||+.++.+||+|||++.....
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999999 67999888764 46999999999999999999999998   99999999999999999999999999987643


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      ..  ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.....          ...+........    
T Consensus       210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~~----  272 (311)
T 3p1a_A          210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPE----  272 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCHH----
T ss_pred             CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCcc----
Confidence            32  2233459999999999876 799999999999999999999776643211          111111111110    


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                          .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       273 ----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          273 ----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                01123467999999999999999999999885

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-39  Score=343.40  Aligned_cols=260  Identities=21%  Similarity=0.250  Sum_probs=201.1

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||.||++... ++..||||++...   +....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR  114 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence            3556789999999999999854 6889999998643   33445788999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..........
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            9999999999998888999999999999999999999998   9999999999999999999999999998765443333


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.......    ..   ..+... ...      ....
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~---~~~~~~-~~~------~~~~  257 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV----MG---AHINQA-IPR------PSTV  257 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH----HH---HHHHSC-CCC------GGGT
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH----HH---HHhccC-CCC------cccc
Confidence            344568999999999999999999999999999999999999997543221    10   111110 000      0011


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhhhcc
Q 004702          638 NKQQLKEVAKLAARCISVRGEERP-TMKEVSLELQGRLSLMS  678 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~~~~~~~  678 (735)
                      ....+.++.+|+.+||+.+|++|| ++.++++.|+..+....
T Consensus       258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            223446789999999999999999 99999999998766543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-39  Score=350.93  Aligned_cols=247  Identities=24%  Similarity=0.295  Sum_probs=203.7

Q ss_pred             hhhccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeE
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---QAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  474 (735)
                      ...+.+.++||+|+||+||+++.. +++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            334556789999999999999964 58899999987431   23456778899999877 89999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||||+++|+|.+++.....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            9999999999999998888999999999999999999999998   9999999999999999999999999998643222


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      . ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....       +....          
T Consensus       173 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-------i~~~~----------  234 (345)
T 1xjd_A          173 A-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS-------IRMDN----------  234 (345)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCC----------
T ss_pred             C-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHhCC----------
Confidence            2 22345699999999999999999999999999999999999999976544322111       11110          


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMK-EVS  667 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~  667 (735)
                      ...+...+.++.+|+.+||+.||.+||++. ||+
T Consensus       235 ~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            011222456789999999999999999997 554

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=352.52  Aligned_cols=247  Identities=22%  Similarity=0.318  Sum_probs=203.2

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.++||+|+||.||++... ++..||+|++...   .....+.+.+|+.+|+.++||||+++++++.+.+..++|||
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   95 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD   95 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            4556789999999999999854 5788999998642   23345778899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+.+|+|.+++.....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++......  .
T Consensus        96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~  170 (384)
T 4fr4_A           96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--Q  170 (384)
T ss_dssp             CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--C
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC--c
Confidence            9999999999998888999999999999999999999999   9999999999999999999999999998765332  2


Q ss_pred             eeeeccccCccCcccccC---CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          558 CTVVQGTLGYLDPEYLQT---CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~---~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      .....||+.|+|||++..   ..++.++||||||++||||++|+.||..............+.    .          ..
T Consensus       171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~----------~~  236 (384)
T 4fr4_A          171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----T----------TV  236 (384)
T ss_dssp             BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----H----------CC
T ss_pred             eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----h----------cc
Confidence            334569999999999874   458999999999999999999999997544332222211111    0          01


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPT-MKEVS  667 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~  667 (735)
                      ...+...+.++.+|+.+||+.+|.+||+ +.+|+
T Consensus       237 ~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          237 VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence            1122334578999999999999999999 55554

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.1e-39  Score=346.45  Aligned_cols=245  Identities=22%  Similarity=0.338  Sum_probs=194.8

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc---------
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV---------  471 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---------  471 (735)
                      +.+.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.+|++++||||+++++++.+...         
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~   87 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE   87 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence            455679999999999999965 7899999998743 34456789999999999999999999999866442         


Q ss_pred             ------------------------------------------------eeEEEEecCCCchhHHhhhcC---CCCHHHHH
Q 004702          472 ------------------------------------------------PLLVYEFVGNGTLFEHIHKKG---NLSWERRL  500 (735)
Q Consensus       472 ------------------------------------------------~~lV~E~~~~gsL~~~l~~~~---~l~~~~~~  500 (735)
                                                                      .++||||+++++|.+++....   ..++..++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~  167 (332)
T 3qd2_B           88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL  167 (332)
T ss_dssp             --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred             hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence                                                            789999999999999998753   45677899


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc-----------cceeeeccccCccC
Q 004702          501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI-----------QNCTVVQGTLGYLD  569 (735)
Q Consensus       501 ~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~-----------~~~~~~~gt~~y~a  569 (735)
                      .++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++.......           .......||+.|+|
T Consensus       168 ~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            99999999999999998   99999999999999999999999999987754321           11233459999999


Q ss_pred             cccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHH
Q 004702          570 PEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLA  649 (735)
Q Consensus       570 PE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li  649 (735)
                      ||.+.+..++.++||||||+++|||++|..|+.     +...    ..........         .........++.+|+
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~----~~~~~~~~~~---------~~~~~~~~~~~~~li  306 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVR----IITDVRNLKF---------PLLFTQKYPQEHMMV  306 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHH----HHHHHHTTCC---------CHHHHHHCHHHHHHH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHH----HHHHhhccCC---------CcccccCChhHHHHH
Confidence            999999999999999999999999999876631     1111    1111111111         111223456789999


Q ss_pred             HHcccCCCCCCCCHHHHHH
Q 004702          650 ARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       650 ~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+||+.||.+|||+.|+++
T Consensus       307 ~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          307 QDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHCSSGGGSCCHHHHHH
T ss_pred             HHHccCCCCcCCCHHHHhh
Confidence            9999999999999999885

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.9e-39  Score=335.74  Aligned_cols=248  Identities=22%  Similarity=0.278  Sum_probs=204.6

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT   89 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence            3556789999999999999854 467899999886555667889999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEeeccCCcccCCCcccc
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++|.+++.....+++..++.++.|++.||+|||+++   |+||||||+|||+   +.++.+||+|||++........  
T Consensus        90 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~--  164 (277)
T 3f3z_A           90 GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--  164 (277)
T ss_dssp             SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC--
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc--
Confidence            9999999998888999999999999999999999999   9999999999999   7889999999999987654332  


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+....       +....... ..     ..
T Consensus       165 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~-~~-----~~  230 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK-------IREGTFTF-PE-----KD  230 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCCCCC-CH-----HH
T ss_pred             hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHhCCCCC-Cc-----hh
Confidence            233458999999999876 499999999999999999999999976544332111       11110000 00     00


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....+.++.+|+.+||+.+|.+|||+.|+++
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          231 WLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0023468899999999999999999999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.4e-39  Score=349.60  Aligned_cols=252  Identities=22%  Similarity=0.269  Sum_probs=202.0

Q ss_pred             hhhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC-----hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD-----QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      .-.+.+.+.||+|+||+||++.. .++..||||++....     ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34567788999999999999985 468899999986321     123577899999999999999999999999999999


Q ss_pred             EEEEecCCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEeeccC
Q 004702          474 LVYEFVGNGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT---PKVSDFGA  546 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGl  546 (735)
                      +||||+++++|.+++...    ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999888653    35899999999999999999999998   999999999999986554   99999999


Q ss_pred             CcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       547 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                      ++....... ......||+.|+|||.+.+..++.++||||||++||||++|+.||.....    .....    +......
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~----i~~~~~~  250 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEG----IIKGKYK  250 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHH----HHHTCCC
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHH----HHcCCCC
Confidence            987654322 22334599999999999998999999999999999999999999975321    11111    1111000


Q ss_pred             hHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       627 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                        ..+..    ....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       251 --~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          251 --MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              00000    01234678999999999999999999999863

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=350.62  Aligned_cols=266  Identities=19%  Similarity=0.221  Sum_probs=200.1

Q ss_pred             hhhccccccccccCcEEEEEEEcC----CCcEEEEEEeeccChh-----------HHHHHHHHHHHHHhcCCCceEEEce
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLP----DRTPVAVKKSKFVDQA-----------KIDEFINELVVVLQINRRNVVRLLG  464 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g  464 (735)
                      ...+.+.+.||+|+||+||+|...    .+..+|||+.......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            345667789999999999999965    5678999988754321           1234678889999999999999999


Q ss_pred             EEee----cCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC--C
Q 004702          465 CCLE----TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC--T  538 (735)
Q Consensus       465 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~--~  538 (735)
                      ++..    ....++||||+ +++|.+++.....+++..++.|+.|++.||+|||+++   |+||||||+||||+.++  .
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCc
Confidence            9988    67889999999 9999999988778999999999999999999999998   99999999999999877  9


Q ss_pred             eEEeeccCCcccCCCccc------ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHH
Q 004702          539 PKVSDFGASKLVPIDAIQ------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSL  612 (735)
Q Consensus       539 ~kl~DFGls~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~  612 (735)
                      +||+|||+++.+......      ......||+.|+|||.+.+..++.++||||||++||||++|+.||.........  
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--  269 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA--  269 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH--
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH--
Confidence            999999999876432211      113345899999999999989999999999999999999999999542221111  


Q ss_pred             HHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          613 AMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       613 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      .......... .+...+.....   ....+.++.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus       270 ~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          270 VQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1111111110 11111111000   01234689999999999999999999999999987543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5e-39  Score=341.80  Aligned_cols=259  Identities=21%  Similarity=0.287  Sum_probs=205.7

Q ss_pred             hhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEee----cCceeEE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE----TQVPLLV  475 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV  475 (735)
                      ..+.+.+.||+|+||.||++.. .++..||||++........+.+.+|+.+++.++||||+++++++..    ....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            4566778999999999999985 5789999999887777778899999999999999999999999873    3467899


Q ss_pred             EEecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          476 YEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      |||+.+++|.+++..    ...+++..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||++....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~  185 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQAC  185 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence            999999999999976    367999999999999999999999998   9999999999999999999999999987653


Q ss_pred             CCccc--------ceeeeccccCccCcccccCCC---CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHh
Q 004702          552 IDAIQ--------NCTVVQGTLGYLDPEYLQTCK---LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL  620 (735)
Q Consensus       552 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  620 (735)
                      .....        ......||+.|+|||.+....   ++.++||||||+++|||++|+.||......             
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------------  252 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-------------  252 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-------------
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-------------
Confidence            21111        111234799999999987544   688999999999999999999998421000             


Q ss_pred             cccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       621 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                       ...+...+......+.....+.++.+|+.+||+.||.+|||+.||++.|+.+...
T Consensus       253 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          253 -GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             -TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             -cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence             0011111111111122233457899999999999999999999999999986543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-39  Score=351.27  Aligned_cols=251  Identities=24%  Similarity=0.303  Sum_probs=194.3

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||+||++... ++..||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            4567789999999999999854 688999999875332 23568899999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC--eEEeeccCCcccCCCcccce
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT--PKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DFGls~~~~~~~~~~~  558 (735)
                      +|+|.+++.....+++..++.++.|++.||+|||+++   |+||||||+||||+.++.  +||+|||+++......  ..
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~  174 (361)
T 3uc3_A          100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP  174 (361)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CC
Confidence            9999999988888999999999999999999999999   999999999999987765  9999999998543222  22


Q ss_pred             eeeccccCccCcccccCCCCCcc-ccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDK-SDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~k-sDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....||+.|+|||.+.+..++.+ +||||||+++|||++|+.||............   .        ..+.......+.
T Consensus       175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~---~--------~~~~~~~~~~~~  243 (361)
T 3uc3_A          175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT---I--------QRILSVKYSIPD  243 (361)
T ss_dssp             ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH---H--------HHHHTTCCCCCT
T ss_pred             CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH---H--------HHHhcCCCCCCC
Confidence            33459999999999988877665 89999999999999999999754332211111   1        111111111111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ....+.++.+|+.+||+.+|.+|||+.|+++.
T Consensus       244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          244 DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            12235678999999999999999999999865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6e-39  Score=340.18  Aligned_cols=260  Identities=24%  Similarity=0.336  Sum_probs=201.2

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||.||++.. .++..||||+++.   .+....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  112 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE  112 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence            456678999999999999984 5788999999874   345667889999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          478 FVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       478 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      |+++++|.+++..    ...+++..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||++......
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            9999999999974    456999999999999999999999998   999999999999999999999999999866433


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      .. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ...    ...+....        .
T Consensus       190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~----~~~~~~~~--------~  255 (310)
T 2wqm_A          190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSL----CKKIEQCD--------Y  255 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHH----HHHHHTTC--------S
T ss_pred             Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHH----HHHhhccc--------C
Confidence            22 1223458999999999999999999999999999999999999986542211 111    11111111        1


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ........+.++.+|+.+||+.||.+|||+.||++.|+.+.....
T Consensus       256 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            011112345679999999999999999999999999999887655

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=348.62  Aligned_cols=247  Identities=24%  Similarity=0.340  Sum_probs=188.8

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||+|+||+||++... ++..||||+++...  ..+.+.+|+.+|++++||||+++++++...+..++||||+++
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  132 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG  132 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence            455679999999999999965 57889999987533  346788999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEeeccCCcccCCCcccce
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      ++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+||||+.   ++.+||+|||+++......  ..
T Consensus       133 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~  207 (349)
T 2w4o_A          133 GELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LM  207 (349)
T ss_dssp             CBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc--cc
Confidence            999999998888999999999999999999999998   999999999999975   8899999999998764322  22


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....||+.|+|||.+.+..++.++||||||++||||++|+.||......+.  ...    .+.....      ....+..
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~----~i~~~~~------~~~~~~~  275 (349)
T 2w4o_A          208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR----RILNCEY------YFISPWW  275 (349)
T ss_dssp             -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH----HHHTTCC------CCCTTTT
T ss_pred             ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH----HHHhCCC------ccCCchh
Confidence            334589999999999999999999999999999999999999976543321  111    1111000      0111112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+.++.+|+.+||+.||++|||+.|+++
T Consensus       276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            234568899999999999999999999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-38  Score=333.74  Aligned_cols=249  Identities=22%  Similarity=0.297  Sum_probs=205.7

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||.||++.. .++..||+|++..  ......+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   87 (284)
T 3kk8_A            8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   87 (284)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence            45567999999999999985 4588999999864  34556678899999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEeeccCCcccCCCccc
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT---PKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGls~~~~~~~~~  556 (735)
                      ++++|.+.+.....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||++........ 
T Consensus        88 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~-  163 (284)
T 3kk8_A           88 TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-  163 (284)
T ss_dssp             CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB-
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc-
Confidence            99999999988888999999999999999999999998   999999999999986655   99999999987654322 


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                       .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+.....       .....      .....
T Consensus       164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------~~~~~------~~~~~  229 (284)
T 3kk8_A          164 -WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------KAGAY------DYPSP  229 (284)
T ss_dssp             -CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCC------CCCTT
T ss_pred             -ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH-------Hhccc------cCCch
Confidence             23345899999999999999999999999999999999999999765443321111       11100      00111


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .....+.++.+|+.+||+.+|++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          230 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            112345678999999999999999999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-39  Score=348.96  Aligned_cols=244  Identities=22%  Similarity=0.285  Sum_probs=201.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||+|.. .++..||||++....   ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY   90 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence            45678999999999999985 678899999986421   12235688999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      + +|+|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++........  .
T Consensus        91 ~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~--~  164 (336)
T 3h4j_B           91 A-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF--L  164 (336)
T ss_dssp             C-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT--T
T ss_pred             C-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc--c
Confidence            9 7899999988889999999999999999999999999   99999999999999999999999999987654332  2


Q ss_pred             eeeccccCccCcccccCCCC-CccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~-~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......+..               ..+..  .....
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~--~~~~~  227 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNS--CVYVM  227 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCS--SCCCC
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHc--CCCCC
Confidence            33459999999999988776 68999999999999999999999654322110               00000  00111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            22345678999999999999999999998764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=357.46  Aligned_cols=251  Identities=23%  Similarity=0.272  Sum_probs=202.0

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.++||+|+||+||+++. .+++.||||+++..   .....+.+.+|..++..++||||+++++++.+.+..++|||
T Consensus        62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE  141 (412)
T 2vd5_A           62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME  141 (412)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred             hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence            344567999999999999986 46899999998742   22234558899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          478 FVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      |+++|+|.+++.+. ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....+...
T Consensus       142 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             CCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence            99999999999875 47999999999999999999999998   999999999999999999999999999877554433


Q ss_pred             ceeeeccccCccCccccc-------CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          557 NCTVVQGTLGYLDPEYLQ-------TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~-------~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      ......||+.|+|||++.       ...++.++||||||+++|||++|+.||......+....+......+.        
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------  290 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS--------  290 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC--------
Confidence            333456999999999987       45789999999999999999999999987654432222211100000        


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEER---PTMKEVSL  668 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ev~~  668 (735)
                          ........+.++.+|+.+||. +|.+|   |++.||++
T Consensus       291 ----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          291 ----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             ----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence                000112345789999999999 99998   57877754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-39  Score=345.42  Aligned_cols=252  Identities=21%  Similarity=0.302  Sum_probs=196.2

Q ss_pred             cccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCCCc
Q 004702          406 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      .++||+|+||+||++.. .++..||||+++.......+.+.+|+.++.++ +||||+++++++.+.+..++||||+++++
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   97 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS   97 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence            36899999999999984 46889999998766556677899999999984 79999999999999999999999999999


Q ss_pred             hhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEeeccCCcccCCCcc-----
Q 004702          484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT---PKVSDFGASKLVPIDAI-----  555 (735)
Q Consensus       484 L~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGls~~~~~~~~-----  555 (735)
                      |.+++.....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||+++.......     
T Consensus        98 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  174 (316)
T 2ac3_A           98 ILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS  174 (316)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence            9999998888999999999999999999999998   999999999999998766   99999999886542211     


Q ss_pred             -cceeeeccccCccCcccccC-----CCCCccccchhHHHHHHHHHhCCccCCCCChHHHH--------HHHHHHHHHhc
Q 004702          556 -QNCTVVQGTLGYLDPEYLQT-----CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER--------SLAMNFLSSLK  621 (735)
Q Consensus       556 -~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~--------~~~~~~~~~~~  621 (735)
                       .......||+.|+|||.+..     ..++.++||||||+++|||++|+.||......+..        .........+.
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  254 (316)
T 2ac3_A          175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ  254 (316)
T ss_dssp             -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHH
T ss_pred             ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHh
Confidence             11223458999999999875     56889999999999999999999999764322100        00000111111


Q ss_pred             ccchhhHhhhcccCCC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          622 QNRLLEILDNRIVNDG--NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       622 ~~~~~~~~d~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..        ....+.  ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       255 ~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          255 EG--------KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HC--------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cc--------CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            11        000000  0123467899999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.2e-39  Score=347.27  Aligned_cols=243  Identities=22%  Similarity=0.287  Sum_probs=203.7

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||.||++... ++..||||+++..   .....+.+.+|+.+|+.++||||+++++++.+.+..++|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            3455679999999999999854 6889999998643   22345678899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++|+|.+++.....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....    
T Consensus       122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----  194 (350)
T 1rdq_E          122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----  194 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC----
Confidence            9999999999998888999999999999999999999999   999999999999999999999999999876432    


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|+|||.+.+..++.++||||||++||||++|+.||......+...       .+...        ..  ..
T Consensus       195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-------~i~~~--------~~--~~  257 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE-------KIVSG--------KV--RF  257 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHC--------CC--CC
T ss_pred             cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH-------HHHcC--------CC--CC
Confidence            123459999999999999999999999999999999999999997654432211       11111        11  11


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPT-----MKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  668 (735)
                      +...+.++.+|+.+||+.||.+||+     +.||++
T Consensus       258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            2234578999999999999999998     666653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.6e-39  Score=337.01  Aligned_cols=262  Identities=19%  Similarity=0.237  Sum_probs=205.7

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEE-eecCceeEEEEec
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC-LETQVPLLVYEFV  479 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~E~~  479 (735)
                      .+.+.+.||+|+||+||+|.. .++..||||++....  ..+.+.+|+.+++.++|++++..++.+ ...+..++||||+
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            355678999999999999984 678899999865432  224578999999999988877666655 5667789999999


Q ss_pred             CCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEeeccCCcccCCCcc
Q 004702          480 GNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       480 ~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGls~~~~~~~~  555 (735)
                       +++|.+++.. ...+++..++.++.|++.||+|||+++   |+||||||+||||   ++++.+||+|||+++.......
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence             9999999985 467999999999999999999999999   9999999999999   7889999999999987654322


Q ss_pred             ------cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          556 ------QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       556 ------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                            .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................... 
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  242 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL-  242 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH-
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh-
Confidence                  1223456899999999999999999999999999999999999999765433222222111111100000000 


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                              ....+.++.+|+.+||+.+|++|||+.+|++.|+.++....
T Consensus       243 --------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          243 --------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             --------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             --------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence                    01224689999999999999999999999999999988765

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.3e-39  Score=336.02  Aligned_cols=261  Identities=19%  Similarity=0.235  Sum_probs=206.1

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEE-eecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC-LETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||.||+|.. .++..||||++.....  .+++.+|+.+++.++|++++..+..+ ...+..++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            45677999999999999984 6788999998765332  24688999999999998866666555 5566789999999 


Q ss_pred             CCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEeeccCCcccCCCccc
Q 004702          481 NGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       481 ~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +++|.+++.. ...+++..++.++.|++.||+|||+++   |+||||||+||||   ++++.+||+|||+++........
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            8999999974 467999999999999999999999998   9999999999999   48889999999999876543321


Q ss_pred             ------ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          557 ------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       557 ------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                            ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........................+  
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--  242 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL--  242 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH--
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH--
Confidence                  123456999999999999999999999999999999999999999764432222222111111100000000  


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                             ....+.++.+|+.+||+.+|.+|||+.+|++.|+.++....
T Consensus       243 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          243 -------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             -------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             -------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence                   11234679999999999999999999999999999887655

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.4e-39  Score=343.49  Aligned_cols=257  Identities=21%  Similarity=0.320  Sum_probs=192.2

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||+||+|... ++..||||+++... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   86 (317)
T 2pmi_A            7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD   86 (317)
T ss_dssp             ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred             eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence            445678999999999999854 58899999987533 3334678899999999999999999999999999999999997


Q ss_pred             CCchhHHhhhc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          481 NGTLFEHIHKK------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       481 ~gsL~~~l~~~------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                       ++|.+++...      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred             -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence             5999998753      35899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             ccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch--------
Q 004702          555 IQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL--------  625 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  625 (735)
                      . ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+................+        
T Consensus       163 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          163 N-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             C-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             c-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence            2 2233458999999999876 46899999999999999999999999876554433222221110000000        


Q ss_pred             -------------hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 -------------LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 -------------~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                                   ...+.+..    ....+.++.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                         00111111    1123467999999999999999999998764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.6e-40  Score=346.67  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=198.0

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce----e
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP----L  473 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~  473 (735)
                      .+.+.++||+|+||.||++.. .++..||||+++..   +......+.+|+.++++++||||+++++++......    +
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            355678999999999999984 67889999998753   344567789999999999999999999998776543    9


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+++++|.++++....+++..++.++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            99999999999999998888999999999999999999999998   999999999999999999999999999876433


Q ss_pred             cc--cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          554 AI--QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       554 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      ..  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...      ...........   
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~~~---  240 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPIPPS---  240 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCCCHH---
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCCCCCcc---
Confidence            22  22233458999999999999999999999999999999999999997655433211      11111110000   


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHHHhh
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVS-LELQGR  673 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~-~~L~~~  673 (735)
                          ......+.++.+|+.+||+.||.+||+..+++ ..|...
T Consensus       241 ----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          241 ----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             ----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                00112346789999999999999999766655 444443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.6e-39  Score=357.15  Aligned_cols=251  Identities=25%  Similarity=0.317  Sum_probs=203.9

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.++||+|+||+||++... ++..||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E  149 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  149 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4455679999999999999864 57899999986421   1223457899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++|+|.++++. ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.........
T Consensus       150 ~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          150 YMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             CCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred             CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence            9999999999976 46999999999999999999999998   9999999999999999999999999998775544333


Q ss_pred             eeeeccccCccCcccccCCC----CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          558 CTVVQGTLGYLDPEYLQTCK----LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~----~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      .....||+.|+|||++....    ++.++||||||++||||++|+.||......+....+.....             .+
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------------~~  292 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-------------SL  292 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-------------HC
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-------------cc
Confidence            34556999999999998755    88999999999999999999999986654432222111000             01


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEE--RPTMKEVSLE  669 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~  669 (735)
                      ..+.....+.++.+|+.+||+.+|.+  ||++.||++.
T Consensus       293 ~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            11111234578899999999999988  9999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.6e-39  Score=345.10  Aligned_cols=247  Identities=26%  Similarity=0.305  Sum_probs=200.1

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      +.+.+.||+|+||.||+++.. ++..||||+++..   .....+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus        11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e   90 (345)
T 3a8x_A           11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE   90 (345)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence            456779999999999999864 5788999998743   445567788999999988 89999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++|+|.+++.....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...... ..
T Consensus        91 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~  166 (345)
T 3a8x_A           91 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT  166 (345)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CC
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC-Cc
Confidence            9999999999998888999999999999999999999998   9999999999999999999999999998643222 12


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHH--HHHHHHHHHhcccchhhHhhhcccC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER--SLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  .........        +.....  
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------i~~~~~--  236 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEKQI--  236 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH--------HHHCCC--
T ss_pred             ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH--------HHcCCC--
Confidence            23456999999999999999999999999999999999999999653221110  000011111        111111  


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                      ..+...+.++.+|+.+||+.||.+||++
T Consensus       237 ~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            1223345788999999999999999996

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=347.59  Aligned_cols=257  Identities=24%  Similarity=0.371  Sum_probs=202.1

Q ss_pred             hhccccccccccCcEEEEEEEcC-CCcE----EEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP-DRTP----VAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~----vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      ..+.+.++||+|+||+||+|... ++..    ||+|.++. ......+.+.+|+.++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            34556789999999999999853 3443    57777653 33445678999999999999999999999998755 789


Q ss_pred             EEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          475 VYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      |+||+.+|+|.+++... ..+++..++.|+.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            99999999999999874 57999999999999999999999998   999999999999999999999999999876433


Q ss_pred             cc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          554 AI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       554 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      .. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+..                ..+..
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~----------------~~~~~  234 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----------------SILEK  234 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------HHHHT
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----------------HHHHc
Confidence            22 12223346889999999999999999999999999999999 99999765443321                11111


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ......+...+.++.+|+.+||+.+|.+|||+.|+++.|+.+....
T Consensus       235 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            1122223345567999999999999999999999999999887643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-38  Score=340.92  Aligned_cols=266  Identities=23%  Similarity=0.308  Sum_probs=201.9

Q ss_pred             HhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhc--CCCceEEEceEEeec----Cce
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI--NRRNVVRLLGCCLET----QVP  472 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~~----~~~  472 (735)
                      ....+.+.+.||+|+||.||+|... +..||||++....   ...+..|.+++..+  +||||+++++++...    ...
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            3446677889999999999999875 7889999986432   34455566666554  899999999999887    678


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeeecCCCCCcEEEcCCCCeEEeec
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE--------TNVPIIHRDVKSANILLDENCTPKVSDF  544 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~--------~~~~ivH~Dlk~~NILl~~~~~~kl~DF  544 (735)
                      ++||||+++|+|.++++.. .+++..++.++.|++.||+|||++        +   |+||||||+||||+.++.+||+||
T Consensus       111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeC
Confidence            9999999999999999764 699999999999999999999998        6   999999999999999999999999


Q ss_pred             cCCcccCCCcccc---eeeeccccCccCcccccCCCCCcc------ccchhHHHHHHHHHhC----------CccCCCCC
Q 004702          545 GASKLVPIDAIQN---CTVVQGTLGYLDPEYLQTCKLTDK------SDVYSFGVVLVELLTG----------KMALLSDK  605 (735)
Q Consensus       545 Gls~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------sDVyS~Gvvl~elltG----------~~p~~~~~  605 (735)
                      |+++.........   .....||+.|+|||.+.+.....+      +||||||+++|||++|          +.||....
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence            9998664332221   123458999999999987766665      9999999999999999          66664432


Q ss_pred             hHHHHHHHHHHHHHhcccchhhHhhhcccC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          606 PEEERSLAMNFLSSLKQNRLLEILDNRIVN-DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       606 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      .......  ...........    .+.... ......+.++.+|+.+||+.||.+|||+.||++.|+.+.+...
T Consensus       267 ~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          267 PSDPSYE--DMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             CSSCCHH--HHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             CCCCchh--hhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            2211100  01111110000    000000 0123677889999999999999999999999999999877543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.2e-39  Score=350.50  Aligned_cols=264  Identities=19%  Similarity=0.219  Sum_probs=201.9

Q ss_pred             hcccccccccc--CcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          402 TNNYADVIGCG--GSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G--~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.++||+|  +||+||++... ++..||||+++..  .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  105 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT  105 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence            35567899999  99999999965 6899999998743  3555677889999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          477 EFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       477 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||+++|+|.+++...  ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||++.......
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred             EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence            999999999999875  67999999999999999999999999   9999999999999999999999999986542211


Q ss_pred             c------cceeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHH-HHHHh-c---
Q 004702          555 I------QNCTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN-FLSSL-K---  621 (735)
Q Consensus       555 ~------~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~-~~~~~-~---  621 (735)
                      .      .......||+.|+|||.+.+  ..++.++||||||+++|||++|+.||......+....... ....+ .   
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST  262 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence            1      11112358899999999987  6799999999999999999999999976544322111000 00000 0   


Q ss_pred             --ccc-------------hhhHhh---h------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          622 --QNR-------------LLEILD---N------RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       622 --~~~-------------~~~~~d---~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                        ...             +.+.+.   +      ....+.....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              000             000000   0      0000112234567999999999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.2e-39  Score=347.41  Aligned_cols=243  Identities=25%  Similarity=0.311  Sum_probs=201.4

Q ss_pred             hhhccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeE
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  474 (735)
                      ...+.+.++||+|+||+||++... ++..||||+++..   .....+.+..|..+|..+ +||||+++++++...+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            334566789999999999999865 4788999998743   223456788999999988 79999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||||+++|+|.+++.....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            9999999999999998888999999999999999999999998   9999999999999999999999999998643222


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      . ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....       +        +.... 
T Consensus       176 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~-------i--------~~~~~-  238 (353)
T 2i0e_A          176 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS-------I--------MEHNV-  238 (353)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------H--------HHCCC-
T ss_pred             c-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH-------H--------HhCCC-
Confidence            1 22345699999999999999999999999999999999999999976544321111       1        11111 


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                       ..+...+.++.+|+.+||+.+|.+||++
T Consensus       239 -~~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          239 -AYPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             1122345789999999999999999964

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.2e-39  Score=361.60  Aligned_cols=246  Identities=24%  Similarity=0.291  Sum_probs=195.2

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.++||+|+||.||++.. .++..||||+++..   .......+.+|+.+|+.++||||+++++++...+..++|||
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  228 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME  228 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence            455677999999999999984 56889999998742   34455678899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      |+++|+|.+++.....+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++.+||+|||+++...... .
T Consensus       229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  304 (446)
T 4ejn_A          229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-A  304 (446)
T ss_dssp             CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC-c
Confidence            99999999999988899999999999999999999998 77   9999999999999999999999999998643322 2


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      ......||+.|+|||++.+..++.++||||||++||||++|+.||......+....+       .        ....  .
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-------~--------~~~~--~  367 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------L--------MEEI--R  367 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------H--------HCCC--C
T ss_pred             ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH-------H--------hCCC--C
Confidence            233456999999999999999999999999999999999999999765443321111       0        0000  1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      .+...+.++.+|+.+||+.||.+||     |+.|+++
T Consensus       368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            1223456889999999999999999     8888874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.3e-39  Score=341.97  Aligned_cols=249  Identities=22%  Similarity=0.280  Sum_probs=204.9

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChh------HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQA------KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.+.||+|+||.||++... ++..||||.++.....      ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (321)
T 2a2a_A           13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL   92 (321)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3567789999999999999854 6889999988753221      36789999999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----CeEEeeccCCccc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC----TPKVSDFGASKLV  550 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGls~~~  550 (735)
                      ||||+++++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||+++..
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            9999999999999998888999999999999999999999998   99999999999999887    7999999999876


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      .....  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....       +......  .+
T Consensus       170 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------i~~~~~~--~~  238 (321)
T 2a2a_A          170 EDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------ITSVSYD--FD  238 (321)
T ss_dssp             CTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-------HHTTCCC--CC
T ss_pred             Ccccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHhcccc--cC
Confidence            54322  2334589999999999999999999999999999999999999976544322111       1110000  00


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +..    ....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       239 ~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          239 EEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000    0123467899999999999999999999886

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.7e-39  Score=337.23  Aligned_cols=251  Identities=25%  Similarity=0.377  Sum_probs=200.6

Q ss_pred             hhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeec-CceeEEEEec
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET-QVPLLVYEFV  479 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~E~~  479 (735)
                      ..+.+.+.||+|+||+||++... +..||||.++...  ..+.+.+|+.++++++||||+++++++.+. +..++||||+
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            34566789999999999999874 7889999987543  457889999999999999999999997654 4789999999


Q ss_pred             CCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      ++++|.+++....  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.......   
T Consensus        98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  171 (278)
T 1byg_A           98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  171 (278)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence            9999999998653  3899999999999999999999998   9999999999999999999999999988654221   


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                       ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+..       ..+.         ......
T Consensus       172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-------~~~~---------~~~~~~  234 (278)
T 1byg_A          172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVE---------KGYKMD  234 (278)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-------HHHT---------TTCCCC
T ss_pred             -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHh---------cCCCCC
Confidence             22347889999999998899999999999999999998 99998765432211       1111         111112


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      .+...+..+.+++.+||+.+|.+|||+.|+++.|+.+....
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            23344578999999999999999999999999999887643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=347.95  Aligned_cols=262  Identities=15%  Similarity=0.202  Sum_probs=205.7

Q ss_pred             hccccccccccCcEEEEEEEcCC---------CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEE-----------
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPD---------RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVR-----------  461 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-----------  461 (735)
                      .+.+.+.||+|+||.||+|....         +..||||.+...     +.+.+|+.++++++||||++           
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            45667899999999999998653         788999998743     46789999999999999987           


Q ss_pred             ----EceEEee-cCceeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc
Q 004702          462 ----LLGCCLE-TQVPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD  534 (735)
Q Consensus       462 ----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~  534 (735)
                          +++++.. ....++||||+ +++|.+++...  ..+++..++.|+.||+.||+|||+++   |+||||||+|||++
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~  193 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVD  193 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEc
Confidence                6677776 67889999999 99999999875  78999999999999999999999998   99999999999999


Q ss_pred             CCC--CeEEeeccCCcccCCCccc------ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCCh
Q 004702          535 ENC--TPKVSDFGASKLVPIDAIQ------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKP  606 (735)
Q Consensus       535 ~~~--~~kl~DFGls~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~  606 (735)
                      .++  .+||+|||+++.+......      ......||+.|+|||.+.+..++.++||||||++||||++|+.||.....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            998  8999999999876533211      11233689999999999999999999999999999999999999976532


Q ss_pred             HHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          607 EEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       607 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ....  .......+.. ....+.+..   ......+.++.+|+.+||+.||.+|||+.||++.|+.+++...
T Consensus       274 ~~~~--~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          274 NTED--IMKQKQKFVD-KPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             CHHH--HHHHHHHHHH-SCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CHHH--HHHHHHhccC-Chhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            2111  1111111100 000000000   0001234689999999999999999999999999999987765

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.5e-39  Score=345.95  Aligned_cols=261  Identities=23%  Similarity=0.346  Sum_probs=207.5

Q ss_pred             HHhhhccccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ  470 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  470 (735)
                      +....+.+.+.||+|+||.||+|...      ++..||||++... ......++.+|+.++++++||||+++++++...+
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            44556677889999999999999842      4678999998643 4556678999999999999999999999999999


Q ss_pred             ceeEEEEecCCCchhHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCCeE
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK-------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPK  540 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~k  540 (735)
                      ..++||||+++++|.+++...       ..+++..++.++.|++.||+|||+.+   |+||||||+||||+   ++..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence            999999999999999999865       34899999999999999999999998   99999999999998   455699


Q ss_pred             EeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHH
Q 004702          541 VSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLS  618 (735)
Q Consensus       541 l~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~  618 (735)
                      |+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+...       
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-------  256 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE-------  256 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-------
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH-------
Confidence            999999875432221 12223457889999999998899999999999999999998 889987654332111       


Q ss_pred             HhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       619 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      .+...         .....+...+..+.+|+.+||+.+|.+|||+.||++.|+.+....
T Consensus       257 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          257 FVTSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHhcC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            11111         111112234567899999999999999999999999999876543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=346.45  Aligned_cols=260  Identities=23%  Similarity=0.310  Sum_probs=193.5

Q ss_pred             HHhhhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEee-------
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLE-------  468 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-------  468 (735)
                      +....+.+.++||+|+||.||++.. .++..||||++........+.+.+|+.++.++. ||||+++++++..       
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            3344567788999999999999985 468899999987777777888999999999996 9999999999853       


Q ss_pred             -cCceeEEEEecCCCchhHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeec
Q 004702          469 -TQVPLLVYEFVGNGTLFEHIHK---KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDF  544 (735)
Q Consensus       469 -~~~~~lV~E~~~~gsL~~~l~~---~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF  544 (735)
                       ....++||||+. |+|.+++..   ...+++..++.|+.||+.||+|||+.+ ++|+||||||+||||+.++.+||+||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence             334789999995 799998875   457999999999999999999999975 45999999999999999999999999


Q ss_pred             cCCcccCCCcccc-----------eeeeccccCccCcccc---cCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHH
Q 004702          545 GASKLVPIDAIQN-----------CTVVQGTLGYLDPEYL---QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER  610 (735)
Q Consensus       545 Gls~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~  610 (735)
                      |+++.........           .....||+.|+|||.+   .+..++.++||||||+++|||++|+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9998765332211           1133489999999998   56678999999999999999999999985432211  


Q ss_pred             HHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          611 SLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                                       ++...............+.+|+.+||+.+|.+|||+.|+++.|+.+.....
T Consensus       261 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          261 -----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             -----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                             011111111111223458899999999999999999999999998876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.2e-39  Score=345.33  Aligned_cols=243  Identities=26%  Similarity=0.361  Sum_probs=199.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +...+.||+|+||+||+|.. .++..||||++...   .....+++.+|+.+|++++||||+++++++...+..++||||
T Consensus        56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  135 (348)
T 1u5q_A           56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY  135 (348)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence            44567899999999999984 67889999998743   234457789999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +. |+|.+++.. ...+++..++.++.|+++||+|||+.+   |+||||||+||||+.++.+||+|||+++.....    
T Consensus       136 ~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----  207 (348)
T 1u5q_A          136 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----  207 (348)
T ss_dssp             CS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence            97 688888764 467999999999999999999999998   999999999999999999999999999876432    


Q ss_pred             eeeeccccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          558 CTVVQGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                       ....||+.|+|||.+.   ...++.++||||||++||||++|+.||......+...   ...    ..        ...
T Consensus       208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---~~~----~~--------~~~  271 (348)
T 1u5q_A          208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIA----QN--------ESP  271 (348)
T ss_dssp             -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHH----HS--------CCC
T ss_pred             -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHH----hc--------CCC
Confidence             2345899999999884   5678999999999999999999999997654332111   110    00        000


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .......+..+.+|+.+||+.+|.+|||+.|+++.
T Consensus       272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11112334678999999999999999999998864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.3e-39  Score=353.54  Aligned_cols=270  Identities=21%  Similarity=0.307  Sum_probs=211.9

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecC--ceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQ--VPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~E  477 (735)
                      .+.+.++||+|+||+||+|... ++..||||+++... ....+.+.+|+.++++++||||+++++++...+  ..++|||
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e   89 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence            4556789999999999999865 48899999987532 334577889999999999999999999998765  6799999


Q ss_pred             ecCCCchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCCeEEeeccCCccc
Q 004702          478 FVGNGTLFEHIHKKG---NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGASKLV  550 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGls~~~  550 (735)
                      |+++|+|.+++....   .+++..++.++.|++.||+|||+.+   |+||||||+||||    +.++.+||+|||+++..
T Consensus        90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            999999999998643   3999999999999999999999999   9999999999999    77788999999999876


Q ss_pred             CCCcccceeeeccccCccCcccccC--------CCCCccccchhHHHHHHHHHhCCccCCCCChHHH-HHHHHHHHHHhc
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQT--------CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE-RSLAMNFLSSLK  621 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~  621 (735)
                      .....  .....||+.|+|||.+..        ..++.++||||||+++|||++|+.||........ ............
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             CCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             cCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            54332  233459999999998865        5678899999999999999999999964332221 112212221111


Q ss_pred             ccchhhH---h--------hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          622 QNRLLEI---L--------DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       622 ~~~~~~~---~--------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      ...+..+   .        +..............+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            1110000   0        00011223467788999999999999999999999999999998875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-38  Score=342.67  Aligned_cols=270  Identities=22%  Similarity=0.310  Sum_probs=210.2

Q ss_pred             HHHHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHh--cCCCceEEEceEEeecC--
Q 004702          395 EEEIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQ--INRRNVVRLLGCCLETQ--  470 (735)
Q Consensus       395 ~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~--  470 (735)
                      ..+.....+.+.+.||+|+||.||+|.. ++..||||+++.   .....+.+|++++..  ++||||+++++++....  
T Consensus        36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            3445556777889999999999999987 488899999864   334677889999888  78999999999998876  


Q ss_pred             --ceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCcEEEcCCCCeE
Q 004702          471 --VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLH--------SETNVPIIHRDVKSANILLDENCTPK  540 (735)
Q Consensus       471 --~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~ivH~Dlk~~NILl~~~~~~k  540 (735)
                        ..++||||+++|+|.+++... .+++..++.++.|++.||+|||        +.+   |+||||||+||||+.++++|
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence              789999999999999999764 6999999999999999999999        666   99999999999999999999


Q ss_pred             EeeccCCcccCCCccc---ceeeeccccCccCcccccCC------CCCccccchhHHHHHHHHHhC----------CccC
Q 004702          541 VSDFGASKLVPIDAIQ---NCTVVQGTLGYLDPEYLQTC------KLTDKSDVYSFGVVLVELLTG----------KMAL  601 (735)
Q Consensus       541 l~DFGls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDVyS~Gvvl~elltG----------~~p~  601 (735)
                      |+|||+++........   ......||+.|+|||.+.+.      .++.++||||||++||||++|          +.||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            9999999876433221   12334589999999998765      344789999999999999999          6787


Q ss_pred             CCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          602 LSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND-GNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ..........  ..+...+....+    .+.+... ...+....+.+|+.+||+.+|.+|||+.||++.|+.+.+...
T Consensus       268 ~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          268 YDLVPSDPSV--EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             TTTSCSSCCH--HHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             cccCcCcccH--HHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence            6543221100  011111111110    0111000 123567889999999999999999999999999999876543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.6e-39  Score=333.62  Aligned_cols=244  Identities=26%  Similarity=0.361  Sum_probs=200.7

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||++... ++..||||++....   ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   90 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence            455679999999999999854 56789999986422   22246788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||++.......   .
T Consensus        91 ~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~---~  164 (279)
T 3fdn_A           91 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---R  164 (279)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc---c
Confidence            999999999998888999999999999999999999998   9999999999999999999999999986543322   2


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+......       .          .....+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~----------~~~~~~  227 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------R----------VEFTFP  227 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------H----------TCCCCC
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH-------h----------CCCCCC
Confidence            33458999999999999999999999999999999999999997654433211110       0          001112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ...+..+.+|+.+||+.+|.+|||+.||++.
T Consensus       228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          228 DFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            2344678999999999999999999999874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.8e-39  Score=346.80  Aligned_cols=263  Identities=21%  Similarity=0.258  Sum_probs=204.6

Q ss_pred             HHHhhhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-----CCceEEEceEEeecC
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-----RRNVVRLLGCCLETQ  470 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~~~~  470 (735)
                      ++....+.+.++||+|+||+||++.. .++..||||+++. .....+.+..|+.+++.+.     ||||+++++++...+
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            33344566678999999999999985 5688999999874 3444567788999999996     999999999999999


Q ss_pred             ceeEEEEecCCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-------------
Q 004702          471 VPLLVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-------------  535 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-------------  535 (735)
                      ..++||||+ +++|.+++....  .+++..++.++.||+.||+|||+.+   |+||||||+||||+.             
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence            999999999 899999998753  5999999999999999999999998   999999999999975             


Q ss_pred             ------------CCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCC
Q 004702          536 ------------NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLS  603 (735)
Q Consensus       536 ------------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~  603 (735)
                                  ++.+||+|||+++......    ....||+.|+|||.+.+..++.++||||||++||||++|+.||..
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        7899999999998654322    234589999999999999999999999999999999999999987


Q ss_pred             CChHHHHHHHHHHHHHhcccchhhHh--------hhc-cc----C-CC---------------CHHHHHHHHHHHHHccc
Q 004702          604 DKPEEERSLAMNFLSSLKQNRLLEIL--------DNR-IV----N-DG---------------NKQQLKEVAKLAARCIS  654 (735)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------d~~-~~----~-~~---------------~~~~~~~l~~li~~cl~  654 (735)
                      ....+................+....        +.. ..    . ..               .....+.+.+|+.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            65544333222211111110000000        000 00    0 00               00012568899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 004702          655 VRGEERPTMKEVSL  668 (735)
Q Consensus       655 ~~p~~RPt~~ev~~  668 (735)
                      .||.+|||+.|+++
T Consensus       342 ~dP~~Rpta~elL~  355 (360)
T 3llt_A          342 IDPTLRPSPAELLK  355 (360)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-38  Score=331.89  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=203.6

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.+.||+|+||.||++... ++..||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence            3456789999999999999864 6889999998643 3345678899999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc-cce
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI-QNC  558 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~-~~~  558 (735)
                      ++++|.+++.....+++..++.++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++........ ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            99999999988778999999999999999999999998   99999999999999999999999999986543221 122


Q ss_pred             eeeccccCccCcccccCCCC-CccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~-~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      ....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||.........  ...+    ...        ......
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~----~~~--------~~~~~~  230 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW----KEK--------KTYLNP  230 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHHH----HTT--------CTTSTT
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHh----hhc--------ccccCc
Confidence            33458999999999987665 78999999999999999999999765432211  1111    110        000011


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          231 WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            1234467889999999999999999999874

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.9e-38  Score=333.61  Aligned_cols=247  Identities=23%  Similarity=0.295  Sum_probs=206.1

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||.||++... ++..||+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   95 (294)
T 2rku_A           16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE   95 (294)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence            3456789999999999999865 5788999987642   44566788999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++++|.+++.....+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++........ .
T Consensus        96 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~  171 (294)
T 2rku_A           96 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-R  171 (294)
T ss_dssp             CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc-c
Confidence            9999999999988888999999999999999999999998   99999999999999999999999999987643222 2


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+...       .+...        ..  ..
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~--------~~--~~  234 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-------RIKKN--------EY--SI  234 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTT--------CC--CC
T ss_pred             cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhhc--------cC--CC
Confidence            233458999999999999899999999999999999999999997654332111       11111        00  11


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +......+.+|+.+||+.+|++|||+.|+++.
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          235 PKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            22334678999999999999999999998863

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.3e-39  Score=344.74  Aligned_cols=251  Identities=24%  Similarity=0.247  Sum_probs=197.0

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeecc-----ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-----DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .+.+.+.||+|+||+||++.. .++..||+|++...     .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  106 (345)
T 3hko_A           27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV  106 (345)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence            456678999999999999985 46788999987642     345567899999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhhc----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 004702          476 YEFVGNGTLFEHIHKK----------------------------------------GNLSWERRLRITAETAGVLSYLHS  515 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~qia~~L~yLH~  515 (735)
                      |||+++|+|.+++...                                        ..+++..++.|+.|++.||+|||+
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~  186 (345)
T 3hko_A          107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN  186 (345)
T ss_dssp             EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999998521                                        123577788999999999999999


Q ss_pred             cCCCCeeecCCCCCcEEEcCCC--CeEEeeccCCcccCCC---cccceeeeccccCccCcccccC--CCCCccccchhHH
Q 004702          516 ETNVPIIHRDVKSANILLDENC--TPKVSDFGASKLVPID---AIQNCTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFG  588 (735)
Q Consensus       516 ~~~~~ivH~Dlk~~NILl~~~~--~~kl~DFGls~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~G  588 (735)
                      .+   |+||||||+||||+.++  .+||+|||+++.+...   .........||+.|+|||.+..  ..++.++||||||
T Consensus       187 ~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          187 QG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             TT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             CC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence            98   99999999999998776  8999999999865321   1112334569999999999875  6789999999999


Q ss_pred             HHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          589 VVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       589 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ++||||++|+.||......+.....   .   .....       ...+.....+.++.+|+.+||+.+|.+|||+.|+++
T Consensus       264 ~il~el~~g~~pf~~~~~~~~~~~~---~---~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDADTISQV---L---NKKLC-------FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHH---H---HCCCC-------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHCCCCCCCCChHHHHHHH---H---hcccc-------cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            9999999999999766543322111   1   00000       001111124568899999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8e-39  Score=338.94  Aligned_cols=263  Identities=22%  Similarity=0.278  Sum_probs=198.3

Q ss_pred             hhhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC-----hhHHHHHHHHHHHHHhc---CCCceEEEceEEeecC
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD-----QAKIDEFINELVVVLQI---NRRNVVRLLGCCLETQ  470 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~  470 (735)
                      ...+.+.+.||+|+||+||++.. .++..||||+++...     ......+.+|+.+++++   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            34566778999999999999995 568899999986422     11123556677666665   5999999999998755


Q ss_pred             -----ceeEEEEecCCCchhHHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEee
Q 004702          471 -----VPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSD  543 (735)
Q Consensus       471 -----~~~lV~E~~~~gsL~~~l~~~~~--l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D  543 (735)
                           ..++||||+. ++|.+++.....  +++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEee
Confidence                 4789999996 599999987643  999999999999999999999999   99999999999999999999999


Q ss_pred             ccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc
Q 004702          544 FGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN  623 (735)
Q Consensus       544 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  623 (735)
                      ||+++.......  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...............
T Consensus       164 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          164 FGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            999987643322  233458999999999999999999999999999999999999997765544332222111111111


Q ss_pred             chhhH---hhhcccC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          624 RLLEI---LDNRIVN-------DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       624 ~~~~~---~d~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+...   .......       ....+...++.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00000   0000000       001123467899999999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.2e-38  Score=332.56  Aligned_cols=247  Identities=23%  Similarity=0.343  Sum_probs=200.1

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEee----cCceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE----TQVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV  475 (735)
                      +.+.+.||+|+||+||+|.. .++..||+|++..  ......+.+.+|+.++++++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            45567899999999999985 4678899998864  356667889999999999999999999999875    3457999


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEeeccCCcccCCCc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGls~~~~~~~  554 (735)
                      |||+++++|.+++.....+++..++.++.|++.||+|||+.+ .+|+||||||+||||+ +++.+||+|||++...... 
T Consensus       108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-  185 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  185 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-
Confidence            999999999999998888999999999999999999999976 4599999999999998 7899999999999765432 


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                        ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||.........      ...+.......       
T Consensus       186 --~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~-------  249 (290)
T 1t4h_A          186 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPA-------  249 (290)
T ss_dssp             --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCCCG-------
T ss_pred             --ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH------HHHHhccCCcc-------
Confidence              2233458999999998874 6999999999999999999999999764433211      11111111110       


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       ......+.++.+|+.+||+.+|.+|||+.||++
T Consensus       250 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 -SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             111122357899999999999999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-38  Score=332.94  Aligned_cols=250  Identities=22%  Similarity=0.264  Sum_probs=202.4

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccCh------hHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ------AKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.+.||+|+||.||++... ++..||+|.++....      ...+.+.+|+.++++++||||+++++++...+..++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            4567789999999999999865 688999998864321      136789999999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----CeEEeeccCCccc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC----TPKVSDFGASKLV  550 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGls~~~  550 (735)
                      ||||+++++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||++...
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            9999999999999988888999999999999999999999998   99999999999998877    8999999999876


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      .....  .....|++.|+|||.+....++.++||||||+++|||++|+.||......+.....    ...........  
T Consensus       163 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~--  234 (283)
T 3bhy_A          163 EAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI----SAVNYDFDEEY--  234 (283)
T ss_dssp             C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HTTCCCCCHHH--
T ss_pred             cCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh----HhcccCCcchh--
Confidence            43322  23345899999999999989999999999999999999999999765433211110    00000000000  


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                             ....+..+.+|+.+||+.+|.+|||+.|+++.
T Consensus       235 -------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          235 -------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             -------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             -------cccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence                   01224678999999999999999999999873

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-38  Score=333.16  Aligned_cols=247  Identities=24%  Similarity=0.329  Sum_probs=196.3

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.+.||+|+||+||++.. .++..||+|++... .....+.+.+|+.+|++++||||+++++++.+.+..++||||+
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  102 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC  102 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence            456678999999999999985 46889999998653 3344678899999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEeeccCCcccCC
Q 004702          480 GNGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       480 ~~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGls~~~~~  552 (735)
                      ++++|.+++...    ..+++..++.|+.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++....
T Consensus       103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            999999998643    67999999999999999999999998   9999999999999   4567899999999987644


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      ...  .....|++.|+|||.+. ..++.++||||||+++|||++|+.||......+......     ...        ..
T Consensus       180 ~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~--------~~  243 (285)
T 3is5_A          180 DEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT-----YKE--------PN  243 (285)
T ss_dssp             ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----HCC--------CC
T ss_pred             ccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc-----cCC--------cc
Confidence            322  23445899999999886 478999999999999999999999997654433211110     000        00


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .. ......++++.+|+.+||+.||.+|||+.||++
T Consensus       244 ~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 YA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00 000113467889999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=346.75  Aligned_cols=267  Identities=26%  Similarity=0.415  Sum_probs=198.5

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHH--HHhcCCCceEEEceEEee-----cCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVV--VLQINRRNVVRLLGCCLE-----TQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~-----~~~~~l  474 (735)
                      .+.+.+.||+|+||.||+|+. ++..||||+++...   ...+..|.++  +..++||||+++++.+..     ....++
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             HhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            455678999999999999987 57889999987433   3344455444  455899999999986543     225689


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE---------TNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~---------~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                      ||||+++|+|.+++... ..++..+++++.|+++||+|||+.         +   |+||||||+||||+.++.+||+|||
T Consensus        90 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeecc
Confidence            99999999999999765 459999999999999999999998         7   9999999999999999999999999


Q ss_pred             CCcccCCCcc-------cceeeeccccCccCcccccC-------CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHH
Q 004702          546 ASKLVPIDAI-------QNCTVVQGTLGYLDPEYLQT-------CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS  611 (735)
Q Consensus       546 ls~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~  611 (735)
                      +++.+.....       .......||+.|+|||.+.+       ..++.++||||||++||||++|..|+..........
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            9987643221       11223458999999999986       456779999999999999999988775433211100


Q ss_pred             HHHHHHHHhccc----chhhHhh-hcccC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          612 LAMNFLSSLKQN----RLLEILD-NRIVN------DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       612 ~~~~~~~~~~~~----~~~~~~d-~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ..  +.......    .+...+. .....      ......+.++.+|+.+||+.||.+|||+.||++.|+.++..+.
T Consensus       246 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          246 MA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CT--THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             Hh--hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            00  00000000    0000000 00000      1123466789999999999999999999999999999998776

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2e-38  Score=335.19  Aligned_cols=249  Identities=24%  Similarity=0.317  Sum_probs=203.4

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||+||++... ++..||+|.++.......+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS   89 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence            4566789999999999999854 688999999886555556778899999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEeeccCCcccCCCcccc
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||+   ++++.+||+|||+++......   
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---  163 (304)
T 2jam_A           90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---  163 (304)
T ss_dssp             SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT---
T ss_pred             CccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc---
Confidence            9999999988888999999999999999999999998   9999999999999   788899999999998654321   


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+..       ..+.....      ....+.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~~------~~~~~~  230 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF-------EKIKEGYY------EFESPF  230 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHCCC------CCCTTT
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHcCCC------CCCccc
Confidence            12335899999999999999999999999999999999999999765433211       11111110      001111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          231 WDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            22345789999999999999999999998863

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.3e-39  Score=347.56  Aligned_cols=263  Identities=24%  Similarity=0.315  Sum_probs=207.1

Q ss_pred             hhccccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      ..+.+.+.||+|+||+||++... ++..||+|+++.. .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            34556779999999999999864 6889999998753 455567899999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++++|.+++.....+++..+..++.|++.||+|||+. +   |+||||||+||||+.++.+||+|||++......   .
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~  186 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M  186 (360)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc---c
Confidence            99999999999888899999999999999999999996 7   999999999999999999999999999755322   1


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH--------------------
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL--------------------  617 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------------------  617 (735)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.........                    
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            233458999999999999999999999999999999999999997655433221110000                    


Q ss_pred             ---HHhcccchhhHhhh----cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          618 ---SSLKQNRLLEILDN----RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       618 ---~~~~~~~~~~~~d~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                         .........+.++.    ..........+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence               00000011111111    11111112245679999999999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-38  Score=348.92  Aligned_cols=259  Identities=23%  Similarity=0.309  Sum_probs=192.7

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecC--ceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQ--VPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~lV  475 (735)
                      .+.+.+.||+|+||.||+|.. .++..||||++..  ......+.+.+|+.+|.++. ||||+++++++...+  ..++|
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv   89 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV   89 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence            455678999999999999984 5688999999853  35566778889999999997 999999999997654  67999


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC--
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID--  553 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~--  553 (735)
                      |||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...  
T Consensus        90 ~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           90 FDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             ecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            99997 689999876 47999999999999999999999999   999999999999999999999999999865321  


Q ss_pred             ------------------cccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHH
Q 004702          554 ------------------AIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM  614 (735)
Q Consensus       554 ------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~  614 (735)
                                        .....+...||+.|+|||.+.+ ..++.++||||||++||||++|+.||......+....+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                              1112234569999999999876 679999999999999999999999998765544333222


Q ss_pred             HHHHHhcccchhh-----------Hhh---hc------ccCC-------------CCHHHHHHHHHHHHHcccCCCCCCC
Q 004702          615 NFLSSLKQNRLLE-----------ILD---NR------IVND-------------GNKQQLKEVAKLAARCISVRGEERP  661 (735)
Q Consensus       615 ~~~~~~~~~~~~~-----------~~d---~~------~~~~-------------~~~~~~~~l~~li~~cl~~~p~~RP  661 (735)
                         ..+.......           .++   ..      ....             .......++.+|+.+||+.||.+||
T Consensus       245 ---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~  321 (388)
T 3oz6_A          245 ---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI  321 (388)
T ss_dssp             ---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             ---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence               1111100000           000   00      0000             0002246789999999999999999


Q ss_pred             CHHHHHH
Q 004702          662 TMKEVSL  668 (735)
Q Consensus       662 t~~ev~~  668 (735)
                      |+.|+++
T Consensus       322 t~~e~l~  328 (388)
T 3oz6_A          322 SANDALK  328 (388)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhC
Confidence            9998875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-38  Score=354.02  Aligned_cols=264  Identities=17%  Similarity=0.231  Sum_probs=210.3

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCC-CceEEEceEEeecCceeEEEEec
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.++||+|+||.||+|.. .++..||||++.....  ..++.+|+++++.++| ++|..+..+....+..+|||||+
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            355678999999999999984 5688999998764332  2457899999999987 55666667777788889999999


Q ss_pred             CCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEeeccCCcccCCCcc
Q 004702          480 GNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       480 ~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGls~~~~~~~~  555 (735)
                       +++|.+++.. ...+++..++.|+.||+.||+|||+++   |+||||||+||||   +.++.+||+|||+++.+.....
T Consensus        86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence             9999999985 467999999999999999999999998   9999999999999   6889999999999987654332


Q ss_pred             c------ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          556 Q------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       556 ~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      .      ......||+.|+|||.+.+..++.++||||||++||||++|+.||..............+........+..+.
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~  241 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALC  241 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHH
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHh
Confidence            1      1224569999999999999999999999999999999999999997755433332222221111111111111


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhccCC
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNG  680 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~~~  680 (735)
                               ...+.++.+|+.+||+.+|++||++.+|++.|+.++......
T Consensus       242 ---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~  283 (483)
T 3sv0_A          242 ---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ  283 (483)
T ss_dssp             ---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             ---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence                     122468999999999999999999999999999998765533

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.8e-38  Score=340.49  Aligned_cols=247  Identities=23%  Similarity=0.292  Sum_probs=206.1

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||.||++... ++..||+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  121 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE  121 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence            3456789999999999999864 5788999987642   44567788999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+.+++|.+++.....+++..++.++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++....... .
T Consensus       122 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~  197 (335)
T 2owb_A          122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-R  197 (335)
T ss_dssp             CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             cCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc-c
Confidence            9999999999988888999999999999999999999998   99999999999999999999999999987643322 2


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....       +...        ..  ..
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------~~~~--------~~--~~  260 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-------IKKN--------EY--SI  260 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------HHHT--------CC--CC
T ss_pred             ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH-------HhcC--------CC--CC
Confidence            2334589999999999998999999999999999999999999976543321111       1110        00  11


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +.....++.+|+.+||+.||.+|||+.|+++.
T Consensus       261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          261 PKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            12234678899999999999999999998863

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-38  Score=356.64  Aligned_cols=246  Identities=24%  Similarity=0.339  Sum_probs=205.0

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||.||+|... ++..||||+++...   ....+.+.+|+.+|+.++||||+++++++...+..++|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            3556789999999999999854 68999999986432   1235678899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++|+|.+++.....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.......  
T Consensus        97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~--  171 (476)
T 2y94_A           97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--  171 (476)
T ss_dssp             CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC--
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc--
Confidence            9999999999998888999999999999999999999998   99999999999999999999999999987654322  


Q ss_pred             eeeeccccCccCcccccCCCC-CccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~-~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......+...       .+        .+...  .
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~-------~i--------~~~~~--~  234 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK-------KI--------CDGIF--Y  234 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH-------HH--------HTTCC--C
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH-------HH--------hcCCc--C
Confidence            233459999999999988765 689999999999999999999997654332111       11        11111  1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       235 ~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            112234678999999999999999999999863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7e-39  Score=334.68  Aligned_cols=248  Identities=26%  Similarity=0.411  Sum_probs=202.7

Q ss_pred             hhccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEee-----------
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE-----------  468 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----------  468 (735)
                      ..+.+.+.||+|+||.||++... ++..||+|+++...    +.+.+|+.++++++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            34556789999999999999865 78999999987543    346789999999999999999998864           


Q ss_pred             -----cCceeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 004702          469 -----TQVPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV  541 (735)
Q Consensus       469 -----~~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl  541 (735)
                           ....++||||+++++|.+++...  ..+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEE
Confidence                 34578999999999999999754  67999999999999999999999998   999999999999999999999


Q ss_pred             eeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhc
Q 004702          542 SDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK  621 (735)
Q Consensus       542 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~  621 (735)
                      +|||++........  .....|++.|+|||.+.+..++.++||||||+++|||++|..|+..     ..    .....+.
T Consensus       164 ~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~----~~~~~~~  232 (284)
T 2a19_B          164 GDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TS----KFFTDLR  232 (284)
T ss_dssp             CCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HH----HHHHHHH
T ss_pred             Ccchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HH----HHHHHhh
Confidence            99999987654322  2334589999999999998999999999999999999999987631     11    1111111


Q ss_pred             ccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          622 QNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       622 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      ..        .+    +...+.++.+|+.+||+.||.+|||+.|+++.|+.+.+...
T Consensus       233 ~~--------~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          233 DG--------II----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             TT--------CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             cc--------cc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            11        11    11234568899999999999999999999999998766543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4e-38  Score=352.38  Aligned_cols=256  Identities=22%  Similarity=0.311  Sum_probs=196.3

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------cee
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------VPL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~  473 (735)
                      +.+.+.||+|+||+||++.. .++..||||++...  .....+.+.+|+.+|+.++||||+++++++....      ..+
T Consensus        64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  143 (464)
T 3ttj_A           64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY  143 (464)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence            45567999999999999984 46889999998743  5566778899999999999999999999997553      469


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+.+ +|.+.+..  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus       144 lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  217 (464)
T 3ttj_A          144 LVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  217 (464)
T ss_dssp             EEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred             EEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence            99999975 57676654  4999999999999999999999998   999999999999999999999999999876432


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc----------
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN----------  623 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------  623 (735)
                        ...+...||+.|+|||.+.+..++.++||||||++||||++|+.||......+....+..   .+...          
T Consensus       218 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~---~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          218 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE---QLGTPCPEFMKKLQP  292 (464)
T ss_dssp             --CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---HHCSCCHHHHTTSCH
T ss_pred             --cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---hcCCCCHHHHHHcch
Confidence              223445699999999999999999999999999999999999999977655443322211   11100          


Q ss_pred             chhhHhh---------------hcccCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          624 RLLEILD---------------NRIVND---GNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       624 ~~~~~~d---------------~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .....++               ..+...   .......++.+|+.+||+.||++|||+.|+++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000110               000000   011235779999999999999999999998864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.9e-39  Score=344.25  Aligned_cols=240  Identities=23%  Similarity=0.324  Sum_probs=201.1

Q ss_pred             hccccccccccCcEEEEEEE-cCCCcEEEEEEeeccCh--------hHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          402 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQ--------AKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      .+.+.+.||+|+||+||++. ..++..||||+++....        ...+.+.+|+.+|++++||||+++++++.+.+..
T Consensus        25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~  104 (335)
T 3dls_A           25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF  104 (335)
T ss_dssp             HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence            45567899999999999998 45688999999875321        1344677899999999999999999999999999


Q ss_pred             eEEEEecCCC-chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          473 LLVYEFVGNG-TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       473 ~lV~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      ++||||+..| +|.+++.....+++..++.|+.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       105 ~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            9999999777 99999998888999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCcccceeeeccccCccCcccccCCCC-CccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          552 IDAIQNCTVVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       552 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      ....  .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....                     ...
T Consensus       182 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------------------~~~  238 (335)
T 3dls_A          182 RGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------------------TVE  238 (335)
T ss_dssp             TTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------------------GTT
T ss_pred             CCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------------------HHh
Confidence            4332  233569999999999988776 7899999999999999999999954211                     001


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ....  .+...+.++.+|+.+||+.+|.+|||+.|+++.
T Consensus       239 ~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 AAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111  111234678999999999999999999998863

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.8e-39  Score=344.16  Aligned_cols=262  Identities=19%  Similarity=0.248  Sum_probs=194.5

Q ss_pred             hccccccccccCcEEEEEEE-cCCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          402 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.+.++||+|+||+||++. ..++..||||+++...  ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY  114 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence            45667899999999999998 4568899999986433  23356788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-----CCCCeEEeeccCCcccCCC
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-----ENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-----~~~~~kl~DFGls~~~~~~  553 (735)
                      ++ |+|.+++.....+++..++.|+.||+.||+|||+++   |+||||||+||||+     +++.+||+|||+++.....
T Consensus       115 ~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          115 AE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             CS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             CC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            97 599999998888999999999999999999999998   99999999999994     4556999999999876433


Q ss_pred             cccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh--
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD--  630 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--  630 (735)
                      .. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+................+.....  
T Consensus       191 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (329)
T 3gbz_A          191 IR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP  269 (329)
T ss_dssp             ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence            22 22334589999999999874 489999999999999999999999977655443222211110000000000000  


Q ss_pred             ------hcccCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 ------NRIVNDG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 ------~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                            +......     ......++.+|+.+||+.||.+|||+.|+++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                  0000000     0113367899999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-38  Score=340.31  Aligned_cols=264  Identities=24%  Similarity=0.305  Sum_probs=201.9

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.+.++||+|+||.||++... ++..||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  105 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF  105 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence            3455679999999999999864 5889999987643  344456788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++....... ..
T Consensus       106 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  181 (331)
T 4aaa_A          106 VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VY  181 (331)
T ss_dssp             CSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             CCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-cc
Confidence            999999998887788999999999999999999999998   99999999999999999999999999986543222 22


Q ss_pred             eeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHh--------cccc-hhhH
Q 004702          559 TVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL--------KQNR-LLEI  628 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~--------~~~~-~~~~  628 (735)
                      ....|++.|+|||.+.+. .++.++||||||+++|||++|+.||......+............        .... ....
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV  261 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred             CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence            334589999999998775 78999999999999999999999997765544332221111000        0000 0000


Q ss_pred             hhhcccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          629 LDNRIVNDGN-----KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       629 ~d~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ..+.......     ...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0001111111     1235789999999999999999999998863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-39  Score=348.67  Aligned_cols=252  Identities=23%  Similarity=0.278  Sum_probs=202.6

Q ss_pred             hccccccccccCcEEEEEEEc----CCCcEEEEEEeecc----ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCce
Q 004702          402 TNNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKFV----DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~  472 (735)
                      .+.+.++||+|+||+||++..    .++..||||+++..    .....+.+.+|+.+|+++ +||||+++++++...+..
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  134 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  134 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence            456678999999999999986    46889999987642    122345677899999999 699999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++||||+++++|.+++.....+++..++.++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             EEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            999999999999999998888999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CcccceeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      ..........||+.|+|||.+.+  ..++.++||||||++||||++|+.||..............   .+        ..
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~--------~~  280 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---RI--------LK  280 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---HH--------HH
T ss_pred             CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH---HH--------hc
Confidence            44444445569999999999985  4578999999999999999999999975433221111111   00        00


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERP-----TMKEVSLE  669 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~  669 (735)
                      .  ....+...+..+.+|+.+||+.||.+||     |+.|+++.
T Consensus       281 ~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          281 S--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             c--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            0  1112233456789999999999999999     88887754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.2e-39  Score=348.01  Aligned_cols=248  Identities=25%  Similarity=0.302  Sum_probs=194.8

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHH-HHhcCCCceEEEceEEeecCceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVV-VLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.++||+|+||+||+++.. ++..||||+++..   .......+..|..+ ++.++||||+++++++.+.+..++||
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~  118 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL  118 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence            4566789999999999999864 5788999998643   23344566777776 57789999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      ||+++|+|.+++.....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...... .
T Consensus       119 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~-~  194 (373)
T 2r5t_A          119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-S  194 (373)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-C
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC-C
Confidence            99999999999998888999999999999999999999999   9999999999999999999999999998643221 1


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....               ++...+  .
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~---------------i~~~~~--~  257 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN---------------ILNKPL--Q  257 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH---------------HHHSCC--C
T ss_pred             ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH---------------HHhccc--C
Confidence            23345699999999999999999999999999999999999999976544322111               111111  1


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      .+...+.++.+|+.+||+.||.+||++.+.++++
T Consensus       258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          258 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence            1123446789999999999999999997554444

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=331.92  Aligned_cols=245  Identities=21%  Similarity=0.284  Sum_probs=181.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||.||++.. .++..||||.+....   ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (278)
T 3cok_A           13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM   92 (278)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence            45567999999999999985 578899999986432   12246788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          479 VGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +++++|.+++... ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++......... 
T Consensus        93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  168 (278)
T 3cok_A           93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-  168 (278)
T ss_dssp             CTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc-
Confidence            9999999999875 67999999999999999999999998   999999999999999999999999999876432221 


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+..       ....        ....  ..
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~--------~~~~--~~  231 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVV--------LADY--EM  231 (278)
T ss_dssp             -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CC--------SSCC--CC
T ss_pred             ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHh--------hccc--CC
Confidence            22345899999999999989999999999999999999999999654332210       0000        0000  11


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +...+.++.+|+.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            2234567899999999999999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.7e-38  Score=330.74  Aligned_cols=245  Identities=23%  Similarity=0.324  Sum_probs=204.1

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||.||++... ++..||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            4556789999999999999864 57789999986432   2224678899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++++|.+++.....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.......   
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---  168 (284)
T 2vgo_A           95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---  168 (284)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc---
Confidence            9999999999998888999999999999999999999998   9999999999999999999999999987654322   


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....       +        ....  ...
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------~--------~~~~--~~~  231 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR-------I--------VNVD--LKF  231 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------H--------HTTC--CCC
T ss_pred             cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH-------H--------hccc--cCC
Confidence            2234589999999999999999999999999999999999999976543322111       1        1100  111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +...+.++.+|+.+||+.+|.+|||+.|+++.
T Consensus       232 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            22344678999999999999999999998863

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.3e-38  Score=370.49  Aligned_cols=261  Identities=22%  Similarity=0.336  Sum_probs=209.4

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcCC----CcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV  471 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  471 (735)
                      ++....+.+.+.||+|+||+||+|.+..    +..||||+++. ......+.|.+|+.++++++||||+++++++. ++.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            3444556677899999999999998642    45799999875 34455678999999999999999999999985 456


Q ss_pred             eeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          472 PLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      .++||||+++|+|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            89999999999999999865 46999999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      ............+++.|+|||.+....++.++||||||+++|||++ |..||......+...       .+...      
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~-------~i~~~------  608 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-------RIENG------  608 (656)
T ss_dssp             CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-------HHHHT------
T ss_pred             CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHHcC------
Confidence            5444333344457889999999998899999999999999999997 999987654433211       11111      


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                         .....+...+..+.+|+.+||+.||.+|||+.||++.|+.++...
T Consensus       609 ---~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          609 ---ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence               111122344578999999999999999999999999999987654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.3e-38  Score=328.49  Aligned_cols=246  Identities=23%  Similarity=0.328  Sum_probs=196.4

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||.||++... ++..||||.+....   ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME   91 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4556789999999999999865 68899999986432   2235678899999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++++|.+++.....+++..++.++.|++.||+|||+++   |+|+||||+|||++.++.+||+|||++........  
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  166 (276)
T 2h6d_A           92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--  166 (276)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred             ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcc--
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999987654322  


Q ss_pred             eeeeccccCccCcccccCCCC-CccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~-~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||......+..       ..+....          ..
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~----------~~  229 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF-------KKIRGGV----------FY  229 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC----------CC
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-------HHhhcCc----------cc
Confidence            223458999999999987765 68999999999999999999999764432211       1111110          01


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+.....++.+++.+||+.||.+|||+.|+++.
T Consensus       230 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            112234678999999999999999999999863

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.3e-38  Score=329.92  Aligned_cols=240  Identities=21%  Similarity=0.286  Sum_probs=197.1

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeec--cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF--VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||+||++... ++..||||+++.  .......++.+|+..+..+ +||||+++++++.+.+..++|||
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e   91 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE   91 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence            3456789999999999999864 789999999875  3344567888999999999 89999999999999999999999


Q ss_pred             ecCCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC------------------
Q 004702          478 FVGNGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE------------------  535 (735)
Q Consensus       478 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~------------------  535 (735)
                      |+++++|.+++...    ..+++..++.|+.|++.||+|||+++   |+||||||+|||++.                  
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------------------
T ss_pred             ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999999864    67999999999999999999999998   999999999999984                  


Q ss_pred             -CCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHH
Q 004702          536 -NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA  613 (735)
Q Consensus       536 -~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~  613 (735)
                       ...+||+|||++........     ..||+.|+|||.+.+. .++.++||||||+++|||++|..++......      
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------  237 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW------  237 (289)
T ss_dssp             -CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH------
T ss_pred             CceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH------
Confidence             44799999999987654322     3489999999999765 6778999999999999999998776432110      


Q ss_pred             HHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       614 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                          ..+.....         ...+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       238 ----~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          238 ----HEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ----HHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                11111111         1112234568999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=345.20  Aligned_cols=252  Identities=15%  Similarity=0.175  Sum_probs=203.6

Q ss_pred             HhhhccccccccccCcEEEEEEE------cCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC---CCceEEEceEEeec
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGF------LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN---RRNVVRLLGCCLET  469 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~  469 (735)
                      ....+.+.++||+|+||+||+|.      ...+..||||+++...   ..++..|+.++..++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            34455667899999999999994      4467889999987544   346777888888876   89999999999999


Q ss_pred             CceeEEEEecCCCchhHHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---------
Q 004702          470 QVPLLVYEFVGNGTLFEHIHK-----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---------  535 (735)
Q Consensus       470 ~~~~lV~E~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---------  535 (735)
                      +..++||||+++|+|.+++..     ...+++..++.|+.||+.||+|||+.+   |+||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            999999999999999999974     457999999999999999999999998   999999999999998         


Q ss_pred             --CCCeEEeeccCCcccCC-CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHH
Q 004702          536 --NCTPKVSDFGASKLVPI-DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSL  612 (735)
Q Consensus       536 --~~~~kl~DFGls~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~  612 (735)
                        ++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++||||||++||||++|+.||.......    
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----  292 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----  292 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence              89999999999976532 22223344569999999999999999999999999999999999999985432211    


Q ss_pred             HHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHhhhhhc
Q 004702          613 AMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEER-PTMKEVSLELQGRLSLM  677 (735)
Q Consensus       613 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~ev~~~L~~~~~~~  677 (735)
                                ..    +...+...   ...+.+.+++..|++.+|.+| |++.++.+.|+.++...
T Consensus       293 ----------~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          293 ----------CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             ----------EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ----------ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                      00    00001111   124567889999999999988 67889999999877653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=333.35  Aligned_cols=244  Identities=23%  Similarity=0.330  Sum_probs=196.5

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCCchh
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLF  485 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  485 (735)
                      .+||+|+||.||+|.. .++..||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            3899999999999984 568899999988766666788999999999999999999999999999999999999999999


Q ss_pred             HHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEeeccCCcccCCCcccceeee
Q 004702          486 EHIHKK---GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       486 ~~l~~~---~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +++...   ..+++..+..++.|++.||+|||+.+   |+|+||||+|||++. ++.+||+|||++........ .....
T Consensus       108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  183 (295)
T 2clq_A          108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETF  183 (295)
T ss_dssp             HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred             HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccccc
Confidence            999865   35678999999999999999999998   999999999999987 89999999999987643221 12334


Q ss_pred             ccccCccCcccccCCC--CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCH
Q 004702          562 QGTLGYLDPEYLQTCK--LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK  639 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~--~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  639 (735)
                      .|++.|+|||.+....  ++.++||||||+++|||++|+.||............    ..          ........+.
T Consensus       184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~----------~~~~~~~~~~  249 (295)
T 2clq_A          184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK----VG----------MFKVHPEIPE  249 (295)
T ss_dssp             CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH----HH----------HHCCCCCCCT
T ss_pred             CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh----hc----------cccccccccc
Confidence            5899999999987643  889999999999999999999998643322211000    00          0011112223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          640 QQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       640 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+.++.+|+.+||+.+|++|||+.|+++
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            34578899999999999999999999874

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.2e-38  Score=336.56  Aligned_cols=256  Identities=21%  Similarity=0.250  Sum_probs=202.9

Q ss_pred             CHHHHHhhhcccc-ccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcC-CCceEEEceEEee
Q 004702          394 TEEEIKTVTNNYA-DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQIN-RRNVVRLLGCCLE  468 (735)
Q Consensus       394 ~~~ei~~~~~~~~-~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~  468 (735)
                      ..+.+.. .+.+. ++||+|+||+||++... ++..||||+++..  .......+.+|+.++..+. ||||+++++++..
T Consensus        22 ~~~~~~~-~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           22 SMENFNN-FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             CHHHHHH-HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHhhhh-EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3344443 34444 79999999999999854 6889999988742  3334678899999999995 6999999999999


Q ss_pred             cCceeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEee
Q 004702          469 TQVPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NCTPKVSD  543 (735)
Q Consensus       469 ~~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~D  543 (735)
                      .+..++||||+++|+|.+++...  ..+++..++.++.|++.||+|||+++   |+||||||+||||+.   ++.+||+|
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEee
Confidence            99999999999999999999654  67999999999999999999999998   999999999999997   78999999


Q ss_pred             ccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc
Q 004702          544 FGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN  623 (735)
Q Consensus       544 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  623 (735)
                      ||+++.......  .....||+.|+|||.+....++.++||||||+++|||++|+.||......+......    ..   
T Consensus       178 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----~~---  248 (327)
T 3lm5_A          178 FGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS----QV---  248 (327)
T ss_dssp             GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HT---
T ss_pred             CccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH----hc---
Confidence            999987643322  233459999999999999999999999999999999999999997655433211110    00   


Q ss_pred             chhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          624 RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       624 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                            ......+.....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       249 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          249 ------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                  011111112234567899999999999999999999874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.3e-39  Score=333.51  Aligned_cols=253  Identities=22%  Similarity=0.339  Sum_probs=201.1

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEee--cCceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE--TQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~  476 (735)
                      .+.+.+.||+|+||.||++... ++..||+|++..  ......+.+.+|+.++++++||||+++++++..  ....++||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   86 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   86 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence            3456679999999999999854 688999999874  345567789999999999999999999998854  56789999


Q ss_pred             EecCCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          477 EFVGNGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSET--NVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       477 E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~  166 (279)
T 2w5a_A           87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  166 (279)
T ss_dssp             ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred             eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence            999999999999753    35999999999999999999999976  245999999999999999999999999999876


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      ...... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+..       ..+.....     
T Consensus       167 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~i~~~~~-----  233 (279)
T 2w5a_A          167 NHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-------GKIREGKF-----  233 (279)
T ss_dssp             ---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCC-----
T ss_pred             cccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH-------HHHhhccc-----
Confidence            433221 12345899999999999989999999999999999999999999765432211       11111111     


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ  671 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  671 (735)
                          ...+...+.++.+|+.+||+.+|.+|||+.||++.+.
T Consensus       234 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          234 ----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ----ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                1112234578999999999999999999999987543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8.5e-39  Score=335.44  Aligned_cols=256  Identities=24%  Similarity=0.354  Sum_probs=198.4

Q ss_pred             hhccccccccccCcEEEEEEEcC--CCc--EEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCcee
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP--DRT--PVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPL  473 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  473 (735)
                      ..+.+.+.||+|+||+||+|.+.  ++.  .||||+++..   .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            34566789999999999999843  233  6899987643   3445678999999999999999999999998765 78


Q ss_pred             EEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          474 LVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      +||||+++++|.+++... ..+++..++.++.|++.||+|||+++   |+|+||||+|||++.++.+||+|||++.....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccc
Confidence            999999999999999864 56999999999999999999999998   99999999999999999999999999987654


Q ss_pred             Cccc--ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          553 DAIQ--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       553 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+...       .+.        
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~--------  238 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-------KID--------  238 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-------HHH--------
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH-------HHH--------
Confidence            3221  1223447889999999998889999999999999999999 999997654432111       111        


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ............+.++.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       239 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            1111111223445789999999999999999999999999987654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.7e-38  Score=332.13  Aligned_cols=247  Identities=27%  Similarity=0.404  Sum_probs=205.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +...+.||+|+||.||+|.. .++..||||.+.... ....+.+.+|+.++++++||||+++++++......++||||++
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  103 (303)
T 3a7i_A           24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG  103 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence            44567899999999999984 568899999987532 3456789999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +++|.+++.. ..+++..++.++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||++........ ....
T Consensus       104 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  178 (303)
T 3a7i_A          104 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNT  178 (303)
T ss_dssp             TEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCC
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc-ccCc
Confidence            9999999965 57999999999999999999999998   99999999999999999999999999987653322 2233


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....       +...         ........
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~---------~~~~~~~~  242 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-------IPKN---------NPPTLEGN  242 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHS---------CCCCCCSS
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------hhcC---------CCCCCccc
Confidence            4589999999999999999999999999999999999999976544321111       1110         01111223


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      .+..+.+|+.+||+.+|.+|||+.|+++..
T Consensus       243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          243 YSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            346789999999999999999999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2e-38  Score=359.59  Aligned_cols=248  Identities=25%  Similarity=0.316  Sum_probs=202.9

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.++||+|+||.||++... ++..||||++...   .......+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus       186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy  265 (576)
T 2acx_A          186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL  265 (576)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence            445679999999999999854 6899999998642   223356788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          479 VGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       479 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +++|+|.+++....  .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....... 
T Consensus       266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~-  341 (576)
T 2acx_A          266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  341 (576)
T ss_dssp             CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcc-
Confidence            99999999998653  4999999999999999999999998   99999999999999999999999999987654322 


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                       .....||+.|+|||++.+..++.++||||||++||||++|+.||...............+...             ...
T Consensus       342 -~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-------------~~~  407 (576)
T 2acx_A          342 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------------PEE  407 (576)
T ss_dssp             -EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-------------CCC
T ss_pred             -ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-------------ccc
Confidence             233469999999999999899999999999999999999999997654322111111111110             111


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      .+...+.++.+|+.+||+.||.+||     ++.||++
T Consensus       408 ~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            2233457899999999999999999     6677664

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-38  Score=354.11  Aligned_cols=192  Identities=26%  Similarity=0.365  Sum_probs=154.7

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeec-----Ccee
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLET-----QVPL  473 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~  473 (735)
                      .+.+.++||+|+||+||++.. .++..||||++..  .+....+.+.+|+.+|++++||||+++++++...     ...+
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  133 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY  133 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence            455678999999999999985 4688999999864  3455677899999999999999999999998543     4689


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+ +++|.+++.....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus       134 lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          134 VVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             EEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            999998 5799999988888999999999999999999999998   999999999999999999999999999876422


Q ss_pred             cc--------------------------cceeeeccccCccCcccc-cCCCCCccccchhHHHHHHHHHhC
Q 004702          554 AI--------------------------QNCTVVQGTLGYLDPEYL-QTCKLTDKSDVYSFGVVLVELLTG  597 (735)
Q Consensus       554 ~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVyS~Gvvl~elltG  597 (735)
                      ..                          ...+...||+.|+|||++ ....++.++||||||++||||++|
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            11                          123345689999999976 566799999999999999999994

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.6e-38  Score=341.78  Aligned_cols=250  Identities=19%  Similarity=0.275  Sum_probs=199.3

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEec
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.+.||+|+||+||++... ++..||||.++....    .+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            3556789999999999999854 588999999875432    235788888887 7999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC----CCeEEeeccCCcccCCCcc
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN----CTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGls~~~~~~~~  555 (735)
                      ++|+|.+++.....+++..+..++.||+.||+|||+++   |+||||||+|||+.++    +.+||+|||+++.......
T Consensus        99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A           99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            99999999998888999999999999999999999998   9999999999998543    2499999999987643322


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............    ..+..+..      ....
T Consensus       176 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~------~~~~  244 (342)
T 2qr7_A          176 -LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKF------SLSG  244 (342)
T ss_dssp             -CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCC------CCCS
T ss_pred             -ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCc------ccCc
Confidence             223345899999999998888999999999999999999999999754222111111    11111111      0111


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ......+.++.+|+.+||+.||++|||+.|+++.
T Consensus       245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1123345789999999999999999999998764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.4e-39  Score=343.00  Aligned_cols=261  Identities=21%  Similarity=0.299  Sum_probs=196.1

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhH-HHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAK-IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||+||+|... ++..||||+++...... ...+.+|+.+|++++||||+++++++...+..++||||++
T Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (324)
T 3mtl_A            4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   83 (324)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence            455679999999999999864 68899999987533222 2245689999999999999999999999999999999997


Q ss_pred             CCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                       ++|.+++... ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ....
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~  158 (324)
T 3mtl_A           84 -KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYD  158 (324)
T ss_dssp             -EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cccc
Confidence             5899988765 46999999999999999999999998   9999999999999999999999999998654322 2223


Q ss_pred             eeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh-------
Q 004702          560 VVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN-------  631 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-------  631 (735)
                      ...||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+................+......       
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN  238 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence            3458999999999876 56899999999999999999999999876655443333222111111111111100       


Q ss_pred             --cccCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 --RIVND----GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 --~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                        .....    .......++.+|+.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence              00000    01123467899999999999999999999885

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.5e-38  Score=339.32  Aligned_cols=249  Identities=25%  Similarity=0.351  Sum_probs=201.5

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--------hhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCc
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--------QAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQV  471 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  471 (735)
                      .+.+.+.||+|+||.||++... ++..||||+++...        ....+.+.+|+.++.++ +||||+++++++.....
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            3555689999999999999965 68999999886432        12245678999999999 79999999999999999


Q ss_pred             eeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          472 PLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      .++||||+++++|.+++.....+++..++.++.||+.||.|||+.+   |+|+||||+||||+.++.+||+|||++..+.
T Consensus       175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            9999999999999999998888999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCcccceeeeccccCccCcccccC------CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          552 IDAIQNCTVVQGTLGYLDPEYLQT------CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       552 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                      ....  .....||+.|+|||++.+      ..++.++||||||+++|||++|+.||...........       +.....
T Consensus       252 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-------i~~~~~  322 (365)
T 2y7j_A          252 PGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM-------IMEGQY  322 (365)
T ss_dssp             TTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTCC
T ss_pred             CCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHhCCC
Confidence            4322  233569999999998863      3588899999999999999999999976543321111       111100


Q ss_pred             hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      . ...+.     ....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       323 ~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          323 Q-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             C-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0 00000     0112457899999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.3e-38  Score=344.40  Aligned_cols=245  Identities=24%  Similarity=0.303  Sum_probs=188.9

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHH-hcCCCceEEEceEEee----cCceeEEEEecC
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVL-QINRRNVVRLLGCCLE----TQVPLLVYEFVG  480 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~----~~~~~lV~E~~~  480 (735)
                      ++||+|+||+||++... ++..||||+++..     ..+.+|+.++. ..+||||+++++++..    ....++||||++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~  142 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD  142 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence            68999999999999854 6889999998632     35668888874 4589999999999875    567899999999


Q ss_pred             CCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEeeccCCcccCCCcc
Q 004702          481 NGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       481 ~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGls~~~~~~~~  555 (735)
                      +|+|.+++...  ..+++..++.|+.||+.||+|||+.+   |+||||||+||||+.   ++.+||+|||+++...... 
T Consensus       143 gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~-  218 (400)
T 1nxk_A          143 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-  218 (400)
T ss_dssp             SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred             CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCC-
Confidence            99999999875  35999999999999999999999998   999999999999997   7899999999998654322 


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                       ......||+.|+|||++.+..++.++||||||++||||++|+.||.............   ..+.....      ....
T Consensus       219 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~i~~~~~------~~~~  288 (400)
T 1nxk_A          219 -SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMGQY------EFPN  288 (400)
T ss_dssp             ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH---HHHHHTCC------CCCT
T ss_pred             -ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH---HHHHcCcc------cCCC
Confidence             2234558999999999999999999999999999999999999997654322100000   00000000      0001


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLEL  670 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  670 (735)
                      ......+.++.+|+.+||+.||.+|||+.||++.-
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            11123457899999999999999999999998753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-38  Score=341.53  Aligned_cols=258  Identities=22%  Similarity=0.284  Sum_probs=195.8

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------ce
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------VP  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~  472 (735)
                      .+.+.+.||+|+||.||+|.. .++..||||++..  ......+.+.+|+.+|++++||||+++++++...+      ..
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  105 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF  105 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence            345567899999999999985 5688999999854  34455678899999999999999999999998653      35


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus       106 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          106 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            9999999 7899999976 57999999999999999999999999   99999999999999999999999999987543


Q ss_pred             CcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHH--------HHHhccc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNF--------LSSLKQN  623 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~  623 (735)
                      .    .+...+|+.|+|||.+.+ ..++.++||||||++++||++|+.||......+....+...        ...+...
T Consensus       181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence            2    233458999999999877 67999999999999999999999999776554332222111        1111100


Q ss_pred             chhhHhhh--c----ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          624 RLLEILDN--R----IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       624 ~~~~~~d~--~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .....+..  .    -..........++.+|+.+||+.||.+|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            00000000  0    000111233567899999999999999999999876

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.1e-38  Score=332.30  Aligned_cols=249  Identities=20%  Similarity=0.275  Sum_probs=185.9

Q ss_pred             hhhccccccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHH-HHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKI-DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ...+.+.+.||+|+||+||++.. .++..||||+++.. ..... +.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            34456678999999999999985 57889999998753 23333 33445555688899999999999999999999999


Q ss_pred             EecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          477 EFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       477 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      ||++ |+|.+++..    ...+++..++.|+.|++.||+|||++ +   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 588877754    46799999999999999999999998 8   9999999999999999999999999998765


Q ss_pred             CCcccceeeeccccCccCcccc----cCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          552 IDAIQNCTVVQGTLGYLDPEYL----QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       552 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      .....  ....||+.|+|||.+    ....++.++||||||+++|||++|+.||.........  ...            
T Consensus       162 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~------------  225 (290)
T 3fme_A          162 DDVAK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQ------------  225 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HHH------------
T ss_pred             ccccc--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HHH------------
Confidence            43222  223589999999996    5667899999999999999999999999753332211  111            


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+............+.++.+|+.+||+.+|.+|||+.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          226 VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            11111111111234567999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.9e-39  Score=352.62  Aligned_cols=236  Identities=15%  Similarity=0.142  Sum_probs=187.4

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec---cChhHHHHHHHHH---HHHHhcCCCceEEEc-------eEEee
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF---VDQAKIDEFINEL---VVVLQINRRNVVRLL-------GCCLE  468 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~~~~  468 (735)
                      +.+.+.||+|+||+||+|.. .++..||||++..   ......+.+.+|+   .+|++++||||++++       +++..
T Consensus        75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~  154 (377)
T 3byv_A           75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  154 (377)
T ss_dssp             EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred             EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence            44567999999999999995 5689999999873   3445678899999   556666899999998       55554


Q ss_pred             cC-----------------ceeEEEEecCCCchhHHhhhcCCCC-------HHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 004702          469 TQ-----------------VPLLVYEFVGNGTLFEHIHKKGNLS-------WERRLRITAETAGVLSYLHSETNVPIIHR  524 (735)
Q Consensus       469 ~~-----------------~~~lV~E~~~~gsL~~~l~~~~~l~-------~~~~~~i~~qia~~L~yLH~~~~~~ivH~  524 (735)
                      .+                 ..++||||+ +|+|.+++.....++       +..++.|+.||+.||+|||+++   |+||
T Consensus       155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHr  230 (377)
T 3byv_A          155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHT  230 (377)
T ss_dssp             TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred             cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            43                 278999999 689999998654344       4888899999999999999998   9999


Q ss_pred             CCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCC-----------CCCccccchhHHHHHHH
Q 004702          525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC-----------KLTDKSDVYSFGVVLVE  593 (735)
Q Consensus       525 Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDVyS~Gvvl~e  593 (735)
                      ||||+||||+.++.+||+|||+++....    ......| +.|+|||.+.+.           .++.++||||||++|||
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            9999999999999999999999986432    2234457 999999999887           89999999999999999


Q ss_pred             HHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          594 LLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       594 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      |++|+.||.......               ....+...      ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       306 lltg~~Pf~~~~~~~---------------~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          306 IWCADLPITKDAALG---------------GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHSSCCC------C---------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHCCCCCccccccc---------------chhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999985432211               01111110      1123467899999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.3e-38  Score=340.74  Aligned_cols=263  Identities=20%  Similarity=0.273  Sum_probs=200.7

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeec--------C
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLET--------Q  470 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~  470 (735)
                      .+.+.+.||+|+||+||++.. .++..||||++....  ......+.+|+.++++++||||+++++++...        +
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            455678999999999999986 578899999875432  23345788999999999999999999999873        4


Q ss_pred             ceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      ..++||||+++ +|.+.+... ..+++..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus        98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A           98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA  173 (351)
T ss_dssp             EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence            67899999975 777777654 67999999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCc---ccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          550 VPIDA---IQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       550 ~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                      +....   ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+................+
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            64221   222234458999999998876 45899999999999999999999999876655443333322211111111


Q ss_pred             hhHhhhccc--------CCCC-HH------HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 LEILDNRIV--------NDGN-KQ------QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 ~~~~d~~~~--------~~~~-~~------~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .........        .... .+      ..+.+.+|+.+||+.||.+|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            111000000        0000 01      1356889999999999999999999885

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.9e-38  Score=350.76  Aligned_cols=249  Identities=23%  Similarity=0.309  Sum_probs=189.9

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC--------hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD--------QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      .+.+.+.||+|+||+||+|.. .++..||||++....        ......+.+|+.+|++++||||+++++++. .+..
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~  214 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY  214 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence            456678999999999999985 457899999986421        122335789999999999999999999975 4557


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CCeEEeeccCCcc
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN---CTPKVSDFGASKL  549 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFGls~~  549 (735)
                      ++||||+++|+|.+++.....+++..++.++.|++.||+|||+++   |+||||||+||||+.+   ..+||+|||+++.
T Consensus       215 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            999999999999999998889999999999999999999999998   9999999999999654   4599999999987


Q ss_pred             cCCCcccceeeeccccCccCcccccC---CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          550 VPIDAIQNCTVVQGTLGYLDPEYLQT---CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       550 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                      ....  .......||+.|+|||++..   ..++.++||||||++||||++|+.||.........  ... +.........
T Consensus       292 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~-i~~~~~~~~~  366 (419)
T 3i6u_A          292 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQ-ITSGKYNFIP  366 (419)
T ss_dssp             CC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHH-HHTTCCCCCH
T ss_pred             cCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHH-HhcCCCCCCc
Confidence            6532  22234569999999999853   67889999999999999999999999754332111  000 0000000000


Q ss_pred             hHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       627 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +.         ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       367 ~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          367 EV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hh---------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00         0123467899999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-37  Score=327.81  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=202.8

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC---------hhHHHHHHHHHHHHHhcC-CCceEEEceEEeecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---------QAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQ  470 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~  470 (735)
                      .+.+.+.||+|+||.||++... ++..||||+++...         ....+.+.+|+.+++++. ||||+++++++...+
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (298)
T 1phk_A           18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   97 (298)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence            3455679999999999999864 67899999987533         233567889999999996 999999999999999


Q ss_pred             ceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      ..++||||+++++|.+++.....+++..++.++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||++...
T Consensus        98 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           98 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999998888999999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCcccceeeeccccCccCccccc------CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQ------TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR  624 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  624 (735)
                      .....  .....|++.|+|||.+.      ...++.++||||||+++|||++|+.||......+....       +....
T Consensus       175 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~  245 (298)
T 1phk_A          175 DPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-------IMSGN  245 (298)
T ss_dssp             CTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTC
T ss_pred             CCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH-------HhcCC
Confidence            53322  23345899999999885      45688999999999999999999999976543321111       11110


Q ss_pred             hhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .      ....+.....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       246 ~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          246 Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             c------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            0      0001111234578999999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2e-37  Score=331.28  Aligned_cols=254  Identities=19%  Similarity=0.275  Sum_probs=199.3

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEee--cCceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLE--TQVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV~E  477 (735)
                      .+.+.+.||+|+||+||++.. .++..||||+++...   .+.+.+|+.++++++ ||||+++++++..  ....++|||
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            345677999999999999984 578899999987443   467889999999997 9999999999987  567899999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEeeccCCcccCCCccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-TPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGls~~~~~~~~~  556 (735)
                      |+.+++|.+++..   +++..++.++.|++.||+|||+++   |+||||||+||||+.++ .+||+|||+++....... 
T Consensus       114 ~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-  186 (330)
T 3nsz_A          114 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-  186 (330)
T ss_dssp             CCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred             ccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc-
Confidence            9999999999853   899999999999999999999999   99999999999999766 899999999987654332 


Q ss_pred             ceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc---
Q 004702          557 NCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR---  632 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~---  632 (735)
                       .....|+..|+|||.+.+ ..++.++||||||++||||++|+.||.........  .......+....+.+.++..   
T Consensus       187 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          187 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             -cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH--HHHHHHhcCCchhhhHHHHhccc
Confidence             223458999999999877 67999999999999999999999999655443221  11111111111111111110   


Q ss_pred             --------------------ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          633 --------------------IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       633 --------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                                          .........+.++.+|+.+||+.||.+|||+.|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                                001111224578999999999999999999999885

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.4e-38  Score=352.24  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=203.9

Q ss_pred             hhccccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      ..+.+.++||+|+||+||++... ++..||||++...  .......+.+|+.+|++++||||+++++++.+....++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            34667889999999999999854 6889999998632  23346788999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCCeEEeeccCCcccCCCc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGls~~~~~~~  554 (735)
                      |+.+++|.+++.....+++..+..++.||+.||+|||+++   |+||||||+||||+   .++.+||+|||+++......
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            9999999999988888999999999999999999999999   99999999999995   55679999999998764332


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                        ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+....       +......      ..
T Consensus       179 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------i~~~~~~------~~  242 (486)
T 3mwu_A          179 --KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR-------VETGKYA------FD  242 (486)
T ss_dssp             -----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTCCC------SC
T ss_pred             --ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhCCCC------CC
Confidence              2234469999999999876 599999999999999999999999976554332111       1111100      00


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+.....+.++.+|+.+||+.+|.+|||+.|+++.
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11112345678999999999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1e-37  Score=352.70  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=199.8

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.+.+.||+|+||+||++... ++..||||+++...  ......+.+|+.+|+.++||||+++++++.+....++||||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  117 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC  117 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            4566789999999999999854 67899999987532  33457789999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEeeccCCcccCCCcc
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGls~~~~~~~~  555 (735)
                      +++|+|.+++.....+++..++.|+.||+.||+|||+.+   |+||||||+||||+.   ++.+||+|||+++...... 
T Consensus       118 ~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-  193 (494)
T 3lij_A          118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-  193 (494)
T ss_dssp             CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-
Confidence            999999999988888999999999999999999999998   999999999999976   4459999999998765432 


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                       ......||+.|+|||.+. ..++.++||||||+++|+|++|+.||......+....       +.....      ....
T Consensus       194 -~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------i~~~~~------~~~~  258 (494)
T 3lij_A          194 -KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK-------VEKGKY------TFDS  258 (494)
T ss_dssp             -CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTCC------CCCS
T ss_pred             -cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhCCC------CCCc
Confidence             223445999999999886 4699999999999999999999999976654332111       111110      0001


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +.....+.++.+|+.+||+.+|.+|||+.|+++.
T Consensus       259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            1112345678999999999999999999998854

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.9e-38  Score=366.12  Aligned_cols=245  Identities=25%  Similarity=0.322  Sum_probs=203.0

Q ss_pred             HHhhhccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCce
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~  472 (735)
                      +....+.+.++||+|+||+||++... ++..||||+++..   .....+.+..|..+|..+ +||||+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            33445566789999999999999854 5788999998742   233456788999999987 699999999999999999


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      +|||||+++|+|.+++.....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999999999998888999999999999999999999998   99999999999999999999999999986433


Q ss_pred             CcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      ... ......||+.|+|||++.+..++.++||||||++||||++|+.||......+...       .+        +...
T Consensus       495 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~-------~i--------~~~~  558 (674)
T 3pfq_A          495 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ-------SI--------MEHN  558 (674)
T ss_dssp             TTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HH--------HSSC
T ss_pred             CCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH-------HH--------HhCC
Confidence            222 2334569999999999999999999999999999999999999997654433211       11        1111


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                      +  ..+...+.++.+|+.+||+.||.+||++
T Consensus       559 ~--~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          559 V--AYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             C--CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             C--CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence            1  1223455789999999999999999998

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=328.61  Aligned_cols=248  Identities=24%  Similarity=0.354  Sum_probs=199.6

Q ss_pred             hhccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      ..+.+.+.||+|+||.||+|... ++..||||.+....  ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            34556779999999999999865 58899999987533  3467899999999999999999999999999999999999


Q ss_pred             CCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          480 GNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       480 ~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      ++++|.+++.. ...+++..++.++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||++........ ..
T Consensus       107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~  182 (314)
T 3com_A          107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KR  182 (314)
T ss_dssp             TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CB
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-cc
Confidence            99999999974 467999999999999999999999998   99999999999999999999999999987643322 22


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||...........       +....       ......+
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~-------~~~~~~~  248 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-------IPTNP-------PPTFRKP  248 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHSC-------CCCCSSG
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------HhcCC-------CcccCCc
Confidence            334589999999999998999999999999999999999999976543321110       00000       0000112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            223467899999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-38  Score=338.20  Aligned_cols=259  Identities=24%  Similarity=0.234  Sum_probs=197.7

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChh-----HHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQA-----KIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .+.+.+.||+|+||.||++... ++..||||+++.....     ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   90 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV   90 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence            3456789999999999999964 5889999998643221     124678999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          476 YEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |||+++ +|.+++... ..+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        91 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           91 FDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            999975 898888765 46899999999999999999999999   9999999999999999999999999998764332


Q ss_pred             ccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc---chhh---
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN---RLLE---  627 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~---  627 (735)
                      . ......||+.|+|||.+.+. .++.++||||||+++|||++|..||......+...   .........   .+..   
T Consensus       167 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          167 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTSSSTTS
T ss_pred             c-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHcCCCChhhhhhhcc
Confidence            2 22334589999999998764 58899999999999999999999987665433222   222221111   0000   


Q ss_pred             Hhhh---cccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          628 ILDN---RIVNDGN-----KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       628 ~~d~---~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+.   ......+     ...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000   0000001     123468999999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.6e-38  Score=353.99  Aligned_cols=250  Identities=22%  Similarity=0.283  Sum_probs=206.0

Q ss_pred             hhccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ..+.+.++||+|+||.||++... ++..||||++...   .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            35667789999999999999854 6889999998643   2345678999999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---cCCCCeEEeeccCCcccCCC
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL---DENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGls~~~~~~  553 (735)
                      ||+.+|+|.+++.....+++..++.++.|++.||+|||+++   |+||||||+||||   +.++.+||+|||+++.....
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            99999999999998889999999999999999999999998   9999999999999   56789999999999876433


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      ..  .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+...       .+......      .
T Consensus       183 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~~~------~  246 (484)
T 3nyv_A          183 KK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK-------KVEKGKYT------F  246 (484)
T ss_dssp             CS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCCCC------C
T ss_pred             cc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHcCCCC------C
Confidence            22  233459999999999876 69999999999999999999999997655433211       11111100      0


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ..+.....+.++.+|+.+||+.+|.+|||+.|+++.
T Consensus       247 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            011112345788999999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.6e-38  Score=347.50  Aligned_cols=196  Identities=25%  Similarity=0.332  Sum_probs=165.8

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeec-----Ccee
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLET-----QVPL  473 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~  473 (735)
                      .+.+.++||+|+||.||++.. .++..||||+++.  ......+.+.+|+.+|++++||||+++++++...     ...+
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            355678999999999999985 4578899999874  3455667899999999999999999999998776     5689


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+. ++|.+++.....+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus       107 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             EEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            9999986 699999998888999999999999999999999999   999999999999999999999999999876433


Q ss_pred             cc---------------------cceeeeccccCccCcccc-cCCCCCccccchhHHHHHHHHHhCCccC
Q 004702          554 AI---------------------QNCTVVQGTLGYLDPEYL-QTCKLTDKSDVYSFGVVLVELLTGKMAL  601 (735)
Q Consensus       554 ~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDVyS~Gvvl~elltG~~p~  601 (735)
                      ..                     ...+...||+.|+|||.+ ....++.++||||||++||||++|..|+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            21                     123455689999999986 5667999999999999999999854443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-37  Score=330.81  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=199.6

Q ss_pred             HhhhccccccccccCcEEEEEEEcCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcC--CCceEEEceEEeecCceeE
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQIN--RRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~l  474 (735)
                      ....+.+.+.||+|+||.||++...++..||||++..  ......+.+.+|+.++.+++  |+||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            3344666789999999999999988899999999864  34556788999999999997  5999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||| +.+++|.+++.....+++..++.++.|+++||+|||+++   |+||||||+|||+++ +.+||+|||+++......
T Consensus       106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred             EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence            999 568899999998888999999999999999999999998   999999999999975 789999999998764332


Q ss_pred             cc-ceeeeccccCccCcccccC-----------CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc
Q 004702          555 IQ-NCTVVQGTLGYLDPEYLQT-----------CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ  622 (735)
Q Consensus       555 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  622 (735)
                      .. ......|++.|+|||.+..           ..++.++||||||+++|||++|+.||........  .          
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~----------  248 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--K----------  248 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H----------
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH--H----------
Confidence            21 1223458999999999875           4688899999999999999999999965433211  0          


Q ss_pred             cchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       623 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                        +..+++.......+...+.++.+|+.+||+.+|.+|||+.|+++.
T Consensus       249 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          249 --LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             --HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence              111122222222222234678999999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.6e-38  Score=331.18  Aligned_cols=249  Identities=20%  Similarity=0.281  Sum_probs=197.6

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   99 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP   99 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred             ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence            3456778999999999999965 588999999887666677889999999999999999999999999999999999999


Q ss_pred             CCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          481 NGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      +++|.+++.. ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....... ....
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  175 (302)
T 2j7t_A          100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRD  175 (302)
T ss_dssp             TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC--
T ss_pred             CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccc
Confidence            9999999876 467999999999999999999999998   9999999999999999999999999876432111 1122


Q ss_pred             eeccccCccCcccc-----cCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          560 VVQGTLGYLDPEYL-----QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       560 ~~~gt~~y~aPE~~-----~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      ...|++.|+|||.+     ....++.++||||||+++|||++|+.||.........   ....   . ....       .
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~---~-~~~~-------~  241 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LKIA---K-SDPP-------T  241 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH---H-SCCC-------C
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---HHHh---c-cCCc-------c
Confidence            34589999999988     4667899999999999999999999999765443211   1110   0 0000       0


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+...+.++.+|+.+||+.+|.+|||+.|+++
T Consensus       242 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0112234567899999999999999999999875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.1e-37  Score=334.06  Aligned_cols=259  Identities=22%  Similarity=0.332  Sum_probs=192.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------cee
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------VPL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~  473 (735)
                      +.+.+.||+|+||.||++.. .++..||||++..  ......+.+.+|+.+++.++||||+++++++...+      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  106 (371)
T 2xrw_A           27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  106 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred             eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence            45667999999999999984 4688899999874  34555678899999999999999999999997655      679


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+. ++|.+++..  .+++..+..++.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       107 lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          107 IVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  180 (371)
T ss_dssp             EEEECCS-EEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEcCC-CCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence            9999996 578888863  5899999999999999999999998   999999999999999999999999999865432


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHH--------HHHHhcc---
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMN--------FLSSLKQ---  622 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~---  622 (735)
                      .  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.......        +...+..   
T Consensus       181 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          181 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             c--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            2  22334689999999999999999999999999999999999999976654332211110        0000000   


Q ss_pred             -----------cchhhHhhhcccCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          623 -----------NRLLEILDNRIVND---GNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       623 -----------~~~~~~~d~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                                 ..+...........   .......++.+|+.+||+.||.+|||+.|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                       00000000000000   112346789999999999999999999999863

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.9e-37  Score=351.27  Aligned_cols=249  Identities=25%  Similarity=0.328  Sum_probs=200.5

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccCh-------------hHHHHHHHHHHHHHhcCCCceEEEceEEe
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ-------------AKIDEFINELVVVLQINRRNVVRLLGCCL  467 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~  467 (735)
                      .+.+.++||+|+||+||++... ++..||||+++....             ...+.+.+|+.+|++++||||+++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4556789999999999999854 578999999864321             23567899999999999999999999999


Q ss_pred             ecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC---CeEEeec
Q 004702          468 ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC---TPKVSDF  544 (735)
Q Consensus       468 ~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DF  544 (735)
                      +....++||||+++|+|.+++.....+++..++.|+.||+.||+|||+.+   |+||||||+||||+.++   .+||+||
T Consensus       117 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            99999999999999999999988888999999999999999999999998   99999999999998775   6999999


Q ss_pred             cCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc
Q 004702          545 GASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR  624 (735)
Q Consensus       545 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  624 (735)
                      |+++.......  .....||+.|+|||.+.. .++.++||||||+++|+|++|+.||......+...       .+....
T Consensus       194 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~  263 (504)
T 3q5i_A          194 GLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK-------KVEKGK  263 (504)
T ss_dssp             TTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCC
T ss_pred             CCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHcCC
Confidence            99987654322  233459999999999874 69999999999999999999999997655433211       111111


Q ss_pred             hhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          625 LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       625 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .....      +.....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       264 ~~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          264 YYFDF------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCCCH------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCc------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00000      0001234678999999999999999999998854

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7e-38  Score=332.83  Aligned_cols=261  Identities=21%  Similarity=0.337  Sum_probs=194.8

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEe--------------
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCL--------------  467 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--------------  467 (735)
                      +.+.+.||+|+||.||+|... ++..||||++...+....+.+.+|+.++++++||||+++++++.              
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~   92 (320)
T 2i6l_A           13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT   92 (320)
T ss_dssp             EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred             eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence            455679999999999999965 48899999998777778889999999999999999999999873              


Q ss_pred             ecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEeeccC
Q 004702          468 ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGA  546 (735)
Q Consensus       468 ~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGl  546 (735)
                      +....++||||+. |+|.+++.. ..+++..++.++.|++.||+|||+++   |+||||||+|||++ +++.+||+|||+
T Consensus        93 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~  167 (320)
T 2i6l_A           93 ELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGL  167 (320)
T ss_dssp             SCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCcc
Confidence            3457799999997 699999965 57999999999999999999999998   99999999999997 567999999999


Q ss_pred             CcccCCCcc--cceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc
Q 004702          547 SKLVPIDAI--QNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN  623 (735)
Q Consensus       547 s~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  623 (735)
                      ++.......  .......++..|+|||.+.. ..++.++||||||+++|||++|+.||......+...............
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE  247 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence            987643221  11223347899999998865 678999999999999999999999998765543322221110000000


Q ss_pred             chhhH-------hhhcccC-CC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          624 RLLEI-------LDNRIVN-DG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       624 ~~~~~-------~d~~~~~-~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...++       +...... ..     ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00000       0000000 00     1123578999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-37  Score=340.31  Aligned_cols=261  Identities=22%  Similarity=0.255  Sum_probs=202.2

Q ss_pred             HHHhhhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC--------CCceEEEceEEe
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN--------RRNVVRLLGCCL  467 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~  467 (735)
                      ++..-.+.+.++||+|+||+||+++. .++..||||+++. .....+.+.+|+.+|++++        |+||+++++++.
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            33345567788999999999999984 5688999999874 3445678899999999985        788999999987


Q ss_pred             ----ecCceeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCC---
Q 004702          468 ----ETQVPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENC---  537 (735)
Q Consensus       468 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~---  537 (735)
                          .....++||||+ +++|.+.+...  ..+++..++.|+.||+.||+|||++ +   |+||||||+||||+.++   
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence                455789999999 55666666543  5699999999999999999999998 8   99999999999999775   


Q ss_pred             ----------------------------------------------CeEEeeccCCcccCCCcccceeeeccccCccCcc
Q 004702          538 ----------------------------------------------TPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE  571 (735)
Q Consensus       538 ----------------------------------------------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE  571 (735)
                                                                    .+||+|||+++.....    .....||+.|+|||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE  263 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence                                                          8999999999876432    22345899999999


Q ss_pred             cccCCCCCccccchhHHHHHHHHHhCCccCCCCChHH---HHHHHHHHHHHhcccch-----------------------
Q 004702          572 YLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE---ERSLAMNFLSSLKQNRL-----------------------  625 (735)
Q Consensus       572 ~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~~~~-----------------------  625 (735)
                      .+.+..++.++||||||++||||++|+.||......+   .................                       
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            9999999999999999999999999999997544322   11111111111111000                       


Q ss_pred             -------hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 -------LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 -------~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                             .+.+..  ...........+.+|+.+||+.||.+|||+.||++
T Consensus       344 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          344 KLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                   000000  11235677788999999999999999999999885

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.5e-37  Score=331.23  Aligned_cols=259  Identities=20%  Similarity=0.303  Sum_probs=203.8

Q ss_pred             hhccccccccccCcEEEEEEEc--CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCC------ceEEEceEEeecCce
Q 004702          401 VTNNYADVIGCGGSGNVYKGFL--PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR------NVVRLLGCCLETQVP  472 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~g~~~~~~~~  472 (735)
                      ..+.+.+.||+|+||+||++..  .++..||||+++.. ....+.+.+|+.+++.++|+      +++++++++...+..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            3566778999999999999985  36789999998753 34467788999999998765      499999999999999


Q ss_pred             eEEEEecCCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---------------
Q 004702          473 LLVYEFVGNGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---------------  535 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---------------  535 (735)
                      ++||||+ +++|.+++....  .+++..++.++.|++.||+|||+++   |+||||||+||||+.               
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccc
Confidence            9999999 889999998764  6899999999999999999999998   999999999999987               


Q ss_pred             ----CCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHH
Q 004702          536 ----NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS  611 (735)
Q Consensus       536 ----~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~  611 (735)
                          ++.+||+|||+++......    ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             ccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                6789999999998654321    23458999999999999999999999999999999999999998765544333


Q ss_pred             HHHHHHHHhcccchhhH----------------------h----hh-cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 004702          612 LAMNFLSSLKQNRLLEI----------------------L----DN-RIVNDGNKQQLKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       612 ~~~~~~~~~~~~~~~~~----------------------~----d~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                      .............+...                      +    .+ ............++.+|+.+||+.||.+|||+.
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            22221111100000000                      0    00 000111234567899999999999999999999


Q ss_pred             HHHH
Q 004702          665 EVSL  668 (735)
Q Consensus       665 ev~~  668 (735)
                      ||++
T Consensus       325 ell~  328 (339)
T 1z57_A          325 EALK  328 (339)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.4e-38  Score=335.57  Aligned_cols=260  Identities=27%  Similarity=0.408  Sum_probs=185.5

Q ss_pred             HHhhhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      +....+.+.+.||+|+||.||++.. .++..||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            3344566778999999999999985 467899999876432 34467788999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCC
Q 004702          476 YEFVGNGTLFEHIHK--------KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS  547 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~--------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls  547 (735)
                      |||+++++|.+++..        ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999974        356999999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCcc----cceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc
Q 004702          548 KLVPIDAI----QNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ  622 (735)
Q Consensus       548 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  622 (735)
                      ........    .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...........   ..... .
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~-~  244 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML---TLQND-P  244 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---HHTSS-C
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH---HhccC-C
Confidence            76543211    11223458999999999875 5689999999999999999999999976544332111   00000 0


Q ss_pred             cchh-hHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          623 NRLL-EILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       623 ~~~~-~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .... ...+...    ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          245 PSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             Cccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000 0111111    1123467899999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.8e-37  Score=350.91  Aligned_cols=245  Identities=21%  Similarity=0.256  Sum_probs=199.6

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD---QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.++||+|+||+||+++.. ++..||||+++...   ....+.+.+|+.+|++++||||+++++++...+..++||||+
T Consensus       188 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~  267 (543)
T 3c4z_A          188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM  267 (543)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence            34568999999999999864 68999999986432   233567889999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          480 GNGTLFEHIHKK----GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       480 ~~gsL~~~l~~~----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ++|+|.+++...    ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~  344 (543)
T 3c4z_A          268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT  344 (543)
T ss_dssp             TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence            999999999763    46999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      . .....||+.|+|||.+.+..++.++||||||++||||++|+.||............   ...        ++...  .
T Consensus       345 ~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~---~~~--------i~~~~--~  410 (543)
T 3c4z_A          345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---KQR--------VLEQA--V  410 (543)
T ss_dssp             C-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH---HHH--------HHHCC--C
T ss_pred             c-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH---HHH--------Hhhcc--c
Confidence            2 23346999999999999999999999999999999999999999765321111111   111        11111  1


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKE  665 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~e  665 (735)
                      ..+...+.++.+|+.+||+.||.+||++.+
T Consensus       411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~  440 (543)
T 3c4z_A          411 TYPDKFSPASKDFCEALLQKDPEKRLGFRD  440 (543)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCCBT
T ss_pred             CCCcccCHHHHHHHHHhccCCHhHCCCCcc
Confidence            122334578899999999999999998743

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=339.67  Aligned_cols=261  Identities=22%  Similarity=0.352  Sum_probs=201.1

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      ++....+.+.+.||+|+||.||+|...+  .+|+|+++..  .....+.+.+|+.++++++||||+++++++...+..++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            4444556678899999999999998754  4999987643  23334567889999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          475 VYEFVGNGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      ||||+++++|.+++.... .+++..++.++.|++.||+|||+++   |+||||||+|||++ ++.+||+|||+++.....
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999999999998754 7999999999999999999999998   99999999999998 679999999998765321


Q ss_pred             c----ccceeeeccccCccCcccccC---------CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHh
Q 004702          554 A----IQNCTVVQGTLGYLDPEYLQT---------CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL  620 (735)
Q Consensus       554 ~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~  620 (735)
                      .    ........|++.|+|||.+..         ..++.++||||||+++|||++|+.||..........       .+
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-------~~  255 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-------QM  255 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH-------HH
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------Hh
Confidence            1    112223458999999999864         457889999999999999999999997654432111       11


Q ss_pred             cccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       621 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      .....     +..   .....+.++.+|+.+||+.+|.+|||+.+|++.|+.+.....
T Consensus       256 ~~~~~-----~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          256 GTGMK-----PNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             HTTCC-----CCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             ccCCC-----CCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence            11100     000   011234578999999999999999999999999998776543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.5e-38  Score=340.30  Aligned_cols=258  Identities=21%  Similarity=0.298  Sum_probs=184.1

Q ss_pred             hccccccccccCcEEEEEEE-cCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeec------Cce
Q 004702          402 TNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLET------QVP  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~  472 (735)
                      .+.+.+.||+|+||.||+|. ..++..||||++..  ......+.+.+|+.+|++++||||+++++++...      ...
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  109 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV  109 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence            34556799999999999998 45688999999864  3445667889999999999999999999998754      457


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus       110 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          110 YLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             EEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             EEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            8999999 6899999876 57999999999999999999999998   99999999999999999999999999986543


Q ss_pred             CcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHH--------hccc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS--------LKQN  623 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~~~  623 (735)
                      .    .+...||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+......        +...
T Consensus       185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          185 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             c----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            2    234568999999999877 67999999999999999999999999776554433322221100        0000


Q ss_pred             chhhHhhhccc-CCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          624 RLLEILDNRIV-NDGN-----KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       624 ~~~~~~d~~~~-~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .....+..... ....     ......+.+|+.+||+.||.+|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            00111100000 0001     112367899999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2e-37  Score=336.42  Aligned_cols=262  Identities=21%  Similarity=0.289  Sum_probs=201.3

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeec-----CceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLET-----QVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l  474 (735)
                      .+.+.++||+|+||.||++.. .++..||||++.. ......+.+.+|+.+|.+++||||+++++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            355678999999999999985 4678899999874 3444567899999999999999999999999765     35799


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||||+. ++|.+++.. ..+++..++.|+.|++.||+|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       108 v~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          108 VQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            999997 599999876 46999999999999999999999999   9999999999999999999999999998765332


Q ss_pred             ccc--eeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh-----
Q 004702          555 IQN--CTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL-----  626 (735)
Q Consensus       555 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  626 (735)
                      ...  .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+................+.     
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            211  233468999999998654 458999999999999999999999997766554333322111110000000     


Q ss_pred             ---hHhhhcc-cCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          627 ---EILDNRI-VNDG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       627 ---~~~d~~~-~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                         ....... ....     ......++.+|+.+||+.||.+|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               0000000 0000     0123467899999999999999999999884

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.2e-37  Score=343.23  Aligned_cols=258  Identities=22%  Similarity=0.252  Sum_probs=200.1

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhc------CCCceEEEceEEeecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQI------NRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.++||+|+||+||+|.. .++..||||+++.. ....+++.+|+.+++.+      +|+||+++++++...+..++
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            456678999999999999985 45889999998753 44456778898888887      57799999999999999999


Q ss_pred             EEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC--eEEeeccCCccc
Q 004702          475 VYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT--PKVSDFGASKLV  550 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DFGls~~~  550 (735)
                      ||||+. ++|.+++...  ..+++..++.|+.||+.||+|||+.+   |+||||||+||||+.++.  +||+|||++...
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            999995 6999999875  35999999999999999999999998   999999999999999887  999999999765


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc------cc
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ------NR  624 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~  624 (735)
                      ...    .....||+.|+|||++.+..++.++||||||++||||++|+.||......+..............      .+
T Consensus       253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~  328 (429)
T 3kvw_A          253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR  328 (429)
T ss_dssp             TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred             CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence            432    22345899999999999999999999999999999999999999776554433222211100000      00


Q ss_pred             hhhHhhhcc---------------------------c-CC--CC------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 LLEILDNRI---------------------------V-ND--GN------KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ~~~~~d~~~---------------------------~-~~--~~------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....++...                           . ..  ..      .....++.+|+.+||+.||++|||+.|+++
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence            000110000                           0 00  00      011367899999999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.8e-38  Score=342.96  Aligned_cols=250  Identities=12%  Similarity=0.073  Sum_probs=181.0

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHHHHHHHHHhc--CCCceEEEc-------eEEeec
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFINELVVVLQI--NRRNVVRLL-------GCCLET  469 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~~~~  469 (735)
                      +.+.+.||+|+||+||+|.. .++..||||+++...   ....+.+.+|+.++..+  +||||++++       +++...
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            55678999999999999995 478899999988643   34456677885444444  699988755       444332


Q ss_pred             -----------------CceeEEEEecCCCchhHHhhhc-CCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeeecC
Q 004702          470 -----------------QVPLLVYEFVGNGTLFEHIHKK-GNLSWERR------LRITAETAGVLSYLHSETNVPIIHRD  525 (735)
Q Consensus       470 -----------------~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~------~~i~~qia~~L~yLH~~~~~~ivH~D  525 (735)
                                       ...++||||++ |+|.+++... ..+.+..+      +.++.||+.||+|||+++   |+|||
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrD  219 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGH  219 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCc
Confidence                             23799999998 8999999863 34566666      788899999999999999   99999


Q ss_pred             CCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccCCC
Q 004702          526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMALLS  603 (735)
Q Consensus       526 lk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~~~  603 (735)
                      |||+||||+.++.+||+|||+++......    ....+|+.|+|||.+.+  ..++.++||||||++||||++|+.||..
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998654221    13447799999999987  6799999999999999999999999976


Q ss_pred             CChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          604 DKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+.....        +...............+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus       296 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          296 VTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             cCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            53321110        0000000111111111112244578999999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-37  Score=330.62  Aligned_cols=249  Identities=24%  Similarity=0.305  Sum_probs=194.9

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC--------hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD--------QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      .+.+.+.||+|+||.||++.. .++..||||.+....        ......+.+|+.+|++++||||+++++++.... .
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~   89 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y   89 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence            466778999999999999985 457899999876422        122345889999999999999999999987655 7


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEeeccCCcc
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT---PKVSDFGASKL  549 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGls~~  549 (735)
                      ++||||+++++|.+++.....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||+++.
T Consensus        90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            999999999999999988888999999999999999999999998   999999999999987654   99999999987


Q ss_pred             cCCCcccceeeeccccCccCccccc---CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          550 VPIDAIQNCTVVQGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       550 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                      .....  ......||+.|+|||.+.   ...++.++||||||+++|||++|+.||........  .... +.........
T Consensus       167 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~-~~~~~~~~~~  241 (322)
T 2ycf_A          167 LGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ-ITSGKYNFIP  241 (322)
T ss_dssp             CCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHH-HHHTCCCCCH
T ss_pred             ccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHH-HHhCccccCc
Confidence            64332  122345899999999874   56789999999999999999999999965433211  1100 0000000000


Q ss_pred             hHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       627 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +.         ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       242 ~~---------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          242 EV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hh---------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            00         0123467899999999999999999999885

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-37  Score=340.45  Aligned_cols=255  Identities=18%  Similarity=0.217  Sum_probs=194.7

Q ss_pred             hhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeec----------
Q 004702          401 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET----------  469 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----------  469 (735)
                      ..+.+.+.||+|+||+||++.. .++..||||++.....    ...+|+.+|+.++||||+++++++...          
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence            3456678999999999999984 5789999999864322    224799999999999999999998543          


Q ss_pred             ----------------------------CceeEEEEecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 004702          470 ----------------------------QVPLLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSET  517 (735)
Q Consensus       470 ----------------------------~~~~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~  517 (735)
                                                  ...++||||++ ++|.+.+..    ...+++..+..++.||++||+|||+.+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                        23789999997 587777653    467999999999999999999999998


Q ss_pred             CCCeeecCCCCCcEEEc-CCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHH
Q 004702          518 NVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELL  595 (735)
Q Consensus       518 ~~~ivH~Dlk~~NILl~-~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~ell  595 (735)
                         |+||||||+||||+ +++.+||+|||+++.......  .....+|+.|+|||.+.+. .++.++||||||+++|||+
T Consensus       162 ---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          162 ---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             ---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             ---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence               99999999999998 688999999999987643332  2334589999999988764 5899999999999999999


Q ss_pred             hCCccCCCCChHHHHHHHHHHHHHhcccchhhHh--hhc--------cc-----CCCCHHHHHHHHHHHHHcccCCCCCC
Q 004702          596 TGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL--DNR--------IV-----NDGNKQQLKEVAKLAARCISVRGEER  660 (735)
Q Consensus       596 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~--------~~-----~~~~~~~~~~l~~li~~cl~~~p~~R  660 (735)
                      +|+.||......+.....   ...+.......+.  ++.        ..     ...+...+.++.+|+.+||+.+|.+|
T Consensus       237 ~g~~pf~~~~~~~~~~~i---~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          237 LGKPLFSGETSIDQLVRI---IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HSSCSSCCSSHHHHHHHH---HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             hCCCCCCCCChHHHHHHH---HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999876554433222   2222111111110  000        00     00112244678999999999999999


Q ss_pred             CCHHHHHH
Q 004702          661 PTMKEVSL  668 (735)
Q Consensus       661 Pt~~ev~~  668 (735)
                      ||+.|+++
T Consensus       314 ~t~~e~l~  321 (383)
T 3eb0_A          314 INPYEAMA  321 (383)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999885

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-37  Score=337.74  Aligned_cols=257  Identities=21%  Similarity=0.232  Sum_probs=192.6

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeecc-----------ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC-
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFV-----------DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-  470 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-  470 (735)
                      +.+.+.||+|+||.||+|...++..||||++...           +....+.+.+|+.++++++||||+++++++...+ 
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (362)
T 3pg1_A           24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE  103 (362)
T ss_dssp             CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred             eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence            4456799999999999999888999999987532           2233478999999999999999999999986433 


Q ss_pred             ----ceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          471 ----VPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       471 ----~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                          ..++||||+. |+|.+++... ..+++..++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          104 PAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFN  179 (362)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTT
T ss_pred             CCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecC
Confidence                5699999997 6888888754 47999999999999999999999998   9999999999999999999999999


Q ss_pred             CCcccCCCcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc
Q 004702          546 ASKLVPIDAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR  624 (735)
Q Consensus       546 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  624 (735)
                      +++......  ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.....   ........
T Consensus       180 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i---~~~~~~~~  254 (362)
T 3pg1_A          180 LAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI---VEVVGTPK  254 (362)
T ss_dssp             C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCC
T ss_pred             ccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCC
Confidence            998554332  2233458999999999876 67999999999999999999999999776554432222   22111111


Q ss_pred             hhh-----------HhhhcccC-------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 LLE-----------ILDNRIVN-------DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ~~~-----------~~d~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...           .+......       .........+.+|+.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            111           11000000       001122467899999999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.6e-37  Score=341.77  Aligned_cols=255  Identities=26%  Similarity=0.276  Sum_probs=193.1

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------ceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------VPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l  474 (735)
                      .+.+.++||+|+||+||+|+.. ++..||||++.....    .+.+|+++|++++||||+++++++....      ..++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            4566789999999999999964 589999999864322    2347999999999999999999986422      3579


Q ss_pred             EEEecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-CCeEEeeccCCcc
Q 004702          475 VYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-CTPKVSDFGASKL  549 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGls~~  549 (735)
                      ||||+++ +|.+.+..    ...+++..++.++.||++||+|||+++   |+||||||+||||+.+ +.+||+|||+++.
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            9999975 66666543    467999999999999999999999998   9999999999999955 5689999999987


Q ss_pred             cCCCcccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH
Q 004702          550 VPIDAIQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI  628 (735)
Q Consensus       550 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (735)
                      +.....  .....||+.|+|||++.+. .++.++||||||++||||++|+.||......+....   .+..+.......+
T Consensus       207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~---i~~~lg~p~~~~~  281 (420)
T 1j1b_A          207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE---IIKVLGTPTREQI  281 (420)
T ss_dssp             CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCSCCHHHH
T ss_pred             cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCHHHH
Confidence            643322  2234589999999998764 799999999999999999999999987654432222   2222211111111


Q ss_pred             --hhhc--------ccCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          629 --LDNR--------IVND-----GNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       629 --~d~~--------~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                        +++.        +...     .....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence              0110        0000     111234689999999999999999999998853

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-37  Score=328.87  Aligned_cols=246  Identities=26%  Similarity=0.381  Sum_probs=192.8

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEee------cCceeE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLE------TQVPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~l  474 (735)
                      +.+.+.||+|+||.||+|.. .++..||||++.... ...+.+.+|+.+++++ +||||+++++++..      .+..++
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l  104 (326)
T 2x7f_A           26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL  104 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence            44567999999999999985 568899999987543 2356788999999999 79999999999987      457899


Q ss_pred             EEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          475 VYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ||||+++++|.+++...  ..+++..++.++.|++.||+|||+.+   |+|+||||+||||+.++.+||+|||++.....
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  181 (326)
T ss_dssp             EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred             EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence            99999999999999864  57999999999999999999999998   99999999999999999999999999986543


Q ss_pred             CcccceeeeccccCccCccccc-----CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ... ......|++.|+|||.+.     ...++.++||||||+++|||++|+.||...........       +....   
T Consensus       182 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~---  250 (326)
T 2x7f_A          182 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------IPRNP---  250 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHSC---
T ss_pred             Ccc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-------hhcCc---
Confidence            221 223345899999999987     56789999999999999999999999976543321111       00000   


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                           .........+..+.+|+.+||+.+|.+|||+.|+++
T Consensus       251 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          251 -----APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             -----CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -----cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                 000111223467899999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.3e-37  Score=339.47  Aligned_cols=256  Identities=23%  Similarity=0.249  Sum_probs=194.3

Q ss_pred             hhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc------eeE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV------PLL  474 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~l  474 (735)
                      ..+.+.++||+|+||+||++....+..||+|++......    ..+|+.+|+.++||||+++++++...+.      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            356677899999999999999877777999987643221    2369999999999999999999966443      789


Q ss_pred             EEEecCCCchhHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEeeccCCccc
Q 004702          475 VYEFVGNGTLFEHIH---KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLV  550 (735)
Q Consensus       475 V~E~~~~gsL~~~l~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGls~~~  550 (735)
                      ||||++++.+.....   ....+++..+..++.|+++||+|||+++   |+||||||+||||+ .++.+||+|||+++..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            999997654333222   2467999999999999999999999998   99999999999999 7999999999999876


Q ss_pred             CCCcccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh--
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE--  627 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--  627 (735)
                      ......  ....||+.|+|||.+.+. .++.++||||||++||||++|+.||......+....+   ...+.......  
T Consensus       193 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~p~~~~~~  267 (394)
T 4e7w_A          193 IAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI---IKVLGTPSREQIK  267 (394)
T ss_dssp             CTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCHHHHH
T ss_pred             cCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHHHH
Confidence            433322  234589999999998764 5899999999999999999999999876554432222   22111111100  


Q ss_pred             Hhhhccc-------------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          628 ILDNRIV-------------NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       628 ~~d~~~~-------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..++...             .......+.++.+|+.+||+.||.+|||+.|+++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            0011100             0011124468999999999999999999999885

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.1e-37  Score=336.10  Aligned_cols=254  Identities=22%  Similarity=0.297  Sum_probs=201.9

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeeccChh-----------------HHHHHHHHHHHHHhcCCCceEEEce
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQA-----------------KIDEFINELVVVLQINRRNVVRLLG  464 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l~g  464 (735)
                      .+.+.+.||+|+||.||++.. ++..||||++......                 ..+.+.+|+.++++++||||+++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~  110 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG  110 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred             ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            455678999999999999998 8899999998642211                 1278999999999999999999999


Q ss_pred             EEeecCceeEEEEecCCCchhHH------hhh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcC
Q 004702          465 CCLETQVPLLVYEFVGNGTLFEH------IHK--KGNLSWERRLRITAETAGVLSYLHS-ETNVPIIHRDVKSANILLDE  535 (735)
Q Consensus       465 ~~~~~~~~~lV~E~~~~gsL~~~------l~~--~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~  535 (735)
                      ++.+.+..++||||+++++|.++      +..  ...+++..++.++.|++.||+|||+ .+   |+||||||+|||++.
T Consensus       111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK  187 (348)
T ss_dssp             EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred             EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence            99999999999999999999999      665  5679999999999999999999999 88   999999999999999


Q ss_pred             CCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCC-CCCc-cccchhHHHHHHHHHhCCccCCCCChHHHHHHH
Q 004702          536 NCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC-KLTD-KSDVYSFGVVLVELLTGKMALLSDKPEEERSLA  613 (735)
Q Consensus       536 ~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~  613 (735)
                      ++.+||+|||++......   ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||........    
T Consensus       188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----  260 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE----  260 (348)
T ss_dssp             TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH----
T ss_pred             CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----
Confidence            999999999999876433   22344589999999999887 6666 99999999999999999999976544211    


Q ss_pred             HHHHHHhcccchhhHh---------hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          614 MNFLSSLKQNRLLEIL---------DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       614 ~~~~~~~~~~~~~~~~---------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                        ....+.........         ............+.++.+|+.+||+.||.+|||+.|+++
T Consensus       261 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 --LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             --HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              11111111110000         000000001234578999999999999999999999885

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.4e-37  Score=323.55  Aligned_cols=247  Identities=21%  Similarity=0.261  Sum_probs=196.1

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC----hhHHHHHHHHHHHHHhcCCCceEEEceEEe--ecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD----QAKIDEFINELVVVLQINRRNVVRLLGCCL--ETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~l  474 (735)
                      .+.+.+.||+|+||.||++.. .++..||+|.++...    ....+.+.+|+.++++++||||+++++++.  +....++
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            356778999999999999996 467899999986432    234678999999999999999999999984  4557899


Q ss_pred             EEEecCCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          475 VYEFVGNGTLFEHIHK--KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ||||+.++ |.+++..  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99999876 7777765  357999999999999999999999998   99999999999999999999999999987643


Q ss_pred             Cc-ccceeeeccccCccCcccccCCC--CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          553 DA-IQNCTVVQGTLGYLDPEYLQTCK--LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       553 ~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      .. ........|++.|+|||.+.+..  .+.++||||||+++|||++|+.||......+..       ..+....     
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~i~~~~-----  229 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF-------ENIGKGS-----  229 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHCC-----
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-------HHHhcCC-----
Confidence            21 22223445899999999987644  477999999999999999999999765432211       1111111     


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                           ...+......+.+|+.+||+.||.+|||+.|+++.
T Consensus       230 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 -----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 01122344678899999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.8e-37  Score=321.25  Aligned_cols=250  Identities=23%  Similarity=0.330  Sum_probs=203.3

Q ss_pred             hhhccccccccccCcEEEEEEEcC-CCcEEEEEEeecc--ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV--DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ...+.+.+.||+|+||.||++... ++..||||++...  .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            345667889999999999999864 6889999998642  3345678999999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC---CCeEEeeccCCcccCCC
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN---CTPKVSDFGASKLVPID  553 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFGls~~~~~~  553 (735)
                      ||+++++|.+++.....+++..++.++.|++.||+|||+++   |+||||||+|||++.+   ..+||+|||++......
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            99999999999988888999999999999999999999998   9999999999999754   47999999999876433


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      ..  .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+..       ..+......      .
T Consensus       178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~------~  241 (287)
T 2wei_A          178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-------KRVETGKYA------F  241 (287)
T ss_dssp             SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCCC------C
T ss_pred             Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCCC------C
Confidence            22  223348999999998876 5899999999999999999999999765433211       111111100      0


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+.....+.++.+|+.+||+.+|.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            00011223467899999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.8e-37  Score=329.52  Aligned_cols=258  Identities=22%  Similarity=0.285  Sum_probs=197.7

Q ss_pred             hccccccccccCcEEEEEEEc--CCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhc---CCCceEEEceEEe-----ec
Q 004702          402 TNNYADVIGCGGSGNVYKGFL--PDRTPVAVKKSKFVD--QAKIDEFINELVVVLQI---NRRNVVRLLGCCL-----ET  469 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~  469 (735)
                      .+.+.+.||+|+||.||++..  .++..||||+++...  ......+.+|+.+++.+   +||||+++++++.     ..
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            345677999999999999986  467889999876422  22233566777776666   8999999999987     45


Q ss_pred             CceeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCC
Q 004702          470 QVPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS  547 (735)
Q Consensus       470 ~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls  547 (735)
                      ...++||||+. |+|.+++...  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCccc
Confidence            67899999997 6999999875  34999999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc---c
Q 004702          548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN---R  624 (735)
Q Consensus       548 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~  624 (735)
                      +......  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+....   ....+...   .
T Consensus       168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~  242 (326)
T 1blx_A          168 RIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPGEED  242 (326)
T ss_dssp             CCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCGGG
T ss_pred             ccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCCccc
Confidence            8764332  22334589999999999998999999999999999999999999976654432222   22211110   0


Q ss_pred             hhhHh-------h---hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 LLEIL-------D---NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ~~~~~-------d---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +....       .   ...........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000       0   00000111234567899999999999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=342.09  Aligned_cols=258  Identities=20%  Similarity=0.265  Sum_probs=180.9

Q ss_pred             cccccccCcEEEEEEEcC---CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEee--cCceeEEEEecC
Q 004702          406 ADVIGCGGSGNVYKGFLP---DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE--TQVPLLVYEFVG  480 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~~~  480 (735)
                      +++||+|+||+||+|...   ++..||||++.....  ...+.+|+.+|++++||||+++++++..  ....++||||+.
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            458999999999999854   477899999875332  3467899999999999999999999965  567899999996


Q ss_pred             CCchhHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----cCCCCeEEeeccCC
Q 004702          481 NGTLFEHIHKK---------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL----DENCTPKVSDFGAS  547 (735)
Q Consensus       481 ~gsL~~~l~~~---------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGls  547 (735)
                       ++|.+++...         ..+++..++.|+.||+.||+|||+.+   |+||||||+||||    +.++.+||+|||++
T Consensus       104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence             5888887632         24999999999999999999999999   9999999999999    77889999999999


Q ss_pred             cccCCCcc--cceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHH------HHHHHHHHH
Q 004702          548 KLVPIDAI--QNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEE------RSLAMNFLS  618 (735)
Q Consensus       548 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~------~~~~~~~~~  618 (735)
                      +.......  .......||+.|+|||.+.+ ..++.++||||||++||||++|+.||........      .........
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~  259 (405)
T 3rgf_A          180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  259 (405)
T ss_dssp             C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred             eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence            87653221  22334568999999999887 4589999999999999999999999965443210      111111111


Q ss_pred             Hhccc---chhhH---------h---hhcccCCCC---------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          619 SLKQN---RLLEI---------L---DNRIVNDGN---------KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       619 ~~~~~---~~~~~---------~---d~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .+...   .+..+         .   .........         .....++.+|+.+||+.||.+|||+.|+++.
T Consensus       260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11110   00000         0   000000000         0113568899999999999999999998863

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.1e-37  Score=334.06  Aligned_cols=258  Identities=21%  Similarity=0.211  Sum_probs=186.6

Q ss_pred             hhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc-------e
Q 004702          401 VTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV-------P  472 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------~  472 (735)
                      ..+.+.++||+|+||+||+|.. .++..||||++.... .....+.+|+..+..++||||+++++++...+.       .
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            3455678999999999999986 468899999886432 233466788899999999999999999976443       7


Q ss_pred             eEEEEecCCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCcEEEcC-CCCeEEeecc
Q 004702          473 LLVYEFVGNGTLFEHIH----KKGNLSWERRLRITAETAGVLSYLH--SETNVPIIHRDVKSANILLDE-NCTPKVSDFG  545 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~qia~~L~yLH--~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFG  545 (735)
                      ++||||+++ +|.+.+.    ....+++..+..++.|++.||.|||  +.+   |+||||||+||||+. ++.+||+|||
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg  177 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFG  177 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCC
Confidence            899999976 5544443    4567999999999999999999999  877   999999999999996 8999999999


Q ss_pred             CCcccCCCcccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc-
Q 004702          546 ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN-  623 (735)
Q Consensus       546 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-  623 (735)
                      +++.......  .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+......   ..+... 
T Consensus       178 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~  252 (360)
T 3e3p_A          178 SAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV---RVLGCPS  252 (360)
T ss_dssp             TCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HHHCCCC
T ss_pred             CceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH---HHcCCCC
Confidence            9987654332  2234589999999998654 48999999999999999999999998765544332222   111110 


Q ss_pred             -chhhHhhhc----------------ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          624 -RLLEILDNR----------------IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       624 -~~~~~~d~~----------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       .....+++.                .........+.++.+|+.+||+.||.+|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence             000111000                011112224678999999999999999999999874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.2e-36  Score=331.17  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=195.7

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce------
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP------  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~------  472 (735)
                      .+.+.+.||+|+||+||+|.. .++..||||++..  ......+.+.+|+.+++.++||||+++++++...+..      
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            345567899999999999984 4688999999875  3444567889999999999999999999999877655      


Q ss_pred             eEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          473 LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      ++||||+. ++|.+++..  .+++..+..++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus       123 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          123 YLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             EEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             EEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            99999997 688888744  4999999999999999999999998   99999999999999999999999999986543


Q ss_pred             CcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHH--------Hhccc
Q 004702          553 DAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS--------SLKQN  623 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~~  623 (735)
                      .    .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..........        .+...
T Consensus       197 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          197 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             C----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            2    233458999999999887 7899999999999999999999999977654443222211100        00000


Q ss_pred             chhhHhhhcccC-C-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          624 RLLEILDNRIVN-D-----GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       624 ~~~~~~d~~~~~-~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ............ .     .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            000000000000 0     01123478999999999999999999999874

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.7e-37  Score=332.46  Aligned_cols=261  Identities=21%  Similarity=0.257  Sum_probs=198.4

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeec-----CceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLET-----QVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV  475 (735)
                      +.+.+.||+|+||.||+|... ++..||||+++.. .......+.+|+.++++++||||+++++++...     ...++|
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   92 (353)
T 2b9h_A           13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII   92 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred             eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence            445679999999999999854 6889999998743 344567788999999999999999999988764     578999


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||+. ++|.+++.. ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        93 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (353)
T 2b9h_A           93 QELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA  167 (353)
T ss_dssp             ECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence            99996 699999876 47999999999999999999999998   99999999999999999999999999987643221


Q ss_pred             c---------ceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhc----
Q 004702          556 Q---------NCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLK----  621 (735)
Q Consensus       556 ~---------~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~----  621 (735)
                      .         ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......+.............    
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T 2b9h_A          168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND  247 (353)
T ss_dssp             ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred             cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence            1         1122458999999998754 6789999999999999999999999977654432222211110000    


Q ss_pred             -----ccchhhHhhhcc-cCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          622 -----QNRLLEILDNRI-VND-----GNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       622 -----~~~~~~~~d~~~-~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                           ..+..+.+.... ...     .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                 000001100000 000     01123467899999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.1e-37  Score=321.81  Aligned_cols=247  Identities=28%  Similarity=0.420  Sum_probs=190.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEee-------------
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE-------------  468 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------------  468 (735)
                      +.+.+.||+|+||.||+|.. .++..||||+++. .....+.+.+|+.++++++||||+++++++.+             
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   86 (303)
T 1zy4_A            8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK   86 (303)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred             chhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence            45667999999999999985 4788999999864 34556789999999999999999999998865             


Q ss_pred             cCceeEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCC
Q 004702          469 TQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS  547 (735)
Q Consensus       469 ~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls  547 (735)
                      .+..++||||+++++|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~  163 (303)
T 1zy4_A           87 KSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLA  163 (303)
T ss_dssp             EEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred             CCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcch
Confidence            35678999999999999999864 46889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCc-------------ccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHH
Q 004702          548 KLVPIDA-------------IQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLA  613 (735)
Q Consensus       548 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~  613 (735)
                      +......             ........|++.|+|||.+.+. .++.++||||||+++|||++   ||...  .+...  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~~~--  236 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MERVN--  236 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH--
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhHHH--
Confidence            8764221             1122334589999999998764 68999999999999999998   44321  11111  


Q ss_pred             HHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       614 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                        ....+...      ............+..+.+|+.+||+.||.+|||+.|+++
T Consensus       237 --~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          237 --ILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             --HHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --HHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence              11111110      111112223344567899999999999999999999885

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.7e-37  Score=329.51  Aligned_cols=256  Identities=21%  Similarity=0.283  Sum_probs=195.9

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc------ee
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV------PL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~  473 (735)
                      +.+.+.||+|+||.||+|.. .++..||||++..  ......+.+.+|+.++++++||||+++++++...+.      .+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  105 (353)
T 3coi_A           26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  105 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence            45567999999999999985 4688999999864  344456788999999999999999999999987654      48


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+. ++|.+++..  .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       106 lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  179 (353)
T 3coi_A          106 LVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE  179 (353)
T ss_dssp             EEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred             EEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence            9999997 689888754  4999999999999999999999998   999999999999999999999999999865422


Q ss_pred             cccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH--------HHhcccc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL--------SSLKQNR  624 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  624 (735)
                          .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.........        ..+....
T Consensus       180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  255 (353)
T 3coi_A          180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  255 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred             ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence                233458999999999876 678999999999999999999999998765443222211110        0000000


Q ss_pred             hhhHhhhc------ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 LLEILDNR------IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ~~~~~d~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....+...      .........+.++.+|+.+||+.||.+|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000000      001111234578999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.9e-37  Score=326.93  Aligned_cols=251  Identities=24%  Similarity=0.314  Sum_probs=178.4

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHH-HHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELV-VVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.+.+.||+|+||.||++.. .++..||||+++.. ......++..|+. +++.++||||+++++++...+..++||||
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~  102 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL  102 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence            345567899999999999986 46889999998753 3445556667766 67778999999999999999999999999


Q ss_pred             cCCCchhHHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCC
Q 004702          479 VGNGTLFEHIHK-----KGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI  552 (735)
Q Consensus       479 ~~~gsL~~~l~~-----~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~  552 (735)
                      +.+ +|.+++..     ...+++..+..++.|++.||.|||+. +   |+||||||+||||+.++.+||+|||+++....
T Consensus       103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            975 88888763     46799999999999999999999998 8   99999999999999999999999999987643


Q ss_pred             CcccceeeeccccCccCcccc----cCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhH
Q 004702          553 DAIQNCTVVQGTLGYLDPEYL----QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI  628 (735)
Q Consensus       553 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (735)
                      ...  .....||+.|+|||.+    .+..++.++||||||+++|||++|+.||........      .........    
T Consensus       179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~----  246 (327)
T 3aln_A          179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQVVKGD----  246 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSC----
T ss_pred             ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHHHHhcCC----
Confidence            322  2233589999999998    456789999999999999999999999965322110      000000000    


Q ss_pred             hhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       629 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                       .+.+........+..+.+|+.+||+.||.+|||+.||++.
T Consensus       247 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          247 -PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             -CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence             0111111122345689999999999999999999999763

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.4e-36  Score=324.68  Aligned_cols=259  Identities=19%  Similarity=0.259  Sum_probs=199.9

Q ss_pred             hhccccccccccCcEEEEEEEcC-C-CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc------eEEEceEEeecCce
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLP-D-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN------VVRLLGCCLETQVP  472 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~  472 (735)
                      ..+.+.+.||+|+||+||++... + +..||||+++.. ....+.+.+|+.++++++|++      ++.+++++...+..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            35667789999999999999853 3 368999998743 345677889999999997765      89999999999999


Q ss_pred             eEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE-----------------
Q 004702          473 LLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL-----------------  533 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl-----------------  533 (735)
                      ++||||+ +++|.+++...  ..+++..++.++.||+.||+|||+++   |+||||||+||||                 
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccc
Confidence            9999999 66777777654  47999999999999999999999998   9999999999999                 


Q ss_pred             --cCCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHH
Q 004702          534 --DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS  611 (735)
Q Consensus       534 --~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~  611 (735)
                        +.++.+||+|||+++......    ....||+.|+|||.+.+..++.++||||||++||||++|+.||......+...
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  249 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV  249 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence              567899999999998654322    23458999999999999999999999999999999999999998765544332


Q ss_pred             HHHHHHHHhcccchhh----------------------Hhhh-----cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 004702          612 LAMNFLSSLKQNRLLE----------------------ILDN-----RIVNDGNKQQLKEVAKLAARCISVRGEERPTMK  664 (735)
Q Consensus       612 ~~~~~~~~~~~~~~~~----------------------~~d~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  664 (735)
                      .............+..                      .+..     ............++.+|+.+||+.||.+|||+.
T Consensus       250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  329 (355)
T 2eu9_A          250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA  329 (355)
T ss_dssp             HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence            2221111000000000                      0000     000111234456899999999999999999999


Q ss_pred             HHHH
Q 004702          665 EVSL  668 (735)
Q Consensus       665 ev~~  668 (735)
                      |+++
T Consensus       330 e~l~  333 (355)
T 2eu9_A          330 EALL  333 (355)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.1e-36  Score=329.04  Aligned_cols=259  Identities=20%  Similarity=0.270  Sum_probs=199.9

Q ss_pred             HhhhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-----------CCceEEEceEE
Q 004702          399 KTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-----------RRNVVRLLGCC  466 (735)
Q Consensus       399 ~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~  466 (735)
                      ....+.+.+.||+|+||+||++.. .++..||||++.. +....+.+.+|+.++++++           ||||+++++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            344567788999999999999985 5688999999874 3445677889999999886           89999999998


Q ss_pred             eecC----ceeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEc-----
Q 004702          467 LETQ----VPLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLD-----  534 (735)
Q Consensus       467 ~~~~----~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~-----  534 (735)
                      ...+    ..++|||++ +++|.+++...  ..+++..++.++.||+.||+|||++ +   |+||||||+||||+     
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            8654    679999999 88999999863  4599999999999999999999998 8   99999999999994     


Q ss_pred             -CCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHH---HH
Q 004702          535 -ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE---ER  610 (735)
Q Consensus       535 -~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~---~~  610 (735)
                       ..+.+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||++||||++|+.||.......   ..
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence             4457999999999876432    223458999999999999999999999999999999999999997543221   11


Q ss_pred             HHHHHHHHHhcccc------------------------------hhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCC
Q 004702          611 SLAMNFLSSLKQNR------------------------------LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEER  660 (735)
Q Consensus       611 ~~~~~~~~~~~~~~------------------------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  660 (735)
                      .........+....                              +..++..  ....+.....++.+|+.+||+.||.+|
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCcccc
Confidence            11111111111100                              0011111  112346778899999999999999999


Q ss_pred             CCHHHHHH
Q 004702          661 PTMKEVSL  668 (735)
Q Consensus       661 Pt~~ev~~  668 (735)
                      ||+.||++
T Consensus       326 pt~~ell~  333 (373)
T 1q8y_A          326 ADAGGLVN  333 (373)
T ss_dssp             BCHHHHHT
T ss_pred             CCHHHHhh
Confidence            99999874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-35  Score=324.90  Aligned_cols=260  Identities=20%  Similarity=0.234  Sum_probs=198.7

Q ss_pred             hccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CC-----ceEEEceEEeecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RR-----NVVRLLGCCLETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.++||+|+||+||+|... ++..||||+++.. .....++..|+.++..++ |+     +|+++++++...+..++
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  133 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL  133 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence            4556789999999999999854 6788999998743 344567788999988885 44     49999999999999999


Q ss_pred             EEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCCeEEeeccCCccc
Q 004702          475 VYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD--ENCTPKVSDFGASKLV  550 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DFGls~~~  550 (735)
                      ||||+. ++|.+++...  ..+++..+..++.|++.||+|||++. .+|+||||||+||||+  .++.+||+|||+++..
T Consensus       134 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          134 VFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            999996 5999999875  46999999999999999999999531 2399999999999994  5778999999999876


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc------cc
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ------NR  624 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~  624 (735)
                      ...    .....||+.|+|||.+.+..++.++||||||++||||++|+.||......+....+.........      ..
T Consensus       212 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  287 (382)
T 2vx3_A          212 GQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK  287 (382)
T ss_dssp             TCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred             ccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence            432    22345899999999999999999999999999999999999999876554433322211100000      00


Q ss_pred             hhhHhhh----c----------------------------c---------cCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 004702          625 LLEILDN----R----------------------------I---------VNDGNKQQLKEVAKLAARCISVRGEERPTM  663 (735)
Q Consensus       625 ~~~~~d~----~----------------------------~---------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  663 (735)
                      ....++.    .                            .         ..........++.+|+.+||+.||.+|||+
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta  367 (382)
T 2vx3_A          288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP  367 (382)
T ss_dssp             HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCH
T ss_pred             HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCH
Confidence            0000000    0                            0         000122344689999999999999999999


Q ss_pred             HHHHH
Q 004702          664 KEVSL  668 (735)
Q Consensus       664 ~ev~~  668 (735)
                      .|+++
T Consensus       368 ~e~L~  372 (382)
T 2vx3_A          368 YYALQ  372 (382)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            99874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.4e-36  Score=337.41  Aligned_cols=244  Identities=25%  Similarity=0.322  Sum_probs=185.6

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecCCCch
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      .++||+|+||+||.+...++..||||++...   ..+.+.+|+.+|.++ +||||+++++++.+.+..++||||+. |+|
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL   95 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL   95 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence            4689999999998766667899999998642   245678999999886 89999999999999999999999995 699


Q ss_pred             hHHhhhcCCC-------CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCC-------------CCeEEeec
Q 004702          485 FEHIHKKGNL-------SWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDEN-------------CTPKVSDF  544 (735)
Q Consensus       485 ~~~l~~~~~l-------~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~-------------~~~kl~DF  544 (735)
                      .+++......       ++..++.++.||+.||+|||+++   |+||||||+||||+.+             ..+||+||
T Consensus        96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             HHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence            9999865322       23345789999999999999998   9999999999999754             48999999


Q ss_pred             cCCcccCCCccc---ceeeeccccCccCcccccC-------CCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHH
Q 004702          545 GASKLVPIDAIQ---NCTVVQGTLGYLDPEYLQT-------CKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLA  613 (735)
Q Consensus       545 Gls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~  613 (735)
                      |+++........   ......||+.|+|||.+.+       ..++.++||||||+++|||++ |+.||......+.    
T Consensus       173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~----  248 (434)
T 2rio_A          173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES----  248 (434)
T ss_dssp             TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH----
T ss_pred             ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH----
Confidence            999977543322   1233469999999999865       678999999999999999999 8999865433221    


Q ss_pred             HHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          614 MNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       614 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       ........  .     +..........+.++.+|+.+||+.||.+|||+.||++
T Consensus       249 -~i~~~~~~--~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          249 -NIIRGIFS--L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -HHHHTCCC--C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHhcCCCC--c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence             11111100  0     01111223466788999999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-37  Score=324.55  Aligned_cols=243  Identities=25%  Similarity=0.402  Sum_probs=191.6

Q ss_pred             HHHhhhccccccccccCcEEEEEEEc-CCCcEEEEEEeeccCh------hHHHHHHHHHHHHHhc----CCCceEEEceE
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQ------AKIDEFINELVVVLQI----NRRNVVRLLGC  465 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~g~  465 (735)
                      +.....+.+.+.||+|+||.||+|.. .++..||||+++....      .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            33344567788999999999999985 5688999999865332      2234456799999998    89999999999


Q ss_pred             EeecCceeEEEEe-cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEee
Q 004702          466 CLETQVPLLVYEF-VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSD  543 (735)
Q Consensus       466 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~D  543 (735)
                      +...+..++|||+ +.+++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+|||++ +++.+||+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~d  183 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLID  183 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEE
Confidence            9999999999999 789999999998888999999999999999999999998   99999999999999 889999999


Q ss_pred             ccCCcccCCCcccceeeeccccCccCcccccCCCCC-ccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc
Q 004702          544 FGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT-DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ  622 (735)
Q Consensus       544 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  622 (735)
                      ||+++......   .....|+..|+|||.+.+..+. .++||||||+++|||++|+.||.....         .      
T Consensus       184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~------  245 (312)
T 2iwi_A          184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------I------  245 (312)
T ss_dssp             CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H------
T ss_pred             cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------H------
Confidence            99998765432   2334589999999998876664 599999999999999999999853210         0      


Q ss_pred             cchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          623 NRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       623 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                            .+...  ..+.....++.+|+.+||+.+|++|||+.|+++
T Consensus       246 ------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 ------LEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ------HHTCC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------hhhcc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  00000  112234467899999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.9e-36  Score=323.56  Aligned_cols=245  Identities=22%  Similarity=0.257  Sum_probs=169.7

Q ss_pred             cccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEee----cCceeEEEEecC
Q 004702          406 ADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLE----TQVPLLVYEFVG  480 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~E~~~  480 (735)
                      .++||+|+||+||++... ++..||||++.... ..   ..+....++.++||||+++++++..    ....++||||++
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  109 (336)
T 3fhr_A           34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME  109 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred             ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence            347999999999999865 68899999986531 11   1223344667899999999999876    445799999999


Q ss_pred             CCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEeeccCCcccCCCcc
Q 004702          481 NGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       481 ~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGls~~~~~~~~  555 (735)
                      +|+|.+++...  ..+++..++.++.|++.||+|||+++   |+||||||+||||+.   ++.+||+|||+++...... 
T Consensus       110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-  185 (336)
T 3fhr_A          110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-  185 (336)
T ss_dssp             TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccc-
Confidence            99999999875  36999999999999999999999998   999999999999976   4559999999998654322 


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                        .....||+.|+|||.+....++.++||||||+++|||++|+.||............   ...+..      .......
T Consensus       186 --~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~------~~~~~~~  254 (336)
T 3fhr_A          186 --LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRL------GQYGFPN  254 (336)
T ss_dssp             --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------CCCT
T ss_pred             --cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhc------cccccCc
Confidence              22345899999999998889999999999999999999999999654332211000   000000      0001111


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ......+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1122345789999999999999999999999873

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.8e-37  Score=328.04  Aligned_cols=240  Identities=25%  Similarity=0.413  Sum_probs=197.2

Q ss_pred             hhhccccccccccCcEEEEEEE-cCCCcEEEEEEeeccCh------hHHHHHHHHHHHHHhcC--CCceEEEceEEeecC
Q 004702          400 TVTNNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQ------AKIDEFINELVVVLQIN--RRNVVRLLGCCLETQ  470 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~  470 (735)
                      ...+.+.++||+|+||.||+|. ..++..||||+++....      ...+.+.+|+.++++++  |+||+++++++...+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            3456677899999999999998 45688999999864321      12245678999999996  599999999999999


Q ss_pred             ceeEEEEecCC-CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEeeccCCc
Q 004702          471 VPLLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASK  548 (735)
Q Consensus       471 ~~~lV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGls~  548 (735)
                      ..++|||++.+ ++|.+++.....+++..++.++.|++.||+|||+.+   |+||||||+||||+ +++.+||+|||+++
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999976 899999998889999999999999999999999998   99999999999999 78899999999998


Q ss_pred             ccCCCcccceeeeccccCccCcccccCCCC-CccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       549 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ......   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....         ..          
T Consensus       199 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~~----------  256 (320)
T 3a99_A          199 LLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------II----------  256 (320)
T ss_dssp             ECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH----------
T ss_pred             cccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------hh----------
Confidence            765332   223458999999999887665 6889999999999999999999853210         00          


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                        ....  ......+.++.+|+.+||+.+|.+|||+.||++
T Consensus       257 --~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 --RGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --HCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --cccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0000  011123467899999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.9e-36  Score=316.58  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=177.8

Q ss_pred             ccccccccccCcEEEEEEEcC-CCcEEEEEEeeccC-hhHH-HHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVD-QAKI-DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~-~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||.||++... ++..||||++.... .... +.+.++..+++.++||||+++++++...+..++||||+
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~  106 (318)
T 2dyl_A           27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM  106 (318)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence            445678999999999999864 68899999987532 2333 33445556788889999999999999999999999999


Q ss_pred             CCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                       ++.+..++.. ...+++..++.++.|+++||+|||++ +   |+||||||+|||++.++.+||+|||++........  
T Consensus       107 -~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  180 (318)
T 2dyl_A          107 -GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA--  180 (318)
T ss_dssp             -SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             -CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc--
Confidence             4555555543 46799999999999999999999995 8   99999999999999999999999999976643322  


Q ss_pred             eeeeccccCccCccccc-----CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          558 CTVVQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                      .....|++.|+|||.+.     ...++.++||||||+++|||++|+.||........  .......    ...     + 
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~----~~~-----~-  248 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLTKVLQ----EEP-----P-  248 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHHHH----SCC-----C-
T ss_pred             ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHHHHhc----cCC-----C-
Confidence            22345899999999984     45688999999999999999999999975433211  1111110    000     0 


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                       ..+.....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       249 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          249 -LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             001111234678999999999999999999998863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=329.79  Aligned_cols=246  Identities=24%  Similarity=0.288  Sum_probs=185.0

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+...++||+|+||+|+.....+++.||||++.....   ..+.+|+.+|+++ +||||+++++++.+....++||||+.
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            4455679999999996555455788999999864322   2356899999999 79999999999999999999999996


Q ss_pred             CCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-----CCCeEEeeccCCcccCCCc
Q 004702          481 NGTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-----NCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       481 ~gsL~~~l~~~~-~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DFGls~~~~~~~  554 (735)
                       |+|.+++.... .+.+..++.++.||+.||+|||+++   |+||||||+||||+.     ...+||+|||+++......
T Consensus       102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A          102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence             69999998653 4556677899999999999999999   999999999999953     3468899999998765332


Q ss_pred             c--cceeeeccccCccCccccc---CCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhH
Q 004702          555 I--QNCTVVQGTLGYLDPEYLQ---TCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEI  628 (735)
Q Consensus       555 ~--~~~~~~~gt~~y~aPE~~~---~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (735)
                      .  .......||+.|+|||.+.   ...++.++||||||+++|||++ |..||..........       ....... ..
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~~~~~~-~~  249 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLGACSL-DC  249 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HTTCCCC-TT
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------HhccCCc-cc
Confidence            1  2233456999999999997   4567889999999999999999 888885443222110       0000000 00


Q ss_pred             hhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       629 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                            ..........+.+|+.+||+.||.+|||+.||++
T Consensus       250 ------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          250 ------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                  0112234566889999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.6e-36  Score=341.31  Aligned_cols=264  Identities=25%  Similarity=0.346  Sum_probs=204.7

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEee------cCcee
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE------TQVPL  473 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~  473 (735)
                      .+.+.+.||+|+||.||++.. .++..||||+++. ......+.+.+|+.++++++||||+++++++..      .+..+
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~   94 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL   94 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence            456788999999999999985 4688999998875 355667889999999999999999999998765      66789


Q ss_pred             EEEEecCCCchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC---eEEeeccCC
Q 004702          474 LVYEFVGNGTLFEHIHKKG---NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT---PKVSDFGAS  547 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGls  547 (735)
                      +||||+++|+|.+++....   .+++..++.|+.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||++
T Consensus        95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            9999999999999998753   6999999999999999999999998   999999999999997665   899999999


Q ss_pred             cccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc---
Q 004702          548 KLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR---  624 (735)
Q Consensus       548 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---  624 (735)
                      ........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........      +...+....   
T Consensus       172 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~------~~~~i~~~~~~~  243 (676)
T 3qa8_A          172 KELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ------WHGKVREKSNEH  243 (676)
T ss_dssp             CBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH------SSTTCC------
T ss_pred             cccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh------hhhhhhcccchh
Confidence            87654332  2335689999999999999999999999999999999999999965432211      000000000   


Q ss_pred             --hhhHhhhc--------ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHhhhhh
Q 004702          625 --LLEILDNR--------IVNDGNKQQLKEVAKLAARCISVRGEERPTMKE-----VSLELQGRLSL  676 (735)
Q Consensus       625 --~~~~~d~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e-----v~~~L~~~~~~  676 (735)
                        ..+.....        .........+..+.+|+.+||+.||.+|||+.|     ..+.++.+++.
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence              00000000        011223456788999999999999999999988     55677766653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-35  Score=343.91  Aligned_cols=240  Identities=25%  Similarity=0.301  Sum_probs=194.2

Q ss_pred             hccccccccccCcEEEEEEEcC--CCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc-----ee
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP--DRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV-----PL  473 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~--~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~  473 (735)
                      .+.+.++||+|+||+||++...  +++.||||++.. ......+.+.+|+.++++++||||+++++++...+.     .+
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~  160 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY  160 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence            4556789999999999999864  578999998864 344556788999999999999999999999988765     69


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      |||||+++++|.+++..  .+++.+++.|+.||+.||.|||+++   |+||||||+||||+.+ .+||+|||+++.....
T Consensus       161 lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          161 IVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             EEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence            99999999999998765  6999999999999999999999998   9999999999999986 8999999999876433


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                           ....||+.|+|||++.+. .+.++||||||++||||++|..|+.......                +.       
T Consensus       235 -----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~-------  285 (681)
T 2pzi_A          235 -----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP-------  285 (681)
T ss_dssp             -----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC-------
T ss_pred             -----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------------cc-------
Confidence                 334599999999998765 4889999999999999999988875321100                00       


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHhhhhh
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPT-MKEVSLELQGRLSL  676 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~~L~~~~~~  676 (735)
                      ...........+.+|+.+||+.||.+||+ +.++...|..++..
T Consensus       286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence            00001123467899999999999999995 66777777776644

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.4e-34  Score=303.00  Aligned_cols=231  Identities=13%  Similarity=0.092  Sum_probs=184.4

Q ss_pred             hhhccccccccccCcEEEEEEEcC-CCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .-.+.+.+.||+|+||.||+|... +++.||||.++..   +....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            345667789999999999999865 4889999998753   245567899999999999999999999999999999999


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||+++++|.+++...  ....++++|+.|++.||+|||+++   |+||||||+||||+.++.+||++++          
T Consensus       110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------
Confidence            9999999999999653  466678999999999999999999   9999999999999999999997443          


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc-
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV-  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-  634 (735)
                                 |++       .++.++||||||++||||++|+.||......+....            ....+..... 
T Consensus       175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~~~  224 (286)
T 3uqc_A          175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQPIE  224 (286)
T ss_dssp             -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSCBCC
T ss_pred             -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccCCCC
Confidence                       333       368899999999999999999999976543221000            0000000000 


Q ss_pred             -CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          635 -NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       635 -~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                       .......+.++.+|+.+||+.||.+| |+.|+++.|+.+...
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence             00112244679999999999999999 999999999987654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.7e-34  Score=300.40  Aligned_cols=219  Identities=25%  Similarity=0.335  Sum_probs=174.1

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHH-HhcCCCceEEEceEEee----cCceeEEEEecC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVV-LQINRRNVVRLLGCCLE----TQVPLLVYEFVG  480 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lV~E~~~  480 (735)
                      ++||+|+||.||++.. .++..||||+++.     ...+.+|+.++ +.++||||+++++++..    ....++||||++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~   98 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   98 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence            6899999999999985 5688999999864     24567888887 66689999999999887    667899999999


Q ss_pred             CCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEeeccCCcccCCCcc
Q 004702          481 NGTLFEHIHKKG--NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       481 ~gsL~~~l~~~~--~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGls~~~~~~~~  555 (735)
                      +++|.+++....  .+++..++.++.|++.||+|||+.+   |+||||||+||||+.   ++.+||+|||++....    
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----  171 (299)
T 3m2w_A           99 GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----  171 (299)
T ss_dssp             SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence            999999998753  6999999999999999999999999   999999999999998   7899999999987432    


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                                         +..++.++||||||+++|||++|+.||.........       ..+.    ..+.....  
T Consensus       172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~~----~~~~~~~~--  219 (299)
T 3m2w_A          172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMK----TRIRMGQY--  219 (299)
T ss_dssp             -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSC----CSSCTTCC--
T ss_pred             -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------HHHH----HHHhhccc--
Confidence                               235678999999999999999999999654322100       0000    00000000  


Q ss_pred             CCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          636 DGN----KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       636 ~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ..+    ...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            011    1235789999999999999999999999863

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-34  Score=318.20  Aligned_cols=235  Identities=16%  Similarity=0.170  Sum_probs=177.3

Q ss_pred             cccccccccCcEEEEEEE-cCCCcEEEEEEeeccCh---hHHHHHHHHHHHHHhcCC-Cce---------------EEEc
Q 004702          404 NYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQ---AKIDEFINELVVVLQINR-RNV---------------VRLL  463 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni---------------v~l~  463 (735)
                      ...++||+|+||+||+|. ..+++.||||+++....   ...+.|.+|+.++..++| +|+               +.+.
T Consensus        81 ~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  160 (413)
T 3dzo_A           81 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP  160 (413)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred             EEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence            345789999999999999 55789999999874322   236778999999999987 321               1111


Q ss_pred             ------eEEee-----cCceeEEEEecCCCchhHHhhh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 004702          464 ------GCCLE-----TQVPLLVYEFVGNGTLFEHIHK-------KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD  525 (735)
Q Consensus       464 ------g~~~~-----~~~~~lV~E~~~~gsL~~~l~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~D  525 (735)
                            .+...     ....+++|+++ +++|.+++..       ...+++..++.|+.|+++||+|||+++   |+|||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrD  236 (413)
T 3dzo_A          161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTY  236 (413)
T ss_dssp             C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred             CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence                  11111     12346667765 6799998841       235788899999999999999999999   99999


Q ss_pred             CCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccCccCcccc----------cCCCCCccccchhHHHHHHHHH
Q 004702          526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL----------QTCKLTDKSDVYSFGVVLVELL  595 (735)
Q Consensus       526 lk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDVyS~Gvvl~ell  595 (735)
                      |||+||||+.++.+||+|||+++.....    .....| +.|+|||++          ....++.++||||||++||||+
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            9999999999999999999999865432    233457 999999999          5566888999999999999999


Q ss_pred             hCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          596 TGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       596 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      +|+.||......+.               ...++..      ....+.++.+|+.+||+.+|++|||+.|+++
T Consensus       312 tg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          312 CADLPNTDDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HSSCCCCTTGGGSC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HCCCCCCCcchhhh---------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999965432211               1111110      0123467999999999999999999888864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.2e-34  Score=308.82  Aligned_cols=242  Identities=17%  Similarity=0.182  Sum_probs=182.1

Q ss_pred             hhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccC--------hhHHHHHHHHHHHHHhcC---------CCceEEE
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD--------QAKIDEFINELVVVLQIN---------RRNVVRL  462 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  462 (735)
                      ...+.+.+.||+|+||+||+|+. ++..||||+++...        ....+.+.+|+.+|+.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            34456678999999999999987 67899999987532        233477889999998886         7777777


Q ss_pred             ceEEe-----------------e-------------cCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004702          463 LGCCL-----------------E-------------TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSY  512 (735)
Q Consensus       463 ~g~~~-----------------~-------------~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~y  512 (735)
                      ++.+.                 +             .+..++||||+++|+|.+.+.+ ..+++..++.|+.||+.||+|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence            76643                 2             6788999999999977777654 568999999999999999999


Q ss_pred             HH-hcCCCCeeecCCCCCcEEEcCCC--------------------CeEEeeccCCcccCCCcccceeeeccccCccCcc
Q 004702          513 LH-SETNVPIIHRDVKSANILLDENC--------------------TPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE  571 (735)
Q Consensus       513 LH-~~~~~~ivH~Dlk~~NILl~~~~--------------------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE  571 (735)
                      || +.+   |+||||||+||||+.++                    .+||+|||+++.....      ...||+.|+|||
T Consensus       177 lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE  247 (336)
T 2vuw_A          177 AEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred             HHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence            99 888   99999999999999887                    8999999999876432      235999999999


Q ss_pred             cccCCCCCccccchhHHHH-HHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHH
Q 004702          572 YLQTCKLTDKSDVYSFGVV-LVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAA  650 (735)
Q Consensus       572 ~~~~~~~~~ksDVyS~Gvv-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~  650 (735)
                      .+.+.. +.++|||||+.+ .+++++|..||......  .............       ............++++.+|+.
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~-------~~~~~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTDKMLKQMTF-------KTKCNTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHHHHHHTCCC-------SSCCCSHHHHHHHHHHHHHHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHHhhhhhhcc-------CcccchhhhhhcCHHHHHHHH
Confidence            998766 889999998776 77888898887211000  0000000000000       000111123457789999999


Q ss_pred             HcccCCCCCCCCHHHHH
Q 004702          651 RCISVRGEERPTMKEVS  667 (735)
Q Consensus       651 ~cl~~~p~~RPt~~ev~  667 (735)
                      +||+.+     |+.|++
T Consensus       318 ~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          318 TMLNFS-----SATDLL  329 (336)
T ss_dssp             HGGGSS-----SHHHHH
T ss_pred             HHhccC-----CHHHHH
Confidence            999976     888876

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=6.3e-29  Score=283.84  Aligned_cols=185  Identities=17%  Similarity=0.068  Sum_probs=132.2

Q ss_pred             cccccCcEEEEEEE-cCCCcEEEEEEeecc----------ChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEE
Q 004702          408 VIGCGGSGNVYKGF-LPDRTPVAVKKSKFV----------DQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV  475 (735)
                      .++.|++|.+..++ .--|..+|+|.+...          .+...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45666666665543 224677999987642          233456799999999999 699999999999999999999


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||++|++|.++|...++++..   +|+.||+.||+|||+++   ||||||||+||||++++++||+|||+++....+..
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~  394 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS  394 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence            9999999999999988888765   47899999999999999   99999999999999999999999999987654332


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCcc
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMA  600 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p  600 (735)
                      . .....||+.|||||.+.+ .+..++|+||+|+++++|.++..+
T Consensus       395 ~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          395 W-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             C-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             c-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            2 234569999999999876 567789999999999888776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.1e-25  Score=255.53  Aligned_cols=182  Identities=14%  Similarity=0.171  Sum_probs=146.1

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccC--------hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD--------QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .++||+|+||+||++.. .+..+++|+.....        ....+.+.+|+++|++++||||+++..++...+..+||||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            46899999999999965 46678888754211        1124558999999999999999977777778888899999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++++|.+++..        ++.++.|+++||+|||+++   |+||||||+|||+++  ++||+|||+++.........
T Consensus       420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999976        5689999999999999999   999999999999999  99999999999875432221


Q ss_pred             ------eeeeccccCccCcccccC--CCCCccccchhHHHHHHHHHhCCccC
Q 004702          558 ------CTVVQGTLGYLDPEYLQT--CKLTDKSDVYSFGVVLVELLTGKMAL  601 (735)
Q Consensus       558 ------~~~~~gt~~y~aPE~~~~--~~~~~ksDVyS~Gvvl~elltG~~p~  601 (735)
                            .....||+.|||||++..  ..|+.+.|+||..+-.++.+.++.+|
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                  134569999999999987  66888999999999988888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=1.3e-22  Score=211.33  Aligned_cols=142  Identities=15%  Similarity=0.144  Sum_probs=116.7

Q ss_pred             ccccccccCcEEEEEEEcCCCcEEEEEEeeccCh------------------hHHHHHHHHHHHHHhcCCCceEEEceEE
Q 004702          405 YADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQ------------------AKIDEFINELVVVLQINRRNVVRLLGCC  466 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~g~~  466 (735)
                      +.+.||+|+||.||+|...++..||||.++....                  .....+.+|+.+|++++  | +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            4579999999999999987789999999864221                  23567899999999999  5 6666654


Q ss_pred             eecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccC
Q 004702          467 LETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGA  546 (735)
Q Consensus       467 ~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl  546 (735)
                      . .+..++||||+++++|.+ +..      .....++.|++.||+|||+.+   |+||||||+||||+ ++.+||+|||+
T Consensus       171 ~-~~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          171 A-WEGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             E-EETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             e-ccceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            3 456799999999999998 522      234579999999999999999   99999999999999 99999999999


Q ss_pred             CcccCCCcccceeeeccccCccCcccccC
Q 004702          547 SKLVPIDAIQNCTVVQGTLGYLDPEYLQT  575 (735)
Q Consensus       547 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~  575 (735)
                      ++.              +..++|||++..
T Consensus       239 a~~--------------~~~~~a~e~l~r  253 (282)
T 1zar_A          239 SVE--------------VGEEGWREILER  253 (282)
T ss_dssp             CEE--------------TTSTTHHHHHHH
T ss_pred             CeE--------------CCCCCHHHHHHH
Confidence            973              345788998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=1.8e-18  Score=177.61  Aligned_cols=135  Identities=21%  Similarity=0.190  Sum_probs=105.3

Q ss_pred             cccccccccCcEEEEEEEc-CCCcE--EEEEEeeccCh------------------------hHHHHHHHHHHHHHhcCC
Q 004702          404 NYADVIGCGGSGNVYKGFL-PDRTP--VAVKKSKFVDQ------------------------AKIDEFINELVVVLQINR  456 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~h  456 (735)
                      .+.+.||+|+||.||+|.. .++..  ||||.++....                        .....+.+|+.+|.+++|
T Consensus        50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            4567899999999999997 67888  99998653211                        112367889999999988


Q ss_pred             Cce--EEEceEEeecCceeEEEEecCC-C----chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCC
Q 004702          457 RNV--VRLLGCCLETQVPLLVYEFVGN-G----TLFEHIHKKGNLSWERRLRITAETAGVLSYLH-SETNVPIIHRDVKS  528 (735)
Q Consensus       457 ~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~ivH~Dlk~  528 (735)
                      +++  +.++..    +..+|||||+.+ |    +|.+++..   .++..+..++.|++.+|.||| +.+   |+||||||
T Consensus       130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp  199 (258)
T 1zth_A          130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSE  199 (258)
T ss_dssp             TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCST
T ss_pred             CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCH
Confidence            764  333332    356899999942 4    66665533   234567889999999999999 888   99999999


Q ss_pred             CcEEEcCCCCeEEeeccCCccc
Q 004702          529 ANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       529 ~NILl~~~~~~kl~DFGls~~~  550 (735)
                      .|||+++  .++|+|||++...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.58  E-value=4.6e-16  Score=166.41  Aligned_cols=136  Identities=14%  Similarity=0.123  Sum_probs=97.7

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccC--------------hhHHHH--------HHHHHHHHHhcCCCceE
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD--------------QAKIDE--------FINELVVVLQINRRNVV  460 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~--------------~~~~~~--------~~~E~~~l~~l~h~niv  460 (735)
                      +.+...||+|+||.||+|...+|+.||||+++...              ......        ..+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            55678999999999999998899999999864210              000111        13466667776554432


Q ss_pred             EEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC--
Q 004702          461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT--  538 (735)
Q Consensus       461 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~--  538 (735)
                      -..-+.  ....+|||||+++++|.++...      +....++.|++.+|.+||+.+   ||||||||.||||++++.  
T Consensus       177 vp~p~~--~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          177 VPEPIA--QSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             CCCEEE--EETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSS
T ss_pred             CCeeee--ccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcc
Confidence            111111  1234799999999888665422      234578899999999999998   999999999999987763  


Q ss_pred             --------eEEeeccCCcc
Q 004702          539 --------PKVSDFGASKL  549 (735)
Q Consensus       539 --------~kl~DFGls~~  549 (735)
                              +.|+||+-+..
T Consensus       246 d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEE
T ss_pred             cccccccceEEEEeCCccc
Confidence                    88999997664

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.18  E-value=3.4e-11  Score=123.37  Aligned_cols=138  Identities=15%  Similarity=0.092  Sum_probs=107.4

Q ss_pred             ccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEecCCCc
Q 004702          405 YADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       405 ~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      +...++.|+.+.||+.... +..+++|............+.+|+.+++.+. +..+.+++++....+..++||||++|.+
T Consensus        18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   96 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL   96 (263)
T ss_dssp             EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred             eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence            4557788888999998754 5789999976422122346789999999985 6778899999988889999999999999


Q ss_pred             hhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 004702          484 LFEHIHKKGNLSWERRLRITAETAGVLSYLHSET----------------------------------------------  517 (735)
Q Consensus       484 L~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~----------------------------------------------  517 (735)
                      |.+.+.     +......++.+++++|+.||+..                                              
T Consensus        97 l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  171 (263)
T 3tm0_A           97 CSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY  171 (263)
T ss_dssp             HHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHH
T ss_pred             hhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHH
Confidence            887642     12234578899999999999811                                              


Q ss_pred             ----------CCCeeecCCCCCcEEEcCCCCeEEeeccCCc
Q 004702          518 ----------NVPIIHRDVKSANILLDENCTPKVSDFGASK  548 (735)
Q Consensus       518 ----------~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~  548 (735)
                                ...++|+|+++.|||++++..+.|+||+.+.
T Consensus       172 ~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                      1338999999999999876667799998775

>1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A

Probab=99.10  E-value=4.1e-11  Score=99.15  Aligned_cols=77  Identities=29%  Similarity=0.696  Sum_probs=64.3

Q ss_pred             ccccccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCC-CcCCCCCCccceeccCCCC
Q 004702          234 TCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCT-HICDNIPGSYTCRCRKGFH  312 (735)
Q Consensus       234 ~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~-~~C~n~~g~y~C~c~~g~~  312 (735)
                      +|.++++|.....|.+ ++|.++.++|+|.|++||+++   ...|+|||||...  ++|. ++|.|++|+|.|.|++||.
T Consensus         1 sC~dideC~~~~~C~~-g~C~n~~g~y~C~C~~Gy~~~---g~~C~dideC~~~--~~C~~~~C~n~~g~y~C~C~~G~~   74 (82)
T 1emn_A            1 SAVDMDECKEPDVCKH-GQCINTDGSYRCECPFGYILA---GNECVDTDECSVG--NPCGNGTCKNVIGGFECTCEEGFE   74 (82)
T ss_dssp             CCCCCCSSSSTTSCSS-SEECCCSSCCCEECCTTEEEE---TTEEEECCGGGTC--CTTSSSCEEECSSSEEECCSSSSC
T ss_pred             CCCccccCCCCCCcCC-CEEEecCCCEEEECCCCeECC---CCccCCcccccCC--CCCCCCEeECCCCCEEeECCCCeE
Confidence            4788899976567975 789999999999999999852   2359999999753  5676 7999999999999999999


Q ss_pred             CCCC
Q 004702          313 GDGR  316 (735)
Q Consensus       313 ~~~~  316 (735)
                      +++.
T Consensus        75 g~~~   78 (82)
T 1emn_A           75 PGPM   78 (82)
T ss_dssp             CCSS
T ss_pred             eCCC
Confidence            8764

>1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1

Probab=99.08  E-value=2.5e-11  Score=101.55  Aligned_cols=78  Identities=28%  Similarity=0.738  Sum_probs=64.3

Q ss_pred             cccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCC-CcCCCCCCccceeccCCCCCC
Q 004702          237 EAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCT-HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       237 ~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~-~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      ++++|.. .+.|.+ ++|.++.++|+|.|++||+++++....|+|||||... ...|. ++|.|++|+|.|.|++||.+.
T Consensus         2 dideC~~~~~~C~~-g~C~n~~g~y~C~C~~Gy~~~~~~g~~C~dideC~~~-~~~C~~~~C~n~~g~y~C~C~~G~~~~   79 (86)
T 1lmj_A            2 DIDECRISPDLCGR-GQCVNTPGDFECKCDEGYESGFMMMKNCMDIDECQRD-PLLCRGGVCHNTEGSYRCECPPGHQLS   79 (86)
T ss_dssp             CCCTTTTCSSTTTT-SCEEEETTEEEECCCSSEEECTTTSSSEEECCHHHHC-SSTTTTSEEEEETTEEEEESCTTSCCC
T ss_pred             ccccccCCCCCCCC-CEEECCCCCEEeeCCCCcCccCCCCCccCCcccccCC-CCcCCCCEeEcCCCCEEEECcCCcccC
Confidence            5678876 356865 4899999999999999999887666789999999753 24576 799999999999999999876


Q ss_pred             CC
Q 004702          315 GR  316 (735)
Q Consensus       315 ~~  316 (735)
                      ..
T Consensus        80 ~~   81 (86)
T 1lmj_A           80 PN   81 (86)
T ss_dssp             SS
T ss_pred             CC
Confidence            53

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.04  E-value=4e-10  Score=114.88  Aligned_cols=129  Identities=16%  Similarity=0.152  Sum_probs=98.1

Q ss_pred             cccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc--eEEEceEEeecCceeEEEEecCCCchhHH
Q 004702          410 GCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN--VVRLLGCCLETQVPLLVYEFVGNGTLFEH  487 (735)
Q Consensus       410 G~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~  487 (735)
                      +.|..+.||+....++..+++|.....   ....+..|+.+++.+.+.+  +.+++++....+..++||||+++.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            456669999998777788999986643   2245778999999886544  556888888777889999999998884  


Q ss_pred             hhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------------
Q 004702          488 IHKKGNLSWERRLRITAETAGVLSYLHSET--------------------------------------------------  517 (735)
Q Consensus       488 l~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------------------------  517 (735)
                      ..   ...   ...++.++++.|+.||+..                                                  
T Consensus       104 ~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  177 (264)
T 1nd4_A          104 SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR  177 (264)
T ss_dssp             TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred             cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHh
Confidence            21   122   2367788888888888743                                                  


Q ss_pred             -----CCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          518 -----NVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       518 -----~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                           ...++|+|++|.|||++++..++|+||+.+..
T Consensus       178 ~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          178 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                 11299999999999998876677999998763

>1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens}

Probab=98.97  E-value=1.7e-10  Score=96.58  Aligned_cols=71  Identities=37%  Similarity=0.934  Sum_probs=58.1

Q ss_pred             cccccCCC-CCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCCCcCCCCCCccceecc--CCCC
Q 004702          237 EAKICGLN-ASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCR--KGFH  312 (735)
Q Consensus       237 ~~~~C~~~-~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~~C~n~~g~y~C~c~--~g~~  312 (735)
                      ++++|..+ ..| ++++|.+..++|+|.|++||++++. ...|+|||||..   .+|.++|.|++|+|.|.|+  .||.
T Consensus         2 dideC~~~~~~C-~~~~C~n~~g~y~C~C~~G~~~~~~-g~~C~dideC~~---~~C~~~C~n~~g~y~C~C~g~~G~~   75 (87)
T 1z6c_A            2 DVDECSLKPSIC-GTAVCKNIPGDFECECPEGYRYNLK-SKSCEDIDECSE---NMCAQLCVNYPGGYTCYCDGKKGFK   75 (87)
T ss_dssp             CSCSSSSSSSSB-TTSSCCCBTTBCCCSSSTTCEEETT-TTEEECCCHHHH---SCCSSEECCCSSSCCEECCSSSCCB
T ss_pred             ccccccCCCCCC-CCCEeECCCCCEEEECCCCceECCC-CCcCCCcCeeCC---CCCCCEEEccCCCEEEECCCCcCCc
Confidence            46778764 348 6788999999999999999998763 346999999963   6799999999999999995  5554

>2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A

Probab=98.95  E-value=1.1e-10  Score=101.59  Aligned_cols=77  Identities=30%  Similarity=0.783  Sum_probs=34.2

Q ss_pred             cccccccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCCCcCCCCCCccceeccCCC
Q 004702          233 KTCEEAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGF  311 (735)
Q Consensus       233 ~~C~~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~  311 (735)
                      ..| ++++|.. ++.|..  +|.+..++|.|.|++||+|+.  ...|+|||||..  ..+|.+.|.|++|+|.|.|++||
T Consensus        25 ~~C-d~neC~~~~~~C~~--~C~n~~g~y~C~C~~Gy~g~~--g~~C~dideC~~--~~~C~~~C~n~~gsy~C~C~~Gy   97 (107)
T 2w2n_E           25 GAM-GTNECLDNNGGCSY--VCNDLKIGYECLCPDGFQLVA--QRRCEDIDECQD--PDTCSQLCVNLEGGYKCQCEEGF   97 (107)
T ss_dssp             CCB-SCCGGGTGGGGCSS--EEECCSBSCEEECCTTCEEET--TTEEEC-------------------------------
T ss_pred             CCC-cCccCcCCCCCCCC--EeEeCCCCeEEECCCCccccC--CCccccccccCC--CCCcCCeeecCCCCEEEECCCCc
Confidence            367 6788976 567863  788888999999999999953  356999999974  36789999999999999999999


Q ss_pred             CCCCC
Q 004702          312 HGDGR  316 (735)
Q Consensus       312 ~~~~~  316 (735)
                      .++..
T Consensus        98 ~~~~d  102 (107)
T 2w2n_E           98 QLDPH  102 (107)
T ss_dssp             -----
T ss_pred             eECCC
Confidence            87643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.95  E-value=1.7e-09  Score=116.22  Aligned_cols=140  Identities=19%  Similarity=0.261  Sum_probs=105.3

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEee--ccC-hhHHHHHHHHHHHHHhcCC--CceEEEceEEeec---CceeEEEEe
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSK--FVD-QAKIDEFINELVVVLQINR--RNVVRLLGCCLET---QVPLLVYEF  478 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~---~~~~lV~E~  478 (735)
                      +.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+.+++.+.+  ..++++++++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            468899999999988765 568888765  221 1224567889999999974  5578888888776   348999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-----------------------------------------  517 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~-----------------------------------------  517 (735)
                      +++..|.+..  ...++..++..++.++++.|+.||+..                                         
T Consensus       123 v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (359)
T 3dxp_A          123 VSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL  200 (359)
T ss_dssp             CCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred             cCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence            9988775422  134788889999999999999999831                                         


Q ss_pred             --------------CCCeeecCCCCCcEEEcCCCC--eEEeeccCCcc
Q 004702          518 --------------NVPIIHRDVKSANILLDENCT--PKVSDFGASKL  549 (735)
Q Consensus       518 --------------~~~ivH~Dlk~~NILl~~~~~--~kl~DFGls~~  549 (735)
                                    ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                          245999999999999997653  68999998875

>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L*

Probab=98.92  E-value=4.5e-10  Score=103.71  Aligned_cols=75  Identities=20%  Similarity=0.537  Sum_probs=60.1

Q ss_pred             ccccccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCCCcC-CCCCCccceeccCCCC
Q 004702          234 TCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHIC-DNIPGSYTCRCRKGFH  312 (735)
Q Consensus       234 ~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~~C-~n~~g~y~C~c~~g~~  312 (735)
                      .|.++++|.. ..|.++++|.+..++|.|.|++||+|..     |+++|+|... ..+|.++| .|++|+|.|.|++||.
T Consensus        44 ~c~dideC~~-~pC~n~g~C~~~~~~y~C~C~~G~~G~~-----C~~~deC~~~-~~~C~~~C~~n~~g~y~C~C~~Gy~  116 (146)
T 1x7a_L           44 QYVDGDQCEP-NPCLNGGLCKDDINSYECWCQVGFEGKN-----CELDATCNIK-NGRCKQFCKTGADSKVLCSCTTGYR  116 (146)
T ss_dssp             ------CCSS-CSSCTTCEEEECSSCEEEECCSSEESTT-----TCEECCTTSG-GGSCSSBCCCCSSSCCCCBCCTTEE
T ss_pred             cCCCcCcCCC-CCCCCCCEeECCCCCEEEecCCCCcCCc-----CCCCccccCC-CCCCcCCCCCCCCCCEEeEcCCCcE
Confidence            6888999974 5699999999999999999999999854     9999999753 35788999 9999999999999998


Q ss_pred             CCC
Q 004702          313 GDG  315 (735)
Q Consensus       313 ~~~  315 (735)
                      +.+
T Consensus       117 l~~  119 (146)
T 1x7a_L          117 LAP  119 (146)
T ss_dssp             ECT
T ss_pred             eCC
Confidence            543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.88  E-value=1.4e-09  Score=114.00  Aligned_cols=185  Identities=20%  Similarity=0.225  Sum_probs=122.6

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCc--eEEEceEEeecC---ceeEEEEecC
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRN--VVRLLGCCLETQ---VPLLVYEFVG  480 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lV~E~~~  480 (735)
                      +.++.|....||+..    ..+++|+...  ......+.+|+.+|+.+. +..  +.+++......+   ..++|||+++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            358899999999853    4588888543  244567889999998884 332  344544433333   4589999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-------------------------------------------  517 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~-------------------------------------------  517 (735)
                      |.+|.+...  ..++..++..++.++++.|+.||+..                                           
T Consensus       100 G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  177 (304)
T 3sg8_A          100 GVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY  177 (304)
T ss_dssp             CEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred             CeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence            988876443  24788888899999999999999621                                           


Q ss_pred             ------------CCCeeecCCCCCcEEEcC--CCCeEEeeccCCcccCCCccc--cee-----------eeccccCccC-
Q 004702          518 ------------NVPIIHRDVKSANILLDE--NCTPKVSDFGASKLVPIDAIQ--NCT-----------VVQGTLGYLD-  569 (735)
Q Consensus       518 ------------~~~ivH~Dlk~~NILl~~--~~~~kl~DFGls~~~~~~~~~--~~~-----------~~~gt~~y~a-  569 (735)
                                  .+.++|+|+++.||++++  +..+.|+||+.+........-  ...           ......+... 
T Consensus       178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~  257 (304)
T 3sg8_A          178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDI  257 (304)
T ss_dssp             HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCH
T ss_pred             HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCc
Confidence                        134799999999999998  556889999988653211000  000           0000001111 


Q ss_pred             cccccCCCCCccccchhHHHHHHHHHhCCccC
Q 004702          570 PEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL  601 (735)
Q Consensus       570 PE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~  601 (735)
                      |+....  ..-..+.|+++.++|.+.+|..++
T Consensus       258 ~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          258 PTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            222111  111358999999999999998765

>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A

Probab=98.83  E-value=8.3e-10  Score=101.95  Aligned_cols=85  Identities=34%  Similarity=0.771  Sum_probs=69.8

Q ss_pred             cccccccccccCCC--CCCCCCCCccCCCCcceeeCCCCCCCCCCC-------CCCccccCCccCCCCCCCC--CcCCCC
Q 004702          231 TDKTCEEAKICGLN--ASCDTPKDNTSTSSGYRCKCNKGYEGNPYL-------SDGCRDVNECEDPSRNNCT--HICDNI  299 (735)
Q Consensus       231 ~~~~C~~~~~C~~~--~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~-------~~gC~di~eC~~~~~~~c~--~~C~n~  299 (735)
                      +...|.++++|..+  ..|.++++|.+..++|.|.|++||+|.+..       ...|+|||||... ..+|.  ++|.|+
T Consensus        37 ~~~~C~dideC~~~~~~~C~~~~~C~n~~g~y~C~C~~Gy~g~~~~~~~~~~~~~~C~dideC~~~-~~~C~~~~~C~n~  115 (143)
T 2bou_A           37 PMETCDDINECATLSKVSCGKFSDCWNTEGSYDCVCSPGYEPVSGAKTFKNESENTCQDVDECSSG-QHQCDSSTVCFNT  115 (143)
T ss_dssp             TTCCCEECCGGGC----CCCTTEEEEECSSCEEEEECTTEEETTCCSCBSSGGGCCEEECCHHHHT-CCCCCTTSEEEEC
T ss_pred             CCCcCCccccccCCCCCCCCCCCEEEcCCCCeEeECCCCcccCcCccccccCCCCCcCCccCccCc-CCCCCCCCEEECC
Confidence            34579999999864  379988899999999999999999998643       3479999999853 35776  799999


Q ss_pred             CCccceeccCCCCCCCC
Q 004702          300 PGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       300 ~g~y~C~c~~g~~~~~~  316 (735)
                      +|+|.|.|++||.+...
T Consensus       116 ~g~y~C~C~~Gy~g~~~  132 (143)
T 2bou_A          116 VGSYSCRCRPGWKPRHG  132 (143)
T ss_dssp             SSCEEEECCSSSCBCTT
T ss_pred             CCCEEeeCCCCcccCCC
Confidence            99999999999988653

>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L*

Probab=98.74  E-value=9.3e-10  Score=105.86  Aligned_cols=74  Identities=22%  Similarity=0.649  Sum_probs=27.5

Q ss_pred             ccccccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc-c-CCccCCCCCCCCCcCCCCCCccceeccCCC
Q 004702          234 TCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD-V-NECEDPSRNNCTHICDNIPGSYTCRCRKGF  311 (735)
Q Consensus       234 ~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d-i-~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~  311 (735)
                      .|.++++|.. ..|.++++|.+..++|.|.|++||+|..     |++ | ++|... ..+|.+.|.|++|+|.|.|++||
T Consensus        38 ~c~dideC~~-~pC~ngg~C~n~~g~y~C~C~~Gf~G~~-----Ce~~i~deC~~~-~~~C~~~C~n~~gsy~C~C~~Gy  110 (195)
T 1nfu_B           38 KYKDGDQCET-SPCQNQGKCKDGLGEYTCTCLEGFEGKN-----CELFTRKLCSLD-NGDCDQFCHEEQNSVVCSCARGY  110 (195)
T ss_dssp             -------------------------------------------------CCGGGTG-GGGCSSEEEEETTEEEEECCTTE
T ss_pred             cCCCCcccCC-CCCCCCCEeECCCCCeeEeCCCCceecc-----ccccccccccCC-CCCCCCEeECCCCCeEEECCCCc
Confidence            6888999974 5699999999999999999999999865     987 6 899753 36799999999999999999999


Q ss_pred             CCC
Q 004702          312 HGD  314 (735)
Q Consensus       312 ~~~  314 (735)
                      .+.
T Consensus       111 ~l~  113 (195)
T 1nfu_B          111 TLA  113 (195)
T ss_dssp             EEC
T ss_pred             eeC
Confidence            854

>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L*

Probab=98.69  E-value=3.5e-09  Score=93.49  Aligned_cols=75  Identities=23%  Similarity=0.542  Sum_probs=56.8

Q ss_pred             cccccccCCC-------CCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCcccc---CCccCCCCCCCCCcCCCCCCccc
Q 004702          235 CEEAKICGLN-------ASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDV---NECEDPSRNNCTHICDNIPGSYT  304 (735)
Q Consensus       235 C~~~~~C~~~-------~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di---~eC~~~~~~~c~~~C~n~~g~y~  304 (735)
                      |.+.++|..+       +.|.++++|.+..++|+|.|++||+|+.     |+++   ++|... ...|.++|.|+.++|.
T Consensus         3 ~~d~d~C~~~p~~~~C~~~C~~~g~C~~~~~~y~C~C~~G~~G~~-----C~~~~~~~~C~~~-~~~C~~~C~n~~g~y~   76 (114)
T 1aut_L            3 HVDGDQCLVLPLEHPCASLCCGHGTCIDGIGSFSCDCRSGWEGRF-----CQREVSFLNCSLD-NGGCTHYCLEEVGWRR   76 (114)
T ss_dssp             -----CCCCCSSCCSSSSTTTTSEEECCCSSCCCEEECTTEESTT-----SCEECCSSSSSSG-GGGCSSEEEECSSSEE
T ss_pred             ceecccccCCCccccccccCCCcCCCCCCCCCcEeeCCCCCcCCC-----cCcCCcCCcCcCC-CCCCCCEeECCCCCEE
Confidence            4455566542       2388888999999999999999999975     8875   468642 3578889999999999


Q ss_pred             eeccCCCCCCC
Q 004702          305 CRCRKGFHGDG  315 (735)
Q Consensus       305 C~c~~g~~~~~  315 (735)
                      |.|++||.+..
T Consensus        77 C~C~~G~~~~~   87 (114)
T 1aut_L           77 CSCAPGYKLGD   87 (114)
T ss_dssp             EECCTTEEECT
T ss_pred             eECCCCeeECC
Confidence            99999998653

>3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens}

Probab=98.69  E-value=1.3e-08  Score=107.17  Aligned_cols=73  Identities=32%  Similarity=0.728  Sum_probs=61.0

Q ss_pred             cccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCcc-ccCCccCCCCCCCCCcCCCCCCccceeccCCCCCCC
Q 004702          237 EAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCR-DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       237 ~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~-di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      +.++|..+ .|.++++|.+..++|.|.|++||+|+.     |+ |+|||......+|.+.|.|+.++|.|.|+.||.+..
T Consensus         4 d~~~C~~~-pC~~~g~C~~~~~~~~C~C~~g~~g~~-----C~~~~~eC~~~~~~~C~~~C~~~~g~~~C~C~~g~~~~~   77 (317)
T 3h5c_B            4 GGSPCISQ-PCLHNGSCQDSIWGYTCTCSPGYEGSN-----CELAKNECHPERTDGCQHFCLPGQESYTCSCAQGYRLGE   77 (317)
T ss_dssp             --CCTTSC-CCTTTCCCCCCSSSCCCCCSSSCCSSS-----SCCCSSSCCTTCTTSCSSEEECCSSSCEEECCTTEECCT
T ss_pred             cCCcCCCC-CCCCCCEeECCCCCeEEECCCCCcCCc-----cccCcccCCCCCCCCCcCccccCCCeeEEeccccccccc
Confidence            45678654 499989999988999999999999864     98 999998633478999999999999999999998753

>3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L

Probab=98.65  E-value=2.1e-08  Score=109.25  Aligned_cols=76  Identities=32%  Similarity=0.845  Sum_probs=60.4

Q ss_pred             ccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCCCcCCCCCCccceeccCCCCCCCCCC
Q 004702          240 ICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKD  318 (735)
Q Consensus       240 ~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~~~~  318 (735)
                      +|.. +..|.  ..|.++.++|.|.|++||++.  ....|+|||||..  ..+|.+.|.|++|+|.|.|.+||.+...  
T Consensus         2 eC~~~~~~c~--~~C~~~~~~y~C~C~~G~~~~--~~~~C~dideC~~--~~~C~~~C~n~~g~~~C~C~~g~~~~~~--   73 (400)
T 3p5b_L            2 ECLDNNGGCS--HVCNDLKIGYECLCPDGFQLV--AQRRCEDIDECQD--PDTCSQLCVNLEGGYKCQCEEGFQLDPH--   73 (400)
T ss_dssp             CTTTTGGGCS--SEEEECSSSEEEECCTTEEEC--SSSCEEECCCCST--TSSCSSCCBCCSSSCBCCCCTTCCCCTT--
T ss_pred             cccCCCCCCC--CEeECCCCCeEEECCCCCCcC--CCCcccCchhhhc--cCCCCCccCCCccceeeecccccccccc--
Confidence            5654 33354  478889999999999999972  3457999999984  3689999999999999999999987743  


Q ss_pred             CCCCc
Q 004702          319 GGGCT  323 (735)
Q Consensus       319 ~~gC~  323 (735)
                      +..|.
T Consensus        74 ~~~C~   78 (400)
T 3p5b_L           74 TKACK   78 (400)
T ss_dssp             TSSCC
T ss_pred             cccee
Confidence            33454

>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ...

Probab=98.64  E-value=2.5e-09  Score=97.26  Aligned_cols=74  Identities=22%  Similarity=0.649  Sum_probs=27.3

Q ss_pred             ccccccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc-c-CCccCCCCCCCCCcCCCCCCccceeccCCC
Q 004702          234 TCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD-V-NECEDPSRNNCTHICDNIPGSYTCRCRKGF  311 (735)
Q Consensus       234 ~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d-i-~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~  311 (735)
                      .|.++++|.. ..|.++++|.+..++|.|.|++||+|..     |++ + |+|... ..+|.++|.|++|+|.|.|++||
T Consensus        38 ~c~d~d~C~~-~pC~n~g~C~~~~~~y~C~C~~G~~G~~-----C~~~i~d~C~~~-~~~C~~~C~~~~g~y~C~C~~Gy  110 (134)
T 2vh0_B           38 KYKDGDQCET-SPCQNQGKCKDGLGEYTCTCLEGFEGKN-----CELFTRKLCSLD-NGDCDQFCHEEQNSVVCSCARGY  110 (134)
T ss_dssp             -------------------------------------------------CCGGGTG-GGGCSSEEEEETTEEEEECCTTE
T ss_pred             cCCCcCcCCC-CCCCCcCCcccCCCCEEeeCCCCccCCc-----cccCCCCccccC-CCCCCCEeECCCCCEEEECCCCc
Confidence            5888889975 4599999999999999999999999854     987 7 899752 35788999999999999999999


Q ss_pred             CCC
Q 004702          312 HGD  314 (735)
Q Consensus       312 ~~~  314 (735)
                      .+.
T Consensus       111 ~l~  113 (134)
T 2vh0_B          111 TLA  113 (134)
T ss_dssp             EEC
T ss_pred             EEC
Confidence            854

>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A*

Probab=98.63  E-value=1.3e-08  Score=92.70  Aligned_cols=74  Identities=31%  Similarity=0.816  Sum_probs=60.4

Q ss_pred             ccccccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCcc-ccCCccCCCCCCCC--CcCCCCCCccceeccC
Q 004702          234 TCEEAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCR-DVNECEDPSRNNCT--HICDNIPGSYTCRCRK  309 (735)
Q Consensus       234 ~C~~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~-di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~  309 (735)
                      +|.++++|.. ...|.++++|.+..++|.|.|++||+|+.     |+ ++++|..   .+|.  ++|.+++++|.|.|++
T Consensus         1 Sc~dideC~~~~~~C~~~g~C~~~~g~~~C~C~~Gy~G~~-----C~~~~~~C~~---~~C~~~~~C~~~~g~~~C~C~~   72 (135)
T 2vj3_A            1 SAQDVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGPR-----CEIDVNECVS---NPCQNDATCLDQIGEFQCICMP   72 (135)
T ss_dssp             --CCCCTTTSSSCSSSTTCEEEECSSSEEEECCTTEESTT-----SCEECCTTTT---CCCCSSCEEEECSSCEEEECCT
T ss_pred             CCcccccccCCCCCCCCCCEeECCCCCEEEECCCCCcCCc-----ccccCccCCC---CCCCCCCEEeCCCCCceeeCCC
Confidence            3678889976 56799999999988999999999999864     74 8999974   4555  6899999999999999


Q ss_pred             CCCCCC
Q 004702          310 GFHGDG  315 (735)
Q Consensus       310 g~~~~~  315 (735)
                      ||.+..
T Consensus        73 G~~G~~   78 (135)
T 2vj3_A           73 GYEGVH   78 (135)
T ss_dssp             TEESSS
T ss_pred             CCcCCc
Confidence            998753

>2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ...

Probab=98.57  E-value=1.4e-08  Score=93.27  Aligned_cols=75  Identities=20%  Similarity=0.572  Sum_probs=61.3

Q ss_pred             ccccccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc-cCCccC--CCCCCCCCcCCCCCC-ccceeccC
Q 004702          234 TCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD-VNECED--PSRNNCTHICDNIPG-SYTCRCRK  309 (735)
Q Consensus       234 ~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d-i~eC~~--~~~~~c~~~C~n~~g-~y~C~c~~  309 (735)
                      .|.++++|.. ..|.++++|.+..++|.|.|++||+|..     |++ +++|..  .....|.++|.|+.+ +|.|.|++
T Consensus        43 ~c~did~C~~-~pC~n~g~C~~~~g~y~C~C~~G~~G~~-----C~~~~~~c~~c~~~~~~C~~~C~~~~g~~y~C~C~~  116 (142)
T 2c4f_L           43 SYSDGDQCAS-SPCQNGGSCKDQLQSYICFCLPAFEGRN-----CETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHE  116 (142)
T ss_dssp             HHTTCCGGGG-CCCCTTCEEEEETTEEEEECCTTEESTT-----SCEEGGGCCSTTTGGGGCSSEEECCTTSCCEEECCT
T ss_pred             cCCccCcCcC-CCcCCCCEEeCCCCCEEeeCCCCccCCc-----cccCccccccccCCCCCccCEeECCCCCCEEEECCC
Confidence            5778888974 5699999999999999999999999865     886 677522  122467789999999 99999999


Q ss_pred             CCCCC
Q 004702          310 GFHGD  314 (735)
Q Consensus       310 g~~~~  314 (735)
                      ||.+.
T Consensus       117 Gy~l~  121 (142)
T 2c4f_L          117 GYSLL  121 (142)
T ss_dssp             TEEEC
T ss_pred             CceEC
Confidence            99854

>3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus}

Probab=98.56  E-value=1.3e-08  Score=110.29  Aligned_cols=80  Identities=26%  Similarity=0.711  Sum_probs=20.3

Q ss_pred             cccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCCCcCCCCCCccceeccCCCCCCC
Q 004702          237 EAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       237 ~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      ++++|.. ++.|.+  .|.+..++|.|.|++||++++. ...|+|+|||..  ..+|.+.|.|++|+|.|.|++||....
T Consensus         2 ~~~~C~~~~~~c~~--~C~~~~g~~~C~C~~G~~l~~~-~~~C~d~~eC~~--~~~C~~~C~~~~g~~~C~C~~g~~l~~   76 (386)
T 3v65_B            2 GEENCNVNNGGCAQ--KCQMIRGAVQCTCHTGYRLTED-GRTCQDVNECAE--EGYCSQGCTNSEGAFQCWCEAGYELRP   76 (386)
T ss_dssp             -------------------------------------------------------CCTTEEC-----CCEECCTTEEECT
T ss_pred             CcCcccCCCCCCCC--CCcCCCCCcEeECCCCceECCC-CCccCccceeCC--cCcccCcCCCCCCCCeEEECCCceEcC
Confidence            4567866 456765  7877778899999999997663 457999999973  468999999999999999999998553


Q ss_pred             CCCCCCCc
Q 004702          316 RKDGGGCT  323 (735)
Q Consensus       316 ~~~~~gC~  323 (735)
                      .  +..|.
T Consensus        77 d--~~~C~   82 (386)
T 3v65_B           77 D--RRSCK   82 (386)
T ss_dssp             T--SSCEE
T ss_pred             C--CCeEC
Confidence            2  33454

>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A*

Probab=98.54  E-value=2.9e-08  Score=111.77  Aligned_cols=85  Identities=31%  Similarity=0.744  Sum_probs=71.2

Q ss_pred             cccccccccccCC-CCCCCCCC---CccCCCCcceee-CCCCCCCCCCC----------CCCccccCCccCCCCCCCC--
Q 004702          231 TDKTCEEAKICGL-NASCDTPK---DNTSTSSGYRCK-CNKGYEGNPYL----------SDGCRDVNECEDPSRNNCT--  293 (735)
Q Consensus       231 ~~~~C~~~~~C~~-~~~C~~~~---~c~~~~~~y~C~-C~~Gy~gn~y~----------~~gC~di~eC~~~~~~~c~--  293 (735)
                      ++.+|+++++|.. .+.|.+++   +|.++.++|+|. |++||+|+.+.          ...|++++||... .++|.  
T Consensus        37 dg~~CeDiDEC~~~p~~C~~gg~~~~CvNt~gsY~C~~C~~Gy~G~~c~g~g~~~~~~dg~~C~dideC~~~-~~pC~~~  115 (634)
T 1yo8_A           37 NGTHCEDLDECALVPDICFSTSKVPRCVNTQPGFHCLPCPPRYRGNQPVGVGLEAAKTEKQVCEPENPCKDK-THNCHKH  115 (634)
T ss_dssp             CSSSCCBCCTTTTSCCCSCCCSSSCCEEECSSSEEECCCCTTEEECCCEESSSHHHHSCCCCEEECCTTTTT-CCCCCTT
T ss_pred             CCCCccccccccCCCCcccCCccccceeeccCceecccCCCCcccCccccccccccccCCCcccccccccCC-CcccccC
Confidence            3457999999976 45699988   899999999999 99999998754          3459999999853 36787  


Q ss_pred             CcCCCCC----CccceeccCCCCCCCC
Q 004702          294 HICDNIP----GSYTCRCRKGFHGDGR  316 (735)
Q Consensus       294 ~~C~n~~----g~y~C~c~~g~~~~~~  316 (735)
                      ++|.|++    ++|.|.|++||.+++.
T Consensus       116 ~~Cvnt~~~~~GsY~C~C~~Gy~GdG~  142 (634)
T 1yo8_A          116 AECIYLGHFSDPMYKCECQTGYAGDGL  142 (634)
T ss_dssp             EEEEECCTTCSSSEEEEECTTEEESSS
T ss_pred             ccccccccccccceeeeccCCccccCc
Confidence            6899999    9999999999998654

>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens}

Probab=98.42  E-value=9.1e-08  Score=88.12  Aligned_cols=75  Identities=32%  Similarity=0.779  Sum_probs=60.7

Q ss_pred             cccccccccCCCCCCCCCCCcc-------CCCCcceeeCCCCCCCCCCCCCCcc-ccCCccCCCCCCCC--CcCCCCCCc
Q 004702          233 KTCEEAKICGLNASCDTPKDNT-------STSSGYRCKCNKGYEGNPYLSDGCR-DVNECEDPSRNNCT--HICDNIPGS  302 (735)
Q Consensus       233 ~~C~~~~~C~~~~~C~~~~~c~-------~~~~~y~C~C~~Gy~gn~y~~~gC~-di~eC~~~~~~~c~--~~C~n~~g~  302 (735)
                      ..|.+.++|.. ..|.++++|.       +..++|.|.|++||+|..     |+ ++++|..   .+|.  ++|.|+.++
T Consensus        47 ~~c~~~~~C~~-~~C~~~g~C~~~~~~~~~~~~~~~C~C~~G~~G~~-----C~~~i~~C~~---~~C~~~~~C~~~~g~  117 (143)
T 4d90_A           47 EEPTSAGPCTP-NPCHNGGTCEISEAYRGDTFIGYVCKCPRGFNGIH-----CQHNINECEV---EPCKNGGICTDLVAN  117 (143)
T ss_dssp             TSCCCCCTTSS-CCCCTTCEEEECCCEETTEECCEEEECCTTEESTT-----SCEECCTTTT---CCSCTTCEEEEETTE
T ss_pred             cccccCCcCCC-CCCCCCCEecCCCccccCCCCCeEeECcCCCcCCC-----cccCCCcCCC---CCCCCCCEeECCCCC
Confidence            35667777854 4588888887       566799999999998854     87 9999973   4565  799999999


Q ss_pred             cceeccCCCCCCCC
Q 004702          303 YTCRCRKGFHGDGR  316 (735)
Q Consensus       303 y~C~c~~g~~~~~~  316 (735)
                      |.|.|++||+|+..
T Consensus       118 ~~C~C~~G~~G~~c  131 (143)
T 4d90_A          118 YSCECPGEFMGRNC  131 (143)
T ss_dssp             EEEECCTTCBSTTS
T ss_pred             eEeECCCCCccCCc
Confidence            99999999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.35  E-value=2.5e-06  Score=89.09  Aligned_cols=135  Identities=18%  Similarity=0.180  Sum_probs=97.4

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCC---ceEEEceEEe-ecCceeEEEEecCCC
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR---NVVRLLGCCL-ETQVPLLVYEFVGNG  482 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lV~E~~~~g  482 (735)
                      +.++.|....||+.    +..+++|+..  .......+..|+.+|..+.+.   .+.+++.+.. ..+..++|||+++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            35788888899987    4568888743  334456788999999999753   3566666664 445678999999998


Q ss_pred             chhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 004702          483 TLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET---------------------------------------------  517 (735)
Q Consensus       483 sL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------------------  517 (735)
                      +|.+...  ..++...+..++.++++.|+.||+..                                             
T Consensus        99 ~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  176 (306)
T 3tdw_A           99 ILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF  176 (306)
T ss_dssp             ECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred             ECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence            8876432  23556666667777777777777532                                             


Q ss_pred             ------------CCCeeecCCCCCcEEEcC---CCC-eEEeeccCCcc
Q 004702          518 ------------NVPIIHRDVKSANILLDE---NCT-PKVSDFGASKL  549 (735)
Q Consensus       518 ------------~~~ivH~Dlk~~NILl~~---~~~-~kl~DFGls~~  549 (735)
                                  ...++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                        223699999999999987   455 48999998764

>2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A*

Probab=98.29  E-value=3.1e-07  Score=83.54  Aligned_cols=73  Identities=27%  Similarity=0.742  Sum_probs=60.5

Q ss_pred             ccc-cccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCcc-ccCCccCCCCCCCC--CcCCCCCCccceeccC
Q 004702          234 TCE-EAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCR-DVNECEDPSRNNCT--HICDNIPGSYTCRCRK  309 (735)
Q Consensus       234 ~C~-~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~-di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~  309 (735)
                      .|+ ++++|.. ..|.++++|.+..++|.|.|++||+|..     |+ ++++|..   .+|.  ++|.++.++|.|.|++
T Consensus        40 ~C~~~~~~C~~-~~C~~~~~C~~~~g~~~C~C~~G~~G~~-----C~~~~~~C~~---~~C~~~g~C~~~~g~~~C~C~~  110 (135)
T 2vj3_A           40 RCEIDVNECVS-NPCQNDATCLDQIGEFQCICMPGYEGVH-----CEVNTDECAS---SPCLHNGRCLDKINEFQCECPT  110 (135)
T ss_dssp             TSCEECCTTTT-CCCCSSCEEEECSSCEEEECCTTEESSS-----SCEECCTTTT---CCSTTTCEEEECSSCEEEECCT
T ss_pred             cccccCccCCC-CCCCCCCEEeCCCCCceeeCCCCCcCCc-----ceecCCcccC---CCcCCCCEeECCCCCeEEECCC
Confidence            564 5677864 4588888999988999999999999864     75 8999974   4665  6999999999999999


Q ss_pred             CCCCCC
Q 004702          310 GFHGDG  315 (735)
Q Consensus       310 g~~~~~  315 (735)
                      ||+|..
T Consensus       111 G~~G~~  116 (135)
T 2vj3_A          111 GFTGHL  116 (135)
T ss_dssp             TEESSS
T ss_pred             CCcCCc
Confidence            998753

>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A

Probab=98.27  E-value=1e-07  Score=84.51  Aligned_cols=61  Identities=30%  Similarity=0.750  Sum_probs=50.7

Q ss_pred             CCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCCCcCCCCCCccceeccCCCCCCCC
Q 004702          251 KDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       251 ~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      ++|.+ .++|.|.|++||++++  ...|+|||||...  .+|.++|.|++|+|.|.|++||.+.+.
T Consensus        53 ~~C~~-~~~y~C~C~~Gy~~~~--g~~C~dideC~~~--~~C~~~C~n~~g~y~C~C~~G~~g~~~  113 (118)
T 1dx5_I           53 ADCDP-NTQASCECPEGYILDD--GFICTDIDECENG--GFCSGVCHNLPGTFECICGPDSALAGQ  113 (118)
T ss_dssp             CEECT-TSTTCEECCTTEEEET--TTEEEECCHHHHC--SSCSSEEEECSSSEEEEECSSSSCEEE
T ss_pred             CcccC-CCCeEeECCCCccCCC--CCccccccccCCC--CCCcCeEEeCCCCEEEECCCCCccCCC
Confidence            35666 4789999999999764  4569999999863  678899999999999999999987653

>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens}

Probab=98.25  E-value=1e-07  Score=88.21  Aligned_cols=39  Identities=36%  Similarity=0.857  Sum_probs=31.7

Q ss_pred             CccccCCccCCCCCCCC-CcCCCCCCccceeccCCCCCCCC
Q 004702          277 GCRDVNECEDPSRNNCT-HICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       277 gC~di~eC~~~~~~~c~-~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      .|+|||||... ..+|. ++|+|++|+|.|.|++||.++..
T Consensus       103 ~C~dideC~~~-~~~C~~g~C~n~~g~y~C~C~~Gy~g~~~  142 (147)
T 2w86_A          103 QCEDIDECEVF-PGVCKNGLCVNTRGSFKCQCPSGMTLDAT  142 (147)
T ss_dssp             EEEECCHHHHS-TTCSSSSEEEEETTEEEEECCTTCCBCTT
T ss_pred             ccCccccccCC-CCCCCCCEEECCCCCEEeeCCCCCccCCC
Confidence            47889999742 35677 59999999999999999998753

>1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A*

Probab=98.25  E-value=4.3e-07  Score=102.36  Aligned_cols=74  Identities=26%  Similarity=0.633  Sum_probs=59.4

Q ss_pred             cccccCCCCCCCCCCCccCCCCc-cee-eCCCCCCCCCCCCCCccccCCccCCCCCCCCC-----cCCCCCCcccee-cc
Q 004702          237 EAKICGLNASCDTPKDNTSTSSG-YRC-KCNKGYEGNPYLSDGCRDVNECEDPSRNNCTH-----ICDNIPGSYTCR-CR  308 (735)
Q Consensus       237 ~~~~C~~~~~C~~~~~c~~~~~~-y~C-~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~-----~C~n~~g~y~C~-c~  308 (735)
                      ++++|. ...|.++++|.++.++ |+| .|++||+|+.   ..|++|+||.. +...|..     +|.|+.++|.|. |+
T Consensus         2 DIDeC~-~nPC~~gg~C~n~~~Gsy~C~~C~~GytGdg---~~CeDiDEC~~-~p~~C~~gg~~~~CvNt~gsY~C~~C~   76 (634)
T 1yo8_A            2 DPDGCL-SNPCFPGAQCSSFPDGSWSCGFCPVGFLGNG---THCEDLDECAL-VPDICFSTSKVPRCVNTQPGFHCLPCP   76 (634)
T ss_dssp             --CGGG-GCCSCTTCCEEECTTSCEEECCCCTTBCSCS---SSCCBCCTTTT-SCCCSCCCSSSCCEEECSSSEEECCCC
T ss_pred             cccccC-CCCCCCCCEEecCCCCCeECCcCCCccCCCC---CCccccccccC-CCCcccCCccccceeeccCceecccCC
Confidence            456785 4569998999988765 999 9999999965   34999999974 3345873     899999999999 99


Q ss_pred             CCCCCCC
Q 004702          309 KGFHGDG  315 (735)
Q Consensus       309 ~g~~~~~  315 (735)
                      +||.+..
T Consensus        77 ~Gy~G~~   83 (634)
T 1yo8_A           77 PRYRGNQ   83 (634)
T ss_dssp             TTEEECC
T ss_pred             CCcccCc
Confidence            9998765

>2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A

Probab=98.24  E-value=2.2e-07  Score=85.46  Aligned_cols=68  Identities=29%  Similarity=0.672  Sum_probs=52.3

Q ss_pred             CCCCCCCCccCCCCcceeeCCCCCCCCCC----CCCCccccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCCC
Q 004702          245 ASCDTPKDNTSTSSGYRCKCNKGYEGNPY----LSDGCRDVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       245 ~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y----~~~gC~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      ..|.++++|.+   .|.|.|++||+|+.+    ....|+|||||......+|.  ++|.|++++|.|.|++||.+..
T Consensus         7 ~~C~~~~~C~~---~~~C~C~~G~~g~~~~~~~~~~~C~dideC~~~~~~~C~~~~~C~n~~g~y~C~C~~Gy~g~~   80 (143)
T 2bou_A            7 RWCPQDSSCVN---ATACRCNPGFSSFSEIITTPMETCDDINECATLSKVSCGKFSDCWNTEGSYDCVCSPGYEPVS   80 (143)
T ss_dssp             TTCCTTEEESS---SSCEEECTTEECSSSSBCSTTCCCEECCGGGC----CCCTTEEEEECSSCEEEEECTTEEETT
T ss_pred             CcCCCCCEEcC---CCEEeCCCCCcCccccccCCCCcCCccccccCCCCCCCCCCCEEEcCCCCeEeECCCCcccCc
Confidence            44777677775   399999999999742    23579999999875444786  6999999999999999998763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.22  E-value=7.3e-06  Score=83.72  Aligned_cols=134  Identities=18%  Similarity=0.191  Sum_probs=96.4

Q ss_pred             ccccCcE-EEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEecCCCchh
Q 004702          409 IGCGGSG-NVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFVGNGTLF  485 (735)
Q Consensus       409 lG~G~~g-~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gsL~  485 (735)
                      +..|..+ .||+.... ++..+++|+...   ....++..|..+|+.+. +--+.++++++.+.+..++|||++++.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            3445444 68987754 456788888653   23556788999998885 334678888888889999999999998887


Q ss_pred             HHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------------
Q 004702          486 EHIHKKGNLSWERRLRITAETAGVLSYLHSET------------------------------------------------  517 (735)
Q Consensus       486 ~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~------------------------------------------------  517 (735)
                      +.....    ......+..++++.|+-||+..                                                
T Consensus       109 ~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  184 (272)
T 4gkh_A          109 QVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH  184 (272)
T ss_dssp             HHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred             ccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence            765432    2233456667777777777521                                                


Q ss_pred             -------CCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          518 -------NVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       518 -------~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                             .+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          185 KLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                   11278999999999999887778999998763

>1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A

Probab=98.20  E-value=1.5e-06  Score=101.31  Aligned_cols=74  Identities=31%  Similarity=0.822  Sum_probs=60.3

Q ss_pred             cccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCCCcCCCCCCccceeccCCCCCCC
Q 004702          237 EAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       237 ~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      +.++|.. ++.|..  .|.++.++|.|.|++||++.  ....|+|||||..  ..+|.+.|.|++|+|.|.|++||.+..
T Consensus       293 ~~~eC~~~~~~C~~--~C~~~~~~~~C~C~~G~~~~--~~~~C~dideC~~--~~~C~~~C~n~~g~y~C~C~~G~~~~~  366 (699)
T 1n7d_A          293 GTNECLDNNGGCSH--VCNDLKIGYECLCPDGFQLV--AQRRCEDIDECQD--PDTCSQLCVNLEGGYKCQCEEGFQLDP  366 (699)
T ss_dssp             CCCCTTSSTTTSCT--TCCCCTTCCCCCCCSSSCCC--SSSCCCCCCCCSS--SSSCTTTCCBCSSCBCCCCCSSCBCCS
T ss_pred             ccccccccccCcCC--CcccCCCCcEEeCCCCeEcC--CCCcccCccccCC--CCccccccccCCCCeeeeeecccccCC
Confidence            3456765 455753  78888899999999999982  3457999999974  367999999999999999999998764


Q ss_pred             C
Q 004702          316 R  316 (735)
Q Consensus       316 ~  316 (735)
                      .
T Consensus       367 ~  367 (699)
T 1n7d_A          367 H  367 (699)
T ss_dssp             S
T ss_pred             C
Confidence            3

>1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A

Probab=98.18  E-value=1.4e-07  Score=90.93  Aligned_cols=77  Identities=29%  Similarity=0.711  Sum_probs=62.4

Q ss_pred             ccccccccCCCCCCCCCCCcc----CCCCcceeeCCCCCCCCCCCCCCcccc--CCccCCCCCCC---CCcCCCCCCccc
Q 004702          234 TCEEAKICGLNASCDTPKDNT----STSSGYRCKCNKGYEGNPYLSDGCRDV--NECEDPSRNNC---THICDNIPGSYT  304 (735)
Q Consensus       234 ~C~~~~~C~~~~~C~~~~~c~----~~~~~y~C~C~~Gy~gn~y~~~gC~di--~eC~~~~~~~c---~~~C~n~~g~y~  304 (735)
                      .|. +++|..+ .|.++++|.    +..++|+|.|++||+|++.....|+++  ++|..    +|   .++|.|++|+|.
T Consensus        88 ~C~-~d~C~~~-~C~~~g~C~~~~~~~~g~~~C~C~~Gy~g~~~~~~~C~~~~~~~C~~----~C~~~~~~C~n~~g~y~  161 (186)
T 1z1y_A           88 TCV-LDVCQYX-NCGESGECIVEYLSEIQSAGCSCAIGXVPNPEDEXXCTXTGETACQL----XCNTDNEVCXNVEGVYX  161 (186)
T ss_dssp             EEE-EGGGTTC-CCCTTEEEEEEEETTEEEEEEEECTEEEEETTTTTEEEEEECCCCCC----CCCTTTEEEEEETTEEE
T ss_pred             CCC-CCcCcCC-CCCCCCEEeeCCcCCCCCceEECCCCCcccCCCCCcceEcCCCcccc----cccccCcceecCCCCee
Confidence            455 5678654 488888888    777899999999999976555679986  89973    67   479999999999


Q ss_pred             eeccCCCCCCCC
Q 004702          305 CRCRKGFHGDGR  316 (735)
Q Consensus       305 C~c~~g~~~~~~  316 (735)
                      |.|++||.++..
T Consensus       162 C~C~~G~~g~~~  173 (186)
T 1z1y_A          162 CQCMEGFTFDXE  173 (186)
T ss_dssp             EEECTTCEEETT
T ss_pred             eECCCCCccCcc
Confidence            999999988754

>3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens}

Probab=98.13  E-value=1.2e-06  Score=103.04  Aligned_cols=71  Identities=32%  Similarity=0.860  Sum_probs=57.2

Q ss_pred             cccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCCCcCCCCCCccceeccCCCCCCC
Q 004702          239 KICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       239 ~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      ++|.. ++.|.+  .|.++.++|.|.|++||++  .....|+|||||..  ...|.+.|.|++|+|.|.|++||.+.+
T Consensus       313 ~~C~~~~~~C~~--~C~~~~~~y~C~C~~Gy~l--~~g~~C~dideC~~--~~~C~~~C~n~~gsy~C~C~~Gy~l~~  384 (791)
T 3m0c_C          313 NECLDNNGGCSH--VCNDLKIGYECLCPDGFQL--VAQRRCEDIDECQD--PDTCSQLCVNLEGGYKCQCEEGFQLDP  384 (791)
T ss_dssp             CSTTTGGGGCSS--EEEECSBSEEEECCTTCEE--ETTTEEECCCCCSS--SSSCTTTCCBCSSCBCCCCCSSEECCS
T ss_pred             ccccccccCccc--cccCCCCCcccCCCCCCcc--CCCCccccCcccCC--CCCCCCeeecCCCCceeecCCCCEeCC
Confidence            45544 344543  7888889999999999986  23456999999984  468999999999999999999998754

>1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A

Probab=98.13  E-value=1.6e-07  Score=90.69  Aligned_cols=81  Identities=25%  Similarity=0.528  Sum_probs=64.6

Q ss_pred             eeeccccccccccccCC---CCCCCCCCCccCCC-----CcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCC--CcC
Q 004702          227 WEIITDKTCEEAKICGL---NASCDTPKDNTSTS-----SGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCT--HIC  296 (735)
Q Consensus       227 w~~~~~~~C~~~~~C~~---~~~C~~~~~c~~~~-----~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~--~~C  296 (735)
                      |...+...|+++++|..   ...|.++++|.+..     ++|.|.|++||+|+..   .|+ +++|..   .+|.  +.|
T Consensus        33 ~~g~~~~~C~~id~C~~~~~~~~C~~~~~C~~~~~~~~~g~y~C~C~~G~~g~~~---~C~-~d~C~~---~~C~~~g~C  105 (186)
T 1z1y_A           33 LVHLSENTCEEXNECXXETLGXACGEFGQCIENPDPAQVNMYXCGCIEGYTLXED---TCV-LDVCQY---XNCGESGEC  105 (186)
T ss_dssp             EEEEETTEEEECCCCSGGGTTSEEETTEEEEECSSTTSSCSEEEEECTTEEEETT---EEE-EGGGTT---CCCCTTEEE
T ss_pred             CccCCCCccCCCCcccCCCCCCCCCCCCEeecCCCCcCCCCEECCCCCCCccCCC---CCC-CCcCcC---CCCCCCCEE
Confidence            43333457999999974   35698888999888     8999999999999763   366 899974   4576  688


Q ss_pred             C----CCCCccceeccCCCCCC
Q 004702          297 D----NIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       297 ~----n~~g~y~C~c~~g~~~~  314 (735)
                      .    |++++|.|.|++||.++
T Consensus       106 ~~~~~~~~g~~~C~C~~Gy~g~  127 (186)
T 1z1y_A          106 IVEYLSEIQSAGCSCAIGXVPN  127 (186)
T ss_dssp             EEEEETTEEEEEEEECTEEEEE
T ss_pred             eeCCcCCCCCceEECCCCCccc
Confidence            8    99999999999999983

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.09  E-value=2.1e-06  Score=91.74  Aligned_cols=80  Identities=9%  Similarity=0.025  Sum_probs=53.6

Q ss_pred             ccc-cccCcEEEEEEEcC-------CCcEEEEEEeeccC---hhHHHHHHHHHHHHHhcCC---CceEEEceEEeec---
Q 004702          407 DVI-GCGGSGNVYKGFLP-------DRTPVAVKKSKFVD---QAKIDEFINELVVVLQINR---RNVVRLLGCCLET---  469 (735)
Q Consensus       407 ~~l-G~G~~g~Vy~g~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~---  469 (735)
                      +.| +.|....+|+....       ++..+++|+.....   ......+..|+.+|+.+..   -.+.+++++..+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            356 78888999988754       25678888754321   0012456778888887743   3467788777655   


Q ss_pred             CceeEEEEecCCCchhH
Q 004702          470 QVPLLVYEFVGNGTLFE  486 (735)
Q Consensus       470 ~~~~lV~E~~~~gsL~~  486 (735)
                      +..++||||+++..|.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999998876543

>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A

Probab=97.92  E-value=9.1e-07  Score=83.22  Aligned_cols=73  Identities=26%  Similarity=0.515  Sum_probs=54.6

Q ss_pred             cccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCC--ccCCCCCCC----CCcCCCCCC----cccee
Q 004702          237 EAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNE--CEDPSRNNC----THICDNIPG----SYTCR  306 (735)
Q Consensus       237 ~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~e--C~~~~~~~c----~~~C~n~~g----~y~C~  306 (735)
                      ++++|.....|. +++|.++.++|+|.|++||++++ ....|+|+++  |... ..+|    .+.|.|+.+    +|.|.
T Consensus         2 dideC~~~~~C~-~~~C~n~~gsy~C~C~~Gy~~~~-~g~~C~d~~~~~C~~~-~~~c~~~~~~~C~~~~~~~~~~~~C~   78 (162)
T 1uzk_A            2 DVNECLDPTTCI-SGNCVNTPGSYICDCPPDFELNP-TRVGCVDTRSGNCYLD-IRPRGDNGDTACSNEIGVGVSKASCC   78 (162)
T ss_dssp             CCCGGGSTTSSB-TSEEEEETTEEEEECCTTCEECT-TSSBEECCCCEEEEEE-C----------CEEEEEEEECHHHHH
T ss_pred             ccccCCCCCCCC-CCEeECCCCCEEEeCCCCCeECC-CCCcccCCCCCcccCC-CcccCCCCCCcccCCcCCcccCceee
Confidence            567887545686 57999999999999999999765 3456999988  8642 1233    468999887    89999


Q ss_pred             ccCCCC
Q 004702          307 CRKGFH  312 (735)
Q Consensus       307 c~~g~~  312 (735)
                      |+.||.
T Consensus        79 C~~G~~   84 (162)
T 1uzk_A           79 CSLGKA   84 (162)
T ss_dssp             TTTCCE
T ss_pred             CCCCCC
Confidence            999997

>1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A

Probab=97.92  E-value=5.4e-07  Score=84.77  Aligned_cols=56  Identities=32%  Similarity=0.705  Sum_probs=42.6

Q ss_pred             CcceeeCCC--CCCCCCCCCCCccccCCccCCCCCCCC-CcCCCCCCccceeccCCCCCCC
Q 004702          258 SGYRCKCNK--GYEGNPYLSDGCRDVNECEDPSRNNCT-HICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       258 ~~y~C~C~~--Gy~gn~y~~~gC~di~eC~~~~~~~c~-~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      ++|+|.|++  ||+|++. ...|+|||||... ..+|. ++|.|++|+|.|.|++||.++.
T Consensus        98 ~~y~C~C~~g~G~~~~~~-~~~c~dideC~~~-~~~C~~g~C~n~~gsy~C~C~~Gy~g~~  156 (162)
T 1uzk_A           98 SEYKILCPGGEGFRPNPI-TVILEDIDECQEL-PGLCQGGKCINTFGSFQCRCPTGYYLNE  156 (162)
T ss_dssp             HHHHHHCTTCTTEEECTT-TCCEEECCHHHHC-GGGGBTSEEEECSSCEEEECCTTCCBCT
T ss_pred             CCceeECCCCCCcccCCC-CCccCccccccCC-CCCcCCCEeEcCCCCEEeeCCCCccCCC
Confidence            456666665  6666652 3468999999752 35687 6999999999999999998864

>1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A

Probab=97.89  E-value=1.3e-06  Score=77.30  Aligned_cols=68  Identities=24%  Similarity=0.615  Sum_probs=51.8

Q ss_pred             cccccCCCCCCCCCCCccCC-CCcceeeCCCCCCCCCCCCCCccccCCccCC-CCCCCCCcCCCCCCccceeccCCCCCC
Q 004702          237 EAKICGLNASCDTPKDNTST-SSGYRCKCNKGYEGNPYLSDGCRDVNECEDP-SRNNCTHICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       237 ~~~~C~~~~~C~~~~~c~~~-~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~-~~~~c~~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      ++++|. ...|.+  +|.+. .++|+|.|++||+|...      ++++|... ...+|.+.|.+ .++|.|.|++||.++
T Consensus         3 dideC~-~~pC~~--~C~~~~~g~y~C~C~~Gy~g~~~------~~~~C~~~C~~~~C~~~C~~-~~~y~C~C~~Gy~~~   72 (118)
T 1dx5_I            3 PVDPCF-RANCEY--QCQPLDQTSYLCVCAEGFAPIPH------EPHRCQMFCNQTACPADCDP-NTQASCECPEGYILD   72 (118)
T ss_dssp             CCCGGG-GCCCSS--EEEECSSSCEEEECCTTEEEETT------EEEEEEECCCSSEEECEECT-TSTTCEECCTTEEEE
T ss_pred             ccccCC-CCCCCC--CCCCCCCCCEEeECCCCccccCC------CCCccccccCCCCCCCcccC-CCCeEeECCCCccCC
Confidence            456774 456875  88888 88999999999999762      45555421 13578889999 599999999999854

>4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens}

Probab=97.89  E-value=5.2e-06  Score=76.16  Aligned_cols=72  Identities=22%  Similarity=0.621  Sum_probs=49.7

Q ss_pred             ccCCCCCCCCCCCccCCC--CcceeeCCCCCCCCCCC--------CCCccccCCccCCCCCCCC--CcCC-------CCC
Q 004702          240 ICGLNASCDTPKDNTSTS--SGYRCKCNKGYEGNPYL--------SDGCRDVNECEDPSRNNCT--HICD-------NIP  300 (735)
Q Consensus       240 ~C~~~~~C~~~~~c~~~~--~~y~C~C~~Gy~gn~y~--------~~gC~di~eC~~~~~~~c~--~~C~-------n~~  300 (735)
                      +|.. ..|.++++|.+..  ++|.|.|++||+|....        ...|.++++|..   .+|.  ++|.       |++
T Consensus         2 ~C~~-~pC~~~g~C~~~~~~g~~~C~C~~G~~G~~C~~~~~~~~~~~~c~~~~~C~~---~~C~~~g~C~~~~~~~~~~~   77 (143)
T 4d90_A            2 ICDP-NPCENGGICLPGLADGSFSCECPDGFTDPNCSSVVEVASDEEEPTSAGPCTP---NPCHNGGTCEISEAYRGDTF   77 (143)
T ss_dssp             -CCS-CCCGGGCEEEC-----CCEEECCTTCCTTTTCSCCCCTTTTTSCCCCCTTSS---CCCCTTCEEEECCCEETTEE
T ss_pred             cCCC-CcCCCCCEeeCCCCCCCEEeECCCCCCCCCCccCccccccccccccCCcCCC---CCCCCCCEecCCCccccCCC
Confidence            4543 3477777777654  58999999999997632        123456677753   4565  6898       788


Q ss_pred             CccceeccCCCCCCC
Q 004702          301 GSYTCRCRKGFHGDG  315 (735)
Q Consensus       301 g~y~C~c~~g~~~~~  315 (735)
                      ++|.|.|++||.+..
T Consensus        78 ~~~~C~C~~G~~G~~   92 (143)
T 4d90_A           78 IGYVCKCPRGFNGIH   92 (143)
T ss_dssp             CCEEEECCTTEESTT
T ss_pred             CCeEeECcCCCcCCC
Confidence            999999999998653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.84  E-value=4.2e-05  Score=82.84  Aligned_cols=74  Identities=18%  Similarity=0.180  Sum_probs=48.4

Q ss_pred             ccccccCcEEEEEEEcC-CCcEEEEEEeeccCh-------hHHHHHHHHHHHHHhcCC--C-ceEEEceEEeecCceeEE
Q 004702          407 DVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQ-------AKIDEFINELVVVLQINR--R-NVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~g~~~~~~~~~lV  475 (735)
                      +.||.|..+.||++... ++..++||.......       ...+.+..|.++|+.+..  + .+.+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            46899999999999754 467899997543211       123456778888887742  3 34455544  44556899


Q ss_pred             EEecCCC
Q 004702          476 YEFVGNG  482 (735)
Q Consensus       476 ~E~~~~g  482 (735)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.76  E-value=0.00013  Score=76.85  Aligned_cols=136  Identities=17%  Similarity=0.194  Sum_probs=77.5

Q ss_pred             cccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCC--CceEEEce------EEeecCceeEEEEec
Q 004702          408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR--RNVVRLLG------CCLETQVPLLVYEFV  479 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g------~~~~~~~~~lV~E~~  479 (735)
                      .|+.|....||+....++ .+++|+... ..   .++..|+.++..|..  -.+.+++.      +....+..++||||+
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            466677889999887655 488898764 22   223344555544421  12333432      123456778999999


Q ss_pred             CCCchh--------------HHhhhc-C----C---------CCHHHH-------------------------------H
Q 004702          480 GNGTLF--------------EHIHKK-G----N---------LSWERR-------------------------------L  500 (735)
Q Consensus       480 ~~gsL~--------------~~l~~~-~----~---------l~~~~~-------------------------------~  500 (735)
                      +|..+.              ..+|.. .    +         ..|...                               .
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            886542              111211 0    1         122211                               0


Q ss_pred             HHHHHHHHHHHHHHh--------c--CCCCeeecCCCCCcEEEcCCCCeEEeeccCCc
Q 004702          501 RITAETAGVLSYLHS--------E--TNVPIIHRDVKSANILLDENCTPKVSDFGASK  548 (735)
Q Consensus       501 ~i~~qia~~L~yLH~--------~--~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~  548 (735)
                      .+..++.+++++|+.        .  ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            111224446667763        1  23459999999999999888899999999775

>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A

Probab=97.63  E-value=1.9e-05  Score=66.14  Aligned_cols=51  Identities=27%  Similarity=0.769  Sum_probs=42.2

Q ss_pred             cCCCCcceeeCCCCCCCCCCCCCCcc--ccCCccCCCCCCCC--CcCCCCC--CccceeccCCCCCC
Q 004702          254 TSTSSGYRCKCNKGYEGNPYLSDGCR--DVNECEDPSRNNCT--HICDNIP--GSYTCRCRKGFHGD  314 (735)
Q Consensus       254 ~~~~~~y~C~C~~Gy~gn~y~~~gC~--di~eC~~~~~~~c~--~~C~n~~--g~y~C~c~~g~~~~  314 (735)
                      .+..++|.|.|++||+       .|+  ++++|..   .+|.  ++|.+.+  ++|.|.|++||.|.
T Consensus        26 ~n~~~~y~C~C~~G~~-------~C~~~~~~~C~~---~pC~ngg~C~~~~~~~~~~C~C~~G~~G~   82 (91)
T 1tpg_A           26 LRSNRVEYCWCNSGRA-------QCHSVPVKSCSE---PRCFNGGTCQQALYFSDFVCQCPEGFAGK   82 (91)
T ss_dssp             SSSSCEEEEECSSSCC-------BCCEECEEECSS---CCSCTTCEEEEESSSSCEEEECCTTCBSS
T ss_pred             ccCCCCcEeECCCCCc-------ccccCcCCcccC---CCCCCCCEeecCCCCCCeEeECCCCCcCC
Confidence            3456799999999996       486  7999974   5675  6899988  99999999999864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.55  E-value=0.00032  Score=72.22  Aligned_cols=74  Identities=23%  Similarity=0.152  Sum_probs=54.0

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCC---ceEEEceEEeecCceeEEEEecCCCc
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR---NVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      +.+|.|..+.||+..+.||+.|++|+...........|..|+..|+.|...   -+.+++++    +..++||||+..+.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence            468999999999999999999999986544333344677899999888532   24455544    23479999997664


Q ss_pred             h
Q 004702          484 L  484 (735)
Q Consensus       484 L  484 (735)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1

Probab=97.50  E-value=2.7e-05  Score=57.94  Aligned_cols=37  Identities=38%  Similarity=0.952  Sum_probs=31.3

Q ss_pred             cccCCccCCC-------CCCCCCcCCCCCCccceeccCCCCCCC
Q 004702          279 RDVNECEDPS-------RNNCTHICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       279 ~di~eC~~~~-------~~~c~~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      +|||||....       ..+|.+.|.|++|+|.|.|+.||.+..
T Consensus         2 ~DidEC~~~~~~~~~~~~~~C~~~C~n~~Gsy~C~C~~Gy~~~~   45 (53)
T 1apq_A            2 VDLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQE   45 (53)
T ss_dssp             CSCCTTTCSTTTCCCSSSCTTSSEEEEETTEEEEECSTTCEECT
T ss_pred             CccccccCcccccccccCCCCCCEeECCCCCeEEECCCCCeECC
Confidence            5899997642       367999999999999999999998754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.49  E-value=0.00068  Score=70.54  Aligned_cols=134  Identities=16%  Similarity=0.126  Sum_probs=89.3

Q ss_pred             ccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC---CCceEEEceEEeecCceeEEEEecCCCc
Q 004702          407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN---RRNVVRLLGCCLETQVPLLVYEFVGNGT  483 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~E~~~~gs  483 (735)
                      +.|+.|....+|+... ++..+++|.....   ....|..|+..|+.|.   ...+++++.+....+..++||||+++..
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            3688999999999886 4567888886532   3567888999888884   3568888888887788999999999875


Q ss_pred             hhH-----------HhhhcCC----------------------CCHHHHH---HHHH----------------HHHHH-H
Q 004702          484 LFE-----------HIHKKGN----------------------LSWERRL---RITA----------------ETAGV-L  510 (735)
Q Consensus       484 L~~-----------~l~~~~~----------------------l~~~~~~---~i~~----------------qia~~-L  510 (735)
                      +..           .||....                      -+|....   ++..                ++.+. .
T Consensus       118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~  197 (312)
T 3jr1_A          118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA  197 (312)
T ss_dssp             CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence            421           2222110                      1354321   1111                11111 2


Q ss_pred             HHHHh-cCCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          511 SYLHS-ETNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       511 ~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                      ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            23432 2245699999999999999887 8888873

>2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ...

Probab=97.42  E-value=3.4e-05  Score=57.77  Aligned_cols=45  Identities=24%  Similarity=0.532  Sum_probs=35.3

Q ss_pred             cccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccC
Q 004702          239 KICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECED  286 (735)
Q Consensus       239 ~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~  286 (735)
                      ++|.. ++.|.+  .|.++.++|.|.|++||...+ ....|+|++||.-
T Consensus         2 dEC~~~~~~C~~--~C~nt~Gsy~C~C~~Gy~L~~-d~~~C~didec~c   47 (55)
T 2jkh_L            2 KLCSLDNGDCDQ--FCHEEQNSVVCSCARGYTLAD-NGKACIPTGPYPC   47 (55)
T ss_dssp             CCTTTGGGGCSS--EEEEETTEEEEECCTTEEECT-TSSCEEESSSSCT
T ss_pred             ccccCCCCCcCc--EeEcCCCCeEEeCCCCCEECC-CCCeeccCccccC
Confidence            46755 566865  788889999999999998765 3456999999853

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.39  E-value=0.00076  Score=73.47  Aligned_cols=79  Identities=14%  Similarity=0.111  Sum_probs=47.2

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCC---CCCccccchhHHHHHHHHH
Q 004702          519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC---KLTDKSDVYSFGVVLVELL  595 (735)
Q Consensus       519 ~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDVyS~Gvvl~ell  595 (735)
                      ..++|+|+++.|||++.++ ++|+||+.+..-.....-......-...|.+|+.....   .-....++......+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            4499999999999998876 99999998875431110000000011345666554321   1122345567788888777


Q ss_pred             hCC
Q 004702          596 TGK  598 (735)
Q Consensus       596 tG~  598 (735)
                      +++
T Consensus       311 ~~~  313 (420)
T 2pyw_A          311 NKR  313 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            653

>2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A

Probab=97.39  E-value=1.9e-05  Score=60.22  Aligned_cols=47  Identities=28%  Similarity=0.563  Sum_probs=37.9

Q ss_pred             ccccccccCCCCCCCCC--CCccCCCCcceeeCCCCCC-CCCCCCCCccccCCccC
Q 004702          234 TCEEAKICGLNASCDTP--KDNTSTSSGYRCKCNKGYE-GNPYLSDGCRDVNECED  286 (735)
Q Consensus       234 ~C~~~~~C~~~~~C~~~--~~c~~~~~~y~C~C~~Gy~-gn~y~~~gC~di~eC~~  286 (735)
                      .|.+.++|.+ .+|.++  ++|.+..++|.|.|++||+ |..     |++.++|..
T Consensus         7 ~~~~~d~C~s-nPC~nga~gtC~~~~g~y~C~C~~Gy~~G~~-----C~~~~~C~~   56 (61)
T 2k2s_B            7 LSETPAACSS-NPCGPEAAGTCKETNSGYICRCNQGYRISLD-----GTGNVTCIV   56 (61)
T ss_dssp             CTTSCCHHHH-CSSCSSSCCEEEECSSEEEEECCTTEEEEEC-----SSSCEEEEE
T ss_pred             hcCCCCcCcC-CCCcCCCccccccCCCceEeECCCCCccCCC-----CCCCCEecc
Confidence            4677788864 559988  7999999999999999999 865     777777753

>1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L*

Probab=97.28  E-value=6.5e-05  Score=58.95  Aligned_cols=47  Identities=21%  Similarity=0.480  Sum_probs=37.6

Q ss_pred             ccccccCC-CCCCCCCCCccCCCC-cceeeCCCCCCCCCCCCCCccccCCcc
Q 004702          236 EEAKICGL-NASCDTPKDNTSTSS-GYRCKCNKGYEGNPYLSDGCRDVNECE  285 (735)
Q Consensus       236 ~~~~~C~~-~~~C~~~~~c~~~~~-~y~C~C~~Gy~gn~y~~~gC~di~eC~  285 (735)
                      .++++|.. |+.|.+  .|.++.+ +|.|.|.+||...+ ....|.|++||.
T Consensus         3 ~d~~eC~~~nggC~h--~C~n~~g~s~~C~C~~Gy~L~~-D~~tC~d~dec~   51 (69)
T 1kli_L            3 DDQLICVNENGGCEQ--YCSDHTGTKRSCRCHEGYSLLA-DGVSCTPTVEYP   51 (69)
T ss_dssp             SCCCCTTSGGGGCSS--EEEEETTTEEEEECCTTEEECT-TSSCEEECSSSC
T ss_pred             cccccccCCCCCcCC--EeEcCCCCCEEEeCCCCCeECC-CCCcccCccccc
Confidence            45678866 677876  6888777 89999999999766 456799999985

>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A

Probab=97.19  E-value=8.3e-05  Score=70.14  Aligned_cols=63  Identities=29%  Similarity=0.806  Sum_probs=48.9

Q ss_pred             cCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCcc-ccCCccCCCCCCCC--CcCCCC-CCccceeccCCCCCC
Q 004702          241 CGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCR-DVNECEDPSRNNCT--HICDNI-PGSYTCRCRKGFHGD  314 (735)
Q Consensus       241 C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~-di~eC~~~~~~~c~--~~C~n~-~g~y~C~c~~g~~~~  314 (735)
                      |..+..|.++ +|.   ++|.|.|.+||+|..     |+ ++++|..  ..+|.  ++|.|+ +++|.|.|++||.|.
T Consensus        99 C~~~~~C~~g-~C~---~~~~C~C~~G~~G~~-----C~~~~~~C~~--~~~C~~~g~C~~~~~~~~~C~C~~G~~G~  165 (169)
T 2vj2_A           99 CIPHPGCVHG-ICN---EPWQCLCETNWGGQL-----CDKDLNYCGT--HQPCLNGGTCSNTGPDKYQCSCPEGYSGP  165 (169)
T ss_dssp             ECCCTTCSSE-ECS---STTCCEECTTEETTT-----TCEESCHHHH--TCCCCTTCEEEECSTTCEEEECCTTCCST
T ss_pred             CCCCCCCCCC-CcC---CCCEEeCCCCCCCCc-----ccCCCCCCCC--CCCCCCCCEEcCCCCCCcEeECCCCCcCc
Confidence            5444446654 666   579999999999864     87 8999974  24665  689997 899999999999865

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.18  E-value=0.0013  Score=63.52  Aligned_cols=97  Identities=14%  Similarity=0.129  Sum_probs=65.3

Q ss_pred             chhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|.++|... .+|+++++|.++.|.+++|.-+-....  -..+=+.|..|+|..+|.+-+.+ ..+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-------------
Confidence            899999864 789999999999999999877632111  11233457899999999988764 1111             


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHh
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT  596 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt  596 (735)
                      .....+.+||... ...+.+.=|||||++||.-+-
T Consensus        98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ---------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence            0122456888764 356678899999999999886

>1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1

Probab=97.16  E-value=0.00013  Score=53.62  Aligned_cols=39  Identities=28%  Similarity=0.510  Sum_probs=31.0

Q ss_pred             CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCcc
Q 004702          244 NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECE  285 (735)
Q Consensus       244 ~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~  285 (735)
                      ++.|.+  .|.++.++|+|.|++||...+ ....|+|||||.
T Consensus         5 ng~C~~--~C~n~~gs~~C~C~~Gy~L~~-d~~tC~dide~p   43 (51)
T 1kig_L            5 NGGCDQ--FCREERSEVRCSCAHGYVLGD-DSKSCVSTERFP   43 (51)
T ss_dssp             TTSSSS--CCCEETTEECCCCCTTEEECT-TSSCEEECSSSC
T ss_pred             CCCcCC--EeEcCCCCeEEeCCCCcEECC-CCCccccCCccc
Confidence            556765  578888999999999998765 446799999874

>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A

Probab=96.99  E-value=0.00035  Score=48.07  Aligned_cols=35  Identities=23%  Similarity=0.571  Sum_probs=29.0

Q ss_pred             cccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          237 EAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       237 ~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      ++++|.. ..|.++++|.+..++|.|.|++||+|..
T Consensus         2 d~d~C~~-~pC~ngg~C~~~~~~~~C~C~~G~~G~~   36 (39)
T 1edm_B            2 DGDQCES-NPCLNGGSCKDDINSYECWCPFGFEGKN   36 (39)
T ss_dssp             CCCTTTT-CCCCTTCEEEEETTEEEEECCTTCCSTT
T ss_pred             ccccCCC-CCCCCCCEeEcCCCceEeECCCCCcCCc
Confidence            3567764 5699999999888999999999999864

>2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B*

Probab=96.98  E-value=0.00035  Score=52.95  Aligned_cols=48  Identities=17%  Similarity=0.416  Sum_probs=36.7

Q ss_pred             CCCCCCCCCccCCC-CcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCCCcCCCCC
Q 004702          244 NASCDTPKDNTSTS-SGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIP  300 (735)
Q Consensus       244 ~~~C~~~~~c~~~~-~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~~C~n~~  300 (735)
                      ++.|.+  .|.++. ++|.|.|.+||...+ ....|.|+++      .+|.+.|.|..
T Consensus         6 nggC~~--~C~n~~~gs~~C~C~~Gy~L~~-D~~tC~d~~~------~pC~~~c~n~~   54 (59)
T 2wph_E            6 NGRCEQ--FCKNSADNKVVCSCTEGYRLAE-NQKSCEPAVP------FPCGRVSVSQT   54 (59)
T ss_dssp             GGGCSS--EEEECSTTCEEEECCTTEEECT-TSSCEEESSS------SCTTCCCSCCC
T ss_pred             CCCcCC--EeEeCCCCCEEeeCCCCcEECC-CCCcccCCCC------CCCCCcccccc
Confidence            556765  577777 599999999999766 4557988763      67888898854

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.92  E-value=0.0016  Score=71.12  Aligned_cols=71  Identities=17%  Similarity=0.185  Sum_probs=47.4

Q ss_pred             cccccCcEEEEEEEcCC--------CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCce-EEEceEEeecCceeEEEEe
Q 004702          408 VIGCGGSGNVYKGFLPD--------RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNV-VRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~  478 (735)
                      .|+.|-...||+....+        +..+++|+......  .+.+..|..++..+...++ .++++.+..    .+||||
T Consensus        80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            57778889999998653        46788888643211  2455689988888854443 566665432    389999


Q ss_pred             cCCCch
Q 004702          479 VGNGTL  484 (735)
Q Consensus       479 ~~~gsL  484 (735)
                      +++.+|
T Consensus       154 l~G~~l  159 (429)
T 1nw1_A          154 IPSRPL  159 (429)
T ss_dssp             CCEEEC
T ss_pred             eCCccc
Confidence            976444

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.89  E-value=0.0023  Score=66.21  Aligned_cols=71  Identities=14%  Similarity=0.150  Sum_probs=42.1

Q ss_pred             cccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCce-EEEceEEeecCceeEEEEec-CCCc
Q 004702          406 ADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNV-VRLLGCCLETQVPLLVYEFV-GNGT  483 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~-~~gs  483 (735)
                      .+.|+.|....+|+.     ..+++|+....... ..+..+|+.+++.+...++ .++++.  ..+.-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            346788999999998     45888876532111 1122457777766643222 345543  344457999999 5544


Q ss_pred             h
Q 004702          484 L  484 (735)
Q Consensus       484 L  484 (735)
                      |
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.89  E-value=0.0033  Score=65.91  Aligned_cols=31  Identities=32%  Similarity=0.484  Sum_probs=26.9

Q ss_pred             CCeeecCCCCCcEEEcCC----CCeEEeeccCCcc
Q 004702          519 VPIIHRDVKSANILLDEN----CTPKVSDFGASKL  549 (735)
Q Consensus       519 ~~ivH~Dlk~~NILl~~~----~~~kl~DFGls~~  549 (735)
                      ..++|+|+.+.|||++.+    ..+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            459999999999999874    6789999998875

>2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L*

Probab=96.86  E-value=0.00024  Score=52.56  Aligned_cols=39  Identities=21%  Similarity=0.474  Sum_probs=30.7

Q ss_pred             CCCCCCCCCccCCCC-cceeeCCCCCCCCCCCCCCccccCCcc
Q 004702          244 NASCDTPKDNTSTSS-GYRCKCNKGYEGNPYLSDGCRDVNECE  285 (735)
Q Consensus       244 ~~~C~~~~~c~~~~~-~y~C~C~~Gy~gn~y~~~gC~di~eC~  285 (735)
                      ++.|.+  .|.++.+ +|.|.|.+||+..+ ....|+|+|||.
T Consensus         6 nggC~~--~C~n~~ggs~~C~C~~Gy~L~~-Dg~tC~d~dec~   45 (53)
T 2bz6_L            6 NGGCEQ--YCSDHTGTKRSCRCHEGYSLLA-DGVSCTPTVEYP   45 (53)
T ss_dssp             GGGCSS--EEEEETTTEEEEECCTTEEECT-TSSCEEECSSSC
T ss_pred             CCCcCC--EeEcCCCCCEEeeCCCCCEECC-CCCcccCCcccc
Confidence            455765  5777777 79999999999765 456799999985

>3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens}

Probab=96.82  E-value=0.00047  Score=51.19  Aligned_cols=38  Identities=21%  Similarity=0.371  Sum_probs=29.1

Q ss_pred             ccc-cccccCCCCCCCCCCCc-----cCCCCcceeeCCCCCCCCC
Q 004702          234 TCE-EAKICGLNASCDTPKDN-----TSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       234 ~C~-~~~~C~~~~~C~~~~~c-----~~~~~~y~C~C~~Gy~gn~  272 (735)
                      +|. +.++|.+ +.|.++++|     .+...+|+|.|++||+|..
T Consensus         3 ~c~~~~~eC~s-~pC~NgGtC~~~~~~d~~~~y~C~C~~g~~G~~   46 (55)
T 3u7u_G            3 SHLVKCAEKEK-TFCVNGGECFMVKDLSNPSRYLCKCPNEFTGDR   46 (55)
T ss_dssp             CCEEECCSTTT-TTSCTTCEEEEECCC--CCCEEEEECTTEESTT
T ss_pred             CCcccCCCCcC-CCCCCCCCcCCCCccCCCCCEeEeCCCCCcCCC
Confidence            454 4678864 569999999     4567899999999999965

>1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A

Probab=96.78  E-value=0.00068  Score=55.34  Aligned_cols=42  Identities=21%  Similarity=0.745  Sum_probs=35.2

Q ss_pred             cccccccccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCC
Q 004702          231 TDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPY  273 (735)
Q Consensus       231 ~~~~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y  273 (735)
                      ++..|.++++|.....|.+ ++|.+..++|.|.|++||+|++.
T Consensus        37 ~g~~C~dideC~~~~~C~~-~~C~n~~g~y~C~C~~G~~g~~~   78 (82)
T 1emn_A           37 AGNECVDTDECSVGNPCGN-GTCKNVIGGFECTCEEGFEPGPM   78 (82)
T ss_dssp             ETTEEEECCGGGTCCTTSS-SCEEECSSSEEECCSSSSCCCSS
T ss_pred             CCCccCCcccccCCCCCCC-CEeECCCCCEEeECCCCeEeCCC
Confidence            3458999999975567875 58999999999999999999874

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.77  E-value=0.0039  Score=65.12  Aligned_cols=138  Identities=17%  Similarity=0.205  Sum_probs=79.0

Q ss_pred             cccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCC--ceEEEceE-----EeecCceeEEEEecC
Q 004702          408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR--NVVRLLGC-----CLETQVPLLVYEFVG  480 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~-----~~~~~~~~lV~E~~~  480 (735)
                      .|+ |....||+....++..+++|...... ...+.+..|..++..+...  .+++++..     ....+..++|||+++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            455 77789999877677779999876321 1234566688777777422  24444443     122445678999998


Q ss_pred             CCchh----H-------H---hhhc---------CCCCHHHH----HHH---------------HHHHHHHHHHHHhc--
Q 004702          481 NGTLF----E-------H---IHKK---------GNLSWERR----LRI---------------TAETAGVLSYLHSE--  516 (735)
Q Consensus       481 ~gsL~----~-------~---l~~~---------~~l~~~~~----~~i---------------~~qia~~L~yLH~~--  516 (735)
                      +..+.    +       .   +|..         ..+++...    ..+               ...+.+.++.+...  
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            75432    0       1   1110         11222211    001               11111223333321  


Q ss_pred             --CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          517 --TNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       517 --~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                        ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              223489999999999999 4 899999987764

>1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A

Probab=96.74  E-value=0.00098  Score=49.28  Aligned_cols=36  Identities=22%  Similarity=0.467  Sum_probs=29.5

Q ss_pred             cccccCCC--CCCCCCCCcc--CCCCcceeeCCCCCCCCC
Q 004702          237 EAKICGLN--ASCDTPKDNT--STSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       237 ~~~~C~~~--~~C~~~~~c~--~~~~~y~C~C~~Gy~gn~  272 (735)
                      ++++|..+  ..|.++++|.  +..++|.|.|++||+|..
T Consensus         2 ~i~~C~~~~~~pC~ngg~C~~~~~~~~~~C~C~~G~~G~~   41 (53)
T 1egf_A            2 SYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDR   41 (53)
T ss_dssp             EECCCCTTSSCSSCSSCEEEEESSSSCEEEECCTTCCSSS
T ss_pred             CcccCCCCCCCcCCCCcEEEeeCCCCCEEEECCCCCcCCc
Confidence            35677653  5799999998  788899999999999965

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.71  E-value=0.0044  Score=64.54  Aligned_cols=138  Identities=14%  Similarity=0.130  Sum_probs=77.3

Q ss_pred             cccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc--eEEEceE------EeecCceeEEEEec
Q 004702          408 VIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN--VVRLLGC------CLETQVPLLVYEFV  479 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~E~~  479 (735)
                      .|+.|....+|+....++ .+++|.....  ...+++..|+.++..+...+  +.+++..      ....+..++||+|+
T Consensus        29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             ccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            466788889999887666 5788886642  11234456777776664222  3333321      12345678999999


Q ss_pred             CCCchhH--------------Hhhhc-----CC----C---CHHHHHH------------HHHHHHHHHHHHHhc----C
Q 004702          480 GNGTLFE--------------HIHKK-----GN----L---SWERRLR------------ITAETAGVLSYLHSE----T  517 (735)
Q Consensus       480 ~~gsL~~--------------~l~~~-----~~----l---~~~~~~~------------i~~qia~~L~yLH~~----~  517 (735)
                      +|..+..              .+|..     .+    .   .|...+.            +...+.+.++.|+..    .
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            8754321              11211     00    1   1222111            011244456666532    1


Q ss_pred             CCCeeecCCCCCcEEEcCCCCeEEeeccCCc
Q 004702          518 NVPIIHRDVKSANILLDENCTPKVSDFGASK  548 (735)
Q Consensus       518 ~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~  548 (735)
                      ...++|+|+.+.|||++++..+.|+||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            2358999999999999987666899998775

>1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A

Probab=96.69  E-value=0.00018  Score=72.23  Aligned_cols=46  Identities=20%  Similarity=0.544  Sum_probs=37.0

Q ss_pred             cccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCcc
Q 004702          237 EAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECE  285 (735)
Q Consensus       237 ~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~  285 (735)
                      ++++|.. .+.|..++.|.++.++|.|.|++||.||..   .|.|+|+..
T Consensus         4 DiDEC~~~~~~C~~~a~C~Nt~Gsy~C~C~~Gy~GnG~---~C~d~d~Pq   50 (285)
T 1gl4_A            4 AQQTCANNRHQCSVHAECRDYATGFCCRCVANYTGNGR---QCVAEGSPQ   50 (285)
T ss_dssp             ---CHHHHGGGSCTTEEEEECSSCEEEEECTTEEECSS---SEEETTCEE
T ss_pred             cchhccCCCCCCCCCCEeEcCCCCeEEEcCCCCCCCCC---cCCCCCCCc
Confidence            5678875 567998899999999999999999998763   599998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.67  E-value=0.0041  Score=66.46  Aligned_cols=137  Identities=20%  Similarity=0.245  Sum_probs=80.4

Q ss_pred             cccccCcEEEEEEEcCC--------CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc-eEEEceEEeecCceeEEEEe
Q 004702          408 VIGCGGSGNVYKGFLPD--------RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN-VVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E~  478 (735)
                      .|..|-...+|+....+        +..+++|+.... ......+.+|..+++.|...+ ..++++.+.+    .+||||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            45556677889887642        467888885321 123456678999888875322 3556666543    299999


Q ss_pred             cCCCchhHH-----------------hhhc-----CCCC--HHHHHHHHHHHHH-------------------HHHHHH-
Q 004702          479 VGNGTLFEH-----------------IHKK-----GNLS--WERRLRITAETAG-------------------VLSYLH-  514 (735)
Q Consensus       479 ~~~gsL~~~-----------------l~~~-----~~l~--~~~~~~i~~qia~-------------------~L~yLH-  514 (735)
                      +++.+|..-                 ||..     ....  +.++.++..++..                   .+..|. 
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            987655311                 1111     1122  4555555544422                   233332 


Q ss_pred             ---hc-CCCCeeecCCCCCcEEEcCC----CCeEEeeccCCcc
Q 004702          515 ---SE-TNVPIIHRDVKSANILLDEN----CTPKVSDFGASKL  549 (735)
Q Consensus       515 ---~~-~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGls~~  549 (735)
                         .. ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               22 22358999999999999876    7899999988763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.52  E-value=0.0064  Score=66.71  Aligned_cols=73  Identities=12%  Similarity=0.027  Sum_probs=45.9

Q ss_pred             ccccccCcEEEEEEEcCC-CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCce-EEEceEEeecCceeEEEEecCCCch
Q 004702          407 DVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNV-VRLLGCCLETQVPLLVYEFVGNGTL  484 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~gsL  484 (735)
                      +.|+.|-...+|+....+ +..+++|+....... .-+...|..++..|...++ .++++.+.  +  .+||||+++.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            357778889999998765 467888875432111 1112478888988875555 46666652  2  359999987544

>1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L*

Probab=96.48  E-value=0.00041  Score=54.35  Aligned_cols=37  Identities=24%  Similarity=0.639  Sum_probs=31.1

Q ss_pred             ccccCCccCCCCCCCCCcCCCCCC-ccceeccCCCCCCC
Q 004702          278 CRDVNECEDPSRNNCTHICDNIPG-SYTCRCRKGFHGDG  315 (735)
Q Consensus       278 C~di~eC~~~~~~~c~~~C~n~~g-~y~C~c~~g~~~~~  315 (735)
                      ..|+|||...+ ..|++.|.|++| +|.|.|+.||....
T Consensus         2 ~~d~~eC~~~n-ggC~h~C~n~~g~s~~C~C~~Gy~L~~   39 (69)
T 1kli_L            2 KDDQLICVNEN-GGCEQYCSDHTGTKRSCRCHEGYSLLA   39 (69)
T ss_dssp             CSCCCCTTSGG-GGCSSEEEEETTTEEEEECCTTEEECT
T ss_pred             CcccccccCCC-CCcCCEeEcCCCCCEEEeCCCCCeECC
Confidence            36899997543 689999999999 89999999998653

>2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A

Probab=96.42  E-value=0.001  Score=57.28  Aligned_cols=37  Identities=30%  Similarity=0.759  Sum_probs=31.3

Q ss_pred             CCccccCCccCCCCCCCCCcCCCCCCccceeccCCCCCC
Q 004702          276 DGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       276 ~gC~di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      +.| |+|||... ...|.+.|.|++++|.|.|++||.+.
T Consensus        25 ~~C-d~neC~~~-~~~C~~~C~n~~g~y~C~C~~Gy~g~   61 (107)
T 2w2n_E           25 GAM-GTNECLDN-NGGCSYVCNDLKIGYECLCPDGFQLV   61 (107)
T ss_dssp             CCB-SCCGGGTG-GGGCSSEEECCSBSCEEECCTTCEEE
T ss_pred             CCC-cCccCcCC-CCCCCCEeEeCCCCeEEECCCCcccc
Confidence            448 89999853 25788999999999999999999873

>1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1

Probab=96.35  E-value=0.0012  Score=48.67  Aligned_cols=40  Identities=25%  Similarity=0.602  Sum_probs=29.4

Q ss_pred             cccccCC---------CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCcc
Q 004702          237 EAKICGL---------NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCR  279 (735)
Q Consensus       237 ~~~~C~~---------~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~  279 (735)
                      ++++|..         ++.|..  .|.++.++|.|.|++||.+.+ ....|+
T Consensus         3 DidEC~~~~~~~~~~~~~~C~~--~C~n~~Gsy~C~C~~Gy~~~~-d~~~C~   51 (53)
T 1apq_A            3 DLDECASRSKSGEEDPQPQCQH--LCHNYVGGYFCSCRPGYELQE-DRHSCQ   51 (53)
T ss_dssp             SCCTTTCSTTTCCCSSSCTTSS--EEEEETTEEEEECSTTCEECT-TSSCEE
T ss_pred             ccccccCcccccccccCCCCCC--EeECCCCCeEEECCCCCeECC-CCCccC
Confidence            4567754         256864  889999999999999999866 233454

>1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1

Probab=96.27  E-value=0.0022  Score=45.54  Aligned_cols=28  Identities=25%  Similarity=0.598  Sum_probs=23.8

Q ss_pred             CCCCCCCCcc--CCCCcceeeCCCCCCCCC
Q 004702          245 ASCDTPKDNT--STSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       245 ~~C~~~~~c~--~~~~~y~C~C~~Gy~gn~  272 (735)
                      ..|.++++|.  +..++|.|.|++||+|..
T Consensus         9 ~pC~ngg~C~~~~~~~~~~C~C~~G~~G~~   38 (45)
T 1a3p_A            9 GYCLNGGVXMHIESLDSYTCNCVIGYSGDR   38 (45)
T ss_dssp             SCCSSSCEEEECTTTSSEEEECCTTEETTT
T ss_pred             CCCCCCCEEEeecCCCCEEEEcCCCCcCCc
Confidence            3698888997  677899999999999965

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.27  E-value=0.0054  Score=65.37  Aligned_cols=72  Identities=18%  Similarity=0.126  Sum_probs=41.5

Q ss_pred             cccccCcEEEEEEEcCC---------CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc-eEEEceEEeecCceeEEEE
Q 004702          408 VIGCGGSGNVYKGFLPD---------RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN-VVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E  477 (735)
                      .|+.|..-.+|+....+         +..+++|+..... ....+...|..++..+...+ +.++++..    ..++|||
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e  114 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE  114 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence            46677778899987654         2578888754321 11122356777777775333 34565443    2378999


Q ss_pred             ecCCCch
Q 004702          478 FVGNGTL  484 (735)
Q Consensus       478 ~~~~gsL  484 (735)
                      |+++.+|
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987544

>2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ...

Probab=96.23  E-value=0.00061  Score=50.85  Aligned_cols=32  Identities=22%  Similarity=0.673  Sum_probs=27.0

Q ss_pred             CCccCCCCCCCCCcCCCCCCccceeccCCCCCC
Q 004702          282 NECEDPSRNNCTHICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       282 ~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      |||... ...|++.|.|++|+|.|.|++||...
T Consensus         2 dEC~~~-~~~C~~~C~nt~Gsy~C~C~~Gy~L~   33 (55)
T 2jkh_L            2 KLCSLD-NGDCDQFCHEEQNSVVCSCARGYTLA   33 (55)
T ss_dssp             CCTTTG-GGGCSSEEEEETTEEEEECCTTEEEC
T ss_pred             ccccCC-CCCcCcEeEcCCCCeEEeCCCCCEEC
Confidence            678653 36799999999999999999999754

>1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A

Probab=96.21  E-value=0.0023  Score=53.33  Aligned_cols=44  Identities=25%  Similarity=0.685  Sum_probs=35.2

Q ss_pred             ccc--cccccCCCCCCCCCCCccCCC--CcceeeCCCCCCCCCCCCCCcc-ccCC
Q 004702          234 TCE--EAKICGLNASCDTPKDNTSTS--SGYRCKCNKGYEGNPYLSDGCR-DVNE  283 (735)
Q Consensus       234 ~C~--~~~~C~~~~~C~~~~~c~~~~--~~y~C~C~~Gy~gn~y~~~gC~-di~e  283 (735)
                      .|+  ++++|.. ..|.++++|.+..  ++|.|.|++||+|..     |+ +|||
T Consensus        42 ~C~~~~~~~C~~-~pC~ngg~C~~~~~~~~~~C~C~~G~~G~~-----Ce~~ide   90 (91)
T 1tpg_A           42 QCHSVPVKSCSE-PRCFNGGTCQQALYFSDFVCQCPEGFAGKS-----CEIDTRA   90 (91)
T ss_dssp             BCCEECEEECSS-CCSCTTCEEEEESSSSCEEEECCTTCBSSS-----CCBCSSC
T ss_pred             ccccCcCCcccC-CCCCCCCEeecCCCCCCeEeECCCCCcCCc-----CCcCCCC
Confidence            575  5778875 4599999998876  899999999999865     75 6765

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.20  E-value=0.032  Score=58.55  Aligned_cols=31  Identities=19%  Similarity=0.385  Sum_probs=27.3

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          519 VPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       519 ~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4589999999999999888899999987764

>1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A

Probab=96.18  E-value=0.0018  Score=49.73  Aligned_cols=41  Identities=24%  Similarity=0.466  Sum_probs=31.9

Q ss_pred             ccCCCCCCCCCCCccC-----CCCcceeeCCCCCCCCCCCCCCcc-ccCCccC
Q 004702          240 ICGLNASCDTPKDNTS-----TSSGYRCKCNKGYEGNPYLSDGCR-DVNECED  286 (735)
Q Consensus       240 ~C~~~~~C~~~~~c~~-----~~~~y~C~C~~Gy~gn~y~~~gC~-di~eC~~  286 (735)
                      +|. ...|.++++|.+     ..++|.|.|++||+|..     |+ ++++|..
T Consensus         8 ~C~-~~pC~ngG~C~~~~~~~~~~~y~C~C~~Gf~G~~-----Ce~~i~~~~~   54 (63)
T 1hae_A            8 EKE-KTFCVNGGECFMVKDLSNPSRYLCKCQPGFTGAR-----CTENVPMKVQ   54 (63)
T ss_dssp             HHH-HTTSCTTCEEEEEESSSSSCCEEEECCTTEESTT-----SCEECCSSCT
T ss_pred             CCC-CCcCCCCcEEecCCccCCCCCEEEECCCCCcCCc-----cCcCcCcccc
Confidence            453 345888888875     56799999999999965     85 7888764

>1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1

Probab=96.15  E-value=0.0015  Score=53.81  Aligned_cols=40  Identities=28%  Similarity=0.561  Sum_probs=33.4

Q ss_pred             ccccccccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          232 DKTCEEAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       232 ~~~C~~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      +..|.++++|.. ...|. +++|.++.++|.|.|++||++.+
T Consensus        40 g~~C~dideC~~~~~~C~-~~~C~n~~g~y~C~C~~G~~~~~   80 (86)
T 1lmj_A           40 MKNCMDIDECQRDPLLCR-GGVCHNTEGSYRCECPPGHQLSP   80 (86)
T ss_dssp             SSSEEECCHHHHCSSTTT-TSEEEEETTEEEEESCTTSCCCS
T ss_pred             CCccCCcccccCCCCcCC-CCEeEcCCCCEEEECcCCcccCC
Confidence            457999999976 34576 46899999999999999999976

>1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A

Probab=96.12  E-value=0.0016  Score=44.62  Aligned_cols=33  Identities=39%  Similarity=0.860  Sum_probs=27.4

Q ss_pred             cccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          279 RDVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       279 ~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      +|+|+|..   .+|.  ++|.+..++|.|.|+.||+|.
T Consensus         1 ~d~d~C~~---~pC~ngg~C~~~~~~~~C~C~~G~~G~   35 (39)
T 1edm_B            1 VDGDQCES---NPCLNGGSCKDDINSYECWCPFGFEGK   35 (39)
T ss_dssp             CCCCTTTT---CCCCTTCEEEEETTEEEEECCTTCCST
T ss_pred             CccccCCC---CCCCCCCEeEcCCCceEeECCCCCcCC
Confidence            37889973   5676  689999999999999999864

>2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens}

Probab=95.92  E-value=0.0018  Score=59.29  Aligned_cols=45  Identities=20%  Similarity=0.575  Sum_probs=36.5

Q ss_pred             eeeccccccccccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          227 WEIITDKTCEEAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       227 w~~~~~~~C~~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      |...++..|+++++|.. .+.|.+ ++|.++.++|+|.|++||+|++
T Consensus        96 y~~~~g~~C~dideC~~~~~~C~~-g~C~n~~g~y~C~C~~Gy~g~~  141 (147)
T 2w86_A           96 YSRIKGTQCEDIDECEVFPGVCKN-GLCVNTRGSFKCQCPSGMTLDA  141 (147)
T ss_dssp             EEEEETTEEEECCHHHHSTTCSSS-SEEEEETTEEEEECCTTCCBCT
T ss_pred             cccCCCCccCccccccCCCCCCCC-CEEECCCCCEEeeCCCCCccCC
Confidence            33334568999999976 466985 4899999999999999999976

>1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L*

Probab=95.76  E-value=0.0041  Score=56.82  Aligned_cols=50  Identities=28%  Similarity=0.598  Sum_probs=39.3

Q ss_pred             ccccccccccCC-CCCCCCCCCc-cCCCCcceeeCCCCCCCCCCCCCCccccCCc
Q 004702          232 DKTCEEAKICGL-NASCDTPKDN-TSTSSGYRCKCNKGYEGNPYLSDGCRDVNEC  284 (735)
Q Consensus       232 ~~~C~~~~~C~~-~~~C~~~~~c-~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC  284 (735)
                      +..|.+.++|.. ++.|.+  +| .++.++|.|.|++||++.+ ....|++++++
T Consensus        79 G~~C~~~deC~~~~~~C~~--~C~~n~~g~y~C~C~~Gy~l~~-dG~~C~~~~~~  130 (146)
T 1x7a_L           79 GKNCELDATCNIKNGRCKQ--FCKTGADSKVLCSCTTGYRLAP-DQKSCKPAVPF  130 (146)
T ss_dssp             STTTCEECCTTSGGGSCSS--BCCCCSSSCCCCBCCTTEEECT-TSSSEEECSSS
T ss_pred             CCcCCCCccccCCCCCCcC--CCCCCCCCCEEeEcCCCcEeCC-CCCcCCCCCCC
Confidence            347988889977 467876  88 8888999999999999654 33469988764

>3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L

Probab=95.69  E-value=0.0078  Score=64.93  Aligned_cols=49  Identities=24%  Similarity=0.767  Sum_probs=39.5

Q ss_pred             cccccccccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccC
Q 004702          231 TDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVN  282 (735)
Q Consensus       231 ~~~~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~  282 (735)
                      ++.+|+++++|.....|.+  .|.++.++|.|.|.+||++.+ ....|.+++
T Consensus        33 ~~~~C~dideC~~~~~C~~--~C~n~~g~~~C~C~~g~~~~~-~~~~C~~~~   81 (400)
T 3p5b_L           33 AQRRCEDIDECQDPDTCSQ--LCVNLEGGYKCQCEEGFQLDP-HTKACKAVG   81 (400)
T ss_dssp             SSSCEEECCCCSTTSSCSS--CCBCCSSSCBCCCCTTCCCCT-TTSSCCCST
T ss_pred             CCCcccCchhhhccCCCCC--ccCCCccceeeeccccccccc-cccceeecc
Confidence            4568999999986677976  899999999999999999976 334566554

>1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A

Probab=95.59  E-value=0.0059  Score=45.00  Aligned_cols=35  Identities=31%  Similarity=0.745  Sum_probs=28.7

Q ss_pred             ccCCccCCCCCCCC--CcCC--CCCCccceeccCCCCCC
Q 004702          280 DVNECEDPSRNNCT--HICD--NIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       280 di~eC~~~~~~~c~--~~C~--n~~g~y~C~c~~g~~~~  314 (735)
                      ||++|.....++|.  ++|.  +..++|.|.|+.||+|.
T Consensus         2 ~i~~C~~~~~~pC~ngg~C~~~~~~~~~~C~C~~G~~G~   40 (53)
T 1egf_A            2 SYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGD   40 (53)
T ss_dssp             EECCCCTTSSCSSCSSCEEEEESSSSCEEEECCTTCCSS
T ss_pred             CcccCCCCCCCcCCCCcEEEeeCCCCCEEEECCCCCcCC
Confidence            68899754345786  6899  88999999999999875

>2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens}

Probab=95.57  E-value=0.0033  Score=49.48  Aligned_cols=35  Identities=34%  Similarity=0.554  Sum_probs=26.2

Q ss_pred             cccCCccCCCCCCCC--CcCCCCCCccceec-cCCCCCC
Q 004702          279 RDVNECEDPSRNNCT--HICDNIPGSYTCRC-RKGFHGD  314 (735)
Q Consensus       279 ~di~eC~~~~~~~c~--~~C~n~~g~y~C~c-~~g~~~~  314 (735)
                      +|||||... .++|.  +.|.|++|+|.|.+ ..||.++
T Consensus         1 ~DidEC~~~-~~~C~~~~~C~Nt~Gsy~C~~~~~g~~~~   38 (71)
T 2kl7_A            1 SDVNECLTI-PEACKGEMKCINHYGGYLCLPRSAAVIND   38 (71)
T ss_dssp             CCSCCTTCC-CCSCTTEEEEEETTCCEEEEETTSCCCSC
T ss_pred             CccccccCC-CCCCCCCCEeECCCCCeEecccCCccccc
Confidence            489999853 36786  58999999999984 3456544

>4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A*

Probab=95.49  E-value=0.00023  Score=71.09  Aligned_cols=69  Identities=10%  Similarity=0.056  Sum_probs=51.0

Q ss_pred             CCCCCCCCCccCCCCcceeeCCCCCCCCCCC-------------------------CCCccccCCccCCCCCCCC--CcC
Q 004702          244 NASCDTPKDNTSTSSGYRCKCNKGYEGNPYL-------------------------SDGCRDVNECEDPSRNNCT--HIC  296 (735)
Q Consensus       244 ~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~-------------------------~~gC~di~eC~~~~~~~c~--~~C  296 (735)
                      +..|.++++|.+..++|.|.|+.||+|....                         ...|++++||..   .+|.  ++|
T Consensus        37 ~~~c~ngG~C~~g~~~y~C~Cp~Gf~G~~Ce~ni~ec~~~~~c~s~pC~nggtc~~G~~c~~~~eC~s---~pC~ngG~C  113 (267)
T 4fbr_A           37 DIKSDDGGKTLKGTMTYNGEGPIGFRGTLSSANNYTVENQWGGTSAPWQPGGVWVLGARDKQNIVAVS---IKSNDGGKT  113 (267)
T ss_dssp             EEECSSTTSEEEEEEEETTSCCEEEEEEECSTTEEEEEEESSSTTSCEEEEEEEECCCCSSCCEEEEE---EECSSTTSE
T ss_pred             CCCcCCCCeecCCCCCeEEeCCCCcccccccccccccccccCcCCCcccCCCeeeccCccccccccCC---CCCCCCCEE
Confidence            3457788888888899999999999885421                         112344455543   3454  689


Q ss_pred             CCCCCccceeccCCCCCCC
Q 004702          297 DNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       297 ~n~~g~y~C~c~~g~~~~~  315 (735)
                      .+..++|+|.|+.||++..
T Consensus       114 ~~~~~sy~C~C~~Gf~G~~  132 (267)
T 4fbr_A          114 LTGTTTYNGEGPIGFKSEV  132 (267)
T ss_dssp             EEEEEEETTSCCEEEEEEE
T ss_pred             ecCCccEEeeCCCCccccC
Confidence            9999999999999999863

>2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens}

Probab=95.49  E-value=0.0037  Score=49.23  Aligned_cols=37  Identities=14%  Similarity=0.252  Sum_probs=29.6

Q ss_pred             cccccCC-CCCCCCCCCccCCCCcceee-CCCCCCCCCC
Q 004702          237 EAKICGL-NASCDTPKDNTSTSSGYRCK-CNKGYEGNPY  273 (735)
Q Consensus       237 ~~~~C~~-~~~C~~~~~c~~~~~~y~C~-C~~Gy~gn~y  273 (735)
                      ++++|.. .+.|..+++|.++.++|+|. |..||.++..
T Consensus         2 DidEC~~~~~~C~~~~~C~Nt~Gsy~C~~~~~g~~~~~~   40 (71)
T 2kl7_A            2 DVNECLTIPEACKGEMKCINHYGGYLCLPRSAAVINDLH   40 (71)
T ss_dssp             CSCCTTCCCCSCTTEEEEEETTCCEEEEETTSCCCSCCS
T ss_pred             ccccccCCCCCCCCCCEeECCCCCeEecccCCccccccc
Confidence            5678876 46798888999999999998 5578988763

>1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A

Probab=95.44  E-value=0.0026  Score=59.21  Aligned_cols=41  Identities=29%  Similarity=0.658  Sum_probs=32.0

Q ss_pred             ccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccC
Q 004702          240 ICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECED  286 (735)
Q Consensus       240 ~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~  286 (735)
                      .|.. ..|.++++|.+..++|.|.|++||+|+.     |++++||..
T Consensus       121 ~c~~-~~C~~~g~C~~~~~~~~c~C~~g~~G~~-----Ce~~~~c~~  161 (162)
T 1g1s_A          121 SCQD-MSCSKQGECLETIGNYTCSCYPGFYGPE-----CEYVRDDDD  161 (162)
T ss_dssp             CCCT-TGGGGSEEEEECSSSEEEEECTTEESTT-----SCEECC---
T ss_pred             CCcC-CCCCCCCEEecCCCCceEeCCCCCcCcc-----cccCcccCC
Confidence            4543 4588888899999999999999999965     999999963

>4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A*

Probab=95.42  E-value=0.00041  Score=69.25  Aligned_cols=78  Identities=10%  Similarity=0.068  Sum_probs=56.6

Q ss_pred             ccccccccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCcc-----------------CC-------
Q 004702          232 DKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECE-----------------DP-------  287 (735)
Q Consensus       232 ~~~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~-----------------~~-------  287 (735)
                      +..|.+.++|.+ ..|.++++|.+...+|+|.|++||+|.....    ++++|.                 ..       
T Consensus        93 G~~c~~~~eC~s-~pC~ngG~C~~~~~sy~C~C~~Gf~G~~Ce~----~~d~C~n~~~c~s~pC~ngg~c~~G~~c~~~i  167 (267)
T 4fbr_A           93 GARDKQNIVAVS-IKSNDGGKTLTGTTTYNGEGPIGFKSEVTDG----DTYSVENQWGGSAAPWHSGGVWVLGTRGKQNV  167 (267)
T ss_dssp             CCCSSCCEEEEE-EECSSTTSEEEEEEEETTSCCEEEEEEECCC----CEEEEEEECSSTTSCCEEEEEEECCSSTTSCE
T ss_pred             cCccccccccCC-CCCCCCCEEecCCccEEeeCCCCccccCCCC----CcccccccCCcCCccccCCcceeccccccccc
Confidence            457888888865 5599999999999999999999999855221    223311                 00       


Q ss_pred             --CCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          288 --SRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       288 --~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                        ...+|.  ++|.+..++|+|.|++||++.
T Consensus       168 ~c~~~~c~ngg~C~dg~~~y~C~Cp~Gf~G~  198 (267)
T 4fbr_A          168 INVDAKSNDGGKTLSGTMTYNGEGPIGFRGT  198 (267)
T ss_dssp             EEEEEECSSTTSEEEEEEEETTSCCEEEEEE
T ss_pred             ccCCCCCCCCCEeeCCCCCeEEeCCCCcccc
Confidence              012343  688898999999999999875

>1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A

Probab=95.42  E-value=0.0057  Score=43.57  Aligned_cols=34  Identities=26%  Similarity=0.492  Sum_probs=25.4

Q ss_pred             ccccCC--CCCCCCCCCccCC--CCcceeeCCCCCCCCC
Q 004702          238 AKICGL--NASCDTPKDNTST--SSGYRCKCNKGYEGNP  272 (735)
Q Consensus       238 ~~~C~~--~~~C~~~~~c~~~--~~~y~C~C~~Gy~gn~  272 (735)
                      +++|..  ++.|.+ ++|...  .++|.|.|++||+|..
T Consensus         3 i~~C~~~~~~pC~n-G~C~~~~~~~~~~C~C~~GytG~~   40 (46)
T 1k36_A            3 ITKCSSDMNGYCLH-GQCIYLVDMSQNYCRCEVGYTGVR   40 (46)
T ss_dssp             EECCCTTCCSSCSS-EEEEEETTTTEEEEEECTTCSSTT
T ss_pred             cccCCCCCCCCCCC-CEeeccCCCCCEEEECCCCCccCC
Confidence            445654  367888 688753  3689999999999965

>2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A

Probab=95.33  E-value=0.0017  Score=49.32  Aligned_cols=36  Identities=25%  Similarity=0.696  Sum_probs=29.7

Q ss_pred             CccccCCccCCCCCCCC----CcCCCCCCccceeccCCCC-CCC
Q 004702          277 GCRDVNECEDPSRNNCT----HICDNIPGSYTCRCRKGFH-GDG  315 (735)
Q Consensus       277 gC~di~eC~~~~~~~c~----~~C~n~~g~y~C~c~~g~~-~~~  315 (735)
                      .|.++|+|..   ++|.    ++|.|++++|.|.|++||+ |..
T Consensus         7 ~~~~~d~C~s---nPC~nga~gtC~~~~g~y~C~C~~Gy~~G~~   47 (61)
T 2k2s_B            7 LSETPAACSS---NPCGPEAAGTCKETNSGYICRCNQGYRISLD   47 (61)
T ss_dssp             CTTSCCHHHH---CSSCSSSCCEEEECSSEEEEECCTTEEEEEC
T ss_pred             hcCCCCcCcC---CCCcCCCccccccCCCceEeECCCCCccCCC
Confidence            3778999973   5675    4899999999999999998 653

>1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A

Probab=95.31  E-value=0.0016  Score=65.45  Aligned_cols=37  Identities=27%  Similarity=0.838  Sum_probs=28.4

Q ss_pred             cccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCCCC
Q 004702          279 RDVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       279 ~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      +|+|||... .++|.  +.|.|++|+|.|.|..||.+++.
T Consensus         3 ~DiDEC~~~-~~~C~~~a~C~Nt~Gsy~C~C~~Gy~GnG~   41 (285)
T 1gl4_A            3 LAQQTCANN-RHQCSVHAECRDYATGFCCRCVANYTGNGR   41 (285)
T ss_dssp             ----CHHHH-GGGSCTTEEEEECSSCEEEEECTTEEECSS
T ss_pred             ccchhccCC-CCCCCCCCEeEcCCCCeEEEcCCCCCCCCC
Confidence            589999753 36787  58999999999999999998875

>1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1

Probab=95.05  E-value=0.0063  Score=44.44  Aligned_cols=25  Identities=20%  Similarity=0.674  Sum_probs=22.7

Q ss_pred             CCCCCcCCCCCCccceeccCCCCCC
Q 004702          290 NNCTHICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       290 ~~c~~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      ..|++.|.|++|+|.|.|++||...
T Consensus         6 g~C~~~C~n~~gs~~C~C~~Gy~L~   30 (51)
T 1kig_L            6 GGCDQFCREERSEVRCSCAHGYVLG   30 (51)
T ss_dssp             TSSSSCCCEETTEECCCCCTTEEEC
T ss_pred             CCcCCEeEcCCCCeEEeCCCCcEEC
Confidence            6789999999999999999999854

>3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens}

Probab=95.03  E-value=0.012  Score=61.33  Aligned_cols=51  Identities=22%  Similarity=0.564  Sum_probs=42.2

Q ss_pred             ccccc-cccccCC--CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCcc
Q 004702          232 DKTCE-EAKICGL--NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECE  285 (735)
Q Consensus       232 ~~~C~-~~~~C~~--~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~  285 (735)
                      +..|+ ++++|..  +..|.+  .|.+..++|.|.|.+||.|.+ ....|.++++|.
T Consensus        36 g~~C~~~~~eC~~~~~~~C~~--~C~~~~g~~~C~C~~g~~~~~-~~~~C~~~~~c~   89 (317)
T 3h5c_B           36 GSNCELAKNECHPERTDGCQH--FCLPGQESYTCSCAQGYRLGE-DHKQCVPHDQCA   89 (317)
T ss_dssp             SSSSCCCSSSCCTTCTTSCSS--EEECCSSSCEEECCTTEECCT-TSSCCEECSSCC
T ss_pred             CCccccCcccCCCCCCCCCcC--ccccCCCeeEEeccccccccc-cccccccccccc
Confidence            34798 8899976  367987  899999999999999999976 355799988875

>1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A

Probab=94.97  E-value=0.041  Score=63.89  Aligned_cols=50  Identities=28%  Similarity=0.731  Sum_probs=40.0

Q ss_pred             cceeeCCCCCCCCCCCCCCccccCCccCCCCCCCCCcCCCCCCccceeccCCCCC
Q 004702          259 GYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHG  313 (735)
Q Consensus       259 ~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~  313 (735)
                      .+.|.|.+|..+..   ..| +++||... ...|.+.|.|++++|.|.|++||.+
T Consensus       276 d~~~dC~dgsDe~~---~~C-~~~eC~~~-~~~C~~~C~~~~~~~~C~C~~G~~~  325 (699)
T 1n7d_A          276 NMARDCRDWSDEPI---KEC-GTNECLDN-NGGCSHVCNDLKIGYECLCPDGFQL  325 (699)
T ss_dssp             CSSCCSSSSCSCCC---SSC-CCCCTTSS-TTTSCTTCCCCTTCCCCCCCSSSCC
T ss_pred             cccceecCcccccc---ccc-cccccccc-ccCcCCCcccCCCCcEEeCCCCeEc
Confidence            45678888876643   235 78999864 3679999999999999999999985

>1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C*

Probab=94.69  E-value=0.0087  Score=44.06  Aligned_cols=29  Identities=24%  Similarity=0.511  Sum_probs=24.4

Q ss_pred             CCCCCCCCCcc--CCCCcceeeCCCCCCCCC
Q 004702          244 NASCDTPKDNT--STSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       244 ~~~C~~~~~c~--~~~~~y~C~C~~Gy~gn~  272 (735)
                      ...|.++++|.  +..++|.|.|++||+|..
T Consensus        11 ~~pC~nGG~C~~~~~~~~~~C~C~~GytG~~   41 (53)
T 1nql_B           11 DGYCLHDGVCMYIEALDKYACNCVVGYIGER   41 (53)
T ss_dssp             CCEECTTCEEEEETTTTEEEEEECTTEESTT
T ss_pred             CCCCCCCeEEeeecCCCCEEEecCCCCcCCC
Confidence            45688888887  667899999999999965

>3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B*

Probab=94.44  E-value=0.016  Score=66.21  Aligned_cols=73  Identities=23%  Similarity=0.542  Sum_probs=51.1

Q ss_pred             ccccc-cccccCCC--CCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCc-cccCCccCCCCCCCC--CcCCCCCCccce
Q 004702          232 DKTCE-EAKICGLN--ASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGC-RDVNECEDPSRNNCT--HICDNIPGSYTC  305 (735)
Q Consensus       232 ~~~C~-~~~~C~~~--~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC-~di~eC~~~~~~~c~--~~C~n~~g~y~C  305 (735)
                      +..|+ +...|..+  ..|.++++|..    +.|.|.+||+|....   | .++++|...+..+|.  +.|.+    ..|
T Consensus       518 G~~Ce~~~~~C~~~~~~~C~~~G~C~~----g~C~C~~Gy~G~~Ce---C~~~~~~C~~~~g~~C~~~G~C~~----g~C  586 (690)
T 3fcs_B          518 GKYCECDDFSCVRYKGEMCSGHGQCSC----GDCLCDSDWTGYYCN---CTTRTDTCMSSNGLLCSGRGKCEC----GSC  586 (690)
T ss_dssp             STTSCBCSSCCCBSSSSBGGGSEEEET----TEEEECTTEESSSSC---EECCCTTTBCTTSSBTSSSCEEET----TEE
T ss_pred             CCCcCcccCcCcCCCCCCCCCCCEecC----CeeECcCCCcCCCCc---cCCCCCcccCCCCCCCCCCCEEeC----CEE
Confidence            34675 44567642  45877777765    899999999997632   2 268888754335676  68866    389


Q ss_pred             ec-cCCCCCCC
Q 004702          306 RC-RKGFHGDG  315 (735)
Q Consensus       306 ~c-~~g~~~~~  315 (735)
                      .| .+||.|..
T Consensus       587 ~C~~~Gy~G~~  597 (690)
T 3fcs_B          587 VCIQPGSYGDT  597 (690)
T ss_dssp             ECCSTTCBSTT
T ss_pred             ECCCCCccCCC
Confidence            99 99998764

>1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens}

Probab=94.33  E-value=0.017  Score=47.45  Aligned_cols=47  Identities=28%  Similarity=0.660  Sum_probs=32.2

Q ss_pred             ccccccccccCCCCCCCCCCCccCCCCcceeeCC--CCCCCCCCCCCCccccC
Q 004702          232 DKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCN--KGYEGNPYLSDGCRDVN  282 (735)
Q Consensus       232 ~~~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~--~Gy~gn~y~~~gC~di~  282 (735)
                      +..|.++++|.. +.|.  ++|.++.++|+|.|+  +||.... ....|+||+
T Consensus        39 g~~C~dideC~~-~~C~--~~C~n~~g~y~C~C~g~~G~~~~~-~~~~C~di~   87 (87)
T 1z6c_A           39 SKSCEDIDECSE-NMCA--QLCVNYPGGYTCYCDGKKGFKLAQ-DQKSCEVVS   87 (87)
T ss_dssp             TTEEECCCHHHH-SCCS--SEECCCSSSCCEECCSSSCCBCCT-TSSSCBCCC
T ss_pred             CCcCCCcCeeCC-CCCC--CEEEccCCCEEEECCCCcCCcccC-CCCcceECc
Confidence            457988999964 4686  589999999999995  5554332 123455553

>3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens}

Probab=94.28  E-value=0.017  Score=42.79  Aligned_cols=34  Identities=32%  Similarity=0.683  Sum_probs=26.0

Q ss_pred             cccCCccCCCCCCCC--CcC-----CCCCCccceeccCCCCCCC
Q 004702          279 RDVNECEDPSRNNCT--HIC-----DNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       279 ~di~eC~~~~~~~c~--~~C-----~n~~g~y~C~c~~g~~~~~  315 (735)
                      .++|||..   .+|.  ++|     .+..++|.|.|++||+|.-
T Consensus         6 ~~~~eC~s---~pC~NgGtC~~~~~~d~~~~y~C~C~~g~~G~~   46 (55)
T 3u7u_G            6 VKCAEKEK---TFCVNGGECFMVKDLSNPSRYLCKCPNEFTGDR   46 (55)
T ss_dssp             EECCSTTT---TTSCTTCEEEEECCC--CCCEEEEECTTEESTT
T ss_pred             ccCCCCcC---CCCCCCCCcCCCCccCCCCCEeEeCCCCCcCCC
Confidence            47899974   5776  799     5677899999999998763

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.88  E-value=0.012  Score=40.90  Aligned_cols=11  Identities=18%  Similarity=0.344  Sum_probs=4.6

Q ss_pred             Eeeecchhhhh
Q 004702          332 VALGVGISFVV  342 (735)
Q Consensus       332 i~v~v~i~~vv  342 (735)
                      |+.++..++++
T Consensus        13 IA~gVVgGv~~   23 (44)
T 2ks1_B           13 IATGMVGALLL   23 (44)
T ss_dssp             STHHHHHHHHH
T ss_pred             EEeehhHHHHH
Confidence            44444443433

>1nzi_A Complement C1S component; calcium, innate immunity, modular structure, CUB, EGF, hydrolase; 1.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1

Probab=93.77  E-value=0.017  Score=53.46  Aligned_cols=38  Identities=34%  Similarity=0.820  Sum_probs=32.1

Q ss_pred             ccccCCccCCCCCCCCCcCCCCCCccceeccCCCCCCC
Q 004702          278 CRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       278 C~di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      |.|++||..+....|.+.|.|.+|+|.|.|.+||.+.+
T Consensus       114 ~~d~~eC~~~~~~~C~~~C~n~~g~~~C~C~~Gy~l~~  151 (159)
T 1nzi_A          114 ATDINECTDFVDVPCSHFCNNFIGGYFCSCPPEYFLHD  151 (159)
T ss_dssp             EEECCTTTC-CCCCSSSEEEEETTEEEEECCTTCEECT
T ss_pred             cccCcccCCCCCCCCCCcccCcCCCEEEecCCCcEECC
Confidence            67899998754467999999999999999999998654

>3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens}

Probab=93.77  E-value=0.03  Score=65.67  Aligned_cols=56  Identities=21%  Similarity=0.733  Sum_probs=44.5

Q ss_pred             eeeccccccccccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCcc
Q 004702          227 WEIITDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECE  285 (735)
Q Consensus       227 w~~~~~~~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~  285 (735)
                      |...++.+|.++++|..+..|..  .|.++.++|.|.|.+||.+++ ....|++++++.
T Consensus       341 y~l~~g~~C~dideC~~~~~C~~--~C~n~~gsy~C~C~~Gy~l~~-~~~~C~~~~~~p  396 (791)
T 3m0c_C          341 FQLVAQRRCEDIDECQDPDTCSQ--LCVNLEGGYKCQCEEGFQLDP-HTKACKAVGSIA  396 (791)
T ss_dssp             CEEETTTEEECCCCCSSSSSCTT--TCCBCSSCBCCCCCSSEECCS-SCCCCEETTSCC
T ss_pred             CccCCCCccccCcccCCCCCCCC--eeecCCCCceeecCCCCEeCC-CCceeeeccccc
Confidence            33345678999999986667865  899999999999999999877 456798887653

>1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1

Probab=93.61  E-value=0.017  Score=54.19  Aligned_cols=38  Identities=32%  Similarity=0.812  Sum_probs=31.5

Q ss_pred             ccccCCccCCCC--CCCCCcCCCCCCccceeccCCCCCCC
Q 004702          278 CRDVNECEDPSR--NNCTHICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       278 C~di~eC~~~~~--~~c~~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      |.|++||.....  ..|.+.|.|++|+|.|.|++||.+.+
T Consensus       121 ~~di~eC~~~~~~~~~C~~~C~n~~g~~~C~C~~Gy~l~~  160 (170)
T 1szb_A          121 AEDIDECQVAPGEAPTCDHHCHNHLGGFYCSCRAGYVLHR  160 (170)
T ss_dssp             EEECCTTCCCTTSCCSSSSEEEEETTEEEEECCTTEEECT
T ss_pred             ccccCcccCCCCCCCccCCccccCCCCEEEeCCCCcEECC
Confidence            678999986431  24999999999999999999998654

>1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A

Probab=93.61  E-value=0.018  Score=40.92  Aligned_cols=35  Identities=23%  Similarity=0.645  Sum_probs=26.4

Q ss_pred             ccCCccCCCCCCCC-CcCCCCC--CccceeccCCCCCC
Q 004702          280 DVNECEDPSRNNCT-HICDNIP--GSYTCRCRKGFHGD  314 (735)
Q Consensus       280 di~eC~~~~~~~c~-~~C~n~~--g~y~C~c~~g~~~~  314 (735)
                      +|++|......+|. ++|.+..  ++|.|.|++||+|.
T Consensus         2 ~i~~C~~~~~~pC~nG~C~~~~~~~~~~C~C~~GytG~   39 (46)
T 1k36_A            2 SITKCSSDMNGYCLHGQCIYLVDMSQNYCRCEVGYTGV   39 (46)
T ss_dssp             CEECCCTTCCSSCSSEEEEEETTTTEEEEEECTTCSST
T ss_pred             ccccCCCCCCCCCCCCEeeccCCCCCEEEECCCCCccC
Confidence            57788754346776 6898654  68999999999875

>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B*

Probab=93.53  E-value=0.033  Score=60.22  Aligned_cols=58  Identities=26%  Similarity=0.798  Sum_probs=39.4

Q ss_pred             CCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc-cC----------CccCCCCCCCC--CcCCCCCCccceeccCCCC
Q 004702          246 SCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD-VN----------ECEDPSRNNCT--HICDNIPGSYTCRCRKGFH  312 (735)
Q Consensus       246 ~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d-i~----------eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~  312 (735)
                      .|.++++|.+  ..+.|.|++||+|..     |+. .+          +|..  ...|.  +.|  .+++|.|.|++||.
T Consensus       204 ~C~~~G~C~~--~~g~C~C~~G~~G~~-----Ce~~C~~g~~g~~C~~~C~~--~~~C~~~g~C--~~~~~~C~C~~G~~  272 (423)
T 2gy5_A          204 ACMNNGVCHE--DTGECICPPGFMGRT-----CEKACELHTFGRTCKERCSG--QEGCKSYVFC--LPDPYGCSCATGWK  272 (423)
T ss_dssp             CCCTTCEECT--TTCCEECCTTEESTT-----SCEECCTTEESTTSCEECCS--TTTTTTCCEE--ETTTTEEECCBTCB
T ss_pred             CCCCCCEEEC--CCCcEeCCCCccCCC-----cccccCCCCCCCCcCccCCC--CCCCCCCCEE--CCCCCeEEeCCCcc
Confidence            5777778876  468999999999976     543 22          2321  12333  234  46789999999998


Q ss_pred             CC
Q 004702          313 GD  314 (735)
Q Consensus       313 ~~  314 (735)
                      |.
T Consensus       273 G~  274 (423)
T 2gy5_A          273 GL  274 (423)
T ss_dssp             SG
T ss_pred             cc
Confidence            75

>2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A

Probab=93.37  E-value=0.016  Score=63.52  Aligned_cols=51  Identities=35%  Similarity=0.901  Sum_probs=20.7

Q ss_pred             CCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          247 CDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       247 C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      |.+ ++|..   .+.|.|.+||+|..     |+ +++|..    +|.  ++|.+.   +.|.|++||++.
T Consensus       399 C~n-G~C~~---~~~C~C~~G~~G~~-----C~-~~~C~~----~C~~~g~C~~~---~~C~C~~G~~G~  451 (463)
T 2wg3_C          399 CRN-GYCTP---TGKCCCSPGWEGDF-----CR-TAKCEP----ACRHGGVCVRP---NKCLCKKGYLGP  451 (463)
T ss_dssp             CCS-EEECT---TSCEEECTTEESTT-----SC-EECC--------------------------------
T ss_pred             CCC-CccCC---CCeECCCCCcCCCc-----CC-cCcCCC----CCCCCCEECCC---CEEECCCCcccC
Confidence            665 56764   35899999999975     73 667863    565  589875   799999999865

>3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus}

Probab=93.19  E-value=0.022  Score=60.97  Aligned_cols=50  Identities=24%  Similarity=0.694  Sum_probs=22.4

Q ss_pred             cccccccccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCC
Q 004702          231 TDKTCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNE  283 (735)
Q Consensus       231 ~~~~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~e  283 (735)
                      ++.+|.++++|..++.|.+  .|.++.++|.|.|.+||+..+ ....|..+++
T Consensus        37 ~~~~C~d~~eC~~~~~C~~--~C~~~~g~~~C~C~~g~~l~~-d~~~C~~~~~   86 (386)
T 3v65_B           37 DGRTCQDVNECAEEGYCSQ--GCTNSEGAFQCWCEAGYELRP-DRRSCKALGP   86 (386)
T ss_dssp             ---------------CCTT--EEC-----CCEECCTTEEECT-TSSCEEECSS
T ss_pred             CCCccCccceeCCcCcccC--cCCCCCCCCeEEECCCceEcC-CCCeECCccc
Confidence            3468999999976677987  489999999999999999765 3345766543

>1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L*

Probab=93.10  E-value=0.032  Score=48.40  Aligned_cols=47  Identities=23%  Similarity=0.450  Sum_probs=34.0

Q ss_pred             ccccc---cccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCC
Q 004702          234 TCEEA---KICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNE  283 (735)
Q Consensus       234 ~C~~~---~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~e  283 (735)
                      .|++.   ++|.. ++.|..  +|.++.++|+|.|.+||+|.. ....|+++++
T Consensus        47 ~C~~~~~~~~C~~~~~~C~~--~C~n~~g~y~C~C~~G~~~~~-~g~~C~~~~~   97 (114)
T 1aut_L           47 FCQREVSFLNCSLDNGGCTH--YCLEEVGWRRCSCAPGYKLGD-DLLQCHPAVK   97 (114)
T ss_dssp             TSCEECCSSSSSSGGGGCSS--EEEECSSSEEEECCTTEEECT-TSSCEEECSS
T ss_pred             CcCcCCcCCcCcCCCCCCCC--EeECCCCCEEeECCCCeeECC-CCCccCcCcc
Confidence            46654   35765 566765  788899999999999999865 3345776543

>2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ...

Probab=93.02  E-value=0.023  Score=50.96  Aligned_cols=48  Identities=29%  Similarity=0.643  Sum_probs=32.0

Q ss_pred             ccccc-c-cccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCC
Q 004702          233 KTCEE-A-KICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNE  283 (735)
Q Consensus       233 ~~C~~-~-~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~e  283 (735)
                      ..|.+ + ++|.. ++.|.+  +|.+..++|.|.|++||++++ ....|+++++
T Consensus        74 ~~C~~~i~d~C~~~~~~C~~--~C~~~~g~y~C~C~~Gy~l~~-~g~~C~~~~~  124 (134)
T 2vh0_B           74 KNCELFTRKLCSLDNGDCDQ--FCHEEQNSVVCSCARGYTLAD-NGKACIPTGP  124 (134)
T ss_dssp             -------CCGGGTGGGGCSS--EEEEETTEEEEECCTTEEECT-TSSCEEESSS
T ss_pred             CccccCCCCccccCCCCCCC--EeECCCCCEEEECCCCcEECC-CCCccCcCCC
Confidence            46876 4 67876 456876  788888999999999999654 2345888754

>3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B*

Probab=92.86  E-value=0.04  Score=62.98  Aligned_cols=58  Identities=21%  Similarity=0.474  Sum_probs=43.3

Q ss_pred             CCCCCCCccCCCCcceeeCC----CCCCCCCCCCCCcc-ccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCCCC
Q 004702          246 SCDTPKDNTSTSSGYRCKCN----KGYEGNPYLSDGCR-DVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       246 ~C~~~~~c~~~~~~y~C~C~----~Gy~gn~y~~~gC~-di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      .|.++++|.+    +.|.|.    +||.|..     |+ ++++|...+...|.  +.|.+    +.|.|.+||.|..-
T Consensus       494 ~Cs~~G~C~~----g~C~C~~~~~~Gy~G~~-----Ce~~~~~C~~~~~~~C~~~G~C~~----g~C~C~~Gy~G~~C  558 (690)
T 3fcs_B          494 VCSQRGECLC----GQCVCHSSDFGKITGKY-----CECDDFSCVRYKGEMCSGHGQCSC----GDCLCDSDWTGYYC  558 (690)
T ss_dssp             GGGGSEEECS----SSEEECCCSSCCCBSTT-----SCBCSSCCCBSSSSBGGGSEEEET----TEEEECTTEESSSS
T ss_pred             CCCCCCEEEC----CeeEeecCCCCCeeCCC-----cCcccCcCcCCCCCCCCCCCEecC----CeeECcCCCcCCCC
Confidence            3666666663    689999    9999965     75 67888743334675  68877    89999999998743

>1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A

Probab=92.75  E-value=0.03  Score=46.31  Aligned_cols=62  Identities=23%  Similarity=0.523  Sum_probs=42.6

Q ss_pred             CCCCCCccC-CCCcceeeCCCCCCCCCCCCCCcccc--CCccCCCCCCCC--CcCCCCC-----CccceeccCCCC
Q 004702          247 CDTPKDNTS-TSSGYRCKCNKGYEGNPYLSDGCRDV--NECEDPSRNNCT--HICDNIP-----GSYTCRCRKGFH  312 (735)
Q Consensus       247 C~~~~~c~~-~~~~y~C~C~~Gy~gn~y~~~gC~di--~eC~~~~~~~c~--~~C~n~~-----g~y~C~c~~g~~  312 (735)
                      |..++.|.. ..+.+.|.|.+||.|+.   ..|..+  +.|... ...|.  +.|..+.     +...|.|.+++.
T Consensus        12 C~~NA~C~r~~~g~e~C~C~~gy~gdg---~~Cv~~~~~sC~~n-NGGCd~nA~C~~~~~~~~~~ki~C~C~~g~~   83 (99)
T 1ob1_C           12 CPQNSGCFRHLDEREECKCLLNYKQEG---DKCVENPNPTCNEN-NGGCDADAKCTEEDSGSNGKKITCECTKPDS   83 (99)
T ss_dssp             CCTTEEEECCTTSCCEEEECTTEEEET---TEEEECSCCCSTTG-GGGCCTTEEEECCSCSSSSCCCEEEECSTTC
T ss_pred             CCCCCCeEEcCCCCEEEEecCCeecCC---CeEeeCCCCChhhc-CCCcCCCceeEecCCcccCCceEeEeCCCCc
Confidence            333334444 34678999999999964   348766  577643 25676  5787764     679999998875

>3f1s_B Vitamin K-dependent protein Z; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens}

Probab=92.61  E-value=0.05  Score=55.51  Aligned_cols=35  Identities=34%  Similarity=0.782  Sum_probs=28.9

Q ss_pred             ccCCccCCCCCCCCCcCCCCCCccceeccCCCCCC
Q 004702          280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       280 di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      |+|||...+...|++.|.|+.++|.|.|..||...
T Consensus         1 ~~~eC~~~~~~~C~~~C~~~~~~~~C~C~~G~~l~   35 (283)
T 3f1s_B            1 AKNECHPERTDGCQHFCLPGQESYTCSCAQGYRLG   35 (283)
T ss_dssp             --CCCCSSCSSSCSSBCCCCTTSCCCBCCTTEEEC
T ss_pred             CCCccCCCCCCCCCCEeeCCCCCeEecCCCCcccC
Confidence            47899875347899999999999999999999754

>3v64_C Agrin; beta propeller, laminin-G, signaling, protein binding; HET: NAG; 2.85A {Rattus norvegicus}

Probab=92.56  E-value=0.047  Score=57.56  Aligned_cols=39  Identities=31%  Similarity=0.806  Sum_probs=22.8

Q ss_pred             cCCccCCCCCCCCCcCCCCCCccceeccCCCCCCCCCCCCCCc
Q 004702          281 VNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCT  323 (735)
Q Consensus       281 i~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~~~~~~gC~  323 (735)
                      ||||.  +...|++.|.|++|+|.|.|++||...+.  +..|.
T Consensus         1 i~ec~--~~~~C~~~C~n~~g~~~C~C~~g~~l~~d--~~~C~   39 (349)
T 3v64_C            1 VNECA--EEGYCSQGCTNSEGAFQCWCEAGYELRPD--RRSCK   39 (349)
T ss_dssp             ----------CCSSEECCC---CCEECCTTEEECTT--SSCEE
T ss_pred             CcccC--CCCCCcCeeecCCCCeEEECCCCccCCCC--CCccc
Confidence            58897  34789999999999999999999986542  34564

>1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L*

Probab=92.53  E-value=0.022  Score=54.33  Aligned_cols=37  Identities=35%  Similarity=0.896  Sum_probs=0.0

Q ss_pred             CCccccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCCC
Q 004702          276 DGCRDVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       276 ~gC~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      ..|.|+|+|..   ++|.  ++|.|..++|.|.|++||.|..
T Consensus        37 ~~c~dideC~~---~pC~ngg~C~n~~g~y~C~C~~Gf~G~~   75 (195)
T 1nfu_B           37 NKYKDGDQCET---SPCQNQGKCKDGLGEYTCTCLEGFEGKN   75 (195)
T ss_dssp             ------------------------------------------
T ss_pred             ccCCCCcccCC---CCCCCCCEeECCCCCeeEeCCCCceecc
Confidence            35899999973   5786  5999999999999999998753

>2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B*

Probab=92.51  E-value=0.023  Score=42.79  Aligned_cols=26  Identities=23%  Similarity=0.751  Sum_probs=22.7

Q ss_pred             CCCCCcCCCCC-CccceeccCCCCCCC
Q 004702          290 NNCTHICDNIP-GSYTCRCRKGFHGDG  315 (735)
Q Consensus       290 ~~c~~~C~n~~-g~y~C~c~~g~~~~~  315 (735)
                      ..|++.|.|++ |+|.|.|++||....
T Consensus         7 ggC~~~C~n~~~gs~~C~C~~Gy~L~~   33 (59)
T 2wph_E            7 GRCEQFCKNSADNKVVCSCTEGYRLAE   33 (59)
T ss_dssp             GGCSSEEEECSTTCEEEECCTTEEECT
T ss_pred             CCcCCEeEeCCCCCEEeeCCCCcEECC
Confidence            57999999999 699999999998653

>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens}

Probab=92.39  E-value=0.069  Score=55.51  Aligned_cols=54  Identities=26%  Similarity=0.676  Sum_probs=35.0

Q ss_pred             CCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          245 ASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       245 ~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      ..|.++++|..   .+.|.|.+||+|..     |+. ++|.    .+|.  ++|.+   .+.|.|++||.|.
T Consensus       153 ~~C~~~G~C~~---~~~C~C~~G~~G~~-----C~~-~~C~----~~C~~~G~C~~---~~~C~C~~G~~G~  208 (324)
T 2ygq_A          153 GGCRNGGFCNE---RRICECPDGFHGPH-----CEK-ALCT----PRCMNGGLCVT---PGFCICPPGFYGV  208 (324)
T ss_dssp             SCCCSSCEECT---TSCEECCTTEESSS-----SCE-ESSS----SCCCTTCEECS---SCCEECCTTCBTT
T ss_pred             CCCCCCCEECC---CCeEECCCCCcCCC-----CCC-CCCC----CCCCCCCEEcC---CCEEeCCCCccCC
Confidence            45777667764   47899999988854     543 3453    2343  56654   4678888888765

>1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4

Probab=92.19  E-value=0.039  Score=45.87  Aligned_cols=72  Identities=19%  Similarity=0.450  Sum_probs=49.0

Q ss_pred             cccccccccccCCCCCCCCCCCccC-CCCcceeeCCCCCCCCCCCCCCccccCC-ccCCCCCCCC--CcCCCCC-Cccce
Q 004702          231 TDKTCEEAKICGLNASCDTPKDNTS-TSSGYRCKCNKGYEGNPYLSDGCRDVNE-CEDPSRNNCT--HICDNIP-GSYTC  305 (735)
Q Consensus       231 ~~~~C~~~~~C~~~~~C~~~~~c~~-~~~~y~C~C~~Gy~gn~y~~~gC~di~e-C~~~~~~~c~--~~C~n~~-g~y~C  305 (735)
                      ..+.|.+. .|..|+.|      .. ..+...|.|..||.+.   ...|..++. |.. +...|.  +.|..+. ....|
T Consensus         9 ~~h~C~~t-~Cp~NA~C------~r~~~G~e~CrCl~gY~~d---g~~Cv~~Np~C~~-nNGGCd~nAeC~~~~~~ki~C   77 (105)
T 1n1i_A            9 SAHKCIDT-NVPENAAC------YRYLDGTEEWRCLLGFKEV---GGKCVPASITCEE-NNGGCAPEAECTMDDKKEVEC   77 (105)
T ss_dssp             CTTSCCSS-CCCTTEEE------EECTTSCEEEEECTTEEEC---SSSEEECCCCTTS-GGGGSCTTSEEEECTTSCEEE
T ss_pred             cCcEecCC-CCCCCCCe------EECCCCCEeEEEECCeecc---CCEEEECCcchhh-cCCCcCCCcEeEECCCCEEEe
Confidence            33456433 34444444      44 4456789999999985   456988888 654 336787  6898774 78899


Q ss_pred             eccCCCCC
Q 004702          306 RCRKGFHG  313 (735)
Q Consensus       306 ~c~~g~~~  313 (735)
                      .|..+|.-
T Consensus        78 ~C~~~~~~   85 (105)
T 1n1i_A           78 KCTKEGSE   85 (105)
T ss_dssp             ECCSTTCC
T ss_pred             ECCCCCCc
Confidence            99988753

>2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L*

Probab=92.06  E-value=0.022  Score=41.90  Aligned_cols=25  Identities=28%  Similarity=0.850  Sum_probs=22.3

Q ss_pred             CCCCCcCCCCCC-ccceeccCCCCCC
Q 004702          290 NNCTHICDNIPG-SYTCRCRKGFHGD  314 (735)
Q Consensus       290 ~~c~~~C~n~~g-~y~C~c~~g~~~~  314 (735)
                      ..|++.|.|++| +|.|.|++||...
T Consensus         7 ggC~~~C~n~~ggs~~C~C~~Gy~L~   32 (53)
T 2bz6_L            7 GGCEQYCSDHTGTKRSCRCHEGYSLL   32 (53)
T ss_dssp             GGCSSEEEEETTTEEEEECCTTEEEC
T ss_pred             CCcCCEeEcCCCCCEEeeCCCCCEEC
Confidence            578999999999 7999999999855

>3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D

Probab=92.01  E-value=0.034  Score=40.64  Aligned_cols=28  Identities=21%  Similarity=0.470  Sum_probs=22.6

Q ss_pred             CCCCCCCCccC----CCCcceeeCCCCCCCCC
Q 004702          245 ASCDTPKDNTS----TSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       245 ~~C~~~~~c~~----~~~~y~C~C~~Gy~gn~  272 (735)
                      ..|.++++|..    ..++|.|.|++||+|..
T Consensus        14 ~pC~NGGtC~~~~~~~~~~y~C~C~~Gf~G~~   45 (52)
T 3ca7_A           14 WYCLNDAHCFAVKIADLPVYSCECAIGFMGQR   45 (52)
T ss_dssp             HTSCTTCEEEEEEETTEEEEEEECCTTEESTT
T ss_pred             CcCCCCCEEecCccCCCCCEEEECCCCCcCCC
Confidence            35888888875    35689999999999965

>2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens}

Probab=91.92  E-value=0.14  Score=53.10  Aligned_cols=54  Identities=24%  Similarity=0.591  Sum_probs=37.9

Q ss_pred             CCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCCC
Q 004702          246 SCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       246 ~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      .|.++++|..   .+.|.|.+||+|..     |+. ++|.    .+|.  ++|.+   .+.|.|++||.|..
T Consensus       186 ~C~~~G~C~~---~~~C~C~~G~~G~~-----C~~-~~C~----~~C~~~G~C~~---~~~C~C~~G~~G~~  241 (324)
T 2ygq_A          186 RCMNGGLCVT---PGFCICPPGFYGVN-----CDK-ANCS----TTCFNGGTCFY---PGKCICPPGLEGEQ  241 (324)
T ss_dssp             CCCTTCEECS---SCCEECCTTCBTTT-----TCB-CCCS----SCCCSSCCBSC---SSCBCCCTTCCTTT
T ss_pred             CCCCCCEEcC---CCEEeCCCCccCCC-----ccc-CcCC----CCCCCCCeeCC---CCeeeCCCCccCCC
Confidence            5777777764   47899999999865     543 3454    2344  57866   37899999998763

>3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D

Probab=91.63  E-value=0.0086  Score=43.92  Aligned_cols=38  Identities=26%  Similarity=0.535  Sum_probs=26.8

Q ss_pred             ceeeCCCCCCCCCCCCCCccccCCccCCCCCCCCCcCCC----CCCccceeccCCCCCC
Q 004702          260 YRCKCNKGYEGNPYLSDGCRDVNECEDPSRNNCTHICDN----IPGSYTCRCRKGFHGD  314 (735)
Q Consensus       260 y~C~C~~Gy~gn~y~~~gC~di~eC~~~~~~~c~~~C~n----~~g~y~C~c~~g~~~~  314 (735)
                      +.|.|++||+.+|.+.                 .++|.+    ..++|.|.|+.||+|.
T Consensus         3 ~~C~C~~g~~~~pC~N-----------------GGtC~~~~~~~~~~y~C~C~~Gf~G~   44 (52)
T 3ca7_A            3 PTYKCPETFDAWYCLN-----------------DAHCFAVKIADLPVYSCECAIGFMGQ   44 (52)
T ss_dssp             CCBCCCHHHHHHTSCT-----------------TCEEEEEEETTEEEEEEECCTTEEST
T ss_pred             eeeECCCCCcCCcCCC-----------------CCEEecCccCCCCCEEEECCCCCcCC
Confidence            4699999997444211                 245654    3468999999999875

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=91.58  E-value=0.37  Score=51.95  Aligned_cols=72  Identities=14%  Similarity=0.054  Sum_probs=44.4

Q ss_pred             cccccCcEEEEEEEcCC--------CcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCc-eEEEceEEeecCceeEEEEe
Q 004702          408 VIGCGGSGNVYKGFLPD--------RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRN-VVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       408 ~lG~G~~g~Vy~g~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E~  478 (735)
                      .|..|-...+|+....+        +..+++|+...... ..-+..+|..+++.+...+ ..++++.+    ..++||||
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ef  151 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEEF  151 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEEC
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEEE
Confidence            46667778899988653        56788887543221 1122346778777775322 34555432    23789999


Q ss_pred             cCCCch
Q 004702          479 VGNGTL  484 (735)
Q Consensus       479 ~~~gsL  484 (735)
                      +++.+|
T Consensus       152 I~G~~l  157 (424)
T 3mes_A          152 IDGEPL  157 (424)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            998654

>1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1

Probab=91.58  E-value=0.084  Score=37.18  Aligned_cols=25  Identities=36%  Similarity=0.788  Sum_probs=20.6

Q ss_pred             CCCC--CcCC--CCCCccceeccCCCCCC
Q 004702          290 NNCT--HICD--NIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       290 ~~c~--~~C~--n~~g~y~C~c~~g~~~~  314 (735)
                      .+|.  ++|.  +..++|.|.|++||+|.
T Consensus         9 ~pC~ngg~C~~~~~~~~~~C~C~~G~~G~   37 (45)
T 1a3p_A            9 GYCLNGGVXMHIESLDSYTCNCVIGYSGD   37 (45)
T ss_dssp             SCCSSSCEEEECTTTSSEEEECCTTEETT
T ss_pred             CCCCCCCEEEeecCCCCEEEEcCCCCcCC
Confidence            3665  6897  78899999999999865

>2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B*

Probab=91.47  E-value=0.13  Score=55.51  Aligned_cols=68  Identities=25%  Similarity=0.674  Sum_probs=41.0

Q ss_pred             ccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc---cCCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          240 ICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD---VNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       240 ~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d---i~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      .|..++.|.+++.|.  .++|.|.|.+||+|..... .|..   -+.|...  .+|.  +.|.+..+   |.|++||.|.
T Consensus       245 ~C~~~~~C~~~g~C~--~~~~~C~C~~G~~G~~C~~-~C~~G~~G~~C~~~--C~C~ngg~C~~~~~---C~C~~G~~G~  316 (423)
T 2gy5_A          245 RCSGQEGCKSYVFCL--PDPYGCSCATGWKGLQCNE-ACHPGFYGPDCKLR--CSCNNGEMCDRFQG---CLCSPGWQGL  316 (423)
T ss_dssp             ECCSTTTTTTCCEEE--TTTTEEECCBTCBSGGGCB-CCCTTBCSBTTCCB--CCCTTCCEEETTTE---EECCTTCBST
T ss_pred             cCCCCCCCCCCCEEC--CCCCeEEeCCCcccccccC-ccCCCCcCCccccc--ccCCCCCEecCCCc---eECCCCCcCC
Confidence            354345576666664  3689999999999965211 1211   1233321  2454  57877643   9999999976


Q ss_pred             C
Q 004702          315 G  315 (735)
Q Consensus       315 ~  315 (735)
                      .
T Consensus       317 ~  317 (423)
T 2gy5_A          317 Q  317 (423)
T ss_dssp             T
T ss_pred             C
Confidence            3

>3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B*

Probab=91.42  E-value=0.086  Score=60.12  Aligned_cols=73  Identities=25%  Similarity=0.656  Sum_probs=47.5

Q ss_pred             cccc-cccccCC--CCCCCC--CCCccCCCCcceeeCCCCCCCCCCCCCCcc-ccCCccCCCCCCCC--CcCCCCCCccc
Q 004702          233 KTCE-EAKICGL--NASCDT--PKDNTSTSSGYRCKCNKGYEGNPYLSDGCR-DVNECEDPSRNNCT--HICDNIPGSYT  304 (735)
Q Consensus       233 ~~C~-~~~~C~~--~~~C~~--~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~-di~eC~~~~~~~c~--~~C~n~~g~y~  304 (735)
                      ..|+ +...|..  ...|.+  +++|..    ..|.|.+||+|....   |. +++.|...+...|.  +.|.+    +.
T Consensus       510 ~~Ce~~~~~C~~~~~~~C~~~~~G~C~~----g~C~C~~G~~G~~Ce---c~~~~~~C~~~~g~~Cs~~G~C~~----g~  578 (687)
T 3k6s_B          510 QYCECDTINCERYNGQVCGGPGRGLCFC----GKCRCHPGFEGSACQ---CERTTEGCLNPRRVECSGRGRCRC----NV  578 (687)
T ss_dssp             TTSCEESSCSCEETTEETSHHHHEEEET----TEEEECTTCCSTTSC---SCCSSCTTBCTTCSBTSSSCCBCS----SC
T ss_pred             cccccccccccCCCCcCcCCCCCCeEEC----CEEEcCCCCcCCCCc---cCCCCCCCCCCCCCCCCCCCcCCC----CE
Confidence            3564 3345643  234665  566663    289999999997632   21 46788754444675  67876    57


Q ss_pred             eeccCCCCCCCC
Q 004702          305 CRCRKGFHGDGR  316 (735)
Q Consensus       305 C~c~~g~~~~~~  316 (735)
                      |.|.+||.|..-
T Consensus       579 C~C~~Gy~G~~C  590 (687)
T 3k6s_B          579 CECHSGYQLPLC  590 (687)
T ss_dssp             BCCSTTCCTTTT
T ss_pred             EECCCCCcCCCC
Confidence            999999998643

>1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1

Probab=91.27  E-value=0.054  Score=50.60  Aligned_cols=44  Identities=23%  Similarity=0.605  Sum_probs=31.3

Q ss_pred             cccccccCC-CC---CCCCCCCccCCCCcceeeCCCCCCCCCCCCCCcccc
Q 004702          235 CEEAKICGL-NA---SCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDV  281 (735)
Q Consensus       235 C~~~~~C~~-~~---~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di  281 (735)
                      |.+.++|.. ++   .|.+  .|.++.++|.|.|.+||++.+ ....|+++
T Consensus       121 ~~di~eC~~~~~~~~~C~~--~C~n~~g~~~C~C~~Gy~l~~-d~~~C~~~  168 (170)
T 1szb_A          121 AEDIDECQVAPGEAPTCDH--HCHNHLGGFYCSCRAGYVLHR-NKRTCSEQ  168 (170)
T ss_dssp             EEECCTTCCCTTSCCSSSS--EEEEETTEEEEECCTTEEECT-TSSCEEEC
T ss_pred             ccccCcccCCCCCCCccCC--ccccCCCCEEEeCCCCcEECC-CCCccccc
Confidence            445567765 33   2866  688888999999999999765 34457664

>2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ...

Probab=90.85  E-value=0.043  Score=49.63  Aligned_cols=35  Identities=29%  Similarity=0.713  Sum_probs=29.9

Q ss_pred             CccccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          277 GCRDVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       277 gC~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      .|.|+|+|..   .+|.  ++|.|+.++|.|.|++||+|.
T Consensus        43 ~c~did~C~~---~pC~n~g~C~~~~g~y~C~C~~G~~G~   79 (142)
T 2c4f_L           43 SYSDGDQCAS---SPCQNGGSCKDQLQSYICFCLPAFEGR   79 (142)
T ss_dssp             HHTTCCGGGG---CCCCTTCEEEEETTEEEEECCTTEEST
T ss_pred             cCCccCcCcC---CCcCCCCEEeCCCCCEEeeCCCCccCC
Confidence            3789999973   5776  599999999999999999865

>3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster}

Probab=90.23  E-value=0.052  Score=40.65  Aligned_cols=27  Identities=22%  Similarity=0.519  Sum_probs=21.5

Q ss_pred             CCCCCCCcc--C--CCCcceeeCCCCCCCCC
Q 004702          246 SCDTPKDNT--S--TSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       246 ~C~~~~~c~--~--~~~~y~C~C~~Gy~gn~  272 (735)
                      .|.++++|.  .  ...+|.|.|++||+|..
T Consensus        15 pC~NGGtC~~~~~~~~~~~~C~C~~Gf~G~~   45 (58)
T 3ltf_D           15 YCLNDAHCFAVKIADLPVYSCECAIGFMGQR   45 (58)
T ss_dssp             TSCSSCEEEEEEETTEEEEEEEECTTEESSS
T ss_pred             cCCCCCEEeCCccCCCCCEEeECCCCCccCC
Confidence            588888886  2  44689999999999965

>2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A

Probab=90.10  E-value=0.11  Score=48.59  Aligned_cols=41  Identities=27%  Similarity=0.769  Sum_probs=33.1

Q ss_pred             ccccc-cccccCCCCCCCCCCCccCC-CCcceeeCCCCCCCCC
Q 004702          232 DKTCE-EAKICGLNASCDTPKDNTST-SSGYRCKCNKGYEGNP  272 (735)
Q Consensus       232 ~~~C~-~~~~C~~~~~C~~~~~c~~~-~~~y~C~C~~Gy~gn~  272 (735)
                      +..|+ ++++|.....|.++++|.+. .++|+|.|++||+|..
T Consensus       124 G~~C~~~~~~C~~~~~C~~~g~C~~~~~~~~~C~C~~G~~G~~  166 (169)
T 2vj2_A          124 GQLCDKDLNYCGTHQPCLNGGTCSNTGPDKYQCSCPEGYSGPN  166 (169)
T ss_dssp             TTTTCEESCHHHHTCCCCTTCEEEECSTTCEEEECCTTCCSTT
T ss_pred             CCcccCCCCCCCCCCCCCCCCEEcCCCCCCcEeECCCCCcCcC
Confidence            34687 67788655679998999886 6789999999999964

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.57  E-value=0.051  Score=37.69  Aligned_cols=9  Identities=33%  Similarity=0.287  Sum_probs=3.5

Q ss_pred             Eeeecchhh
Q 004702          332 VALGVGISF  340 (735)
Q Consensus       332 i~v~v~i~~  340 (735)
                      |+.++..++
T Consensus        12 IA~gVVgGv   20 (44)
T 2l2t_A           12 IAAGVIGGL   20 (44)
T ss_dssp             HHHHHHHHH
T ss_pred             EEEeehHHH
Confidence            334443333

>3f1s_B Vitamin K-dependent protein Z; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens}

Probab=89.42  E-value=0.16  Score=51.63  Aligned_cols=45  Identities=20%  Similarity=0.522  Sum_probs=34.4

Q ss_pred             ccccCC--CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCcc
Q 004702          238 AKICGL--NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNECE  285 (735)
Q Consensus       238 ~~~C~~--~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC~  285 (735)
                      .++|..  |+.|.+  .|.++.++|+|.|.+||..+. ....|...++|.
T Consensus         2 ~~eC~~~~~~~C~~--~C~~~~~~~~C~C~~G~~l~~-d~~sC~p~~~c~   48 (283)
T 3f1s_B            2 KNECHPERTDGCQH--FCLPGQESYTCSCAQGYRLGE-DHKQCVPHDQCA   48 (283)
T ss_dssp             -CCCCSSCSSSCSS--BCCCCTTSCCCBCCTTEEECT-TSSCEEECSTTC
T ss_pred             CCccCCCCCCCCCC--EeeCCCCCeEecCCCCcccCC-CCCccccccccc
Confidence            357765  477876  678888999999999998766 345688887774

>3v64_C Agrin; beta propeller, laminin-G, signaling, protein binding; HET: NAG; 2.85A {Rattus norvegicus}

Probab=88.99  E-value=0.12  Score=54.40  Aligned_cols=42  Identities=24%  Similarity=0.657  Sum_probs=24.9

Q ss_pred             cccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCC
Q 004702          239 KICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNE  283 (735)
Q Consensus       239 ~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~e  283 (735)
                      ++|..++.|.+  .|.++.++|.|.|.+||...+ ....|...++
T Consensus         2 ~ec~~~~~C~~--~C~n~~g~~~C~C~~g~~l~~-d~~~C~~~~~   43 (349)
T 3v64_C            2 NECAEEGYCSQ--GCTNSEGAFQCWCEAGYELRP-DRRSCKALGP   43 (349)
T ss_dssp             -------CCSS--EECCC---CCEECCTTEEECT-TSSCEEESSS
T ss_pred             cccCCCCCCcC--eeecCCCCeEEECCCCccCCC-CCCccccccc
Confidence            56765667876  788889999999999999766 3456776554

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.07  E-value=2.2  Score=45.49  Aligned_cols=29  Identities=34%  Similarity=0.447  Sum_probs=24.6

Q ss_pred             eeecCCCCCcEEE------cCCCCeEEeeccCCcc
Q 004702          521 IIHRDVKSANILL------DENCTPKVSDFGASKL  549 (735)
Q Consensus       521 ivH~Dlk~~NILl------~~~~~~kl~DFGls~~  549 (735)
                      ++|+|+.+.|||+      +++..++++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5699999999999      4567799999988763

>1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ...

Probab=87.97  E-value=0.15  Score=56.77  Aligned_cols=33  Identities=24%  Similarity=0.607  Sum_probs=28.4

Q ss_pred             cccCCCCCCCCCCCccC-CCCcceeeCC-CCCCCCC
Q 004702          239 KICGLNASCDTPKDNTS-TSSGYRCKCN-KGYEGNP  272 (735)
Q Consensus       239 ~~C~~~~~C~~~~~c~~-~~~~y~C~C~-~Gy~gn~  272 (735)
                      ++|.+ ..|.++++|.+ ..++|.|.|. +||+|..
T Consensus         3 d~C~~-~PC~ngG~C~~~~~~~y~C~C~~~G~~G~~   37 (553)
T 1q4g_A            3 NPCCY-YPCQHQGICVRFGLDRYQCDCTRTGYSGPN   37 (553)
T ss_dssp             CGGGG-CCCCTTCEEEEETTTEEEEECTTSSEETTT
T ss_pred             CcCCC-CCCCCCCCcCCCCCCceEeeCCCCCcCCCC
Confidence            56764 55999999998 8899999999 9999976

>3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ...

Probab=86.89  E-value=0.16  Score=56.69  Aligned_cols=33  Identities=24%  Similarity=0.656  Sum_probs=27.2

Q ss_pred             cccCCCCCCCCCCCccC-CCCcceeeCC-CCCCCCC
Q 004702          239 KICGLNASCDTPKDNTS-TSSGYRCKCN-KGYEGNP  272 (735)
Q Consensus       239 ~~C~~~~~C~~~~~c~~-~~~~y~C~C~-~Gy~gn~  272 (735)
                      ++|.+ ..|.++++|.+ ..++|.|.|. +||+|..
T Consensus         2 d~C~s-~PC~ngG~C~~~~~~~y~C~C~~~G~~G~~   36 (587)
T 3nt1_A            2 NPCCS-NPCQNRGECMSTGFDQYKCDCTRTGFYGEN   36 (587)
T ss_dssp             CTTTT-CCCCTTCEEEEEETTEEEEECTTSSEETTT
T ss_pred             CCCCC-CCCCCCCEeeCCCCCCeEEecCCCCccCCC
Confidence            56864 46999999995 4479999999 9999976

>3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A

Probab=86.64  E-value=0.35  Score=34.75  Aligned_cols=28  Identities=21%  Similarity=0.408  Sum_probs=21.0

Q ss_pred             CCCCCCCCCccC--CCCcceeeCCCCCCCCC
Q 004702          244 NASCDTPKDNTS--TSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       244 ~~~C~~~~~c~~--~~~~y~C~C~~Gy~gn~  272 (735)
                      ++.|.++ +|..  ....+.|.|.+||+|..
T Consensus        13 ~~yC~nG-~C~~~~~~~~~~C~C~~gy~G~R   42 (50)
T 3e50_C           13 TQFCFHG-TCRFLVQEDKPACVCHSGYVGAR   42 (50)
T ss_pred             cCcccCC-EEeeccCCCCeEEECCCCCcccC
Confidence            4557765 6653  34679999999999976

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.21  E-value=1.1  Score=43.06  Aligned_cols=116  Identities=10%  Similarity=0.146  Sum_probs=76.1

Q ss_pred             cCCCceEEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 004702          454 INRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILL  533 (735)
Q Consensus       454 l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl  533 (735)
                      ..||+.+.. .+-.+++...+.|+.-+.+.=...+   ..++...+++++..|+....++++     -+|--|.|+||++
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f  112 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF  112 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence            367888765 4555556555555544322112223   347889999999999988866654     5688899999999


Q ss_pred             cCCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccC
Q 004702          534 DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL  601 (735)
Q Consensus       534 ~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~  601 (735)
                      +.++.++|.-.|+-..++                  |.     ..++..=.-.+=+++..+++++..|
T Consensus       113 ~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             cCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999999998777644332                  21     1111222334667788888888776

>1nzi_A Complement C1S component; calcium, innate immunity, modular structure, CUB, EGF, hydrolase; 1.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1

Probab=84.72  E-value=0.31  Score=44.70  Aligned_cols=42  Identities=19%  Similarity=0.377  Sum_probs=27.8

Q ss_pred             ccccccCC--CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc
Q 004702          236 EEAKICGL--NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD  280 (735)
Q Consensus       236 ~~~~~C~~--~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d  280 (735)
                      .+.++|..  ...|..  .|.+..++|.|.|.+||++.. ....|++
T Consensus       115 ~d~~eC~~~~~~~C~~--~C~n~~g~~~C~C~~Gy~l~~-~~~~C~~  158 (159)
T 1nzi_A          115 TDINECTDFVDVPCSH--FCNNFIGGYFCSCPPEYFLHD-DMKNCGV  158 (159)
T ss_dssp             EECCTTTC-CCCCSSS--EEEEETTEEEEECCTTCEECT-TSSCEEC
T ss_pred             ccCcccCCCCCCCCCC--cccCcCCCEEEecCCCcEECC-CCCcccc
Confidence            34456654  245754  577888899999999999654 2234543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.58  E-value=1.8  Score=41.72  Aligned_cols=114  Identities=11%  Similarity=0.100  Sum_probs=74.0

Q ss_pred             CCCceEEEceEEeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeecCCCCCcEEE
Q 004702          455 NRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS-YLHSETNVPIIHRDVKSANILL  533 (735)
Q Consensus       455 ~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~-yLH~~~~~~ivH~Dlk~~NILl  533 (735)
                      .||++  -...-.+++...+.|+.-+++.=...+   ..++...+++++..|+.... +++.     -+|--|.|+||++
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f  117 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMF  117 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEE
Confidence            57777  333335566666666655443223333   35789999999999987766 5544     6788899999999


Q ss_pred             cCCCCeEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccC
Q 004702          534 DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMAL  601 (735)
Q Consensus       534 ~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~  601 (735)
                      +.++.++|.-.|+-..+                  +|.-     .++.-=.-.+=+++..++.++..|
T Consensus       118 ~~~~~p~i~hRGi~~~l------------------pP~e-----~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          118 NRALEPFFLHVGVKESL------------------PPDE-----WDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             CTTCCEEESCCEETTTB------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             eCCCcEEEEEcCCcccC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999887765433                  2221     111111234667778888887765

>2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A

Probab=84.46  E-value=0.88  Score=39.67  Aligned_cols=27  Identities=26%  Similarity=0.527  Sum_probs=21.2

Q ss_pred             CCCCCCCccCCC--Ccc-eeeCCCCCCCCC
Q 004702          246 SCDTPKDNTSTS--SGY-RCKCNKGYEGNP  272 (735)
Q Consensus       246 ~C~~~~~c~~~~--~~y-~C~C~~Gy~gn~  272 (735)
                      .|.++++|.+..  .+| +|.|++||+|..
T Consensus         2 pC~nggtC~~~~~~~~~~~C~Cp~g~~G~~   31 (122)
T 2fd6_A            2 DCLNGGTCVSNKYFSNIHWCNCPKKFGGQH   31 (122)
T ss_dssp             CCCSSCEEEECTTTTTCEEEECCTTEESTT
T ss_pred             CCCCcCCcCCCcccCCCCCccCCCCCCCcc
Confidence            477778887663  566 999999999965

>1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C*

Probab=84.39  E-value=0.24  Score=36.22  Aligned_cols=26  Identities=27%  Similarity=0.819  Sum_probs=20.9

Q ss_pred             CCCCC--CcCC--CCCCccceeccCCCCCC
Q 004702          289 RNNCT--HICD--NIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       289 ~~~c~--~~C~--n~~g~y~C~c~~g~~~~  314 (735)
                      ..+|.  ++|.  +..++|.|.|++||+|.
T Consensus        11 ~~pC~nGG~C~~~~~~~~~~C~C~~GytG~   40 (53)
T 1nql_B           11 DGYCLHDGVCMYIEALDKYACNCVVGYIGE   40 (53)
T ss_dssp             CCEECTTCEEEEETTTTEEEEEECTTEEST
T ss_pred             CCCCCCCeEEeeecCCCCEEEecCCCCcCC
Confidence            35565  6897  67789999999999876

>2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens}

Probab=81.85  E-value=1.2  Score=32.03  Aligned_cols=28  Identities=21%  Similarity=0.474  Sum_probs=21.0

Q ss_pred             CCCCCCCCCcc--CCCCcceeeCCCCCCCCC
Q 004702          244 NASCDTPKDNT--STSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       244 ~~~C~~~~~c~--~~~~~y~C~C~~Gy~gn~  272 (735)
                      ++.|.++ +|.  ...+.+.|.|.+||+|.-
T Consensus        17 ~~yC~nG-~C~~i~~~~~~~C~C~~gy~G~R   46 (50)
T 2rnl_A           17 QNFCIHG-ECKYIEHLEAVTCKCQQEYFGER   46 (50)
T ss_dssp             GGTCSSS-EEEEETTTTEEEEECCSSCCSSS
T ss_pred             hCcCCCC-EEEEecCCCCeeEECCCCccccc
Confidence            4567764 775  455678999999999965

>1ijq_A LDL receptor, low-density lipoprotein receptor; beta-propeller, lipid transport; 1.50A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1

Probab=81.24  E-value=0.44  Score=49.12  Aligned_cols=36  Identities=31%  Similarity=0.692  Sum_probs=27.5

Q ss_pred             ccCCccCCC--CCCCCCcCCCCC------CccceeccCCCCCCC
Q 004702          280 DVNECEDPS--RNNCTHICDNIP------GSYTCRCRKGFHGDG  315 (735)
Q Consensus       280 di~eC~~~~--~~~c~~~C~n~~------g~y~C~c~~g~~~~~  315 (735)
                      +.++|....  ...|++.|.+++      ++|+|.|+.||....
T Consensus       266 ~~n~C~~~~~~ng~Cs~~C~~~p~~~~~~~~~~C~C~~g~~l~~  309 (316)
T 1ijq_A          266 GVNWCERTTLSNGGCQYLCLPAPQINPHSPKFTCACPDGMLLAR  309 (316)
T ss_dssp             CCCTTSSSSSGGGGCSSEEEECCCCSTTCCSEEEECCTTCEECT
T ss_pred             ccccccccccCCCCcCcccCCCccccCCCCCeEeeCCCCCEECC
Confidence            567887530  257999999886      589999999997653

>4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus}

Probab=80.68  E-value=0.85  Score=50.75  Aligned_cols=53  Identities=21%  Similarity=0.402  Sum_probs=12.7

Q ss_pred             cceeeCCCCCCCCCCCC------CCccccCCccCCCCCCCC--CcCCCC--CCccceeccCCCCCC
Q 004702          259 GYRCKCNKGYEGNPYLS------DGCRDVNECEDPSRNNCT--HICDNI--PGSYTCRCRKGFHGD  314 (735)
Q Consensus       259 ~y~C~C~~Gy~gn~y~~------~gC~di~eC~~~~~~~c~--~~C~n~--~g~y~C~c~~g~~~~  314 (735)
                      .+.|.|++||+|.....      +...++++|..   .+|.  +.|.+.  ...+.|.|++||.|.
T Consensus       459 tg~C~C~~g~~G~~Ce~C~~G~~g~~~~~~~C~~---C~C~~~gs~~~~C~~~tG~C~C~~G~~G~  521 (525)
T 4aqs_A          459 TGYCYCKRLVTGQRCDQCLPQHWGLSNDLDGCRP---CDCDLGGALNNSCSEDSGQCSCLPHMIGR  521 (525)
T ss_dssp             TCCBCBCTTCCSTTTCC-------------------------------------------------
T ss_pred             CCEEECCCCCcCCCcccCCCCccCCCCCCCCCcC---CCCCCCCccCCccCCCCCeeECCCCCcCC
Confidence            56899999999966321      00124556642   3343  233222  234589999999865

>4a0p_A LRP6, LRP-6, low-density lipoprotein receptor-related protein; signaling, WNT signalling, WNT3A, DKK1, MESD; HET: NAG; 1.90A {Homo sapiens} PDB: 3s2k_A* 3s8z_A* 3s8v_A*

Probab=80.22  E-value=0.53  Score=53.67  Aligned_cols=42  Identities=26%  Similarity=0.836  Sum_probs=33.0

Q ss_pred             ccCCccCCCCCCCCCcCCCCC-CccceeccCCCCCCCCCCCCCCcC
Q 004702          280 DVNECEDPSRNNCTHICDNIP-GSYTCRCRKGFHGDGRKDGGGCTP  324 (735)
Q Consensus       280 di~eC~~~~~~~c~~~C~n~~-g~y~C~c~~g~~~~~~~~~~gC~~  324 (735)
                      ++|+|...+ ..|++.|.+.+ ++|.|.|+.||.....  +..|..
T Consensus       264 ~~n~C~~~n-g~C~~~C~~~~~~~~~C~C~~g~~l~~d--~~~C~~  306 (628)
T 4a0p_A          264 GWNECASSN-GHCSHLCLAVPVGGFVCGCPAHYSLNAD--NRTCSA  306 (628)
T ss_dssp             CCCTTTTTG-GGCSSEEEEETTTEEEEECSTTCEECTT--SSCEEC
T ss_pred             cceEeccCC-CCcchhhhcCCCCCeeEEcCCCcEeccc--CCcCcc
Confidence            578997543 68999999999 9999999999986543  345654

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.14  E-value=0.26  Score=53.95  Aligned_cols=62  Identities=6%  Similarity=0.077  Sum_probs=19.0

Q ss_pred             cccccccccCcEEEEEEEcCC-CcEEEE------EEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEee
Q 004702          404 NYADVIGCGGSGNVYKGFLPD-RTPVAV------KKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE  468 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~-~~~vav------K~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~  468 (735)
                      .+.+.||   ||.||+|.+.. ..+|||      |+.+.  ...+....|.+|..++..++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3455676   99999999764 467888      76553  233445678899999999999999999888653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	735
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-63
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-57
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-52
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-51
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-39
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-16
d1emoa1	43	g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sa	3e-10
d1dx5i3	40	g.3.11.1 (I:423-462) Thrombomodulin, different EGF	2e-09
d1nzia2	42	g.3.11.1 (A:118-159) Complement C1S component {Hum	3e-09
d1lmja1	44	g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens	7e-09
d1uzka2	43	g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sa	1e-08
d1i0ua2	41	g.3.11.1 (A:42-82) Low density lipoprotein (LDL) r	2e-08
d1uzka1	43	g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sa	2e-08
d1apqa_	53	g.3.11.1 (A:) Complement protease C1R {Human (Homo	3e-08
d1lmja2	42	g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapien	3e-08
d1szba2	45	g.3.11.1 (A:124-168) Mannose-binding protein assoc	5e-08
d1nt0a3	45	g.3.11.1 (A:120-164) Mannose-binding protein assoc	2e-07
d3bpse1	40	g.3.11.1 (E:293-332) Low density lipoprotein (LDL)	1e-06
d2vj3a1	42	g.3.11.1 (A:411-452) Neurogenic locus notch homolo	1e-06
d1gl4a2	40	g.3.11.5 (A:359-398) EGF-like domain of nidogen-1	2e-05
d1autl2	50	g.3.11.1 (L:97-146) Activated protein c (autoproth	5e-05
d2p3ua1	51	g.3.11.1 (A:87-137) Factor X, N-terminal module {H	5e-05
d1kigl_	51	g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bo	6e-05
d1ijqa2	50	g.3.11.1 (A:643-692) Low density lipoprotein (LDL)	1e-04
d2c4fl1	37	g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrof	3e-04
d1edmb_	39	g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens	5e-04
d2vj3a2	39	g.3.11.1 (A:453-491) Neurogenic locus notch homolo	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 3e-63
 Identities = 67/270 (24%), Positives = 121/270 (44%), Gaps = 20/270 (7%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             IG G  G VYKG       V +         ++  F NE+ V+ +    N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 467 LETQVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
              Q+  +V ++    +L+ H+H  +      + + I  +TA  + YLH++    IIHRD
Sbjct: 74  TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRD 129

Query: 526 VKSANILLDENCTPKVSDFGASKLVP-IDAIQNCTVVQGTLGYLDPEYLQT---CKLTDK 581
           +KS NI L E+ T K+ DFG + +            + G++ ++ PE ++       + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189

Query: 582 SDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ 641
           SDVY+FG+VL EL+TG+       P    +     +  + +  L   L            
Sbjct: 190 SDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLSPDLSKV-----RSNC 238

Query: 642 LKEVAKLAARCISVRGEERPTMKEVSLELQ 671
            K + +L A C+  + +ERP   ++   ++
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 2e-59
 Identities = 64/267 (23%), Positives = 124/267 (46%), Gaps = 22/267 (8%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           + +G G  G V+ G+    T VAVK  K       D F+ E  ++ Q+  + +VRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHR 524
            +  +  ++ E++ NG+L + +       L+  + L + A+ A  ++++        IHR
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ +  + K++DFG ++L+  +        +  + +  PE +     T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193

Query: 585 YSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE 644
           +SFG++L E++T        +           + +L++   +   DN           +E
Sbjct: 194 WSFGILLTEIVTHG------RIPYPGMTNPEVIQNLERGYRMVRPDNC---------PEE 238

Query: 645 VAKLAARCISVRGEERPTMKEVSLELQ 671
           + +L   C   R E+RPT   +   L+
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 7e-59
 Identities = 68/301 (22%), Positives = 120/301 (39%), Gaps = 38/301 (12%)

Query: 397 EIKTVTNNY--ADVIGCGGSGNVYKGF-LPDRTPVAVKK-SKFVDQAKIDEFINELVVVL 452
           E+K   +++     +G G  G V+K    P    +A K     +  A  ++ I EL V+ 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59

Query: 453 QINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSY 512
           + N   +V   G         +  E +  G+L + + K G +  +   +++      L+Y
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 513 LHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
           L  +    I+HRDVK +NIL++     K+ DFG S  +      +     GT  Y+ PE 
Sbjct: 120 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPER 174

Query: 573 LQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEE-----------------------E 609
           LQ    + +SD++S G+ LVE+  G+  +     +E                        
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 610 RSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL----KEVAKLAARCISVRGEERPTMKE 665
           R L+   + S     + E+LD  +     K        E      +C+     ER  +K+
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 666 V 666
           +
Sbjct: 295 L 295

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 1e-57
 Identities = 65/268 (24%), Positives = 120/268 (44%), Gaps = 28/268 (10%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             IG G  G+V  G       VAVK  K  + A    F+ E  V+ Q+   N+V+LLG  
Sbjct: 13  QTIGKGEFGDVMLGDYRGN-KVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 467 LETQVPL-LVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIH 523
           +E +  L +V E++  G+L +++  +G   L  +  L+ + +    + YL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 126

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+ + N+L+ E+   KVSDFG +K             +  + +  PE L+  K + KSD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREKKFSTKSD 182

Query: 584 VYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           V+SFG++L E+ +         P ++       +  +++   ++  D             
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDGC---------PP 227

Query: 644 EVAKLAARCISVRGEERPTMKEVSLELQ 671
            V ++   C  +    RP+  ++  +L+
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 5e-57
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 20/266 (7%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             IG G  G V+ G+  ++  VA+K  +       ++FI E  V+++++   +V+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGNL-SWERRLRITAETAGVLSYLHSETNVPIIHRD 525
           LE     LV+EF+ +G L +++  +  L + E  L +  +   V   +       +IHRD
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD---VCEGMAYLEEACVIHRD 126

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           + + N L+ EN   KVSDFG ++ V  D   + T  +  + +  PE     + + KSDV+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186

Query: 586 SFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV 645
           SFGV++ E+ +       ++   E               ++E +         +     V
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSE---------------VVEDISTGFRLYKPRLASTHV 231

Query: 646 AKLAARCISVRGEERPTMKEVSLELQ 671
            ++   C   R E+RP    +  +L 
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 5e-56
 Identities = 68/287 (23%), Positives = 124/287 (43%), Gaps = 29/287 (10%)

Query: 392 IFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPDR---TPVAVK--KSKFVDQAKIDEFIN 446
           ++ + ++ T+ +     +G G  G V KG+   +     VAVK  K++  D A  DE + 
Sbjct: 1   VYLDRKLLTLEDK---ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA 57

Query: 447 ELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAET 506
           E  V+ Q++   +VR++G C E +  +LV E    G L +++ +  ++  +  + +  + 
Sbjct: 58  EANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116

Query: 507 AGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT--VVQGT 564
           +  + YL        +HRD+ + N+LL      K+SDFG SK +  D          +  
Sbjct: 117 SMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173

Query: 565 LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR 624
           + +  PE +   K + KSDV+SFGV++ E  +            E        + L++  
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGE 227

Query: 625 LLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
            +                +E+  L   C +   E RP    V L L+
Sbjct: 228 RMGCPAG---------CPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (487), Expect = 5e-56
 Identities = 66/288 (22%), Positives = 111/288 (38%), Gaps = 35/288 (12%)

Query: 388 EKAKIFTEEEIKTVTNNYAD--VIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKI 441
           + A++F +++ + +   ++D   IG G  G VY    + +   VA+K    S      K 
Sbjct: 3   DVAELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59

Query: 442 DEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLR 501
            + I E+  + ++   N ++  GC L      LV E+            K  L       
Sbjct: 60  QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV 561
           +T      L+YLHS     +IHRDVK+ NILL E    K+ DFG++ +     +      
Sbjct: 120 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPANSF 171

Query: 562 QGTLGYLDPEYLQTC---KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
            GT  ++ PE +      +   K DV+S G+  +EL   K  L +               
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------- 222

Query: 619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                 L  I  N      +    +        C+    ++RPT + +
Sbjct: 223 ------LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 7e-56
 Identities = 63/267 (23%), Positives = 117/267 (43%), Gaps = 22/267 (8%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             +G G  G V+ G     T VA+K  K       + F+ E  V+ ++    +V+L    
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81

Query: 467 LETQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIHR 524
            E  +  +V E++  G+L + +  +    L   + + + A+ A  ++Y+     +  +HR
Sbjct: 82  SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+++ANIL+ EN   KV+DFG ++L+  +        +  + +  PE     + T KSDV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197

Query: 585 YSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKE 644
           +SFG++L EL T            E               +L+ ++         +  + 
Sbjct: 198 WSFGILLTELTTKGRVPYPGMVNRE---------------VLDQVERGYRMPCPPECPES 242

Query: 645 VAKLAARCISVRGEERPTMKEVSLELQ 671
           +  L  +C     EERPT + +   L+
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 8e-56
 Identities = 80/318 (25%), Positives = 143/318 (44%), Gaps = 29/318 (9%)

Query: 375 LRQELSKLHGQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPD----RTPVAV 430
           +  +LS L+ +  +  +        ++  ++ +VIG G  G VY G L D    +   AV
Sbjct: 2   VHIDLSALNPELVQAVQ-HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60

Query: 431 KK-SKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ-VPLLVYEFVGNGTLFEHI 488
           K  ++  D  ++ +F+ E +++   +  NV+ LLG CL ++  PL+V  ++ +G L   I
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120

Query: 489 H-KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGAS 547
             +  N + +  +    + A     +    +   +HRD+ + N +LDE  T KV+DFG +
Sbjct: 121 RNETHNPTVKDLIGFGLQVA---KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177

Query: 548 KLVP---IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSD 604
           + +     D++ N T  +  + ++  E LQT K T KSDV+SFGV+L EL+T        
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG------ 231

Query: 605 KPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMK 664
            P        +    L Q R L   +              + ++  +C   + E RP+  
Sbjct: 232 APPYPDVNTFDITVYLLQGRRLLQPEY---------CPDPLYEVMLKCWHPKAEMRPSFS 282

Query: 665 EVSLELQGRLSLMSNGQY 682
           E+   +    S      Y
Sbjct: 283 ELVSRISAIFSTFIGEHY 300

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-55
 Identities = 60/288 (20%), Positives = 116/288 (40%), Gaps = 26/288 (9%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
           + IG G  G V++G       VAVK      + +      E+   + +   N++  +   
Sbjct: 9   ESIGKGRFGEVWRGKWRGE-EVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 467 LETQ----VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE-----T 517
            +         LV ++  +G+LF+++++   ++ E  +++   TA  L++LH E      
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQG 125

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ---NCTVVQGTLGYLDPEYLQ 574
              I HRD+KS NIL+ +N T  ++D G +                  GT  Y+ PE L 
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185

Query: 575 TC------KLTDKSDVYSFGVVLVELLTGKMALLSDK----PEEERSLAMNFLSSLKQNR 624
                   +   ++D+Y+ G+V  E+          +    P  +   +   +  +++  
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245

Query: 625 LLEILDNRIVNDG-NKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
             + L   I N   + + L+ +AK+   C    G  R T   +   L 
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 6e-55
 Identities = 68/264 (25%), Positives = 112/264 (42%), Gaps = 27/264 (10%)

Query: 407 DVIGCGGSGNVYKGFLP-DRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
             +G G  GNVY       +  +A+K   K++        +   E+ +   +   N++RL
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G   +     L+ E+   GT++  + K      +R      E A  LSY HS+    +I
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVI 128

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+K  N+LL      K++DFG S   P       T + GTL YL PE ++     +K 
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGRMHDEKV 185

Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           D++S GV+  E L GK    ++  +E          + K+   +E      V +      
Sbjct: 186 DLWSLGVLCYEFLVGKPPFEANTYQE----------TYKRISRVEFTFPDFVTE------ 229

Query: 643 KEVAKLAARCISVRGEERPTMKEV 666
                L +R +     +RP ++EV
Sbjct: 230 -GARDLISRLLKHNPSQRPMLREV 252

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 6e-55
 Identities = 64/270 (23%), Positives = 119/270 (44%), Gaps = 26/270 (9%)

Query: 409 IGCGGSGNVYKGFLPDR---TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           +GCG  G+V +G    R     VA+K   +  ++A  +E + E  ++ Q++   +VRL+G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
            C + +  +LV E  G G L + +  K+  +       +  + +  + YL  +     +H
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVH 132

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPID--AIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           RD+ + N+LL      K+SDFG SK +  D       +  +  L +  PE +   K + +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192

Query: 582 SDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ 641
           SDV+S+GV + E L+            E       ++ ++Q + +E              
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMECPPE---------C 237

Query: 642 LKEVAKLAARCISVRGEERPTMKEVSLELQ 671
             E+  L + C   + E+RP    V   ++
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 6e-55
 Identities = 61/261 (23%), Positives = 112/261 (42%), Gaps = 20/261 (7%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCC 466
             +G G  G V  G    +  VA+K  K       DEFI E  V++ ++   +V+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 467 LETQVPLLVYEFVGNGTLFEHIH-KKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            + +   ++ E++ NG L  ++   +     ++ L +  +    + YL S+     +HRD
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRD 125

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           + + N L+++    KVSDFG S+ V  D   +    +  + +  PE L   K + KSD++
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185

Query: 586 SFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV 645
           +FGV++ E+ +            E                 E +   +         ++V
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSE---------------TAEHIAQGLRLYRPHLASEKV 230

Query: 646 AKLAARCISVRGEERPTMKEV 666
             +   C   + +ERPT K +
Sbjct: 231 YTIMYSCWHEKADERPTFKIL 251

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (476), Expect = 9e-55
 Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 22/268 (8%)

Query: 407 DVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
             +G G  G VY+G        VAVK  K  D  +++EF+ E  V+ +I   N+V+LLG 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLHSETNVPIIH 523
           C       ++ EF+  G L +++ +     +S    L +  + +  + YL  +     IH
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 138

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+ + N L+ EN   KV+DFG S+L+  D        +  + +  PE L   K + KSD
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198

Query: 584 VYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK 643
           V++FGV+L E+ T  M+        +               + E+L+     +  +   +
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDYRMERPEGCPE 243

Query: 644 EVAKLAARCISVRGEERPTMKEVSLELQ 671
           +V +L   C      +RP+  E+    +
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-54
 Identities = 61/267 (22%), Positives = 108/267 (40%), Gaps = 27/267 (10%)

Query: 408 VIGCGGSGNVYKGFLPD-RTPVAVKK--SKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
            IG G    VYKG   +    VA  +   + + +++   F  E  ++  +   N+VR   
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 465 CCLET----QVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
               T    +  +LV E + +GTL  ++ +   +  +       +    L +LH+    P
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPP 134

Query: 521 IIHRDVKSANILL-DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLT 579
           IIHRD+K  NI +     + K+ D G + L           V GT  ++ PE  +  K  
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYD 190

Query: 580 DKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK 639
           +  DVY+FG+ ++E+ T +       P  E   A      +         D   +     
Sbjct: 191 ESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSGVKPASFDKVAI----- 239

Query: 640 QQLKEVAKLAARCISVRGEERPTMKEV 666
               EV ++   CI    +ER ++K++
Sbjct: 240 ---PEVKEIIEGCIRQNKDERYSIKDL 263

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (469), Expect = 1e-53
 Identities = 64/303 (21%), Positives = 121/303 (39%), Gaps = 39/303 (12%)

Query: 393 FTEEEIKTVTNNYAD-----------VIGCGGSGNVYKGFLP----DRTPVAVKK-SKFV 436
           FT E+       +A            VIG G  G V  G L         VA+K      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 437 DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLS 495
            + +  +F++E  ++ Q +  NV+ L G   ++   +++ EF+ NG+L   + +  G  +
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
             + + +    A  + YL    ++  +HRD+ + NIL++ N   KVSDFG S+ +  D  
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 556 QNCTV----VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS 611
                     +  + +  PE +Q  K T  SDV+S+G+V+ E+++       D   ++  
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-- 241

Query: 612 LAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
                        ++  ++              + +L   C       RP   ++   L 
Sbjct: 242 -------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

Query: 672 GRL 674
             +
Sbjct: 289 KMI 291

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 5e-53
 Identities = 58/271 (21%), Positives = 111/271 (40%), Gaps = 28/271 (10%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
             IG G  G   K     D   +  K      + +A+    ++E+ ++ ++   N+VR  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 464 GCCLET--QVPLLVYEFVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLH--S 515
              ++       +V E+   G L   I K    +  L  E  LR+  +    L   H  S
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT 575
           +    ++HRD+K AN+ LD     K+ DFG ++++  D         GT  Y+ PE +  
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNR 188

Query: 576 CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN 635
               +KSD++S G +L EL        +   +E           +++ +   I       
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRI------- 234

Query: 636 DGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
               +   E+ ++  R ++++   RP+++E+
Sbjct: 235 --PYRYSDELNEIITRMLNLKDYHRPSVEEI 263

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-52
 Identities = 62/300 (20%), Positives = 117/300 (39%), Gaps = 44/300 (14%)

Query: 407 DVIGCGGSGNVYKGFL------PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINR-RN 458
             +G G  G V +              VAVK         + +  ++EL V+  +    N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 459 VVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN------------------LSWERRL 500
           +V LLG C      L++ E+   G L   + +K +                  L  E  L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA-IQNCT 559
             + + A  +++L S+     IHRD+ + NILL      K+ DFG ++ +  D+      
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS 619
             +  + ++ PE +  C  T +SDV+S+G+ L EL +   +     P +           
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---------- 255

Query: 620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSN 679
               +  +++         +    E+  +   C      +RPT K++   ++ ++S  +N
Sbjct: 256 ----KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (458), Expect = 4e-52
 Identities = 67/297 (22%), Positives = 117/297 (39%), Gaps = 50/297 (16%)

Query: 407 DVIGCGGSGNVYKGFLP------DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNV 459
             IG G  G V++   P        T VAVK   +        +F  E  ++ + +  N+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN------------------------LS 495
           V+LLG C   +   L++E++  G L E +                             LS
Sbjct: 79  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138

Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP-IDA 554
              +L I  + A  ++YL        +HRD+ + N L+ EN   K++DFG S+ +   D 
Sbjct: 139 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195

Query: 555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM 614
            +        + ++ PE +   + T +SDV+++GVVL E+ +  +        EE     
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE----- 250

Query: 615 NFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
             +  ++   +L   +N            E+  L   C S    +RP+   +   LQ
Sbjct: 251 -VIYYVRDGNILACPEN---------CPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 4e-52
 Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 22/262 (8%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           + IG G SG VY    +     VA+++     Q K +  INE++V+ +    N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRD 525
            L      +V E++  G+L + + +       +   +  E    L +LHS     +IHRD
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN---QVIHRD 141

Query: 526 VKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVY 585
           +KS NILL  + + K++DFG    +  +  +  T+V GT  ++ PE +       K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 200

Query: 586 SFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEV 645
           S G++ +E++ G+   L++ P                  L  I  N      N ++L  +
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRA---------------LYLIATNGTPELQNPEKLSAI 245

Query: 646 AK-LAARCISVRGEERPTMKEV 666
            +    RC+ +  E+R + KE+
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKEL 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-51
 Identities = 57/268 (21%), Positives = 104/268 (38%), Gaps = 27/268 (10%)

Query: 407 DVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
             +G G  G VYK    +     A K      + ++++++ E+ ++   +  N+V+LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHR 524
                   ++ EF   G +   + +    L+  +   +  +T   L+YLH      IIHR
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHR 134

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD---- 580
           D+K+ NIL   +   K++DFG S       IQ      GT  ++ PE +      D    
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 581 -KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNK 639
            K+DV+S G+ L+E+   +       P                  LL+I  +        
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRV---------------LLKIAKSEPPTLAQP 238

Query: 640 QQL-KEVAKLAARCISVRGEERPTMKEV 666
            +          +C+    + R T  ++
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-51
 Identities = 60/264 (22%), Positives = 99/264 (37%), Gaps = 21/264 (7%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDE-FINELVVVLQINRRNVVRLLG 464
             +G G  G V           VAVK           E    E+ +   +N  NVV+  G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
              E  +  L  E+   G LF+ I     +      R   +    + YLH      I HR
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHR 127

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKL-TDKS 582
           D+K  N+LLDE    K+SDFG + +   +   +    + GTL Y+ PE L+  +   +  
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187

Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           DV+S G+VL  +L G++         +                 +  + +   +  K+  
Sbjct: 188 DVWSCGIVLTAMLAGELPWDQPSDSCQ--------------EYSDWKEKKTYLNPWKKID 233

Query: 643 KEVAKLAARCISVRGEERPTMKEV 666
                L  + +      R T+ ++
Sbjct: 234 SAPLALLHKILVENPSARITIPDI 257

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 4e-51
 Identities = 60/300 (20%), Positives = 117/300 (39%), Gaps = 49/300 (16%)

Query: 407 DVIGCGGSGNVYKGFLPD------RTPVAVKK-SKFVDQAKIDEFINELVVVLQINR-RN 458
            V+G G  G V                VAVK   +  D ++ +  ++EL ++ Q+    N
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 459 VVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK-----------------------GNLS 495
           +V LLG C  +    L++E+   G L  ++  K                         L+
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 496 WERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI 555
           +E  L    + A  + +L  +     +HRD+ + N+L+      K+ DFG ++ +  D+ 
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 556 Q-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAM 614
                  +  + ++ PE L     T KSDV+S+G++L E+ +  +      P +      
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA----- 274

Query: 615 NFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL 674
                       +++ N    D      +E+  +   C +    +RP+   ++  L  +L
Sbjct: 275 ---------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 5e-51
 Identities = 65/274 (23%), Positives = 121/274 (44%), Gaps = 27/274 (9%)

Query: 408 VIGCGGSGNVYKGFLPDRT-----PVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
           VIG G  G VYKG L   +     PVA+K       + +  +F+ E  ++ Q +  N++R
Sbjct: 14  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVP 520
           L G   + +  +++ E++ NG L + + +K G  S  + + +     G+ + +    N+ 
Sbjct: 74  LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYLANMN 130

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQ--GTLGYLDPEYLQTCKL 578
            +HRD+ + NIL++ N   KVSDFG S+++  D     T       + +  PE +   K 
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190

Query: 579 TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN 638
           T  SDV+SFG+V+ E++T       +    E               +++ +++       
Sbjct: 191 TSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKAINDGFRLPTP 235

Query: 639 KQQLKEVAKLAARCISVRGEERPTMKEVSLELQG 672
                 + +L  +C       RP   ++   L  
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-50
 Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 41/286 (14%)

Query: 407 DVIGCGGSGNVYKGFLPD---RTPVAVKK-SKFVDQAKIDEFINELVVVLQINR-RNVVR 461
           DVIG G  G V K  +     R   A+K+  ++  +    +F  EL V+ ++    N++ 
Sbjct: 16  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAE 505
           LLG C       L  E+  +G L + + K                   LS ++ L   A+
Sbjct: 76  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 506 TAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTL 565
            A  + YL  +     IHRD+ + NIL+ EN   K++DFG S+   +      T+ +  +
Sbjct: 136 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPV 190

Query: 566 GYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL 625
            ++  E L     T  SDV+S+GV+L E+++            E               L
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------------L 235

Query: 626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
            E L      +       EV  L  +C   +  ERP+  ++ + L 
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-49
 Identities = 70/301 (23%), Positives = 124/301 (41%), Gaps = 33/301 (10%)

Query: 391 KIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPD-----RTPVAVKK-SKFVDQAKIDEF 444
           +I  E E K +      V+G G  G VYKG         + PVA+K+  +        E 
Sbjct: 4   RILKETEFKKI-----KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 58

Query: 445 INELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITA 504
           ++E  V+  ++  +V RLLG CL + V L+         L      K N+  +  L    
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 118

Query: 505 ETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV-PIDAIQNCTVVQG 563
           + A  ++YL       ++HRD+ + N+L+      K++DFG +KL+   +   +    + 
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175

Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN 623
            + ++  E +     T +SDV+S+GV + EL+T         P  E              
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------------- 221

Query: 624 RLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMSNGQYY 683
            +  IL+             +V  +  +C  +  + RP  +E+ +E      +  + Q Y
Sbjct: 222 -ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQRY 277

Query: 684 L 684
           L
Sbjct: 278 L 278

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-48
 Identities = 55/271 (20%), Positives = 109/271 (40%), Gaps = 25/271 (9%)

Query: 407 DVIGCGGSGNVYKGFLPDR----TPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNVVR 461
             IG G  G+V++G           VA+K        +  ++F+ E + + Q +  ++V+
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVP 520
           L+G   E  V  ++ E    G L   +  +  +L     +    + +  L+YL S+    
Sbjct: 73  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---R 128

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
            +HRD+ + N+L+  N   K+ DFG S+ +        +  +  + ++ PE +   + T 
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188

Query: 581 KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ 640
            SDV+ FGV + E+L   +         +       +  ++    L +  N         
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPPNC-------- 234

Query: 641 QLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
               +  L  +C +     RP   E+  +L 
Sbjct: 235 -PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 4e-48
 Identities = 56/265 (21%), Positives = 103/265 (38%), Gaps = 25/265 (9%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
            ++G G    V     L      A+K   K   + + K+     E  V+ +++    V+L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
                + +       +  NG L ++I K G+         TAE    L YLH +    II
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GII 130

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDK 581
           HRD+K  NILL+E+   +++DFG +K++  ++ Q       GT  Y+ PE L        
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 190

Query: 582 SDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ 641
           SD+++ G ++ +L+ G     +          +       +    +  D           
Sbjct: 191 SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD----------- 239

Query: 642 LKEVAKLAARCISVRGEERPTMKEV 666
                 L  + + +   +R   +E+
Sbjct: 240 ------LVEKLLVLDATKRLGCEEM 258

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 1e-47
 Identities = 63/275 (22%), Positives = 112/275 (40%), Gaps = 28/275 (10%)

Query: 407 DVIGCGGSGNVYKGFLPDRT----PVAVK---KSKFVDQAKIDEFINELVVVLQINRRNV 459
           + +G G  G V +G     +     VAVK            +D+FI E+  +  ++ RN+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETN 518
           +RL G  L   +  +V E    G+L + + K  G+       R   + A  + YL S+  
Sbjct: 74  IRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 130

Query: 519 VPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC--TVVQGTLGYLDPEYLQTC 576
              IHRD+ + N+LL      K+ DFG  + +P +          +    +  PE L+T 
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189

Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND 636
             +  SD + FGV L E+ T        +P    + +       K+   L   ++     
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYG-----QEPWIGLNGSQILHKIDKEGERLPRPED----- 239

Query: 637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQ 671
                 +++  +  +C + + E+RPT   +   L 
Sbjct: 240 ----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  168 bits (426), Expect = 6e-47
 Identities = 49/274 (17%), Positives = 103/274 (37%), Gaps = 24/274 (8%)

Query: 399 KTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN 455
             V ++Y   + +G G  G V++          A K      ++  +    E+  +  + 
Sbjct: 22  DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 81

Query: 456 RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLH 514
              +V L     +    +++YEF+  G LFE +  + N +S +  +    +    L ++H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 515 SETNVPIIHRDVKSANILL--DENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEY 572
                  +H D+K  NI+     +   K+ DFG +    +D  Q+  V  GT  +  PE 
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAPEV 196

Query: 573 LQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR 632
            +   +   +D++S GV+   LL+G      +  +E      +   ++  +    I +  
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE-- 254

Query: 633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                      +      + +      R T+ + 
Sbjct: 255 -----------DGKDFIRKLLLADPNTRMTIHQA 277

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  165 bits (418), Expect = 9e-47
 Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 29/286 (10%)

Query: 399 KTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVL 452
             +++ Y   +++G GG   V+    L     VAVK        D +    F  E     
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 453 QINRRNVVRLLGCCLET----QVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAG 508
            +N   +V +            +P +V E+V   TL + +H +G ++ +R + + A+   
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 509 VLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV--PIDAIQNCTVVQGTLG 566
            L++ H      IIHRDVK ANI++      KV DFG ++ +    +++     V GT  
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 567 YLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL 626
           YL PE  +   +  +SDVYS G VL E+LTG+     D P             ++++ + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP 233

Query: 627 EILDNRIVNDGNKQQLKEVAKLAARCISVRGEERP-TMKEVSLELQ 671
               +  ++        ++  +  + ++   E R  T  E+  +L 
Sbjct: 234 PSARHEGLSA-------DLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-46
 Identities = 70/299 (23%), Positives = 124/299 (41%), Gaps = 45/299 (15%)

Query: 407 DVIGCGGSGNVYKGFLP--------DRTPVAVKK-SKFVDQAKIDEFINELVVVLQINR- 456
             +G G  G V                T VAVK       +  + + I+E+ ++  I + 
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIH----------------KKGNLSWERRL 500
           +N++ LLG C +     ++ E+   G L E++                  +  LS +  +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 501 RITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP-IDAIQNCT 559
               + A  + YL S+     IHRD+ + N+L+ E+   K++DFG ++ +  ID  +  T
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS 619
             +  + ++ PE L     T +SDV+SFGV+L E+ T   +     P EE          
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 245

Query: 620 LKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS 678
                L ++L      D       E+  +   C      +RPT K++  +L   ++L S
Sbjct: 246 -----LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 1e-45
 Identities = 69/286 (24%), Positives = 122/286 (42%), Gaps = 36/286 (12%)

Query: 407 DVIGCGGSGNVYKGFL------PDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRRNV 459
             +G G  G VY+G           T VA+K  ++     +  EF+NE  V+ + N  +V
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 460 VRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN----------LSWERRLRITAETAGV 509
           VRLLG   + Q  L++ E +  G L  ++                S  + +++  E A  
Sbjct: 86  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP-IDAIQNCTVVQGTLGYL 568
           ++YL++      +HRD+ + N ++ E+ T K+ DFG ++ +   D  +        + ++
Sbjct: 146 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202

Query: 569 DPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI 628
            PE L+    T  SDV+SFGVVL E+ T           E+       L  + +  LL+ 
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRFVMEGGLLDK 256

Query: 629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL 674
            DN             + +L   C     + RP+  E+   ++  +
Sbjct: 257 PDNC---------PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (412), Expect = 2e-45
 Identities = 65/303 (21%), Positives = 111/303 (36%), Gaps = 23/303 (7%)

Query: 396 EEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKK-SKFVDQAKIDEFINELVVV 451
           ++ + + + Y   DV+G G    V        +  VA+K  +K   + K     NE+ V+
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 452 LQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLS 511
            +I   N+V L           L+ + V  G LF+ I +KG  +     R+  +    + 
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 121

Query: 512 YLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPE 571
           YLH    V    +        LDE+    +SDFG SK+   D     +   GT GY+ PE
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPE 179

Query: 572 YLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN 631
            L     +   D +S GV+   LL G      +   +     +            +I D 
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD- 238

Query: 632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE---LQGRLSLMSNGQYYLRDNV 688
                                +    E+R T ++  L+   + G  +L  N    + + +
Sbjct: 239 ------------SAKDFIRHLMEKDPEKRFTCEQA-LQHPWIAGDTALDKNIHQSVSEQI 285

Query: 689 ESN 691
           + N
Sbjct: 286 KKN 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 3e-45
 Identities = 70/294 (23%), Positives = 114/294 (38%), Gaps = 43/294 (14%)

Query: 407 DVIGCGGSGNVYKGF------LPDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINRR-N 458
             +G G  G V +              VAVK   +    ++    ++EL +++ I    N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 459 VVRLLGCCLETQVPL-LVYEFVGNGTLFEHIHKKGN----------------LSWERRLR 501
           VV LLG C +   PL ++ EF   G L  ++  K N                L+ E  + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 502 ITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP-IDAIQNCTV 560
            + + A  + +L S      IHRD+ + NILL E    K+ DFG ++ +           
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
            +  L ++ PE +     T +SDV+SFGV+L E+ +   +     P     +   F   L
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRL 250

Query: 621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL 674
           K+   +   D             E+ +    C      +RPT  E+   L   L
Sbjct: 251 KEGTRMRAPDYTT---------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  159 bits (404), Expect = 8e-45
 Identities = 65/277 (23%), Positives = 114/277 (41%), Gaps = 35/277 (12%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKK---------SKFVDQAKIDEFINELVVVLQINR 456
           +++G G S  V +    P     AVK          S    Q   +  + E+ ++ +++ 
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 457 -RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHS 515
             N+++L           LV++ +  G LF+++ +K  LS +   +I      V+  LH 
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 128

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT 575
                I+HRD+K  NILLD++   K++DFG S    +D  +    V GT  YL PE ++ 
Sbjct: 129 L---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPSYLAPEIIEC 183

Query: 576 ------CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL 629
                      + D++S GV++  LL G       K      + M+           +  
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243

Query: 630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           D              V  L +R + V+ ++R T +E 
Sbjct: 244 D-------------TVKDLVSRFLVVQPQKRYTAEEA 267

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  162 bits (410), Expect = 9e-45
 Identities = 50/279 (17%), Positives = 101/279 (36%), Gaps = 24/279 (8%)

Query: 394 TEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVV 450
            E +  +V + Y   + +G G  G V++            K              NE+ +
Sbjct: 20  VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISI 79

Query: 451 VLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGV 509
           + Q++   ++ L     +    +L+ EF+  G LF+ I  +   +S    +    +    
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 510 LSYLHSETNVPIIHRDVKSANILLD--ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGY 567
           L ++H      I+H D+K  NI+ +  +  + K+ DFG +  +  D I   T    T  +
Sbjct: 140 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEF 194

Query: 568 LDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE 627
             PE +    +   +D+++ GV+   LL+G      +   E               + ++
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------------TLQNVK 241

Query: 628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
             D     D       E        +     +R T+ + 
Sbjct: 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 5e-44
 Identities = 51/264 (19%), Positives = 100/264 (37%), Gaps = 23/264 (8%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
           + +G G  G V++      +     K  K V          E+ ++     RN++ L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 466 CLETQVPLLVYEFVGNGTLFEHIHKKGN-LSWERRLRITAETAGVLSYLHSETNVPIIHR 524
               +  ++++EF+    +FE I+     L+    +    +    L +LHS     I H 
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHF 126

Query: 525 DVKSANILLD--ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           D++  NI+     + T K+ +FG ++ +      N  ++     Y  PE  Q   ++  +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           D++S G ++  LL+G    L++  ++     MN   +  +    EI              
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI------------ 232

Query: 643 KEVAKLAARCISVRGEERPTMKEV 666
            E      R +    + R T  E 
Sbjct: 233 -EAMDFVDRLLVKERKSRMTASEA 255

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-42
 Identities = 60/278 (21%), Positives = 101/278 (36%), Gaps = 22/278 (7%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDE-----FINELVVVLQINRRNVV 460
           D +G G    VYK         VA+KK K   +++  +      + E+ ++ +++  N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 461 RLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVP 520
            LL          LV++F+              L+          T   L YLH      
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---W 120

Query: 521 IIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD 580
           I+HRD+K  N+LLDEN   K++DFG +K       +  T    T  Y  PE L   ++  
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 581 -KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL-----------SSLKQNRLLEI 628
              D+++ G +L ELL     L  D   ++ +     L            SL      + 
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 629 LDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                ++        ++  L           R T  + 
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  153 bits (388), Expect = 3e-42
 Identities = 62/267 (23%), Positives = 109/267 (40%), Gaps = 28/267 (10%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
             +G G  G V+      +    A+K   K   V   +++   +E +++  +    ++R+
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
            G   + Q   ++ +++  G LF  + K             AE    L YLHS+    II
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DII 126

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           +RD+K  NILLD+N   K++DFG +K VP         + GT  Y+ PE + T       
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKPYNKSI 182

Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           D +SFG+++ E+L G          +     +N      + R     +            
Sbjct: 183 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-----AELRFPPFFN------------ 225

Query: 643 KEVAKLAARCISVRGEERPTMKEVSLE 669
           ++V  L +R I+    +R    +   E
Sbjct: 226 EDVKDLLSRLITRDLSQRLGNLQNGTE 252

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  151 bits (383), Expect = 7e-42
 Identities = 47/274 (17%), Positives = 98/274 (35%), Gaps = 17/274 (6%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVKK--SKFVDQAKIDEFINELVVVLQINRRNVVRLLG 464
           + IG G  G VYK         A+KK   +  D+      I E+ ++ ++   N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 465 CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHR 524
                +  +LV+E +           +G L          +    ++Y H      ++HR
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHR 124

Query: 525 DVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDV 584
           D+K  N+L++     K++DFG ++   I   +    +           + + K +   D+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184

Query: 585 YSFGVVLVELLTGKMALLSDKPEEERSLAMNFL------------SSLKQNRLLEILDNR 632
           +S G +  E++ G          ++       L               K +    + +  
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244

Query: 633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                 K   +    L ++ + +   +R T K+ 
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-41
 Identities = 63/264 (23%), Positives = 99/264 (37%), Gaps = 26/264 (9%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVV-LQINRRNVVR 461
            ++G G  G V+           A+K   K   +    ++  + E  V+ L      +  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 462 LLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPI 521
           +       +    V E++  G L  HI         R     AE    L +LHS+    I
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GI 124

Query: 522 IHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDK 581
           ++RD+K  NILLD++   K++DFG  K   +   +  T   GT  Y+ PE L   K    
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYNHS 183

Query: 582 SDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ 641
            D +SFGV+L E+L G+        EE               R+      R +       
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEEL----------FHSIRMDNPFYPRWLE------ 227

Query: 642 LKEVAKLAARCISVRGEERPTMKE 665
            KE   L  +      E+R  ++ 
Sbjct: 228 -KEAKDLLVKLFVREPEKRLGVRG 250

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  149 bits (378), Expect = 3e-40
 Identities = 61/277 (22%), Positives = 103/277 (37%), Gaps = 30/277 (10%)

Query: 403 NNYA--DVIGCGGSGNVYKGFLPD-RTPVAVK---KSKFVDQAKIDEFINE---LVVVLQ 453
           N+++   +IG GG G VY     D     A+K   K +   +      +NE   L +V  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 454 INRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYL 513
            +   +V +            + + +  G L  H+ + G  S        AE    L ++
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 514 HSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL 573
           H+     +++RD+K ANILLDE+   ++SD G +               GT GY+ PE L
Sbjct: 124 HNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVL 177

Query: 574 QTCKLTD-KSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR 632
           Q     D  +D +S G +L +LL G       K +++  +    L+      L +     
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFS-- 233

Query: 633 IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE 669
                      E+  L    +      R        +
Sbjct: 234 ----------PELRSLLEGLLQRDVNRRLGCLGRGAQ 260

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 9e-40
 Identities = 63/286 (22%), Positives = 109/286 (38%), Gaps = 35/286 (12%)

Query: 397 EIK--TVTNNY---ADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVV 450
           +IK   + ++Y   + V+G G +G V + F    +   A+K  +        +   E+ +
Sbjct: 3   QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVEL 57

Query: 451 VLQINR-RNVVRLLGCC----LETQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRIT 503
             + ++  ++VR++          +  L+V E +  G LF  I  +G+   +      I 
Sbjct: 58  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117

Query: 504 AETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQNCTV 560
                 + YLHS     I HRDVK  N+L      N   K++DFG +K        + T 
Sbjct: 118 KSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 172

Query: 561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSL 620
              T  Y+ PE L   K     D++S GV++  LL G     S+                
Sbjct: 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--------- 223

Query: 621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                + +      N    +  +EV  L    +     +R T+ E 
Sbjct: 224 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-39
 Identities = 61/290 (21%), Positives = 114/290 (39%), Gaps = 27/290 (9%)

Query: 401 VTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINR 456
           V   Y     IG G  G V   +   ++  VA+KK S F  Q      + E+ ++L+   
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65

Query: 457 RNVVRLLGCCLETQVPLLVYEFVGN---GTLFEHIHKKGNLSWERRLRITAETAGVLSYL 513
            N++ +        +  +   ++     G     + K  +LS +       +    L Y+
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 514 HSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN--CTVVQGTLGYLDPE 571
           HS     ++HRD+K +N+LL+  C  K+ DFG +++   D       T    T  Y  PE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 572 YLQTCKLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD 630
            +   K   KS D++S G +L E+L+ +         ++ +  +  L S  Q  L  I++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 631 NRIVNDGNKQQLK--------------EVAKLAARCISVRGEERPTMKEV 666
            +  N       K              +   L  + ++    +R  +++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-39
 Identities = 56/283 (19%), Positives = 105/283 (37%), Gaps = 28/283 (9%)

Query: 407 DVIGCGGSGNVYKGF--LPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINR---RNV 459
             IG G  G V+K          VA+K  + +  ++      I E+ V+  +      NV
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 460 VRLLGCCLETQVP-----LLVYEFVGNGTL-FEHIHKKGNLSWERRLRITAETAGVLSYL 513
           VRL   C  ++        LV+E V      +     +  +  E    +  +    L +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 514 HSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYL 573
           HS     ++HRD+K  NIL+  +   K++DFG +++         T V  TL Y  PE L
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWYRAPEVL 187

Query: 574 QTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEI--LDN 631
                    D++S G +  E+   K         ++    ++ +    +        L  
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 632 RIVNDGNKQQLKEVAK--------LAARCISVRGEERPTMKEV 666
           +  +  + Q +++           L  +C++    +R +    
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (360), Expect = 2e-38
 Identities = 53/279 (18%), Positives = 90/279 (32%), Gaps = 27/279 (9%)

Query: 401 VTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRR 457
           V N Y     IG G  G++Y G  +     VA+K      + K  +   E  +   +   
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGG 62

Query: 458 NVVRLLG-CCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
             +  +  C  E    ++V E +G              S +  L +  +    + Y+HS+
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122

Query: 517 TNVPIIHRDVKSANIL---LDENCTPKVSDFGASKLVPIDAIQNC------TVVQGTLGY 567
                IHRDVK  N L     +     + DFG +K                  + GT  Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 568 LDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE 627
                    + + + D+ S G VL+    G +     K   +R              +  
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
           +               E A     C S+R +++P    +
Sbjct: 240 LCKG---------YPSEFATYLNFCRSLRFDDKPDYSYL 269

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  142 bits (358), Expect = 3e-38
 Identities = 43/281 (15%), Positives = 91/281 (32%), Gaps = 29/281 (10%)

Query: 401 VTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKK-SKFVDQAKIDEFINELVVVLQINR 456
           V  +Y     IG G  G +++G  L +   VA+K   +  D  ++ +      ++     
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT- 61

Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
             +  +     E    +LV + +G              S +       +    +  +H +
Sbjct: 62  -GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 517 TNVPIIHRDVKSANILLDENCTP-----KVSDFGASKLVPIDAIQNC------TVVQGTL 565
               +++RD+K  N L+    +       V DFG  K       +          + GT 
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 566 GYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL 625
            Y+        + + + D+ + G V +  L G +     K    +          K  R+
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK---------QKYERI 228

Query: 626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
            E   +  + +      +E  K      ++  +  P    +
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-38
 Identities = 65/272 (23%), Positives = 117/272 (43%), Gaps = 41/272 (15%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKK------SKFVDQAKIDEFINELVVVLQINR--R 457
            ++G GG G+VY G  + D  PVA+K       S + +         E+V++ +++    
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 458 NVVRLLGCCLETQVPLLVYEFV-GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
            V+RLL         +L+ E       LF+ I ++G L  E       +    + + H+ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129

Query: 517 TNVPIIHRDVKSANILLDEN-CTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQT 575
               ++HRD+K  NIL+D N    K+ DFG+  L+        T   GT  Y  PE+++ 
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 183

Query: 576 CKLTDKS-DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV 634
            +   +S  V+S G++L +++ G +    D+                     EI+  ++ 
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------------EIIRGQVF 222

Query: 635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
                    E   L   C+++R  +RPT +E+
Sbjct: 223 FRQRVS--SECQHLIRWCLALRPSDRPTFEEI 252

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-37
 Identities = 54/290 (18%), Positives = 108/290 (37%), Gaps = 33/290 (11%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKK--SKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
             IG G  G V+K         VA+KK   +   +      + E+ ++  +   NVV L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 464 GCCLETQVP--------LLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHS 515
             C     P         LV++F  +       +     +     R+      +L+ L+ 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM---LLNGLYY 132

Query: 516 ETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPI---DAIQNCTVVQGTLGYLDPEY 572
                I+HRD+K+AN+L+  +   K++DFG ++   +         T    TL Y  PE 
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 573 LQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN 631
           L   +      D++  G ++ E+ T    +  +  + + +L      S+       + + 
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252

Query: 632 RIVN-----DGNKQQLKEVAK----------LAARCISVRGEERPTMKEV 666
            +        G K+++K+  K          L  + + +   +R    + 
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 4e-37
 Identities = 56/288 (19%), Positives = 107/288 (37%), Gaps = 34/288 (11%)

Query: 392 IFTEEEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKK------SKFVDQAKID 442
           +F +E +    + Y   + +G G    V K          A K                +
Sbjct: 2   VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58

Query: 443 EFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRI 502
           +   E+ ++ +I   NV+ L          +L+ E V  G LF+ + +K +L+ E     
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF 118

Query: 503 TAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTP----KVSDFGASKLVPIDAIQNC 558
             +   +L+ ++   ++ I H D+K  NI+L +   P    K+ DFG +    ID     
Sbjct: 119 LKQ---ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEF 173

Query: 559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
             + GT  ++ PE +    L  ++D++S GV+   LL+G    L D  +E  +       
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233

Query: 619 SLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV 666
             +                             R +    ++R T+++ 
Sbjct: 234 EFEDEYFSNTSA-------------LAKDFIRRLLVKDPKKRMTIQDS 268

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (351), Expect = 7e-37
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 11/206 (5%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINRRNVVRL 462
             +G G  G V            A+K   K K V   +I+  +NE  ++  +N   +V+L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 463 LGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
                +     +V E+V  G +F H+ + G  S        A+      YLHS     +I
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLI 163

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           +RD+K  N+L+D+    +V+DFG +K            + GT   L PE + +       
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAV 219

Query: 583 DVYSFGVVLVELLTGKMALLSDKPEE 608
           D ++ GV++ E+  G     +D+P +
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQ 245

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 7e-37
 Identities = 47/276 (17%), Positives = 95/276 (34%), Gaps = 19/276 (6%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           + IG G  G VYK         VA+K  +     +      I E+ ++ ++N  N+V+LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 464 GCCLETQVPLLVYEFVGNGTL-FEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
                     LV+EF+      F        +          +    L++ HS     ++
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVL 124

Query: 523 HRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKS 582
           HRD+K  N+L++     K++DFG ++   +        V           L     +   
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184

Query: 583 DVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQL 642
           D++S G +  E++T +     D   ++       L +  +     +           +  
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244

Query: 643 K------------EVAKLAARCISVRGEERPTMKEV 666
           +            +   L ++ +     +R + K  
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-36
 Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 10/212 (4%)

Query: 403 NNY--ADVIGCGGSGNVYKGF-LPDRTPVAVK---KSKFVDQAKIDEFINELVVVLQINR 456
           N++    ++G G  G V            A+K   K   + + ++   + E  V+     
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE 516
             +  L            V E+   G LF H+ ++   + ER     AE   ++S L   
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE---IVSALEYL 121

Query: 517 TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTC 576
            +  +++RD+K  N++LD++   K++DFG  K    D     T   GT  YL PE L+  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 180

Query: 577 KLTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
                 D +  GVV+ E++ G++   +   E 
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 9e-36
 Identities = 47/276 (17%), Positives = 93/276 (33%), Gaps = 19/276 (6%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVK--KSKFVDQAKIDEFINELVVVLQINRRNVVRLL 463
           + IG G  G V+K         VA+K  +    D+      + E+ ++ ++  +N+VRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 464 GCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIH 523
                 +   LV+EF             G+L  E       +   +L  L    +  ++H
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ---LLKGLGFCHSRNVLH 124

Query: 524 RDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSD 583
           RD+K  N+L++ N   K+++FG ++   I        V                 +   D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184

Query: 584 VYSFGVVLVELLTGKMALLSDKPEEE------------RSLAMNFLSSLKQNRLLEILDN 631
           ++S G +  EL      L      ++                   ++ L   +   +   
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244

Query: 632 RIVNDGNKQQLKEVAK-LAARCISVRGEERPTMKEV 666
                    +L    + L    +     +R + +E 
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 9e-35
 Identities = 70/306 (22%), Positives = 112/306 (36%), Gaps = 39/306 (12%)

Query: 384 GQSSEKAKIFTEEEIKTVTNNYADVIGCGGSGNVYKGFLPD-RTPVAVKKSKFVDQAKID 442
           GQ  ++ +  +  + K        VIG G  G VY+  L D    VA+KK   V Q K  
Sbjct: 11  GQGPDRPQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKR- 58

Query: 443 EFINELVVVLQINRRNVVRLLGCCLETQVP------LLVYEFVGNGTLFEHIH---KKGN 493
               EL ++ +++  N+VRL      +          LV ++V         H    K  
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118

Query: 494 LSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPI 552
           L          +    L+Y+HS     I HRD+K  N+LLD +    K+ DFG++K + +
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-V 174

Query: 553 DAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSL 612
               N + +                 T   DV+S G VL ELL G+     D   ++   
Sbjct: 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

Query: 613 AMNFL------------SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEER 660
            +  L             +  + +  +I  +        +   E   L +R +      R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

Query: 661 PTMKEV 666
            T  E 
Sbjct: 295 LTPLEA 300

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-32
 Identities = 56/303 (18%), Positives = 102/303 (33%), Gaps = 37/303 (12%)

Query: 393 FTEEEIKTVTNNYAD------VIGCGGSGNVYKGF-LPDRTPVAVK--KSKFVDQAKIDE 443
           F  +E+                +G G  G V           VA+K     F  +     
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 444 FINELVVVLQINRRNVVRLLGCCLETQVP------LLVYEFVGNGTLFEHIHKKGNLSWE 497
              EL ++  +   NV+ LL      +         LV  F+G       + K   L  +
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGED 121

Query: 498 RRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN 557
           R   +  +    L Y+H+      IHRD+K  N+ ++E+C  K+ DFG ++       + 
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQADS---EM 175

Query: 558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL 617
              V           L   + T   D++S G ++ E++TGK         ++    M   
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235

Query: 618 SSLKQNRLLEILDNRIVN------DGNKQQLKEVAK--------LAARCISVRGEERPTM 663
            +     +  +  +   N      +  K+    +          L  + + +  E+R T 
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295

Query: 664 KEV 666
            E 
Sbjct: 296 GEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  120 bits (301), Expect = 2e-30
 Identities = 52/287 (18%), Positives = 103/287 (35%), Gaps = 38/287 (13%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR-RNVVRLLG 464
             +G G    V++   + +   V VK    +   K  +   E+ ++  +    N++ L  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPNIITLAD 97

Query: 465 CCLE--TQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPII 522
              +  ++ P LV+E V N    +       L+         E    L Y HS     I+
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IM 151

Query: 523 HRDVKSANILLD-ENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTD- 580
           HRDVK  N+++D E+   ++ D+G ++        N  V   +  +  PE L   ++ D 
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQMYDY 209

Query: 581 KSDVYSFGVVLVELLTGKMALLSDKPEEE--------------------RSLAMNFLSSL 620
             D++S G +L  ++  K          +                     ++ ++   + 
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269

Query: 621 KQNRLLEILDNRIVNDGNKQQLKEVAK-LAARCISVRGEERPTMKEV 666
              R       R V+  N+  +   A     + +    + R T +E 
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 2e-29
 Identities = 62/307 (20%), Positives = 114/307 (37%), Gaps = 44/307 (14%)

Query: 396 EEIKTVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVKK--SKFVDQAKIDEFINELVV 450
           +   TV   Y     IG G  G V   +       VA+KK    F +Q        ELV+
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 451 VLQINRRNVVRLLGCCL------ETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITA 504
           +  +N +N++ LL          E Q   LV E +          +      ER   +  
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLY 126

Query: 505 ETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGT 564
           +    + +LHS     IIHRD+K +NI++  +CT K+ DFG ++      +    V   T
Sbjct: 127 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VT 181

Query: 565 LGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL------- 617
             Y  PE +      +  D++S G ++ E++  K+        ++ +  +  L       
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241

Query: 618 ------------------SSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEE 659
                             + L   +L         ++ NK +  +   L ++ + +   +
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301

Query: 660 RPTMKEV 666
           R ++ + 
Sbjct: 302 RISVDDA 308

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 4e-29
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 14/213 (6%)

Query: 407 DVIGCGGSGNVYKGFL----PDRTPVAVK---KSKFVDQAK-IDEFINELVVVLQIN-RR 457
            V+G G  G V+              A+K   K+  V +AK  +    E  V+  I    
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 458 NVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET 517
            +V L           L+ +++  G LF H+ ++   +         E   ++  L    
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE---IVLALEHLH 146

Query: 518 NVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCK 577
            + II+RD+K  NILLD N    ++DFG SK    D  +      GT+ Y+ P+ ++   
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206

Query: 578 --LTDKSDVYSFGVVLVELLTGKMALLSDKPEE 608
                  D +S GV++ ELLTG      D  + 
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 3e-27
 Identities = 60/302 (19%), Positives = 104/302 (34%), Gaps = 35/302 (11%)

Query: 393 FTEEEIK----TVTNNYA--DVIGCGGSGNVYKGF-LPDRTPVAVK--KSKFVDQAKIDE 443
           F  +E+      V   Y     +G G  G+V   F       VAVK     F        
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 444 FINELVVVLQINRRNVVRLLGCC-----LETQVPLLVYEFVGNGTLFEHIHKKGNLSWER 498
              EL ++  +   NV+ LL        LE    + +   +  G    +I K   L+ + 
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDH 122

Query: 499 RLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC 558
              +  +    L Y+HS     IIHRD+K +N+ ++E+C  K+ DFG ++       +  
Sbjct: 123 VQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMT 176

Query: 559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS 618
             V           L         D++S G ++ ELLTG+         ++  L +  + 
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236

Query: 619 SLKQNRLLEILDNRIVNDGNKQQLK--------------EVAKLAARCISVRGEERPTMK 664
           +     L +I      N                          L  + + +  ++R T  
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

Query: 665 EV 666
           + 
Sbjct: 297 QA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 99.3 bits (246), Expect = 5e-23
 Identities = 50/314 (15%), Positives = 105/314 (33%), Gaps = 61/314 (19%)

Query: 407 DVIGCGGSGNVYKGF-LPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGC 465
             +G G    V+    + + T VA+K  +  D+   +   +E+ ++ ++N  +  +    
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 466 CLETQVPLLVYEFVGNGT----------------LFEHIHKKGNLSWERRLRITAETAGV 509
                + LL +                            ++   +      +I+ +    
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 510 LSYLHSETNVPIIHRDVKSANILLDENCTP------KVSDFGASKLVPIDAIQNCTVVQG 563
           L Y+H      IIH D+K  N+L++   +P      K++D G +        ++ T    
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEHYTNSIQ 191

Query: 564 TLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK---------------------MALL 602
           T  Y  PE L        +D++S   ++ EL+TG                      + LL
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251

Query: 603 SDKPEE---ERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLK-------EVAKLAARC 652
            + P            F +S    R +  L    + D   ++ K       E++   +  
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311

Query: 653 ISVRGEERPTMKEV 666
           + +   +R     +
Sbjct: 312 LQLDPRKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.4 bits (182), Expect = 7e-16
 Identities = 28/154 (18%), Positives = 48/154 (31%), Gaps = 21/154 (13%)

Query: 407 DVIGCGGSGNVYKGFLPDRTPVAVK----------KSKFVDQAKIDEFINELVVVLQINR 456
            ++G G    V+  +        VK          K K         F    +   +   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 457 RNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHKKGN--LSWERRLRITAETAGVLSYLH 514
           R + +L G  +        Y + GN  L E I  K    +  E    +       ++  +
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 515 SETNVPIIHRDVKSANILLDENCTPKVSDFGASK 548
                 I+H D+   N+L+ E     + DF  S 
Sbjct: 121 HR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 43

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (129), Expect = 3e-10
 Identities = 13/40 (32%), Positives = 19/40 (47%), Gaps = 1/40 (2%)

Query: 278 CRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRK 317
             D++EC++P        C N  GSY C C  G+   G +
Sbjct: 2   AVDMDECKEPD-VCKHGQCINTDGSYRCECPFGYILAGNE 40

>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Length = 40

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Thrombomodulin, different EGF-like domains
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (123), Expect = 2e-09
 Identities = 14/43 (32%), Positives = 23/43 (53%), Gaps = 3/43 (6%)

Query: 280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGC 322
           D++ECE+     C+ +C N+PG++ C C       G+  G  C
Sbjct: 1   DIDECENG--GFCSGVCHNLPGTFECICGPDSALAGQ-IGTDC 40

>d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} Length = 42

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Complement C1S component
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.0 bits (122), Expect = 3e-09
 Identities = 15/44 (34%), Positives = 18/44 (40%), Gaps = 2/44 (4%)

Query: 282 NECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCTPN 325
           NEC D     C+H C+N  G Y C C   +      D   C  N
Sbjct: 1   NECTDFVDVPCSHFCNNFIGGYFCSCPPEYFLHD--DMKNCGVN 42

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 44

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.8 bits (119), Expect = 7e-09
 Identities = 11/43 (25%), Positives = 17/43 (39%), Gaps = 1/43 (2%)

Query: 280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGC 322
           D++EC           C N PG + C+C +G+          C
Sbjct: 2   DIDECRISPDLCGRGQCVNTPGDFECKCDEGYESGFM-MMKNC 43

>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 43

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.4 bits (118), Expect = 1e-08
 Identities = 13/43 (30%), Positives = 21/43 (48%), Gaps = 2/43 (4%)

Query: 280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGC 322
           D++EC++         C N  GS+ CRC  G++ +   D   C
Sbjct: 2   DIDECQELPGLCQGGKCINTFGSFQCRCPTGYYLNE--DTRVC 42

>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Length = 41

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.6 bits (116), Expect = 2e-08
 Identities = 13/38 (34%), Positives = 23/38 (60%), Gaps = 4/38 (10%)

Query: 281 VNECEDPSRNNCTHICDNIPGSYTCRCRKGF--HGDGR 316
           ++EC+DP  + C+ +C N+ G Y C+C +GF      +
Sbjct: 1   IDECQDP--DTCSQLCVNLEGGYKCQCEEGFQLDPHTK 36

>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 43

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (116), Expect = 2e-08
 Identities = 18/44 (40%), Positives = 21/44 (47%), Gaps = 3/44 (6%)

Query: 280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCT 323
           DVNEC DP+    +  C N PGSY C C   F  +      GC 
Sbjct: 2   DVNECLDPT-TCISGNCVNTPGSYICDCPPDFELNP--TRVGCV 42

>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} Length = 53

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Complement protease C1R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (115), Expect = 3e-08
 Identities = 16/51 (31%), Positives = 22/51 (43%), Gaps = 9/51 (17%)

Query: 280 DVNECEDPSRN-------NCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCT 323
           D++EC   S++        C H+C N  G Y C CR G+      D   C 
Sbjct: 3   DLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQE--DRHSCQ 51

>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.9 bits (114), Expect = 3e-08
 Identities = 12/43 (27%), Positives = 17/43 (39%), Gaps = 2/43 (4%)

Query: 280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGC 322
           D++EC+         +C N  GSY C C  G       +   C
Sbjct: 1   DIDECQRDPLLCRGGVCHNTEGSYRCECPPGHQLSP--NISAC 41

>d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 45

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Mannose-binding protein associated serine protease 2, MASP2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.2 bits (112), Expect = 5e-08
 Identities = 13/40 (32%), Positives = 19/40 (47%), Gaps = 4/40 (10%)

Query: 281 VNECEDPSRNN--CTHICDNIPGSYTCRCRKGF--HGDGR 316
           ++EC+        C H C N  G + C CR G+  H + R
Sbjct: 1   IDECQVAPGEAPTCDHHCHNHLGGFYCSCRAGYVLHRNKR 40

>d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 45

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Mannose-binding protein associated serine protease 2, MASP2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.0 bits (109), Expect = 2e-07
 Identities = 14/45 (31%), Positives = 20/45 (44%), Gaps = 4/45 (8%)

Query: 281 VNECEDPSRNN--CTHICDNIPGSYTCRCRKGFHGDGRKDGGGCT 323
           V+EC     ++  C H C N  G Y C CR G+      +   C+
Sbjct: 1   VDECRTSLGDSVPCDHYCHNYLGGYYCSCRVGYILHQ--NKHTCS 43

>d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Length = 40

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (102), Expect = 1e-06
 Identities = 13/37 (35%), Positives = 19/37 (51%), Gaps = 2/37 (5%)

Query: 281 VNECEDPSRNNCTHICDNIPGSYTCRCRKGFH-GDGR 316
            NEC D +   C+H+C+++   Y C C  GF     R
Sbjct: 2   TNECLD-NNGGCSHVCNDLKIGYECLCPDGFQLVAQR 37

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (102), Expect = 1e-06
 Identities = 15/38 (39%), Positives = 22/38 (57%), Gaps = 3/38 (7%)

Query: 279 RDVNECEDPSRNNCTH--ICDNIPGSYTCRCRKGFHGD 314
           +DV+EC   + N C H   C N  GS+ C+C +G+ G 
Sbjct: 1   QDVDECSLGA-NPCEHAGKCINTLGSFECQCLQGYTGP 37

>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 40

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-like domain of nidogen-1
domain: EGF-like domain of nidogen-1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 40.2 bits (94), Expect = 2e-05
 Identities = 11/43 (25%), Positives = 20/43 (46%), Gaps = 7/43 (16%)

Query: 284 CEDPSRNNCTH--ICDNIPGSYTCRCRKGFHGDGRKDGGGCTP 324
           C + +R+ C+    C +    + CRC   + G+GR+    C  
Sbjct: 2   CAN-NRHQCSVHAECRDYATGFCCRCVANYTGNGRQ----CVA 39

>d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} Length = 50

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Activated protein c (autoprothrombin IIa)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (92), Expect = 5e-05
 Identities = 9/29 (31%), Positives = 10/29 (34%), Gaps = 2/29 (6%)

Query: 290 NNCTHICDNIPGSYTCRCRKGF--HGDGR 316
             CTH C    G   C C  G+    D  
Sbjct: 7   GGCTHYCLEEVGWRRCSCAPGYKLGDDLL 35

>d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Length = 51

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (91), Expect = 5e-05
 Identities = 9/35 (25%), Positives = 13/35 (37%), Gaps = 2/35 (5%)

Query: 290 NNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCTP 324
            +C   C     S  C C +G+      +G  C P
Sbjct: 8   GDCDQFCHEEQNSVVCSCARGYTLA--DNGKACIP 40

>d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} Length = 51

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 39.0 bits (91), Expect = 6e-05
 Identities = 6/29 (20%), Positives = 8/29 (27%), Gaps = 2/29 (6%)

Query: 290 NNCTHICDNIPGSYTCRCRKGF--HGDGR 316
             C   C        C C  G+    D +
Sbjct: 6   GGCDQFCREERSEVRCSCAHGYVLGDDSK 34

>d1ijqa2 g.3.11.1 (A:643-692) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Length = 50

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (88), Expect = 1e-04
 Identities = 13/47 (27%), Positives = 19/47 (40%), Gaps = 10/47 (21%)

Query: 281 VNECEDPSRNN--CTHIC------DNIPGSYTCRCRKGF--HGDGRK 317
           VN CE  + +N  C ++C      +     +TC C  G     D R 
Sbjct: 1   VNWCERTTLSNGGCQYLCLPAPQINPHSPKFTCACPDGMLLARDMRS 47

>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} Length = 37

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Pig (Sus scrofa) [TaxId: 9823]

 Score = 36.6 bits (85), Expect = 3e-04
 Identities = 11/36 (30%), Positives = 16/36 (44%), Gaps = 3/36 (8%)

Query: 280 DVNECE-DPSRNNCTHICDNIPGSYTCRCRKGFHGD 314
           D ++C   P +N  +  C +   SY C C   F G 
Sbjct: 1   DGDQCASSPCQNGGS--CKDQLQSYICFCLPAFEGR 34

>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} Length = 39

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.8 bits (83), Expect = 5e-04
 Identities = 13/36 (36%), Positives = 18/36 (50%), Gaps = 3/36 (8%)

Query: 280 DVNECE-DPSRNNCTHICDNIPGSYTCRCRKGFHGD 314
           D ++CE +P  N  +  C +   SY C C  GF G 
Sbjct: 2   DGDQCESNPCLNGGS--CKDDINSYECWCPFGFEGK 35

>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 39

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 33.9 bits (78), Expect = 0.002
 Identities = 13/35 (37%), Positives = 19/35 (54%), Gaps = 3/35 (8%)

Query: 281 VNECE-DPSRNNCTHICDNIPGSYTCRCRKGFHGD 314
           VNEC  +P +N+ T  C +  G + C C  G+ G 
Sbjct: 1   VNECVSNPCQNDAT--CLDQIGEFQCICMPGYEGV 33

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	735
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1emoa1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	98.47
d1dx5i3	40	Thrombomodulin, different EGF-like domains {Human	98.18
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.14
d1uzka1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	98.1
d1uzka2	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	98.09
d1lmja1	44	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	98.07
d1apqa_	53	Complement protease C1R {Human (Homo sapiens) [Tax	97.97
d1lmja2	42	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.94
d1emoa1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.92
d1i0ua2	41	Low density lipoprotein (LDL) receptor, different	97.89
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	97.87
d1nzia2	42	Complement C1S component {Human (Homo sapiens) [Ta	97.79
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.77
d1i0ua2	41	Low density lipoprotein (LDL) receptor, different	97.76
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	97.68
d1nt0a3	45	Mannose-binding protein associated serine protease	97.63
d1lmja1	44	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.61
d1szba2	45	Mannose-binding protein associated serine protease	97.6
d1dx5i3	40	Thrombomodulin, different EGF-like domains {Human	97.58
d1uzka1	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.54
d1edmb_	39	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	97.5
d2c4fl1	37	Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}	97.48
d3bpse1	40	Low density lipoprotein (LDL) receptor, different	97.4
d1lmja2	42	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.39
d2vj3a2	39	Neurogenic locus notch homolog protein 1, Notch1 {	97.36
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.36
d1uzka2	43	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	97.34
d1xkba1	39	Factor X, N-terminal module {Human (Homo sapiens)	97.28
d1apqa_	53	Complement protease C1R {Human (Homo sapiens) [Tax	97.2
d2vj3a3	35	Neurogenic locus notch homolog protein 1, Notch1 {	97.08
d1gl4a2	40	EGF-like domain of nidogen-1 {Mouse (Mus musculus)	96.98
d1nt0a3	45	Mannose-binding protein associated serine protease	96.92
d1g1sa2	40	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	96.92
d1szba2	45	Mannose-binding protein associated serine protease	96.88
d1nzia2	42	Complement C1S component {Human (Homo sapiens) [Ta	96.74
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.71
d1kigl_	51	Factor X, N-terminal module {Cow (Bos taurus) [Tax	96.66
d3bpse1	40	Low density lipoprotein (LDL) receptor, different	96.53
d1g1ta2	39	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	96.5
d1tpga1	41	Plasminogen activator (tissue-type), t-PA {Human (	96.46
d2c4fl1	37	Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}	96.42
d1edmb_	39	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	96.4
d1autl2	50	Activated protein c (autoprothrombin IIa) {Human (	96.22
d2vj3a2	39	Neurogenic locus notch homolog protein 1, Notch1 {	96.19
d1gl4a2	40	EGF-like domain of nidogen-1 {Mouse (Mus musculus)	96.07
d1autl1	48	Activated protein c (autoprothrombin IIa) {Human (	95.93
d2p3ua1	51	Factor X, N-terminal module {Human (Homo sapiens)	95.9
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.83
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	95.78
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	95.59
d1q4ga2	42	Prostaglandin H2 synthase-1, EGF-like module {Shee	95.34
d1cvua2	41	Prostaglandin H2 synthase-1, EGF-like module {Mous	95.34
d1autl2	50	Activated protein c (autoprothrombin IIa) {Human (	95.23
d3egfa_	53	Epidermal growth factor, EGF {Mouse (Mus musculus)	95.17
d1kigl_	51	Factor X, N-terminal module {Cow (Bos taurus) [Tax	95.1
d1xkba1	39	Factor X, N-terminal module {Human (Homo sapiens)	95.09
d2p3ua1	51	Factor X, N-terminal module {Human (Homo sapiens)	95.02
d1ijqa2	50	Low density lipoprotein (LDL) receptor, different	94.86
d1ijqa2	50	Low density lipoprotein (LDL) receptor, different	94.76
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.57
d2vj3a3	35	Neurogenic locus notch homolog protein 1, Notch1 {	94.41
d1autl1	48	Activated protein c (autoprothrombin IIa) {Human (	94.35
d1haea_	63	Heregulin-alpha, EGF-like domain {Human (Homo sapi	94.15
d1nqlb_	48	Epidermal growth factor, EGF {Human (Homo sapiens)	93.98
d1rfnb_	57	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	93.96
d1ioxa_	50	Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]	91.19
d2bz6l1	53	Coagulation factor VIIa {Human (Homo sapiens) [Tax	90.7
d1k36a_	46	Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI	90.56
d1moxc_	49	Transforming growth factor alpha {Human (Homo sapi	90.55
d1g1ta2	39	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	90.47
d1g1sa2	40	E-selectin, EGF-domain {Human (Homo sapiens) [TaxI	90.19
d1rfnb_	57	Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606	89.93
d2bz6l1	53	Coagulation factor VIIa {Human (Homo sapiens) [Tax	88.74
d1q4ga2	42	Prostaglandin H2 synthase-1, EGF-like module {Shee	86.37
d2i9aa1	40	Plasminogen activator (urokinase-type) {Human (Hom	82.94

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-51  Score=420.17  Aligned_cols=254  Identities=26%  Similarity=0.424  Sum_probs=201.0

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      +.+.+.||+|+||+||+|.+.++..||||+++... ...++|.+|+.++++++|||||+++|++.+.+..++||||+++|
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g   85 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG   85 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence            45677999999999999999888899999987533 33578999999999999999999999999999999999999999


Q ss_pred             chhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|.+++... ..+++..+++|+.|+|.||+|||+++   |+||||||+||||++++++||+|||+++.............
T Consensus        86 ~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~  162 (263)
T d1sm2a_          86 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  162 (263)
T ss_dssp             BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred             cHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence            999998765 57899999999999999999999998   99999999999999999999999999987765544444455


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQ  641 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  641 (735)
                      .||+.|+|||.+.+..++.|+||||||++||||+|+..|+........  ....    +..         ......+...
T Consensus       163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--~~~~----i~~---------~~~~~~p~~~  227 (263)
T d1sm2a_         163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVED----IST---------GFRLYKPRLA  227 (263)
T ss_dssp             --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--HHHH----HHH---------TCCCCCCTTS
T ss_pred             ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--HHHH----HHh---------cCCCCCcccc
Confidence            689999999999999999999999999999999996555444333221  1111    111         1111122334


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          642 LKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       642 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ++++.+|+.+||+.||++||||+||++.|+++++
T Consensus       228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            5689999999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-51  Score=420.89  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=214.1

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      ||....+.+.+.||+|+||+||+|.++++..||||+++... ...++|.+|+.+|++++|||||+++|++.+ +..++||
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            45555667788999999999999999888899999987533 345789999999999999999999998865 5668999


Q ss_pred             EecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          477 EFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       477 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||+++|+|.+++...  ..+++..+++|+.||++||+|||+++   |+||||||+||||++++.+||+|||+++......
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence            999999999988654  36999999999999999999999998   9999999999999999999999999999876555


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      ........||+.|||||.+.+..++.++||||||++||||+||..|+........  .    ...+..         ...
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~----~~~i~~---------~~~  228 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--V----IQNLER---------GYR  228 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--H----HHHHHT---------TCC
T ss_pred             cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--H----HHHHHh---------cCC
Confidence            4444556689999999999998999999999999999999997666554433221  1    111111         111


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ...+...++++.+|+.+||+.+|++||||.||++.|+.+..
T Consensus       229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            12223455689999999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.2e-51  Score=423.67  Aligned_cols=264  Identities=27%  Similarity=0.400  Sum_probs=222.2

Q ss_pred             cCHHHHHhhhccccccccccCcEEEEEEEcC-CCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCc
Q 004702          393 FTEEEIKTVTNNYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQV  471 (735)
Q Consensus       393 ~~~~ei~~~~~~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  471 (735)
                      +..+||....+.+.+.||+|+||+||+|.+. ++..||||+++.. ....++|.+|+.+|++++|||||+++|++.+.+.
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            4445666667778899999999999999865 5788999998753 3346789999999999999999999999999999


Q ss_pred             eeEEEEecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          472 PLLVYEFVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      .++||||+++|+|.+++...  ..+++..++.|+.||++||+|||+++   |+||||||+||||++++++||+|||+++.
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence            99999999999999999764  57999999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          550 VPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       550 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      ...+.........|++.|+|||.+.+..++.|+||||||++||||++|..|+.........               .+++
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~---------------~~~i  229 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELL  229 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---------------HHHH
T ss_pred             cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH---------------HHHH
Confidence            7665555555556899999999999999999999999999999999987776554432211               1112


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ......+.+...++++.+|+.+||+.||++|||+.||++.|+.+++
T Consensus       230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            2222233334456789999999999999999999999999987654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=418.48  Aligned_cols=263  Identities=26%  Similarity=0.412  Sum_probs=208.1

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      ||....+.+.+.||+|+||+||+|++++  .||||+++.  .+....+.|.+|+.+|++++|||||+++|++.+ +..++
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            3444556778899999999999998754  599999864  355667899999999999999999999998765 56799


Q ss_pred             EEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          475 VYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      ||||+++|+|.++++.. ..+++..++.|+.||++||+|||+++   ||||||||+||||+.++.+||+|||+++.....
T Consensus        81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            99999999999999764 57999999999999999999999998   999999999999999999999999999876543


Q ss_pred             c-ccceeeeccccCccCcccccC---CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          554 A-IQNCTVVQGTLGYLDPEYLQT---CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       554 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      . ........||+.|||||++.+   ..++.++||||||++||||+||+.||...........  ..........+    
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~--~~~~~~~~p~~----  231 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF--MVGRGYLSPDL----  231 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH--HHHHTSCCCCG----
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH--HHhcCCCCCcc----
Confidence            2 223345569999999999864   3588999999999999999999999976544332111  11111111111    


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                           ...+...++++.+|+.+||+.+|++||||.||++.|+.+.+.
T Consensus       232 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         232 -----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             -----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence                 111233457899999999999999999999999999987764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-50  Score=420.29  Aligned_cols=256  Identities=24%  Similarity=0.361  Sum_probs=203.1

Q ss_pred             hccccccccccCcEEEEEEEcCC-C---cEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPD-R---TPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~-~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      .+.+.++||+|+||+||+|.+.. +   ..||||++.. ......++|.+|+.+|++++|||||+++|++.+.+..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            34556799999999999998643 2   3589998764 45566788999999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+++|+|.+++... ..+++.++++|+.||++||+|||+++   |+||||||+||||+.++++||+|||+++.+.....
T Consensus       107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            999999999988874 57999999999999999999999998   99999999999999999999999999987754332


Q ss_pred             cc----eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          556 QN----CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       556 ~~----~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      ..    .....||+.|||||.+.+..++.++||||||++||||+| |+.||......+...       .+         .
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~-------~i---------~  247 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN-------AI---------E  247 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-------HH---------H
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHH-------HH---------H
Confidence            21    122457899999999999999999999999999999998 899987654432111       11         1


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .....+.+...+.++.+|+.+||+.||++||||.||++.|+.+++.
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            1122223345567899999999999999999999999999988764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=404.12  Aligned_cols=250  Identities=26%  Similarity=0.411  Sum_probs=213.1

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCCC
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGNG  482 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g  482 (735)
                      ..+.++||+|+||+||+|+++++..||||+++.... ..++|++|+.++++++||||++++|++.+.+..++||||+++|
T Consensus         6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g   84 (258)
T d1k2pa_           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG   84 (258)
T ss_dssp             CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence            356789999999999999998888999999886433 3578999999999999999999999999999999999999999


Q ss_pred             chhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceeee
Q 004702          483 TLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTVV  561 (735)
Q Consensus       483 sL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~~  561 (735)
                      +|.+++.. ...+++..+++|+.|+++||+|||+.+   |+||||||+||||++++.+||+|||+++.............
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  161 (258)
T d1k2pa_          85 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS  161 (258)
T ss_dssp             EHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred             cHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence            99999765 467999999999999999999999998   99999999999999999999999999987765554444556


Q ss_pred             ccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          562 QGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       562 ~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      .||+.|+|||.+.+..++.|+||||||+++|||+| |+.||......+...       .+..+         .....+..
T Consensus       162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~-------~i~~~---------~~~~~p~~  225 (258)
T d1k2pa_         162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-------HIAQG---------LRLYRPHL  225 (258)
T ss_dssp             CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-------HHHTT---------CCCCCCTT
T ss_pred             CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH-------HHHhC---------CCCCCccc
Confidence            68999999999999999999999999999999998 788987665433211       11111         11122233


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      .++++.+|+.+||+.||++|||+.||++.|.+
T Consensus       226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            45789999999999999999999999999865

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=411.80  Aligned_cols=256  Identities=26%  Similarity=0.391  Sum_probs=204.9

Q ss_pred             ccccccccccCcEEEEEEEcCCC-----cEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDR-----TPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      +.+.++||+|+||+||+|.+++.     ..||||+++. .......+|++|+.+|++++|||||+++|++.+.+..++||
T Consensus         9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~   88 (283)
T d1mqba_           9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT   88 (283)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence            44567999999999999986542     3699999864 44555678999999999999999999999999999999999


Q ss_pred             EecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+.+++|.+++... ..+++.++++++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus        89 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          89 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             EecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            999999999988765 67999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             c--ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          556 Q--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       556 ~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      .  ......||+.|||||++.+..++.++||||||++||||+++..|+........      ..         +.+....
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~------~~---------~~i~~~~  230 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VM---------KAINDGF  230 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH---------HHHHTTC
T ss_pred             cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH------HH---------HHHhccC
Confidence            2  22334589999999999999999999999999999999997766654433221      11         1112222


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      ..+.+...+.++.+|+.+||+.+|++||||.||++.|+.+++.
T Consensus       231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            2333445567899999999999999999999999999987764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=408.63  Aligned_cols=249  Identities=28%  Similarity=0.380  Sum_probs=204.9

Q ss_pred             ccccccCcEEEEEEEcCC---CcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          407 DVIGCGGSGNVYKGFLPD---RTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~---~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      ++||+|+||+||+|.+.+   ++.||||+++.  .+....++|++|+.+|++++|||||+++|++.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            379999999999998543   46799999864  334456789999999999999999999999864 567899999999


Q ss_pred             CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc--cee
Q 004702          482 GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ--NCT  559 (735)
Q Consensus       482 gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~--~~~  559 (735)
                      |+|.+++++...+++..+++|+.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+......  ...
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            999999999889999999999999999999999998   999999999999999999999999999876543322  223


Q ss_pred             eeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          560 VVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ...||+.|||||.+.+..++.++||||||+++|||+| |+.||......+..       ..+..         ....+.+
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-------~~i~~---------~~~~~~p  232 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEK---------GERMGCP  232 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHT---------TCCCCCC
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-------HHHHc---------CCCCCCC
Confidence            3468999999999999999999999999999999998 89999765443211       11111         1112223


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                      ...+.++.+|+.+||+.||++|||+.||++.|+....
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            3456789999999999999999999999999987654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=409.66  Aligned_cols=255  Identities=26%  Similarity=0.415  Sum_probs=210.1

Q ss_pred             cccc-cccccCcEEEEEEEcC---CCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          404 NYAD-VIGCGGSGNVYKGFLP---DRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       404 ~~~~-~lG~G~~g~Vy~g~~~---~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      .+.+ +||+|+||+||+|.+.   ++..||||+++. ......++|.+|+.+|++++|||||+++|++.. +..++||||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~   89 (285)
T d1u59a_          11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM   89 (285)
T ss_dssp             EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             EECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEe
Confidence            3455 4999999999999753   355799999874 455667889999999999999999999999864 567999999


Q ss_pred             cCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc-
Q 004702          479 VGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ-  556 (735)
Q Consensus       479 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~-  556 (735)
                      +++|+|.+++... ..+++..+++|+.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+...... 
T Consensus        90 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  166 (285)
T d1u59a_          90 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  166 (285)
T ss_dssp             CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             CCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence            9999999998654 67999999999999999999999998   999999999999999999999999999977543322 


Q ss_pred             -ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          557 -NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       557 -~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                       ......||+.|||||.+.+..++.++||||||++||||+| |+.||......+..       ..+..+         ..
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-------~~i~~~---------~~  230 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQG---------KR  230 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTT---------CC
T ss_pred             ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcC---------CC
Confidence             2223458999999999999999999999999999999998 89999765443321       111111         11


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      .+.+...+.++.+|+.+||+.+|++||||.+|++.|+.....+.
T Consensus       231 ~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         231 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            22234456789999999999999999999999999998765443

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=409.18  Aligned_cols=259  Identities=25%  Similarity=0.347  Sum_probs=207.7

Q ss_pred             HHhhhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      |....+.+.+.||+|+||+||+|+++++..||||+++... ...+.|.+|+.+|++++|||||+++|++.+ +..++|||
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E   91 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   91 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence            4445677888999999999999999888899999987543 345789999999999999999999999855 56789999


Q ss_pred             ecCCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          478 FVGNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       478 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |+++|+|..++...  ..++|.+++.|+.||+.||+|||+++   |+||||||+||||++++++||+|||+++.......
T Consensus        92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence            99999999998753  57999999999999999999999998   99999999999999999999999999998765554


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      .......||+.|+|||++....++.++||||||++||||++|..|+.........      ...+.         .....
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~------~~~i~---------~~~~~  233 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVE---------RGYRM  233 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHH---------TTCCC
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH------HHHHH---------hcCCC
Confidence            4455566999999999999999999999999999999999977766554432211      11111         11122


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      +.+...++++.+|+.+||+.||++||||.+|++.|+.....
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            23344567899999999999999999999999999986654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-49  Score=405.03  Aligned_cols=248  Identities=24%  Similarity=0.347  Sum_probs=202.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..++||||++
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~   86 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   86 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence            45678999999999999985 468899999987533 3345678999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc-cccee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA-IQNCT  559 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~-~~~~~  559 (735)
                      +|+|.+++.....+++..+..++.|++.||+|||+++   |+||||||+||||++++++||+|||+++...... ....+
T Consensus        87 gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~  163 (271)
T d1nvra_          87 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  163 (271)
T ss_dssp             TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             CCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence            9999999988888999999999999999999999999   9999999999999999999999999999764332 22334


Q ss_pred             eeccccCccCcccccCCCC-CccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          560 VVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~~-~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ...||+.|||||.+.+..+ +.++||||||++||||++|+.||.........  ...    ..        .........
T Consensus       164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~~----~~--------~~~~~~~~~  229 (271)
T d1nvra_         164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSD----WK--------EKKTYLNPW  229 (271)
T ss_dssp             CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HHH----HH--------TTCTTSTTG
T ss_pred             ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HHH----Hh--------cCCCCCCcc
Confidence            5669999999999988776 67899999999999999999999654432211  100    00        111111112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVS  667 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~  667 (735)
                      ...++++.+|+.+||+.||++|||+.|++
T Consensus       230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil  258 (271)
T d1nvra_         230 KKIDSAPLALLHKILVENPSARITIPDIK  258 (271)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            23456788999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-48  Score=402.64  Aligned_cols=248  Identities=25%  Similarity=0.393  Sum_probs=207.7

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||+||+|.. .+++.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..++||||++
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            356678999999999999985 5689999999886555567789999999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      +|+|.+++.+ ..+++.++..++.||+.||+|||+++   |+||||||+||||+.++++||+|||+++.+..+... ...
T Consensus       101 gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~~~  175 (293)
T d1yhwa1         101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST  175 (293)
T ss_dssp             TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-BCC
T ss_pred             CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc-ccc
Confidence            9999998866 46999999999999999999999999   999999999999999999999999999977543322 234


Q ss_pred             eccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHH
Q 004702          561 VQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQ  640 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  640 (735)
                      ..||+.|||||.+.+..++.++||||||++||||++|+.||......+....   ...   ..        ......+..
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---~~~---~~--------~~~~~~~~~  241 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IAT---NG--------TPELQNPEK  241 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH---HC--------SCCCSSGGG
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH---HHh---CC--------CCCCCCccc
Confidence            4699999999999999999999999999999999999999976544332111   100   00        001111233


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          641 QLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       641 ~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .+.++.+|+.+||+.||.+|||+.|+++
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            4578999999999999999999999863

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=399.07  Aligned_cols=243  Identities=26%  Similarity=0.372  Sum_probs=206.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||+++. .+++.||||++...   +....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            45678999999999999986 46889999998642   223356788999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|+|.+++.....+++..+..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++......   .
T Consensus        88 ~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---~  161 (263)
T d2j4za1          88 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---R  161 (263)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC---C
T ss_pred             cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc---c
Confidence            999999999998889999999999999999999999999   9999999999999999999999999998765332   2


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....||+.|||||.+.+..++.++||||||++||||++|+.||......+...       .+...        .  ...+
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-------~i~~~--------~--~~~p  224 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-------RISRV--------E--FTFP  224 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTT--------C--CCCC
T ss_pred             cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH-------HHHcC--------C--CCCC
Confidence            34569999999999999999999999999999999999999997654332211       11111        1  1112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...++++.+|+.+||+.||++|||+.|+++
T Consensus       225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            234578899999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-48  Score=398.07  Aligned_cols=246  Identities=24%  Similarity=0.356  Sum_probs=200.6

Q ss_pred             cccccccccCcEEEEEEEcC-CCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEee----cCceeEEE
Q 004702          404 NYADVIGCGGSGNVYKGFLP-DRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE----TQVPLLVY  476 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~  476 (735)
                      .|.++||+|+||+||+|... ++..||+|++..  ......+.|.+|+++|++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45678999999999999854 578999999864  355667789999999999999999999999875    34578999


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc-CCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD-ENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGls~~~~~~~~  555 (735)
                      ||+++|+|.+++.+...+++..++.++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++.....  
T Consensus        92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--  168 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--  168 (270)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred             eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence            99999999999998889999999999999999999999976 5699999999999996 5789999999999865432  


Q ss_pred             cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          556 QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                       ......||+.|||||.+.+ .++.++||||||++||||++|+.||........  .    ...+..+....        
T Consensus       169 -~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~----~~~i~~~~~~~--------  232 (270)
T d1t4ha_         169 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I----YRRVTSGVKPA--------  232 (270)
T ss_dssp             -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H----HHHHTTTCCCG--------
T ss_pred             -ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H----HHHHHcCCCCc--------
Confidence             2234569999999999875 699999999999999999999999975443321  1    11111111100        


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+...++++.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            111223457899999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=413.43  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=208.9

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcCCC------cEEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEEee
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLPDR------TPVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLE  468 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~~~------~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~  468 (735)
                      |+....+.+.++||+|+||+||+|+....      ..||||++.. ........|.+|+.+|.++ +|||||++++++.+
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            45555667788999999999999985431      3689998764 3444567899999999998 89999999999999


Q ss_pred             cCceeEEEEecCCCchhHHhhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 004702          469 TQVPLLVYEFVGNGTLFEHIHKK-----------------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRD  525 (735)
Q Consensus       469 ~~~~~lV~E~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~D  525 (735)
                      .+..++||||+++|+|.++|+..                       ..+++..++.|+.||++||+|||+++   |||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence            99999999999999999999754                       24899999999999999999999998   99999


Q ss_pred             CCCCcEEEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCC
Q 004702          526 VKSANILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLS  603 (735)
Q Consensus       526 lk~~NILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~  603 (735)
                      |||+|||++.++.+||+|||+|+........ ......||+.|||||.+.+..++.++||||||++||||+| |+.||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876543322 2233458999999999999999999999999999999998 8999976


Q ss_pred             CChHHHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 004702          604 DKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQG  672 (735)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  672 (735)
                      ....+..               .+++......+.+...++++.+|+.+||+.+|++|||++||++.|.-
T Consensus       270 ~~~~~~~---------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         270 IPVDANF---------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCCSHHH---------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHHHH---------------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            5433211               11112222223334456789999999999999999999999999863

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=399.27  Aligned_cols=249  Identities=22%  Similarity=0.354  Sum_probs=193.8

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEee--cCceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE--TQVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~E  477 (735)
                      +.+.+.||+|+||+||+|+. .+++.||||+++.  .++...+.+.+|+++|++++|||||++++++.+  .+..++|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence            45678999999999999985 5688999999864  355667789999999999999999999999865  456789999


Q ss_pred             ecCCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          478 FVGNGTLFEHIHK----KGNLSWERRLRITAETAGVLSYLHSET--NVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       478 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      |+++|+|.+++.+    ...+++..++.++.|++.||+|||+++  ..+|+||||||+||||+.++.+||+|||+++.+.
T Consensus        86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  165 (269)
T d2java1          86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  165 (269)
T ss_dssp             CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred             cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence            9999999999864    367999999999999999999999865  2359999999999999999999999999998765


Q ss_pred             CCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       552 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      .+.. ......||+.|||||.+.+..++.++||||||++||||++|+.||......+..       ..+.....      
T Consensus       166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~-------~~i~~~~~------  231 (269)
T d2java1         166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-------GKIREGKF------  231 (269)
T ss_dssp             -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHTCC------
T ss_pred             cCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHH-------HHHHcCCC------
Confidence            4332 233456999999999999999999999999999999999999999765443211       11111111      


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                         ...+...++++.+|+.+||+.||.+|||+.|+++
T Consensus       232 ---~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 ---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               1122334578999999999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-48  Score=401.11  Aligned_cols=248  Identities=21%  Similarity=0.274  Sum_probs=205.7

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||+|+||+||+|.. .++..||||+++.......+.|.+|+++|++++|||||++++++.+.+..++||||+++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~   93 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence            44567899999999999985 46889999999877777778899999999999999999999999999999999999999


Q ss_pred             CchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          482 GTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       482 gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      |+|.+++.+ ...+++.++..++.||+.||+|||+++   |+||||||+||||+.++++||+|||+++....... ....
T Consensus        94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~~~  169 (288)
T d2jfla1          94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDS  169 (288)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HHTC
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-cccc
Confidence            999999875 457999999999999999999999999   99999999999999999999999999986533211 2233


Q ss_pred             eccccCccCccccc-----CCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          561 VQGTLGYLDPEYLQ-----TCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       561 ~~gt~~y~aPE~~~-----~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      ..||+.|||||++.     ...++.++|||||||+||||++|+.||......+....   ..    ....       ...
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~---i~----~~~~-------~~~  235 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK---IA----KSEP-------PTL  235 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---HH----HSCC-------CCC
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH---HH----cCCC-------CCC
Confidence            56999999999984     45688999999999999999999999976654432111   11    0000       011


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+...++++.+|+.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            112344578999999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-48  Score=398.86  Aligned_cols=261  Identities=21%  Similarity=0.329  Sum_probs=203.2

Q ss_pred             HHhhhccccccccccCcEEEEEEEcCC----CcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCce
Q 004702          398 IKTVTNNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVP  472 (735)
Q Consensus       398 i~~~~~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  472 (735)
                      |....+.+.+.||+|+||+||+|++..    +..||||+++. ......+.|.+|+.+|++++|||||+++|++. .+..
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            444556778899999999999998643    34689998864 34555678999999999999999999999986 4678


Q ss_pred             eEEEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          473 LLVYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       473 ~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      ++||||+++|+|.+++... ..+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999999987654 57999999999999999999999999   9999999999999999999999999999776


Q ss_pred             CCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          552 IDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       552 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      .......+...||+.|+|||.+....++.++||||||++||||++ |..||......+....       +..+       
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~-------i~~~-------  225 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------IENG-------  225 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTT-------
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-------HHcC-------
Confidence            554444455668999999999999999999999999999999998 8888876554332111       1111       


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                        ...+.+...++++.+|+.+||+.||++|||+.||++.|+.+++..+
T Consensus       226 --~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k  271 (273)
T d1mp8a_         226 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  271 (273)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence              1112233456789999999999999999999999999998876543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-48  Score=407.69  Aligned_cols=264  Identities=23%  Similarity=0.326  Sum_probs=207.2

Q ss_pred             hhhccccccccccCcEEEEEEEc-CCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEE
Q 004702          400 TVTNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       400 ~~~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      .-.+.+.++||+|+||+||+|.. .++..||+|+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            33455678999999999999985 56889999998753 44556789999999999999999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSE-TNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      |+++|+|.+++.+...+++..+..++.|++.||.|||++ +   |+||||||+||||++++++||+|||+|+.....   
T Consensus        85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  158 (322)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence            999999999999888999999999999999999999985 7   999999999999999999999999999865432   


Q ss_pred             ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHH-----------------
Q 004702          557 NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSS-----------------  619 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-----------------  619 (735)
                      ..+...||+.|||||++.+..++.++|||||||+||||++|+.||......+...........                 
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            223456999999999999999999999999999999999999999765443221110000000                 


Q ss_pred             ------hcccchhhHhhhcccC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          620 ------LKQNRLLEILDNRIVN----DGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       620 ------~~~~~~~~~~d~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                            .......+.++.....    ......+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                  0000011111110000    0011234678999999999999999999999863

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=399.81  Aligned_cols=260  Identities=29%  Similarity=0.424  Sum_probs=210.3

Q ss_pred             hhccccccccccCcEEEEEEEcCCC----cEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeec-CceeE
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPDR----TPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLET-QVPLL  474 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~l  474 (735)
                      .+.+|.++||+|+||+||+|.+.++    ..||||+++. .+....++|.+|+++|++++||||++++|++.+. ...++
T Consensus        27 ~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          27 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             ceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            3456788999999999999986442    3589999874 5666778999999999999999999999998764 57899


Q ss_pred             EEEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          475 VYEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      ||||+++|+|.++++.. ..+++..+++++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++.....
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            99999999999999865 56889999999999999999999998   999999999999999999999999999876543


Q ss_pred             ccc---ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          554 AIQ---NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       554 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      ...   ......||+.|+|||.+....++.++||||||++||||++|+.||........  ..    ..+..+.      
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~----~~i~~g~------  251 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--IT----VYLLQGR------  251 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH----HHHHTTC------
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcCC------
Confidence            222   22234589999999999999999999999999999999998888765432211  11    1111111      


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                         ....+...++++.+|+.+||+.||++||+|.||++.|+.+++...
T Consensus       252 ---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         252 ---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ---CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence               111122345689999999999999999999999999999887543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=396.82  Aligned_cols=247  Identities=21%  Similarity=0.300  Sum_probs=205.7

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.++||+|+||+||+|.. .++..||||+++..   .....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            56778999999999999985 56889999998642   233457789999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc-ccc
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA-IQN  557 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~-~~~  557 (735)
                      +++|+|.+++...+.+++..+..++.|++.||+|||+.+   |+||||||+||||++++.+||+|||+++.+.... ...
T Consensus        90 ~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~  166 (288)
T d1uu3a_          90 AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR  166 (288)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             cCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence            999999999998889999999999999999999999999   9999999999999999999999999999775432 223


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|||||++.+..++.++|||||||+||||++|+.||......+...       .+...        .  ...
T Consensus       167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-------~i~~~--------~--~~~  229 (288)
T d1uu3a_         167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ-------KIIKL--------E--YDF  229 (288)
T ss_dssp             ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHTT--------C--CCC
T ss_pred             cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH-------HHHcC--------C--CCC
Confidence            334569999999999999999999999999999999999999997654332211       11111        1  111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      +...++++.+|+.+||+.||.+|||++|++..
T Consensus       230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            22345788999999999999999999998653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-47  Score=398.30  Aligned_cols=243  Identities=26%  Similarity=0.335  Sum_probs=202.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +...+.||+|+||+||+|+. .++..||||+++..   .....+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   96 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence            45567899999999999984 56888999998643   234457799999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +.+|+|..++.....+++..++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++.....     
T Consensus        97 ~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-----  168 (309)
T d1u5ra_          97 CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  168 (309)
T ss_dssp             CSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-----
Confidence            999999888887888999999999999999999999999   999999999999999999999999999865432     


Q ss_pred             eeeccccCccCcccccC---CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccC
Q 004702          559 TVVQGTLGYLDPEYLQT---CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVN  635 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~---~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  635 (735)
                      ....||+.|||||++.+   ..++.++||||||++||||++|+.||......+...   .            +.......
T Consensus       169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~---~------------i~~~~~~~  233 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---H------------IAQNESPA  233 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---H------------HHHSCCCC
T ss_pred             CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH---H------------HHhCCCCC
Confidence            23459999999999864   468999999999999999999999997654432111   1            11111111


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          636 DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       636 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ..+...++++.+|+.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            112234578999999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-47  Score=399.71  Aligned_cols=254  Identities=26%  Similarity=0.359  Sum_probs=208.6

Q ss_pred             hccccccccccCcEEEEEEEcC------CCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.+.||+|+||+||+|++.      ++..||||+++.. .....++|.+|+.+|++++||||+++++++...+..++
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~   93 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL   93 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence            4556789999999999999853      3568999998753 44456789999999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 004702          475 VYEFVGNGTLFEHIHKK------------------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN  530 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~N  530 (735)
                      ||||+++|+|.++++..                        ..+++..++.|+.|++.||+|||+++   ||||||||+|
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~N  170 (301)
T d1lufa_          94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRN  170 (301)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccc
Confidence            99999999999999753                        24899999999999999999999998   9999999999


Q ss_pred             EEEcCCCCeEEeeccCCcccCCCc-ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCc-cCCCCChHH
Q 004702          531 ILLDENCTPKVSDFGASKLVPIDA-IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM-ALLSDKPEE  608 (735)
Q Consensus       531 ILl~~~~~~kl~DFGls~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~-p~~~~~~~~  608 (735)
                      |||+.++.+||+|||+++.+.... ....+...|++.|+|||.+.+..++.++||||||++||||++|.. ||......+
T Consensus       171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e  250 (301)
T d1lufa_         171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE  250 (301)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence            999999999999999998664332 223334568999999999999999999999999999999999864 565544333


Q ss_pred             HHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 004702          609 ERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRL  674 (735)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  674 (735)
                      ..       ..+..+..         .+.+...++++.+|+.+||+.+|++||||.||+++|+++.
T Consensus       251 ~~-------~~v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         251 VI-------YYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HH-------HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HH-------HHHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            21       11122111         1223345578999999999999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=392.30  Aligned_cols=250  Identities=25%  Similarity=0.376  Sum_probs=200.5

Q ss_pred             hhccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeec-CceeEEEEec
Q 004702          401 VTNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLET-QVPLLVYEFV  479 (735)
Q Consensus       401 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~E~~  479 (735)
                      ..+.+.+.||+|+||.||+|.++ +..||||+++..  ...++|.+|+++|++++||||++++|++.+. +..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            34557789999999999999985 678999998753  3457899999999999999999999999764 5679999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      ++|+|.++|...  ..+++..+++|+.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....    
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----
Confidence            999999999764  35999999999999999999999998   999999999999999999999999999865432    


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVND  636 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  636 (735)
                      .....+++.|+|||++.+..++.++||||||+++|||+| |+.||......+..       ..+         ......+
T Consensus       157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~-------~~i---------~~~~~~~  220 (262)
T d1byga_         157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRV---------EKGYKMD  220 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-------HHH---------TTTCCCC
T ss_pred             CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH-------HHH---------HcCCCCC
Confidence            223458899999999999999999999999999999998 67776554332211       111         1122233


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          637 GNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       637 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .+...++++.+|+.+||+.||.+||||.||+++|+++...
T Consensus       221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            3444557899999999999999999999999999987643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-47  Score=397.41  Aligned_cols=248  Identities=24%  Similarity=0.307  Sum_probs=191.0

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC-hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD-QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +.+.++||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..+|||||++
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            56778999999999999985 468899999986432 2334568899999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCCeEEeeccCCcccCCCcccc
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +|+|.++|.....+++..+..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+++.......  
T Consensus        91 gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~--  165 (307)
T d1a06a_          91 GGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--  165 (307)
T ss_dssp             SCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred             CCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCCe--
Confidence            9999999998889999999999999999999999999   99999999999994   578999999999987643322  


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|||||.+.+..++.++||||||++||||++|+.||......+....       +....      .....+.
T Consensus       166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~-------i~~~~------~~~~~~~  232 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ-------ILKAE------YEFDSPY  232 (307)
T ss_dssp             -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-------HHTTC------CCCCTTT
T ss_pred             eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH-------HhccC------CCCCCcc
Confidence            2335699999999999999999999999999999999999999976544332111       11100      0111112


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....++++.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            2344578999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.6e-46  Score=399.29  Aligned_cols=250  Identities=18%  Similarity=0.249  Sum_probs=208.9

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      .+.+.+.||+|+||+||+|.. .++..||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||++
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            456778999999999999985 5688999999987777778889999999999999999999999999999999999999


Q ss_pred             CCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCCeEEeeccCCcccCCCcccc
Q 004702          481 NGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD--ENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       481 ~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      +|+|.+++.. ...+++..+..|+.||+.||+|||+++   ||||||||+||||+  .++.+||+|||+++.+....  .
T Consensus       107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~  181 (350)
T d1koaa2         107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S  181 (350)
T ss_dssp             SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--C
T ss_pred             CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc--c
Confidence            9999999964 467999999999999999999999999   99999999999995  46789999999998765433  2


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .....||+.|||||++.+..++.++||||||+++|||++|+.||......+....+       ....      .......
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-------~~~~------~~~~~~~  248 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-------KSCD------WNMDDSA  248 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTC------CCSCCGG
T ss_pred             cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCC------CCCCccc
Confidence            34456999999999999999999999999999999999999999765443321111       1100      0001111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ....++++.+|+.+||+.||.+|||+.|+++.
T Consensus       249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            12344678999999999999999999998763

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-47  Score=396.97  Aligned_cols=263  Identities=27%  Similarity=0.328  Sum_probs=203.4

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcC------CCcEEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEEe
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCL  467 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~  467 (735)
                      +||....+.+.++||+|+||+||+|...      +++.||||+++. ......+.+.+|..++.++ +|+||+.+++++.
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            4555566778899999999999999843      245799999874 4455667888898888877 6899999999987


Q ss_pred             ecC-ceeEEEEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 004702          468 ETQ-VPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN  530 (735)
Q Consensus       468 ~~~-~~~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~N  530 (735)
                      +.+ ..++||||+++|+|.++|+..                ..+++.+++.++.||++||+|||+++   ||||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccc
Confidence            654 578999999999999999753                24899999999999999999999998   9999999999


Q ss_pred             EEEcCCCCeEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCC-ccCCCCChHH
Q 004702          531 ILLDENCTPKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK-MALLSDKPEE  608 (735)
Q Consensus       531 ILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~-~p~~~~~~~~  608 (735)
                      |||++++.+||+|||+++....... .......||+.|||||.+.+..++.++||||||+++|||++|. .||......+
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~  244 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  244 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987643332 2233456999999999999999999999999999999999975 4665443322


Q ss_pred             HHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          609 ERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .      +...+..         ....+.+...++++.+|+.+||+.||++|||+.||+++|+++++.
T Consensus       245 ~------~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         245 E------FCRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             H------HHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H------HHHHHhc---------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            1      1111111         111222334457899999999999999999999999999998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=397.56  Aligned_cols=254  Identities=25%  Similarity=0.397  Sum_probs=203.3

Q ss_pred             ccccccccccCcEEEEEEEcC-CCc----EEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLP-DRT----PVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVY  476 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  476 (735)
                      +.+.++||+|+||+||+|.+. +++    .||+|+++. .+....++|++|+.+|++++|||||+++|++.+. ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            556789999999999999854 333    589998864 3445577899999999999999999999999865 567889


Q ss_pred             EecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          477 EFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       477 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |++.+|+|.+++... ..+++..+++|+.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.......
T Consensus        90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            999999999888764 67999999999999999999999998   99999999999999999999999999997754333


Q ss_pred             c-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcc
Q 004702          556 Q-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRI  633 (735)
Q Consensus       556 ~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  633 (735)
                      . ......||+.|||||.+.+..++.++||||||++||||+| |+.||......+...                .+....
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~----------------~i~~~~  230 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----------------ILEKGE  230 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH----------------HHHHTC
T ss_pred             cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH----------------HHHcCC
Confidence            2 2334468999999999999999999999999999999999 777876544332111                111112


Q ss_pred             cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          634 VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       634 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      ..+.+...+.++.+|+.+||+.+|.+|||+.||++.|+.+.+.
T Consensus       231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            2223334557899999999999999999999999999887654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-46  Score=394.95  Aligned_cols=254  Identities=28%  Similarity=0.395  Sum_probs=204.0

Q ss_pred             ccccccccccCcEEEEEEEcCC-Cc--EEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEEeecCceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLPD-RT--PVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~-~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      ..+.++||+|+||+||+|++.+ +.  .||||+++. ......++|.+|+++|+++ +|||||+++|++.+.+..++|||
T Consensus        12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e   91 (309)
T d1fvra_          12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   91 (309)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence            3457899999999999998654 33  578888764 3444567899999999998 79999999999999999999999


Q ss_pred             ecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEE
Q 004702          478 FVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKV  541 (735)
Q Consensus       478 ~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl  541 (735)
                      |+++|+|.++|+..                ..+++..+++++.|||+||.|||+.+   |+||||||+|||++.++.+||
T Consensus        92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl  168 (309)
T d1fvra_          92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKI  168 (309)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEE
T ss_pred             ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEE
Confidence            99999999999753                56999999999999999999999998   999999999999999999999


Q ss_pred             eeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCc-cCCCCChHHHHHHHHHHHHHh
Q 004702          542 SDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKM-ALLSDKPEEERSLAMNFLSSL  620 (735)
Q Consensus       542 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~  620 (735)
                      +|||+++.......  .....||..|+|||.+.+..++.++||||||+++|||++|.. ||......+       +...+
T Consensus       169 ~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~~i  239 (309)
T d1fvra_         169 ADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKL  239 (309)
T ss_dssp             CCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHG
T ss_pred             cccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHHHH
Confidence            99999986543222  223458999999999999999999999999999999999765 554433222       11111


Q ss_pred             cccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          621 KQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       621 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ..         ....+.+...++++.+|+.+||+.||++||||.||++.|+++++..
T Consensus       240 ~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         240 PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             GG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             Hh---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            11         1122233345678999999999999999999999999999987643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=396.16  Aligned_cols=264  Identities=24%  Similarity=0.358  Sum_probs=216.7

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEc------CCCcEEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEEe
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFL------PDRTPVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCCL  467 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~------~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~  467 (735)
                      +|+..-.+.+.++||+|+||.||+|++      ..+..||||+++. .......+|.+|+.+++++ +|||||+++|++.
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            455556777889999999999999974      2456899999875 4455667899999999999 6999999999999


Q ss_pred             ecCceeEEEEecCCCchhHHhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 004702          468 ETQVPLLVYEFVGNGTLFEHIHKKG------------------NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSA  529 (735)
Q Consensus       468 ~~~~~~lV~E~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~  529 (735)
                      +.+..++||||+++|+|.++++...                  .+++..+++++.||++||+|||+++   |+||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence            9999999999999999999997542                  5899999999999999999999999   999999999


Q ss_pred             cEEEcCCCCeEEeeccCCcccCCCcc-cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCcc-CCCCChH
Q 004702          530 NILLDENCTPKVSDFGASKLVPIDAI-QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMA-LLSDKPE  607 (735)
Q Consensus       530 NILl~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p-~~~~~~~  607 (735)
                      |||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||++||||+|+..| +......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999997754332 233345689999999999999999999999999999999995544 4333322


Q ss_pred             HHHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          608 EERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       608 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      +.               +.+++........+...+.++.+|+.+||+.||.+||||.||++.|+++++..
T Consensus       255 ~~---------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~  309 (311)
T d1t46a_         255 SK---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (311)
T ss_dssp             HH---------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HH---------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence            21               11122222222333345578999999999999999999999999999887653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=389.61  Aligned_cols=249  Identities=22%  Similarity=0.269  Sum_probs=205.2

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC------hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD------QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  474 (735)
                      .+.+.+.||+|+||+||+|.. .+++.||||+++...      ....+.|.+|+.+|++++|||||++++++.+.+..+|
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            356778999999999999985 568999999886421      2236789999999999999999999999999999999


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC----CeEEeeccCCccc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC----TPKVSDFGASKLV  550 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGls~~~  550 (735)
                      ||||+++|+|.+++...+.+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||+++..
T Consensus        91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            9999999999999998889999999999999999999999999   99999999999998776    5999999999876


Q ss_pred             CCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD  630 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  630 (735)
                      .....  .....||+.|+|||.+.+..++.++||||||++||||++|+.||......+....       +.....     
T Consensus       168 ~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~-------i~~~~~-----  233 (293)
T d1jksa_         168 DFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------VSAVNY-----  233 (293)
T ss_dssp             TTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHTTCC-----
T ss_pred             CCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHH-------HHhcCC-----
Confidence            54322  2334589999999999999999999999999999999999999976544332111       111100     


Q ss_pred             hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          631 NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       631 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                       ..........+.++.+|+.+||+.||.+|||+.|+++
T Consensus       234 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 -EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000001123467899999999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6e-46  Score=396.80  Aligned_cols=248  Identities=19%  Similarity=0.260  Sum_probs=209.1

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      +.+.+.||+|+||+||+|.. .++..||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||+++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            56778999999999999985 56899999999877667777889999999999999999999999999999999999999


Q ss_pred             CchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc--CCCCeEEeeccCCcccCCCcccce
Q 004702          482 GTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD--ENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       482 gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      |+|.+++... ..+++..++.|+.||+.||+|||+++   |+||||||+||||+  .++.+||+|||+++.+..+..  .
T Consensus       111 g~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--~  185 (352)
T d1koba_         111 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--V  185 (352)
T ss_dssp             CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--E
T ss_pred             ChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCc--e
Confidence            9999988765 46999999999999999999999999   99999999999998  678999999999998764432  3


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....||+.|||||++.+..++.++||||||++||||++|+.||......+....       +...      +........
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~-------i~~~------~~~~~~~~~  252 (352)
T d1koba_         186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN-------VKRC------DWEFDEDAF  252 (352)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-------HHHC------CCCCCSSTT
T ss_pred             eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhC------CCCCCcccc
Confidence            445699999999999999999999999999999999999999976544332111       1110      001111122


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            345578899999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=387.40  Aligned_cols=252  Identities=25%  Similarity=0.355  Sum_probs=196.8

Q ss_pred             ccccccccccCcEEEEEEEcCC----CcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFLPD----RTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      +.+.+.||+|+||+||+|++..    ...||||+++..   .....++|.+|+.+|++++||||++++|++.+ ...++|
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv   88 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV   88 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence            4567789999999999998532    236899987642   34456789999999999999999999999975 466899


Q ss_pred             EEecCCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          476 YEFVGNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      |||+++|+|.+++... ..+++..+++++.|+++||+|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus        89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            9999999999887754 57999999999999999999999998   9999999999999999999999999999875433


Q ss_pred             cc--ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          555 IQ--NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       555 ~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      ..  ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+...       .+        ...
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~-------~i--------~~~  230 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-------KI--------DKE  230 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-------HH--------HTS
T ss_pred             CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH-------HH--------HhC
Confidence            22  2233457889999999999999999999999999999998 899987654433211       11        111


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGR  673 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  673 (735)
                      ....+.+...+.++.+|+.+||+.||++||||.||++.|++.
T Consensus       231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            112222334557899999999999999999999999988764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=389.75  Aligned_cols=261  Identities=26%  Similarity=0.355  Sum_probs=209.3

Q ss_pred             HHHhhhccccccccccCcEEEEEEEcCC--------CcEEEEEEeec-cChhHHHHHHHHHHHHHhc-CCCceEEEceEE
Q 004702          397 EIKTVTNNYADVIGCGGSGNVYKGFLPD--------RTPVAVKKSKF-VDQAKIDEFINELVVVLQI-NRRNVVRLLGCC  466 (735)
Q Consensus       397 ei~~~~~~~~~~lG~G~~g~Vy~g~~~~--------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~  466 (735)
                      +|..-.+.+.+.||+|+||.||+|+...        +..||||+++. .......++.+|+..+.++ +|||||++++++
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            4445566778899999999999998432        24799999875 4455668899999999888 799999999999


Q ss_pred             eecCceeEEEEecCCCchhHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 004702          467 LETQVPLLVYEFVGNGTLFEHIHKK----------------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSAN  530 (735)
Q Consensus       467 ~~~~~~~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~N  530 (735)
                      .+++..++||||+++|+|.++|...                ..+++.++++++.||+.||+|||+.+   ||||||||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N  165 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  165 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence            9999999999999999999999754                35899999999999999999999999   9999999999


Q ss_pred             EEEcCCCCeEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHh-CCccCCCCChHH
Q 004702          531 ILLDENCTPKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLT-GKMALLSDKPEE  608 (735)
Q Consensus       531 ILl~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~ellt-G~~p~~~~~~~~  608 (735)
                      ||++.++.+||+|||+++........ ......|++.|+|||.+.+..++.|+||||||++||||++ |..||......+
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            99999999999999999977543322 2333458999999999999999999999999999999998 677776544322


Q ss_pred             HHHHHHHHHHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhh
Q 004702          609 ERSLAMNFLSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSL  676 (735)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  676 (735)
                      .       ...+         ......+.+...++++.+|+.+||+.||.+|||+.||++.|+++++.
T Consensus       246 ~-------~~~i---------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         246 L-------FKLL---------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             H-------HHHH---------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H-------HHHH---------HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            1       1111         11122222334557899999999999999999999999999998753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.8e-45  Score=381.59  Aligned_cols=256  Identities=26%  Similarity=0.385  Sum_probs=204.1

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec---cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC----ceeE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF---VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ----VPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~l  474 (735)
                      +.+.+.||+|+||+||+|.. .+++.||||+++.   .+....+.|.+|+.+|+.++||||+++++++...+    ..++
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            55678999999999999984 5788999999864   24455678999999999999999999999988754    3789


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||||+++++|.+++...+.+++.+++.|+.||+.||+|||+++   |+||||||+||||+.++..+|+|||++.......
T Consensus        89 vmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            9999999999999998889999999999999999999999999   9999999999999999999999999987654322


Q ss_pred             --ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhc
Q 004702          555 --IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNR  632 (735)
Q Consensus       555 --~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  632 (735)
                        ........||+.|||||.+.+..++.++||||||++||||+||+.||......+..      ...+......      
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~~------  233 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIP------  233 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCC------
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCCCC------
Confidence              22334456999999999999999999999999999999999999999765443321      1111111110      


Q ss_pred             ccCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhh
Q 004702          633 IVNDGNKQQLKEVAKLAARCISVRGEERP-TMKEVSLELQGRL  674 (735)
Q Consensus       633 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~~~  674 (735)
                       ........++++.+|+.+||+.||.+|| |+++++..|.+++
T Consensus       234 -~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         234 -PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             -GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence             0011223457899999999999999999 8999999888764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-45  Score=387.52  Aligned_cols=245  Identities=24%  Similarity=0.288  Sum_probs=206.4

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.++||+|+||+||+++. .++..||||+++..   .....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            45678999999999999985 57899999998742   233467789999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|+|.+++.....+++..+..++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++....... ..
T Consensus        87 ~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~~  162 (337)
T d1o6la_          87 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM  162 (337)
T ss_dssp             CTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-CB
T ss_pred             cCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc-cc
Confidence            999999999999899999999999999999999999999   99999999999999999999999999987643322 23


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....||+.|||||++.+..++.++|||||||+||||++|+.||......+...       .+...        .  ...+
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-------~i~~~--------~--~~~p  225 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-------LILME--------E--IRFP  225 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHC--------C--CCCC
T ss_pred             ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH-------HHhcC--------C--CCCC
Confidence            34569999999999999999999999999999999999999998765433211       11111        1  1122


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPT-----MKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  668 (735)
                      ...++++.+|+.+||+.||.+||+     +.|+++
T Consensus       226 ~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            335577899999999999999995     666654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-46  Score=389.02  Aligned_cols=261  Identities=25%  Similarity=0.335  Sum_probs=212.4

Q ss_pred             HHHHhhhccccccccccCcEEEEEEEcC------CCcEEEEEEeec-cChhHHHHHHHHHHHHHhcCCCceEEEceEEee
Q 004702          396 EEIKTVTNNYADVIGCGGSGNVYKGFLP------DRTPVAVKKSKF-VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE  468 (735)
Q Consensus       396 ~ei~~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~  468 (735)
                      +||....+.+.+.||+|+||+||+|.+.      ++..||||+++. ........|.+|+.++++++||||++++|++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            4555556667889999999999999863      257899999874 455556779999999999999999999999999


Q ss_pred             cCceeEEEEecCCCchhHHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCC
Q 004702          469 TQVPLLVYEFVGNGTLFEHIHKK----------GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCT  538 (735)
Q Consensus       469 ~~~~~lV~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~  538 (735)
                      .+..++||||+++|+|.+++...          ..+++..+++++.|+|+||+|||+++   |+||||||+||||+++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence            99999999999999999998743          35799999999999999999999998   999999999999999999


Q ss_pred             eEEeeccCCcccCCCccc-ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCC-ccCCCCChHHHHHHHHHH
Q 004702          539 PKVSDFGASKLVPIDAIQ-NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGK-MALLSDKPEEERSLAMNF  616 (735)
Q Consensus       539 ~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~  616 (735)
                      +||+|||+++........ ......||+.|+|||.+.+..++.++||||||++||||+||. .||......+..      
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------  245 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------  245 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH------
Confidence            999999999876433222 223335899999999999999999999999999999999985 555443332211      


Q ss_pred             HHHhcccchhhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhh
Q 004702          617 LSSLKQNRLLEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLS  675 (735)
Q Consensus       617 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  675 (735)
                       ..+..+.         ..+.+...+..+.+|+.+||+.+|++||||.||++.|++.+.
T Consensus       246 -~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 -RFVMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHHHhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             1111111         111223345789999999999999999999999999987654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.1e-45  Score=374.99  Aligned_cols=248  Identities=25%  Similarity=0.339  Sum_probs=204.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC---------hhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCc
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---------QAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQV  471 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~  471 (735)
                      +.+.+.||+|+||+||+++. .+++.||||+++...         ....+.+.+|+.+|++++ ||||+++++++.+.+.
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~   84 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   84 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence            45678999999999999985 578899999986432         122356889999999997 9999999999999999


Q ss_pred             eeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccC
Q 004702          472 PLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVP  551 (735)
Q Consensus       472 ~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~  551 (735)
                      .+|||||+++|+|.++|+.+..+++.++..++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        85 ~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          85 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEcc
Confidence            9999999999999999998889999999999999999999999999   9999999999999999999999999999775


Q ss_pred             CCcccceeeeccccCccCcccccC------CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccch
Q 004702          552 IDAIQNCTVVQGTLGYLDPEYLQT------CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRL  625 (735)
Q Consensus       552 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  625 (735)
                      ....  .+...||+.|+|||.+.+      ..++.++||||+|++|+||++|+.||......+....+   .    ....
T Consensus       162 ~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i---~----~~~~  232 (277)
T d1phka_         162 PGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI---M----SGNY  232 (277)
T ss_dssp             TTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H----HTCC
T ss_pred             CCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH---H----hCCC
Confidence            4332  234569999999998853      35788999999999999999999999876543321111   1    1100


Q ss_pred             hhHhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 LEILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                            ....+.....++++.+|+.+||+.+|++|||+.||++
T Consensus       233 ------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         233 ------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                  0111112245578999999999999999999998853

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-46  Score=388.07  Aligned_cols=267  Identities=22%  Similarity=0.284  Sum_probs=198.9

Q ss_pred             hccccccccccCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHH--HHHHHHhcCCCceEEEceEEeecC----ceeEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFIN--ELVVVLQINRRNVVRLLGCCLETQ----VPLLV  475 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~g~~~~~~----~~~lV  475 (735)
                      ++.+.+.||+|+||+||+|++ ++..||||+++...   .+++..  |+..+.+++||||++++|++.+.+    ..++|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            445678999999999999997 57889999986432   334444  455556789999999999998765    57899


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSET-----NVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      |||+++|+|.++|++. .++|..+++++.|+|.||+|||+..     ..+|+||||||+||||++++++||+|||+++..
T Consensus        80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            9999999999999865 6999999999999999999999741     234999999999999999999999999999876


Q ss_pred             CCCccc---ceeeeccccCccCcccccCC------CCCccccchhHHHHHHHHHhCCccCCCCChHHHHH--------HH
Q 004702          551 PIDAIQ---NCTVVQGTLGYLDPEYLQTC------KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERS--------LA  613 (735)
Q Consensus       551 ~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~--------~~  613 (735)
                      ......   ......||+.|||||++.+.      .++.|+||||||++||||+||..|+..........        ..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            433221   22345699999999998764      26779999999999999999988764322111000        00


Q ss_pred             HHHHHHhcccchhhHhhhcccCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          614 MNFLSSLKQNRLLEILDNRIVND-GNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       614 ~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                      ...........    +.+.+... ...+....+.+|+.+||+.||.+|||+.||++.|+++.+..
T Consensus       239 ~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         239 EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence            00001111100    11111111 12345677999999999999999999999999999887654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.6e-45  Score=382.45  Aligned_cols=242  Identities=25%  Similarity=0.330  Sum_probs=205.2

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||+++. .++..||||+++..   .....+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            45678999999999999985 56899999998642   233467889999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +++|+|..++.....+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....    .
T Consensus        86 ~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----~  158 (316)
T d1fota_          86 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T  158 (316)
T ss_dssp             CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----B
T ss_pred             cCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc----c
Confidence            999999999999889999999999999999999999999   999999999999999999999999999876532    2


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....||+.|||||.+.+..++.++||||||++||||++|+.||......+....+               +....  ..+
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---------------~~~~~--~~p  221 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI---------------LNAEL--RFP  221 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---------------HHCCC--CCC
T ss_pred             ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH---------------HcCCC--CCC
Confidence            3356999999999999999999999999999999999999999765443321111               11111  112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      ...++++.+++.+||+.||.+||     |++|+++
T Consensus       222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            23456789999999999999996     7888765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-45  Score=380.38  Aligned_cols=258  Identities=23%  Similarity=0.222  Sum_probs=198.0

Q ss_pred             ccccccCcEEEEEEEc-CCCcEEEEEEeeccChhH-----HHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          407 DVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAK-----IDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      ++||+|+||+||+|.. .+++.||||+++......     .+.+.+|+.+|++++|||||++++++...+..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            5899999999999995 468899999986432221     3468899999999999999999999999999999999999


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ++++..++.....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++........ ...
T Consensus        84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~~~  159 (299)
T d1ua2a_          84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTH  159 (299)
T ss_dssp             EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-CCC
T ss_pred             chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc-ccc
Confidence            9888877777778999999999999999999999999   999999999999999999999999999876543322 223


Q ss_pred             eccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh---hh---cc
Q 004702          561 VQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL---DN---RI  633 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---d~---~~  633 (735)
                      ..||+.|+|||.+.. ..++.++||||||++||||++|+.||......+....+...........+....   ..   ..
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS  239 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence            458999999998865 457999999999999999999999997665544322222111000000000000   00   00


Q ss_pred             cCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          634 VNDGN-----KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       634 ~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....+     ...++++.+|+.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00001     122467899999999999999999999863

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=378.98  Aligned_cols=248  Identities=19%  Similarity=0.271  Sum_probs=203.7

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecCC
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVGN  481 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~  481 (735)
                      |.+.+.||+|+||+||+|.. .+++.||||.++.... +...+.+|+.+|++++|||||++++++.+.+..+|||||+++
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g   85 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence            55678999999999999985 4688899999876543 345688999999999999999999999999999999999999


Q ss_pred             CchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC--CCCeEEeeccCCcccCCCcccce
Q 004702          482 GTLFEHIHKKG-NLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE--NCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       482 gsL~~~l~~~~-~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      |+|.+++...+ .+++.++..|+.||+.||+|||+++   |+||||||+||||+.  ...+||+|||+++.......  .
T Consensus        86 g~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~--~  160 (321)
T d1tkia_          86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--F  160 (321)
T ss_dssp             CBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE--E
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCc--c
Confidence            99999998764 7999999999999999999999999   999999999999984  45899999999987644322  2


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....+|+.|+|||.+.+..++.++||||||++||||++|+.||......+....+       ......  .+.    ...
T Consensus       161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i-------~~~~~~--~~~----~~~  227 (321)
T d1tkia_         161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-------MNAEYT--FDE----EAF  227 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HHTCCC--CCH----HHH
T ss_pred             cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCC--CCh----hhc
Confidence            3345899999999999999999999999999999999999999766543321111       110000  000    000


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      ...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         228 KEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1234678999999999999999999999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-44  Score=382.79  Aligned_cols=242  Identities=22%  Similarity=0.285  Sum_probs=204.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEe
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEF  478 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~  478 (735)
                      +.+.+.||+|+||+||++.. .++..||||+++..   +....+.+++|+.+|++++|||||++++++.+....++||||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~  122 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence            45567999999999999985 56899999998632   233457789999999999999999999999999999999999


Q ss_pred             cCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccce
Q 004702          479 VGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNC  558 (735)
Q Consensus       479 ~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~  558 (735)
                      +.+|+|.+++...+.+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.+...    .
T Consensus       123 ~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----~  195 (350)
T d1rdqe_         123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----T  195 (350)
T ss_dssp             CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----B
T ss_pred             ccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc----c
Confidence            999999999998889999999999999999999999999   999999999999999999999999999976532    2


Q ss_pred             eeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCCC
Q 004702          559 TVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDGN  638 (735)
Q Consensus       559 ~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  638 (735)
                      ....||+.|||||++.+..++.++|||||||+||||++|+.||...........       +..        ...  ..+
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-------i~~--------~~~--~~p  258 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK-------IVS--------GKV--RFP  258 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHH--------CCC--CCC
T ss_pred             ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH-------Hhc--------CCC--CCC
Confidence            235699999999999999999999999999999999999999976543321111       111        111  112


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 004702          639 KQQLKEVAKLAARCISVRGEERP-----TMKEVSL  668 (735)
Q Consensus       639 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  668 (735)
                      ...++++.+|+.+||+.||.+|+     |+.|+++
T Consensus       259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            23457899999999999999994     7888764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=380.92  Aligned_cols=245  Identities=24%  Similarity=0.305  Sum_probs=203.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeecc---ChhHHHHHHHHHHHHH-hcCCCceEEEceEEeecCceeEEEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFV---DQAKIDEFINELVVVL-QINRRNVVRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lV~E  477 (735)
                      +.+.++||+|+||+||+|+. .+++.||||+++..   .....+.+..|..++. .++|||||++++++.+.+..++|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            45678999999999999985 46889999998642   2334566777777765 6899999999999999999999999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      |+++|+|.+++.....+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....... .
T Consensus        84 y~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-~  159 (320)
T d1xjda_          84 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-K  159 (320)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-C
T ss_pred             ecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccc-c
Confidence            9999999999998889999999999999999999999999   99999999999999999999999999986643322 2


Q ss_pred             eeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhcccCCC
Q 004702          558 CTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIVNDG  637 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  637 (735)
                      .+...||+.|+|||++.+..++.++|||||||+||||++|+.||......+...       .+....          ...
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~-------~i~~~~----------~~~  222 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH-------SIRMDN----------PFY  222 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCC----------CCC
T ss_pred             ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH-------HHHcCC----------CCC
Confidence            334569999999999999999999999999999999999999997655433211       111111          111


Q ss_pred             CHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 004702          638 NKQQLKEVAKLAARCISVRGEERPTMK-EVSL  668 (735)
Q Consensus       638 ~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~~  668 (735)
                      +...++++.+|+.+||+.||.+|||+. |+++
T Consensus       223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            223457799999999999999999996 6643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.3e-44  Score=381.78  Aligned_cols=246  Identities=22%  Similarity=0.238  Sum_probs=197.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC---hhHHHHHH---HHHHHHHhcCCCceEEEceEEeecCceeEE
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD---QAKIDEFI---NELVVVLQINRRNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  475 (735)
                      +.+.++||+|+||+||+|+. .++..||||++....   ......+.   +|+.+++.++|||||++++++.+.+..++|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            45678999999999999985 468999999975321   11122333   456777788899999999999999999999


Q ss_pred             EEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcc
Q 004702          476 YEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       476 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~  555 (735)
                      |||+++|+|.++|.....+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++.+.....
T Consensus        86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~  162 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  162 (364)
T ss_dssp             ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred             EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence            999999999999998889999999999999999999999999   99999999999999999999999999987654322


Q ss_pred             cceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          556 QNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       556 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                         ....||+.|||||++.. ..++.++|||||||+||||++|+.||......+....    ......          ..
T Consensus       163 ---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~----------~~  225 (364)
T d1omwa3         163 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT----------MA  225 (364)
T ss_dssp             ---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSSS----------CC
T ss_pred             ---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhccc----------CC
Confidence               33469999999999875 5689999999999999999999999976543322111    111100          01


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPT-----MKEVSL  668 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  668 (735)
                      ...+...++++.+|+.+||+.||.+|||     +.|+++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            1112234578999999999999999999     466553

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-44  Score=377.57  Aligned_cols=245  Identities=24%  Similarity=0.308  Sum_probs=194.1

Q ss_pred             cccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHh-cCCCceEEEceEEee----cCceeEEEEec
Q 004702          406 ADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQ-INRRNVVRLLGCCLE----TQVPLLVYEFV  479 (735)
Q Consensus       406 ~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~----~~~~~lV~E~~  479 (735)
                      .++||+|+||+||+|.. .++..||||+++..     ..+.+|+.++.+ ++|||||++++++.+    ....++||||+
T Consensus        17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~   91 (335)
T d2ozaa1          17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   91 (335)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence            35799999999999984 56899999998642     456789988765 489999999999875    45689999999


Q ss_pred             CCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC---CCCeEEeeccCCcccCCCc
Q 004702          480 GNGTLFEHIHKK--GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE---NCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       480 ~~gsL~~~l~~~--~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGls~~~~~~~  554 (735)
                      ++|+|.++|.+.  ..+++.++..|+.||+.||+|||+++   |+||||||+|||+++   ++.+||+|||+++......
T Consensus        92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~  168 (335)
T d2ozaa1          92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  168 (335)
T ss_dssp             CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred             CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCC
Confidence            999999999864  46999999999999999999999999   999999999999985   5579999999998765433


Q ss_pred             ccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhhccc
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDNRIV  634 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  634 (735)
                      .  .....||+.|||||++.+..++.++||||||++||||++|+.||......+....   ....+.....      ...
T Consensus       169 ~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~~~------~~~  237 (335)
T d2ozaa1         169 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQY------EFP  237 (335)
T ss_dssp             C--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS------SCC
T ss_pred             c--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH---HHHHHhcCCC------CCC
Confidence            2  2345699999999999999999999999999999999999999965433221110   0111110000      000


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 004702          635 NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLE  669 (735)
Q Consensus       635 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  669 (735)
                      .......++++.+|+.+||+.||++|||+.|++..
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            11123456789999999999999999999999763

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.4e-43  Score=367.33  Aligned_cols=262  Identities=19%  Similarity=0.246  Sum_probs=202.3

Q ss_pred             ccccccccccCcEEEEEEEcCCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEecC
Q 004702          403 NNYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFVG  480 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~  480 (735)
                      +...++||+|+||+||+|..++++.||||+++...  ....+.+.+|+.+|++++||||+++++++...+..+++||++.
T Consensus         4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~   83 (286)
T d1ob3a_           4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD   83 (286)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence            34567899999999999998889999999986532  3335789999999999999999999999999999999999998


Q ss_pred             CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccceee
Q 004702          481 NGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCTV  560 (735)
Q Consensus       481 ~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~~  560 (735)
                      ++.+..+......+++..+..++.||+.||+|||+.+   ||||||||+||||+.++.+||+|||++........ ....
T Consensus        84 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~  159 (286)
T d1ob3a_          84 QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTH  159 (286)
T ss_dssp             EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             hhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-ccce
Confidence            8888777777788999999999999999999999998   99999999999999999999999999987654322 2233


Q ss_pred             eccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhh-----hcc-
Q 004702          561 VQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILD-----NRI-  633 (735)
Q Consensus       561 ~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----~~~-  633 (735)
                      ..+++.|+|||.+.. ..++.++||||||+++|||++|+.||......+......................     ... 
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (286)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence            458999999999875 4578999999999999999999999976654433222211110000000000000     000 


Q ss_pred             ------cCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          634 ------VNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       634 ------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                            ........++++.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00111223467899999999999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-43  Score=366.77  Aligned_cols=261  Identities=21%  Similarity=0.266  Sum_probs=196.3

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeeccC--hhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVD--QAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||+||+|.. .+++.||||+++...  ....+.+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus         4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~   83 (298)
T d1gz8a_           4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   83 (298)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence            34567999999999999985 568999999986432  233578899999999999999999999999999999999999


Q ss_pred             CCCchhHHhh-h-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCcccc
Q 004702          480 GNGTLFEHIH-K-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQN  557 (735)
Q Consensus       480 ~~gsL~~~l~-~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~  557 (735)
                      .++ +.+++. . ...+++..+..++.|++.||+|||+++   ||||||||+|||++.++.+||+|||+++........ 
T Consensus        84 ~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~-  158 (298)
T d1gz8a_          84 HQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-  158 (298)
T ss_dssp             SEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC-
T ss_pred             CCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCccc-
Confidence            764 444443 3 357999999999999999999999999   999999999999999999999999999876543322 


Q ss_pred             eeeeccccCccCcccccCCC-CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh-hhcccC
Q 004702          558 CTVVQGTLGYLDPEYLQTCK-LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL-DNRIVN  635 (735)
Q Consensus       558 ~~~~~gt~~y~aPE~~~~~~-~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~~~~  635 (735)
                      .....||+.|+|||.+.... ++.++||||||+++|||++|+.||......+.............+....... ......
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence            23345999999999877655 5789999999999999999999997655433222111110000000000000 000000


Q ss_pred             ------CC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          636 ------DG-----NKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       636 ------~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                            ..     ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                  00     0122367899999999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-44  Score=367.64  Aligned_cols=238  Identities=25%  Similarity=0.408  Sum_probs=195.0

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccCh------hHHHHHHHHHHHHHhcC--CCceEEEceEEeecCce
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQ------AKIDEFINELVVVLQIN--RRNVVRLLGCCLETQVP  472 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~  472 (735)
                      .+.+.++||+|+||+||+|+. .++..||||+++....      .....+.+|+.+|++++  |||||++++++.+.+..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            456778999999999999985 5789999999864211      11234678999999997  89999999999999999


Q ss_pred             eEEEEecCC-CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-CCCeEEeeccCCccc
Q 004702          473 LLVYEFVGN-GTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-NCTPKVSDFGASKLV  550 (735)
Q Consensus       473 ~lV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGls~~~  550 (735)
                      ++||||+.+ ++|.+++.....+++..+..++.||+.||+|||+++   |+||||||+||||+. ++.+||+|||+++..
T Consensus        85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceec
Confidence            999999975 688889988889999999999999999999999999   999999999999985 478999999999875


Q ss_pred             CCCcccceeeeccccCccCcccccCCCC-CccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQTCKL-TDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                      ....   .+...||+.|+|||++.+..+ +.++||||||++||||++|+.||.....         ..            
T Consensus       162 ~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i~------------  217 (273)
T d1xwsa_         162 KDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------II------------  217 (273)
T ss_dssp             CSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH------------
T ss_pred             cccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------Hh------------
Confidence            4332   234569999999999987665 5779999999999999999999954210         00            


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ....  ..+...++++.+|+.+||+.||++|||++|+++
T Consensus       218 ~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 RGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hccc--CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            0000  111223568899999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=364.12  Aligned_cols=262  Identities=21%  Similarity=0.262  Sum_probs=195.4

Q ss_pred             hccccccccccCcEEEEEEEc-CC-CcEEEEEEeec--cChhHHHHHHHHHHHHHhc---CCCceEEEceEEee-----c
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PD-RTPVAVKKSKF--VDQAKIDEFINELVVVLQI---NRRNVVRLLGCCLE-----T  469 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~-~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~  469 (735)
                      .+.+.++||+|+||+||+|.. .+ ++.||||+++.  ........+.+|+.+|+.|   +||||+++++++..     .
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~   87 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   87 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence            345667999999999999985 33 56799998764  2222234456777776655   89999999999864     2


Q ss_pred             CceeEEEEecCCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCc
Q 004702          470 QVPLLVYEFVGNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASK  548 (735)
Q Consensus       470 ~~~~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~  548 (735)
                      ...+++|||+.++.+...... ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++
T Consensus        88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhh
Confidence            467899999988777655443 367999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh-
Q 004702          549 LVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE-  627 (735)
Q Consensus       549 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  627 (735)
                      ......  ......||+.|+|||++.+..++.++||||||++||||++|+.||......+................+.. 
T Consensus       165 ~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         165 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            654332  23445699999999999999999999999999999999999999987655443322222111100000000 


Q ss_pred             -----Hh----hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          628 -----IL----DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       628 -----~~----d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                           ..    ............++.+.+|+.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                 00    000001111223467889999999999999999999864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-41  Score=356.92  Aligned_cols=261  Identities=20%  Similarity=0.237  Sum_probs=198.4

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceE-EEceEEeecCceeEEEEec
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVV-RLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~  479 (735)
                      ++.+.+.||+|+||+||+|+. .+++.||||.+.....  .+++..|+++++.++|+|++ .+.++..+.+..++||||+
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            356778999999999999985 5688999998765332  34578899999999877655 4555567777889999999


Q ss_pred             CCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEc---CCCCeEEeeccCCcccCCCcc
Q 004702          480 GNGTLFEHIHK-KGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLD---ENCTPKVSDFGASKLVPIDAI  555 (735)
Q Consensus       480 ~~gsL~~~l~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGls~~~~~~~~  555 (735)
                      . ++|.+.+.. ...+++..++.++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+++.+.....
T Consensus        86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          86 G-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             C-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             C-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            4 566665544 568999999999999999999999999   99999999999985   456799999999997653322


Q ss_pred             ------cceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHh
Q 004702          556 ------QNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEIL  629 (735)
Q Consensus       556 ------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (735)
                            .......||+.|||||.+.+..++.++||||||+++|||++|+.||..........................  
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--  239 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV--  239 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH--
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH--
Confidence                  122345699999999999999999999999999999999999999976554433222211111100000010  


Q ss_pred             hhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhc
Q 004702          630 DNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLM  677 (735)
Q Consensus       630 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~  677 (735)
                         +    ....++++.+|+.+||+.+|++||++.++.+.|+++....
T Consensus       240 ---~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         240 ---L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ---H----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---h----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence               0    1123467899999999999999999999999998876543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-41  Score=353.03  Aligned_cols=262  Identities=15%  Similarity=0.158  Sum_probs=207.8

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCC-CceEEEceEEeecCceeEEEEec
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      .+.+.++||+|+||+||+|+. .+++.||||.+....  ..+.+.+|++.++.+.| +|++.+++++.+....++||||+
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            456778999999999999994 468899999876432  23456789999999976 89999999999999999999999


Q ss_pred             CCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcC-----CCCeEEeeccCCcccCCC
Q 004702          480 GNGTLFEHIHKK-GNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDE-----NCTPKVSDFGASKLVPID  553 (735)
Q Consensus       480 ~~gsL~~~l~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DFGls~~~~~~  553 (735)
                       +++|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+||||+.     ++.+||+|||+++.....
T Consensus        84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence             68999998765 47999999999999999999999999   999999999999974     568999999999876432


Q ss_pred             ccc------ceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhh
Q 004702          554 AIQ------NCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLE  627 (735)
Q Consensus       554 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (735)
                      ...      ......||+.|||||.+.+..++.++||||||+++|||++|+.||.........................+
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  239 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence            211      22345699999999999999999999999999999999999999975544332222211111111111111


Q ss_pred             HhhhcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhhhcc
Q 004702          628 ILDNRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSLELQGRLSLMS  678 (735)
Q Consensus       628 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~~~  678 (735)
                      +         ....++++.+++..|++.+|++||+++.+.+.|+++++...
T Consensus       240 l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         240 L---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             H---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             h---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence            1         11234678999999999999999999999999998876554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=359.72  Aligned_cols=264  Identities=19%  Similarity=0.227  Sum_probs=198.8

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEee--------cC
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLE--------TQ  470 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~  470 (735)
                      .+.+.+.||+|+||+||+|+. .+++.||||++..  ......+++.+|+.+|++++||||+++++.+..        ..
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~   90 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   90 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence            345667999999999999995 5789999998753  233445778999999999999999999998865        34


Q ss_pred             ceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCccc
Q 004702          471 VPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLV  550 (735)
Q Consensus       471 ~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~  550 (735)
                      ..++||||+.++.+..+......+++..+..++.|++.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus        91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeec
Confidence            57899999988877777666778999999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCccc---ceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchh
Q 004702          551 PIDAIQ---NCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLL  626 (735)
Q Consensus       551 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (735)
                      ......   ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+..................
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            533221   12224589999999998764 68999999999999999999999997665544443333322111111000


Q ss_pred             h--------HhhhcccCCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          627 E--------ILDNRIVNDGNK-------QQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       627 ~--------~~d~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .        ............       ....++.+|+.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            0        000000000011       11356788999999999999999999873

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-41  Score=362.48  Aligned_cols=255  Identities=25%  Similarity=0.249  Sum_probs=192.3

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------ceeE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------VPLL  474 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l  474 (735)
                      +++..++||+|+||+||+|+. .+++.||||+++....    .+.+|+.+|++++||||+++++++....      ..+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            455667899999999999995 4689999999875332    2347999999999999999999986432      4689


Q ss_pred             EEEecCCCchhHHh---hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEeeccCCccc
Q 004702          475 VYEFVGNGTLFEHI---HKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-TPKVSDFGASKLV  550 (735)
Q Consensus       475 V~E~~~~gsL~~~l---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGls~~~  550 (735)
                      ||||++++.+..+.   .....+++..+..|+.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            99999876433333   34467999999999999999999999998   99999999999999765 8999999999876


Q ss_pred             CCCcccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc---chh
Q 004702          551 PIDAIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN---RLL  626 (735)
Q Consensus       551 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~  626 (735)
                      ......  ....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.....   ...+...   .+.
T Consensus       174 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i---~~~~g~~~~~~~~  248 (350)
T d1q5ka_         174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI---IKVLGTPTREQIR  248 (350)
T ss_dssp             CTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCCCHHHHH
T ss_pred             cCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHH---HHHhCCChHHhhh
Confidence            543322  23459999999998764 57899999999999999999999999766544332222   1111110   000


Q ss_pred             hHh----hhc--------ccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          627 EIL----DNR--------IVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       627 ~~~----d~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ...    +..        .........++++.+|+.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000    000        000111234567899999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-41  Score=359.31  Aligned_cols=262  Identities=20%  Similarity=0.289  Sum_probs=196.3

Q ss_pred             ccccccccccCcEEEEEEE-cCCCcEEEEEEeecc-ChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC----ceeEEE
Q 004702          403 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKFV-DQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ----VPLLVY  476 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~  476 (735)
                      +.+.++||+|+||+||+|. ..+++.||||+++.. .....+.+++|+.+|++++||||+++++++....    ..++++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~   89 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV   89 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence            4556899999999999998 457899999998753 4555678999999999999999999999987654    235566


Q ss_pred             EecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccc
Q 004702          477 EFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       477 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~  556 (735)
                      +++.+|+|.+++... .+++..+..++.|++.||+|||+++   ||||||||+||||++++.+||+|||+++........
T Consensus        90 ~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          90 THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  165 (345)
T ss_dssp             EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence            777799999999754 7999999999999999999999999   999999999999999999999999999876433221


Q ss_pred             --ceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc--------h
Q 004702          557 --NCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR--------L  625 (735)
Q Consensus       557 --~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~  625 (735)
                        ......||+.|+|||.+.. ..++.++||||+|++++||++|+.||......+................        .
T Consensus       166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T d1pmea_         166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA  245 (345)
T ss_dssp             CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence              2234558999999999854 5678899999999999999999999976655443322211110000000        0


Q ss_pred             hh-HhhhcccCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 LE-ILDNRIVNDGN-----KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 ~~-~~d~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      .. ..........+     ...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00 00000000001     112357899999999999999999999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-41  Score=349.64  Aligned_cols=260  Identities=20%  Similarity=0.259  Sum_probs=205.5

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecCceeEEEEec
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQVPLLVYEFV  479 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~  479 (735)
                      +.+.+.||+|+||+||+|+. .+++.||||+++.  ......+.+.+|+.+|++++||||+++++++.+....++|+|++
T Consensus         4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~   83 (292)
T d1unla_           4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence            45567999999999999995 5788999999864  33455788999999999999999999999999999999999999


Q ss_pred             CCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCccccee
Q 004702          480 GNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDAIQNCT  559 (735)
Q Consensus       480 ~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~~~~~~  559 (735)
                      .+++|..++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++........ ..
T Consensus        84 ~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~-~~  159 (292)
T d1unla_          84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YS  159 (292)
T ss_dssp             SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-CC
T ss_pred             cccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc-ce
Confidence            99999999888889999999999999999999999998   999999999999999999999999999876543322 22


Q ss_pred             eeccccCccCcccccCCC-CCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhccc---ch---hhHhhh-
Q 004702          560 VVQGTLGYLDPEYLQTCK-LTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQN---RL---LEILDN-  631 (735)
Q Consensus       560 ~~~gt~~y~aPE~~~~~~-~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~d~-  631 (735)
                      ...++..|+|||.+.... ++.++||||||+++|||++|+.||.........  ...+.......   ..   ....+. 
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhhhhccccc
Confidence            334788999999887655 689999999999999999999998665543322  11111111110   00   000000 


Q ss_pred             --------cccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          632 --------RIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       632 --------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                              ...........+.+.+|+.+||+.||.+|||++||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0011112233467889999999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=356.40  Aligned_cols=257  Identities=22%  Similarity=0.286  Sum_probs=192.3

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeecC------cee
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLETQ------VPL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~  473 (735)
                      +.+.++||+|+||+||+|.. .+++.||||+++.  .+....+.+.+|+.+|++++|||||++++++...+      ..+
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~   99 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY   99 (346)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence            44567899999999999985 5689999999874  34555678999999999999999999999998655      458


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+ +.+|..+++ ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       100 lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~  174 (346)
T d1cm8a_         100 LVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE  174 (346)
T ss_dssp             EEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             EEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCc
Confidence            999999 557777665 457999999999999999999999999   999999999999999999999999999876432


Q ss_pred             cccceeeeccccCccCcccccC-CCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHH--------HHhcccc
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQT-CKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFL--------SSLKQNR  624 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  624 (735)
                          .+...||+.|+|||.+.+ ..++.++||||||++||||++|+.||................        .......
T Consensus       175 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         175 ----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             ----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             ----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence                234569999999999876 457899999999999999999999997665443322211110        0000000


Q ss_pred             hhhHhh--hccc----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 LLEILD--NRIV----NDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ~~~~~d--~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ......  +...    ........+++.+|+.+||..||.+|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000  0000    0011223467889999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=357.25  Aligned_cols=249  Identities=23%  Similarity=0.274  Sum_probs=202.5

Q ss_pred             ccccccccccCcEEEEEEEc----CCCcEEEEEEeecc----ChhHHHHHHHHHHHHHhcCC-CceEEEceEEeecCcee
Q 004702          403 NNYADVIGCGGSGNVYKGFL----PDRTPVAVKKSKFV----DQAKIDEFINELVVVLQINR-RNVVRLLGCCLETQVPL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~  473 (735)
                      +.+.+.||+|+||+||+|..    .+++.||||.++..    +....+.+.+|+.+|++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            56778999999999999974    24789999987532    22335668899999999977 89999999999999999


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+.+|+|.+++.....+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~  182 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  182 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence            99999999999999998888999999999999999999999999   999999999999999999999999999877655


Q ss_pred             cccceeeeccccCccCcccccCC--CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccchhhHhhh
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTC--KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNRLLEILDN  631 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  631 (735)
                      .........|++.|++||.+...  .++.++||||||++||||++|+.||......+........   .        .. 
T Consensus       183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~---~--------~~-  250 (322)
T d1vzoa_         183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR---I--------LK-  250 (322)
T ss_dssp             GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---H--------HH-
T ss_pred             ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---c--------cc-
Confidence            44444556799999999998754  4778999999999999999999999765443322221110   0        00 


Q ss_pred             cccCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 004702          632 RIVNDGNKQQLKEVAKLAARCISVRGEERPT-----MKEVS  667 (735)
Q Consensus       632 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~  667 (735)
                       .....+...+.++.+|+.+||+.||++|||     ++|++
T Consensus       251 -~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil  290 (322)
T d1vzoa_         251 -SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK  290 (322)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred             -CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence             011123345678999999999999999995     56654

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.5e-40  Score=346.84  Aligned_cols=254  Identities=19%  Similarity=0.265  Sum_probs=195.4

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEeec--CceeEEEE
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLET--QVPLLVYE  477 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~E  477 (735)
                      .+.+.++||+|+||+||+|+. .+++.||||+++...   .+++.+|+.+|++++ ||||+++++++...  ...++|||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            355678999999999999985 568899999987543   457889999999995 99999999998754  46889999


Q ss_pred             ecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCC-CeEEeeccCCcccCCCccc
Q 004702          478 FVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENC-TPKVSDFGASKLVPIDAIQ  556 (735)
Q Consensus       478 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGls~~~~~~~~~  556 (735)
                      |+.+++|..+.   +.+++..+..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+++....... 
T Consensus       113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~-  185 (328)
T d3bqca1         113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-  185 (328)
T ss_dssp             CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC-
T ss_pred             ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc-
Confidence            99999997764   46999999999999999999999999   99999999999998654 599999999987654332 


Q ss_pred             ceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcccc-----------
Q 004702          557 NCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQNR-----------  624 (735)
Q Consensus       557 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------  624 (735)
                       .....+|+.|+|||.+.+. .++.++||||||++++||++|+.||...........  .....+....           
T Consensus       186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~--~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         186 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV--RIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH--HHHHHHCHHHHHHHHHHTTCC
T ss_pred             -ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH--HHHHHHCCchhhhhhhhcccc
Confidence             2344589999999998765 479999999999999999999999976654332111  1111110000           


Q ss_pred             ----hhhHhh--------hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          625 ----LLEILD--------NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       625 ----~~~~~d--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                          ......        ...........++++.+|+.+||+.||.+|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000000        00011111233467899999999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=348.98  Aligned_cols=258  Identities=23%  Similarity=0.315  Sum_probs=190.1

Q ss_pred             ccccccccccCcEEEEEEEc-CCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeec------Ccee
Q 004702          403 NNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLET------QVPL  473 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~  473 (735)
                      +.+.++||+|+||+||+|.. .++..||||+++.  .+......+.+|+.+|++++||||+++++++...      ...+
T Consensus        19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~   98 (355)
T d2b1pa1          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY   98 (355)
T ss_dssp             EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence            44567999999999999985 4689999999874  3455667889999999999999999999999643      5779


Q ss_pred             EEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCC
Q 004702          474 LVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPID  553 (735)
Q Consensus       474 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~  553 (735)
                      +||||+.++ |.+.+.  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||+++.....
T Consensus        99 iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          99 LVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccc
Confidence            999999665 445553  45899999999999999999999999   999999999999999999999999998865433


Q ss_pred             cccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHH--------Hhcc---
Q 004702          554 AIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLS--------SLKQ---  622 (735)
Q Consensus       554 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~~---  622 (735)
                      .  ..+...+|+.|+|||.+.+..++.++||||+|++++||++|+.||.................        ....   
T Consensus       173 ~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         173 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             c--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            2  23345689999999999999999999999999999999999999976654333222211100        0000   


Q ss_pred             -----------cchhhHhhhcccC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          623 -----------NRLLEILDNRIVN---DGNKQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       623 -----------~~~~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                                 .............   ......+.++.+|+.+||+.||++|||++||++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                       0001111111111   112345678999999999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-39  Score=347.58  Aligned_cols=258  Identities=21%  Similarity=0.275  Sum_probs=194.6

Q ss_pred             ccccccccccCcEEEEEEE-cCCCcEEEEEEeec--cChhHHHHHHHHHHHHHhcCCCceEEEceEEeec-----CceeE
Q 004702          403 NNYADVIGCGGSGNVYKGF-LPDRTPVAVKKSKF--VDQAKIDEFINELVVVLQINRRNVVRLLGCCLET-----QVPLL  474 (735)
Q Consensus       403 ~~~~~~lG~G~~g~Vy~g~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l  474 (735)
                      +...++||+|+||+||+|+ ..+++.||||+++.  .+....+.+.+|+.+|++++|||||++++++...     ...++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence            4556799999999999998 45789999999864  3445567889999999999999999999998643     34477


Q ss_pred             EEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeeccCCcccCCCc
Q 004702          475 VYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFGASKLVPIDA  554 (735)
Q Consensus       475 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~~~~~~  554 (735)
                      ||+++.+|+|.+++.. +.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++...... 
T Consensus       100 i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-  174 (348)
T d2gfsa1         100 LVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-  174 (348)
T ss_dssp             EEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGG-
T ss_pred             EEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCcc-
Confidence            7888889999999965 47999999999999999999999999   999999999999999999999999999765322 


Q ss_pred             ccceeeeccccCccCcccccCC-CCCccccchhHHHHHHHHHhCCccCCCCChHHHHHHHHHHHHHhcc--------cch
Q 004702          555 IQNCTVVQGTLGYLDPEYLQTC-KLTDKSDVYSFGVVLVELLTGKMALLSDKPEEERSLAMNFLSSLKQ--------NRL  625 (735)
Q Consensus       555 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~  625 (735)
                         .....|++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+.........        ...
T Consensus       175 ---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         175 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             ---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             ---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence               2334589999999987665 4688999999999999999999999766554433322211100000        000


Q ss_pred             hhHhhhccc-CCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 004702          626 LEILDNRIV-NDGN-----KQQLKEVAKLAARCISVRGEERPTMKEVSL  668 (735)
Q Consensus       626 ~~~~d~~~~-~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  668 (735)
                      ......... ....     ...++++.+|+.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            000000000 0000     123467889999999999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-34  Score=311.52  Aligned_cols=258  Identities=18%  Similarity=0.198  Sum_probs=186.6

Q ss_pred             hccccccccccCcEEEEEEEc-CCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-----------CCceEEEceEEeec
Q 004702          402 TNNYADVIGCGGSGNVYKGFL-PDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-----------RRNVVRLLGCCLET  469 (735)
Q Consensus       402 ~~~~~~~lG~G~~g~Vy~g~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~  469 (735)
                      ++.+.++||+|+||+||+|+. .+++.||||+++.. ....+.+.+|+.+++.++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            367788999999999999985 57899999998743 334567788999988875           47899999888653


Q ss_pred             --CceeEEEEecCCCchhHH-hh--hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEcCCCC-----
Q 004702          470 --QVPLLVYEFVGNGTLFEH-IH--KKGNLSWERRLRITAETAGVLSYLHS-ETNVPIIHRDVKSANILLDENCT-----  538 (735)
Q Consensus       470 --~~~~lV~E~~~~gsL~~~-l~--~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~-----  538 (735)
                        ...+++|++...+..... ..  ....+++..+..++.|+++||+|||+ .+   |+||||||+||||+.++.     
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence              355667776655433222 22  33678999999999999999999998 66   999999999999986543     


Q ss_pred             -eEEeeccCCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHHHHHHhCCccCCCCChHHHH---HHHH
Q 004702          539 -PKVSDFGASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVLVELLTGKMALLSDKPEEER---SLAM  614 (735)
Q Consensus       539 -~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl~elltG~~p~~~~~~~~~~---~~~~  614 (735)
                       +|++|||.+......    .....||+.|+|||.+....++.++||||+|++++||++|+.||.........   ....
T Consensus       170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence             899999999865422    23345999999999999999999999999999999999999998644321111   1111


Q ss_pred             HHHHHhcccch---------hhHhh-------------------hcccCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 004702          615 NFLSSLKQNRL---------LEILD-------------------NRIVNDGNKQQLKEVAKLAARCISVRGEERPTMKEV  666 (735)
Q Consensus       615 ~~~~~~~~~~~---------~~~~d-------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev  666 (735)
                      .....+.....         ....+                   ...........++++.+|+.+||..||.+|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            11111110000         00000                   000122345677899999999999999999999998


Q ss_pred             H
Q 004702          667 S  667 (735)
Q Consensus       667 ~  667 (735)
                      +
T Consensus       326 L  326 (362)
T d1q8ya_         326 V  326 (362)
T ss_dssp             H
T ss_pred             h
Confidence            6

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=1.1e-22  Score=197.00  Aligned_cols=169  Identities=15%  Similarity=0.150  Sum_probs=121.0

Q ss_pred             cccccccccCcEEEEEEEcCCCcEEEEEEeeccC------------------hhHHHHHHHHHHHHHhcCCCceEEEceE
Q 004702          404 NYADVIGCGGSGNVYKGFLPDRTPVAVKKSKFVD------------------QAKIDEFINELVVVLQINRRNVVRLLGC  465 (735)
Q Consensus       404 ~~~~~lG~G~~g~Vy~g~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~g~  465 (735)
                      .++++||+|+||+||+|...++..||||.++...                  ......+.+|+..+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4578999999999999998889999999764210                  0112334568899999999999988765


Q ss_pred             EeecCceeEEEEecCCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEcCCCCeEEeecc
Q 004702          466 CLETQVPLLVYEFVGNGTLFEHIHKKGNLSWERRLRITAETAGVLSYLHSETNVPIIHRDVKSANILLDENCTPKVSDFG  545 (735)
Q Consensus       466 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG  545 (735)
                      .    ..+++|||+++..+.+       ++......++.|++++|+|||+.+   |+||||||+|||++++ .++|+|||
T Consensus        83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCT
T ss_pred             c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECC
Confidence            3    3479999998765433       344556789999999999999999   9999999999999976 48999999


Q ss_pred             CCcccCCCcccceeeeccccCccCcccccCCCCCccccchhHHHHH
Q 004702          546 ASKLVPIDAIQNCTVVQGTLGYLDPEYLQTCKLTDKSDVYSFGVVL  591 (735)
Q Consensus       546 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVyS~Gvvl  591 (735)
                      ++.............  ..... -.+.+ ...|..++|+||..--+
T Consensus       148 ~a~~~~~~~~~~~l~--rd~~~-~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         148 QSVEVGEEGWREILE--RDVRN-IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TCEETTSTTHHHHHH--HHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CcccCCCCCcHHHHH--HHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence            997654222111000  00000 01111 35678899999985443

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.47  E-value=3.8e-08  Score=67.61  Aligned_cols=39  Identities=33%  Similarity=0.698  Sum_probs=33.4

Q ss_pred             CccccCCccCCCCCCCCCcCCCCCCccceeccCCCCCCCC
Q 004702          277 GCRDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       277 gC~di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      .|.|||||..++ ..|.+.|.|++|+|.|.|++||.++++
T Consensus         1 sCvDidEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~~g~   39 (43)
T d1emoa1           1 SAVDMDECKEPD-VCKHGQCINTDGSYRCECPFGYILAGN   39 (43)
T ss_dssp             CCCCCCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEESSS
T ss_pred             CCcceeccCCcC-CCCCCEeECCCCCeEeECCCCcccCCC
Confidence            389999998654 567889999999999999999987654

>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Thrombomodulin, different EGF-like domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.18  E-value=8.3e-08  Score=64.02  Aligned_cols=35  Identities=34%  Similarity=0.946  Sum_probs=31.1

Q ss_pred             ccCCccCCCCCCCCCcCCCCCCccceeccCCCCCCCC
Q 004702          280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       280 di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      |||||..+  .+|++.|.|++|+|+|.|++||.+++.
T Consensus         1 DidEC~~~--~~C~~~C~N~~Gsy~C~C~~Gy~l~g~   35 (40)
T d1dx5i3           1 DIDECENG--GFCSGVCHNLPGTFECICGPDSALAGQ   35 (40)
T ss_dssp             ECCHHHHC--SSCSSEEEECSSSEEEEECSSSSCEEE
T ss_pred             CccccCCC--cCccCEeeCCCCCeEeECCCCCeeCCC
Confidence            79999853  789999999999999999999998753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.14  E-value=3.5e-06  Score=83.18  Aligned_cols=132  Identities=16%  Similarity=0.128  Sum_probs=90.8

Q ss_pred             cCcEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcC-CCceEEEceEEeecCceeEEEEecCCCchhHHhhh
Q 004702          412 GGSGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQIN-RRNVVRLLGCCLETQVPLLVYEFVGNGTLFEHIHK  490 (735)
Q Consensus       412 G~~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  490 (735)
                      ++...||+... ++..++||+...........+..|...+..+. +--+.+++.+...++..++||+++++.++.+....
T Consensus        25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            34468998865 44557788866443333445678888887774 33366778888888889999999999887655422


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------------
Q 004702          491 KGNLSWERRLRITAETAGVLSYLHSET-----------------------------------------------------  517 (735)
Q Consensus       491 ~~~l~~~~~~~i~~qia~~L~yLH~~~-----------------------------------------------------  517 (735)
                      .     .....++.++++.|+.||+..                                                     
T Consensus       104 ~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  178 (263)
T d1j7la_         104 E-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEK  178 (263)
T ss_dssp             C-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSC
T ss_pred             c-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcC
Confidence            1     122334556666666666421                                                     


Q ss_pred             ---CCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          518 ---NVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       518 ---~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                         ...++|+|+.+.|||++++..+-|.||+.+..
T Consensus       179 ~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         179 PEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence               11278999999999999876677999988763

>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.10  E-value=2.6e-07  Score=63.49  Aligned_cols=37  Identities=43%  Similarity=0.836  Sum_probs=31.8

Q ss_pred             cccCCccCCCCCCCCCcCCCCCCccceeccCCCCCCCC
Q 004702          279 RDVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       279 ~di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      +|||||..++ ..|.+.|.|++|+|.|.|++||..+..
T Consensus         1 TDidEC~~~~-~~c~~~C~Nt~G~y~C~C~~Gy~l~~d   37 (43)
T d1uzka1           1 TDVNECLDPT-TCISGNCVNTPGSYICDCPPDFELNPT   37 (43)
T ss_dssp             CCCCGGGSTT-SSBTSEEEEETTEEEEECCTTCEECTT
T ss_pred             CCccccCCCC-cCcCCEeECCCCCEEEecCCCCEECCC
Confidence            4899998764 568899999999999999999987643

>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.09  E-value=1.7e-07  Score=64.34  Aligned_cols=36  Identities=33%  Similarity=0.803  Sum_probs=30.2

Q ss_pred             cccCCccCCCCCCC-CCcCCCCCCccceeccCCCCCCC
Q 004702          279 RDVNECEDPSRNNC-THICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       279 ~di~eC~~~~~~~c-~~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      +|||||.... ..| .+.|.|++|+|.|.|++||..+.
T Consensus         1 qDinEC~~~~-~~c~~~~C~Nt~Gsy~C~C~~Gy~l~~   37 (43)
T d1uzka2           1 EDIDECQELP-GLCQGGKCINTFGSFQCRCPTGYYLNE   37 (43)
T ss_dssp             EECCHHHHCG-GGGBTSEEEECSSCEEEECCTTCCBCT
T ss_pred             CCcccccCCC-CCcCCCEEECCCCCeEeECCCCCeECc
Confidence            6999998644 455 48999999999999999998764

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.07  E-value=3.2e-07  Score=62.87  Aligned_cols=36  Identities=31%  Similarity=0.871  Sum_probs=30.3

Q ss_pred             cccCCccCCCCCCCC-CcCCCCCCccceeccCCCCCCC
Q 004702          279 RDVNECEDPSRNNCT-HICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       279 ~di~eC~~~~~~~c~-~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      +|||||.... ..|. +.|.|++|+|.|.|++||.++.
T Consensus         1 TDidEC~~~~-~~C~~~~C~Nt~Gsy~C~C~~Gy~~~~   37 (44)
T d1lmja1           1 TDIDECRISP-DLCGRGQCVNTPGDFECKCDEGYESGF   37 (44)
T ss_dssp             CCCCTTTTCS-STTTTSCEEEETTEEEECCCSSEEECT
T ss_pred             CcccccCCCC-CCCCCCEeEcCCCCeEEeCCCCCccCC
Confidence            4899998654 5565 5999999999999999998764

>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Complement protease C1R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.97  E-value=8.1e-07  Score=64.14  Aligned_cols=38  Identities=37%  Similarity=0.950  Sum_probs=30.0

Q ss_pred             cccCCccCCCCC-------CCCCcCCCCCCccceeccCCCCCCCC
Q 004702          279 RDVNECEDPSRN-------NCTHICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       279 ~di~eC~~~~~~-------~c~~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      .|||||......       .|++.|.|++|+|.|.|++||+++..
T Consensus         2 vDidEC~~~~~~c~~~~~~~c~~~C~Nt~GsY~C~C~~Gy~l~~d   46 (53)
T d1apqa_           2 VDLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQED   46 (53)
T ss_dssp             CSCCTTTCSTTTCCCSSSCTTSSEEEEETTEEEEECSTTCEECTT
T ss_pred             eecccccCCCCCcccCCCCCccCEeEcCCCCeEeECCCCCeECCC
Confidence            489999765422       35678999999999999999986543

>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.94  E-value=6.5e-07  Score=60.98  Aligned_cols=36  Identities=33%  Similarity=0.820  Sum_probs=29.9

Q ss_pred             ccCCccCCCCCCCC-CcCCCCCCccceeccCCCCCCCC
Q 004702          280 DVNECEDPSRNNCT-HICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       280 di~eC~~~~~~~c~-~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      |||||.... ..|. +.|.|++|+|.|.|++||..++.
T Consensus         1 DidEC~~~~-~~C~~~~C~Nt~Gsy~C~C~~Gy~l~~d   37 (42)
T d1lmja2           1 DIDECQRDP-LLCRGGVCHNTEGSYRCECPPGHQLSPN   37 (42)
T ss_dssp             ECCHHHHCS-STTTTSEEEEETTEEEEESCTTSCCCSS
T ss_pred             CccccCCCC-CCCCCCEeECCCCCeEEeCCCCCeECcC
Confidence            799998654 5565 59999999999999999987643

>d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.92  E-value=2e-06  Score=58.78  Aligned_cols=43  Identities=23%  Similarity=0.448  Sum_probs=33.7

Q ss_pred             ccccccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc
Q 004702          234 TCEEAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD  280 (735)
Q Consensus       234 ~C~~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d  280 (735)
                      +|.+++||..+. |..++.|.|+.++|.|.|++||+++.   +.|+|
T Consensus         1 sCvDidEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~~g---~~C~D   43 (43)
T d1emoa1           1 SAVDMDECKEPD-VCKHGQCINTDGSYRCECPFGYILAG---NECVD   43 (43)
T ss_dssp             CCCCCCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEESS---SCEEE
T ss_pred             CCcceeccCCcC-CCCCCEeECCCCCeEeECCCCcccCC---CcccC
Confidence            588999997643 33457899999999999999998754   34765

>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.89  E-value=2.2e-06  Score=57.91  Aligned_cols=34  Identities=38%  Similarity=1.130  Sum_probs=29.6

Q ss_pred             cCCccCCCCCCCCCcCCCCCCccceeccCCCCCCCC
Q 004702          281 VNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       281 i~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      ||||..  .++|++.|.|++|+|.|.|++||..++.
T Consensus         1 idEC~~--~~~C~~~C~n~~Gsy~C~C~~Gy~L~~d   34 (41)
T d1i0ua2           1 IDECQD--PDTCSQLCVNLEGGYKCQCEEGFQLDPH   34 (41)
T ss_dssp             CCTTTT--TTSCSSCEECSSSCCEECCCTTEEECTT
T ss_pred             CccCCC--CCCCCCEeECCCCCEEeECCCCCeECCC
Confidence            689975  3789999999999999999999987643

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.87  E-value=2.5e-06  Score=58.09  Aligned_cols=36  Identities=25%  Similarity=0.715  Sum_probs=31.9

Q ss_pred             cccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          237 EAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       237 ~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      ++++|.. .+.|.++++|.++.++|+|.|++||+|..
T Consensus         2 DideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G~~   38 (42)
T d2vj3a1           2 DVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGPR   38 (42)
T ss_dssp             CCCTTTSSSCSSSTTCEEEECSSSEEEECCTTEESTT
T ss_pred             CCccccCCCCCCCCCcEeECCCCCEEeECCCCCcCCC
Confidence            6778876 56799999999999999999999999965

>d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Complement C1S component
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.79  E-value=2.6e-06  Score=57.63  Aligned_cols=35  Identities=34%  Similarity=0.810  Sum_probs=29.4

Q ss_pred             CCccCCCCCCCCCcCCCCCCccceeccCCCCCCCC
Q 004702          282 NECEDPSRNNCTHICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       282 ~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      |||......+|++.|.|++|+|.|.|+.||.....
T Consensus         1 dEC~~~~~~~C~~~C~n~~Gsy~C~C~~Gy~L~~d   35 (42)
T d1nzia2           1 NECTDFVDVPCSHFCNNFIGGYFCSCPPEYFLHDD   35 (42)
T ss_dssp             CTTTC-CCCCSSSEEEEETTEEEEECCTTCEECTT
T ss_pred             CCCCCCCCcCCCCEeecCCCCEEEeCCCCCEECCC
Confidence            68876555789999999999999999999987643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.77  E-value=3.1e-05  Score=75.64  Aligned_cols=129  Identities=16%  Similarity=0.141  Sum_probs=83.3

Q ss_pred             cccC-cEEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCC--CceEEEceEEeecCceeEEEEecCCCchhH
Q 004702          410 GCGG-SGNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINR--RNVVRLLGCCLETQVPLLVYEFVGNGTLFE  486 (735)
Q Consensus       410 G~G~-~g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~  486 (735)
                      ..|. .+.||+...+++..+++|.......   ..+..|...|+.+..  -.+.+++++..+.+..++|||++++.++.+
T Consensus        19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             SCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             CCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            3443 3679999888888888897654432   345667777776643  335677888888888999999998766533


Q ss_pred             HhhhcCCCCHHHHHHHHHHHHHHH---------------------------------------------------HHHHh
Q 004702          487 HIHKKGNLSWERRLRITAETAGVL---------------------------------------------------SYLHS  515 (735)
Q Consensus       487 ~l~~~~~l~~~~~~~i~~qia~~L---------------------------------------------------~yLH~  515 (735)
                      ..     ...   ..++.++++.|                                                   ..+..
T Consensus        96 ~~-----~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  167 (255)
T d1nd4a_          96 SH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA  167 (255)
T ss_dssp             SC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred             cc-----ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence            11     000   01112222222                                                   33322


Q ss_pred             cC----CCCeeecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          516 ET----NVPIIHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       516 ~~----~~~ivH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      ..    .+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus       168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            21    12379999999999999886678999987753

>d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.76  E-value=5.1e-06  Score=56.09  Aligned_cols=41  Identities=24%  Similarity=0.737  Sum_probs=32.5

Q ss_pred             ccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCcccc
Q 004702          238 AKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDV  281 (735)
Q Consensus       238 ~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di  281 (735)
                      +++|..++.|.+  .|.++.++|+|.|++||+.++ ....|++|
T Consensus         1 idEC~~~~~C~~--~C~n~~Gsy~C~C~~Gy~L~~-d~~~C~ai   41 (41)
T d1i0ua2           1 IDECQDPDTCSQ--LCVNLEGGYKCQCEEGFQLDP-HTKACKAV   41 (41)
T ss_dssp             CCTTTTTTSCSS--CEECSSSCCEECCCTTEEECT-TTCCEEEC
T ss_pred             CccCCCCCCCCC--EeECCCCCEEeECCCCCeECC-CCCccccC
Confidence            367866667865  789999999999999999877 44567764

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.68  E-value=5.9e-06  Score=56.21  Aligned_cols=35  Identities=40%  Similarity=0.906  Sum_probs=29.8

Q ss_pred             cccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          279 RDVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       279 ~di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      +|||||... ..+|.  ++|.|++++|.|.|++||+|.
T Consensus         1 qDideC~~~-~~pC~n~g~C~n~~g~y~C~C~~G~~G~   37 (42)
T d2vj3a1           1 QDVDECSLG-ANPCEHAGKCINTLGSFECQCLQGYTGP   37 (42)
T ss_dssp             CCCCTTTSS-SCSSSTTCEEEECSSSEEEECCTTEEST
T ss_pred             CCCccccCC-CCCCCCCcEeECCCCCEEeECCCCCcCC
Confidence            589999753 36776  699999999999999999865

>d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Mannose-binding protein associated serine protease 2, MASP2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.63  E-value=4e-06  Score=57.99  Aligned_cols=35  Identities=37%  Similarity=0.845  Sum_probs=26.8

Q ss_pred             cCCccCCC--CCCCCCcCCCCCCccceeccCCCCCCC
Q 004702          281 VNECEDPS--RNNCTHICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       281 i~eC~~~~--~~~c~~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      ||||...+  ..+|++.|.|++|+|.|.|++||....
T Consensus         1 IdEC~~~~~~~~~C~~~C~Nt~gsy~C~C~~Gy~L~~   37 (45)
T d1nt0a3           1 VDECRTSLGDSVPCDHYCHNYLGGYYCSCRVGYILHQ   37 (45)
T ss_dssp             CCTTC-------CCSSEEEEETTEEEEECCTTEEECT
T ss_pred             CcCCccCCCCcCCCCCEeecCCCCEEEeCCCCCEECC
Confidence            68997653  346899999999999999999997653

>d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.61  E-value=8.5e-06  Score=55.60  Aligned_cols=41  Identities=24%  Similarity=0.703  Sum_probs=31.7

Q ss_pred             cccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCc
Q 004702          237 EAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGC  278 (735)
Q Consensus       237 ~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC  278 (735)
                      |++||.. ...|. ++.|.|+.++|.|.|++||+++......|
T Consensus         2 DidEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~~~~~~g~~C   43 (44)
T d1lmja1           2 DIDECRISPDLCG-RGQCVNTPGDFECKCDEGYESGFMMMKNC   43 (44)
T ss_dssp             CCCTTTTCSSTTT-TSCEEEETTEEEECCCSSEEECTTTSSSE
T ss_pred             cccccCCCCCCCC-CCEeEcCCCCeEEeCCCCCccCCCCCCcC
Confidence            6789977 56675 46899999999999999999864333334

>d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Mannose-binding protein associated serine protease 2, MASP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.60  E-value=6.9e-06  Score=56.75  Aligned_cols=35  Identities=31%  Similarity=0.832  Sum_probs=29.1

Q ss_pred             cCCccCCC--CCCCCCcCCCCCCccceeccCCCCCCC
Q 004702          281 VNECEDPS--RNNCTHICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       281 i~eC~~~~--~~~c~~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      ||||...+  ...|++.|.|++|+|.|.|++||....
T Consensus         1 IdEC~~~~~~~~~C~~~C~Nt~Gsy~C~C~~Gy~l~~   37 (45)
T d1szba2           1 IDECQVAPGEAPTCDHHCHNHLGGFYCSCRAGYVLHR   37 (45)
T ss_dssp             CCTTCCCTTSCCSSSSEEEEETTEEEEECCTTEEECT
T ss_pred             CcCCcCCCCCCCCCCCCCccCCCCeEEECCCCCeECC
Confidence            68997653  236889999999999999999998654

>d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Thrombomodulin, different EGF-like domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.58  E-value=3.2e-06  Score=56.16  Aligned_cols=34  Identities=12%  Similarity=0.284  Sum_probs=28.4

Q ss_pred             cccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          237 EAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       237 ~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      |++||..++.|..  .|.++.++|+|.|++||+++.
T Consensus         1 DidEC~~~~~C~~--~C~N~~Gsy~C~C~~Gy~l~g   34 (40)
T d1dx5i3           1 DIDECENGGFCSG--VCHNLPGTFECICGPDSALAG   34 (40)
T ss_dssp             ECCHHHHCSSCSS--EEEECSSSEEEEECSSSSCEE
T ss_pred             CccccCCCcCccC--EeeCCCCCeEeECCCCCeeCC
Confidence            4677866677865  899999999999999999865

>d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.54  E-value=1e-05  Score=55.31  Aligned_cols=42  Identities=29%  Similarity=0.610  Sum_probs=31.3

Q ss_pred             cccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc
Q 004702          237 EAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD  280 (735)
Q Consensus       237 ~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d  280 (735)
                      +++||.....|. +..|.++.++|.|.|++||+.++ ....|.|
T Consensus         2 DidEC~~~~~~c-~~~C~Nt~G~y~C~C~~Gy~l~~-d~~~C~D   43 (43)
T d1uzka1           2 DVNECLDPTTCI-SGNCVNTPGSYICDCPPDFELNP-TRVGCVD   43 (43)
T ss_dssp             CCCGGGSTTSSB-TSEEEEETTEEEEECCTTCEECT-TSSBEEC
T ss_pred             CccccCCCCcCc-CCEeECCCCCEEEecCCCCEECC-CCCcccC
Confidence            678897643342 45899999999999999999876 3445654

>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.50  E-value=2.1e-05  Score=52.21  Aligned_cols=35  Identities=23%  Similarity=0.571  Sum_probs=30.0

Q ss_pred             cccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          237 EAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       237 ~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      +.++|.+ +.|.++++|.+..++|.|.|++||+|..
T Consensus         2 d~d~C~~-~PC~ngg~C~~~~~~y~C~C~~g~~G~~   36 (39)
T d1edmb_           2 DGDQCES-NPCLNGGSCKDDINSYECWCPFGFEGKN   36 (39)
T ss_dssp             CCCTTTT-CCCCTTCEEEEETTEEEEECCTTCCSTT
T ss_pred             ccccCCC-CCCCCCcEEEcCCCCEEEECCCCCCCCC
Confidence            4567864 5699999999999999999999999964

>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=97.48  E-value=1.3e-05  Score=52.54  Aligned_cols=35  Identities=20%  Similarity=0.552  Sum_probs=29.8

Q ss_pred             cccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          237 EAKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       237 ~~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      |+++|.+ ..|.++++|.+...+|.|.|++||+|..
T Consensus         1 D~d~C~~-~PC~ngg~C~~~~~~y~C~C~~g~~G~~   35 (37)
T d2c4fl1           1 DGDQCAS-SPCQNGGSCKDQLQSYICFCLPAFEGRN   35 (37)
T ss_dssp             TCCGGGG-CCCCTTCEEEEETTEEEEECCTTEESTT
T ss_pred             CcccCCC-CCCCCCCEEECCCCCeEEECCCCCcCCC
Confidence            4567864 5599999999999999999999999954

>d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.40  E-value=1.3e-05  Score=53.48  Aligned_cols=34  Identities=35%  Similarity=0.909  Sum_probs=29.4

Q ss_pred             ccCCccCCCCCCCCCcCCCCCCccceeccCCCCCC
Q 004702          280 DVNECEDPSRNNCTHICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       280 di~eC~~~~~~~c~~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      .+|||... ...|++.|.|++|+|.|.|++||...
T Consensus         1 G~neC~~~-nggC~h~C~n~~g~~~C~C~~Gy~L~   34 (40)
T d3bpse1           1 GTNECLDN-NGGCSHVCNDLKIGYECLCPDGFQLV   34 (40)
T ss_dssp             CSCGGGTG-GGGCSSEEEECSSSEEEECCTTCCEE
T ss_pred             CcccCCCC-CCCCcCEEEcCCCCEEEECCCCCEEC
Confidence            36899864 47899999999999999999999864

>d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.39  E-value=1.8e-05  Score=53.62  Aligned_cols=35  Identities=26%  Similarity=0.544  Sum_probs=28.6

Q ss_pred             cccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          237 EAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       237 ~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      |++||.. +..|. ++.|.|+.++|+|.|++||..++
T Consensus         1 DidEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~~   36 (42)
T d1lmja2           1 DIDECQRDPLLCR-GGVCHNTEGSYRCECPPGHQLSP   36 (42)
T ss_dssp             ECCHHHHCSSTTT-TSEEEEETTEEEEESCTTSCCCS
T ss_pred             CccccCCCCCCCC-CCEeECCCCCeEEeCCCCCeECc
Confidence            4677866 56675 46899999999999999999876

>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.36  E-value=3.3e-05  Score=51.22  Aligned_cols=34  Identities=24%  Similarity=0.563  Sum_probs=29.1

Q ss_pred             ccccCCCCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          238 AKICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       238 ~~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      +++|.+ ..|.++++|.+..++|+|.|++||+|.-
T Consensus         1 Id~C~~-~PC~n~g~C~~~~~~y~C~C~~G~~G~~   34 (39)
T d2vj3a2           1 VNECVS-NPCQNDATCLDQIGEFQCICMPGYEGVH   34 (39)
T ss_dssp             CCTTTT-CCCCSSCEEEECSSCEEEECCTTEESSS
T ss_pred             CcCCcC-CCCCCCCEEECCCCCEEEeCCCCCccCc
Confidence            356864 5599999999999999999999999965

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.36  E-value=0.00029  Score=73.42  Aligned_cols=75  Identities=19%  Similarity=0.210  Sum_probs=47.2

Q ss_pred             ccccccCcEEEEEEEcCC-CcEEEEEEeec----cC---hhHHHHHHHHHHHHHhcC-C--CceEEEceEEeecCceeEE
Q 004702          407 DVIGCGGSGNVYKGFLPD-RTPVAVKKSKF----VD---QAKIDEFINELVVVLQIN-R--RNVVRLLGCCLETQVPLLV  475 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~-~~~vavK~~~~----~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~lV  475 (735)
                      +.||.|..-.||+....+ ++.|+||....    ..   ....++...|.+.|..+. +  ..+++++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            368999999999998654 56788996432    11   112334456777777663 2  345666654  45566899


Q ss_pred             EEecCCCc
Q 004702          476 YEFVGNGT  483 (735)
Q Consensus       476 ~E~~~~gs  483 (735)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.34  E-value=1.6e-05  Score=54.23  Aligned_cols=35  Identities=23%  Similarity=0.541  Sum_probs=28.7

Q ss_pred             cccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          237 EAKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       237 ~~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      |++||.. ++.|.+ +.|.++.++|+|.|.+||..++
T Consensus         2 DinEC~~~~~~c~~-~~C~Nt~Gsy~C~C~~Gy~l~~   37 (43)
T d1uzka2           2 DIDECQELPGLCQG-GKCINTFGSFQCRCPTGYYLNE   37 (43)
T ss_dssp             ECCHHHHCGGGGBT-SEEEECSSCEEEECCTTCCBCT
T ss_pred             CcccccCCCCCcCC-CEEECCCCCeEeECCCCCeECc
Confidence            6778865 556753 5899999999999999999876

>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.28  E-value=5.4e-05  Score=50.12  Aligned_cols=33  Identities=24%  Similarity=0.682  Sum_probs=28.3

Q ss_pred             cccCCCCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          239 KICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       239 ~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      ++|.+ ..|.++++|.+..++|.|.|++||+|..
T Consensus         1 D~C~~-~PC~ngg~C~~~~~~y~C~C~~G~~G~~   33 (39)
T d1xkba1           1 DQCET-SPCQNQGKCKDGLGEYTCTCLEGFEGKN   33 (39)
T ss_dssp             CTTTT-CCCCSSCEECCCSSSCCEECCTTEETTT
T ss_pred             CcCCC-CCCCCCcEEECCCCCEEEECCCCCCcCc
Confidence            35764 5699999999999999999999999965

>d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Complement protease C1R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.20  E-value=6.9e-05  Score=53.68  Aligned_cols=42  Identities=24%  Similarity=0.495  Sum_probs=28.1

Q ss_pred             cccccCC-CCCCC------CCCCccCCCCcceeeCCCCCCCCCCCCCCcc
Q 004702          237 EAKICGL-NASCD------TPKDNTSTSSGYRCKCNKGYEGNPYLSDGCR  279 (735)
Q Consensus       237 ~~~~C~~-~~~C~------~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~  279 (735)
                      |++||.. +..|.      ....|.|+.++|+|.|++||+++. ....|+
T Consensus         3 DidEC~~~~~~c~~~~~~~c~~~C~Nt~GsY~C~C~~Gy~l~~-d~~tC~   51 (53)
T d1apqa_           3 DLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQE-DRHSCQ   51 (53)
T ss_dssp             SCCTTTCSTTTCCCSSSCTTSSEEEEETTEEEEECSTTCEECT-TSSCEE
T ss_pred             ecccccCCCCCcccCCCCCccCEeEcCCCCeEeECCCCCeECC-CCCcee
Confidence            4556654 33332      233689999999999999999765 233453

>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.08  E-value=9.7e-05  Score=47.64  Aligned_cols=32  Identities=19%  Similarity=0.589  Sum_probs=27.4

Q ss_pred             ccCCCCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          240 ICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       240 ~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      +|.+ ..|.++++|.+...+|.|.|++||+|..
T Consensus         2 ~C~~-~PC~ngg~C~~~~~~y~C~C~~g~~G~~   33 (35)
T d2vj3a3           2 ECAS-SPCLHNGRCLDKINEFQCECPTGFTGHL   33 (35)
T ss_dssp             TTTT-CCSTTTCEEEECSSCEEEECCTTEESSS
T ss_pred             CCCC-CCCCCCcEEECCCCCeEEECCCCCCCCC
Confidence            5654 5599999999999999999999999954

>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-like domain of nidogen-1
domain: EGF-like domain of nidogen-1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=96.98  E-value=2.6e-05  Score=51.88  Aligned_cols=28  Identities=25%  Similarity=0.730  Sum_probs=24.2

Q ss_pred             CCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          245 ASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       245 ~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      +.|..++.|.++.++|.|.|++||.||.
T Consensus         7 ~~C~~~A~C~Nt~Gsy~C~C~~Gy~GdG   34 (40)
T d1gl4a2           7 HQCSVHAECRDYATGFCCRCVANYTGNG   34 (40)
T ss_dssp             GGSCTTEEEEECSSCEEEEECTTEEECS
T ss_pred             CCCCCCCEeecCCCCeEeECCCCCcCCC
Confidence            4577777888899999999999999975

>d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Mannose-binding protein associated serine protease 2, MASP2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=96.92  E-value=9.8e-05  Score=50.75  Aligned_cols=41  Identities=20%  Similarity=0.376  Sum_probs=26.6

Q ss_pred             cccCC-CCC-CCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc
Q 004702          239 KICGL-NAS-CDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD  280 (735)
Q Consensus       239 ~~C~~-~~~-C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d  280 (735)
                      +||.. ++. +.....|.++.++|+|.|++||..++ ....|+.
T Consensus         2 dEC~~~~~~~~~C~~~C~Nt~gsy~C~C~~Gy~L~~-d~~tC~~   44 (45)
T d1nt0a3           2 DECRTSLGDSVPCDHYCHNYLGGYYCSCRVGYILHQ-NKHTCSA   44 (45)
T ss_dssp             CTTC-------CCSSEEEEETTEEEEECCTTEEECT-TSSCEEE
T ss_pred             cCCccCCCCcCCCCCEeecCCCCEEEeCCCCCEECC-CCCcccc
Confidence            56754 332 22234789999999999999998766 3445654

>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: E-selectin, EGF-domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.92  E-value=6.8e-05  Score=50.01  Aligned_cols=36  Identities=31%  Similarity=0.683  Sum_probs=29.2

Q ss_pred             ccCCCCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCcccc
Q 004702          240 ICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDV  281 (735)
Q Consensus       240 ~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di  281 (735)
                      .|.. ..|.++++|....++|.|.|++||+|..     |+.+
T Consensus         3 ~C~~-~pC~ngg~C~~~~~~y~C~C~~g~~G~~-----Ce~~   38 (40)
T d1g1sa2           3 SCQD-MSCSKQGECLETIGNYTCSCYPGFYGPE-----CEYV   38 (40)
T ss_dssp             CCCT-TGGGGSEEEEECSSSEEEEECTTEESTT-----SCEE
T ss_pred             cccC-CcCCCCcEEECCCCCeEEeCCCCccCCC-----CCCC
Confidence            4543 4598889999999999999999999965     6654

>d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Mannose-binding protein associated serine protease 2, MASP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.88  E-value=0.00013  Score=50.05  Aligned_cols=42  Identities=17%  Similarity=0.426  Sum_probs=29.2

Q ss_pred             ccccCC-CCC-CCCCCCccCCCCcceeeCCCCCCCCCCCCCCccc
Q 004702          238 AKICGL-NAS-CDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRD  280 (735)
Q Consensus       238 ~~~C~~-~~~-C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~d  280 (735)
                      ++||.. ++. +.....|.++.++|+|.|++||+.+. ....|+|
T Consensus         1 IdEC~~~~~~~~~C~~~C~Nt~Gsy~C~C~~Gy~l~~-d~~tC~D   44 (45)
T d1szba2           1 IDECQVAPGEAPTCDHHCHNHLGGFYCSCRAGYVLHR-NKRTCSE   44 (45)
T ss_dssp             CCTTCCCTTSCCSSSSEEEEETTEEEEECCTTEEECT-TSSCEEE
T ss_pred             CcCCcCCCCCCCCCCCCCccCCCCeEEECCCCCeECC-CCCCccC
Confidence            356755 332 22344889999999999999999866 3445765

>d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Complement C1S component
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.74  E-value=0.00022  Score=47.87  Aligned_cols=37  Identities=22%  Similarity=0.446  Sum_probs=28.1

Q ss_pred             cccCC--CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCc
Q 004702          239 KICGL--NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGC  278 (735)
Q Consensus       239 ~~C~~--~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC  278 (735)
                      +||..  ++.|.+  .|.++.++|+|.|++||+.++ ....|
T Consensus         1 dEC~~~~~~~C~~--~C~n~~Gsy~C~C~~Gy~L~~-d~~tC   39 (42)
T d1nzia2           1 NECTDFVDVPCSH--FCNNFIGGYFCSCPPEYFLHD-DMKNC   39 (42)
T ss_dssp             CTTTC-CCCCSSS--EEEEETTEEEEECCTTCEECT-TSSCE
T ss_pred             CCCCCCCCcCCCC--EeecCCCCEEEeCCCCCEECC-CCCee
Confidence            36753  466876  789999999999999999876 33344

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.71  E-value=0.0021  Score=64.88  Aligned_cols=132  Identities=18%  Similarity=0.225  Sum_probs=75.7

Q ss_pred             EEEEEEEcCCCcEEEEEEeeccChhHHHHHHHHHHHHHhcCCCce--EEEc-----eEEeecCceeEEEEecCCCchh--
Q 004702          415 GNVYKGFLPDRTPVAVKKSKFVDQAKIDEFINELVVVLQINRRNV--VRLL-----GCCLETQVPLLVYEFVGNGTLF--  485 (735)
Q Consensus       415 g~Vy~g~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----g~~~~~~~~~lV~E~~~~gsL~--  485 (735)
                      -.||+...++|..+++|..+... ...+++..|...+..|....+  +..+     ......+..+.++++++|..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            47999999999999999876432 234567788888877753222  1111     1123455678899998764321  


Q ss_pred             ---H---------Hhhh----c-----CCCCHH-------------------HHHHHHHHHHHHHHHHHhc----CCCCe
Q 004702          486 ---E---------HIHK----K-----GNLSWE-------------------RRLRITAETAGVLSYLHSE----TNVPI  521 (735)
Q Consensus       486 ---~---------~l~~----~-----~~l~~~-------------------~~~~i~~qia~~L~yLH~~----~~~~i  521 (735)
                         .         .++.    .     ..+++.                   .+..+...+.+.++.+...    ....+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               0         0110    0     111111                   1111222223333333322    23458


Q ss_pred             eecCCCCCcEEEcCCCCeEEeeccCCcc
Q 004702          522 IHRDVKSANILLDENCTPKVSDFGASKL  549 (735)
Q Consensus       522 vH~Dlk~~NILl~~~~~~kl~DFGls~~  549 (735)
                      ||+|+.+.|||++++  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  46899998764

>d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Cow (Bos taurus) [TaxId: 9913]

Probab=96.66  E-value=0.00029  Score=49.66  Aligned_cols=38  Identities=29%  Similarity=0.528  Sum_probs=31.5

Q ss_pred             CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCc
Q 004702          244 NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNEC  284 (735)
Q Consensus       244 ~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC  284 (735)
                      |+.|.+  .|.++.++|.|.|++||+..+ ....|+++++|
T Consensus         5 NGgC~h--~C~~~~~~~~C~C~~Gy~L~~-D~~tC~~~~~~   42 (51)
T d1kigl_           5 NGGCDQ--FCREERSEVRCSCAHGYVLGD-DSKSCVSTERF   42 (51)
T ss_dssp             TTSSSS--CCCEETTEECCCCCTTEEECT-TSSCEEECSSS
T ss_pred             CCCccc--EeEcCCCcEEeEcCCCCEECC-CCCccccCCcc
Confidence            667876  577888999999999999887 56779988876

>d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.53  E-value=0.00028  Score=46.87  Aligned_cols=32  Identities=25%  Similarity=0.559  Sum_probs=26.8

Q ss_pred             ccccCC-CCCCCCCCCccCCCCcceeeCCCCCCCC
Q 004702          238 AKICGL-NASCDTPKDNTSTSSGYRCKCNKGYEGN  271 (735)
Q Consensus       238 ~~~C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn  271 (735)
                      .++|.. ++.|.+  .|.++.++|+|.|++||...
T Consensus         2 ~neC~~~nggC~h--~C~n~~g~~~C~C~~Gy~L~   34 (40)
T d3bpse1           2 TNECLDNNGGCSH--VCNDLKIGYECLCPDGFQLV   34 (40)
T ss_dssp             SCGGGTGGGGCSS--EEEECSSSEEEECCTTCCEE
T ss_pred             cccCCCCCCCCcC--EEEcCCCCEEEECCCCCEEC
Confidence            467866 677977  88999999999999999873

>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: E-selectin, EGF-domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.50  E-value=0.00015  Score=47.94  Aligned_cols=32  Identities=31%  Similarity=0.745  Sum_probs=27.1

Q ss_pred             ccCCCCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          240 ICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       240 ~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      .|.+ +.|.++++|.+..++|.|.|++||+|..
T Consensus         3 ~C~~-~pC~ngg~C~~~~~~~~C~C~~g~~G~~   34 (39)
T d1g1ta2           3 ACTN-TSCSGHGECVETINNYTCKCDPGFSGLK   34 (39)
T ss_dssp             CCCT-TGGGGSEEEEEETTEEEEEECTTEESTT
T ss_pred             cccC-CcCCCCcEEECCCCCEEEeCCCCCcCcC
Confidence            4643 5599999999999999999999999965

>d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Plasminogen activator (tissue-type), t-PA
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.46  E-value=0.00071  Score=45.19  Aligned_cols=28  Identities=21%  Similarity=0.605  Sum_probs=23.0

Q ss_pred             CCCCCCCCccCC--CCcceeeCCCCCCCCC
Q 004702          245 ASCDTPKDNTST--SSGYRCKCNKGYEGNP  272 (735)
Q Consensus       245 ~~C~~~~~c~~~--~~~y~C~C~~Gy~gn~  272 (735)
                      ..|.++++|...  ..+|.|.|++||+|.-
T Consensus         4 nPC~ngG~C~~~~~~~~y~C~C~~g~~G~~   33 (41)
T d1tpga1           4 PRCFNGGTCQQALYFSDFVCQCPEGFAGKS   33 (41)
T ss_dssp             CCSCTTCEEEEESSSSCEEEECCTTCBSSS
T ss_pred             CCCCCCCEEecCCCCCCeEECCCCCCCCCC
Confidence            458888888753  5689999999999966

>d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=96.42  E-value=0.00025  Score=46.25  Aligned_cols=32  Identities=31%  Similarity=0.783  Sum_probs=27.4

Q ss_pred             ccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          280 DVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       280 di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      |+|+|..   ++|.  ++|.+..++|.|.|++||+|.
T Consensus         1 D~d~C~~---~PC~ngg~C~~~~~~y~C~C~~g~~G~   34 (37)
T d2c4fl1           1 DGDQCAS---SPCQNGGSCKDQLQSYICFCLPAFEGR   34 (37)
T ss_dssp             TCCGGGG---CCCCTTCEEEEETTEEEEECCTTEEST
T ss_pred             CcccCCC---CCCCCCCEEECCCCCeEEECCCCCcCC
Confidence            6889974   5776  799999999999999999865

>d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.40  E-value=0.00044  Score=45.66  Aligned_cols=32  Identities=41%  Similarity=0.908  Sum_probs=27.7

Q ss_pred             ccCCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          280 DVNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       280 di~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      |+|+|..   .+|.  ++|.+..++|.|.|++||+|.
T Consensus         2 d~d~C~~---~PC~ngg~C~~~~~~y~C~C~~g~~G~   35 (39)
T d1edmb_           2 DGDQCES---NPCLNGGSCKDDINSYECWCPFGFEGK   35 (39)
T ss_dssp             CCCTTTT---CCCCTTCEEEEETTEEEEECCTTCCST
T ss_pred             ccccCCC---CCCCCCcEEEcCCCCEEEECCCCCCCC
Confidence            7889974   6776  799999999999999999875

>d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Activated protein c (autoprothrombin IIa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.22  E-value=0.00069  Score=47.35  Aligned_cols=41  Identities=24%  Similarity=0.456  Sum_probs=31.9

Q ss_pred             cCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCc
Q 004702          241 CGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNEC  284 (735)
Q Consensus       241 C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC  284 (735)
                      |.. |+.|.+  .|.++.++|+|.|++||+.++ ....|+.++++
T Consensus         2 C~~~NGgC~~--~C~~~~g~~~C~C~~Gy~L~~-D~~tC~~~~~~   43 (50)
T d1autl2           2 CSLDNGGCTH--YCLEEVGWRRCSCAPGYKLGD-DLLQCHPAVKF   43 (50)
T ss_dssp             SSSGGGGCSS--EEEECSSSEEEECCTTEEECT-TSSCEEECSSS
T ss_pred             CCCCCCCccc--EeecCCCCeEEECCCCCEECC-CCCccccCCCC
Confidence            444 667876  678888999999999999987 56678877653

>d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.19  E-value=0.00071  Score=44.57  Aligned_cols=31  Identities=39%  Similarity=0.914  Sum_probs=26.4

Q ss_pred             cCCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          281 VNECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       281 i~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      ||+|..   .+|.  ++|.+..++|+|.|++||.|.
T Consensus         1 Id~C~~---~PC~n~g~C~~~~~~y~C~C~~G~~G~   33 (39)
T d2vj3a2           1 VNECVS---NPCQNDATCLDQIGEFQCICMPGYEGV   33 (39)
T ss_dssp             CCTTTT---CCCCSSCEEEECSSCEEEECCTTEESS
T ss_pred             CcCCcC---CCCCCCCEEECCCCCEEEeCCCCCccC
Confidence            688864   5676  699999999999999999875

>d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-like domain of nidogen-1
domain: EGF-like domain of nidogen-1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=96.07  E-value=0.00043  Score=45.81  Aligned_cols=23  Identities=30%  Similarity=0.927  Sum_probs=21.4

Q ss_pred             CcCCCCCCccceeccCCCCCCCC
Q 004702          294 HICDNIPGSYTCRCRKGFHGDGR  316 (735)
Q Consensus       294 ~~C~n~~g~y~C~c~~g~~~~~~  316 (735)
                      +.|.|++|+|.|.|++||.|++.
T Consensus        13 A~C~Nt~Gsy~C~C~~Gy~GdG~   35 (40)
T d1gl4a2          13 AECRDYATGFCCRCVANYTGNGR   35 (40)
T ss_dssp             EEEEECSSCEEEEECTTEEECSS
T ss_pred             CEeecCCCCeEeECCCCCcCCCC
Confidence            58999999999999999999875

>d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Activated protein c (autoprothrombin IIa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.93  E-value=0.0012  Score=45.57  Aligned_cols=32  Identities=22%  Similarity=0.617  Sum_probs=26.4

Q ss_pred             cccCCCCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          239 KICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       239 ~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      +.|.. +.|.+ ++|.+..++|.|.|++||+|..
T Consensus         9 ~~C~~-~PC~n-G~C~~~~~~y~C~C~~G~~G~~   40 (48)
T d1autl1           9 HPCAS-LCCGH-GTCIDGIGSFSCDCRSGWEGRF   40 (48)
T ss_dssp             CSSSS-TTTTS-EEECCCSSCCCEEECTTEESTT
T ss_pred             CcccC-CCCCC-CEEECCCCCCeEeCCCCCcCCC
Confidence            45754 56887 6899989999999999999965

>d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.90  E-value=0.00084  Score=47.11  Aligned_cols=41  Identities=24%  Similarity=0.565  Sum_probs=31.9

Q ss_pred             cCC-CCCCCCCCCccCCCCcceeeCCCCCCCCCCCCCCccccCCc
Q 004702          241 CGL-NASCDTPKDNTSTSSGYRCKCNKGYEGNPYLSDGCRDVNEC  284 (735)
Q Consensus       241 C~~-~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~y~~~gC~di~eC  284 (735)
                      |.. |+.|.+  .|.++.++|+|.|++||+.++ +...|..++++
T Consensus         3 C~~~NGgC~h--~C~n~~g~~~C~C~~Gy~L~~-D~~tC~~~~~~   44 (51)
T d2p3ua1           3 CSLDNGDCDQ--FCHEEQNSVVCSCARGYTLAD-NGKACIPTGPY   44 (51)
T ss_dssp             GGTGGGGCSS--EEEEETTEEEEECCTTEEECT-TSSCEEESSSS
T ss_pred             cCCCCCCccc--EeecCCCCeEeEcCCCCEECC-CCCccccCCcc
Confidence            444 666876  678888999999999999887 55678877654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.83  E-value=0.0077  Score=62.24  Aligned_cols=72  Identities=17%  Similarity=0.181  Sum_probs=46.1

Q ss_pred             ccccccCcEEEEEEEcCCC--------cEEEEEEeeccChhHHHHHHHHHHHHHhcCCCce-EEEceEEeecCceeEEEE
Q 004702          407 DVIGCGGSGNVYKGFLPDR--------TPVAVKKSKFVDQAKIDEFINELVVVLQINRRNV-VRLLGCCLETQVPLLVYE  477 (735)
Q Consensus       407 ~~lG~G~~g~Vy~g~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E  477 (735)
                      +.|+.|-.=.+|+....++        ..|.+++... .. ...+..+|..+++.+.-.++ .++++++..    .+|||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            3577777788999886542        4466665442 22 23345678888888864444 467776642    68999


Q ss_pred             ecCCCch
Q 004702          478 FVGNGTL  484 (735)
Q Consensus       478 ~~~~gsL  484 (735)
                      |+++.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9986544

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.78  E-value=0.0026  Score=39.46  Aligned_cols=33  Identities=24%  Similarity=0.806  Sum_probs=26.9

Q ss_pred             cccCCCCCCCCCCCccCCCCcceeeCCCCCCCCC
Q 004702          239 KICGLNASCDTPKDNTSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       239 ~~C~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn~  272 (735)
                      ++|..+..|.+ ++|.+-.++|.|.|.+||+--|
T Consensus         2 dECsignpCGn-GTCtNviGgFec~C~~GFepgp   34 (39)
T d1emoa2           2 DECSVGNPCGN-GTCKNVIGGFECTCEEGFEPGP   34 (39)
T ss_dssp             CGGGTTCSSSS-SCEEECSSSEEECCSSSSCCCS
T ss_pred             CccccCCccCC-ceeeecccceEEeecCCcCCCc
Confidence            46766667875 5889999999999999998766

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.59  E-value=0.0027  Score=39.39  Aligned_cols=32  Identities=34%  Similarity=0.915  Sum_probs=26.4

Q ss_pred             CCccCCCCCCCC-CcCCCCCCccceeccCCCCCCC
Q 004702          282 NECEDPSRNNCT-HICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       282 ~eC~~~~~~~c~-~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      |||...  ++|. ++|.|..|+|.|.|..||...+
T Consensus         2 dECsig--npCGnGTCtNviGgFec~C~~GFepgp   34 (39)
T d1emoa2           2 DECSVG--NPCGNGTCKNVIGGFECTCEEGFEPGP   34 (39)
T ss_dssp             CGGGTT--CSSSSSCEEECSSSEEECCSSSSCCCS
T ss_pred             CccccC--CccCCceeeecccceEEeecCCcCCCc
Confidence            678764  5776 7999999999999999996443

>d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Prostaglandin H2 synthase-1, EGF-like module
species: Sheep (Ovis aries) [TaxId: 9940]

Probab=95.34  E-value=0.0022  Score=42.89  Aligned_cols=33  Identities=24%  Similarity=0.622  Sum_probs=25.9

Q ss_pred             cccCCCCCCCCCCCccCC-CCcceeeCCC-CCCCCC
Q 004702          239 KICGLNASCDTPKDNTST-SSGYRCKCNK-GYEGNP  272 (735)
Q Consensus       239 ~~C~~~~~C~~~~~c~~~-~~~y~C~C~~-Gy~gn~  272 (735)
                      +.|.. ..|.++++|... .++|.|.|+. ||+|..
T Consensus         3 d~C~~-nPC~ngG~C~~~~~~~y~C~C~~~G~~G~~   37 (42)
T d1q4ga2           3 NPCCY-YPCQHQGICVRFGLDRYQCDCTRTGYSGPN   37 (42)
T ss_dssp             CGGGG-CCCCTTCEEEEETTTEEEEECTTSSEETTT
T ss_pred             ccCcC-CCCCCCCEeeeCCCCCEEEECCCCCcCCcC
Confidence            45654 559999999764 6789999986 999965

>d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Prostaglandin H2 synthase-1, EGF-like module
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=95.34  E-value=0.0026  Score=42.29  Aligned_cols=33  Identities=27%  Similarity=0.692  Sum_probs=25.9

Q ss_pred             cccCCCCCCCCCCCccCC-CCcceeeCC-CCCCCCC
Q 004702          239 KICGLNASCDTPKDNTST-SSGYRCKCN-KGYEGNP  272 (735)
Q Consensus       239 ~~C~~~~~C~~~~~c~~~-~~~y~C~C~-~Gy~gn~  272 (735)
                      +.|.. ..|.++++|... .++|+|.|+ +||+|..
T Consensus         2 d~C~~-~PC~ngG~C~~~~~~~y~C~C~~~gy~G~~   36 (41)
T d1cvua2           2 NPCCS-NPCQNRGECMSTGFDQYKCDCTRTGFYGEN   36 (41)
T ss_dssp             CTTTT-CCCCTTCEEEEEETTEEEEECTTSSEETTT
T ss_pred             CcCcC-CCCCCCCEEEECCCCCEEEeCcCCCcCCcC
Confidence            45754 569999999764 578999996 6999965

>d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Activated protein c (autoprothrombin IIa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.23  E-value=0.0015  Score=45.51  Aligned_cols=32  Identities=28%  Similarity=0.585  Sum_probs=26.4

Q ss_pred             CCCCCcCCCCCCccceeccCCCCCCCCCCCCCCc
Q 004702          290 NNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCT  323 (735)
Q Consensus       290 ~~c~~~C~n~~g~y~C~c~~g~~~~~~~~~~gC~  323 (735)
                      ..|++.|.|++++|.|.|+.||+....  +..|.
T Consensus         7 GgC~~~C~~~~g~~~C~C~~Gy~L~~D--~~tC~   38 (50)
T d1autl2           7 GGCTHYCLEEVGWRRCSCAPGYKLGDD--LLQCH   38 (50)
T ss_dssp             GGCSSEEEECSSSEEEECCTTEEECTT--SSCEE
T ss_pred             CCcccEeecCCCCeEEECCCCCEECCC--CCccc
Confidence            579999999999999999999987643  34454

>d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Epidermal growth factor, EGF
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=95.17  E-value=0.0073  Score=42.55  Aligned_cols=29  Identities=24%  Similarity=0.586  Sum_probs=23.8

Q ss_pred             CCCCCCCCCcc--CCCCcceeeCCCCCCCCC
Q 004702          244 NASCDTPKDNT--STSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       244 ~~~C~~~~~c~--~~~~~y~C~C~~Gy~gn~  272 (735)
                      .+.|.++++|.  ....+|.|.|++||+|.-
T Consensus        11 ~~~C~NgG~C~~~~~~~~~~C~C~~gy~G~~   41 (53)
T d3egfa_          11 DGYCLNGGVCMHIESLDSYTCNCVIGYSGDR   41 (53)
T ss_dssp             SCCSCSSCEEEEESSSSCEEEECCTTCCSSS
T ss_pred             CCCCCCCcEeeccCCCCCeEeECCCCCcCCC
Confidence            35699999996  455789999999999965

>d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Cow (Bos taurus) [TaxId: 9913]

Probab=95.10  E-value=0.0028  Score=44.42  Aligned_cols=33  Identities=18%  Similarity=0.625  Sum_probs=26.6

Q ss_pred             CCCCCCcCCCCCCccceeccCCCCCCCCCCCCCCc
Q 004702          289 RNNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCT  323 (735)
Q Consensus       289 ~~~c~~~C~n~~g~y~C~c~~g~~~~~~~~~~gC~  323 (735)
                      ...|++.|.|++++|.|.|+.||.....  +..|.
T Consensus         5 NGgC~h~C~~~~~~~~C~C~~Gy~L~~D--~~tC~   37 (51)
T d1kigl_           5 NGGCDQFCREERSEVRCSCAHGYVLGDD--SKSCV   37 (51)
T ss_dssp             TTSSSSCCCEETTEECCCCCTTEEECTT--SSCEE
T ss_pred             CCCcccEeEcCCCcEEeEcCCCCEECCC--CCccc
Confidence            3679999999999999999999987643  34454

>d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.09  E-value=0.005  Score=40.34  Aligned_cols=31  Identities=39%  Similarity=1.018  Sum_probs=25.1

Q ss_pred             CCccCCCCCCCC--CcCCCCCCccceeccCCCCCCC
Q 004702          282 NECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       282 ~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      |+|..   ++|.  ++|.+..++|.|.|++||+|.-
T Consensus         1 D~C~~---~PC~ngg~C~~~~~~y~C~C~~G~~G~~   33 (39)
T d1xkba1           1 DQCET---SPCQNQGKCKDGLGEYTCTCLEGFEGKN   33 (39)
T ss_dssp             CTTTT---CCCCSSCEECCCSSSCCEECCTTEETTT
T ss_pred             CcCCC---CCCCCCcEEECCCCCEEEECCCCCCcCc
Confidence            56753   5676  7999999999999999998753

>d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor X, N-terminal module
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.02  E-value=0.0013  Score=46.20  Aligned_cols=33  Identities=27%  Similarity=0.850  Sum_probs=27.0

Q ss_pred             CCCCCcCCCCCCccceeccCCCCCCCCCCCCCCcC
Q 004702          290 NNCTHICDNIPGSYTCRCRKGFHGDGRKDGGGCTP  324 (735)
Q Consensus       290 ~~c~~~C~n~~g~y~C~c~~g~~~~~~~~~~gC~~  324 (735)
                      ..|++.|.|++++|.|.|+.||.....  +..|.+
T Consensus         8 GgC~h~C~n~~g~~~C~C~~Gy~L~~D--~~tC~~   40 (51)
T d2p3ua1           8 GDCDQFCHEEQNSVVCSCARGYTLADN--GKACIP   40 (51)
T ss_dssp             GGCSSEEEEETTEEEEECCTTEEECTT--SSCEEE
T ss_pred             CCcccEeecCCCCeEeEcCCCCEECCC--CCcccc
Confidence            679999999999999999999987643  345543

>d1ijqa2 g.3.11.1 (A:643-692) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.86  E-value=0.0044  Score=43.07  Aligned_cols=33  Identities=18%  Similarity=0.450  Sum_probs=25.8

Q ss_pred             CCccCCCCCCCCCcCC------CCCCccceeccCCCCCCC
Q 004702          282 NECEDPSRNNCTHICD------NIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       282 ~eC~~~~~~~c~~~C~------n~~g~y~C~c~~g~~~~~  315 (735)
                      |||...+ ..|++.|.      |+.++|.|.|+.||....
T Consensus         5 neC~~~N-GGC~h~Cl~~p~~~n~~~~y~C~C~~G~~L~~   43 (50)
T d1ijqa2           5 ERTTLSN-GGCQYLCLPAPQINPHSPKFTCACPDGMLLAR   43 (50)
T ss_dssp             SSSSSGG-GGCSSEEEECCCCSTTCCSEEEECCTTCEECT
T ss_pred             cccCCCC-CCCcCccCCCcCcccCCCCEEEeCCCCCEECC
Confidence            5665543 67999995      666899999999998764

>d1ijqa2 g.3.11.1 (A:643-692) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Low density lipoprotein (LDL) receptor, different EGF domains
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.76  E-value=0.0067  Score=42.10  Aligned_cols=32  Identities=22%  Similarity=0.395  Sum_probs=24.2

Q ss_pred             cccCC-CCCCCCCCCc------cCCCCcceeeCCCCCCCCC
Q 004702          239 KICGL-NASCDTPKDN------TSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       239 ~~C~~-~~~C~~~~~c------~~~~~~y~C~C~~Gy~gn~  272 (735)
                      ++|.. |+.|.+  .|      .+..++|+|.|++||+..+
T Consensus         5 neC~~~NGGC~h--~Cl~~p~~~n~~~~y~C~C~~G~~L~~   43 (50)
T d1ijqa2           5 ERTTLSNGGCQY--LCLPAPQINPHSPKFTCACPDGMLLAR   43 (50)
T ss_dssp             SSSSSGGGGCSS--EEEECCCCSTTCCSEEEECCTTCEECT
T ss_pred             cccCCCCCCCcC--ccCCCcCcccCCCCEEEeCCCCCEECC
Confidence            35665 677877  55      3456899999999999876

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.57  E-value=0.072  Score=52.54  Aligned_cols=30  Identities=20%  Similarity=0.236  Sum_probs=26.7

Q ss_pred             CCeeecCCCCCcEEEcCCCCeEEeeccCCc
Q 004702          519 VPIIHRDVKSANILLDENCTPKVSDFGASK  548 (735)
Q Consensus       519 ~~ivH~Dlk~~NILl~~~~~~kl~DFGls~  548 (735)
                      .++||+|+.+.||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            359999999999999998777899999875

>d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.41  E-value=0.0061  Score=38.90  Aligned_cols=30  Identities=30%  Similarity=0.864  Sum_probs=24.3

Q ss_pred             CCccCCCCCCCC--CcCCCCCCccceeccCCCCCC
Q 004702          282 NECEDPSRNNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       282 ~eC~~~~~~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      |+|..   ++|.  ++|++..++|.|.|+.+|.|.
T Consensus         1 d~C~~---~PC~ngg~C~~~~~~y~C~C~~g~~G~   32 (35)
T d2vj3a3           1 DECAS---SPCLHNGRCLDKINEFQCECPTGFTGH   32 (35)
T ss_dssp             CTTTT---CCSTTTCEEEECSSCEEEECCTTEESS
T ss_pred             CCCCC---CCCCCCcEEECCCCCeEEECCCCCCCC
Confidence            45653   5666  799999999999999999865

>d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Activated protein c (autoprothrombin IIa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.35  E-value=0.0086  Score=41.07  Aligned_cols=31  Identities=32%  Similarity=0.828  Sum_probs=25.5

Q ss_pred             cCCccCCCCCCCC-CcCCCCCCccceeccCCCCCC
Q 004702          281 VNECEDPSRNNCT-HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       281 i~eC~~~~~~~c~-~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      .++|..   ++|. ++|.+..++|.|.|++||.|.
T Consensus         8 ~~~C~~---~PC~nG~C~~~~~~y~C~C~~G~~G~   39 (48)
T d1autl1           8 EHPCAS---LCCGHGTCIDGIGSFSCDCRSGWEGR   39 (48)
T ss_dssp             CCSSSS---TTTTSEEECCCSSCCCEEECTTEEST
T ss_pred             CCcccC---CCCCCCEEECCCCCCeEeCCCCCcCC
Confidence            566753   5675 699999999999999999865

>d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Heregulin-alpha, EGF-like domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.15  E-value=0.0097  Score=43.68  Aligned_cols=29  Identities=31%  Similarity=0.665  Sum_probs=23.6

Q ss_pred             CCCCCCCCCc-----cCCCCcceeeCCCCCCCCC
Q 004702          244 NASCDTPKDN-----TSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       244 ~~~C~~~~~c-----~~~~~~y~C~C~~Gy~gn~  272 (735)
                      .+.|.++++|     .+..++|.|.|++||+|..
T Consensus        11 ~~~C~NgG~C~~~~~~~~~~~y~C~C~~gy~G~~   44 (63)
T d1haea_          11 KTFCVNGGECFMVKDLSNPSRYLCKCQPGFTGAR   44 (63)
T ss_dssp             HTTSCTTCEEEEEESSSSSCCEEEECCTTEESTT
T ss_pred             CCcCCCCCEEeecccccCCCCEEeECCCCCCCCC
Confidence            3558888888     3556789999999999966

>d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Epidermal growth factor, EGF
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.98  E-value=0.0071  Score=41.64  Aligned_cols=29  Identities=24%  Similarity=0.511  Sum_probs=23.4

Q ss_pred             CCCCCCCCCcc--CCCCcceeeCCCCCCCCC
Q 004702          244 NASCDTPKDNT--STSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       244 ~~~C~~~~~c~--~~~~~y~C~C~~Gy~gn~  272 (735)
                      .+.|.++++|.  ....+|.|.|++||+|.-
T Consensus         9 ~~~C~ngG~C~~~~~~~~~~C~C~~gy~G~~   39 (48)
T d1nqlb_           9 DGYCLHDGVCMYIEALDKYACNCVVGYIGER   39 (48)
T ss_dssp             CCEECTTCEEEEETTTTEEEEEECTTEESTT
T ss_pred             CCCCCCCcEEeeeCCCCCeEEeCCCCcccCC
Confidence            35588888885  455789999999999965

>d1rfnb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=93.96  E-value=0.008  Score=42.94  Aligned_cols=41  Identities=20%  Similarity=0.548  Sum_probs=30.2

Q ss_pred             cCC-CCCCCCCCCccCCC-CcceeeCCCCCCCCCCCCCCccccCCc
Q 004702          241 CGL-NASCDTPKDNTSTS-SGYRCKCNKGYEGNPYLSDGCRDVNEC  284 (735)
Q Consensus       241 C~~-~~~C~~~~~c~~~~-~~y~C~C~~Gy~gn~y~~~gC~di~eC  284 (735)
                      |.. |+.|.+  .|.++. ++|.|.|.+||+..+ +...|+.++++
T Consensus         3 C~~~NGgC~h--~C~~~~~~~~~C~C~~Gy~L~~-D~~tC~~~~~f   45 (57)
T d1rfnb_           3 CNIKNGRCEQ--FCKNSADNKVVCSCTEGYRLAE-NQKSCEPAVPF   45 (57)
T ss_dssp             TTGGGGGCSS--EEEECTTSCEEEECCTTEEECT-TSSSEEECSSS
T ss_pred             cCCCCCCccc--EeeeCCCCCeEeECCCCCEECC-CCCccccCCCc
Confidence            444 566776  676664 589999999999877 56678877654

>d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Betacellulin-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.19  E-value=0.042  Score=37.84  Aligned_cols=29  Identities=21%  Similarity=0.453  Sum_probs=22.7

Q ss_pred             CCCCCCCCCcc-CCCCcceeeCCCCCCCCC
Q 004702          244 NASCDTPKDNT-STSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       244 ~~~C~~~~~c~-~~~~~y~C~C~~Gy~gn~  272 (735)
                      .+.|.++++|. .....+.|.|+.||+|.-
T Consensus        13 ~~yC~nGgcc~~~~~~~~~C~C~~gy~G~r   42 (50)
T d1ioxa_          13 KHYCIKGRCRFVVAEQTPSCVCDEGYIGAR   42 (50)
T ss_dssp             TTSCTTCCEEEETTTTEEEECCCTTEETTT
T ss_pred             CCCccCCeEEEeCCCCCcEeECCCCCeeCC
Confidence            45688877773 455679999999999975

>d2bz6l1 g.3.11.1 (L:90-142) Coagulation factor VIIa {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Coagulation factor VIIa
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.70  E-value=0.034  Score=38.90  Aligned_cols=38  Identities=21%  Similarity=0.528  Sum_probs=26.1

Q ss_pred             cCC-CCCCCCCCCccCCCC-cceeeCCCCCCCCCCCCCCcccc
Q 004702          241 CGL-NASCDTPKDNTSTSS-GYRCKCNKGYEGNPYLSDGCRDV  281 (735)
Q Consensus       241 C~~-~~~C~~~~~c~~~~~-~y~C~C~~Gy~gn~y~~~gC~di  281 (735)
                      |.. |+.|.+  .|.++.+ .|.|.|..||+.++ ....|+..
T Consensus         2 C~~~NGGC~h--~C~~~~~~~~~C~C~~Gy~L~~-D~~tC~~~   41 (53)
T d2bz6l1           2 CVNENGGCEQ--YCSDHTGTKRSCRCHEGYSLLA-DGVSCTPT   41 (53)
T ss_dssp             TTSGGGGCSS--EEEEETTTEEEEECCTTEEECT-TSSCEEEC
T ss_pred             CCCCCCCCcC--EeeeCCCCCEEeECCCCCEECC-CCCcccCC
Confidence            444 566766  5655544 58999999999877 45567654

>d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Epiregulin, EGF-domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.56  E-value=0.072  Score=35.90  Aligned_cols=28  Identities=29%  Similarity=0.532  Sum_probs=20.6

Q ss_pred             CCCCCCCCCc--cCCCCcceeeCCCCCCCCC
Q 004702          244 NASCDTPKDN--TSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       244 ~~~C~~~~~c--~~~~~~y~C~C~~Gy~gn~  272 (735)
                      .+.|.+ +.|  .....+|.|.|++||.|..
T Consensus        11 ~~yC~n-G~C~~~~~~~~~~C~C~~gY~G~R   40 (46)
T d1k36a_          11 NGYCLH-GQCIYLVDMSQNYCRCEVGYTGVR   40 (46)
T ss_dssp             CSSCSS-EEEEEETTTTEEEEEECTTCSSTT
T ss_pred             CCcCcC-CEEEEeCCCCccEeECCCCceecC
Confidence            356776 344  2455789999999999965

>d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Transforming growth factor alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.55  E-value=0.035  Score=38.10  Aligned_cols=29  Identities=21%  Similarity=0.391  Sum_probs=22.2

Q ss_pred             CCCCCCCCCc-cCCCCcceeeCCCCCCCCC
Q 004702          244 NASCDTPKDN-TSTSSGYRCKCNKGYEGNP  272 (735)
Q Consensus       244 ~~~C~~~~~c-~~~~~~y~C~C~~Gy~gn~  272 (735)
                      .+.|.+++.| ......+.|.|++||.|.-
T Consensus        12 ~~yClnGgcc~~~~~~~~~C~C~~gy~G~R   41 (49)
T d1moxc_          12 TQFCFHGTCRFLVQEDKPACVCHSGYVGAR   41 (49)
T ss_dssp             SCSSTTEEEEEETTTTEEEEEECTTEESTT
T ss_pred             CCEeeCCeEEecCCCCCcEeECCCCCEecC
Confidence            4568877766 3445689999999999976

>d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: E-selectin, EGF-domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.47  E-value=0.02  Score=37.33  Aligned_cols=25  Identities=36%  Similarity=0.919  Sum_probs=21.9

Q ss_pred             CCCC--CcCCCCCCccceeccCCCCCC
Q 004702          290 NNCT--HICDNIPGSYTCRCRKGFHGD  314 (735)
Q Consensus       290 ~~c~--~~C~n~~g~y~C~c~~g~~~~  314 (735)
                      ++|.  ++|.+..++|.|.|++||.|.
T Consensus         7 ~pC~ngg~C~~~~~~~~C~C~~g~~G~   33 (39)
T d1g1ta2           7 TSCSGHGECVETINNYTCKCDPGFSGL   33 (39)
T ss_dssp             TGGGGSEEEEEETTEEEEEECTTEEST
T ss_pred             CcCCCCcEEECCCCCEEEeCCCCCcCc
Confidence            5665  699999999999999999876

>d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: E-selectin, EGF-domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.19  E-value=0.031  Score=36.63  Aligned_cols=26  Identities=38%  Similarity=0.865  Sum_probs=22.1

Q ss_pred             CCCC--CcCCCCCCccceeccCCCCCCC
Q 004702          290 NNCT--HICDNIPGSYTCRCRKGFHGDG  315 (735)
Q Consensus       290 ~~c~--~~C~n~~g~y~C~c~~g~~~~~  315 (735)
                      ++|.  ++|.+..++|.|.|++||.|.-
T Consensus         7 ~pC~ngg~C~~~~~~y~C~C~~g~~G~~   34 (40)
T d1g1sa2           7 MSCSKQGECLETIGNYTCSCYPGFYGPE   34 (40)
T ss_dssp             TGGGGSEEEEECSSSEEEEECTTEESTT
T ss_pred             CcCCCCcEEECCCCCeEEeCCCCccCCC
Confidence            5665  6999999999999999998753

>d1rfnb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Factor IX (IXa)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.93  E-value=0.025  Score=40.30  Aligned_cols=33  Identities=24%  Similarity=0.767  Sum_probs=25.8

Q ss_pred             CCCCCcCCCCCC-ccceeccCCCCCCCCCCCCCCcC
Q 004702          290 NNCTHICDNIPG-SYTCRCRKGFHGDGRKDGGGCTP  324 (735)
Q Consensus       290 ~~c~~~C~n~~g-~y~C~c~~g~~~~~~~~~~gC~~  324 (735)
                      ..|++.|.++++ +|.|.|+.||.....  +..|.+
T Consensus         8 GgC~h~C~~~~~~~~~C~C~~Gy~L~~D--~~tC~~   41 (57)
T d1rfnb_           8 GRCEQFCKNSADNKVVCSCTEGYRLAEN--QKSCEP   41 (57)
T ss_dssp             GGCSSEEEECTTSCEEEECCTTEEECTT--SSSEEE
T ss_pred             CCcccEeeeCCCCCeEeECCCCCEECCC--CCcccc
Confidence            679999999975 899999999987542  445543

>d2bz6l1 g.3.11.1 (L:90-142) Coagulation factor VIIa {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Coagulation factor VIIa
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.74  E-value=0.026  Score=39.49  Aligned_cols=33  Identities=33%  Similarity=0.901  Sum_probs=25.5

Q ss_pred             CCCCCcCCCCCC-ccceeccCCCCCCCCCCCCCCcC
Q 004702          290 NNCTHICDNIPG-SYTCRCRKGFHGDGRKDGGGCTP  324 (735)
Q Consensus       290 ~~c~~~C~n~~g-~y~C~c~~g~~~~~~~~~~gC~~  324 (735)
                      ..|++.|.++++ +|.|.|+.||.....  +..|.+
T Consensus         7 GGC~h~C~~~~~~~~~C~C~~Gy~L~~D--~~tC~~   40 (53)
T d2bz6l1           7 GGCEQYCSDHTGTKRSCRCHEGYSLLAD--GVSCTP   40 (53)
T ss_dssp             GGCSSEEEEETTTEEEEECCTTEEECTT--SSCEEE
T ss_pred             CCCcCEeeeCCCCCEEeECCCCCEECCC--CCcccC
Confidence            679999999986 689999999987643  345543

>d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Prostaglandin H2 synthase-1, EGF-like module
species: Sheep (Ovis aries) [TaxId: 9940]

Probab=86.37  E-value=0.064  Score=35.48  Aligned_cols=31  Identities=35%  Similarity=0.882  Sum_probs=23.1

Q ss_pred             cCCccCCCCCCCC--CcCCCC-CCccceeccC-CCCCC
Q 004702          281 VNECEDPSRNNCT--HICDNI-PGSYTCRCRK-GFHGD  314 (735)
Q Consensus       281 i~eC~~~~~~~c~--~~C~n~-~g~y~C~c~~-g~~~~  314 (735)
                      ||.|..   ++|.  ++|.+. .++|.|.|+. ||.|.
T Consensus         2 id~C~~---nPC~ngG~C~~~~~~~y~C~C~~~G~~G~   36 (42)
T d1q4ga2           2 VNPCCY---YPCQHQGICVRFGLDRYQCDCTRTGYSGP   36 (42)
T ss_dssp             CCGGGG---CCCCTTCEEEEETTTEEEEECTTSSEETT
T ss_pred             CccCcC---CCCCCCCEeeeCCCCCEEEECCCCCcCCc
Confidence            566763   5666  799875 6899999985 89765

>d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Plasminogen activator (urokinase-type)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=82.94  E-value=0.23  Score=30.86  Aligned_cols=26  Identities=27%  Similarity=0.469  Sum_probs=19.1

Q ss_pred             CCCCCCccCC---CCcceeeCCCCCCCCC
Q 004702          247 CDTPKDNTST---SSGYRCKCNKGYEGNP  272 (735)
Q Consensus       247 C~~~~~c~~~---~~~y~C~C~~Gy~gn~  272 (735)
                      |.++++|...   +.-.+|.|+++|+|.-
T Consensus         4 ClNGG~Cvsyk~FS~I~rC~CPk~f~G~H   32 (40)
T d2i9aa1           4 CLNGGTCVSNKYFSNIHWCNCPKKFGGQH   32 (40)
T ss_dssp             CCTTCEEEECSSSTTCEEEECCTTEESTT
T ss_pred             cccCCEEEEEehhcCCEEecCCcccCcee
Confidence            6666677643   2456899999999965